hgnc_symbol	description	keep_in_list	comments	ensembl_gene_ids	uniprot_gn_ids	Protein.families	consensus_score	generic_categories	all_categories	receptor_uniprot	receptor_symbol	receptor_references	GO_cellular_component	GO_molecular_function	GO_biological_process	genecards_url	islet_tpm	islet_tpm_rank	islet_proteomics	islet_proteomics_rank	islet_specificity	islet_specificity_rank	Immune	Duct	Endothelial	Pericytes	Acinar	INS/SST	INS/GCG	PPY	Delta	Beta	Alpha	delta_rank	beta_rank	alpha_rank	mean_scRNAseq	delta_specificity	beta_specificity	alpha_specificity	delta_specificity_rank	beta_specificity_rank	alpha_specificity_rank
	novel protein			ENSG00000268655	A0A1B0GTJ6	NA	1	ligand	ligand, secreted	P22888	LHCGR	LHCGR [Baccin2019:12727981;Baccin2019:1922095;Baccin2019:3470775]	NA	NA	NA	https://www.genecards.org/cgi-bin/carddisp.pl?gene=&keywords=	0.0564745797752809	726	NA	NA	0.1686990031878055	559	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
ACE	angiotensin I converting enzyme	No	modulator	ENSG00000159640	P12821	Peptidase M2 family	1	cell_surface_enzyme, cell_surface_ligand, receptor	cell_surface, cell_surface_enzyme, cell_surface_ligand, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, secreted, transmembrane, transmembrane_predicted	P01019, P30411, P50052	AGT, AGTR2, BDKRB2	AGT [BioGRID:23056909;Lit-BM-17:10969042;Lit-BM-17:15283675;Lit-BM-17:23056909;SIGNOR:11076943], BDKRB2 [Baccin2019:10748135;CellTalkDB:10748135;HPRD:10748135;LRdb:10748135;Lit-BM-17:17077303;connectomeDB2020:10748135], AGTR2 [Baccin2019:11459796;HPRD:11459796;LRdb:11459796]	basal plasma membrane [GO:0009925]; brush border membrane [GO:0031526]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; lysosome [GO:0005764]; plasma membrane [GO:0005886]; sperm midpiece [GO:0097225]	actin binding [GO:0003779]; bradykinin receptor binding [GO:0031711]; carboxypeptidase activity [GO:0004180]; chloride ion binding [GO:0031404]; endopeptidase activity [GO:0004175]; exopeptidase activity [GO:0008238]; heterocyclic compound binding [GO:1901363]; metallodipeptidase activity [GO:0070573]; metallopeptidase activity [GO:0008237]; mitogen-activated protein kinase binding [GO:0051019]; mitogen-activated protein kinase kinase binding [GO:0031434]; peptidyl-dipeptidase activity [GO:0008241]; tripeptidyl-peptidase activity [GO:0008240]; zinc ion binding [GO:0008270]	aging [GO:0007568]; amyloid-beta metabolic process [GO:0050435]; angiogenesis involved in coronary vascular morphogenesis [GO:0060978]; angiotensin maturation [GO:0002003]; animal organ regeneration [GO:0031100]; antigen processing and presentation of peptide antigen via MHC class I [GO:0002474]; arachidonic acid secretion [GO:0050482]; blood vessel diameter maintenance [GO:0097746]; blood vessel remodeling [GO:0001974]; bradykinin catabolic process [GO:0010815]; brain development [GO:0007420]; cell proliferation in bone marrow [GO:0071838]; cellular response to aldosterone [GO:1904045]; cellular response to glucose stimulus [GO:0071333]; eating behavior [GO:0042755]; embryo development ending in birth or egg hatching [GO:0009792]; female pregnancy [GO:0007565]; heart contraction [GO:0060047]; hematopoietic stem cell differentiation [GO:0060218]; hormone catabolic process [GO:0042447]; kidney development [GO:0001822]; lung alveolus development [GO:0048286]; male gonad development [GO:0008584]; mononuclear cell proliferation [GO:0032943]; negative regulation of calcium ion import [GO:0090281]; negative regulation of gap junction assembly [GO:1903597]; negative regulation of gene expression [GO:0010629]; negative regulation of glucose import [GO:0046325]; negative regulation of protein binding [GO:0032091]; negative regulation of renal sodium excretion [GO:0035814]; neutrophil mediated immunity [GO:0002446]; peptide catabolic process [GO:0043171]; positive regulation of apoptotic process [GO:0043065]; positive regulation of inflammatory response [GO:0050729]; positive regulation of neurogenesis [GO:0050769]; positive regulation of peptidyl-cysteine S-nitrosylation [GO:2000170]; positive regulation of peptidyl-tyrosine autophosphorylation [GO:1900086]; positive regulation of protein binding [GO:0032092]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of systemic arterial blood pressure [GO:0003084]; positive regulation of vasoconstriction [GO:0045907]; posttranscriptional regulation of gene expression [GO:0010608]; proteolysis [GO:0006508]; regulation of angiotensin metabolic process [GO:0060177]; regulation of blood pressure [GO:0008217]; regulation of hematopoietic stem cell proliferation [GO:1902033]; regulation of renal output by angiotensin [GO:0002019]; regulation of smooth muscle cell migration [GO:0014910]; regulation of systemic arterial blood pressure by renin-angiotensin [GO:0003081]; regulation of vasoconstriction [GO:0019229]; response to dexamethasone [GO:0071548]; response to hypoxia [GO:0001666]; response to laminar fluid shear stress [GO:0034616]; response to lipopolysaccharide [GO:0032496]; response to nutrient levels [GO:0031667]; response to thyroid hormone [GO:0097066]; response to xenobiotic stimulus [GO:0009410]; sensory perception of pain [GO:0019233]; spermatogenesis [GO:0007283]; vasoconstriction [GO:0042310]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=ACE&keywords=ACE	9.422505174314292	246	6933.79	82	1.099114667861902	245	0.015748031496062992	0.010978043912175646	0.0807522123893806	0.018705035971223017	0.0016835016835016834	0.023688663282571906	0.01813236627379873	0.022838499184339316	0.005549389567147615	0.014421151021498161	0.011744253428626542	285	224	242	0.020385558928211474	0.5117361705896015	0.8037091264042651	0.7156114350240926	337	210	230
ACE2	angiotensin converting enzyme 2	No		ENSG00000130234	Q9BYF1	Peptidase M2 family	2	adhesion, ligand, receptor	adhesion, cell_adhesion, cell_surface, extracellular, intracellular, ligand, plasma_membrane, plasma_membrane_transmembrane, receptor, secreted, transmembrane, transmembrane_predicted	P01019, Q495A1, Q695T7, Q9ULZ1	AGT, APLN, SLC6A19, TIGIT	AGT [HPRD:10969042;HPRD:11815627;InnateDB:10969042;IntAct:10969042;IntAct:11815627;SIGNOR:11815627], APLN [SIGNOR:11815627], SLC6A19 [IntAct:32132184;IntAct:34189428], TIGIT [Cellinker:32589946]	apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; cilium [GO:0005929]; endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]	carboxypeptidase activity [GO:0004180]; endopeptidase activity [GO:0004175]; identical protein binding [GO:0042802]; metallocarboxypeptidase activity [GO:0004181]; metallopeptidase activity [GO:0008237]; peptidyl-dipeptidase activity [GO:0008241]; virus receptor activity [GO:0001618]; zinc ion binding [GO:0008270]	angiotensin maturation [GO:0002003]; angiotensin-mediated drinking behavior [GO:0003051]; blood vessel diameter maintenance [GO:0097746]; maternal process involved in female pregnancy [GO:0060135]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of signaling receptor activity [GO:2000272]; negative regulation of smooth muscle cell proliferation [GO:0048662]; positive regulation of amino acid transport [GO:0051957]; positive regulation of cardiac muscle contraction [GO:0060452]; positive regulation of gap junction assembly [GO:1903598]; positive regulation of L-proline import across plasma membrane [GO:1905737]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; receptor-mediated virion attachment to host cell [GO:0046813]; regulation of cardiac conduction [GO:1903779]; regulation of cell population proliferation [GO:0042127]; regulation of cytokine production [GO:0001817]; regulation of inflammatory response [GO:0050727]; regulation of systemic arterial blood pressure by renin-angiotensin [GO:0003081]; regulation of transmembrane transporter activity [GO:0022898]; regulation of vasoconstriction [GO:0019229]; tryptophan transport [GO:0015827]; viral entry into host cell [GO:0046718]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=ACE2&keywords=ACE2	2.8058621382022473	346	2124.37	130	1.0597124445836892	253	0	0	0	0.01726618705035971	0.003367003367003367	0	9.066183136899365e-4	0	0	2.3367605821872085e-4	1.9316206297083252e-4	303	401	396	0.001996967895658415	0.833543949352311	0.8530218757959823	0.8496448562356858	208	190	165
ADA2	adenosine deaminase 2	No		ENSG00000093072	Q9NZK5	Metallo-dependent hydrolases superfamily, Adenosine and AMP deaminases family, ADGF subfamily	2	ligand	extracellular, intracellular, ligand, secreted	NA	NA	NA	azurophil granule lumen [GO:0035578]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	adenosine deaminase activity [GO:0004000]; adenosine receptor binding [GO:0031685]; growth factor activity [GO:0008083]; heparin binding [GO:0008201]; protein homodimerization activity [GO:0042803]; proteoglycan binding [GO:0043394]; zinc ion binding [GO:0008270]	adenosine catabolic process [GO:0006154]; inosine biosynthetic process [GO:0046103]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=ADA2&keywords=ADA2	38.47955101358123	109	NA	NA	3.161162433505948	105	0.06299212598425197	0.024950099800399184	0.00995575221238938	0.010791366906474817	0.013468013468013466	0.1455160744500844	0.10607434270172234	0.08646003262642751	0.13799482056973655	0.10128188009079893	0.06644774966196444	97	104	135	0.06963020531566028	1.858526170855314	1.3974832747155301	0.9600345667692262	38	63	113
ADAM12	ADAM metallopeptidase domain 12	No		ENSG00000148848	O43184	NA	1	adhesion, cell_surface_enzyme, cell_surface_ligand	adhesion, cell_adhesion, cell_surface, cell_surface_enzyme, cell_surface_ligand, ecm_regulator, intracellular, plasma_membrane, plasma_membrane_transmembrane, secreted, transmembrane, transmembrane_predicted	P01133, P05556, P12931, P31431, P42336, Q13797	EGF, ITGA9, ITGB1, PIK3CA, SDC4, SRC	SDC4 [Adhesome:12509413;CellTalkDB:12509413;LRdb:12509413;SIGNOR:12509413;connectomeDB2020:12509413], SRC [Adhesome:11127814;HPRD:11127814], PIK3CA [Adhesome:11313349], ITGB1 [Adhesome:15242759;CellTalkDB:10944520;LRdb:10944520;connectomeDB2020:10944520], ITGA9 [CellTalkDB:10944520;LRdb:10944520;connectomeDB2020:10944520], EGF [HPRD:11786904]	extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; SH3 domain binding [GO:0017124]	cell adhesion [GO:0007155]; myoblast fusion [GO:0007520]; positive regulation of angiogenesis [GO:0045766]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=ADAM12&keywords=ADAM12	3.2351247516853934	330	NA	NA	1.9748710179594415	158	0	0.11526946107784418	0.00663716814159292	0.1952038369304565	0.011784511784511783	0.023688663282571906	0.022665457842248413	0.011419249592169658	0.035516093229744694	0.008746161036186386	0.013675874058334826	196	250	236	0.04041877063415102	0.9027608697565999	0.3718091655231419	0.4695845170468721	182	352	338
ADAM17	ADAM metallopeptidase domain 17	No		ENSG00000151694	P78536	NA	1	adhesion, cell_surface_enzyme, cell_surface_ligand	adhesion, cell_adhesion, cell_surface, cell_surface_enzyme, cell_surface_ligand, ecm_regulator, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, secreted, transmembrane, transmembrane_predicted	O14944, P01135, P01375, P05067, P05556, P07359, P08581, P08648, P08887, P15514, P15941, P46531, Q15303, Q6PJF5, Q99075	APP, AREG, ERBB4, EREG, GP1BA, HBEGF, IL6R, ITGA5, ITGB1, MET, MUC1, NOTCH1, RHBDF2, TGFA, TNF	AREG [SIGNOR:26284334], MUC1 [CellTalkDB:12441351;SIGNOR:12441351], NOTCH1 [ACSN:19601831;ACSN:19704010;ACSN:19726682;CellTalkDB:10882063;Cellinker:10882063;Cellinker:9620803;HPRD-phos:10882063;HPRD-phos:9620803;HPRD:10882063;HPRD:9620803;LRdb:10882063;LRdb:96;SIGNOR:10882063;connectomeDB2020:10882063;connectomeDB2020:9620803], EREG [SIGNOR:26284334], TGFA [HPRD:11823465;SIGNOR:26284334], TNF [HPRD-phos:10799478;HPRD-phos:12135369;HPRD:10799478;HPRD:12135369;SIGNOR:9034190], APP [SIGNOR:9774383], GP1BA [SIGNOR:25297919], HBEGF [ACSN:16054021;ACSN:18372913;SIGNOR:26284334], ITGB1 [CellTalkDB:14970227;IntAct:22413019;IntAct:30455686;LRdb:14970227;connectomeDB2020:14970227], RHBDF2 [CellTalkDB:28104813], IL6R [CellTalkDB:22575642;InnateDB:24790088], MET [CellTalkDB:22689693], ERBB4 [Baccin2019:15534001;CellTalkDB:26554003;HPRD:15534001;LRdb:15534001;ProtMapper:10744726;ProtMapper:15746097;ProtMapper:17486069;ProtMapper:9685416], ITGA5 [CellTalkDB:14970227;LRdb:14970227;connectomeDB2020:14970227]	actin cytoskeleton [GO:0015629]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum lumen [GO:0005788]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]	endopeptidase activity [GO:0004175]; integrin binding [GO:0005178]; interleukin-6 receptor binding [GO:0005138]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metalloendopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902945]; metallopeptidase activity [GO:0008237]; Notch binding [GO:0005112]; PDZ domain binding [GO:0030165]; peptidase activity [GO:0008233]; SH3 domain binding [GO:0017124]	amyloid precursor protein catabolic process [GO:0042987]; B cell differentiation [GO:0030183]; cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cell motility [GO:0048870]; cellular response to high density lipoprotein particle stimulus [GO:0071403]; defense response to Gram-positive bacterium [GO:0050830]; epidermal growth factor receptor signaling pathway [GO:0007173]; germinal center formation [GO:0002467]; membrane protein ectodomain proteolysis [GO:0006509]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; neutrophil mediated immunity [GO:0002446]; Notch receptor processing [GO:0007220]; Notch signaling pathway [GO:0007219]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cellular component movement [GO:0051272]; positive regulation of chemokine production [GO:0032722]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of epidermal growth factor-activated receptor activity [GO:0045741]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of leukocyte chemotaxis [GO:0002690]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of T cell chemotaxis [GO:0010820]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; positive regulation of tumor necrosis factor-mediated signaling pathway [GO:1903265]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; protein processing [GO:0016485]; proteolysis [GO:0006508]; receptor transactivation [GO:0035624]; regulation of mast cell apoptotic process [GO:0033025]; response to hypoxia [GO:0001666]; response to lipopolysaccharide [GO:0032496]; response to xenobiotic stimulus [GO:0009410]; spleen development [GO:0048536]; T cell differentiation in thymus [GO:0033077]; wound healing, spreading of epidermal cells [GO:0035313]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=ADAM17&keywords=ADAM17	23.23813452735503	161	1738.32	137	2.207756680797452	142	0.13385826771653542	0.16217564870259557	0.1294247787610621	0.10863309352518088	0.12289562289562306	0.14382402707275788	0.13417951042611026	0.07504078303425782	0.09027007029226762	0.09206836693817623	0.06911338613096178	134	111	133	0.11468032322686623	0.8042172790153733	0.8186405384308664	0.6345298446733121	221	202	269
ADAM23	ADAM metallopeptidase domain 23	No		ENSG00000114948	O75077	NA	1	adhesion, cell_surface_enzyme, cell_surface_ligand, receptor	adhesion, cell_adhesion, cell_surface, cell_surface_enzyme, cell_surface_ligand, ecm_regulator, extracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, secreted, transmembrane, transmembrane_predicted	P05106, P08648, P13612	ITGA4, ITGA5, ITGB3	ITGA4 [connectomeDB2020:28913673], ITGA5 [LRdb:10749942;connectomeDB2020:10749942], ITGB3 [LRdb:10749942;connectomeDB2020:10749942]	extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of presynaptic membrane [GO:0099056]; plasma membrane [GO:0005886]	integrin binding [GO:0005178]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]	cell adhesion [GO:0007155]; cellular response to leukemia inhibitory factor [GO:1990830]; central nervous system development [GO:0007417]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=ADAM23&keywords=ADAM23	1.2523511258426967	427	NA	NA	0.17375036391390833	553	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
ADAM28	ADAM metallopeptidase domain 28	No		ENSG00000042980	Q9UKQ2	NA	1	adhesion, cell_surface_enzyme, cell_surface_ligand, receptor	adhesion, cell_adhesion, cell_surface, cell_surface_enzyme, cell_surface_ligand, ecm_regulator, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, secreted, transmembrane, transmembrane_predicted	P13612	ITGA4	ITGA4 [CellTalkDB:11724793;HPRD:11724793;LRdb:11724793;connectomeDB2020:11724793]	extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]	endopeptidase activity [GO:0004175]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]	spermatogenesis [GO:0007283]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=ADAM28&keywords=ADAM28	5.493158071327743	286	NA	NA	1.9682842118517747	161	0.09448818897637795	0.011976047904191614	0	0	0.003367003367003367	0	0	0	0	0	0	303	409	401	0.009984658204324813	0.5003838393311092	0.5003838393311092	0.5003838393311092	341	321	327
ADAM9	ADAM metallopeptidase domain 9	No		ENSG00000282230, ENSG00000168615	Q13443	NA	1	adhesion, cell_surface_enzyme, cell_surface_ligand, receptor	adhesion, cell_adhesion, cell_surface, cell_surface_enzyme, cell_surface_ligand, ecm_regulator, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, secreted, transmembrane, transmembrane_predicted	P05556, P06756, P18084, P21802, P23229, P26006	FGFR2, ITGA3, ITGA6, ITGAV, ITGB1, ITGB5	FGFR2 [SIGNOR:22632802], ITGA3 [CellTalkDB:15361064;HPRD:15361064;LRdb:15361064;connectomeDB2020:15361064], ITGAV [CellTalkDB:11162558;HPMR:11162558;HPRD:15361064;LRdb:11162558;LRdb:15;connectomeDB2020:11162558;connectomeDB2020:15361064], ITGB5 [CellTalkDB:11162558;HPMR:11162558;LRdb:11162558;connectomeDB2020:11162558], ITGB1 [CellTalkDB:10825303;LRdb:10825303;connectomeDB2020:10825303], ITGA6 [CellTalkDB:10825303;HPRD:15361064;LRdb:10825303;LRdb:15;connectomeDB2020:10825303;connectomeDB2020:15361064]	cell surface [GO:0009986]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; intrinsic component of external side of plasma membrane [GO:0031233]	collagen binding [GO:0005518]; integrin binding [GO:0005178]; laminin binding [GO:0043236]; metal ion binding [GO:0046872]; metalloendopeptidase activity [GO:0004222]; metalloendopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902945]; metallopeptidase activity [GO:0008237]; protein kinase C binding [GO:0005080]; SH3 domain binding [GO:0017124]	amyloid precursor protein catabolic process [GO:0042987]; cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cell-cell adhesion mediated by integrin [GO:0033631]; cell-matrix adhesion [GO:0007160]; cell migration [GO:0016477]; cellular response to lipopolysaccharide [GO:0071222]; integrin-mediated signaling pathway [GO:0007229]; keratinocyte differentiation [GO:0030216]; membrane protein ectodomain proteolysis [GO:0006509]; membrane protein intracellular domain proteolysis [GO:0031293]; monocyte activation [GO:0042117]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cell migration [GO:0030335]; positive regulation of keratinocyte migration [GO:0051549]; positive regulation of macrophage fusion [GO:0034241]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; positive regulation of protein secretion [GO:0050714]; protein processing [GO:0016485]; response to calcium ion [GO:0051592]; response to glucocorticoid [GO:0051384]; response to hydrogen peroxide [GO:0042542]; response to manganese ion [GO:0010042]; response to tumor necrosis factor [GO:0034612]; transforming growth factor beta receptor signaling pathway [GO:0007179]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=ADAM9&keywords=ADAM9	115.66810449647755	44	NA	NA	4.079109372291703	88	0.3307086614173226	0.8143712574850288	0.08296460176991159	0.28944844124700414	0.3265993265993263	0.15905245346869698	0.18585675430643647	0.12398042414355646	0.1387347391786897	0.0897983709440517	0.14019702530422382	96	114	89	0.24379200507856805	0.5860497423181039	0.39322897864003425	0.5918114924767877	304	347	287
ADAMTS3	ADAM metallopeptidase with thrombospondin type 1 motif 3	No		ENSG00000156140	O15072	NA	1	ecm, ligand, receptor, secreted_enzyme	ecm, ecm_regulator, extracellular, intracellular, ligand, receptor, secreted, secreted_enzyme, secreted_peptidase	Q6UXH8	CCBE1	CCBE1 [CellTalkDB:27159393]	extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	endopeptidase activity [GO:0004175]; heparin binding [GO:0008201]; metalloendopeptidase activity [GO:0004222]; zinc ion binding [GO:0008270]	collagen biosynthetic process [GO:0032964]; collagen catabolic process [GO:0030574]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; in utero embryonic development [GO:0001701]; positive regulation of vascular endothelial growth factor signaling pathway [GO:1900748]; protein processing [GO:0016485]; supramolecular fiber organization [GO:0097435]; vascular endothelial growth factor production [GO:0010573]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=ADAMTS3&keywords=ADAMTS3	0.414652027266259	542	NA	NA	0.36605255778349655	435	0	4.99001996007984e-4	0.0022123893805309734	0.029016786570743396	0.0016835016835016834	0	0	0	0	0	1.1589723778249952e-4	303	409	398	0.003047961533506049	0.7664032404081554	0.7664032404081554	0.7752856422672415	235	228	202
ADCYAP1	adenylate cyclase activating polypeptide 1	Yes	also known as PACAP	ENSG00000141433	P18509	Glucagon family	15	ligand	extracellular, intracellular, ligand, secreted	O60895, O60896, P07550, P13945, P16473, P27487, P32241, P41586, P41587, P47872, Q03431, Q99678, Q9NQS5	ADCYAP1R1, ADRB2, ADRB3, DPP4, GPR20, GPR84, PTH1R, RAMP2, RAMP3, SCTR, TSHR, VIPR1, VIPR2	ADCYAP1R1 [Baccin2019:10100920;Baccin2019:10583729;Baccin2019:11931347;Baccin2019:16930633;Baccin2019:8253796;Baccin2019:8703026;CellChatDB:21350482;CellTalkDB:10100920;Cellinker:10100920;Cellinker:10583729;Cellinker:11931347;Cellinker:12488235;Cellinker:16930633;Cellinker:21350482;Cellinker:8253796;Cellinker:8703026;DIP:17470806;Guide2Pharma:10583729;Guide2Pharma:11931347;Guide2Pharma:16930633;HPMR:10100920;HPRD:10583729;HPRD:8253796;LRdb:10100920;LRdb:10583729;LRdb:11931347;LRdb:16930633;LRdb:8253796;LRdb:8703026;SIGNOR:8703026;connectomeDB2020:10100920;connectomeDB2020:10583729;connectomeDB2020:11931347;connectomeDB2020:16930633;connectomeDB2020:8253796;connectomeDB2020:8703026;scConnect:10583729;scConnect:11931347;scConnect:16930633], VIPR1 [Baccin2019:11897681;Baccin2019:11931347;Baccin2019:12429744;Baccin2019:16930633;Baccin2019:8791009;Baccin2019:9928018;CellTalkDB:11897681;Cellinker:11897681;Cellinker:11931347;Cellinker:12429744;Cellinker:12488235;Cellinker:16930633;Cellinker:8791009;Cellinker:9928018;Guide2Pharma:11931347;Guide2Pharma:16930633;Guide2Pharma:8791009;Guide2Pharma:9928018;HPRD:12429744;LRdb:11897681;LRdb:11931347;LRdb:12429744;LRdb:16930633;LRdb:8791009;LRdb:9928018;SIGNOR:11897681;connectomeDB2020:11897681;connectomeDB2020:11931347;connectomeDB2020:12429744;connectomeDB2020:16930633;connectomeDB2020:8791009;connectomeDB2020:9928018;scConnect:11931347;scConnect:16930633;scConnect:8791009;scConnect:9928018], VIPR2 [Baccin2019:11931347;Baccin2019:11978642;Baccin2019:16930633;Baccin2019:8146174;Baccin2019:9928018;CellTalkDB:9928018;Cellinker:11931347;Cellinker:11978642;Cellinker:12488235;Cellinker:16930633;Cellinker:8146174;Cellinker:9928018;Guide2Pharma:11931347;Guide2Pharma:11978642;Guide2Pharma:16930633;Guide2Pharma:9928018;HPRD:8146174;LRdb:11931347;LRdb:11978642;LRdb:16930633;LRdb:8146174;LRdb:9928018;connectomeDB2020:11931347;connectomeDB2020:11978642;connectomeDB2020:16930633;connectomeDB2020:8146174;connectomeDB2020:9928018;scConnect:11931347;scConnect:11978642;scConnect:16930633;scConnect:9928018], SCTR [Baccin2019:1335692;CellTalkDB:1335692;HPRD:1335692;LRdb:1335692;connectomeDB2020:1335692], RAMP3 [CellTalkDB:23745705], RAMP2 [CellTalkDB:23745705], ADRB2 [CellTalkDB:32196115], PTH1R [CellTalkDB:32196115], ADRB3 [CellTalkDB:32196115], DPP4 [Cellinker:21314817], GPR20 [CellTalkDB:32196115], TSHR [CellTalkDB:32196115], GPR84 [CellTalkDB:32196115]	extracellular region [GO:0005576]; neuron projection [GO:0043005]; perikaryon [GO:0043204]	neuropeptide hormone activity [GO:0005184]; peptide hormone receptor binding [GO:0051428]; pituitary adenylate cyclase activating polypeptide activity [GO:0016521]; pituitary adenylate cyclase-activating polypeptide receptor binding [GO:0031858]; signaling receptor binding [GO:0005102]	activation of adenylate cyclase activity [GO:0007190]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cAMP-mediated signaling [GO:0019933]; cell-cell signaling [GO:0007267]; female pregnancy [GO:0007565]; insulin secretion [GO:0030073]; negative regulation of cell cycle [GO:0045786]; neuron projection development [GO:0031175]; neuropeptide signaling pathway [GO:0007218]; positive regulation of chemokine (C-C motif) ligand 5 production [GO:0071651]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of growth hormone secretion [GO:0060124]; positive regulation of GTPase activity [GO:0043547]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of protein localization [GO:0032880]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=ADCYAP1&keywords=ADCYAP1	55.515113831460674	77	3590.02	104	30.28751197716063	21	0.007874015748031496	0.09830339321357277	0.0055309734513274336	0.013669064748201435	0.0723905723905724	0.896785109983079	1.226654578422489	0.11092985318107676	0.019977802441731404	1.1983575911339284	0.02997875217307328	235	25	183	0.3345865188079167	0.08699644590112933	3.5066885243049937	0.1160194900003	482	4	466
ADGRB1	adhesion G protein-coupled receptor B1	No		ENSG00000181790	O14514	G-protein coupled receptor 2 family, LN-TM7 subfamily	1	adhesion, cell_surface_ligand, receptor	adhesion, cell_adhesion, cell_surface, cell_surface_ligand, extracellular, intracellular, matrix_adhesion, plasma_membrane, plasma_membrane_transmembrane, receptor, secreted, transmembrane	Q86UN2, Q86UN3, Q9BZR6	RTN4R, RTN4RL1, RTN4RL2	RTN4R [connectomeDB2020:30477585], RTN4RL1 [connectomeDB2020:30477585], RTN4RL2 [connectomeDB2020:30477585]	cell-cell junction [GO:0005911]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; perinuclear region of cytoplasm [GO:0048471]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]	G protein-coupled receptor activity [GO:0004930]; lipopolysaccharide binding [GO:0001530]; PDZ domain binding [GO:0030165]; phosphatidylserine binding [GO:0001786]	adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; apoptotic cell clearance [GO:0043277]; axonogenesis [GO:0007409]; cell adhesion [GO:0007155]; cell surface receptor signaling pathway [GO:0007166]; defense response to Gram-negative bacterium [GO:0050829]; engulfment of apoptotic cell [GO:0043652]; G protein-coupled receptor signaling pathway [GO:0007186]; innate immune response [GO:0045087]; muscle organ development [GO:0007517]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of protein ubiquitination [GO:0031397]; peripheral nervous system development [GO:0007422]; phagocytosis, recognition [GO:0006910]; positive regulation of myoblast fusion [GO:1901741]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of synapse assembly [GO:0051965]; regulation of synaptic plasticity [GO:0048167]; signal transduction [GO:0007165]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=ADGRB1&keywords=ADGRB1	0.06869602471910112	699	NA	NA	0.008011597964571368	848	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
ADGRE5	adhesion G protein-coupled receptor E5	No		ENSG00000123146	P48960	G-protein coupled receptor 2 family, LN-TM7 subfamily	1	adhesion, cell_surface_ligand, ligand, receptor	adhesion, cell_adhesion, cell_surface, cell_surface_ligand, extracellular, intracellular, ligand, matrix_adhesion, plasma_membrane, plasma_membrane_transmembrane, receptor, secreted, transmembrane	P08174	CD55	CD55 [Baccin2019:23447688;CellChatDB:11297558;HPMR:12417446;HPRD:10540231;connectomeDB2020:23447688]	extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]	calcium ion binding [GO:0005509]; G protein-coupled receptor activity [GO:0004930]; transmembrane signaling receptor activity [GO:0004888]	adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell adhesion [GO:0007155]; cell-cell signaling [GO:0007267]; cell surface receptor signaling pathway [GO:0007166]; G protein-coupled receptor signaling pathway [GO:0007186]; immune response [GO:0006955]; inflammatory response [GO:0006954]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=ADGRE5&keywords=ADGRE5	11.129005567500968	230	3097.51	112	0.22508614053475967	515	0.03937007874015748	0.16217564870259535	0.011061946902654867	0.11031175059952142	0.20875420875420866	0.001692047377326565	9.066183136899365e-4	0.0016313213703099511	0.0014798372179060304	0.0010348511149686208	8.112806644774968e-4	299	370	375	0.04902087179616513	0.19450470432820563	0.18696523414765298	0.1831772445147101	439	420	429
ADIPOQ	adiponectin, C1Q and collagen domain containing	Yes		ENSG00000181092	Q15848	NA	16	ecm, ligand	ecm, extracellular, intracellular, ligand, secreted	O15529, P07307, P34972, Q86V24, Q8NFJ6, Q8TDT2, Q96A54, Q9UHP7	ADIPOR1, ADIPOR2, ASGR2, CLEC2D, CNR2, GPR152, GPR42, PROKR2	ADIPOR2 [Baccin2019:12802330;Baccin2019:12802337;CellChatDB:21284979;CellTalkDB:12802337;Cellinker:12802337;Cellinker:21284979;HPRD:12802337;LRdb:12802337;SIGNOR:12802337;SIGNOR:16622416;connectomeDB2020:12802337], ADIPOR1 [Baccin2019:12802337;CellChatDB:21284979;CellTalkDB:12802337;Cellinker:12802337;Cellinker:21284979;HPMR:12802337;LRdb:12802337;SIGNOR:16622416;connectomeDB2020:12802337], GPR42 [CellTalkDB:32103204], CNR2 [CellTalkDB:32103204], ASGR2 [NA], PROKR2 [NA], CLEC2D [NA], GPR152 [NA]	cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; collagen trimer [GO:0005581]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	cytokine activity [GO:0005125]; hormone activity [GO:0005179]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; sialic acid binding [GO:0033691]; signaling receptor binding [GO:0005102]	brown fat cell differentiation [GO:0050873]; cellular response to cAMP [GO:0071320]; cellular response to epinephrine stimulus [GO:0071872]; cellular response to insulin stimulus [GO:0032869]; cellular response to xenobiotic stimulus [GO:0071466]; circadian rhythm [GO:0007623]; detection of oxidative stress [GO:0070994]; fatty acid beta-oxidation [GO:0006635]; fatty acid oxidation [GO:0019395]; gene expression [GO:0010467]; generation of precursor metabolites and energy [GO:0006091]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; low-density lipoprotein particle clearance [GO:0034383]; negative regulation of blood pressure [GO:0045776]; negative regulation of cell migration [GO:0030336]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of DNA biosynthetic process [GO:2000279]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of gluconeogenesis [GO:0045721]; negative regulation of granulocyte differentiation [GO:0030853]; negative regulation of heterotypic cell-cell adhesion [GO:0034115]; negative regulation of hormone secretion [GO:0046888]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of inflammatory response [GO:0050728]; negative regulation of intracellular protein transport [GO:0090317]; negative regulation of low-density lipoprotein receptor activity [GO:1905598]; negative regulation of macrophage derived foam cell differentiation [GO:0010745]; negative regulation of macrophage differentiation [GO:0045650]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of metanephric mesenchymal cell migration [GO:2000590]; negative regulation of phagocytosis [GO:0050765]; negative regulation of platelet-derived growth factor receptor-alpha signaling pathway [GO:2000584]; negative regulation of platelet-derived growth factor receptor signaling pathway [GO:0010642]; negative regulation of protein autophosphorylation [GO:0031953]; negative regulation of receptor binding [GO:1900121]; negative regulation of synaptic transmission [GO:0050805]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of tumor necrosis factor-mediated signaling pathway [GO:0010804]; negative regulation of tumor necrosis factor production [GO:0032720]; negative regulation of vascular associated smooth muscle cell migration [GO:1904753]; negative regulation of vascular associated smooth muscle cell proliferation [GO:1904706]; positive regulation of cAMP-dependent protein kinase activity [GO:2000481]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of fatty acid metabolic process [GO:0045923]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen (starch) synthase activity [GO:2000467]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of lipid transporter activity [GO:0110113]; positive regulation of metanephric glomerular visceral epithelial cell development [GO:2000478]; positive regulation of monocyte chemotactic protein-1 production [GO:0071639]; positive regulation of myeloid cell apoptotic process [GO:0033034]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein kinase A signaling [GO:0010739]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of renal albumin absorption [GO:2000534]; positive regulation of signal transduction [GO:0009967]; protein localization to plasma membrane [GO:0072659]; regulation of glucose metabolic process [GO:0010906]; response to activity [GO:0014823]; response to bacterium [GO:0009617]; response to ethanol [GO:0045471]; response to glucocorticoid [GO:0051384]; response to glucose [GO:0009749]; response to hypoxia [GO:0001666]; response to linoleic acid [GO:0070543]; response to nutrient [GO:0007584]; response to sucrose [GO:0009744]; response to tumor necrosis factor [GO:0034612]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=ADIPOQ&keywords=ADIPOQ	0.032100158378520045	766	NA	NA	0.0016987128203338245	891	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
ADM	adrenomedullin	Yes		ENSG00000148926	P35318	Adrenomedullin family	15	ligand	extracellular, intracellular, ligand, secreted	O15218, O60894, O60895, O60896, P07550, P13945, P16473, P25106, P30988, P32241, P41586, Q03431, Q16602, Q96LB1, Q99678, Q9C098, Q9NQS5	ACKR3, ADCYAP1R1, ADRB2, ADRB3, CALCR, CALCRL, CALCRL_RAMP2, DCLK3, GPR182, GPR20, GPR84, MRGPRX2, PTH1R, RAMP1, RAMP2, RAMP3, TSHR, VIPR1	CALCRL [CellTalkDB:9620797;Cellinker:9620797;Guide2Pharma:10347248;Guide2Pharma:11693189;Guide2Pharma:9620797;HPRD:9620797;LRdb:9620797;connectomeDB2020:9620797;scConnect:10347248;scConnect:11693189;scConnect:9620797], RAMP2 [CellTalkDB:9620797;Cellinker:30139742;Cellinker:9620797;Guide2Pharma:11693189;Guide2Pharma:12565884;Guide2Pharma:9620797;HPMR:9620797;LRdb:9620797;connectomeDB2020:9620797], RAMP3 [CellTalkDB:14712479;Cellinker:27391260;Guide2Pharma:10347248;Guide2Pharma:11693189;Guide2Pharma:12565884;Guide2Pharma:15692146;connectomeDB2020:30139742], CALCR [Baccin2019:12565884;Baccin2019:15692146;CellTalkDB:10781016;Cellinker:12565884;Cellinker:15692146;Guide2Pharma:12565884;Guide2Pharma:15692146;LRdb:13;LRdb:15692146;connectomeDB2020:12565884;connectomeDB2020:15692146;scConnect:12565884;scConnect:15692146], RAMP1 [CellTalkDB:15361343;Cellinker:30139742;Guide2Pharma:11693189;Guide2Pharma:12565884;Guide2Pharma:15692146;Guide2Pharma:9620797], MRGPRX2 [Baccin2019:1611167315823560;Cellinker:15823563;Cellinker:16111673;Guide2Pharma:15823563;LRdb:16;LRdb:16111673;connectomeDB2020:15823563;connectomeDB2020:16111673;scConnect:15823563], ADCYAP1R1 [CellTalkDB:32196115], TSHR [CellTalkDB:32196115], GPR84 [CellTalkDB:32196115], GPR182 [CellTalkDB:7592696;Cellinker:7592696;HPMR:7592696;LRdb:7592696], ADRB2 [CellTalkDB:32196115], PTH1R [CellTalkDB:32196115], VIPR1 [CellTalkDB:32196115], ADRB3 [CellTalkDB:32196115], GPR20 [CellTalkDB:32196115], DCLK3 [Cellinker:30139742], ACKR3 [Cellinker:29637711]	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	adrenomedullin receptor binding [GO:0031700]; hormone activity [GO:0005179]; signaling receptor binding [GO:0005102]	adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adrenomedullin receptor signaling pathway [GO:1990410]; aging [GO:0007568]; amylin receptor signaling pathway [GO:0097647]; androgen metabolic process [GO:0008209]; animal organ regeneration [GO:0031100]; antibacterial humoral response [GO:0019731]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; branching involved in labyrinthine layer morphogenesis [GO:0060670]; cAMP-mediated signaling [GO:0019933]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; developmental growth [GO:0048589]; female pregnancy [GO:0007565]; G protein-coupled receptor internalization [GO:0002031]; heart development [GO:0007507]; hormone secretion [GO:0046879]; inflammatory response [GO:0006954]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of vascular permeability [GO:0043116]; negative regulation of vasoconstriction [GO:0045906]; neural tube closure [GO:0001843]; neuron projection regeneration [GO:0031102]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of angiogenesis [GO:0045766]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of heart rate [GO:0010460]; positive regulation of progesterone biosynthetic process [GO:2000184]; positive regulation of vasculogenesis [GO:2001214]; receptor internalization [GO:0031623]; regulation of systemic arterial blood pressure [GO:0003073]; regulation of the force of heart contraction [GO:0002026]; regulation of urine volume [GO:0035809]; response to cold [GO:0009409]; response to glucocorticoid [GO:0051384]; response to hypoxia [GO:0001666]; response to insulin [GO:0032868]; response to lipopolysaccharide [GO:0032496]; response to starvation [GO:0042594]; response to wounding [GO:0009611]; signal transduction [GO:0007165]; spongiotrophoblast layer development [GO:0060712]; vascular associated smooth muscle cell development [GO:0097084]; vasculogenesis [GO:0001570]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=ADM&keywords=ADM	25.238527450180136	151	NA	NA	0.41776414124766864	409	0.6692913385826769	0.29740518962076123	0.17035398230088517	0.1772182254196646	0.14309764309764322	0.213197969543147	0.18766999093381645	0.36704730831973925	0.15057343692193803	0.18657364134062598	0.11435194127872944	91	81	103	0.24334369703269337	0.6338165851476322	0.7759168419937388	0.490842846043579	291	220	331
ADM2	adrenomedullin 2	Yes		ENSG00000128165	Q7Z4H4	Adrenomedullin family	13	ligand	extracellular, ligand, secreted	O60894, O60895, O60896, P07550, P13945, P16473, P30988, P32241, P41586, Q03431, Q16602, Q99678, Q9C098, Q9NQS5	ADCYAP1R1, ADRB2, ADRB3, CALCR, CALCRL, DCLK3, GPR20, GPR84, PTH1R, RAMP1, RAMP2, RAMP3, TSHR, VIPR1	CALCRL [Baccin2019:14615490;CellTalkDB:14615490;Cellinker:14615490;Guide2Pharma:21658025;LRdb:14615490;connectomeDB2020:14615490;scConnect:21658025], RAMP2 [CellTalkDB:32196115;Cellinker:20596793;Guide2Pharma:21658025;connectomeDB2020:30139743], RAMP3 [CellTalkDB:27013657;Cellinker:20596793;Guide2Pharma:21658025;connectomeDB2020:30139742], CALCR [Baccin2019:15692146;CellTalkDB:15692146;Guide2Pharma:15692146;Guide2Pharma:21658025;LRdb:15692146;connectomeDB2020:15692146;scConnect:15692146;scConnect:21658025], RAMP1 [Baccin2019:12684503;CellTalkDB:12684503;Cellinker:12684503;Cellinker:30139742;Guide2Pharma:21658025;LRdb:12684503;connectomeDB2020:12684503], ADCYAP1R1 [CellTalkDB:32196115], TSHR [CellTalkDB:32196115], GPR84 [CellTalkDB:32196115], ADRB2 [CellTalkDB:32196115], PTH1R [CellTalkDB:32196115], VIPR1 [CellTalkDB:32196115], ADRB3 [CellTalkDB:32196115], GPR20 [CellTalkDB:32196115], DCLK3 [Cellinker:30139742]	extracellular region [GO:0005576]	hormone activity [GO:0005179]; protein-containing complex binding [GO:0044877]	adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; angiogenesis [GO:0001525]; digestion [GO:0007586]; feeding behavior [GO:0007631]; negative regulation of blood pressure [GO:0045776]; positive regulation of angiogenesis [GO:0045766]; positive regulation of gene expression [GO:0010628]; protein phosphorylation [GO:0006468]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=ADM2&keywords=ADM2	1.2120437189494129	433	NA	NA	0.7894387216636435	301	0	0.018463073852295397	0.0022123893805309734	0.001199040767386091	0.03703703703703703	0.011844331641285955	0.012692656391659111	0.0016313213703099511	0.0036995930447650763	0.015489384430498025	0.0033996523082866553	292	220	310	0.009788043656732207	0.6923166980230638	1.2881204869297995	0.6771590229298832	266	78	244
ADO	2-aminoethanethiol dioxygenase			ENSG00000181915	Q96SZ5	NA	1	ligand	intracellular, ligand, secreted	P0DMS8, P29274, P29275, P30542	ADORA1, ADORA2A, ADORA2B, ADORA3	ADORA3 [Cellinker:23994158], ADORA2B [Cellinker:23994158], ADORA1 [Cellinker:23994158], ADORA2A [Cellinker:23994158]	cytosol [GO:0005829]	cysteamine dioxygenase activity [GO:0047800]; metal ion binding [GO:0046872]	NA	https://www.genecards.org/cgi-bin/carddisp.pl?gene=ADO&keywords=ADO	10.149853820224719	235	6752.3	85	0.6898568129076285	322	0	0.04740518962075843	0.021017699115044253	0.04820143884892085	0.021885521885521883	0.07275803722504232	0.0589301903898458	0.019575856443719414	0.02034776174620791	0.04169448524502693	0.01734595325478066	233	157	216	0.0335601939795335	0.6966856428707968	1.1867368007891628	0.6277739090792157	263	96	272
AGER	advanced glycosylation end-product specific receptor	No		ENSG00000231268, ENSG00000229058, ENSG00000230514, ENSG00000237405, ENSG00000206320, ENSG00000234729, ENSG00000204305	Q15109	NA	1	adhesion, ligand, receptor	adhesion, cell_adhesion, cell_surface, extracellular, intracellular, ligand, matrix_adhesion, plasma_membrane, plasma_membrane_transmembrane, receptor, secreted, transmembrane	P01106, P05412, P14635, Q86T13	CCNB1, CLEC14A, JUN, MYC	CLEC14A [Cellinker:32589946], JUN [HPRD:10421840], MYC [HPRD:10421840], CCNB1 [HPRD:10421840]	apical plasma membrane [GO:0016324]; cell junction [GO:0030054]; cell surface [GO:0009986]; extracellular region [GO:0005576]; fibrillar center [GO:0001650]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]	advanced glycation end-product receptor activity [GO:0050785]; amyloid-beta binding [GO:0001540]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; S100 protein binding [GO:0044548]; scavenger receptor activity [GO:0005044]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]	astrocyte activation [GO:0048143]; cell surface receptor signaling pathway [GO:0007166]; cellular response to amyloid-beta [GO:1904646]; glucose mediated signaling pathway [GO:0010255]; induction of positive chemotaxis [GO:0050930]; inflammatory response [GO:0006954]; learning or memory [GO:0007611]; microglial cell activation [GO:0001774]; modulation of age-related behavioral decline [GO:0090647]; negative regulation of blood circulation [GO:1903523]; negative regulation of interleukin-10 production [GO:0032693]; negative regulation of long-term synaptic depression [GO:1900453]; negative regulation of long-term synaptic potentiation [GO:1900272]; neuron projection development [GO:0031175]; positive regulation of activated T cell proliferation [GO:0042104]; positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902961]; positive regulation of chemokine production [GO:0032722]; positive regulation of dendritic cell differentiation [GO:2001200]; positive regulation of endothelin production [GO:1904472]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of heterotypic cell-cell adhesion [GO:0034116]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of JNK cascade [GO:0046330]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of monocyte chemotactic protein-1 production [GO:0071639]; positive regulation of monocyte extravasation [GO:2000439]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of tumor necrosis factor production [GO:0032760]; protein localization to membrane [GO:0072657]; regulation of CD4-positive, alpha-beta T cell activation [GO:2000514]; regulation of DNA binding [GO:0051101]; regulation of inflammatory response [GO:0050727]; regulation of long-term synaptic potentiation [GO:1900271]; regulation of NIK/NF-kappaB signaling [GO:1901222]; regulation of p38MAPK cascade [GO:1900744]; regulation of spontaneous synaptic transmission [GO:0150003]; regulation of synaptic plasticity [GO:0048167]; regulation of T cell mediated cytotoxicity [GO:0001914]; response to amyloid-beta [GO:1904645]; response to hypoxia [GO:0001666]; response to wounding [GO:0009611]; transcytosis [GO:0045056]; transport across blood-brain barrier [GO:0150104]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=AGER&keywords=AGER	0.22919369413309887	604	NA	NA	0.006971133954758281	854	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
AGRN	agrin	No	manually added ensembl_gene_ID, hgnc_symbol, and description by searching the uniprot ID on genenames.org	ENSG00000188157	O00468	NA	1	cell_surface_ligand, ecm	cell_surface, cell_surface_ligand, ecm, extracellular, intracellular, receptor_regulator, secreted, transmembrane	O15146, O75096, P05556, P13637, P98164, Q05901, Q07954, Q14118	ATP1A3, CHRNB3, DAG1, ITGB1, LRP1, LRP2, LRP4, MUSK	MUSK [Baccin2019:8653787;CellTalkDB:8653787;Cellinker:8653787;HPMR:8653787;LRdb:8653787;SignaLink3:18848351;SignaLink3:23331499;connectomeDB2020:8653787], CHRNB3 [SIGNOR:14502292], ITGB1 [CellTalkDB:9367446], ATP1A3 [LRdb:16630822;Ramilowski2015:16630822;connectomeDB2020:16630822;talklr:16630822], LRP1 [CellTalkDB:32196115], LRP2 [CellTalkDB:32196115], LRP4 [Cellinker:18848351;LRdb:18848351;Ramilowski2015:18848351;connectomeDB2020:18848351;talklr:18848351], DAG1 [Cellinker:30478082;connectomeDB2020:7531888]	basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; Golgi lumen [GO:0005796]; integral component of membrane [GO:0016021]; lysosomal lumen [GO:0043202]; plasma membrane [GO:0005886]; synapse [GO:0045202]	calcium ion binding [GO:0005509]; chondroitin sulfate binding [GO:0035374]; dystroglycan binding [GO:0002162]; heparan sulfate proteoglycan binding [GO:0043395]; laminin binding [GO:0043236]; sialic acid binding [GO:0033691]; structural constituent of cytoskeleton [GO:0005200]	animal organ morphogenesis [GO:0009887]; clustering of voltage-gated sodium channels [GO:0045162]; G protein-coupled acetylcholine receptor signaling pathway [GO:0007213]; neuromuscular junction development [GO:0007528]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of GTPase activity [GO:0043547]; positive regulation of synaptic assembly at neuromuscular junction [GO:0045887]; positive regulation of transcription by RNA polymerase II [GO:0045944]; receptor clustering [GO:0043113]; signal transduction [GO:0007165]; synapse organization [GO:0050808]; tissue development [GO:0009888]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=AGRN&keywords=AGRN	16.3314723386602	185	3029.24	115	0.6310366534822148	332	0.03937007874015748	0.4061876247505047	0.033185840707964626	0.020623501199040762	0.042087542087542076	0.018612521150592212	0.02901178603807797	0.022838499184339316	0.01479837217906031	0.01231806649752968	0.01440988989762398	250	232	228	0.05940397476658483	0.35730478351507483	0.32156755535383136	0.35170737669878155	390	370	373
AGRP	agouti related neuropeptide	Yes		ENSG00000159723	O00253	NA	14	ligand, receptor	extracellular, intracellular, ligand, ligand_regulator, receptor, secreted	O75056, P18827, P32245, P33032, P41968, Q01726	MC1R, MC3R, MC4R, MC5R, SDC1, SDC3	MC3R [Baccin2019:11747427;Baccin2019:9311920;Baccin2019:9819197;Baccin2019:9893984;CellTalkDB:9311920;Cellinker:11747427;Cellinker:9311920;Cellinker:9819197;Cellinker:9893984;Guide2Pharma:9819197;HPRD:11747427;HPRD:9893984;LRdb:11747427;LRdb:9311920;LRdb:9819197;LRdb:9893984;SIGNOR:10318826;SIGNOR:9311920;connectomeDB2020:11747427;connectomeDB2020:9311920;connectomeDB2020:9819197;connectomeDB2020:9893984;scConnect:9819197], MC4R [Baccin2019:10318826;Baccin2019:11747427;Baccin2019:12815165;Baccin2019:9299416;Baccin2019:9311920;BioGRID:10318826;BioGRID:12815165;CellTalkDB:9311920;Cellinker:10318826;Cellinker:11747427;Cellinker:12815165;Cellinker:9299416;Cellinker:9311920;Guide2Pharma:9299416;HPMR:9311920;HPRD:10318826;HPRD:11747427;HPRD:12815165;LRdb:10318826;LRdb:11747427;LRdb:12815165;LRdb:9299416;LRdb:9311920;SIGNOR:10318826;SIGNOR:9311920;connectomeDB2020:10318826;connectomeDB2020:11747427;connectomeDB2020:12815165;connectomeDB2020:9299416;connectomeDB2020:9311920;scConnect:9299416], MC5R [Baccin2019:98920209892020;CellTalkDB:9892020;Cellinker:9892020;Guide2Pharma:9892020;HPRD:9892020;LRdb:9892020;connectomeDB2020:9892020;scConnect:9892020], SDC3 [CellTalkDB:11461706;Cellinker:11461706;LRdb:11461706;Ramilowski2015:11461706;connectomeDB2020:11461706;talklr:11461706], MC1R [Cellinker:14535656], SDC1 [Cellinker:11461706]	extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; neuronal cell body [GO:0043025]	melanocortin receptor binding [GO:0031779]; neuropeptide hormone activity [GO:0005184]; signaling receptor binding [GO:0005102]; type 1 melanocortin receptor binding [GO:0070996]	adult feeding behavior [GO:0008343]; circadian rhythm [GO:0007623]; eating behavior [GO:0042755]; feeding behavior [GO:0007631]; hormone-mediated signaling pathway [GO:0009755]; long-day photoperiodism [GO:0048571]; maternal process involved in female pregnancy [GO:0060135]; neuropeptide signaling pathway [GO:0007218]; positive regulation of feeding behavior [GO:2000253]; regulation of feeding behavior [GO:0060259]; response to insulin [GO:0032868]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=AGRP&keywords=AGRP	0.03146497752808989	768	NA	NA	0.07249049239064723	670	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
AGT	angiotensinogen	Yes	manually added ensembl_gene_ID, hgnc_symbol, and description by searching the uniprot ID on genenames.org	ENSG00000135744	P01019	Serpin family	16	ligand, receptor	ecm_regulator, extracellular, intracellular, ligand, receptor, secreted	P00797, P04201, P08913, P30556, P48039, P50052, P98164, Q07075, Q14831	ADRA2A, AGTR1, AGTR2, ENPEP, GRM7, LRP2, MAS1, MTNR1A, REN	AGTR1 [CellTalkDB:10993080;Guide2Pharma:10193788;Guide2Pharma:12006574;Guide2Pharma:21464395;HPRD:15930094;LRdb:10193788;LRdb:10993080;LRdb:12006574;LRdb:15930094;LRdb:21464395;SIGNOR:16597412;SIGNOR:17346243;connectomeDB2020:10193788;connectomeDB2020:10993080;connectomeDB2020:12006574;connectomeDB2020:15930094;connectomeDB2020:21464395;scConnect:10193788;scConnect:12006574;scConnect:21464395], AGTR2 [Baccin2019:17138938;Baccin2019:21464395;Baccin2019:2775266;Baccin2019:7850406;Baccin2019:8185599;Baccin2019:8242249;Baccin2019:8315512;CellTalkDB:17138938;Guide2Pharma:21542804;Guide2Pharma:2775266;Guide2Pharma:7850406;Guide2Pharma:8242249;HPRD:8185599;LRdb:17138938;LRdb:21464395;LRdb:2775266;LRdb:7850406;LRdb:8185599;LRdb:8242249;LRdb:8315512;connectomeDB2020:17138938;connectomeDB2020:21464395;connectomeDB2020:2775266;connectomeDB2020:7850406;connectomeDB2020:8185599;connectomeDB2020:8242249;connectomeDB2020:8315512;scConnect:17138938;scConnect:21464395;scConnect:21542804;scConnect:2775266;scConnect:7850406;scConnect:8242249], REN [DIP:20927107;InnateDB:20927107;Lit-BM-17:12045255;Lit-BM-17:20927107;SIGNOR:32201502], MAS1 [Baccin2019:1282979212829790;Cellinker:12829792;HPMR:12829792;HPRD:12829792;LRdb:12829792;connectomeDB2020:12829792], LRP2 [Baccin2019:15467006;CellTalkDB:15467006;Cellinker:15467006;HPMR:15467006;LRdb:15467006;connectomeDB2020:15467006], ENPEP [CellTalkDB:29900035;HPRD:1756856;LRdb:29900035], ADRA2A [CellTalkDB:32196115], MTNR1A [CellTalkDB:32196115], GRM7 [CellTalkDB:32196115]	blood microparticle [GO:0072562]; collagen-containing extracellular matrix [GO:0062023]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	growth factor activity [GO:0008083]; hormone activity [GO:0005179]; receptor ligand activity [GO:0048018]; serine-type endopeptidase inhibitor activity [GO:0004867]; sodium channel regulator activity [GO:0017080]; superoxide-generating NADPH oxidase activator activity [GO:0016176]; type 1 angiotensin receptor binding [GO:0031702]; type 2 angiotensin receptor binding [GO:0031703]	activation of phospholipase C activity [GO:0007202]; aging [GO:0007568]; angiotensin-activated signaling pathway [GO:0038166]; angiotensin-mediated drinking behavior [GO:0003051]; artery smooth muscle contraction [GO:0014824]; associative learning [GO:0008306]; blood vessel remodeling [GO:0001974]; cell-cell signaling [GO:0007267]; cell growth involved in cardiac muscle cell development [GO:0061049]; cell surface receptor signaling pathway [GO:0007166]; cellular response to angiotensin [GO:1904385]; cellular response to mechanical stimulus [GO:0071260]; cellular sodium ion homeostasis [GO:0006883]; ERK1 and ERK2 cascade [GO:0070371]; female pregnancy [GO:0007565]; fibroblast proliferation [GO:0048144]; G protein-coupled receptor signaling pathway [GO:0007186]; G protein-coupled receptor signaling pathway coupled to cGMP nucleotide second messenger [GO:0007199]; kidney development [GO:0001822]; low-density lipoprotein particle remodeling [GO:0034374]; maintenance of blood vessel diameter homeostasis by renin-angiotensin [GO:0002034]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell growth [GO:0030308]; negative regulation of endopeptidase activity [GO:0010951]; negative regulation of gene expression [GO:0010629]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of neurotrophin TRK receptor signaling pathway [GO:0051387]; negative regulation of sodium ion transmembrane transporter activity [GO:2000650]; negative regulation of tissue remodeling [GO:0034104]; nitric oxide mediated signal transduction [GO:0007263]; operant conditioning [GO:0035106]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of activation of Janus kinase activity [GO:0010536]; positive regulation of blood pressure [GO:0045777]; positive regulation of branching involved in ureteric bud morphogenesis [GO:0090190]; positive regulation of cardiac muscle cell apoptotic process [GO:0010666]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of cellular protein metabolic process [GO:0032270]; positive regulation of cholesterol esterification [GO:0010873]; positive regulation of cytokine production [GO:0001819]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of extracellular matrix constituent secretion [GO:0003331]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of gap junction assembly [GO:1903598]; positive regulation of inflammatory response [GO:0050729]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of L-arginine import across plasma membrane [GO:1905589]; positive regulation of L-lysine import across plasma membrane [GO:1905010]; positive regulation of macrophage derived foam cell differentiation [GO:0010744]; positive regulation of membrane hyperpolarization [GO:1902632]; positive regulation of NAD(P)H oxidase activity [GO:0033864]; positive regulation of neuron projection development [GO:0010976]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; positive regulation of renal sodium excretion [GO:0035815]; positive regulation of superoxide anion generation [GO:0032930]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; protein import into nucleus [GO:0006606]; regulation of apoptotic process [GO:0042981]; regulation of blood pressure [GO:0008217]; regulation of blood volume by renin-angiotensin [GO:0002016]; regulation of calcium ion transport [GO:0051924]; regulation of cardiac conduction [GO:1903779]; regulation of cell growth [GO:0001558]; regulation of cell population proliferation [GO:0042127]; regulation of extracellular matrix assembly [GO:1901201]; regulation of heart rate [GO:0002027]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of norepinephrine secretion [GO:0014061]; regulation of renal output by angiotensin [GO:0002019]; regulation of renal sodium excretion [GO:0035813]; regulation of transmission of nerve impulse [GO:0051969]; regulation of vasoconstriction [GO:0019229]; renal system process [GO:0003014]; renin-angiotensin regulation of aldosterone production [GO:0002018]; response to estradiol [GO:0032355]; response to muscle activity involved in regulation of muscle adaptation [GO:0014873]; smooth muscle cell proliferation [GO:0048659]; stress-activated MAPK cascade [GO:0051403]; uterine smooth muscle contraction [GO:0070471]; vasodilation [GO:0042311]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=AGT&keywords=AGT	NA	NA	2691.67	121	NA	NA	0	0.08832335329341306	0.00663716814159292	0.02350119904076738	0.042087542087542076	0.2047377326565142	0.1831368993653668	0.13050570962479613	0.12874583795782438	0.20009347042328282	0.15201854355804165	103	75	84	0.10543522328628559	1.2019367573251643	1.8200118165166943	1.4035451134029249	86	25	40
AIMP1	aminoacyl tRNA synthetase complex interacting multifunctional protein 1	No		ENSG00000164022	Q12904	NA	2	ligand, receptor	extracellular, intracellular, ligand, receptor, secreted	P04629, Q9HAU4	NTRK1, SMURF2	SMURF2 [SIGNOR:18448069], NTRK1 [NA]	aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cell surface [GO:0009986]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; nucleus [GO:0005634]	cytokine activity [GO:0005125]; GTPase binding [GO:0051020]; protein homodimerization activity [GO:0042803]; tRNA binding [GO:0000049]	angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cell-cell signaling [GO:0007267]; inflammatory response [GO:0006954]; leukocyte migration [GO:0050900]; negative regulation of endothelial cell proliferation [GO:0001937]; positive regulation of glucagon secretion [GO:0070094]; translation [GO:0006412]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=AIMP1&keywords=AIMP1	30.601424215307997	132	19873.2	48	0.9964243425789225	268	0.3228346456692912	0.8647704590818311	0.3539823008849545	0.7815347721822782	1.3265993265993348	0.7309644670050768	0.7561196736174127	0.5562805872756943	0.6074731779504273	0.4788356255842816	0.7480007726482089	36	47	31	0.6843087098635265	0.8893352037479092	0.7040609150364356	1.0917345006333012	193	250	78
ALCAM	activated leukocyte cell adhesion molecule	No		ENSG00000170017	Q13740	NA	1	adhesion, cell_surface_ligand, ligand	adhesion, cell_adhesion, cell_surface, cell_surface_ligand, extracellular, intracellular, ligand, plasma_membrane, plasma_membrane_transmembrane, secreted, transmembrane	O00533, O14786, P30203, P32004	CD6, CHL1, L1CAM, NRP1	CD6 [Baccin2019:24496453;BioGRID:7543097;CellPhoneDB:23602662;DIP:26146185;HPRD:7543097;HPRD:9436462;IntAct:24945728;IntAct:26146185;Lit-BM-17:24945728;Lit-BM-17:7543097;connectomeDB2020:23602662], CHL1 [connectomeDB2020:31300520], L1CAM [Baccin2019:22983139;connectomeDB2020:31300520], NRP1 [connectomeDB2020:31300520]	axon [GO:0030424]; dendrite [GO:0030425]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; immunological synapse [GO:0001772]; integral component of plasma membrane [GO:0005887]; intrinsic component of plasma membrane [GO:0031226]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]	identical protein binding [GO:0042802]; signaling receptor binding [GO:0005102]	adaptive immune response [GO:0002250]; axon extension involved in axon guidance [GO:0048846]; cell adhesion [GO:0007155]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; motor neuron axon guidance [GO:0008045]; neuron projection extension [GO:1990138]; retinal ganglion cell axon guidance [GO:0031290]; signal transduction [GO:0007165]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=ALCAM&keywords=ALCAM	121.54186370424443	43	31401.1	31	4.000620856233578	90	0.3228346456692911	0.24950099800399364	0.004424778761061947	0.08992805755395737	0.3367003367003363	1.4382402707275765	1.350861287398014	0.6998368678629713	0.7140214576396607	1.0795500066766948	0.4541240100444016	32	28	39	0.6127293379125417	1.1626583389609706	1.749636544070636	0.7453061575679044	95	31	216
ALKAL1	ALK and LTK ligand 1	Yes		ENSG00000196711	Q6UXT8	ALKAL family	2	ligand	intracellular, ligand, secreted	P29376, Q9UM73	ALK, LTK	ALK [CellTalkDB:26418745;IntAct:26418745;connectomeDB2020:26630010], LTK [connectomeDB2020:26630010]	extracellular region [GO:0005576]	receptor signaling protein tyrosine kinase activator activity [GO:0030298]; receptor tyrosine kinase binding [GO:0030971]	positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of ERK5 cascade [GO:0070378]; positive regulation of neuron projection development [GO:0010976]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=ALKAL1&keywords=ALKAL1	0.11429751235955056	664	NA	NA	0.5982419725898165	341	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
ALKAL2	ALK and LTK ligand 2	Yes		ENSG00000189292	Q6UX46	ALKAL family	2	ligand	extracellular, intracellular, ligand, secreted	P29376, Q9UM73	ALK, LTK	ALK [CellTalkDB:26418745;connectomeDB2020:26630010], LTK [connectomeDB2020:26630010]	extracellular region [GO:0005576]	receptor signaling protein tyrosine kinase activator activity [GO:0030298]; receptor tyrosine kinase binding [GO:0030971]	positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of ERK5 cascade [GO:0070378]; positive regulation of neuron projection development [GO:0010976]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=ALKAL2&keywords=ALKAL2	13.704207667842386	201	NA	NA	1.4350979975334337	208	0	0.1452095808383233	0.09402654867256638	1.4822541966426845	0.008417508417508417	0.001692047377326565	0.006346328195829556	0.0032626427406199023	0.0014798372179060304	0.0032047002269995945	0.0032837550705041556	299	317	311	0.15901610412729714	0.06792155858272422	0.07812687610557079	0.07859461167380409	494	482	486
AMBN	ameloblastin	Yes		ENSG00000178522	Q9NP70	Ameloblastin family	3	ecm, ligand	ecm, extracellular, intracellular, ligand, secreted	P08962	CD63	CD63 [connectomeDB2020:17708745;connectomeDB2020:21149578]	endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]	growth factor activity [GO:0008083]; structural constituent of tooth enamel [GO:0030345]	biomineral tissue development [GO:0031214]; cell adhesion [GO:0007155]; odontogenesis of dentin-containing tooth [GO:0042475]; regulation of cell population proliferation [GO:0042127]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=AMBN&keywords=AMBN	0.3325314557280899	567	NA	NA	3.7948129658947614	96	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
AMELX	amelogenin X-linked	No		ENSG00000125363	Q99217	Amelogenin family	10	ecm, ligand, receptor	ecm, extracellular, intracellular, ligand, receptor, secreted	P08962, P11279, P13473	CD63, LAMP1, LAMP2	LAMP1 [CellTalkDB:20382373;Cellinker:20382373;LRdb:20382373;Ramilowski2015:20382373;connectomeDB2020:20382373;talklr:20382373], CD63 [connectomeDB2020:17708745], LAMP2 [connectomeDB2020:17708745]	cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; endocytic vesicle [GO:0030139]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]	growth factor activity [GO:0008083]; hydroxyapatite binding [GO:0046848]; identical protein binding [GO:0042802]; structural constituent of tooth enamel [GO:0030345]	amelogenesis [GO:0097186]; biomineral tissue development [GO:0031214]; cell adhesion [GO:0007155]; chondrocyte differentiation [GO:0002062]; enamel mineralization [GO:0070166]; epithelial to mesenchymal transition [GO:0001837]; odontogenesis of dentin-containing tooth [GO:0042475]; osteoblast differentiation [GO:0001649]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of tooth mineralization [GO:0070172]; regulation of cell population proliferation [GO:0042127]; response to calcium ion [GO:0051592]; response to nutrient [GO:0007584]; response to xenobiotic stimulus [GO:0009410]; signal transduction [GO:0007165]; tooth mineralization [GO:0034505]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=AMELX&keywords=AMELX	0.004592469662921348	858	NA	NA	0.7555275859038774	311	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
AMELY	amelogenin Y-linked	No		ENSG00000099721	Q99218	Amelogenin family	7	ecm, ligand	ecm, extracellular, ligand, secreted	P08962, P11279, P13473	CD63, LAMP1, LAMP2	CD63 [connectomeDB2020:17708745], LAMP1 [Cellinker:20382373;LRdb:20382373;Ramilowski2015:20382373;connectomeDB2020:20382373;talklr:20382373], LAMP2 [connectomeDB2020:17708745]	collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]	structural constituent of tooth enamel [GO:0030345]	biomineral tissue development [GO:0031214]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=AMELY&keywords=AMELY	0.006236347191011235	847	NA	NA	0.553029262164421	366	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
AMH	anti-Mullerian hormone	Yes		ENSG00000104899	P03971	TGF-beta family	19	ligand	extracellular, intracellular, ligand, secreted	O00238, P00533, P36894, Q04771, Q16671, Q9H772	ACVR1, ACVR1_AMHR2, AMHR2, AMHR2_BMPR1A, AMHR2_BMPR1B, BMPR1A, BMPR1B, EGFR, GREM2	AMHR2 [Baccin2019:79972308889695;CellTalkDB:7997230;HPMR:7997230;HPRD:8889695;LRdb:7997230;LRdb:889;SIGNOR:8119126;SignaLink3:16446785;SignaLink3:18988627;SignaLink3:23331499;SignaLink3:8889695;connectomeDB2020:7997230;connectomeDB2020:8889695], BMPR1B [Cellinker:11420127], BMPR1A [NA], ACVR1 [CellTalkDB:14656470;LRdb:14656470;Ramilowski2015:14656470;connectomeDB2020:14656470;talklr:14656470], EGFR [Baccin2019:8596488;CellTalkDB:8596488;Cellinker:8596488;HPRD:8596488;LRdb:8596488;connectomeDB2020:8596488], GREM2 [Cellinker:24614542]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	growth factor activity [GO:0008083]; hormone activity [GO:0005179]; signaling receptor binding [GO:0005102]; type II transforming growth factor beta receptor binding [GO:0005114]	aging [GO:0007568]; cell-cell signaling [GO:0007267]; gonadal mesoderm development [GO:0007506]; Leydig cell differentiation [GO:0033327]; Mullerian duct regression [GO:0001880]; negative regulation of ovarian follicle development [GO:2000355]; ovarian follicle development [GO:0001541]; pathway-restricted SMAD protein phosphorylation [GO:0060389]; positive regulation of gene expression [GO:0010628]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; preantral ovarian follicle growth [GO:0001546]; response to organic cyclic compound [GO:0014070]; response to xenobiotic stimulus [GO:0009410]; sex determination [GO:0007530]; sex differentiation [GO:0007548]; urogenital system development [GO:0001655]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=AMH&keywords=AMH	0.1136708404494382	665	NA	NA	0.04276439948591257	728	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
ANG	angiogenin	No		ENSG00000214274	P03950	Pancreatic ribonuclease family	2	ecm, ligand	ecm, extracellular, intracellular, ligand, secreted	O15031, P00533	EGFR, PLXNB2	EGFR [CellTalkDB:30449278;ProtMapper:19254952], PLXNB2 [connectomeDB2020:29100074]	actin cytoskeleton [GO:0015629]; angiogenin-PRI complex [GO:0032311]; basement membrane [GO:0005604]; chromosome [GO:0005694]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; growth cone [GO:0030426]; neuronal cell body [GO:0043025]; nucleolus [GO:0005730]; nucleus [GO:0005634]	actin binding [GO:0003779]; copper ion binding [GO:0005507]; DNA binding [GO:0003677]; endonuclease activity [GO:0004519]; endoribonuclease activity [GO:0004521]; heparin binding [GO:0008201]; peptide binding [GO:0042277]; protein homodimerization activity [GO:0042803]; ribonuclease activity [GO:0004540]; rRNA binding [GO:0019843]; signaling receptor binding [GO:0005102]	actin filament polymerization [GO:0030041]; activation of phospholipase A2 activity [GO:0032431]; activation of phospholipase C activity [GO:0007202]; activation of protein kinase B activity [GO:0032148]; angiogenesis [GO:0001525]; antibacterial humoral response [GO:0019731]; antifungal humoral response [GO:0019732]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cell communication [GO:0007154]; cell migration [GO:0016477]; defense response to Gram-positive bacterium [GO:0050830]; diacylglycerol biosynthetic process [GO:0006651]; homeostatic process [GO:0042592]; innate immune response [GO:0045087]; negative regulation of smooth muscle cell proliferation [GO:0048662]; negative regulation of translation [GO:0017148]; oocyte maturation [GO:0001556]; ovarian follicle development [GO:0001541]; placenta development [GO:0001890]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of phosphorylation [GO:0042327]; positive regulation of protein secretion [GO:0050714]; response to hormone [GO:0009725]; response to hypoxia [GO:0001666]; response to yeast [GO:0001878]; rRNA transcription [GO:0009303]; tRNA catabolic process [GO:0016078]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=ANG&keywords=ANG	11.22413791011236	229	1265.94	150	0.30209374121390464	463	0.023622047244094488	0.0543912175648702	0.02433628318584071	0.06858513189448454	0.3686868686868682	0.05245346869712353	0.05167724388032631	0.12398042414355644	0.04328523862375141	0.016323941781279168	0.11454510334169907	178	215	102	0.08562608809489945	0.5572249130474842	0.27527991896055876	1.3024176333355846	325	391	48
ANGPT1	angiopoietin 1	Yes		ENSG00000154188	Q15389	NA	16	ligand	extracellular, intracellular, ligand, secreted	O15123, P05556, P08648, P35590, Q02763	ANGPT2, ITGA5, ITGAV_ITGB5, ITGB1, TEK, TIE1	TEK [Baccin2019:12427764;Baccin2019:8980223;Baccin2019:8980224;Baccin2019:9723709;BioGRID:8980223;CellChatDB:20651738;CellTalkDB:8980223;Cellinker:12427764;Cellinker:20651738;Cellinker:28396397;Cellinker:8980223;Cellinker:8980224;Cellinker:9723709;HPMR:8980223;HPRD:12427764;HPRD:8980223;HPRD:8980224;HPRD:9723709;IntAct:20708158;IntAct:29106382;LRdb:12427764;LRdb:8980223;LRdb:8980224;LRdb:9723709;Lit-BM-17:12427764;Lit-BM-17:20708158;Lit-BM-17:8980223;Lit-BM-17:9204896;Lit-BM-17:9723709;ProtMapper:21858121;SIGNOR:9204896;SignaLink3:12427764;SignaLink3:18988627;SignaLink3:20937382;SignaLink3:21071413;SignaLink3:23331499;SignaLink3:8980223;SignaLink3:8980224;SignaLink3:9204896;SignaLink3:9723709;connectomeDB2020:12427764;connectomeDB2020:8980223;connectomeDB2020:8980224;connectomeDB2020:9723709], TIE1 [Baccin2019:11172728;CellTalkDB:11172728;Cellinker:11172728;HPMR:11172728;LRdb:11172728;SIGNOR:11172728;connectomeDB2020:11172728], ITGA5 [CellTalkDB:15781448;Cellinker:15781448;HPRD:15781448;LRdb:15781448;connectomeDB2020:15781448], ITGB1 [Baccin2019:11346644;CellTalkDB:15781448;connectomeDB2020:15690488;connectomeDB2020:19379779], ANGPT2 [HPRD:9204896]	collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane raft [GO:0045121]; microvillus [GO:0005902]; plasma membrane [GO:0005886]	identical protein binding [GO:0042802]; receptor tyrosine kinase binding [GO:0030971]; signaling receptor binding [GO:0005102]	activation of transmembrane receptor protein tyrosine kinase activity [GO:0007171]; angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; cell-substrate adhesion [GO:0031589]; glomerulus vasculature development [GO:0072012]; hemopoiesis [GO:0030097]; heparin biosynthetic process [GO:0030210]; in utero embryonic development [GO:0001701]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cytokine production involved in immune response [GO:0002719]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of vascular permeability [GO:0043116]; positive chemotaxis [GO:0050918]; positive regulation of blood-brain barrier permeability [GO:1905605]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell adhesion [GO:0045785]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of receptor internalization [GO:0002092]; protein localization to cell surface [GO:0034394]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of macrophage migration inhibitory factor signaling pathway [GO:2000446]; regulation of protein binding [GO:0043393]; regulation of skeletal muscle satellite cell proliferation [GO:0014842]; regulation of tumor necrosis factor production [GO:0032680]; sprouting angiogenesis [GO:0002040]; Tie signaling pathway [GO:0048014]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=ANGPT1&keywords=ANGPT1	0.4437313502089888	535	NA	NA	0.07142580734703834	671	0	4.99001996007984e-4	0	0.010311750599520381	0	0.001692047377326565	0	0.0016313213703099511	0	1.0014688209373749e-4	3.8632412594166507e-5	303	406	400	0.0012975364216229804	0.8851487286078094	0.89401321714374	0.8885682716968871	194	172	150
ANGPT2	angiopoietin 2	Yes		ENSG00000091879	O15123	NA	14	ligand	extracellular, intracellular, ligand, secreted	P35590, Q02763, Q15389	ANGPT1, ITGA5_ITGB1, TEK, TIE1	TEK [Baccin2019:9204896;Baccin2019:9723709;CellChatDB:20651738;CellTalkDB:9204896;Cellinker:20651738;Cellinker:28396397;Cellinker:9204896;Cellinker:9723709;DIP:15893672;DIP:16732286;HPRD:9723709;IntAct:15893672;IntAct:16732286;IntAct:20708158;LRdb:9204896;LRdb:972;Lit-BM-17:12427764;Lit-BM-17:15893672;Lit-BM-17:16732286;Lit-BM-17:20708158;Lit-BM-17:25237190;Lit-BM-17:9204896;Lit-BM-17:9723709;SIGNOR:9723709;SignaLink3:12427764;SignaLink3:15893672;SignaLink3:18988627;SignaLink3:21071413;SignaLink3:23331499;SignaLink3:9204896;SignaLink3:9723709;connectomeDB2020:9204896;connectomeDB2020:9723709], TIE1 [Baccin2019:27548530;CellTalkDB:22342979;connectomeDB2020:27548530], ANGPT1 [HPRD:9204896]	cell projection [GO:0042995]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	metal ion binding [GO:0046872]; receptor tyrosine kinase binding [GO:0030971]; signaling receptor binding [GO:0005102]	angiogenesis [GO:0001525]; animal organ regeneration [GO:0031100]; cellular response to growth factor stimulus [GO:0071363]; gene expression [GO:0010467]; germ cell development [GO:0007281]; glomerulus vasculature development [GO:0072012]; maternal process involved in female pregnancy [GO:0060135]; negative regulation of angiogenesis [GO:0016525]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of positive chemotaxis [GO:0050928]; positive regulation of angiogenesis [GO:0045766]; response to activity [GO:0014823]; response to glucose [GO:0009749]; response to hypoxia [GO:0001666]; response to mechanical stimulus [GO:0009612]; response to organic cyclic compound [GO:0014070]; response to radiation [GO:0009314]; signal transduction [GO:0007165]; Tie signaling pathway [GO:0048014]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=ANGPT2&keywords=ANGPT2	13.629110139325842	203	NA	NA	4.588336067045961	79	0	0.030439121756487005	3.762168141592911	0.5549160671462867	0.011784511784511783	0.05583756345177668	0.03898458748866726	0.1060358890701469	0.039955604883462795	0.03565229002537086	0.042920610392118655	185	165	161	0.4253358534174309	0.1147518737345114	0.10486682791457612	0.1215627198556849	468	466	461
ANGPT4	angiopoietin 4	Yes		ENSG00000101280	Q9Y264	NA	15	ligand	ligand, secreted, transmembrane	P35590, Q02763	TEK, TIE1	TEK [Baccin2019:10051567;CellTalkDB:10051567;Cellinker:10051567;HPRD:10051567;LRdb:10051567;SIGNOR:15284220;SignaLink3:10051567;SignaLink3:15284220;SignaLink3:18988627;SignaLink3:21071413;SignaLink3:23331499;connectomeDB2020:10051567;connectomeDB2020:15284220], TIE1 [CellTalkDB:15851516;SignaLink3:10051567;SignaLink3:23331499]	collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	receptor tyrosine kinase binding [GO:0030971]; signaling receptor binding [GO:0005102]; transmembrane receptor protein tyrosine kinase activator activity [GO:0030297]	angiogenesis [GO:0001525]; cellular response to hypoxia [GO:0071456]; negative regulation of angiogenesis [GO:0016525]; negative regulation of apoptotic process [GO:0043066]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; Notch signaling pathway [GO:0007219]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; signal transduction [GO:0007165]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=ANGPT4&keywords=ANGPT4	0.014607790674157304	808	NA	NA	0.013735646727576182	817	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
ANGPTL1	angiopoietin like 1	Yes		ENSG00000116194	O95841	NA	13	ligand	extracellular, ligand, secreted	O75022, Q02763, Q8N423	ITGA1_ITGB1, LILRB2, LILRB3, TEK	TEK [CellTalkDB:10051567;Cellinker:10051567;HPRD:10051567;LRdb:10051567;SIGNOR:10051567;SIGNOR:15284220;SignaLink3:10051567;SignaLink3:15284220;SignaLink3:23331499;connectomeDB2020:10051567], LILRB3 [CellChatDB:24478758], LILRB2 [Cellinker:24478758]	collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]	signaling receptor binding [GO:0005102]	transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=ANGPTL1&keywords=ANGPTL1	2.0804815725647505	383	NA	NA	0.1092087426392681	616	0	0.007984031936127746	0	0.015347721822541962	0.0101010101010101	0.038917089678511	0.03445149592021758	0.03752039151712889	0.0199778024417314	0.032047002269995975	0.0022020475178674923	236	169	332	0.01804987210955747	1.068732232526544	1.4990086979993482	0.4350125900827146	119	53	345
ANGPTL2	angiopoietin like 2	Yes		ENSG00000136859	Q9UKU9	NA	9	ligand	extracellular, ligand, secreted	O00206, O75022, P05556, P08648, P35590, Q8N423	ITGA5, ITGA5_ITGB1, ITGB1, LILRB2, LILRB3, TIE1, TLR4	LILRB2 [CellTalkDB:24899623;Cellinker:24478758;DIP:22660330;IntAct:22660330;IntAct:24899623;connectomeDB2020:26056041], TIE1 [CellTalkDB:32196115], TLR4 [CellChatDB:24478758;Cellinker:24478758], LILRB3 [CellChatDB:24478758], ITGA5 [connectomeDB2020:29074299], ITGB1 [connectomeDB2020:29074299]	collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]	signaling receptor binding [GO:0005102]	multicellular organism development [GO:0007275]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=ANGPTL2&keywords=ANGPTL2	12.626912592325967	211	NA	NA	0.3347060929071334	449	0	0.011477045908183632	0.7079646017699102	0.33069544364508785	0.015151515151515148	0.15397631133671733	0.1586582048957385	0.01468189233278956	0.02552719200887899	0.17926291894778335	0.004558624686111651	218	83	295	0.1456321591529742	0.22827667624888853	1.2160913269972227	0.09354509225693942	423	90	476
ANGPTL3	angiopoietin like 3	Yes		ENSG00000132855	Q9Y5C1	NA	14	ligand, receptor	extracellular, intracellular, ligand, receptor, secreted	P05106, P06756, P06858, P08648	ITGA5, ITGAV, ITGAV_ITGB3, ITGB3, LPL	ITGB3 [CellTalkDB:11877390;HPRD:11877390;LRdb:11877390;connectomeDB2020:11877390], ITGAV [CellTalkDB:11877390;HPRD:11877390;LRdb:11877390;connectomeDB2020:11877390], ITGA5 [CellTalkDB:11877390;Cellinker:11877390;HPRD:11877390;LRdb:11877390;connectomeDB2020:11877390], LPL [LMPID:19246456]	cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; early endosome [GO:0005769]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; lamellipodium [GO:0030027]	enzyme inhibitor activity [GO:0004857]; growth factor activity [GO:0008083]; heparin binding [GO:0008201]; integrin binding [GO:0005178]; phospholipase inhibitor activity [GO:0004859]; signaling receptor binding [GO:0005102]	acylglycerol homeostasis [GO:0055090]; angiogenesis [GO:0001525]; artery morphogenesis [GO:0048844]; cell-matrix adhesion [GO:0007160]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; fatty acid metabolic process [GO:0006631]; glycerol metabolic process [GO:0006071]; integrin-mediated signaling pathway [GO:0007229]; lipid homeostasis [GO:0055088]; lipid storage [GO:0019915]; negative regulation of lipoprotein lipase activity [GO:0051005]; negative regulation of phospholipase activity [GO:0010519]; phospholipid catabolic process [GO:0009395]; phospholipid homeostasis [GO:0055091]; phospholipid metabolic process [GO:0006644]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell migration [GO:0030335]; positive regulation of lipid catabolic process [GO:0050996]; response to hormone [GO:0009725]; signal transduction [GO:0007165]; triglyceride homeostasis [GO:0070328]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=ANGPTL3&keywords=ANGPTL3	0.4566190597752809	533	NA	NA	0.16923235442304813	557	0	0	0	0	0	0.00676818950930626	0.004533091568449683	0.02773246329526917	0.028486866444691047	0.006509547336092922	0.007533320455862476	209	270	262	0.007414861691788324	2.2100012693663174	0.9480148409032564	1.0068021650800711	25	152	98
ANGPTL4	angiopoietin like 4	Yes		ENSG00000167772	Q9BY76	NA	8	ecm, ligand	ecm, extracellular, intracellular, ligand, secreted, transmembrane	O75056, P06858, P18827, P31431, P33151, P34741, P35590, P55287, Q8IV16	CDH11, CDH5, GPIHBP1, ITGA5_ITGB1, ITGAV_ITGB3, LPL, SDC1, SDC2, SDC3, SDC4, TIE1	GPIHBP1 [CellTalkDB:25809481], TIE1 [CellTalkDB:32196115], CDH5 [CellChatDB:30049845;Cellinker:30049845], CDH11 [CellChatDB:30049845;Cellinker:30049845], SDC1 [CellChatDB:29017031;Cellinker:29017031], SDC2 [CellChatDB:29017031;Cellinker:29017031], SDC3 [CellChatDB:29017031;Cellinker:29017031], SDC4 [CellChatDB:29017031;Cellinker:29017031], LPL [LMPID:19246456]	blood microparticle [GO:0072562]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	enzyme inhibitor activity [GO:0004857]; identical protein binding [GO:0042802]; signaling receptor binding [GO:0005102]	angiogenesis [GO:0001525]; lipid metabolic process [GO:0006629]; negative regulation of apoptotic process [GO:0043066]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of lipoprotein lipase activity [GO:0051005]; positive regulation of angiogenesis [GO:0045766]; protein unfolding [GO:0043335]; response to hypoxia [GO:0001666]; triglyceride homeostasis [GO:0070328]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=ANGPTL4&keywords=ANGPTL4	28.217724863819985	140	NA	NA	0.9250397209337264	280	0	0.04441117764471054	0.04646017699115046	1.005515587529989	0.05723905723905722	0.011844331641285955	0.007252946509519492	0.024469820554649267	0.005179430262671108	0.00837895580184269	0.013714506470929038	287	254	235	0.11131509005870953	0.125124007700321	0.15149768914113104	0.19547862066831573	467	443	423
ANGPTL5	angiopoietin like 5	Yes		ENSG00000187151	Q86XS5	NA	3	ligand	ligand, secreted	NA	NA	NA	collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615]	NA	NA	https://www.genecards.org/cgi-bin/carddisp.pl?gene=ANGPTL5&keywords=ANGPTL5	0.10148535247191011	674	NA	NA	0.12602547304385694	596	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
ANGPTL6	angiopoietin like 6	Yes		ENSG00000130812	Q8NI99	NA	3	ligand	extracellular, intracellular, ligand, secreted	NA	NA	NA	collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; secretory granule [GO:0030141]	signaling receptor binding [GO:0005102]	angiogenesis [GO:0001525]; cell differentiation [GO:0030154]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=ANGPTL6&keywords=ANGPTL6	0.09038704719101123	679	NA	NA	0.04318360459321263	725	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
ANGPTL7	angiopoietin like 7	Yes		ENSG00000171819	O43827	NA	4	ligand	ligand, secreted	O75022, Q8N423	LILRB2, LILRB3	LILRB3 [CellChatDB:24478758], LILRB2 [Cellinker:24478758]	collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	identical protein binding [GO:0042802]; signaling receptor binding [GO:0005102]	negative regulation of vasculature development involved in avascular cornea development in camera-type eye [GO:1901346]; regulation of extracellular matrix organization [GO:1903053]; response to oxidative stress [GO:0006979]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=ANGPTL7&keywords=ANGPTL7	0.05445562134831461	729	NA	NA	0.002886155801536971	883	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
ANGPTL8	angiopoietin like 8	Yes		ENSG00000130173	Q6UXH0	ANGPTL8 family	3	ligand	intracellular, ligand, secreted	NA	NA	NA	extracellular region [GO:0005576]	hormone activity [GO:0005179]	cell maturation [GO:0048469]; cellular lipid metabolic process [GO:0044255]; fat cell differentiation [GO:0045444]; positive regulation of protein processing [GO:0010954]; regulation of lipid metabolic process [GO:0019216]; regulation of lipoprotein metabolic process [GO:0050746]; triglyceride homeostasis [GO:0070328]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=ANGPTL8&keywords=ANGPTL8	0.05718923258426966	722	NA	NA	0.01915740937089428	799	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
ANOS1	anosmin 1	No		ENSG00000011201	P23352	NA	6	adhesion, cell_surface_ligand, ecm, ligand	adhesion, cell_adhesion, cell_surface_ligand, ecm, ligand, matrix_adhesion, plasma_membrane, secreted	P11362, P34741	FGFR1, SDC2	SDC2 [Cellinker:8832397;HPRD:8832397;connectomeDB2020:8832397], FGFR1 [BioGRID:20874775;BioGRID:23189990;CellTalkDB:19696444;Cellinker:19696444;IntAct:19696444;LRdb:19696444;Lit-BM-17:19696444;Ramilowski2015:19696444;connectomeDB2020:19696444;talklr:19696444]	cell surface [GO:0009986]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]	extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; serine-type endopeptidase inhibitor activity [GO:0004867]	axon guidance [GO:0007411]; cell adhesion [GO:0007155]; chemotaxis [GO:0006935]; neuron differentiation [GO:0030182]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=ANOS1&keywords=ANOS1	0.6475075247191011	500	NA	NA	0.23293239542214322	509	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
ANXA1	annexin A1	Yes	autocrine/paracrine https://www.pnas.org/doi/full/10.1073/pnas.1209362110	ENSG00000135046	P04083	Annexin family	12	adhesion, cell_surface_ligand, ligand, receptor	adhesion, cell_adhesion, cell_surface, cell_surface_ligand, extracellular, intracellular, ligand, plasma_membrane, receptor, secreted	O75923, P00533, P08913, P12931, P21462, P25089, P25090, P48039, Q14831	ADRA2A, DYSF, EGFR, FPR1, FPR2, FPR2_FPR3, FPR3, GRM7, MTNR1A, SRC	FPR2 [Baccin2019:10882119;Baccin2019:12368905;Baccin2019:12560218;Baccin2019:16278303;CellChatDB:23230437;CellPhoneDB:22610094;CellTalkDB:22610094;Cellinker:10882119;Cellinker:12368905;Cellinker:12560218;Cellinker:16278303;Cellinker:22610094;Cellinker:23230437;Guide2Pharma:12368905;LRdb:10882119;LRdb:12368905;LRdb:12560218;LRdb:16278303;SIGNOR:15187149;connectomeDB2020:10882119;connectomeDB2020:12368905;connectomeDB2020:12560218;connectomeDB2020:16278303;scConnect:10882119;scConnect:12368905;scConnect:12560218;scConnect:16278303], FPR3 [CellTalkDB:15187149;Cellinker:15187149;Guide2Pharma:15187149;LRdb:15187149;SIGNOR:15187149;connectomeDB2020:15187149;scConnect:15187149], SRC [HPRD:2457390;SIGNOR:24103589], EGFR [CellTalkDB:15581623;Cellinker:15581623;HPRD:15581623;IntAct:15581623;IntAct:20029029;IntAct:31980649;LRdb:15581623;Lit-BM-17:15581623;Lit-BM-17:20029029;Lit-BM-17:24189400;connectomeDB2020:15581623], FPR1 [Baccin2019:10882119;Baccin2019:12560218;CellChatDB:23230437;CellTalkDB:10882119;Cellinker:10882119;Cellinker:12560218;Cellinker:23230437;HPMR:10882119;HPRD:10882119;LRdb:10882119;LRdb:13;SIGNOR:15187149;connectomeDB2020:10882119;connectomeDB2020:12560218;scConnect:10882119;scConnect:12560218], DYSF [Baccin2019:14506282;Cellinker:14506282;HPRD:14506282;LRdb:14506282;connectomeDB2020:14506282], ADRA2A [CellTalkDB:32196115], MTNR1A [CellTalkDB:32196115], GRM7 [CellTalkDB:32196115]	adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; cornified envelope [GO:0001533]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extrinsic component of endosome membrane [GO:0031313]; extrinsic component of external side of plasma membrane [GO:0031232]; extrinsic component of membrane [GO:0019898]; focal adhesion [GO:0005925]; lateral plasma membrane [GO:0016328]; motile cilium [GO:0031514]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886]; sarcolemma [GO:0042383]; vesicle [GO:0031982]	cadherin binding involved in cell-cell adhesion [GO:0098641]; calcium-dependent phospholipid binding [GO:0005544]; calcium-dependent protein binding [GO:0048306]; calcium ion binding [GO:0005509]; phospholipase A2 inhibitor activity [GO:0019834]; phospholipid binding [GO:0005543]; signaling receptor binding [GO:0005102]	actin cytoskeleton reorganization [GO:0031532]; adaptive immune response [GO:0002250]; alpha-beta T cell differentiation [GO:0046632]; arachidonic acid secretion [GO:0050482]; cell surface receptor signaling pathway [GO:0007166]; cellular response to glucocorticoid stimulus [GO:0071385]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; DNA duplex unwinding [GO:0032508]; endocrine pancreas development [GO:0031018]; gliogenesis [GO:0042063]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; granulocyte chemotaxis [GO:0071621]; hepatocyte differentiation [GO:0070365]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; insulin secretion [GO:0030073]; keratinocyte differentiation [GO:0030216]; monocyte chemotaxis [GO:0002548]; myoblast migration involved in skeletal muscle regeneration [GO:0014839]; negative regulation of apoptotic process [GO:0043066]; negative regulation of exocytosis [GO:0045920]; negative regulation of interleukin-8 production [GO:0032717]; negative regulation of phospholipase A2 activity [GO:1900138]; negative regulation of T-helper 2 cell differentiation [GO:0045629]; neutrophil activation [GO:0042119]; neutrophil clearance [GO:0097350]; neutrophil homeostasis [GO:0001780]; peptide cross-linking [GO:0018149]; phagocytosis [GO:0006909]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of neutrophil apoptotic process [GO:0033031]; positive regulation of prostaglandin biosynthetic process [GO:0031394]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of T-helper 1 cell differentiation [GO:0045627]; positive regulation of vesicle fusion [GO:0031340]; positive regulation of wound healing [GO:0090303]; prolactin secretion [GO:0070459]; prostate gland development [GO:0030850]; regulation of cell shape [GO:0008360]; regulation of hormone secretion [GO:0046883]; regulation of inflammatory response [GO:0050727]; regulation of interleukin-1 production [GO:0032652]; regulation of leukocyte migration [GO:0002685]; response to estradiol [GO:0032355]; response to interleukin-1 [GO:0070555]; response to peptide hormone [GO:0043434]; response to X-ray [GO:0010165]; signal transduction [GO:0007165]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=ANXA1&keywords=ANXA1	96.08601548764045	51	31130.4	32	0.5586647618595013	363	3.4566929133858246	0.26646706586826446	0.2057522123893808	3.731414868105477	0.10101010101010102	0.00338409475465313	0.007252946509519492	0.008156606851549756	0.006289308176100631	0.005674989985311781	0.007726482518833309	281	279	260	0.7090746899595469	0.02265315189583021	0.021798834257667463	0.024651795934898708	523	518	521
ANXA2	annexin A2	No		ENSG00000182718	P07355	Annexin family	1	adhesion, cell_surface_ligand, ecm, ligand, receptor	adhesion, cell_adhesion, cell_surface, cell_surface_ligand, ecm, extracellular, intracellular, ligand, plasma_membrane, receptor, secreted	O60603, O75923, P00533, P00747, P00750, Q8WZ75	DYSF, EGFR, PLAT, PLG, ROBO4, TLR2	ROBO4 [connectomeDB2020:29786451], TLR2 [connectomeDB2020:26885373], EGFR [Cellinker:26438086], DYSF [Cellinker:14506282;HPRD:14506282], PLG [HPRD:10077593;MatrixDB:10077593], PLAT [HPRD:11978811;HPRD:12468550]	adherens junction [GO:0005912]; AnxA2-p11 complex [GO:1990665]; azurophil granule lumen [GO:0035578]; basement membrane [GO:0005604]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; late endosome membrane [GO:0031902]; lipid droplet [GO:0005811]; lysosomal membrane [GO:0005765]; melanosome [GO:0042470]; membrane [GO:0016020]; midbody [GO:0030496]; nucleus [GO:0005634]; PCSK9-AnxA2 complex [GO:1990667]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]; vesicle [GO:0031982]	cadherin binding involved in cell-cell adhesion [GO:0098641]; calcium channel activity [GO:0005262]; calcium-dependent phospholipid binding [GO:0005544]; calcium-dependent protein binding [GO:0048306]; calcium ion binding [GO:0005509]; cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylserine binding [GO:0001786]; phospholipase A2 inhibitor activity [GO:0019834]; protease binding [GO:0002020]; RNA binding [GO:0003723]; S100 protein binding [GO:0044548]; serine-type endopeptidase inhibitor activity [GO:0004867]; virion binding [GO:0046790]	angiogenesis [GO:0001525]; membrane raft assembly [GO:0001765]; negative regulation of low-density lipoprotein particle receptor catabolic process [GO:0032804]; negative regulation of receptor internalization [GO:0002091]; osteoclast development [GO:0036035]; positive regulation of low-density lipoprotein particle clearance [GO:1905581]; positive regulation of low-density lipoprotein particle receptor binding [GO:1905597]; positive regulation of low-density lipoprotein receptor activity [GO:1905599]; positive regulation of plasminogen activation [GO:0010756]; positive regulation of receptor-mediated endocytosis involved in cholesterol transport [GO:1905602]; positive regulation of receptor recycling [GO:0001921]; positive regulation of vacuole organization [GO:0044090]; positive regulation of vesicle fusion [GO:0031340]; vesicle budding from membrane [GO:0006900]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=ANXA2&keywords=ANXA2	1978.5234392253333	13	143070	10	10.118045402070676	44	4.149606299212594	21.007485029940195	2.247787610619468	3.7580335731414145	9.644781144781193	2.5769881556683556	4.642792384406183	2.0277324632952634	0.910839807621158	2.6076912805454344	4.768282789261659	25	14	9	5.303820048953901	0.17329149258685153	0.4926194821107581	0.8992180286952566	450	322	144
APELA	apelin receptor early endogenous ligand	Yes		ENSG00000248329	P0DMC3	Elabela/Toddler family	9	ligand	intracellular, ligand, secreted	P35414	APLNR	APLNR [CellChatDB:25995451;CellTalkDB:28663440;Cellinker:25995451;Cellinker:29079036;Cellinker:29357134;Guide2Pharma:25995451;connectomeDB2020:25639753;connectomeDB2020:26611206;connectomeDB2020:28137936;scConnect:25995451]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	apelin receptor binding [GO:0031704]; hormone activity [GO:0005179]	adult heart development [GO:0007512]; angiogenesis [GO:0001525]; apelin receptor signaling pathway [GO:0060183]; cell migration involved in mesendoderm migration [GO:0090134]; coronary vasculature development [GO:0060976]; embryonic heart tube development [GO:0035050]; endoderm development [GO:0007492]; heart development [GO:0007507]; mesendoderm migration [GO:0090133]; mesoderm migration involved in gastrulation [GO:0007509]; placenta blood vessel development [GO:0060674]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:1903589]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of G protein-coupled receptor internalization [GO:1904022]; positive regulation of heart contraction [GO:0045823]; positive regulation of trophoblast cell migration [GO:1901165]; vasculogenesis [GO:0001570]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=APELA&keywords=APELA	0.31434043707865167	571	NA	NA	2.826148599112371	121	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
APLN	apelin	Yes		ENSG00000171388	Q9ULZ1	Apelin family	14	ligand	extracellular, ligand, secreted	P08913, P35414, P48039, Q14831	ADRA2A, APLNR, GRM7, MTNR1A	APLNR [Baccin2019:10617103;Baccin2019:10777510;Baccin2019:11336787;Baccin2019:12603839;Baccin2019:12939143;Baccin2019:15341513;Baccin2019:9792798;CellTalkDB:10617103;Guide2Pharma:10777510;Guide2Pharma:11336787;Guide2Pharma:12603839;Guide2Pharma:12939143;Guide2Pharma:15341513;HPMR:10802050;HPMR:9792798;HPRD:12603839;LRdb:10617103;LRdb:10777510;LRdb:11336787;LRdb:12603839;LRdb:12939143;LRdb:15341513;LRdb:9792798;connectomeDB2020:10617103;connectomeDB2020:10777510;connectomeDB2020:11336787;connectomeDB2020:12603839;connectomeDB2020:12939143;connectomeDB2020:15341513;connectomeDB2020:9792798;scConnect:10777510;scConnect:11336787;scConnect:12603839;scConnect:12939143;scConnect:15341513], ADRA2A [CellTalkDB:32196115], MTNR1A [CellTalkDB:32196115], GRM7 [CellTalkDB:32196115;LRdb:10617103;LRdb:10777510;LRdb:11336787;LRdb:12603839;LRdb:12939143;LRdb:15341513;LRdb:9792798]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	apelin receptor binding [GO:0031704]; hormone activity [GO:0005179]; signaling receptor binding [GO:0005102]	angiogenesis [GO:0001525]; apelin receptor signaling pathway [GO:0060183]; coronary vasculature development [GO:0060976]; drinking behavior [GO:0042756]; gastrulation [GO:0007369]; immune response [GO:0006955]; lactation [GO:0007595]; negative regulation of blood pressure [GO:0045776]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of gene expression [GO:0010629]; negative regulation of vascular associated smooth muscle cell proliferation [GO:1904706]; positive regulation of G protein-coupled receptor internalization [GO:1904022]; positive regulation of heart contraction [GO:0045823]; positive regulation of pri-miRNA transcription by RNA polymerase II [GO:1902895]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; signal transduction [GO:0007165]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=APLN&keywords=APLN	1.5245690449438203	410	NA	NA	0.29040248594568563	471	0	0.00249500998003992	0.06526548672566376	0.0074340527577937635	0	0.001692047377326565	0.0027198549410698096	0	0	0.0021364668179997305	9.658103148541628e-4	303	343	368	0.007518975355886156	0.5708096390831514	0.6927612244127068	0.6259390228076203	312	255	274
APOA1	apolipoprotein A1	No		ENSG00000118137	P02647	Apolipoprotein A1/A4/E family	2	adhesion, ligand	adhesion, cell_adhesion, extracellular, intracellular, ligand, plasma_membrane, secreted	O95477, P01130, P02649, P04180, P08571, P98164, Q07954	ABCA1, APOE, CD14, LCAT, LDLR, LRP1, LRP2	ABCA1 [CellTalkDB:27100352;HPRD:12084722;InnateDB:22271762;IntAct:12084722;IntAct:30458687;SIGNOR:12869555], APOE [SIGNOR:20642861], LCAT [BioGRID:10026251;BioGRID:10222237;BioGRID:15654758;BioGRID:1587806;BioGRID:1644835;BioGRID:4335615;DIP:17676061;HPRD:1587806;HPRD:1644835;IntAct:1587806;IntAct:17676061;SIGNOR:19860440], LRP2 [CellTalkDB:32196115], LDLR [CellTalkDB:16150825], LRP1 [CellTalkDB:32196115], CD14 [Cellinker:22329401]	blood microparticle [GO:0072562]; chylomicron [GO:0042627]; collagen-containing extracellular matrix [GO:0062023]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endocytic vesicle lumen [GO:0071682]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular vesicle [GO:1903561]; high-density lipoprotein particle [GO:0034364]; plasma membrane [GO:0005886]; secretory granule lumen [GO:0034774]; spherical high-density lipoprotein particle [GO:0034366]; very-low-density lipoprotein particle [GO:0034361]	amyloid-beta binding [GO:0001540]; apolipoprotein A-I receptor binding [GO:0034191]; apolipoprotein receptor binding [GO:0034190]; chemorepellent activity [GO:0045499]; cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; enzyme binding [GO:0019899]; heat shock protein binding [GO:0031072]; high-density lipoprotein particle binding [GO:0008035]; high-density lipoprotein particle receptor binding [GO:0070653]; identical protein binding [GO:0042802]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine-sterol O-acyltransferase activator activity [GO:0060228]; phospholipid binding [GO:0005543]; signaling receptor binding [GO:0005102]	adrenal gland development [GO:0030325]; blood vessel endothelial cell migration [GO:0043534]; cholesterol biosynthetic process [GO:0006695]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol import [GO:0070508]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; endothelial cell proliferation [GO:0001935]; glucocorticoid metabolic process [GO:0008211]; G protein-coupled receptor signaling pathway [GO:0007186]; high-density lipoprotein particle assembly [GO:0034380]; high-density lipoprotein particle clearance [GO:0034384]; high-density lipoprotein particle remodeling [GO:0034375]; integrin-mediated signaling pathway [GO:0007229]; lipid storage [GO:0019915]; lipoprotein biosynthetic process [GO:0042158]; lipoprotein metabolic process [GO:0042157]; negative chemotaxis [GO:0050919]; negative regulation of cell adhesion molecule production [GO:0060354]; negative regulation of cytokine production involved in immune response [GO:0002719]; negative regulation of heterotypic cell-cell adhesion [GO:0034115]; negative regulation of hydrolase activity [GO:0051346]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of response to cytokine stimulus [GO:0060761]; negative regulation of tumor necrosis factor-mediated signaling pathway [GO:0010804]; negative regulation of very-low-density lipoprotein particle remodeling [GO:0010903]; peptidyl-methionine modification [GO:0018206]; phosphatidylcholine biosynthetic process [GO:0006656]; phosphatidylcholine metabolic process [GO:0046470]; phospholipid efflux [GO:0033700]; phospholipid homeostasis [GO:0055091]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of cholesterol esterification [GO:0010873]; positive regulation of fatty acid biosynthetic process [GO:0045723]; positive regulation of hydrolase activity [GO:0051345]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of lipoprotein lipase activity [GO:0051006]; positive regulation of phagocytosis [GO:0050766]; positive regulation of phospholipid efflux [GO:1902995]; positive regulation of Rho protein signal transduction [GO:0035025]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive regulation of triglyceride catabolic process [GO:0010898]; protein oxidation [GO:0018158]; protein stabilization [GO:0050821]; regulation of Cdc42 protein signal transduction [GO:0032489]; regulation of intestinal cholesterol absorption [GO:0030300]; regulation of protein phosphorylation [GO:0001932]; reverse cholesterol transport [GO:0043691]; triglyceride homeostasis [GO:0070328]; very-low-density lipoprotein particle remodeling [GO:0034372]; vitamin transport [GO:0051180]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=APOA1&keywords=APOA1	0.13378301827066022	648	7803.92	80	0.0011882860627540491	896	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
APOA2	apolipoprotein A2	No		ENSG00000158874	P02652	Apolipoprotein A2 family	1	ligand	extracellular, intracellular, ligand, secreted	P01130, P98164, Q07954	LDLR, LRP1, LRP2	LDLR [CellTalkDB:32196115], LRP1 [CellTalkDB:32196115], LRP2 [CellTalkDB:32196115]	blood microparticle [GO:0072562]; chylomicron [GO:0042627]; cytosol [GO:0005829]; early endosome [GO:0005769]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; high-density lipoprotein particle [GO:0034364]; spherical high-density lipoprotein particle [GO:0034366]; very-low-density lipoprotein particle [GO:0034361]	apolipoprotein receptor binding [GO:0034190]; cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; heat shock protein binding [GO:0031072]; high-density lipoprotein particle binding [GO:0008035]; high-density lipoprotein particle receptor binding [GO:0070653]; lipase inhibitor activity [GO:0055102]; lipid binding [GO:0008289]; lipid transporter activity [GO:0005319]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine-sterol O-acyltransferase activator activity [GO:0060228]; phospholipid binding [GO:0005543]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]	acute inflammatory response [GO:0002526]; animal organ regeneration [GO:0031100]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; diacylglycerol catabolic process [GO:0046340]; high-density lipoprotein particle assembly [GO:0034380]; high-density lipoprotein particle clearance [GO:0034384]; high-density lipoprotein particle remodeling [GO:0034375]; lipoprotein metabolic process [GO:0042157]; low-density lipoprotein particle remodeling [GO:0034374]; negative regulation of cholesterol import [GO:0060621]; negative regulation of cholesterol transport [GO:0032375]; negative regulation of cholesterol transporter activity [GO:0060695]; negative regulation of cytokine production involved in immune response [GO:0002719]; negative regulation of lipase activity [GO:0060192]; negative regulation of lipid catabolic process [GO:0050995]; negative regulation of very-low-density lipoprotein particle remodeling [GO:0010903]; peptidyl-methionine modification [GO:0018206]; phosphatidylcholine biosynthetic process [GO:0006656]; phospholipid catabolic process [GO:0009395]; phospholipid efflux [GO:0033700]; positive regulation of cholesterol esterification [GO:0010873]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of lipid catabolic process [GO:0050996]; positive regulation of phagocytosis [GO:0050766]; protein oxidation [GO:0018158]; protein stabilization [GO:0050821]; regulation of intestinal cholesterol absorption [GO:0030300]; regulation of protein stability [GO:0031647]; response to estrogen [GO:0043627]; response to glucocorticoid [GO:0051384]; response to glucose [GO:0009749]; response to xenobiotic stimulus [GO:0009410]; reverse cholesterol transport [GO:0043691]; triglyceride metabolic process [GO:0006641]; triglyceride-rich lipoprotein particle remodeling [GO:0034370]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=APOA2&keywords=APOA2	0.1444961404494382	645	1591.85	144	0.0015079921628645063	893	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
APOA4	apolipoprotein A4	No		ENSG00000110244	P06727	Apolipoprotein A1/A4/E family	1	ligand	extracellular, intracellular, ligand, secreted	P01130, P98164, Q07954	LDLR, LRP1, LRP2	LDLR [CellTalkDB:32196115], LRP1 [CellTalkDB:32196115], LRP2 [CellTalkDB:32196115]	blood microparticle [GO:0072562]; chylomicron [GO:0042627]; collagen-containing extracellular matrix [GO:0062023]; cytosol [GO:0005829]; early endosome [GO:0005769]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; high-density lipoprotein particle [GO:0034364]; synapse [GO:0045202]; very-low-density lipoprotein particle [GO:0034361]	antioxidant activity [GO:0016209]; cholesterol binding [GO:0015485]; cholesterol transfer activity [GO:0120020]; copper ion binding [GO:0005507]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]; lipid transporter activity [GO:0005319]; phosphatidylcholine binding [GO:0031210]; phosphatidylcholine-sterol O-acyltransferase activator activity [GO:0060228]; phospholipid binding [GO:0005543]; protein homodimerization activity [GO:0042803]	cholesterol biosynthetic process [GO:0006695]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; chylomicron assembly [GO:0034378]; chylomicron remodeling [GO:0034371]; high-density lipoprotein particle assembly [GO:0034380]; high-density lipoprotein particle remodeling [GO:0034375]; hydrogen peroxide catabolic process [GO:0042744]; innate immune response in mucosa [GO:0002227]; leukocyte cell-cell adhesion [GO:0007159]; lipid catabolic process [GO:0016042]; lipid homeostasis [GO:0055088]; lipid transport [GO:0006869]; lipoprotein metabolic process [GO:0042157]; negative regulation of plasma lipoprotein oxidation [GO:0034445]; peripheral nervous system axon regeneration [GO:0014012]; phosphatidylcholine metabolic process [GO:0046470]; phospholipid efflux [GO:0033700]; positive regulation of cholesterol esterification [GO:0010873]; positive regulation of fatty acid biosynthetic process [GO:0045723]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of lipoprotein lipase activity [GO:0051006]; positive regulation of triglyceride catabolic process [GO:0010898]; protein-lipid complex assembly [GO:0065005]; regulation of cholesterol transport [GO:0032374]; regulation of intestinal cholesterol absorption [GO:0030300]; removal of superoxide radicals [GO:0019430]; response to lipid hydroperoxide [GO:0006982]; response to stilbenoid [GO:0035634]; response to triglyceride [GO:0034014]; reverse cholesterol transport [GO:0043691]; triglyceride homeostasis [GO:0070328]; very-low-density lipoprotein particle remodeling [GO:0034372]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=APOA4&keywords=APOA4	0.004331044943820225	860	4995.03	92	0.0032790508785286283	878	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
APOB	apolipoprotein B	No	manually added ensembl_gene_ID, hgnc_symbol, and description by searching the uniprot ID on genenames.org	ENSG00000084674	P04114	NA	9	ligand	intracellular, ligand, secreted	O00206, O75581, P01130, P05107, P06733, P07550, P11215, P30988, P55157, P78380, P98155, P98164, Q07954, Q14114, Q86X29, Q9NZC2, Q9Y2C9	ADRB2, CALCR, ENO1, ITGAM, ITGB2, LDLR, LRP1, LRP2, LRP6, LRP8, LSR, MTTP, OLR1, TLR4, TLR6, TREM2, VLDLR	LDLR [Baccin2019:1132787812031600;CellTalkDB:11327878;Cellinker:11327878;Cellinker:12031600;Cellinker:15840700;HPRD:12031600;LRdb:11327878;LRdb:12;Lit-BM-17:24447298;SIGNOR:11986215;connectomeDB2020:11327878;connectomeDB2020:12031600], MTTP [BioGRID:26224785;BioGRID:9915855;CellTalkDB:29650752;HPRD:11358959;HPRD:9915855;IntAct:26224785;IntAct:27487388;Lit-BM-17:26224785;Lit-BM-17:9915855], ITGAM [CellTalkDB:32196115], LRP6 [NA], OLR1 [CellTalkDB:9763524;LRdb:9763524;Ramilowski2015:9763524;connectomeDB2020:9763524;talklr:9763524], LRP2 [Baccin2019:10330424;CellTalkDB:10330424;Cellinker:10330424;HPRD:10330424;LRdb:10330424;connectomeDB2020:10330424], VLDLR [CellTalkDB:32196115], CALCR [CellTalkDB:32196115], LSR [CellTalkDB:7615497;Cellinker:7615497;LRdb:7615497;Ramilowski2015:7615497;connectomeDB2020:7615497;talklr:7615497], ADRB2 [CellTalkDB:32196115], TLR6 [CellTalkDB:32196115], LRP1 [CellTalkDB:32196115], ITGB2 [CellTalkDB:32196115], TLR4 [CellTalkDB:32196115], LRP8 [CellTalkDB:32196115], ENO1 [connectomeDB2020:29997113], TREM2 [Cellinker:28432014]	chylomicron [GO:0042627]; chylomicron remnant [GO:0034360]; clathrin-coated endocytic vesicle membrane [GO:0030669]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endocytic vesicle lumen [GO:0071682]; endoplasmic reticulum exit site [GO:0070971]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; endosome lumen [GO:0031904]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; high-density lipoprotein particle [GO:0034364]; intermediate-density lipoprotein particle [GO:0034363]; intracellular membrane-bounded organelle [GO:0043231]; lipid droplet [GO:0005811]; low-density lipoprotein particle [GO:0034362]; lysosomal lumen [GO:0043202]; mature chylomicron [GO:0034359]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; smooth endoplasmic reticulum [GO:0005790]; very-low-density lipoprotein particle [GO:0034361]; vesicle lumen [GO:0031983]	cholesterol transfer activity [GO:0120020]; heparin binding [GO:0008201]; lipase binding [GO:0035473]; low-density lipoprotein particle receptor binding [GO:0050750]; phospholipid binding [GO:0005543]	artery morphogenesis [GO:0048844]; cellular response to prostaglandin stimulus [GO:0071379]; cellular response to tumor necrosis factor [GO:0071356]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; fertilization [GO:0009566]; flagellated sperm motility [GO:0030317]; in utero embryonic development [GO:0001701]; lipoprotein biosynthetic process [GO:0042158]; lipoprotein catabolic process [GO:0042159]; lipoprotein transport [GO:0042953]; low-density lipoprotein particle clearance [GO:0034383]; low-density lipoprotein particle remodeling [GO:0034374]; nervous system development [GO:0007399]; positive regulation of cholesterol storage [GO:0010886]; positive regulation of gene expression [GO:0010628]; positive regulation of lipid storage [GO:0010884]; positive regulation of macrophage derived foam cell differentiation [GO:0010744]; post-embryonic development [GO:0009791]; regulation of cholesterol biosynthetic process [GO:0045540]; response to carbohydrate [GO:0009743]; response to estradiol [GO:0032355]; response to lipopolysaccharide [GO:0032496]; response to selenium ion [GO:0010269]; response to virus [GO:0009615]; spermatogenesis [GO:0007283]; triglyceride catabolic process [GO:0019433]; triglyceride mobilization [GO:0006642]; very-low-density lipoprotein particle assembly [GO:0034379]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=APOB&keywords=APOB	0.03260359526643854	764	8821.02	74	0.0056654148028821485	858	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
APOC2	apolipoprotein C2	No		ENSG00000234906	P02655	Apolipoprotein C2 family	1	ligand	extracellular, intracellular, ligand, secreted	P01130, P06858, P98164, Q07954	LDLR, LPL, LRP1, LRP2	LDLR [CellTalkDB:32196115], LRP1 [CellTalkDB:32196115], LRP2 [CellTalkDB:32196115], LPL [HPRD:10727238;HPRD:11579204]	chylomicron [GO:0042627]; early endosome [GO:0005769]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intermediate-density lipoprotein particle [GO:0034363]; low-density lipoprotein particle [GO:0034362]; spherical high-density lipoprotein particle [GO:0034366]; very-low-density lipoprotein particle [GO:0034361]	identical protein binding [GO:0042802]; lipase inhibitor activity [GO:0055102]; lipid binding [GO:0008289]; lipoprotein lipase activator activity [GO:0060230]; phospholipase activator activity [GO:0016004]; phospholipase binding [GO:0043274]	cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; chylomicron remnant clearance [GO:0034382]; chylomicron remodeling [GO:0034371]; high-density lipoprotein particle clearance [GO:0034384]; lipid catabolic process [GO:0016042]; negative regulation of cholesterol transport [GO:0032375]; negative regulation of lipid metabolic process [GO:0045833]; negative regulation of receptor-mediated endocytosis [GO:0048261]; negative regulation of very-low-density lipoprotein particle clearance [GO:0010916]; phospholipid efflux [GO:0033700]; positive regulation of fatty acid biosynthetic process [GO:0045723]; positive regulation of lipoprotein lipase activity [GO:0051006]; positive regulation of phospholipase activity [GO:0010518]; positive regulation of phospholipid catabolic process [GO:0060697]; positive regulation of triglyceride catabolic process [GO:0010898]; positive regulation of very-low-density lipoprotein particle remodeling [GO:0010902]; reverse cholesterol transport [GO:0043691]; triglyceride homeostasis [GO:0070328]; triglyceride-rich lipoprotein particle remodeling [GO:0034370]; very-low-density lipoprotein particle remodeling [GO:0034372]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=APOC2&keywords=APOC2	1.2186140751685393	431	NA	NA	0.033272952911232244	759	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
APOC3	apolipoprotein C3	No		ENSG00000110245	P02656	Apolipoprotein C3 family	2	ligand	extracellular, intracellular, ligand, secreted	O60603, P01130, P34741, P98164, Q07954	LDLR, LRP1, LRP2, SDC2, TLR2	LRP2 [CellTalkDB:32196115], LDLR [CellTalkDB:27400128], LRP1 [CellTalkDB:27400128], SDC2 [CellTalkDB:27400128], TLR2 [CellTalkDB:32196115]	chylomicron [GO:0042627]; collagen-containing extracellular matrix [GO:0062023]; early endosome [GO:0005769]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intermediate-density lipoprotein particle [GO:0034363]; spherical high-density lipoprotein particle [GO:0034366]; very-low-density lipoprotein particle [GO:0034361]	cholesterol binding [GO:0015485]; enzyme regulator activity [GO:0030234]; high-density lipoprotein particle receptor binding [GO:0070653]; lipase inhibitor activity [GO:0055102]; phospholipid binding [GO:0005543]	cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; chylomicron remnant clearance [GO:0034382]; G protein-coupled receptor signaling pathway [GO:0007186]; high-density lipoprotein particle remodeling [GO:0034375]; lipoprotein metabolic process [GO:0042157]; negative regulation of cholesterol import [GO:0060621]; negative regulation of fatty acid biosynthetic process [GO:0045717]; negative regulation of high-density lipoprotein particle clearance [GO:0010987]; negative regulation of lipid catabolic process [GO:0050995]; negative regulation of lipid metabolic process [GO:0045833]; negative regulation of lipoprotein lipase activity [GO:0051005]; negative regulation of low-density lipoprotein particle clearance [GO:0010989]; negative regulation of receptor-mediated endocytosis [GO:0048261]; negative regulation of triglyceride catabolic process [GO:0010897]; negative regulation of very-low-density lipoprotein particle clearance [GO:0010916]; negative regulation of very-low-density lipoprotein particle remodeling [GO:0010903]; phospholipid efflux [GO:0033700]; regulation of Cdc42 protein signal transduction [GO:0032489]; reverse cholesterol transport [GO:0043691]; triglyceride catabolic process [GO:0019433]; triglyceride homeostasis [GO:0070328]; triglyceride metabolic process [GO:0006641]; very-low-density lipoprotein particle assembly [GO:0034379]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=APOC3&keywords=APOC3	0.05190400288764045	734	285.579	166	4.3305409011496073e-4	902	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
APOC4	apolipoprotein C4	No		ENSG00000267467	P55056	Apolipoprotein C4 family	1	ligand	extracellular, intracellular, ligand, secreted	P98155	VLDLR	VLDLR [CellTalkDB:10996355]	extracellular region [GO:0005576]; high-density lipoprotein particle [GO:0034364]; very-low-density lipoprotein particle [GO:0034361]	lipid transporter activity [GO:0005319]	lipid metabolic process [GO:0006629]; positive regulation of sequestering of triglyceride [GO:0010890]; triglyceride homeostasis [GO:0070328]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=APOC4&keywords=APOC4	0.1217757484269663	657	NA	NA	0.022161011977480757	793	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
APOD	apolipoprotein D	No		ENSG00000189058	P05090	Calycin superfamily, Lipocalin family	9	ligand	extracellular, intracellular, ligand, secreted	P48357	LEPR	LEPR [Baccin2019:11344130;CellTalkDB:11344130;Cellinker:11344130;HPRD:11344130;LRdb:11344130;connectomeDB2020:11344130]	cytoplasm [GO:0005737]; cytosolic ribosome [GO:0022626]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; neuronal cell body [GO:0043025]; perinuclear region of cytoplasm [GO:0048471]	cholesterol binding [GO:0015485]; lipid transporter activity [GO:0005319]	aging [GO:0007568]; angiogenesis [GO:0001525]; brain development [GO:0007420]; glucose metabolic process [GO:0006006]; lipid metabolic process [GO:0006629]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of lipoprotein lipid oxidation [GO:0060588]; negative regulation of monocyte chemotactic protein-1 production [GO:0071638]; negative regulation of platelet-derived growth factor receptor signaling pathway [GO:0010642]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of smooth muscle cell-matrix adhesion [GO:2000098]; negative regulation of smooth muscle cell proliferation [GO:0048662]; negative regulation of T cell migration [GO:2000405]; peripheral nervous system axon regeneration [GO:0014012]; response to axon injury [GO:0048678]; response to reactive oxygen species [GO:0000302]; tissue regeneration [GO:0042246]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=APOD&keywords=APOD	30.82470144061236	131	5138.55	91	0.04209957589403825	731	0	0.001497005988023952	0.008849557522123894	0.6515587529976109	0.00505050505050505	0.00338409475465313	9.066183136899365e-4	0.0032626427406199023	0.004069552349241584	0.002169849112030976	8.499130770716634e-4	290	342	373	0.06196349926414282	0.19550956378037063	0.16911141393168516	0.15076967056933874	437	432	448
APOE	apolipoprotein E	No		ENSG00000130203	P02649	Apolipoprotein A1/A4/E family	9	ecm, ligand	ecm, extracellular, intracellular, ligand, secreted	O75096, O75197, O75581, O95477, P01130, P05067, P10636, P11150, P34741, P43681, P98155, P98164, Q07954, Q14114, Q86X29, Q8WTV0, Q92673, Q9NZC2	ABCA1, APP, CHRNA4, LDLR, LIPC, LRP1, LRP2, LRP4, LRP5, LRP6, LRP8, LSR, MAPT, SCARB1, SDC2, SORL1, TREM2, VLDLR	MAPT [BioGRID:7566652;BioGRID:8620924;HPRD-phos:9512010;HPRD:7566652;HPRD:9147408;HPRD:9512010;SIGNOR:7566652], VLDLR [AlzPathway:16504486;Baccin2019:12167620;Baccin2019:12870663;CellTalkDB:12870663;Cellinker:12167620;Cellinker:12870663;DIP:19116273;HPRD:12167620;LRdb:12;LRdb:12870663;SIGNOR:11278667;connectomeDB2020:12167620;connectomeDB2020:12870663], SORL1 [Baccin2019:11294867;CellTalkDB:11294867;Cellinker:11294867;HPMR:11294867;HPMR:11557679;LRdb:11294867;SIGNOR:11557679;connectomeDB2020:11294867], LRP6 [CellTalkDB:22461740], LRP2 [Baccin2019:11421580;CellTalkDB:16266282;Cellinker:11421580;HPRD:11421580;LRdb:11421580;connectomeDB2020:1464627], LDLR [Baccin2019:11327878;Baccin2019:12036960;CellTalkDB:11327878;Cellinker:11327878;Cellinker:12036962;Cellinker:15840700;Cellinker:31677479;HPRD:12036962;IntAct:20030366;IntAct:24447298;LRdb:11327878;LRdb:12;Lit-BM-17:24447298;connectomeDB2020:11327878;connectomeDB2020:12036962], LRP5 [Baccin2019:9832610;CellTalkDB:9832610;HPMR:9832610], CHRNA4 [CellTalkDB:32196115], TREM2 [CellTalkDB:27477018;Cellinker:28432014;IntAct:30341064], LSR [Cellinker:7615497], ABCA1 [CellTalkDB:24814386], SCARB1 [Baccin2019:12138091;CellTalkDB:12138091;Cellinker:12138091;HPRD:12138091;LRdb:12138091;connectomeDB2020:12138091], SDC2 [AlzPathway:9869645;CellTalkDB:15583000], LRP8 [AlzPathway:16504486;Baccin2019:12167620;Baccin2019:12950167;BioGRID:12950167;BioGRID:8626535;CellTalkDB:12950167;Cellinker:12167620;Cellinker:12950167;HPRD:12167620;HPRD:12950167;LRdb:12167620;LRdb:12950167;connectomeDB2020:12167620;connectomeDB2020:12950167], LRP4 [CellTalkDB:25688974], LRP1 [AlzPathway:19026743;Baccin2019:11421580;CellTalkDB:11421580;Cellinker:11421580;Cellinker:31677479;HPRD:11421580;IntAct:15182176;IntAct:20030366;LRdb:11421580;connectomeDB2020:22622580;connectomeDB2020:2779654], APP [BioGRID:10842709;DIP:10428074;HPRD:10559559;IntAct:17116874;MPPI:9202294], LIPC [AlzPathway:9869645]	blood microparticle [GO:0072562]; chylomicron [GO:0042627]; clathrin-coated endocytic vesicle membrane [GO:0030669]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; discoidal high-density lipoprotein particle [GO:0034365]; early endosome [GO:0005769]; endocytic vesicle lumen [GO:0071682]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular vesicle [GO:1903561]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; high-density lipoprotein particle [GO:0034364]; intermediate-density lipoprotein particle [GO:0034363]; lipoprotein particle [GO:1990777]; low-density lipoprotein particle [GO:0034362]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; synaptic cleft [GO:0043083]; very-low-density lipoprotein particle [GO:0034361]	amyloid-beta binding [GO:0001540]; antioxidant activity [GO:0016209]; cholesterol transfer activity [GO:0120020]; heparan sulfate proteoglycan binding [GO:0043395]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]; lipid transporter activity [GO:0005319]; lipoprotein particle binding [GO:0071813]; low-density lipoprotein particle receptor binding [GO:0050750]; metal chelating activity [GO:0046911]; phosphatidylcholine-sterol O-acyltransferase activator activity [GO:0060228]; phospholipid binding [GO:0005543]; protein-containing complex binding [GO:0044877]; protein dimerization activity [GO:0046983]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]; structural molecule activity [GO:0005198]; tau protein binding [GO:0048156]; very-low-density lipoprotein particle receptor binding [GO:0070326]	AMPA glutamate receptor clustering [GO:0097113]; amyloid precursor protein metabolic process [GO:0042982]; artery morphogenesis [GO:0048844]; cellular calcium ion homeostasis [GO:0006874]; cGMP-mediated signaling [GO:0019934]; cholesterol catabolic process [GO:0006707]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; chylomicron remnant clearance [GO:0034382]; cytoskeleton organization [GO:0007010]; fatty acid homeostasis [GO:0055089]; gene expression [GO:0010467]; G protein-coupled receptor signaling pathway [GO:0007186]; high-density lipoprotein particle assembly [GO:0034380]; high-density lipoprotein particle clearance [GO:0034384]; high-density lipoprotein particle remodeling [GO:0034375]; intermediate-density lipoprotein particle clearance [GO:0071831]; intracellular transport [GO:0046907]; lipid transport involved in lipid storage [GO:0010877]; lipoprotein biosynthetic process [GO:0042158]; lipoprotein catabolic process [GO:0042159]; locomotory exploration behavior [GO:0035641]; long-chain fatty acid transport [GO:0015909]; long-term memory [GO:0007616]; low-density lipoprotein particle remodeling [GO:0034374]; maintenance of location in cell [GO:0051651]; negative regulation of amyloid-beta formation [GO:1902430]; negative regulation of amyloid fibril formation [GO:1905907]; negative regulation of blood coagulation [GO:0030195]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cellular protein metabolic process [GO:0032269]; negative regulation of cholesterol biosynthetic process [GO:0045541]; negative regulation of cholesterol efflux [GO:0090370]; negative regulation of dendritic spine development [GO:0061000]; negative regulation of dendritic spine maintenance [GO:1902951]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of gene expression [GO:0010629]; negative regulation of inflammatory response [GO:0050728]; negative regulation of lipid biosynthetic process [GO:0051055]; negative regulation of lipid transport across blood-brain barrier [GO:1903001]; negative regulation of long-term synaptic potentiation [GO:1900272]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron death [GO:1901215]; negative regulation of neuron projection development [GO:0010977]; negative regulation of phospholipid efflux [GO:1902999]; negative regulation of platelet activation [GO:0010544]; negative regulation of postsynaptic membrane organization [GO:1901627]; negative regulation of protein secretion [GO:0050709]; negative regulation of smooth muscle cell proliferation [GO:0048662]; negative regulation of triglyceride metabolic process [GO:0090209]; neuron projection development [GO:0031175]; nitric oxide mediated signal transduction [GO:0007263]; NMDA glutamate receptor clustering [GO:0097114]; phospholipid efflux [GO:0033700]; positive regulation by host of viral process [GO:0044794]; positive regulation of amyloid-beta clearance [GO:1900223]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of amyloid fibril formation [GO:1905908]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of cholesterol esterification [GO:0010873]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of dendritic spine maintenance [GO:1902952]; positive regulation of endocytosis [GO:0045807]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of heparan sulfate binding [GO:1905855]; positive regulation of heparan sulfate proteoglycan binding [GO:1905860]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of lipid transport across blood-brain barrier [GO:1903002]; positive regulation of low-density lipoprotein particle receptor catabolic process [GO:0032805]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; positive regulation of neurofibrillary tangle assembly [GO:1902998]; positive regulation of neuron death [GO:1901216]; positive regulation of neuron projection development [GO:0010976]; positive regulation of nitric-oxide synthase activity [GO:0051000]; positive regulation of phospholipid efflux [GO:1902995]; positive regulation of presynaptic membrane organization [GO:1901631]; positive regulation of transcription, DNA-templated [GO:0045893]; protein import [GO:0017038]; receptor-mediated endocytosis [GO:0006898]; regulation of amyloid-beta clearance [GO:1900221]; regulation of amyloid fibril formation [GO:1905906]; regulation of amyloid precursor protein catabolic process [GO:1902991]; regulation of axon extension [GO:0030516]; regulation of behavioral fear response [GO:2000822]; regulation of Cdc42 protein signal transduction [GO:0032489]; regulation of cellular response to very-low-density lipoprotein particle stimulus [GO:1905890]; regulation of cholesterol metabolic process [GO:0090181]; regulation of innate immune response [GO:0045088]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of neuron death [GO:1901214]; regulation of proteasomal protein catabolic process [GO:0061136]; regulation of protein-containing complex assembly [GO:0043254]; regulation of protein metabolic process [GO:0051246]; regulation of tau-protein kinase activity [GO:1902947]; response to caloric restriction [GO:0061771]; response to dietary excess [GO:0002021]; response to reactive oxygen species [GO:0000302]; reverse cholesterol transport [GO:0043691]; synaptic transmission, cholinergic [GO:0007271]; triglyceride homeostasis [GO:0070328]; triglyceride metabolic process [GO:0006641]; triglyceride-rich lipoprotein particle clearance [GO:0071830]; vasodilation [GO:0042311]; very-low-density lipoprotein particle clearance [GO:0034447]; very-low-density lipoprotein particle remodeling [GO:0034372]; virion assembly [GO:0019068]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=APOE&keywords=APOE	3.9003226277209406	316	8510.6	77	0.008026251202747183	847	0.8031496062992126	0.018463073852295397	0.0011061946902654867	0.6124700239808181	0.0016835016835016834	0	0.005439709882139619	0.0016313213703099511	3.699593044765076e-4	0.001635732407531044	0.0015839289163608276	302	354	342	0.13159391385335556	0.07323732371164168	0.08217678352744605	0.08181092393814288	492	478	483
APOO	apolipoprotein O	No		ENSG00000184831	Q9BUR5	Apolipoprotein O/MICOS complex subunit Mic27 family	1	ligand	intracellular, ligand, secreted, transmembrane, transmembrane_predicted	Q9NP60, Q9NZN1	IL1RAPL1, IL1RAPL2	IL1RAPL2 [Cellinker:32589946], IL1RAPL1 [Cellinker:32589946]	cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi membrane [GO:0000139]; high-density lipoprotein particle [GO:0034364]; integral component of mitochondrial inner membrane [GO:0031305]; low-density lipoprotein particle [GO:0034362]; MIB complex [GO:0140275]; MICOS complex [GO:0061617]; mitochondrion [GO:0005739]; SAM complex [GO:0001401]; very-low-density lipoprotein particle [GO:0034361]	NA	cristae formation [GO:0042407]; inner mitochondrial membrane organization [GO:0007007]; lipid transport [GO:0006869]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=APOO&keywords=APOO	30.402896206741573	133	21151.5	46	2.4821272918377284	129	0.07874015748031496	0.13922155688622773	0.021017699115044253	0.12973621103117638	0.11616161616161634	0.292724196277496	0.31459655485040705	0.21533442088091334	0.31816500184979774	0.19001201762584233	0.2778443113772311	56	79	58	0.19032306759418793	1.6381787968352723	0.9984472583608008	1.4369004769852198	51	131	38
APP	amyloid beta precursor protein			ENSG00000142192	P05067	APP family	3	adhesion, cell_surface_ligand, receptor	adhesion, cell_adhesion, cell_surface, cell_surface_ligand, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, secreted, transmembrane, transmembrane_predicted	O75509, O75581, O95858, O95859, P04233, P04406, P04629, P08138, P08865, P08913, P10636, P17948, P25090, P29474, P35052, P43116, P43146, P45983, P46531, P48039, P49841, P51693, P56817, P98155, Q00535, Q03135, Q04721, Q06481, Q07954, Q13393, Q13564, Q14831, Q15109, Q7Z4F1, Q92542, Q92673, Q96JT2, Q99767, Q9P232	ADRA2A, AGER, APBA2, APLP1, APLP2, BACE1, CAV1, CD74, CDK5, CNTN3, DCC, FLT1, FPR2, GAPDH, GPC1, GRM7, GSK3B, LRP1, LRP10, LRP6, MAPK8, MAPT, MTNR1A, NAE1, NCSTN, NGFR, NOS3, NOTCH1, NOTCH2, NTRK1, PLD1, PTGER2, RPSA, SLC45A3, SORL1, TNFRSF21, TSPAN12, TSPAN15, VLDLR	BACE1 [BioGRID:19251705;BioGRID:28869759;HPRD:10531052;IntAct:10677483;IntAct:12901838;IntAct:22801501;IntAct:30538620;IntAct:32814053], NAE1 [HPRD:8626687;SIGNOR:25568892], MAPK8 [InnateDB:12917434], GSK3B [HPRD:10936190;HPRD:15178331;HPRD:8764598;ProtMapper:29215943;SIGNOR:8764598], CDK5 [HPRD:10936190;HPRD:15178331;HPRD:8764598;ProtMapper:19700222;SIGNOR:10936190], VLDLR [CellTalkDB:22429478], MTNR1A [CellTalkDB:32196115], FPR2 [CellTalkDB:11316806;Cellinker:11160457;Cellinker:11316806;LRdb:11;LRdb:11316806;connectomeDB2020:11160457;connectomeDB2020:11316806;scConnect:11160457;scConnect:11316806], GRM7 [CellTalkDB:32196115], LRP10 [CellTalkDB:22734645], PLD1 [CellTalkDB:16797788], TSPAN15 [CellTalkDB:28066176], DCC [CellTalkDB:22782894], CAV1 [CellTalkDB:9553108;HPRD:9553108;LRdb:9553108;connectomeDB2020:9553108], RPSA [CellTalkDB:24990253], TNFRSF21 [CellTalkDB:19225519;Cellinker:19225519;DIP:19225519;LRdb:19225519;Lit-BM-17:19225519;Ramilowski2015:19225519;connectomeDB2020:19225519;talklr:19225519], NCSTN [CancerCellMap:12011466;CellTalkDB:10993067;HPRD:10993067;LRdb:10993067;connectomeDB2020:10993067], AGER [CellTalkDB:26758977], CD74 [CellChatDB:19849849;CellTalkDB:19849849;Cellinker:19849849;InnateDB:21832049;LRdb:19849849;Ramilowski2015:19849849;connectomeDB2020:19849849;talklr:19849849], NGFR [BioGRID:19710315;CellTalkDB:11756426;Cellinker:24224055;DIP:19225519;Lit-BM-17:11756426;Lit-BM-17:19225519], APLP1 [CellTalkDB:19126676], TSPAN12 [CellTalkDB:28066176], LRP1 [CellTalkDB:12212791;HPRD:12212791;HPRD:7543026;LRdb:12212791;LRdb:75;connectomeDB2020:12212791;connectomeDB2020:7543026], PTGER2 [CellTalkDB:24069330], NOTCH2 [CellTalkDB:16118793], SORL1 [AlzPathway:18332244;CellTalkDB:24833601;IntAct:16174740;IntAct:16407538;IntAct:25643321;IntAct:32814053], LRP6 [CellTalkDB:30232325], APLP2 [CellTalkDB:19126676], GPC1 [CellTalkDB:15084524;HPRD:15084524;LRdb:15084524;connectomeDB2020:15084524], ADRA2A [CellTalkDB:32196115], SLC45A3 [NA], NTRK1 [Cellinker:24224055], CNTN3 [Cellinker:32589946], FLT1 [Cellinker:32589946], NOTCH1 [BioGRID:16175584], GAPDH [HPRD:8473906;InnateDB:21832049], MAPT [IntAct:16446437;IntAct:32814053;ProtMapper:23020770;ProtMapper:26118757;ProtMapper:27520374;ProtMapper:28790888], NOS3 [Lit-BM-17:21163940;ProtMapper:25935150], APBA2 [HPRD:9890987;Lit-BM-17:12196555;Lit-BM-17:12972431;Lit-BM-17:9890987]	amyloid-beta complex [GO:0106003]; apical part of cell [GO:0045177]; astrocyte projection [GO:0097449]; axon [GO:0030424]; cell-cell junction [GO:0005911]; cell surface [GO:0009986]; ciliary rootlet [GO:0035253]; clathrin-coated pit [GO:0005905]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endosome [GO:0005768]; endosome lumen [GO:0031904]; endosome to plasma membrane transport vesicle [GO:0070381]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi-associated vesicle [GO:0005798]; Golgi lumen [GO:0005796]; growth cone filopodium [GO:1990812]; growth cone lamellipodium [GO:1990761]; high-density lipoprotein particle [GO:0034364]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intermediate-density lipoprotein particle [GO:0034363]; lipoprotein particle [GO:1990777]; main axon [GO:0044304]; membrane [GO:0016020]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; neuromuscular junction [GO:0031594]; nuclear envelope lumen [GO:0005641]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; platelet alpha granule lumen [GO:0031093]; presynaptic active zone [GO:0048786]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235]; recycling endosome [GO:0055037]; rough endoplasmic reticulum [GO:0005791]; smooth endoplasmic reticulum [GO:0005790]; spindle midzone [GO:0051233]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; trans-Golgi network membrane [GO:0032588]	acetylcholine receptor activator activity [GO:0030549]; acetylcholine receptor binding [GO:0033130]; amylin binding [GO:0097645]; apolipoprotein binding [GO:0034185]; chaperone binding [GO:0051087]; chemoattractant activity [GO:0042056]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; enzyme binding [GO:0019899]; ephrin receptor binding [GO:0046875]; frizzled binding [GO:0005109]; G protein-coupled receptor binding [GO:0001664]; growth factor receptor binding [GO:0070851]; heparan sulfate binding [GO:1904399]; heparan sulfate proteoglycan binding [GO:0043395]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; insulin receptor binding [GO:0005158]; integrin binding [GO:0005178]; low-density lipoprotein particle receptor binding [GO:0050750]; peptidase activator activity [GO:0016504]; protein dimerization activity [GO:0046983]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; PTB domain binding [GO:0051425]; RAGE receptor binding [GO:0050786]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; serine-type endopeptidase inhibitor activity [GO:0004867]; signaling receptor activator activity [GO:0030546]; signaling receptor binding [GO:0005102]; transition metal ion binding [GO:0046914]	adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; adult locomotory behavior [GO:0008344]; amyloid fibril formation [GO:1990000]; antibacterial humoral response [GO:0019731]; antifungal humoral response [GO:0019732]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; associative learning [GO:0008306]; astrocyte activation [GO:0048143]; astrocyte activation involved in immune response [GO:0002265]; axo-dendritic transport [GO:0008088]; axon midline choice point recognition [GO:0016199]; axonogenesis [GO:0007409]; calcium-mediated signaling [GO:0019722]; cell adhesion [GO:0007155]; cellular copper ion homeostasis [GO:0006878]; cellular response to amyloid-beta [GO:1904646]; cellular response to cAMP [GO:0071320]; cellular response to copper ion [GO:0071280]; cellular response to manganese ion [GO:0071287]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to norepinephrine stimulus [GO:0071874]; cholesterol metabolic process [GO:0008203]; cognition [GO:0050890]; collateral sprouting in absence of injury [GO:0048669]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; dendrite development [GO:0016358]; endocytosis [GO:0006897]; extracellular matrix organization [GO:0030198]; forebrain development [GO:0030900]; G protein-coupled receptor signaling pathway [GO:0007186]; innate immune response [GO:0045087]; ionotropic glutamate receptor signaling pathway [GO:0035235]; learning [GO:0007612]; learning or memory [GO:0007611]; lipoprotein metabolic process [GO:0042157]; locomotory behavior [GO:0007626]; mating behavior [GO:0007617]; memory [GO:0007613]; microglia development [GO:0014005]; microglial cell activation [GO:0001774]; modulation of age-related behavioral decline [GO:0090647]; modulation of excitatory postsynaptic potential [GO:0098815]; mRNA polyadenylation [GO:0006378]; negative regulation of blood circulation [GO:1903523]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of dendritic spine maintenance [GO:1902951]; negative regulation of gene expression [GO:0010629]; negative regulation of long-term synaptic potentiation [GO:1900272]; negative regulation of mitochondrion organization [GO:0010823]; negative regulation of neuron death [GO:1901215]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of pri-miRNA transcription by RNA polymerase II [GO:1902894]; negative regulation of protein localization to nucleus [GO:1900181]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of Wnt signaling pathway [GO:0030178]; neuromuscular process controlling balance [GO:0050885]; neuron apoptotic process [GO:0051402]; neuron projection development [GO:0031175]; neuron projection maintenance [GO:1990535]; neuron remodeling [GO:0016322]; Notch signaling pathway [GO:0007219]; positive regulation of 1-phosphatidylinositol-3-kinase activity [GO:0061903]; positive regulation of amyloid fibril formation [GO:1905908]; positive regulation of apoptotic process [GO:0043065]; positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902961]; positive regulation of cell activation [GO:0050867]; positive regulation of cellular response to thapsigargin [GO:1905893]; positive regulation of cellular response to tunicamycin [GO:1905896]; positive regulation of chemokine production [GO:0032722]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of endothelin production [GO:1904472]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of gene expression [GO:0010628]; positive regulation of glycolytic process [GO:0045821]; positive regulation of G protein-coupled receptor internalization [GO:1904022]; positive regulation of G protein-coupled receptor signaling pathway [GO:0045745]; positive regulation of histone acetylation [GO:0035066]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of JNK cascade [GO:0046330]; positive regulation of long-term synaptic depression [GO:1900454]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of monocyte chemotaxis [GO:0090026]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of neuron death [GO:1901216]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of phosphorylation [GO:0042327]; positive regulation of protein binding [GO:0032092]; positive regulation of protein import [GO:1904591]; positive regulation of protein kinase A signaling [GO:0010739]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of receptor binding [GO:1900122]; positive regulation of response to endoplasmic reticulum stress [GO:1905898]; positive regulation of superoxide anion generation [GO:0032930]; positive regulation of tau-protein kinase activity [GO:1902949]; positive regulation of T cell migration [GO:2000406]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; protein homooligomerization [GO:0051260]; protein phosphorylation [GO:0006468]; protein tetramerization [GO:0051262]; protein trimerization [GO:0070206]; regulation of acetylcholine-gated cation channel activity [GO:1903048]; regulation of amyloid-beta clearance [GO:1900221]; regulation of amyloid fibril formation [GO:1905906]; regulation of dendritic spine maintenance [GO:1902950]; regulation of epidermal growth factor-activated receptor activity [GO:0007176]; regulation of gene expression [GO:0010468]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of multicellular organism growth [GO:0040014]; regulation of NMDA receptor activity [GO:2000310]; regulation of peptidyl-tyrosine phosphorylation [GO:0050730]; regulation of presynapse assembly [GO:1905606]; regulation of response to calcium ion [GO:1905945]; regulation of signaling receptor activity [GO:0010469]; regulation of spontaneous synaptic transmission [GO:0150003]; regulation of synapse structure or activity [GO:0050803]; regulation of toll-like receptor signaling pathway [GO:0034121]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of translation [GO:0006417]; regulation of Wnt signaling pathway [GO:0030111]; response to interleukin-1 [GO:0070555]; response to lead ion [GO:0010288]; response to oxidative stress [GO:0006979]; response to yeast [GO:0001878]; smooth endoplasmic reticulum calcium ion homeostasis [GO:0051563]; suckling behavior [GO:0001967]; synapse organization [GO:0050808]; synaptic assembly at neuromuscular junction [GO:0051124]; visual learning [GO:0008542]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=APP&keywords=APP	756.6369449469918	17	5701.96	89	2.913353892940663	115	0.40944881889763757	1.3428143712574843	2.4723451327433645	0.734532374100736	0.5454545454545453	1.4551607445008417	1.3372620126926655	0.9771615008156647	1.0295967443581202	0.917645880625145	0.7541433262506796	23	31	30	1.0886877683360805	0.9462167271895169	0.844321660220199	0.6955054459265936	157	193	238
AREG	amphiregulin	Yes		ENSG00000109321	P15514	Amphiregulin family	19	cell_surface_ligand, ligand	cell_surface, cell_surface_ligand, extracellular, intracellular, ligand, plasma_membrane_transmembrane, secreted, transmembrane, transmembrane_predicted	P00533, P04626, P05362, P14780, P21860	EGFR, EGFR_ERBB2, ERBB2, ERBB3, ICAM1, MMP9	EGFR [Baccin2019:10085134;Baccin2019:2466334;CellTalkDB:2466334;HPRD:10085134;ICELLNET:2466334;LRdb:101;LRdb:2466334;ProtMapper:23762360;ProtMapper:29045902;SIGNOR:10085134;SIGNOR:10209155;SIGNOR:20513444;SignaLink3:10085134;SignaLink3:10209155;SignaLink3:21071413;SignaLink3:23331499;connectomeDB2020:10085134;connectomeDB2020:2466334], ERBB2 [SIGNOR:7679104;SignaLink3:23331499;SignaLink3:7679104], ERBB3 [CellTalkDB:8702723;LRdb:8702723;Ramilowski2015:8702723;connectomeDB2020:8702723;talklr:8702723], ICAM1 [NA], MMP9 [HPRD:10389762]	cell surface [GO:0009986]; clathrin-coated endocytic vesicle membrane [GO:0030669]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]	cytokine activity [GO:0005125]; epidermal growth factor receptor binding [GO:0005154]; growth factor activity [GO:0008083]	cell-cell signaling [GO:0007267]; dichotomous subdivision of terminal units involved in mammary gland duct morphogenesis [GO:0060598]; epidermal growth factor receptor signaling pathway [GO:0007173]; epithelial cell proliferation involved in mammary gland duct elongation [GO:0060750]; glial cell proliferation [GO:0014009]; G protein-coupled receptor signaling pathway [GO:0007186]; mammary gland alveolus development [GO:0060749]; mammary gland branching involved in thelarche [GO:0060744]; negative regulation of osteoblast differentiation [GO:0045668]; neuron projection development [GO:0031175]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epidermal growth factor-activated receptor activity [GO:0045741]; positive regulation of keratinocyte proliferation [GO:0010838]; response to cAMP [GO:0051591]; response to estradiol [GO:0032355]; response to glucocorticoid [GO:0051384]; response to hydrogen peroxide [GO:0042542]; response to peptide hormone [GO:0043434]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=AREG&keywords=AREG	16.051959292134832	188	NA	NA	1.8555115186243232	172	0.11023622047244094	1.143712574850297	0.004424778761061947	0.14244604316546777	0.08922558922558924	0.055837563451776664	0.03173164097914778	0.017944535073409464	0.09988901220865691	0.019395112832153796	0.14661000579485983	126	202	86	0.16922300698316922	0.6131412147268377	0.16401417054069561	0.873827576219425	299	435	153
ARTN	artemin	Yes		ENSG00000117407	Q5T4W7	TGF-beta family, GDNF subfamily	15	ligand	extracellular, ligand, secreted, transmembrane	O00451, O60609, P07949, P13591, P56159	GFRA1, GFRA1_RET, GFRA2, GFRA3, GFRA3_RET, NCAM1, RET	GFRA3 [Baccin2019:98837239883723;CellTalkDB:9883723;Cellinker:11544105;Cellinker:9883723;DIP:16765900;HPMR:9883723;HPRD:9883723;IntAct:16765900;LRdb:9883723;Lit-BM-17:16765900;Lit-BM-17:9883723;SIGNOR:9883723;connectomeDB2020:9883723], GFRA2 [CellTalkDB:32196115;Cellinker:9883723], GFRA1 [CellTalkDB:9883723;Cellinker:11544105;Cellinker:28937965;Cellinker:9883723;LRdb:9883723;Ramilowski2015:9883723;connectomeDB2020:9883723;talklr:9883723], RET [Baccin2019:9883723;CellTalkDB:9883723;Cellinker:9883723;HPMR:9883723;LRdb:9883723;connectomeDB2020:9883723], NCAM1 [Cellinker:30853893]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	glial cell-derived neurotrophic factor receptor binding [GO:0030116]; growth factor activity [GO:0008083]; receptor tyrosine kinase binding [GO:0030971]; signaling receptor binding [GO:0005102]	axon guidance [GO:0007411]; induction of positive chemotaxis [GO:0050930]; lymphocyte migration into lymphoid organs [GO:0097021]; neuroblast proliferation [GO:0007405]; peripheral nervous system development [GO:0007422]; Peyer's patch morphogenesis [GO:0061146]; signal transduction [GO:0007165]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=ARTN&keywords=ARTN	0.25000773347078653	593	NA	NA	0.1636343624082715	564	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
ASGR1	asialoglycoprotein receptor 1	No		ENSG00000141505	P07306	NA	1	ligand, receptor	cell_surface, extracellular, intracellular, ligand, plasma_membrane, plasma_membrane_transmembrane, receptor, secreted, transmembrane	NA	NA	NA	external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	asialoglycoprotein receptor activity [GO:0004873]; carbohydrate binding [GO:0030246]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]	cellular response to extracellular stimulus [GO:0031668]; receptor-mediated endocytosis [GO:0006898]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=ASGR1&keywords=ASGR1	0.43772090112811984	537	NA	NA	0.04296055664798873	727	0.007874015748031496	0.009980039920159679	0.0254424778761062	0.011270983213429253	0.0016835016835016834	0.033840947546531296	0.04261106074342698	0.04078303425774879	0.061043285238623846	0.013052476966217086	0.041298049063163526	156	228	162	0.02626180656881271	1.9591766644005333	0.6357233449599716	1.4146578429791434	32	278	39
AVP	arginine vasopressin	Yes		ENSG00000101200	P01185	Vasopressin/oxytocin family	15	ligand	extracellular, intracellular, ligand, secreted	O60895, O60896, P01130, P07550, P13945, P16473, P30518, P30559, P32241, P37288, P41586, P47901, P98164, Q03431, Q99678, Q9NQS5	ADCYAP1R1, ADRB2, ADRB3, AVPR1A, AVPR1B, AVPR2, GPR20, GPR84, LDLR, LRP2, OXTR, PTH1R, RAMP2, RAMP3, TSHR, VIPR1	OXTR [Baccin2019:10519430;Baccin2019:11337500;Baccin2019:12446593;Baccin2019:15084136;Baccin2019:16158071;Baccin2019:7475979;Baccin2019:7774575;Baccin2019:7921229;Baccin2019:8955347;CellTalkDB:12446593;Guide2Pharma:10519430;Guide2Pharma:11337500;Guide2Pharma:12446593;Guide2Pharma:15084136;Guide2Pharma:16158071;Guide2Pharma:7475979;Guide2Pharma:7774575;Guide2Pharma:8955347;HPRD:7921229;LRdb:10519430;LRdb:11337500;LRdb:12446593;LRdb:15084136;LRdb:16158071;LRdb:7475979;LRdb:7774575;LRdb:7921229;LRdb:8955347;connectomeDB2020:10519430;connectomeDB2020:11337500;connectomeDB2020:12446593;connectomeDB2020:15084136;connectomeDB2020:16158071;connectomeDB2020:7475979;connectomeDB2020:7774575;connectomeDB2020:7921229;connectomeDB2020:8955347;scConnect:10519430;scConnect:11337500;scConnect:12446593;scConnect:15084136;scConnect:16158071;scConnect:7475979;scConnect:7774575;scConnect:8955347], AVPR1A [Baccin2019:10519430;Baccin2019:10780976;Baccin2019:10866830;Baccin2019:12446593;Baccin2019:15084136;Baccin2019:1560825;Baccin2019:8106369;Baccin2019:9264324;Baccin2019:9322919;Baccin2019:9334232;Baccin2019:9459574;Baccin2019:9864265;Baccin2019:9884074;CellTalkDB:1560825;Cellinker:10519430;Cellinker:10780976;Cellinker:10866830;Cellinker:12446593;Cellinker:15084136;Cellinker:1560825;Cellinker:8106369;Cellinker:9264324;Cellinker:9322919;Cellinker:9334232;Cellinker:9459574;Cellinker:9864265;Cellinker:9884074;Guide2Pharma:10519430;Guide2Pharma:10780976;Guide2Pharma:10866830;Guide2Pharma:12446593;Guide2Pharma:15084136;Guide2Pharma:8106369;Guide2Pharma:9264324;Guide2Pharma:9322919;Guide2Pharma:9334232;Guide2Pharma:9459574;Guide2Pharma:9864265;Guide2Pharma:9884074;HPMR:1560825;HPRD:8106369;LRdb:10519430;LRdb:10780976;LRdb:10866830;LRdb:12446593;LRdb:15084136;LRdb:1560825;LRdb:8106369;LRdb:9264324;LRdb:9322919;LRdb:9334232;LRdb:9459574;LRdb:9864265;LRdb:9884074;connectomeDB2020:10519430;connectomeDB2020:10780976;connectomeDB2020:10866830;connectomeDB2020:12446593;connectomeDB2020:15084136;connectomeDB2020:1560825;connectomeDB2020:8106369;connectomeDB2020:9264324;connectomeDB2020:9322919;connectomeDB2020:9334232;connectomeDB2020:9459574;connectomeDB2020:9864265;connectomeDB2020:9884074;scConnect:10519430;scConnect:10780976;scConnect:10866830;scConnect:12446593;scConnect:15084136;scConnect:8106369;scConnect:9264324;scConnect:9322919;scConnect:9334232;scConnect:9459574;scConnect:9864265;scConnect:9884074], AVPR1B [Baccin2019:10519430;Baccin2019:10780976;Baccin2019:12446593;Baccin2019:15084136;Baccin2019:16158071;Baccin2019:7929452;Baccin2019:9264324;Baccin2019:9322919;Baccin2019:9459574;Baccin2019:9864265;Baccin2019:9884074;CellTalkDB:7929452;Cellinker:10519430;Cellinker:10780976;Cellinker:12446593;Cellinker:15084136;Cellinker:16158071;Cellinker:7929452;Cellinker:9264324;Cellinker:9322919;Cellinker:9459574;Cellinker:9864265;Cellinker:9884074;Guide2Pharma:10519430;Guide2Pharma:10780976;Guide2Pharma:12446593;Guide2Pharma:15084136;Guide2Pharma:16158071;Guide2Pharma:9264324;Guide2Pharma:9322919;Guide2Pharma:9459574;Guide2Pharma:9864265;Guide2Pharma:9884074;HPRD:7929452;LRdb:10519430;LRdb:10780976;LRdb:12446593;LRdb:15084136;LRdb:16158071;LRdb:7929452;LRdb:9264324;LRdb:9322919;LRdb:9459574;LRdb:9864265;LRdb:9884074;connectomeDB2020:10519430;connectomeDB2020:10780976;connectomeDB2020:12446593;connectomeDB2020:15084136;connectomeDB2020:16158071;connectomeDB2020:7929452;connectomeDB2020:9264324;connectomeDB2020:9322919;connectomeDB2020:9459574;connectomeDB2020:9864265;connectomeDB2020:9884074;scConnect:10519430;scConnect:10780976;scConnect:12446593;scConnect:15084136;scConnect:16158071;scConnect:9264324;scConnect:9322919;scConnect:9459574;scConnect:9864265;scConnect:9884074], AVPR2 [Baccin2019:10519430;Baccin2019:10780976;Baccin2019:11012895;Baccin2019:11857925;Baccin2019:12446593;Baccin2019:15084136;Baccin2019:7774575;Baccin2019:9264324;Baccin2019:9322919;Baccin2019:9459574;Baccin2019:9864265;Baccin2019:9884074;CellTalkDB:9884074;Cellinker:10519430;Cellinker:10780976;Cellinker:11012895;Cellinker:11857925;Cellinker:12446593;Cellinker:15084136;Cellinker:7774575;Cellinker:9264324;Cellinker:9322919;Cellinker:9459574;Cellinker:9864265;Cellinker:9884074;Guide2Pharma:10519430;Guide2Pharma:10780976;Guide2Pharma:11012895;Guide2Pharma:12446593;Guide2Pharma:15084136;Guide2Pharma:7774575;Guide2Pharma:9264324;Guide2Pharma:9322919;Guide2Pharma:9459574;Guide2Pharma:9864265;Guide2Pharma:9884074;HPRD:11857925;LRdb:10519430;LRdb:10780976;LRdb:11012895;LRdb:11857925;LRdb:12446593;LRdb:15084136;LRdb:7774575;LRdb:9264324;LRdb:9322919;LRdb:9459574;LRdb:9864265;LRdb:9884074;SIGNOR:1560825;connectomeDB2020:10519430;connectomeDB2020:10780976;connectomeDB2020:11012895;connectomeDB2020:11857925;connectomeDB2020:12446593;connectomeDB2020:15084136;connectomeDB2020:7774575;connectomeDB2020:9264324;connectomeDB2020:9322919;connectomeDB2020:9459574;connectomeDB2020:9864265;connectomeDB2020:9884074;scConnect:10519430;scConnect:10780976;scConnect:11012895;scConnect:12446593;scConnect:15084136;scConnect:7774575;scConnect:9264324;scConnect:9322919;scConnect:9459574;scConnect:9864265;scConnect:9884074], ADCYAP1R1 [CellTalkDB:32196115], LDLR [CellTalkDB:32196115], GPR84 [CellTalkDB:32196115], TSHR [CellTalkDB:32196115], RAMP3 [CellTalkDB:32196115], RAMP2 [CellTalkDB:32196115], LRP2 [CellTalkDB:32196115], ADRB2 [CellTalkDB:32196115], PTH1R [CellTalkDB:32196115], VIPR1 [CellTalkDB:32196115], ADRB3 [CellTalkDB:32196115], GPR20 [CellTalkDB:32196115]	clathrin-coated endocytic vesicle membrane [GO:0030669]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; secretory granule [GO:0030141]	cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; neurohypophyseal hormone activity [GO:0005185]; neuropeptide hormone activity [GO:0005184]; protein kinase activity [GO:0004672]; signaling receptor binding [GO:0005102]; V1A vasopressin receptor binding [GO:0031894]; V1B vasopressin receptor binding [GO:0031895]	cell-cell signaling [GO:0007267]; ERK1 and ERK2 cascade [GO:0070371]; generation of precursor metabolites and energy [GO:0006091]; grooming behavior [GO:0007625]; hyperosmotic salinity response [GO:0042538]; locomotory behavior [GO:0007626]; maternal aggressive behavior [GO:0002125]; maternal behavior [GO:0042711]; multicellular organismal water homeostasis [GO:0050891]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of female receptivity [GO:0007621]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; negative regulation of transmission of nerve impulse [GO:0051970]; penile erection [GO:0043084]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cellular pH reduction [GO:0032849]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of gene expression [GO:0010628]; positive regulation of glutamate secretion [GO:0014049]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of prostaglandin biosynthetic process [GO:0031394]; positive regulation of systemic arterial blood pressure [GO:0003084]; positive regulation of vasoconstriction [GO:0045907]; protein kinase C signaling [GO:0070528]; regulation of renal sodium excretion [GO:0035813]; response to ethanol [GO:0045471]; response to nicotine [GO:0035094]; response to testosterone [GO:0033574]; signal transduction [GO:0007165]; social behavior [GO:0035176]; vasoconstriction [GO:0042310]; viral entry into host cell [GO:0046718]; water transport [GO:0006833]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=AVP&keywords=AVP	0	899	NA	NA	0.001390344786572634	894	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
AZGP1	alpha-2-glycoprotein 1, zinc-binding	No		ENSG00000160862	P25311	MHC class I family	6	ligand	extracellular, intracellular, ligand, secreted	P06756	ITGAV	ITGAV [CellTalkDB:9813179;HPRD:9813179;LRdb:9813179;connectomeDB2020:9813179]	collagen-containing extracellular matrix [GO:0062023]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nucleus [GO:0005634]	protein transmembrane transporter activity [GO:0008320]; ribonuclease activity [GO:0004540]	antigen processing and presentation of endogenous peptide antigen via MHC class Ib [GO:0002476]; cell adhesion [GO:0007155]; detection of chemical stimulus involved in sensory perception of bitter taste [GO:0001580]; negative regulation of cell population proliferation [GO:0008285]; retina homeostasis [GO:0001895]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=AZGP1&keywords=AZGP1	39.528098370786516	106	10346.3	69	0.35961120573105193	439	0	0.04540918163672652	0	7.194244604316547e-4	1.4090909090909165	0	0.006346328195829556	0.022838499184339316	0.001849796522382538	0.001001468820937375	0.00579486188912498	298	371	281	0.13573186089097167	0.08131232559534722	0.07549117093322545	0.10838303849658383	487	483	471
B2M	beta-2-microglobulin	No		ENSG00000273686, ENSG00000166710	P61769	Beta-2-microglobulin family	1	cell_surface_ligand	cell_surface_ligand, extracellular, intracellular, secreted, transmembrane	O15533, P02786, P04234, P06126, P09693, P13747, P20963, P26715, P26717, P27797, P27824, P29016, P29017, P30101, P30511, P43626, P43628, P43629, Q03518, Q03519, Q13241, Q30201, Q8N423, Q8NHL6	CALR, CANX, CD1A, CD1B, CD1C, CD247, CD3D, CD3G, HFE, HLA-E, HLA-F, KIR2DL1, KIR2DL3, KIR3DL1, KLRC1, KLRC2, KLRD1, LILRB1, LILRB2, PDIA3, TAP1, TAP2, TAPBP, TFRC	CANX [Macrophage:9597133], CALR [HPRD:8769474;Macrophage:10618487;Macrophage:9597133], PDIA3 [Macrophage:10618487;Macrophage:9597133], TAP1 [Macrophage:10618487], TAP2 [Macrophage:10618487], TAPBP [Macrophage:10618487], HLA-F [CellTalkDB:11169396;HPRD:11169396;LRdb:11169396;connectomeDB2020:11169396], CD1A [CellTalkDB:12833155;Cellinker:12833155;HPRD:12833155;IntAct:12833155;IntAct:15723809;LRdb:12833155;Lit-BM-17:12833155;Lit-BM-17:15723809;connectomeDB2020:12833155], CD3D [CellTalkDB:32196115], LILRB1 [CellTalkDB:12897781;HPRD:12897781;LRdb:12897781;connectomeDB2020:12897781], KIR2DL1 [CellTalkDB:32196115], KIR2DL3 [CellTalkDB:32196115], TFRC [CellTalkDB:32196115], CD247 [CellTalkDB:32196115], CD1B [CellTalkDB:12118248;Cellinker:12118248;HPRD:12118248;IntAct:12118248;IntAct:14764708;LRdb:12118248;Lit-BM-17:12118248;Lit-BM-17:14764708;Lit-BM-17:26186194;connectomeDB2020:12118248], KLRC2 [CellTalkDB:32196115], KLRD1 [CellTalkDB:32196115;InnateDB:18083576;InnateDB:18448674], KIR3DL1 [CellTalkDB:32196115], LILRB2 [CellTalkDB:32196115], HFE [BioGRID:20618438;CellTalkDB:10791995;DIP:9546397;HPRD:10791995;IntAct:15965644;IntAct:20618438;LRdb:10791995;Lit-BM-17:10638746;Lit-BM-17:20618438;Lit-BM-17:9546397], CD3G [CellTalkDB:32196115], KLRC1 [CellTalkDB:32196115;InnateDB:18083576;InnateDB:18448674], CD1C [Cellinker:9209486], HLA-E [DIP:9660937;HPRD:10064069;HPRD:9605335;Lit-BM-17:9605335;Lit-BM-17:9660937]	cytosol [GO:0005829]; early endosome lumen [GO:0031905]; early endosome membrane [GO:0031901]; endoplasmic reticulum lumen [GO:0005788]; ER to Golgi transport vesicle membrane [GO:0012507]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; HFE-transferrin receptor complex [GO:1990712]; membrane [GO:0016020]; MHC class II protein complex [GO:0042613]; MHC class I peptide loading complex [GO:0042824]; MHC class I protein complex [GO:0042612]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724]	identical protein binding [GO:0042802]; MHC class II protein complex binding [GO:0023026]; protein homodimerization activity [GO:0042803]	amyloid fibril formation [GO:1990000]; antibacterial humoral response [GO:0019731]; antigen processing and presentation of endogenous peptide antigen via MHC class I [GO:0019885]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-dependent [GO:0002481]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cellular response to iron(III) ion [GO:0071283]; cellular response to iron ion [GO:0071281]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to nicotine [GO:0071316]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; immune response [GO:0006955]; innate immune response [GO:0045087]; iron ion homeostasis [GO:0055072]; iron ion transport [GO:0006826]; learning or memory [GO:0007611]; modulation of age-related behavioral decline [GO:0090647]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of forebrain neuron differentiation [GO:2000978]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron projection development [GO:0010977]; negative regulation of receptor binding [GO:1900121]; peptide antigen assembly with MHC class II protein complex [GO:0002503]; positive regulation of cellular senescence [GO:2000774]; positive regulation of ferrous iron binding [GO:1904434]; positive regulation of protein binding [GO:0032092]; positive regulation of receptor binding [GO:1900122]; positive regulation of receptor-mediated endocytosis [GO:0048260]; positive regulation of T cell activation [GO:0050870]; positive regulation of T cell cytokine production [GO:0002726]; positive regulation of T cell mediated cytotoxicity [GO:0001916]; positive regulation of transferrin receptor binding [GO:1904437]; protein homotetramerization [GO:0051289]; protein refolding [GO:0042026]; regulation of erythrocyte differentiation [GO:0045646]; regulation of iron ion transport [GO:0034756]; regulation of membrane depolarization [GO:0003254]; response to molecule of bacterial origin [GO:0002237]; retina homeostasis [GO:0001895]; sensory perception of smell [GO:0007608]; T cell differentiation in thymus [GO:0033077]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=B2M&keywords=B2M	3398.839864484447	8	23169.3	43	3.0860107274851947	107	53.007874015748065	22.018962075848435	36.07300884955759	27.277937649879593	22.12289562289574	17.587140439932337	23.33363553943807	25.517128874388288	17.66185719570819	12.122479636804076	33.02634730538945	5	4	3	26.34084247323544	0.6706372752088477	0.4604209390696726	1.2537112367069279	270	331	57
BAG6	BAG cochaperone 6	No		ENSG00000228760, ENSG00000229524, ENSG00000234651, ENSG00000096155, ENSG00000227761, ENSG00000233348, ENSG00000204463	P46379	NA	2	cell_surface_ligand, ligand	cell_surface_ligand, extracellular, intracellular, ligand, secreted, transmembrane	O14931, P35558	NCR3, PCK1	PCK1 [SIGNOR:21726808], NCR3 [CellChatDB:30021652;IntAct:18055229;IntAct:18852879;IntAct:22807449;IntAct:24133212;Lit-BM-17:18055229;Lit-BM-17:18852879;Lit-BM-17:24133212;connectomeDB2020:18055229;connectomeDB2020:18852879;connectomeDB2020:24133212]	BAT3 complex [GO:0071818]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	Hsp70 protein binding [GO:0030544]; identical protein binding [GO:0042802]; misfolded protein binding [GO:0051787]; polyubiquitin modification-dependent protein binding [GO:0031593]; proteasome binding [GO:0070628]; ribosome binding [GO:0043022]; signaling receptor binding [GO:0005102]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-specific protease binding [GO:1990381]	apoptotic process [GO:0006915]; brain development [GO:0007420]; cell differentiation [GO:0030154]; chromatin organization [GO:0006325]; endoplasmic reticulum stress-induced pre-emptive quality control [GO:0061857]; ER-associated misfolded protein catabolic process [GO:0071712]; immune response-activating cell surface receptor signaling pathway [GO:0002429]; internal peptidyl-lysine acetylation [GO:0018393]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; kidney development [GO:0001822]; lung development [GO:0030324]; maintenance of unfolded protein involved in ERAD pathway [GO:1904378]; natural killer cell activation [GO:0030101]; negative regulation of apoptotic process [GO:0043066]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of proteolysis [GO:0045861]; positive regulation of ERAD pathway [GO:1904294]; posttranslational protein targeting to endoplasmic reticulum membrane [GO:0006620]; proteasomal protein catabolic process [GO:0010498]; protein localization to cytosolic proteasome complex involved in ERAD pathway [GO:1904379]; protein stabilization [GO:0050821]; regulation of embryonic development [GO:0045995]; regulation of protein stability [GO:0031647]; spermatogenesis [GO:0007283]; synaptonemal complex assembly [GO:0007130]; tail-anchored membrane protein insertion into ER membrane [GO:0071816]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=BAG6&keywords=BAG6	38.083958063728396	110	19847.7	49	0.40277736374479944	414	0.19685039370078733	0.3742514970059933	0.233407079646018	0.3817745803357378	0.28282828282828254	0.3333333333333336	0.30190389845874793	0.22512234910277298	0.2175360710321847	0.24225530778473714	0.1945141974116185	75	67	72	0.2712524536945649	0.8090100834436977	0.8968999362355141	0.7271552469146357	219	169	223
BCAN	brevican	No		ENSG00000132692	Q96GW7	Aggrecan/versican proteoglycan family	3	ecm, ligand	cell_surface, ecm, extracellular, intracellular, ligand, plasma_membrane_peripheral, secreted	P00533, Q92823	EGFR, NRCAM	NRCAM [CellTalkDB:32196115], EGFR [CellTalkDB:32196115]	anchored component of membrane [GO:0031225]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi lumen [GO:0005796]; lysosomal lumen [GO:0043202]	carbohydrate binding [GO:0030246]; hyaluronic acid binding [GO:0005540]	cell adhesion [GO:0007155]; central nervous system development [GO:0007417]; hippocampus development [GO:0021766]; skeletal system development [GO:0001501]; synapse maturation [GO:0060074]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=BCAN&keywords=BCAN	0.4187800968539326	538	NA	NA	0.015625771835571164	810	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
BDNF	brain derived neurotrophic factor	Yes		ENSG00000176697	P23560	NGF-beta family	20	ligand	extracellular, intracellular, ligand, secreted, transmembrane, transmembrane_predicted	P04626, P08138, P20783, P21917, Q00994, Q08345, Q16620, Q8TDT2, Q99523, Q9Y624	BEX3, DDR1, DRD4, ERBB2, F11R, GPR152, NGFR, NTF3, NTRK2, SORT1	NTRK2 [AlzPathway:9775403;Baccin2019:76445409312147;BioGRID:21651720;BioGRID:9312147;CA1:1645620;CA1:9648856;CellChatDB:27908981;CellTalkDB:7644540;Cellinker:27908981;Cellinker:7644540;Cellinker:9312147;DIP:9312147;HPMR:7644540;HPRD:9312147;LRdb:7644540;LRdb:931;Lit-BM-17:11855816;Lit-BM-17:21651720;Lit-BM-17:9312147;ProtMapper:21849472;ProtMapper:26740873;ProtMapper:26899129;ProtMapper:28679669;SIGNOR:7679912;SignaLink3:23331499;SignaLink3:9312147;connectomeDB2020:7644540;connectomeDB2020:9312147], NGFR [AlzPathway:9775403;Cellinker:19908279;connectomeDB2020:25354496], DRD4 [CellTalkDB:32196115], SORT1 [Baccin2019:15987945;CellTalkDB:15987945;Cellinker:15987945;DIP:19122660;HPRD:15987945;LRdb:15987945;connectomeDB2020:15987945], BEX3 [CellTalkDB:10764727;HPMR:7644540;LRdb:7644540], DDR1 [NA], ERBB2 [Cellinker:28446206], F11R [NA], GPR152 [NA], NTF3 [BioGRID:7703225;DIP:7703225;HPRD:7703225]	axon [GO:0030424]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; perinuclear region of cytoplasm [GO:0048471]; synaptic vesicle [GO:0008021]	growth factor activity [GO:0008083]; nerve growth factor receptor binding [GO:0005163]	axon guidance [GO:0007411]; brain-derived neurotrophic factor receptor signaling pathway [GO:0031547]; collateral sprouting [GO:0048668]; memory [GO:0007613]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neuron apoptotic process [GO:0043524]; nerve development [GO:0021675]; nerve growth factor signaling pathway [GO:0038180]; nervous system development [GO:0007399]; neuron projection morphogenesis [GO:0048812]; peripheral nervous system development [GO:0007422]; positive regulation of brain-derived neurotrophic factor receptor signaling pathway [GO:0031550]; positive regulation of collateral sprouting [GO:0048672]; positive regulation of neuron projection development [GO:0010976]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of receptor binding [GO:1900122]; positive regulation of synapse assembly [GO:0051965]; regulation of neuron differentiation [GO:0045664]; regulation of protein localization to cell surface [GO:2000008]; synapse assembly [GO:0007416]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=BDNF&keywords=BDNF	0.41637350973483145	540	NA	NA	0.5706596752111621	356	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
BMP1	bone morphogenetic protein 1	Yes		ENSG00000168487	P13497	NA	5	ecm, ligand, receptor	ecm, ecm_regulator, extracellular, intracellular, ligand, receptor, secreted	O00238, P02452, P05997, P20908, P36894, Q02388, Q13873	BMPR1A, BMPR1B, BMPR2, COL1A1, COL5A1, COL5A2, COL7A1	COL1A1 [HPRD-phos:11283002;HPRD:11283002;SIGNOR:11283002], COL5A2 [HPRD-phos:11741999;HPRD:11741999;SIGNOR:11741999], COL5A1 [HPRD-phos:11741999;HPRD:11741999;MatrixDB:20979576;SIGNOR:11741999], COL7A1 [HPRD:11986329;SIGNOR:11986329], BMPR2 [CellTalkDB:15621726], BMPR1A [CellTalkDB:15621726], BMPR1B [CellTalkDB:15621726]	extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; vesicle [GO:0031982]	calcium ion binding [GO:0005509]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; identical protein binding [GO:0042802]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252]; zinc ion binding [GO:0008270]	cartilage condensation [GO:0001502]; cell differentiation [GO:0030154]; collagen fibril organization [GO:0030199]; multicellular organism development [GO:0007275]; ossification [GO:0001503]; positive regulation of cartilage development [GO:0061036]; proteolysis [GO:0006508]; skeletal system development [GO:0001501]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=BMP1&keywords=BMP1	9.478210964516197	244	1382.51	148	0.33266427461877796	451	0	0.06187624750498995	0.014380530973451327	0.1350119904076752	0.030303030303030293	0.03214890016920473	0.01813236627379873	0.013050570962479609	0.01331853496115428	0.013052476966217086	0.008112806644774968	253	228	257	0.03085340501516147	0.5707855918619349	0.5642730870942552	0.4433610035210765	313	298	343
BMP10	bone morphogenetic protein 10	Yes		ENSG00000163217	O95393	TGF-beta family	19	ligand, receptor	intracellular, ligand, receptor, secreted	O00238, O15552, P17813, P27037, P36894, P37023, P43628, P43629, Q04771, Q13705, Q13873, Q14943, Q8TDT2, Q9H7M9	ACVR1, ACVR2A, ACVR2A_ACVRL1, ACVR2B, ACVR2B_ACVRL1, ACVRL1, ACVRL1_BMPR2, BMPR1A, BMPR1B, BMPR2, ENG, FFAR2, GPR152, KIR2DL3, KIR3DL1, KIR3DS1, VSIR	BMPR1B [CellTalkDB:15621726;Cellinker:31127068;LRdb:16049014;Ramilowski2015:16049014;connectomeDB2020:16049014;talklr:16049014], ACVR2A [Baccin2019:16049014;CellTalkDB:16049014;LRdb:16049014;connectomeDB2020:16049014], BMPR1A [Baccin2019:16049014;Cellinker:16049014;LRdb:16049014;SIGNOR:16049014;connectomeDB2020:16049014], ACVRL1 [Baccin2019:17068149;CellTalkDB:17068149;LRdb:17068149;SIGNOR:17068149;connectomeDB2020:17068149], ACVR1 [Cellinker:27252362;Cellinker:30246251;Cellinker:30246252;Cellinker:31127068], ACVR2B [Cellinker:27252362], BMPR2 [Baccin2019:16049014;CellTalkDB:15621726;LRdb:16049014;connectomeDB2020:16049014], ENG [CellTalkDB:21737454;Cellinker:31540324;LRdb:21737454;Ramilowski2015:21737454;connectomeDB2020:21737454;talklr:21737454], KIR3DL1 [NA], KIR2DL3 [NA], VSIR [NA], KIR3DS1 [NA], GPR152 [NA], FFAR2 [NA]	cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Z disc [GO:0030018]	cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; hormone activity [GO:0005179]; receptor serine/threonine kinase binding [GO:0033612]; telethonin binding [GO:0031433]	activin receptor signaling pathway [GO:0032924]; adult heart development [GO:0007512]; atrial cardiac muscle tissue morphogenesis [GO:0055009]; BMP signaling pathway [GO:0030509]; cardiac muscle cell proliferation [GO:0060038]; cell adhesion [GO:0007155]; heart trabecula formation [GO:0060347]; kidney development [GO:0001822]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of cell growth [GO:0030308]; negative regulation of cell migration [GO:0030336]; negative regulation of endothelial cell migration [GO:0010596]; pathway-restricted SMAD protein phosphorylation [GO:0060389]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of cartilage development [GO:0061036]; positive regulation of cell proliferation involved in heart morphogenesis [GO:2000138]; positive regulation of gene expression [GO:0010628]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle hypertrophy in response to stress [GO:1903242]; sarcomere organization [GO:0045214]; SMAD protein signal transduction [GO:0060395]; ventricular cardiac muscle cell development [GO:0055015]; ventricular cardiac muscle tissue morphogenesis [GO:0055010]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=BMP10&keywords=BMP10	0.005619854831460674	851	NA	NA	0.0025390621426517115	885	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
BMP15	bone morphogenetic protein 15	Yes		ENSG00000130385	O95972	TGF-beta family	17	ligand	extracellular, intracellular, ligand, secreted	O00238, P27037, P36894, P36897, P61160, Q04771, Q13705, Q13873	ACTR2, ACVR1, ACVR2A, ACVR2B, BMPR1A, BMPR1A_BMPR1B_BMPR2, BMPR1B, BMPR1B_BMPR2, BMPR2, TGFBR1	ACTR2 [SignaLink3:16446785;SignaLink3:23331499], BMPR2 [Baccin2019:12419820;CellTalkDB:15621726;HPMR:12419820;LRdb:12419820;SIGNOR:16446785;SignaLink3:16446785;SignaLink3:23331499;connectomeDB2020:12419820], BMPR1A [LRdb:2419820;Ramilowski2015:2419820;connectomeDB2020:2419820;talklr:2419820], BMPR1B [Baccin2019:1204491412419820;CellTalkDB:15621726;HPRD:12419820;LRdb:12;LRdb:12044914;connectomeDB2020:12044914;connectomeDB2020:12419820], ACVR2A [CellTalkDB:26198319;Cellinker:27252362;Ramilowski2015:2419820;connectomeDB2020:2419820;talklr:2419820], ACVR1 [NA], ACVR2B [Cellinker:27252362], TGFBR1 [Cellinker:27252362]	endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]	cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; type I activin receptor binding [GO:0070698]	BMP signaling pathway [GO:0030509]; female gamete generation [GO:0007292]; granulosa cell development [GO:0060016]; ovarian follicle development [GO:0001541]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; SMAD protein signal transduction [GO:0060395]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=BMP15&keywords=BMP15	0	899	NA	NA	0.583281846108646	349	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
BMP2	bone morphogenetic protein 2	Yes		ENSG00000125845	P12643	TGF-beta family	21	ligand	extracellular, intracellular, ligand, secreted, transmembrane	O00238, O60565, P08493, P17813, P27037, P35052, P36894, P37023, P61160, Q04771, Q13705, Q13873, Q6NW40, Q6ZVN8, Q99835, Q9H2X0	ACTR2, ACVR1, ACVR2A, ACVR2A_BMPR1A, ACVR2A_BMPR1B, ACVR2B, ACVR2B_BMPR1A, ACVR2B_BMPR1B, ACVRL1, BMPR1A, BMPR1A_BMPR1B_BMPR2, BMPR1A_BMPR2, BMPR1B, BMPR1B_BMPR2, BMPR2, CHRD, ENG, GPC1, GREM1, HJV, MGP, RGMB, SMO	BMPR2 [Baccin2019:10880440;Baccin2019:11263668;DIP:10880444;DIP:25938661;HPRD:10880444;InnateDB:17295905;InnateDB:18342887;LRdb:11;LRdb:11263668;Lit-BM-17:10712517;Lit-BM-17:10880444;Lit-BM-17:7791754;SIGNOR:7791754;SignaLink3:16446785;SignaLink3:17295905;SignaLink3:18342887;SignaLink3:23180781;SignaLink3:23331499;connectomeDB2020:10880444;connectomeDB2020:11263668], ACVR2B [Baccin2019:15064755;CellTalkDB:20385559;HPRD:15064755;InnateDB:17295905;LRdb:15064755;SignaLink3:15064755;SignaLink3:16446785;SignaLink3:18988627;SignaLink3:23331499;connectomeDB2020:28977600], ACTR2 [SignaLink3:16446785;SignaLink3:23331499], BMPR1B [Baccin2019:12700180;Baccin2019:15064755;Baccin2019:7811286;Baccin2019:9872992;HPMR:12700180;HPRD:15064755;HPRD:7811286;HPRD:9872992;LRdb:12700180;LRdb:15064755;LRdb:7811286;LRdb:9872992;Lit-BM-17:10712517;Lit-BM-17:19229295;connectomeDB2020:12700180;connectomeDB2020:15064755;connectomeDB2020:7811286;connectomeDB2020:9872992], ACVR2A [Baccin2019:20959140;CellTalkDB:21702718;DIP:10880444;DIP:25938661;InnateDB:17295905;InnateDB:17483092;Ramilowski2015:21702718;connectomeDB2020:21702718;talklr:21702718], BMPR1A [Baccin2019:10692589;Baccin2019:10881198;Baccin2019:11263668;Baccin2019:12700180;Baccin2019:15064755;BioGRID:10692589;BioGRID:11263668;CellTalkDB:15621726;DIP:10880444;DIP:10881198;DIP:11263668;DIP:16672363;DIP:25938661;HPMR:12700180;HPRD:10692589;HPRD:10881198;HPRD:11263668;HPRD:15064755;InnateDB:16672363;InnateDB:17483092;InnateDB:18937504;IntAct:10881198;IntAct:15064755;IntAct:16672363;IntAct:19804412;IntAct:20860622;IntAct:21054789;IntAct:25938661;LRdb:10692589;LRdb:10881198;LRdb:11263668;LRdb:12700180;LRdb:15064755;Lit-BM-17:10692589;Lit-BM-17:10712517;Lit-BM-17:10880444;Lit-BM-17:10881198;Lit-BM-17:11263668;Lit-BM-17:15064755;Lit-BM-17:19804412;Lit-BM-17:20860622;Lit-BM-17:21054789;SIGNOR:18937504;SIGNOR:26330344;connectomeDB2020:10692589;connectomeDB2020:10881198;connectomeDB2020:11263668;connectomeDB2020:12700180;connectomeDB2020:15064755], ACVRL1 [NA], ACVR1 [Baccin2019:8006002;CellTalkDB:28977600;HPRD:8006002;LRdb:8006002], SMO [CellTalkDB:32103204], GPC1 [CellTalkDB:23624389], HJV [CellTalkDB:18287331;Cellinker:18287331;DIP:25938661;LRdb:18287331;Ramilowski2015:18287331;connectomeDB2020:18287331;talklr:18287331], ENG [Baccin2019:9872992;CellTalkDB:9872992;Cellinker:9872992;HPRD:9872992;LRdb:9872992;connectomeDB2020:9872992], RGMB [DIP:25938661;IntAct:25938661;connectomeDB2020:15671031], GREM1 [Cellinker:29317497;HPRD:15064755], MGP [HPRD:11741887], CHRD [HPRD:15064755]	BMP receptor complex [GO:0070724]; cell surface [GO:0009986]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]	BMP receptor binding [GO:0070700]; co-receptor binding [GO:0039706]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; phosphatase activator activity [GO:0019211]; protein serine/threonine kinase activator activity [GO:0043539]; signaling receptor binding [GO:0005102]; SMAD binding [GO:0046332]	animal organ morphogenesis [GO:0009887]; aortic valve development [GO:0003176]; atrioventricular canal morphogenesis [GO:1905222]; atrioventricular valve morphogenesis [GO:0003181]; BMP signaling pathway [GO:0030509]; BMP signaling pathway involved in heart development [GO:0061312]; BMP signaling pathway involved in heart induction [GO:0003130]; bone mineralization [GO:0030282]; bone mineralization involved in bone maturation [GO:0035630]; branching involved in ureteric bud morphogenesis [GO:0001658]; cardiac atrium formation [GO:0003210]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac jelly development [GO:1905072]; cardiac muscle cell differentiation [GO:0055007]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiocyte differentiation [GO:0035051]; cell-cell signaling [GO:0007267]; cell fate commitment [GO:0045165]; cellular response to BMP stimulus [GO:0071773]; cellular response to organic cyclic compound [GO:0071407]; chondrocyte differentiation [GO:0002062]; corticotropin hormone secreting cell differentiation [GO:0060128]; embryonic heart tube anterior/posterior pattern specification [GO:0035054]; endocardial cushion formation [GO:0003272]; endocardial cushion morphogenesis [GO:0003203]; epithelial to mesenchymal transition [GO:0001837]; heart development [GO:0007507]; inflammatory response [GO:0006954]; inner ear development [GO:0048839]; in utero embryonic development [GO:0001701]; mesenchymal cell differentiation [GO:0048762]; mesenchymal cell proliferation involved in ureteric bud development [GO:0072138]; mesenchyme development [GO:0060485]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of calcium-independent cell-cell adhesion [GO:0051042]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle cell differentiation [GO:2000726]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of gene expression [GO:0010629]; negative regulation of insulin-like growth factor receptor signaling pathway [GO:0043569]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of smooth muscle cell proliferation [GO:0048662]; negative regulation of steroid biosynthetic process [GO:0010894]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of Wnt signaling pathway involved in heart development [GO:0003308]; Notch signaling pathway [GO:0007219]; odontogenesis of dentin-containing tooth [GO:0042475]; osteoblast differentiation [GO:0001649]; pathway-restricted SMAD protein phosphorylation [GO:0060389]; pericardium development [GO:0060039]; positive regulation of apoptotic process [GO:0043065]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cartilage development [GO:0061036]; positive regulation of cell migration [GO:0030335]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of extracellular matrix constituent secretion [GO:0003331]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of gene expression [GO:0010628]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of odontogenesis [GO:0042482]; positive regulation of ossification [GO:0045778]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of peroxisome proliferator activated receptor signaling pathway [GO:0035360]; positive regulation of phosphatase activity [GO:0010922]; positive regulation of pri-miRNA transcription by RNA polymerase II [GO:1902895]; positive regulation of protein binding [GO:0032092]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus [GO:1901522]; positive regulation of Wnt signaling pathway [GO:0030177]; positive regulation of Wnt signaling pathway by BMP signaling pathway [GO:0060804]; protein destabilization [GO:0031648]; protein phosphorylation [GO:0006468]; proteoglycan metabolic process [GO:0006029]; regulation of odontogenesis of dentin-containing tooth [GO:0042487]; regulation of transcription, DNA-templated [GO:0006355]; response to bacterium [GO:0009617]; response to hypoxia [GO:0001666]; skeletal system development [GO:0001501]; SMAD protein signal transduction [GO:0060395]; telencephalon development [GO:0021537]; telencephalon regionalization [GO:0021978]; thyroid-stimulating hormone-secreting cell differentiation [GO:0060129]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=BMP2&keywords=BMP2	9.453219550561798	245	NA	NA	1.6353677471121584	192	0	0.2999001996008008	0.03539823008849559	0.3052757793765013	0.08585858585858588	0.04737732656514383	0.025385312783318223	0.01468189233278956	0.05512393636699961	0.006409400453999185	0.018620822870388173	162	272	209	0.08127558966336565	0.7134868874272279	0.17977862991100738	0.31356491890049576	256	425	388
BMP3	bone morphogenetic protein 3	Yes		ENSG00000152785	P12645	TGF-beta family	14	ligand	extracellular, ligand, ligand_regulator, secreted	O00238, P01137, P27037, P36894, P36896, Q04771, Q13705, Q13873	ACVR1, ACVR1B, ACVR1B_ACVR2A, ACVR2A, ACVR2B, BMPR1A, BMPR1B, BMPR2, TGFB1	ACVR2B [CellTalkDB:22074949;Cellinker:27252362;Ramilowski2015:22074949;connectomeDB2020:22074949;talklr:22074949], BMPR2 [Cellinker:27252362], BMPR1A [Cellinker:26511181], BMPR1B [Cellinker:13678778], ACVR1 [NA], ACVR2A [Baccin2019:20959140;Cellinker:27252362], ACVR1B [Cellinker:27252362], TGFB1 [HPRD:9434787]	extracellular exosome [GO:0070062]; extracellular space [GO:0005615]	BMP receptor binding [GO:0070700]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; signaling receptor binding [GO:0005102]	cartilage development [GO:0051216]; cell-cell signaling [GO:0007267]; osteoblast differentiation [GO:0001649]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; skeletal system development [GO:0001501]; SMAD protein signal transduction [GO:0060395]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=BMP3&keywords=BMP3	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
BMP4	bone morphogenetic protein 4	Yes		ENSG00000125378	P12644	TGF-beta family	21	ecm, ligand	ecm, extracellular, intracellular, ligand, secreted	O00238, O75581, P0CG37, P27037, P36894, P37023, Q04771, Q13705, Q13873, Q6NW40, Q6ZVN8, Q9H772	ACVR1, ACVR2A, ACVR2A_BMPR1A, ACVR2A_BMPR1B, ACVR2B, ACVR2B_BMPR1A, ACVR2B_BMPR1B, ACVRL1, BMPR1A, BMPR1A_BMPR1B_BMPR2, BMPR1A_BMPR2, BMPR1B, BMPR1B_BMPR2, BMPR2, CFC1, GREM2, HJV, LRP6, RGMB	BMPR2 [Baccin2019:7644468;Baccin2019:7673243;Baccin2019:8702914;BioGRID:12045205;DIP:7644468;DIP:7673243;HPRD:7644468;HPRD:8702914;LRdb:7644468;LRdb:7673243;LRdb:8702914;SIGNOR:7673243;SIGNOR:8006002;SignaLink3:16446785;SignaLink3:21071413;SignaLink3:23331499;SignaLink3:7644468;connectomeDB2020:7644468;connectomeDB2020:7673243;connectomeDB2020:8702914], BMPR1B [Baccin2019:11282024;Baccin2019:7811286;Baccin2019:8006002;Baccin2019:8702914;HPRD:11282024;HPRD:7811286;HPRD:8702914;LRdb:11282024;LRdb:7811286;LRdb:8006002;LRdb:8702914;connectomeDB2020:11282024;connectomeDB2020:7811286;connectomeDB2020:8006002;connectomeDB2020:8702914], ACVR2A [Baccin2019:20959140], BMPR1A [Baccin2019:11241215;Baccin2019:7644468;Baccin2019:8006002;Baccin2019:8702914;HPRD:11241215;HPRD:7644468;HPRD:8702914;IntAct:20860622;IntAct:21054789;LRdb:11241215;LRdb:7644468;LRdb:8006002;LRdb:8702914;Lit-BM-17:20860622;Lit-BM-17:21054789;Lit-BM-17:8006002;SIGNOR:26330344;connectomeDB2020:11241215;connectomeDB2020:7644468;connectomeDB2020:8006002;connectomeDB2020:8702914], ACVRL1 [NA], ACVR1 [Baccin2019:20959140], ACVR2B [NA], LRP6 [CellTalkDB:19553665], HJV [CellTalkDB:18326817], CFC1 [connectomeDB2020:28126904], RGMB [connectomeDB2020:15671031], GREM2 [Cellinker:24614542;HPRD:15039429]	endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	BMP receptor binding [GO:0070700]; chemoattractant activity [GO:0042056]; co-receptor binding [GO:0039706]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; heparin binding [GO:0008201]	anterior/posterior axis specification [GO:0009948]; aortic valve morphogenesis [GO:0003180]; blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:0002043]; BMP signaling pathway [GO:0030509]; BMP signaling pathway involved in heart development [GO:0061312]; BMP signaling pathway involved in heart induction [GO:0003130]; BMP signaling pathway involved in nephric duct formation [GO:0071893]; BMP signaling pathway involved in renal system segmentation [GO:0061151]; BMP signaling pathway involved in ureter morphogenesis [GO:0061149]; branching involved in prostate gland morphogenesis [GO:0060442]; branching involved in ureteric bud morphogenesis [GO:0001658]; branching morphogenesis of an epithelial tube [GO:0048754]; bronchus development [GO:0060433]; bud dilation involved in lung branching [GO:0060503]; bud elongation involved in lung branching [GO:0060449]; cardiac muscle cell differentiation [GO:0055007]; cardiac septum development [GO:0003279]; cellular response to BMP stimulus [GO:0071773]; chondrocyte differentiation [GO:0002062]; cloacal septation [GO:0060197]; common-partner SMAD protein phosphorylation [GO:0007182]; coronary vasculature development [GO:0060976]; cranial suture morphogenesis [GO:0060363]; deltoid tuberosity development [GO:0035993]; dorsal/ventral neural tube patterning [GO:0021904]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic digit morphogenesis [GO:0042733]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic skeletal joint morphogenesis [GO:0060272]; endocardial cushion development [GO:0003197]; endochondral ossification [GO:0001958]; endoderm development [GO:0007492]; epithelial cell proliferation involved in lung morphogenesis [GO:0060502]; epithelial-mesenchymal cell signaling [GO:0060684]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; erythrocyte differentiation [GO:0030218]; germ cell development [GO:0007281]; glomerular capillary formation [GO:0072104]; glomerular visceral epithelial cell development [GO:0072015]; hematopoietic progenitor cell differentiation [GO:0002244]; inner ear receptor cell differentiation [GO:0060113]; intermediate mesodermal cell differentiation [GO:0048392]; kidney development [GO:0001822]; lens induction in camera-type eye [GO:0060235]; lung alveolus development [GO:0048286]; lung morphogenesis [GO:0060425]; lymphoid progenitor cell differentiation [GO:0002320]; macrophage differentiation [GO:0030225]; mammary gland formation [GO:0060592]; membranous septum morphogenesis [GO:0003149]; mesenchymal cell differentiation involved in kidney development [GO:0072161]; mesenchymal cell proliferation involved in ureter development [GO:0072198]; mesenchymal cell proliferation involved in ureteric bud development [GO:0072138]; mesenchymal to epithelial transition involved in metanephros morphogenesis [GO:0003337]; mesodermal cell fate determination [GO:0007500]; mesonephros development [GO:0001823]; metanephric collecting duct development [GO:0072205]; monocyte differentiation [GO:0030224]; negative regulation of apoptotic process [GO:0043066]; negative regulation of branch elongation involved in ureteric bud branching by BMP signaling pathway [GO:0072097]; negative regulation of branching involved in ureteric bud morphogenesis [GO:0090191]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell death [GO:0060548]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell proliferation involved in heart morphogenesis [GO:2000137]; negative regulation of chondrocyte differentiation [GO:0032331]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of gene expression [GO:0010629]; negative regulation of glomerular mesangial cell proliferation [GO:0072125]; negative regulation of glomerulus development [GO:0090194]; negative regulation of immature T cell proliferation in thymus [GO:0033088]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of mesenchymal cell proliferation involved in ureter development [GO:0072200]; negative regulation of metanephric comma-shaped body morphogenesis [GO:2000007]; negative regulation of metanephric S-shaped body morphogenesis [GO:2000005]; negative regulation of mitotic nuclear division [GO:0045839]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of phosphorylation [GO:0042326]; negative regulation of pri-miRNA transcription by RNA polymerase II [GO:1902894]; negative regulation of prostatic bud formation [GO:0060686]; negative regulation of striated muscle tissue development [GO:0045843]; negative regulation of T cell differentiation in thymus [GO:0033085]; negative regulation of thymocyte apoptotic process [GO:0070244]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube closure [GO:0001843]; neuron fate commitment [GO:0048663]; odontogenesis [GO:0042476]; odontogenesis of dentin-containing tooth [GO:0042475]; osteoblast differentiation [GO:0001649]; outflow tract septum morphogenesis [GO:0003148]; pharyngeal arch artery morphogenesis [GO:0061626]; pituitary gland development [GO:0021983]; positive regulation of apoptotic process [GO:0043065]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of bone mineralization [GO:0030501]; positive regulation of branching involved in lung morphogenesis [GO:0061047]; positive regulation of cardiac muscle fiber development [GO:0055020]; positive regulation of cardiac neural crest cell migration involved in outflow tract morphogenesis [GO:1905312]; positive regulation of cartilage development [GO:0061036]; positive regulation of cell death [GO:0010942]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell proliferation involved in outflow tract morphogenesis [GO:1901964]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of epidermal cell differentiation [GO:0045606]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of kidney development [GO:0090184]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of ossification [GO:0045778]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of production of miRNAs involved in gene silencing by miRNA [GO:1903800]; positive regulation of protein binding [GO:0032092]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-embryonic development [GO:0009791]; protein localization to nucleus [GO:0034504]; pulmonary artery endothelial tube morphogenesis [GO:0061155]; pulmonary valve morphogenesis [GO:0003184]; regulation of branching involved in prostate gland morphogenesis [GO:0060687]; regulation of cell fate commitment [GO:0010453]; regulation of odontogenesis of dentin-containing tooth [GO:0042487]; regulation of pathway-restricted SMAD protein phosphorylation [GO:0060393]; regulation of protein import into nucleus [GO:0042306]; regulation of smooth muscle cell differentiation [GO:0051150]; renal system process [GO:0003014]; secondary heart field specification [GO:0003139]; sinoatrial node development [GO:0003163]; SMAD protein signal transduction [GO:0060395]; smooth muscle tissue development [GO:0048745]; specification of animal organ position [GO:0010159]; specification of ureteric bud anterior/posterior symmetry by BMP signaling pathway [GO:0072101]; steroid hormone mediated signaling pathway [GO:0043401]; telencephalon development [GO:0021537]; telencephalon regionalization [GO:0021978]; tendon cell differentiation [GO:0035990]; trachea development [GO:0060438]; trachea formation [GO:0060440]; type B pancreatic cell development [GO:0003323]; ureter epithelial cell differentiation [GO:0072192]; ureteric bud development [GO:0001657]; ureter smooth muscle cell differentiation [GO:0072193]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=BMP4&keywords=BMP4	2.0214278090767404	385	NA	NA	0.23707226462143596	505	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
BMP5	bone morphogenetic protein 5	Yes		ENSG00000112175	P22003	TGF-beta family	20	ligand	extracellular, intracellular, ligand, secreted	O00238, P23468, P27037, P36894, P37023, Q04771, Q13705, Q13873, Q6ZVN8	ACVR1, ACVR1_ACVR2A, ACVR1_ACVR2B, ACVR1_BMPR2, ACVR2A, ACVR2A_BMPR1A, ACVR2A_BMPR1B, ACVR2B, ACVR2B_BMPR1A, ACVR2B_BMPR1B, ACVRL1, BMPR1A, BMPR1A_BMPR2, BMPR1B, BMPR1B_BMPR2, BMPR2, HJV, PTPRD	BMPR1B [NA], ACVR2A [NA], BMPR1A [Baccin2019:11580864;HPRD:11580864;LRdb:11580864], ACVRL1 [NA], ACVR1 [NA], ACVR2B [NA], BMPR2 [NA], HJV [CellTalkDB:23029472;connectomeDB2020:23029472], PTPRD [Cellinker:32589946]	extracellular space [GO:0005615]; vesicle [GO:0031982]	BMP receptor binding [GO:0070700]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]	allantois development [GO:1905069]; anterior head development [GO:0097065]; BMP signaling pathway [GO:0030509]; cardiac muscle tissue development [GO:0048738]; cardiac septum morphogenesis [GO:0060411]; cartilage development [GO:0051216]; chorio-allantoic fusion [GO:0060710]; ear development [GO:0043583]; endocardial cushion formation [GO:0003272]; heart trabecula morphogenesis [GO:0061384]; hindbrain development [GO:0030902]; male genitalia development [GO:0030539]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of insulin-like growth factor receptor signaling pathway [GO:0043569]; negative regulation of mononuclear cell migration [GO:0071676]; negative regulation of steroid biosynthetic process [GO:0010894]; neural fold elevation formation [GO:0021502]; ossification [GO:0001503]; pattern specification process [GO:0007389]; pericardium morphogenesis [GO:0003344]; pharyngeal system development [GO:0060037]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of dendrite development [GO:1900006]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of transcription by RNA polymerase II [GO:0045944]; skeletal system development [GO:0001501]; SMAD protein signal transduction [GO:0060395]; type B pancreatic cell development [GO:0003323]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=BMP5&keywords=BMP5	33.67533606741573	125	1418.92	147	25.99949682209194	23	0.007874015748031496	0.06287425149700594	0.007743362831858407	0.013908872901678653	0.09595959595959597	0.993231810490695	0.8603807796917552	0.15660685154975526	0.6762856085830549	0.8944785685674235	0.022754491017964056	34	32	199	0.34473620080352896	1.9346365187102934	2.5497216425012397	0.09233478552166478	35	10	477
BMP6	bone morphogenetic protein 6	Yes		ENSG00000153162	P22004	TGF-beta family	21	ligand	extracellular, intracellular, ligand, secreted	O00238, P27037, P36894, P37023, Q04771, Q13705, Q13873, Q16671, Q6ZVN8, Q99717	ACVR1, ACVR1_ACVR2A, ACVR1_ACVR2B, ACVR1_BMPR2, ACVR2A, ACVR2A_BMPR1A, ACVR2A_BMPR1B, ACVR2B, ACVR2B_BMPR1A, ACVR2B_BMPR1B, ACVRL1, AMHR2, BMPR1A, BMPR1A_BMPR2, BMPR1B, BMPR1B_BMPR2, BMPR2, HJV, SMAD5	ACVR2B [SignaLink3:10504300;SignaLink3:16446785;SignaLink3:21071413;SignaLink3:23331499], BMPR2 [Baccin2019:11401330;HPRD:11401330;LRdb:11401330;SignaLink3:10504300;SignaLink3:16446785;SignaLink3:21071413;SignaLink3:23331499;connectomeDB2020:10504300], AMHR2 [SignaLink3:16446785;SignaLink3:23331499], BMPR1B [Baccin2019:10504300;Baccin2019:11401330;HPRD:10504300;HPRD:11401330;LRdb:10504300;LRdb:11;connectomeDB2020:10504300;connectomeDB2020:11401330], ACVR2A [Baccin2019:10504300;CellTalkDB:10504300;HPRD:10504300;LRdb:10504300;connectomeDB2020:10504300], BMPR1A [Baccin2019:10504300;Baccin2019:11401330;Baccin2019:12297674;HPRD:10504300;HPRD:11401330;LRdb:10504300;LRdb:11401330;LRdb:12297674;connectomeDB2020:10504300;connectomeDB2020:11401330;connectomeDB2020:12297674], ACVRL1 [NA], ACVR1 [Baccin2019:12297674;CellTalkDB:12297674;LRdb:12297674;connectomeDB2020:12297674], HJV [CellTalkDB:23029472;InnateDB:19252486;connectomeDB2020:23029472], SMAD5 [HPRD:10504300]	cytoplasm [GO:0005737]; extracellular space [GO:0005615]; vesicle [GO:0031982]	BMP receptor binding [GO:0070700]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; protein heterodimerization activity [GO:0046982]	BMP signaling pathway [GO:0030509]; cartilage development [GO:0051216]; cellular iron ion homeostasis [GO:0006879]; cellular response to BMP stimulus [GO:0071773]; cellular response to iron ion [GO:0071281]; cellular response to mechanical stimulus [GO:0071260]; endochondral ossification [GO:0001958]; eye development [GO:0001654]; immune response [GO:0006955]; inflammatory response [GO:0006954]; kidney development [GO:0001822]; male genitalia development [GO:0030539]; multicellular organismal iron ion homeostasis [GO:0060586]; negative regulation of adherens junction organization [GO:1903392]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of transcription by RNA polymerase II [GO:0000122]; osteoblast differentiation [GO:0001649]; positive regulation of aldosterone biosynthetic process [GO:0032349]; positive regulation of aldosterone secretion [GO:2000860]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of gene expression [GO:0010628]; positive regulation of lipopolysaccharide-mediated signaling pathway [GO:0031666]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein secretion [GO:0050714]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of vascular permeability [GO:0043117]; response to activity [GO:0014823]; response to glucocorticoid [GO:0051384]; response to magnesium ion [GO:0032026]; response to retinoic acid [GO:0032526]; skeletal system development [GO:0001501]; SMAD protein signal transduction [GO:0060395]; type B pancreatic cell development [GO:0003323]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=BMP6&keywords=BMP6	1.2773221348314607	424	NA	NA	0.21372479709172268	526	0	4.99001996007984e-4	0.03207964601769914	0.013429256594724217	0	0	0	0.0016313213703099511	3.699593044765076e-4	6.676458806249166e-5	1.1589723778249952e-4	302	407	398	0.004381077009914799	0.7210836363178578	0.7000007427205991	0.7034172218678933	252	253	235
BMP7	bone morphogenetic protein 7	Yes		ENSG00000101144	P18075	TGF-beta family	21	ecm, ligand	ecm, extracellular, intracellular, ligand, secreted	O00238, P17813, P27037, P36894, P36896, P37023, P61160, Q04771, Q13705, Q13873, Q15262, Q6X4U4, Q6ZVN8	ACTR2, ACVR1, ACVR1_ACVR2A, ACVR1_ACVR2B, ACVR1_BMPR2, ACVR1B, ACVR2A, ACVR2A_BMPR1A, ACVR2A_BMPR1B, ACVR2B, ACVR2B_BMPR1A, ACVR2B_BMPR1B, ACVRL1, BMPR1A, BMPR1A_BMPR1B_BMPR2, BMPR1A_BMPR2, BMPR1B, BMPR1B_BMPR2, BMPR2, ENG, HJV, PTPRK, SOSTDC1	ACVR2B [Baccin2019:9748228;CellTalkDB:9748228;HPRD:9748228;LRdb:9748228;SIGNOR:9748228;SignaLink3:16446785;SignaLink3:23331499;connectomeDB2020:9748228], BMPR2 [Baccin2019:7791754;DIP:7644468;HPRD:7791754;InnateDB:18342887;LRdb:7791754;SIGNOR:7644468;SignaLink3:16446785;SignaLink3:23331499;connectomeDB2020:7791754], ACTR2 [SIGNOR:16446785;SignaLink3:16446785;SignaLink3:23331499], BMPR1B [Baccin2019:106311828605097;CellTalkDB:15621726;HPRD:8605097;LRdb:10631182;LRdb:86;connectomeDB2020:10631182;connectomeDB2020:8605097], ACVR2A [Baccin2019:12667445;Baccin2019:7790373;Baccin2019:9748228;CellTalkDB:7790373;HPRD:12667445;HPRD:9748228;LRdb:12667445;LRdb:7790373;LRdb:9748228;SIGNOR:9748228;connectomeDB2020:12667445;connectomeDB2020:7790373;connectomeDB2020:9748228], BMPR1A [Baccin2019:12297674;Baccin2019:7791754;Baccin2019:8605097;HPRD:7791754;HPRD:8605097;LRdb:12297674;LRdb:7791754;LRdb:8605097;connectomeDB2020:12297674;connectomeDB2020:7791754;connectomeDB2020:8605097], ACVRL1 [NA], ACVR1 [Baccin2019:122976748006002;CellTalkDB:31619522;HPRD:8006002;LRdb:12297674;LRdb:8;SIGNOR:11282024;connectomeDB2020:12297674;connectomeDB2020:8006002], ENG [Baccin2019:9872992;CellTalkDB:9872992;Cellinker:9872992;HPRD:9872992;LRdb:9872992;connectomeDB2020:9872992], HJV [connectomeDB2020:23029472], ACVR1B [Cellinker:31619522], PTPRK [NA], SOSTDC1 [HPRD:14623234;HPRD:15020244]	collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; vesicle [GO:0031982]	BMP receptor binding [GO:0070700]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; heparin binding [GO:0008201]	allantois development [GO:1905069]; axon guidance [GO:0007411]; BMP signaling pathway [GO:0030509]; branching involved in salivary gland morphogenesis [GO:0060445]; branching morphogenesis of an epithelial tube [GO:0048754]; cardiac muscle tissue development [GO:0048738]; cardiac septum morphogenesis [GO:0060411]; cartilage development [GO:0051216]; cellular response to BMP stimulus [GO:0071773]; cellular response to hypoxia [GO:0071456]; chorio-allantoic fusion [GO:0060710]; dendrite development [GO:0016358]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic limb morphogenesis [GO:0030326]; embryonic pattern specification [GO:0009880]; embryonic skeletal joint morphogenesis [GO:0060272]; endocardial cushion formation [GO:0003272]; epithelial cell differentiation [GO:0030855]; epithelial to mesenchymal transition [GO:0001837]; heart trabecula morphogenesis [GO:0061384]; hindbrain development [GO:0030902]; mesenchymal cell differentiation [GO:0048762]; mesenchyme development [GO:0060485]; mesoderm formation [GO:0001707]; mesonephros development [GO:0001823]; metanephric mesenchymal cell proliferation involved in metanephros development [GO:0072136]; metanephric mesenchyme morphogenesis [GO:0072133]; metanephros development [GO:0001656]; monocyte aggregation [GO:0070487]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell death [GO:0060548]; negative regulation of glomerular mesangial cell proliferation [GO:0072125]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis [GO:0072040]; negative regulation of mitotic nuclear division [GO:0045839]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of phosphorylation [GO:0042326]; negative regulation of prostatic bud formation [GO:0060686]; negative regulation of striated muscle cell apoptotic process [GO:0010664]; negative regulation of transcription, DNA-templated [GO:0045892]; nephrogenic mesenchyme morphogenesis [GO:0072134]; neural fold elevation formation [GO:0021502]; neuron projection morphogenesis [GO:0048812]; odontogenesis of dentin-containing tooth [GO:0042475]; ossification [GO:0001503]; pericardium morphogenesis [GO:0003344]; pharyngeal system development [GO:0060037]; positive regulation of apoptotic process [GO:0043065]; positive regulation of bone mineralization [GO:0030501]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of cardiac neural crest cell migration involved in outflow tract morphogenesis [GO:1905312]; positive regulation of dendrite development [GO:1900006]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of gene expression [GO:0010628]; positive regulation of heterotypic cell-cell adhesion [GO:0034116]; positive regulation of hyaluranon cable assembly [GO:1900106]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to nucleus [GO:0034504]; regulation of branching involved in prostate gland morphogenesis [GO:0060687]; regulation of pathway-restricted SMAD protein phosphorylation [GO:0060393]; regulation of removal of superoxide radicals [GO:2000121]; response to estradiol [GO:0032355]; response to peptide hormone [GO:0043434]; response to vitamin D [GO:0033280]; skeletal system development [GO:0001501]; SMAD protein signal transduction [GO:0060395]; steroid hormone mediated signaling pathway [GO:0043401]; ureteric bud development [GO:0001657]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=BMP7&keywords=BMP7	0.2485658117376226	594	NA	NA	0.031033960106411008	765	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
BMP8A	bone morphogenetic protein 8a	Yes		ENSG00000183682	Q7Z5Y6	TGF-beta family	14	ligand	extracellular, ligand, secreted	O00238, P27037, P36894, P36897, P37023, P37173, Q04771, Q13705, Q13873	ACVR1, ACVR1_ACVR2A, ACVR1_ACVR2B, ACVR1_BMPR2, ACVR2A, ACVR2A_BMPR1A, ACVR2A_BMPR1B, ACVR2B, ACVR2B_BMPR1A, ACVR2B_BMPR1B, ACVRL1, BMPR1A, BMPR1A_BMPR2, BMPR1B, BMPR1B_BMPR2, BMPR2, TGFBR1, TGFBR2	BMPR1B [CellTalkDB:15621726], ACVR2A [connectomeDB2020:28465413], BMPR1A [connectomeDB2020:28465413], ACVRL1 [NA], ACVR1 [NA], ACVR2B [connectomeDB2020:28465413], BMPR2 [connectomeDB2020:28465413], TGFBR1 [connectomeDB2020:28465413], TGFBR2 [connectomeDB2020:28465413]	extracellular space [GO:0005615]	BMP receptor binding [GO:0070700]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]	BMP signaling pathway [GO:0030509]; cartilage development [GO:0051216]; cell differentiation [GO:0030154]; diet induced thermogenesis [GO:0002024]; energy homeostasis [GO:0097009]; negative regulation of insulin secretion [GO:0046676]; ossification [GO:0001503]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; SMAD protein signal transduction [GO:0060395]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=BMP8A&keywords=BMP8A	4.954437314606742	291	NA	NA	3.386964239538817	103	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
BMP8B	bone morphogenetic protein 8b	Yes		ENSG00000116985	P34820	TGF-beta family	15	ligand	extracellular, ligand, secreted	O00238, P27037, P36894, P37023, Q03405, Q04771, Q13705, Q13873	ACVR1, ACVR1_ACVR2A, ACVR1_ACVR2B, ACVR1_BMPR2, ACVR2A, ACVR2A_BMPR1A, ACVR2A_BMPR1B, ACVR2B, ACVR2B_BMPR1A, ACVR2B_BMPR1B, ACVRL1, BMPR1A, BMPR1A_BMPR2, BMPR1B, BMPR1B_BMPR2, BMPR2, PLAUR	BMPR1A [SignaLink3:10504300;SignaLink3:23331499], ACVR1 [SignaLink3:10504300;SignaLink3:23331499], BMPR1B [NA], ACVR2A [NA], ACVRL1 [NA], ACVR2B [NA], BMPR2 [NA], PLAUR [CellTalkDB:32103204]	extracellular space [GO:0005615]	BMP receptor binding [GO:0070700]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]	BMP signaling pathway [GO:0030509]; cartilage development [GO:0051216]; cell differentiation [GO:0030154]; ossification [GO:0001503]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; skeletal system development [GO:0001501]; SMAD protein signal transduction [GO:0060395]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=BMP8B&keywords=BMP8B	4.514435280898876	299	NA	NA	1.1748744773219666	240	0.007874015748031496	0.013473053892215562	0	0.017745803357314145	0.03703703703703703	0.06937394247038918	0.08250226654578405	0.04078303425774879	0.019607843137254898	0.04072639871812072	0.05107204944948721	238	158	152	0.03456322223758028	0.6644008590628019	1.1383018590460683	1.370458561633925	273	103	42
BMPER	BMP binding endothelial regulator	Yes	secondary regulator?	ENSG00000164619	Q8N8U9	NA	1	ecm, ligand	ecm, extracellular, intracellular, ligand, ligand_regulator, secreted	NA	NA	NA	extracellular matrix [GO:0031012]; extracellular space [GO:0005615]	NA	blood vessel development [GO:0001568]; blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:0002043]; endothelial cell activation [GO:0042118]; inner ear development [GO:0048839]; negative regulation of BMP signaling pathway [GO:0030514]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of sprouting angiogenesis [GO:1903672]; regulation of angiogenesis [GO:0045765]; regulation of endothelial cell migration [GO:0010594]; regulation of pathway-restricted SMAD protein phosphorylation [GO:0060393]; ureteric bud development [GO:0001657]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=BMPER&keywords=BMPER	1.4954719609470086	412	NA	NA	0.569725780976857	357	0	0	0	0.0016786570743405273	0.0016835016835016834	0.00676818950930626	0.007252946509519492	0	0.006659267480577139	0.006976899452530362	6.567510141008307e-4	280	263	378	0.002879655702170572	1.2934559638709597	1.318117490490782	0.8274096187450786	74	73	172
BPI	bactericidal permeability increasing protein	No		ENSG00000101425	P17213	BPI/LBP/Plunc superfamily, BPI/LBP family	1	ligand	intracellular, ligand, secreted	Q96A28	SLAMF9	SLAMF9 [Cellinker:32822567]	azurophil granule lumen [GO:0035578]; cytoplasmic stress granule [GO:0010494]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; specific granule lumen [GO:0035580]	lipopolysaccharide binding [GO:0001530]	antibacterial humoral response [GO:0019731]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cellular response to lipopolysaccharide [GO:0071222]; defense response to Gram-negative bacterium [GO:0050829]; innate immune response [GO:0045087]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of interleukin-8 production [GO:0032717]; negative regulation of macrophage activation [GO:0043031]; negative regulation of tumor necrosis factor production [GO:0032720]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=BPI&keywords=BPI	0.014434506280898877	810	NA	NA	0.0267281544380087	779	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
BRINP2	BMP/retinoic acid inducible neural specific 2	No		ENSG00000198797	Q9C0B6	BRINP family	1	ligand	intracellular, ligand, secreted	NA	NA	NA	dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; neuronal cell body [GO:0043025]	NA	cell cycle [GO:0007049]; cellular response to retinoic acid [GO:0071300]; negative regulation of mitotic cell cycle [GO:0045930]; nervous system development [GO:0007399]; positive regulation of neuron differentiation [GO:0045666]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=BRINP2&keywords=BRINP2	0.27300199976404493	586	NA	NA	0.06561672370041376	685	0	0.0029940119760479044	0	4.7961630695443646e-4	0	0.001692047377326565	0.005439709882139619	0.01468189233278956	0.005179430262671108	7.344104686874084e-4	0.0010044427274483296	287	382	366	0.0029277783030968118	1.1741716099072428	0.8303368310482251	0.8512245854968171	92	197	161
BRINP3	BMP/retinoic acid inducible neural specific 3	No		ENSG00000162670	Q76B58	BRINP family	1	ligand	intracellular, ligand, secreted, transmembrane, transmembrane_predicted	NA	NA	NA	dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]	NA	cell cycle [GO:0007049]; cellular response to retinoic acid [GO:0071300]; negative regulation of mitotic cell cycle [GO:0045930]; nervous system development [GO:0007399]; positive regulation of neuron differentiation [GO:0045666]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=BRINP3&keywords=BRINP3	0.46794477719101124	530	NA	NA	0.25233288322787595	494	0	0	0	2.3980815347721823e-4	0	0.015228426395939085	0	0	0.015168331483536817	0	3.8632412594166507e-5	249	409	400	0.0027886544041406626	1.9680203005085437	0.7819430945574882	0.7849639293828986	31	218	195
BTC	betacellulin	Yes		ENSG00000174808	P35070	NA	18	cell_surface_ligand, ligand	cell_surface, cell_surface_ligand, extracellular, intracellular, ligand, plasma_membrane, plasma_membrane_transmembrane, secreted, transmembrane, transmembrane_predicted	P00533, P04626, P21860, Q15303	EGFR, EGFR_ERBB2, ERBB2, ERBB2_ERBB4, ERBB3, ERBB4	EGFR [Baccin2019:8144591;Baccin2019:9528863;CellTalkDB:8144591;HPRD:9528863;LRdb:8144591;LRdb:953;ProtMapper:24440602;SIGNOR:10209155;SIGNOR:14967450;SIGNOR:23382875;SIGNOR:9528863;SignaLink3:10209155;SignaLink3:23331499;SignaLink3:9528863;connectomeDB2020:8144591;connectomeDB2020:9528863], ERBB4 [Baccin2019:10214951;Baccin2019:11254912;CellTalkDB:10214951;HPRD:11254912;LRdb:10214951;LRdb:11;SIGNOR:10209155;SIGNOR:16829981;SIGNOR:22232668;SignaLink3:10209155;SignaLink3:23331499;connectomeDB2020:10214951;connectomeDB2020:11254912], ERBB3 [CellTalkDB:9312020;Cellinker:9312020;LRdb:9312020;Ramilowski2015:9312020;connectomeDB2020:9312020;talklr:9312020], ERBB2 [Baccin2019:9662041;CellTalkDB:9662041;HPRD:9662041;LRdb:9662041;ProtMapper:15163624;connectomeDB2020:9662041]	clathrin-coated endocytic vesicle membrane [GO:0030669]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	epidermal growth factor receptor binding [GO:0005154]; growth factor activity [GO:0008083]	epidermal growth factor receptor signaling pathway [GO:0007173]; negative regulation of apoptotic process [GO:0043066]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epidermal growth factor-activated receptor activity [GO:0045741]; positive regulation of mitotic nuclear division [GO:0045840]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=BTC&keywords=BTC	3.055569043573034	337	NA	NA	0.5578323995392162	365	0	0.02794411177644708	0.0022123893805309734	0.0035971223021582727	0.030303030303030297	0.06429780033840951	0.04805077062556658	0.039151712887438836	0.03736588975212725	0.03024435839230864	0.043229669692871724	192	171	160	0.029672441404626288	1.193924247540859	1.01441597661836	1.3417291149282409	88	125	47
BTN1A1	butyrophilin subfamily 1 member A1	No		ENSG00000124557	Q13410	Immunoglobulin superfamily, BTN/MOG family	1	cell_surface_ligand, ligand, receptor	cell_surface, cell_surface_ligand, extracellular, ligand, plasma_membrane_transmembrane, receptor, secreted, transmembrane, transmembrane_predicted	B6A8C7, Q7Z3B1, Q86YT9	JAML, NEGR1, TARM1	TARM1 [Cellinker:32822567], NEGR1 [Cellinker:32822567], JAML [Cellinker:32822567]	external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	signaling receptor activity [GO:0038023]; signaling receptor binding [GO:0005102]	regulation of cytokine production [GO:0001817]; T cell receptor signaling pathway [GO:0050852]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=BTN1A1&keywords=BTN1A1	0.002081161797752809	881	NA	NA	0.1175250495542517	606	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
C10orf99	chromosome 10 open reading frame 99	TBD		ENSG00000188373	Q6UWK7	NA	2	ligand	ligand, secreted	P49685	GPR15	GPR15 [scConnect:28900043;scConnect:31675498]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	chemokine activity [GO:0008009]; G protein-coupled receptor binding [GO:0001664]; receptor ligand activity [GO:0048018]	defense response to fungus [GO:0050832]; defense response to Gram-positive bacterium [GO:0050830]; G protein-coupled receptor signaling pathway [GO:0007186]; lymphocyte chemotaxis [GO:0048247]; negative regulation of cell cycle G1/S phase transition [GO:1902807]; negative regulation of cell division [GO:0051782]; regulation of T cell migration [GO:2000404]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=C10orf99&keywords=C10orf99	0.056686249438202246	725	NA	NA	0.0052933144502544174	860	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
C17orf99	chromosome 17 open reading frame 99	TBD		ENSG00000187997	Q6UX52	NA	1	ligand	ligand, secreted, transmembrane	NA	NA	NA	extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]	cytokine activity [GO:0005125]; transmembrane signaling receptor activity [GO:0004888]	adaptive immune response [GO:0002250]; cell surface receptor signaling pathway [GO:0007166]; mature B cell differentiation involved in immune response [GO:0002313]; positive regulation of immunoglobulin production in mucosal tissue [GO:2000558]; regulation of immune response [GO:0050776]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=C17orf99&keywords=C17orf99	0.06272055617977527	710	NA	NA	0.5680370325622003	358	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
C1QL1	complement C1q like 1	TBD		ENSG00000131094	O75973	NA	1	ligand	intracellular, ligand, secreted	NA	NA	NA	climbing fiber [GO:0044301]; collagen trimer [GO:0005581]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; presynapse [GO:0098793]; synaptic cleft [GO:0043083]	signaling receptor binding [GO:0005102]	locomotory behavior [GO:0007626]; maintenance of synapse structure [GO:0099558]; motor learning [GO:0061743]; neuron remodeling [GO:0016322]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=C1QL1&keywords=C1QL1	9.515729123595506	241	365.057	163	1.020216404917086	263	0.015748031496062992	0.08383233532934123	0.0011061946902654867	0.007434052757793763	0.04545454545454544	1.0423011844331636	1.045330915684503	0.10277324632952702	0.13355530891601866	0.7755708372280584	0.04577940892408676	100	36	157	0.29989873284030605	0.4632329651699291	2.534927555295526	0.17999237496989204	356	12	432
C1QL2	complement C1q like 2	TBD		ENSG00000144119	Q7Z5L3	NA	1	ligand	ligand, secreted	NA	NA	NA	collagen trimer [GO:0005581]; extracellular space [GO:0005615]	identical protein binding [GO:0042802]	NA	https://www.genecards.org/cgi-bin/carddisp.pl?gene=C1QL2&keywords=C1QL2	0.01026515393258427	828	NA	NA	0.008032190976268653	846	0	0.0034930139720558886	0	0.001199040767386091	0	0	9.066183136899365e-4	0	0.008509064002959676	0.0018694084657497648	0.0012748696156074954	272	349	353	0.0015683650124953502	1.5999723368831689	1.0260229905374916	0.9746294833737661	53	122	106
C1QL3	complement C1q like 3	TBD		ENSG00000165985	Q5VWW1	NA	1	ligand	ligand, secreted	NA	NA	NA	collagen trimer [GO:0005581]; extracellular space [GO:0005615]	identical protein binding [GO:0042802]	regulation of synapse organization [GO:0050807]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=C1QL3&keywords=C1QL3	0.9084666153286752	462	NA	NA	0.639919836785886	329	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
C1QL4	complement C1q like 4	TBD		ENSG00000186897	Q86Z23	NA	1	ligand	extracellular, intracellular, ligand, secreted	NA	NA	NA	collagen trimer [GO:0005581]; extracellular space [GO:0005615]	identical protein binding [GO:0042802]	negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of fibroblast proliferation [GO:0048147]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=C1QL4&keywords=C1QL4	0.02830047752808989	775	NA	NA	0.09833021962466562	635	0	0	0	0	0	0	9.066183136899365e-4	0.008156606851549756	7.399186089530152e-4	0.0024035251702496964	7.726482518833301e-5	301	335	399	0.0011167212517846125	0.9661048762222847	1.1157539070486728	0.9064961328926537	146	110	141
C1QTNF1	C1q and TNF related 1	TBD		ENSG00000173918	Q9BXJ1	NA	9	adhesion, ligand	adhesion, cell_adhesion, intracellular, ligand, plasma_membrane, secreted, transmembrane	P30518	AVPR2	AVPR2 [Baccin2019:12409230;CellTalkDB:12409230;Cellinker:12409230;HPRD:12409230;LRdb:12409230;Lit-BM-17:12409230;connectomeDB2020:12409230]	collagen trimer [GO:0005581]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]	collagen binding [GO:0005518]; identical protein binding [GO:0042802]	negative regulation of platelet activation [GO:0010544]; negative regulation of platelet aggregation [GO:0090331]; positive regulation of aldosterone secretion [GO:2000860]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of gene expression [GO:0010628]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of protein kinase B signaling [GO:0051897]; regulation of glucose metabolic process [GO:0010906]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=C1QTNF1&keywords=C1QTNF1	2.4163552185194233	370	NA	NA	0.05008177790310598	707	0.08661417322834646	0.022954091816367247	0.0011061946902654867	0.3800959232613962	0.003367003367003367	0.005076142131979695	9.066183136899365e-4	0.0032626427406199023	0.0014798372179060304	0.0013019094672185867	3.09059300753332e-4	299	363	392	0.04604305413959511	0.20483960758654268	0.2016647672174891	0.18394892032605792	433	415	427
C1QTNF12	C1q and TNF related 12	TBD		ENSG00000184163	Q5T7M4	Adipolin/erythroferrone family	3	ligand	intracellular, ligand, secreted	NA	NA	NA	extracellular region [GO:0005576]; extracellular space [GO:0005615]	hormone activity [GO:0005179]	negative regulation of gluconeogenesis [GO:0045721]; negative regulation of inflammatory response [GO:0050728]; positive regulation of glucose import [GO:0046326]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of protein kinase B signaling [GO:0051897]; regulation of glucose import [GO:0046324]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=C1QTNF12&keywords=C1QTNF12	0.03875195617977528	753	NA	NA	0.021729713284763235	794	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
C1QTNF2	C1q and TNF related 2	TBD		ENSG00000145861	Q9BXJ5	NA	1	ligand	intracellular, ligand, secreted	NA	NA	NA	collagen trimer [GO:0005581]; extracellular region [GO:0005576]	NA	regulation of lipid metabolic process [GO:0019216]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=C1QTNF2&keywords=C1QTNF2	0.050776476457078654	738	NA	NA	0.017627521661135	805	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
C1QTNF3	C1q and TNF related 3	TBD		ENSG00000082196	Q9BXJ4	NA	1	ligand	extracellular, intracellular, ligand, secreted	NA	NA	NA	collagen trimer [GO:0005581]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; membrane [GO:0016020]	identical protein binding [GO:0042802]	cellular triglyceride homeostasis [GO:0035356]; fat cell differentiation [GO:0045444]; negative regulation of gene expression [GO:0010629]; negative regulation of gluconeogenesis [GO:0045721]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of monocyte chemotactic protein-1 production [GO:0071638]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; positive regulation of adiponectin secretion [GO:0070165]; positive regulation of cytokine production [GO:0001819]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=C1QTNF3&keywords=C1QTNF3	2.774386620859981	350	NA	NA	0.3791555993299765	429	0	0.014970059880239512	0.00663716814159292	0.005995203836930454	0.011784511784511783	0.030456852791878163	0.03445149592021758	0.032626427406199025	0.007399186089530154	0.02273334223527835	0.025342862661773307	276	187	195	0.017490646431650114	0.6329129485110393	1.1907083493530475	1.2856322876817803	292	95	51
C1QTNF4	C1q and TNF related 4	TBD		ENSG00000284838, ENSG00000172247	Q9BXJ3	NA	2	ligand	intracellular, ligand, secreted	NA	NA	NA	extracellular space [GO:0005615]	cytokine activity [GO:0005125]	positive regulation of interleukin-6-mediated signaling pathway [GO:0070105]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of tumor necrosis factor production [GO:0032760]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=C1QTNF4&keywords=C1QTNF4	0.037772755056179774	757	NA	NA	0.00316975556972776	880	0.031496062992125984	0.02594810379241515	0.00995575221238938	0.010071942446043163	0.008417508417508417	0.33333333333333365	0.3517679057116943	0.2544861337683521	0.2619311875693661	0.23664708238749058	0.1344021634150998	66	69	92	0.15076883418598352	1.6914421812301366	1.5341722395160233	0.8981974904915332	47	52	145
C1QTNF5	C1q and TNF related 5	TBD		ENSG00000223953	Q9BXJ0	NA	7	adhesion, ligand	adhesion, cell_adhesion, extracellular, intracellular, ligand, plasma_membrane, secreted, tight_junction	Q9BY79	MFRP	MFRP [Baccin2019:12944416;CellTalkDB:21810984;Cellinker:12944416;HPRD:12944416;LRdb:12944416]	apical plasma membrane [GO:0016324]; bicellular tight junction [GO:0005923]; cell projection [GO:0042995]; collagen trimer [GO:0005581]; extracellular space [GO:0005615]; lateral plasma membrane [GO:0016328]; plasma membrane [GO:0005886]; transport vesicle [GO:0030133]	identical protein binding [GO:0042802]	inner ear development [GO:0048839]; protein secretion [GO:0009306]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=C1QTNF5&keywords=C1QTNF5	7.201911550561798	266	NA	NA	11.813475900266898	42	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
C1QTNF6	C1q and TNF related 6	TBD		ENSG00000133466	Q9BXI9	NA	1	ligand	intracellular, ligand, secreted, transmembrane, transmembrane_predicted	NA	NA	NA	collagen trimer [GO:0005581]; extracellular space [GO:0005615]	identical protein binding [GO:0042802]	NA	https://www.genecards.org/cgi-bin/carddisp.pl?gene=C1QTNF6&keywords=C1QTNF6	4.44701516868672	302	NA	NA	1.0455256004966649	255	0	0.008483033932135729	0.0022123893805309734	0.017745803357314145	0.0101010101010101	0.04060913705583757	0.05983680870353571	0.017944535073409464	0.010358860525342217	0.040526104953933224	0.021750048290515727	263	159	200	0.020869793761233168	0.6595075005298298	1.6367490286697284	1.0285150764560014	277	38	91
C1QTNF7	C1q and TNF related 7	TBD		ENSG00000163145	Q9BXJ2	NA	1	ligand	intracellular, ligand, secreted	NA	NA	NA	collagen trimer [GO:0005581]; extracellular region [GO:0005576]	NA	NA	https://www.genecards.org/cgi-bin/carddisp.pl?gene=C1QTNF7&keywords=C1QTNF7	0.2012111552138761	613	NA	NA	0.04177433630481905	733	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
C1QTNF8	C1q and TNF related 8	TBD		ENSG00000184471	P60827	NA	1	ligand	intracellular, ligand, secreted, transmembrane	NA	NA	NA	collagen trimer [GO:0005581]; extracellular space [GO:0005615]	NA	positive regulation of cell motility [GO:2000147]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=C1QTNF8&keywords=C1QTNF8	0.0033133842696629213	866	NA	NA	0.038967272608913486	740	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
C1QTNF9	C1q and TNF related 9	TBD		ENSG00000240654	P0C862	NA	3	ligand	extracellular, intracellular, ligand, secreted	NA	NA	NA	collagen trimer [GO:0005581]; extracellular region [GO:0005576]	hormone activity [GO:0005179]; identical protein binding [GO:0042802]	NA	https://www.genecards.org/cgi-bin/carddisp.pl?gene=C1QTNF9&keywords=C1QTNF9	0.11741063716782381	662	NA	NA	0.2170606866186932	523	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
C1QTNF9B	C1q and TNF related 9B	TBD		ENSG00000205863	B2RNN3	NA	2	ligand	extracellular, intracellular, ligand, secreted	NA	NA	NA	collagen trimer [GO:0005581]; extracellular region [GO:0005576]	NA	NA	https://www.genecards.org/cgi-bin/carddisp.pl?gene=C1QTNF9B&keywords=C1QTNF9B	0.37420957752808987	549	NA	NA	0.7955492983962882	300	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
C4B	complement C4B (Chido blood group)	TBD		ENSG00000224639, ENSG00000228454, ENSG00000236625, ENSG00000228267, ENSG00000224389	P0C0L5	NA	7	ligand	extracellular, intracellular, ligand, secreted	P15529, P17927	CD46, CR1	CD46 [CellTalkDB:1717583;Cellinker:1717583;HPRD:1717583;InnateDB:8666815;LRdb:1717583;connectomeDB2020:1717583], CR1 [CellTalkDB:10528211;Cellinker:10528211;HPRD:10528211;LRdb:10528211;connectomeDB2020:10528211]	axon [GO:0030424]; blood microparticle [GO:0072562]; classical-complement-pathway C3/C5 convertase complex [GO:0005601]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; symbiont cell surface [GO:0106139]; synapse [GO:0045202]	carbohydrate binding [GO:0030246]; complement binding [GO:0001848]; endopeptidase inhibitor activity [GO:0004866]	complement activation [GO:0006956]; complement activation, classical pathway [GO:0006958]; detection of molecule of bacterial origin [GO:0032490]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; opsonization [GO:0008228]; positive regulation of apoptotic cell clearance [GO:2000427]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=C4B&keywords=C4B	2.8480067750297002	345	5495.11	90	0.48620412962005977	388	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
C4B_2	complement component 4B (Chido blood group), copy 2	TBD		ENSG00000233312	P0C0L5	NA	7	ligand	extracellular, intracellular, ligand, secreted	P15529, P17927	CD46, CR1	CD46 [CellTalkDB:1717583;Cellinker:1717583;HPRD:1717583;InnateDB:8666815;LRdb:1717583;connectomeDB2020:1717583], CR1 [CellTalkDB:10528211;Cellinker:10528211;HPRD:10528211;LRdb:10528211;connectomeDB2020:10528211]	axon [GO:0030424]; blood microparticle [GO:0072562]; classical-complement-pathway C3/C5 convertase complex [GO:0005601]; dendrite [GO:0030425]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; symbiont cell surface [GO:0106139]; synapse [GO:0045202]	carbohydrate binding [GO:0030246]; complement binding [GO:0001848]; endopeptidase inhibitor activity [GO:0004866]	complement activation [GO:0006956]; complement activation, classical pathway [GO:0006958]; detection of molecule of bacterial origin [GO:0032490]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; opsonization [GO:0008228]; positive regulation of apoptotic cell clearance [GO:2000427]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=C4B_2&keywords=C4B_2	1.7464894641858553	397	5495.11	90	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
C6orf15	chromosome 6 open reading frame 15	TBD		ENSG00000231624, ENSG00000206461, ENSG00000224105, ENSG00000225543, ENSG00000229432, ENSG00000204542	Q6UXA7	NA	1	ecm, ligand	ecm, intracellular, ligand, secreted	Q08345	DDR1	DDR1 [NA]	extracellular matrix [GO:0031012]; extracellular region [GO:0005576]	NA	extracellular matrix organization [GO:0030198]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=C6orf15&keywords=C6orf15	0.009499129325842697	830	NA	NA	0.05745647487758459	700	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
CALCA	calcitonin related polypeptide alpha	Yes		ENSG00000110680	P01258, P06881	Calcitonin family	15	ligand	extracellular, intracellular, ligand, secreted, extracellular, ligand, secreted	O60894, O60895, O60896, P07550, P13945, P16473, P25106, P30988, P32241, P41586, Q03431, Q16602, Q99678, Q9C098, Q9NQS5	ACKR3, ADCYAP1R1, ADRB2, ADRB3, CALCR, CALCRL, DCLK3, GPR20, GPR84, PTH1R, RAMP1, RAMP2, RAMP3, TSHR, VIPR1, ACKR3, ADCYAP1R1, ADRB2, ADRB3, CALCR, CALCRL, CALCRL_RAMP1, CALCRL_RAMP2, CALCRL_RAMP3, DCLK3, GPR20, GPR84, PTH1R, RAMP1, RAMP2, RAMP3, TSHR, VIPR1	CALCRL [Baccin2019:12234182;Baccin2019:14668209;Baccin2019:3001670;Baccin2019:8626685;Baccin2019:9620797;CellTalkDB:9620797;Cellinker:12234182;Cellinker:14668209;Cellinker:3001670;Cellinker:8626685;Cellinker:9620797;Guide2Pharma:10347248;Guide2Pharma:11693189;Guide2Pharma:9620797;HPRD:12234182;HPRD:14668209;HPRD:3001670;HPRD:8626685;HPRD:9620797;LRdb:12234182;LRdb:14668209;LRdb:3001670;LRdb:8626685;LRdb:9620797;connectomeDB2020:12234182;connectomeDB2020:14668209;connectomeDB2020:3001670;connectomeDB2020:8626685;connectomeDB2020:9620797;scConnect:10347248;scConnect:11693189;scConnect:9620797], RAMP2 [Baccin2019:16531504;CellTalkDB:16531504;Cellinker:30139742;Guide2Pharma:11033437;Guide2Pharma:12565884;Guide2Pharma:14722252;Guide2Pharma:15692146;Guide2Pharma:9620797;HPRD:16531504;LRdb:16531504;connectomeDB2020:16531504], RAMP3 [CellTalkDB:30139742;Cellinker:30139742;Guide2Pharma:10347248;Guide2Pharma:11033437;Guide2Pharma:11693189;Guide2Pharma:12565884;Guide2Pharma:14722252;Guide2Pharma:15692146], CALCR [Baccin2019:10342886;Baccin2019:11023820;Baccin2019:11033437;Baccin2019:12565884;Baccin2019:14722252;Baccin2019:15692146;Baccin2019:2158663;Baccin2019:7588285;Baccin2019:9487987;CellTalkDB:2158663;Cellinker:10342886;Cellinker:11023820;Cellinker:11033437;Cellinker:12565884;Cellinker:14722252;Cellinker:15692146;Cellinker:2158663;Cellinker:7588285;Cellinker:9487987;Guide2Pharma:10342886;Guide2Pharma:11023820;Guide2Pharma:11033437;Guide2Pharma:12565884;Guide2Pharma:14722252;Guide2Pharma:15692146;Guide2Pharma:26125036;Guide2Pharma:7588285;Guide2Pharma:9487987;LRdb:10342886;LRdb:11023820;LRdb:11033437;LRdb:12565884;LRdb:14722252;LRdb:15692146;LRdb:2158663;LRdb:7588285;LRdb:9487987;connectomeDB2020:10342886;connectomeDB2020:11023820;connectomeDB2020:11033437;connectomeDB2020:12565884;connectomeDB2020:14722252;connectomeDB2020:15692146;connectomeDB2020:2158663;connectomeDB2020:7588285;connectomeDB2020:9487987;scConnect:10342886;scConnect:11023820;scConnect:11033437;scConnect:12565884;scConnect:14722252;scConnect:15692146;scConnect:26125036;scConnect:7588285;scConnect:9487987], RAMP1 [Baccin2019:962079712234182;CellTalkDB:9620797;Cellinker:30139742;Guide2Pharma:11023820;Guide2Pharma:11033437;Guide2Pharma:11693189;Guide2Pharma:12565884;Guide2Pharma:14722252;Guide2Pharma:15692146;Guide2Pharma:26125036;Guide2Pharma:9620797;HPRD:12234182;LRdb:122;LRdb:9620797;connectomeDB2020:12234182;connectomeDB2020:9620797], ADCYAP1R1 [CellTalkDB:32196115], GPR84 [CellTalkDB:32196115], GPR20 [CellTalkDB:32196115], ADRB3 [CellTalkDB:32196115], TSHR [CellTalkDB:32196115], ADRB2 [CellTalkDB:32196115], PTH1R [CellTalkDB:32196115], VIPR1 [CellTalkDB:32196115], DCLK3 [Cellinker:30139742], ACKR3 [Cellinker:15193773], CALCRL [CellTalkDB:9620797;Cellinker:12234182;Cellinker:14668209;Cellinker:3001670;Cellinker:8626685;Cellinker:9620797;Guide2Pharma:10347248;Guide2Pharma:11693189;Guide2Pharma:9620797;HPRD:12234182;HPRD:14668209;HPRD:3001670;HPRD:8626685;HPRD:9620797;IntAct:23597562;LRdb:12234182;LRdb:14668209;LRdb:3001670;LRdb:8626685;LRdb:9620797;Lit-BM-17:16293613;Lit-BM-17:23597562;Lit-BM-17:9620797;connectomeDB2020:12234182;connectomeDB2020:14668209;connectomeDB2020:3001670;connectomeDB2020:8626685;connectomeDB2020:9620797;scConnect:10347248;scConnect:11693189;scConnect:9620797], RAMP2 [CellTalkDB:16531504;Cellinker:30139742;Guide2Pharma:11033437;Guide2Pharma:12565884;Guide2Pharma:14722252;Guide2Pharma:15692146;Guide2Pharma:9620797;HPRD:16531504;LRdb:16531504;connectomeDB2020:16531504], RAMP3 [CellTalkDB:30139742;Cellinker:30139742;Guide2Pharma:10347248;Guide2Pharma:11033437;Guide2Pharma:11693189;Guide2Pharma:12565884;Guide2Pharma:14722252;Guide2Pharma:15692146], CALCR [CellTalkDB:2158663;Cellinker:10342886;Cellinker:11023820;Cellinker:11033437;Cellinker:12565884;Cellinker:14722252;Cellinker:15692146;Cellinker:2158663;Cellinker:7588285;Cellinker:9487987;Guide2Pharma:10342886;Guide2Pharma:11023820;Guide2Pharma:11033437;Guide2Pharma:12565884;Guide2Pharma:14722252;Guide2Pharma:15692146;Guide2Pharma:26125036;Guide2Pharma:7588285;Guide2Pharma:9487987;ICELLNET:1331173;ICELLNET:6148938;LRdb:10342886;LRdb:11023820;LRdb:11033437;LRdb:12565884;LRdb:14722252;LRdb:15692146;LRdb:2158663;LRdb:7588285;LRdb:9487987;connectomeDB2020:10342886;connectomeDB2020:11023820;connectomeDB2020:11033437;connectomeDB2020:12565884;connectomeDB2020:14722252;connectomeDB2020:15692146;connectomeDB2020:2158663;connectomeDB2020:7588285;connectomeDB2020:9487987;scConnect:10342886;scConnect:11023820;scConnect:11033437;scConnect:12565884;scConnect:14722252;scConnect:15692146;scConnect:26125036;scConnect:7588285;scConnect:9487987], RAMP1 [CellTalkDB:9620797;Cellinker:30139742;Guide2Pharma:11023820;Guide2Pharma:11033437;Guide2Pharma:11693189;Guide2Pharma:12565884;Guide2Pharma:14722252;Guide2Pharma:15692146;Guide2Pharma:26125036;Guide2Pharma:9620797;HPRD:12234182;LRdb:122;LRdb:9620797;connectomeDB2020:12234182;connectomeDB2020:9620797], ADCYAP1R1 [CellTalkDB:32196115], GPR84 [CellTalkDB:32196115], GPR20 [CellTalkDB:32196115], ADRB3 [CellTalkDB:32196115], TSHR [CellTalkDB:32196115], ADRB2 [CellTalkDB:32196115], PTH1R [CellTalkDB:32196115], VIPR1 [CellTalkDB:32196115], DCLK3 [Cellinker:30139742], ACKR3 [Cellinker:15193773]	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; terminal bouton [GO:0043195], cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	calcitonin receptor binding [GO:0031716]; hormone activity [GO:0005179]; identical protein binding [GO:0042802], hormone activity [GO:0005179]; protein-containing complex binding [GO:0044877]; signaling receptor binding [GO:0005102]	activation of adenylate cyclase activity [GO:0007190]; activation of protein kinase activity [GO:0032147]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; aging [GO:0007568]; artery vasodilation involved in baroreceptor response to increased systemic arterial blood pressure [GO:0001984]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to tumor necrosis factor [GO:0071356]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; embryo implantation [GO:0007566]; feeding behavior [GO:0007631]; inflammatory response [GO:0006954]; monocyte chemotaxis [GO:0002548]; negative regulation of bone resorption [GO:0045779]; negative regulation of ossification [GO:0030279]; negative regulation of smooth muscle contraction [GO:0045986]; negative regulation of transcription, DNA-templated [GO:0045892]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway [GO:0051482]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of heart contraction [GO:0008016]; response to heat [GO:0009408]; response to pain [GO:0048265], activation of adenylate cyclase activity [GO:0007190]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; amylin receptor signaling pathway [GO:0097647]; antibacterial humoral response [GO:0019731]; antifungal humoral response [GO:0019732]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; calcitonin gene-related peptide receptor signaling pathway [GO:1990408]; cell-cell signaling [GO:0007267]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; endothelial cell migration [GO:0043542]; endothelial cell proliferation [GO:0001935]; G protein-coupled receptor internalization [GO:0002031]; innate immune response [GO:0045087]; leukocyte cell-cell adhesion [GO:0007159]; negative regulation of blood pressure [GO:0045776]; negative regulation of bone resorption [GO:0045779]; negative regulation of calcium ion transport into cytosol [GO:0010523]; negative regulation of osteoclast differentiation [GO:0045671]; nervous system process involved in regulation of systemic arterial blood pressure [GO:0001976]; positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway [GO:0051482]; positive regulation of interleukin-1 alpha production [GO:0032730]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of macrophage differentiation [GO:0045651]; protein phosphorylation [GO:0006468]; receptor internalization [GO:0031623]; regulation of blood pressure [GO:0008217]; regulation of cytosolic calcium ion concentration [GO:0051480]; response to yeast [GO:0001878]; vasculature development [GO:0001944]; vasodilation [GO:0042311]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CALCA&keywords=CALCA	0.23483072074200786	601	NA	NA	0.28739908409793935	474	0	0	0	0.005755395683453237	0	0.005076142131979695	0.004533091568449683	0.0032626427406199023	0.13281539030706616	0.002737348110562156	0.013830403708711551	101	325	232	0.015273674022803854	5.650756996319852	0.5039769089001283	0.9428943210714014	4	319	121
CALCB	calcitonin related polypeptide beta	Yes		ENSG00000175868	P10092	Calcitonin family	14	ligand	extracellular, ligand, secreted	O60894, O60895, O60896, P07550, P13945, P16473, P30988, P32241, P41586, Q03431, Q16602, Q99678, Q9NQS5	ADCYAP1R1, ADRB2, ADRB3, CALCR, CALCRL, GPR20, GPR84, PTH1R, RAMP1, RAMP2, RAMP3, TSHR, VIPR1	CALCRL [Baccin2019:12196113;Baccin2019:12234182;Baccin2019:14668209;Baccin2019:3001670;Baccin2019:8626685;Baccin2019:9620797;CellTalkDB:12196113;Cellinker:12196113;Guide2Pharma:10347248;Guide2Pharma:11693189;Guide2Pharma:9620797;LRdb:12196113;connectomeDB2020:12196113;scConnect:10347248;scConnect:11693189;scConnect:9620797], RAMP2 [Baccin2019:16531504;CellTalkDB:26423127;Guide2Pharma:11693189;Guide2Pharma:9620797], RAMP3 [CellTalkDB:26423127;Guide2Pharma:10347248;Guide2Pharma:11693189;Guide2Pharma:15692146], CALCR [Baccin2019:10342886;Baccin2019:11023820;Baccin2019:11033437;Baccin2019:12565884;Baccin2019:14722252;Baccin2019:15692146;Baccin2019:2158663;Baccin2019:7588285;Baccin2019:9487987;CellTalkDB:15692146;Cellinker:15692146;Guide2Pharma:15692146;LRdb:15692146;connectomeDB2020:15692146;scConnect:15692146], RAMP1 [Baccin2019:12529937;Baccin2019:962079712234182;CellTalkDB:12529937;Guide2Pharma:11693189;Guide2Pharma:15692146;Guide2Pharma:9620797;HPMR:12529937;LRdb:12529937;connectomeDB2020:12529937], ADCYAP1R1 [CellTalkDB:32196115], TSHR [CellTalkDB:32196115], GPR84 [CellTalkDB:32196115], ADRB2 [CellTalkDB:32196115], PTH1R [CellTalkDB:32196115], VIPR1 [CellTalkDB:32196115], ADRB3 [CellTalkDB:32196115], GPR20 [CellTalkDB:32196115]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	calcitonin receptor binding [GO:0031716]; neuropeptide hormone activity [GO:0005184]	adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular calcium ion homeostasis [GO:0006874]; regulation of cytosolic calcium ion concentration [GO:0051480]; signal transduction [GO:0007165]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CALCB&keywords=CALCB	6.051844569662921	277	NA	NA	41.474538610508965	17	0	0.0054890219560878245	0.00331858407079646	0.004076738609112709	0.026936026936026928	0.21150592216582054	0.08159564823209417	0.024469820554649267	0.18349981502034746	0.08859660835892724	0.07073594745991786	85	116	129	0.06365673939670731	2.62704834079307	1.338595886357343	1.0961107988378727	19	72	76
CALR	calreticulin	No		ENSG00000179218	P27797	Calreticulin family	8	adhesion, ecm, ligand	adhesion, ecm, extracellular, intracellular, ligand, matrix_adhesion, secreted, transmembrane	O15533, P06756, P06858, P08514, P10275, P16473, P26006, P30101, P30511, P40238, P48039, Q03518, Q03519, Q07954, Q14162	AR, HLA-F, ITGA2B, ITGA3, ITGAV, LPL, LRP1, MPL, MTNR1A, PDIA3, SCARF1, TAP1, TAP2, TAPBP, TSHR	PDIA3 [BioGRID:12052826;HPRD:10436013;Lit-BM-17:10436013;Lit-BM-17:12052826;Macrophage:10618487;Macrophage:9597133], TAP1 [Macrophage:10618487], TAP2 [Macrophage:10618487], TAPBP [BioGRID:8769474;HPRD:8769474;Macrophage:10618487], LRP1 [Adhesome:12821648;Adhesome:14980518;Cellinker:11560994;Cellinker:12821648;Cellinker:14980518;HPRD:12821648;HPRD:14980518;LRdb:13;LRdb:14980518;connectomeDB2020:12821648;connectomeDB2020:14980518], ITGAV [Adhesome:12196561;CellTalkDB:12196561;HPRD:12196561;LRdb:12196561;connectomeDB2020:12196561], ITGA3 [Adhesome:11327697;Adhesome:8006073;CellTalkDB:8006073;HPRD:11327697;HPRD:8006073;LMPID:1911778;LRdb:113;LRdb:8006073;connectomeDB2020:11327697;connectomeDB2020:8006073], MPL [CellTalkDB:32462673;Cellinker:29288169], TSHR [Baccin2019:12383251;CellTalkDB:12383251;HPRD:12383251;LRdb:12383251;NetPath:12383251;connectomeDB2020:12383251], HLA-F [CellTalkDB:32196115], ITGA2B [CellTalkDB:14985176;HPRD:14985176;LRdb:14985176], SCARF1 [CellTalkDB:15371419;Cellinker:15371419;HPMR:15371419;HPRD:15371419;LRdb:15371419;connectomeDB2020:15371419], MTNR1A [Baccin2019:17215244;CellTalkDB:17215244;HPRD:17215244;IntAct:28298427;LRdb:17215244;connectomeDB2020:17215244], AR [HPRD:8107809;NetPath:8107809], LPL [HPRD:12740382]	acrosomal vesicle [GO:0001669]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; cortical granule [GO:0060473]; cytolytic granule [GO:0044194]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endocytic vesicle lumen [GO:0071682]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum quality control compartment [GO:0044322]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; integral component of lumenal side of endoplasmic reticulum membrane [GO:0071556]; membrane [GO:0016020]; MHC class I peptide loading complex [GO:0042824]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle membrane [GO:0030670]; polysome [GO:0005844]; sarcoplasmic reticulum lumen [GO:0033018]; smooth endoplasmic reticulum [GO:0005790]	androgen receptor binding [GO:0050681]; calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; chaperone binding [GO:0051087]; complement component C1q complex binding [GO:0001849]; DNA binding [GO:0003677]; hormone binding [GO:0042562]; integrin binding [GO:0005178]; iron ion binding [GO:0005506]; mRNA binding [GO:0003729]; peptide binding [GO:0042277]; protein folding chaperone [GO:0044183]; RNA binding [GO:0003723]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082]; zinc ion binding [GO:0008270]	cardiac muscle cell differentiation [GO:0055007]; cellular calcium ion homeostasis [GO:0006874]; cellular response to lithium ion [GO:0071285]; cellular senescence [GO:0090398]; cortical actin cytoskeleton organization [GO:0030866]; glucocorticoid receptor signaling pathway [GO:0042921]; negative regulation of intracellular steroid hormone receptor signaling pathway [GO:0033144]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translation [GO:0017148]; negative regulation of trophoblast cell migration [GO:1901164]; peptide antigen assembly with MHC class I protein complex [GO:0002502]; positive regulation of cell cycle [GO:0045787]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of dendritic cell chemotaxis [GO:2000510]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of gene expression [GO:0010628]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of phagocytosis [GO:0050766]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein export from nucleus [GO:0006611]; protein folding [GO:0006457]; protein folding in endoplasmic reticulum [GO:0034975]; protein localization to nucleus [GO:0034504]; protein maturation by protein folding [GO:0022417]; protein stabilization [GO:0050821]; regulation of apoptotic process [GO:0042981]; regulation of meiotic nuclear division [GO:0040020]; regulation of transcription, DNA-templated [GO:0006355]; response to estradiol [GO:0032355]; response to testosterone [GO:0033574]; response to xenobiotic stimulus [GO:0009410]; sequestering of calcium ion [GO:0051208]; spermatogenesis [GO:0007283]; ubiquitin-dependent ERAD pathway [GO:0030433]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CALR&keywords=CALR	694.3523145202247	21	248401	8	1.822060420192054	175	2.5748031496062964	2.4805389221556835	1.9424778761062031	3.9407673860910672	1.7760942760942826	3.529610829103216	3.905711695376266	1.9265905383360467	2.022197558268609	3.4219521965558406	1.8966969287238107	17	12	17	2.674312850583393	0.7570643480795999	1.2785216878911712	0.7103109938580446	239	80	232
CARTPT	CART prepropeptide	Yes		ENSG00000164326	Q16568	CART family	1	ligand	extracellular, intracellular, ligand, secreted	NA	NA	NA	extracellular space [GO:0005615]; secretory granule [GO:0030141]; synapse [GO:0045202]	neuropeptide hormone activity [GO:0005184]	adult feeding behavior [GO:0008343]; cell-cell signaling [GO:0007267]; cellular glucose homeostasis [GO:0001678]; cellular response to starvation [GO:0009267]; chemical synaptic transmission [GO:0007268]; circadian regulation of gene expression [GO:0032922]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of appetite [GO:0032099]; negative regulation of bone resorption [GO:0045779]; negative regulation of glucagon secretion [GO:0070093]; negative regulation of osteoclast differentiation [GO:0045671]; neuropeptide signaling pathway [GO:0007218]; positive regulation of blood pressure [GO:0045777]; positive regulation of epinephrine secretion [GO:0032812]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of transmission of nerve impulse [GO:0051971]; regulation of insulin secretion [GO:0050796]; signal transduction [GO:0007165]; somatostatin secretion [GO:0070253]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CARTPT&keywords=CARTPT	2.940278191011236	340	NA	NA	0.36936821705332035	434	0	0	0	2.3980815347721823e-4	0.0016835016835016834	0	9.066183136899365e-4	0.6753670473083203	0.031076581576026635	5.007344104686875e-4	0.0014293992659841607	204	388	347	0.06465488097376988	0.5502196378889006	0.14065703773820415	0.15309647697382173	327	448	445
CBLN1	cerebellin 1 precursor	Yes		ENSG00000102924	P23435	NA	1	ligand	extracellular, ligand, secreted	NA	NA	NA	collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; parallel fiber to Purkinje cell synapse [GO:0098688]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; synaptic cleft [GO:0043083]	identical protein binding [GO:0042802]	cerebellar granule cell differentiation [GO:0021707]; chemical synaptic transmission [GO:0007268]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; maintenance of synapse structure [GO:0099558]; negative regulation of excitatory postsynaptic potential [GO:0090394]; negative regulation of inhibitory synapse assembly [GO:1905703]; nervous system development [GO:0007399]; positive regulation of long-term synaptic depression [GO:1900454]; positive regulation of synapse assembly [GO:0051965]; protein secretion [GO:0009306]; regulation of postsynaptic density assembly [GO:0099151]; regulation of presynapse assembly [GO:1905606]; synapse organization [GO:0050808]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CBLN1&keywords=CBLN1	0.7510758894943774	489	NA	NA	0.024464606842417528	787	0	0	0	0.001199040767386091	0.0016835016835016834	0.01015228426395939	0.007252946509519492	0.0016313213703099511	3.699593044765076e-4	0.00644278274803043	2.31794475564999e-4	302	271	395	0.0026330573747953222	0.8208590364804322	1.3015679625453165	0.809922267588116	213	75	181
CBLN2	cerebellin 2 precursor	Yes		ENSG00000141668	Q8IUK8	NA	1	ligand	ligand, secreted	NA	NA	NA	extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; synapse [GO:0045202]	NA	maintenance of synapse structure [GO:0099558]; positive regulation of synapse assembly [GO:0051965]; regulation of presynapse assembly [GO:1905606]; spontaneous synaptic transmission [GO:0098814]; synapse organization [GO:0050808]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CBLN2&keywords=CBLN2	0.08771727083559079	685	NA	NA	0.04924636421807994	709	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
CBLN3	cerebellin 3 precursor	Yes		ENSG00000139899	Q6UW01	NA	1	ligand	intracellular, ligand, secreted	NA	NA	NA	endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; synapse [GO:0045202]	NA	maintenance of synapse structure [GO:0099558]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CBLN3&keywords=CBLN3	0.6084124769233251	505	NA	NA	0.01721716166035955	807	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
CBLN4	cerebellin 4 precursor	Yes		ENSG00000054803	Q9NTU7	NA	1	ligand	ligand, secreted	NA	NA	NA	collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; GABA-ergic synapse [GO:0098982]; synapse [GO:0045202]	NA	inhibitory synapse assembly [GO:1904862]; maintenance of synapse structure [GO:0099558]; protein secretion [GO:0009306]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CBLN4&keywords=CBLN4	0.8889110786516854	466	NA	NA	0.4280541436535022	407	0	0.001497005988023952	0	0.0014388489208633092	0	0.15397631133671727	0.003626473254759746	0.004893964110929854	0.20273769885312495	0.0012017625851248495	0.001313502028201662	77	366	351	0.03369868791615869	4.868285731170886	0.25634093652003487	0.258897979955554	5	394	404
CCBE1	collagen and calcium binding EGF domains 1	No		ENSG00000183287	Q6UXH8	CCBE1 family	1	ecm, ligand, receptor	ecm, intracellular, ligand, receptor, secreted	NA	NA	NA	collagen trimer [GO:0005581]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]	calcium ion binding [GO:0005509]; collagen binding [GO:0005518]; protease binding [GO:0002020]	lung development [GO:0030324]; lymphangiogenesis [GO:0001946]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of lymphangiogenesis [GO:1901492]; positive regulation of protein processing [GO:0010954]; positive regulation of vascular endothelial growth factor production [GO:0010575]; positive regulation of vascular endothelial growth factor signaling pathway [GO:1900748]; respiratory system process [GO:0003016]; sprouting angiogenesis [GO:0002040]; venous blood vessel morphogenesis [GO:0048845]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CCBE1&keywords=CCBE1	0.9183777444732135	459	NA	NA	0.14321471307151584	582	0	0.004990019960079841	0.00331858407079646	0.046282973621103105	0	0.013536379018612519	0.006346328195829556	0.008156606851549756	0.009248982611912693	0.007477633862999048	0.005717597063936648	267	257	282	0.009552282296074511	0.9844877605811414	0.8938922627210641	0.8038753136810147	138	173	185
CCK	cholecystokinin	Yes		ENSG00000187094	P06307	Gastrin/cholecystokinin family	15	ligand	extracellular, ligand, secreted	P32238, P32239	CCKAR, CCKBR	CCKAR [Baccin2019:10368033;Baccin2019:10400673;Baccin2019:10595537;Baccin2019:11300760;Baccin2019:9006937;Baccin2019:9603948;CellTalkDB:10368033;Cellinker:10368033;Cellinker:10400673;Cellinker:10595537;Cellinker:11300760;Cellinker:9006937;Cellinker:9603948;HPRD:10400673;HPRD:10595537;HPRD:11300760;HPRD:9006937;HPRD:9603948;LRdb:10368033;LRdb:10400673;LRdb:10595537;LRdb:11300760;LRdb:9006937;LRdb:9603948;SIGNOR:10368033;connectomeDB2020:10368033;connectomeDB2020:10400673;connectomeDB2020:10595537;connectomeDB2020:11300760;connectomeDB2020:9006937;connectomeDB2020:9603948], CCKBR [Baccin2019:10368033;Baccin2019:10438490;Baccin2019:12695525;Baccin2019:15001692;Baccin2019:15068617;Baccin2019:15520004;Baccin2019:7681836;Baccin2019:8349705;BioGRID:12695525;BioGRID:15001692;BioGRID:15520004;CellTalkDB:10368033;Cellinker:10368033;Cellinker:10438490;Cellinker:12695525;Cellinker:15001692;Cellinker:15068617;Cellinker:15520004;Cellinker:7681836;Cellinker:8349705;Guide2Pharma:7681836;Guide2Pharma:8349705;HPRD:10438490;HPRD:12695525;HPRD:15001692;HPRD:15068617;HPRD:15520004;LRdb:10368033;LRdb:10438490;LRdb:12695525;LRdb:15001692;LRdb:15068617;LRdb:15520004;LRdb:7681836;LRdb:8349705;Lit-BM-17:12695525;Lit-BM-17:15001692;Lit-BM-17:15520004;Lit-BM-17:23597562;SIGNOR:10368033;connectomeDB2020:10368033;connectomeDB2020:10438490;connectomeDB2020:12695525;connectomeDB2020:15001692;connectomeDB2020:15068617;connectomeDB2020:15520004;connectomeDB2020:7681836;connectomeDB2020:8349705;scConnect:7681836;scConnect:8349705]	axon [GO:0030424]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	hormone activity [GO:0005179]; neuropeptide hormone activity [GO:0005184]; peptide hormone receptor binding [GO:0051428]	axonogenesis [GO:0007409]; digestion [GO:0007586]; eating behavior [GO:0042755]; neuron migration [GO:0001764]; signal transduction [GO:0007165]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CCK&keywords=CCK	0.310812706741573	573	NA	NA	0.012091817715519931	822	0.007874015748031496	0.0034930139720558886	0	0.07098321342925676	0.01683501683501683	0.008460236886632826	0.015412511332728921	0.008156606851549756	0.0022197558268590455	0.0011016157030311123	0.018582190457794006	297	369	210	0.013919834276632423	0.5108628966880708	0.4641175843712436	1.1949159064917223	338	329	64
CCL1	C-C motif chemokine ligand 1	Yes		ENSG00000108702	P22362	Intercrine beta (chemokine CC) family	18	ligand	extracellular, intracellular, ligand, secreted	P32246, P51685, Q16570, Q9NPB9	ACKR1, ACKR4, CCR1, CCR8	CCR8 [Baccin2019:10419462;Baccin2019:11154210;Baccin2019:12645948;Baccin2019:12967681;Baccin2019:16221874;Baccin2019:9211859;CellPhoneDB:24218476;Cellinker:10419462;Cellinker:11154210;Cellinker:12645948;Cellinker:12967681;Cellinker:16221874;Cellinker:9211859;DIP:10910894;DIP:11470772;DIP:9211859;DIP:9469461;Guide2Pharma:10419462;Guide2Pharma:11154210;Guide2Pharma:16221874;HPMR:12645948;HPRD:12967681;HPRD:9211859;ICELLNET:9207005;InnateDB:9211859;LRdb:10699158;SIGNOR:12645948;connectomeDB2020:10419462;connectomeDB2020:11154210;connectomeDB2020:12645948;connectomeDB2020:12967681;connectomeDB2020:16221874;connectomeDB2020:9211859;scConnect:10419462;scConnect:11154210;scConnect:16221874], ACKR4 [NA], ACKR1 [CellChatDB:26740381;Cellinker:26740381], CCR1 [DIP:10910894;DIP:11470772]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	CCR chemokine receptor binding [GO:0048020]; chemokine activity [GO:0008009]	antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cellular calcium ion homeostasis [GO:0006874]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; chemokine-mediated signaling pathway [GO:0070098]; chemotaxis [GO:0006935]; eosinophil chemotaxis [GO:0048245]; G protein-coupled receptor signaling pathway [GO:0007186]; inflammatory response [GO:0006954]; killing of cells of other organism [GO:0031640]; lymphocyte chemotaxis [GO:0048247]; monocyte chemotaxis [GO:0002548]; neutrophil chemotaxis [GO:0030593]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of GTPase activity [GO:0043547]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of monocyte chemotaxis [GO:0090026]; signal transduction [GO:0007165]; viral process [GO:0016032]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CCL1&keywords=CCL1	0.019922932584269665	795	NA	NA	0.8975863009465551	285	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
CCL11	C-C motif chemokine ligand 11	Yes		ENSG00000172156	P51671	Intercrine beta (chemokine CC) family	19	ligand	extracellular, intracellular, ligand, secreted	O00590, P27487, P41597, P49682, P51677, P51681, Q16570, Q9NPB9	ACKR1, ACKR2, ACKR4, CCR2, CCR3, CCR5, CXCR3, DPP4	CCR2 [Baccin2019:11264152;Baccin2019:12149192;Baccin2019:12554737;Baccin2019:15207250;Baccin2019:9115216;Baccin2019:9195948;Baccin2019:9276730;CellTalkDB:12554737;Cellinker:11264152;Cellinker:12554737;Cellinker:15207250;Guide2Pharma:12554737;Guide2Pharma:15207250;HPRD:11264152;ICELLNET:22633458;InnateDB:11264152;LRdb:11264152;LRdb:12554737;LRdb:15207250;connectomeDB2020:11264152;connectomeDB2020:12554737;connectomeDB2020:15207250;scConnect:12554737;scConnect:15207250], CCR3 [Baccin2019:10488147;Baccin2019:10854442;Baccin2019:12149192;Baccin2019:12761559;Baccin2019:16339911;Baccin2019:8609214;Baccin2019:8642344;Baccin2019:8676064;Baccin2019:9005985;Baccin2019:9276730;Baccin2019:9712872;CellPhoneDB:24218476;CellTalkDB:10699158;Cellinker:10488147;Cellinker:10854442;Cellinker:12761559;Cellinker:16339911;Cellinker:8609214;Cellinker:8642344;Cellinker:8676064;Cellinker:9276730;Cellinker:9712872;DIP:10733106;DIP:25450766;DIP:9169459;DIP:9207005;Guide2Pharma:10488147;Guide2Pharma:10854442;Guide2Pharma:12761559;Guide2Pharma:16339911;Guide2Pharma:8642344;Guide2Pharma:9276730;HPRD:8609214;HPRD:8642344;HPRD:8676064;HPRD:9712872;ICELLNET:22633458;InnateDB:12218106;InnateDB:16102831;InnateDB:8642344;LRdb:10699158;Lit-BM-17:10733106;Lit-BM-17:23597562;Lit-BM-17:8642344;Lit-BM-17:9169459;Lit-BM-17:9207005;SIGNOR:10706854;SIGNOR:24702154;connectomeDB2020:10488147;connectomeDB2020:10854442;connectomeDB2020:12761559;connectomeDB2020:16339911;connectomeDB2020:8609214;connectomeDB2020:8642344;connectomeDB2020:8676064;connectomeDB2020:9276730;connectomeDB2020:9712872;scConnect:10488147;scConnect:10854442;scConnect:12761559;scConnect:16339911;scConnect:8642344;scConnect:9276730], CCR5 [Baccin2019:10477718;Baccin2019:11264152;Baccin2019:12964882;Baccin2019:9468473;Baccin2019:9790730;CellTalkDB:10699158;Cellinker:10477718;Cellinker:11264152;DIP:10477718;Guide2Pharma:10477718;HPRD:10477718;HPRD:11264152;ICELLNET:22633458;InnateDB:10477718;LRdb:10699158;connectomeDB2020:10477718;connectomeDB2020:11264152;scConnect:10477718], CXCR3 [Baccin2019:96607939660793;CellTalkDB:9660793;Cellinker:9660793;DIP:9660793;Guide2Pharma:9660793;ICELLNET:22633458;LRdb:9660793;connectomeDB2020:9660793;scConnect:9660793], ACKR1 [CellChatDB:26740381;CellTalkDB:10699158;Cellinker:26740381;Cellinker:29637711;ICELLNET:22633458;LRdb:10699158], ACKR2 [CellChatDB:26740381;CellPhoneDB:24218476;CellTalkDB:10699158;Cellinker:26740381;Cellinker:9405404;HPRD:9405404;ICELLNET:22633458;InnateDB:9405404;LRdb:10699158;connectomeDB2020:9405404], DPP4 [CellPhoneDB:24218476;CellTalkDB:9660793;Cellinker:17156337;HPRD:11390394;IntAct:18275857;IntAct:21314817], ACKR4 [CellTalkDB:10734104;Cellinker:10734104;HPRD:10734104;HPRD:9405404;LRdb:10734104;connectomeDB2020:10734104]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	CCR3 chemokine receptor binding [GO:0031728]; CCR chemokine receptor binding [GO:0048020]; chemokine activity [GO:0008009]; protein dimerization activity [GO:0046983]; receptor ligand activity [GO:0048018]	antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; branching involved in mammary gland duct morphogenesis [GO:0060444]; cell adhesion [GO:0007155]; cellular calcium ion homeostasis [GO:0006874]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; chemokine-mediated signaling pathway [GO:0070098]; chemotaxis [GO:0006935]; cytoskeleton organization [GO:0007010]; eosinophil chemotaxis [GO:0048245]; G protein-coupled receptor signaling pathway [GO:0007186]; inflammatory response [GO:0006954]; killing of cells of other organism [GO:0031640]; learning or memory [GO:0007611]; lymphocyte chemotaxis [GO:0048247]; mammary duct terminal end bud growth [GO:0060763]; modulation of age-related behavioral decline [GO:0090647]; monocyte chemotaxis [GO:0002548]; negative regulation of neurogenesis [GO:0050768]; neutrophil chemotaxis [GO:0030593]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell migration [GO:0030335]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of GTPase activity [GO:0043547]; protein phosphorylation [GO:0006468]; regulation of cell shape [GO:0008360]; response to radiation [GO:0009314]; response to virus [GO:0009615]; signal transduction [GO:0007165]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CCL11&keywords=CCL11	0.26876030561797754	587	NA	NA	0.09356018678691808	640	0	4.99001996007984e-4	0.0022123893805309734	0.18369304556354935	0	0	9.066183136899365e-4	0	0	1.0014688209373749e-4	5.022213637241645e-4	303	406	384	0.017083038499963284	0.3692347887779858	0.3729325600636513	0.3877785486934342	386	351	356
CCL13	C-C motif chemokine ligand 13	Yes		ENSG00000181374	Q99616	Intercrine beta (chemokine CC) family	19	ligand	extracellular, intracellular, ligand, secreted	O00590, P13500, P32246, P41597, P49682, P51677, P51681, P51686, Q16570, Q9NPB9	ACKR1, ACKR2, ACKR4, CCL2, CCR1, CCR2, CCR3, CCR5, CCR9, CXCR3	CCR1 [CellTalkDB:10699158;Cellinker:23846739;LRdb:10699158], CCR2 [Baccin2019:24890717;CellPhoneDB:24218476;Cellinker:12149192;Cellinker:12554737;Cellinker:9195948;Cellinker:9276730;DIP:9195948;Guide2Pharma:12554737;Guide2Pharma:9276730;HPRD:12149192;HPRD:9195948;ICELLNET:22633458;LRdb:10699158;connectomeDB2020:12149192;connectomeDB2020:12554737;connectomeDB2020:9195948;connectomeDB2020:9276730;scConnect:12554737;scConnect:9276730], CCR3 [CellPhoneDB:24218476;Cellinker:12149192;Cellinker:16339911;Cellinker:9005985;Cellinker:9276730;DIP:10733106;Guide2Pharma:16339911;Guide2Pharma:9276730;HPRD:12149192;ICELLNET:22633458;LRdb:10699158;connectomeDB2020:12149192;connectomeDB2020:16339911;connectomeDB2020:9005985;connectomeDB2020:9276730;scConnect:16339911;scConnect:9276730], CCR5 [CellTalkDB:9790730;Cellinker:10477718;Cellinker:9790730;DIP:10477718;Guide2Pharma:9790730;HPRD:10477718;InnateDB:10477718;LRdb:105;LRdb:9790730;connectomeDB2020:10477718;connectomeDB2020:9790730;scConnect:9790730], CXCR3 [CellTalkDB:9660793;Cellinker:9660793;DIP:9660793;Guide2Pharma:9660793;LRdb:9660793;connectomeDB2020:9660793;scConnect:9660793], ACKR1 [Baccin2019:24890717;CellChatDB:26740381;CellTalkDB:10699158;Cellinker:26740381;Cellinker:29637711;ICELLNET:22633458;LRdb:10699158], ACKR2 [Baccin2019:24890717;CellChatDB:26740381;CellPhoneDB:24218476;Cellinker:26740381;Cellinker:9405404;HPRD:9405404;ICELLNET:22633458;InnateDB:9405404;LRdb:10699158;connectomeDB2020:9405404], ACKR4 [CellChatDB:26740381;CellTalkDB:10734104;Cellinker:10734104;Cellinker:26740381;DIP:10734104;HPRD:10734104;HPRD:9405404;InnateDB:10734104;LRdb:10734104;connectomeDB2020:10734104], CCR9 [CellTalkDB:32196115], CCL2 [InnateDB:16803905]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	CCR chemokine receptor binding [GO:0048020]; chemokine activity [GO:0008009]; signaling receptor binding [GO:0005102]	antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cell-cell signaling [GO:0007267]; cellular calcium ion homeostasis [GO:0006874]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; chemokine-mediated signaling pathway [GO:0070098]; chemotaxis [GO:0006935]; cytoskeleton organization [GO:0007010]; eosinophil chemotaxis [GO:0048245]; G protein-coupled receptor signaling pathway [GO:0007186]; inflammatory response [GO:0006954]; killing of cells of other organism [GO:0031640]; lymphocyte chemotaxis [GO:0048247]; monocyte chemotaxis [GO:0002548]; neutrophil chemotaxis [GO:0030593]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of GTPase activity [GO:0043547]; regulation of cell shape [GO:0008360]; signal transduction [GO:0007165]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CCL13&keywords=CCL13	0.08975862584269663	680	NA	NA	0.02815184488685042	773	0	0	0	0.0052757793764988	0	0	0	0	0	0	0	303	409	401	4.796163069544364e-4	0.954233409610984	0.954233409610984	0.954233409610984	152	149	116
CCL14	C-C motif chemokine ligand 14	Yes		ENSG00000277236, ENSG00000276409	Q16627	Intercrine beta (chemokine CC) family	17	ligand	extracellular, intracellular, ligand, secreted	O00590, P32246, P51677, P51681, Q16570	ACKR1, ACKR2, CCR1, CCR3, CCR5	CCR1 [CellPhoneDB:24218476;CellTalkDB:24218476;Cellinker:11085751;Cellinker:12381680;Cellinker:20483925;Cellinker:9687537;DIP:9687537;Guide2Pharma:12381680;HPRD:11085751;ICELLNET:22633458;InnateDB:12381680;InnateDB:15905581;InnateDB:9346309;InnateDB:9548457;LRdb:9405404;connectomeDB2020:11085751;connectomeDB2020:12381680;connectomeDB2020:9687537;scConnect:12381680], CCR5 [CellTalkDB:11085751;Cellinker:11085751;Cellinker:12964882;Cellinker:16298345;Cellinker:20483925;Guide2Pharma:16298345;HPRD:11085751;ICELLNET:22633458;LRdb:11085751;LRdb:12964882;LRdb:16298345;connectomeDB2020:11085751;connectomeDB2020:12964882;connectomeDB2020:16298345;scConnect:16298345], ACKR1 [CellChatDB:26740381;CellTalkDB:9405404;Cellinker:26740381;Cellinker:29637711;ICELLNET:22633458;LRdb:9405404], ACKR2 [CellChatDB:26740381;CellPhoneDB:24218476;CellTalkDB:9660793;Cellinker:26740381;Cellinker:9405404;HPRD:9405404;ICELLNET:22633458;InnateDB:9405404;LRdb:9660793;connectomeDB2020:9405404], CCR3 [CellPhoneDB:24218476;CellTalkDB:11085751;Cellinker:11085751;HPRD:11085751;InnateDB:9346309;InnateDB:9548457;LRdb:11085751;connectomeDB2020:11085751]	extracellular space [GO:0005615]	CCR chemokine receptor binding [GO:0048020]; chemokine activity [GO:0008009]	cellular calcium ion homeostasis [GO:0006874]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; chemokine-mediated signaling pathway [GO:0070098]; G protein-coupled receptor signaling pathway [GO:0007186]; inflammatory response [GO:0006954]; lymphocyte chemotaxis [GO:0048247]; monocyte chemotaxis [GO:0002548]; neutrophil chemotaxis [GO:0030593]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of GTPase activity [GO:0043547]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CCL14&keywords=CCL14	0.12878413405882044	652	NA	NA	0.005972102197978516	857	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
CCL15	C-C motif chemokine ligand 15	Yes		ENSG00000275528, ENSG00000275718	Q16663	Intercrine beta (chemokine CC) family	17	ligand	intracellular, ligand, secreted	P32246, P51677	CCR1, CCR3	CCR1 [CellTalkDB:10699158;Cellinker:9346309;DIP:9346309;Guide2Pharma:9346309;HPRD:9346309;ICELLNET:9346309;LRdb:10699158;connectomeDB2020:9346309;scConnect:9346309], CCR3 [CellTalkDB:10699158;Cellinker:9346309;DIP:9346309;Guide2Pharma:9346309;HPRD:9346309;ICELLNET:9346309;LRdb:10699158;connectomeDB2020:9346309;scConnect:9346309]	extracellular space [GO:0005615]	CCR chemokine receptor binding [GO:0048020]; chemoattractant activity [GO:0042056]; chemokine activity [GO:0008009]; heparin binding [GO:0008201]; signaling receptor binding [GO:0005102]	cell-cell signaling [GO:0007267]; cellular calcium ion homeostasis [GO:0006874]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; chemokine-mediated signaling pathway [GO:0070098]; chemotaxis [GO:0006935]; G protein-coupled receptor signaling pathway [GO:0007186]; inflammatory response [GO:0006954]; lymphocyte chemotaxis [GO:0048247]; monocyte chemotaxis [GO:0002548]; neutrophil chemotaxis [GO:0030593]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of GTPase activity [GO:0043547]; signal transduction [GO:0007165]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CCL15&keywords=CCL15	1.5501493619628393	408	NA	NA	1.065948862185605	250	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
CCL16	C-C motif chemokine ligand 16	Yes		ENSG00000275095, ENSG00000275152	O15467	Intercrine beta (chemokine CC) family	17	ligand	extracellular, intracellular, ligand, secreted	P08913, P32246, P32302, P41597, P48039, P51681, P51685, Q14831, Q16570, Q9H3N8	ACKR1, ADRA2A, CCR1, CCR2, CCR5, CCR8, CXCR5, GRM7, HRH4, MTNR1A	CCR2 [CellPhoneDB:24218476;CellTalkDB:11470772;Cellinker:11470772;DIP:11470772;HPRD:11470772;ICELLNET:22633458;InnateDB:11470772;LRdb:11470772;connectomeDB2020:11470772], CCR5 [CellTalkDB:11470772;Cellinker:11470772;HPRD:11470772;ICELLNET:22633458;InnateDB:11470772;LRdb:11470772;connectomeDB2020:11470772], HRH4 [CellTalkDB:15265943;Cellinker:15265943;Guide2Pharma:15265943;HPRD:15265943;ICELLNET:15265943;LRdb:15265943;connectomeDB2020:15265943;scConnect:15265943], CCR1 [CellPhoneDB:24218476;CellTalkDB:11470772;Cellinker:10910894;Cellinker:11470772;DIP:10910894;DIP:11470772;HPRD:10910894;HPRD:11470772;ICELLNET:22633458;InnateDB:11470772;LRdb:11;LRdb:11470772;connectomeDB2020:10910894;connectomeDB2020:11470772], CCR8 [CellTalkDB:10910894;Cellinker:10910894;DIP:10910894;HPRD:10910894;ICELLNET:22633458;LRdb:10910894;connectomeDB2020:10910894], ADRA2A [CellTalkDB:32196115], MTNR1A [CellTalkDB:32196115], GRM7 [CellTalkDB:32196115], ACKR1 [CellChatDB:26740381;Cellinker:26740381], CXCR5 [DIP:11470772]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	CCR chemokine receptor binding [GO:0048020]; chemoattractant activity [GO:0042056]; chemokine activity [GO:0008009]	cell-cell signaling [GO:0007267]; cell communication [GO:0007154]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; chemokine-mediated signaling pathway [GO:0070098]; chemotaxis [GO:0006935]; G protein-coupled receptor signaling pathway [GO:0007186]; inflammatory response [GO:0006954]; lymphocyte chemotaxis [GO:0048247]; monocyte chemotaxis [GO:0002548]; neutrophil chemotaxis [GO:0030593]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of GTPase activity [GO:0043547]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CCL16&keywords=CCL16	0.08938007859652056	682	NA	NA	0.058207326926161096	697	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
CCL17	C-C motif chemokine ligand 17	Yes		ENSG00000102970	Q92583	Intercrine beta (chemokine CC) family	17	ligand	extracellular, intracellular, ligand, secreted	O00590, P51679, P51685, Q16570	ACKR1, ACKR2, CCR4, CCR8	CCR4 [CellPhoneDB:24218476;Cellinker:29637711;DIP:10488147;DIP:10498628;DIP:9169459;DIP:9169480;DIP:9430724;Guide2Pharma:9430724;HPMR:9169480;HPRD:9169480;HPRD:9430724;ICELLNET:10540332;ICELLNET:22633458;InnateDB:9169480;LRdb:10699158;connectomeDB2020:9169480;connectomeDB2020:9430724;scConnect:9430724], ACKR1 [CellChatDB:26740381;Cellinker:13679391;Cellinker:26740381;HPRD:13679391;ICELLNET:22633458;LRdb:10699158;LRdb:13679391;connectomeDB2020:13679391], ACKR2 [CellChatDB:26740381;CellTalkDB:10699158;Cellinker:26740381;Cellinker:29637711;ICELLNET:22633458;LRdb:10699158;connectomeDB2020:25297873], CCR8 [CellTalkDB:10699158;Cellinker:12832759;Cellinker:9521068;DIP:10910894;HPRD:12832759;HPRD:9521068;LRdb:10699158;connectomeDB2020:12832759;connectomeDB2020:9521068]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	CCR4 chemokine receptor binding [GO:0031729]; CCR chemokine receptor binding [GO:0048020]; chemokine activity [GO:0008009]; signaling receptor binding [GO:0005102]	antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cell-cell signaling [GO:0007267]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; chemokine-mediated signaling pathway [GO:0070098]; chemotaxis [GO:0006935]; G protein-coupled receptor signaling pathway [GO:0007186]; inflammatory response [GO:0006954]; killing of cells of other organism [GO:0031640]; lymphocyte chemotaxis [GO:0048247]; monocyte chemotaxis [GO:0002548]; multicellular organism development [GO:0007275]; negative regulation of myoblast differentiation [GO:0045662]; neutrophil chemotaxis [GO:0030593]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of GTPase activity [GO:0043547]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CCL17&keywords=CCL17	0.1857485213483146	617	NA	NA	0.3803919929714195	428	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
CCL18	C-C motif chemokine ligand 18	Yes		ENSG00000278006, ENSG00000278167, ENSG00000275385	P55774	Intercrine beta (chemokine CC) family	15	ligand	extracellular, intracellular, ligand, secreted	P32246, P51677, P51685, Q16570, Q9BZ71, Q9UKR5	ACKR1, CCR1, CCR3, CCR8, ERG28, PITPNM3	CCR8 [CellPhoneDB:24218476;CellTalkDB:24218476;Cellinker:24218476;ICELLNET:23999500;InnateDB:23999500;LRdb:24218476;connectomeDB2020:24218476], CCR3 [CellTalkDB:23951310;Cellinker:23951310;Cellinker:29637711;ICELLNET:22633458;ICELLNET:23999500;InnateDB:10640766;connectomeDB2020:24218476;scConnect:23951310], PITPNM3 [ICELLNET:22633458;InnateDB:21481794;connectomeDB2020:24218476], CCR1 [CellTalkDB:32103204;scConnect:23951310], ACKR1 [CellChatDB:26740381;Cellinker:26740381], ERG28 [HPRD:16169070;InnateDB:16169070;LRdb:16169070]	extracellular space [GO:0005615]	CCR chemokine receptor binding [GO:0048020]; chemokine activity [GO:0008009]	antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cell-cell signaling [GO:0007267]; cell communication [GO:0007154]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; chemokine-mediated signaling pathway [GO:0070098]; chemotaxis [GO:0006935]; G protein-coupled receptor signaling pathway [GO:0007186]; immune response [GO:0006955]; inflammatory response [GO:0006954]; killing of cells of other organism [GO:0031640]; lymphocyte chemotaxis [GO:0048247]; monocyte chemotaxis [GO:0002548]; neutrophil chemotaxis [GO:0030593]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of GTPase activity [GO:0043547]; signal transduction [GO:0007165]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CCL18&keywords=CCL18	0.35828765101123594	556	NA	NA	0.1176538810506186	605	0.16535433070866135	0	0	0.004076738609112709	0	0.013536379018612519	0.010879419764279238	0.0065252854812398045	0.0014798372179060304	0.010882627854186117	0.008653660421093296	299	238	254	0.02012620718864464	0.38105816460802544	0.6931714876493755	0.6191838323452926	382	254	277
CCL19	C-C motif chemokine ligand 19	Yes		ENSG00000172724	Q99731	Intercrine beta (chemokine CC) family	17	ligand	extracellular, intracellular, ligand, secreted	O00421, O00590, P08913, P32248, P46092, P48039, P49682, Q14831, Q9NPB9	ACKR2, ACKR4, ADRA2A, CCR10, CCR7, CCRL2, CXCR3, GRM7, MTNR1A	ACKR4 [CellPhoneDB:24218476;CellTalkDB:23341447;Cellinker:10706668;Cellinker:23341447;Guide2Pharma:23341447;HPRD:10706668;ICELLNET:22633458;InnateDB:10706668;LRdb:11;LRdb:23341447;connectomeDB2020:10706668;connectomeDB2020:23341447;scConnect:23341447], CCR7 [Baccin2019:11342595;Baccin2019:9153236;Baccin2019:9507024;CellPhoneDB:24218476;CellTalkDB:24218476;Cellinker:11342595;Cellinker:9153236;Cellinker:9507024;DIP:9153236;DIP:9507024;Guide2Pharma:10512740;Guide2Pharma:16904643;Guide2Pharma:9153236;Guide2Pharma:9507024;HPMR:11342595;HPRD:9153236;ICELLNET:22633458;InnateDB:15546958;InnateDB:9153236;LRdb:10699158;connectomeDB2020:11342595;connectomeDB2020:9153236;connectomeDB2020:9507024;scConnect:10512740;scConnect:16904643;scConnect:9153236;scConnect:9507024], CCRL2 [Baccin2019:20002784;CellTalkDB:20002784;Cellinker:20002784;Guide2Pharma:20002784;ICELLNET:22633458;InnateDB:20002784;LRdb:20002784;connectomeDB2020:20002784;scConnect:20002784], CXCR3 [Baccin2019:9660793;CellTalkDB:9660793;Cellinker:9660793;Guide2Pharma:9660793;LRdb:9660793;connectomeDB2020:9660793;scConnect:9660793], CCR10 [Baccin2019:10706668;CellTalkDB:10706668;Cellinker:10706668;HPRD:10706668;InnateDB:10706668;LRdb:10706668;connectomeDB2020:10706668], GRM7 [CellTalkDB:32196115], ACKR2 [CellTalkDB:10706668;Cellinker:10706668;HPRD:10706668;LRdb:10706668;connectomeDB2020:10706668], ADRA2A [CellTalkDB:32196115], MTNR1A [CellTalkDB:32196115]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	CCR10 chemokine receptor binding [GO:0031735]; CCR7 chemokine receptor binding [GO:0031732]; CCR chemokine receptor binding [GO:0048020]; chemokine activity [GO:0008009]; chemokine receptor binding [GO:0042379]	antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cell communication [GO:0007154]; cell maturation [GO:0048469]; cellular calcium ion homeostasis [GO:0006874]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to virus [GO:0098586]; chemokine-mediated signaling pathway [GO:0070098]; dendritic cell chemotaxis [GO:0002407]; establishment of T cell polarity [GO:0001768]; G protein-coupled receptor signaling pathway [GO:0007186]; immune response [GO:0006955]; immunological synapse formation [GO:0001771]; inflammatory response [GO:0006954]; killing of cells of other organism [GO:0031640]; lymphocyte chemotaxis [GO:0048247]; mature conventional dendritic cell differentiation [GO:0097029]; monocyte chemotaxis [GO:0002548]; myeloid dendritic cell chemotaxis [GO:0002408]; negative regulation of dendritic cell apoptotic process [GO:2000669]; neutrophil chemotaxis [GO:0030593]; positive regulation of cell motility [GO:2000147]; positive regulation of chemotaxis [GO:0050921]; positive regulation of dendritic cell antigen processing and presentation [GO:0002606]; positive regulation of dendritic cell dendrite assembly [GO:2000549]; positive regulation of endocytosis [GO:0045807]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of glycoprotein biosynthetic process [GO:0010560]; positive regulation of GTPase activity [GO:0043547]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of JNK cascade [GO:0046330]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of receptor-mediated endocytosis [GO:0048260]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of T-helper 1 cell differentiation [GO:0045627]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of cell projection assembly [GO:0060491]; release of sequestered calcium ion into cytosol [GO:0051209]; response to nitric oxide [GO:0071731]; response to prostaglandin E [GO:0034695]; response to virus [GO:0009615]; T cell costimulation [GO:0031295]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CCL19&keywords=CCL19	0.34217941348314607	560	NA	NA	0.03920691129171947	739	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
CCL2	C-C motif chemokine ligand 2	Yes		ENSG00000108691	P13500	Intercrine beta (chemokine CC) family	18	ligand	extracellular, intracellular, ligand, secreted, transmembrane	O00590, P32246, P41597, P46092, P50281, P51677, P51679, P51681, Q16570, Q9NPB9	ACKR1, ACKR2, ACKR4, CCR1, CCR10, CCR2, CCR3, CCR4, CCR5, MMP14	MMP14 [SPIKE:15516694], CCR2 [Baccin2019:10529171;Baccin2019:10770925;Baccin2019:12554737;Baccin2019:15207250;Baccin2019:9276730;Baccin2019:9287323;Baccin2019:9346309;CellPhoneDB:24218476;Cellinker:10529171;Cellinker:10770925;Cellinker:12554737;Cellinker:15207250;Cellinker:28389721;Cellinker:9276730;Cellinker:9287323;Cellinker:9346309;DIP:10488147;DIP:10770925;DIP:11470772;DIP:8530354;DIP:9115216;DIP:9169459;DIP:9312096;DIP:9336350;Guide2Pharma:10770925;Guide2Pharma:12554737;Guide2Pharma:15207250;Guide2Pharma:9276730;Guide2Pharma:9346309;HPMR:9287323;HPRD:10529171;HPRD:9287323;ICELLNET:22633458;InnateDB:10529171;InnateDB:11310855;InnateDB:15629146;InnateDB:7759884;InnateDB:8530354;InnateDB:9115216;InnateDB:9287323;InnateDB:9837883;LRdb:10699158;SIGNOR:20219869;connectomeDB2020:10529171;connectomeDB2020:10770925;connectomeDB2020:12554737;connectomeDB2020:15207250;connectomeDB2020:9276730;connectomeDB2020:9287323;connectomeDB2020:9346309;scConnect:10770925;scConnect:12554737;scConnect:15207250;scConnect:9276730;scConnect:9346309], CCR3 [Baccin2019:8642344;CellTalkDB:8642344;Cellinker:8642344;Guide2Pharma:8642344;InnateDB:8642344;LRdb:8642344;connectomeDB2020:8642344;scConnect:8642344], CCR5 [Baccin2019:1629834510477710;CellTalkDB:16298345;Cellinker:10477718;Cellinker:16298345;DIP:10477718;Guide2Pharma:16298345;HPRD:10477718;InnateDB:10477718;LRdb:1;LRdb:16298345;connectomeDB2020:10477718;connectomeDB2020:16298345;scConnect:16298345], CCR4 [Baccin2019:16421945;CellTalkDB:16421945;LRdb:16421945;SIGNOR:17160712;connectomeDB2020:16421945], ACKR1 [CellChatDB:26740381;CellPhoneDB:24218476;Cellinker:13679391;Cellinker:17416748;Cellinker:26740381;HPRD:13679391;HPRD:17416748;ICELLNET:22633458;InnateDB:8132497;LRdb:10699158;LRdb:13679391;LRdb:17;connectomeDB2020:13679391;connectomeDB2020:17416748], ACKR2 [Baccin2019:9364936;Baccin2019:9405404;CellChatDB:26740381;CellPhoneDB:24218476;Cellinker:26740381;Cellinker:9364936;Cellinker:9405404;HPRD:9364936;HPRD:9405404;ICELLNET:22633458;InnateDB:9405404;LRdb:10699158;connectomeDB2020:9364936;connectomeDB2020:9405404], CCR1 [Baccin2019:76793288631787;CellTalkDB:10699158;Cellinker:7679328;Cellinker:8631787;DIP:9115216;HPMR:7679328;HPRD:8631787;InnateDB:9115216;LRdb:10699158;connectomeDB2020:7679328;connectomeDB2020:8631787], CCR10 [Baccin2019:10706668;Baccin2019:9364936;CellTalkDB:9364936;Cellinker:10706668;Cellinker:9364936;HPRD:10706668;HPRD:9364936;LRdb:107;LRdb:9364936;connectomeDB2020:10706668;connectomeDB2020:9364936], ACKR4 [Baccin2019:10734104;CellTalkDB:10734104;Cellinker:10734104;DIP:10734104;HPRD:10734104;HPRD:9364936;HPRD:9405404;InnateDB:10734104;LRdb:10734104;connectomeDB2020:10734104]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	CCR2 chemokine receptor binding [GO:0031727]; CCR chemokine receptor binding [GO:0048020]; chemokine activity [GO:0008009]; protein kinase activity [GO:0004672]; signaling receptor binding [GO:0005102]	angiogenesis [GO:0001525]; animal organ morphogenesis [GO:0009887]; astrocyte cell migration [GO:0043615]; cell adhesion [GO:0007155]; cell surface receptor signaling pathway [GO:0007166]; cellular homeostasis [GO:0019725]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-1 [GO:0071347]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to organic cyclic compound [GO:0071407]; cellular response to tumor necrosis factor [GO:0071356]; chemokine-mediated signaling pathway [GO:0070098]; chemotaxis [GO:0006935]; cytokine-mediated signaling pathway [GO:0019221]; cytoskeleton organization [GO:0007010]; eosinophil chemotaxis [GO:0048245]; G protein-coupled receptor signaling pathway [GO:0007186]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; helper T cell extravasation [GO:0035684]; humoral immune response [GO:0006959]; inflammatory response [GO:0006954]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; lymphocyte chemotaxis [GO:0048247]; macrophage chemotaxis [GO:0048246]; MAPK cascade [GO:0000165]; monocyte chemotaxis [GO:0002548]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of glial cell apoptotic process [GO:0034351]; negative regulation of natural killer cell chemotaxis [GO:2000502]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of vascular endothelial cell proliferation [GO:1905563]; neutrophil chemotaxis [GO:0030593]; positive regulation of apoptotic cell clearance [GO:2000427]; positive regulation of calcium ion import [GO:0090280]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of GTPase activity [GO:0043547]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of NMDA glutamate receptor activity [GO:1904783]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; positive regulation of T cell activation [GO:0050870]; protein kinase B signaling [GO:0043491]; protein phosphorylation [GO:0006468]; receptor signaling pathway via JAK-STAT [GO:0007259]; regulation of cell shape [GO:0008360]; response to bacterium [GO:0009617]; sensory perception of pain [GO:0019233]; signal transduction [GO:0007165]; viral genome replication [GO:0019079]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CCL2&keywords=CCL2	287.36113129966293	30	NA	NA	13.200118464396837	38	0.700787401574803	6.173652694610787	0.6338495575221239	0.41870503597122544	0.9882154882154884	0.005076142131979695	0.006346328195829556	0.0016313213703099511	0.0022197558268590455	0.005074108692749356	0.016225613289549932	297	289	219	0.8137984952183369	0.014833428196078897	0.018298295979229925	0.03183498566915831	525	519	518
CCL20	C-C motif chemokine ligand 20	Yes		ENSG00000115009	P78556	Intercrine beta (chemokine CC) family	18	ligand	extracellular, intracellular, ligand, secreted	P08913, P48039, P49682, P51684, Q14831, Q9NPB9	ACKR4, ADRA2A, CCR6, CXCR3, GRM7, MTNR1A	CCR6 [Baccin2019:12081481;Baccin2019:12964882;Baccin2019:9169459;Baccin2019:9223454;Baccin2019:9294137;CellPhoneDB:24218476;CellTalkDB:24218476;Cellinker:12081481;Cellinker:12964882;Cellinker:9169459;Cellinker:9223454;Cellinker:9294137;DIP:10488147;DIP:10498628;DIP:9169459;Guide2Pharma:12081481;Guide2Pharma:9169459;Guide2Pharma:9294137;HPMR:12964882;HPRD:9169459;HPRD:9223454;HPRD:9294137;ICELLNET:22633458;InnateDB:9169459;LRdb:10699158;connectomeDB2020:12081481;connectomeDB2020:12964882;connectomeDB2020:9169459;connectomeDB2020:9223454;connectomeDB2020:9294137;scConnect:12081481;scConnect:9169459;scConnect:9294137], CXCR3 [Baccin2019:9660793;Cellinker:9660793;Guide2Pharma:9660793;LRdb:9660793;connectomeDB2020:9660793;scConnect:9660793], ADRA2A [CellTalkDB:32196115], MTNR1A [CellTalkDB:32196115], GRM7 [CellTalkDB:32196115], ACKR4 [Cellinker:32480426;connectomeDB2020:32533638]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	CCR6 chemokine receptor binding [GO:0031731]; CCR chemokine receptor binding [GO:0048020]; chemokine activity [GO:0008009]	antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; calcium-mediated signaling using intracellular calcium source [GO:0035584]; cell-cell signaling [GO:0007267]; cell chemotaxis [GO:0060326]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; chemokine-mediated signaling pathway [GO:0070098]; chemotaxis [GO:0006935]; defense response to bacterium [GO:0042742]; G protein-coupled receptor signaling pathway [GO:0007186]; immune response [GO:0006955]; inflammatory response [GO:0006954]; killing of cells of other organism [GO:0031640]; lymphocyte chemotaxis [GO:0048247]; monocyte chemotaxis [GO:0002548]; neutrophil chemotaxis [GO:0030593]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of GTPase activity [GO:0043547]; positive regulation of T cell migration [GO:2000406]; signal transduction [GO:0007165]; T cell migration [GO:0072678]; thymocyte migration [GO:0072679]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CCL20&keywords=CCL20	53.187647651685396	80	NA	NA	58.8707529425988	13	0.9842519685039368	0.2689620758483039	0.00331858407079646	0.16378896882494015	0.0016835016835016834	0	0.001813236627379873	0.048939641109298535	0.0036995930447650755	0.0015689678194685537	0.01707552636662158	293	356	217	0.13591836944536478	0.09388532161397624	0.07928383426598144	0.18555255564830914	478	480	426
CCL21	C-C motif chemokine ligand 21	Yes		ENSG00000137077	O00585	Intercrine beta (chemokine CC) family	18	ligand	extracellular, intracellular, ligand, secreted	O00590, P08913, P13611, P32248, P46092, P48039, P49682, Q14831, Q9NPB9	ACKR2, ACKR4, ADRA2A, CCR10, CCR7, CXCR3, GRM7, MTNR1A, VCAN	ACKR4 [CellPhoneDB:24218476;CellTalkDB:23341447;Cellinker:10706668;Cellinker:23341447;Guide2Pharma:23341447;HPRD:10706668;ICELLNET:22633458;InnateDB:10706668;LRdb:11;LRdb:23341447;connectomeDB2020:10706668;connectomeDB2020:23341447;scConnect:23341447], CCR7 [Baccin2019:11970971;Baccin2019:9507024;Baccin2019:9585422;CellPhoneDB:24218476;CellTalkDB:10699158;Cellinker:11970971;Cellinker:9507024;Cellinker:9585422;DIP:10488147;DIP:9507024;Guide2Pharma:9507024;HPRD:9507024;HPRD:9585422;ICELLNET:22633458;InnateDB:22221265;InnateDB:9507024;LRdb:10699158;SIGNOR:11970971;connectomeDB2020:11970971;connectomeDB2020:9507024;connectomeDB2020:9585422;scConnect:9507024], ADRA2A [CellTalkDB:32196115], MTNR1A [CellTalkDB:32196115], CXCR3 [Baccin2019:26888559;CellTalkDB:11907075;Cellinker:26888559;Ramilowski2015:11907075;connectomeDB2020:11907075;talklr:11907075], GRM7 [CellTalkDB:32196115], ACKR2 [CellTalkDB:10706668;HPRD:10706668;LRdb:10706668;connectomeDB2020:10706668], CCR10 [connectomeDB2020:10706668], VCAN [Cellinker:16045811;HPRD:11083865]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	CCR7 chemokine receptor binding [GO:0031732]; CCR chemokine receptor binding [GO:0048020]; chemokine activity [GO:0008009]; chemokine receptor binding [GO:0042379]	activation of GTPase activity [GO:0090630]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cell-cell signaling [GO:0007267]; cell chemotaxis [GO:0060326]; cell maturation [GO:0048469]; cellular response to chemokine [GO:1990869]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; chemokine (C-C motif) ligand 21 signaling pathway [GO:0038116]; chemokine-mediated signaling pathway [GO:0070098]; dendritic cell chemotaxis [GO:0002407]; dendritic cell dendrite assembly [GO:0097026]; eosinophil chemotaxis [GO:0048245]; establishment of T cell polarity [GO:0001768]; G protein-coupled receptor signaling pathway [GO:0007186]; immune response [GO:0006955]; immunological synapse formation [GO:0001771]; inflammatory response [GO:0006954]; killing of cells of other organism [GO:0031640]; lymphocyte chemotaxis [GO:0048247]; mesangial cell-matrix adhesion [GO:0035759]; monocyte chemotaxis [GO:0002548]; negative regulation of dendritic cell apoptotic process [GO:2000669]; negative regulation of dendritic cell dendrite assembly [GO:2000548]; negative regulation of leukocyte tethering or rolling [GO:1903237]; neutrophil chemotaxis [GO:0030593]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of cell motility [GO:2000147]; positive regulation of chemotaxis [GO:0050921]; positive regulation of dendritic cell antigen processing and presentation [GO:0002606]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of glycoprotein biosynthetic process [GO:0010560]; positive regulation of GTPase activity [GO:0043547]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of JNK cascade [GO:0046330]; positive regulation of myeloid dendritic cell chemotaxis [GO:2000529]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of pseudopodium assembly [GO:0031274]; positive regulation of receptor-mediated endocytosis [GO:0048260]; positive regulation of T cell chemotaxis [GO:0010820]; positive regulation of T cell migration [GO:2000406]; release of sequestered calcium ion into cytosol [GO:0051209]; response to prostaglandin E [GO:0034695]; ruffle organization [GO:0031529]; T cell costimulation [GO:0031295]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CCL21&keywords=CCL21	2.517950355667416	360	NA	NA	0.04342283865691511	724	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
CCL22	C-C motif chemokine ligand 22	Yes		ENSG00000102962	O00626	Intercrine beta (chemokine CC) family	19	ligand	intracellular, ligand, secreted	O00590, P27487, P32248, P51679, Q16570	ACKR1, ACKR2, CCR4, CCR7, DPP4	CCR4 [Baccin2019:9430724;Baccin2019:9743322;Baccin2019:9933589;CellPhoneDB:24218476;Cellinker:29637711;DIP:9430724;Guide2Pharma:9430724;HPRD:9430724;HPRD:9743322;HPRD:9933589;ICELLNET:22633458;InnateDB:9430724;LRdb:10699158;connectomeDB2020:9430724;connectomeDB2020:9743322;connectomeDB2020:9933589;scConnect:9430724], ACKR2 [CellChatDB:26740381;CellTalkDB:10699158;Cellinker:26740381;Cellinker:29637711;ICELLNET:22633458;LRdb:10699158;connectomeDB2020:25297873], DPP4 [CellPhoneDB:24218476;CellTalkDB:24218476;Cellinker:21314817;HPRD:11390394;HPRD:9933589;InnateDB:9933589], ACKR1 [Baccin2019:24013383], CCR7 [InnateDB:15546958]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	CCR chemokine receptor binding [GO:0048020]; chemokine activity [GO:0008009]	antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cell-cell signaling [GO:0007267]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; chemokine-mediated signaling pathway [GO:0070098]; chemotaxis [GO:0006935]; G protein-coupled receptor signaling pathway [GO:0007186]; immune response [GO:0006955]; inflammatory response [GO:0006954]; killing of cells of other organism [GO:0031640]; lymphocyte chemotaxis [GO:0048247]; monocyte chemotaxis [GO:0002548]; neutrophil chemotaxis [GO:0030593]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of GTPase activity [GO:0043547]; response to virus [GO:0009615]; signal transduction [GO:0007165]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CCL22&keywords=CCL22	2.502324859550562	362	NA	NA	0.20210711938278544	531	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
CCL23	C-C motif chemokine ligand 23	Yes		ENSG00000276114, ENSG00000274736	P55773	Intercrine beta (chemokine CC) family	17	ligand	extracellular, intracellular, ligand, secreted	O00590, P08913, P25090, P32246, P48039, Q14831	ACKR2, ADRA2A, CCR1, FPR2, GRM7, MTNR1A	CCR1 [CellPhoneDB:24218476;CellTalkDB:10699158;Cellinker:10660125;Cellinker:12381680;Cellinker:9558365;Cellinker:9886417;Guide2Pharma:12381680;HPRD:10660125;HPRD:9558365;HPRD:9886417;ICELLNET:22633458;LRdb:10699158;connectomeDB2020:10660125;connectomeDB2020:12381680;connectomeDB2020:9558365;connectomeDB2020:9886417;scConnect:12381680], ACKR2 [CellTalkDB:10699158;ICELLNET:22633458;LRdb:10699158], FPR2 [Cellinker:29637711;ICELLNET:22633458], ADRA2A [NA], GRM7 [NA], MTNR1A [NA]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	CCR1 chemokine receptor binding [GO:0031726]; CCR chemokine receptor binding [GO:0048020]; chemokine activity [GO:0008009]; heparin binding [GO:0008201]	cell-cell signaling [GO:0007267]; cellular calcium ion homeostasis [GO:0006874]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; chemokine-mediated signaling pathway [GO:0070098]; chemotaxis [GO:0006935]; G protein-coupled receptor signaling pathway [GO:0007186]; immune response [GO:0006955]; inflammatory response [GO:0006954]; lymphocyte chemotaxis [GO:0048247]; monocyte chemotaxis [GO:0002548]; negative regulation of C-C chemokine binding [GO:2001264]; negative regulation of cell population proliferation [GO:0008285]; neutrophil chemotaxis [GO:0030593]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of GTPase activity [GO:0043547]; signal transduction [GO:0007165]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CCL23&keywords=CCL23	0.01837884328477528	800	NA	NA	0.0075653030363399655	851	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
CCL24	C-C motif chemokine ligand 24	Yes		ENSG00000106178	O00175	Intercrine beta (chemokine CC) family	18	ligand	extracellular, intracellular, ligand, secreted	O00590, P41597, P51677	ACKR2, CCR2, CCR3	CCR2 [Baccin2019:15207250;CellTalkDB:15207250;Cellinker:15207250;Guide2Pharma:15207250;LRdb:15207250;connectomeDB2020:15207250;scConnect:15207250], CCR3 [Baccin2019:10488147;Baccin2019:12218106;Baccin2019:15207250;Baccin2019:16339911;CellPhoneDB:24218476;CellTalkDB:10699158;Cellinker:10488147;Cellinker:12218106;Cellinker:15207250;Cellinker:16339911;DIP:10733106;Guide2Pharma:15207250;Guide2Pharma:16339911;HPRD:12218106;ICELLNET:22633458;InnateDB:12218106;InnateDB:16102831;LRdb:10699158;connectomeDB2020:10488147;connectomeDB2020:12218106;connectomeDB2020:15207250;connectomeDB2020:16339911;scConnect:15207250;scConnect:16339911], ACKR2 [CellChatDB:26740381;CellTalkDB:10699158;Cellinker:26740381;ICELLNET:22633458;LRdb:10699158]	extracellular space [GO:0005615]	CCR3 chemokine receptor binding [GO:0031728]; CCR chemokine receptor binding [GO:0048020]; chemokine activity [GO:0008009]; receptor ligand activity [GO:0048018]	cell-cell signaling [GO:0007267]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; chemokine-mediated signaling pathway [GO:0070098]; chemotaxis [GO:0006935]; cytoskeleton organization [GO:0007010]; eosinophil chemotaxis [GO:0048245]; G protein-coupled receptor signaling pathway [GO:0007186]; immune response [GO:0006955]; inflammatory response [GO:0006954]; lymphocyte chemotaxis [GO:0048247]; monocyte chemotaxis [GO:0002548]; neutrophil chemotaxis [GO:0030593]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell migration [GO:0030335]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of eosinophil migration [GO:2000418]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of GTPase activity [GO:0043547]; positive regulation of inflammatory response [GO:0050729]; regulation of cell shape [GO:0008360]; signal transduction [GO:0007165]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CCL24&keywords=CCL24	0.00546718017994382	852	NA	NA	0.005535911952198001	859	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
CCL25	C-C motif chemokine ligand 25	Yes		ENSG00000131142	O15444	Intercrine beta (chemokine CC) family	20	ligand	extracellular, intracellular, ligand, secreted	O00590, P08913, P46092, P48039, P51686, Q14831, Q9NPB9	ACKR2, ACKR4, ADRA2A, CCR10, CCR9, GRM7, MTNR1A	ACKR4 [CellPhoneDB:24218476;CellTalkDB:23341447;Cellinker:10706668;Cellinker:23341447;Guide2Pharma:23341447;HPRD:10706668;ICELLNET:22633458;InnateDB:10706668;LRdb:11;LRdb:23341447;connectomeDB2020:10706668;connectomeDB2020:23341447;scConnect:23341447], CCR9 [Baccin2019:10229797;Baccin2019:10498628;Baccin2019:11159507;CellPhoneDB:24218476;CellTalkDB:10699158;Cellinker:11159507;DIP:10229797;DIP:10498628;HPMR:11159507;HPRD:10229797;HPRD:10498628;ICELLNET:22633458;LRdb:10699158;SIGNOR:11159507;connectomeDB2020:10229797;connectomeDB2020:10498628;connectomeDB2020:11159507], ACKR2 [CellTalkDB:10706668;Cellinker:10706668;HPRD:10706668;LRdb:10706668;connectomeDB2020:10706668], ADRA2A [CellTalkDB:32196115], MTNR1A [CellTalkDB:32196115], CCR10 [Baccin2019:10706668;CellTalkDB:10706668;Cellinker:10706668;HPRD:10706668;LRdb:10706668;connectomeDB2020:10706668], GRM7 [CellTalkDB:32196115]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	CCR10 chemokine receptor binding [GO:0031735]; CCR chemokine receptor binding [GO:0048020]; chemokine activity [GO:0008009]; chemokine receptor binding [GO:0042379]; hormone activity [GO:0005179]	antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cell chemotaxis [GO:0060326]; cell surface receptor signaling pathway [GO:0007166]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; chemokine-mediated signaling pathway [GO:0070098]; chemotaxis [GO:0006935]; G protein-coupled receptor signaling pathway [GO:0007186]; immune response [GO:0006955]; inflammatory response [GO:0006954]; killing of cells of other organism [GO:0031640]; lymphocyte chemotaxis [GO:0048247]; monocyte chemotaxis [GO:0002548]; negative regulation of leukocyte tethering or rolling [GO:1903237]; neutrophil chemotaxis [GO:0030593]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of GTPase activity [GO:0043547]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CCL25&keywords=CCL25	0.013151129213483145	815	NA	NA	0.018773515766105926	800	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
CCL26	C-C motif chemokine ligand 26	Yes		ENSG00000006606	Q9Y258	Intercrine beta (chemokine CC) family	17	ligand	extracellular, intracellular, ligand, secreted	O00590, P32246, P41597, P49238, P51677, P51681	ACKR2, CCR1, CCR2, CCR3, CCR5, CX3CR1	CCR2 [CellPhoneDB:24218476;Cellinker:15207250;Guide2Pharma:15207250;ICELLNET:22633458;InnateDB:12689946;LRdb:15207250;connectomeDB2020:15207250;scConnect:15207250], CCR3 [CellPhoneDB:24218476;Cellinker:10488147;Cellinker:15207250;Cellinker:16339911;DIP:10488147;Guide2Pharma:10488147;Guide2Pharma:15207250;Guide2Pharma:16339911;HPRD:10488147;ICELLNET:22633458;InnateDB:10488147;InnateDB:16102831;LRdb:10699158;connectomeDB2020:10488147;connectomeDB2020:15207250;connectomeDB2020:16339911;scConnect:10488147;scConnect:15207250;scConnect:16339911], CCR1 [CellPhoneDB:24218476;Cellinker:15039444;HPRD:15039444;ICELLNET:15039444;ICELLNET:22633458;InnateDB:15039444;LRdb:15039444;connectomeDB2020:15039444], CCR5 [Cellinker:29637711;ICELLNET:15039444;ICELLNET:22633458;InnateDB:15039444], CX3CR1 [Cellinker:29637711;ICELLNET:20974991;ICELLNET:22633458;InnateDB:20974991], ACKR2 [CellChatDB:26740381;Cellinker:26740381]	extracellular space [GO:0005615]	CCR3 chemokine receptor binding [GO:0031728]; CCR chemokine receptor binding [GO:0048020]; chemokine activity [GO:0008009]; CX3C chemokine receptor binding [GO:0031737]; receptor ligand activity [GO:0048018]	cell-cell signaling [GO:0007267]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; chemokine-mediated signaling pathway [GO:0070098]; chemotaxis [GO:0006935]; eosinophil chemotaxis [GO:0048245]; G protein-coupled receptor signaling pathway [GO:0007186]; inflammatory response [GO:0006954]; lymphocyte chemotaxis [GO:0048247]; monocyte chemotaxis [GO:0002548]; neutrophil chemotaxis [GO:0030593]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell migration [GO:0030335]; positive regulation of chemotaxis [GO:0050921]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of GTPase activity [GO:0043547]; signal transduction [GO:0007165]; T cell chemotaxis [GO:0010818]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CCL26&keywords=CCL26	0.010852865168539325	823	NA	NA	0.012771533153030621	821	0	4.99001996007984e-4	0.012168141592920354	0.6175059952038414	0	0.00338409475465313	0	0	0	5.007344104686875e-4	8.112806644774968e-4	303	388	375	0.05771538623839719	0.14767692478034808	0.15507161656731971	0.1596576681467275	459	442	443
CCL27	C-C motif chemokine ligand 27	Yes		ENSG00000213927	Q9Y4X3	Intercrine beta (chemokine CC) family	17	ligand	extracellular, ligand, secreted	O00590, P08913, P41597, P46092, P48039, P51677, Q14831	ACKR2, ADRA2A, CCR10, CCR2, CCR3, GRM7, MTNR1A	CCR10 [CellPhoneDB:24218476;CellTalkDB:11821900;Cellinker:10725697;Cellinker:11821900;Cellinker:12718728;DIP:10725697;DIP:10781587;Guide2Pharma:10725697;HPMR:11821900;HPMR:12718728;HPRD:10725697;HPRD:11821900;ICELLNET:22633458;LRdb:10725697;LRdb:11821900;LRdb:12718728;connectomeDB2020:10725697;connectomeDB2020:11821900;connectomeDB2020:12718728;scConnect:10725697], ADRA2A [CellTalkDB:32196115], GRM7 [CellTalkDB:32196115], ACKR2 [CellTalkDB:10725697;Cellinker:10725696;Cellinker:10725697;Cellinker:11821900;HPRD:10725696;HPRD:10725697;HPRD:11821900;LRdb:10725696;LRdb:10725697;LRdb:11821900;connectomeDB2020:10725696;connectomeDB2020:10725697;connectomeDB2020:11821900], MTNR1A [CellTalkDB:32196115], CCR2 [NA], CCR3 [NA]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	CCR3 chemokine receptor binding [GO:0031728]; chemokine activity [GO:0008009]	antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cell-cell signaling [GO:0007267]; chemotaxis [GO:0006935]; immune response [GO:0006955]; killing of cells of other organism [GO:0031640]; positive regulation of actin cytoskeleton reorganization [GO:2000251]; positive regulation of T cell chemotaxis [GO:0010820]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CCL27&keywords=CCL27	0.600601202247191	507	NA	NA	0.11627566974856435	607	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
CCL28	C-C motif chemokine ligand 28	Yes		ENSG00000151882	Q9NRJ3	Intercrine beta (chemokine CC) family	19	ligand	extracellular, ligand, secreted	O00590, P08913, P46092, P48039, P51677, Q14831, Q9NPB9	ACKR2, ACKR4, ADRA2A, CCR10, CCR3, GRM7, MTNR1A	CCR10 [Baccin2019:10781587;Baccin2019:10975800;Cellinker:10781587;Cellinker:10975800;HPRD:10781587;HPRD:10975800;ICELLNET:22633458;LRdb:10781587;LRdb:11;connectomeDB2020:10781587;connectomeDB2020:10975800], CCR3 [Baccin2019:10975800;Baccin2019:12964882;CellTalkDB:12964882;Cellinker:10975800;Cellinker:12964882;HPRD:10975800;ICELLNET:22633458;LRdb:11;LRdb:12964882;connectomeDB2020:10975800;connectomeDB2020:12964882], ACKR2 [Baccin2019:10781587;Cellinker:10781587;HPRD:10781587;LRdb:28843907;connectomeDB2020:10781587], ADRA2A [CellTalkDB:32196115], MTNR1A [CellTalkDB:32196115], GRM7 [CellTalkDB:32196115], ACKR4 [HPRD:10781587]	extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	chemokine activity [GO:0008009]	antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cell chemotaxis [GO:0060326]; chemotaxis [GO:0006935]; cytolysis in other organism [GO:0051715]; immune response [GO:0006955]; killing of cells of other organism [GO:0031640]; negative regulation of leukocyte tethering or rolling [GO:1903237]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; response to nutrient [GO:0007584]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CCL28&keywords=CCL28	18.57269147191011	175	NA	NA	2.689176783411468	123	0	0.10628742514970048	0.0022123893805309734	0.010791366906474817	0.0740740740740741	0.08460236886632823	0.08975521305530354	0.08156606851549765	0.0699223085460599	0.04903858993190172	0.03994591462236786	150	145	165	0.0552905199134763	1.2241028046946754	0.904244444831199	0.7649795818528743	84	168	205
CCL3	C-C motif chemokine ligand 3	Yes		ENSG00000278567, ENSG00000274221, ENSG00000277632	P10147	Intercrine beta (chemokine CC) family	17	ligand	extracellular, intracellular, ligand, secreted	O00590, P32246, P32302, P41597, P51677, P51679, P51681	ACKR2, CCR1, CCR2, CCR3, CCR4, CCR5, CXCR5	CCR1 [CellPhoneDB:24218476;Cellinker:10202040;Cellinker:10660125;Cellinker:11170631;Cellinker:12381680;Cellinker:7545673;Cellinker:8530354;Cellinker:9115216;Cellinker:9624164;DIP:10488147;DIP:10498628;DIP:10910894;DIP:7545673;DIP:7622448;DIP:8530354;DIP:9115216;DIP:9169459;DIP:9207005;DIP:9336350;DIP:9687537;Guide2Pharma:11170631;Guide2Pharma:12381680;Guide2Pharma:8530354;Guide2Pharma:9624164;HPRD:10202040;HPRD:10660125;HPRD:7545673;ICELLNET:22633458;InnateDB:12381680;InnateDB:23765404;InnateDB:7545673;InnateDB:8530354;InnateDB:9115216;LRdb:10699158;SIGNOR:10734056;SIGNOR:20219869;connectomeDB2020:10202040;connectomeDB2020:10660125;connectomeDB2020:11170631;connectomeDB2020:12381680;connectomeDB2020:7545673;connectomeDB2020:8530354;connectomeDB2020:9115216;connectomeDB2020:9624164;scConnect:11170631;scConnect:12381680;scConnect:8530354;scConnect:9624164], CCR5 [CellPhoneDB:15251452;Cellinker:10477718;Cellinker:11170631;Cellinker:11700073;Cellinker:12964882;Cellinker:16298345;Cellinker:9790730;DIP:10477718;DIP:9169459;DIP:9334377;DIP:9468473;Guide2Pharma:11170631;Guide2Pharma:16298345;Guide2Pharma:9790730;HPMR:12964882;HPRD:10477718;HPRD:11700073;ICELLNET:22633458;InnateDB:10477718;InnateDB:23765404;LRdb:10699158;SIGNOR:15075201;SIGNOR:20219869;connectomeDB2020:10477718;connectomeDB2020:11170631;connectomeDB2020:11700073;connectomeDB2020:12964882;connectomeDB2020:16298345;connectomeDB2020:9790730;scConnect:11170631;scConnect:16298345;scConnect:9790730], CCR2 [SIGNOR:15075201], ACKR2 [CellChatDB:26740381;CellPhoneDB:24218476;Cellinker:26740381;Cellinker:9405404;HPRD:9405404;ICELLNET:22633458;InnateDB:9405404;LRdb:10699158;connectomeDB2020:9405404], CCR4 [CellTalkDB:8573157;HPRD:8573157;LRdb:8573157;connectomeDB2020:8573157], CCR3 [CellPhoneDB:24218476;CellTalkDB:24218476;Cellinker:7594543;DIP:7622448;HPRD:7594543;LRdb:7594543;connectomeDB2020:7594543], CXCR5 [DIP:11470772;DIP:9312096]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	calcium-dependent protein kinase C activity [GO:0004698]; CCR1 chemokine receptor binding [GO:0031726]; CCR5 chemokine receptor binding [GO:0031730]; CCR chemokine receptor binding [GO:0048020]; chemoattractant activity [GO:0042056]; chemokine activity [GO:0008009]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; phospholipase activator activity [GO:0016004]; protein kinase activity [GO:0004672]	astrocyte cell migration [GO:0043615]; calcium ion transport [GO:0006816]; calcium-mediated signaling [GO:0019722]; cell activation [GO:0001775]; cell-cell signaling [GO:0007267]; cellular calcium ion homeostasis [GO:0006874]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-1 [GO:0071347]; cellular response to organic cyclic compound [GO:0071407]; cellular response to tumor necrosis factor [GO:0071356]; chemokine-mediated signaling pathway [GO:0070098]; chemotaxis [GO:0006935]; cytoskeleton organization [GO:0007010]; eosinophil chemotaxis [GO:0048245]; eosinophil degranulation [GO:0043308]; exocytosis [GO:0006887]; G protein-coupled receptor signaling pathway [GO:0007186]; granulocyte chemotaxis [GO:0071621]; inflammatory response [GO:0006954]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; lymphocyte chemotaxis [GO:0048247]; macrophage chemotaxis [GO:0048246]; MAPK cascade [GO:0000165]; monocyte chemotaxis [GO:0002548]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of bone mineralization [GO:0030502]; negative regulation of gene expression [GO:0010629]; negative regulation of osteoclast differentiation [GO:0045671]; neutrophil chemotaxis [GO:0030593]; osteoblast differentiation [GO:0001649]; positive regulation of calcium ion import [GO:0090280]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of calcium-mediated signaling [GO:0050850]; positive regulation of cell migration [GO:0030335]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of GTPase activity [GO:0043547]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of microglial cell activation [GO:1903980]; positive regulation of microglial cell migration [GO:1904141]; positive regulation of natural killer cell chemotaxis [GO:2000503]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of tumor necrosis factor production [GO:0032760]; protein kinase B signaling [GO:0043491]; regulation of behavior [GO:0050795]; regulation of cell shape [GO:0008360]; regulation of sensory perception of pain [GO:0051930]; release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0014808]; response to cholesterol [GO:0070723]; response to toxic substance [GO:0009636]; signaling [GO:0023052]; T cell chemotaxis [GO:0010818]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CCL3&keywords=CCL3	1.2573602778610111	426	NA	NA	0.09754392885011037	636	14.118110236220465	9.98003992015968e-4	0	0.2052757793764989	0	0	9.066183136899365e-4	0	7.399186089530152e-4	7.010281746561626e-4	8.885454896658299e-4	301	383	371	1.3025109209250858	0.008182727044574449	0.00815309648403828	0.008295965630511744	528	526	527
CCL3L1	C-C motif chemokine ligand 3 like 1, C-C motif chemokine ligand 3 like 3	Yes		ENSG00000277796, ENSG00000277768, ENSG00000277336, ENSG00000276085	P16619	Intercrine beta (chemokine CC) family	15	ligand	intracellular, ligand, secreted	O00590, P32246, P51677, P51679, P51681	ACKR2, CCR1, CCR3, CCR4, CCR5	CCR5 [Baccin2019:10364178;Baccin2019:10477718;Baccin2019:11170631;Baccin2019:11700073;Baccin2019:11734558;Baccin2019:12964882;Baccin2019:16298345;Baccin2019:9790730;BioGRID:11734558;CellTalkDB:10364178;Cellinker:10364178;Cellinker:11449371;Cellinker:11734558;HPRD:10364178;HPRD:11449371;HPRD:11734558;ICELLNET:22633458;LRdb:11;LRdb:11734558;SPIKE:11734558;connectomeDB2020:10364178;connectomeDB2020:11449371;connectomeDB2020:11734558], ACKR2 [CellChatDB:26740381;CellTalkDB:10364178;Cellinker:26740381;Cellinker:29637711;HPRD:10364178;ICELLNET:22633458;LRdb:10699158;connectomeDB2020:10364178;connectomeDB2020:25297873], CCR1 [Baccin2019:10202040;Baccin2019:10660125;Baccin2019:11170631;Baccin2019:12381680;Baccin2019:7545673;Baccin2019:8530354;Baccin2019:9115216;Baccin2019:9624164;CellPhoneDB:24218476;Cellinker:11449371;HPRD:11449371;ICELLNET:22633458;LRdb:11449371;connectomeDB2020:11449371], CCR3 [Baccin2019:7594543;CellPhoneDB:24218476;Cellinker:11449371;HPRD:11449371;ICELLNET:22633458;LRdb:11449371;connectomeDB2020:11449371], CCR4 [Baccin2019:8573157]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	CCR chemokine receptor binding [GO:0048020]; chemokine activity [GO:0008009]	cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; chemokine-mediated signaling pathway [GO:0070098]; G protein-coupled receptor signaling pathway [GO:0007186]; inflammatory response [GO:0006954]; lymphocyte chemotaxis [GO:0048247]; monocyte chemotaxis [GO:0002548]; negative regulation of cell population proliferation [GO:0008285]; neutrophil chemotaxis [GO:0030593]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of GTPase activity [GO:0043547]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CCL3L1&keywords=CCL3L1	0.663773726741573	497	NA	NA	0.2301742000187762	511	2.472440944881889	0	0	0.009832134292565945	0	0	0	0	0	6.676458806249166e-5	2.704268881591655e-4	303	407	394	0.22569184278642515	0.042428282123711906	0.042711552801530786	0.04357565695417736	510	503	510
CCL3L3	C-C motif chemokine ligand 3 like 1, C-C motif chemokine ligand 3 like 3	Yes		ENSG00000277796, ENSG00000277768, ENSG00000277336, ENSG00000276085	P16619	Intercrine beta (chemokine CC) family	15	ligand	intracellular, ligand, secreted	O00590, P32246, P51677, P51679, P51681	ACKR2, CCR1, CCR3, CCR4, CCR5	CCR5 [Baccin2019:10364178;Baccin2019:10477718;Baccin2019:11170631;Baccin2019:11700073;Baccin2019:11734558;Baccin2019:12964882;Baccin2019:16298345;Baccin2019:9790730;BioGRID:11734558;CellTalkDB:10364178;Cellinker:10364178;Cellinker:11449371;Cellinker:11734558;HPRD:10364178;HPRD:11449371;HPRD:11734558;ICELLNET:22633458;LRdb:11;LRdb:11734558;SPIKE:11734558;connectomeDB2020:10364178;connectomeDB2020:11449371;connectomeDB2020:11734558], ACKR2 [CellChatDB:26740381;CellTalkDB:10364178;Cellinker:26740381;Cellinker:29637711;HPRD:10364178;ICELLNET:22633458;LRdb:10699158;connectomeDB2020:10364178;connectomeDB2020:25297873], CCR1 [Baccin2019:10202040;Baccin2019:10660125;Baccin2019:11170631;Baccin2019:12381680;Baccin2019:7545673;Baccin2019:8530354;Baccin2019:9115216;Baccin2019:9624164;CellPhoneDB:24218476;Cellinker:11449371;HPRD:11449371;ICELLNET:22633458;LRdb:11449371;connectomeDB2020:11449371], CCR3 [Baccin2019:7594543;CellPhoneDB:24218476;Cellinker:11449371;HPRD:11449371;ICELLNET:22633458;LRdb:11449371;connectomeDB2020:11449371], CCR4 [Baccin2019:8573157]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	CCR chemokine receptor binding [GO:0048020]; chemokine activity [GO:0008009]	cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; chemokine-mediated signaling pathway [GO:0070098]; G protein-coupled receptor signaling pathway [GO:0007186]; inflammatory response [GO:0006954]; lymphocyte chemotaxis [GO:0048247]; monocyte chemotaxis [GO:0002548]; negative regulation of cell population proliferation [GO:0008285]; neutrophil chemotaxis [GO:0030593]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of GTPase activity [GO:0043547]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CCL3L3&keywords=CCL3L3	0.663773726741573	497	NA	NA	0.2301742000187762	511	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
CCL4	C-C motif chemokine ligand 4	Yes		ENSG00000277943, ENSG00000275824, ENSG00000275302	P13236	Intercrine beta (chemokine CC) family	19	ligand	extracellular, intracellular, ligand, secreted	O00590, P10147, P30825, P32246, P32302, P34972, P51677, P51681, P51685, Q8TDT2, Q9NZD1	ACKR2, CCL3, CCR1, CCR3, CCR5, CCR8, CNR2, CXCR5, GPR152, GPRC5D, SLC7A1	CCR5 [Baccin2019:12427015;Baccin2019:12964882;Baccin2019:16298345;Baccin2019:8663314;Baccin2019:9790730;CellTalkDB:10699158;Cellinker:12427015;Cellinker:12964882;Cellinker:16298345;Cellinker:8663314;Cellinker:9790730;DIP:10477718;DIP:10498628;DIP:9334377;DIP:9468473;Guide2Pharma:16298345;Guide2Pharma:9790730;HPRD:12427015;HPRD:8663314;ICELLNET:22633458;InnateDB:10477718;InnateDB:12427015;InnateDB:16467191;LRdb:10699158;Lit-BM-17:10477718;Lit-BM-17:10498628;Lit-BM-17:23597562;Lit-BM-17:9334377;Lit-BM-17:9468473;SIGNOR:20219869;SPIKE:12427015;SPIKE:8663314;connectomeDB2020:12427015;connectomeDB2020:12964882;connectomeDB2020:16298345;connectomeDB2020:8663314;connectomeDB2020:9790730;scConnect:16298345;scConnect:9790730], CCR1 [Baccin2019:12381680;Baccin2019:7594543;Baccin2019:8530354;CellTalkDB:10699158;Cellinker:12381680;Cellinker:7594543;Cellinker:8530354;DIP:10910894;DIP:7545673;Guide2Pharma:12381680;Guide2Pharma:8530354;HPRD:7594543;InnateDB:12381680;LRdb:10699158;connectomeDB2020:12381680;connectomeDB2020:7594543;connectomeDB2020:8530354;scConnect:12381680;scConnect:8530354], ACKR2 [CellChatDB:26740381;CellPhoneDB:24218476;Cellinker:26740381;Cellinker:29637711;Cellinker:9405404;HPRD:9405404;ICELLNET:22633458;InnateDB:9405404;LRdb:10699158;connectomeDB2020:9405404], CCR8 [Baccin2019:9521068;CellTalkDB:10699158;Cellinker:9521068;HPRD:9521068;LRdb:10699158;connectomeDB2020:9521068], CNR2 [CellTalkDB:32103204], CCR3 [Baccin2019:7622448;CellTalkDB:7622448;Cellinker:7622448;DIP:7622448;HPRD:7622448;LRdb:7622448;connectomeDB2020:7622448], GPRC5D [NA], GPR152 [NA], SLC7A1 [NA], CXCR5 [DIP:9312096], CCL3 [HPRD:11278300]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	CCR1 chemokine receptor binding [GO:0031726]; CCR5 chemokine receptor binding [GO:0031730]; CCR chemokine receptor binding [GO:0048020]; chemokine activity [GO:0008009]; cytokine activity [GO:0005125]; identical protein binding [GO:0042802]	cell adhesion [GO:0007155]; cell-cell signaling [GO:0007267]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; chemokine-mediated signaling pathway [GO:0070098]; eosinophil chemotaxis [GO:0048245]; establishment or maintenance of cell polarity [GO:0007163]; G protein-coupled receptor signaling pathway [GO:0007186]; immune response [GO:0006955]; inflammatory response [GO:0006954]; lymphocyte chemotaxis [GO:0048247]; monocyte chemotaxis [GO:0002548]; negative regulation by host of viral transcription [GO:0043922]; neutrophil chemotaxis [GO:0030593]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of calcium-mediated signaling [GO:0050850]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of GTPase activity [GO:0043547]; positive regulation of natural killer cell chemotaxis [GO:2000503]; response to toxic substance [GO:0009636]; response to virus [GO:0009615]; signal transduction [GO:0007165]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CCL4&keywords=CCL4	3.0168349135057304	339	NA	NA	0.29285966519251705	469	6.566929133858266	0	0	0.0028776978417266183	0	0	0	0	0	4.339698224061959e-4	4.63588951129998e-4	303	391	386	0.5973367627703208	0.016465329637523927	0.0171798752553895	0.017228644127190867	524	520	522
CCL4L2	C-C motif chemokine ligand 4 like 2	Yes		ENSG00000282604, ENSG00000275313, ENSG00000276125, ENSG00000276070	Q8NHW4	Intercrine beta (chemokine CC) family	8	ligand	intracellular, ligand, secreted	O00590, O15173, O15529, O15552, P32246, P51677, P51681, Q8TDT2, Q8TDV0, Q96P66, Q9H7M9	ACKR2, CCR1, CCR3, CCR5, FFAR2, GPR101, GPR151, GPR152, GPR42, PGRMC2, VSIR	ACKR2 [Cellinker:29637711;ICELLNET:22633458], CCR1 [connectomeDB2020:15240137], CCR3 [connectomeDB2020:15240137], CCR5 [connectomeDB2020:15240137], FFAR2 [NA], GPR42 [NA], GPR151 [NA], VSIR [NA], GPR152 [NA], GPR101 [NA], PGRMC2 [NA]	extracellular space [GO:0005615]	CCR chemokine receptor binding [GO:0048020]; chemokine activity [GO:0008009]	cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; chemokine-mediated signaling pathway [GO:0070098]; eosinophil chemotaxis [GO:0048245]; G protein-coupled receptor signaling pathway [GO:0007186]; inflammatory response [GO:0006954]; lymphocyte chemotaxis [GO:0048247]; monocyte chemotaxis [GO:0002548]; neutrophil chemotaxis [GO:0030593]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of GTPase activity [GO:0043547]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CCL4L2&keywords=CCL4L2	0.30713695337180896	574	NA	NA	0.154681653009485	573	3.9763779527559047	0	0	0	0	0	0	0	0	1.0014688209373749e-4	3.8632412594166507e-5	303	406	400	0.3615015210955084	0.026917790189691107	0.0271873634657262	0.027021780107364238	520	515	520
CCL5	C-C motif chemokine ligand 5	Yes		ENSG00000274233, ENSG00000271503	P13501	Intercrine beta (chemokine CC) family	19	ligand	extracellular, intracellular, ligand, secreted	O00421, O00590, O95800, P08913, P18827, P27487, P31431, P32246, P32302, P48039, P49682, P51677, P51679, P51681, Q14831, Q16570, Q9NPB9	ACKR1, ACKR2, ACKR4, ADRA2A, CCR1, CCR3, CCR4, CCR5, CCRL2, CXCR3, CXCR5, DPP4, GPR75, GRM7, MTNR1A, SDC1, SDC4	CCR5 [Baccin2019:10318947;Baccin2019:10477718;Baccin2019:11116158;Baccin2019:12964882;Baccin2019:14637022;Baccin2019:16298345;Baccin2019:8663314;Baccin2019:9289016;Baccin2019:9790730;BioGRID:14637022;CellPhoneDB:24218476;Cellinker:10318947;Cellinker:10477718;Cellinker:11116158;Cellinker:12964882;Cellinker:14637022;Cellinker:16298345;Cellinker:8663314;Cellinker:9289016;Cellinker:9790730;DIP:10477718;DIP:10488147;DIP:9207005;DIP:9334377;Guide2Pharma:10318947;Guide2Pharma:16298345;Guide2Pharma:9790730;HPRD:10477718;HPRD:11116158;HPRD:14637022;HPRD:8663314;HPRD:9289016;ICELLNET:22633458;InnateDB:10477718;InnateDB:12213786;IntAct:23480650;IntAct:28381538;LRdb:10699158;Lit-BM-17:10477718;Lit-BM-17:10488147;Lit-BM-17:11116158;Lit-BM-17:11449371;Lit-BM-17:14637022;Lit-BM-17:23480650;Lit-BM-17:9207005;Lit-BM-17:9334377;ProtMapper:25923671;SPIKE:10477718;connectomeDB2020:10318947;connectomeDB2020:10477718;connectomeDB2020:11116158;connectomeDB2020:12964882;connectomeDB2020:14637022;connectomeDB2020:16298345;connectomeDB2020:8663314;connectomeDB2020:9289016;connectomeDB2020:9790730;scConnect:10318947;scConnect:16298345;scConnect:9790730], CCR1 [Baccin2019:11116158;Baccin2019:12270118;Baccin2019:14637022;Baccin2019:7545673;Baccin2019:8530354;Baccin2019:9289016;Baccin2019:9624164;CellPhoneDB:24218476;Cellinker:11116158;Cellinker:12270118;Cellinker:14637022;Cellinker:7545673;Cellinker:8530354;Cellinker:9289016;Cellinker:9624164;DIP:10910894;DIP:7545673;DIP:7622448;DIP:8530354;DIP:9115216;DIP:9336350;Guide2Pharma:8530354;Guide2Pharma:9624164;HPRD:11116158;HPRD:12270118;HPRD:14637022;HPRD:7545673;HPRD:9289016;ICELLNET:22633458;InnateDB:7545673;InnateDB:8530354;InnateDB:9115216;LRdb:10699158;SIGNOR:10734056;connectomeDB2020:11116158;connectomeDB2020:12270118;connectomeDB2020:14637022;connectomeDB2020:7545673;connectomeDB2020:8530354;connectomeDB2020:9289016;connectomeDB2020:9624164;scConnect:8530354;scConnect:9624164], CCR3 [Baccin2019:8642344;Baccin2019:9289016;BioGRID:8642344;CellPhoneDB:24218476;Cellinker:8642344;Cellinker:9289016;DIP:10733106;DIP:7622448;Guide2Pharma:8642344;HPMR:8642344;HPRD:8642344;HPRD:9289016;ICELLNET:22633458;InnateDB:8642344;LRdb:10699158;SIGNOR:10734056;connectomeDB2020:8642344;connectomeDB2020:9289016;scConnect:8642344], CXCR3 [Baccin2019:9660793;Cellinker:9660793;DIP:9660793;Guide2Pharma:9660793;LRdb:9660793;connectomeDB2020:9660793;scConnect:9660793], GPR75 [Baccin2019:17001303;CellTalkDB:17001303;Cellinker:17001303;Guide2Pharma:17001303;LRdb:17001303;connectomeDB2020:17001303;scConnect:17001303], ACKR1 [CellChatDB:26740381;CellPhoneDB:24218476;Cellinker:12081195;Cellinker:17416748;Cellinker:26740381;HPRD:12081195;HPRD:17416748;ICELLNET:22633458;InnateDB:7592830;InnateDB:8132497;InnateDB:9195930;LRdb:10699158;LRdb:12081195;LRdb:17;connectomeDB2020:12081195;connectomeDB2020:17416748], ACKR2 [CellChatDB:26740381;CellPhoneDB:24218476;Cellinker:26740381;Cellinker:9405404;HPRD:9405404;ICELLNET:22633458;InnateDB:9405404;LRdb:10699158;connectomeDB2020:9405404], ACKR4 [Cellinker:9469451;HPRD:9405404;HPRD:9469451;LRdb:9469451], ADRA2A [CellTalkDB:32196115], MTNR1A [CellTalkDB:32196115], CCR4 [Baccin2019:12270118;Baccin2019:8573157;CellPhoneDB:24218476;Cellinker:12270118;HPRD:12270118;HPRD:8573157;LRdb:12270118;LRdb:86;connectomeDB2020:12270118;connectomeDB2020:8573157], CCRL2 [NA], GRM7 [CellTalkDB:32196115], SDC4 [Baccin2019:14637022;Cellinker:14637022;HPRD:14637022;LRdb:14637022;connectomeDB2020:14637022], SDC1 [Baccin2019:14637022;CellTalkDB:14637022;Cellinker:12270118;Cellinker:14637022;Cellinker:8573157;HPRD:14637022;LRdb:14637022;connectomeDB2020:14637022], DPP4 [Cellinker:21314817;HPRD:11390394;HPRD:9516414], CXCR5 [DIP:9312096]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	CCR1 chemokine receptor binding [GO:0031726]; CCR4 chemokine receptor binding [GO:0031729]; CCR5 chemokine receptor binding [GO:0031730]; CCR chemokine receptor binding [GO:0048020]; chemoattractant activity [GO:0042056]; chemokine activity [GO:0008009]; chemokine receptor antagonist activity [GO:0046817]; chemokine receptor binding [GO:0042379]; identical protein binding [GO:0042802]; phosphatidylinositol phospholipase C activity [GO:0004435]; phospholipase activator activity [GO:0016004]; protein homodimerization activity [GO:0042803]; protein kinase activity [GO:0004672]; protein self-association [GO:0043621]; receptor signaling protein tyrosine kinase activator activity [GO:0030298]	activation of phospholipase D activity [GO:0031584]; calcium ion transport [GO:0006816]; cell-cell signaling [GO:0007267]; cellular calcium ion homeostasis [GO:0006874]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-1 [GO:0071347]; cellular response to organic cyclic compound [GO:0071407]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to virus [GO:0098586]; chemokine-mediated signaling pathway [GO:0070098]; chemotaxis [GO:0006935]; dendritic cell chemotaxis [GO:0002407]; eosinophil chemotaxis [GO:0048245]; exocytosis [GO:0006887]; G protein-coupled receptor signaling pathway [GO:0007186]; inflammatory response [GO:0006954]; leukocyte cell-cell adhesion [GO:0007159]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; lymphocyte chemotaxis [GO:0048247]; macrophage chemotaxis [GO:0048246]; MAPK cascade [GO:0000165]; monocyte chemotaxis [GO:0002548]; negative regulation by host of viral transcription [GO:0043922]; negative regulation of G protein-coupled receptor signaling pathway [GO:0045744]; negative regulation of T cell apoptotic process [GO:0070233]; negative regulation of viral genome replication [GO:0045071]; neutrophil activation [GO:0042119]; neutrophil chemotaxis [GO:0030593]; positive regulation of activation of Janus kinase activity [GO:0010536]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell-cell adhesion mediated by integrin [GO:0033634]; positive regulation of cell migration [GO:0030335]; positive regulation of cellular biosynthetic process [GO:0031328]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of GTPase activity [GO:0043547]; positive regulation of homotypic cell-cell adhesion [GO:0034112]; positive regulation of innate immune response [GO:0045089]; positive regulation of macrophage chemotaxis [GO:0010759]; positive regulation of monocyte chemotaxis [GO:0090026]; positive regulation of natural killer cell chemotaxis [GO:2000503]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of phosphorylation [GO:0042327]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of smooth muscle cell migration [GO:0014911]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of T cell apoptotic process [GO:0070234]; positive regulation of T cell chemotaxis [GO:0010820]; positive regulation of T cell migration [GO:2000406]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of translational initiation [GO:0045948]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; positive regulation of viral genome replication [GO:0045070]; protein kinase B signaling [GO:0043491]; regulation of chronic inflammatory response [GO:0002676]; regulation of insulin secretion [GO:0050796]; regulation of neuron death [GO:1901214]; regulation of T cell activation [GO:0050863]; response to toxic substance [GO:0009636]; response to virus [GO:0009615]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CCL5&keywords=CCL5	1.1526134836803035	438	NA	NA	0.08152620086742603	658	0.3228346456692913	0.00249500998003992	0.028761061946902658	0.2498800959232618	0.0016835016835016834	0.001692047377326565	0.0027198549410698096	0.0032626427406199023	3.699593044765076e-4	9.680865269061294e-4	0.0012362372030133289	302	373	355	0.05599119484512815	0.15714156000377494	0.16620530288391736	0.170268734024034	453	434	438
CCL7	C-C motif chemokine ligand 7	Yes		ENSG00000108688	P80098	Intercrine beta (chemokine CC) family	19	ligand	extracellular, intracellular, ligand, secreted	O00590, P32246, P41597, P46092, P49682, P51677, P51681, Q16570, Q9NPB9	ACKR1, ACKR2, ACKR4, CCR1, CCR10, CCR2, CCR3, CCR5, CXCR3	CCR1 [Baccin2019:11994538;Baccin2019:12381680;Baccin2019:7545673;Baccin2019:8530354;Baccin2019:9115216;CellPhoneDB:24218476;Cellinker:11994538;Cellinker:12381680;Cellinker:7545673;Cellinker:8530354;Cellinker:9115216;DIP:7545673;DIP:8530354;DIP:9336350;Guide2Pharma:11994538;Guide2Pharma:12381680;HPRD:7545673;HPRD:8530354;ICELLNET:22633458;InnateDB:12381680;InnateDB:7545673;InnateDB:8530354;LRdb:10699158;SIGNOR:14991608;connectomeDB2020:11994538;connectomeDB2020:12381680;connectomeDB2020:7545673;connectomeDB2020:8530354;connectomeDB2020:9115216;scConnect:11994538;scConnect:12381680], CCR2 [Baccin2019:12554737;Baccin2019:8530354;Baccin2019:9276730;Baccin2019:9346309;CellPhoneDB:24218476;Cellinker:12554737;Cellinker:8530354;Cellinker:9276730;Cellinker:9346309;DIP:8530354;DIP:9195948;DIP:9312096;DIP:9336350;Guide2Pharma:12554737;Guide2Pharma:9276730;Guide2Pharma:9346309;HPRD:8530354;ICELLNET:22633458;InnateDB:7759884;InnateDB:8530354;InnateDB:9115216;LRdb:10699158;connectomeDB2020:12554737;connectomeDB2020:8530354;connectomeDB2020:9276730;connectomeDB2020:9346309;scConnect:12554737;scConnect:9276730;scConnect:9346309], CCR3 [CellPhoneDB:24218476;Cellinker:8642344;DIP:10733106;Guide2Pharma:8642344;HPRD:8642344;ICELLNET:22633458;InnateDB:8642344;LRdb:10699158;connectomeDB2020:8642344;scConnect:8642344], CCR5 [Baccin2019:10477710;Baccin2019:16298345;CellPhoneDB:24218476;Cellinker:10477718;Cellinker:16298345;DIP:10477718;Guide2Pharma:16298345;HPRD:10477718;ICELLNET:10477718;ICELLNET:22633458;InnateDB:10477718;LRdb:10699158;connectomeDB2020:10477718;connectomeDB2020:16298345;scConnect:16298345], CXCR3 [Baccin2019:9660793;CellTalkDB:9660793;Cellinker:9660793;DIP:9660793;Guide2Pharma:9660793;LRdb:9660793;connectomeDB2020:9660793;scConnect:9660793], ACKR2 [CellChatDB:26740381;CellPhoneDB:24218476;Cellinker:26740381;Cellinker:9364936;Cellinker:9405404;HPRD:9364936;HPRD:9405404;ICELLNET:22633458;InnateDB:9405404;LRdb:10699158;connectomeDB2020:9364936;connectomeDB2020:9405404], ACKR4 [CellTalkDB:10734104;Cellinker:10734104;DIP:10734104;HPRD:10734104;HPRD:9364936;HPRD:9405404;InnateDB:10734104;LRdb:10734104;connectomeDB2020:10734104], CCR10 [Baccin2019:9364936;CellTalkDB:9364936;Cellinker:9364936;HPRD:9364936;LRdb:9364936;connectomeDB2020:10706668;connectomeDB2020:9364936], ACKR1 [Baccin2019:13679391;CellChatDB:26740381;Cellinker:13679391;Cellinker:26740381;HPRD:13679391;LRdb:10699158;LRdb:13679391;connectomeDB2020:13679391]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	CCR1 chemokine receptor binding [GO:0031726]; CCR2 chemokine receptor binding [GO:0031727]; CCR chemokine receptor binding [GO:0048020]; chemokine activity [GO:0008009]; heparin binding [GO:0008201]	cell-cell signaling [GO:0007267]; cellular calcium ion homeostasis [GO:0006874]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; chemokine-mediated signaling pathway [GO:0070098]; chemotaxis [GO:0006935]; cytoskeleton organization [GO:0007010]; eosinophil chemotaxis [GO:0048245]; G protein-coupled receptor signaling pathway [GO:0007186]; inflammatory response [GO:0006954]; lymphocyte chemotaxis [GO:0048247]; monocyte chemotaxis [GO:0002548]; neutrophil chemotaxis [GO:0030593]; positive regulation of cell migration [GO:0030335]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of GTPase activity [GO:0043547]; positive regulation of natural killer cell chemotaxis [GO:2000503]; regulation of cell shape [GO:0008360]; signal transduction [GO:0007165]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CCL7&keywords=CCL7	4.464609916713483	301	NA	NA	56.44187337448957	15	0.047244094488188976	0.060379241516966026	0	0.004796163069544363	0.00505050505050505	0	0	0	0	0	0	303	409	401	0.010679091284109493	0.48358024357116386	0.48358024357116386	0.48358024357116386	349	325	332
CCL8	C-C motif chemokine ligand 8	Yes		ENSG00000108700	P80075	Intercrine beta (chemokine CC) family	18	ligand	extracellular, intracellular, ligand, secreted	O00590, P32246, P41597, P46092, P51677, P51679, P51681, Q16570, Q9NPB9	ACKR1, ACKR2, ACKR4, CCR1, CCR10, CCR2, CCR3, CCR4, CCR5	CCR5 [Baccin2019:1629834510477710;CellPhoneDB:24218476;Cellinker:10477718;Cellinker:12964882;Cellinker:9468473;Cellinker:9790730;DIP:10477718;DIP:9468473;Guide2Pharma:9790730;HPRD:10477718;HPRD:9468473;ICELLNET:22633458;InnateDB:10477718;LRdb:10699158;SPIKE:10477718;connectomeDB2020:10477718;connectomeDB2020:12964882;connectomeDB2020:9468473;connectomeDB2020:9790730;scConnect:9790730], CCR1 [Baccin2019:76793288631787;CellPhoneDB:24218476;Cellinker:9115216;DIP:9115216;HPRD:9115216;ICELLNET:22633458;InnateDB:9115216;LRdb:10699158;connectomeDB2020:9115216], CCR2 [Baccin2019:10529171;Baccin2019:10770925;Baccin2019:12554737;Baccin2019:15207250;Baccin2019:9276730;Baccin2019:9287323;Baccin2019:9346309;CellPhoneDB:24218476;Cellinker:12149192;Cellinker:12554737;Cellinker:9115216;DIP:9115216;DIP:9195948;Guide2Pharma:12554737;HPRD:12149192;HPRD:9115216;ICELLNET:22633458;InnateDB:9115216;LRdb:10699158;connectomeDB2020:12149192;connectomeDB2020:12554737;connectomeDB2020:9115216;scConnect:12554737], CCR3 [Baccin2019:8642344;CellPhoneDB:24218476;Cellinker:9005985;HPRD:9005985;LRdb:10699158;connectomeDB2020:9005985], ACKR2 [Baccin2019:9364936;Baccin2019:9405404;CellChatDB:26740381;CellPhoneDB:24218476;Cellinker:26740381;Cellinker:9405404;HPRD:9405404;ICELLNET:22633458;InnateDB:9405404;LRdb:10699158;connectomeDB2020:9405404], ACKR4 [Baccin2019:10734104;CellChatDB:26740381;CellTalkDB:10734104;Cellinker:10734104;Cellinker:26740381;DIP:10734104;HPRD:10734104;HPRD:9405404;InnateDB:10734104;LRdb:10734104;connectomeDB2020:10734104], ACKR1 [CellChatDB:26740381;CellTalkDB:13679391;Cellinker:13679391;Cellinker:26740381;HPRD:13679391;LRdb:13679391;connectomeDB2020:13679391], CCR10 [Baccin2019:10706668;Baccin2019:9364936], CCR4 [Baccin2019:16421945]	extracellular space [GO:0005615]	CCR2 chemokine receptor binding [GO:0031727]; CCR chemokine receptor binding [GO:0048020]; chemokine activity [GO:0008009]; heparin binding [GO:0008201]; phospholipase activator activity [GO:0016004]; protein kinase activity [GO:0004672]	angiogenesis [GO:0001525]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; calcium ion transport [GO:0006816]; cell-cell signaling [GO:0007267]; cellular calcium ion homeostasis [GO:0006874]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; chemokine-mediated signaling pathway [GO:0070098]; chemotaxis [GO:0006935]; eosinophil chemotaxis [GO:0048245]; exocytosis [GO:0006887]; G protein-coupled receptor signaling pathway [GO:0007186]; inflammatory response [GO:0006954]; killing of cells of other organism [GO:0031640]; lymphocyte chemotaxis [GO:0048247]; monocyte chemotaxis [GO:0002548]; negative regulation by host of viral genome replication [GO:0044828]; negative regulation of leukocyte proliferation [GO:0070664]; neutrophil chemotaxis [GO:0030593]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of GTPase activity [GO:0043547]; positive regulation of leukocyte migration [GO:0002687]; response to virus [GO:0009615]; signal transduction [GO:0007165]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CCL8&keywords=CCL8	0.9844236561797752	454	NA	NA	0.964448943782365	274	0.007874015748031496	0.0034930139720558877	0	0	0.02356902356902357	0	0	0	0	0	0	303	409	401	0.003176004844464632	0.7589553979407573	0.7589553979407573	0.7589553979407573	238	237	209
CCN1	cellular communication network factor 1	Yes		ENSG00000142871	O00622	CCN family	10	ecm, ligand	ecm, extracellular, intracellular, ligand, ligand_regulator, secreted	O00206, O60603, P05106, P05107, P06756, P08648, P11215, P18084, P31431, Q03135	CAV1, ITGA2B_ITGB3, ITGA5, ITGA6_ITGB1, ITGAD_ITGB2, ITGAM, ITGAV, ITGAV_ITGB3, ITGB2, ITGB3, ITGB5, SDC4, TLR2, TLR4	ITGAM [CellTalkDB:12036876;Cellinker:12036876;LRdb:12036876;connectomeDB2020:12036876], ITGB3 [CellTalkDB:9446626;Cellinker:9446626;LRdb:9446626;connectomeDB2020:9446626], TLR2 [CellTalkDB:32144270], ITGAV [CellTalkDB:10821835;Cellinker:10821835;Cellinker:11287419;HPRD:10821835;HPRD:11287419;LRdb:10821835;LRdb:11;connectomeDB2020:11287419], ITGA5 [CellTalkDB:9446626;Cellinker:9446626;LRdb:9446626;connectomeDB2020:9446626], ITGB5 [CellTalkDB:11287419;Cellinker:11287419;HPRD:11287419;LRdb:11287419;connectomeDB2020:11287419], CAV1 [CellTalkDB:32196115], TLR4 [CellTalkDB:32144270], ITGB2 [CellTalkDB:12036876;Cellinker:12036876;LRdb:12036876;connectomeDB2020:12036876], SDC4 [Baccin2019:16275757;connectomeDB2020:16275757]	collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]	extracellular matrix binding [GO:0050840]; heparin binding [GO:0008201]; insulin-like growth factor binding [GO:0005520]; integrin binding [GO:0005178]	apoptotic process involved in heart morphogenesis [GO:0003278]; atrial septum morphogenesis [GO:0060413]; atrioventricular valve morphogenesis [GO:0003181]; cell adhesion [GO:0007155]; chemotaxis [GO:0006935]; chondroblast differentiation [GO:0060591]; chorio-allantoic fusion [GO:0060710]; extracellular matrix organization [GO:0030198]; intussusceptive angiogenesis [GO:0002041]; labyrinthine layer blood vessel development [GO:0060716]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell death [GO:0060548]; osteoblast differentiation [GO:0001649]; positive regulation of apoptotic process [GO:0043065]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cartilage development [GO:0061036]; positive regulation of cell migration [GO:0030335]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of ceramide biosynthetic process [GO:2000304]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of phospholipase activity [GO:0010518]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription by RNA polymerase II [GO:0045944]; reactive oxygen species metabolic process [GO:0072593]; regulation of ERK1 and ERK2 cascade [GO:0070372]; signal transduction [GO:0007165]; ventricular septum development [GO:0003281]; wound healing, spreading of cells [GO:0044319]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CCN1&keywords=CCN1	55.080405258426964	78	NA	NA	0.23084622479600336	510	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
CCN2	cellular communication network factor 2	Yes		ENSG00000118523	P29279	CCN family	12	ecm, ligand	ecm, extracellular, intracellular, ligand, ligand_regulator, secreted	O75581, P00533, P01137, P02751, P04629, P05107, P08648, P10600, P11215, P11717, P21802, P61812, Q07954, Q15303	EGFR, ERBB4, FGFR2, FN1, IGF2R, ITGA2B_ITGB3, ITGA5, ITGA5_ITGB1, ITGAM, ITGAV_ITGB3, ITGB2, LRP1, LRP6, NTRK1, TGFB1, TGFB2, TGFB3	LRP6 [Baccin2019:15105373;CellTalkDB:15105373;Cellinker:15105373;LRdb:15105373;SIGNOR:18528331;connectomeDB2020:15105373], ITGAM [CellTalkDB:12736251;Cellinker:12736251;LRdb:12736251;connectomeDB2020:12736251], NTRK1 [CellTalkDB:15601748;Cellinker:15601748;LRdb:15601748;Ramilowski2015:15601748;connectomeDB2020:15601748;talklr:15601748], ITGB2 [CellTalkDB:12736251;Cellinker:12736251;LRdb:12736251;connectomeDB2020:12736251], LRP1 [Baccin2019:14585398;CellTalkDB:14585398;Cellinker:14585398;HPRD:14585398;LRdb:14585398;connectomeDB2020:14585398], EGFR [CellTalkDB:23929714], ITGA5 [LRdb:18167060;Ramilowski2015:18167060;connectomeDB2020:18167060;talklr:18167060], ERBB4 [Baccin2019:12297288;Cellinker:12297288;HPRD:12297288;LRdb:12297288], FGFR2 [Baccin2019:23142580;connectomeDB2020:23142580], IGF2R [Baccin2019:22511630;connectomeDB2020:22511630], FN1 [IntAct:16457822;Lit-BM-17:16457822], TGFB1 [HPRD:10457363], TGFB2 [HPRD:10457363], TGFB3 [HPRD:10457363]	cell cortex [GO:0005938]; cis-Golgi network [GO:0005801]; cytosol [GO:0005829]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]	fibronectin binding [GO:0001968]; growth factor activity [GO:0008083]; heparin binding [GO:0008201]; insulin-like growth factor binding [GO:0005520]; integrin binding [GO:0005178]; protein C-terminus binding [GO:0008022]	aging [GO:0007568]; angiogenesis [GO:0001525]; cartilage condensation [GO:0001502]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; cell-matrix adhesion [GO:0007160]; cell migration [GO:0016477]; chondrocyte proliferation [GO:0035988]; cytosolic calcium ion transport [GO:0060401]; DNA biosynthetic process [GO:0071897]; epidermis development [GO:0008544]; extracellular matrix constituent secretion [GO:0070278]; fibroblast growth factor receptor signaling pathway [GO:0008543]; integrin-mediated signaling pathway [GO:0007229]; intracellular signal transduction [GO:0035556]; lung development [GO:0030324]; negative regulation of cell death [GO:0060548]; negative regulation of gene expression [GO:0010629]; ossification [GO:0001503]; positive regulation of cardiac muscle contraction [GO:0060452]; positive regulation of cell activation [GO:0050867]; positive regulation of cell death [GO:0010942]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of G0 to G1 transition [GO:0070318]; positive regulation of gene expression [GO:0010628]; positive regulation of JNK cascade [GO:0046330]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; reactive oxygen species metabolic process [GO:0072593]; regulation of chondrocyte differentiation [GO:0032330]; response to amino acid [GO:0043200]; response to anoxia [GO:0034059]; response to estradiol [GO:0032355]; response to fatty acid [GO:0070542]; response to glucose [GO:0009749]; response to mineralocorticoid [GO:0051385]; response to peptide hormone [GO:0043434]; response to wounding [GO:0009611]; signal transduction [GO:0007165]; tissue homeostasis [GO:0001894]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CCN2&keywords=CCN2	52.49035382022472	81	NA	NA	0.21823740639125935	521	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
CCN3	cellular communication network factor 3	Yes		ENSG00000136999	P48745	CCN family	14	ecm, ligand	ecm, gap_junction, intracellular, ligand, secreted	P46531, Q9UIW2	NOTCH1, PLXNA1	NOTCH1 [Baccin2019:1590625312050160;CellTalkDB:15906253;Cellinker:12050162;Cellinker:15906253;HPRD:12050162;LRdb:12;LRdb:15906253;NetPath:12050162;SignaLink3:12050162;SignaLink3:23331499;connectomeDB2020:12050162;connectomeDB2020:15906253], PLXNA1 [CellTalkDB:32196115]	axon [GO:0030424]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; gap junction [GO:0005921]; intracellular membrane-bounded organelle [GO:0043231]; neuronal cell body [GO:0043025]	growth factor activity [GO:0008083]; heparin binding [GO:0008201]; insulin-like growth factor binding [GO:0005520]; integrin binding [GO:0005178]; Notch binding [GO:0005112]	angiogenesis [GO:0001525]; bone regeneration [GO:1990523]; cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cell chemotaxis [GO:0060326]; chondrocyte differentiation [GO:0002062]; endothelial cell-cell adhesion [GO:0071603]; endothelial cell chemotaxis [GO:0035767]; fibroblast migration [GO:0010761]; hematopoietic stem cell homeostasis [GO:0061484]; negative regulation of cell death [GO:0060548]; negative regulation of cell growth [GO:0030308]; negative regulation of chondrocyte proliferation [GO:1902731]; negative regulation of inflammatory response [GO:0050728]; negative regulation of insulin secretion [GO:0046676]; negative regulation of monocyte chemotaxis [GO:0090027]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; negative regulation of sensory perception of pain [GO:1904057]; negative regulation of SMAD protein signal transduction [GO:0060392]; positive regulation of Notch signaling pathway [GO:0045747]; regulation of gene expression [GO:0010468]; signal transduction [GO:0007165]; smooth muscle cell migration [GO:0014909]; smooth muscle cell proliferation [GO:0048659]; type B pancreatic cell proliferation [GO:0044342]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CCN3&keywords=CCN3	3.3560241123595507	327	NA	NA	0.05604477266160819	701	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
CCN4	cellular communication network factor 4	Yes		ENSG00000104415	O95388	CCN family	2	ecm, ligand	ecm, extracellular, intracellular, ligand, ligand_regulator, secreted	P05556, P08648	ITGA5, ITGB1	ITGA5 [connectomeDB2020:29330021], ITGB1 [connectomeDB2020:29330021]	cytosol [GO:0005829]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]	heparin binding [GO:0008201]; insulin-like growth factor binding [GO:0005520]; integrin binding [GO:0005178]	bone development [GO:0060348]; cell adhesion [GO:0007155]; cell-cell signaling [GO:0007267]; glucose homeostasis [GO:0042593]; negative regulation of cell death [GO:0060548]; negative regulation of chondrocyte differentiation [GO:0032331]; negative regulation of fat cell differentiation [GO:0045599]; osteoblast differentiation [GO:0001649]; osteoclast differentiation [GO:0030316]; positive regulation of inflammatory response [GO:0050729]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of smooth muscle cell migration [GO:0014911]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of Wnt signaling pathway [GO:0030177]; positive regulation of wound healing [GO:0090303]; regulation of cytokine production [GO:0001817]; signal transduction [GO:0007165]; Wnt signaling pathway [GO:0016055]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CCN4&keywords=CCN4	3.1263818111235953	334	NA	NA	0.5994399221263904	339	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
CCN5	cellular communication network factor 5	Yes		ENSG00000064205	O76076	CCN family	1	ecm, ligand	ecm, extracellular, intracellular, ligand, ligand_regulator, secreted	NA	NA	NA	extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; nucleus [GO:0005634]	heparin binding [GO:0008201]; insulin-like growth factor binding [GO:0005520]; integrin binding [GO:0005178]	cell adhesion [GO:0007155]; cell-cell signaling [GO:0007267]; negative regulation of cell death [GO:0060548]; signal transduction [GO:0007165]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CCN5&keywords=CCN5	0.0874773606741573	686	NA	NA	0.0022858361954420274	887	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
CCN6	cellular communication network factor 6	Yes		ENSG00000112761	O95389	CCN family	5	ligand	intracellular, ligand, ligand_regulator, secreted	Q92673	SORL1	SORL1 [CellTalkDB:32103204]	extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; mitochondrion [GO:0005739]	growth factor activity [GO:0008083]; heparin binding [GO:0008201]; insulin-like growth factor binding [GO:0005520]; integrin binding [GO:0005178]	cell adhesion [GO:0007155]; cell-cell signaling [GO:0007267]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell death [GO:0060548]; negative regulation of cell population proliferation [GO:0008285]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of reactive oxygen species biosynthetic process [GO:1903426]; signal transduction [GO:0007165]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CCN6&keywords=CCN6	0.0577800202247191	719	NA	NA	0.10820509221016637	618	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
CD14	CD14 molecule	Yes		ENSG00000170458	P08571	NA	2	adhesion, cell_surface_ligand, receptor	adhesion, cell_adhesion, cell_surface, cell_surface_ligand, extracellular, intracellular, plasma_membrane, plasma_membrane_peripheral, receptor, secreted, transmembrane	O00206, O15455, O60603, P05107, P05556, P13612, Q13546, Q15399, Q9NR96, Q9Y2C9, Q9Y4D7	ITGA4, ITGA4_ITGB1, ITGB1, ITGB2, PLXND1, RIPK1, TLR1, TLR2, TLR3, TLR4, TLR6, TLR9	TLR4 [CellTalkDB:32196115;HPRD:12196527;InnateDB:11745332;InnateDB:12196527;Macrophage:17535871], ITGA4 [CellTalkDB:17274987;Cellinker:17274987;LRdb:17274987;Ramilowski2015:17274987;connectomeDB2020:17274987;talklr:17274987], ITGB1 [CellTalkDB:17274987;Cellinker:17274987;LRdb:17274987;Ramilowski2015:17274987;connectomeDB2020:17274987;talklr:17274987], TLR6 [CellTalkDB:32196115;Cellinker:23350913], TLR9 [CellTalkDB:21078886;InnateDB:21078886], ITGB2 [CellTalkDB:32196115;HPRD:11745332], TLR1 [CellTalkDB:15714590], RIPK1 [CellTalkDB:32196115], TLR2 [DIP:18765807;HPRD:10395652;InnateDB:10395652;InnateDB:11986301;Lit-BM-17:10395652;Lit-BM-17:18765807], PLXND1 [Cellinker:32589946], TLR3 [HPRD:16473828;InnateDB:21078886]	anchored component of external side of plasma membrane [GO:0031362]; endosome membrane [GO:0010008]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; lipopolysaccharide receptor complex [GO:0046696]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]	lipopeptide binding [GO:0071723]; lipopolysaccharide binding [GO:0001530]; lipoteichoic acid binding [GO:0070891]; opsonin receptor activity [GO:0001847]; peptidoglycan immune receptor activity [GO:0016019]	apoptotic process [GO:0006915]; cell surface receptor signaling pathway [GO:0007166]; cellular response to diacyl bacterial lipopeptide [GO:0071726]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to lipoteichoic acid [GO:0071223]; cellular response to molecule of bacterial origin [GO:0071219]; cellular response to triacyl bacterial lipopeptide [GO:0071727]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; phagocytosis [GO:0006909]; positive regulation of endocytosis [GO:0045807]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of type I interferon production [GO:0032481]; receptor-mediated endocytosis [GO:0006898]; response to electrical stimulus [GO:0051602]; response to ethanol [GO:0045471]; response to heat [GO:0009408]; response to magnesium ion [GO:0032026]; response to tumor necrosis factor [GO:0034612]; toll-like receptor 4 signaling pathway [GO:0034142]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CD14&keywords=CD14	10.057555382632382	237	3300.82	108	0.21736730614901723	522	1.5669291338582667	0.011477045908183629	0.007743362831858407	0.010791366906474817	0.0101010101010101	0.14043993231810475	0.1532184950135989	0.1190864600326266	0.11098779134295177	0.17919615435972075	0.05698280857639424	115	84	147	0.21517759647719914	0.537299417152286	0.8402086056499773	0.2974665758241928	331	194	396
CD160	CD160 molecule	No		ENSG00000117281	O95971	NA	4	adhesion, ligand, receptor	adhesion, cell_adhesion, cell_surface, extracellular, intracellular, ligand, peripheral, plasma_membrane, plasma_membrane_peripheral, receptor, secreted, transmembrane	Q92956	TNFRSF14	TNFRSF14 [CellTalkDB:21959263;Cellinker:21959263;Cellinker:30885361;ICELLNET:18193050;LRdb:21959263;Lit-BM-17:21982860;connectomeDB2020:21959263]	anchored component of plasma membrane [GO:0046658]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]	activating MHC class I receptor activity [GO:0032397]; kinase binding [GO:0019900]; MHC class Ib receptor activity [GO:0032394]; MHC class I protein complex binding [GO:0023024]; MHC class I receptor activity [GO:0032393]; signaling receptor binding [GO:0005102]	adaptive immune response [GO:0002250]; angiogenesis [GO:0001525]; defense response to Gram-negative bacterium [GO:0050829]; innate immune response [GO:0045087]; mucosal immune response [GO:0002385]; negative regulation of adaptive immune memory response [GO:1905675]; negative regulation of angiogenesis [GO:0016525]; negative regulation of CD4-positive, alpha-beta T cell costimulation [GO:1900280]; negative regulation of T cell receptor signaling pathway [GO:0050860]; phosphatidylinositol 3-kinase signaling [GO:0014065]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of natural killer cell cytokine production [GO:0002729]; positive regulation of natural killer cell degranulation [GO:0043323]; positive regulation of natural killer cell mediated cytotoxicity [GO:0045954]; positive regulation of natural killer cell mediated immune response to tumor cell [GO:0002857]; T cell costimulation [GO:0031295]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CD160&keywords=CD160	0.31657654808988767	570	NA	NA	0.6484350467554137	326	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
CD177	CD177 molecule	No	manually added ensembl_gene_ID, hgnc_symbol, and description by searching the uniprot ID on genenames.org	ENSG00000204936	Q8N6Q3	NA	1	adhesion, cell_surface_ligand, ligand, receptor	adhesion, cell_adhesion, cell_surface, cell_surface_ligand, intracellular, ligand, plasma_membrane, receptor, receptor_regulator, secreted, transmembrane	P16284	PECAM1	PECAM1 [Cellinker:17580308;LRdb:17580308;connectomeDB2020:17580308]	anchored component of plasma membrane [GO:0046658]; extracellular exosome [GO:0070062]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; secretory granule membrane [GO:0030667]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]	calcium-dependent protein binding [GO:0048306]; integrin binding [GO:0005178]; protease binding [GO:0002020]	cell adhesion [GO:0007155]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; cell-cell junction maintenance [GO:0045217]; innate immune response [GO:0045087]; leukocyte cell-cell adhesion [GO:0007159]; neutrophil extravasation [GO:0072672]; neutrophil migration [GO:1990266]; positive regulation of neutrophil degranulation [GO:0043315]; positive regulation of superoxide anion generation [GO:0032930]; protein localization to cell surface [GO:0034394]; regulation of endocytosis [GO:0030100]; regulation of integrin-mediated signaling pathway [GO:2001044]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CD177&keywords=CD177	0.2927421325842697	579	NA	NA	0.03565776038535859	750	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
CD200R1	CD200 receptor 1	No	manually added ensembl_gene_ID, hgnc_symbol, and description by searching the uniprot ID on genenames.org	ENSG00000163606	Q8TD46	CD200R family	1	adhesion, cell_surface_ligand, ligand, receptor	adhesion, cell_adhesion, cell_surface, cell_surface_ligand, extracellular, intracellular, ligand, plasma_membrane, plasma_membrane_transmembrane, receptor, secreted, transmembrane	P41217	CD200	CD200 [BioGRID:12960329;CellPhoneDB:22020332;HPRD:10981966;HPRD:12960329;Lit-BM-17:12960329;Lit-BM-17:21982860;connectomeDB2020:12960329]	cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	glycosylated region protein binding [GO:0140081]; immunoglobulin receptor activity [GO:0019763]; signaling receptor activity [GO:0038023]	heterotypic cell-cell adhesion [GO:0034113]; intracellular signal transduction [GO:0035556]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of macrophage migration [GO:1905522]; negative regulation of neuroinflammatory response [GO:0150079]; negative regulation of neuron death [GO:1901215]; negative regulation of T cell migration [GO:2000405]; regulation of neuroinflammatory response [GO:0150077]; signal transduction [GO:0007165]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CD200R1&keywords=CD200R1	0.292294006323482	580	NA	NA	0.5006117050161892	382	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
CD209	CD209 molecule	No		ENSG00000090659	Q9NNX6	NA	2	adhesion, cell_surface_ligand, ligand, receptor	adhesion, cell_adhesion, cell_surface, cell_surface_ligand, extracellular, intracellular, ligand, plasma_membrane, receptor, secreted, transmembrane, transmembrane_predicted	P13688, P32942	CEACAM1, ICAM3	ICAM3 [Cellinker:10721994;HPRD:10721994;HPRD:11017109;HPRD:11799126;ICELLNET:10721994;connectomeDB2020:10721994], CEACAM1 [CellChatDB:16282604;CellChatDB:6246332;HPRD:16246332]	cell surface [GO:0009986]; cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; host cell [GO:0043657]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]	carbohydrate binding [GO:0030246]; mannose binding [GO:0005537]; metal ion binding [GO:0046872]; peptide antigen binding [GO:0042605]; virion binding [GO:0046790]; virus receptor activity [GO:0001618]	adaptive immune response [GO:0002250]; antigen processing and presentation [GO:0019882]; B cell adhesion [GO:0097323]; cell-cell recognition [GO:0009988]; endocytosis [GO:0006897]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; immune response [GO:0006955]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; intracellular transport of virus [GO:0075733]; leukocyte cell-cell adhesion [GO:0007159]; peptide antigen transport [GO:0046968]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of viral life cycle [GO:1903902]; regulation of T cell proliferation [GO:0042129]; viral entry into host cell [GO:0046718]; viral genome replication [GO:0019079]; virion attachment to host cell [GO:0019062]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CD209&keywords=CD209	0.3962603361760127	545	NA	NA	0.18068753442075589	547	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
CD40LG	CD40 ligand	Yes		ENSG00000102245	P29965	Tumor necrosis factor family	16	cell_surface_ligand, ligand, receptor	cell_surface, cell_surface_ligand, extracellular, ligand, plasma_membrane, plasma_membrane_transmembrane, receptor, secreted, transmembrane, transmembrane_predicted	P04637, P05107, P11215, P19397, P21926, P25942, Q13114	CD40, CD53, CD9, ITGA2B_ITGB3, ITGA5_ITGB1, ITGAM, ITGAM_ITGB2, ITGB2, TP53, TRAF3	CD40 [CellPhoneDB:23602662;Cellinker:10647992;Cellinker:1374165;Cellinker:7516405;Cellinker:7543281;DIP:1280226;HPRD:10647992;HPRD:7516405;HPRD:7543281;ICELLNET:11163401;LRdb:10647992;LRdb:1374165;LRdb:7516405;LRdb:7543281;SIGNOR:12324477;SIGNOR:19426221;SPIKE:17183360;connectomeDB2020:10647992;connectomeDB2020:1374165;connectomeDB2020:7516405;connectomeDB2020:7543281], ITGAM [CellTalkDB:32196115], ITGB2 [CellTalkDB:24652469], TRAF3 [CellTalkDB:16429118], CD53 [Cellinker:21428930], CD9 [Cellinker:21428930], TP53 [HPRD:12011072]	cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	CD40 receptor binding [GO:0005174]; cytokine activity [GO:0005125]; integrin binding [GO:0005178]; protein serine/threonine kinase activator activity [GO:0043539]; tumor necrosis factor receptor binding [GO:0005164]	B cell differentiation [GO:0030183]; B cell proliferation [GO:0042100]; CD40 signaling pathway [GO:0023035]; inflammatory response [GO:0006954]; integrin-mediated signaling pathway [GO:0007229]; isotype switching [GO:0045190]; leukocyte cell-cell adhesion [GO:0007159]; negative regulation of apoptotic process [GO:0043066]; platelet activation [GO:0030168]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-4 production [GO:0032753]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of T cell proliferation [GO:0042102]; regulation of immunoglobulin production [GO:0002637]; T cell costimulation [GO:0031295]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CD40LG&keywords=CD40LG	0.014301823595505619	811	NA	NA	0.04101292479174692	734	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
CD44	CD44 molecule (Indian blood group)	No		ENSG00000026508	P16070	NA	2	adhesion, cell_surface_ligand, receptor	adhesion, cell_adhesion, cell_surface, cell_surface_ligand, extracellular, intracellular, matrix_adhesion, plasma_membrane, plasma_membrane_transmembrane, receptor, secreted, transmembrane, transmembrane_predicted	O95471, P16422, P16581, Q13009, Q13705, Q92819, Q92888, Q9NZN5	ACVR2B, ARHGEF1, ARHGEF12, CLDN7, EPCAM, HAS2, SELE, TIAM1	HAS2 [HPMR:1694723], SELE [HPRD:11402070;connectomeDB2020:29777742], EPCAM [Cellinker:17579117], CLDN7 [Cellinker:17579117;Cellinker:23230278], ACVR2B [Cellinker:30297743], TIAM1 [HPRD:10636882], ARHGEF1 [HPRD:12748184], ARHGEF12 [HPRD:16565089]	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cell projection [GO:0042995]; cell surface [GO:0009986]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; lamellipodium membrane [GO:0031258]; macrophage migration inhibitory factor receptor complex [GO:0035692]; microvillus [GO:0005902]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]	collagen binding [GO:0005518]; hyaluronic acid binding [GO:0005540]; transmembrane signaling receptor activity [GO:0004888]	cartilage development [GO:0051216]; cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; cell migration [GO:0016477]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cytokine-mediated signaling pathway [GO:0019221]; hyaluronan catabolic process [GO:0030214]; inflammatory response [GO:0006954]; monocyte aggregation [GO:0070487]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043518]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of heterotypic cell-cell adhesion [GO:0034116]; positive regulation of monocyte aggregation [GO:1900625]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; regulation of lamellipodium morphogenesis [GO:2000392]; T cell activation [GO:0042110]; wound healing, spreading of cells [GO:0044319]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CD44&keywords=CD44	755.9456748825479	18	7888.12	79	14.073402365789114	36	1.5039370078740142	6.538423153692568	0.023230088495575223	2.029016786570703	7.794612794612814	0.1895093062605751	0.28649138712601907	0.38009787928221855	0.12652608213096508	0.08786219789023961	0.28839096001543874	104	117	55	1.7498270585410118	0.07757926068266749	0.055608985789417545	0.16955697923114124	488	490	439
CD55	CD55 molecule (Cromer blood group)	Yes		ENSG00000196352	P08174	Receptors of complement activation (RCA) family	2	adhesion, cell_surface_ligand, receptor	adhesion, cell_adhesion, cell_surface, cell_surface_ligand, extracellular, intracellular, peripheral, plasma_membrane, plasma_membrane_peripheral, plasma_membrane_transmembrane, receptor, secreted, transmembrane	P17927, P48960, Q9UHX3	ADGRE2, ADGRE5, CR1	ADGRE5 [Baccin2019:23447688;CellTalkDB:12417446;Cellinker:10540231;Cellinker:12417446;HPMR:12417446;HPRD:10540231;LRdb:11;LRdb:12417446;SIGNOR:12417446;connectomeDB2020:10540231;connectomeDB2020:12417446], ADGRE2 [CellTalkDB:9064337], CR1 [CellTalkDB:11694537;Cellinker:11694537;HPRD:11694537;LRdb:11694537]	anchored component of membrane [GO:0031225]; cell surface [GO:0009986]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule membrane [GO:0101003]; Golgi membrane [GO:0000139]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; transport vesicle [GO:0030133]	lipid binding [GO:0008289]; virus receptor activity [GO:0001618]	complement activation, classical pathway [GO:0006958]; innate immune response [GO:0045087]; negative regulation of complement activation [GO:0045916]; negative regulation of complement activation, classical pathway [GO:0045959]; positive regulation of CD4-positive, alpha-beta T cell activation [GO:2000516]; positive regulation of CD4-positive, alpha-beta T cell proliferation [GO:2000563]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of T cell cytokine production [GO:0002726]; regulation of complement activation [GO:0030449]; regulation of complement-dependent cytotoxicity [GO:1903659]; regulation of lipopolysaccharide-mediated signaling pathway [GO:0031664]; respiratory burst [GO:0045730]; T cell mediated immunity [GO:0002456]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CD55&keywords=CD55	89.15322674981326	56	NA	NA	2.855207096183817	119	0.18897637795275585	0.6696606786427158	0.8285398230088474	0.4609112709832209	0.8468013468013482	0.39593908629441693	0.4687216681776957	0.45350734094616696	0.26193118756936634	0.2171852049672752	0.4428819779795003	65	71	41	0.47591417848393724	0.5596280158315148	0.4675418315145649	0.9320205049222928	319	327	127
CD59	CD59 molecule (CD59 blood group)	No		ENSG00000085063	P13987	NA	4	ligand, receptor	cell_surface, extracellular, intracellular, ligand, peripheral, plasma_membrane, plasma_membrane_peripheral, receptor, receptor_regulator, secreted, secreted_receptor	O95150, P02748, P06729, P07357, Q9BZZ2, Q9NY15	C8A, C9, CD2, SIGLEC1, STAB1, TNFSF15	CD2 [CellTalkDB:1385156;Cellinker:1385156;HPRD:1377404;LRdb:1385156;connectomeDB2020:1377404], SIGLEC1 [Cellinker:32589946], STAB1 [Cellinker:32589946], TNFSF15 [Cellinker:32589946], C9 [BioGRID:1377690;BioGRID:7523406;HPRD:1377690;HPRD:7523406], C8A [HPRD:7544344]	anchored component of external side of plasma membrane [GO:0031362]; cell surface [GO:0009986]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; Golgi membrane [GO:0000139]; membrane [GO:0016020]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]; transport vesicle [GO:0030133]; vesicle [GO:0031982]	complement binding [GO:0001848]	blood coagulation [GO:0007596]; cell surface receptor signaling pathway [GO:0007166]; negative regulation of activation of membrane attack complex [GO:0001971]; regulation of complement activation [GO:0030449]; regulation of complement-dependent cytotoxicity [GO:1903659]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CD59&keywords=CD59	1621.2624223406503	14	13190.2	59	5.756409402995871	66	1.9291338582677153	7.213073852295371	7.159292035398211	10.68609112709801	2.395622895622906	1.7512690355329865	1.448776065276523	2.12724306688417	2.0788013318535183	1.2693617305384366	1.580220204752248	16	24	19	3.6035350185018267	0.5780492844703456	0.35404713777171604	0.4400732791048346	308	361	344
CD5L	CD5 molecule like	Yes		ENSG00000073754	O43866	NA	9	ligand	extracellular, intracellular, ligand, secreted	P06127	CD5	CD5 [CellTalkDB:9723705;Cellinker:9723705;LRdb:9723705;Ramilowski2015:9723705;connectomeDB2020:9723705;talklr:9723705]	blood microparticle [GO:0072562]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]	scavenger receptor activity [GO:0005044]; serine-type endopeptidase activity [GO:0004252]	apoptotic process [GO:0006915]; cellular defense response [GO:0006968]; immune system process [GO:0002376]; inflammatory response [GO:0006954]; positive regulation of complement-dependent cytotoxicity [GO:1903661]; regulation of complement activation [GO:0030449]; zymogen activation [GO:0031638]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CD5L&keywords=CD5L	0.04527226516853933	746	NA	NA	0.006514279839796618	855	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
CD6	CD6 molecule	Yes		ENSG00000013725	P30203	NA	3	adhesion, cell_surface_ligand, ligand, receptor	adhesion, cell_adhesion, cell_surface, cell_surface_ligand, extracellular, ligand, plasma_membrane, plasma_membrane_transmembrane, receptor, secreted, transmembrane, transmembrane_predicted	Q13740, Q14118, Q99075, Q9NYZ4	ALCAM, DAG1, HBEGF, SIGLEC8	ALCAM [Baccin2019:24496453;BioGRID:7543097;CellChatDB:23602662;CellPhoneDB:23602662;CellTalkDB:26146185;Cellinker:23602662;Cellinker:29526637;DIP:26146185;HPRD:7543097;HPRD:9436462;IntAct:24945728;IntAct:26146185;LRdb:26146185;Lit-BM-17:24945728;Lit-BM-17:7543097;connectomeDB2020:26146185], HBEGF [Cellinker:32589946], SIGLEC8 [Cellinker:32589946], DAG1 [Cellinker:32589946]	external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; immunological synapse [GO:0001772]; integral component of plasma membrane [GO:0005887]; intrinsic component of plasma membrane [GO:0031226]; spanning component of plasma membrane [GO:0044214]	identical protein binding [GO:0042802]; lipopolysaccharide binding [GO:0001530]; lipoteichoic acid binding [GO:0070891]; protein kinase binding [GO:0019901]; scavenger receptor activity [GO:0005044]	acute inflammatory response to antigenic stimulus [GO:0002438]; adaptive immune response [GO:0002250]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; immunological synapse formation [GO:0001771]; innate immune response [GO:0045087]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; positive regulation of cytokine production involved in inflammatory response [GO:1900017]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of T cell proliferation [GO:0042102]; response to lipopolysaccharide [GO:0032496]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CD6&keywords=CD6	1.5685631032066787	406	NA	NA	0.6958969957882934	321	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
CD70	CD70 molecule	Yes	there is evidence that a soluble form of the ligand is secreted, even though traditionaly is thought to be membrane bound	ENSG00000125726	P32970	Tumor necrosis factor family	13	adhesion, cell_surface_ligand, ligand	adhesion, cell_adhesion, cell_surface, cell_surface_ligand, extracellular, intracellular, ligand, plasma_membrane, secreted, transmembrane, transmembrane_predicted	O14836, P26842, Q02223, Q9NZH0	CD27, GPRC5B, TNFRSF13B, TNFRSF17	CD27 [Baccin2019:15723067;Baccin2019:7479974;Baccin2019:8120384;Baccin2019:8186199;Baccin2019:8580829;Baccin2019:9767422;Baccin2019:9862673;BioGRID:21917027;CellPhoneDB:26697006;CellTalkDB:8120384;Cellinker:15723067;Cellinker:7479974;Cellinker:8120384;Cellinker:8186199;Cellinker:8580829;Cellinker:9767422;Cellinker:9862673;HPMR:8120384;HPRD:15723067;HPRD:7479974;HPRD:8120384;HPRD:8186199;HPRD:8580829;HPRD:9767422;HPRD:9862673;ICELLNET:26697006;ICELLNET:8120384;LRdb:15723067;LRdb:7479974;LRdb:8120384;LRdb:8186199;LRdb:8580829;LRdb:9767422;LRdb:9862673;SIGNOR:12324477;SIGNOR:8120384;SPIKE:9862673;connectomeDB2020:15723067;connectomeDB2020:7479974;connectomeDB2020:8120384;connectomeDB2020:8186199;connectomeDB2020:8580829;connectomeDB2020:9767422;connectomeDB2020:9862673], TNFRSF13B [CellTalkDB:32103204], TNFRSF17 [CellTalkDB:32103204], GPRC5B [NA]	extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	cytokine activity [GO:0005125]; protease binding [GO:0002020]; signaling receptor binding [GO:0005102]; tumor necrosis factor receptor binding [GO:0005164]	B cell mediated immunity [GO:0019724]; B cell proliferation [GO:0042100]; cell-cell signaling [GO:0007267]; extrinsic apoptotic signaling pathway [GO:0097191]; positive regulation of T cell proliferation [GO:0042102]; signal transduction [GO:0007165]; T cell mediated immunity [GO:0002456]; tumor necrosis factor-mediated signaling pathway [GO:0033209]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CD70&keywords=CD70	0.05278103370786517	732	NA	NA	0.009498618418800132	836	0	0.00249500998003992	0.00995575221238938	0.0021582733812949635	0	0	0	0	0	0	1.5452965037666603e-4	303	409	397	0.0013421422931000845	0.8816676551557135	0.8816676551557135	0.8952920346056763	195	177	147
CD86	CD86 molecule			ENSG00000114013	P42081	NA	3	adhesion, cell_surface_ligand, receptor	adhesion, cell_adhesion, cell_surface, cell_surface_ligand, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, secreted, transmembrane	P10747, P16410	CD28, CTLA4	CD28 [CellChatDB:23954143;CellTalkDB:23954143;Cellinker:21530327;Cellinker:23954143;DIP:21931534;HPRD:11021528;HPRD:7513726;ICELLNET:18205792;LRdb:22437870;SPIKE:11021528;SPIKE:21487479;connectomeDB2020:23954143], CTLA4 [BioGRID:11279501;CellChatDB:23954143;CellTalkDB:23954143;Cellinker:21530327;Cellinker:23223433;Cellinker:23954143;HPRD:11021528;HPRD:11162656;HPRD:11279501;HPRD:12071705;HPRD:12582153;HPRD:12606712;HPRD:7513726;HPRD:7694153;ICELLNET:10583602;ICELLNET:11976720;IntAct:11279501;IntAct:21982860;IntAct:25241761;LRdb:22437870;Lit-BM-17:11279501;Lit-BM-17:21982860;Lit-BM-17:25241761;connectomeDB2020:23954143]	cell surface [GO:0009986]; centriolar satellite [GO:0034451]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	coreceptor activity [GO:0015026]; signaling receptor activity [GO:0038023]; virus receptor activity [GO:0001618]	activation of phospholipase C activity [GO:0007202]; activation of protein kinase C activity [GO:1990051]; adaptive immune response [GO:0002250]; B cell activation [GO:0042113]; CD40 signaling pathway [GO:0023035]; cell surface receptor signaling pathway [GO:0007166]; cellular response to lipopolysaccharide [GO:0071222]; immune response [GO:0006955]; negative regulation of T cell proliferation [GO:0042130]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of immunoglobulin production [GO:0002639]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of interleukin-4 production [GO:0032753]; positive regulation of lymphotoxin A production [GO:0032761]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of T-helper 2 cell differentiation [GO:0045630]; positive regulation of transcription, DNA-templated [GO:0045893]; T cell costimulation [GO:0031295]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CD86&keywords=CD86	1.1890835765533445	434	NA	NA	0.35356279171295907	443	0.2677165354330708	0	0	0	0	0	0	0	0	0	3.8632412594166507e-5	303	409	400	0.02434137889506045	0.2911938984907321	0.2911938984907321	0.2923188507738718	411	381	398
CD8A	CD8a molecule	No		ENSG00000153563	P01732	NA	1	adhesion, cell_surface_ligand, ligand, receptor	adhesion, cell_adhesion, cell_surface, cell_surface_ligand, extracellular, intracellular, ligand, plasma_membrane, plasma_membrane_transmembrane, receptor, secreted, transmembrane, transmembrane_predicted	O43561, P06239, P06731, Q07955	CEACAM5, LAT, LCK, SRSF1	CEACAM5 [CellChatDB:24104458;Cellinker:24104458], LAT [HPRD:10562325;NetPath:10562325], LCK [HPRD:14500983;NetPath:8814252], SRSF1 [HPRD:10022843]	external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]; receptor complex [GO:0043235]; T cell receptor complex [GO:0042101]	coreceptor activity [GO:0015026]; MHC class I protein binding [GO:0042288]; MHC class I protein complex binding [GO:0023024]; protein kinase binding [GO:0019901]	antigen processing and presentation [GO:0019882]; cell surface receptor signaling pathway [GO:0007166]; cytotoxic T cell differentiation [GO:0045065]; immune response [GO:0006955]; T cell activation [GO:0042110]; T cell mediated immunity [GO:0002456]; T cell receptor signaling pathway [GO:0050852]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CD8A&keywords=CD8A	1.167064539213483	435	508.645	160	0.2472551954277066	497	0	0.00249500998003992	0.00331858407079646	9.592326139088729e-4	0.006734006734006734	0.013536379018612519	0.02085222121486854	0	0.0014798372179060304	0.01622379489918543	0.0021247826926791592	299	216	333	0.006156713494727606	0.7105304690618068	1.6230896777208432	0.750448579572561	259	40	214
CD8B	CD8b molecule	No		ENSG00000172116	P10966	NA	1	ligand, receptor	cell_surface, extracellular, intracellular, ligand, plasma_membrane, plasma_membrane_transmembrane, receptor, secreted, transmembrane, transmembrane_predicted	NA	NA	NA	cell surface [GO:0009986]; early endosome membrane [GO:0031901]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; T cell receptor complex [GO:0042101]	coreceptor activity [GO:0015026]; MHC class I protein binding [GO:0042288]	adaptive immune response [GO:0002250]; immune response [GO:0006955]; T cell activation [GO:0042110]; T cell receptor signaling pathway [GO:0050852]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CD8B&keywords=CD8B	0.1645825802247191	633	NA	NA	0.11148195398894384	612	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
CD9	CD9 molecule			ENSG00000010278	P21926	Tetraspanin (TM4SF) family	2	adhesion, cell_surface_ligand	adhesion, cell_adhesion, cell_surface, cell_surface_ligand, extracellular, intracellular, plasma_membrane, secreted, transmembrane	O95832, P10721, P16671, P32004, Q14005, Q969P0, Q99965	ADAM2, CD36, CLDN1, IGSF8, IL16, KIT, L1CAM	IL16 [InnateDB:16144798], ADAM2 [Cellinker:10518536;HPRD:10518536], L1CAM [Baccin2019:8838570;connectomeDB2020:8838570], CD36 [Cellinker:11238109;HPRD:11238109], KIT [Cellinker:12036870;HPRD:12036870], CLDN1 [Cellinker:17644758], IGSF8 [BioGRID:11504738;HPRD:11504738]	clathrin-coated endocytic vesicle membrane [GO:0030669]; endocytic vesicle membrane [GO:0030666]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; extracellular vesicle [GO:1903561]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]; platelet alpha granule membrane [GO:0031092]; protein-containing complex [GO:0032991]	integrin binding [GO:0005178]	cell adhesion [GO:0007155]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; fusion of sperm to egg plasma membrane involved in single fertilization [GO:0007342]; glial cell migration [GO:0008347]; myoblast fusion involved in skeletal muscle regeneration [GO:0014905]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cellular component movement [GO:0051271]; negative regulation of platelet aggregation [GO:0090331]; paranodal junction assembly [GO:0030913]; platelet activation [GO:0030168]; receptor internalization [GO:0031623]; regulation of macrophage migration [GO:1905521]; sperm-egg recognition [GO:0035036]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CD9&keywords=CD9	172.04897890843995	37	3591.06	103	1.43043087313316	210	0.8740157480314954	2.132235528942114	5.210176991150436	1.2693045563549152	1.212121212121218	0.9187817258883256	0.330009066183136	0.12234910277324648	1.0684424713281524	0.37785418613969995	0.04346146416843696	21	56	158	1.2326138230073798	0.8678822425442693	0.3121276932209023	0.043023394057414614	199	372	512
CD99	CD99 molecule (Xg blood group)			ENSG00000002586	P14209	CD99 family	3	adhesion, cell_surface_ligand, ligand, receptor	adhesion, cell_adhesion, cell_surface, cell_surface_ligand, extracellular, intracellular, ligand, plasma_membrane, plasma_membrane_transmembrane, receptor, secreted, transmembrane	P60033, Q8TCZ2, Q9UKJ0, Q9UKJ1	CD81, CD99L2, PILRA, PILRB	PILRA [CellChatDB:18234675;CellTalkDB:18234675;Cellinker:18234675;LRdb:18234675;connectomeDB2020:18234675], CD81 [CellTalkDB:21838920], CD99L2 [NA], PILRB [Cellinker:18234675;connectomeDB2020:18234675]	cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	NA	homotypic cell-cell adhesion [GO:0034109]; positive regulation of neutrophil extravasation [GO:2000391]; T cell extravasation [GO:0072683]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CD99&keywords=CD99	733.0375147909721	19	31904	29	5.276062491645476	73	0.787401574803149	0.7170658682634716	1.3230088495575265	1.2287769784172509	1.1700336700336738	4.9881556683587265	6.728014505893053	5.722675367047303	3.70921198668147	4.606990252371588	6.616998261543407	12	10	7	3.418030271179147	1.0849414073003985	1.3468347380676635	1.9331796213292785	116	70	20
CDNF	cerebral dopamine neurotrophic factor	Yes		ENSG00000185267	Q49AH0	ARMET family	2	ligand	extracellular, intracellular, ligand, secreted	NA	NA	NA	endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]	growth factor activity [GO:0008083]	dopaminergic neuron differentiation [GO:0071542]; neuron projection development [GO:0031175]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CDNF&keywords=CDNF	2.79792930241573	349	NA	NA	0.9968567593575925	267	0	0	0.0011061946902654867	0.0016786570743405273	0.0101010101010101	0.011844331641285955	0.008159564823209429	0.009787928221859707	0.006659267480577139	0.00934704232874881	0.008924087309252447	280	246	252	0.0061461894245954185	1.031777036828278	1.1982420012537165	1.1720466551956508	124	94	66
CEACAM1	CEA cell adhesion molecule 1	No		ENSG00000079385	P13688	Immunoglobulin superfamily, CEA family	4	adhesion, cell_surface_ligand, receptor	adhesion, cell_adhesion, cell_surface, cell_surface_ligand, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, secreted, transmembrane	P00533, P06731, P16581, Q8TDQ0, Q9NNX6	CD209, CEACAM5, EGFR, HAVCR2, SELE	HAVCR2 [ICELLNET:25363763;ICELLNET:27192565;InnateDB:25363763;connectomeDB2020:26982724], EGFR [CellTalkDB:15467833;HPRD:15467833], SELE [CellTalkDB:1378450;connectomeDB2020:1378450], CD209 [CellTalkDB:16282604;Cellinker:16282604;HPRD:16246332;LRdb:16282604;connectomeDB2020:16246332;connectomeDB2020:16282604], CEACAM5 [CellChatDB:11590190;Cellinker:11590190;Lit-BM-17:21982860]	adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; cell-cell junction [GO:0005911]; cell junction [GO:0030054]; cell surface [GO:0009986]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; microvillus membrane [GO:0031528]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tertiary granule membrane [GO:0070821]; transport vesicle membrane [GO:0030658]	actin binding [GO:0003779]; bile acid transmembrane transporter activity [GO:0015125]; calmodulin binding [GO:0005516]; filamin binding [GO:0031005]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; protein dimerization activity [GO:0046983]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; protein tyrosine kinase binding [GO:1990782]	angiogenesis [GO:0001525]; bile acid and bile salt transport [GO:0015721]; blood vessel development [GO:0001568]; cell adhesion [GO:0007155]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; cell migration [GO:0016477]; cellular response to insulin stimulus [GO:0032869]; common myeloid progenitor cell proliferation [GO:0035726]; granulocyte colony-stimulating factor signaling pathway [GO:0038158]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; insulin catabolic process [GO:1901143]; insulin receptor internalization [GO:0038016]; integrin-mediated signaling pathway [GO:0007229]; negative regulation of cytotoxic T cell degranulation [GO:0043318]; negative regulation of fatty acid biosynthetic process [GO:0045717]; negative regulation of granulocyte differentiation [GO:0030853]; negative regulation of hepatocyte proliferation [GO:2000346]; negative regulation of interleukin-1 production [GO:0032692]; negative regulation of lipid biosynthetic process [GO:0051055]; negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target [GO:0002859]; negative regulation of platelet aggregation [GO:0090331]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of T cell mediated cytotoxicity [GO:0001915]; negative regulation of T cell receptor signaling pathway [GO:0050860]; negative regulation of vascular permeability [GO:0043116]; positive regulation of vasculogenesis [GO:2001214]; regulation of blood vessel remodeling [GO:0060312]; regulation of cell growth [GO:0001558]; regulation of cell migration [GO:0030334]; regulation of endothelial cell differentiation [GO:0045601]; regulation of endothelial cell migration [GO:0010594]; regulation of epidermal growth factor receptor signaling pathway [GO:0042058]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of homophilic cell adhesion [GO:1903385]; regulation of phosphatidylinositol 3-kinase signaling [GO:0014066]; regulation of sprouting angiogenesis [GO:1903670]; wound healing, spreading of cells [GO:0044319]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CEACAM1&keywords=CEACAM1	12.162916316317496	219	1935.88	133	1.3523588081942173	216	0	0.04640718562874247	0.025442477876106206	0.0079136690647482	0.02188552188552188	0.07783417935702201	0.053490480507706176	0.09135399673735738	0.08546059933407302	0.02617171852049666	0.06606142553602284	139	181	136	0.04563829585889062	1.715735499451302	0.6501226890959253	1.367069648015985	45	271	43
CEACAM16	CEA cell adhesion molecule 16, tectorial membrane component	No		ENSG00000213892	Q2WEN9	Immunoglobulin superfamily, CEA family	1	ligand	ligand, secreted	O75443, Q96PL2	TECTA, TECTB	TECTB [CellTalkDB:25080593], TECTA [CellTalkDB:25080593]	extracellular space [GO:0005615]; stereocilium tip [GO:0032426]	identical protein binding [GO:0042802]	sensory perception of sound [GO:0007605]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CEACAM16&keywords=CEACAM16	0.007759093258426966	839	NA	NA	0.28878811837937823	473	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
CER1	cerberus 1, DAN family BMP antagonist	Yes	similar to things were including	ENSG00000147869	O95813	DAN family	4	ligand	extracellular, ligand, ligand_regulator, secreted	Q9UBG0	MRC2	MRC2 [CellTalkDB:32103204]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	BMP binding [GO:0036122]; cytokine activity [GO:0005125]; morphogen activity [GO:0016015]; protein homodimerization activity [GO:0042803]	anterior/posterior axis specification [GO:0009948]; anterior/posterior pattern specification [GO:0009952]; bone mineralization [GO:0030282]; cell migration involved in gastrulation [GO:0042074]; cellular response to BMP stimulus [GO:0071773]; cellular response to cadmium ion [GO:0071276]; determination of dorsal identity [GO:0048263]; determination of heart left/right asymmetry [GO:0061371]; gastrulation [GO:0007369]; growth plate cartilage chondrocyte proliferation [GO:0003419]; negative regulation of activin receptor signaling pathway [GO:0032926]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of mesoderm development [GO:2000381]; negative regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry [GO:1900176]; nervous system development [GO:0007399]; sequestering of BMP in extracellular matrix [GO:0035582]; signal transduction involved in regulation of gene expression [GO:0023019]; ureteric bud development [GO:0001657]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CER1&keywords=CER1	0.06855407078651686	700	NA	NA	0.7790923652305918	306	0	0	0	2.3980815347721823e-4	0	0	0.0027198549410698096	0	0.00628930817610063	3.338229403124583e-4	0	282	398	401	8.711631100872833e-4	1.4983960787954589	0.950571970603934	0.9198647742412276	57	150	134
CFC1B	cripto, FRL-1, cryptic family 1B	TBD		ENSG00000152093	P0CG36	EGF-CFC (Cripto-1/FRL1/Cryptic) family	1	ligand, receptor	cell_surface, ligand, receptor, secreted	NA	NA	NA	cell surface [GO:0009986]; extracellular region [GO:0005576]	activin receptor binding [GO:0070697]; nodal binding [GO:0038100]; signaling receptor binding [GO:0005102]	anatomical structure development [GO:0048856]; anterior/posterior pattern specification [GO:0009952]; blood vessel development [GO:0001568]; determination of left/right symmetry [GO:0007368]; gastrulation [GO:0007369]; heart development [GO:0007507]; nodal signaling pathway [GO:0038092]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CFC1B&keywords=CFC1B	2.260290731984872	376	NA	NA	176.57405161527439	7	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
CFP	complement factor properdin	TBD		ENSG00000126759	P27918	NA	1	ligand	extracellular, intracellular, ligand, secreted	O76036	NCR1	NCR1 [connectomeDB2020:28480349]	endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724]	NA	complement activation, alternative pathway [GO:0006957]; defense response to bacterium [GO:0042742]; immune response [GO:0006955]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CFP&keywords=CFP	0.20307328679651568	612	NA	NA	0.023051602918768937	791	0.1732283464566929	0	0	4.7961630695443646e-4	0	0.001692047377326565	0.003626473254759746	0	0	0.0015689678194685526	0.0015452965037666612	303	357	343	0.016558249792633532	0.3765308361085489	0.435607312597739	0.4347160145684368	383	336	346
CGA	glycoprotein hormones, alpha polypeptide	Yes		ENSG00000135346	P01215	Glycoprotein hormones subunit alpha family	14	ligand	extracellular, intracellular, ligand, secreted	O60895, O60896, P07550, P13945, P16473, P22888, P23945, P32241, P41586, P78324, Q03431, Q99678, Q9NQS5	ADCYAP1R1, ADRB2, ADRB3, FSHR, GPR20, GPR84, LHCGR, PTH1R, RAMP2, RAMP3, SIRPA, TSHR, VIPR1	FSHR [CellTalkDB:30910395;HPMR:2126341;NetPath:12374801;NetPath:15662415], LHCGR [Baccin2019:10342833;Baccin2019:12727981;Baccin2019:1922095;CellTalkDB:1922095;Cellinker:10342833;Cellinker:12727981;Cellinker:1922095;Guide2Pharma:12727981;Guide2Pharma:1922095;HPRD:10342833;LRdb:10342833;LRdb:12727981;LRdb:1922095;connectomeDB2020:10342833;connectomeDB2020:12727981;connectomeDB2020:1922095;scConnect:12727981;scConnect:1922095], TSHR [HPMR:15571461;NetPath:20181794;SIGNOR:12045258], ADCYAP1R1 [CellTalkDB:32196115], RAMP3 [CellTalkDB:32196115], RAMP2 [CellTalkDB:32196115], ADRB2 [CellTalkDB:32196115], PTH1R [CellTalkDB:32196115], VIPR1 [CellTalkDB:32196115], ADRB3 [CellTalkDB:32196115], GPR20 [CellTalkDB:32196115], GPR84 [CellTalkDB:32196115], SIRPA [NA]	extracellular region [GO:0005576]; extracellular space [GO:0005615]; follicle-stimulating hormone complex [GO:0016914]; Golgi lumen [GO:0005796]; pituitary gonadotropin complex [GO:0061696]	follicle-stimulating hormone activity [GO:0016913]; hormone activity [GO:0005179]	cellular response to hormone stimulus [GO:0032870]; developmental growth [GO:0048589]; follicle-stimulating hormone secretion [GO:0046884]; gonad development [GO:0008406]; G protein-coupled receptor signaling pathway [GO:0007186]; luteinizing hormone secretion [GO:0032275]; negative regulation of organ growth [GO:0046621]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of steroid biosynthetic process [GO:0010893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of signaling receptor activity [GO:0010469]; thyroid gland development [GO:0030878]; thyroid hormone generation [GO:0006590]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CGA&keywords=CGA	0.4964379124791264	523	NA	NA	0.007846694066139592	849	0	0.003992015968063872	0	0.006714628297362109	0.0016835016835016834	0.018612521150592216	0.001813236627379873	0.0016313213703099511	0.004069552349241583	9.680865269061294e-4	0.010971605176743282	291	373	246	0.004586951740918246	0.9645299853686845	0.7519107982059925	1.4376962061179155	147	241	37
CGB1	chorionic gonadotropin subunit beta 1	Yes	manually added ensembl_gene_ID, hgnc_symbol, and description by searching the uniprot ID on genenames.org	ENSG00000267631	A6NKQ9	Glycoprotein hormones subunit beta family	2	ligand	extracellular, intracellular, ligand, secreted	NA	NA	NA	cytoplasm [GO:0005737]; extracellular space [GO:0005615]	hormone activity [GO:0005179]	G protein-coupled receptor signaling pathway [GO:0007186]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CGB1&keywords=CGB1	0.004921801123595505	856	NA	NA	1.005671584513066	265	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
CGB2	chorionic gonadotropin subunit beta 2			ENSG00000104818	Q6NT52	Glycoprotein hormones subunit beta family	2	ligand	extracellular, intracellular, ligand, secreted	NA	NA	NA	cytoplasm [GO:0005737]; extracellular space [GO:0005615]	hormone activity [GO:0005179]	G protein-coupled receptor signaling pathway [GO:0007186]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CGB2&keywords=CGB2	0.005906521348314607	848	NA	NA	0.5357959066586477	371	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
CGB3	chorionic gonadotropin subunit beta 3	Yes		ENSG00000104827	P0DN86	Glycoprotein hormones subunit beta family	8	ligand	extracellular, intracellular, ligand, secreted	P22888, P78324	LHCGR, SIRPA	LHCGR [CellTalkDB:24554412;CellTalkDB:26441830;Guide2Pharma:12727981;Guide2Pharma:1922095;HPRD:2254302;SIGNOR:10446903;connectomeDB2020:10446903;connectomeDB2020:12727981;connectomeDB2020:1922095;connectomeDB2020:2254302], SIRPA [NA]	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; pituitary gonadotropin complex [GO:0061696]	hormone activity [GO:0005179]	apoptotic process [GO:0006915]; cell-cell signaling [GO:0007267]; female gamete generation [GO:0007292]; G protein-coupled receptor signaling pathway [GO:0007186]; signal transduction [GO:0007165]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CGB3&keywords=CGB3	0.005688677528089887	850	NA	NA	0.37829876615286673	430	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
CGB5	chorionic gonadotropin subunit beta 5	Yes		ENSG00000189052	P0DN86	Glycoprotein hormones subunit beta family	8	ligand	extracellular, intracellular, ligand, secreted	P22888, P78324	LHCGR, SIRPA	LHCGR [CellTalkDB:24554412;CellTalkDB:26441830;Guide2Pharma:12727981;Guide2Pharma:1922095;HPRD:2254302;SIGNOR:10446903;connectomeDB2020:10446903;connectomeDB2020:12727981;connectomeDB2020:1922095;connectomeDB2020:2254302], SIRPA [NA]	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; pituitary gonadotropin complex [GO:0061696]	hormone activity [GO:0005179]	apoptotic process [GO:0006915]; cell-cell signaling [GO:0007267]; female gamete generation [GO:0007292]; G protein-coupled receptor signaling pathway [GO:0007186]; signal transduction [GO:0007165]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CGB5&keywords=CGB5	0.02777591797752809	777	NA	NA	2.0618833712912243	147	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
CGB7	chorionic gonadotropin subunit beta 7	Yes		ENSG00000196337	P0DN87	Glycoprotein hormones subunit beta family	2	ligand	extracellular, intracellular, ligand, secreted	P22888	LHCGR	LHCGR [SIGNOR:10446903]	cytoplasm [GO:0005737]; extracellular space [GO:0005615]	hormone activity [GO:0005179]	apoptotic process [GO:0006915]; cell-cell signaling [GO:0007267]; female gamete generation [GO:0007292]; G protein-coupled receptor signaling pathway [GO:0007186]; signal transduction [GO:0007165]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CGB7&keywords=CGB7	0.01655523370786517	805	NA	NA	0.06503949515535697	686	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
CGB8	chorionic gonadotropin subunit beta 8	Yes		ENSG00000213030	P0DN86	Glycoprotein hormones subunit beta family	8	ligand	extracellular, intracellular, ligand, secreted	P22888, P78324	LHCGR, SIRPA	LHCGR [CellTalkDB:24554412;CellTalkDB:26441830;Guide2Pharma:12727981;Guide2Pharma:1922095;HPRD:2254302;SIGNOR:10446903;connectomeDB2020:10446903;connectomeDB2020:12727981;connectomeDB2020:1922095;connectomeDB2020:2254302], SIRPA [NA]	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; pituitary gonadotropin complex [GO:0061696]	hormone activity [GO:0005179]	apoptotic process [GO:0006915]; cell-cell signaling [GO:0007267]; female gamete generation [GO:0007292]; G protein-coupled receptor signaling pathway [GO:0007186]; signal transduction [GO:0007165]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CGB8&keywords=CGB8	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
CGN	cingulin		manually added ensembl_gene_ID, hgnc_symbol, and description by searching the uniprot ID on genenames.org	ENSG00000143375	Q9P2M7	Cingulin family	7	cell_surface_ligand, ligand, receptor	cell_surface, cell_surface_ligand, intracellular, ligand, receptor, secreted, tight_junction	P36897, P37173, Q16625, Q92974, Q9Y624	ARHGEF2, F11R, OCLN, TGFBR1, TGFBR2	F11R [Baccin2019:10877843;CellTalkDB:10877843;HPRD:10877843;LRdb:10877843;connectomeDB2020:10877843], TGFBR2 [CellTalkDB:32196115], OCLN [CellTalkDB:32196115], TGFBR1 [CellTalkDB:32196115], ARHGEF2 [HPRD:15866167]	bicellular tight junction [GO:0005923]; cell junction [GO:0030054]; myosin complex [GO:0016459]; plasma membrane [GO:0005886]	actin binding [GO:0003779]; cadherin binding [GO:0045296]	NA	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CGN&keywords=CGN	23.175175822001123	162	10859.9	67	2.0591423103011244	148	0	0.24600798403193813	0	0.0014388489208633092	0.14814814814814825	0.08460236886632824	0.037171350861287394	0.017944535073409464	0.050314465408805055	0.012685271731873383	0.013791771296117333	168	230	234	0.05564588584897914	0.9187851550599955	0.34557034974075473	0.3624259310149491	172	363	368
CHAD	chondroadherin	No		ENSG00000136457	O15335	Small leucine-rich proteoglycan (SLRP) family, SLRP class IV subfamily	7	adhesion, ecm, ligand	adhesion, cell_adhesion, ecm, extracellular, intracellular, ligand, plasma_membrane, secreted	P05556, P17301	ITGA2, ITGA2_ITGB1, ITGB1	ITGA2 [CellTalkDB:9281592;LRdb:9281592;connectomeDB2020:9281592], ITGB1 [CellTalkDB:9281592;LRdb:9281592;connectomeDB2020:9281592]	extracellular matrix [GO:0031012]; extracellular space [GO:0005615]	NA	bone development [GO:0060348]; negative regulation of bone trabecula formation [GO:1900155]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CHAD&keywords=CHAD	0.1625703797752809	638	NA	NA	0.027958615790048852	775	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
CHGB	chromogranin B	TBD		ENSG00000089199	P05060	Chromogranin/secretogranin protein family	3	ligand	intracellular, ligand, secreted	NA	NA	NA	endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; secretory granule [GO:0030141]	hormone activity [GO:0005179]	NA	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CHGB&keywords=CHGB	2344.1112202078652	11	33608	28	36.71996135498904	20	0.18110236220472442	0.6851297405189618	0.11504424778761067	0.2942446043165478	0.7474747474747476	12.91878172588834	9.317316409791506	20.143556280587287	10.88161302256752	6.0623247429583245	7.444156847596988	6	6	6	6.253704066517505	1.738845403119921	0.969446301816493	1.1900557191778938	42	141	65
CHRD	chordin	TBD		ENSG00000090539	Q9H2X0	Chordin family	2	ligand	ligand, ligand_regulator, secreted	P12643	BMP2	BMP2 [HPRD:15064755]	extracellular space [GO:0005615]	cytokine binding [GO:0019955]	BMP signaling pathway involved in spinal cord dorsal/ventral patterning [GO:0021919]; floor plate development [GO:0033504]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of cell migration [GO:0030336]; negative regulation of osteoblast differentiation [GO:0045668]; positive regulation of cell adhesion [GO:0045785]; positive regulation of mesenchymal cell proliferation [GO:0002053]; skeletal system development [GO:0001501]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CHRD&keywords=CHRD	0.3286536646476382	568	NA	NA	0.01018073675208103	831	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
CHRDL1	chordin like 1	TBD		ENSG00000101938	Q9BU40	NA	2	ligand	intracellular, ligand, secreted	NA	NA	NA	endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]	NA	cell differentiation [GO:0030154]; eye development [GO:0001654]; negative regulation of BMP signaling pathway [GO:0030514]; nervous system development [GO:0007399]; ossification [GO:0001503]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CHRDL1&keywords=CHRDL1	1.2917122209386365	421	NA	NA	0.031255500963273314	764	0	0.001497005988023952	0	0.014388489208633089	0	0	0	0	3.699593044765076e-4	3.338229403124583e-5	0	302	408	401	0.0014808033450149814	0.9032433526508572	0.8739268492381056	0.8710191873761209	181	180	154
CHRDL2	chordin like 2	TBD		ENSG00000054938	Q6WN34	NA	2	ligand	extracellular, intracellular, ligand, secreted	NA	NA	NA	cytoplasm [GO:0005737]; extracellular space [GO:0005615]	NA	cartilage development [GO:0051216]; cell differentiation [GO:0030154]; ossification [GO:0001503]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CHRDL2&keywords=CHRDL2	4.031151081160747	313	NA	NA	0.6383614949344248	330	0	0.008982035928143712	0.00995575221238938	0.01294964028776978	0.040404040404040394	0	0	0	3.699593044765076e-4	1.0014688209373749e-4	0	302	406	401	0.006614688638083046	0.6241440649514912	0.6079046741172672	0.6018770629910384	295	286	285
CIRBP	cold inducible RNA binding protein			ENSG00000099622	Q14011	NA	1	ligand	extracellular, intracellular, ligand, secreted	Q9NP99	TREM1	TREM1 [connectomeDB2020:32027618;connectomeDB2020:32506691]	cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]	mRNA 3'-UTR binding [GO:0003730]; RNA binding [GO:0003723]; small ribosomal subunit rRNA binding [GO:0070181]; translation repressor activity [GO:0030371]	mRNA stabilization [GO:0048255]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; positive regulation of translation [GO:0045727]; response to cold [GO:0009409]; response to UV [GO:0009411]; stress granule assembly [GO:0034063]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CIRBP&keywords=CIRBP	402.78230889967887	25	65326.3	17	2.2721718475259776	139	1.2992125984251954	2.0948103792415176	1.1017699115044257	2.023501199040722	3.749158249158268	6.003384094754656	6.131459655485071	4.508972267536698	4.159082500924924	5.921384697558338	4.046938381303196	10	7	11	3.7308794486302737	1.1144658784584565	1.5855588983842075	1.0844878689658517	108	43	82
CKLF	chemokine like factor	Yes		ENSG00000217555	Q9UBR5	Chemokine-like factor family	4	cell_surface_ligand, ligand	cell_surface_ligand, intracellular, ligand, secreted, transmembrane	O75581, P51679	CCR4, LRP6	CCR4 [CellTalkDB:10699158;LRdb:10699158], LRP6 [CellTalkDB:32103204]	extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; membrane [GO:0016020]	chemokine activity [GO:0008009]	lymphocyte chemotaxis [GO:0048247]; macrophage chemotaxis [GO:0048246]; neutrophil chemotaxis [GO:0030593]; secretion by cell [GO:0032940]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CKLF&keywords=CKLF	56.90311474769663	74	NA	NA	3.605069756882216	99	0.30708661417322813	0.3787425149700647	0.13274336283185856	0.1697841726618709	0.3973063973063968	0.3316412859560072	0.37715321849501254	0.33442088091354005	0.37402885682575243	0.21401388703430616	0.4640911724936971	53	72	38	0.31645566942379405	1.176358362847786	0.6862000204490205	1.452237522265994	91	260	35
CLCF1	cardiotrophin like cytokine factor 1	Yes		ENSG00000175505	Q9UBD9	IL-6 superfamily	17	ligand	extracellular, intracellular, ligand, secreted	O75462, P26992, P40189, P42702, Q92673	CNTFR, CNTFR_IL6ST_LIFR, CRLF1, IL6ST, LIFR, SORL1	IL6ST [Baccin2019:10966616;CellTalkDB:10966616;HPMR:10966616;LRdb:10966616;SIGNOR:9143707;connectomeDB2020:10966616], CNTFR [CellTalkDB:10966616;HPMR:10966616;HPRD:10966616;HPRD:11285233;HPRD:11294841;LRdb:10966616;LRdb:11285233;LRdb:11294841;SIGNOR:10966616;connectomeDB2020:10966616;connectomeDB2020:11285233;connectomeDB2020:11294841], LIFR [Baccin2019:10966616;CellTalkDB:10966616;HPMR:10966616;LRdb:10966616;connectomeDB2020:10966616], CRLF1 [CellTalkDB:10966616;HPMR:10966616;HPRD:10966616;LRdb:10966616;connectomeDB2020:10966616], SORL1 [Cellinker:26858303]	CNTFR-CLCF1 complex [GO:0097059]; CRLF-CLCF1 complex [GO:0097058]; extracellular region [GO:0005576]	ciliary neurotrophic factor receptor binding [GO:0005127]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; signaling receptor binding [GO:0005102]	B cell differentiation [GO:0030183]; cell surface receptor signaling pathway [GO:0007166]; cytokine-mediated signaling pathway [GO:0019221]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of immunoglobulin production [GO:0002639]; positive regulation of isotype switching to IgE isotypes [GO:0048295]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; receptor signaling pathway via JAK-STAT [GO:0007259]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CLCF1&keywords=CLCF1	4.618791528089887	297	NA	NA	0.4934304842183472	384	0.015748031496062992	0.22155688622754663	0.008849557522123894	0.17290167865707462	0.12121212121212137	0.00338409475465313	0	0	7.399186089530152e-4	8.679396448123918e-4	8.885454896658299e-4	301	376	371	0.049649888510273986	0.18004926542491678	0.18219547288743915	0.18254091938144038	446	423	430
CLEC11A	C-type lectin domain containing 11A	No		ENSG00000105472	Q9Y240	NA	5	ligand	extracellular, intracellular, ligand, secreted	O75578, P05556, P10721, Q9UKX5	ITGA10, ITGA11, ITGB1, KIT	ITGA10 [connectomeDB2020:30632962], ITGA11 [connectomeDB2020:30632962], ITGB1 [connectomeDB2020:30632962], KIT [NA]	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	carbohydrate binding [GO:0030246]; growth factor activity [GO:0008083]	ossification [GO:0001503]; positive regulation of cell population proliferation [GO:0008284]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CLEC11A&keywords=CLEC11A	1.100096097752809	440	NA	NA	0.045624938961682474	718	0.023622047244094488	0.03792415169660675	0.011061946902654867	0.15419664268585204	0.02861952861952861	0.10659898477157354	0.12148685403445122	0.2381729200652525	0.13984461709211918	0.052276672452932646	0.20343828472087092	94	143	69	0.10156751366235789	1.3430846684062632	0.5581971884880712	1.913086325171765	70	300	22
CLEC4M	C-type lectin domain family 4 member M	No		ENSG00000104938	Q9H2X3	NA	1	ligand, receptor	cell_surface, extracellular, intracellular, ligand, plasma_membrane, plasma_membrane_transmembrane, receptor, secreted, transmembrane, transmembrane_predicted	NA	NA	NA	cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; host cell [GO:0043657]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]	calcium-dependent protein binding [GO:0048306]; carbohydrate binding [GO:0030246]; ICAM-3 receptor activity [GO:0030369]; mannose binding [GO:0005537]; metal ion binding [GO:0046872]; peptide antigen binding [GO:0042605]; signaling receptor activity [GO:0038023]; virion binding [GO:0046790]; virus receptor activity [GO:0001618]	adaptive immune response [GO:0002250]; antigen processing and presentation [GO:0019882]; cell-cell recognition [GO:0009988]; endocytosis [GO:0006897]; immune response [GO:0006955]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; intracellular transport of virus [GO:0075733]; leukocyte cell-cell adhesion [GO:0007159]; peptide antigen transport [GO:0046968]; receptor-mediated virion attachment to host cell [GO:0046813]; viral entry into host cell [GO:0046718]; viral genome replication [GO:0019079]; virion attachment to host cell [GO:0019062]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CLEC4M&keywords=CLEC4M	0.12147907831460673	658	NA	NA	0.17701584805228493	551	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
CLUL1	clusterin like 1	No		ENSG00000079101	Q15846	Clusterin family	1	ligand	extracellular, intracellular, ligand, secreted	Q9Y2T6	GPR55	GPR55 [scConnect:31675498]	extracellular space [GO:0005615]; nucleus [GO:0005634]	misfolded protein binding [GO:0051787]	NA	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CLUL1&keywords=CLUL1	3.4474669747401356	324	NA	NA	5.6573448825246615	69	0.007874015748031496	0.003992015968063873	0	0	0.003367003367003367	0.01015228426395939	0.015412511332728921	0.026101141924959218	0.011098779134295233	0.01639070636934166	0.003747344021634154	261	214	303	0.008921436557274301	1.115072794310845	1.3947517298413483	0.7265486412736997	107	64	224
CNMD	chondromodulin	No		ENSG00000136110	O75829	Chondromodulin-1 family	1	ecm, ligand	ecm, extracellular, intracellular, ligand, secreted, transmembrane	P23468	PTPRD	PTPRD [Cellinker:32589946]	endomembrane system [GO:0012505]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]	NA	cartilage development [GO:0051216]; endothelial cell morphogenesis [GO:0001886]; negative regulation of angiogenesis [GO:0016525]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030948]; proteoglycan metabolic process [GO:0006029]; skeletal system development [GO:0001501]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CNMD&keywords=CNMD	1.1246385481309775	439	NA	NA	1.5468341951530309	200	0	0	0	7.194244604316547e-4	0.00505050505050505	0.018612521150592212	0.02357207615593835	0.02773246329526917	0.002589715131335553	0.016490853251435397	0.0033996523082866553	296	213	310	0.008924291891254004	0.6652674352985424	1.3998332621194842	0.7080662455053021	272	62	234
CNTN2	contactin 2	No		ENSG00000184144	Q02246	Immunoglobulin superfamily, Contactin family	7	adhesion, cell_surface_ligand, ligand	adhesion, cell_adhesion, cell_surface, cell_surface_ligand, extracellular, intracellular, ligand, plasma_membrane, secreted	O14786, P32004, Q12860, Q92823, Q96MU8, Q9UHC6	CNTN1, CNTN2_CNTNAP2, CNTNAP2, KREMEN1, L1CAM, NRCAM, NRP1	CNTNAP2 [Baccin2019:12975355;BioGRID:28533267;CellTalkDB:12975355;HPRD:12975355;LRdb:12975355;connectomeDB2020:12975355], CNTN1 [Baccin2019:12139915;CellTalkDB:12139915;HPRD:12139915;LRdb:12139915;connectomeDB2020:12139915], NRCAM [CellTalkDB:12139915;Cellinker:12139915;HPRD:12139915;LRdb:12139915;connectomeDB2020:12139915], NRP1 [CellTalkDB:22836270], L1CAM [HPRD:12139915], KREMEN1 [Cellinker:32589946]	anchored component of postsynaptic membrane [GO:0099025]; axon [GO:0030424]; axon initial segment [GO:0043194]; cell surface [GO:0009986]; juxtaparanode region of axon [GO:0044224]; myelin sheath [GO:0043209]; neuronal cell body [GO:0043025]; node of Ranvier [GO:0033268]; plasma membrane [GO:0005886]; synapse [GO:0045202]	carbohydrate binding [GO:0030246]; cell-cell adhesion mediator activity [GO:0098632]; identical protein binding [GO:0042802]; protein self-association [GO:0043621]	adult walking behavior [GO:0007628]; axonal fasciculation [GO:0007413]; axon guidance [GO:0007411]; cell adhesion [GO:0007155]; central nervous system myelination [GO:0022010]; cerebral cortex GABAergic interneuron migration [GO:0021853]; clustering of voltage-gated potassium channels [GO:0045163]; dendrite self-avoidance [GO:0070593]; establishment of protein localization to juxtaparanode region of axon [GO:0071206]; fat cell differentiation [GO:0045444]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; learning [GO:0007612]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of neuron differentiation [GO:0045665]; positive regulation of adenosine receptor signaling pathway [GO:0060168]; positive regulation of protein processing [GO:0010954]; presynaptic membrane organization [GO:0097090]; protein localization to juxtaparanode region of axon [GO:0071205]; receptor internalization [GO:0031623]; reduction of food intake in response to dietary excess [GO:0002023]; regulation of astrocyte differentiation [GO:0048710]; regulation of axon diameter [GO:0031133]; regulation of cell morphogenesis involved in differentiation [GO:0010769]; regulation of neuronal synaptic plasticity [GO:0048168]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CNTN2&keywords=CNTN2	0.10492133325843034	672	NA	NA	0.009415446336186807	838	0	4.99001996007984e-4	0	0.0016786570743405275	0.0016835016835016834	0.001692047377326565	0.0027198549410698096	0	7.399186089530152e-4	0.0023367605821872045	0.002665636468997491	301	338	322	0.001274125339307662	0.9526165698644388	1.0942543399951947	1.123425195996205	154	113	73
CNTN4	contactin 4	No		ENSG00000144619	Q8IWV2	Immunoglobulin superfamily, Contactin family	8	adhesion, cell_surface_ligand, ligand	adhesion, cell_adhesion, cell_surface, cell_surface_ligand, ligand, plasma_membrane, secreted	P05067, P23470, P51693, Q6Q4G3	APLP1, APP, LVRN, PTPRG	PTPRG [CellTalkDB:20133774;Cellinker:20133774;LRdb:20133774;Ramilowski2015:20133774;connectomeDB2020:20133774;talklr:20133774], APLP1 [Cellinker:32589946], APP [Cellinker:32589946], LVRN [Cellinker:32589946]	anchored component of membrane [GO:0031225]; axon [GO:0030424]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]	cell-cell adhesion mediator activity [GO:0098632]	axonal fasciculation [GO:0007413]; axon guidance [GO:0007411]; axonogenesis [GO:0007409]; brain development [GO:0007420]; dendrite self-avoidance [GO:0070593]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of neuron differentiation [GO:0045665]; nervous system development [GO:0007399]; neuron cell-cell adhesion [GO:0007158]; neuron projection development [GO:0031175]; regulation of synaptic plasticity [GO:0048167]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CNTN4&keywords=CNTN4	12.262524226270822	217	NA	NA	3.082263174574511	108	0	0.0334331337325349	0.0022123893805309734	0.015107913669064743	0.011784511784511783	0.16412859560067666	0.2284678150498634	0.1174551386623166	0.007029226785053647	0.2105087461610264	0.08248020088854253	279	73	124	0.07932797015582924	0.19063711797488303	2.4685296864616686	1.0352882834706123	444	13	89
CNTN6	contactin 6			ENSG00000134115	Q9UQ52	Immunoglobulin superfamily, Contactin family	2	adhesion, cell_surface_ligand, ligand	adhesion, cell_adhesion, cell_surface, cell_surface_ligand, ligand, plasma_membrane, secreted	P23470, P46531	NOTCH1, PTPRG	NOTCH1 [SIGNOR:15082708;connectomeDB2020:15082708], PTPRG [Cellinker:20133774]	anchored component of presynaptic membrane [GO:0099026]; axon [GO:0030424]; parallel fiber to Purkinje cell synapse [GO:0098688]; plasma membrane [GO:0005886]	cell-cell adhesion mediator activity [GO:0098632]	axon guidance [GO:0007411]; cell adhesion [GO:0007155]; central nervous system development [GO:0007417]; dendrite self-avoidance [GO:0070593]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; Notch signaling pathway [GO:0007219]; positive regulation of Notch signaling pathway [GO:0045747]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CNTN6&keywords=CNTN6	0.05626881752808989	727	NA	NA	0.06681175692361271	682	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
COL10A1	collagen type X alpha 1 chain	No		ENSG00000123500	Q03692	NA	2	ecm, ligand	ecm, extracellular, intracellular, ligand, secreted	Q6GTX8	ITGA1_ITGB1, ITGA10_ITGB1, ITGA11_ITGB1, ITGA2_ITGB1, LAIR1	LAIR1 [Cellinker:16754721]	collagen-containing extracellular matrix [GO:0062023]; collagen trimer [GO:0005581]; collagen type X trimer [GO:0005599]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; metal ion binding [GO:0046872]	extracellular matrix organization [GO:0030198]; skeletal system development [GO:0001501]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=COL10A1&keywords=COL10A1	1.516481671306983	411	NA	NA	5.865730287391578	65	0	0	0	0.008872901678657072	0	0.001692047377326565	9.066183136899365e-4	0	0	3.0044064628121254e-4	1.1589723778249952e-4	303	399	398	0.0010807186594306625	0.9024685408368458	0.9295823640025943	0.9129279019437051	183	156	138
COL11A2	collagen type XI alpha 2 chain	No		ENSG00000235708, ENSG00000232541, ENSG00000223699, ENSG00000206290, ENSG00000230930, ENSG00000227801, ENSG00000204248	P13942	Fibrillar collagen family	2	ecm, ligand	ecm, extracellular, intracellular, ligand, secreted	NA	ITGA1_ITGB1, ITGA10_ITGB1, ITGA11_ITGB1, ITGA2_ITGB1	NA	collagen-containing extracellular matrix [GO:0062023]; collagen trimer [GO:0005581]; collagen type XI trimer [GO:0005592]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; metal ion binding [GO:0046872]; protein-macromolecule adaptor activity [GO:0030674]	cartilage development [GO:0051216]; collagen fibril organization [GO:0030199]; extracellular matrix organization [GO:0030198]; roof of mouth development [GO:0060021]; sensory perception of sound [GO:0007605]; skeletal system development [GO:0001501]; soft palate development [GO:0060023]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=COL11A2&keywords=COL11A2	0.04015580739325843	752	NA	NA	0.010077523161279313	832	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
COL12A1	collagen type XII alpha 1 chain	No		ENSG00000111799	Q99715	Fibril-associated collagens with interrupted helices (FACIT) family	2	ecm, ligand	ecm, extracellular, intracellular, ligand, secreted	NA	ITGA1_ITGB1, ITGA10_ITGB1, ITGA11_ITGB1, ITGA2_ITGB1	NA	collagen-containing extracellular matrix [GO:0062023]; collagen type XII trimer [GO:0005595]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular vesicle [GO:1903561]	extracellular matrix structural constituent conferring tensile strength [GO:0030020]	cell adhesion [GO:0007155]; collagen fibril organization [GO:0030199]; endodermal cell differentiation [GO:0035987]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=COL12A1&keywords=COL12A1	6.552965128380092	272	NA	NA	0.19114288829806472	539	0	0.016966067864271447	0.004424778761061947	0.1398081534772194	0.0101010101010101	0	0	0	3.699593044765076e-4	4.6735211643744175e-4	5.022213637241645e-4	302	389	384	0.015694503908018274	0.40358667135972376	0.4073770855397205	0.40873415580702543	377	344	351
COL15A1	collagen type XV alpha 1 chain	No		ENSG00000204291	P39059	Multiplexin collagen family	2	ecm, ligand	ecm, extracellular, intracellular, ligand, secreted, transmembrane	NA	ITGA1_ITGB1, ITGA10_ITGB1, ITGA11_ITGB1, ITGA2_ITGB1	NA	collagen-containing extracellular matrix [GO:0062023]; collagen type XV trimer [GO:0005582]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]	extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]	angiogenesis [GO:0001525]; cell adhesion [GO:0007155]; endothelial cell morphogenesis [GO:0001886]; extracellular matrix organization [GO:0030198]; signal transduction [GO:0007165]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=COL15A1&keywords=COL15A1	50.39366254494382	85	NA	NA	1.6014645867645911	195	0	0.009980039920159679	0.37610619469026413	0.5249400479616395	0.00505050505050505	0.001692047377326565	0.001813236627379873	0.014681892332789562	3.699593044765076e-4	7.010281746561626e-4	0.0013135020282016617	302	383	352	0.08514985940612715	0.10898554521467571	0.1124649919763	0.11890193110966524	472	462	463
COL16A1	collagen type XVI alpha 1 chain	No		ENSG00000084636	Q07092	Fibril-associated collagens with interrupted helices (FACIT) family	3	ecm, ligand	ecm, extracellular, intracellular, ligand, secreted	P05556	ITGA1_ITGB1, ITGA10_ITGB1, ITGA11_ITGB1, ITGA2_ITGB1, ITGB1	ITGB1 [CellTalkDB:32196115]	collagen-containing extracellular matrix [GO:0062023]; collagen type V trimer [GO:0005588]; collagen type XVI trimer [GO:0005597]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; integrin binding [GO:0005178]	cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cellular response to amino acid stimulus [GO:0071230]; extracellular matrix organization [GO:0030198]; female pregnancy [GO:0007565]; integrin activation [GO:0033622]; integrin-mediated signaling pathway [GO:0007229]; positive regulation of focal adhesion assembly [GO:0051894]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=COL16A1&keywords=COL16A1	4.758965784924528	295	NA	NA	0.07489690505923656	667	0	0.022954091816367247	0.0022123893805309734	0.07002398081534787	0.006734006734006734	0.001692047377326565	0.003626473254759746	0.0032626427406199023	0.0029596744358120607	0.007210575510749082	0.0012748696156074954	295	259	353	0.011086431971011607	0.6145977875075433	0.8161919254243284	0.53469783940249	297	205	310
COL17A1	collagen type XVII alpha 1 chain	No		ENSG00000065618	Q9UMD9	NA	2	ecm, ligand	ecm, extracellular, intracellular, ligand, secreted, transmembrane, transmembrane_predicted	NA	ITGA1_ITGB1, ITGA10_ITGB1, ITGA11_ITGB1, ITGA2_ITGB1	NA	basement membrane [GO:0005604]; cell-cell junction [GO:0005911]; collagen-containing extracellular matrix [GO:0062023]; collagen trimer [GO:0005581]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; hemidesmosome [GO:0030056]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]	cell-matrix adhesion [GO:0007160]; epidermis development [GO:0008544]; extracellular matrix organization [GO:0030198]; hemidesmosome assembly [GO:0031581]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=COL17A1&keywords=COL17A1	0.5181527503034641	519	NA	NA	0.022237423757201544	792	0	0.02195608782435128	0.0011061946902654867	9.592326139088729e-4	0.003367003367003367	0.00338409475465313	0.001813236627379873	0	7.399186089530152e-4	8.679396448123918e-4	2.704268881591655e-4	301	376	394	0.0031331031835896894	0.8177746309320826	0.8275225963649091	0.7820259039000359	214	199	198
COL19A1	collagen type XIX alpha 1 chain	No		ENSG00000082293	Q14993	Fibril-associated collagens with interrupted helices (FACIT) family	2	ecm, ligand	ecm, extracellular, intracellular, ligand, secreted	NA	ITGA1_ITGB1, ITGA10_ITGB1, ITGA11_ITGB1, ITGA2_ITGB1	NA	collagen-containing extracellular matrix [GO:0062023]; collagen trimer [GO:0005581]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	extracellular matrix structural constituent [GO:0005201]; protein-macromolecule adaptor activity [GO:0030674]	cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; cell differentiation [GO:0030154]; extracellular matrix organization [GO:0030198]; skeletal muscle tissue development [GO:0007519]; skeletal system development [GO:0001501]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=COL19A1&keywords=COL19A1	0.15986652786516853	640	NA	NA	0.3912269446125699	422	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
COL20A1	collagen type XX alpha 1 chain	No		ENSG00000101203	Q9P218	NA	2	ecm, ligand	ecm, extracellular, intracellular, ligand, secreted	NA	ITGA1_ITGB1, ITGA10_ITGB1, ITGA11_ITGB1, ITGA2_ITGB1	NA	collagen-containing extracellular matrix [GO:0062023]; collagen trimer [GO:0005581]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	NA	NA	https://www.genecards.org/cgi-bin/carddisp.pl?gene=COL20A1&keywords=COL20A1	0.013908650898876404	812	NA	NA	0.026386028347560087	782	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
COL21A1	collagen type XXI alpha 1 chain	No		ENSG00000124749	Q96P44	Fibril-associated collagens with interrupted helices (FACIT) family	2	ecm, ligand	ecm, extracellular, intracellular, ligand, secreted	NA	ITGA1_ITGB1, ITGA10_ITGB1, ITGA11_ITGB1, ITGA2_ITGB1	NA	collagen-containing extracellular matrix [GO:0062023]; collagen trimer [GO:0005581]; cytosol [GO:0005829]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	NA	NA	https://www.genecards.org/cgi-bin/carddisp.pl?gene=COL21A1&keywords=COL21A1	0.404022062339809	543	NA	NA	0.06307072404923153	690	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
COL22A1	collagen type XXII alpha 1 chain	No		ENSG00000169436	Q8NFW1	Fibril-associated collagens with interrupted helices (FACIT) family	2	ecm, ligand	ecm, extracellular, intracellular, ligand, secreted	NA	ITGA1_ITGB1, ITGA10_ITGB1, ITGA11_ITGB1, ITGA2_ITGB1	NA	collagen trimer [GO:0005581]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	extracellular matrix structural constituent [GO:0005201]	angiogenesis [GO:0001525]; endothelial cell morphogenesis [GO:0001886]; extracellular matrix organization [GO:0030198]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=COL22A1&keywords=COL22A1	1.021874754596232	449	NA	NA	0.33239620860871144	452	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
COL24A1	collagen type XXIV alpha 1 chain	No		ENSG00000171502	Q17RW2	Fibrillar collagen family	2	ecm, ligand	ecm, extracellular, intracellular, ligand, secreted	NA	ITGA1_ITGB1, ITGA10_ITGB1, ITGA11_ITGB1, ITGA2_ITGB1	NA	collagen-containing extracellular matrix [GO:0062023]; collagen trimer [GO:0005581]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	extracellular matrix structural constituent [GO:0005201]	extracellular matrix organization [GO:0030198]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=COL24A1&keywords=COL24A1	0.05103108224719101	737	NA	NA	0.03515106103146617	754	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
COL26A1	collagen type XXVI alpha 1 chain	No		ENSG00000160963	Q96A83	NA	2	ecm, ligand	ecm, extracellular, intracellular, ligand, secreted	NA	ITGA1_ITGB1, ITGA10_ITGB1, ITGA11_ITGB1, ITGA2_ITGB1	NA	collagen-containing extracellular matrix [GO:0062023]; collagen trimer [GO:0005581]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]	NA	positive regulation of cell-substrate adhesion [GO:0010811]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=COL26A1&keywords=COL26A1	0.18396173226966292	618	NA	NA	0.0691472320675436	676	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
COL27A1	collagen type XXVII alpha 1 chain	No		ENSG00000196739	Q8IZC6	Fibrillar collagen family	2	ecm, ligand	ecm, extracellular, intracellular, ligand, secreted	NA	ITGA1_ITGB1, ITGA10_ITGB1, ITGA11_ITGB1, ITGA2_ITGB1	NA	collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; fibrillar collagen trimer [GO:0005583]	extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring tensile strength [GO:0030020]; metal ion binding [GO:0046872]	extracellular matrix organization [GO:0030198]; growth plate cartilage chondrocyte development [GO:0003431]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=COL27A1&keywords=COL27A1	5.868127191011236	280	NA	NA	0.298742351864984	467	0	0.11077844311377232	0.04535398230088499	0.22709832134292587	0.035353535353535345	0.07614213197969544	0.13871260199456	0.05872756933115829	0.012208657047724756	0.059353718787557574	0.09712188526173095	255	133	113	0.07825916786486778	0.2516300298879781	0.7857962007272034	1.2137196378935227	417	217	60
COL28A1	collagen type XXVIII alpha 1 chain	No		ENSG00000215018	Q2UY09	VWA-containing collagen family	2	ecm, ligand	ecm, extracellular, intracellular, ligand, secreted	NA	ITGA1_ITGB1, ITGA10_ITGB1, ITGA11_ITGB1, ITGA2_ITGB1	NA	basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; collagen trimer [GO:0005581]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	extracellular matrix structural constituent [GO:0005201]; serine-type endopeptidase inhibitor activity [GO:0004867]	cell adhesion [GO:0007155]; extracellular matrix organization [GO:0030198]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=COL28A1&keywords=COL28A1	0.37694657971101125	548	NA	NA	0.0892168572601042	646	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
COL6A3	collagen type VI alpha 3 chain	No		ENSG00000163359	P12111	Type VI collagen family	4	ecm, ligand	ecm, extracellular, intracellular, ligand, secreted	P05556, P16070, P17301, P18827, P31431, P56199, Q9HCN6	CD44, GP6, ITGA1, ITGA1_ITGB1, ITGA10_ITGB1, ITGA11_ITGB1, ITGA2, ITGA2_ITGB1, ITGA3_ITGB1, ITGA9_ITGB1, ITGAV_ITGB8, ITGB1, SDC1, SDC4	ITGB1 [CellTalkDB:32196115], ITGA2 [CellTalkDB:32196115], ITGA1 [CellTalkDB:32196115], CD44 [NA], SDC1 [NA], SDC4 [NA], GP6 [NA]	collagen-containing extracellular matrix [GO:0062023]; collagen type VI trimer [GO:0005589]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular vesicle [GO:1903561]; sarcolemma [GO:0042383]	extracellular matrix structural constituent conferring tensile strength [GO:0030020]; serine-type endopeptidase inhibitor activity [GO:0004867]	cell adhesion [GO:0007155]; muscle organ development [GO:0007517]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=COL6A3&keywords=COL6A3	45.876500570717376	95	115248	13	0.579952677526765	352	0	0.0034930139720558886	0.0011061946902654867	1.3937649880095877	0.00505050505050505	0.005076142131979695	0.006346328195829556	0.004893964110929854	0.002589715131335553	0.002403525170249696	0.0024724744060266577	296	336	325	0.12974516826079682	0.09009052182641643	0.08875816834755852	0.0892515609752613	480	474	480
COL6A5	collagen type VI alpha 5 chain			ENSG00000172752	A8TX70	Type VI collagen family	2	ecm, ligand	ecm, intracellular, ligand, secreted	P16070, P18827, P31431, Q9HCN6	CD44, GP6, ITGA1_ITGB1, ITGA10_ITGB1, ITGA11_ITGB1, ITGA2_ITGB1, ITGA3_ITGB1, ITGA9_ITGB1, ITGAV_ITGB8, SDC1, SDC4	CD44 [NA], SDC1 [NA], SDC4 [NA], GP6 [NA]	collagen-containing extracellular matrix [GO:0062023]; collagen trimer [GO:0005581]; extracellular region [GO:0005576]	extracellular matrix structural constituent conferring tensile strength [GO:0030020]	cell adhesion [GO:0007155]; extracellular matrix organization [GO:0030198]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=COL6A5&keywords=COL6A5	0.012540535039033707	819	NA	NA	0.10794646575760797	620	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
COL6A6	collagen type VI alpha 6 chain	No		ENSG00000206384	A6NMZ7	Type VI collagen family	2	ecm, ligand	ecm, ligand, secreted, transmembrane	P16070, P18827, P31431, Q9HCN6	CD44, GP6, ITGA1_ITGB1, ITGA10_ITGB1, ITGA11_ITGB1, ITGA2_ITGB1, ITGA3_ITGB1, ITGA9_ITGB1, ITGAV_ITGB8, SDC1, SDC4	CD44 [NA], SDC1 [NA], SDC4 [NA], GP6 [NA]	collagen-containing extracellular matrix [GO:0062023]; collagen trimer [GO:0005581]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]	NA	cell adhesion [GO:0007155]; extracellular matrix organization [GO:0030198]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=COL6A6&keywords=COL6A6	0.030828777866292133	769	1629.76	141	0.04602581098617124	716	0	0	0	0.009352517985611509	0	0.001692047377326565	0	0.0016313213703099511	0	2.00293764187475e-4	2.31794475564999e-4	303	403	395	0.0011916340884545909	0.8935245667400891	0.9114213066267245	0.9142359725752852	189	167	137
COL8A2	collagen type VIII alpha 2 chain	No		ENSG00000171812	P25067	NA	3	ecm, ligand	ecm, extracellular, intracellular, ligand, secreted, transmembrane	Q08345, Q8NBS3	DDR1, ITGA1_ITGB1, ITGA10_ITGB1, ITGA11_ITGB1, ITGA2_ITGB1, SLC4A11	SLC4A11 [CellTalkDB:31691803], DDR1 [Cellinker:11254672]	basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; collagen trimer [GO:0005581]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	extracellular matrix structural constituent [GO:0005201]; protein-macromolecule adaptor activity [GO:0030674]	angiogenesis [GO:0001525]; camera-type eye morphogenesis [GO:0048593]; cell-cell adhesion [GO:0098609]; epithelial cell proliferation [GO:0050673]; extracellular matrix organization [GO:0030198]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=COL8A2&keywords=COL8A2	0.1812390102341758	621	NA	NA	0.019183538203057043	798	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
COLEC10	collectin subfamily member 10	No		ENSG00000184374	Q9Y6Z7	COLEC10/COLEC11 family	1	ligand, receptor	extracellular, intracellular, ligand, receptor, secreted	NA	NA	NA	collagen trimer [GO:0005581]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]	chemoattractant activity [GO:0042056]; mannose binding [GO:0005537]	complement activation, lectin pathway [GO:0001867]; cranial skeletal system development [GO:1904888]; positive regulation of opsonization [GO:1903028]; proteolysis [GO:0006508]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=COLEC10&keywords=COLEC10	0.3878840831460674	547	NA	NA	1.0302029902181624	259	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
COMP	cartilage oligomeric matrix protein	No		ENSG00000105664	P49747	Thrombospondin family	2	ecm, ligand	ecm, extracellular, ligand, secreted	P02452, P05106, P05556, P08123, P08648, P16671, P18827, P31431, Q08722, Q13683	CD36, CD47, COL1A1, COL1A2, ITGA3_ITGB1, ITGA5, ITGA7, ITGAV_ITGB3, ITGB1, ITGB3, SDC1, SDC4	ITGB1 [CellTalkDB:32196115], ITGB3 [CellTalkDB:32196115;connectomeDB2020:20033473], CD36 [CellTalkDB:30231922], SDC1 [NA], SDC4 [NA], CD47 [connectomeDB2020:20033473], ITGA5 [connectomeDB2020:20033473], COL1A2 [Cellinker:27318326], ITGA7 [Cellinker:20019333], COL1A1 [Cellinker:27318326]	collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; protein-containing complex [GO:0032991]	BMP binding [GO:0036122]; calcium ion binding [GO:0005509]; collagen binding [GO:0005518]; extracellular matrix structural constituent [GO:0005201]; heparan sulfate proteoglycan binding [GO:0043395]; heparin binding [GO:0008201]; integrin binding [GO:0005178]; protease binding [GO:0002020]; proteoglycan binding [GO:0043394]	animal organ morphogenesis [GO:0009887]; animal organ senescence [GO:0010260]; apoptotic process [GO:0006915]; artery morphogenesis [GO:0048844]; BMP signaling pathway [GO:0030509]; bone mineralization [GO:0030282]; cartilage homeostasis [GO:1990079]; chondrocyte development [GO:0002063]; chondrocyte proliferation [GO:0035988]; collagen fibril organization [GO:0030199]; growth plate cartilage development [GO:0003417]; limb development [GO:0060173]; multicellular organism aging [GO:0010259]; multicellular organism growth [GO:0035264]; musculoskeletal movement [GO:0050881]; negative regulation of apoptotic process [GO:0043066]; negative regulation of hemostasis [GO:1900047]; platelet aggregation [GO:0070527]; positive regulation of chondrocyte proliferation [GO:1902732]; protein homooligomerization [GO:0051260]; protein processing [GO:0016485]; protein secretion [GO:0009306]; regulation of bone mineralization [GO:0030500]; regulation of gene expression [GO:0010468]; response to unfolded protein [GO:0006986]; skeletal system development [GO:0001501]; skin development [GO:0043588]; tendon development [GO:0035989]; vascular associated smooth muscle cell development [GO:0097084]; vascular associated smooth muscle contraction [GO:0014829]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=COMP&keywords=COMP	1.6995060415730336	399	NA	NA	0.08303692591680953	655	0	9.98003992015968e-4	0	0.7709832134292632	0	0.001692047377326565	0.001813236627379873	0.0032626427406199023	7.399186089530152e-4	0.001635732407531044	0.0019316206297083265	301	354	337	0.07118694689207254	0.13228627285652628	0.14332023623205384	0.14696476572237482	465	447	449
COPA	COPI coat complex subunit alpha	Yes	source of xenin, may have hormone activity	ENSG00000122218	P53621	NA	4	ecm, ligand	ecm, intracellular, ligand, secreted	P04233, P04629, P49286, Q15077, Q99523	CD74, MTNR1B, NTRK1, P2RY6, SORT1	CD74 [NA], MTNR1B [HPRD:17215244], SORT1 [NA], P2RY6 [NA], NTRK1 [NA]	COPI vesicle coat [GO:0030126]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi membrane [GO:0000139]; growth cone [GO:0030426]; membrane [GO:0016020]; transport vesicle [GO:0030133]	hormone activity [GO:0005179]; structural molecule activity [GO:0005198]	endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; intracellular protein transport [GO:0006886]; intra-Golgi vesicle-mediated transport [GO:0006891]; pancreatic juice secretion [GO:0030157]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=COPA&keywords=COPA	170.17056215052722	38	63423.4	19	2.0299677672848153	151	0.24409448818897628	0.5723552894211614	0.24225663716814194	0.6131894484412621	0.38215488215488147	0.832487309644671	0.8123300090661891	0.5693311582381743	0.4776174620791763	0.5209306983576785	0.4223681668919983	39	45	45	0.5171923226956646	0.9249327827572825	1.007091104139944	0.8201336557429232	168	128	176
CORT	cortistatin	Yes		ENSG00000241563	O00230	Somatostatin family	14	ligand	extracellular, intracellular, ligand, secreted	P08913, P30872, P30874, P31391, P32745, P35346, P48039, Q14831, Q92847, Q96LB1	ADRA2A, GHSR, GRM7, MRGPRX2, MTNR1A, SSTR1, SSTR2, SSTR3, SSTR4, SSTR5	SSTR1 [Baccin2019:10598788;Baccin2019:11011067;Baccin2019:15333679;Baccin2019:9125122;Baccin2019:9205124;Baccin2019:9650799;CellTalkDB:9650799;Cellinker:10598788;Cellinker:11011067;Cellinker:15333679;Cellinker:9125122;Cellinker:9205124;Cellinker:9650799;Guide2Pharma:10598788;Guide2Pharma:15333679;Guide2Pharma:9650799;HPMR:11011067;HPMR:9125122;HPRD:9125122;HPRD:9205124;LRdb:10598788;LRdb:11011067;LRdb:15333679;LRdb:9125122;LRdb:9205124;LRdb:9650799;connectomeDB2020:10598788;connectomeDB2020:11011067;connectomeDB2020:15333679;connectomeDB2020:9125122;connectomeDB2020:9205124;connectomeDB2020:9650799;scConnect:10598788;scConnect:15333679;scConnect:9650799], SSTR2 [Baccin2019:10598788;Baccin2019:15333679;Baccin2019:9125122;Baccin2019:9650799;CellTalkDB:10598788;Cellinker:10598788;Cellinker:15333679;Cellinker:9125122;Cellinker:9650799;Guide2Pharma:10598788;Guide2Pharma:15333679;Guide2Pharma:9650799;HPRD:9125122;LRdb:10598788;LRdb:15333679;LRdb:9125122;LRdb:9650799;connectomeDB2020:10598788;connectomeDB2020:15333679;connectomeDB2020:9125122;connectomeDB2020:9650799;scConnect:10598788;scConnect:15333679;scConnect:9650799], SSTR3 [Baccin2019:10598788;Baccin2019:15333679;Baccin2019:9125122;Baccin2019:9205124;Baccin2019:9650799;CellTalkDB:10598788;Cellinker:10598788;Cellinker:15333679;Cellinker:9125122;Cellinker:9205124;Cellinker:9650799;Guide2Pharma:10598788;Guide2Pharma:15333679;Guide2Pharma:9650799;HPMR:9125122;HPRD:9125122;HPRD:9205124;LRdb:10598788;LRdb:15333679;LRdb:9125122;LRdb:9205124;LRdb:9650799;connectomeDB2020:10598788;connectomeDB2020:15333679;connectomeDB2020:9125122;connectomeDB2020:9205124;connectomeDB2020:9650799;scConnect:10598788;scConnect:15333679;scConnect:9650799], SSTR4 [Baccin2019:10598788;Baccin2019:11011067;Baccin2019:9125122;Baccin2019:9205124;Baccin2019:9650799;CellTalkDB:10598788;Cellinker:10598788;Cellinker:11011067;Cellinker:9125122;Cellinker:9205124;Cellinker:9650799;Guide2Pharma:10598788;Guide2Pharma:9650799;HPRD:9125122;HPRD:9205124;LRdb:10598788;LRdb:11011067;LRdb:9125122;LRdb:9205124;LRdb:9650799;SIGNOR:11011067;connectomeDB2020:10598788;connectomeDB2020:11011067;connectomeDB2020:9125122;connectomeDB2020:9205124;connectomeDB2020:9650799;scConnect:10598788;scConnect:9650799], SSTR5 [Baccin2019:10598788;Baccin2019:11011067;Baccin2019:15333679;Baccin2019:9125122;Baccin2019:9205124;Baccin2019:9650799;CellTalkDB:9125122;Cellinker:10598788;Cellinker:11011067;Cellinker:15333679;Cellinker:9125122;Cellinker:9205124;Cellinker:9650799;Guide2Pharma:10598788;Guide2Pharma:15333679;Guide2Pharma:9650799;HPRD:9125122;HPRD:9205124;LRdb:10598788;LRdb:11011067;LRdb:15333679;LRdb:9125122;LRdb:9205124;LRdb:9650799;connectomeDB2020:10598788;connectomeDB2020:11011067;connectomeDB2020:15333679;connectomeDB2020:9125122;connectomeDB2020:9205124;connectomeDB2020:9650799;scConnect:10598788;scConnect:15333679;scConnect:9650799], GHSR [Baccin2019:1122773711227730;CellTalkDB:11227737;Cellinker:11227737;HPRD:11227737;LRdb:11227737;SIGNOR:12161511;connectomeDB2020:11227737], MRGPRX2 [Baccin2019:1291540212915400;CellTalkDB:12915402;Cellinker:12915402;HPMR:12915402;HPRD:12915402;LRdb:12915402;SIGNOR:16111673;connectomeDB2020:12915402], ADRA2A [CellTalkDB:32196115], MTNR1A [CellTalkDB:32196115], GRM7 [CellTalkDB:32196115]	extracellular region [GO:0005576]; extracellular space [GO:0005615]; FANCM-MHF complex [GO:0071821]; Fanconi anaemia nuclear complex [GO:0043240]; synapse [GO:0045202]	chromatin binding [GO:0003682]; G protein-coupled receptor binding [GO:0001664]; neuropeptide hormone activity [GO:0005184]	adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; chemical synaptic transmission [GO:0007268]; replication fork processing [GO:0031297]; resolution of meiotic recombination intermediates [GO:0000712]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CORT&keywords=CORT	0.23630102921348314	599	NA	NA	0.04854102702024891	711	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
CP	ceruloplasmin	No	manually added ensembl_gene_ID, hgnc_symbol, and description by searching the uniprot ID on genenames.org	ENSG00000047457	P00450	Multicopper oxidase family	7	ligand	extracellular, intracellular, ligand, secreted	Q99835, Q9NP59	SLC40A1, SMO	SMO [SIGNOR:16885213], SLC40A1 [CellTalkDB:24921009;LRdb:24921009;Ramilowski2015:24921009;connectomeDB2020:24921009;talklr:24921009]	blood microparticle [GO:0072562]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]	chaperone binding [GO:0051087]; copper ion binding [GO:0005507]; ferroxidase activity [GO:0004322]; oxidoreductase activity [GO:0016491]	cellular iron ion homeostasis [GO:0006879]; copper ion transport [GO:0006825]; iron ion homeostasis [GO:0055072]; iron ion transport [GO:0006826]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CP&keywords=CP	26.82344446441113	143	358.34	164	2.007495397441293	154	0.023622047244094488	0.012974051896207579	0.0011061946902654867	0.004076738609112709	0.14983164983164982	0.0338409475465313	0.030825022665457842	0.24632952691680257	0.07547169811320753	0.004740285752436904	0.06501835039598157	144	294	137	0.05889422851470435	1.2406220369383334	0.21395530612975555	1.0888916533838553	82	411	79
CRH	corticotropin releasing hormone	Yes		ENSG00000147571	P06850	Sauvagine/corticotropin-releasing factor/urotensin I family	16	ligand	extracellular, intracellular, ligand, secreted, transmembrane	O60895, O60896, P07550, P13945, P16473, P32241, P34998, P41586, Q01718, Q03431, Q13324, Q99678, Q9NQS5	ADCYAP1R1, ADRB2, ADRB3, CRHR1, CRHR2, GPR20, GPR84, MC2R, PTH1R, RAMP2, RAMP3, TSHR, VIPR1	CRHR1 [Baccin2019:11123370;Baccin2019:7477349;Baccin2019:7692441;Baccin2019:8536644;Baccin2019:8612563;Baccin2019:9178757;Baccin2019:9326293;Baccin2019:9851694;BioGRID:10598591;BioGRID:19124613;CellTalkDB:11123370;Cellinker:11123370;Cellinker:7477349;Cellinker:7692441;Cellinker:8536644;Cellinker:8612563;Cellinker:9178757;Cellinker:9326293;Cellinker:9851694;Guide2Pharma:11123370;Guide2Pharma:7477349;Guide2Pharma:7692441;Guide2Pharma:8612563;Guide2Pharma:9326293;Guide2Pharma:9851694;HPMR:8536644;HPRD:9178757;IntAct:18801728;IntAct:20966082;LRdb:11123370;LRdb:7477349;LRdb:7692441;LRdb:8536644;LRdb:8612563;LRdb:9178757;LRdb:9326293;LRdb:9851694;SIGNOR:11416224;connectomeDB2020:11123370;connectomeDB2020:7477349;connectomeDB2020:7692441;connectomeDB2020:8536644;connectomeDB2020:8612563;connectomeDB2020:9178757;connectomeDB2020:9326293;connectomeDB2020:9851694;scConnect:11123370;scConnect:7477349;scConnect:7692441;scConnect:8612563;scConnect:9326293;scConnect:9851694], CRHR2 [CellTalkDB:11123370;Cellinker:11123370;Cellinker:8243338;Cellinker:8536644;Guide2Pharma:11123370;HPMR:8536644;HPRD:8243338;LRdb:11123370;LRdb:8243338;LRdb:8536644;connectomeDB2020:11123370;connectomeDB2020:8243338;connectomeDB2020:8536644;scConnect:11123370], ADCYAP1R1 [CellTalkDB:32196115], ADRB2 [CellTalkDB:32196115], GPR84 [CellTalkDB:32196115], PTH1R [CellTalkDB:32196115], VIPR1 [CellTalkDB:32196115], GPR20 [CellTalkDB:32196115], MC2R [NA], ADRB3 [CellTalkDB:32196115], TSHR [CellTalkDB:32196115], RAMP3 [CellTalkDB:32196115], RAMP2 [CellTalkDB:32196115]	extracellular region [GO:0005576]; extracellular space [GO:0005615]; neuronal cell body [GO:0043025]; synapse [GO:0045202]	corticotropin-releasing hormone activity [GO:0017045]; hormone activity [GO:0005179]; neuropeptide hormone activity [GO:0005184]; signaling receptor binding [GO:0005102]	adrenal gland development [GO:0030325]; chemical synaptic transmission [GO:0007268]; female pregnancy [GO:0007565]; glucocorticoid biosynthetic process [GO:0006704]; inflammatory response [GO:0006954]; learning or memory [GO:0007611]; locomotory exploration behavior [GO:0035641]; lung development [GO:0030324]; negative regulation of circadian sleep/wake cycle, REM sleep [GO:0042322]; negative regulation of epinephrine secretion [GO:0032811]; negative regulation of glucagon secretion [GO:0070093]; parturition [GO:0007567]; positive regulation of circadian sleep/wake cycle, wakefulness [GO:0010841]; positive regulation of corticotropin secretion [GO:0051461]; positive regulation of cortisol secretion [GO:0051464]; regulation of NMDA receptor activity [GO:2000310]; signal transduction [GO:0007165]; synaptic transmission, dopaminergic [GO:0001963]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CRH&keywords=CRH	4.392638404494382	305	16989.8	53	4.4935854195549245	81	0.007874015748031496	0.005489021956087825	0.0022123893805309734	0.00647482014388489	0	0.11675126903553294	0.29918404351767847	0.03099510603588907	0.05586385497595272	0.0035385231673120536	0.2264245702144012	161	309	65	0.06861887401593651	0.8377613620185114	0.17220449080163264	3.0072240689490997	205	430	7
CRHBP	corticotropin releasing hormone binding protein	TBD	secondary	ENSG00000145708	P24387	CRF-binding protein family	1	ligand	extracellular, intracellular, ligand, secreted, transmembrane	NA	NA	NA	axon terminus [GO:0043679]; dendrite [GO:0030425]; dense core granule [GO:0031045]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; microtubule [GO:0005874]; multivesicular body [GO:0005771]; nucleus [GO:0005634]; perikaryon [GO:0043204]; secondary lysosome [GO:0005767]; secretory granule [GO:0030141]; varicosity [GO:0043196]	corticotropin-releasing hormone binding [GO:0051424]; peptide binding [GO:0042277]	behavioral response to ethanol [GO:0048149]; cellular response to calcium ion [GO:0071277]; cellular response to cAMP [GO:0071320]; cellular response to cocaine [GO:0071314]; cellular response to estradiol stimulus [GO:0071392]; cellular response to estrogen stimulus [GO:0071391]; cellular response to gonadotropin-releasing hormone [GO:0097211]; cellular response to potassium ion [GO:0035865]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to xenobiotic stimulus [GO:0071466]; female pregnancy [GO:0007565]; hormone-mediated signaling pathway [GO:0009755]; inflammatory response [GO:0006954]; learning or memory [GO:0007611]; negative regulation of corticotropin-releasing hormone receptor activity [GO:1900011]; negative regulation of corticotropin secretion [GO:0051460]; regulated exocytosis [GO:0045055]; regulation of cellular response to stress [GO:0080135]; regulation of corticotropin secretion [GO:0051459]; regulation of NMDA receptor activity [GO:2000310]; signal transduction [GO:0007165]; synaptic transmission, dopaminergic [GO:0001963]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CRHBP&keywords=CRHBP	0.5026735594382022	522	NA	NA	0.1429308780902285	584	0.015748031496062992	4.99001996007984e-4	0.0011061946902654867	0.0369304556354916	0	0	0.004533091568449683	0.0065252854812398045	0.0011098779134295228	5.674989985311792e-4	0.004288197797952486	300	386	299	0.006482512325220976	0.6740403219010228	0.6411339964455026	0.8668701418829928	269	276	156
CRIM1	cysteine rich transmembrane BMP regulator 1	No		ENSG00000277354, ENSG00000150938	Q9NZV1	NA	1	ecm, ligand, receptor	cell_surface, ecm, ligand, plasma_membrane, plasma_membrane_transmembrane, receptor, secreted, transmembrane, transmembrane_predicted	NA	NA	NA	extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	insulin-like growth factor-activated receptor activity [GO:0005010]; insulin-like growth factor binding [GO:0005520]; PDZ domain binding [GO:0030165]; serine-type endopeptidase inhibitor activity [GO:0004867]	negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of osteoblast differentiation [GO:0045668]; nervous system development [GO:0007399]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CRIM1&keywords=CRIM1	24.32403297905618	155	NA	NA	0.5466992296449386	368	0.03937007874015748	0.334331337325353	0.19800884955752238	0.06330935251798561	0.03872053872053871	0.17428087986463603	0.08250226654578405	0.12887438825448624	0.13947465778764273	0.022299372412872154	0.07467645354452161	95	190	126	0.11780437957013636	1.1695581817336251	0.2527250828297863	0.662547354240337	94	395	252
CRISP2	cysteine rich secretory protein 2	Yes		ENSG00000124490	P16562	CRISP family	1	ligand, transporter	ion_channel, ligand, secreted, transporter	Q8NEC5	CATSPER1	CATSPER1 [CellTalkDB:30759213]	extracellular space [GO:0005615]	NA	NA	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CRISP2&keywords=CRISP2	0.22366021541158013	606	NA	NA	0.0108547908153178	827	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
CRISP3	cysteine rich secretory protein 3	Yes	manually added ensembl_gene_ID, hgnc_symbol, and description by searching the uniprot ID on genenames.org	ENSG00000096006	P54108	CRISP family	1	ecm, ligand, transporter	ecm, intracellular, ion_channel, ligand, secreted, transporter	P04217	A1BG	A1BG [CellTalkDB:15461460;HPRD:15461460]	extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; specific granule [GO:0042581]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724]	NA	defense response [GO:0006952]; innate immune response [GO:0045087]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CRISP3&keywords=CRISP3	1.6180705600933853	404	NA	NA	0.030328974436519378	766	0	0.006986027944111777	0	0	0	0	0	0	0	0	0	303	409	401	6.35093449464707e-4	0.9402832281180686	0.9402832281180686	0.9402832281180686	161	154	122
CRLF1	cytokine receptor like factor 1	No		ENSG00000006016	O75462	Type I cytokine receptor family, Type 3 subfamily	6	ligand, receptor	cell_surface, extracellular, intracellular, ligand, plasma_membrane_transmembrane, receptor, secreted, transmembrane	P26992, P40189, P42702, Q92673	CNTFR, IL6ST, LIFR, SORL1	IL6ST [NA], CNTFR [HPRD:10966616;connectomeDB2020:23355913], LIFR [NA], SORL1 [Cellinker:26858303]	CRLF-CLCF1 complex [GO:0097058]; cytosol [GO:0005829]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; receptor complex [GO:0043235]	cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]	cytokine-mediated signaling pathway [GO:0019221]; negative regulation of motor neuron apoptotic process [GO:2000672]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; ureteric bud development [GO:0001657]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CRLF1&keywords=CRLF1	11.973368411728051	223	NA	NA	0.4990642224111324	383	0	4.99001996007984e-4	0.0022123893805309734	0.5414868105515644	0	0	0.003626473254759746	0.0016313213703099511	7.399186089530152e-4	0.0018694084657497642	0.0010430751400424961	301	350	364	0.0502825817061744	0.17815956624586612	0.1968961535788712	0.18318849039790572	447	417	428
CRLF2	cytokine receptor like factor 2	No		ENSG00000205755	Q9HC73	Type I cytokine receptor family, Type 5 subfamily	1	ligand, receptor	cell_surface, extracellular, intracellular, ligand, plasma_membrane, plasma_membrane_transmembrane, receptor, secreted, transmembrane, transmembrane_predicted	O60674	CRLF2_IL7R_TSLP, JAK2	JAK2 [HPRD:10872831;NetPath:10872831;SignaLink3:10872831;SignaLink3:18988627;SignaLink3:23331499]	external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	ciliary neurotrophic factor receptor binding [GO:0005127]; cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]; leukemia inhibitory factor receptor activity [GO:0004923]	cytokine-mediated signaling pathway [GO:0019221]; oncostatin-M-mediated signaling pathway [GO:0038165]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of interleukin-5 production [GO:0032754]; positive regulation of mast cell activation [GO:0033005]; positive regulation of receptor signaling pathway via STAT [GO:1904894]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CRLF2&keywords=CRLF2	0.1635073640907636	636	NA	NA	1.3401846423568808	219	0.06299212598425197	0	0	0	0	0	0	0	0	0	3.8632412594166507e-5	303	409	400	0.005730068945167831	0.6357251220486182	0.6357251220486182	0.638181081569764	288	277	266
CRLF3	cytokine receptor like factor 3			ENSG00000176390	Q8IUI8	Cytokine receptor-like factor 3 family	1	ligand, receptor	cell_surface, intracellular, ligand, receptor, secreted	NA	NA	NA	cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	DNA binding [GO:0003677]; identical protein binding [GO:0042802]	negative regulation of cell growth [GO:0030308]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CRLF3&keywords=CRLF3	9.781972153932584	239	1077.73	155	1.343006376439431	218	0.03937007874015748	0.07285429141716558	0.04092920353982304	0.041007194244604306	0.03198653198653198	0.03722504230118443	0.05530371713508604	0.03099510603588907	0.02367739548649646	0.03284817732674597	0.03202627004056417	223	168	179	0.03983845529584078	0.675731125424888	0.8597412795480808	0.8432498517680069	268	185	169
CRNN	cornulin			ENSG00000143536	Q9UBG3	S100-fused protein family	1	ligand	intracellular, ligand, secreted	NA	NA	NA	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; membrane [GO:0016020]	calcium-dependent protein binding [GO:0048306]; calcium ion binding [GO:0005509]; transition metal ion binding [GO:0046914]	cell-cell adhesion [GO:0098609]; cellular response to cytokine stimulus [GO:0071345]; positive regulation of cell cycle G1/S phase transition [GO:1902808]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; regulation of gene expression [GO:0010468]; regulation of phosphatidylinositol 3-kinase signaling [GO:0014066]; response to heat [GO:0009408]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CRNN&keywords=CRNN	0.009472330337078652	831	NA	NA	1.1554587475427422e-4	906	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
CSF1	colony stimulating factor 1	Yes		ENSG00000184371	P09603	NA	19	cell_surface_ligand, ligand, receptor	cell_surface, cell_surface_ligand, extracellular, intracellular, ligand, plasma_membrane, plasma_membrane_transmembrane, receptor, secreted, transmembrane, transmembrane_predicted	P01375, P07333, P15509, P30825, P78324, Q99062, Q9NYQ7	CELSR3, CSF1R, CSF2RA, CSF3R, SIRPA, SLC7A1, TNF	CSF1R [Baccin2019:2408759;Baccin2019:7883784;Baccin2019:8355686;CellTalkDB:8355686;Cellinker:2408759;Cellinker:7883784;Cellinker:8355686;DIP:22153499;DIP:22483114;DIP:22902366;DIP:26235028;HPMR:1702217;HPMR:7883784;HPRD:2408759;HPRD:8355686;ICELLNET:26095744;IntAct:22153499;IntAct:22483114;IntAct:22902366;IntAct:26235028;LRdb:2408759;LRdb:7883784;LRdb:8355686;SIGNOR:24890514;connectomeDB2020:2408759;connectomeDB2020:7883784;connectomeDB2020:8355686], CSF2RA [SIGNOR:10572088;SignaLink3:10572088;SignaLink3:23331499], CSF3R [SIGNOR:16492764;SignaLink3:16492764;SignaLink3:23331499], SIRPA [CellTalkDB:32103204], SLC7A1 [NA], CELSR3 [NA], TNF [HPRD:8336080]	CSF1-CSF1R complex [GO:1990682]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; nuclear body [GO:0016604]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]	cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; identical protein binding [GO:0042802]; macrophage colony-stimulating factor receptor binding [GO:0005157]; protein homodimerization activity [GO:0042803]	branching involved in mammary gland duct morphogenesis [GO:0060444]; developmental process involved in reproduction [GO:0003006]; homeostasis of number of cells within a tissue [GO:0048873]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; macrophage colony-stimulating factor signaling pathway [GO:0038145]; macrophage differentiation [GO:0030225]; mammary duct terminal end bud growth [GO:0060763]; mammary gland fat development [GO:0060611]; microglial cell proliferation [GO:0061518]; monocyte activation [GO:0042117]; negative regulation of neuron death [GO:1901215]; odontogenesis [GO:0042476]; ossification [GO:0001503]; osteoclast differentiation [GO:0030316]; osteoclast proliferation [GO:0002158]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cellular protein metabolic process [GO:0032270]; positive regulation of gene expression [GO:0010628]; positive regulation of macrophage chemotaxis [GO:0010759]; positive regulation of macrophage colony-stimulating factor signaling pathway [GO:1902228]; positive regulation of macrophage derived foam cell differentiation [GO:0010744]; positive regulation of macrophage differentiation [GO:0045651]; positive regulation of macrophage migration [GO:1905523]; positive regulation of microglial cell migration [GO:1904141]; positive regulation of monocyte differentiation [GO:0045657]; positive regulation of mononuclear cell proliferation [GO:0032946]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of odontogenesis of dentin-containing tooth [GO:0042488]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of Ras protein signal transduction [GO:0046579]; regulation of macrophage derived foam cell differentiation [GO:0010743]; regulation of ossification [GO:0030278]; response to ischemia [GO:0002931]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CSF1&keywords=CSF1	9.201618176236476	249	NA	NA	0.30768195416248323	461	0.023622047244094488	0.10778443113772443	0.017699115044247787	0.019184652278177453	0.01515151515151515	0.023688663282571906	0.030825022665457842	0.03425774877650897	0.011838697743248248	0.011450126852717294	0.014564419548000645	258	233	226	0.028187858156751292	0.5718754284046526	0.5617001813683832	0.6432520893727542	310	299	264
CSF2	colony stimulating factor 2	Yes		ENSG00000164400	P04141	GM-CSF family	19	ligand	extracellular, intracellular, ligand, secreted	P05556, P07333, P15509, P26951, P32927, P34741, Q13797, Q99062	CSF1R, CSF2_CSF2RA_CSF2RB, CSF2RA, CSF2RA_CSF2RB, CSF2RB, CSF3R, IL3RA, ITGA9, ITGB1, SDC2	CSF2RA [Baccin2019:10572088;Baccin2019:1702217;Baccin2019:2828352;Baccin2019:8910448;Baccin2019:9211889;CellTalkDB:2828352;DIP:2555171;DIP:27396825;DIP:7957082;HPMR:10753826;HPMR:2828352;HPRD:10572088;HPRD:1702217;HPRD:8910448;HPRD:9211889;InnateDB:10572088;LRdb:10572088;LRdb:1702217;LRdb:2828352;LRdb:8910448;LRdb:9211889;Lit-BM-17:18692472;Lit-BM-17:2555171;Lit-BM-17:7957082;SIGNOR:10572088;SIGNOR:18551128;SIGNOR:9187659;SPIKE:10572088;SPIKE:2645577;SignaLink3:10572088;SignaLink3:11015446;SignaLink3:11306493;SignaLink3:11777960;SignaLink3:11867689;SignaLink3:12393492;SignaLink3:12811837;SignaLink3:14610620;SignaLink3:19833085;SignaLink3:20406969;SignaLink3:20805416;SignaLink3:21765015;SignaLink3:22323450;SignaLink3:22869907;SignaLink3:23046136;SignaLink3:23331499;SignaLink3:24030977;SignaLink3:24091328;SignaLink3:26192618;SignaLink3:27216177;connectomeDB2020:10572088;connectomeDB2020:1702217;connectomeDB2020:2828352;connectomeDB2020:8910448;connectomeDB2020:9211889], CSF3R [Baccin2019:11091218;CellTalkDB:11091218;Cellinker:11091218;Cellinker:16720384;DIP:11468284;HPMR:11091218;HPMR:7691413;LRdb:11091218;Lit-BM-17:11468284;Lit-BM-17:9187659;SIGNOR:16492764;SIGNOR:7691413;SignaLink3:16492764;SignaLink3:23331499;connectomeDB2020:11091218], CSF1R [NA], CSF2RB [Baccin2019:2645577;Baccin2019:2828352;Baccin2019:8278375;CellTalkDB:2828352;DIP:1702217;DIP:7957082;HPMR:10753826;HPMR:2828352;HPRD:2645577;HPRD:8278375;LMPID:7957082;LRdb:2645577;LRdb:2828352;LRdb:8278375;Lit-BM-17:1702217;Lit-BM-17:18692472;Lit-BM-17:7957082;connectomeDB2020:2645577;connectomeDB2020:2828352;connectomeDB2020:8278375], ITGB1 [CellTalkDB:32196115], IL3RA [Baccin2019:7957082;CellTalkDB:7957082;Cellinker:7957082;HPRD:7957082;LRdb:7957082;connectomeDB2020:7957082], SDC2 [Baccin2019:10734053;CellTalkDB:10734053;Cellinker:10734053;HPRD:10734053;InnateDB:10734053;LRdb:10734053;connectomeDB2020:10734053], ITGA9 [CellTalkDB:32196115]	extracellular region [GO:0005576]; extracellular space [GO:0005615]; granulocyte macrophage colony-stimulating factor receptor complex [GO:0030526]; intracellular membrane-bounded organelle [GO:0043231]; plasma membrane [GO:0005886]	cytokine activity [GO:0005125]; granulocyte macrophage colony-stimulating factor receptor binding [GO:0005129]; growth factor activity [GO:0008083]	cellular response to granulocyte macrophage colony-stimulating factor stimulus [GO:0097011]; cellular response to lipopolysaccharide [GO:0071222]; dendritic cell differentiation [GO:0097028]; embryonic placenta development [GO:0001892]; epithelial fluid transport [GO:0042045]; granulocyte-macrophage colony-stimulating factor signaling pathway [GO:0038157]; histamine secretion [GO:0001821]; immune response [GO:0006955]; macrophage activation [GO:0042116]; macrophage differentiation [GO:0030225]; monocyte differentiation [GO:0030224]; myeloid cell differentiation [GO:0030099]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of transcription, DNA-templated [GO:0045892]; neutrophil differentiation [GO:0030223]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of interleukin-23 production [GO:0032747]; positive regulation of leukocyte proliferation [GO:0070665]; positive regulation of macrophage derived foam cell differentiation [GO:0010744]; positive regulation of podosome assembly [GO:0071803]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein phosphorylation [GO:0006468]; receptor signaling pathway via JAK-STAT [GO:0007259]; regulation of circadian sleep/wake cycle, sleep [GO:0045187]; response to fluid shear stress [GO:0034405]; response to silicon dioxide [GO:0034021]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CSF2&keywords=CSF2	0.37362169662921346	550	NA	NA	8.433131778826542	53	0.023622047244094488	0.03842315369261475	0.0022123893805309734	0	0	0	0	0	0	0	7.726482518833301e-5	303	409	399	0.005848623194766232	0.6309696354761182	0.6309696354761182	0.6358448113345391	293	279	267
CSF2RA	colony stimulating factor 2 receptor subunit alpha	No		ENSG00000198223	P15509	Type I cytokine receptor family, Type 5 subfamily	1	ligand, receptor	cell_surface, extracellular, ligand, plasma_membrane, plasma_membrane_transmembrane, receptor, secreted, transmembrane	O60674	JAK2	JAK2 [SIGNOR:8977526;SignaLink3:23331499;SignaLink3:9028317]	external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; granulocyte macrophage colony-stimulating factor receptor complex [GO:0030526]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]; signaling receptor activity [GO:0038023]	cytokine-mediated signaling pathway [GO:0019221]; granulocyte-macrophage colony-stimulating factor signaling pathway [GO:0038157]; positive regulation of leukocyte proliferation [GO:0070665]; protein phosphorylation [GO:0006468]; receptor signaling pathway via JAK-STAT [GO:0007259]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CSF2RA&keywords=CSF2RA	1.6535261487250146	402	NA	NA	0.5460510333117499	369	0.6692913385826766	0.0029940119760479044	0.00331858407079646	0.0026378896882493998	0	0.00676818950930626	0.004533091568449683	0.0016313213703099511	0.004439511653718092	0.003905728401655754	0.004674521923894151	289	304	292	0.06401765352228221	0.195081996882963	0.18787043009232368	0.1982570538996693	438	419	421
CSF3	colony stimulating factor 3	Yes		ENSG00000108342	P09919	IL-6 superfamily	20	ligand	extracellular, intracellular, ligand, secreted	P07333, P15509, P32927, Q99062	CSF1R, CSF2RA, CSF2RB, CSF3R	CSF3R [Baccin2019:10364174;CellTalkDB:10364174;Cellinker:10364174;DIP:16492764;HPRD:10364174;ICELLNET:10537111;LRdb:10364174;SIGNOR:16492764;SPIKE:15676205;SignaLink3:10364174;SignaLink3:16492764;SignaLink3:23331499;connectomeDB2020:10364174], CSF2RA [SIGNOR:10572088;SignaLink3:10572088;SignaLink3:23331499], CSF1R [NA], CSF2RB [NA]	endocytic vesicle lumen [GO:0071682]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosomal lumen [GO:0043202]	cytokine activity [GO:0005125]; enzyme binding [GO:0019899]; granulocyte colony-stimulating factor receptor binding [GO:0005130]; growth factor activity [GO:0008083]	cellular response to cytokine stimulus [GO:0071345]; cellular response to lipopolysaccharide [GO:0071222]; cytokine-mediated signaling pathway [GO:0019221]; granulocyte differentiation [GO:0030851]; immune response [GO:0006955]; negative regulation of neuron death [GO:1901215]; positive regulation of actin cytoskeleton reorganization [GO:2000251]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of myeloid cell differentiation [GO:0045639]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein binding [GO:0032092]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of transcription by RNA polymerase II [GO:0045944]; response to ethanol [GO:0045471]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CSF3&keywords=CSF3	0.6515471540102854	499	NA	NA	0.3976149991337529	421	0	0.001996007984031936	0.05309734513274337	0.16786570743405307	0	0	0	0	3.699593044765076e-4	2.00293764187475e-4	1.9316206297083252e-4	302	403	396	0.02033840688022393	0.3418096192531507	0.3362171851824075	0.3359821134713319	395	366	379
CSF3R	colony stimulating factor 3 receptor	No		ENSG00000119535	Q99062	Type I cytokine receptor family, Type 2 subfamily	1	adhesion, ligand, receptor	adhesion, cell_adhesion, cell_surface, extracellular, intracellular, ligand, plasma_membrane, plasma_membrane_transmembrane, receptor, secreted, transmembrane, transmembrane_predicted	O60674, P23458, P29597, Q96ID5, Q9BZW8	CD244, IGSF21, JAK1, JAK2, TYK2	JAK1 [HPRD:7512720;SignaLink3:23331499;SignaLink3:7512720], TYK2 [SignaLink3:23331499;SignaLink3:9015216], JAK2 [HPRD:7775438;SignaLink3:11812652;SignaLink3:23331499], CD244 [Cellinker:32589946], IGSF21 [Cellinker:32589946]	endocytic vesicle membrane [GO:0030666]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]; granulocyte colony-stimulating factor binding [GO:0051916]; signaling receptor activity [GO:0038023]	cell adhesion [GO:0007155]; cytokine-mediated signaling pathway [GO:0019221]; defense response [GO:0006952]; neutrophil chemotaxis [GO:0030593]; regulation of myeloid cell differentiation [GO:0045637]; signal transduction [GO:0007165]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CSF3R&keywords=CSF3R	0.2009771496230292	614	NA	NA	0.00381246375764129	869	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
CSH1	chorionic somatomammotropin hormone 1	Yes		ENSG00000136488	P0DML2	Somatotropin/prolactin family	13	ligand	extracellular, intracellular, ligand, secreted	P16471	PRLR	PRLR [CellTalkDB:10966654;Cellinker:10966654;HPRD:10966654;LRdb:10966654;connectomeDB2020:10966654]	endoplasmic reticulum [GO:0005783]; endosome lumen [GO:0031904]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; vesicle [GO:0031982]	growth factor activity [GO:0008083]; growth hormone receptor binding [GO:0005131]; hormone activity [GO:0005179]; metal ion binding [GO:0046872]	animal organ development [GO:0048513]; growth hormone receptor signaling pathway [GO:0060396]; positive regulation of growth [GO:0045927]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; response to nutrient levels [GO:0031667]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CSH1&keywords=CSH1	0.0035540449438202244	863	NA	NA	0.03553799089729309	752	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
CSH2	chorionic somatomammotropin hormone 2	Yes		ENSG00000213218	P0DML3	Somatotropin/prolactin family	11	ligand	extracellular, intracellular, ligand, secreted	P16471	PRLR	PRLR [Cellinker:10966654]	endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; vesicle [GO:0031982]	growth factor activity [GO:0008083]; growth hormone receptor binding [GO:0005131]; hormone activity [GO:0005179]; metal ion binding [GO:0046872]	animal organ development [GO:0048513]; growth hormone receptor signaling pathway [GO:0060396]; positive regulation of growth [GO:0045927]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; response to nutrient levels [GO:0031667]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CSH2&keywords=CSH2	0.0020517247191011237	882	NA	NA	0.16813114751014746	560	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
CSHL1	chorionic somatomammotropin hormone like 1	Yes		ENSG00000204414	Q14406	Somatotropin/prolactin family	11	ligand	extracellular, ligand, secreted	P10912, P16471	GHR, PRLR	PRLR [NA], GHR [CellTalkDB:32196115]	extracellular space [GO:0005615]	growth factor activity [GO:0008083]; growth hormone receptor binding [GO:0005131]; hormone activity [GO:0005179]; metal ion binding [GO:0046872]	animal organ development [GO:0048513]; growth hormone receptor signaling pathway [GO:0060396]; positive regulation of growth [GO:0045927]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; response to nutrient levels [GO:0031667]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CSHL1&keywords=CSHL1	0.008276068539325844	837	NA	NA	0.09890562279676095	634	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
CTF1	cardiotrophin 1	Yes		ENSG00000150281	Q16619	IL-6 superfamily	19	ligand	extracellular, intracellular, ligand, secreted	P40189, P42702	IL6ST, IL6ST_LIFR, LIFR	IL6ST [Baccin2019:11834704;CellTalkDB:11834704;HPRD:11834704;LRdb:11834704;SIGNOR:9030543;SignaLink3:23331499;SignaLink3:9030543;connectomeDB2020:11834704], LIFR [Baccin2019:11834704;CellTalkDB:11834704;HPRD:11834704;LRdb:11834704;SIGNOR:11834704;SignaLink3:11834704;SignaLink3:23331499;SignaLink3:9030543;connectomeDB2020:11834704]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	cytokine activity [GO:0005125]; leukemia inhibitory factor receptor binding [GO:0005146]	cell-cell signaling [GO:0007267]; cell surface receptor signaling pathway [GO:0007166]; leukemia inhibitory factor signaling pathway [GO:0048861]; muscle organ development [GO:0007517]; neuron development [GO:0048666]; neuron differentiation [GO:0030182]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CTF1&keywords=CTF1	0.09564080898876404	677	NA	NA	0.008369139985059552	842	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
CX3CL1	C-X3-C motif chemokine ligand 1	Yes		ENSG00000006210	P78423	Intercrine delta family	19	cell_surface_ligand, ligand, receptor	cell_surface, cell_surface_ligand, extracellular, intracellular, ligand, plasma_membrane, plasma_membrane_transmembrane, receptor, secreted, transmembrane, transmembrane_predicted	P05106, P06756, P49238	CX3CR1, ITGA4_ITGB1, ITGAV, ITGAV_ITGB3, ITGB3	CX3CR1 [Baccin2019:11432858;Baccin2019:14607932;Baccin2019:9390561;Baccin2019:9931005;CellPhoneDB:24218476;Cellinker:11432858;Cellinker:14607932;Cellinker:28389721;Cellinker:9390561;Cellinker:9931005;DIP:10488147;Guide2Pharma:14607932;HPMR:11432858;HPRD:9390561;HPRD:9931005;ICELLNET:22633458;InnateDB:9390561;InnateDB:9931005;LRdb:10699158;Lit-BM-17:10488147;Lit-BM-17:9931005;SIGNOR:11432858;connectomeDB2020:11432858;connectomeDB2020:14607932;connectomeDB2020:9390561;connectomeDB2020:9931005;scConnect:14607932], ITGAV [connectomeDB2020:24789099], ITGB3 [IntAct:24789099;connectomeDB2020:24789099]	cell projection [GO:0042995]; cell surface [GO:0009986]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]	CCR chemokine receptor binding [GO:0048020]; chemoattractant activity [GO:0042056]; chemokine activity [GO:0008009]; CX3C chemokine receptor binding [GO:0031737]; CXCR1 chemokine receptor binding [GO:0045237]; integrin binding [GO:0005178]; signaling receptor binding [GO:0005102]	aging [GO:0007568]; angiogenesis involved in wound healing [GO:0060055]; autocrine signaling [GO:0035425]; cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; cell-cell signaling [GO:0007267]; cell chemotaxis [GO:0060326]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; chemokine-mediated signaling pathway [GO:0070098]; chemotaxis [GO:0006935]; cytokine-mediated signaling pathway [GO:0019221]; defense response [GO:0006952]; eosinophil chemotaxis [GO:0048245]; G protein-coupled receptor signaling pathway [GO:0007186]; immune response [GO:0006955]; inflammatory response [GO:0006954]; integrin activation [GO:0033622]; leukocyte adhesive activation [GO:0050902]; leukocyte chemotaxis [GO:0030595]; leukocyte migration involved in inflammatory response [GO:0002523]; lymphocyte chemotaxis [GO:0048247]; microglial cell activation [GO:0001774]; microglial cell proliferation [GO:0061518]; monocyte chemotaxis [GO:0002548]; negative regulation of apoptotic process [GO:0043066]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of cell migration [GO:0030336]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of glutamate receptor signaling pathway [GO:1900450]; negative regulation of hippocampal neuron apoptotic process [GO:0110091]; negative regulation of interleukin-1 alpha production [GO:0032690]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of microglial cell activation [GO:1903979]; negative regulation of neuron migration [GO:2001223]; negative regulation of tumor necrosis factor production [GO:0032720]; neuron cellular homeostasis [GO:0070050]; neuron remodeling [GO:0016322]; neutrophil chemotaxis [GO:0030593]; positive chemotaxis [GO:0050918]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of calcium-independent cell-cell adhesion [GO:0051041]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of GTPase activity [GO:0043547]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of I-kappaB phosphorylation [GO:1903721]; positive regulation of inflammatory response [GO:0050729]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of microglial cell migration [GO:1904141]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron projection development [GO:0010976]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta1 production [GO:0032914]; regulation of lipopolysaccharide-mediated signaling pathway [GO:0031664]; regulation of neurogenesis [GO:0050767]; regulation of synaptic plasticity [GO:0048167]; response to ischemia [GO:0002931]; synapse pruning [GO:0098883]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CX3CL1&keywords=CX3CL1	8.45665014145865	252	NA	NA	0.35974280022692645	438	0	0.040918163672654655	0.02433628318584071	0.004556354916067145	0.006734006734006734	0.001692047377326565	0.0027198549410698096	0.013050570962479609	0.0029596744358120607	0.0022366137000934673	0.006103921189878314	295	339	276	0.009573408283202642	0.6621061722262083	0.62516519979786	0.8227448667536483	275	280	174
CXADR	CXADR Ig-like cell adhesion molecule	No		ENSG00000154639	P78310	NA	2	adhesion, cell_surface_ligand, receptor	adherens_junction, adhesion, cell_adhesion, cell_surface, cell_surface_ligand, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, secreted, tight_junction, transmembrane, transmembrane_predicted	Q86YT9	JAML	JAML [Baccin2019:15800062;Cellinker:32822567;Lit-BM-17:21982860;connectomeDB2020:15800062]	acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; apicolateral plasma membrane [GO:0016327]; basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; cell body [GO:0044297]; cell-cell junction [GO:0005911]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; filopodium [GO:0030175]; growth cone [GO:0030426]; integral component of plasma membrane [GO:0005887]; intercalated disc [GO:0014704]; membrane raft [GO:0045121]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]	beta-catenin binding [GO:0008013]; cell adhesion molecule binding [GO:0050839]; cell adhesive protein binding involved in AV node cell-bundle of His cell communication [GO:0086082]; connexin binding [GO:0071253]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; PDZ domain binding [GO:0030165]; signaling receptor binding [GO:0005102]; virus receptor activity [GO:0001618]	actin cytoskeleton reorganization [GO:0031532]; AV node cell-bundle of His cell adhesion involved in cell communication [GO:0086072]; AV node cell to bundle of His cell communication [GO:0086067]; cardiac muscle cell development [GO:0055013]; cell-cell junction organization [GO:0045216]; defense response to virus [GO:0051607]; epithelial structure maintenance [GO:0010669]; gamma-delta T cell activation [GO:0046629]; germ cell migration [GO:0008354]; heart development [GO:0007507]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homotypic cell-cell adhesion [GO:0034109]; mitochondrion organization [GO:0007005]; neutrophil chemotaxis [GO:0030593]; regulation of AV node cell action potential [GO:0098904]; transepithelial transport [GO:0070633]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CXADR&keywords=CXADR	23.369909303370786	159	2920.36	116	4.231848891612484	84	0	0.6876247504990004	0	0.0031175059952038365	0.34680134680134633	0.2064297800338407	0.12873980054397063	0.05383360522022842	0.22493525712171472	0.11356656429429704	0.04863820745605477	74	98	155	0.16488061981505972	1.3434036165366074	0.7065766602667094	0.33530420648134723	69	248	380
CXCL1	C-X-C motif chemokine ligand 1	Yes		ENSG00000163739	P09341	Intercrine alpha (chemokine CxC) family	18	ligand	extracellular, intracellular, ligand, secreted	P08913, P17612, P25024, P25025, P48039, Q14831, Q16570, Q9P212	ACKR1, ADRA2A, CXCR1, CXCR2, GRM7, MTNR1A, PLCE1, PRKACA	CXCR2 [CellPhoneDB:24218476;Cellinker:10188995;Cellinker:1379593;Cellinker:28389721;Cellinker:8550564;Cellinker:8702798;Cellinker:8940121;DIP:10216072;DIP:8550564;DIP:9195914;Guide2Pharma:10188995;Guide2Pharma:1379593;Guide2Pharma:8940121;HPRD:1379593;HPRD:8550564;HPRD:8702798;HPRD:8940121;ICELLNET:22633458;ICELLNET:24218476;ICELLNET:8702798;InnateDB:12549928;InnateDB:12628493;InnateDB:7592830;InnateDB:8662882;InnateDB:8702798;InnateDB:9126332;LRdb:10699158;connectomeDB2020:10188995;connectomeDB2020:1379593;connectomeDB2020:8550564;connectomeDB2020:8702798;connectomeDB2020:8940121;scConnect:10188995;scConnect:1379593;scConnect:8940121], PRKACA [SIGNOR:17251915], PLCE1 [SIGNOR:17251915], ACKR1 [CellChatDB:26740381;CellPhoneDB:24218476;Cellinker:12734373;Cellinker:26740381;Cellinker:7592830;DIP:7592830;HPMR:12734373;HPRD:7592830;ICELLNET:22633458;ICELLNET:24625696;InnateDB:7592830;InnateDB:8132497;InnateDB:9195930;LRdb:10699158;LRdb:12734373;LRdb:76;connectomeDB2020:12734373;connectomeDB2020:7592830], ADRA2A [CellTalkDB:32196115], CXCR1 [CellPhoneDB:24218476;Cellinker:12964882;Cellinker:1379593;Cellinker:8702798;DIP:9195914;HPRD:1379593;HPRD:8702798;LRdb:10699158;connectomeDB2020:12964882;connectomeDB2020:1379593;connectomeDB2020:8702798;scConnect:1379593], MTNR1A [CellTalkDB:32196115], GRM7 [CellTalkDB:32196115]	extracellular region [GO:0005576]; extracellular space [GO:0005615]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724]	chemokine activity [GO:0008009]; CXCR chemokine receptor binding [GO:0045236]; enzyme activator activity [GO:0008047]; growth factor activity [GO:0008083]; signaling receptor binding [GO:0005102]	actin cytoskeleton organization [GO:0030036]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cellular response to lipopolysaccharide [GO:0071222]; chemokine-mediated signaling pathway [GO:0070098]; chemotaxis [GO:0006935]; G protein-coupled receptor signaling pathway [GO:0007186]; inflammatory response [GO:0006954]; intracellular signal transduction [GO:0035556]; killing of cells of other organism [GO:0031640]; negative regulation of cell population proliferation [GO:0008285]; nervous system development [GO:0007399]; neutrophil chemotaxis [GO:0030593]; signal transduction [GO:0007165]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CXCL1&keywords=CXCL1	56.38145913483146	75	NA	NA	5.596388538120331	71	2.3543307086614167	1.3577844311377272	0.05641592920353983	0.47434052757793843	0.047138047138047125	0.00338409475465313	0.005439709882139619	0.13376835236541595	0.046984831668516476	0.00443984510615569	0.038014293992659716	171	297	171	0.41109461558983723	0.13532548163480188	0.034291212880814104	0.11402257881023949	462	510	467
CXCL10	C-X-C motif chemokine ligand 10	Yes		ENSG00000169245	P02778	Intercrine alpha (chemokine CxC) family	19	ligand, receptor	extracellular, ligand, receptor, secreted	O00206, P08913, P27487, P31431, P48039, P49682, P51677, Q14831, Q16570	ACKR1, ADRA2A, CCR3, CXCR3, DPP4, GRM7, MTNR1A, SDC4, TLR4	CXCR3 [Baccin2019:10233762;Baccin2019:12571234;Baccin2019:12884299;Baccin2019:15761110;Baccin2019:9064356;Baccin2019:9660793;CellPhoneDB:24218476;Cellinker:10233762;Cellinker:12571234;Cellinker:12884299;Cellinker:15761110;Cellinker:9064356;Cellinker:9660793;DIP:9625760;DIP:9660793;Guide2Pharma:15761110;Guide2Pharma:9660793;HPMR:9064356;HPRD:10233762;HPRD:12571234;ICELLNET:12884299;LRdb:10699158;SIGNOR:12750173;SPIKE:10233762;SPIKE:12571234;connectomeDB2020:10233762;connectomeDB2020:12571234;connectomeDB2020:12884299;connectomeDB2020:15761110;connectomeDB2020:9064356;connectomeDB2020:9660793;scConnect:15761110;scConnect:9660793], CCR3 [Baccin2019:11110785;CellTalkDB:11110785;Cellinker:11110785;DIP:11110785;HPRD:11110785;ICELLNET:22633458;LRdb:11110785;connectomeDB2020:11110785], DPP4 [CellPhoneDB:24218476;CellTalkDB:24218476;Cellinker:21314817;HPRD:11390394;IntAct:18275857;IntAct:21314817], SDC4 [Baccin2019:20484822;Cellinker:20484822;LRdb:20484822;Ramilowski2015:20484822;connectomeDB2020:20484822;talklr:20484822], GRM7 [CellTalkDB:32196115], ADRA2A [CellTalkDB:32196115], MTNR1A [CellTalkDB:32196115], ACKR1 [CellChatDB:26740381;Cellinker:26740381], TLR4 [Cellinker:21595283]	external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	cAMP-dependent protein kinase regulator activity [GO:0008603]; chemoattractant activity [GO:0042056]; chemokine activity [GO:0008009]; CXCR3 chemokine receptor binding [GO:0048248]; CXCR chemokine receptor binding [GO:0045236]; heparin binding [GO:0008201]; signaling receptor binding [GO:0005102]	adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; antiviral innate immune response [GO:0140374]; blood circulation [GO:0008015]; cell-cell signaling [GO:0007267]; cell surface receptor signaling pathway [GO:0007166]; cellular response to heat [GO:0034605]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to virus [GO:0098586]; chemokine-mediated signaling pathway [GO:0070098]; chemotaxis [GO:0006935]; endothelial cell activation [GO:0042118]; G protein-coupled receptor signaling pathway [GO:0007186]; inflammatory response [GO:0006954]; killing of cells of other organism [GO:0031640]; muscle organ development [GO:0007517]; negative regulation of angiogenesis [GO:0016525]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myoblast fusion [GO:1901740]; neutrophil chemotaxis [GO:0030593]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of monocyte chemotaxis [GO:0090026]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; positive regulation of T cell migration [GO:2000406]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of apoptotic process [GO:0042981]; regulation of cell population proliferation [GO:0042127]; regulation of endothelial tube morphogenesis [GO:1901509]; regulation of T cell chemotaxis [GO:0010819]; response to auditory stimulus [GO:0010996]; response to cold [GO:0009409]; response to gamma radiation [GO:0010332]; response to vitamin D [GO:0033280]; signal transduction [GO:0007165]; T cell chemotaxis [GO:0010818]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CXCL10&keywords=CXCL10	1.6366226460674158	403	NA	NA	1.094665501285878	246	0	0.016966067864271454	0.014380530973451327	0.014628297362110312	0.011784511784511785	0	0.001813236627379873	0.0065252854812398045	0	6.676458806249166e-5	0.0016225613289549935	303	407	340	0.006162477819089277	0.618717013067708	0.62284785171818	0.7191076429647284	296	282	229
CXCL11	C-X-C motif chemokine ligand 11	Yes		ENSG00000169248	O14625	Intercrine alpha (chemokine CxC) family	17	ligand	extracellular, ligand, secreted	P08913, P25106, P27487, P48039, P49682, P51677, P51681, Q14831, Q16570	ACKR1, ACKR3, ADRA2A, CCR3, CCR5, CXCR3, DPP4, GRM7, MTNR1A	CXCR3 [Baccin2019:12884299;Baccin2019:15273303;Baccin2019:15761110;Baccin2019:9625760;CellPhoneDB:24218476;Cellinker:12884299;Cellinker:15273303;Cellinker:15761110;Cellinker:9625760;DIP:11259614;DIP:9625760;Guide2Pharma:15761110;HPRD:15273303;HPRD:9625760;ICELLNET:12884299;LRdb:10699158;SIGNOR:12750173;SPIKE:16189514;connectomeDB2020:12884299;connectomeDB2020:15273303;connectomeDB2020:15761110;connectomeDB2020:9625760;scConnect:15761110], ACKR3 [CellTalkDB:27875312;ICELLNET:20161793;ICELLNET:22633458;ICELLNET:24218476;connectomeDB2020:27875312;connectomeDB2020:29180449;connectomeDB2020:29386406], CCR3 [Baccin2019:11110785;CellTalkDB:11110785;Cellinker:11110785;DIP:11110785;HPRD:11110785;ICELLNET:15178708;ICELLNET:22633458;LRdb:11110785;connectomeDB2020:11110785], CCR5 [ICELLNET:15178708;ICELLNET:22633458], DPP4 [CellPhoneDB:24218476;CellTalkDB:24218476;Cellinker:11390394;HPRD:11390394;IntAct:18275857;IntAct:21314817], ACKR1 [CellChatDB:26740381;CellTalkDB:10699158;Cellinker:26740381;Cellinker:29637711;LRdb:10699158], GRM7 [CellTalkDB:32196115], ADRA2A [CellTalkDB:32196115], MTNR1A [CellTalkDB:32196115]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	chemokine activity [GO:0008009]; CXCR3 chemokine receptor binding [GO:0048248]; CXCR chemokine receptor binding [GO:0045236]; heparin binding [GO:0008201]	adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cell-cell signaling [GO:0007267]; cellular response to lipopolysaccharide [GO:0071222]; chemokine-mediated signaling pathway [GO:0070098]; chemotaxis [GO:0006935]; inflammatory response [GO:0006954]; killing of cells of other organism [GO:0031640]; neutrophil chemotaxis [GO:0030593]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; regulation of cell population proliferation [GO:0042127]; signal transduction [GO:0007165]; T cell chemotaxis [GO:0010818]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CXCL11&keywords=CXCL11	1.6625313707865168	401	NA	NA	5.918204783322437	64	0	0.00249500998003992	0	0.0014388489208633094	0.013468013468013466	0.005076142131979695	0	0	0.0036995930447650763	0	5.794861889124977e-4	292	409	380	0.0024324630667794515	1.1019210731758777	0.804345844124871	0.8509565749028237	109	209	162
CXCL12	C-X-C motif chemokine ligand 12	Yes		ENSG00000107562	P48061	Intercrine alpha (chemokine CxC) family	20	ligand, receptor	extracellular, intracellular, ligand, receptor, secreted	P01730, P02751, P05106, P05556, P06756, P08648, P08913, P13612, P25106, P27487, P31431, P37288, P48039, P49682, P51679, P61073, Q14831	ACKR3, ADRA2A, AVPR1A, CCR4, CD4, CXCR3, CXCR4, DPP4, FN1, GRM7, ITGA4, ITGA5, ITGAV, ITGB1, ITGB3, MTNR1A, SDC4	ACKR3 [Baccin2019:16107333;CellTalkDB:16107333;Cellinker:16107333;Cellinker:20956518;Cellinker:23396314;Guide2Pharma:20956518;Guide2Pharma:23396314;HPMR:16107333;ICELLNET:20161793;ICELLNET:22633458;ICELLNET:24218476;LRdb:16107333;LRdb:20956518;LRdb:23396314;SIGNOR:16107333;connectomeDB2020:16107333;connectomeDB2020:20956518;connectomeDB2020:23396314;scConnect:20956518;scConnect:23396314], CXCR3 [Cellinker:9660793;Guide2Pharma:9660793;LRdb:9660793;connectomeDB2020:9660793;scConnect:9660793], CXCR4 [Baccin2019:10233851;Baccin2019:12714578;Baccin2019:8752280;Baccin2019:8752281;Baccin2019:9551924;Baccin2019:9712844;BioGRID:21757744;BioGRID:25495026;CellPhoneDB:24218476;Cellinker:10233851;Cellinker:12714578;Cellinker:18448868;Cellinker:8752280;Cellinker:8752281;Cellinker:9551924;Cellinker:9712844;Guide2Pharma:16626895;Guide2Pharma:18648536;Guide2Pharma:30476826;Guide2Pharma:9551924;Guide2Pharma:9712844;HPMR:8752280;HPRD:10233851;HPRD:8752281;ICELLNET:22633458;InnateDB:16725153;InnateDB:19837984;LRdb:10699158;ProtMapper:24023874;ProtMapper:26582643;SIGNOR:11859124;connectomeDB2020:10233851;connectomeDB2020:12714578;connectomeDB2020:8752280;connectomeDB2020:8752281;connectomeDB2020:9551924;connectomeDB2020:9712844;scConnect:16626895;scConnect:18648536;scConnect:30476826;scConnect:9551924;scConnect:9712844], ITGB1 [CellTalkDB:18448868;Cellinker:18448868;LRdb:18448868;Ramilowski2015:18448868;connectomeDB2020:18448868;talklr:18448868], CD4 [CellTalkDB:10600606;Cellinker:10600606;HPRD:10600606;LRdb:10600606;connectomeDB2020:10600606], ADRA2A [CellTalkDB:32196115], AVPR1A [CellTalkDB:29386406], MTNR1A [CellTalkDB:32196115], CCR4 [CellTalkDB:32196115], GRM7 [CellTalkDB:32196115], DPP4 [CellPhoneDB:24218476;CellTalkDB:30759373;Cellinker:11390394;HPRD:11390394], SDC4 [Baccin2019:19695308;CellTalkDB:32196115], ITGA4 [connectomeDB2020:29301984], ITGA5 [connectomeDB2020:29301984], ITGAV [connectomeDB2020:29301984], ITGB3 [connectomeDB2020:29301984], FN1 [HPRD:11023498]	collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; nucleus [GO:0005634]	chemokine activity [GO:0008009]; chemokine receptor binding [GO:0042379]; CXCR chemokine receptor binding [GO:0045236]; growth factor activity [GO:0008083]; integrin binding [GO:0005178]; signaling receptor binding [GO:0005102]	adult locomotory behavior [GO:0008344]; animal organ regeneration [GO:0031100]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; axon guidance [GO:0007411]; blood circulation [GO:0008015]; cell adhesion [GO:0007155]; cell chemotaxis [GO:0060326]; cellular calcium ion homeostasis [GO:0006874]; cellular response to chemokine [GO:1990869]; chemokine (C-X-C motif) ligand 12 signaling pathway [GO:0038146]; chemokine-mediated signaling pathway [GO:0070098]; chemotaxis [GO:0006935]; defense response [GO:0006952]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; G protein-coupled receptor signaling pathway [GO:0007186]; immune response [GO:0006955]; induction of positive chemotaxis [GO:0050930]; integrin activation [GO:0033622]; killing of cells of other organism [GO:0031640]; negative regulation of dendritic cell apoptotic process [GO:2000669]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902230]; negative regulation of leukocyte tethering or rolling [GO:1903237]; neuron migration [GO:0001764]; positive regulation of axon extension involved in axon guidance [GO:0048842]; positive regulation of calcium ion import [GO:0090280]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell migration [GO:0030335]; positive regulation of dopamine secretion [GO:0033603]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of monocyte chemotaxis [GO:0090026]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of T cell migration [GO:2000406]; regulation of actin polymerization or depolymerization [GO:0008064]; response to heat [GO:0009408]; response to hypoxia [GO:0001666]; response to peptide hormone [GO:0043434]; response to radiation [GO:0009314]; response to ultrasound [GO:1990478]; response to virus [GO:0009615]; signal transduction [GO:0007165]; T cell chemotaxis [GO:0010818]; telencephalon cell migration [GO:0022029]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CXCL12&keywords=CXCL12	8.107037528089888	257	NA	NA	0.16492824597963257	563	0.047244094488188976	0.001497005988023952	0.1460176991150444	0.048920863309352504	0.15824915824915828	0.013536379018612519	0.0027198549410698096	0.013050570962479609	0.03070662227155009	0.001001468820937375	0.006335715665443312	205	371	271	0.042661766620896435	0.7729824668547582	0.20890808506549305	0.31020067714479643	232	413	390
CXCL13	C-X-C motif chemokine ligand 13	Yes		ENSG00000156234	O43927	Intercrine alpha (chemokine CxC) family	18	ligand	extracellular, ligand, ligand_regulator, secreted	P08913, P09038, P28223, P32302, P41143, P46092, P48039, P49682, Q14831, Q16570, Q9NPB9	ACKR1, ACKR4, ADRA2A, CCR10, CXCR3, CXCR5, FGF2, GRM7, HTR2A, MTNR1A, OPRD1	CXCR5 [Baccin2019:9463416;Baccin2019:9486651;CellPhoneDB:24218476;Cellinker:28389721;Cellinker:9463416;Cellinker:9486651;DIP:9463416;Guide2Pharma:22913878;HPMR:9463416;HPRD:9463416;HPRD:9486651;ICELLNET:22633458;LRdb:10699158;connectomeDB2020:9463416;connectomeDB2020:9486651;scConnect:22913878], CXCR3 [Baccin2019:11554781;CellTalkDB:11554781;Cellinker:11554781;HPRD:11554781;ICELLNET:11554781;ICELLNET:22633458;LRdb:11554781;connectomeDB2020:11554781], ACKR4 [Baccin2019:10706668;CellPhoneDB:24218476;Cellinker:10706668;HPRD:10706668;ICELLNET:22633458;ICELLNET:706668;LRdb:10706668;connectomeDB2020:10706668], CCR10 [Baccin2019:10706668;CellTalkDB:10706668;Cellinker:10706668;HPRD:10706668;LRdb:10706668;connectomeDB2020:10706668], GRM7 [CellTalkDB:32196115], MTNR1A [CellTalkDB:32196115], OPRD1 [CellTalkDB:32196115], ADRA2A [CellTalkDB:32196115], ACKR1 [CellChatDB:26740381;Cellinker:26740381], HTR2A [NA], FGF2 [HPRD:11708770]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	CCR10 chemokine receptor binding [GO:0031735]; chemokine activity [GO:0008009]; CXCR3 chemokine receptor binding [GO:0048248]; CXCR5 chemokine receptor binding [GO:0031724]; CXCR chemokine receptor binding [GO:0045236]; fibroblast growth factor binding [GO:0017134]; heparin binding [GO:0008201]; receptor ligand activity [GO:0048018]	activation of GTPase activity [GO:0090630]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; B cell chemotaxis [GO:0035754]; cell-cell signaling [GO:0007267]; cell surface receptor signaling pathway [GO:0007166]; cellular response to lipopolysaccharide [GO:0071222]; chemokine-mediated signaling pathway [GO:0070098]; chronic inflammatory response [GO:0002544]; defense response to bacterium [GO:0042742]; endothelial cell chemotaxis to fibroblast growth factor [GO:0035768]; germinal center formation [GO:0002467]; immune response [GO:0006955]; inflammatory response [GO:0006954]; killing of cells of other organism [GO:0031640]; lymphocyte chemotaxis across high endothelial venule [GO:0002518]; negative regulation of endothelial cell chemotaxis to fibroblast growth factor [GO:2000545]; neutrophil chemotaxis [GO:0030593]; positive regulation of cell-cell adhesion mediated by integrin [GO:0033634]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of integrin activation [GO:0033625]; positive regulation of T cell chemotaxis [GO:0010820]; regulation of angiogenesis [GO:0045765]; regulation of humoral immune response [GO:0002920]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CXCL13&keywords=CXCL13	0.18364864494382022	620	NA	NA	0.018116893140289317	802	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
CXCL14	C-X-C motif chemokine ligand 14	Yes		ENSG00000145824	O95715	Intercrine alpha (chemokine CxC) family	6	ligand	intracellular, ligand, secreted	P61073	CXCR4	CXCR4 [CellTalkDB:32239134;connectomeDB2020:28360196]	extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]	chemokine activity [GO:0008009]	antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cell-cell signaling [GO:0007267]; chemotaxis [GO:0006935]; killing of cells of other organism [GO:0031640]; signal transduction [GO:0007165]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CXCL14&keywords=CXCL14	0.17227647191011236	627	NA	NA	0.0016478819998520574	892	0.023622047244094488	0.019960079840319347	0.01327433628318584	0.02853717026378896	0.05723905723905722	0.08629441624365482	0.024478694469628286	0.03425774877650898	0.025157232704402486	0.027006275871277803	0.02441568475951328	219	179	197	0.033112976699584684	0.815467531954043	0.8583558525578284	0.7982674218791488	216	188	189
CXCL16	C-X-C motif chemokine ligand 16	Yes		ENSG00000161921	Q9H2A7	Intercrine alpha (chemokine CxC) family	1	cell_surface_ligand, receptor	cell_surface, cell_surface_ligand, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, secreted, transmembrane	O00574, P08913, P48039, Q14831	ADRA2A, CXCR6, GRM7, MTNR1A	CXCR6 [Baccin2019:11017100;Baccin2019:11290797;Baccin2019:14625285;CellTalkDB:14625285;Cellinker:11017100;Cellinker:11290797;Cellinker:14625285;Guide2Pharma:11290797;HPMR:14625285;HPRD:11017100;HPRD:11290797;ICELLNET:22633458;LRdb:11017100;LRdb:11290797;LRdb:14625285;SPIKE:14625285;connectomeDB2020:11017100;connectomeDB2020:11290797;connectomeDB2020:14625285;scConnect:11290797], GRM7 [CellTalkDB:32196115], MTNR1A [CellTalkDB:32196115], ADRA2A [CellTalkDB:32196115]	extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]	chemokine activity [GO:0008009]; low-density lipoprotein particle receptor activity [GO:0005041]; scavenger receptor activity [GO:0005044]	chemotaxis [GO:0006935]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; receptor-mediated endocytosis [GO:0006898]; response to cytokine [GO:0034097]; response to interferon-gamma [GO:0034341]; response to tumor necrosis factor [GO:0034612]; T cell chemotaxis [GO:0010818]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CXCL16&keywords=CXCL16	55.966188168670875	76	NA	NA	2.2310427766316794	141	0.7401574803149599	0.3787425149700646	0.012168141592920354	0.01942446043165467	0.07744107744107746	0.0439932318104907	0.04714415231187666	0.024469820554649267	0.0199778024417314	0.030678328214714834	0.035039598222908974	236	170	175	0.12993060075518625	0.2142333576783442	0.29070359160311954	0.3218709701797637	427	382	385
CXCL17	C-X-C motif chemokine ligand 17	Yes		ENSG00000189377	Q6UXB2	Intercrine alpha (chemokine CxC) family	5	ligand	intracellular, ligand, secreted	Q9HC97	GPR35	GPR35 [CellTalkDB:25411203;connectomeDB2020:25411203;scConnect:25411203]	extracellular space [GO:0005615]	NA	angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; macrophage chemotaxis [GO:0048246]; negative regulation of inflammatory response [GO:0050728]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of macrophage chemotaxis [GO:0010759]; positive regulation of monocyte chemotaxis [GO:0090026]; positive regulation of vascular endothelial growth factor production [GO:0010575]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CXCL17&keywords=CXCL17	42.74421915009226	100	NA	NA	2.327299559614721	137	0	0.04790419161676645	0.0011061946902654867	2.3980815347721823e-4	2.72222222222223	0.001692047377326565	9.066183136899365e-4	0	0.0022197558268590455	5.674989985311792e-4	0.0013521344407958285	297	386	350	0.2525645883309038	0.046539999565587964	0.040247236177992196	0.043235588290714236	504	504	511
CXCL2	C-X-C motif chemokine ligand 2	Yes		ENSG00000081041	P19875	Intercrine alpha (chemokine CxC) family	18	ligand	extracellular, ligand, secreted	P08913, P25024, P25025, P27487, P46094, P48039, Q14831, Q16570	ACKR1, ADRA2A, CXCR1, CXCR2, DPP4, GRM7, MTNR1A, XCR1	CXCR2 [Baccin2019:10188995;Baccin2019:1379593;Baccin2019:8550564;Baccin2019:8702798;Baccin2019:8940121;Baccin2019:9260277;CellPhoneDB:24218476;Cellinker:8702798;Cellinker:9260277;DIP:8702798;Guide2Pharma:8702798;HPMR:12964882;HPRD:8702798;HPRD:9260277;ICELLNET:22633458;ICELLNET:8702798;LRdb:10699158;connectomeDB2020:8702798;connectomeDB2020:9260277;scConnect:8702798], ACKR1 [Baccin2019:28553950;CellChatDB:26740381;Cellinker:26740381;Cellinker:29637711;ICELLNET:22633458;ICELLNET:30446388], ADRA2A [CellTalkDB:32196115], CXCR1 [Baccin2019:12964882;Baccin2019:1379593;Baccin2019:8702798;Baccin2019:9260277;CellTalkDB:12964882;Cellinker:12964882;Cellinker:9260277;HPRD:9260277;LRdb:12964882;LRdb:93;connectomeDB2020:12964882;connectomeDB2020:9260277], MTNR1A [CellTalkDB:32196115], XCR1 [Baccin2019:10518929;CellTalkDB:10679309;Cellinker:10518929;LRdb:10518929;connectomeDB2020:10518929], GRM7 [CellTalkDB:32196115], DPP4 [CellPhoneDB:24218476;CellTalkDB:24218476;Cellinker:21314817;IntAct:18275857;IntAct:21314817]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	chemokine activity [GO:0008009]; CXCR chemokine receptor binding [GO:0045236]	antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cellular response to lipopolysaccharide [GO:0071222]; chemokine-mediated signaling pathway [GO:0070098]; chemotaxis [GO:0006935]; inflammatory response [GO:0006954]; killing of cells of other organism [GO:0031640]; neutrophil chemotaxis [GO:0030593]; response to molecule of bacterial origin [GO:0002237]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CXCL2&keywords=CXCL2	45.427624303370784	96	NA	NA	3.0283528866040936	112	0.5039370078740155	0.7544910179640711	0.061946902654867284	0.8095923261390924	0.7727272727272736	0.005076142131979695	0.022665457842248413	0.11582381729200655	0.03588605253422123	0.011283215382561078	0.056055630674135284	195	234	148	0.2863168039287702	0.15485470930380144	0.07182588061282283	0.2229223243445012	454	484	411
CXCL3	C-X-C motif chemokine ligand 3	Yes		ENSG00000163734	P19876	Intercrine alpha (chemokine CxC) family	18	ligand	extracellular, ligand, secreted	P08913, P25024, P25025, P48039, Q14831, Q16570	ACKR1, ADRA2A, CXCR1, CXCR2, GRM7, MTNR1A	CXCR2 [Baccin2019:8702798;CellPhoneDB:24218476;Cellinker:8702798;DIP:8702798;Guide2Pharma:8702798;HPRD:8702798;ICELLNET:22633458;ICELLNET:8702798;LRdb:10699158;connectomeDB2020:8702798;scConnect:8702798], MTNR1A [CellTalkDB:32196115], GRM7 [CellTalkDB:32196115], ADRA2A [CellTalkDB:32196115], CXCR1 [Baccin2019:129648828702798;CellTalkDB:12964882;Cellinker:12964882;Cellinker:8702798;HPRD:8702798;LRdb:12964882;LRdb:87;connectomeDB2020:12964882;connectomeDB2020:8702798], ACKR1 [CellChatDB:26740381;Cellinker:26740381;Cellinker:29637711]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	chemokine activity [GO:0008009]; CXCR chemokine receptor binding [GO:0045236]	antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cellular response to lipopolysaccharide [GO:0071222]; chemokine-mediated signaling pathway [GO:0070098]; inflammatory response [GO:0006954]; killing of cells of other organism [GO:0031640]; neutrophil chemotaxis [GO:0030593]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CXCL3&keywords=CXCL3	11.463452717865168	227	NA	NA	7.515204846500264	56	3.2755905511810997	0.4496007984031957	0.06194690265486727	1.3163069544364463	0.19696969696969696	0.001692047377326565	0.022665457842248413	0.009787928221859707	0.009988901220865707	0.007778074509280265	0.017809542205910727	265	256	213	0.48819425954752704	0.04012270482405828	0.035685024804233544	0.05582067973077023	511	508	498
CXCL5	C-X-C motif chemokine ligand 5	Yes		ENSG00000163735	P42830	Intercrine alpha (chemokine CxC) family	17	ligand	extracellular, intracellular, ligand, secreted	P08913, P25024, P25025, P48039, Q14831, Q16570	ACKR1, ADRA2A, CXCR1, CXCR2, GRM7, MTNR1A	CXCR2 [CellPhoneDB:24218476;Cellinker:8702798;Cellinker:9692902;DIP:8702798;Guide2Pharma:8702798;HPRD:8702798;HPRD:9692902;ICELLNET:22633458;InnateDB:8702798;InnateDB:9485196;LRdb:10699158;connectomeDB2020:8702798;connectomeDB2020:9692902;scConnect:8702798], MTNR1A [CellTalkDB:32196115], ACKR1 [CellChatDB:26740381;Cellinker:13679391;Cellinker:26740381;HPRD:13679391;LRdb:10699158;LRdb:13679391;connectomeDB2020:13679391], GRM7 [CellTalkDB:32196115], ADRA2A [CellTalkDB:32196115], CXCR1 [CellPhoneDB:24218476;Cellinker:12964882;Cellinker:8702798;Cellinker:9692902;DIP:8702798;HPRD:8702798;HPRD:9692902;InnateDB:9485196;LRdb:10699158;connectomeDB2020:12964882;connectomeDB2020:8702798;connectomeDB2020:9692902]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	chemokine activity [GO:0008009]; CXCR chemokine receptor binding [GO:0045236]; identical protein binding [GO:0042802]	antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cell-cell signaling [GO:0007267]; cellular response to lipopolysaccharide [GO:0071222]; chemokine-mediated signaling pathway [GO:0070098]; chemotaxis [GO:0006935]; inflammatory response [GO:0006954]; neutrophil chemotaxis [GO:0030593]; positive regulation of cell population proliferation [GO:0008284]; signal transduction [GO:0007165]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CXCL5&keywords=CXCL5	13.208098629213483	206	NA	NA	2.3616058305036804	133	0.4881889763779528	0.012475049900199599	0	0.18441247002398126	0	0.00338409475465313	0.003626473254759746	0.0032626427406199023	0.0011098779134295228	0.0037054346374682805	0.0011589723778249955	300	307	359	0.0637567265437172	0.1506286739399214	0.18581945375985165	0.1512943008826569	456	422	447
CXCL6	C-X-C motif chemokine ligand 6	Yes		ENSG00000124875	P80162	Intercrine alpha (chemokine CxC) family	18	ligand	extracellular, ligand, secreted	P08913, P25024, P25025, P48039, Q14831, Q16570	ACKR1, ADRA2A, CXCR1, CXCR2, GRM7, MTNR1A	CXCR1 [Baccin2019:10593335;Baccin2019:12964882;Baccin2019:8702798;Baccin2019:9692902;CellPhoneDB:24218476;Cellinker:10593335;Cellinker:12964882;Cellinker:9692902;Guide2Pharma:9692902;HPMR:12964882;HPRD:10593335;HPRD:9692902;ICELLNET:22633458;InnateDB:9485196;LRdb:10699158;connectomeDB2020:10593335;connectomeDB2020:12964882;connectomeDB2020:9692902;scConnect:9692902], CXCR2 [Baccin2019:10593335;Baccin2019:12964882;Baccin2019:8702798;Baccin2019:9692902;CellPhoneDB:24218476;CellTalkDB:9692902;Cellinker:10593335;Cellinker:12964882;Cellinker:9692902;Guide2Pharma:9692902;HPRD:10593335;HPRD:9692902;ICELLNET:22633458;InnateDB:9485196;LRdb:10593335;LRdb:12964882;LRdb:9692902;connectomeDB2020:10593335;connectomeDB2020:12964882;connectomeDB2020:9692902;scConnect:9692902], ADRA2A [CellTalkDB:32196115], ACKR1 [Baccin2019:20643340;CellChatDB:26740381;CellTalkDB:10699158;Cellinker:26740381;Cellinker:29637711;LRdb:10699158], GRM7 [CellTalkDB:32196115], MTNR1A [CellTalkDB:32196115]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	chemokine activity [GO:0008009]; CXCR chemokine receptor binding [GO:0045236]; heparin binding [GO:0008201]	antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cell-cell signaling [GO:0007267]; cellular response to lipopolysaccharide [GO:0071222]; chemokine-mediated signaling pathway [GO:0070098]; chemotaxis [GO:0006935]; defense response to bacterium [GO:0042742]; inflammatory response [GO:0006954]; leukocyte homeostasis [GO:0001776]; neutrophil activation [GO:0042119]; neutrophil chemotaxis [GO:0030593]; regulation of chemokine production [GO:0032642]; regulation of neutrophil mediated killing of gram-negative bacterium [GO:0070951]; signal transduction [GO:0007165]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CXCL6&keywords=CXCL6	46.2957561235955	94	NA	NA	19.184778281078756	29	0	0.298403193612776	0.0011061946902654867	0.03645083932853716	0.006734006734006734	0	0.006346328195829556	0.0978792822185971	0.01220865704772475	0.0014020563493123241	0.015337067799884056	257	360	223	0.04326069327063029	0.416980247231805	0.2140801339437276	0.47571794965454856	370	410	334
CXCL8	C-X-C motif chemokine ligand 8	Yes		ENSG00000169429	P10145	Intercrine alpha (chemokine CxC) family	17	ligand	extracellular, intracellular, ligand, secreted	O75056, P08913, P11912, P14780, P18827, P25024, P25025, P34741, P35968, P48039, Q14831, Q16570	ACKR1, ADRA2A, CD79A, CXCR1, CXCR2, GRM7, KDR, MMP9, MTNR1A, SDC1, SDC2, SDC3	CXCR1 [CellPhoneDB:24218476;CellTalkDB:1379593;Cellinker:10188995;Cellinker:1379593;Cellinker:15282370;Cellinker:15946947;Cellinker:1840701;Cellinker:8137938;Cellinker:8940121;DIP:10206993;DIP:10368283;DIP:8550564;DIP:9195914;DIP:9553055;DIP:9725262;Guide2Pharma:10188995;Guide2Pharma:1379593;Guide2Pharma:15282370;Guide2Pharma:15946947;Guide2Pharma:8940121;HPRD:1840701;ICELLNET:1840701;InnateDB:10368283;InnateDB:12628493;InnateDB:1840701;InnateDB:8245475;InnateDB:8662882;InnateDB:8702798;InnateDB:9485196;LRdb:10188995;LRdb:10699158;LRdb:1379593;LRdb:15282370;LRdb:15946947;LRdb:1840701;LRdb:8137938;LRdb:8940121;Lit-BM-17:10206993;Lit-BM-17:10368283;Lit-BM-17:8550564;Lit-BM-17:9195914;Lit-BM-17:9553055;Lit-BM-17:9725262;SIGNOR:11350788;connectomeDB2020:10188995;connectomeDB2020:1379593;connectomeDB2020:15282370;connectomeDB2020:15946947;connectomeDB2020:1840701;connectomeDB2020:8137938;connectomeDB2020:8940121;scConnect:10188995;scConnect:1379593;scConnect:15282370;scConnect:15946947;scConnect:22262769;scConnect:8940121], CXCR2 [CellPhoneDB:24218476;CellTalkDB:1379593;Cellinker:10188995;Cellinker:11511101;Cellinker:1379593;Cellinker:15282370;Cellinker:15946947;Cellinker:8626516;Cellinker:8702798;Cellinker:8940121;Cellinker:9464567;DIP:10206993;DIP:10216072;DIP:22904195;DIP:7559482;DIP:8550564;DIP:9195914;DIP:9553055;DIP:9725262;Guide2Pharma:10188995;Guide2Pharma:1379593;Guide2Pharma:15282370;Guide2Pharma:15946947;Guide2Pharma:8940121;HPRD:8626516;HPRD:8702798;HPRD:9464567;ICELLNET:1891716;InnateDB:12628493;InnateDB:19190236;InnateDB:7592830;InnateDB:8245475;InnateDB:8662882;InnateDB:8702798;InnateDB:9126332;InnateDB:9464567;InnateDB:9485196;IntAct:22904195;IntAct:23597562;LRdb:10188995;LRdb:10699158;LRdb:1379593;LRdb:15282370;LRdb:15946947;LRdb:8626516;LRdb:8702798;LRdb:8940121;LRdb:9464567;Lit-BM-17:10206993;Lit-BM-17:10216072;Lit-BM-17:23597562;Lit-BM-17:7559482;Lit-BM-17:8550564;Lit-BM-17:9195914;Lit-BM-17:9464567;Lit-BM-17:9553055;Lit-BM-17:9725262;SIGNOR:11350788;connectomeDB2020:10188995;connectomeDB2020:1379593;connectomeDB2020:15282370;connectomeDB2020:15946947;connectomeDB2020:8626516;connectomeDB2020:8702798;connectomeDB2020:8940121;connectomeDB2020:9464567;scConnect:10188995;scConnect:1379593;scConnect:15282370;scConnect:15946947;scConnect:8940121], ACKR1 [CellChatDB:26740381;CellPhoneDB:24218476;Cellinker:17416748;Cellinker:26740381;Cellinker:9921412;DIP:10206993;DIP:7592830;DIP:8558064;DIP:9195930;HPRD:17416748;HPRD:9921412;ICELLNET:22633458;InnateDB:15720550;InnateDB:7592830;InnateDB:8132497;InnateDB:9195930;LRdb:10699158;LRdb:174;LRdb:9921412;connectomeDB2020:17416748;connectomeDB2020:9921412], SDC1 [CellTalkDB:12902511;Cellinker:12902511;HPRD:12902511;InnateDB:12902511;LRdb:12902511;connectomeDB2020:12902511], SDC3 [CellTalkDB:32196115], SDC2 [CellTalkDB:14527339;Cellinker:14527339;LRdb:14527339;Ramilowski2015:14527339;connectomeDB2020:14527339;talklr:14527339], GRM7 [CellTalkDB:32196115], CD79A [CellTalkDB:32196115], KDR [CellTalkDB:32196115], ADRA2A [CellTalkDB:32196115], MTNR1A [CellTalkDB:32196115], MMP9 [HPRD:11023497;InnateDB:17375198;InnateDB:18660381]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	chemokine activity [GO:0008009]; CXCR chemokine receptor binding [GO:0045236]; heparin binding [GO:0008201]; interleukin-8 receptor binding [GO:0005153]	angiogenesis [GO:0001525]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; calcium-mediated signaling [GO:0019722]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to interleukin-1 [GO:0071347]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to tumor necrosis factor [GO:0071356]; chemokine-mediated signaling pathway [GO:0070098]; chemotaxis [GO:0006935]; embryonic digestive tract development [GO:0048566]; G protein-coupled receptor signaling pathway [GO:0007186]; induction of positive chemotaxis [GO:0050930]; inflammatory response [GO:0006954]; intracellular signal transduction [GO:0035556]; killing of cells of other organism [GO:0031640]; negative regulation of cell adhesion molecule production [GO:0060354]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; negative regulation of G protein-coupled receptor signaling pathway [GO:0045744]; neutrophil activation [GO:0042119]; neutrophil chemotaxis [GO:0030593]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cellular biosynthetic process [GO:0031328]; positive regulation of gene expression [GO:0010628]; positive regulation of neutrophil chemotaxis [GO:0090023]; receptor internalization [GO:0031623]; regulation of cell adhesion [GO:0030155]; regulation of entry of bacterium into host cell [GO:2000535]; regulation of single stranded viral RNA replication via double stranded DNA intermediate [GO:0045091]; response to endoplasmic reticulum stress [GO:0034976]; response to molecule of bacterial origin [GO:0002237]; signal transduction [GO:0007165]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CXCL8&keywords=CXCL8	365.5623997977528	26	2386.51	126	98.04841043397933	11	59.236220472440984	3.7325349301397046	3.0752212389380484	31.384652278176887	1.0892255892255907	0.12182741116751265	0.08612873980054389	0.6117455138662324	0.29448760636330035	0.06946855387902347	0.31052733243190356	60	125	52	9.092003606039066	0.03345281100100605	0.008730885782806883	0.035215030262044464	517	525	514
CXCL9	C-X-C motif chemokine ligand 9	Yes		ENSG00000138755	Q07325	Intercrine alpha (chemokine CxC) family	18	ligand, receptor	extracellular, ligand, receptor, secreted	P08913, P12318, P27487, P43628, P48039, P49682, P51677, Q14831, Q16570	ACKR1, ADRA2A, CCR3, CXCR3, DPP4, FCGR2A, GRM7, KIR2DL3, MTNR1A	CXCR3 [Baccin2019:12782716;Baccin2019:12884299;Baccin2019:15761110;Baccin2019:9660793;BioGRID:12782716;BioGRID:9660793;CellPhoneDB:24218476;Cellinker:12782716;Cellinker:12884299;Cellinker:15761110;Cellinker:9660793;DIP:11259614;DIP:9625760;DIP:9660793;Guide2Pharma:15761110;Guide2Pharma:9660793;HPRD:12782716;HPRD:9660793;ICELLNET:12884299;LRdb:10699158;SIGNOR:12750173;SPIKE:9660793;connectomeDB2020:12782716;connectomeDB2020:12884299;connectomeDB2020:15761110;connectomeDB2020:9660793;scConnect:15761110;scConnect:9660793], CCR3 [Baccin2019:11110785;CellTalkDB:11110785;Cellinker:11110785;DIP:11110785;HPRD:11110785;ICELLNET:22633458;LRdb:11110785;connectomeDB2020:11110785], FCGR2A [CellTalkDB:32103204], ADRA2A [CellTalkDB:32196115], MTNR1A [CellTalkDB:32196115], KIR2DL3 [CellTalkDB:32103204], GRM7 [CellTalkDB:32196115], DPP4 [CellPhoneDB:24218476;CellTalkDB:24218476;Cellinker:21314817;HPRD:11390394;IntAct:18275857;IntAct:21314817], ACKR1 [CellChatDB:26740381;Cellinker:26740381]	external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	chemokine activity [GO:0008009]; CXCR3 chemokine receptor binding [GO:0048248]; CXCR chemokine receptor binding [GO:0045236]; cytokine activity [GO:0005125]	adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cell-cell signaling [GO:0007267]; cellular defense response [GO:0006968]; cellular response to lipopolysaccharide [GO:0071222]; chemokine-mediated signaling pathway [GO:0070098]; chemotaxis [GO:0006935]; defense response [GO:0006952]; defense response to virus [GO:0051607]; G protein-coupled receptor signaling pathway [GO:0007186]; inflammatory response [GO:0006954]; killing of cells of other organism [GO:0031640]; neutrophil chemotaxis [GO:0030593]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of myoblast fusion [GO:1901741]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; regulation of cell population proliferation [GO:0042127]; signal transduction [GO:0007165]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CXCL9&keywords=CXCL9	0.6205469719101123	503	NA	NA	0.5239729398215913	375	0	0	0	9.592326139088729e-4	0	0	0	0	0	6.676458806249166e-5	2.7042688815916556e-4	303	407	393	1.1785673546641183e-4	0.9883516105685421	0.994950299382593	1.0150792956138572	137	134	94
CYB5D2	cytochrome b5 domain containing 2	No		ENSG00000167740	Q8WUJ1	Cytochrome b5 family, MAPR subfamily	0	ligand	extracellular, intracellular, ligand, secreted	NA	NA	NA	endomembrane system [GO:0012505]; extracellular region [GO:0005576]; membrane [GO:0016020]	heme binding [GO:0020037]	nervous system development [GO:0007399]; positive regulation of neuron differentiation [GO:0045666]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CYB5D2&keywords=CYB5D2	19.77902209585604	169	NA	NA	0.9184706313568337	281	0.05511811023622047	0.0633732534930139	0.08407079646017708	0.08609112709832192	0.06228956228956227	0.3299492385786805	0.3000906618313681	0.26590538336052183	0.2578616352201242	0.28174656162372036	0.1829631060459637	68	66	75	0.17904176693069768	1.4169442000524768	1.5432915506480325	1.0207432419773328	60	48	93
CYTL1	cytokine like 1	Yes		ENSG00000170891	Q9NRR1	NA	1	ligand	extracellular, ligand, secreted	P41597	CCR2	CCR2 [connectomeDB2020:27084102]	extracellular space [GO:0005615]	signaling receptor binding [GO:0005102]	cartilage homeostasis [GO:1990079]; chondrocyte differentiation [GO:0002062]; chondroitin sulfate proteoglycan biosynthetic process [GO:0050650]; inner ear development [GO:0048839]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of transcription by RNA polymerase II [GO:0045944]; signal transduction [GO:0007165]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=CYTL1&keywords=CYTL1	0.20747118038896967	611	NA	NA	0.023715877532012673	789	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
DAND5	DAN domain BMP antagonist family member 5	Yes		ENSG00000179284	Q8N907	DAN family	2	ligand	ligand, secreted	NA	NA	NA	extracellular region [GO:0005576]; extracellular space [GO:0005615]	morphogen activity [GO:0016015]	atrial septum development [GO:0003283]; determination of heart left/right asymmetry [GO:0061371]; determination of left/right asymmetry in lateral mesoderm [GO:0003140]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of nodal signaling pathway [GO:1900108]; negative regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry [GO:1900176]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; sequestering of BMP in extracellular matrix [GO:0035582]; sequestering of nodal from receptor via nodal binding [GO:0038101]; signal transduction involved in regulation of gene expression [GO:0023019]; ventricular septum development [GO:0003281]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=DAND5&keywords=DAND5	0.06512801123595506	705	NA	NA	0.12358167121517855	599	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
DBP	D-box binding PAR bZIP transcription factor			ENSG00000105516	Q10586	BZIP family, PAR subfamily	1	ligand	intracellular, ligand, secreted	Q16570	ACKR1	ACKR1 [Cellinker:29637711]	chromatin [GO:0000785]; nucleus [GO:0005634]	DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]	circadian rhythm [GO:0007623]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=DBP&keywords=DBP	2.7573868821662133	352	NA	NA	0.16333929782356366	565	0.023622047244094488	0.026946107784431114	0.0055309734513274336	0.025179856115107906	0.02188552188552188	0.11844331641285948	0.12964641885766062	0.050570962479608524	0.042915279319274885	0.097743356923488	0.032992080355418264	180	107	178	0.052315992802617506	0.8491444481496289	1.7289840388928597	0.6899044438173892	202	35	242
DCN	decorin	No		ENSG00000011465	P07585	Small leucine-rich proteoglycan (SLRP) family, SLRP class I subfamily	9	adhesion, ecm, ligand, receptor	adhesion, cell_adhesion, ecm, extracellular, intracellular, ligand, ligand_regulator, plasma_membrane, receptor, secreted	O00206, O60603, P00533, P01137, P08069, P08581, P35968, Q07954, Q15303	EGFR, ERBB4, IGF1R, KDR, LRP1, MET, TGFB1, TLR2, TLR4	EGFR [Baccin2019:12105206;Baccin2019:9988678;BioGRID:9988678;CellTalkDB:12105207;Cellinker:12105206;Cellinker:23350913;Cellinker:9988678;HPRD:12105206;HPRD:9988678;LRdb:12105207;Lit-BM-17:12105206;Lit-BM-17:9988678;connectomeDB2020:12105206;connectomeDB2020:9988678], MET [Baccin2019:26522384;CellTalkDB:10942781;LRdb:10942781;Ramilowski2015:10942781;connectomeDB2020:10942781;talklr:10942781], ERBB4 [CellTalkDB:10942781;Cellinker:10942781;LRdb:10942781;Ramilowski2015:10942781;connectomeDB2020:10942781;talklr:10942781], TLR2 [Cellinker:23350913;InnateDB:22087031;connectomeDB2020:22087031], TLR4 [Cellinker:23350913;InnateDB:22087031;connectomeDB2020:22087031], KDR [Cellinker:23350913], TGFB1 [BioGRID:7798269;BioGRID:8093006;BioGRID:9675033;HPRD:7638106;HPRD:7798269], IGF1R [Cellinker:23350913], LRP1 [Cellinker:23350913]	collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; lysosomal lumen [GO:0043202]	collagen binding [GO:0005518]; extracellular matrix binding [GO:0050840]; extracellular matrix structural constituent conferring compression resistance [GO:0030021]; glycosaminoglycan binding [GO:0005539]; RNA binding [GO:0003723]	animal organ morphogenesis [GO:0009887]; negative regulation of angiogenesis [GO:0016525]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of vascular endothelial growth factor signaling pathway [GO:1900747]; peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan [GO:0019800]; positive regulation of autophagy [GO:0010508]; positive regulation of macroautophagy [GO:0016239]; positive regulation of mitochondrial depolarization [GO:0051901]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of transcription by RNA polymerase II [GO:0045944]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=DCN&keywords=DCN	30.371563718337327	134	NA	NA	0.17745782575242852	550	0	0.003992015968063872	0.00331858407079646	2.5002398081534354	0.0016835016835016834	0.005076142131979695	0.0027198549410698096	0.0032626427406199023	0.0011098779134295228	0.002703965816530909	0.0024724744060266577	300	328	325	0.22968898798413218	0.04635122375403002	0.05300187515236175	0.05203607604556433	505	492	501
DDR1	discoidin domain receptor tyrosine kinase 1	No		ENSG00000223680, ENSG00000229767, ENSG00000234078, ENSG00000215522, ENSG00000230456, ENSG00000137332, ENSG00000204580	Q08345	Protein kinase superfamily, Tyr protein kinase family, Insulin receptor subfamily	1	adhesion, ligand, receptor	adhesion, cell_adhesion, cell_surface, extracellular, intracellular, ligand, matrix_adhesion, plasma_membrane, plasma_membrane_transmembrane, receptor, secreted, transmembrane, transmembrane_predicted	O43639, O95295, P02458, P02461, P02766, P05997, P06493, P12107, P19174, P24941, P29353, P30408, P41220, Q06124, Q5SQ64, Q7L4P6, Q8WU20, Q96DI7	BEND5, CDK1, CDK2, COL11A1, COL2A1, COL3A1, COL5A2, FRS2, LY6G6F, NCK2, PLCG1, PTPN11, RGS2, SHC1, SNAPIN, SNRNP40, TM4SF1, TTR	SHC1 [HPRD:10783152;SignaLink3:23331499;SignaLink3:9659899], COL3A1 [DIP:22483115;HPRD:9659900;MatrixDB:21044884], COL11A1 [HPRD:9659900], COL5A2 [HPRD:9659900], COL2A1 [HPRD:9659900], LY6G6F [Cellinker:32589946], TTR [HPRD:16169070], NCK2 [DOMINO:16337946;HPRD:16337946;Lit-BM-17:16337946], CDK1 [dbPTM:16565220;dbPTM:17924679;dbPTM:18220336;dbPTM:18691976;dbPTM:19369195;dbPTM:19690332;dbPTM:20360007], CDK2 [dbPTM:1396589;dbPTM:14597612;dbPTM:16325401;dbPTM:17095507;dbPTM:17192257;dbPTM:17570665;dbPTM:19690332;dbPTM:20147522;dbPTM:20360007;dbPTM:21565702], RGS2 [HPRD:16169070;Lit-BM-17:16169070;Lit-BM-17:21900206], PLCG1 [HPRD:10783152], FRS2 [HPRD:10783152], TM4SF1 [HPRD:16169070], SNAPIN [HPRD:16169070], SNRNP40 [HPRD:16169070], BEND5 [HPRD:16169070], PTPN11 [HPRD:16337946]	extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	ATP binding [GO:0005524]; collagen binding [GO:0005518]; metal ion binding [GO:0046872]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase collagen receptor activity [GO:0038062]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]	axon development [GO:0061564]; branching involved in mammary gland duct morphogenesis [GO:0060444]; cell adhesion [GO:0007155]; collagen-activated tyrosine kinase receptor signaling pathway [GO:0038063]; ear development [GO:0043583]; embryo implantation [GO:0007566]; lactation [GO:0007595]; mammary gland alveolus development [GO:0060749]; negative regulation of cell population proliferation [GO:0008285]; neuron projection extension [GO:1990138]; peptidyl-tyrosine autophosphorylation [GO:0038083]; positive regulation of kinase activity [GO:0033674]; protein autophosphorylation [GO:0046777]; regulation of cell growth [GO:0001558]; regulation of cell-matrix adhesion [GO:0001952]; regulation of extracellular matrix disassembly [GO:0010715]; smooth muscle cell-matrix adhesion [GO:0061302]; smooth muscle cell migration [GO:0014909]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; wound healing, spreading of cells [GO:0044319]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=DDR1&keywords=DDR1	78.55541241089888	61	2422.04	125	2.080045942650488	146	0.031496062992125984	0.4356287425149756	0.014380530973451327	0.03141486810551558	0.3333333333333327	0.7411167512690355	0.728014505893023	0.5089722675367052	0.419533851276364	0.5211309921218712	0.23225806451611727	45	44	63	0.36338908823022886	1.1503653020827345	1.4224598652287874	0.6488086346185424	100	60	259
DEFB1	defensin beta 1	TBD		ENSG00000284881, ENSG00000164825	P60022	Beta-defensin family	6	ligand	extracellular, intracellular, ligand, secreted	P51684	CCR6	CCR6 [CellTalkDB:20068036;HPRD:12149255;LRdb:20068036;LRdb:25122636;LRdb:25585877;connectomeDB2020:12149255]	extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extrinsic component of membrane [GO:0019898]; Golgi lumen [GO:0005796]; microvesicle [GO:1990742]; sperm midpiece [GO:0097225]	CCR6 chemokine receptor binding [GO:0031731]; identical protein binding [GO:0042802]	antibacterial humoral response [GO:0019731]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; calcium-mediated signaling using intracellular calcium source [GO:0035584]; cAMP-mediated signaling [GO:0019933]; chemotaxis [GO:0006935]; defense response to bacterium [GO:0042742]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; G protein-coupled receptor signaling pathway [GO:0007186]; immune response [GO:0006955]; innate immune response [GO:0045087]; innate immune response in mucosa [GO:0002227]; positive regulation of flagellated sperm motility involved in capacitation [GO:0060474]; response to bacterium [GO:0009617]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=DEFB1&keywords=DEFB1	142.70318930337078	41	NA	NA	1.4805530508082476	202	0.007874015748031496	0.9825349301397157	0.0022123893805309734	7.194244604316547e-4	0.6414141414141421	0.00338409475465313	9.066183136899365e-4	0	0.0022197558268590455	5.674989985311792e-4	0.001506664091172494	297	386	344	0.14939450301161433	0.07666359627200349	0.06629776309011845	0.07218984264679477	489	488	489
DEFB103A	defensin beta 103A	TBD		ENSG00000285376, ENSG00000284978, ENSG00000176797	P81534	Beta-defensin family	7	ligand	extracellular, intracellular, ligand, secreted	P41597, P51684	CCR2, CCR6	CCR6 [CellTalkDB:23390582;HPRD:11714836;LRdb:23390582;Ramilowski2015:23390582;connectomeDB2020:11714836;connectomeDB2020:23390582;talklr:23390582], CCR2 [CellTalkDB:23390582;InnateDB:20483750;LRdb:23390582;Ramilowski2015:23390582;connectomeDB2020:23390582;talklr:23390582]	extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]	CCR6 chemokine receptor binding [GO:0031731]; chemoattractant activity [GO:0042056]	antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cell chemotaxis [GO:0060326]; defense response to bacterium [GO:0042742]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; killing by host of symbiont cells [GO:0051873]; killing of cells of other organism [GO:0031640]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=DEFB103A&keywords=DEFB103A	0.08160934831460674	688	NA	NA	9.160934831460674	49	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
DEFB103B	defensin beta 103B	TBD		ENSG00000273641, ENSG00000177243	P81534	Beta-defensin family	7	ligand	extracellular, intracellular, ligand, secreted	P41597, P51684	CCR2, CCR6	CCR6 [CellTalkDB:23390582;HPRD:11714836;LRdb:23390582;Ramilowski2015:23390582;connectomeDB2020:11714836;connectomeDB2020:23390582;talklr:23390582], CCR2 [CellTalkDB:23390582;InnateDB:20483750;LRdb:23390582;Ramilowski2015:23390582;connectomeDB2020:23390582;talklr:23390582]	extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]	CCR6 chemokine receptor binding [GO:0031731]; chemoattractant activity [GO:0042056]	antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cell chemotaxis [GO:0060326]; defense response to bacterium [GO:0042742]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; killing by host of symbiont cells [GO:0051873]; killing of cells of other organism [GO:0031640]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=DEFB103B&keywords=DEFB103B	0.0026859932584269663	872	NA	NA	1.2685993258426966	229	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
DEFB104A	defensin beta 104A	TBD		ENSG00000285034, ENSG00000176782	Q8WTQ1	Beta-defensin family	1	ligand	extracellular, ligand, secreted	NA	NA	NA	extracellular region [GO:0005576]	chemoattractant activity [GO:0042056]	cellular response to phorbol 13-acetate 12-myristate [GO:1904628]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; innate immune response [GO:0045087]; monocyte chemotaxis [GO:0002548]; positive chemotaxis [GO:0050918]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=DEFB104A&keywords=DEFB104A	0	899	NA	NA	1	266	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
DEFB104B	defensin beta 104B	TBD		ENSG00000277006, ENSG00000177023	Q8WTQ1	Beta-defensin family	1	ligand	extracellular, ligand, secreted	NA	NA	NA	extracellular region [GO:0005576]	chemoattractant activity [GO:0042056]	cellular response to phorbol 13-acetate 12-myristate [GO:1904628]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; innate immune response [GO:0045087]; monocyte chemotaxis [GO:0002548]; positive chemotaxis [GO:0050918]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=DEFB104B&keywords=DEFB104B	0	899	NA	NA	1	266	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
DEFB106A	defensin beta 106A	TBD		ENSG00000285617, ENSG00000186579	Q8N104	Beta-defensin family	4	ligand	extracellular, intracellular, ligand, secreted	P41597	CCR2	CCR2 [CellTalkDB:23938203;Cellinker:23938203;InnateDB:23938203;LRdb:23938203;connectomeDB2020:23938203]	extrinsic component of membrane [GO:0019898]; microvesicle [GO:1990742]; nucleus [GO:0005634]	CCR2 chemokine receptor binding [GO:0031727]; heparin binding [GO:0008201]; lipopolysaccharide binding [GO:0001530]	antifungal innate immune response [GO:0061760]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; innate immune response [GO:0045087]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=DEFB106A&keywords=DEFB106A	0	899	NA	NA	1	266	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
DEFB106B	defensin beta 106B	TBD		ENSG00000275794, ENSG00000187082	Q8N104	Beta-defensin family	4	ligand	extracellular, intracellular, ligand, secreted	P41597	CCR2	CCR2 [CellTalkDB:23938203;Cellinker:23938203;InnateDB:23938203;LRdb:23938203;connectomeDB2020:23938203]	extrinsic component of membrane [GO:0019898]; microvesicle [GO:1990742]; nucleus [GO:0005634]	CCR2 chemokine receptor binding [GO:0031727]; heparin binding [GO:0008201]; lipopolysaccharide binding [GO:0001530]	antifungal innate immune response [GO:0061760]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; innate immune response [GO:0045087]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=DEFB106B&keywords=DEFB106B	0	899	NA	NA	1	266	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
DEFB109B	defensin beta 109B		manually added ensembl_gene_ID, hgnc_symbol, and description by searching the uniprot ID on genenames.org	ENSG00000206034	Q30KR1	Beta-defensin family	1	ligand	extracellular, ligand, secreted	NA	NA	NA	extracellular space [GO:0005615]	CCR6 chemokine receptor binding [GO:0031731]; chemoattractant activity [GO:0042056]	cell chemotaxis [GO:0060326]; defense response to bacterium [GO:0042742]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=DEFB109B&keywords=DEFB109B	0.05302202247191011	730	NA	NA	6.30220224719101	62	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
DEFB130A	defensin beta 130A	TBD		ENSG00000285249, ENSG00000232948	P0DP74	Beta-defensin family	1	ligand	ligand, secreted	NA	NA	NA	cytosol [GO:0005829]; extracellular space [GO:0005615]	CCR6 chemokine receptor binding [GO:0031731]; chemoattractant activity [GO:0042056]	antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cell chemotaxis [GO:0060326]; cytolysis by host of symbiont cells [GO:0051838]; defense response to bacterium [GO:0042742]; defense response to protozoan [GO:0042832]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=DEFB130A&keywords=DEFB130A	0	899	NA	NA	1	266	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
DEFB130B	defensin beta 130B	TBD		ENSG00000233050	P0DP73	Beta-defensin family	1	ligand	ligand, secreted	NA	NA	NA	extracellular space [GO:0005615]	CCR6 chemokine receptor binding [GO:0031731]; chemoattractant activity [GO:0042056]	cell chemotaxis [GO:0060326]; defense response to bacterium [GO:0042742]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=DEFB130B&keywords=DEFB130B	0	899	NA	NA	1	266	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
DEFB4A	defensin beta 4A	TBD		ENSG00000285181, ENSG00000171711	O15263	Beta-defensin family, LAP/TAP subfamily	8	ligand	extracellular, intracellular, ligand, secreted	O00206, P51684	CCR6, TLR4	CCR6 [CellTalkDB:20068036;CellTalkDB:26198319;Guide2Pharma:10521347;HPRD:11714836;InnateDB:10521347;LRdb:20068036;LRdb:25122636;LRdb:25585877;connectomeDB2020:10521347;connectomeDB2020:11714836;scConnect:10521347], TLR4 [HPRD:12411706;LRdb:12411706;connectomeDB2020:12411706]	extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]	CCR6 chemokine receptor binding [GO:0031731]; chemoattractant activity [GO:0042056]	antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cell chemotaxis [GO:0060326]; chemotaxis [GO:0006935]; defense response to bacterium [GO:0042742]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; G protein-coupled receptor signaling pathway [GO:0007186]; immune response [GO:0006955]; killing of cells of other organism [GO:0031640]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=DEFB4A&keywords=DEFB4A	0.16412533718989922	635	NA	NA	2.4257477186637444	132	0	0	0	7.194244604316547e-4	0	0	0.003626473254759746	0.0032626427406199023	0.008509064002959676	3.672052343437042e-4	0.0037087116090399872	272	395	304	0.0018357746638322427	1.5638236219146406	0.8759211398324276	1.1582437143663324	54	179	68
DEFB4B	defensin beta 4B	TBD		ENSG00000275444, ENSG00000285433, ENSG00000177257	O15263	Beta-defensin family, LAP/TAP subfamily	8	ligand	extracellular, intracellular, ligand, secreted	O00206, P51684	CCR6, TLR4	CCR6 [CellTalkDB:20068036;CellTalkDB:26198319;Guide2Pharma:10521347;HPRD:11714836;InnateDB:10521347;LRdb:20068036;LRdb:25122636;LRdb:25585877;connectomeDB2020:10521347;connectomeDB2020:11714836;scConnect:10521347], TLR4 [HPRD:12411706;LRdb:12411706;connectomeDB2020:12411706]	extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]	CCR6 chemokine receptor binding [GO:0031731]; chemoattractant activity [GO:0042056]	antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cell chemotaxis [GO:0060326]; chemotaxis [GO:0006935]; defense response to bacterium [GO:0042742]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; G protein-coupled receptor signaling pathway [GO:0007186]; immune response [GO:0006955]; killing of cells of other organism [GO:0031640]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=DEFB4B&keywords=DEFB4B	0.16412533718989922	635	NA	NA	17.412533718989923	31	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
DHH	desert hedgehog signaling molecule	Yes		ENSG00000139549	O43323	Hedgehog family	14	cell_surface_ligand, ligand	cell_surface_ligand, extracellular, ligand, plasma_membrane, secreted	Q13635, Q4KMG0, Q96QV1, Q9BWV1, Q9Y6C5	BOC, CDON, HHIP, PTCH1, PTCH1_SMO, PTCH2, PTCH2_SMO	PTCH2 [Baccin2019:98118519811851;CancerCellMap:9811851;CellTalkDB:9811851;Cellinker:9811851;HPMR:9811851;HPRD:9811851;LRdb:9811851;NetPath:9811851;SignaLink3:23331499;SignaLink3:9811851;connectomeDB2020:9811851], HHIP [Baccin2019:10050855;Baccin2019:11435703;CancerCellMap:10050855;CancerCellMap:11435703;CellTalkDB:10050855;Cellinker:10050855;Cellinker:11435703;DIP:19561611;HPRD:10050855;HPRD:11435703;IntAct:19561611;LRdb:10050855;LRdb:11;Lit-BM-17:19561609;Lit-BM-17:19561611;NetPath:10050855;connectomeDB2020:10050855;connectomeDB2020:11435703], PTCH1 [Baccin2019:9811851;CancerCellMap:8906787;CancerCellMap:9811851;CellTalkDB:9811851;Cellinker:9811851;HPRD:9811851;LRdb:9811851;NetPath:9811851;SignaLink3:19399989;SignaLink3:23331499;SignaLink3:9811851;connectomeDB2020:9811851], BOC [Baccin2019:18698484;CellTalkDB:20519495;Cellinker:20519495;LRdb:20519495;Ramilowski2015:20519495;connectomeDB2020:20519495;talklr:20519495], CDON [Baccin2019:18698484;CellTalkDB:20519495;Cellinker:20519495;LRdb:20519495;Ramilowski2015:20519495;connectomeDB2020:20519495;talklr:20519495]	extracellular space [GO:0005615]; plasma membrane [GO:0005886]	calcium ion binding [GO:0005509]; patched binding [GO:0005113]; peptidase activity [GO:0008233]; zinc ion binding [GO:0008270]	cell-cell signaling [GO:0007267]; cell fate specification [GO:0001708]; Leydig cell differentiation [GO:0033327]; male sex determination [GO:0030238]; myelination [GO:0042552]; osteoblast differentiation [GO:0001649]; protein autoprocessing [GO:0016540]; regulation of gene expression [GO:0010468]; regulation of steroid biosynthetic process [GO:0050810]; response to estradiol [GO:0032355]; response to estrogen [GO:0043627]; smoothened signaling pathway [GO:0007224]; spermatid development [GO:0007286]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=DHH&keywords=DHH	0.025040776404494383	780	NA	NA	0.015184615923239534	811	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
DKK1	dickkopf WNT signaling pathway inhibitor 1	Yes	soluble WNT regulators	ENSG00000107984	O94907	Dickkopf family	12	ligand	extracellular, intracellular, ligand, ligand_regulator, secreted	O75096, O75197, O75581, P56704, Q8NCW0, Q96MU8	KREMEN1, KREMEN2, LRP4, LRP5, LRP6, WNT3A	LRP6 [Baccin2019:11357136;Baccin2019:11448771;CancerCellMap:11448771;CellTalkDB:11516963;Cellinker:11357136;Cellinker:11448771;Cellinker:12527209;Cellinker:29925589;DIP:21944579;DIP:21984209;ELM:21944579;HPRD:11357136;HPRD:11448771;IntAct:11448771;IntAct:21944579;IntAct:21984209;LMPID:21944579;LRdb:11;LRdb:11357136;NetPath:11448771;NetPath:19339249;SIGNOR:11448771;SPIKE:11516963;SignaLink3:11357136;SignaLink3:11448771;SignaLink3:18988627;SignaLink3:21071413;SignaLink3:23331499;connectomeDB2020:11357136;connectomeDB2020:11448771], LRP5 [AlzPathway:16307379;AlzPathway:18786602;AlzPathway:19101658;Baccin2019:11516963;CancerCellMap:11448771;Cellinker:11516963;HPRD:11516963;LRdb:11516963;NetPath:11448771;SPIKE:11516963;connectomeDB2020:11448771], KREMEN2 [AlzPathway:16307379;AlzPathway:18786602;AlzPathway:19101658;Baccin2019:12050670;CellTalkDB:12050670;Cellinker:12050670;Cellinker:12527209;HPMR:12050670;LRdb:12050670;SIGNOR:12050670;SignaLink3:12050670;SignaLink3:23331499;connectomeDB2020:12050670], KREMEN1 [Baccin2019:12050670;CellTalkDB:12050670;Cellinker:12050670;Cellinker:12527209;HPMR:12050670;HPRD:12050670;LRdb:12050670;SIGNOR:12050670;SignaLink3:12050670;SignaLink3:23331499;connectomeDB2020:12050670], LRP4 [connectomeDB2020:19936252], WNT3A [ACSN:11448771;ACSN:17804805;ACSN:22807036;NetPath:19339249]	early endosome membrane [GO:0031901]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]	co-receptor binding [GO:0039706]; growth factor activity [GO:0008083]; low-density lipoprotein particle receptor binding [GO:0050750]; receptor antagonist activity [GO:0048019]	cell morphogenesis involved in differentiation [GO:0000904]; embryonic limb morphogenesis [GO:0030326]; endoderm formation [GO:0001706]; face morphogenesis [GO:0060325]; forebrain development [GO:0030900]; hair follicle development [GO:0001942]; learning or memory [GO:0007611]; limb development [GO:0060173]; mesoderm formation [GO:0001707]; modulation of age-related behavioral decline [GO:0090647]; motor learning [GO:0061743]; negative regulation of apoptotic process [GO:0043066]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment [GO:1901296]; negative regulation of cardiac muscle cell differentiation [GO:2000726]; negative regulation of mesodermal cell fate specification [GO:0042662]; negative regulation of neuron projection development [GO:0010977]; negative regulation of ossification [GO:0030279]; negative regulation of pathway-restricted SMAD protein phosphorylation [GO:0060394]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of presynapse assembly [GO:1905607]; negative regulation of protein binding [GO:0032091]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of Wnt-Frizzled-LRP5/6 complex assembly [GO:1904723]; negative regulation of Wnt signaling pathway [GO:0030178]; positive regulation of cell death [GO:0010942]; positive regulation of gene expression [GO:0010628]; positive regulation of heart induction by negative regulation of canonical Wnt signaling pathway [GO:0090082]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of midbrain dopaminergic neuron differentiation [GO:1904958]; positive regulation of neuron death [GO:1901216]; positive regulation of tau-protein kinase activity [GO:1902949]; positive regulation of Wnt signaling pathway, calcium modulating pathway [GO:0045813]; positive regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000096]; regulation of dopaminergic neuron differentiation [GO:1904338]; regulation of endodermal cell fate specification [GO:0042663]; regulation of receptor internalization [GO:0002090]; regulation of synaptic transmission, glutamatergic [GO:0051966]; response to retinoic acid [GO:0032526]; synapse pruning [GO:0098883]; Wnt signaling pathway involved in somitogenesis [GO:0090244]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=DKK1&keywords=DKK1	2.2494804878651684	378	NA	NA	0.1249747968130525	597	0	0.09680638722554884	0	9.592326139088729e-4	0.0016835016835016834	0.001692047377326565	9.066183136899365e-4	0	0	3.338229403124583e-5	2.704268881591655e-4	303	408	394	0.009304690581469665	0.5180088205919694	0.5197380528679474	0.532017171931138	333	309	312
DKK2	dickkopf WNT signaling pathway inhibitor 2	Yes		ENSG00000155011	Q9UBU2	Dickkopf family	10	ligand	ligand, ligand_regulator, secreted	O75197, O75581, Q8NCW0, Q96MU8	KREMEN1, KREMEN2, LRP5, LRP6	KREMEN2 [CellTalkDB:12527209;Cellinker:12527209;LRdb:12527209;Ramilowski2015:12527209;connectomeDB2020:12527209;talklr:12527209], LRP6 [Baccin2019:11357136;Baccin2019:11742004;CellTalkDB:11357136;Cellinker:11357136;Cellinker:11742004;Cellinker:12527209;Cellinker:29925589;DIP:21944579;HPRD:11357136;HPRD:11742004;LMPID:21944579;LRdb:11357136;LRdb:11742004;connectomeDB2020:11357136;connectomeDB2020:11742004], KREMEN1 [Cellinker:12527209;connectomeDB2020:23484855], LRP5 [connectomeDB2020:22589387]	extracellular space [GO:0005615]	co-receptor binding [GO:0039706]; receptor antagonist activity [GO:0048019]	negative regulation of canonical Wnt signaling pathway [GO:0090090]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; Wnt signaling pathway [GO:0016055]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=DKK2&keywords=DKK2	0.07184974685393258	694	NA	NA	0.08162154371918504	657	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
DKK3	dickkopf WNT signaling pathway inhibitor 3	Yes		ENSG00000050165	Q9UBP4	Dickkopf family	1	ligand	extracellular, intracellular, ligand, secreted	Q96MU8	KREMEN1	KREMEN1 [CellTalkDB:12527209]	extracellular space [GO:0005615]	co-receptor binding [GO:0039706]; receptor antagonist activity [GO:0048019]	adrenal gland development [GO:0030325]; anatomical structure morphogenesis [GO:0009653]; negative regulation of aldosterone biosynthetic process [GO:0032348]; negative regulation of anti-Mullerian hormone signaling pathway [GO:1902613]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cortisol biosynthetic process [GO:2000065]; negative regulation of transcription, DNA-templated [GO:0045892]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]; Wnt signaling pathway [GO:0016055]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=DKK3&keywords=DKK3	50.44091962510899	84	NA	NA	0.38365003685114224	425	0	0.006487025948103794	0.00331858407079646	0.15827338129496477	0.003367003367003367	0.00676818950930626	0.005439709882139619	0.0032626427406199023	0.0014798372179060304	0.0067766056883428885	8.499130770716634e-4	299	265	373	0.017820262981477705	0.41264301583163054	0.6030354817103092	0.3900003779365913	372	288	354
DKK4	dickkopf WNT signaling pathway inhibitor 4	Yes		ENSG00000104371	Q9UBT3	Dickkopf family	4	ligand	extracellular, ligand, ligand_regulator, secreted	O75197, O75581, Q8NCW0, Q96MU8	KREMEN1, KREMEN2, LRP5, LRP6	LRP6 [CellTalkDB:29925589;Cellinker:29925589;connectomeDB2020:29925589], LRP5 [CellTalkDB:29925589;Cellinker:29925589], KREMEN1 [Cellinker:29925589;connectomeDB2020:29925589], KREMEN2 [Cellinker:12527209;connectomeDB2020:12527209]	extracellular space [GO:0005615]	co-receptor binding [GO:0039706]; receptor antagonist activity [GO:0048019]	negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of hair follicle placode formation [GO:0061170]; negative regulation of Wnt signaling pathway [GO:0030178]; Wnt signaling pathway [GO:0016055]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=DKK4&keywords=DKK4	0.8169016966292135	474	NA	NA	1.964251787822282	162	0	0.0034930139720558886	0	2.3980815347721823e-4	0.003367003367003367	0.0287648054145516	0.021758839528558477	0.0032626427406199023	0.0014798372179060304	0.02156496194418475	8.499130770716634e-4	299	192	373	0.00770734776503899	0.6483092425942849	1.7825911798324725	0.6127350759154062	279	27	280
DLK1	delta like non-canonical Notch ligand 1			ENSG00000185559	P80370	NA	7	adhesion, cell_surface_ligand, ligand, receptor	adhesion, cell_adhesion, cell_surface, cell_surface_ligand, extracellular, intracellular, ligand, plasma_membrane, plasma_membrane_transmembrane, receptor, secreted, transmembrane, transmembrane_predicted	P02751, P46531, Q04721, Q99466, Q9UM47	FN1, NOTCH1, NOTCH2, NOTCH3, NOTCH4	FN1 [SIGNOR:20457810], NOTCH1 [Baccin2019:26791579;CellChatDB:22353464;CellPhoneDB:22353464;CellTalkDB:22353464;Cellinker:21419176;Cellinker:22353464;LRdb:22353464;Ramilowski2015:21419176;SIGNOR:21419176;connectomeDB2020:21419176;talklr:21419176], NOTCH2 [CellChatDB:22353464;CellPhoneDB:22353464;CellTalkDB:22353464;Cellinker:22353464;LRdb:22353464;connectomeDB2020:22353464], NOTCH3 [CellChatDB:22353464;CellPhoneDB:22353464;CellTalkDB:22353464;Cellinker:22353464;LRdb:22353464;connectomeDB2020:22353464], NOTCH4 [CellChatDB:22353464;CellPhoneDB:22353464;Cellinker:22353464;LRdb:22353464;connectomeDB2020:22353464]	cytoplasm [GO:0005737]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; membrane [GO:0016020]	calcium ion binding [GO:0005509]	cell differentiation [GO:0030154]; negative regulation of Notch signaling pathway [GO:0045746]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=DLK1&keywords=DLK1	71.6355923483146	62	NA	NA	2.8905996390293685	116	0.05511811023622047	0.10379241516966058	0.004424778761061947	0.021822541966426853	0.23232323232323235	0.8240270727580375	1.0190389845874934	0.07014681892332793	0.02663706992230853	1.1659433836295041	0.01618698087695568	215	26	220	0.32176921719583906	0.11042938290649836	3.5444620015345185	0.078931315865564	470	2	485
DMP1	dentin matrix acidic phosphoprotein 1	No		ENSG00000152592	Q13316	NA	1	ecm, ligand	ecm, extracellular, intracellular, ligand, secreted	P05106, P78562	ITGAV_ITGB3, ITGB3, PHEX	PHEX [CellTalkDB:22339660], ITGB3 [CellTalkDB:32196115]	endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; nucleus [GO:0005634]	calcium ion binding [GO:0005509]; extracellular matrix binding [GO:0050840]; integrin binding [GO:0005178]	biomineral tissue development [GO:0031214]; extracellular matrix organization [GO:0030198]; ossification [GO:0001503]; positive regulation of cell-substrate adhesion [GO:0010811]; regulation of enamel mineralization [GO:0070173]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=DMP1&keywords=DMP1	0	899	NA	NA	0.157097201205138	571	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
DPP4	dipeptidyl peptidase 4	No		ENSG00000197635	P27487	Peptidase S9B family, DPPIV subfamily	2	adhesion, ligand, receptor	adhesion, cell_adhesion, cell_surface, extracellular, intracellular, ligand, plasma_membrane, receptor, secreted, transmembrane	O14625, P00813, P01275, P09681, P48061	ADA, CXCL11, CXCL12, GCG, GIP	CXCL11 [CellPhoneDB:24218476;HPRD:11390394;IntAct:18275857;IntAct:21314817], GIP [NA], GCG [NA], CXCL12 [CellPhoneDB:24218476;HPRD:11390394], ADA [DIP:8568233;HPRD:11772392]	apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; endocytic vesicle [GO:0030139]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; intercellular canaliculus [GO:0046581]; lamellipodium [GO:0030027]; lamellipodium membrane [GO:0031258]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]	aminopeptidase activity [GO:0004177]; chemorepellent activity [GO:0045499]; dipeptidyl-peptidase activity [GO:0008239]; identical protein binding [GO:0042802]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; signaling receptor binding [GO:0005102]; virus receptor activity [GO:0001618]	behavioral fear response [GO:0001662]; cell adhesion [GO:0007155]; endothelial cell migration [GO:0043542]; glucagon processing [GO:0120116]; locomotory exploration behavior [GO:0035641]; negative regulation of extracellular matrix disassembly [GO:0010716]; negative regulation of neutrophil chemotaxis [GO:0090024]; peptide hormone processing [GO:0016486]; positive regulation of cell population proliferation [GO:0008284]; proteolysis [GO:0006508]; psychomotor behavior [GO:0036343]; regulation of cell-cell adhesion mediated by integrin [GO:0033632]; response to hypoxia [GO:0001666]; T cell activation [GO:0042110]; T cell costimulation [GO:0031295]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=DPP4&keywords=DPP4	13.406645465869794	205	13797.6	58	2.466005490158452	130	0.07874015748031496	0.010479041916167662	0	0.026858513189448433	0.0016835016835016834	0.016920473773265648	0.11242067089755187	0.0407830342577488	0.0048094709581946	0.002537054346374679	0.12710063743480213	288	334	98	0.038393868721579134	0.3060195712683529	0.25906286638299547	2.833016682827593	406	393	9
DRAXIN	dorsal inhibitory axon guidance protein	Yes		ENSG00000162490	Q8NBI3	Draxin family	2	ligand	extracellular, ligand, ligand_regulator, secreted	P43146	DCC	DCC [CellTalkDB:29503192;Cellinker:29503192]	extracellular region [GO:0005576]	NA	anterior commissure morphogenesis [GO:0021960]; axon guidance [GO:0007411]; commissural neuron differentiation in spinal cord [GO:0021528]; dorsal spinal cord development [GO:0021516]; forebrain development [GO:0030900]; negative regulation of axon extension [GO:0030517]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of neuron apoptotic process [GO:0043524]; Wnt signaling pathway [GO:0016055]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=DRAXIN&keywords=DRAXIN	0.06683510561797752	702	NA	NA	0.2483241616951191	496	0	0.005489021956087825	0.004424778761061947	0.0079136690647482	0.0016835016835016834	0.011844331641285955	0.006346328195829556	0.011419249592169658	0.008879023307436186	0.006342635865936693	0.008692292833687451	269	273	253	0.006639530263795014	1.1345887178386254	0.9821572849021876	1.1233666177679862	104	138	74
DSPP	dentin sialophosphoprotein	TBD		ENSG00000152591	Q9NZW4	NA	2	ecm, ligand	ecm, extracellular, intracellular, ligand, secreted	P05556, P18564	ITGAV_ITGB1, ITGAV_ITGB6, ITGB1, ITGB6	ITGB1 [CellTalkDB:32196115], ITGB6 [connectomeDB2020:27430624]	cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; nucleus [GO:0005634]	calcium ion binding [GO:0005509]; collagen binding [GO:0005518]; extracellular matrix structural constituent [GO:0005201]	biomineral tissue development [GO:0031214]; dentinogenesis [GO:0097187]; multicellular organism development [GO:0007275]; odontoblast differentiation [GO:0071895]; ossification [GO:0001503]; regulation of odontoblast differentiation [GO:1901329]; skeletal system development [GO:0001501]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=DSPP&keywords=DSPP	0.002193374157303371	878	NA	NA	0.7889261665691201	302	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
EBI3	Epstein-Barr virus induced 3	Yes	IL-27 Subunit Beta	ENSG00000105246	Q14213	Type I cytokine receptor family, Type 3 subfamily	14	ligand	extracellular, intracellular, ligand, secreted, transmembrane	P40189, Q6UWB1	IL27RA, IL27RA_IL6ST, IL6ST	IL6ST [Baccin2019:28280243;CellTalkDB:22306691;connectomeDB2020:28280243], IL27RA [Baccin2019:12121660;CellTalkDB:12121660;HPRD:12121660;LRdb:12121660;connectomeDB2020:12121660]	endoplasmic reticulum lumen [GO:0005788]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	cytokine activity [GO:0005125]; cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]; interleukin-27 receptor binding [GO:0045523]; peptide hormone binding [GO:0017046]	cytokine-mediated signaling pathway [GO:0019221]; humoral immune response [GO:0006959]; leptin-mediated signaling pathway [GO:0033210]; positive regulation of alpha-beta T cell proliferation [GO:0046641]; positive regulation of interferon-gamma production [GO:0032729]; T cell proliferation [GO:0042098]; T-helper 1 type immune response [GO:0042088]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=EBI3&keywords=EBI3	0.04543876516853933	745	NA	NA	0.004718388967121914	863	0.11023622047244094	0	0.0022123893805309734	0.001199040767386091	0	0	9.066183136899365e-4	0.0032626427406199023	0.0048094709581946	7.677927627186543e-4	8.499130770716633e-4	288	380	374	0.011294917133877523	0.695446282560762	0.5056508412323641	0.5095071752972836	265	318	319
ECM1	extracellular matrix protein 1	No		ENSG00000143369	Q16610	NA	3	ecm, ligand	ecm, extracellular, intracellular, ligand, secreted	P16144, Q5VU97	CACHD1, ITGB4	ITGB4 [connectomeDB2020:29059156], CACHD1 [NA]	collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; platelet dense granule lumen [GO:0031089]	enzyme binding [GO:0019899]; interleukin-2 receptor binding [GO:0005134]; laminin binding [GO:0043236]; protease binding [GO:0002020]; protein C-terminus binding [GO:0008022]	angiogenesis [GO:0001525]; biomineral tissue development [GO:0031214]; chondrocyte development [GO:0002063]; endochondral bone growth [GO:0003416]; inflammatory response [GO:0006954]; negative regulation of bone mineralization [GO:0030502]; negative regulation of cytokine-mediated signaling pathway [GO:0001960]; negative regulation of peptidase activity [GO:0010466]; ossification [GO:0001503]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; regulation of bone mineralization [GO:0030500]; regulation of T cell migration [GO:2000404]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of type 2 immune response [GO:0002828]; signal transduction [GO:0007165]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=ECM1&keywords=ECM1	6.71621767026035	269	469.008	161	0.15921552936539168	570	0.047244094488188976	0.006986027944111778	0.0055309734513274336	0.20047961630695435	0.006734006734006734	0.020304568527918777	0.02901178603807797	0.0032626427406199023	0.004069552349241584	0.02239951929496589	0.004906316399459151	290	188	290	0.03190264584317023	0.33576763629437495	0.7732093915078333	0.3557368776962028	397	224	369
EDA	ectodysplasin A	Yes		ENSG00000158813	Q92838	Tumor necrosis factor family	17	adhesion, cell_surface_ligand, ligand	adhesion, cell_adhesion, cell_surface, cell_surface_ligand, extracellular, intracellular, ligand, plasma_membrane, secreted, transmembrane, transmembrane_predicted	Q01638, Q9HAV5, Q9UNE0	EDA2R, EDAR, IL1RL1	EDAR [CellTalkDB:11039935;Cellinker:11039935;Cellinker:11309369;Cellinker:12084975;Guide2Pharma:11039935;HPMR:12084975;HPRD:11309369;ICELLNET:10484778;LRdb:11039935;LRdb:11309369;LRdb:12084975;SIGNOR:18304980;connectomeDB2020:11039935;connectomeDB2020:11309369;connectomeDB2020:12084975;scConnect:11039935], EDA2R [Baccin2019:11039935;Baccin2019:12084975;Baccin2019:12270937;CellTalkDB:11039935;Cellinker:11039935;Cellinker:12084975;Cellinker:12270937;Guide2Pharma:11039935;HPMR:12084975;HPRD:11039935;HPRD:12270937;ICELLNET:10484778;LRdb:11039935;LRdb:12084975;LRdb:12270937;SIGNOR:12084975;connectomeDB2020:11039935;connectomeDB2020:12084975;connectomeDB2020:12270937;scConnect:11039935], IL1RL1 [Cellinker:32589946]	apical part of cell [GO:0045177]; collagen trimer [GO:0005581]; cytoskeleton [GO:0005856]; endoplasmic reticulum membrane [GO:0005789]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; lipid droplet [GO:0005811]; membrane [GO:0016020]; plasma membrane [GO:0005886]	death receptor agonist activity [GO:0038177]; death receptor binding [GO:0005123]; receptor ligand activity [GO:0048018]; signaling receptor binding [GO:0005102]; tumor necrosis factor receptor binding [GO:0005164]	animal organ development [GO:0048513]; cell differentiation [GO:0030154]; cell-matrix adhesion [GO:0007160]; cytokine-mediated signaling pathway [GO:0019221]; gene expression [GO:0010467]; hair follicle placode formation [GO:0060789]; immune response [GO:0006955]; odontogenesis of dentin-containing tooth [GO:0042475]; pigmentation [GO:0043473]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of gene expression [GO:0010628]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; regulation of NIK/NF-kappaB signaling [GO:1901222]; salivary gland cavitation [GO:0060662]; trachea gland development [GO:0061153]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=EDA&keywords=EDA	2.64475987788461	354	NA	NA	0.9302437868934418	279	0	0.013473053892215562	0.00331858407079646	0.004076738609112709	0.01683501683501683	0.020304568527918777	0.024478694469628286	0.01468189233278956	0.004069552349241583	0.02069702229937236	0.007571952868456642	291	195	261	0.011773370568595343	0.6461816421539573	1.4098424588266538	0.8070387087335672	281	61	183
EDIL3	EGF like repeats and discoidin domains 3	TBD		ENSG00000164176	O43854	NA	9	adhesion, ecm, ligand	adhesion, cell_adhesion, ecm, extracellular, ligand, secreted	P05106, P06756, P18084	ITGA5_ITGB1, ITGAV, ITGAV_ITGB3, ITGB3, ITGB5	ITGAV [CellTalkDB:11959660;Cellinker:11959660;HPRD:11959660;LRdb:11959660], ITGB5 [CellTalkDB:32196115], ITGB3 [connectomeDB2020:28846069]	collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular vesicle [GO:1903561]	calcium ion binding [GO:0005509]; integrin binding [GO:0005178]	cell adhesion [GO:0007155]; positive regulation of cell-substrate adhesion [GO:0010811]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=EDIL3&keywords=EDIL3	39.281959528089885	108	14225.2	57	1.5476945376505866	199	0.03937007874015748	0.08383233532934124	0.019911504424778764	0.13117505995203946	0.07744107744107745	0.7360406091370565	1.3553943789664635	0.4861337683523659	0.26378098409174877	0.6221124315664073	0.8228703882556978	63	40	28	0.42164205602337584	0.6342778241166611	1.464436615351899	1.9295394798383436	290	56	21
EDN1	endothelin 1	Yes		ENSG00000078401	P05305	Endothelin/sarafotoxin family	17	ligand	extracellular, intracellular, ligand, secreted	P23276, P24530, P25101, P42892, Q9HBW9	ADGRL4, ECE1, EDNRA, EDNRB, KEL	EDNRA [Baccin2019:6479761;Baccin2019:90829707;CellTalkDB:7647976;Cellinker:10770212;Cellinker:7647976;Cellinker:9082970;Guide2Pharma:7647976;HPMR:9082970;HPRD:10770212;ICELLNET:8440682;LRdb:10770212;LRdb:7647976;LRdb:9082970;Lit-BM-17:23597562;Lit-BM-17:7509919;SIGNOR:16597412;connectomeDB2020:10770212;connectomeDB2020:7647976;connectomeDB2020:9082970;scConnect:7647976], EDNRB [Baccin2019:12972292;CellTalkDB:12972292;Cellinker:12972292;HPRD:12972292;ICELLNET:8440682;LRdb:12972292;SIGNOR:16597412;connectomeDB2020:12972292], KEL [Baccin2019:10438732;CellTalkDB:10438732;Cellinker:10438732;HPRD:10438732;LRdb:10438732;connectomeDB2020:10438732], ADGRL4 [CellTalkDB:32196115], ECE1 [HPRD:10438732;HPRD:10620363;HPRD:9595387]	basal part of cell [GO:0045178]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; rough endoplasmic reticulum lumen [GO:0048237]; transport vesicle [GO:0030133]; Weibel-Palade body [GO:0033093]	cytokine activity [GO:0005125]; endothelin A receptor binding [GO:0031707]; endothelin B receptor binding [GO:0031708]; hormone activity [GO:0005179]	adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; artery smooth muscle contraction [GO:0014824]; axon extension [GO:0048675]; axonogenesis involved in innervation [GO:0060385]; body fluid secretion [GO:0007589]; branching involved in blood vessel morphogenesis [GO:0001569]; calcium ion transmembrane transport [GO:0070588]; calcium-mediated signaling [GO:0019722]; canonical Wnt signaling pathway [GO:0060070]; cardiac neural crest cell migration involved in outflow tract morphogenesis [GO:0003253]; cartilage development [GO:0051216]; cell-cell signaling [GO:0007267]; cell surface receptor signaling pathway [GO:0007166]; cellular calcium ion homeostasis [GO:0006874]; cellular response to calcium ion [GO:0071277]; cellular response to fatty acid [GO:0071398]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to glucocorticoid stimulus [GO:0071385]; cellular response to human chorionic gonadotropin stimulus [GO:0044751]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to hypoxia [GO:0071456]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-1 [GO:0071347]; cellular response to luteinizing hormone stimulus [GO:0071373]; cellular response to mineralocorticoid stimulus [GO:0071389]; cellular response to organic substance [GO:0071310]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to xenobiotic stimulus [GO:0071466]; dorsal/ventral pattern formation [GO:0009953]; embryonic heart tube development [GO:0035050]; endothelin receptor signaling pathway [GO:0086100]; endothelin receptor signaling pathway involved in heart process [GO:0086101]; epithelial fluid transport [GO:0042045]; ERK1 and ERK2 cascade [GO:0070371]; G protein-coupled receptor signaling pathway [GO:0007186]; histamine secretion [GO:0001821]; I-kappaB kinase/NF-kappaB signaling [GO:0007249]; inositol phosphate-mediated signaling [GO:0048016]; in utero embryonic development [GO:0001701]; leukocyte activation [GO:0045321]; maternal process involved in parturition [GO:0060137]; meiotic cell cycle process involved in oocyte maturation [GO:1903537]; membrane depolarization [GO:0051899]; middle ear morphogenesis [GO:0042474]; mitochondrion organization [GO:0007005]; multicellular organism aging [GO:0010259]; negative regulation of blood coagulation [GO:0030195]; negative regulation of cellular protein metabolic process [GO:0032269]; negative regulation of gene expression [GO:0010629]; negative regulation of hormone secretion [GO:0046888]; negative regulation of nitric-oxide synthase biosynthetic process [GO:0051771]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural crest cell fate commitment [GO:0014034]; nitric oxide transport [GO:0030185]; noradrenergic neuron differentiation [GO:0003357]; peptide hormone secretion [GO:0030072]; pharyngeal arch artery morphogenesis [GO:0061626]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phospholipase D-activating G protein-coupled receptor signaling pathway [GO:0031583]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of cation channel activity [GO:2001259]; positive regulation of cell growth involved in cardiac muscle cell development [GO:0061051]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell size [GO:0045793]; positive regulation of chemokine-mediated signaling pathway [GO:0070101]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway [GO:0051482]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of heart rate [GO:0010460]; positive regulation of hormone secretion [GO:0046887]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of odontogenesis [GO:0042482]; positive regulation of prostaglandin-endoperoxide synthase activity [GO:0060585]; positive regulation of prostaglandin secretion [GO:0032308]; positive regulation of renal sodium excretion [GO:0035815]; positive regulation of sarcomere organization [GO:0060298]; positive regulation of signaling receptor activity [GO:2000273]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of smooth muscle contraction [GO:0045987]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of urine volume [GO:0035810]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; prostaglandin biosynthetic process [GO:0001516]; protein kinase A signaling [GO:0010737]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; protein kinase C deactivation [GO:0042313]; protein phosphorylation [GO:0006468]; regulation of glucose transmembrane transport [GO:0010827]; regulation of pH [GO:0006885]; regulation of sensory perception of pain [GO:0051930]; regulation of systemic arterial blood pressure by endothelin [GO:0003100]; regulation of vasoconstriction [GO:0019229]; renal sodium ion absorption [GO:0070294]; respiratory gaseous exchange by respiratory system [GO:0007585]; response to activity [GO:0014823]; response to amino acid [GO:0043200]; response to amphetamine [GO:0001975]; response to dexamethasone [GO:0071548]; response to leptin [GO:0044321]; response to lipopolysaccharide [GO:0032496]; response to muscle stretch [GO:0035994]; response to nicotine [GO:0035094]; response to ozone [GO:0010193]; response to prostaglandin F [GO:0034696]; response to salt [GO:1902074]; response to testosterone [GO:0033574]; rhythmic excitation [GO:0043179]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]; sensory perception of pain [GO:0019233]; superoxide anion generation [GO:0042554]; sympathetic neuron axon guidance [GO:0097492]; thyroid gland development [GO:0030878]; transcription by RNA polymerase II [GO:0006366]; vasoconstriction [GO:0042310]; vein smooth muscle contraction [GO:0014826]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=EDN1&keywords=EDN1	19.709554943820226	170	NA	NA	1.5749110670019886	197	0	1.6771457085828338	0.29977876106194656	0.024940047961630688	0.30303030303030293	0.001692047377326565	9.066183136899365e-4	0.0016313213703099511	0.001849796522382538	0.0014354386433435699	0.002279312343055825	298	359	330	0.21042630501880205	0.05375854084825205	0.0518787385306311	0.05570710964831723	500	494	499
EDN2	endothelin 2	Yes		ENSG00000127129	P20800	Endothelin/sarafotoxin family	18	ligand	intracellular, ligand, secreted	P23276, P24530, P25101	EDNRA, EDNRB, KEL	EDNRA [Baccin2019:2175397;Baccin2019:7647976;Baccin2019:9082970;CellTalkDB:2175397;Cellinker:2175397;Cellinker:7647976;Cellinker:9082970;Guide2Pharma:7647976;ICELLNET:8440682;LRdb:2175397;LRdb:7647976;LRdb:9082970;connectomeDB2020:2175397;connectomeDB2020:7647976;connectomeDB2020:9082970;scConnect:7647976], EDNRB [Cellinker:18199583;LRdb:14659083;Ramilowski2015:14659083;connectomeDB2020:14659083;talklr:14659083], KEL [Baccin2019:10438732;CellTalkDB:10438732;Cellinker:10438732;HPRD:10438732;LRdb:10438732;connectomeDB2020:10438732]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	endothelin B receptor binding [GO:0031708]; hormone activity [GO:0005179]	angiogenesis [GO:0001525]; artery smooth muscle contraction [GO:0014824]; axon extension [GO:0048675]; calcium-mediated signaling [GO:0019722]; cell surface receptor signaling pathway [GO:0007166]; cell tip growth [GO:0009932]; cellular calcium ion homeostasis [GO:0006874]; cytokine-mediated signaling pathway [GO:0019221]; endothelial cell migration [GO:0043542]; energy homeostasis [GO:0097009]; hormonal regulation of the force of heart contraction [GO:0003058]; inositol phosphate-mediated signaling [GO:0048016]; lung alveolus development [GO:0048286]; macrophage activation [GO:0042116]; macrophage chemotaxis [GO:0048246]; neutrophil chemotaxis [GO:0030593]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of heart rate [GO:0010460]; positive regulation of leukocyte chemotaxis [GO:0002690]; positive regulation of prostaglandin-endoperoxide synthase activity [GO:0060585]; positive regulation of smooth muscle contraction [GO:0045987]; positive regulation of the force of heart contraction by chemical signal [GO:0003099]; prostaglandin biosynthetic process [GO:0001516]; regulation of systemic arterial blood pressure by endothelin [GO:0003100]; regulation of vasoconstriction [GO:0019229]; temperature homeostasis [GO:0001659]; vasoconstriction [GO:0042310]; vein smooth muscle contraction [GO:0014826]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=EDN2&keywords=EDN2	0.8094009210348314	477	NA	NA	0.5239012705483205	376	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
EDN3	endothelin 3	Yes		ENSG00000124205	P14138	Endothelin/sarafotoxin family	17	ligand	extracellular, intracellular, ligand, secreted	P23276, P24530, P25101	EDNRA, EDNRB, KEL	EDNRB [Baccin2019:11982704;Baccin2019:7524189;Baccin2019:8001160;Baccin2019:8086489;Baccin2019:8460684;Baccin2019:8904635;CellTalkDB:11982704;Cellinker:11982704;Cellinker:7524189;Cellinker:8001160;Cellinker:8086489;Cellinker:8460684;Cellinker:8904635;Guide2Pharma:7524189;Guide2Pharma:8460684;Guide2Pharma:8904635;HPMR:8001160;HPRD:11982704;HPRD:8001160;ICELLNET:8440682;LRdb:11982704;LRdb:7524189;LRdb:8001160;LRdb:8086489;LRdb:8460684;LRdb:8904635;SIGNOR:8086489;connectomeDB2020:11982704;connectomeDB2020:7524189;connectomeDB2020:8001160;connectomeDB2020:8086489;connectomeDB2020:8460684;connectomeDB2020:8904635;scConnect:7524189;scConnect:8460684;scConnect:8904635], KEL [Baccin2019:10438732;CellTalkDB:10438732;Cellinker:10438732;HPRD:10438732;LRdb:10438732;connectomeDB2020:10438732], EDNRA [Baccin2019:11982704;CellTalkDB:11982704;Cellinker:11982704;HPRD:11982704;LRdb:11982704;connectomeDB2020:11982704]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	endothelin B receptor binding [GO:0031708]; hormone activity [GO:0005179]; signaling receptor binding [GO:0005102]	axon extension [GO:0048675]; axon guidance [GO:0007411]; blood circulation [GO:0008015]; cell-cell signaling [GO:0007267]; cell surface receptor signaling pathway [GO:0007166]; cellular calcium ion homeostasis [GO:0006874]; cellular magnesium ion homeostasis [GO:0010961]; inositol phosphate-mediated signaling [GO:0048016]; melanocyte differentiation [GO:0030318]; multicellular organism development [GO:0007275]; neural crest cell migration [GO:0001755]; neutrophil chemotaxis [GO:0030593]; peptide hormone secretion [GO:0030072]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of heart rate [GO:0010460]; positive regulation of hormone secretion [GO:0046887]; positive regulation of leukocyte chemotaxis [GO:0002690]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of potassium ion transmembrane transport [GO:1901381]; positive regulation of prostaglandin-endoperoxide synthase activity [GO:0060585]; regulation of developmental pigmentation [GO:0048070]; regulation of gene expression [GO:0010468]; regulation of systemic arterial blood pressure by endothelin [GO:0003100]; regulation of vasoconstriction [GO:0019229]; signal transduction [GO:0007165]; vasoconstriction [GO:0042310]; vein smooth muscle contraction [GO:0014826]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=EDN3&keywords=EDN3	32.43063100829224	127	26769.6	38	5.122344027596948	74	0	0.017964071856287418	0.00995575221238938	0.013429256594724217	0.02861952861952861	0.6852791878172592	0.428830462375339	0.42088091353996787	0.7758046614872333	0.5599879823742231	0.08607301525980124	28	41	122	0.2751658938306139	2.7556053458272065	1.9987943674385937	0.3369021939098642	17	21	378
EFEMP1	EGF containing fibulin extracellular matrix protein 1	No		ENSG00000115380	Q12805	Fibulin family	10	ecm, ligand, receptor	ecm, extracellular, ligand, receptor, secreted, transmembrane	P00533	EGFR	EGFR [Baccin2019:19804359;CellTalkDB:19804359;Cellinker:19804359;LRdb:19804359;Ramilowski2015:19804359;connectomeDB2020:19804359;talklr:19804359]	collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	calcium ion binding [GO:0005509]; epidermal growth factor-activated receptor activity [GO:0005006]; epidermal growth factor receptor binding [GO:0005154]; growth factor activity [GO:0008083]	camera-type eye development [GO:0043010]; embryonic eye morphogenesis [GO:0048048]; epidermal growth factor receptor signaling pathway [GO:0007173]; negative regulation of chondrocyte differentiation [GO:0032331]; peptidyl-tyrosine phosphorylation [GO:0018108]; post-embryonic eye morphogenesis [GO:0048050]; regulation of transcription, DNA-templated [GO:0006355]; visual perception [GO:0007601]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=EFEMP1&keywords=EFEMP1	23.527235622441275	157	NA	NA	0.17594253271507881	552	0	0.14520958083832358	0.00331858407079646	0.09784172661870572	0.0101010101010101	0.015228426395939083	0.001813236627379873	0	0.03292637809840914	9.013219388436377e-4	0.0017770909793316605	199	375	338	0.028101577788067204	1.126629934780627	0.2861120869975562	0.3090971991984031	105	385	392
EFEMP2	EGF containing fibulin extracellular matrix protein 2	No		ENSG00000172638	O95967	Fibulin family	7	ecm, ligand	ecm, extracellular, ligand, secreted	P15502, P29972, Q8NEC5, Q96FE5, Q9NRQ2	AQP1, CATSPER1, ELN, LINGO1, PLSCR4	ELN [IntAct:19570982;Lit-BM-17:19570982;MatrixDB:19570982;SIGNOR:19570982], AQP1 [CellTalkDB:16189514;HPRD:16189514;LRdb:16189514], PLSCR4 [CellTalkDB:16189514;Cellinker:16189514;HPRD:16189514;LRdb:16189514], CATSPER1 [Baccin2019:16189514;Cellinker:16189514;HPRD:16189514;LRdb:16189514], LINGO1 [Baccin2019:16189514;Cellinker:16189514;HPRD:16189514;LRdb:16189514]	basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; elastic fiber [GO:0071953]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular vesicle [GO:1903561]; microfibril [GO:0001527]	calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; protein homodimerization activity [GO:0042803]	aorta development [GO:0035904]; aorta smooth muscle tissue morphogenesis [GO:0060414]; elastic fiber assembly [GO:0048251]; negative regulation of vascular associated smooth muscle cell proliferation [GO:1904706]; positive regulation of aortic smooth muscle cell differentiation [GO:1904831]; positive regulation of collagen fibril organization [GO:1904028]; positive regulation of smooth muscle cell-matrix adhesion [GO:1905609]; regulation of collagen fibril organization [GO:1904026]; vascular associated smooth muscle cell development [GO:0097084]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=EFEMP2&keywords=EFEMP2	4.7246566025422	296	NA	NA	0.06746016092463582	679	0	0.06936127744510971	0.039823008849557556	0.19856115107913663	0.003367003367003367	0.0490693739424704	0.017225747960108794	0.035889070146818934	0.04476507584165743	0.005007344104686864	0.026192775738844962	174	291	191	0.044478348043217694	1.0052631514856558	0.27547355314044275	0.6643515642238861	134	390	251
EFNA1	ephrin A1	Yes		ENSG00000169242	P20827	Ephrin family	10	adhesion, cell_surface_ligand, ligand	adhesion, cell_adhesion, cell_surface, cell_surface_ligand, extracellular, intracellular, ligand, plasma_membrane, plasma_membrane_peripheral, secreted, transmembrane	O15197, P21709, P29317, P29320, P29322, P54756, P54762, P54764, Q15375, Q5JZY3, Q9UF33	EPHA1, EPHA10, EPHA2, EPHA3, EPHA4, EPHA5, EPHA6, EPHA7, EPHA8, EPHB1, EPHB6	EPHA1 [Baccin2019:11519828;Baccin2019:8755474;Baccin2019:9330863;CellChatDB:15114347;CellPhoneDB:15114347;Cellinker:11519828;Cellinker:15114347;Cellinker:8755474;Cellinker:9330863;HPMR:9330863;HPRD:11519828;HPRD:8755474;LRdb:11114742;SIGNOR:9330863;SIGNOR:9576626;SignaLink3:11519828;SignaLink3:18988627;SignaLink3:23331499;SignaLink3:8755474;SignaLink3:9267020;connectomeDB2020:11519828;connectomeDB2020:8755474;connectomeDB2020:9330863], EPHA6 [Baccin2019:93308638755474;CellTalkDB:11114742;Cellinker:8755474;Cellinker:9330863;HPRD:8755474;LRdb:11114742;SIGNOR:9576626;SignaLink3:23331499;SignaLink3:9576626;connectomeDB2020:8755474;connectomeDB2020:9330863], EPHA8 [Baccin2019:10515610;CellChatDB:15114347;CellPhoneDB:15114347;Cellinker:10515610;Cellinker:15114347;HPRD:10515610;LRdb:11114742;SIGNOR:17420126;SIGNOR:9576626;SignaLink3:23331499;SignaLink3:9576626;connectomeDB2020:10515610], EPHA4 [Baccin2019:9330863;CellChatDB:15114347;CellPhoneDB:15114347;Cellinker:15114347;DIP:19836338;HPRD:8755474;LRdb:11114742;Lit-BM-17:10366629;Lit-BM-17:19836338;SIGNOR:9330863;SIGNOR:9576626;SignaLink3:23331499;SignaLink3:9576626;connectomeDB2020:8755474;connectomeDB2020:9330863], EPHA2 [Baccin2019:11248553;Baccin2019:14692877;Baccin2019:7973638;Baccin2019:8755474;CellChatDB:15114347;CellPhoneDB:15114347;Cellinker:11248553;Cellinker:14692877;Cellinker:15114347;Cellinker:7973638;Cellinker:8755474;DIP:20505120;DIP:22244754;DIP:8139691;DOMINO:19525919;HPMR:11248553;HPRD:14692877;HPRD:7973638;HPRD:8755474;IntAct:19525919;IntAct:19573808;IntAct:20505120;LRdb:11114742;Lit-BM-17:19525919;Lit-BM-17:19573808;Lit-BM-17:8139691;SIGNOR:9330863;SIGNOR:9576626;SignaLink3:14692877;SignaLink3:18988627;SignaLink3:23331499;SignaLink3:7973638;SignaLink3:8755474;SignaLink3:9576626;connectomeDB2020:11248553;connectomeDB2020:14692877;connectomeDB2020:7973638;connectomeDB2020:8755474], EPHA3 [Baccin2019:93308638070404;CellChatDB:15114347;CellPhoneDB:15114347;Cellinker:15114347;Cellinker:8070404;Cellinker:9330863;HPRD:8070404;LRdb:11114742;SIGNOR:9330863;SIGNOR:9576626;SignaLink3:18988627;SignaLink3:21071413;SignaLink3:23331499;SignaLink3:8070404;SignaLink3:9195962;SignaLink3:9576626;connectomeDB2020:8070404;connectomeDB2020:9330863], EPHA5 [Baccin2019:9330863;CellChatDB:15114347;CellPhoneDB:15114347;Cellinker:15114347;Cellinker:8755474;Cellinker:9330863;HPRD:8755474;LRdb:11114742;SIGNOR:9576626;SignaLink3:23331499;SignaLink3:9576626;connectomeDB2020:8755474;connectomeDB2020:9330863], EPHA7 [Baccin2019:93308638755474;CellChatDB:15114347;CellPhoneDB:15114347;Cellinker:15114347;Cellinker:8755474;Cellinker:9330863;HPMR:9330863;HPRD:8755474;LRdb:11114742;SIGNOR:9576626;SignaLink3:23331499;SignaLink3:8755474;SignaLink3:9576626;connectomeDB2020:8755474;connectomeDB2020:9330863], EPHB6 [CellTalkDB:32196115], EPHA10 [CellTalkDB:11114742;Cellinker:28589441;LRdb:11114742], EPHB1 [CellTalkDB:8755474;HPRD:7973638;HPRD:8070404;HPRD:8755474;LRdb:7973638;LRdb:8070404;LRdb:8755474]	anchored component of plasma membrane [GO:0046658]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]	ephrin receptor binding [GO:0046875]; signaling receptor binding [GO:0005102]	angiogenesis [GO:0001525]; aortic valve morphogenesis [GO:0003180]; axon guidance [GO:0007411]; cell-cell signaling [GO:0007267]; cell migration [GO:0016477]; endocardial cushion to mesenchymal transition involved in heart valve formation [GO:0003199]; ephrin receptor signaling pathway [GO:0048013]; mitral valve morphogenesis [GO:0003183]; negative regulation of dendritic spine morphogenesis [GO:0061002]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of proteolysis involved in cellular protein catabolic process [GO:1903051]; negative regulation of thymocyte apoptotic process [GO:0070244]; negative regulation of transcription by RNA polymerase II [GO:0000122]; notochord formation [GO:0014028]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902961]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein tyrosine kinase activity [GO:0061098]; protein stabilization [GO:0050821]; regulation of angiogenesis [GO:0045765]; regulation of axonogenesis [GO:0050770]; regulation of blood vessel endothelial cell migration [GO:0043535]; regulation of cell adhesion mediated by integrin [GO:0033628]; regulation of peptidyl-tyrosine phosphorylation [GO:0050730]; substrate adhesion-dependent cell spreading [GO:0034446]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=EFNA1&keywords=EFNA1	40.20734750224719	104	NA	NA	0.9690853685947679	273	0.007874015748031496	0.5424151696606829	0.9867256637168131	0.11438848920863375	0.447811447811447	0.0642978003384095	0.15412511332728882	0.11256117455138677	0.04550499445061046	0.027774068633996455	0.24075719528683354	173	177	62	0.24947592115764852	0.2139119275614309	0.14557831981275152	0.9663987092447096	428	446	110
EFNA4	ephrin A4	Yes		ENSG00000243364	P52798	Ephrin family	10	adhesion, cell_surface_ligand, ligand	adhesion, cell_adhesion, cell_surface, cell_surface_ligand, ligand, plasma_membrane, plasma_membrane_peripheral, plasma_membrane_transmembrane, secreted, transmembrane, transmembrane_predicted	P09619, P21709, P29317, P29320, P29322, P54756, P54764, Q15375, Q5JZY3, Q9UF33	EPHA1, EPHA10, EPHA2, EPHA3, EPHA4, EPHA5, EPHA6, EPHA7, EPHA8, PDGFRB	EPHA6 [Baccin2019:933086310607706;CellTalkDB:11114742;Cellinker:10607706;Cellinker:9330863;HPRD:10607706;LRdb:11114742;SignaLink3:23331499;SignaLink3:9576626;connectomeDB2020:10607706;connectomeDB2020:9330863], EPHA4 [Baccin2019:10366629;CellChatDB:15114347;CellPhoneDB:15114347;Cellinker:15114347;DIP:19836338;HPRD:10366629;ICELLNET:9530499;LRdb:11114742;SignaLink3:23331499;SignaLink3:9267020;connectomeDB2020:10366629], EPHA7 [Baccin2019:8755474;CellChatDB:15114347;CellPhoneDB:15114347;Cellinker:15114347;Cellinker:8755474;HPRD:8755474;ICELLNET:9530499;LRdb:11114742;SignaLink3:23331499;SignaLink3:9576626;connectomeDB2020:8755474], EPHA8 [Baccin2019:10515610;CellChatDB:15114347;CellPhoneDB:15114347;Cellinker:10515610;Cellinker:15114347;HPRD:10515610;LRdb:11114742;SignaLink3:23331499;SignaLink3:9576626;connectomeDB2020:10515610], EPHA2 [Baccin2019:10607706;Baccin2019:8755474;Baccin2019:9330863;CellChatDB:15114347;CellPhoneDB:15114347;Cellinker:10607706;Cellinker:15114347;Cellinker:8755474;Cellinker:9330863;HPRD:10607706;HPRD:8755474;ICELLNET:9530499;LRdb:11114742;SignaLink3:23331499;SignaLink3:9576626;connectomeDB2020:10607706;connectomeDB2020:8755474;connectomeDB2020:9330863], EPHA3 [CellChatDB:15114347;CellPhoneDB:15114347;Cellinker:15114347;Cellinker:28589441;ICELLNET:9530499;LRdb:11114742;Ramilowski2015:8755474;SignaLink3:23331499;SignaLink3:9195962;SignaLink3:9576626;connectomeDB2020:8755474;talklr:8755474], EPHA5 [Baccin2019:10607706;Baccin2019:8755474;Baccin2019:9330863;CellChatDB:15114347;CellPhoneDB:15114347;Cellinker:10607706;Cellinker:15114347;Cellinker:8755474;Cellinker:9330863;HPRD:10607706;HPRD:8755474;LRdb:11114742;SIGNOR:9330863;SignaLink3:23331499;SignaLink3:9576626;connectomeDB2020:10607706;connectomeDB2020:8755474;connectomeDB2020:9330863], EPHA1 [CellChatDB:15114347;CellPhoneDB:15114347;Cellinker:15114347;Cellinker:28589441;LRdb:11114742;connectomeDB2020:15114347], EPHA10 [CellTalkDB:11114742;Cellinker:28589441;LRdb:11114742], PDGFRB [Cellinker:32116646]	anchored component of membrane [GO:0031225]; extracellular region [GO:0005576]; intrinsic component of plasma membrane [GO:0031226]; plasma membrane [GO:0005886]	ephrin receptor binding [GO:0046875]; transmembrane-ephrin receptor activity [GO:0005005]	axon guidance [GO:0007411]; cell-cell signaling [GO:0007267]; ephrin receptor signaling pathway [GO:0048013]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=EFNA4&keywords=EFNA4	4.284308123595506	309	NA	NA	0.47649508226702647	394	0.023622047244094488	0.13023952095808383	0.03982300884955755	0.05347721822541965	0.05218855218855217	0.001692047377326565	0	0	0.0011098779134295228	8.679396448123918e-4	0.0010430751400424961	300	376	364	0.02764211704921079	0.2951448745272539	0.28871754557811863	0.2933701929040154	409	384	397
EGF	epidermal growth factor	Yes		ENSG00000138798	P01133	NA	19	cell_surface_ligand, ligand	cell_surface, cell_surface_ligand, extracellular, intracellular, ligand, plasma_membrane_transmembrane, secreted, transmembrane, transmembrane_predicted	O00300, O00459, O14786, O14939, P00533, P01130, P04626, P07550, P21860, P22681, P23945, P25098, P27986, P29353, P30530, P62993, P98164, Q03135, Q07889, Q15303, Q9NX52	ADRB2, AXL, CAV1, CBL, EGFR, EGFR_ERBB2, EGFR_ERBB4, ERBB2, ERBB3, ERBB4, FSHR, GRB2, GRK2, LDLR, LRP2, NRP1, PIK3R1, PIK3R2, PLD2, RHBDL2, SHC1, SOS1, TNFRSF11B	EGFR [AlzPathway:18270696;Baccin2019:10788520;Baccin2019:12093292;Baccin2019:12297050;Baccin2019:12620237;Baccin2019:15620700;Baccin2019:16274239;Baccin2019:6289330;BioGRID:12093292;BioGRID:26280537;CancerCellMap:3494473;CellTalkDB:12093292;DIP:10085134;DIP:10970856;DIP:11684674;DIP:17697999;DIP:18427122;DIP:21822280;DIP:26280537;DIP:8663535;HPMR:6289330;HPRD:10788520;HPRD:12093292;HPRD:12297050;HPRD:12620237;HPRD:15620700;HPRD:16274239;ICELLNET:8639530;IntAct:12297050;IntAct:12620237;IntAct:17697999;IntAct:21439278;IntAct:21822280;IntAct:25241761;IntAct:26280537;IntAct:2790960;IntAct:28988771;IntAct:30083275;IntAct:9135143;LRdb:10788520;LRdb:12093292;LRdb:12297050;LRdb:12620237;LRdb:15620700;LRdb:16274239;LRdb:6289330;Lit-BM-17:10085134;Lit-BM-17:10970856;Lit-BM-17:11684674;Lit-BM-17:12093292;Lit-BM-17:12297050;Lit-BM-17:12620237;Lit-BM-17:17697999;Lit-BM-17:18271526;Lit-BM-17:18427122;Lit-BM-17:19531499;Lit-BM-17:21439278;Lit-BM-17:23597562;Lit-BM-17:25080504;Lit-BM-17:25241761;Lit-BM-17:25453753;Lit-BM-17:26280537;Lit-BM-17:2790960;Lit-BM-17:8663535;NetPath:19531499;NetPath:3494473;ProtMapper:11116185;ProtMapper:12771140;ProtMapper:14568001;ProtMapper:15708576;ProtMapper:15958209;ProtMapper:16729043;ProtMapper:16843263;ProtMapper:17081983;ProtMapper:17563729;ProtMapper:17575160;ProtMapper:17971399;ProtMapper:18253097;ProtMapper:18320059;ProtMapper:18762250;ProtMapper:19129184;ProtMapper:19135477;ProtMapper:19531623;ProtMapper:19895983;ProtMapper:20813200;ProtMapper:20953304;ProtMapper:21107857;ProtMapper:21303971;ProtMapper:21311755;ProtMapper:21532939;ProtMapper:21649524;ProtMapper:21722395;ProtMapper:21858221;ProtMapper:22216880;ProtMapper:22260327;ProtMapper:23185569;ProtMapper:23613900;ProtMapper:23912460;ProtMapper:23950932;ProtMapper:24096486;ProtMapper:24709886;ProtMapper:25366117;ProtMapper:26821125;ProtMapper:26921391;ProtMapper:27387652;ProtMapper:27462018;ProtMapper:27564112;ProtMapper:29617357;ProtMapper:30197274;SIGNOR:12297050;SIGNOR:12648462;SPIKE:20458382;SignaLink3:10085134;SignaLink3:10209155;SignaLink3:19531499;SignaLink3:21071413;SignaLink3:23331499;connectomeDB2020:10788520;connectomeDB2020:12093292;connectomeDB2020:12297050;connectomeDB2020:12620237;connectomeDB2020:15620700;connectomeDB2020:16274239;connectomeDB2020:6289330], ERBB2 [Baccin2019:12093292;CellTalkDB:12093292;HPRD:12093292;LRdb:12093292;ProtMapper:15748904;SIGNOR:11279155;SignaLink3:11279155;SignaLink3:23331499;connectomeDB2020:12093292], LDLR [CellTalkDB:32196115], FSHR [CellTalkDB:32196115], ERBB3 [Baccin2019:12093292;CellTalkDB:12093292;Cellinker:12093292;HPRD:12093292;LRdb:12093292;connectomeDB2020:12093292], ADRB2 [CellTalkDB:32196115], CAV1 [CellTalkDB:32196115], RHBDL2 [CellTalkDB:21494248], ERBB4 [CellTalkDB:9305636;LRdb:9305636;Ramilowski2015:9305636;connectomeDB2020:9305636;talklr:9305636], NRP1 [CellTalkDB:24556756], AXL [CellTalkDB:27775700], PLD2 [CellTalkDB:9837959], LRP2 [CellTalkDB:32196115], TNFRSF11B [Cellinker:32589946], CBL [NetPath:19531499], GRB2 [ACSN:17673906;HPRD:10973965;NetPath:19531499;ProtMapper:17081983], SOS1 [ACSN:17673906;NetPath:19531499], SHC1 [ACSN:17673906;NetPath:19531499], PIK3R2 [ACSN:17496910;HPRD:1334406;NetPath:19531499], PIK3R1 [ACSN:17496910;NetPath:19531499], GRK2 [HPRD:15620700]	clathrin-coated endocytic vesicle membrane [GO:0030669]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; platelet alpha granule lumen [GO:0031093]	calcium ion binding [GO:0005509]; epidermal growth factor receptor binding [GO:0005154]; growth factor activity [GO:0008083]; guanyl-nucleotide exchange factor activity [GO:0005085]; transmembrane receptor protein tyrosine kinase activator activity [GO:0030297]	angiogenesis [GO:0001525]; branching morphogenesis of an epithelial tube [GO:0048754]; epidermal growth factor receptor signaling pathway [GO:0007173]; epidermal growth factor receptor signaling pathway via MAPK cascade [GO:0038029]; ERK1 and ERK2 cascade [GO:0070371]; mammary gland alveolus development [GO:0060749]; negative regulation of cholesterol efflux [GO:0090370]; negative regulation of secretion [GO:0051048]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cerebellar granule cell precursor proliferation [GO:0021940]; positive regulation of DNA binding [GO:0043388]; positive regulation of DNA replication [GO:0045740]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of epidermal growth factor-activated receptor activity [GO:0045741]; positive regulation of epithelial tube formation [GO:1905278]; positive regulation of gene expression [GO:0010628]; positive regulation of hyaluronan biosynthetic process [GO:1900127]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of phosphorylation [GO:0042327]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein localization to early endosome [GO:1902966]; positive regulation of receptor internalization [GO:0002092]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; regulation of calcium ion import [GO:0090279]; regulation of protein localization to cell surface [GO:2000008]; regulation of receptor signaling pathway via JAK-STAT [GO:0046425]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=EGF&keywords=EGF	2.4447814019756224	366	NA	NA	1.0461758282548783	254	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
EGFL6	EGF like domain multiple 6	TBD		ENSG00000198759	Q8IUX8	Nephronectin family	1	ecm, ligand	ecm, ligand, secreted	NA	NA	NA	basement membrane [GO:0005604]; extracellular space [GO:0005615]; membrane [GO:0016020]	calcium ion binding [GO:0005509]; integrin binding [GO:0005178]	cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; extracellular matrix organization [GO:0030198]; positive regulation of cell-substrate adhesion [GO:0010811]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=EGFL6&keywords=EGFL6	0.029362760764959552	774	NA	NA	0.026411621560807192	781	0	0	0.0022123893805309734	0.001199040767386091	0	0	0	0	0	0	1.9316206297083252e-4	303	409	396	3.2769020098980884e-4	0.9682707174002564	0.9682707174002564	0.9869740343289845	144	144	104
EGFL7	EGF like domain multiple 7	TBD	may be sigl receptor binding	ENSG00000172889	Q9UHF1	NA	1	ligand, receptor	extracellular, ligand, receptor, secreted	NA	NA	NA	cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	calcium ion binding [GO:0005509]; signaling receptor binding [GO:0005102]	anatomical structure development [GO:0048856]; angiogenesis [GO:0001525]; blood vessel development [GO:0001568]; cell adhesion [GO:0007155]; negative regulation of Notch signaling pathway [GO:0045746]; positive regulation of endothelial cell proliferation [GO:0001938]; vasculogenesis [GO:0001570]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=EGFL7&keywords=EGFL7	3.900754201960343	315	NA	NA	0.0580218942833654	698	0.047244094488188976	0.05688622754491013	0.8584070796460163	0.19904076738609147	0.042087542087542076	0.3451776649746201	0.4542157751586574	0.2381729200652525	0.3144654088050337	0.20463346241153	0.6785010623913146	57	74	35	0.3126210913599234	1.0057166673057119	0.6652803184900272	2.1340857148834305	133	266	13
EGFL8	EGF like domain multiple 8	TBD		ENSG00000240389, ENSG00000239974, ENSG00000242038, ENSG00000240592, ENSG00000244444, ENSG00000243897, ENSG00000241404	Q99944	NA	2	ligand	extracellular, intracellular, ligand, secreted	O14931	NCR3	NCR3 [NA]	cell surface [GO:0009986]; extracellular region [GO:0005576]	calcium ion binding [GO:0005509]; signaling receptor binding [GO:0005102]	anatomical structure development [GO:0048856]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=EGFL8&keywords=EGFL8	0.16691852217136224	631	NA	NA	0.0034846135553228265	874	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
ENAM	enamelin	No		ENSG00000132464	Q9NRM1	NA	1	ecm, ligand	ecm, extracellular, intracellular, ligand, secreted, transmembrane	P08962	CD63	CD63 [connectomeDB2020:17708745]	endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]	structural constituent of tooth enamel [GO:0030345]	ameloblast differentiation [GO:0036305]; amelogenesis [GO:0097186]; biomineral tissue development [GO:0031214]; positive regulation of enamel mineralization [GO:0070175]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=ENAM&keywords=ENAM	10.255239303370786	234	NA	NA	40.01066533417407	18	0	0.013473053892215564	0	4.7961630695443646e-4	0.003367003367003367	0.0439932318104907	0.07615593834995452	0.0652528548123981	0.03292637809840913	0.025437308051809254	0.06868842959242591	200	183	134	0.02997943766196918	1.0737114028805677	0.8863883567206682	1.968222521230683	118	176	19
ENDOU	endonuclease, poly(U) specific	No		ENSG00000111405	P21128	ENDOU family	2	ligand, secreted_enzyme	intracellular, ligand, secreted, secreted_enzyme, secreted_peptidase	NA	NA	NA	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]	endoribonuclease activity [GO:0004521]; growth factor activity [GO:0008083]; lyase activity [GO:0016829]; manganese ion binding [GO:0030145]; polysaccharide binding [GO:0030247]; RNA binding [GO:0003723]; scavenger receptor activity [GO:0005044]; serine-type peptidase activity [GO:0008236]	female pregnancy [GO:0007565]; immune response [GO:0006955]; proteolysis [GO:0006508]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=ENDOU&keywords=ENDOU	0.192930125	615	NA	NA	0.03751768408817221	742	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
ENHO	energy homeostasis associated	Yes		ENSG00000168913	Q6UWT2	NA	6	ligand	ligand, secreted, transmembrane, transmembrane_predicted	Q15760	GPR19	GPR19 [CellChatDB:28476646;Cellinker:28476646;connectomeDB2020:28476646;scConnect:28476646]	extracellular region [GO:0005576]; plasma membrane [GO:0005886]	hormone activity [GO:0005179]	positive regulation of Notch signaling pathway [GO:0045747]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=ENHO&keywords=ENHO	0.6108625752808989	504	NA	NA	0.010590776779653572	829	0	9.98003992015968e-4	0	4.7961630695443646e-4	0.00505050505050505	0.020304568527918777	0.025385312783318223	0.0032626427406199023	0.0011098779134295228	0.020496728535184885	3.476917133474985e-4	300	197	391	0.007039540687572205	0.6520057152439863	1.7897623588778822	0.6072752724429121	278	26	282
EPGN	epithelial mitogen	Yes	member of the epidermal growth factor family	ENSG00000182585	Q6UW88	NA	12	adhesion, cell_surface_ligand, ligand	adhesion, cell_adhesion, cell_surface, cell_surface_ligand, extracellular, intracellular, ligand, plasma_membrane, plasma_membrane_transmembrane, secreted, transmembrane, transmembrane_predicted	P00533, Q15303	EGFR, ERBB4	EGFR [CellChatDB:27298358;CellTalkDB:28988771;Cellinker:27298358;IntAct:28988771;SIGNOR:20513444;connectomeDB2020:28988771], ERBB4 [SIGNOR:16469638;SIGNOR:16829981]	clathrin-coated endocytic vesicle membrane [GO:0030669]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]	epidermal growth factor receptor binding [GO:0005154]; growth factor activity [GO:0008083]	angiogenesis [GO:0001525]; epidermal growth factor receptor signaling pathway [GO:0007173]; MAPK cascade [GO:0000165]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epidermal growth factor-activated receptor activity [GO:0045741]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of mitotic nuclear division [GO:0045840]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=EPGN&keywords=EPGN	0.17086253573033708	629	NA	NA	0.3077955245026441	460	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
EPHA3	EPH receptor A3	No		ENSG00000044524	P29320	Protein kinase superfamily, Tyr protein kinase family, Ephrin receptor subfamily	1	adhesion, cell_surface_ligand, ligand, receptor	adhesion, cell_adhesion, cell_surface, cell_surface_ligand, extracellular, intracellular, ligand, plasma_membrane, plasma_membrane_transmembrane, receptor, secreted, transmembrane, transmembrane_predicted	O14672, O43921, P06241, P11362, P12931, P20827, P22607, P40763, P46108, P52797, P52798, P52799, P52803, Q8N6C8, Q8WXA3, Q96T51, Q9NZQ7	ADAM10, CD274, CRK, EFNA1, EFNA2, EFNA3, EFNA4, EFNA5, EFNB2, FGFR1, FGFR3, FYN, LILRA3, RUFY1, RUFY2, SRC, STAT3	EFNA1 [CellPhoneDB:15114347;HPRD:8070404], EFNA5 [BioGRID:9245480;CellPhoneDB:15114347;HPMR:9330863;HPRD:9195962;HPRD:9245480;HPRD:9751130], CRK [HPRD:11870224;SIGNOR:11870224;SignaLink3:11870224;SignaLink3:18988627;SignaLink3:21071413;SignaLink3:23331499], EFNA3 [CellPhoneDB:15114347], EFNA4 [CellPhoneDB:15114347], EFNB2 [BioGRID:8559144;HPRD:8559144], SRC [SIGNOR:9632142;SignaLink3:23331499;SignaLink3:9632142], FYN [SignaLink3:23331499;SignaLink3:9632142], EFNA2 [CellPhoneDB:15114347;HPRD:9751130], ADAM10 [Cellinker:16239146;HPRD:16239146], LILRA3 [Cellinker:32589946], FGFR1 [Cellinker:26024354], FGFR3 [Cellinker:26024354], CD274 [Cellinker:32589946], STAT3 [HPRD-phos:10918587;HPRD-phos:11294897;HPRD-phos:11350938;HPRD-phos:11940572;HPRD-phos:12244095;HPRD-phos:12576423;HPRD-phos:12626508;HPRD-phos:14551213;HPRD-phos:16497976;HPRD-phos:17016520;HPRD-phos:17389395;HPRD-phos:19901323;HPRD-phos:8626374;HPRD:16186805;KEA:16186805;iPTMnet:10918587;iPTMnet:11294897;iPTMnet:11350938;iPTMnet:11940572;iPTMnet:12244095;iPTMnet:12576423;iPTMnet:12626508;iPTMnet:14551213;iPTMnet:16497976;iPTMnet:17016520;iPTMnet:17389395;iPTMnet:19901323;iPTMnet:8626374], RUFY2 [HPRD:11877430], RUFY1 [HPRD:11877430]	actin cytoskeleton [GO:0015629]; cytosol [GO:0005829]; early endosome [GO:0005769]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	ATP binding [GO:0005524]; ephrin receptor activity [GO:0005003]; GPI-linked ephrin receptor activity [GO:0005004]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; transmembrane-ephrin receptor activity [GO:0005005]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]	axon guidance [GO:0007411]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cellular response to retinoic acid [GO:0071300]; ephrin receptor signaling pathway [GO:0048013]; fasciculation of motor neuron axon [GO:0097156]; fasciculation of sensory neuron axon [GO:0097155]; negative regulation of endocytosis [GO:0045806]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of kinase activity [GO:0033674]; positive regulation of neuron projection development [GO:0010976]; positive regulation of protein localization to plasma membrane [GO:1903078]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of epithelial to mesenchymal transition [GO:0010717]; regulation of focal adhesion assembly [GO:0051893]; regulation of GTPase activity [GO:0043087]; regulation of microtubule cytoskeleton organization [GO:0070507]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=EPHA3&keywords=EPHA3	1.4403093801826197	414	NA	NA	0.3888946585128451	423	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
EPHB6	EPH receptor B6		manually added ensembl_gene_ID, hgnc_symbol, and description by searching the uniprot ID on genenames.org	ENSG00000106123	O15197	Protein kinase superfamily, Tyr protein kinase family, Ephrin receptor subfamily	1	adhesion, cell_surface_ligand, receptor	adhesion, cell_adhesion, cell_surface, cell_surface_ligand, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, secreted, transmembrane	P17948, P21673, P22681, P46108, P46109, P52799, P52803, P55196, P62993, P98172, Q15768, Q9H0R4	AFDN, CBL, CRK, CRKL, EFNA5, EFNB1, EFNB2, EFNB3, FLT1, GRB2, HDHD2, SAT1	AFDN [DOMINO:9707552;HPRD:9707552], EFNB1 [CellPhoneDB:15114347;HPMR:11713248], EFNB3 [CellPhoneDB:15114347], EFNB2 [CellPhoneDB:15114347;HPRD:10648835], EFNA5 [NA], FLT1 [Cellinker:32589946], CRK [ELM:27686861;HPRD:11466354], CBL [HPRD:11713248], GRB2 [HPRD:11466354], CRKL [HPRD:11466354], SAT1 [HPRD:16169070], HDHD2 [HPRD:16169070]	cytosol [GO:0005829]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	ATP binding [GO:0005524]; ephrin receptor activity [GO:0005003]; signaling receptor activity [GO:0038023]; transmembrane-ephrin receptor activity [GO:0005005]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]	axon guidance [GO:0007411]; central nervous system projection neuron axonogenesis [GO:0021952]; positive regulation of kinase activity [GO:0033674]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=EPHB6&keywords=EPHB6	2.899596827781146	342	NA	NA	0.08038668929206816	659	0.007874015748031496	0.49950099800399744	0	0.011510791366906472	0.05723905723905722	0.033840947546531296	0.005439709882139619	0.004893964110929854	0.03625601183869773	0.0014688209373748158	0.016843731891056483	194	358	218	0.06135164077861113	0.6482823847347846	0.16073661113078133	0.37621744360927645	280	438	360
EPO	erythropoietin	Yes		ENSG00000130427	P01588	EPO/TPO family	19	ligand, receptor	extracellular, intracellular, ligand, receptor, secreted	P19235, P52799, P54760, Q8IUI8, Q9UIK4	CRLF3, DAPK2, EFNB2, EPHB4, EPOR	EPOR [Baccin2019:10318834;Baccin2019:16982323;Baccin2019:9442088;Baccin2019:9808045;BioGRID:10318834;BioGRID:15358619;BioGRID:17327410;BioGRID:9808045;Cellinker:10318834;Cellinker:16982323;Cellinker:9442088;Cellinker:9808045;DIP:10318834;DIP:8662939;DIP:9030560;DIP:9774108;Guide2Pharma:16982323;HPMR:9442088;HPRD:10318834;HPRD:9808045;ICELLNET:2163696;ICELLNET:9974393;InnateDB:21889455;InnateDB:9774108;IntAct:29997244;IntAct:9774108;LRdb:10318834;LRdb:16982323;LRdb:9442088;LRdb:9808045;Lit-BM-17:10318834;Lit-BM-17:15358619;Lit-BM-17:17327410;Lit-BM-17:8662939;Lit-BM-17:9030560;Lit-BM-17:9774108;Lit-BM-17:9808045;SIGNOR:9442088;SIGNOR:9774108;SPIKE:18586265;SignaLink3:23331499;SignaLink3:9774108;connectomeDB2020:10318834;connectomeDB2020:16982323;connectomeDB2020:9442088;connectomeDB2020:9808045;scConnect:16982323], DAPK2 [SPIKE:18535204], EPHB4 [CellTalkDB:26481148;connectomeDB2020:25586589;connectomeDB2020:26481148], CRLF3 [connectomeDB2020:28769759], EFNB2 [NA]	cell body [GO:0044297]; cell surface [GO:0009986]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	cytokine activity [GO:0005125]; erythropoietin receptor binding [GO:0005128]; hormone activity [GO:0005179]; protein kinase activator activity [GO:0030295]	acute-phase response [GO:0006953]; aging [GO:0007568]; apoptotic process [GO:0006915]; blood circulation [GO:0008015]; cellular hyperosmotic response [GO:0071474]; embryo implantation [GO:0007566]; erythrocyte differentiation [GO:0030218]; erythrocyte maturation [GO:0043249]; erythropoietin-mediated signaling pathway [GO:0038162]; hemoglobin biosynthetic process [GO:0042541]; negative regulation of calcium ion transport into cytosol [GO:0010523]; negative regulation of cation channel activity [GO:2001258]; negative regulation of erythrocyte apoptotic process [GO:1902251]; negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress [GO:1902219]; negative regulation of neuron death [GO:1901215]; negative regulation of transcription by RNA polymerase II [GO:0000122]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of activated T cell proliferation [GO:0042104]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of neuron projection development [GO:0010976]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; response to axon injury [GO:0048678]; response to dexamethasone [GO:0071548]; response to electrical stimulus [GO:0051602]; response to estrogen [GO:0043627]; response to hyperoxia [GO:0055093]; response to hypoxia [GO:0001666]; response to interleukin-1 [GO:0070555]; response to lipopolysaccharide [GO:0032496]; response to salt stress [GO:0009651]; response to testosterone [GO:0033574]; response to vitamin A [GO:0033189]; signal transduction [GO:0007165]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=EPO&keywords=EPO	0.11618020561797752	663	NA	NA	0.16991389709539945	554	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
EPOR	erythropoietin receptor	No		ENSG00000187266	P19235	Type I cytokine receptor family, Type 1 subfamily	1	adhesion, ligand, receptor	adhesion, cell_adhesion, cell_surface, extracellular, intracellular, ligand, plasma_membrane, plasma_membrane_transmembrane, receptor, secreted, transmembrane, transmembrane_predicted	O60674, P01588, P18031, P19174, P22681, P27986, P29350, P29353, P42229, P46109, P62993, Q13480, Q13507, Q92835, Q9Y4H2	CBL, CRKL, EPO, GAB1, GRB2, INPP5D, IRS2, JAK2, PIK3R1, PLCG1, PTPN1, PTPN6, SHC1, STAT5A, TRPC3	TRPC3 [TRIP:18276585;TRIP:19074769;TRIP:21757714], JAK2 [BioGRID:8343951;HPRD:11779507;HPRD:12441334;HPRD:8343951;SignaLink3:11779507;SignaLink3:18160720;SignaLink3:23331499;SignaLink3:8343951], EPO [BioGRID:10318834;BioGRID:15358619;BioGRID:17327410;BioGRID:9808045;DIP:10318834;DIP:8662939;DIP:9030560;DIP:9774108;HPMR:9442088;HPRD:10318834;HPRD:9808045;InnateDB:21889455;InnateDB:9774108;IntAct:29997244;IntAct:9774108;Lit-BM-17:10318834;Lit-BM-17:15358619;Lit-BM-17:17327410;Lit-BM-17:8662939;Lit-BM-17:9030560;Lit-BM-17:9774108;Lit-BM-17:9808045], PIK3R1 [HPRD:7559499;Lit-BM-17:15644415;Lit-BM-17:24113870;Lit-BM-17:7559499;Lit-BM-17:9162069;SignaLink3:23331499;SignaLink3:7559499;SignaLink3:9162069], CRKL [HPRD:11443118], PTPN1 [IntAct:14527337], PTPN6 [DOMINO:7228577;DOMINO:7528577;HPRD:7528577;HPRD:7889566;IntAct:7228577;IntAct:7528537;IntAct:7528577], GRB2 [HPRD:7534299;InnateDB:8647802], INPP5D [HPRD:10660611;HPRD:15644415;Lit-BM-17:10660611;Lit-BM-17:15644415], STAT5A [HPRD:15644415;HPRD:8977232;Lit-BM-17:10374881;Lit-BM-17:15644415;Lit-BM-17:8977232;ProtMapper:27752093], CBL [HPRD:11443118], PLCG1 [HPRD:15329338;HPRD:15953601], GAB1 [HPRD:10455108], SHC1 [HPRD:8400282], IRS2 [HPRD:9334184]	extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; nuclear speck [GO:0016607]; plasma membrane [GO:0005886]	erythropoietin receptor activity [GO:0004900]; identical protein binding [GO:0042802]	brain development [GO:0007420]; decidualization [GO:0046697]; heart development [GO:0007507]; signal transduction [GO:0007165]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=EPOR&keywords=EPOR	2.883126283736191	343	NA	NA	0.17860380376703827	549	0.015748031496062992	0.012974051896207579	0.05199115044247793	0.06978417266187065	0.026936026936026928	0.08291032148900171	0.09156844968268338	0.06035889070146825	0.054014058453570164	0.062191213780213896	0.04075719528684523	163	132	163	0.05174850571149352	1.0366900010934994	1.169116773732334	0.8219987625934982	123	99	175
ERBB3	erb-b2 receptor tyrosine kinase 3	No		ENSG00000065361	P21860	Protein kinase superfamily, Tyr protein kinase family, EGF receptor subfamily	1	adhesion, cell_surface_ligand, receptor	adhesion, cell_adhesion, cell_surface, cell_surface_ligand, extracellular, intracellular, ligand_regulator, plasma_membrane, plasma_membrane_transmembrane, receptor, secreted, transmembrane, transmembrane_predicted	O00329, O00459, O14511, O43374, O43639, O60674, O60880, O75553, O75815, P01133, P04083, P12931, P15498, P15514, P15941, P16333, P17028, P19174, P20936, P27701, P27986, P29353, P31943, P40189, P42336, P42338, P42681, P43403, P43405, P46108, P46109, P48736, P49798, P50052, P52333, P52735, P52757, P61925, P62993, Q02297, Q05397, Q07889, Q08881, Q12792, Q13671, Q14289, Q14451, Q15185, Q15303, Q4VC44, Q63HR2, Q68CZ2, Q8IZW8, Q92529, Q92569, Q9H4P4, Q9UKW4, Q9ULJ1, Q9UN19, Q9UQ80, Q9UQQ2	AGTR2, ANXA1, AREG, BCAR3, CD82, CHN2, CRK, CRKL, DAB1, DAPP1, EGF, ERBB4, FLYWCH1, GRB2, GRB7, HNRNPH1, IL6ST, ITK, JAK2, JAK3, MUC1, NCK1, NCK2, NRG1, NRG2, ODF2L, PA2G4, PIK3CA, PIK3CA_PIK3R1, PIK3CB, PIK3CD, PIK3CG, PIK3R1, PIK3R2, PIK3R3, PKIA, PLCG1, PTGES3, PTK2, PTK2B, RASA1, RASA4, RGS4, RIN1, RNF41, SH2B3, SH2D1A, SHC1, SHC3, SOS1, SRC, SYK, TNS2, TNS3, TNS4, TWF1, TXK, VAV1, VAV2, VAV3, ZAP70, ZNF24	GRB7 [BioGRID:9516479;DOMINO:16273093;HPRD:9516479;IntAct:16273093;IntAct:9516479;Lit-BM-17:16273093;Lit-BM-17:24189400;Lit-BM-17:9516479;SPIKE:16189514;SPIKE:16273093;SPIKE:9516479], PIK3R1 [ACSN:17496910;BioGRID:10383151;BioGRID:11694521;DOMINO:16273093;HPRD:10383151;HPRD:11546794;IntAct:10572067;IntAct:16273093;IntAct:20007781;IntAct:20227043;IntAct:21278786;Lit-BM-17:10383151;Lit-BM-17:10572067;Lit-BM-17:11546794;Lit-BM-17:16273093;Lit-BM-17:18803287;Lit-BM-17:20007781;Lit-BM-17:20227043;Lit-BM-17:21075308;Lit-BM-17:22439932;Lit-BM-17:24189400;Lit-BM-17:9130710;Lit-BM-17:9756944;SignaLink3:10383151;SignaLink3:11546794;SignaLink3:18988627;SignaLink3:21071413;SignaLink3:23331499], NRG2 [HPMR:9168115;HPRD:9168114;HPRD:9168115], NRG1 [BioGRID:7592681;DIP:17697999;HPRD:11555649;HPRD:7592681;HPRD:8702572;HPRD:9565587;IntAct:7592681;Lit-BM-17:10970856;Lit-BM-17:11555649;Lit-BM-17:17697999;Lit-BM-17:7592681;Lit-BM-17:9168115], GRB2 [DOMINO:16729043;HPRD:11173924;HPRD:16729043;IntAct:16729043;IntAct:24658140;Lit-BM-17:16729043;Lit-BM-17:24189400;Lit-BM-17:24658140;Lit-BM-17:9756944;SIGNOR:14967450;SIGNOR:16729043], PIK3CD [ACSN:17496910;SIGNOR:16729043], PIK3CA [ACSN:17496910;SIGNOR:16729043], PIK3CB [ACSN:17496910;SIGNOR:16729043], PIK3CG [ACSN:17496910;SIGNOR:16729043], EGF [HPRD:12093292], AREG [NA], IL6ST [HPRD:11821958], PA2G4 [BioGRID:11325528;BioGRID:11708806;HPRD:10682683;HPRD:11325528;HPRD:15583694;Lit-BM-17:10682683;Lit-BM-17:11325528;Lit-BM-17:11708806;Lit-BM-17:19037095], SHC1 [DOMINO:16273093;DOMINO:16729043;ELM:8026468;HPRD:16729043;HPRD:9694850;IntAct:16273093;IntAct:16729043;LMPID:7537849;LMPID:8026468;Lit-BM-17:16273093;Lit-BM-17:16729043;Lit-BM-17:24189400;Lit-BM-17:24658140;Lit-BM-17:9756944;NetPath:9590694], PIK3R2 [ACSN:17496910;DOMINO:16273093;DOMINO:16729043;HPRD:16729043;IntAct:16273093;IntAct:16729043;Lit-BM-17:16273093;Lit-BM-17:16729043;Lit-BM-17:24189400], NCK2 [DOMINO:16273093], JAK2 [DOMINO:16273093], SH2D1A [DOMINO:16273093], DAB1 [DOMINO:16273093], SRC [DOMINO:16273093], NCK1 [DOMINO:16273093], PLCG1 [DOMINO:16273093], RASA1 [DOMINO:16273093], TXK [DOMINO:16273093], ZAP70 [DOMINO:16273093], SYK [DOMINO:16273093], CRK [DOMINO:16273093], CRKL [DOMINO:16273093], JAK3 [DOMINO:16273093], VAV2 [DOMINO:16273093], CHN2 [DOMINO:16273093], ITK [DOMINO:16273093], RIN1 [DOMINO:16273093], PIK3R3 [ACSN:17496910;DOMINO:16273093;Lit-BM-17:16273093;Lit-BM-17:24189400], BCAR3 [DOMINO:16273093], TNS2 [DOMINO:16273093], TNS3 [DOMINO:16273093], TNS4 [DOMINO:16273093], SHC3 [DOMINO:16273093], VAV1 [DOMINO:16273093], VAV3 [DOMINO:16273093], DAPP1 [DOMINO:16273093], SH2B3 [DOMINO:16273093], ANXA1 [KEA:17570479], HNRNPH1 [KEA:17570479], PKIA [KEA:17570479], TWF1 [KEA:17570479], ZNF24 [KEA:17570479], RNF41 [BioGRID:17384230;BioGRID:27353365;HPRD:12411582], SOS1 [HPRD:11173924], AGTR2 [HPRD:10710290], ERBB4 [HPRD:7689552], PTK2 [ACSN:10545505;ACSN:16919435;ACSN:17496910;ACSN:19339212;ACSN:7529872;ACSN:7657702;HPRD:11807823], RGS4 [HPRD:12840049], PTGES3 [HPRD:10095121], CD82 [HPRD:14576349], PTK2B [HPRD:15499613], ODF2L [HPRD:16169070], RASA4 [HPRD:16169070], FLYWCH1 [HPRD:16169070], MUC1 [HPRD:11278868;HPRD:12939402]	apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; ERBB3:ERBB2 complex [GO:0038143]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; lateral plasma membrane [GO:0016328]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	ATP binding [GO:0005524]; ErbB-3 class receptor binding [GO:0043125]; growth factor binding [GO:0019838]; identical protein binding [GO:0042802]; neuregulin binding [GO:0038132]; neuregulin receptor activity [GO:0038131]; protein heterodimerization activity [GO:0046982]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activator activity [GO:0030296]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; transmembrane signaling receptor activity [GO:0004888]; ubiquitin protein ligase binding [GO:0031625]	cranial nerve development [GO:0021545]; endocardial cushion development [GO:0003197]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; heart development [GO:0007507]; negative regulation of cell adhesion [GO:0007162]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of secretion [GO:0051048]; negative regulation of signal transduction [GO:0009968]; nervous system development [GO:0007399]; neuron apoptotic process [GO:0051402]; peripheral nervous system development [GO:0007422]; phosphatidylinositol 3-kinase signaling [GO:0014065]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of cardiac muscle tissue development [GO:0055025]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of kinase activity [GO:0033674]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein tyrosine kinase activity [GO:0061098]; regulation of cell population proliferation [GO:0042127]; Schwann cell differentiation [GO:0014037]; signal transduction [GO:0007165]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; wound healing [GO:0042060]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=ERBB3&keywords=ERBB3	30.864108692342153	130	NA	NA	1.6710394472373007	190	0	0.19311377245509084	0.0011061946902654867	0.003836930455635491	0.26767676767676746	0.023688663282571906	0.019945602901178604	0.011419249592169658	0.00813910469848317	0.004740285752436898	0.02136372416457406	273	295	203	0.05045729960628851	0.3000316722150855	0.2438131681108641	0.5187748107974002	407	398	317
EREG	epiregulin	Yes		ENSG00000124882	O14944	NA	16	cell_surface_ligand, ligand	cell_surface, cell_surface_ligand, extracellular, intracellular, ligand, plasma_membrane, plasma_membrane_transmembrane, secreted, transmembrane, transmembrane_predicted	P00533, P04626, P21860, Q15303	EGFR, EGFR_ERBB2, ERBB2, ERBB2_ERBB4, ERBB3, ERBB4	EGFR [Baccin2019:8626392;Baccin2019:9419975;CellTalkDB:8626392;HPRD:9419975;IntAct:28988771;LRdb:8626392;LRdb:942;SIGNOR:20513444;SIGNOR:9419975;connectomeDB2020:8626392;connectomeDB2020:9419975], ERBB4 [Baccin2019:9419975;CellTalkDB:9419975;HPRD:9419975;LRdb:9419975;SIGNOR:16829981;SIGNOR:22891299;connectomeDB2020:9419975], ERBB3 [CellTalkDB:32196115;SIGNOR:16829981;SIGNOR:22891299], ERBB2 [CellTalkDB:32196115]	clathrin-coated endocytic vesicle membrane [GO:0030669]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]	epidermal growth factor receptor binding [GO:0005154]; growth factor activity [GO:0008083]	anatomical structure morphogenesis [GO:0009653]; angiogenesis [GO:0001525]; animal organ morphogenesis [GO:0009887]; cell-cell signaling [GO:0007267]; cytokine-mediated signaling pathway [GO:0019221]; epidermal growth factor receptor signaling pathway [GO:0007173]; female meiotic nuclear division [GO:0007143]; keratinocyte differentiation [GO:0030216]; keratinocyte proliferation [GO:0043616]; luteinizing hormone signaling pathway [GO:0042700]; mRNA transcription [GO:0009299]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of smooth muscle cell differentiation [GO:0051151]; negative regulation of transcription, DNA-templated [GO:0045892]; oocyte maturation [GO:0001556]; ovarian cumulus expansion [GO:0001550]; ovulation [GO:0030728]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytokine production [GO:0001819]; positive regulation of DNA replication [GO:0045740]; positive regulation of epidermal growth factor-activated receptor activity [GO:0045741]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of innate immune response [GO:0045089]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of phosphorylation [GO:0042327]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of smooth muscle cell proliferation [GO:0048661]; primary follicle stage [GO:0048160]; response to peptide hormone [GO:0043434]; wound healing [GO:0042060]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=EREG&keywords=EREG	0.8274546808988764	472	NA	NA	0.7522123103114691	312	1.2125984251968496	0.02894211576846307	0.00331858407079646	0.0050359712230215814	0.0016835016835016834	0.001692047377326565	0.005439709882139619	0.0016313213703099511	0.0011098779134295228	0.0027039658165309076	0.0020088854548966596	300	329	335	0.11510585506884233	0.08880382063106528	0.10154573348737565	0.0959897955878124	481	469	474
ERFE	erythroferrone	Yes		ENSG00000178752	Q4G0M1	Adipolin/erythroferrone family	4	ligand	intracellular, ligand, secreted	Q07954	LRP1	LRP1 [NA]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	hormone activity [GO:0005179]; identical protein binding [GO:0042802]	cellular iron ion homeostasis [GO:0006879]; negative regulation of gluconeogenesis [GO:0045721]; positive regulation of fatty acid transport [GO:2000193]; positive regulation of glucose import [GO:0046326]; positive regulation of insulin receptor signaling pathway [GO:0046628]; regulation of fatty acid metabolic process [GO:0019217]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=ERFE&keywords=ERFE	1.020764994494382	451	NA	NA	0.5989787553809256	340	0	0.0034930139720558886	0	0.004316546762589927	0.003367003367003367	0	0.009972801450589302	0	3.699593044765076e-4	0.005307784750968075	7.726482518833301e-5	302	287	399	0.0024458522211701274	0.8332060448891905	1.2299507079900773	0.8096886132110039	209	88	182
ESM1	endothelial cell specific molecule 1	Yes		ENSG00000164283	Q9NQ30	NA	1	ecm, ligand	ecm, extracellular, ligand, secreted	NA	ITGAL_ITGB2	NA	extracellular region [GO:0005576]	hepatocyte growth factor receptor binding [GO:0005171]; insulin-like growth factor binding [GO:0005520]; integrin binding [GO:0005178]	angiogenesis [GO:0001525]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of hepatocyte growth factor receptor signaling pathway [GO:1902204]; sprouting angiogenesis [GO:0002040]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=ESM1&keywords=ESM1	46.864655426966294	93	NA	NA	56.67370493891935	14	0.007874015748031496	0.08033932135728537	5.76659292035397	0.5230215827338139	0.00505050505050505	0	0.014505893019038985	0.0016313213703099511	0.006289308176100629	0.004272933635999459	0.017577747730345743	283	299	215	0.5842868681068546	0.027409840348637422	0.024016909008046837	0.04640477387325876	519	516	507
ETV5	ETS variant transcription factor 5			ENSG00000244405	P41161	ETS family	1	ligand	intracellular, ligand, secreted	P04626	ERBB2	ERBB2 [Cellinker:27029001]	chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]	cell differentiation [GO:0030154]; cellular response to oxidative stress [GO:0034599]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=ETV5&keywords=ETV5	15.381508810644778	192	NA	NA	1.569528284270519	198	0.07086614173228346	0.05788423153692608	0.036504424778761084	0.12853717026379044	0.09595959595959602	0.09475465313028761	0.1287398005439707	0.08156606851549764	0.07325194228634849	0.08946454800373937	0.05960981263279737	146	115	144	0.08337621721672711	0.8915754435963058	1.0652021571283101	0.7454768966623729	191	119	215
FAM3B	FAM3 metabolism regulating signaling molecule B	TBD		ENSG00000183844	P58499	FAM3 family	2	ligand	extracellular, intracellular, ligand, secreted, transmembrane	O75197	LRP5	LRP5 [NA]	extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	cytokine activity [GO:0005125]	apoptotic process [GO:0006915]; glucose homeostasis [GO:0042593]; insulin secretion [GO:0030073]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=FAM3B&keywords=FAM3B	37.61459308895303	112	4146.7	98	8.564980105371601	52	0.015748031496062992	0.331836327345313	0.0011061946902654867	0.013189448441246998	1.9781144781144848	0.45685279187817407	0.41704442429736954	0.2071778140293636	0.44173140954495593	0.18133262117771975	0.3927757388448708	42	82	46	0.4033553890781661	1.0928402567881674	0.4628768034315829	0.974405437759287	114	330	107
FAM3C	FAM3 metabolism regulating signaling molecule C	TBD		ENSG00000196937	Q92520	FAM3 family	4	ligand	extracellular, intracellular, ligand, secreted	O15529, O15552, P10321, P11279, P23416, P42702, P43628, Q15116, Q8IZF4, Q9UHP7	ADGRG5, CLEC2D, FFAR2, GLRA2, GPR42, HLA-C, KIR2DL3, LAMP1, LIFR, PDCD1	GLRA2 [CellTalkDB:32103204], LAMP1 [CellTalkDB:32103204], LIFR [connectomeDB2020:30692635], FFAR2 [NA], CLEC2D [NA], KIR2DL3 [NA], HLA-C [NA], GPR42 [NA], ADGRG5 [NA], PDCD1 [NA]	extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; platelet dense granule lumen [GO:0031089]	cytokine activity [GO:0005125]	negative regulation of gluconeogenesis [GO:0045721]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=FAM3C&keywords=FAM3C	90.79358093667867	54	21963.9	44	2.939873939097862	114	0.29921259842519665	1.2809381237524953	0.551991150442475	1.0625899280575686	0.883838383838387	1.14213197969543	1.1786038077969263	0.585644371941274	0.831298557158708	0.9728601949528513	0.7345566930654397	27	30	32	0.8657877990115229	0.9606191797924772	1.1222583781849644	0.8501565035569117	149	106	163
FAM3D	FAM3 metabolism regulating signaling molecule D	TBD		ENSG00000198643	Q96BQ1	FAM3 family	2	ligand	ligand, secreted, transmembrane, transmembrane_predicted	P21462, P25090	FPR1, FPR2	FPR1 [connectomeDB2020:29853563], FPR2 [connectomeDB2020:29853563]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	cytokine activity [GO:0005125]	negative regulation of glucagon secretion [GO:0070093]; negative regulation of insulin secretion [GO:0046676]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=FAM3D&keywords=FAM3D	4.317027178651686	307	NA	NA	0.31120379621430705	459	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
FAS	Fas cell surface death receptor	No		ENSG00000026103	P25445	NA	1	adhesion, ligand, receptor	adhesion, cell_adhesion, cell_surface, extracellular, intracellular, ligand, plasma_membrane, plasma_membrane_transmembrane, receptor, secreted, transmembrane	P00533, P29350, P55957, Q13158, Q13546, Q99683, Q9UER7, Q9UKL3	BID, CASP8AP2, DAXX, EGFR, FADD, MAP3K5, PTPN6, RIPK1	CASP8AP2 [HPRD:10235259;SPIKE:10235259], DAXX [BioGRID:11773067;BioGRID:14637155;HPRD:11193028;HPRD:11483955;HPRD:9215629;IntAct:11003656;IntAct:11495919;IntAct:25241761;Lit-BM-17:11003656;Lit-BM-17:11495919;Lit-BM-17:11773067;Lit-BM-17:14637155;Lit-BM-17:25241761;Lit-BM-17:9215629;Macrophage:15725726;Macrophage:9215629;Macrophage:9743501;SPIKE:9743501], FADD [CA1:8521815;DIP:19118384;DIP:20935634;DIP:21713032;DIP:26942442;DIP:7538907;DOMINO:7538907;HPRD:17159907;HPRD:19118384;HPRD:7536190;HPRD:7538907;HPRD:9325248;InnateDB:11464215;InnateDB:12721308;InnateDB:15993755;InnateDB:16410793;InnateDB:16762833;InnateDB:9880544;IntAct:16498403;IntAct:17159907;IntAct:18328427;IntAct:19118384;IntAct:20935634;IntAct:21382479;IntAct:25241761;IntAct:7536190;IntAct:7538907;Lit-BM-17:11035039;Lit-BM-17:11717445;Lit-BM-17:12107169;Lit-BM-17:15659383;Lit-BM-17:16498403;Lit-BM-17:17159907;Lit-BM-17:18328427;Lit-BM-17:20935634;Lit-BM-17:21382479;Lit-BM-17:21625644;Lit-BM-17:21803845;Lit-BM-17:22864571;Lit-BM-17:25241761;Lit-BM-17:26186194;Lit-BM-17:27321185;Lit-BM-17:7536190;Lit-BM-17:7538907;Lit-BM-17:8967952;Lit-BM-17:9082980;Lit-BM-17:9325248;MPPI:10196099;Macrophage:15725726;Macrophage:7538907;Macrophage:8967952;ProtMapper:23606538;ProtMapper:25563855;SIGNOR:21959933;SPIKE:7536190;SPIKE:7538907;SPIKE:8967952], RIPK1 [DIP:7538908;HPRD:7538908;HPRD:9740801;SIGNOR:7538908], MAP3K5 [Lit-BM-17:11495919;Lit-BM-17:25241761;SIGNOR:11495919], BID [Lit-BM-17:15659383;Lit-BM-17:25241761], EGFR [HPRD:12586732], PTPN6 [HPRD:11786908]	CD95 death-inducing signaling complex [GO:0031265]; cell surface [GO:0009986]; cytosol [GO:0005829]; death-inducing signaling complex [GO:0031264]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; membrane raft [GO:0045121]; nuclear body [GO:0016604]; plasma membrane [GO:0005886]	calmodulin binding [GO:0005516]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; signaling receptor activity [GO:0038023]; tumor necrosis factor-activated receptor activity [GO:0005031]	activation-induced cell death of T cells [GO:0006924]; apoptotic process [GO:0006915]; cellular response to amino acid starvation [GO:0034198]; cellular response to hyperoxia [GO:0071455]; cellular response to mechanical stimulus [GO:0071260]; extrinsic apoptotic signaling pathway [GO:0097191]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; Fas signaling pathway [GO:0036337]; immune response [GO:0006955]; motor neuron apoptotic process [GO:0097049]; necroptotic signaling pathway [GO:0097527]; negative regulation of apoptotic process [GO:0043066]; positive regulation of apoptotic process [GO:0043065]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:2001269]; positive regulation of protein phosphorylation [GO:0001934]; protein-containing complex assembly [GO:0065003]; regulation of apoptotic process [GO:0042981]; regulation of stress-activated MAPK cascade [GO:0032872]; signal transduction [GO:0007165]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=FAS&keywords=FAS	10.557460356529301	233	768.245	156	0.7725650904625503	307	0.023622047244094488	0.12275449101796393	0	0.24844124700239806	0.035353535353535345	0.015228426395939083	0.011786038077969175	0.02936378466557912	0.021827598964113935	0.011016157030311096	0.011242032064902395	228	236	244	0.048239577983346056	0.5464943268169837	0.3608569594429545	0.3647353363545436	329	358	366
FASLG	Fas ligand	Yes		ENSG00000117560	P48023	Tumor necrosis factor family	16	adhesion, cell_surface_ligand, ligand, receptor	adhesion, cell_adhesion, cell_surface, cell_surface_ligand, extracellular, intracellular, ligand, plasma_membrane, receptor, secreted, transmembrane, transmembrane_predicted	O14763, O95407, P19438, P25445, P55957	BID, FAS, TNFRSF10B, TNFRSF1A, TNFRSF6B	FAS [Baccin2019:9126929;Baccin2019:9228058;BioGRID:9126929;BioGRID:9228058;CA1:1375228;CA1:1713127;CA1:7505205;CellTalkDB:9126929;Cellinker:9126929;Cellinker:9228058;HPMR:9126929;HPRD:9126929;HPRD:9228058;ICELLNET:11239407;IntAct:21803845;IntAct:25241761;LRdb:9126929;LRdb:9228058;Lit-BM-17:12753742;Lit-BM-17:12887920;Lit-BM-17:15659383;Lit-BM-17:21803845;Lit-BM-17:25241761;Lit-BM-17:9126929;Lit-BM-17:9228058;Macrophage:15725726;Macrophage:8521815;Macrophage:9039262;Macrophage:9126929;Macrophage:9228058;SIGNOR:14965271;SIGNOR:9228058;SPIKE:9126929;SPIKE:9228058;connectomeDB2020:9126929;connectomeDB2020:9228058], TNFRSF6B [BioGRID:9872321;CellTalkDB:14697332;Cellinker:10318773;Cellinker:11994433;Cellinker:14697332;Cellinker:9872321;HPMR:14697332;HPRD:10318773;HPRD:11994433;HPRD:9872321;ICELLNET:11239407;LRdb:10318773;LRdb:11994433;LRdb:14697332;LRdb:9872321;connectomeDB2020:10318773;connectomeDB2020:11994433;connectomeDB2020:14697332;connectomeDB2020:9872321], TNFRSF1A [NA], TNFRSF10B [CellTalkDB:32103204], BID [Lit-BM-17:15659383;Lit-BM-17:25241761]	caveola [GO:0005901]; cytoplasmic vesicle lumen [GO:0060205]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; lysosomal lumen [GO:0043202]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]	cytokine activity [GO:0005125]; death receptor binding [GO:0005123]; signaling receptor binding [GO:0005102]; tumor necrosis factor receptor binding [GO:0005164]	activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; cell-cell signaling [GO:0007267]; cellular chloride ion homeostasis [GO:0030644]; cellular response to interferon-gamma [GO:0071346]; endosomal lumen acidification [GO:0048388]; extrinsic apoptotic signaling pathway [GO:0097191]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; inflammatory cell apoptotic process [GO:0006925]; necroptotic process [GO:0070266]; necroptotic signaling pathway [GO:0097527]; negative regulation of angiogenesis [GO:0016525]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of phosphatidylserine exposure on apoptotic cell surface [GO:1905782]; release of sequestered calcium ion into cytosol by endoplasmic reticulum [GO:1903514]; response to growth factor [GO:0070848]; response to lipopolysaccharide [GO:0032496]; retinal cell programmed cell death [GO:0046666]; signal transduction [GO:0007165]; T cell apoptotic process [GO:0070231]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=FASLG&keywords=FASLG	0.02941931797752809	773	NA	NA	0.12246166841040411	601	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
FAT4	FAT atypical cadherin 4	No	manually added ensembl_gene_ID, hgnc_symbol, and description by searching the uniprot ID on genenames.org	ENSG00000196159	Q6V0I7	NA	1	adhesion, cell_surface_ligand, receptor	adhesion, cell_adhesion, cell_surface, cell_surface_ligand, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, secreted, transmembrane, transmembrane_predicted	Q96JQ0	DCHS1	DCHS1 [CellTalkDB:24056717;Cellinker:21303848;LRdb:21303848;LRdb:24056717;Ramilowski2015:21303848;Ramilowski2015:24056717;connectomeDB2020:21303848;connectomeDB2020:24056717;talklr:21303848;talklr:24056717]	extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	calcium ion binding [GO:0005509]	cell-cell adhesion [GO:0098609]; cerebral cortex development [GO:0021987]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; hippo signaling [GO:0035329]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; neurogenesis [GO:0022008]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=FAT4&keywords=FAT4	0.17186720778143438	628	NA	NA	0.04487184829014991	721	0	0.012475049900199596	0.0055309734513274336	0.003836930455635491	0	0.011844331641285955	0.009066183136899365	0	0.004069552349241584	0.00550807851515555	0.001313502028201662	290	284	351	0.004876781952540603	0.9457389638515765	1.042435021540874	0.7604804630661124	158	120	206
FBLN1	fibulin 1	No		ENSG00000077942	P23142	Fibulin family	8	ecm, ligand	ecm, extracellular, intracellular, ligand, secreted	P02751, P05556, P13611	FN1, ITGB1, VCAN	ITGB1 [CellTalkDB:2527614;Cellinker:2527614;HPRD:2527614;LRdb:2527614;connectomeDB2020:2527614], VCAN [Cellinker:16045811;HPRD:10400671], FN1 [BioGRID:1400330;HPRD:1400330;Lit-BM-17:1400330;Lit-BM-17:21988832]	basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; elastic fiber [GO:0071953]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]; fibrinogen binding [GO:0070051]; fibronectin binding [GO:0001968]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; peptidase activator activity [GO:0016504]; protein-containing complex binding [GO:0044877]; protein C-terminus binding [GO:0008022]	blood coagulation, fibrin clot formation [GO:0072378]; embryo implantation [GO:0007566]; extracellular matrix organization [GO:0030198]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cell motility [GO:2000146]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of stem cell proliferation [GO:2000647]; negative regulation of substrate adhesion-dependent cell spreading [GO:1900025]; negative regulation of transformation of host cell by virus [GO:1904188]; negative regulation of transforming growth factor beta production [GO:0071635]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of gene expression [GO:0010628]; positive regulation of substrate-dependent cell migration, cell attachment to substrate [GO:1904237]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=FBLN1&keywords=FBLN1	7.186213991570813	267	NA	NA	0.043062294660929507	726	0	0.005489021956087825	0	0.29208633093525344	0	0.00338409475465313	0	0	0	3.338229403124584e-4	5.022213637241645e-4	303	397	384	0.027435953813639183	0.2671228853893035	0.27604006009184406	0.28053836736751847	413	389	401
FBLN2	fibulin 2	No		ENSG00000163520	P98095	Fibulin family	7	ecm, ligand	ecm, extracellular, ligand, secreted	P05106, P13611	ITGB3, VCAN	ITGB3 [CellTalkDB:10848816;Cellinker:10848816;HPRD:10848816;LRdb:10848816], VCAN [Cellinker:16045811;HPRD:11038354]	collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular vesicle [GO:1903561]	calcium ion binding [GO:0005509]; extracellular matrix binding [GO:0050840]; extracellular matrix constituent conferring elasticity [GO:0030023]; extracellular matrix structural constituent [GO:0005201]	extracellular matrix organization [GO:0030198]; positive regulation of cell-substrate adhesion [GO:0010811]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=FBLN2&keywords=FBLN2	0.5680267251304719	512	NA	NA	0.00989752960573767	833	0	0	0.0022123893805309734	0.03453237410071942	0	0	0	0	0	0	7.726482518833301e-5	303	409	399	0.0033474571187671566	0.7492063777406355	0.7492063777406355	0.7549951077212469	242	242	211
FCER2	Fc fragment of IgE receptor II	No		ENSG00000104921	P06734	NA	2	cell_surface_ligand, receptor	cell_surface, cell_surface_ligand, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, secreted, transmembrane, transmembrane_predicted	P05107, P20023	CR2, ITGAM_ITGB2, ITGAV_ITGB3, ITGAX_ITGB2, ITGB2	CR2 [CellChatDB:16785534;Cellinker:16785534;HPRD:7515913;HPRD:8766552;LRdb:16785534;connectomeDB2020:16172256;connectomeDB2020:16785534], ITGB2 [HPRD:7621072]	external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	carbohydrate binding [GO:0030246]; IgE binding [GO:0019863]; integrin binding [GO:0005178]; metal ion binding [GO:0046872]	positive regulation of humoral immune response mediated by circulating immunoglobulin [GO:0002925]; positive regulation of killing of cells of other organism [GO:0051712]; positive regulation of nitric-oxide synthase activity [GO:0051000]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=FCER2&keywords=FCER2	0.020129102466404494	794	NA	NA	0.0030014916671111057	882	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
FCN1	ficolin 1	No		ENSG00000085265	O00602	Ficolin lectin family	1	ligand, receptor	extracellular, intracellular, ligand, plasma_membrane, receptor, secreted	NA	NA	NA	collagen-containing extracellular matrix [GO:0062023]; collagen trimer [GO:0005581]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extrinsic component of external side of plasma membrane [GO:0031232]; ficolin-1-rich granule lumen [GO:1904813]; secretory granule lumen [GO:0034774]; serine-type endopeptidase complex [GO:1905370]	antigen binding [GO:0003823]; carbohydrate binding [GO:0030246]; carbohydrate derivative binding [GO:0097367]; G protein-coupled receptor binding [GO:0001664]; metal ion binding [GO:0046872]; pattern recognition receptor activity [GO:0038187]; sialic acid binding [GO:0033691]; signaling receptor binding [GO:0005102]	cell surface pattern recognition receptor signaling pathway [GO:0002752]; complement activation, lectin pathway [GO:0001867]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of viral entry into host cell [GO:0046597]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of opsonization [GO:1903028]; protein localization to cell surface [GO:0034394]; proteolysis [GO:0006508]; recognition of apoptotic cell [GO:0043654]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=FCN1&keywords=FCN1	0.037074244719101125	759	NA	NA	0.006485127127844715	856	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
FCN2	ficolin 2	No		ENSG00000160339	Q15485	Ficolin lectin family	6	ligand	extracellular, ligand, secreted	O00187, P48740, Q07954	LRP1, MASP1, MASP2	MASP2 [HPRD:12421953;SIGNOR:17204478], MASP1 [HPRD:12421953;SIGNOR:11907111], LRP1 [CellTalkDB:21054788;LRdb:21054788;Lit-BM-17:21054788;Ramilowski2015:21054788;connectomeDB2020:21054788;talklr:21054788]	blood microparticle [GO:0072562]; collagen-containing extracellular matrix [GO:0062023]; collagen trimer [GO:0005581]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; serine-type endopeptidase complex [GO:1905370]	antigen binding [GO:0003823]; calcium-dependent protein binding [GO:0048306]; carbohydrate derivative binding [GO:0097367]; mannan binding [GO:2001065]; metal ion binding [GO:0046872]; proteoglycan binding [GO:0043394]; signaling receptor binding [GO:0005102]	complement activation, lectin pathway [GO:0001867]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; opsonization [GO:0008228]; positive regulation of opsonization [GO:1903028]; proteolysis [GO:0006508]; recognition of apoptotic cell [GO:0043654]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=FCN2&keywords=FCN2	0.01171789213483146	822	NA	NA	0.010201943485757549	830	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
FGF1	fibroblast growth factor 1	Yes		ENSG00000113578	P05230	Heparin-binding growth factors family	18	ligand	extracellular, intracellular, ligand, secreted	O14786, P00533, P05106, P06756, P11362, P16070, P21802, P22455, P22607, Q03167, Q6UVK1, Q8N441	CD44, CSPG4, EGFR, FGFR1, FGFR2, FGFR3, FGFR4, FGFRL1, ITGAV, ITGB3, NRP1, TGFBR3	FGFR1 [Baccin2019:10336501;Baccin2019:11032250;Baccin2019:8663044;Baccin2019:8756477;BioGRID:1309595;BioGRID:1383494;BioGRID:8756477;BioGRID:9624181;CellTalkDB:16597617;Cellinker:10336501;Cellinker:11032250;Cellinker:16597617;Cellinker:25772309;Cellinker:8663044;Cellinker:8756477;DIP:10830168;DIP:1722683;DIP:22244757;DIP:7730326;HPMR:8663044;HPRD:10336501;HPRD:11032250;IntAct:10830168;IntAct:14613973;IntAct:18441324;IntAct:25241761;LRdb:16597617;Lit-BM-17:10830168;Lit-BM-17:11030354;Lit-BM-17:11714710;Lit-BM-17:1722683;Lit-BM-17:18441324;Lit-BM-17:23597563;Lit-BM-17:25241761;Lit-BM-17:7730326;Lit-BM-17:8576175;MatrixDB:18441324;SIGNOR:11030354;SIGNOR:18940940;SignaLink3:11030354;SignaLink3:21071413;SignaLink3:23331499;SignaLink3:8576175;connectomeDB2020:10336501;connectomeDB2020:11032250;connectomeDB2020:8663044;connectomeDB2020:8756477], FGFR2 [Baccin2019:10618369;Baccin2019:11069186;Baccin2019:14732692;BioGRID:10618369;CellTalkDB:16597617;Cellinker:10618369;Cellinker:11069186;Cellinker:14732692;Cellinker:25772309;DIP:10339576;DIP:10618369;DIP:11069186;DIP:8663044;HPRD:10618369;HPRD:11069186;HPRD:14732692;LRdb:16597617;Lit-BM-17:10339576;Lit-BM-17:10618369;Lit-BM-17:11069186;Lit-BM-17:11714710;Lit-BM-17:23597563;Lit-BM-17:25241761;Lit-BM-17:8576175;Lit-BM-17:8663044;SIGNOR:10618369;SignaLink3:10618369;SignaLink3:21071413;SignaLink3:23331499;SignaLink3:8576175;connectomeDB2020:10618369;connectomeDB2020:11069186;connectomeDB2020:14732692], FGFR4 [Baccin2019:10336501;Baccin2019:10736564;Baccin2019:8663044;BioGRID:10336501;BioGRID:10736564;CellTalkDB:16597617;Cellinker:10336501;Cellinker:10736564;Cellinker:25772309;Cellinker:8663044;DIP:7680645;HPRD:10336501;HPRD:10736564;LRdb:16597617;Lit-BM-17:10336501;Lit-BM-17:10736564;Lit-BM-17:11714710;Lit-BM-17:25241761;Lit-BM-17:7680645;SIGNOR:1385111;connectomeDB2020:10336501;connectomeDB2020:10736564;connectomeDB2020:8663044], FGFR3 [Baccin2019:10574949;Baccin2019:14732692;CellTalkDB:16597617;Cellinker:10574949;Cellinker:14732692;Cellinker:25772309;DIP:22244757;DIP:9045692;HPRD:10574949;HPRD:14732692;LRdb:16597617;Lit-BM-17:10574949;Lit-BM-17:14732692;Lit-BM-17:8576175;Lit-BM-17:9045692;SIGNOR:22298955;connectomeDB2020:10574949;connectomeDB2020:14732692], TGFBR3 [CellTalkDB:32103204], NRP1 [Baccin2019:15695515;CellTalkDB:15695515;Cellinker:15695515;HPRD:15695515;LRdb:15695515;connectomeDB2020:15695515], EGFR [CellTalkDB:32196115], FGFRL1 [CellTalkDB:32196115], CD44 [Baccin2019:29812912;CellTalkDB:29812912;connectomeDB2020:29812912], CSPG4 [connectomeDB2020:29812912], ITGB3 [Cellinker:18441324], ITGAV [Cellinker:18441324]	cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	fibroblast growth factor receptor binding [GO:0005104]; growth factor activity [GO:0008083]; heparin binding [GO:0008201]; Hsp70 protein binding [GO:0030544]; integrin binding [GO:0005178]; S100 protein binding [GO:0044548]	activation of protein kinase B activity [GO:0032148]; anatomical structure morphogenesis [GO:0009653]; angiogenesis [GO:0001525]; animal organ morphogenesis [GO:0009887]; branch elongation involved in ureteric bud branching [GO:0060681]; cell differentiation [GO:0030154]; cellular response to heat [GO:0034605]; fibroblast growth factor receptor signaling pathway [GO:0008543]; lung development [GO:0030324]; mesonephric epithelium development [GO:0072163]; organ induction [GO:0001759]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell division [GO:0051781]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cholesterol biosynthetic process [GO:0045542]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of hepatocyte proliferation [GO:2000347]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of sprouting angiogenesis [GO:1903672]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell migration [GO:0030334]; regulation of endothelial cell chemotaxis to fibroblast growth factor [GO:2000544]; regulation of endothelial tube morphogenesis [GO:1901509]; signal transduction [GO:0007165]; wound healing [GO:0042060]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=FGF1&keywords=FGF1	1.288865797676425	422	NA	NA	0.046998368765921186	714	0	0.013972055888223546	0	0.027817745803357306	0	0.00338409475465313	0.006346328195829556	0.024469820554649267	0.0029596744358120607	0.0034383762852183137	6.567510141008307e-4	295	313	378	0.007549531539258547	0.738462699521129	0.765739886284513	0.6072384889739951	246	230	283
FGF10	fibroblast growth factor 10	Yes		ENSG00000070193	O15520	Heparin-binding growth factors family	18	ecm, ligand, receptor	ecm, extracellular, intracellular, ligand, receptor, secreted	P11362, P21802, P22455, P22607, Q8N441	FGFR1, FGFR2, FGFR3, FGFR4, FGFRL1	FGFR2 [Baccin2019:12591959;Baccin2019:9582367;CellTalkDB:16597617;Cellinker:12591959;Cellinker:16597617;Cellinker:25772309;Cellinker:9582367;HPRD:9582367;LRdb:16597617;Lit-BM-17:10339576;Lit-BM-17:12591959;Lit-BM-17:25241761;Lit-BM-17:9582367;SIGNOR:8663044;SIGNOR:9582367;SignaLink3:21071413;SignaLink3:23331499;SignaLink3:8663044;SignaLink3:9582367;connectomeDB2020:12591959;connectomeDB2020:9582367], FGFRL1 [CellTalkDB:19920134;connectomeDB2020:19920134], FGFR1 [CellTalkDB:16597617;Cellinker:16597617;Cellinker:25772309;Cellinker:30809251;LRdb:16597617;connectomeDB2020:16597617], FGFR3 [NA], FGFR4 [NA]	cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	chemoattractant activity [GO:0042056]; fibroblast growth factor receptor binding [GO:0005104]; growth factor activity [GO:0008083]; heparin binding [GO:0008201]; type 2 fibroblast growth factor receptor binding [GO:0005111]	actin cytoskeleton reorganization [GO:0031532]; angiogenesis [GO:0001525]; animal organ morphogenesis [GO:0009887]; blood vessel remodeling [GO:0001974]; branch elongation involved in salivary gland morphogenesis [GO:0060667]; branching morphogenesis of an epithelial tube [GO:0048754]; bronchiole morphogenesis [GO:0060436]; bud elongation involved in lung branching [GO:0060449]; bud outgrowth involved in lung branching [GO:0060447]; cell differentiation [GO:0030154]; determination of left/right symmetry [GO:0007368]; embryonic camera-type eye development [GO:0031076]; embryonic digestive tract morphogenesis [GO:0048557]; embryonic genitalia morphogenesis [GO:0030538]; embryonic pattern specification [GO:0009880]; epithelial cell proliferation [GO:0050673]; epithelial cell proliferation involved in salivary gland morphogenesis [GO:0060664]; ERK1 and ERK2 cascade [GO:0070371]; establishment of mitotic spindle orientation [GO:0000132]; female genitalia morphogenesis [GO:0048807]; fibroblast growth factor receptor signaling pathway [GO:0008543]; fibroblast growth factor receptor signaling pathway involved in mammary gland specification [GO:0060595]; hair follicle morphogenesis [GO:0031069]; Harderian gland development [GO:0070384]; induction of positive chemotaxis [GO:0050930]; lacrimal gland development [GO:0032808]; limb bud formation [GO:0060174]; limb development [GO:0060173]; lung epithelium development [GO:0060428]; lung proximal/distal axis specification [GO:0061115]; lung saccule development [GO:0060430]; male genitalia morphogenesis [GO:0048808]; mammary gland bud formation [GO:0060615]; mesenchymal cell differentiation involved in lung development [GO:0060915]; mesenchymal-epithelial cell signaling involved in lung development [GO:0060496]; mesonephros development [GO:0001823]; metanephros development [GO:0001656]; metanephros morphogenesis [GO:0003338]; muscle cell fate commitment [GO:0042693]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; odontogenesis of dentin-containing tooth [GO:0042475]; organ induction [GO:0001759]; otic vesicle formation [GO:0030916]; pancreas development [GO:0031016]; pituitary gland development [GO:0021983]; positive chemotaxis [GO:0050918]; positive regulation of ATPase activity [GO:0032781]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA repair [GO:0045739]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial cell proliferation involved in wound healing [GO:0060054]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of gene expression [GO:0010628]; positive regulation of hair follicle cell proliferation [GO:0071338]; positive regulation of keratinocyte migration [GO:0051549]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of lymphocyte proliferation [GO:0050671]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of urothelial cell proliferation [GO:0050677]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; positive regulation of white fat cell proliferation [GO:0070352]; prostatic bud formation [GO:0060513]; protein localization to cell surface [GO:0034394]; radial glial cell differentiation [GO:0060019]; regulation of activin receptor signaling pathway [GO:0032925]; regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling [GO:0060665]; regulation of cell migration [GO:0030334]; regulation of saliva secretion [GO:0046877]; regulation of smoothened signaling pathway [GO:0008589]; response to estradiol [GO:0032355]; response to lipopolysaccharide [GO:0032496]; salivary gland development [GO:0007431]; secretion by lung epithelial cell involved in lung growth [GO:0061033]; semicircular canal fusion [GO:0060879]; smooth muscle cell differentiation [GO:0051145]; somatic stem cell population maintenance [GO:0035019]; spleen development [GO:0048536]; submandibular salivary gland formation [GO:0060661]; tear secretion [GO:0070075]; thymus development [GO:0048538]; thyroid gland development [GO:0030878]; tissue regeneration [GO:0042246]; type II pneumocyte differentiation [GO:0060510]; urothelial cell proliferation [GO:0050674]; white fat cell differentiation [GO:0050872]; wound healing [GO:0042060]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=FGF10&keywords=FGF10	0.4756509827438539	528	NA	NA	0.1462850154262799	580	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
FGF11	fibroblast growth factor 11	Yes		ENSG00000283903, ENSG00000161958	Q92914	Heparin-binding growth factors family	9	ligand	intracellular, ligand, secreted	P11362, P21802, P22455, P22607, P35498, P35499, Q14524, Q15858, Q99250, Q9NY46, Q9UI33, Q9UQD0, Q9Y5Y9	FGFR1, FGFR2, FGFR3, FGFR4, SCN10A, SCN11A, SCN1A, SCN2A, SCN3A, SCN4A, SCN5A, SCN8A, SCN9A	SCN1A [SIGNOR:20679355], SCN4A [SIGNOR:20679355], SCN5A [SIGNOR:20679355], SCN9A [SIGNOR:20679355], SCN2A [SIGNOR:20679355], SCN3A [SIGNOR:20679355], SCN11A [SIGNOR:20679355], SCN8A [SIGNOR:20679355], SCN10A [SIGNOR:20679355], FGFR2 [CellTalkDB:16597617;LRdb:16597617], FGFR1 [CellTalkDB:16597617;LRdb:16597617], FGFR3 [CellTalkDB:16597617;LRdb:16597617], FGFR4 [CellTalkDB:16597617;LRdb:16597617]	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; nucleus [GO:0005634]	growth factor activity [GO:0008083]; sodium channel regulator activity [GO:0017080]	cell-cell signaling [GO:0007267]; nervous system development [GO:0007399]; regulation of voltage-gated sodium channel activity [GO:1905150]; signal transduction [GO:0007165]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=FGF11&keywords=FGF11	0.6551770257156699	498	NA	NA	0.1464383175065062	579	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
FGF12	fibroblast growth factor 12			ENSG00000114279	P61328	Heparin-binding growth factors family	9	ligand	intracellular, ligand, secreted	P11362, P21802, P22455, P22607, P35498, P35499, Q14524, Q15858, Q99250, Q9NY46, Q9UI33, Q9UQD0, Q9Y5Y9	FGFR1, FGFR2, FGFR3, FGFR4, SCN10A, SCN11A, SCN1A, SCN2A, SCN3A, SCN4A, SCN5A, SCN8A, SCN9A	SCN1A [DIP:22705208;SIGNOR:20679355], SCN4A [SIGNOR:20679355], SCN5A [DIP:22705208;SIGNOR:20679355], SCN9A [SIGNOR:20679355], SCN2A [SIGNOR:20679355], SCN3A [SIGNOR:20679355], SCN11A [SIGNOR:20679355], SCN8A [SIGNOR:20679355], SCN10A [SIGNOR:20679355], FGFR4 [CellTalkDB:16597617;LRdb:16597617], FGFR3 [CellTalkDB:16597617;LRdb:16597617], FGFR1 [CellTalkDB:16597617;LRdb:16597617], FGFR2 [CellTalkDB:16597617;LRdb:16597617]	cytoplasm [GO:0005737]; extracellular space [GO:0005615]; nucleus [GO:0005634]; synapse [GO:0045202]	growth factor activity [GO:0008083]; heparin binding [GO:0008201]; sodium channel regulator activity [GO:0017080]; transmembrane transporter binding [GO:0044325]	adult locomotory behavior [GO:0008344]; cardiac muscle cell action potential involved in contraction [GO:0086002]; cell-cell signaling [GO:0007267]; chemical synaptic transmission [GO:0007268]; fibroblast growth factor receptor signaling pathway [GO:0008543]; heart development [GO:0007507]; JNK cascade [GO:0007254]; nervous system development [GO:0007399]; neuromuscular process [GO:0050905]; positive regulation of sodium ion transport [GO:0010765]; regulation of neuronal action potential [GO:0098908]; regulation of sodium ion transmembrane transport [GO:1902305]; regulation of sodium ion transmembrane transporter activity [GO:2000649]; regulation of voltage-gated sodium channel activity [GO:1905150]; signal transduction [GO:0007165]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=FGF12&keywords=FGF12	15.082884312383147	193	NA	NA	3.111747844891545	106	0.015748031496062992	0.022455089820359268	0.054203539823008906	0.014868105515587525	0.030303030303030293	0.23011844331641254	0.21305530371713446	0.20065252854812374	0.2016278209396952	0.09807717986380024	0.1624879273710568	78	106	78	0.11305427279220655	1.7197925446851963	0.8782887209963273	1.4017223738530846	44	178	41
FGF13	fibroblast growth factor 13	Yes		ENSG00000129682	Q92913	Heparin-binding growth factors family	14	ligand	extracellular, intracellular, ligand, secreted	P00533, P11362, P21802, P22455, P22607, P35498, P35499, Q14524, Q15858, Q99250, Q9NY46, Q9UI33, Q9UQD0, Q9Y5Y9	EGFR, FGFR1, FGFR2, FGFR3, FGFR4, SCN10A, SCN11A, SCN1A, SCN2A, SCN3A, SCN4A, SCN5A, SCN8A, SCN9A	SCN1A [SIGNOR:20679355], SCN4A [SIGNOR:20679355], SCN5A [CellTalkDB:21817159;Cellinker:21817159;LRdb:21817159;Ramilowski2015:21817159;SIGNOR:20679355;connectomeDB2020:21817159;talklr:21817159], SCN9A [SIGNOR:20679355], SCN2A [SIGNOR:20679355], SCN3A [SIGNOR:20679355], SCN11A [SIGNOR:20679355], SCN8A [Baccin2019:15282281;CellTalkDB:15282281;Cellinker:15282281;HPRD:15282281;LRdb:15282281;SIGNOR:20679355;connectomeDB2020:15282281], SCN10A [SIGNOR:20679355], FGFR1 [CellTalkDB:16597617;LRdb:16597617], FGFR2 [CellTalkDB:16597617;LRdb:16597617], FGFR3 [CellTalkDB:16597617;LRdb:16597617], EGFR [CellTalkDB:32196115], FGFR4 [CellTalkDB:16597617;LRdb:16597617]	axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; extracellular region [GO:0005576]; filopodium [GO:0030175]; growth cone [GO:0030426]; intercalated disc [GO:0014704]; lateral plasma membrane [GO:0016328]; microtubule [GO:0005874]; neuron projection [GO:0043005]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	beta-tubulin binding [GO:0048487]; growth factor activity [GO:0008083]; microtubule binding [GO:0008017]; protein kinase activator activity [GO:0030295]; sodium channel regulator activity [GO:0017080]; transmembrane transporter binding [GO:0044325]	cell-cell signaling [GO:0007267]; cerebral cortex cell migration [GO:0021795]; establishment of neuroblast polarity [GO:0045200]; hippocampus development [GO:0021766]; inhibitory synapse assembly [GO:1904862]; learning [GO:0007612]; MAPK cascade [GO:0000165]; memory [GO:0007613]; microtubule polymerization [GO:0046785]; negative regulation of collateral sprouting [GO:0048671]; negative regulation of microtubule depolymerization [GO:0007026]; nervous system development [GO:0007399]; neuron migration [GO:0001764]; protein localization to plasma membrane [GO:0072659]; regulation of cardiac muscle cell action potential involved in regulation of contraction [GO:0098909]; regulation of voltage-gated sodium channel activity [GO:1905150]; signal transduction [GO:0007165]; sodium ion transport [GO:0006814]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=FGF13&keywords=FGF13	4.840636424011907	293	NA	NA	2.5190483896150524	127	0	0.05389221556886222	0.00331858407079646	0.0014388489208633092	0.10269360269360277	0	0.001813236627379873	0.004893964110929854	0.0022197558268590455	0.0013686740552810784	0.002395209580838325	297	362	327	0.015821281041401177	0.4732435934245944	0.4402831151968347	0.4800385217512705	353	335	333
FGF14	fibroblast growth factor 14	Yes		ENSG00000102466	Q92915	Heparin-binding growth factors family	9	ligand	intracellular, ligand, secreted	P11362, P21802, P22455, P22607, P35498, P35499, Q14524, Q15858, Q99250, Q9NY46, Q9UI33, Q9UQD0, Q9Y5Y9	FGFR1, FGFR2, FGFR3, FGFR4, SCN10A, SCN11A, SCN1A, SCN2A, SCN3A, SCN4A, SCN5A, SCN8A, SCN9A	SCN1A [SIGNOR:20679355], SCN4A [SIGNOR:20679355], SCN5A [SIGNOR:20679355], SCN9A [SIGNOR:20679355], SCN2A [SIGNOR:20679355], SCN3A [SIGNOR:20679355], SCN11A [SIGNOR:20679355], SCN8A [BioGRID:29359916;IntAct:22364545;IntAct:25659151;SIGNOR:20679355], SCN10A [SIGNOR:20679355], FGFR2 [CellTalkDB:16597617;LRdb:16597617], FGFR1 [CellTalkDB:16597617;LRdb:16597617], FGFR4 [CellTalkDB:16597617;LRdb:16597617], FGFR3 [CellTalkDB:16597617;LRdb:16597617]	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; nucleus [GO:0005634]	growth factor activity [GO:0008083]; heparin binding [GO:0008201]; sodium channel regulator activity [GO:0017080]	cell-cell signaling [GO:0007267]; JNK cascade [GO:0007254]; nervous system development [GO:0007399]; regulation of voltage-gated sodium channel activity [GO:1905150]; signal transduction [GO:0007165]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=FGF14&keywords=FGF14	5.92314293258427	278	NA	NA	3.0041186017430426	113	0.015748031496062992	0.015469061876247501	0.008849557522123894	0.01942446043165467	0.016835016835016835	0.3248730964467007	0.2647325475974606	0.22185970636215308	0.32519422863485126	0.16187074375750476	0.1469190650956086	55	88	85	0.13834322873230773	2.2595856346077303	1.1586018804245763	1.0578107705797368	24	101	86
FGF16	fibroblast growth factor 16	Yes		ENSG00000196468	O43320	Heparin-binding growth factors family	15	ligand	intracellular, ligand, secreted	P11362, P21802, P22455, P22607	FGFR1, FGFR2, FGFR3, FGFR4	FGFR2 [CellTalkDB:16597617;Cellinker:16597617;Cellinker:25772309;LRdb:16597617;Ramilowski2015:16597617;connectomeDB2020:16597617;talklr:16597617], FGFR4 [CellTalkDB:16597617;Cellinker:25772309;LRdb:16597617;Ramilowski2015:16597617;connectomeDB2020:16597617;talklr:16597617], FGFR3 [CellTalkDB:16597617;Cellinker:16597617;Cellinker:25772309;LRdb:16597617;Ramilowski2015:16597617;connectomeDB2020:16597617;talklr:16597617], FGFR1 [CellTalkDB:16597617;Cellinker:25772309;LRdb:16597617]	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	fibroblast growth factor receptor binding [GO:0005104]; growth factor activity [GO:0008083]	animal organ morphogenesis [GO:0009887]; cell-cell signaling [GO:0007267]; cell differentiation [GO:0030154]; fibroblast growth factor receptor signaling pathway [GO:0008543]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell chemotaxis to fibroblast growth factor [GO:2000546]; positive regulation of gene expression [GO:0010628]; positive regulation of protein phosphorylation [GO:0001934]; regulation of cell migration [GO:0030334]; response to temperature stimulus [GO:0009266]; signal transduction [GO:0007165]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=FGF16&keywords=FGF16	0.013810147191011236	814	NA	NA	0.2443744555738233	501	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
FGF17	fibroblast growth factor 17	Yes		ENSG00000158815	O60258	Heparin-binding growth factors family	18	ligand	extracellular, intracellular, ligand, secreted	P11362, P21802, P22455, P22607	FGFR1, FGFR2, FGFR3, FGFR4	FGFR2 [Baccin2019:10751172;CellTalkDB:16597617;Cellinker:10751172;Cellinker:25772309;HPRD:10751172;LRdb:16597617;SIGNOR:8663044;SignaLink3:23331499;SignaLink3:8663044;connectomeDB2020:10751172], FGFR1 [Baccin2019:10751172;CellTalkDB:16597617;Cellinker:25772309;HPRD:10751172;LRdb:16597617;connectomeDB2020:10751172], FGFR4 [Baccin2019:10751172;CellTalkDB:16597617;Cellinker:10751172;Cellinker:25772309;HPRD:10751172;LRdb:16597617;connectomeDB2020:10751172], FGFR3 [Baccin2019:10751172;CellTalkDB:16597617;Cellinker:10751172;Cellinker:16597617;Cellinker:25772309;HPRD:10751172;LRdb:16597617;connectomeDB2020:10751172]	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	fibroblast growth factor receptor binding [GO:0005104]; growth factor activity [GO:0008083]; type 1 fibroblast growth factor receptor binding [GO:0005105]; type 2 fibroblast growth factor receptor binding [GO:0005111]	animal organ morphogenesis [GO:0009887]; cell-cell signaling [GO:0007267]; cell differentiation [GO:0030154]; fibroblast growth factor receptor signaling pathway [GO:0008543]; nervous system development [GO:0007399]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of protein phosphorylation [GO:0001934]; regulation of cell migration [GO:0030334]; signal transduction [GO:0007165]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=FGF17&keywords=FGF17	0.27349768101123595	585	NA	NA	0.035587988392976305	751	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
FGF18	fibroblast growth factor 18	Yes		ENSG00000156427	O76093	Heparin-binding growth factors family	18	ligand	extracellular, intracellular, ligand, secreted	P11362, P21802, P22455, P22607	FGFR1, FGFR2, FGFR3, FGFR4	FGFR2 [Baccin2019:10751172;CellTalkDB:16597617;Cellinker:10751172;Cellinker:25772309;HPRD:10751172;LRdb:16597617;SIGNOR:8663044;SignaLink3:23331499;SignaLink3:8663044;connectomeDB2020:10751172], FGFR4 [Baccin2019:10751172;CellTalkDB:16597617;Cellinker:10751172;Cellinker:25772309;HPRD:10751172;LRdb:16597617;connectomeDB2020:10751172], FGFR1 [Baccin2019:10751172;CellTalkDB:16597617;Cellinker:25772309;HPRD:10751172;LRdb:16597617;connectomeDB2020:10751172], FGFR3 [Baccin2019:1578147310751170;CellTalkDB:16597617;Cellinker:10751172;Cellinker:15781473;Cellinker:16597617;Cellinker:25772309;HPRD:10751172;LRdb:16597617;connectomeDB2020:10751172;connectomeDB2020:15781473]	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nucleolus [GO:0005730]	fibroblast growth factor receptor binding [GO:0005104]; growth factor activity [GO:0008083]; type 1 fibroblast growth factor receptor binding [GO:0005105]; type 2 fibroblast growth factor receptor binding [GO:0005111]	anatomical structure morphogenesis [GO:0009653]; angiogenesis [GO:0001525]; animal organ morphogenesis [GO:0009887]; cell-cell signaling [GO:0007267]; cell differentiation [GO:0030154]; chondrocyte development [GO:0002063]; endochondral ossification [GO:0001958]; fibroblast growth factor receptor signaling pathway [GO:0008543]; intramembranous ossification [GO:0001957]; lung development [GO:0030324]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of endothelial cell chemotaxis to fibroblast growth factor [GO:2000546]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; regulation of cell migration [GO:0030334]; signal transduction [GO:0007165]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=FGF18&keywords=FGF18	0.1766133404494382	623	NA	NA	0.12719464928568483	594	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
FGF19	fibroblast growth factor 19	Yes		ENSG00000162344	O95750	Heparin-binding growth factors family	18	ligand	extracellular, intracellular, ligand, secreted	P11362, P21802, P22455, P22607, Q86Z14	FGFR1, FGFR2, FGFR3, FGFR4, KLB	FGFR4 [Baccin2019:1473096710525310;CellTalkDB:16597617;Cellinker:10525310;Cellinker:14730967;Cellinker:22442730;Cellinker:31529503;DIP:10525310;DIP:19706524;Guide2Pharma:10525310;HPRD:10525310;LRdb:16597617;connectomeDB2020:10525310;connectomeDB2020:14730967], FGFR2 [CellTalkDB:16597617;LRdb:16597617;Ramilowski2015:16597617;connectomeDB2020:16597617;talklr:16597617], FGFR1 [CellTalkDB:16597617;Cellinker:22442730;LRdb:16597617;Ramilowski2015:16597617;connectomeDB2020:16597617;talklr:16597617], FGFR3 [CellTalkDB:16597617;LRdb:16597617;Ramilowski2015:16597617;connectomeDB2020:16597617;talklr:16597617], KLB [CellTalkDB:22442730;LRdb:22442730;Ramilowski2015:22442730;connectomeDB2020:22442730;talklr:22442730]	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	fibroblast growth factor receptor binding [GO:0005104]; growth factor activity [GO:0008083]	animal organ morphogenesis [GO:0009887]; bile acid and bile salt transport [GO:0015721]; cell differentiation [GO:0030154]; fibroblast growth factor receptor signaling pathway [GO:0008543]; heart development [GO:0007507]; negative regulation of bile acid biosynthetic process [GO:0070858]; negative regulation of gene expression [GO:0010629]; nervous system development [GO:0007399]; neural crest cell migration [GO:0001755]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of glucose import [GO:0046326]; positive regulation of JNK cascade [GO:0046330]; positive regulation of protein phosphorylation [GO:0001934]; regulation of cell migration [GO:0030334]; response to bacterium [GO:0009617]; response to ethanol [GO:0045471]; response to organic cyclic compound [GO:0014070]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=FGF19&keywords=FGF19	4.8011767898876405	294	NA	NA	135.24349230469963	9	0	0.009481037924151696	0	0	0	0	0	0	0	0	0	303	409	401	8.619125385592451e-4	0.9206481790845306	0.9206481790845306	0.9206481790845306	170	164	133
FGF2	fibroblast growth factor 2	Yes		ENSG00000138685	P09038	Heparin-binding growth factors family	18	ligand	extracellular, intracellular, ligand, secreted	O14786, O75056, O75487, P05106, P06756, P07996, P11362, P16070, P18827, P21802, P22455, P22607, P31431, P34741, P35442, Q8N441	CD44, FGFR1, FGFR2, FGFR3, FGFR4, FGFRL1, GPC4, ITGAV, ITGB3, NRP1, SDC1, SDC2, SDC3, SDC4, THBS1, THBS2	FGFR2 [Baccin2019:8663044;CellTalkDB:16597617;Cellinker:25772309;Cellinker:8663044;HPMR:8663044;IntAct:10830168;IntAct:11390973;LRdb:16597617;Lit-BM-17:10950949;Lit-BM-17:11121055;Lit-BM-17:11390973;Lit-BM-17:17981115;Lit-BM-17:26267536;ProtMapper:18332103;SIGNOR:11390973;SIGNOR:7687739;SignaLink3:23331499;SignaLink3:8663044;connectomeDB2020:8663044], FGFR4 [Baccin2019:86630448530375;CellTalkDB:16597617;Cellinker:25772309;Cellinker:8530375;Cellinker:8663044;DIP:7680645;HPRD:8530375;LRdb:16597617;SIGNOR:1385111;connectomeDB2020:8530375;connectomeDB2020:8663044], FGFR3 [Baccin2019:866304410574949;CellTalkDB:16597617;Cellinker:10574949;Cellinker:25772309;Cellinker:8663044;DIP:9045692;HPMR:8663044;HPRD:10574949;LRdb:16597617;SIGNOR:15780951;SIGNOR:22298955;connectomeDB2020:10574949;connectomeDB2020:8663044], SDC1 [Baccin2019:16982797;BioGRID:19802384;CellTalkDB:16982797;Cellinker:16982797;Cellinker:1969657;HPRD:16982797;LRdb:16982797;connectomeDB2020:16982797], FGFR1 [Baccin2019:10950949;Baccin2019:11030354;BioGRID:10950949;BioGRID:11786412;BioGRID:14505356;BioGRID:15096041;BioGRID:16829530;BioGRID:8868466;BioGRID:9174056;CellTalkDB:16597617;Cellinker:10950949;Cellinker:11030354;Cellinker:16597617;Cellinker:25772309;DIP:10574979;DIP:10950949;DIP:17086194;DIP:1722683;DIP:7730326;HPRD:10950949;HPRD:11030354;IntAct:10490103;IntAct:11030354;IntAct:14613973;IntAct:23597563;IntAct:26267536;LRdb:16597617;Lit-BM-17:10490103;Lit-BM-17:10574979;Lit-BM-17:10950949;Lit-BM-17:11030354;Lit-BM-17:1722683;Lit-BM-17:23597562;Lit-BM-17:23597563;Lit-BM-17:26267536;Lit-BM-17:7730326;Lit-BM-17:9174056;connectomeDB2020:10950949;connectomeDB2020:11030354], CD44 [Baccin2019:7532176;CellTalkDB:7532176;Cellinker:7532176;HPRD:7532176;LRdb:7532176;connectomeDB2020:7532176], SDC3 [Baccin2019:16982797;Baccin2019:8344959;CellTalkDB:16982797;Cellinker:16982797;Cellinker:8344959;HPRD:16982797;HPRD:8344959;LRdb:16982797;LRdb:83;connectomeDB2020:8344959], SDC4 [Baccin2019:9012653;CellTalkDB:9012653;Cellinker:9012653;HPMR:9012653;HPMR:9556568;LRdb:9012653;Lit-BM-17:16982797;Lit-BM-17:20382221;MatrixDB:20382221;connectomeDB2020:9012653], GPC4 [Baccin2019:11066092;CellTalkDB:11066092;Cellinker:11066092;HPRD:11066092;LRdb:11066092;connectomeDB2020:11066092], SDC2 [Baccin2019:1101561416982790;CellTalkDB:11015614;Cellinker:11015614;Cellinker:16982797;HPRD:16982797;LRdb:11015614;LRdb:17;Lit-BM-17:16982797;Lit-BM-17:20382221;MatrixDB:20382221;connectomeDB2020:11015614;connectomeDB2020:16982797], FGFRL1 [Baccin2019:11418238;CellTalkDB:11418238;Cellinker:11418238;HPRD:11418238;LRdb:11418238;connectomeDB2020:11418238], NRP1 [Baccin2019:15695515;CellTalkDB:15695515;Cellinker:15695515;HPRD:15695515;LRdb:15695515;connectomeDB2020:15695515], ITGAV [Cellinker:15297314], ITGB3 [Cellinker:15297314], THBS1 [Cellinker:30168023], THBS2 [Cellinker:30168023]	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nucleus [GO:0005634]	chemoattractant activity [GO:0042056]; chemokine binding [GO:0019956]; cytokine activity [GO:0005125]; fibroblast growth factor receptor binding [GO:0005104]; growth factor activity [GO:0008083]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; nuclear receptor coactivator activity [GO:0030374]; receptor-receptor interaction [GO:0090722]	aging [GO:0007568]; angiogenesis involved in coronary vascular morphogenesis [GO:0060978]; animal organ morphogenesis [GO:0009887]; branching involved in ureteric bud morphogenesis [GO:0001658]; cell differentiation [GO:0030154]; cell migration involved in sprouting angiogenesis [GO:0002042]; chemotaxis [GO:0006935]; chondroblast differentiation [GO:0060591]; corticotropin hormone secreting cell differentiation [GO:0060128]; embryo development ending in birth or egg hatching [GO:0009792]; embryonic morphogenesis [GO:0048598]; fibroblast growth factor receptor signaling pathway [GO:0008543]; glial cell differentiation [GO:0010001]; growth factor dependent regulation of skeletal muscle satellite cell proliferation [GO:0014843]; hyaluronan catabolic process [GO:0030214]; inositol phosphate biosynthetic process [GO:0032958]; lung development [GO:0030324]; mammary gland epithelial cell differentiation [GO:0060644]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of cell death [GO:0060548]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of fibroblast migration [GO:0010764]; negative regulation of gene expression [GO:0010629]; negative regulation of wound healing [GO:0061045]; nervous system development [GO:0007399]; organ induction [GO:0001759]; paracrine signaling [GO:0038001]; phosphatidylinositol biosynthetic process [GO:0006661]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell division [GO:0051781]; positive regulation of cell fate specification [GO:0042660]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cerebellar granule cell precursor proliferation [GO:0021940]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis to fibroblast growth factor [GO:2000546]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial tube formation [GO:1905278]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of lens fiber cell differentiation [GO:1902748]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of phospholipase C activity [GO:0010863]; positive regulation of pri-miRNA transcription by RNA polymerase II [GO:1902895]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of sprouting angiogenesis [GO:1903672]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; Ras protein signal transduction [GO:0007265]; regulation of angiogenesis [GO:0045765]; regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:1903587]; regulation of cell cycle [GO:0051726]; regulation of cell migration [GO:0030334]; regulation of cell migration involved in sprouting angiogenesis [GO:0090049]; regulation of endothelial cell chemotaxis to fibroblast growth factor [GO:2000544]; regulation of retinal cell programmed cell death [GO:0046668]; release of sequestered calcium ion into cytosol [GO:0051209]; response to axon injury [GO:0048678]; signal transduction [GO:0007165]; stem cell development [GO:0048864]; stem cell proliferation [GO:0072089]; substantia nigra development [GO:0021762]; thyroid-stimulating hormone-secreting cell differentiation [GO:0060129]; wound healing [GO:0042060]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=FGF2&keywords=FGF2	16.302004386043507	186	NA	NA	1.455928467648345	206	0	0.5129740518962123	0.012168141592920354	1.4170263788968835	0.03367003367003367	0.01015228426395939	0.012692656391659111	0.009787928221859707	0.006289308176100631	0.00574175457337427	0.005678964651342482	281	277	283	0.1841983183940314	0.08387975915965128	0.08106020023012765	0.08073687136430101	485	479	484
FGF20	fibroblast growth factor 20	Yes		ENSG00000078579	Q9NP95	Heparin-binding growth factors family	15	ligand	extracellular, intracellular, ligand, secreted, transmembrane	P11362, P21802, P22455, P22607	FGFR1, FGFR2, FGFR3, FGFR4	FGFR2 [CellTalkDB:16597617;Cellinker:16597617;Cellinker:25772309;LRdb:16597617;connectomeDB2020:16597617], FGFR4 [Cellinker:25772309;LRdb:15621532;LRdb:17;Ramilowski2015:15621532;connectomeDB2020:15621532;talklr:15621532], FGFR1 [CellTalkDB:16597617;Cellinker:25772309;Cellinker:31276493;LRdb:16597617;connectomeDB2020:16597617], FGFR3 [CellTalkDB:16597617;Cellinker:16597617;Cellinker:25772309;LRdb:16597617;connectomeDB2020:16597617]	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	fibroblast growth factor receptor binding [GO:0005104]; growth factor activity [GO:0008083]; heparan sulfate proteoglycan binding [GO:0043395]; receptor-receptor interaction [GO:0090722]; signaling receptor binding [GO:0005102]	animal organ morphogenesis [GO:0009887]; cell-cell signaling [GO:0007267]; cell differentiation [GO:0030154]; fibroblast growth factor receptor signaling pathway [GO:0008543]; inner ear receptor cell differentiation [GO:0060113]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of dopaminergic neuron differentiation [GO:1904340]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of protein phosphorylation [GO:0001934]; regulation of cardiac muscle cell proliferation [GO:0060043]; regulation of cell migration [GO:0030334]; regulation of dopamine secretion [GO:0014059]; signal transduction [GO:0007165]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=FGF20&keywords=FGF20	0.12455361011235955	653	NA	NA	0.3584318150527554	440	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
FGF21	fibroblast growth factor 21	Yes		ENSG00000105550	Q9NSA1	Heparin-binding growth factors family	14	ligand	intracellular, ligand, secreted	P11362, P21802, P22455, P22607, Q86Z14	FGFR1, FGFR2, FGFR3, FGFR4, KLB	KLB [CellTalkDB:22442730;HPRD:19059246], FGFR4 [CellTalkDB:22442730;Cellinker:22442730;LRdb:16597617;LRdb:22;Ramilowski2015:22442730;connectomeDB2020:22442730;talklr:22442730], FGFR3 [CellTalkDB:16597617;Cellinker:25772309;LRdb:16597617], FGFR1 [CellTalkDB:16597617;Cellinker:22442730;Cellinker:25772309;LRdb:16597617], FGFR2 [CellTalkDB:16597617;LRdb:16597617]	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	fibroblast growth factor receptor binding [GO:0005104]; growth factor activity [GO:0008083]	animal organ morphogenesis [GO:0009887]; cell-cell signaling [GO:0007267]; cell differentiation [GO:0030154]; cellular response to glucagon stimulus [GO:0071377]; cellular response to glucose stimulus [GO:0071333]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cellular response to xenobiotic stimulus [GO:0071466]; endoplasmic reticulum unfolded protein response [GO:0030968]; endothelial cell apoptotic process [GO:0072577]; fibroblast growth factor receptor signaling pathway [GO:0008543]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of neuron death [GO:1901215]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of glucose import [GO:0046326]; positive regulation of low-density lipoprotein receptor activity [GO:1905599]; positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway [GO:0090080]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of triglyceride catabolic process [GO:0010898]; regulation of cell migration [GO:0030334]; regulation of low-density lipoprotein particle clearance [GO:0010988]; response to activity [GO:0014823]; response to methionine [GO:1904640]; response to nutrient levels [GO:0031667]; signal transduction [GO:0007165]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=FGF21&keywords=FGF21	0.017600640449438203	803	NA	NA	0.07510438792846637	664	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
FGF22	fibroblast growth factor 22	Yes		ENSG00000070388	Q9HCT0	Heparin-binding growth factors family	15	ligand	extracellular, intracellular, ligand, secreted, transmembrane, transmembrane_predicted	P11362, P21802, Q8N441	FGFR1, FGFR2, FGFRL1	FGFR2 [Baccin2019:12591959;CellTalkDB:16597617;Cellinker:12591959;Cellinker:16597617;Cellinker:25772309;LRdb:16597617;SignaLink3:23331499;SignaLink3:8663044;connectomeDB2020:12591959], FGFR1 [CellTalkDB:16597617;LRdb:16597617;connectomeDB2020:16597617], FGFRL1 [connectomeDB2020:19920134]	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	fibroblast growth factor receptor binding [GO:0005104]; growth factor activity [GO:0008083]	animal organ morphogenesis [GO:0009887]; cell differentiation [GO:0030154]; fibroblast growth factor receptor signaling pathway [GO:0008543]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of protein phosphorylation [GO:0001934]; regulation of cell migration [GO:0030334]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=FGF22&keywords=FGF22	0.0568597595505618	724	NA	NA	0.026516430636190313	780	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
FGF23	fibroblast growth factor 23	Yes		ENSG00000118972	Q9GZV9	Heparin-binding growth factors family	16	ligand	extracellular, intracellular, ligand, secreted	P11362, P21802, P22455, P22607, P78562, Q9UEF7	FGFR1, FGFR2, FGFR3, FGFR4, KL, PHEX	FGFR2 [Baccin2019:1608163512032140;CellTalkDB:16597617;Cellinker:12032146;Cellinker:16081635;HPRD:12032146;LRdb:16597617;connectomeDB2020:12032146;connectomeDB2020:16081635], PHEX [Baccin2019:11409890;CellTalkDB:11409890;Cellinker:11409890;HPRD:11409890;LRdb:11409890], KL [CellTalkDB:30451736;connectomeDB2020:30605400], FGFR4 [Baccin2019:16081635;CellTalkDB:16597617;Cellinker:16081635;Cellinker:25772309;LRdb:16597617;connectomeDB2020:16081635], FGFR1 [Baccin2019:16081635;BioGRID:27879395;CellTalkDB:16597617;Cellinker:25772309;DIP:19966287;LRdb:16597617;Lit-BM-17:19966287;Lit-BM-17:22393163;connectomeDB2020:16081635], FGFR3 [Baccin2019:12032146;CellTalkDB:16597617;Cellinker:12032146;Cellinker:25772309;HPRD:12032146;LRdb:16597617;connectomeDB2020:12032146]	cytoplasm [GO:0005737]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]	fibroblast growth factor receptor binding [GO:0005104]; growth factor activity [GO:0008083]; type 1 fibroblast growth factor receptor binding [GO:0005105]	animal organ morphogenesis [GO:0009887]; cell differentiation [GO:0030154]; cellular phosphate ion homeostasis [GO:0030643]; cellular response to interleukin-6 [GO:0071354]; cellular response to leptin stimulus [GO:0044320]; cellular response to parathyroid hormone stimulus [GO:0071374]; cellular response to vitamin D [GO:0071305]; fibroblast growth factor receptor signaling pathway [GO:0008543]; MAPK cascade [GO:0000165]; negative regulation of bone mineralization [GO:0030502]; negative regulation of hormone secretion [GO:0046888]; negative regulation of osteoblast differentiation [GO:0045668]; phosphate-containing compound metabolic process [GO:0006796]; phosphate ion homeostasis [GO:0055062]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway [GO:0090080]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of vitamin D 24-hydroxylase activity [GO:0010980]; regulation of cell migration [GO:0030334]; regulation of phosphate transport [GO:0010966]; response to magnesium ion [GO:0032026]; response to sodium phosphate [GO:1904383]; vitamin D catabolic process [GO:0042369]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=FGF23&keywords=FGF23	0.3695697595505618	552	NA	NA	12.046618372127803	41	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
FGF3	fibroblast growth factor 3	Yes		ENSG00000186895	P11487	Heparin-binding growth factors family	17	ligand	extracellular, intracellular, ligand, secreted, transmembrane	P11362, P21802, P22455, P22607, Q12951, Q8N441	FGFR1, FGFR2, FGFR3, FGFR4, FGFRL1, FOXI1	FOXI1 [SPIKE:12702667], FGFR2 [Baccin2019:75926248663044;CellTalkDB:16597617;Cellinker:16597617;Cellinker:25772309;Cellinker:7592624;Cellinker:8663044;DIP:8663044;HPRD:8663044;LRdb:16597617;SIGNOR:8663044;SignaLink3:23331499;SignaLink3:8663044;connectomeDB2020:7592624;connectomeDB2020:8663044], FGFR1 [Baccin2019:75926248663044;CellTalkDB:16597617;Cellinker:16597617;Cellinker:25772309;Cellinker:7592624;Cellinker:8663044;HPRD:8663044;LRdb:16597617;connectomeDB2020:7592624;connectomeDB2020:8663044], FGFR3 [Baccin2019:8663044;CellTalkDB:8663044;Cellinker:8663044;HPRD:8663044;LRdb:8663044;connectomeDB2020:8663044], FGFR4 [Baccin2019:8663044;CellTalkDB:8663044;Cellinker:8663044;HPRD:8663044;LRdb:8663044;connectomeDB2020:8663044], FGFRL1 [connectomeDB2020:19920134]	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	fibroblast growth factor receptor binding [GO:0005104]; growth factor activity [GO:0008083]	anatomical structure morphogenesis [GO:0009653]; animal organ morphogenesis [GO:0009887]; cell-cell signaling [GO:0007267]; cell differentiation [GO:0030154]; fibroblast growth factor receptor signaling pathway [GO:0008543]; negative regulation of cardiac muscle tissue development [GO:0055026]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of protein phosphorylation [GO:0001934]; regulation of cell migration [GO:0030334]; signal transduction [GO:0007165]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=FGF3&keywords=FGF3	8.563258426966293e-4	894	NA	NA	0.011539439278661384	825	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
FGF4	fibroblast growth factor 4	Yes		ENSG00000075388	P08620	Heparin-binding growth factors family	17	ligand	extracellular, intracellular, ligand, secreted	O14786, P11362, P21802, P22455, P22607, Q8N441	FGFR1, FGFR2, FGFR3, FGFR4, FGFRL1, NRP1	FGFR2 [Baccin2019:114860338663044;CellTalkDB:16597617;Cellinker:11486033;Cellinker:16597617;Cellinker:25772309;Cellinker:8663044;HPRD:8663044;LRdb:16597617;SIGNOR:8663044;SignaLink3:23331499;SignaLink3:8663044;connectomeDB2020:11486033;connectomeDB2020:8663044], FGFR4 [Baccin2019:114860338663044;CellTalkDB:16597617;Cellinker:11486033;Cellinker:25772309;Cellinker:8663044;HPMR:11486033;HPRD:8663044;LRdb:16597617;SIGNOR:1385111;connectomeDB2020:11486033;connectomeDB2020:8663044], FGFR1 [Baccin2019:1148603311486030;CellTalkDB:16597617;Cellinker:16597617;Cellinker:25772309;HPRD:11486033;LRdb:16597617;connectomeDB2020:11486033], FGFR3 [Baccin2019:114860338663044;CellTalkDB:16597617;Cellinker:11486033;Cellinker:16597617;Cellinker:25772309;Cellinker:8663044;DIP:9045692;HPRD:8663044;LRdb:16597617;connectomeDB2020:11486033;connectomeDB2020:8663044], NRP1 [Baccin2019:15695515;CellTalkDB:16597617;Cellinker:15695515;HPRD:15695515;LRdb:15695515;connectomeDB2020:15695515], FGFRL1 [connectomeDB2020:19920134]	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	fibroblast growth factor receptor binding [GO:0005104]; growth factor activity [GO:0008083]; heparin binding [GO:0008201]	animal organ morphogenesis [GO:0009887]; apoptotic process involved in morphogenesis [GO:0060561]; cartilage condensation [GO:0001502]; cell-cell signaling [GO:0007267]; cell differentiation [GO:0030154]; cellular response to leukemia inhibitory factor [GO:1990830]; chondroblast differentiation [GO:0060591]; cranial suture morphogenesis [GO:0060363]; embryonic hindlimb morphogenesis [GO:0035116]; fibroblast growth factor receptor signaling pathway [GO:0008543]; mesenchymal cell proliferation [GO:0010463]; negative regulation of apoptotic process [GO:0043066]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell migration [GO:0030334]; regulation of endothelial cell chemotaxis to fibroblast growth factor [GO:2000544]; signal transduction [GO:0007165]; stem cell population maintenance [GO:0019827]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=FGF4&keywords=FGF4	9.318775280898877e-4	893	NA	NA	0.06982498645962464	673	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
FGF5	fibroblast growth factor 5	Yes		ENSG00000138675	P12034	Heparin-binding growth factors family	16	ligand	extracellular, intracellular, ligand, secreted	P11362, P21802, P22455, P22607	FGFR1, FGFR2, FGFR3, FGFR4	FGFR1 [Baccin2019:83868288386828;CellTalkDB:16597617;Cellinker:16597617;Cellinker:25772309;DIP:8386828;HPRD:8386828;LRdb:16597617;SIGNOR:8386828;connectomeDB2020:8386828], FGFR2 [Baccin2019:838682811876253;CellTalkDB:16597617;Cellinker:11876253;Cellinker:16597617;Cellinker:25772309;Cellinker:8386828;HPRD:11876253;LRdb:16597617;SIGNOR:8386828;connectomeDB2020:11876253;connectomeDB2020:8386828], FGFR3 [Baccin2019:8663044;CellTalkDB:16597617;Cellinker:16597617;Cellinker:25772309;Cellinker:8663044;DIP:9045692;HPRD:8663044;LRdb:16597617;connectomeDB2020:8663044], FGFR4 [Baccin2019:13851118663044;CellTalkDB:16597617;Cellinker:1385111;Cellinker:25772309;Cellinker:8663044;HPRD:8663044;LRdb:16597617;connectomeDB2020:1385111;connectomeDB2020:8663044]	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	fibroblast growth factor receptor binding [GO:0005104]; growth factor activity [GO:0008083]	animal organ morphogenesis [GO:0009887]; cell-cell signaling [GO:0007267]; cell differentiation [GO:0030154]; fibroblast growth factor receptor signaling pathway [GO:0008543]; glial cell differentiation [GO:0010001]; nervous system development [GO:0007399]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of protein phosphorylation [GO:0001934]; regulation of cell migration [GO:0030334]; signal transduction involved in regulation of gene expression [GO:0023019]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=FGF5&keywords=FGF5	0.1634092733835955	637	NA	NA	0.23875283085238555	504	0	0	0	0.0038369304556354913	0	0	0	0	0	3.338229403124583e-5	2.704268881591655e-4	303	408	394	3.7643087616599113e-4	0.9637225091499786	0.966939635966476	0.9897841570698157	148	146	103
FGF6	fibroblast growth factor 6	Yes		ENSG00000111241	P10767	Heparin-binding growth factors family	18	ligand	extracellular, intracellular, ligand, secreted, transmembrane, transmembrane_predicted	P11362, P21802, P22455, P22607, P31431	FGFR1, FGFR2, FGFR3, FGFR4, SDC4	FGFR2 [Baccin2019:8663044;CellTalkDB:16597617;Cellinker:16597617;Cellinker:25772309;Cellinker:8663044;HPRD:8663044;LRdb:16597617;SIGNOR:8663044;SignaLink3:23331499;SignaLink3:8663044;connectomeDB2020:8663044], FGFR4 [Baccin2019:13851111385111;CellTalkDB:16597617;Cellinker:1385111;Cellinker:25772309;HPRD:1385111;LRdb:16597617;SIGNOR:1385111;connectomeDB2020:1385111], SDC4 [CellTalkDB:32196115], FGFR1 [Baccin2019:8663044;CellTalkDB:16597617;Cellinker:16597617;Cellinker:25772309;HPRD:8663044;LRdb:16597617;connectomeDB2020:8663044], FGFR3 [Baccin2019:8663044;CellTalkDB:16597617;Cellinker:16597617;Cellinker:25772309;Cellinker:8663044;HPRD:8663044;LRdb:16597617;connectomeDB2020:8663044]	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; sarcolemma [GO:0042383]	fibroblast growth factor receptor binding [GO:0005104]; growth factor activity [GO:0008083]	angiogenesis [GO:0001525]; animal organ morphogenesis [GO:0009887]; cartilage condensation [GO:0001502]; cell differentiation [GO:0030154]; fibroblast growth factor receptor signaling pathway [GO:0008543]; myoblast differentiation [GO:0045445]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of protein phosphorylation [GO:0001934]; regulation of cell migration [GO:0030334]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=FGF6&keywords=FGF6	0.01056973033707865	825	NA	NA	0.44594396693161054	402	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
FGF7	fibroblast growth factor 7	Yes		ENSG00000140285	P21781	Heparin-binding growth factors family	18	ligand	extracellular, intracellular, ligand, secreted, transmembrane	O14786, P11362, P21802, P22455, P22607	FGFR1, FGFR2, FGFR3, FGFR4, NRP1	FGFR2 [Baccin2019:125919597687739;CellTalkDB:16597617;Cellinker:12591959;Cellinker:16597617;Cellinker:25772309;Cellinker:27192911;Cellinker:7687739;DIP:10339576;DIP:10950949;DIP:11121055;DIP:8663044;HPRD:7687739;LRdb:16597617;Lit-BM-17:10339576;Lit-BM-17:10950949;Lit-BM-17:11121055;Lit-BM-17:11714710;Lit-BM-17:1309608;Lit-BM-17:8663044;Lit-BM-17:9582367;SignaLink3:21071413;SignaLink3:23331499;SignaLink3:8663044;SignaLink3:9582367;connectomeDB2020:12591959;connectomeDB2020:7687739], FGFR4 [CellTalkDB:7680645;Cellinker:7680645;HPRD:7680645;LRdb:7680645], FGFR1 [Baccin2019:8663044;CellTalkDB:16597617;Cellinker:16597617;Cellinker:25772309;Cellinker:8663044;HPRD:8663044;LRdb:16597617;connectomeDB2020:8663044], FGFR3 [CellTalkDB:8663044;Cellinker:8663044;DIP:9045692;HPRD:8663044;LRdb:8663044;connectomeDB2020:8663044], NRP1 [Baccin2019:15695515;CellTalkDB:16597617;Cellinker:15695515;HPRD:15695515;LRdb:15695515;connectomeDB2020:15695515]	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]	chemoattractant activity [GO:0042056]; fibroblast growth factor receptor binding [GO:0005104]; growth factor activity [GO:0008083]; heparin binding [GO:0008201]; type 2 fibroblast growth factor receptor binding [GO:0005111]	actin cytoskeleton reorganization [GO:0031532]; animal organ morphogenesis [GO:0009887]; branching involved in salivary gland morphogenesis [GO:0060445]; cell differentiation [GO:0030154]; epidermis development [GO:0008544]; fibroblast growth factor receptor signaling pathway [GO:0008543]; hair follicle morphogenesis [GO:0031069]; lung development [GO:0030324]; mesenchymal cell proliferation [GO:0010463]; positive chemotaxis [GO:0050918]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial cell proliferation involved in lung morphogenesis [GO:0060501]; positive regulation of gene expression [GO:0010628]; positive regulation of keratinocyte migration [GO:0051549]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription, DNA-templated [GO:0045893]; protein localization to cell surface [GO:0034394]; regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling [GO:0060665]; regulation of cell migration [GO:0030334]; response to wounding [GO:0009611]; secretion by lung epithelial cell involved in lung growth [GO:0061033]; signal transduction [GO:0007165]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=FGF7&keywords=FGF7	3.161388341573034	331	NA	NA	0.2749451344805456	479	0	0.049401197604790364	0.021017699115044253	0.23357314148681058	0.04882154882154881	0.17766497461928915	0.16137805983680822	0.09951060358890713	0.12208657047724686	0.1553611964214124	0.08135986092331178	109	90	125	0.10456135026319724	1.1529767253422432	1.4434291848123808	0.7974754200558779	99	57	191
FGF8	fibroblast growth factor 8	Yes		ENSG00000107831	P55075	Heparin-binding growth factors family	18	ligand	extracellular, intracellular, ligand, secreted	P11362, P21802, P22455, P22607, Q8N441	FGFR1, FGFR2, FGFR3, FGFR4, FGFRL1	FGFR2 [Baccin2019:10751172;Baccin2019:8663044;CellTalkDB:16597617;Cellinker:10751172;Cellinker:25772309;Cellinker:8663044;HPRD:10751172;HPRD:8663044;LRdb:16597617;SignaLink3:23331499;SignaLink3:8663044;connectomeDB2020:10751172;connectomeDB2020:8663044], FGFRL1 [CellTalkDB:23112089;connectomeDB2020:19920134], FGFR1 [Baccin2019:829025710574949;CellTalkDB:16597617;Cellinker:25772309;DIP:22244757;HPRD:10574949;LRdb:16597617;connectomeDB2020:10574949;connectomeDB2020:8290257], FGFR3 [Baccin2019:10574949;Baccin2019:11486033;Baccin2019:8663044;CellTalkDB:16597617;Cellinker:10574949;Cellinker:11486033;Cellinker:16597617;Cellinker:25772309;Cellinker:8663044;DIP:22244757;HPRD:10574949;LRdb:16597617;connectomeDB2020:10574949;connectomeDB2020:11486033;connectomeDB2020:8663044], FGFR4 [Baccin2019:1148603310736560;CellTalkDB:16597617;Cellinker:10736564;Cellinker:11486033;Cellinker:25772309;HPRD:10736564;LRdb:16597617;connectomeDB2020:10736564;connectomeDB2020:11486033]	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	fibroblast growth factor receptor binding [GO:0005104]; growth factor activity [GO:0008083]; type 1 fibroblast growth factor receptor binding [GO:0005105]; type 2 fibroblast growth factor receptor binding [GO:0005111]	anatomical structure morphogenesis [GO:0009653]; animal organ morphogenesis [GO:0009887]; aorta morphogenesis [GO:0035909]; blood vessel remodeling [GO:0001974]; bone development [GO:0060348]; branching involved in blood vessel morphogenesis [GO:0001569]; branching involved in salivary gland morphogenesis [GO:0060445]; branching involved in ureteric bud morphogenesis [GO:0001658]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; cell migration involved in mesendoderm migration [GO:0090134]; cell proliferation in forebrain [GO:0021846]; corticotropin hormone secreting cell differentiation [GO:0060128]; dopaminergic neuron differentiation [GO:0071542]; dorsal/ventral pattern formation [GO:0009953]; embryonic heart tube development [GO:0035050]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic neurocranium morphogenesis [GO:0048702]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; fibroblast growth factor receptor signaling pathway [GO:0008543]; forebrain dorsal/ventral pattern formation [GO:0021798]; forebrain morphogenesis [GO:0048853]; gastrulation [GO:0007369]; gonad development [GO:0008406]; heart looping [GO:0001947]; heart morphogenesis [GO:0003007]; larynx morphogenesis [GO:0120223]; limb morphogenesis [GO:0035108]; lung morphogenesis [GO:0060425]; male genitalia development [GO:0030539]; MAPK cascade [GO:0000165]; mesodermal cell migration [GO:0008078]; mesonephros development [GO:0001823]; metanephros development [GO:0001656]; midbrain-hindbrain boundary development [GO:0030917]; negative regulation of cardiac muscle tissue development [GO:0055026]; negative regulation of neuron apoptotic process [GO:0043524]; neural plate morphogenesis [GO:0001839]; neuroepithelial cell differentiation [GO:0060563]; neuron differentiation [GO:0030182]; odontogenesis [GO:0042476]; organ induction [GO:0001759]; otic vesicle formation [GO:0030916]; outflow tract septum morphogenesis [GO:0003148]; pallium development [GO:0021543]; pharyngeal system development [GO:0060037]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of G protein-coupled receptor signaling pathway [GO:0045745]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of organ growth [GO:0046622]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein phosphorylation [GO:0001934]; regulation of cell migration [GO:0030334]; regulation of odontogenesis of dentin-containing tooth [GO:0042487]; signal transduction involved in regulation of gene expression [GO:0023019]; subpallium development [GO:0021544]; thyroid gland development [GO:0030878]; thyroid-stimulating hormone-secreting cell differentiation [GO:0060129]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=FGF8&keywords=FGF8	0.0011773820224719102	891	NA	NA	0.07442129252457678	668	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
FGF9	fibroblast growth factor 9	Yes		ENSG00000102678	P31371	Heparin-binding growth factors family	17	ligand, receptor	extracellular, intracellular, ligand, receptor, secreted	O15520, P11362, P21802, P22455, P22607	FGF10, FGFR1, FGFR2, FGFR3, FGFR4	FGF10 [SignaLink3:23331499;SignaLink3:8663044], FGFR3 [Baccin2019:10574949;Baccin2019:15231666;Baccin2019:8576175;CellTalkDB:16597617;Cellinker:10574949;Cellinker:15231666;Cellinker:16597617;Cellinker:25772309;Cellinker:8576175;HPRD:10574949;HPRD:8576175;LRdb:16597617;SignaLink3:10574949;SignaLink3:23331499;SignaLink3:8576175;SignaLink3:8663044;connectomeDB2020:10574949;connectomeDB2020:15231666;connectomeDB2020:8576175], FGFR2 [Baccin2019:86630448576175;CellTalkDB:16597617;Cellinker:16597617;Cellinker:25772309;Cellinker:8576175;Cellinker:8663044;HPRD:8576175;LRdb:16597617;connectomeDB2020:8576175;connectomeDB2020:8663044], FGFR1 [Baccin2019:10574949;CellTalkDB:16597617;Cellinker:25772309;HPRD:10574949;LRdb:16597617;connectomeDB2020:10574949], FGFR4 [Baccin2019:8663044;CellTalkDB:16597617;Cellinker:25772309;Cellinker:8663044;HPRD:8663044;LRdb:16597617;connectomeDB2020:8663044]	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	fibroblast growth factor receptor binding [GO:0005104]; growth factor activity [GO:0008083]; heparin binding [GO:0008201]	angiogenesis [GO:0001525]; animal organ morphogenesis [GO:0009887]; cell-cell signaling [GO:0007267]; cell differentiation [GO:0030154]; chondrocyte differentiation [GO:0002062]; embryonic digestive tract development [GO:0048566]; embryonic limb morphogenesis [GO:0030326]; embryonic skeletal system development [GO:0048706]; eye development [GO:0001654]; fibroblast growth factor receptor signaling pathway [GO:0008543]; inner ear morphogenesis [GO:0042472]; lung-associated mesenchyme development [GO:0060484]; lung development [GO:0030324]; male gonad development [GO:0008584]; male sex determination [GO:0030238]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of vascular associated smooth muscle cell differentiation involved in phenotypic switching [GO:1905931]; negative regulation of Wnt signaling pathway [GO:0030178]; osteoblast differentiation [GO:0001649]; positive regulation of activin receptor signaling pathway [GO:0032927]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of gene expression [GO:0010628]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of smoothened signaling pathway [GO:0045880]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; protein import into nucleus [GO:0006606]; regulation of cell migration [GO:0030334]; regulation of timing of cell differentiation [GO:0048505]; signal transduction [GO:0007165]; substantia nigra development [GO:0021762]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=FGF9&keywords=FGF9	2.196683380523725	379	NA	NA	0.811927953219908	297	0	0.003992015968063873	0.0022123893805309734	0.0016786570743405273	0.008417508417508417	0.04399323181049071	0.022665457842248413	0.019575856443719414	0.014058453570107295	0.033315529443183445	0.013057755456828182	252	166	238	0.014815168673365568	0.9695059456085637	1.7455262953612136	0.9291798802712293	141	32	128
FGFBP2	fibroblast growth factor binding protein 2	Yes		ENSG00000137441	Q9BYJ0	Fibroblast growth factor-binding protein family	1	ligand	extracellular, ligand, ligand_regulator, secreted	NA	NA	NA	extracellular space [GO:0005615]	growth factor binding [GO:0019838]	cell-cell signaling [GO:0007267]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=FGFBP2&keywords=FGFBP2	0.06012676404494382	715	NA	NA	0.008126107605726478	843	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
FGFBP3	fibroblast growth factor binding protein 3	Yes		ENSG00000174721	Q8TAT2	Fibroblast growth factor-binding protein family	1	ecm, ligand	ecm, ligand, ligand_regulator, secreted	NA	NA	NA	collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]	fibroblast growth factor binding [GO:0017134]; growth factor binding [GO:0019838]; heparin binding [GO:0008201]	cell-cell signaling [GO:0007267]; positive regulation of fibroblast growth factor receptor signaling pathway [GO:0045743]; positive regulation of vascular permeability [GO:0043117]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=FGFBP3&keywords=FGFBP3	1.2820537415730338	423	241.228	167	0.44427493148129243	403	0	0.013473053892215562	0	0.005995203836930454	0.006734006734006734	0.05245346869712354	0.08068902991840421	0.035889070146818934	0.02330743618201996	0.04282948324208935	0.018157233919258168	224	155	212	0.025411635142624265	0.9405788817113524	1.4918679419719758	0.7951407441608331	159	54	192
FGFR2	fibroblast growth factor receptor 2	No		ENSG00000066468	P21802	Protein kinase superfamily, Tyr protein kinase family, Fibroblast growth factor receptor subfamily	1	adhesion, cell_surface_ligand, receptor	adhesion, cell_adhesion, cell_surface, cell_surface_ligand, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, secreted, transmembrane	O15520, O60258, O60894, O76093, P05230, P08620, P08648, P08922, P09038, P10767, P11362, P11487, P12034, P13591, P16070, P19174, P21781, P31371, P31431, P54764, P55075, P60484, P62993, Q01151, Q01668, Q13588, Q14289, Q15256, Q7Z3B1, Q8WU20, Q9GZV9, Q9UBH6	CACNA1D, CD44, CD83, EPHA4, FGF1, FGF10, FGF17, FGF18, FGF2, FGF23, FGF3, FGF4, FGF5, FGF6, FGF7, FGF8, FGF9, FGFR1, FRS2, GRAP, GRB2, ITGA5, NCAM1, NEGR1, PLCG1, PTEN, PTK2B, PTPRR, RAMP1, ROS1, SDC4, XPR1	FGF1 [BioGRID:10618369;DIP:10339576;DIP:10618369;DIP:11069186;DIP:8663044;HPRD:10618369;HPRD:11069186;HPRD:14732692;Lit-BM-17:10339576;Lit-BM-17:10618369;Lit-BM-17:11069186;Lit-BM-17:11714710;Lit-BM-17:23597563;Lit-BM-17:25241761;Lit-BM-17:8576175;Lit-BM-17:8663044], FGF2 [HPMR:8663044;IntAct:10830168;IntAct:11390973;Lit-BM-17:10950949;Lit-BM-17:11121055;Lit-BM-17:11390973;Lit-BM-17:17981115;Lit-BM-17:26267536], FGF3 [DIP:8663044;HPRD:8663044], FGF4 [HPRD:8663044], FGF7 [DIP:10339576;DIP:10950949;DIP:11121055;DIP:8663044;HPRD:7687739;Lit-BM-17:10339576;Lit-BM-17:10950949;Lit-BM-17:11121055;Lit-BM-17:11714710;Lit-BM-17:1309608;Lit-BM-17:8663044;Lit-BM-17:9582367], FGF8 [HPRD:10751172;HPRD:8663044], FGF10 [HPRD:9582367;Lit-BM-17:10339576;Lit-BM-17:12591959;Lit-BM-17:25241761;Lit-BM-17:9582367], GRAP [SignaLink3:19735729;SignaLink3:23331499], FGF6 [HPRD:8663044], FGF17 [HPRD:10751172], FGF18 [HPRD:10751172], PTEN [ProtMapper:22891331;ProtMapper:30827889;SIGNOR:22891331;iPTMnet:22891331], GRB2 [InnateDB:19735729;IntAct:22726438;Lit-BM-17:22726438;PhosphoSite:20554525;PhosphoSite:26103942;ProtMapper:23420874;ProtMapper:26103942;SIGNOR:22726438;iPTMnet:22726438], FGF5 [HPRD:11876253], FRS2 [ACSN:11274345;ACSN:11447289;ACSN:11777939;ACSN:11997436;ACSN:12040186;ACSN:14585353;ACSN:15173823;ACSN:15567848;ACSN:15574420;ACSN:16488589;ACSN:17496910;ACSN:19568798;ACSN:6321473;SIGNOR:9182757], FGF23 [HPRD:12032146], FGF9 [HPRD:8576175], NCAM1 [Baccin2019:21710437], RAMP1 [Cellinker:32589946], SDC4 [Cellinker:23970415], NEGR1 [Cellinker:30059965], CD83 [NA], FGFR1 [NA], EPHA4 [HPRD:16365308], CD44 [NA], XPR1 [NA], PTPRR [NA], ROS1 [NA], PLCG1 [DIP:24440983;HPRD:7999363;IntAct:24440983;KEA:12601080;KEA:15144186;KEA:15592455;KEA:16038803;KEA:16126727;KEA:16153436;KEA:1689310;KEA:17081983;KEA:1708307;KEA:7682059;KEA:8657103;KEA:8885868], CACNA1D [HPRD:11292657], ITGA5 [HPRD:15728256], PTK2B [HPRD:15105428]	cell cortex [GO:0005938]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; excitatory synapse [GO:0060076]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	ATP binding [GO:0005524]; fibroblast growth factor-activated receptor activity [GO:0005007]; fibroblast growth factor binding [GO:0017134]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]	angiogenesis [GO:0001525]; animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; axonogenesis [GO:0007409]; bone development [GO:0060348]; bone mineralization [GO:0030282]; bone morphogenesis [GO:0060349]; branch elongation involved in salivary gland morphogenesis [GO:0060667]; branching involved in labyrinthine layer morphogenesis [GO:0060670]; branching involved in prostate gland morphogenesis [GO:0060442]; branching involved in salivary gland morphogenesis [GO:0060445]; branching morphogenesis of a nerve [GO:0048755]; bud elongation involved in lung branching [GO:0060449]; cell-cell signaling [GO:0007267]; cell fate commitment [GO:0045165]; cellular response to retinoic acid [GO:0071300]; cellular response to transforming growth factor beta stimulus [GO:0071560]; digestive tract development [GO:0048565]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic digestive tract morphogenesis [GO:0048557]; embryonic organ development [GO:0048568]; embryonic organ morphogenesis [GO:0048562]; embryonic pattern specification [GO:0009880]; endochondral bone growth [GO:0003416]; epidermis morphogenesis [GO:0048730]; epithelial cell differentiation [GO:0030855]; epithelial cell proliferation involved in salivary gland morphogenesis [GO:0060664]; epithelial to mesenchymal transition [GO:0001837]; fibroblast growth factor receptor signaling pathway [GO:0008543]; fibroblast growth factor receptor signaling pathway involved in hemopoiesis [GO:0035603]; fibroblast growth factor receptor signaling pathway involved in mammary gland specification [GO:0060595]; fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow cell [GO:0035602]; fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development [GO:0035607]; fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow [GO:0035604]; gland morphogenesis [GO:0022612]; hair follicle morphogenesis [GO:0031069]; inner ear morphogenesis [GO:0042472]; in utero embryonic development [GO:0001701]; lacrimal gland development [GO:0032808]; lateral sprouting from an epithelium [GO:0060601]; limb bud formation [GO:0060174]; lung alveolus development [GO:0048286]; lung-associated mesenchyme development [GO:0060484]; lung development [GO:0030324]; lung lobe morphogenesis [GO:0060463]; mammary gland bud formation [GO:0060615]; membranous septum morphogenesis [GO:0003149]; mesenchymal cell differentiation [GO:0048762]; mesenchymal cell differentiation involved in lung development [GO:0060915]; mesenchymal cell proliferation involved in lung development [GO:0060916]; mesodermal cell differentiation [GO:0048333]; midbrain development [GO:0030901]; morphogenesis of embryonic epithelium [GO:0016331]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of transcription by RNA polymerase II [GO:0000122]; odontogenesis [GO:0042476]; orbitofrontal cortex development [GO:0021769]; organ growth [GO:0035265]; otic vesicle formation [GO:0030916]; outflow tract septum morphogenesis [GO:0003148]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell cycle [GO:0045787]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial cell proliferation involved in lung morphogenesis [GO:0060501]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of phospholipase activity [GO:0010518]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of Wnt signaling pathway [GO:0030177]; post-embryonic development [GO:0009791]; prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis [GO:0060527]; prostate epithelial cord elongation [GO:0060523]; prostate gland morphogenesis [GO:0060512]; protein autophosphorylation [GO:0046777]; pyramidal neuron development [GO:0021860]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of morphogenesis of a branching structure [GO:0060688]; regulation of osteoblast differentiation [GO:0045667]; regulation of osteoblast proliferation [GO:0033688]; regulation of smoothened signaling pathway [GO:0008589]; regulation of smooth muscle cell differentiation [GO:0051150]; reproductive structure development [GO:0048608]; response to ethanol [GO:0045471]; response to lipopolysaccharide [GO:0032496]; skeletal system morphogenesis [GO:0048705]; squamous basal epithelial stem cell differentiation involved in prostate gland acinus development [GO:0060529]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; ureteric bud development [GO:0001657]; ventricular cardiac muscle tissue morphogenesis [GO:0055010]; ventricular zone neuroblast division [GO:0021847]; wound healing [GO:0042060]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=FGFR2&keywords=FGFR2	6.892304516624051	268	NA	NA	0.40502215861817853	413	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
FGFR3	fibroblast growth factor receptor 3	No		ENSG00000068078	P22607	Protein kinase superfamily, Tyr protein kinase family, Fibroblast growth factor receptor subfamily	1	adhesion, ligand, receptor	adhesion, cell_adhesion, cell_surface, extracellular, intracellular, ligand, plasma_membrane, plasma_membrane_transmembrane, receptor, secreted, transmembrane	O43300, O60258, O75380, O76093, O95873, P02008, P05060, P05230, P05787, P08620, P09038, P10767, P11487, P12034, P12236, P14866, P18847, P19174, P21781, P31371, P31431, P40763, P42224, P43235, P51812, P54764, P55075, P60484, P62917, P62993, Q12789, Q13627, Q14181, Q14289, Q15486, Q6N021, Q6PGQ7, Q86XS8, Q92540, Q96LX7, Q96P48, Q9GZV9, Q9NRF2, Q9P2H0, Q9UEF7, Q9UPZ9, Q9Y4H4	ARAP1, ATF3, BORA, C6orf47, CCDC17, CEP126, CHGB, CILK1, CTSK, DYRK1A, EPHA4, FGF1, FGF17, FGF18, FGF2, FGF23, FGF3, FGF4, FGF5, FGF6, FGF7, FGF8, FGF9, GPSM3, GRB2, GTF3C1, GUSBP1, HBZ, HNRNPL, KL, KRT8, LRRTM2, NDUFS6, PLCG1, POLA2, PTEN, PTK2B, RNF130, RPL8, RPS6KA3, SDC4, SH2B1, SLC25A6, SMG7, STAT1, STAT3, TET2	FGF9 [HPRD:10574949;HPRD:8576175], FGF1 [DIP:22244757;DIP:9045692;HPRD:10574949;HPRD:14732692;Lit-BM-17:10574949;Lit-BM-17:14732692;Lit-BM-17:8576175;Lit-BM-17:9045692], FGF2 [DIP:9045692;HPMR:8663044;HPRD:10574949], STAT3 [HPRD-phos:10918587;HPRD-phos:11294897;HPRD-phos:11350938;HPRD-phos:11940572;HPRD-phos:12244095;HPRD-phos:12576423;HPRD-phos:12626508;HPRD-phos:14551213;HPRD-phos:16497976;HPRD-phos:17016520;HPRD-phos:17389395;HPRD-phos:19901323;HPRD-phos:8626374;HPRD:10918587;HPRD:11294897;HPRD:11350938;HPRD:11940572;HPRD:12244095;HPRD:12576423;HPRD:12626508;HPRD:14551213;HPRD:8626374;KEA:10918587;KEA:11294897;KEA:11350938;KEA:11429593;KEA:11850821;KEA:11940572;KEA:12244095;KEA:12576423;KEA:12626508;KEA:14551213;KEA:15592455;KEA:8272872;KEA:8626374;KEA:9083098;KEA:9305919;KEA:9566874;KEA:9582023;ProtMapper:10918587;SIGNOR:10918587;iPTMnet:10918587;iPTMnet:11294897;iPTMnet:11350938;iPTMnet:11940572;iPTMnet:12244095;iPTMnet:12576423;iPTMnet:12626508;iPTMnet:14551213;iPTMnet:16497976;iPTMnet:17016520;iPTMnet:17389395;iPTMnet:19901323;iPTMnet:8626374], STAT1 [ACSN:11447289;ACSN:11997436;ACSN:12040186;ACSN:14585353;ACSN:15173823;ACSN:15199124;ACSN:15567848;ACSN:16488589;ACSN:17496910;ACSN:19568798;ACSN:19615955;ACSN:6321473;HPRD-phos:10918587;HPRD-phos:11294897;HPRD-phos:11839738;HPRD-phos:12637327;HPRD-phos:12817007;HPRD-phos:15322115;HPRD-phos:7543024;HPRD-phos:7657660;HPRD-phos:7690989;HPRD:10918587;HPRD:11294897;HPRD:11839738;HPRD:12637327;HPRD:12817007;HPRD:15322115;HPRD:7543024;HPRD:7657660;HPRD:7690989;KEA:10748192;KEA:10918587;KEA:10982844;KEA:11152457;KEA:11294897;KEA:11438544;KEA:11839738;KEA:12637327;KEA:12817007;KEA:15322115;KEA:7543024;KEA:7592750;KEA:7657660;KEA:7690989;KEA:9355737;ProtMapper:10918587;ProtMapper:19088846;SIGNOR:10918587;iPTMnet:10918587;iPTMnet:11294897;iPTMnet:11839738;iPTMnet:12637327;iPTMnet:12817007;iPTMnet:15322115;iPTMnet:7543024;iPTMnet:7657660;iPTMnet:7690989], PTEN [ProtMapper:22891331;SIGNOR:22891331;iPTMnet:22891331], FGF4 [DIP:9045692;HPRD:8663044], FGF6 [HPRD:8663044], FGF23 [HPRD:12032146], FGF7 [DIP:9045692;HPRD:8663044], FGF18 [HPRD:10751172], FGF5 [DIP:9045692;HPRD:8663044], FGF8 [DIP:22244757;HPRD:10574949], FGF3 [HPRD:8663044], FGF17 [HPRD:10751172], KL [Cellinker:32589946], EPHA4 [HPRD:16365308], SDC4 [Cellinker:23970415], LRRTM2 [Cellinker:32589946], RPS6KA3 [KEA:18156174;PhosphoSite:25014166;ProtMapper:17785199;ProtMapper:18156174;ProtMapper:19223461;ProtMapper:23936765;iPTMnet:17785202;iPTMnet:19223461], CILK1 [PhosphoSite:30782830], TET2 [PhosphoSite:33097695], DYRK1A [KEA:17570479], PLCG1 [ACSN:17496910;KEA:12601080;KEA:15144186;KEA:15592455;KEA:16038803;KEA:16126727;KEA:16153436;KEA:1689310;KEA:17081983;KEA:1708307;KEA:7682059;KEA:8657103;KEA:8885868], GUSBP1 [IntAct:16169070;IntAct:32814053], GRB2 [HPRD:9045692], PTK2B [HPRD:15105428], SLC25A6 [HPRD:16169070], RPL8 [HPRD:16169070], CEP126 [HPRD:16169070], HBZ [HPRD:16169070], KRT8 [HPRD:16169070], HNRNPL [HPRD:16169070], GTF3C1 [HPRD:16169070], CCDC17 [HPRD:16169070], ARAP1 [HPRD:16169070], POLA2 [HPRD:16169070], NDUFS6 [HPRD:16169070], SMG7 [HPRD:16169070], RNF130 [HPRD:16169070], BORA [HPRD:16169070], CTSK [HPRD:16169070], ATF3 [HPRD:16169070], CHGB [HPRD:16169070], SH2B1 [HPRD:11827956], C6orf47 [HPRD:14667819], GPSM3 [HPRD:14667819]	cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; transport vesicle [GO:0030133]	ATP binding [GO:0005524]; fibroblast growth factor-activated receptor activity [GO:0005007]; fibroblast growth factor binding [GO:0017134]; identical protein binding [GO:0042802]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]	bone maturation [GO:0070977]; bone mineralization [GO:0030282]; bone morphogenesis [GO:0060349]; cell-cell signaling [GO:0007267]; chondrocyte differentiation [GO:0002062]; chondrocyte proliferation [GO:0035988]; endochondral bone growth [GO:0003416]; endochondral ossification [GO:0001958]; fibroblast growth factor receptor apoptotic signaling pathway [GO:1902178]; fibroblast growth factor receptor signaling pathway [GO:0008543]; MAPK cascade [GO:0000165]; negative regulation of developmental growth [GO:0048640]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of phospholipase activity [GO:0010518]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein autophosphorylation [GO:0046777]; skeletal system development [GO:0001501]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=FGFR3&keywords=FGFR3	0.5149291002505236	520	NA	NA	0.011611227559018906	824	0	0.031936127744510955	0	0	0.0016835016835016834	0.001692047377326565	9.066183136899365e-4	0.0016313213703099511	0	3.0044064628121254e-4	3.8632412594166507e-5	303	399	400	0.003471699049837679	0.7422968671587487	0.7645984822089181	0.745164539042692	245	233	217
FGFR4	fibroblast growth factor receptor 4	No		ENSG00000160867	P22455	Protein kinase superfamily, Tyr protein kinase family, Fibroblast growth factor receptor subfamily	1	adhesion, ligand, receptor	adhesion, cell_adhesion, cell_surface, extracellular, intracellular, ligand, plasma_membrane, plasma_membrane_transmembrane, receptor, secreted, transmembrane	O00220, O60258, O76093, O95750, P05230, P08620, P09038, P10767, P11487, P12034, P19022, P19174, P21781, P23468, P31371, P31431, P40763, P42224, P43121, P50895, P54764, P55075, P58401, Q13332, Q15256, Q6GTX8, Q6PI73, Q6ZMC9, Q6ZN44, Q8WU20, Q9HDB5, Q9P2S2, Q9UEF7, Q9Y4C0, Q9Y625	BCAM, CDH2, EPHA4, FGF1, FGF17, FGF18, FGF19, FGF2, FGF3, FGF4, FGF5, FGF6, FGF7, FGF8, FGF9, FRS2, GPC6, KL, LAIR1, LILRA6, MCAM, NRXN2, NRXN3, PLCG1, PTPRD, PTPRR, PTPRS, SDC4, SIGLEC15, STAT1, STAT3, TNFRSF10A, UNC5A	FGF19 [DIP:10525310;DIP:19706524;HPRD:10525310], FGF6 [HPRD:1385111], STAT3 [HPRD-phos:10918587;HPRD-phos:11294897;HPRD-phos:11350938;HPRD-phos:11940572;HPRD-phos:12244095;HPRD-phos:12576423;HPRD-phos:12626508;HPRD-phos:14551213;HPRD-phos:16497976;HPRD-phos:17016520;HPRD-phos:17389395;HPRD-phos:19901323;HPRD-phos:8626374;HPRD:10918587;HPRD:11294897;HPRD:11350938;HPRD:11940572;HPRD:12244095;HPRD:12576423;HPRD:12626508;HPRD:14551213;HPRD:8626374;KEA:10918587;KEA:11294897;KEA:11350938;KEA:11429593;KEA:11850821;KEA:11940572;KEA:12244095;KEA:12576423;KEA:12626508;KEA:14551213;KEA:15592455;KEA:8272872;KEA:8626374;KEA:9083098;KEA:9305919;KEA:9566874;KEA:9582023;ProtMapper:10918587;SIGNOR:10918587;iPTMnet:10918587;iPTMnet:11294897;iPTMnet:11350938;iPTMnet:11940572;iPTMnet:12244095;iPTMnet:12576423;iPTMnet:12626508;iPTMnet:14551213;iPTMnet:16497976;iPTMnet:17016520;iPTMnet:17389395;iPTMnet:19901323;iPTMnet:8626374], FRS2 [ACSN:11274345;ACSN:11447289;ACSN:11777939;ACSN:11997436;ACSN:12040186;ACSN:14585353;ACSN:15173823;ACSN:15567848;ACSN:15574420;ACSN:16488589;ACSN:17496910;ACSN:19568798;ACSN:6321473;SIGNOR:9182757], FGF1 [BioGRID:10336501;BioGRID:10736564;DIP:7680645;HPRD:10336501;HPRD:10736564;Lit-BM-17:10336501;Lit-BM-17:10736564;Lit-BM-17:11714710;Lit-BM-17:25241761;Lit-BM-17:7680645], FGF4 [HPMR:11486033;HPRD:8663044], FGF2 [DIP:7680645;HPRD:8530375], STAT1 [ACSN:11447289;ACSN:11997436;ACSN:12040186;ACSN:14585353;ACSN:15173823;ACSN:15199124;ACSN:15567848;ACSN:16488589;ACSN:17496910;ACSN:19568798;ACSN:19615955;ACSN:6321473;HPRD-phos:10918587;HPRD-phos:11294897;HPRD-phos:11839738;HPRD-phos:12637327;HPRD-phos:12817007;HPRD-phos:15322115;HPRD-phos:7543024;HPRD-phos:7657660;HPRD-phos:7690989;HPRD:10918587;HPRD:11294897;HPRD:11839738;HPRD:12637327;HPRD:12817007;HPRD:15322115;HPRD:7543024;HPRD:7657660;HPRD:7690989;KEA:10748192;KEA:10918587;KEA:10982844;KEA:11152457;KEA:11294897;KEA:11438544;KEA:11839738;KEA:12637327;KEA:12817007;KEA:15322115;KEA:7543024;KEA:7592750;KEA:7657660;KEA:7690989;KEA:9355737;ProtMapper:10918587;SIGNOR:10918587;iPTMnet:10918587;iPTMnet:11294897;iPTMnet:11839738;iPTMnet:12637327;iPTMnet:12817007;iPTMnet:15322115;iPTMnet:7543024;iPTMnet:7657660;iPTMnet:7690989], FGF7 [HPRD:7680645], FGF18 [HPRD:10751172], FGF3 [HPRD:8663044], FGF5 [HPRD:8663044], FGF17 [HPRD:10751172], FGF9 [HPRD:8663044], FGF8 [HPRD:10736564], LILRA6 [Cellinker:32822567], MCAM [Cellinker:32589946], NRXN3 [Cellinker:32589946], LAIR1 [Cellinker:32822567], KL [Cellinker:32589946], UNC5A [Cellinker:32822567], SDC4 [Cellinker:23970415], BCAM [Cellinker:32822567], NRXN2 [Cellinker:32589946], NRXN3 [Cellinker:32589946], GPC6 [Cellinker:32589946], PTPRD [Cellinker:32822567], PTPRS [Cellinker:32822567], NRXN2 [Cellinker:32589946], SIGLEC15 [Cellinker:32589946], TNFRSF10A [NA], PTPRR [NA], EPHA4 [HPRD:16365308], PLCG1 [ACSN:17496910;HPRD:7518429;KEA:12601080;KEA:15144186;KEA:15592455;KEA:16038803;KEA:16126727;KEA:16153436;KEA:1689310;KEA:17081983;KEA:1708307;KEA:7682059;KEA:8657103;KEA:8885868], CDH2 [HPRD:9168198]	endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; transport vesicle [GO:0030133]	ATP binding [GO:0005524]; fibroblast growth factor-activated receptor activity [GO:0005007]; fibroblast growth factor binding [GO:0017134]; heparin binding [GO:0008201]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]	cell migration [GO:0016477]; cholesterol homeostasis [GO:0042632]; fibroblast growth factor receptor signaling pathway [GO:0008543]; glucose homeostasis [GO:0042593]; peptidyl-tyrosine phosphorylation [GO:0018108]; phosphate ion homeostasis [GO:0055062]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of kinase activity [GO:0033674]; positive regulation of proteolysis [GO:0045862]; protein autophosphorylation [GO:0046777]; regulation of bile acid biosynthetic process [GO:0070857]; regulation of extracellular matrix disassembly [GO:0010715]; regulation of lipid metabolic process [GO:0019216]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=FGFR4&keywords=FGFR4	5.473013001252837	287	NA	NA	0.5996703699653186	338	0	0.07784431137724543	0.0011061946902654867	0.0038369304556354904	0.003367003367003367	0.00676818950930626	0.005439709882139619	0.0032626427406199023	0.009988901220865709	7.677927627186543e-4	0.009155881784817441	264	380	250	0.011048868890056124	0.9496425354385117	0.5115615864663188	0.910067038987878	156	313	140
FGL1	fibrinogen like 1	No		ENSG00000104760	Q08830	NA	10	ecm, ligand	ecm, extracellular, ligand, secreted	P00533, P18627	EGFR, LAG3	LAG3 [ICELLNET:30580966;connectomeDB2020:30580966], EGFR [CellTalkDB:24768768;Cellinker:24768768;LRdb:24768768;Ramilowski2015:24768768;connectomeDB2020:24768768;talklr:24768768]	collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; fibrinogen complex [GO:0005577]	signaling receptor binding [GO:0005102]	adaptive immune response [GO:0002250]; hepatocyte proliferation [GO:0072574]; negative regulation of T cell activation [GO:0050868]; regulation of immune response [GO:0050776]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=FGL1&keywords=FGL1	47.71286782722345	89	3179.81	111	1.9111155268324564	166	0	0.01447105788423153	0.00331858407079646	0.011031175059952035	1.5656565656565686	0.2199661590524532	0.11967361740707146	0.17618270799347469	0.41694413614502535	0.017091734543997823	0.19783658489471984	46	209	71	0.249288392973481	1.646599491974527	0.10448494910749306	0.8015653246613957	50	467	187
FLG	filaggrin			ENSG00000143631	P20930	S100-fused protein family	1	ecm, ligand	ecm, extracellular, intracellular, ligand, secreted	NA	NA	NA	collagen-containing extracellular matrix [GO:0062023]; cornified envelope [GO:0001533]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; keratohyalin granule [GO:0036457]; nucleus [GO:0005634]	calcium ion binding [GO:0005509]; structural constituent of skin epidermis [GO:0030280]; transition metal ion binding [GO:0046914]	establishment of skin barrier [GO:0061436]; keratinocyte differentiation [GO:0030216]; peptide cross-linking [GO:0018149]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=FLG&keywords=FLG	0.5451387575280899	515	1725.28	139	0.043858721049815697	723	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
FLG2	filaggrin family member 2			ENSG00000143520	Q5D862	S100-fused protein family; S-100 family	1	ecm, ligand	ecm, intracellular, ligand, secreted	NA	NA	NA	cornified envelope [GO:0001533]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; keratohyalin granule [GO:0036457]; nucleus [GO:0005634]; tertiary granule lumen [GO:1904724]	calcium ion binding [GO:0005509]; structural molecule activity [GO:0005198]; transition metal ion binding [GO:0046914]	cell adhesion [GO:0007155]; epidermis morphogenesis [GO:0048730]; establishment of skin barrier [GO:0061436]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=FLG2&keywords=FLG2	0.010128793932584269	829	310.904	165	8.9266681718088e-4	898	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
FLRT2	fibronectin leucine rich transmembrane protein 2	No		ENSG00000185070	O43155	NA	1	adhesion, ecm, ligand	adhesion, cell_adhesion, cell_surface, ecm, intracellular, ligand, plasma_membrane, plasma_membrane_transmembrane, secreted, transmembrane, transmembrane_predicted	Q6UXZ4, Q6ZN44, Q8IZJ1	UNC5A, UNC5B, UNC5D	UNC5D [Cellinker:32589946], UNC5B [Cellinker:32589946], UNC5A [Cellinker:32589946]	cell-cell junction [GO:0005911]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; synapse [GO:0045202]	chemorepellent activity [GO:0045499]; fibroblast growth factor receptor binding [GO:0005104]; protein-macromolecule adaptor activity [GO:0030674]	axon guidance [GO:0007411]; basement membrane organization [GO:0071711]; cell adhesion involved in heart morphogenesis [GO:0061343]; fibroblast growth factor receptor signaling pathway [GO:0008543]; heart morphogenesis [GO:0003007]; positive regulation of synapse assembly [GO:0051965]; regulation of neuron migration [GO:2001222]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=FLRT2&keywords=FLRT2	35.55312805168539	121	NA	NA	16.208206697222057	33	0.007874015748031496	0.7285429141716562	0	0.05731414868105514	0.3131313131313128	0.0964467005076142	0.014505893019038985	0.017944535073409464	0.11320754716981102	0.003972492989718246	0.013791771296117354	114	303	233	0.12424830288979681	0.91775869428271994	0.10407947578442117	0.1772221382615749	175	468	433
FLRT3	fibronectin leucine rich transmembrane protein 3	No		ENSG00000125848	Q9NZU0	NA	2	adhesion, ligand, receptor	adhesion, cell_adhesion, cell_surface, extracellular, intracellular, ligand, plasma_membrane, plasma_membrane_transmembrane, receptor, secreted, transmembrane, transmembrane_predicted	Q6UXZ4, Q6ZN44, Q8IZJ1	UNC5A, UNC5B, UNC5D	UNC5A [Cellinker:32589946], UNC5D [Cellinker:32589946], UNC5B [Cellinker:32589946]	axonal growth cone [GO:0044295]; axon terminus [GO:0043679]; cell-cell junction [GO:0005911]; cell junction [GO:0030054]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; growth cone membrane [GO:0032584]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; synaptic membrane [GO:0097060]	chemorepellent activity [GO:0045499]; fibroblast growth factor receptor binding [GO:0005104]; protein homodimerization activity [GO:0042803]; protein-macromolecule adaptor activity [GO:0030674]	axon guidance [GO:0007411]; cell-cell adhesion via plasma-membrane adhesion molecules [GO:0098742]; embryonic morphogenesis [GO:0048598]; fibroblast growth factor receptor signaling pathway [GO:0008543]; head development [GO:0060322]; heart development [GO:0007507]; neuron projection development [GO:0031175]; neuron projection extension [GO:1990138]; positive regulation of synapse assembly [GO:0051965]; proepicardium cell migration involved in pericardium morphogenesis [GO:0003345]; response to axon injury [GO:0048678]; synapse assembly [GO:0007416]; synaptic membrane adhesion [GO:0099560]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=FLRT3&keywords=FLRT3	11.931724561797752	225	NA	NA	4.060458873069736	89	0	0.23602794411177794	0.004424778761061947	0.0158273381294964	0.05555555555555554	0.0998307952622673	0.1695376246600177	0.15008156606851558	0.09655937846836815	0.03682067031646456	0.2588757967934971	130	163	60	0.10214013164791111	0.9502341124668466	0.4175193093536619	2.397676842735413	155	343	10
FLT3LG	fms related receptor tyrosine kinase 3 ligand	Yes		ENSG00000090554	P49771	NA	17	cell_surface_ligand, ligand, receptor	cell_surface, cell_surface_ligand, extracellular, intracellular, ligand, plasma_membrane, plasma_membrane_transmembrane, receptor, secreted, transmembrane, transmembrane_predicted	P36888	FLT3	FLT3 [Baccin2019:15147956;Baccin2019:7505204;Baccin2019:9651358;CellChatDB:25992210;CellTalkDB:9651358;Cellinker:15147956;Cellinker:15618475;Cellinker:19830725;Cellinker:25992210;Cellinker:7505204;Cellinker:9651358;HPMR:12681969;HPMR:15147956;HPRD:7505204;HPRD:9651358;ICELLNET:21389326;LRdb:15147956;LRdb:7505204;LRdb:9651358;SIGNOR:10080542;SIGNOR:12681969;SPIKE:7505204;SPIKE:9651358;connectomeDB2020:15147956;connectomeDB2020:7505204;connectomeDB2020:9651358]	cell surface [GO:0009986]; cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]	cytokine activity [GO:0005125]; receptor tyrosine kinase binding [GO:0030971]; signaling receptor binding [GO:0005102]	embryonic hemopoiesis [GO:0035162]; positive regulation of cell population proliferation [GO:0008284]; signal transduction [GO:0007165]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=FLT3LG&keywords=FLT3LG	0.7752754531500428	483	NA	NA	0.09117626474324847	643	0.015748031496062992	0.0034930139720558886	0.007743362831858407	0.02470023980815347	0.006734006734006734	0.008460236886632826	0.001813236627379873	0.008156606851549756	0.011098779134295233	0.006576311924155413	0.01564612710063728	261	268	221	0.010015450306071625	1.0541246293067403	0.8281758177145304	1.281316518412659	121	198	53
FLT4	fms related receptor tyrosine kinase 4	No		ENSG00000037280	P35916	Protein kinase superfamily, Tyr protein kinase family, CSF-1/PDGF receptor subfamily	1	adhesion, ligand, receptor	adhesion, cell_adhesion, cell_surface, extracellular, intracellular, ligand, plasma_membrane, plasma_membrane_transmembrane, receptor, secreted, transmembrane, transmembrane_predicted	O43155, O43915, O60462, O75871, P05556, P08648, P29353, P35968, P49767, P51812, P62993, Q05397, Q06124, Q14953, Q6VMQ6, Q71H61, Q8N387, Q8NHL6, Q92529, Q96LA6, Q9UKJ8	ADAM21, ATF7IP, CEACAM4, FCRL1, FLRT2, GRB2, ILDR2, ITGA5, ITGB1, KDR, KIR2DS5, LILRB1, MUC15, NRP2, PTK2, PTPN11, RPS6KA3, SHC1, SHC3, VEGFC, VEGFD	SHC1 [HPRD:7675451;HPRD:8662748;HPRD:9927207;KEA:10482988;KEA:10764799;KEA:10816433;KEA:10891441;KEA:10896916;KEA:10921922;KEA:11075717;KEA:11687594;KEA:12237775;KEA:12522270;KEA:15592455;KEA:8610109;KEA:8702728;KEA:9096689;KEA:9121430;KEA:9388490;KEA:9446569;KEA:9685404;KEA:9710204;KEA:9741627;KEA:9927207;ProtMapper:9927207;SIGNOR:9927207;SignaLink3:23331499;SignaLink3:9927207;iPTMnet:9927207;phosphoELM:9927207], VEGFC [DIP:8700872;HPMR:12881528;HPRD:16530705;HPRD:8700872], VEGFD [BioGRID:11279005;HPRD:9435229], RPS6KA3 [ProtMapper:12601080;SIGNOR:12601080;iPTMnet:12601080], CEACAM4 [Cellinker:32822567], FLRT2 [Cellinker:32589946], NRP2 [Cellinker:32589946], KIR2DS5 [Cellinker:32589946], MUC15 [Cellinker:32589946], ILDR2 [Cellinker:32589946], ADAM21 [Cellinker:32589946], FCRL1 [Cellinker:32589946], LILRB1 [Cellinker:32589946], KDR [HPRD:15474514;IntAct:16530705;IntAct:20224550;IntAct:21130043], GRB2 [HPRD:7675451;HPRD:7970715;HPRD:8662748;HPRD:9927207], ITGA5 [HPRD:15389531], PTPN11 [HPRD:15102829], PTK2 [HPRD:16452200], SHC3 [HPRD:9345034], ITGB1 [HPRD:11553610], ATF7IP [HPRD:15231748]	cytosol [GO:0005829]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	ATP binding [GO:0005524]; growth factor binding [GO:0019838]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; vascular endothelial growth factor-activated receptor activity [GO:0005021]	blood vessel morphogenesis [GO:0048514]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; hematopoietic progenitor cell differentiation [GO:0002244]; lung alveolus development [GO:0048286]; lymphangiogenesis [GO:0001946]; lymph vessel development [GO:0001945]; negative regulation of apoptotic process [GO:0043066]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of JNK cascade [GO:0046330]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of protein kinase C signaling [GO:0090037]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of vascular endothelial growth factor production [GO:0010575]; protein autophosphorylation [GO:0046777]; regulation of blood vessel remodeling [GO:0060312]; respiratory system process [GO:0003016]; sprouting angiogenesis [GO:0002040]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; vascular endothelial growth factor signaling pathway [GO:0038084]; vasculature development [GO:0001944]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=FLT4&keywords=FLT4	1.528139544348145	409	NA	NA	0.1476533047250756	578	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
FNDC5	fibronectin type III domain containing 5	No		ENSG00000160097	Q8NAU1	NA	3	ligand	cell_surface, extracellular, intracellular, ligand, plasma_membrane, plasma_membrane_transmembrane, secreted, transmembrane, transmembrane_predicted	P06756, P18084	ITGAV, ITGB5	ITGAV [connectomeDB2020:30550785], ITGB5 [connectomeDB2020:30550785]	endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; peroxisomal membrane [GO:0005778]; plasma membrane [GO:0005886]	hormone activity [GO:0005179]	positive regulation of brown fat cell differentiation [GO:0090336]; response to muscle activity [GO:0014850]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=FNDC5&keywords=FNDC5	1.3976187773426967	418	NA	NA	0.11909770352782477	604	0	0.001497005988023952	0	0.001199040767386091	0.003367003367003367	0.033840947546531296	0.03354487760652765	0.008156606851549756	0.017758046614872368	0.028107891574308916	0.003940506084604987	241	176	301	0.011946538763709854	1.2648029337898263	1.7363964306445898	0.6352029463368773	79	33	268
FRS3	fibroblast growth factor receptor substrate 3			ENSG00000137218	O43559	NA	1	ligand	intracellular, ligand, secreted	P11362, P28482	FGFR1, MAPK1	FGFR1 [Cellinker:9660748;HPRD:10629055;HPRD:9660748], MAPK1 [HPRD:15485655;NetPath:15485655]	cytoplasm [GO:0005737]; plasma membrane [GO:0005886]	fibroblast growth factor receptor binding [GO:0005104]; identical protein binding [GO:0042802]; transmembrane receptor protein tyrosine kinase adaptor activity [GO:0005068]	fibroblast growth factor receptor signaling pathway [GO:0008543]; signal transduction [GO:0007165]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=FRS3&keywords=FRS3	1.247947491788055	428	NA	NA	0.10717294067305241	622	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
FRZB	frizzled related protein	Yes		ENSG00000162998	Q92765	Secreted frizzled-related protein (sFRP) family	1	ligand	intracellular, ligand, ligand_regulator, secreted	P04628, P41221, Q99972, Q9H1J5	MYOC, WNT1, WNT5A, WNT8A	WNT1 [SIGNOR:9326585;SignaLink3:23331499;SignaLink3:9326585], WNT5A [NetPath:9326585;SignaLink3:21494614], WNT8A [SIGNOR:9326585;SignaLink3:23331499;SignaLink3:9326585], MYOC [Cellinker:19188438]	cytoplasm [GO:0005737]; extracellular space [GO:0005615]; membrane [GO:0016020]	Wnt-protein binding [GO:0017147]	canonical Wnt signaling pathway [GO:0060070]; cochlea morphogenesis [GO:0090103]; convergent extension involved in organogenesis [GO:0060029]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cartilage development [GO:0061037]; negative regulation of cell development [GO:0010721]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of hepatocyte differentiation [GO:0070367]; negative regulation of Wnt signaling pathway [GO:0030178]; neural crest cell differentiation [GO:0014033]; positive regulation of apoptotic process [GO:0043065]; positive regulation of fat cell differentiation [GO:0045600]; skeletal system development [GO:0001501]; somite development [GO:0061053]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=FRZB&keywords=FRZB	4.080754516853933	312	NA	NA	0.14306419872308407	583	0	0.004491017964071857	0.00331858407079646	0.3381294964028814	0.006734006734006734	0.22842639593908606	0.003626473254759746	0.008156606851549756	0.18941916389197083	0.004640138870343161	0.004404095035734985	83	296	298	0.07194054354683646	2.433705651195549	0.17866782714194462	0.1757871550791183	21	426	434
FSHB	follicle stimulating hormone subunit beta	Yes		ENSG00000131808	P01225	Glycoprotein hormones subunit beta family	14	ligand	extracellular, intracellular, ligand, secreted	O60895, O60896, P07550, P13945, P16473, P23945, P32241, P41586, Q03431, Q99678, Q9NQS5	ADCYAP1R1, ADRB2, ADRB3, FSHR, GPR20, GPR84, PTH1R, RAMP2, RAMP3, TSHR, VIPR1	FSHR [Baccin2019:10395410;Baccin2019:2126341;CellTalkDB:2126341;Cellinker:10395410;Cellinker:2126341;HPMR:2126341;HPRD:10395410;LRdb:104;LRdb:2126341;NetPath:15662415;connectomeDB2020:10395410;connectomeDB2020:2126341], ADCYAP1R1 [CellTalkDB:32196115], TSHR [CellTalkDB:32196115], GPR84 [CellTalkDB:32196115], RAMP3 [CellTalkDB:32196115], RAMP2 [CellTalkDB:32196115], ADRB2 [CellTalkDB:32196115], PTH1R [CellTalkDB:32196115], VIPR1 [CellTalkDB:32196115], ADRB3 [CellTalkDB:32196115], GPR20 [CellTalkDB:32196115]	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; follicle-stimulating hormone complex [GO:0016914]	follicle-stimulating hormone activity [GO:0016913]	female gamete generation [GO:0007292]; female pregnancy [GO:0007565]; follicle-stimulating hormone signaling pathway [GO:0042699]; G protein-coupled receptor signaling pathway [GO:0007186]; positive regulation of bone resorption [GO:0045780]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of steroid biosynthetic process [GO:0010893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progesterone biosynthetic process [GO:0006701]; regulation of osteoclast differentiation [GO:0045670]; regulation of signaling receptor activity [GO:0010469]; Sertoli cell proliferation [GO:0060011]; spermatogenesis [GO:0007283]; transforming growth factor beta receptor signaling pathway [GO:0007179]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=FSHB&keywords=FSHB	0	899	NA	NA	0.003674314210073804	872	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
FST	follistatin	Yes		ENSG00000134363	P19883	NA	4	ligand	extracellular, intracellular, ligand, ligand_regulator, secreted	O00238, O14793, O95390, P08476, P58166, Q13873, Q6ZVN8	BMPR1B, BMPR2, GDF11, HJV, INHBA, INHBE, MSTN	MSTN [SIGNOR:11459935;SIGNOR:24627466], GDF11 [SIGNOR:24627466], INHBA [HPRD:7887917;SIGNOR:22037168;SIGNOR:24627466], HJV [CellTalkDB:32196115], BMPR2 [CellTalkDB:32196115], BMPR1B [CellTalkDB:32196115], INHBE [HPRD:12242034]	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nucleus [GO:0005634]	activin binding [GO:0048185]; activin receptor antagonist activity [GO:0038102]; heparan sulfate proteoglycan binding [GO:0043395]	BMP signaling pathway [GO:0030509]; cell differentiation [GO:0030154]; female gonad development [GO:0008585]; gamete generation [GO:0007276]; hair follicle morphogenesis [GO:0031069]; hematopoietic progenitor cell differentiation [GO:0002244]; keratinocyte proliferation [GO:0043616]; negative regulation of activin receptor signaling pathway [GO:0032926]; negative regulation of cell differentiation [GO:0045596]; negative regulation of transcription by RNA polymerase II [GO:0000122]; odontogenesis of dentin-containing tooth [GO:0042475]; pattern specification process [GO:0007389]; positive regulation of hair follicle development [GO:0051798]; regulation of BMP signaling pathway [GO:0030510]; skeletal system development [GO:0001501]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=FST&keywords=FST	2.515641410575949	361	NA	NA	0.2920724970700367	470	0	0.0643712574850299	0.0011061946902654867	0.016067146282973618	0.048821548821548814	0.00338409475465313	0.025385312783318223	0.03588907014681893	0.012208657047724752	7.677927627186543e-4	0.0187367201081707	256	380	208	0.020612526807565656	0.7254761159485879	0.35174465768234053	0.9387242121113843	251	362	123
FSTL1	follistatin like 1	Yes		ENSG00000163430	Q12841	NA	2	ligand	extracellular, intracellular, ligand, ligand_regulator, secreted	P01137, Q14689	DIP2A, TGFB1	DIP2A [IntAct:20860622;Lit-BM-17:20860622;SIGNOR:20054002;connectomeDB2020:20054002], TGFB1 [Lit-BM-17:20860622]	endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	calcium ion binding [GO:0005509]; heparin binding [GO:0008201]	cell differentiation [GO:0030154]; endothelial cell differentiation [GO:0045446]; endothelial cell migration [GO:0043542]; hematopoietic stem cell homeostasis [GO:0061484]; negative regulation of apoptotic process [GO:0043066]; regulation of BMP signaling pathway [GO:0030510]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=FSTL1&keywords=FSTL1	85.03364398876404	59	NA	NA	0.7035981437047605	318	0.015748031496062992	0.1831337325349311	0.44800884955751985	0.5762589928057682	0.015151515151515148	0.008460236886632826	0.019038984587488667	0.04730831973898861	0.004439511653718092	0.007110428628655345	0.015066640911724806	289	260	224	0.12179320399572778	0.10956188343509855	0.1298278523466961	0.19019676395861332	471	453	425
FSTL3	follistatin like 3	Yes		ENSG00000070404	O95633	NA	1	ligand	extracellular, intracellular, ligand, secreted	O14793	MSTN	MSTN [HPRD:12194980;SIGNOR:23038772]	endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	activin binding [GO:0048185]; fibronectin binding [GO:0001968]	cell differentiation [GO:0030154]; hematopoietic progenitor cell differentiation [GO:0002244]; negative regulation of activin receptor signaling pathway [GO:0032926]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of osteoclast differentiation [GO:0045671]; negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway [GO:0090101]; ossification [GO:0001503]; positive regulation of cell-cell adhesion [GO:0022409]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of BMP signaling pathway [GO:0030510]; regulation of transcription by RNA polymerase II [GO:0006357]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=FSTL3&keywords=FSTL3	27.957587370786516	141	NA	NA	0.47348822627843434	396	0.007874015748031496	0.5683632734530971	0.004424778761061947	0.13908872901678757	0.08585858585858586	0.03722504230118444	0.016319129646418858	0.009787928221859707	0.022197558268590444	0.014688209373748129	0.013328182344987336	226	221	237	0.08355958481766844	0.34413960185199577	0.26387685902904773	0.2493403790798127	393	392	406
FSTL5	follistatin like 5	Yes		ENSG00000168843	Q8N475	NA	1	ligand	intracellular, ligand, secreted	O00533, O43699, O75019, O94779, P08887, P42081, Q58EX2, Q7Z692, Q8N423, Q9HCN6	CD86, CEACAM19, CHL1, CNTN5, GP6, IL6R, LILRA1, LILRB2, SDK2, SIGLEC6	CD86 [Cellinker:32822567], CEACAM19 [Cellinker:32822567], SIGLEC6 [Cellinker:32822567], LILRB2 [Cellinker:32822567], LILRA1 [Cellinker:32822567], CNTN5 [Cellinker:32822567], GP6 [Cellinker:32822567], IL6R [Cellinker:32822567], CHL1 [Cellinker:32822567], SDK2 [Cellinker:32822567]	extracellular region [GO:0005576]	calcium ion binding [GO:0005509]	cell differentiation [GO:0030154]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=FSTL5&keywords=FSTL5	12.268734393659809	216	755.167	157	3.3993977400828	102	0	0.00249500998003992	0.0011061946902654867	0.0052757793764987996	0.003367003367003367	0.08967851099830795	0.08884859474161358	0.17944535073409454	0.09803921568627422	0.024102016290559428	0.13247054278539122	128	185	94	0.05680256533182259	1.6172914191187178	0.5104896214863522	2.132710653815608	52	314	14
FZD8	frizzled class receptor 8			ENSG00000177283	Q9H461	G-protein coupled receptor Fz/Smo family	1	cell_surface_ligand, ligand, receptor	cell_surface, cell_surface_ligand, extracellular, intracellular, ligand, plasma_membrane, plasma_membrane_transmembrane, receptor, secreted, transmembrane	O75197, O75581, Q07065	CKAP4, LRP5, LRP6	LRP5 [HPRD:11448771;NetPath:11448771;SIGNOR:21078818], LRP6 [HPRD:11029007;HPRD:11448771;NetPath:11448771;NetPath:20093360;SIGNOR:21078818], CKAP4 [connectomeDB2020:28893174]	Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; Wnt-Frizzled-LRP5/6 complex [GO:1990851]	G protein-coupled receptor activity [GO:0004930]; PDZ domain binding [GO:0030165]; signaling receptor binding [GO:0005102]; ubiquitin protein ligase binding [GO:0031625]; Wnt-activated receptor activity [GO:0042813]; Wnt-protein binding [GO:0017147]	angiogenesis [GO:0001525]; canonical Wnt signaling pathway [GO:0060070]; neuron differentiation [GO:0030182]; positive regulation of JUN kinase activity [GO:0043507]; T cell differentiation in thymus [GO:0033077]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=FZD8&keywords=FZD8	NA	NA	NA	NA	NA	NA	0	0.03842315369261473	0.02323008849557523	0.013189448441246998	0.0101010101010101	0	9.066183136899365e-4	0	0.0011098779134295228	0.002002937641874747	5.794861889124976e-4	300	345	381	0.008140238253486705	0.6124438807353653	0.6616747516845696	0.5832054706822294	300	268	290
GAL	galanin and GMAP prepropeptide	Yes		ENSG00000069482	P22466	Galanin family	15	ligand	extracellular, intracellular, ligand, secreted, transmembrane	O43603, O60755, P08913, P20036, P47211, P48039, Q14831, Q8TDV0	ADRA2A, GALR1, GALR2, GALR3, GPR151, GRM7, HLA-DPA1, MTNR1A	GALR1 [Baccin2019:10689365;Baccin2019:11481429;Baccin2019:11600206;Baccin2019:7524088;Baccin2019:8617199;Baccin2019:9168941;Baccin2019:9685625;Baccin2019:9808667;Baccin2019:9880084;CellTalkDB:11481429;Cellinker:10689365;Cellinker:11481429;Cellinker:11600206;Cellinker:7524088;Cellinker:8617199;Cellinker:9168941;Cellinker:9685625;Cellinker:9808667;Cellinker:9880084;Guide2Pharma:11481429;Guide2Pharma:11600206;Guide2Pharma:7524088;Guide2Pharma:9168941;Guide2Pharma:9685625;Guide2Pharma:9808667;Guide2Pharma:9880084;HPMR:10689365;HPRD:7524088;HPRD:8617199;HPRD:9808667;LRdb:10689365;LRdb:11481429;LRdb:11600206;LRdb:7524088;LRdb:8617199;LRdb:9168941;LRdb:9685625;LRdb:9808667;LRdb:9880084;connectomeDB2020:10689365;connectomeDB2020:11481429;connectomeDB2020:11600206;connectomeDB2020:7524088;connectomeDB2020:8617199;connectomeDB2020:9168941;connectomeDB2020:9685625;connectomeDB2020:9808667;connectomeDB2020:9880084;scConnect:11481429;scConnect:11600206;scConnect:7524088;scConnect:9168941;scConnect:9685625;scConnect:9808667;scConnect:9880084], GALR2 [Baccin2019:11600206;Baccin2019:9480833;Baccin2019:9685625;Baccin2019:9832121;Baccin2019:9880084;CellTalkDB:9880084;Cellinker:11600206;Cellinker:9480833;Cellinker:9685625;Cellinker:9832121;Cellinker:9880084;Guide2Pharma:11600206;Guide2Pharma:9480833;Guide2Pharma:9685625;Guide2Pharma:9880084;HPMR:9832121;HPRD:9685625;ICELLNET:9685625;ICELLNET:9880084;LRdb:11600206;LRdb:9480833;LRdb:9685625;LRdb:9832121;LRdb:9880084;SIGNOR:10601261;connectomeDB2020:11600206;connectomeDB2020:9480833;connectomeDB2020:9685625;connectomeDB2020:9832121;connectomeDB2020:9880084;scConnect:11600206;scConnect:9480833;scConnect:9685625;scConnect:9880084], GALR3 [Baccin2019:9722565;Baccin2019:9832121;Baccin2019:9880084;CellTalkDB:9722565;Cellinker:9722565;Cellinker:9832121;Cellinker:9880084;Guide2Pharma:9722565;Guide2Pharma:9832121;Guide2Pharma:9880084;HPMR:9832121;LRdb:9722565;LRdb:9832121;LRdb:9880084;connectomeDB2020:9722565;connectomeDB2020:9832121;connectomeDB2020:9880084;scConnect:9722565;scConnect:9832121;scConnect:9880084], ADRA2A [CellTalkDB:32196115], MTNR1A [CellTalkDB:32196115], GRM7 [CellTalkDB:32196115], GPR151 [Baccin2019:15111018;CellTalkDB:15111018;Cellinker:15111018;HPRD:15111018;LRdb:15111018;connectomeDB2020:15111018], HLA-DPA1 [NA]	extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; neuronal cell body [GO:0043025]; secretory granule [GO:0030141]	galanin receptor activity [GO:0004966]; galanin receptor binding [GO:0031763]; neuropeptide hormone activity [GO:0005184]; type 1 galanin receptor binding [GO:0031764]; type 2 galanin receptor binding [GO:0031765]; type 3 galanin receptor binding [GO:0031766]	cAMP-mediated signaling [GO:0019933]; feeding behavior [GO:0007631]; inflammatory response [GO:0006954]; insulin secretion [GO:0030073]; negative regulation of lymphocyte proliferation [GO:0050672]; neuropeptide signaling pathway [GO:0007218]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cortisol secretion [GO:0051464]; positive regulation of large conductance calcium-activated potassium channel activity [GO:1902608]; positive regulation of timing of catagen [GO:0051795]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein kinase A signaling [GO:0010737]; regulation of glucocorticoid metabolic process [GO:0031943]; response to estrogen [GO:0043627]; response to immobilization stress [GO:0035902]; response to insulin [GO:0032868]; response to xenobiotic stimulus [GO:0009410]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=GAL&keywords=GAL	2.805200662921348	348	NA	NA	0.22860182800579487	513	0.13385826771653542	0.22455089820359359	0.0022123893805309734	0.48872901678657316	0.31986531986531974	0.9204737732656513	0.012692656391659111	0.01468189233278956	0.6219015908250092	0.014421151021498166	0.0063743480780374786	35	223	270	0.25088739126065435	2.422123920100347	0.0936080157170142	0.06276404543321819	22	472	495
GALP	galanin like peptide	Yes		ENSG00000197487	Q9UBC7	Galanin family	14	ligand	ligand, secreted	O43603, O60755, P47211	GALR1, GALR2, GALR3	GALR2 [Baccin2019:15944009;Baccin2019:20880399;Baccin2019:9832121;CellChatDB:23233848;CellTalkDB:15944009;Cellinker:15944009;Cellinker:20880399;Cellinker:23233848;Cellinker:9832121;LRdb:15944009;LRdb:20880399;LRdb:9832121;SIGNOR:10601261;connectomeDB2020:15944009;connectomeDB2020:20880399;connectomeDB2020:9832121;scConnect:15944009;scConnect:20880399], GALR3 [Baccin2019:983212115944009;CellTalkDB:9832121;Cellinker:15944009;Cellinker:9832121;LRdb:159;LRdb:9832121;connectomeDB2020:15944009;connectomeDB2020:9832121;scConnect:15944009], GALR1 [Baccin2019:1068936515944000;CellChatDB:23233848;CellTalkDB:10689365;Cellinker:10689365;Cellinker:15944009;Cellinker:23233848;LRdb:10689365;LRdb:16;connectomeDB2020:10689365;connectomeDB2020:15944009;scConnect:15944009]	extracellular region [GO:0005576]	hormone activity [GO:0005179]	antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; behavioral response to starvation [GO:0042595]; defense response to Gram-negative bacterium [GO:0050829]; modulation of process of other organism [GO:0035821]; neuropeptide signaling pathway [GO:0007218]; regulation of appetite [GO:0032098]; response to insulin [GO:0032868]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=GALP&keywords=GALP	0.002122076404494382	880	NA	NA	0.4800002448006473	391	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
GAS6	growth arrest specific 6	Yes		ENSG00000183087	Q14393	NA	16	adhesion, ecm, ligand	adhesion, cell_adhesion, ecm, extracellular, intracellular, ligand, secreted	P30530, Q06418, Q12866	AXL, MERTK, TYRO3	AXL [Baccin2019:16362042;Baccin2019:7854420;Baccin2019:8621659;Baccin2019:8939948;CellChatDB:27801848;CellTalkDB:7854420;Cellinker:16362042;Cellinker:27801848;Cellinker:7854420;Cellinker:8621659;Cellinker:8939948;DOMINO:16362042;Guide2Pharma:8939948;HPMR:7854420;HPMR:8939948;HPRD:16362042;HPRD:8621659;InnateDB:12218057;InnateDB:16362042;InnateDB:7854420;InnateDB:8939948;LRdb:16362042;LRdb:7854420;LRdb:8621659;LRdb:8939948;Lit-BM-17:16362042;Lit-BM-17:8939948;ProtMapper:27829217;SIGNOR:16362042;SIGNOR:7867073;SignaLink3:16362042;SignaLink3:18988627;SignaLink3:23331499;SignaLink3:8621659;connectomeDB2020:16362042;connectomeDB2020:7854420;connectomeDB2020:8621659;connectomeDB2020:8939948;scConnect:8939948], MERTK [CellChatDB:27801848;CellTalkDB:9160883;Cellinker:27801848;Cellinker:8939948;Cellinker:9160883;Guide2Pharma:8939948;HPMR:9160883;HPRD:8939948;ICELLNET:9160883;InnateDB:9160883;LRdb:894;LRdb:9160883;SIGNOR:8939948;SignaLink3:23331499;SignaLink3:8939948;connectomeDB2020:8939948;connectomeDB2020:9160883;scConnect:8939948], TYRO3 [Baccin2019:7867073;Baccin2019:8621659;Baccin2019:8939948;BioGRID:8621659;BioGRID:8939948;CellChatDB:27801848;CellTalkDB:7867073;Cellinker:27801848;Cellinker:7867073;Cellinker:8621659;Cellinker:8939948;Guide2Pharma:8939948;HPMR:7867073;HPRD:8621659;HPRD:8939948;InnateDB:8939948;LRdb:7867073;LRdb:8621659;LRdb:8939948;SIGNOR:7867073;connectomeDB2020:7867073;connectomeDB2020:8621659;connectomeDB2020:8939948;scConnect:8939948]	cytoplasm [GO:0005737]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; platelet alpha granule lumen [GO:0031093]	calcium ion binding [GO:0005509]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; phosphatidylserine binding [GO:0001786]; protein-macromolecule adaptor activity [GO:0030674]; protein tyrosine kinase activator activity [GO:0030296]; receptor ligand activity [GO:0048018]; receptor tyrosine kinase binding [GO:0030971]; signaling receptor binding [GO:0005102]	activation of protein kinase B activity [GO:0032148]; animal organ regeneration [GO:0031100]; apoptotic cell clearance [GO:0043277]; B cell chemotaxis [GO:0035754]; blood coagulation [GO:0007596]; calcium ion transmembrane transport [GO:0070588]; cell-substrate adhesion [GO:0031589]; cellular response to glucose stimulus [GO:0071333]; cellular response to growth factor stimulus [GO:0071363]; cellular response to interferon-alpha [GO:0035457]; cellular response to starvation [GO:0009267]; cellular response to vitamin K [GO:0071307]; cellular response to xenobiotic stimulus [GO:0071466]; dendritic cell differentiation [GO:0097028]; enzyme linked receptor protein signaling pathway [GO:0007167]; extracellular matrix assembly [GO:0085029]; fusion of virus membrane with host plasma membrane [GO:0019064]; hematopoietic stem cell migration to bone marrow [GO:0097241]; negative regulation of apoptotic process [GO:0043066]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of dendritic cell apoptotic process [GO:2000669]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of fibroblast apoptotic process [GO:2000270]; negative regulation of interferon-gamma production [GO:0032689]; negative regulation of interleukin-1 production [GO:0032692]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of oligodendrocyte apoptotic process [GO:1900142]; negative regulation of renal albumin absorption [GO:2000533]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of tumor necrosis factor-mediated signaling pathway [GO:0010804]; negative regulation of tumor necrosis factor production [GO:0032720]; neuron migration [GO:0001764]; peptidyl-serine phosphorylation [GO:0018105]; phagocytosis [GO:0006909]; positive regulation of cytokine-mediated signaling pathway [GO:0001961]; positive regulation of dendritic cell chemotaxis [GO:2000510]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of gene expression [GO:0010628]; positive regulation of glomerular filtration [GO:0003104]; positive regulation of natural killer cell differentiation [GO:0032825]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of phagocytosis [GO:0050766]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of TOR signaling [GO:0032008]; protein kinase B signaling [GO:0043491]; protein localization to plasma membrane [GO:0072659]; protein phosphorylation [GO:0006468]; receptor-mediated virion attachment to host cell [GO:0046813]; regulation of growth [GO:0040008]; signal transduction [GO:0007165]; viral entry into host cell [GO:0046718]; viral genome replication [GO:0019079]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=GAS6&keywords=GAS6	9.318379315438218	247	NA	NA	0.04025204139273008	737	0.007874015748031496	0.2345309381237541	0.0353982300884956	0.04004796163069543	0.03198653198653198	0.015228426395939083	0.014505893019038985	0.008156606851549756	0.005549389567147615	0.007077046334624099	5.40853776318331e-4	285	261	383	0.03644508122928423	0.33479087893904946	0.3676825593289478	0.22695307010620935	398	354	410
GAST	gastrin	Yes		ENSG00000184502	P01350	Gastrin/cholecystokinin family	15	ligand	extracellular, ligand, secreted	P32239, P43628, Q8TDT2	CCKBR, GPR152, KIR2DL3	CCKBR [Baccin2019:7681836;CellTalkDB:7681836;Cellinker:7681836;DIP:8824290;ICELLNET:8349705;LRdb:7681836;SIGNOR:10368033;connectomeDB2020:7681836], KIR2DL3 [NA], GPR152 [NA]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	hormone activity [GO:0005179]	G protein-coupled receptor signaling pathway [GO:0007186]; response to food [GO:0032094]; signal transduction [GO:0007165]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=GAST&keywords=GAST	1.320448370786517	419	NA	NA	16.709753942940914	32	0	0.004990019960079841	0.0011061946902654867	0.001199040767386091	0	0.042301184433164135	0.003626473254759746	0	0.23529411764705857	0.005541460809186802	0.0010044427274483296	71	283	366	0.026823903117213544	6.661274250756826	0.4220481669125905	0.29883966108699217	2	340	395
GC	GC vitamin D binding protein	No		ENSG00000145321	P02774	ALB/AFP/VDB family	1	ligand	extracellular, intracellular, ligand, secreted	P98164	LRP2	LRP2 [CellTalkDB:18194670;HPRD:11717447]	blood microparticle [GO:0072562]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosomal lumen [GO:0043202]	actin binding [GO:0003779]; calcidiol binding [GO:1902118]; vitamin D binding [GO:0005499]; vitamin transmembrane transporter activity [GO:0090482]	vitamin D metabolic process [GO:0042359]; vitamin transport [GO:0051180]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=GC&keywords=GC	329.3512780280899	29	60277.7	20	17.902673989546766	30	0.11811023622047244	0.20059880239521016	0.02323008849557523	0.13693045563549203	0.07912457912457915	0.5956006768189517	2.3427017225748124	1.6998368678629654	0.11431742508324061	0.05795166243824433	4.042341124204453	113	135	12	0.8555221491685452	0.14363286393382865	0.0785094436965263	4.681961204687012	460	481	2
GCG	glucagon	Yes		ENSG00000115263	P01275	Glucagon family	16	ligand	extracellular, intracellular, ligand, secreted	O60895, O60896, O95838, P07550, P13945, P16473, P27487, P32241, P41586, P43220, P47871, P48546, Q03431, Q12884, Q99678, Q9NQS5	ADCYAP1R1, ADRB2, ADRB3, DPP4, FAP, GCGR, GIPR, GLP1R, GLP2R, GPR20, GPR84, PTH1R, RAMP2, RAMP3, TSHR, VIPR1	GLP1R [Baccin2019:11116211;Baccin2019:15528268;Baccin2019:7937318;Baccin2019:8404634;BioGRID:11116211;BioGRID:18248821;CellTalkDB:11116211;Cellinker:11116211;Cellinker:15528268;Cellinker:7937318;Cellinker:8404634;Guide2Pharma:15528268;Guide2Pharma:8404634;HPMR:8404634;HPRD:11116211;LRdb:11116211;LRdb:15528268;LRdb:7937318;LRdb:8404634;SIGNOR:7937318;connectomeDB2020:11116211;connectomeDB2020:15528268;connectomeDB2020:7937318;connectomeDB2020:8404634;scConnect:15528268;scConnect:8404634], GLP2R [CellTalkDB:9990065;Cellinker:11738243;Cellinker:24990862;Cellinker:9990065;Guide2Pharma:11738243;HPMR:9990065;HPRD:11738243;LRdb:117;LRdb:9990065;connectomeDB2020:11738243;connectomeDB2020:9990065;scConnect:11738243], GCGR [CellTalkDB:12529935;Cellinker:12529935;Cellinker:4305077;Cellinker:8382034;Guide2Pharma:4305077;HPMR:12529935;HPRD:8382034;LRdb:12529935;LRdb:4305077;LRdb:8382034;SIGNOR:12529935;SIGNOR:22863277;connectomeDB2020:12529935;connectomeDB2020:4305077;connectomeDB2020:8382034;scConnect:4305077], ADCYAP1R1 [CellTalkDB:32196115], GPR84 [CellTalkDB:32196115], TSHR [CellTalkDB:32196115], RAMP3 [CellTalkDB:19886671], RAMP2 [CellTalkDB:32196115], ADRB2 [CellTalkDB:32196115], PTH1R [CellTalkDB:32196115], VIPR1 [CellTalkDB:32196115], ADRB3 [CellTalkDB:32196115], DPP4 [CellTalkDB:16517403;Cellinker:15655705;Cellinker:21314817], GPR20 [CellTalkDB:32196115], GIPR [DIP:17715056;Lit-BM-17:17715056], FAP [Cellinker:21314817]	endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; secretory granule lumen [GO:0034774]	gastric inhibitory polypeptide receptor binding [GO:0031767]; glucagon receptor binding [GO:0031769]; hormone activity [GO:0005179]; identical protein binding [GO:0042802]; signaling receptor binding [GO:0005102]	adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; feeding behavior [GO:0007631]; glucose homeostasis [GO:0042593]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of apoptotic process [GO:0043066]; negative regulation of execution phase of apoptosis [GO:1900118]; positive regulation of calcium ion import [GO:0090280]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gluconeogenesis [GO:0045722]; positive regulation of histone H3-K4 methylation [GO:0051571]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of protein binding [GO:0032092]; positive regulation of protein kinase activity [GO:0045860]; protein kinase A signaling [GO:0010737]; regulation of insulin secretion [GO:0050796]; response to activity [GO:0014823]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=GCG&keywords=GCG	60559.67151416854	1	626838	2	9682.06161427599	3	4.43307086614173	12.642215568862486	1.6294247787610718	10.378657074340218	3.380471380471402	51.113367174280626	223.29737080689014	148.5709624796075	6.653348131705592	3.5363533182008555	321.58663318523713	7	11	2	71.56562497859079	0.09309521409975373	0.049546941703430686	4.493102690775398	479	498	4
GDF1	growth differentiation factor 1	Yes		ENSG00000130283	P27539	TGF-beta family	12	ligand	ligand, secreted	O00238, P27037, P36894, P36896, P36897, P61160, P84022, Q04771, Q13639, Q13705, Q13873, Q8NER5	ACTR2, ACVR1, ACVR1B, ACVR1B_ACVR2A, ACVR1B_ACVR2A_CFC1, ACVR1B_ACVR2B, ACVR1B_ACVR2B_CFC1, ACVR1C, ACVR1C_ACVR2A, ACVR1C_ACVR2A_CFC1, ACVR1C_ACVR2B, ACVR1C_ACVR2B_CFC1, ACVR2A, ACVR2B, BMPR1A, BMPR1B, BMPR2, HTR4, SMAD3, TGFBR1	ACTR2 [SignaLink3:16446785;SignaLink3:23331499], BMPR1B [NA], ACVR2A [CellTalkDB:24798330], BMPR1A [connectomeDB2020:28955827], ACVR1B [CellTalkDB:32196115], TGFBR1 [NA], ACVR2B [CellTalkDB:32196115], BMPR2 [connectomeDB2020:28955827], ACVR1C [NA], SMAD3 [CellTalkDB:32196115], ACVR1 [connectomeDB2020:28955827], HTR4 [NA]	extracellular space [GO:0005615]	cytokine activity [GO:0005125]; growth factor activity [GO:0008083]	BMP signaling pathway [GO:0030509]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; SMAD protein signal transduction [GO:0060395]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=GDF1&keywords=GDF1	0	899	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
GDF10	growth differentiation factor 10	Yes		ENSG00000266524	P55107	TGF-beta family	12	ligand	extracellular, ligand, secreted	O00238, P27037, P36894, P36896, P36897, Q13705, Q13873, Q8NER5	ACVR1B, ACVR1B_ACVR2A, ACVR1B_ACVR2B, ACVR1C, ACVR2A, ACVR2B, BMPR1A, BMPR1B, BMPR2, TGFBR1	BMPR1B [NA], ACVR2A [NA], BMPR1A [NA], ACVR1B [CellTalkDB:22155034], TGFBR1 [NA], ACVR2B [Cellinker:27252362], BMPR2 [Cellinker:27252362], ACVR1C [NA]	collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615]	cytokine activity [GO:0005125]; growth factor activity [GO:0008083]	cerebellum development [GO:0021549]; fat cell differentiation [GO:0045444]; negative regulation of osteoblast differentiation [GO:0045668]; osteoblast differentiation [GO:0001649]; ovulation cycle [GO:0042698]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; regulation of ossification [GO:0030278]; skeletal system development [GO:0001501]; SMAD protein signal transduction [GO:0060395]; transforming growth factor beta receptor signaling pathway [GO:0007179]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=GDF10&keywords=GDF10	0.08863210561797753	683	NA	NA	0.016622822622732084	809	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
GDF11	growth differentiation factor 11	Yes		ENSG00000135414	O95390	TGF-beta family	16	ligand	extracellular, intracellular, ligand, secreted	O00238, P27037, P36894, P36896, P61160, Q13705, Q13873, Q8NER5, Q9H6X2	ACTR2, ACVR1B, ACVR1B_ACVR2A, ACVR1B_ACVR2B, ACVR1C, ACVR2A, ACVR2A_TGFBR1, ACVR2B, ACVR2B_TGFBR1, ANTXR1, BMPR1A, BMPR1B, BMPR2	ACTR2 [SIGNOR:16446785;SignaLink3:16446785;SignaLink3:23331499], ACVR2B [Baccin2019:1241472616845370;CellTalkDB:12414726;HPRD:16845371;LRdb:12414726;LRdb:17;SIGNOR:12414726;SIGNOR:16845371;SignaLink3:16446785;SignaLink3:16845371;SignaLink3:23331499;connectomeDB2020:12414726;connectomeDB2020:16845371], ACVR1B [Baccin2019:12414726;CellTalkDB:12414726;LRdb:12414726;connectomeDB2020:12414726], BMPR2 [CellTalkDB:32196115], BMPR1A [CellTalkDB:32196115], BMPR1B [CellTalkDB:32196115], ACVR2A [Baccin2019:12414726;LRdb:12414726;connectomeDB2020:12414726], ACVR1C [Cellinker:16845371], ANTXR1 [NA]	extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]	cytokine activity [GO:0005125]; growth factor activity [GO:0008083]	camera-type eye morphogenesis [GO:0048593]; cell maturation [GO:0048469]; mesoderm development [GO:0007498]; metanephros development [GO:0001656]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of neuron differentiation [GO:0045665]; nervous system development [GO:0007399]; pancreas development [GO:0031016]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; roof of mouth development [GO:0060021]; skeletal system development [GO:0001501]; SMAD protein signal transduction [GO:0060395]; spinal cord anterior/posterior patterning [GO:0021512]; ureteric bud development [GO:0001657]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=GDF11&keywords=GDF11	5.135317424741009	290	NA	NA	0.8058228641123701	298	0.015748031496062992	0.05588822355289415	0.045353982300884985	0.08321342925659521	0.02188552188552188	0.08967851099830791	0.0734360834088847	0.06688417618270806	0.07029226785053647	0.04857123781546417	0.039134633957890394	149	146	166	0.055462372609613717	1.2265407538672812	0.8947313621636513	0.7505782634996422	83	171	213
GDF15	growth differentiation factor 15	Yes		ENSG00000130513	Q99988	TGF-beta family	9	ligand	extracellular, intracellular, ligand, secreted	P04626, P07949, P37173, Q6UXV0	ERBB2, GFRAL, RET, TGFBR2	GFRAL [CellTalkDB:28846098;Guide2Pharma:28846098;connectomeDB2020:28846097;connectomeDB2020:28846098;connectomeDB2020:28846099;connectomeDB2020:28953886;scConnect:28846098], ERBB2 [CA1:6328316], RET [CellTalkDB:28846099], TGFBR2 [NA]	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634]	BMP receptor binding [GO:0070700]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; protein homodimerization activity [GO:0042803]	BMP signaling pathway [GO:0030509]; cell-cell signaling [GO:0007267]; glial cell-derived neurotrophic factor receptor signaling pathway [GO:0035860]; negative regulation of growth hormone receptor signaling pathway [GO:0060400]; negative regulation of multicellular organism growth [GO:0040015]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of myoblast fusion [GO:1901741]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of protein kinase B signaling [GO:0051897]; reduction of food intake in response to dietary excess [GO:0002023]; signal transduction [GO:0007165]; SMAD protein signal transduction [GO:0060395]; transforming growth factor beta receptor signaling pathway [GO:0007179]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=GDF15&keywords=GDF15	47.31181048314607	92	NA	NA	3.9282074324721488	93	0.015748031496062992	0.6362275449101807	0.012168141592920354	0.15707434052757796	4.0387205387205425	0.31979695431472105	0.10607434270172242	0.15497553017944538	0.23529411764705796	0.07748030444652255	0.15588178481745874	72	120	81	0.5372219664867466	0.448253419397408	0.15986255999217325	0.30313436772731656	358	440	394
GDF2	growth differentiation factor 2	Yes		ENSG00000263761	Q9UK05	TGF-beta family	16	ligand	ligand, secreted	O00238, P17813, P27037, P36894, P37023, Q04771, Q13705, Q13873	ACVR1, ACVR2A, ACVR2A_ACVRL1, ACVR2B, ACVR2B_ACVRL1, ACVRL1, ACVRL1_BMPR2, BMPR1A, BMPR1B, BMPR2, ENG	BMPR1B [NA], ACVR2A [CellTalkDB:22622516;LRdb:19996292;Ramilowski2015:19996292;connectomeDB2020:19996292;talklr:19996292], BMPR1A [NA], ACVRL1 [Baccin2019:17068149;BioGRID:25237187;CellTalkDB:17068149;LRdb:17068149;SIGNOR:17068149;connectomeDB2020:17068149], ACVR1 [CellTalkDB:19996292;Cellinker:27252362;LRdb:19996292;Ramilowski2015:19996292;connectomeDB2020:19996292;talklr:19996292], ACVR2B [Cellinker:26047946;Cellinker:27252362;LRdb:15851468;Ramilowski2015:15851468;connectomeDB2020:15851468;talklr:15851468], BMPR2 [CellTalkDB:28646109;LRdb:15851468;Ramilowski2015:15851468;connectomeDB2020:15851468;talklr:15851468], ENG [CellTalkDB:28564608;Cellinker:31540324;IntAct:28564608;LRdb:7068149;Ramilowski2015:7068149;connectomeDB2020:7068149;talklr:7068149]	extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	cytokine activity [GO:0005125]; growth factor activity [GO:0008083]	activin receptor signaling pathway [GO:0032924]; angiogenesis [GO:0001525]; blood vessel morphogenesis [GO:0048514]; BMP signaling pathway [GO:0030509]; branching involved in blood vessel morphogenesis [GO:0001569]; cartilage development [GO:0051216]; cellular iron ion homeostasis [GO:0006879]; cellular response to BMP stimulus [GO:0071773]; negative regulation of angiogenesis [GO:0016525]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of cell growth [GO:0030308]; negative regulation of DNA biosynthetic process [GO:2000279]; negative regulation of DNA replication [GO:0008156]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of endothelial cell proliferation [GO:0001937]; ossification [GO:0001503]; osteoblast differentiation [GO:0001649]; pathway-restricted SMAD protein phosphorylation [GO:0060389]; positive regulation of angiogenesis [GO:0045766]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cartilage development [GO:0061036]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; SMAD protein signal transduction [GO:0060395]; vasculogenesis [GO:0001570]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=GDF2&keywords=GDF2	0	899	NA	NA	0.059733488422117884	695	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
GDF3	growth differentiation factor 3	Yes		ENSG00000184344	Q9NR23	TGF-beta family	10	ligand	extracellular, intracellular, ligand, secreted	O00238, P13385, P27037, P36894, P36896, P36897, Q13705, Q13873, Q8NER5	ACVR1B, ACVR1B_ACVR2A, ACVR1B_ACVR2A_CFC1, ACVR1B_ACVR2B, ACVR1B_ACVR2B_CFC1, ACVR1C, ACVR1C_ACVR2A, ACVR1C_ACVR2A_CFC1, ACVR1C_ACVR2B, ACVR1C_ACVR2B_CFC1, ACVR2A, ACVR2B, BMPR1A, BMPR1B, BMPR2, TDGF1, TGFBR1	BMPR1B [NA], ACVR2A [NA], BMPR1A [NA], ACVR1B [NA], TGFBR1 [NA], ACVR2B [NA], BMPR2 [NA], ACVR1C [NA], TDGF1 [connectomeDB2020:28126904]	cytoplasm [GO:0005737]; extracellular space [GO:0005615]	cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; protein kinase binding [GO:0019901]	BMP signaling pathway [GO:0030509]; endoderm development [GO:0007492]; eye development [GO:0001654]; formation of anatomical boundary [GO:0048859]; in utero embryonic development [GO:0001701]; mesoderm development [GO:0007498]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of epidermal cell differentiation [GO:0045605]; negative regulation of myoblast differentiation [GO:0045662]; notochord development [GO:0030903]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; primitive streak formation [GO:0090009]; regulation of cell fate commitment [GO:0010453]; response to dietary excess [GO:0002021]; skeletal system development [GO:0001501]; SMAD protein signal transduction [GO:0060395]; somite rostral/caudal axis specification [GO:0032525]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=GDF3&keywords=GDF3	0.019221315730337078	798	NA	NA	0.16276608368210443	566	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
GDF5	growth differentiation factor 5	Yes	manually added ensembl_gene_ID, hgnc_symbol, and description by searching the uniprot ID on genenames.org	ENSG00000125965	P43026	TGF-beta family	17	cell_surface_ligand, ligand	cell_surface_ligand, extracellular, ligand, plasma_membrane, secreted, transmembrane	O00238, P27037, P36894, Q01974, Q04771, Q13705, Q13873, Q9UHF7	ACVR1, ACVR2A, ACVR2A_BMPR1A, ACVR2A_BMPR1B, ACVR2B, ACVR2B_BMPR1A, ACVR2B_BMPR1B, BMPR1A, BMPR1A_BMPR2, BMPR1B, BMPR1B_BMPR2, BMPR2, ROR2, TRPS1	BMPR2 [Baccin2019:87029149525338;CellTalkDB:8702914;HPRD:9525338;InnateDB:18342887;LRdb:8702914;LRdb:953;Lit-BM-17:19229295;Lit-BM-17:9525338;SignaLink3:16446785;SignaLink3:18342887;SignaLink3:23180781;SignaLink3:23331499;SignaLink3:9525338;connectomeDB2020:8702914;connectomeDB2020:9525338], ACVR2B [Baccin2019:8702914;CellTalkDB:8702914;HPRD:8702914;LRdb:8702914;SignaLink3:16446785;SignaLink3:23331499;SignaLink3:8702914;connectomeDB2020:8702914], BMPR1B [Baccin2019:11282024;Baccin2019:15569154;Baccin2019:8702914;CellTalkDB:11282024;HPMR:15569154;HPRD:11282024;IntAct:16127465;IntAct:19229295;LRdb:11282024;LRdb:15569154;LRdb:8702914;Lit-BM-17:19229295;Lit-BM-17:9525338;SIGNOR:15890363;connectomeDB2020:11282024;connectomeDB2020:15569154;connectomeDB2020:8702914], TRPS1 [SIGNOR:18363966], ROR2 [Baccin2019:15569154;Cellinker:15569154;HPMR:15569154;LRdb:15569154;connectomeDB2020:15569154], ACVR2A [Baccin2019:8702914;CellTalkDB:8702914;HPRD:8702914;LRdb:8702914;connectomeDB2020:8702914], ACVR1 [Baccin2019:8702914;CellTalkDB:8702914;HPRD:8702914;LRdb:8702914;connectomeDB2020:8702914], BMPR1A [Baccin2019:11282024;Baccin2019:9525338;CellTalkDB:11282024;HPRD:11282024;HPRD:9525338;IntAct:16127465;IntAct:19229295;IntAct:21543859;LRdb:11282024;LRdb:95;Lit-BM-17:19229295;Lit-BM-17:9525338;connectomeDB2020:9525338]	extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]	BMP binding [GO:0036122]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; identical protein binding [GO:0042802]	BMP signaling pathway [GO:0030509]; cell-cell signaling [GO:0007267]; chondroblast differentiation [GO:0060591]; embryonic limb morphogenesis [GO:0030326]; forelimb morphogenesis [GO:0035136]; hindlimb morphogenesis [GO:0035137]; negative regulation of chondrocyte differentiation [GO:0032331]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of mesenchymal cell apoptotic process [GO:2001054]; negative regulation of neuron apoptotic process [GO:0043524]; ossification involved in bone remodeling [GO:0043932]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; regulation of multicellular organism growth [GO:0040014]; regulation of SMAD protein signal transduction [GO:0060390]; response to mechanical stimulus [GO:0009612]; SMAD protein signal transduction [GO:0060395]; transforming growth factor beta receptor signaling pathway [GO:0007179]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=GDF5&keywords=GDF5	0.013854751685393258	813	NA	NA	0.04642891011388938	715	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
GDF6	growth differentiation factor 6	Yes		ENSG00000156466	Q6KF10	TGF-beta family	17	ligand	extracellular, intracellular, ligand, secreted	O00238, P36894, Q13873	ACVR2A_BMPR1A, ACVR2A_BMPR1B, ACVR2B_BMPR1A, ACVR2B_BMPR1B, BMPR1A, BMPR1A_BMPR1B_BMPR2, BMPR1A_BMPR2, BMPR1B, BMPR1B_BMPR2, BMPR2	BMPR2 [Baccin2019:160490149525338;CellTalkDB:16049014;HPRD:9525338;LRdb:16049014;LRdb:95;SIGNOR:16049014;SignaLink3:16446785;SignaLink3:18988627;SignaLink3:23331499;SignaLink3:9525338;connectomeDB2020:16049014;connectomeDB2020:9525338], BMPR1A [Baccin2019:160490149525338;CellTalkDB:16049014;HPRD:9525338;LRdb:16049014;LRdb:95;SIGNOR:16049014;connectomeDB2020:16049014;connectomeDB2020:9525338], BMPR1B [Baccin2019:9525338;CellTalkDB:9525338;HPRD:9525338;LRdb:9525338;connectomeDB2020:9525338]	extracellular space [GO:0005615]	cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; identical protein binding [GO:0042802]	activin receptor signaling pathway [GO:0032924]; apoptotic process [GO:0006915]; BMP signaling pathway [GO:0030509]; cell migration involved in metanephros development [GO:0035788]; fat cell differentiation [GO:0045444]; metanephros development [GO:0001656]; pathway-restricted SMAD protein phosphorylation [GO:0060389]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of transcription, DNA-templated [GO:0045893]; retinal cell apoptotic process [GO:1990009]; SMAD protein signal transduction [GO:0060395]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=GDF6&keywords=GDF6	0.3117108606741573	572	NA	NA	0.443616153212553	404	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
GDF7	growth differentiation factor 7	Yes		ENSG00000143869	Q7Z4P5	TGF-beta family	17	ligand	ligand, secreted	O00238, P27037, P36894, P36896, P36897, Q13705, Q13873, Q8NER5	ACVR1B, ACVR1C, ACVR2A, ACVR2A_BMPR1A, ACVR2A_BMPR1B, ACVR2B, ACVR2B_BMPR1A, ACVR2B_BMPR1B, BMPR1A, BMPR1A_BMPR2, BMPR1B, BMPR1B_BMPR2, BMPR2, TGFBR1	BMPR1B [NA], ACVR2A [Baccin2019:16049014;CellTalkDB:16049014;LRdb:16049014;connectomeDB2020:16049014], BMPR1A [Baccin2019:16049014;CellTalkDB:16049014;LRdb:16049014;connectomeDB2020:16049014], ACVR1B [NA], TGFBR1 [NA], ACVR2B [NA], BMPR2 [Baccin2019:16049014;CellTalkDB:16049014;LRdb:16049014;connectomeDB2020:16049014], ACVR1C [NA]	extracellular space [GO:0005615]	cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; identical protein binding [GO:0042802]	activin receptor signaling pathway [GO:0032924]; axon guidance [GO:0007411]; BMP signaling pathway [GO:0030509]; branching morphogenesis of an epithelial tube [GO:0048754]; cell fate commitment [GO:0045165]; epithelial cell differentiation [GO:0030855]; forebrain morphogenesis [GO:0048853]; gland morphogenesis [GO:0022612]; midbrain development [GO:0030901]; morphogenesis of an epithelial fold [GO:0060571]; pathway-restricted SMAD protein phosphorylation [GO:0060389]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of tendon cell differentiation [GO:2001051]; positive regulation of transcription, DNA-templated [GO:0045893]; reproductive structure development [GO:0048608]; roof plate formation [GO:0021509]; SMAD protein signal transduction [GO:0060395]; spinal cord association neuron differentiation [GO:0021527]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=GDF7&keywords=GDF7	0.08835251775280899	684	NA	NA	0.034922991351514124	755	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
GDF9	growth differentiation factor 9	Yes		ENSG00000164404	O60383	TGF-beta family	17	ligand	extracellular, ligand, secreted	O00238, P27037, P36894, P36896, P36897, Q13705, Q13873, Q8NER5, Q96SN7, Q9H0Q3	ACVR1B, ACVR1B_BMPR2, ACVR1C, ACVR2A, ACVR2B, BMPR1A, BMPR1B, BMPR2, BMPR2_TGFBR1, FXYD6, ORAI2, TGFBR1	BMPR1B [Baccin2019:12135884;CellTalkDB:12135884;Cellinker:12135884;HPRD:12135884;LRdb:12135884;connectomeDB2020:12135884], ACVR2A [Baccin2019:12135884;CellTalkDB:12135884;Cellinker:12135884;HPRD:12135884;LRdb:12135884;connectomeDB2020:12135884], BMPR1A [Baccin2019:10712517;Baccin2019:12135884;CellTalkDB:12135884;Cellinker:10712517;Cellinker:12135884;HPRD:10712517;HPRD:12135884;LRdb:11;LRdb:12135884;connectomeDB2020:12135884], ACVR1B [NA], TGFBR1 [Baccin2019:14684852;CellTalkDB:14514671;Cellinker:14684852;Cellinker:27252362;LRdb:14684852;connectomeDB2020:14684852], ACVR2B [NA], BMPR2 [Baccin2019:1213588412135880;CellTalkDB:12135884;HPRD:12135884;LRdb:12135884;connectomeDB2020:12135884], ACVR1C [NA], FXYD6 [Baccin2019:16169070;Cellinker:16169070;HPRD:16169070;LRdb:16169070], ORAI2 [Baccin2019:16169070;Cellinker:16169070;HPRD:16169070;LRdb:16169070]	extracellular space [GO:0005615]	cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; type I activin receptor binding [GO:0070698]	BMP signaling pathway [GO:0030509]; female gamete generation [GO:0007292]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; regulation of progesterone secretion [GO:2000870]; SMAD protein signal transduction [GO:0060395]; transforming growth factor beta receptor signaling pathway [GO:0007179]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=GDF9&keywords=GDF9	0.5902631797752809	510	NA	NA	0.5776003332993597	354	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
GDNF	glial cell derived neurotrophic factor	Yes		ENSG00000168621	P39905	TGF-beta family, GDNF subfamily	16	adhesion, ligand	adhesion, cell_adhesion, extracellular, intracellular, ligand, plasma_membrane, secreted	O00451, O60609, P07949, P13591, P24530, P56159, Q8NCS7	EDNRB, GFRA1, GFRA1_RET, GFRA2, GFRA2_RET, GFRA3, NCAM1, RET, SLC44A5	RET [Baccin2019:14514671;Baccin2019:8674117;Baccin2019:9182803;Baccin2019:9482105;CellTalkDB:9182803;Cellinker:14514671;Cellinker:8674117;Cellinker:9182803;Cellinker:9482105;HPMR:11106404;HPMR:14514671;HPRD:8674117;LRdb:14514671;LRdb:8674117;LRdb:9182803;LRdb:9482105;ProtMapper:22751117;ProtMapper:23429478;ProtMapper:25684228;SIGNOR:9182803;SignaLink3:23331499;SignaLink3:8674117;connectomeDB2020:14514671;connectomeDB2020:8674117;connectomeDB2020:9182803;connectomeDB2020:9482105], NCAM1 [HPRD:12837245;SIGNOR:15212950], GFRA2 [Baccin2019:91828039407096;CellTalkDB:9182803;Cellinker:9182803;Cellinker:9407096;HPRD:9407096;LRdb:9182803;LRdb:941;SIGNOR:9192898;connectomeDB2020:9182803;connectomeDB2020:9407096], GFRA1 [Baccin2019:14514671;Baccin2019:8674117;Baccin2019:9482105;CellTalkDB:14514671;Cellinker:11544105;Cellinker:14514671;Cellinker:8674117;Cellinker:9482105;DIP:20473317;HPMR:11106404;HPMR:14514671;HPRD:8674117;HPRD:9482105;LRdb:14514671;LRdb:8674117;LRdb:9482105;SIGNOR:9182803;connectomeDB2020:14514671;connectomeDB2020:8674117;connectomeDB2020:9482105], GFRA3 [CellTalkDB:32196115], EDNRB [CellTalkDB:32196115], SLC44A5 [NA]	extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]	chemoattractant activity involved in axon guidance [GO:1902379]; glial cell-derived neurotrophic factor receptor binding [GO:0030116]; growth factor activity [GO:0008083]; protein homodimerization activity [GO:0042803]; receptor tyrosine kinase binding [GO:0030971]; signaling receptor binding [GO:0005102]	adult locomotory behavior [GO:0008344]; branching involved in ureteric bud morphogenesis [GO:0001658]; commissural neuron axon guidance [GO:0071679]; dorsal spinal cord development [GO:0021516]; embryonic organ development [GO:0048568]; enteric nervous system development [GO:0048484]; mesenchymal to epithelial transition involved in metanephros morphogenesis [GO:0003337]; metanephros development [GO:0001656]; mRNA stabilization [GO:0048255]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of neuron apoptotic process [GO:0043524]; nervous system development [GO:0007399]; neural crest cell migration [GO:0001755]; neuron projection development [GO:0031175]; organ induction [GO:0001759]; peripheral nervous system development [GO:0007422]; peristalsis [GO:0030432]; positive regulation of branching involved in ureteric bud morphogenesis [GO:0090190]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of dopamine secretion [GO:0033603]; positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis [GO:0072108]; positive regulation of monooxygenase activity [GO:0032770]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of ureteric bud formation [GO:0072107]; postganglionic parasympathetic fiber development [GO:0021784]; postsynaptic membrane organization [GO:0001941]; regulation of dopamine uptake involved in synaptic transmission [GO:0051584]; regulation of gene expression [GO:0010468]; regulation of morphogenesis of a branching structure [GO:0060688]; regulation of semaphorin-plexin signaling pathway [GO:2001260]; regulation of stem cell differentiation [GO:2000736]; signal transduction [GO:0007165]; sympathetic nervous system development [GO:0048485]; ureteric bud formation [GO:0060676]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=GDNF&keywords=GDNF	0.34595411261956127	559	NA	NA	0.28523344524297584	475	0.007874015748031496	0	0	0.00911270983213429	0	0	9.066183136899365e-4	0	0.0011098779134295228	8.34557350781146e-4	2.704268881591655e-4	300	378	394	0.0018280187314750507	0.9392847750456708	0.9160077944372672	0.8683133770179917	162	165	155
GFRA4	GDNF family receptor alpha 4	No		ENSG00000125861	Q9GZZ7	GDNFR family	1	adhesion, ligand, receptor	adhesion, cell_adhesion, cell_surface, extracellular, intracellular, ligand, plasma_membrane, plasma_membrane_transmembrane, receptor, secreted, transmembrane	NA	NA	NA	anchored component of membrane [GO:0031225]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	glial cell-derived neurotrophic factor receptor activity [GO:0016167]; signaling receptor activity [GO:0038023]	negative regulation of ossification [GO:0030279]; nervous system development [GO:0007399]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=GFRA4&keywords=GFRA4	0	899	NA	NA	0.12056612493776332	602	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
GH1	growth hormone 1	Yes		ENSG00000259384	P01241	Somatotropin/prolactin family	18	ligand	extracellular, intracellular, ligand, secreted	P10912, P16471, P19235	EPOR, GHR, PRLR	PRLR [CellChatDB:23192981;CellTalkDB:27003442;Cellinker:23192981;Cellinker:31100495;Cellinker:9556914;HPRD:9556914;LRdb:9556914;SIGNOR:7984244;SignaLink3:15082796;SignaLink3:16546209;SignaLink3:20053995;SignaLink3:23331499;SignaLink3:24243840;SignaLink3:29145629;SignaLink3:7984244;connectomeDB2020:9556914], GHR [BioGRID:7862673;CellChatDB:10551877;CellTalkDB:7862673;Cellinker:10551877;Cellinker:31100495;Cellinker:7862673;DIP:9571026;ICELLNET:2387255;InnateDB:21889455;IntAct:31279174;IntAct:8943276;IntAct:9353194;LRdb:7862673;Lit-BM-17:17500058;Lit-BM-17:24280222;Lit-BM-17:7862673;Lit-BM-17:8943276;Lit-BM-17:9353194;Lit-BM-17:9571026;SIGNOR:7862673;SignaLink3:1549776;SignaLink3:1935820;SignaLink3:19927328;SignaLink3:23331499;SignaLink3:24243840;SignaLink3:2825030;SignaLink3:29145629;SignaLink3:3349036;SignaLink3:7691587;SignaLink3:9030599;connectomeDB2020:7862673], EPOR [Cellinker:11751584]	endosome lumen [GO:0031904]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; growth hormone receptor complex [GO:0070195]	growth factor activity [GO:0008083]; growth hormone receptor binding [GO:0005131]; hormone activity [GO:0005179]; metal ion binding [GO:0046872]; prolactin receptor binding [GO:0005148]	animal organ development [GO:0048513]; bone maturation [GO:0070977]; growth hormone receptor signaling pathway [GO:0060396]; positive regulation of activation of Janus kinase activity [GO:0010536]; positive regulation of glucose transmembrane transport [GO:0010828]; positive regulation of growth [GO:0045927]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; receptor signaling pathway via JAK-STAT [GO:0007259]; response to estradiol [GO:0032355]; response to nutrient levels [GO:0031667]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=GH1&keywords=GH1	0.020885712359550564	790	NA	NA	3.1400550570964346e-5	908	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
GH2	growth hormone 2	Yes		ENSG00000136487	P01242	Somatotropin/prolactin family	16	ligand	extracellular, intracellular, ligand, secreted	P10912	GHR	GHR [CellTalkDB:1955498;Cellinker:1955498;HPRD:1955498;ICELLNET:2387255;LRdb:1955498;connectomeDB2020:1955498]	endosome lumen [GO:0031904]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	growth factor activity [GO:0008083]; growth hormone receptor binding [GO:0005131]; hormone activity [GO:0005179]	animal organ development [GO:0048513]; growth hormone receptor signaling pathway [GO:0060396]; positive regulation of growth [GO:0045927]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; response to nutrient levels [GO:0031667]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=GH2&keywords=GH2	0.0029850460674157304	868	NA	NA	0.040116511201531535	738	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
GHR	growth hormone receptor	No		ENSG00000112964	P10912	Type I cytokine receptor family, Type 1 subfamily	1	adhesion, ligand, receptor	adhesion, cell_adhesion, cell_surface, extracellular, intracellular, ligand, ligand_regulator, plasma_membrane, plasma_membrane_transmembrane, receptor, secreted, transmembrane, transmembrane_predicted	O60674, P19174, P19235, P23458, P27986, P29597, P35568, P42229, Q13163	EPOR, IRS1, JAK1, JAK2, MAP2K5, PIK3R1, PLCG1, STAT5A, TYK2	JAK2 [BioGRID:10502458;BioGRID:21347402;BioGRID:7540178;BioGRID:8063815;HPRD:10502458;HPRD:7540178;HPRD:8063815;SPIKE:17312100;SignaLink3:10502458;SignaLink3:18988627;SignaLink3:23331499;SignaLink3:7540178;SignaLink3:8063815;SignaLink3:9211920], TYK2 [HPRD:10502458;SignaLink3:10502458;SignaLink3:23331499], JAK1 [HPRD:10502458;SignaLink3:10502458;SignaLink3:23331499], MAP2K5 [SIGNOR:23612709], EPOR [Cellinker:11751584], PLCG1 [DOMINO:17474147;InnateDB:17474147;Lit-BM-17:17474147;Lit-BM-17:9632636], PIK3R1 [DOMINO:17474147;HPRD:9632636], STAT5A [HPRD:8702683], IRS1 [HPRD:7782332]	cell surface [GO:0009986]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; growth hormone receptor complex [GO:0070195]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]; growth factor binding [GO:0019838]; growth hormone receptor activity [GO:0004903]; identical protein binding [GO:0042802]; peptide hormone binding [GO:0017046]; proline-rich region binding [GO:0070064]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; SH2 domain binding [GO:0042169]	activation of Janus kinase activity [GO:0042976]; cartilage development involved in endochondral bone morphogenesis [GO:0060351]; cellular response to hormone stimulus [GO:0032870]; cellular response to insulin stimulus [GO:0032869]; cytokine-mediated signaling pathway [GO:0019221]; endocytosis [GO:0006897]; growth hormone receptor signaling pathway [GO:0060396]; hormone-mediated signaling pathway [GO:0009755]; hormone metabolic process [GO:0042445]; insulin-like growth factor receptor signaling pathway [GO:0048009]; negative regulation of neuron death [GO:1901215]; positive regulation of cell differentiation [GO:0045597]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; receptor internalization [GO:0031623]; receptor signaling pathway via JAK-STAT [GO:0007259]; regulation of multicellular organism growth [GO:0040014]; response to cycloheximide [GO:0046898]; response to estradiol [GO:0032355]; response to food [GO:0032094]; response to glucocorticoid [GO:0051384]; response to interleukin-1 [GO:0070555]; response to morphine [GO:0043278]; taurine metabolic process [GO:0019530]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=GHR&keywords=GHR	1.679194346133568	400	NA	NA	0.24450830470773702	500	0	4.99001996007984e-4	0.0022123893805309734	0.052757793764987994	0	0.027072758037225034	0.0027198549410698096	0	0.03070662227155008	0.0040058752837494925	0.0013521344407958285	206	302	350	0.01102967546508338	1.9356752480149928	0.6660052984176645	0.5398150085408757	34	265	308
GHRH	growth hormone releasing hormone	Yes		ENSG00000118702	P01286	Glucagon family	15	ligand	extracellular, ligand, secreted	O60895, O60896, P07550, P13945, P16473, P27487, P32241, P41586, P41587, Q02643, Q03431, Q92847, Q99678, Q9NQS5	ADCYAP1R1, ADRB2, ADRB3, DPP4, GHRHR, GHSR, GPR20, GPR84, PTH1R, RAMP2, RAMP3, TSHR, VIPR1, VIPR2	GHRHR [Baccin2019:76804131333056;CellChatDB:26917260;CellTalkDB:7680413;Cellinker:1333056;Cellinker:26917260;Cellinker:7680413;HPMR:7680413;HPRD:1333056;LRdb:133;LRdb:7680413;connectomeDB2020:1333056;connectomeDB2020:7680413], VIPR1 [Baccin2019:8791009;CellChatDB:10655511;CellTalkDB:8791009;Cellinker:10655511;Cellinker:8791009;Guide2Pharma:8791009;LRdb:8791009;connectomeDB2020:8791009;scConnect:8791009], ADCYAP1R1 [CellTalkDB:32196115], GPR20 [CellTalkDB:32196115], TSHR [CellTalkDB:32196115], GPR84 [CellTalkDB:32196115], RAMP3 [CellTalkDB:32196115], RAMP2 [CellTalkDB:32196115], ADRB2 [CellTalkDB:32196115], PTH1R [CellTalkDB:32196115], ADRB3 [CellTalkDB:32196115], VIPR2 [CellChatDB:10655511;Cellinker:10655511], GHSR [CellChatDB:19088192;Cellinker:19088192], DPP4 [Cellinker:21314817]	extracellular region [GO:0005576]; extracellular space [GO:0005615]; perikaryon [GO:0043204]; terminal bouton [GO:0043195]	growth hormone-releasing hormone activity [GO:0016608]; growth hormone-releasing hormone receptor binding [GO:0031770]; neuropeptide hormone activity [GO:0005184]; peptide hormone receptor binding [GO:0051428]	adenohypophysis development [GO:0021984]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell-cell signaling [GO:0007267]; growth hormone secretion [GO:0030252]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of circadian sleep/wake cycle, REM sleep [GO:0046005]; positive regulation of growth hormone secretion [GO:0060124]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; positive regulation of multicellular organism growth [GO:0040018]; response to food [GO:0032094]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=GHRH&keywords=GHRH	NA	NA	NA	NA	NA	NA	0	0	0	0	0	0	0	0	0.021087680355160923	2.00293764187475e-4	7.726482518833301e-5	231	403	399	0.001942294449503339	2.6031580854593486	0.8541318259500533	0.843829874384602	20	189	167
GHRL	ghrelin and obestatin prepropeptide	Yes		ENSG00000157017	Q9UBU3	Motilin family	15	ligand	extracellular, intracellular, ligand, secreted	O43193, O43194, P01303, P21731, P41159, P43115, P43119, Q02643, Q92847	GHRHR, GHSR, GPR39, LEP, MLNR, NPY, PTGER3, PTGIR, TBXA2R	GHSR [Baccin2019:10604470;Baccin2019:10628755;Baccin2019:11227737;Baccin2019:11314756;Baccin2019:12907757;Baccin2019:15905359;Baccin2019:21402696;CellChatDB:29233536;CellTalkDB:10604470;Cellinker:10604470;Cellinker:10628755;Cellinker:11227737;Cellinker:11314756;Cellinker:12907757;Cellinker:15905359;Cellinker:21402696;Guide2Pharma:10628755;Guide2Pharma:11314756;Guide2Pharma:12907757;Guide2Pharma:15905359;Guide2Pharma:21402696;HPMR:10604470;HPRD:10604470;HPRD:11227737;LRdb:10604470;LRdb:10628755;LRdb:11227737;LRdb:11314756;LRdb:12907757;LRdb:15905359;LRdb:21402696;SIGNOR:15070777;connectomeDB2020:10604470;connectomeDB2020:10628755;connectomeDB2020:11227737;connectomeDB2020:11314756;connectomeDB2020:12907757;connectomeDB2020:15905359;connectomeDB2020:21402696;scConnect:10628755;scConnect:11314756;scConnect:12907757;scConnect:15905359;scConnect:21402696;scConnect:29233536], PTGER3 [CellTalkDB:32103204;Lit-BM-17:18573679], TBXA2R [CellTalkDB:32103204;Lit-BM-17:18573679], MLNR [CellTalkDB:12606621;Cellinker:12606621;HPRD:12606621;LRdb:12606621;connectomeDB2020:12606621], PTGIR [CellTalkDB:32103204], GHRHR [Baccin2019:10461027;CellTalkDB:10461027;Cellinker:10461027;HPRD:10461027;LRdb:10461027], GPR39 [Baccin2019:16284174;CellTalkDB:16284174;Cellinker:16284174;LRdb:16284174;connectomeDB2020:16284174], NPY [HPRD:11196643;HPRD:12663466], LEP [HPRD:11196643]	axon [GO:0030424]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; postsynapse [GO:0098794]; Schaffer collateral - CA1 synapse [GO:0098685]; secretory granule lumen [GO:0034774]	ghrelin receptor binding [GO:0031768]; G protein-coupled receptor binding [GO:0001664]; growth hormone-releasing hormone activity [GO:0016608]; protein tyrosine kinase activator activity [GO:0030296]	actin polymerization or depolymerization [GO:0008154]; adult feeding behavior [GO:0008343]; cartilage development [GO:0051216]; cortisol secretion [GO:0043400]; decidualization [GO:0046697]; dendrite development [GO:0016358]; excitatory postsynaptic potential [GO:0060079]; gastric acid secretion [GO:0001696]; gastric emptying [GO:0035483]; glucose metabolic process [GO:0006006]; G protein-coupled receptor signaling pathway [GO:0007186]; growth hormone secretion [GO:0030252]; hormone-mediated signaling pathway [GO:0009755]; negative regulation of angiogenesis [GO:0016525]; negative regulation of apoptotic process [GO:0043066]; negative regulation of circadian sleep/wake cycle, REM sleep [GO:0042322]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of inflammatory response [GO:0050728]; negative regulation of insulin secretion [GO:0046676]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of locomotion [GO:0040013]; negative regulation of tumor necrosis factor production [GO:0032720]; positive regulation of adipose tissue development [GO:1904179]; positive regulation of appetite [GO:0032100]; positive regulation of bone development [GO:1903012]; positive regulation of circadian sleep/wake cycle, non-REM sleep [GO:0046010]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of corticotropin secretion [GO:0051461]; positive regulation of cortisol secretion [GO:0051464]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of eating behavior [GO:1904000]; positive regulation of gastric mucosal blood circulation [GO:1904346]; positive regulation of growth hormone receptor signaling pathway [GO:0060399]; positive regulation of growth hormone secretion [GO:0060124]; positive regulation of growth rate [GO:0040010]; positive regulation of insulin secretion [GO:0032024]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of small intestinal transit [GO:0120058]; positive regulation of small intestine smooth muscle contraction [GO:1904349]; positive regulation of sprouting angiogenesis [GO:1903672]; positive regulation of synapse assembly [GO:0051965]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; regulation of cell population proliferation [GO:0042127]; regulation of gastric motility [GO:1905333]; regulation of postsynapse organization [GO:0099175]; regulation of response to food [GO:0032095]; regulation of transmission of nerve impulse [GO:0051969]; response to electrical stimulus [GO:0051602]; response to estrogen [GO:0043627]; response to hormone [GO:0009725]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=GHRL&keywords=GHRL	30.178975163172396	137	27734.2	37	8.60286335641992	51	0	0.20908183632734553	0.0254424778761062	0.02086330935251798	0.0101010101010101	0.02368866328257191	0.028105167724388033	0.09624796084828711	0.016648168701442846	0.016724529309654117	1.0223681668920233	245	211	26	0.1335701173104861	0.18561083044748974	0.18614270023795687	7.190689721729585	445	421	1
GIP	gastric inhibitory polypeptide	Yes		ENSG00000159224	P09681	Glucagon family	16	ligand	extracellular, intracellular, ligand, secreted	O60895, O60896, P06213, P07550, P13945, P16473, P27487, P32241, P41586, P48546, Q03431, Q12884, Q99678, Q9NQS5	ADCYAP1R1, ADRB2, ADRB3, DPP4, FAP, GIPR, GPR20, GPR84, INSR, PTH1R, RAMP2, RAMP3, TSHR, VIPR1	GIPR [Baccin2019:12627975;Baccin2019:15655707;Baccin2019:7589426;Baccin2019:8795084;CellTalkDB:15655705;Cellinker:12627975;Cellinker:15655707;Cellinker:7589426;Cellinker:8795084;DIP:17715056;Guide2Pharma:7589426;HPRD:12627975;HPRD:15655707;HPRD:7589426;HPRD:8795084;IntAct:17715056;LRdb:12627975;LRdb:15655707;LRdb:7589426;LRdb:8795084;Lit-BM-17:17715056;connectomeDB2020:12627975;connectomeDB2020:15655707;connectomeDB2020:7589426;connectomeDB2020:8795084;scConnect:26572091;scConnect:7589426], ADCYAP1R1 [CellTalkDB:32196115], DPP4 [CellTalkDB:15655705;Cellinker:15655705;LRdb:15655705;Ramilowski2015:15655705;connectomeDB2020:15655705;talklr:15655705], TSHR [CellTalkDB:32196115], GPR20 [CellTalkDB:32196115], GPR84 [CellTalkDB:32196115], RAMP3 [CellTalkDB:32196115], RAMP2 [CellTalkDB:32196115], INSR [CellTalkDB:32196115], ADRB2 [CellTalkDB:32196115], PTH1R [CellTalkDB:32196115], VIPR1 [CellTalkDB:32196115], ADRB3 [CellTalkDB:32196115], FAP [Cellinker:21314817]	endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; neuronal cell body [GO:0043025]; secretory granule lumen [GO:0034774]	gastric inhibitory polypeptide receptor binding [GO:0031767]; glucagon receptor binding [GO:0031769]; hormone activity [GO:0005179]	adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; adult locomotory behavior [GO:0008344]; digestive system development [GO:0055123]; endocrine pancreas development [GO:0031018]; exploration behavior [GO:0035640]; female pregnancy [GO:0007565]; gastric inhibitory peptide signaling pathway [GO:0038192]; long-term synaptic potentiation [GO:0060291]; memory [GO:0007613]; positive regulation of cAMP-mediated signaling [GO:0043950]; positive regulation of glucagon secretion [GO:0070094]; positive regulation of glucose transmembrane transport [GO:0010828]; positive regulation of insulin secretion [GO:0032024]; regulation of fatty acid biosynthetic process [GO:0042304]; regulation of insulin secretion [GO:0050796]; response to acidic pH [GO:0010447]; response to amino acid [GO:0043200]; response to axon injury [GO:0048678]; response to glucose [GO:0009749]; response to lipid [GO:0033993]; response to organic cyclic compound [GO:0014070]; response to peptide hormone [GO:0043434]; response to selenium ion [GO:0010269]; response to starvation [GO:0042594]; response to xenobiotic stimulus [GO:0009410]; sensory perception of pain [GO:0019233]; signal transduction [GO:0007165]; triglyceride homeostasis [GO:0070328]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=GIP&keywords=GIP	0.11317124831460675	666	NA	NA	4.3533949516561155	82	0	0	0	7.194244604316547e-4	0	0.013536379018612519	0	0	0.05142434332223458	4.673521164374417e-4	0	167	390	401	0.006013408992519654	3.8358068135852736	0.6536616982259716	0.6244766498296086	7	270	275
GLG1	golgi glycoprotein 1			ENSG00000090863	Q92896	NA	2	adhesion, cell_surface_ligand, receptor	adhesion, cell_adhesion, cell_surface, cell_surface_ligand, intracellular, ligand_regulator, plasma_membrane, plasma_membrane_transmembrane, receptor, secreted, transmembrane, transmembrane_predicted	P16581, Q16653, Q8IZJ1	MOG, SELE, UNC5B	SELE [HPRD:11404363;connectomeDB2020:11404363], UNC5B [Cellinker:32589946], MOG [Cellinker:32589946]	cytoskeleton [GO:0005856]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; plasma membrane [GO:0005886]	fibroblast growth factor binding [GO:0017134]; signaling receptor binding [GO:0005102]	bone morphogenesis [GO:0060349]; negative regulation of protein processing [GO:0010955]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; regulation of chondrocyte differentiation [GO:0032330]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=GLG1&keywords=GLG1	86.77940725399972	57	18396.2	51	1.8969688838473475	168	0.19685039370078727	0.3887225548902247	0.21902654867256666	0.36858513189449094	0.4023569023569016	0.6632825719120137	0.5965548504079801	0.4404567699836871	0.3758786533481342	0.4327346775271093	0.3191423604403919	52	49	51	0.4003264922849352	0.9404185705859222	1.0789814595243572	0.8021474767752306	160	116	186
GNRH1	gonadotropin releasing hormone 1	Yes		ENSG00000147437	P01148	GnRH family	15	ligand	extracellular, ligand, secreted	P10275, P18146, P30968, Q13554, Q96P88, Q9UQM7	AR, CAMK2A, CAMK2B, EGR1, GNRHR, GNRHR2	CAMK2A [SPIKE:12810529], CAMK2B [SPIKE:12810529], GNRHR [Baccin2019:11726197;Baccin2019:17095587;Baccin2019:17452338;Baccin2019:414473;Baccin2019:9414473;CellChatDB:19640273;CellTalkDB:17452338;Cellinker:11726197;Cellinker:17095587;Cellinker:17452338;Cellinker:19640273;Cellinker:414473;Cellinker:9414473;Guide2Pharma:11726197;Guide2Pharma:17095587;Guide2Pharma:17452338;Guide2Pharma:26398856;Guide2Pharma:26774084;HPRD:9414473;LRdb:11726197;LRdb:17095587;LRdb:17452338;LRdb:414473;LRdb:9414473;SPIKE:4930860;connectomeDB2020:11726197;connectomeDB2020:17095587;connectomeDB2020:17452338;connectomeDB2020:414473;connectomeDB2020:9414473;scConnect:11726197;scConnect:17095587;scConnect:17452338;scConnect:26398856;scConnect:26774084], EGR1 [SIGNOR:19106114], AR [SIGNOR:17202804], GNRHR2 [NA]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	gonadotropin hormone-releasing hormone activity [GO:0005183]; gonadotropin-releasing hormone receptor binding [GO:0031530]; hormone activity [GO:0005179]	cell-cell signaling [GO:0007267]; negative regulation of neuron migration [GO:2001223]; regulation of gene expression [GO:0010468]; regulation of ovarian follicle development [GO:2000354]; reproduction [GO:0000003]; response to ethanol [GO:0045471]; response to steroid hormone [GO:0048545]; signal transduction [GO:0007165]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=GNRH1&keywords=GNRH1	0.28605314269662924	583	NA	NA	0.0363435199810467	747	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
GNRH2	gonadotropin releasing hormone 2	Yes		ENSG00000125787	O43555	GnRH family	13	ligand	extracellular, ligand, secreted	P30968, Q96P88	GNRHR, GNRHR2	GNRHR [CellTalkDB:17942747;Cellinker:17452338;Cellinker:17942747;Cellinker:19638591;Guide2Pharma:17452338;Guide2Pharma:17942747;Guide2Pharma:19638591;LRdb:17452338;LRdb:17942747;LRdb:19638591;connectomeDB2020:17452338;connectomeDB2020:17942747;connectomeDB2020:19638591;scConnect:17452338;scConnect:17942747;scConnect:19638591], GNRHR2 [HPRD:11889221]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	gonadotropin hormone-releasing hormone activity [GO:0005183]; gonadotropin-releasing hormone receptor binding [GO:0031530]; hormone activity [GO:0005179]	reproduction [GO:0000003]; signal transduction [GO:0007165]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=GNRH2&keywords=GNRH2	0.07172596966292134	695	NA	NA	0.12636218877111502	595	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
GPC3	glypican 3	No		ENSG00000147257	P51654	Glypican family	2	cell_surface_ligand, ecm, receptor	cell_surface, cell_surface_ligand, ecm, extracellular, intracellular, ligand_regulator, plasma_membrane, receptor, receptor_regulator, secreted, transmembrane	O00300, O95185, P01344, P08069, P17948, P22455, P27487, P60033, P98164, Q07954, Q15465, Q6UXZ4, Q86VR7	CD81, DPP4, FGFR4, FLT1, IGF1R, IGF2, LRP1, LRP2, SHH, TNFRSF11B, UNC5C, UNC5D, VSIG10L	SHH [SignaLink3:18505598;SignaLink3:23331499], DPP4 [SIGNOR:17549790], LRP1 [CellTalkDB:32196115], CD81 [Baccin2019:28098909;CellTalkDB:19574424;Cellinker:23665349;LRdb:23665349;Ramilowski2015:23665349;connectomeDB2020:23665349;talklr:23665349], LRP2 [CellTalkDB:32196115], IGF1R [Baccin2019:18413366;CellTalkDB:18413366;Cellinker:18413366;LRdb:18413366;Ramilowski2015:18413366;connectomeDB2020:18413366;talklr:18413366], FLT1 [Cellinker:32589946], FGFR4 [Cellinker:32589946], UNC5C [Cellinker:32589946], VSIG10L [Cellinker:32589946], UNC5D [Cellinker:32589946], TNFRSF11B [Cellinker:32589946], IGF2 [HPRD:8589713]	anchored component of plasma membrane [GO:0046658]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; Golgi lumen [GO:0005796]; intrinsic component of plasma membrane [GO:0031226]; lysosomal lumen [GO:0043202]; plasma membrane [GO:0005886]	peptidyl-dipeptidase inhibitor activity [GO:0060422]	anatomical structure morphogenesis [GO:0009653]; anterior/posterior axis specification [GO:0009948]; body morphogenesis [GO:0010171]; bone mineralization [GO:0030282]; branching involved in ureteric bud morphogenesis [GO:0001658]; cell migration [GO:0016477]; cell migration involved in gastrulation [GO:0042074]; cell proliferation involved in kidney development [GO:0072111]; cell proliferation involved in metanephros development [GO:0072203]; coronary vasculature development [GO:0060976]; embryonic hindlimb morphogenesis [GO:0035116]; lung development [GO:0030324]; mesenchymal cell proliferation involved in ureteric bud development [GO:0072138]; mesonephric duct morphogenesis [GO:0072180]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of growth [GO:0045926]; negative regulation of peptidase activity [GO:0010466]; negative regulation of smoothened signaling pathway [GO:0045879]; osteoclast differentiation [GO:0030316]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of endocytosis [GO:0045807]; positive regulation of glucose import [GO:0046326]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of smoothened signaling pathway [GO:0045880]; positive regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000096]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of non-canonical Wnt signaling pathway [GO:2000050]; regulation of protein localization to membrane [GO:1905475]; response to bacterium [GO:0009617]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=GPC3&keywords=GPC3	2.4848959919959293	364	NA	NA	0.10751444396091504	621	0	0	0	0.06498800959232617	0.01683501683501683	0	0.001813236627379873	0	0	1.6691147015622916e-4	1.5452965037666603e-4	303	404	397	0.007632518561386889	0.5671339556618308	0.5766000718933342	0.5758978568503467	316	293	298
GPHA2	glycoprotein hormone subunit alpha 2	Yes		ENSG00000149735	Q96T91	Glycoprotein hormones subunit alpha family	10	adhesion, ligand	adhesion, cell_adhesion, ligand, plasma_membrane, secreted	P16473, Q8WXG9, Q9UF33	ADGRV1, EPHA6, TSHR	TSHR [Baccin2019:12045258;CellTalkDB:12045258;Cellinker:12045258;LRdb:12045258;SIGNOR:12045258;connectomeDB2020:12045258], EPHA6 [CellTalkDB:32103204], ADGRV1 [NA]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	hormone activity [GO:0005179]; hormone receptor binding [GO:0051427]; protein heterodimerization activity [GO:0046982]; thyrotropin-releasing hormone receptor binding [GO:0031531]	adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cell surface receptor signaling pathway [GO:0007166]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=GPHA2&keywords=GPHA2	0.8523447292134831	469	NA	NA	0.5895928604837373	345	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
GPHB5	glycoprotein hormone subunit beta 5	Yes		ENSG00000179600	Q86YW7	Glycoprotein hormones subunit beta family	3	ligand	intracellular, ligand, secreted	P16473	TSHR	TSHR [connectomeDB2020:16210345]	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	hormone activity [GO:0005179]; protein heterodimerization activity [GO:0046982]; thyrotropin-releasing hormone receptor binding [GO:0031531]	adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; G protein-coupled receptor signaling pathway [GO:0007186]; regulation of thyroid hormone mediated signaling pathway [GO:0002155]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=GPHB5&keywords=GPHB5	0.0025444269662921347	873	NA	NA	0.5858404029623945	346	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
GPI	glucose-6-phosphate isomerase	No		ENSG00000282019, ENSG00000105220	P06744	GPI family	11	adhesion, ligand	adhesion, cell_adhesion, extracellular, intracellular, ligand, plasma_membrane, secreted	P04629, Q9UKV5	AMFR, NTRK1	AMFR [Baccin2019:1252736016563430;CellTalkDB:12527360;Cellinker:12527360;Cellinker:16563432;HPMR:12527360;HPRD:16563432;LRdb:12527360;LRdb:17;SIGNOR:12527360;connectomeDB2020:12527360;connectomeDB2020:16563432], NTRK1 [NA]	ciliary membrane [GO:0060170]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; neuron projection [GO:0043005]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; secretory granule lumen [GO:0034774]	cytokine activity [GO:0005125]; glucose-6-phosphate isomerase activity [GO:0004347]; growth factor activity [GO:0008083]; monosaccharide binding [GO:0048029]; ubiquitin protein ligase binding [GO:0031625]	carbohydrate metabolic process [GO:0005975]; erythrocyte homeostasis [GO:0034101]; gluconeogenesis [GO:0006094]; glucose 6-phosphate metabolic process [GO:0051156]; glucose homeostasis [GO:0042593]; glycolytic process [GO:0006096]; hemostasis [GO:0007599]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; learning or memory [GO:0007611]; mesoderm formation [GO:0001707]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of immunoglobulin production [GO:0002639]; response to cadmium ion [GO:0046686]; response to estradiol [GO:0032355]; response to immobilization stress [GO:0035902]; response to morphine [GO:0043278]; response to muscle stretch [GO:0035994]; response to progesterone [GO:0032570]; response to testosterone [GO:0033574]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=GPI&keywords=GPI	231.17490215435956	32	258976	7	1.7677189425866466	183	0.27559055118110215	0.4685628742515039	0.09955752212389392	0.27673860911271125	0.4208754208754202	0.5956006768189516	0.6409791477787876	0.4926590538336061	0.43729189789123774	0.4739951929497507	0.48050994784621665	43	48	37	0.4238509904239256	1.0309804697096085	1.115579320164345	1.1305954317793034	125	111	70
GREM1	gremlin 1, DAN family BMP antagonist	Yes		ENSG00000276886, ENSG00000282046, ENSG00000166923	O60565	DAN family	7	ligand, receptor	extracellular, intracellular, ligand, ligand_regulator, plasma_membrane, receptor, secreted, transmembrane	P35968	KDR	KDR [Baccin2019:27174917;CellTalkDB:20660291;IntAct:20660291;connectomeDB2020:20660291;connectomeDB2020:25810250;connectomeDB2020:27174917;connectomeDB2020:27894090]	cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615]	BMP binding [GO:0036122]; cytokine activity [GO:0005125]; morphogen activity [GO:0016015]; protein homodimerization activity [GO:0042803]; receptor ligand activity [GO:0048018]; transmembrane receptor protein tyrosine kinase activator activity [GO:0030297]; vascular endothelial growth factor receptor 2 binding [GO:0043184]	animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; cell-cell signaling [GO:0007267]; cell migration involved in sprouting angiogenesis [GO:0002042]; cell morphogenesis [GO:0000902]; collagen fibril organization [GO:0030199]; determination of dorsal identity [GO:0048263]; embryonic limb morphogenesis [GO:0030326]; limb development [GO:0060173]; mesenchymal to epithelial transition involved in metanephros morphogenesis [GO:0003337]; negative regulation of apoptotic process [GO:0043066]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of bone mineralization [GO:0030502]; negative regulation of bone mineralization involved in bone maturation [GO:1900158]; negative regulation of bone remodeling [GO:0046851]; negative regulation of bone trabecula formation [GO:1900155]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell growth [GO:0030308]; negative regulation of chondrocyte differentiation [GO:0032331]; negative regulation of monocyte chemotaxis [GO:0090027]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of osteoblast proliferation [GO:0033689]; negative regulation of osteoclast proliferation [GO:0090291]; negative regulation of pathway-restricted SMAD protein phosphorylation [GO:0060394]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of angiogenesis [GO:0045766]; positive regulation of branching involved in ureteric bud morphogenesis [GO:0090190]; positive regulation of cardiac muscle cell differentiation [GO:2000727]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of peptidyl-tyrosine autophosphorylation [GO:1900086]; positive regulation of receptor internalization [GO:0002092]; positive regulation of signaling receptor activity [GO:2000273]; positive regulation of telomerase activity [GO:0051973]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation [GO:0003257]; proximal/distal pattern formation [GO:0009954]; regulation of epithelial to mesenchymal transition [GO:0010717]; regulation of focal adhesion assembly [GO:0051893]; sequestering of BMP from receptor via BMP binding [GO:0038098]; signal transduction [GO:0007165]; ureteric bud formation [GO:0060676]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=GREM1&keywords=GREM1	11.063080499380609	231	NA	NA	1.2431307846060444	233	0.047244094488188976	0.09481037924151688	0.025442477876106206	1.4997601918465213	0.1599326599326601	0.4788494077834187	0.4152311876699898	0.3621533442088096	0.26267110617831985	0.4034584056616712	0.20560169982614562	64	53	68	0.3595595413375771	0.7378272664573048	1.1187869867064109	0.5834017951364501	247	109	289
GREM2	gremlin 2, DAN family BMP antagonist	Yes		ENSG00000180875	Q9H772	DAN family	2	ligand, receptor	extracellular, ligand, ligand_regulator, plasma_membrane, receptor, secreted	NA	NA	NA	extracellular region [GO:0005576]; extracellular space [GO:0005615]	BMP binding [GO:0036122]; cytokine activity [GO:0005125]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; receptor ligand activity [GO:0048018]	animal organ morphogenesis [GO:0009887]; cytokine-mediated signaling pathway [GO:0019221]; determination of dorsal identity [GO:0048263]; embryonic body morphogenesis [GO:0010172]; regulation of cytokine activity [GO:0060300]; sequestering of BMP from receptor via BMP binding [GO:0038098]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=GREM2&keywords=GREM2	1.411669820224719	417	NA	NA	0.36025740430515474	437	0.015748031496062992	0	0	0.0023980815347721817	0.00505050505050505	0.027072758037225034	0.030825022665457842	0.021207177814029365	7.399186089530152e-4	0.02533716116971552	8.885454896658299e-4	301	184	371	0.011751563806035167	0.4937538608591042	1.6245802593701748	0.5005867893803895	345	39	326
GRN	granulin precursor	Yes		ENSG00000030582	P28799	Granulin family	7	ligand	extracellular, intracellular, ligand, secreted	P00533, P04629, P19438, P20333, Q99523, Q9H2X3	CLEC4M, EGFR, NTRK1, SORT1, TNFRSF1A, TNFRSF1B	TNFRSF1A [CellTalkDB:24070898;IntAct:24070898;Lit-BM-17:24070898;SIGNOR:21393509;connectomeDB2020:21393509], EGFR [CellTalkDB:32103204], SORT1 [CellChatDB:29555433;CellTalkDB:23706646;Cellinker:29555433;IntAct:23236149;IntAct:24070898;connectomeDB2020:22361451;connectomeDB2020:24163244], TNFRSF1B [CellTalkDB:29740434;IntAct:24070898;Lit-BM-17:24070898;connectomeDB2020:21393509], CLEC4M [CellTalkDB:32103204], NTRK1 [NA]	azurophil granule lumen [GO:0035578]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886]; trans-Golgi network [GO:0005802]	chaperone binding [GO:0051087]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; RNA binding [GO:0003723]	astrocyte activation involved in immune response [GO:0002265]; lysosomal lumen acidification [GO:0007042]; lysosomal transport [GO:0007041]; lysosome organization [GO:0007040]; microglial cell activation involved in immune response [GO:0002282]; negative regulation of microglial cell activation [GO:1903979]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neutrophil activation [GO:1902564]; negative regulation of respiratory burst involved in inflammatory response [GO:0060266]; positive regulation of angiogenesis [GO:0045766]; positive regulation of aspartic-type peptidase activity [GO:1905247]; positive regulation of axon regeneration [GO:0048680]; positive regulation of cell migration [GO:0030335]; positive regulation of defense response to bacterium [GO:1900426]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of inflammatory response to wounding [GO:0106016]; positive regulation of lysosome organization [GO:1905673]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of protein folding [GO:1903334]; protein stabilization [GO:0050821]; regulation of inflammatory response [GO:0050727]; signal transduction [GO:0007165]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=GRN&keywords=GRN	97.87998207058325	49	3214.94	110	0.743380005921308	313	3.456692913385823	0.6477045908183642	0.5807522123893784	0.4995203836930563	0.473063973063972	1.069373942470387	1.2048957388939363	0.9934747145187647	0.8479467258601481	0.8466751235147192	1.0659841607108897	26	34	24	1.0623713163017672	0.8000463205402637	0.7988605350515076	1.0033690237273243	222	211	99
GRP	gastrin releasing peptide	Yes		ENSG00000134443	P07492	Bombesin/neuromedin-B/ranatensin family	14	ligand	extracellular, intracellular, ligand, secreted	P28336, P30550, P32247, Q12884	BRS3, FAP, GRPR, NMBR	GRPR [Baccin2019:10454496;Baccin2019:1720612;Baccin2019:19463875;Baccin2019:7838118;CellTalkDB:19463875;Cellinker:10454496;Cellinker:1720612;Cellinker:19463875;Cellinker:7838118;Guide2Pharma:10454496;Guide2Pharma:21729729;Guide2Pharma:7838118;HPRD:7838118;LRdb:10454496;LRdb:1720612;LRdb:19463875;LRdb:7838118;SIGNOR:17251915;connectomeDB2020:10454496;connectomeDB2020:1720612;connectomeDB2020:19463875;connectomeDB2020:7838118;scConnect:10454496;scConnect:19463875;scConnect:21729729;scConnect:7838118], BRS3 [CellTalkDB:11112777;LRdb:11112777;Ramilowski2015:11112777;connectomeDB2020:11112777;talklr:11112777], NMBR [CellTalkDB:10545285;LRdb:10545285;Ramilowski2015:10545285;connectomeDB2020:10545285;talklr:10545285], FAP [Cellinker:21314817]	extracellular region [GO:0005576]; extracellular space [GO:0005615]; secretory granule lumen [GO:0034774]	neuropeptide hormone activity [GO:0005184]; signaling receptor binding [GO:0005102]	neuropeptide signaling pathway [GO:0007218]; positive regulation of peptide hormone secretion [GO:0090277]; positive regulation of phospholipase C-activating G protein-coupled receptor signaling pathway [GO:1900738]; psychomotor behavior [GO:0036343]; response to external biotic stimulus [GO:0043207]; signal transduction [GO:0007165]; social behavior [GO:0035176]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=GRP&keywords=GRP	3.527260065167724	320	NA	NA	4.675818685246876	78	0	0	0	7.194244604316547e-4	0	0.023688663282571906	0	0.0016313213703099511	0.060673325934147315	2.336760582187208e-4	3.8632412594166507e-5	157	402	400	0.007907731228933974	3.9465259462884186	0.571466922715699	0.5605753338744829	6	294	302
GUCA2A	guanylate cyclase activator 2A	Yes		ENSG00000197273	Q02747	Guanylin family	16	ligand	extracellular, ligand, secreted	P25092	GUCY2C	GUCY2C [Baccin2019:10601865;Baccin2019:10845107;Baccin2019:11889121;CellChatDB:22384056;CellTalkDB:10845107;Cellinker:10601865;Cellinker:10845107;Cellinker:11889121;Cellinker:22384056;HPMR:10845107;HPRD:10601865;HPRD:11889121;ICELLNET:23269669;LRdb:10601865;LRdb:10845107;LRdb:11889121;SIGNOR:10845107;connectomeDB2020:10601865;connectomeDB2020:10845107;connectomeDB2020:11889121]	extracellular region [GO:0005576]	guanylate cyclase activator activity [GO:0030250]; hormone activity [GO:0005179]	NA	https://www.genecards.org/cgi-bin/carddisp.pl?gene=GUCA2A&keywords=GUCA2A	0.8676408314606742	468	NA	NA	0.07819018894665704	662	0	0.028443113772455068	0	2.3980815347721823e-4	0	0	9.066183136899365e-4	0	0	0	0.002395209580838325	303	409	327	0.002907704529132777	0.7747310900578744	0.7747310900578744	0.9602954230058686	230	221	112
GUCA2B	guanylate cyclase activator 2B	Yes	Prepro-Uroguanylin	ENSG00000044012	Q16661	Guanylin family	12	ligand	intracellular, ligand, secreted	P25092, Q02846	GUCY2C, GUCY2D	GUCY2C [Baccin2019:10845107;CellChatDB:22384056;CellTalkDB:10845107;Cellinker:10845107;Cellinker:22384056;LRdb:10845107;SIGNOR:10845107;connectomeDB2020:10845107], GUCY2D [Baccin2019:9698373;CellTalkDB:9698373;Cellinker:9698373;HPRD:9698373;LRdb:9698373;connectomeDB2020:9698373]	extracellular exosome [GO:0070062]; extracellular region [GO:0005576]	calcium sensitive guanylate cyclase activator activity [GO:0008048]; guanylate cyclase activator activity [GO:0030250]	cGMP-mediated signaling [GO:0019934]; excretion [GO:0007588]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=GUCA2B&keywords=GUCA2B	0.2671481011235955	588	NA	NA	0.2357352744756263	506	0	0.00898203592814371	0	0	0.03535353535353535	0	0	0.0032626427406199023	0.0011098779134295228	2.00293764187475e-4	9.271779022599963e-4	300	403	370	0.004530505782015996	0.7645898966008403	0.7019916524042883	0.7520163486521069	237	252	212
GZMA	granzyme A	No		ENSG00000145649	P12544	Peptidase S1 family, Granzyme subfamily	1	ligand, receptor, secreted_enzyme	extracellular, intracellular, ligand, receptor, secreted, secreted_enzyme, secreted_peptidase, transmembrane	O00254, P01584, P12956, P20700, P25116, P26583, P27695, P55085, Q01105, Q8TEW0, Q96RI0	APEX1, F2R, F2RL1, F2RL2, F2RL3, HMGB2, IL1B, LMNB1, PARD3, SET, XRCC6	SET [BioGRID:11555662;HPRD:11555662;InnateDB:11555662;InnateDB:19059912;InnateDB:9256474;SIGNOR:11555662;SPIKE:19254476], IL1B [SPIKE:19254476], APEX1 [HPRD-phos:12524539;HPRD-phos:12555094;HPRD:12524539;HPRD:12555094;InnateDB:12524539;SPIKE:12524539], HMGB2 [HPRD-phos:11909973;HPRD:11909973;SPIKE:11909973], F2R [NA], F2RL1 [NA], F2RL2 [NA], F2RL3 [NA], PARD3 [NA], LMNB1 [HPRD-phos:11331782;HPRD:11331782], XRCC6 [InnateDB:16440001]	extracellular region [GO:0005576]; immunological synapse [GO:0001772]; nucleus [GO:0005634]	protein homodimerization activity [GO:0042803]; serine-type endopeptidase activity [GO:0004252]	apoptotic process [GO:0006915]; cytolysis [GO:0019835]; cytotoxic T cell pyroptotic process [GO:1902483]; granzyme-mediated programmed cell death signaling pathway [GO:0140507]; immune response [GO:0006955]; negative regulation of DNA binding [GO:0043392]; negative regulation of endodeoxyribonuclease activity [GO:0032078]; negative regulation of oxidoreductase activity [GO:0051354]; positive regulation of apoptotic process [GO:0043065]; proteolysis involved in cellular protein catabolic process [GO:0051603]; pyroptosis [GO:0070269]; response to bacterium [GO:0009617]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=GZMA&keywords=GZMA	0.07820779325842697	690	NA	NA	0.020640497756716593	795	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HAMP	hepcidin antimicrobial peptide	TBD		ENSG00000105697	P81172	Hepcidin family	2	ligand	extracellular, intracellular, ligand, secreted	NA	NA	NA	apical cortex [GO:0045179]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intercalated disc [GO:0014704]; nucleus [GO:0005634]	copper ion binding [GO:0005507]; hormone activity [GO:0005179]; iron ion transmembrane transporter inhibitor activity [GO:0097690]; signaling receptor binding [GO:0005102]	acute-phase response [GO:0006953]; aging [GO:0007568]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cellular iron ion homeostasis [GO:0006879]; cellular response to bile acid [GO:1903413]; cellular response to interleukin-6 [GO:0071354]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to X-ray [GO:0071481]; defense response to bacterium [GO:0042742]; defense response to fungus [GO:0050832]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; immune response [GO:0006955]; killing of cells of other organism [GO:0031640]; liver regeneration [GO:0097421]; multicellular organismal iron ion homeostasis [GO:0060586]; myeloid cell homeostasis [GO:0002262]; negative regulation of bone resorption [GO:0045779]; negative regulation of inflammatory response [GO:0050728]; negative regulation of intestinal absorption [GO:1904479]; negative regulation of ion transmembrane transporter activity [GO:0032413]; negative regulation of iron export across plasma membrane [GO:1904039]; negative regulation of iron ion transmembrane transport [GO:0034760]; negative regulation of iron ion transmembrane transporter activity [GO:1904255]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell growth involved in cardiac muscle cell development [GO:0061051]; positive regulation of cellular protein catabolic process [GO:1903364]; positive regulation of macrophage activation [GO:0043032]; positive regulation of protein polyubiquitination [GO:1902916]; positive regulation of receptor catabolic process [GO:2000646]; positive regulation of receptor internalization [GO:0002092]; positive regulation of transcription by RNA polymerase II [GO:0045944]; receptor signaling pathway via JAK-STAT [GO:0007259]; response to erythropoietin [GO:0036017]; response to ethanol [GO:0045471]; response to iron ion [GO:0010039]; response to iron ion starvation [GO:1990641]; response to vitamin A [GO:0033189]; response to zinc ion [GO:0010043]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=HAMP&keywords=HAMP	2.80551354494382	347	NA	NA	0.18849513796473122	540	0	0	0.00331858407079646	4.7961630695443646e-4	0.018518518518518517	0.001692047377326565	0.0027198549410698096	0	0.0029596744358120607	1.6691147015622916e-4	5.40853776318331e-4	295	404	383	0.00276327826335931	1.0153875962272612	0.7965752419065637	0.8258735380375517	131	212	173
HAPLN1	hyaluronan and proteoglycan link protein 1	No		ENSG00000145681	P10915	HAPLN family	1	ecm, ligand	ecm, extracellular, intracellular, ligand, secreted	O00300, O95866, Q01638, Q15109, Q29983, Q2VWP7, Q5T2D2, Q8TDY8, Q96PE1	ADGRA2, AGER, IGDCC4, IL1RL1, MICA, MPIG6B, PRTG, TNFRSF11B, TREML2	ADGRA2 [Cellinker:32822567], MICA [Cellinker:32822567], PRTG [Cellinker:32822567], TREML2 [Cellinker:32822567], IL1RL1 [Cellinker:32822567], IGDCC4 [Cellinker:32822567], TNFRSF11B [Cellinker:32822567], MPIG6B [Cellinker:32822567], AGER [Cellinker:32822567]	collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; synapse [GO:0045202]	hyaluronic acid binding [GO:0005540]	cell adhesion [GO:0007155]; central nervous system development [GO:0007417]; skeletal system development [GO:0001501]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=HAPLN1&keywords=HAPLN1	0.00756630393258427	841	2762.62	120	0.03637249837702878	746	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HBEGF	heparin binding EGF like growth factor	Yes		ENSG00000113070	Q99075	NA	18	adhesion, cell_surface_ligand, ligand	adhesion, cell_adhesion, cell_surface, cell_surface_ligand, extracellular, intracellular, ligand, plasma_membrane, plasma_membrane_transmembrane, secreted, transmembrane, transmembrane_predicted	P00533, P04626, P16070, P16471, P21926, P27701, Q15303, Q16653	CD44, CD82, CD9, EGFR, EGFR_ERBB2, ERBB2, ERBB2_ERBB4, ERBB4, MOG, PRLR	EGFR [Baccin2019:12725245;BioGRID:12725245;CellTalkDB:12725245;HPRD:12725245;ICELLNET:12097488;ICELLNET:12621152;IntAct:28988771;IntAct:9135143;LRdb:12725245;ProtMapper:19531065;ProtMapper:22529914;ProtMapper:23888518;ProtMapper:28943431;ProtMapper:29274275;ProtMapper:30071291;SIGNOR:14967450;SignaLink3:10209155;SignaLink3:23331499;connectomeDB2020:12725245], ERBB4 [Baccin2019:1840698;Baccin2019:9135143;CellTalkDB:1840698;HPRD:9135143;ICELLNET:12621152;LRdb:1840698;LRdb:914;SIGNOR:10209155;SIGNOR:9135143;SignaLink3:10209155;SignaLink3:23331499;connectomeDB2020:1840698;connectomeDB2020:9135143], CD44 [Baccin2019:7532176;BioGRID:7532176;CellTalkDB:7532176;Cellinker:7532176;HPRD:7532176;LRdb:7532176;connectomeDB2020:7532176], CD9 [Cellinker:11735113;Cellinker:11846885;Cellinker:1939101;Cellinker:8194524;HPRD:11735113;HPRD:11846885;HPRD:1939101;HPRD:8194524;LRdb:11735113;LRdb:11846885;LRdb:1939101;LRdb:8194524;connectomeDB2020:11735113;connectomeDB2020:11846885;connectomeDB2020:1939101;connectomeDB2020:8194524], PRLR [CellTalkDB:32196115], ERBB2 [CellTalkDB:12958167;LRdb:12958167;Ramilowski2015:12958167;connectomeDB2020:12958167;talklr:12958167], CD82 [CellTalkDB:10749879;Cellinker:10749879;HPRD:10749879;LRdb:10749879;connectomeDB2020:10749879], MOG [Cellinker:32589946]	cell surface [GO:0009986]; clathrin-coated endocytic vesicle membrane [GO:0030669]; endocytic vesicle membrane [GO:0030666]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	epidermal growth factor receptor binding [GO:0005154]; growth factor activity [GO:0008083]; heparin binding [GO:0008201]	cell chemotaxis [GO:0060326]; epidermal growth factor receptor signaling pathway [GO:0007173]; muscle organ development [GO:0007517]; negative regulation of elastin biosynthetic process [GO:0051545]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epidermal growth factor-activated receptor activity [GO:0045741]; positive regulation of keratinocyte migration [GO:0051549]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of wound healing [GO:0090303]; regulation of heart contraction [GO:0008016]; signal transduction [GO:0007165]; wound healing, spreading of epidermal cells [GO:0035313]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=HBEGF&keywords=HBEGF	12.058446542696629	221	NA	NA	0.6244924359357859	333	1.3937007874015737	0.28592814371257713	0.08849557522123902	0.10000000000000074	0.025252525252525245	0.03722504230118443	0.037171350861287394	0.01468189233278956	0.039585645578986306	0.014588062491654391	0.018891249758547356	186	222	207	0.18686547953748775	0.25187577677651735	0.12489778578459335	0.14675630195006226	416	457	450
HCFC2	host cell factor C2			ENSG00000111727	Q9Y5Z7	NA	1	ligand	intracellular, ligand, secreted	NA	NA	NA	cytoplasm [GO:0005737]; cytosol [GO:0005829]; histone methyltransferase complex [GO:0035097]; MLL1 complex [GO:0071339]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	transcription coactivator activity [GO:0003713]	chromatin remodeling [GO:0006338]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; viral process [GO:0016032]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=HCFC2&keywords=HCFC2	18.774806039325842	174	3548.42	105	2.026634814699815	153	0.031496062992125984	0.056886227544910115	0.03207964601769913	0.05707434052757792	0.07239057239057241	0.2521150592216579	0.25022665457842175	0.14192495921696588	0.13503514613392456	0.19849112030977858	0.12196252655977824	99	76	101	0.12269839231758295	1.0929683743780139	1.5711653824019454	0.99445459929881	113	44	101
HCRT	hypocretin neuropeptide precursor	Yes		ENSG00000161610	O43612	Orexin family	14	ligand	extracellular, intracellular, ligand, secreted	O43613, O43614, Q9Y5X5	HCRTR1, HCRTR2, NPFFR2	HCRTR1 [Baccin2019:10498827;Baccin2019:11162621;Baccin2019:11250867;Baccin2019:11266181;Baccin2019:11403934;Baccin2019:12208495;Baccin2019:12606634;Baccin2019:12702704;Baccin2019:14691055;Baccin2019:18599270;Baccin2019:21362456;Baccin2019:9491897;CellTalkDB:9491897;Cellinker:10498827;Cellinker:11162621;Cellinker:11250867;Cellinker:11266181;Cellinker:11403934;Cellinker:12208495;Cellinker:12606634;Cellinker:12702704;Cellinker:14691055;Cellinker:18599270;Cellinker:21362456;Cellinker:9491897;Guide2Pharma:10498827;Guide2Pharma:11162621;Guide2Pharma:11266181;Guide2Pharma:12208495;Guide2Pharma:12606634;Guide2Pharma:12702704;Guide2Pharma:14691055;Guide2Pharma:17115071;Guide2Pharma:18488139;Guide2Pharma:20002100;Guide2Pharma:21362456;Guide2Pharma:21718304;Guide2Pharma:22550093;Guide2Pharma:26582739;Guide2Pharma:9491897;HPMR:9491897;HPRD:9491897;LRdb:10498827;LRdb:11162621;LRdb:11250867;LRdb:11266181;LRdb:11403934;LRdb:12208495;LRdb:12606634;LRdb:12702704;LRdb:14691055;LRdb:18599270;LRdb:21362456;LRdb:9491897;SIGNOR:9491897;connectomeDB2020:10498827;connectomeDB2020:11162621;connectomeDB2020:11250867;connectomeDB2020:11266181;connectomeDB2020:11403934;connectomeDB2020:12208495;connectomeDB2020:12606634;connectomeDB2020:12702704;connectomeDB2020:14691055;connectomeDB2020:18599270;connectomeDB2020:21362456;connectomeDB2020:9491897;scConnect:10498827;scConnect:11162621;scConnect:11205421;scConnect:11266181;scConnect:11403934;scConnect:12208495;scConnect:12606634;scConnect:12702704;scConnect:14691055;scConnect:15271651;scConnect:17115071;scConnect:18488139;scConnect:20002100;scConnect:21362456;scConnect:21718304;scConnect:22550093;scConnect:26582739;scConnect:9491897], HCRTR2 [Baccin2019:11162621;Baccin2019:12208495;Baccin2019:12702704;Baccin2019:18599270;Baccin2019:9491897;CellTalkDB:9491897;Cellinker:11162621;Cellinker:12208495;Cellinker:12702704;Cellinker:18599270;Cellinker:9491897;Guide2Pharma:10498827;Guide2Pharma:11162621;Guide2Pharma:12208495;Guide2Pharma:12606634;Guide2Pharma:12702704;Guide2Pharma:18599270;Guide2Pharma:26582739;Guide2Pharma:27237973;Guide2Pharma:9491897;HPMR:9491897;HPRD:9491897;LRdb:11162621;LRdb:12208495;LRdb:12702704;LRdb:18599270;LRdb:9491897;SIGNOR:9491897;connectomeDB2020:11162621;connectomeDB2020:12208495;connectomeDB2020:12702704;connectomeDB2020:18599270;connectomeDB2020:9491897;scConnect:10498827;scConnect:11162621;scConnect:12208495;scConnect:12606634;scConnect:12702704;scConnect:12890892;scConnect:18599270;scConnect:26582739;scConnect:27237973;scConnect:9491897], NPFFR2 [Baccin2019:12609745;CellTalkDB:12609745;Cellinker:12609745;HPRD:12609745;LRdb:12609745;connectomeDB2020:12609745]	extracellular region [GO:0005576]; perinuclear region of cytoplasm [GO:0048471]; postsynapse [GO:0098794]; rough endoplasmic reticulum [GO:0005791]; secretory granule [GO:0030141]; synaptic vesicle [GO:0008021]	neuropeptide hormone activity [GO:0005184]; type 1 hypocretin receptor binding [GO:0031771]; type 2 hypocretin receptor binding [GO:0031772]	chemical synaptic transmission [GO:0007268]; eating behavior [GO:0042755]; excitatory postsynaptic potential [GO:0060079]; negative regulation of DNA replication [GO:0008156]; negative regulation of potassium ion transport [GO:0043267]; negative regulation of transmission of nerve impulse [GO:0051970]; neuropeptide signaling pathway [GO:0007218]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of calcium ion transport [GO:0051928]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of transmission of nerve impulse [GO:0051971]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; regulation of neurotransmitter secretion [GO:0046928]; response to starvation [GO:0042594]; sleep [GO:0030431]; temperature homeostasis [GO:0001659]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=HCRT&keywords=HCRT	0.01574779775280899	806	NA	NA	0.031471449840109446	763	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HDGF	heparin binding growth factor			ENSG00000143321	P51858	HDGF family	2	ligand	extracellular, intracellular, ligand, secreted	NA	NA	NA	collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053]	actin binding [GO:0003779]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; double-stranded DNA binding [GO:0003690]; growth factor activity [GO:0008083]; heparin binding [GO:0008201]; nucleotide binding [GO:0000166]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714]; transcription corepressor binding [GO:0001222]; tubulin binding [GO:0015631]	cellular response to interleukin-7 [GO:0098761]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell division [GO:0051781]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to nucleus [GO:0034504]; regulation of transcription by RNA polymerase II [GO:0006357]; signal transduction [GO:0007165]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=HDGF&keywords=HDGF	131.78215428129587	42	74314.4	16	1.3099800314611203	222	0.22834645669291334	1.6417165668662665	0.23893805309734545	0.4258992805755458	0.5858585858585856	0.49576988155668483	0.5285584768812323	0.28058727569331143	0.2608213096559363	0.3365936707170788	0.29121112613481115	67	60	54	0.48311824397542835	0.5492015616226746	0.7028611797505291	0.6108294102171167	328	251	281
HEBP1	heme binding protein 1			ENSG00000013583	Q9NRV9	HEBP family	1	cell_surface_ligand	cell_surface_ligand, intracellular, secreted, transmembrane	P08913, P25089, P48039, Q14831	ADRA2A, FPR3, GRM7, MTNR1A	FPR3 [CellTalkDB:15623572;Guide2Pharma:15623572;LRdb:15623572;connectomeDB2020:15623572;scConnect:15623572], ADRA2A [CellTalkDB:32196115], MTNR1A [CellTalkDB:32196115], GRM7 [CellTalkDB:32196115]	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]	heme binding [GO:0020037]	circadian rhythm [GO:0007623]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=HEBP1&keywords=HEBP1	64.12345095161297	68	23969.9	42	2.152247177520312	144	0.3149606299212598	0.32834331337325734	0.10508849557522136	0.27074340527578006	0.19528619528619526	0.16751269035532979	0.1822302810516767	0.06362153344208814	0.06474287828338887	0.12738683402323173	0.04898589916940223	154	94	154	0.16990019597789374	0.41546857621307604	0.7636836262263657	0.32788123908797995	371	234	382
HGF	hepatocyte growth factor	Yes		ENSG00000019991	P14210	Peptidase S1 family, Plasminogen subfamily	19	ligand	extracellular, intracellular, ligand, secreted	O14786, P00749, P02751, P05556, P08581, P16070, P18827, P34741, Q9Y5Y6	CD44, FN1, ITGB1, MET, NRP1, PLAU, SDC1, SDC2, ST14	MET [Baccin2019:15167892;Baccin2019:1655405;Baccin2019:1846706;Baccin2019:18495663;BioGRID:1655405;CellChatDB:28475121;CellTalkDB:1846706;Cellinker:15167892;Cellinker:1655405;Cellinker:1846706;Cellinker:18495663;Cellinker:28475121;DIP:16537482;DIP:17804794;DIP:20624990;HPRD:15167892;HPRD:1655405;HPRD:18495663;ICELLNET:15218027;IntAct:15167892;IntAct:16537482;IntAct:17804794;IntAct:17981115;IntAct:1846706;IntAct:20624990;IntAct:22897854;LRdb:15167892;LRdb:1655405;LRdb:1846706;LRdb:18495663;Lit-BM-17:15167892;Lit-BM-17:17804794;Lit-BM-17:17981115;Lit-BM-17:1846706;Lit-BM-17:19433454;Lit-BM-17:22897854;Lit-BM-17:8380735;ProtMapper:16397249;ProtMapper:17667909;ProtMapper:20178463;ProtMapper:22001117;ProtMapper:24362531;ProtMapper:27147579;ProtMapper:28534512;SIGNOR:8380735;SPIKE:14685170;SPIKE:17145710;SPIKE:1846706;SignaLink3:23331499;SignaLink3:8380735;connectomeDB2020:15167892;connectomeDB2020:1655405;connectomeDB2020:1846706;connectomeDB2020:18495663], CD44 [CellTalkDB:10037743;Cellinker:10037743;Cellinker:26181364;LRdb:10037743;Ramilowski2015:10037743;connectomeDB2020:10037743;talklr:10037743], SDC1 [Baccin2019:11830493;CellTalkDB:11830493;Cellinker:11830493;HPRD:11830493;LRdb:11830493;connectomeDB2020:11830493], ITGB1 [CellTalkDB:32196115], SDC2 [Baccin2019:8157651;CellTalkDB:8157651;Cellinker:8157651;HPRD:8157651;LRdb:8157651;connectomeDB2020:8157651], NRP1 [CellTalkDB:18065694], ST14 [Baccin2019:10962009;Baccin2019:12372819;Cellinker:10962009;Cellinker:12372819;HPRD:10962009;HPRD:12372819;LRdb:11;LRdb:12372819;connectomeDB2020:10962009], FN1 [HPRD:15717924;Lit-BM-17:25241761;Lit-BM-17:8780385;MatrixDB:8780385], PLAU [HPRD:1334458]	extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; platelet alpha granule lumen [GO:0031093]	chemoattractant activity [GO:0042056]; growth factor activity [GO:0008083]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; signaling receptor binding [GO:0005102]	animal organ regeneration [GO:0031100]; cell chemotaxis [GO:0060326]; cell morphogenesis [GO:0000902]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; epithelial cell proliferation [GO:0050673]; epithelial to mesenchymal transition [GO:0001837]; hepatocyte growth factor receptor signaling pathway [GO:0048012]; liver development [GO:0001889]; mitotic cell cycle [GO:0000278]; myoblast proliferation [GO:0051450]; negative regulation of apoptotic process [GO:0043066]; negative regulation of autophagy [GO:0010507]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of hydrogen peroxide-mediated programmed cell death [GO:1901299]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell migration [GO:0030335]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of myelination [GO:0031643]; positive regulation of neuron projection regeneration [GO:0070572]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling [GO:0060665]; regulation of p38MAPK cascade [GO:1900744]; regulation of tau-protein kinase activity [GO:1902947]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=HGF&keywords=HGF	3.5612747112469867	318	NA	NA	1.1753657169627494	239	0	9.98003992015968e-4	0.0011061946902654867	0.22134292565947275	0	0.005076142131979695	0.0027198549410698096	0.0032626427406199023	0.005179430262671108	0.005608225397249287	0.0014293992659841616	287	281	346	0.022429347189211652	0.46807696047982383	0.4812994016247639	0.35244000439781925	354	326	372
HGFAC	HGF activator	TBD		ENSG00000109758	Q04756	Peptidase S1 family	1	ligand	extracellular, intracellular, ligand, secreted	P14210	HGF	HGF [HPRD:8631970]	cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; rough endoplasmic reticulum [GO:0005791]	serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]	blood coagulation [GO:0007596]; proteolysis [GO:0006508]; zymogen activation [GO:0031638]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=HGFAC&keywords=HGFAC	0.008398959258426967	836	NA	NA	0.0034550932554843444	875	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HHIP	hedgehog interacting protein	TBD		ENSG00000164161	Q96QV1	HHIP family	1	adhesion, ligand, receptor	adhesion, cell_adhesion, cell_surface, extracellular, intracellular, ligand, plasma_membrane, receptor, receptor_regulator, secreted, transmembrane	O43323, Q14623, Q15465	DHH, IHH, SHH	SHH [HPRD:10050855;IntAct:19561609;Lit-BM-17:19561609;NetPath:10050855;SIGNOR:10050855;SignaLink3:10050855;SignaLink3:23331499], DHH [CancerCellMap:10050855;CancerCellMap:11435703;DIP:19561611;HPRD:10050855;HPRD:11435703;IntAct:19561611;Lit-BM-17:19561609;Lit-BM-17:19561611;NetPath:10050855;SignaLink3:10050855;SignaLink3:23331499], IHH [CancerCellMap:10050855;CancerCellMap:11435703;HPMR:10050855;HPRD:10050855;HPRD:11435703;NetPath:10050855;SIGNOR:10050855;SignaLink3:10050855;SignaLink3:23331499]	cell surface [GO:0009986]; ciliary membrane [GO:0060170]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; nucleus [GO:0005634]	catalytic activity [GO:0003824]; hedgehog family protein binding [GO:0097108]; zinc ion binding [GO:0008270]	dorsal/ventral pattern formation [GO:0009953]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; negative regulation of apoptotic process [GO:0043066]; negative regulation of signal transduction [GO:0009968]; negative regulation of smoothened signaling pathway [GO:0045879]; neuroblast proliferation [GO:0007405]; regulation of fibroblast growth factor receptor signaling pathway [GO:0040036]; signal transduction [GO:0007165]; skeletal system morphogenesis [GO:0048705]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=HHIP&keywords=HHIP	0.24274404380898876	595	NA	NA	0.21675880226886796	524	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HLA-E	major histocompatibility complex, class I, E	No		ENSG00000206493, ENSG00000236632, ENSG00000225201, ENSG00000230254, ENSG00000229252, ENSG00000233904, ENSG00000204592	P13747	MHC class I family	6	adhesion, cell_surface_ligand, ligand, receptor	adhesion, cell_adhesion, cell_surface, cell_surface_ligand, extracellular, intracellular, ligand, plasma_membrane, plasma_membrane_transmembrane, receptor, secreted, transmembrane	A6NJW9, O15374, P01732, P10966, P26715, P26717, P26718, P43629, Q13241	CD8A, CD8B, CD8B2, KIR3DL1, KLRC1, KLRC1_KLRD1, KLRC2, KLRC2_KLRD1, KLRC3_KLRD1, KLRD1, KLRK1, SLC16A4	KLRC2 [CellChatDB:26697006;CellPhoneDB:26697006;HPRD:9103421;HPRD:9486650;LRdb:91;LRdb:9486650;connectomeDB2020:9103421;connectomeDB2020:9486650], KLRD1 [Baccin2019:14734748;Baccin2019:9486650;Baccin2019:9815261;Baccin2019:9886400;HPRD:14734748;HPRD:9486650;HPRD:9815261;HPRD:9886400;LRdb:14734748;LRdb:9486650;LRdb:9815261;LRdb:9886400;connectomeDB2020:14734748;connectomeDB2020:9486650;connectomeDB2020:9815261;connectomeDB2020:9886400], KIR3DL1 [CellTalkDB:32196115], KLRC1 [CellChatDB:24223577;CellPhoneDB:24223577;HPRD:9486650;LRdb:9486650;connectomeDB2020:9486650], KLRK1 [CellChatDB:28484462;CellPhoneDB:24223577;Cellinker:14734748;Cellinker:24223577;Cellinker:9486650;Cellinker:9815261;Cellinker:9886400;LRdb:24223577;connectomeDB2020:24223577], CD8A [HPRD:10809759], CD8B [NA], CD8B2 [NA], SLC16A4 [NA]	cell surface [GO:0009986]; early endosome membrane [GO:0031901]; ER to Golgi transport vesicle membrane [GO:0012507]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi membrane [GO:0000139]; integral component of lumenal side of endoplasmic reticulum membrane [GO:0071556]; MHC class Ib protein complex [GO:0032398]; MHC class I protein complex [GO:0042612]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]	beta-2-microglobulin binding [GO:0030881]; MHC class I protein binding [GO:0042288]; natural killer cell lectin-like receptor binding [GO:0046703]; peptide antigen binding [GO:0042605]; signaling receptor binding [GO:0005102]; T cell receptor binding [GO:0042608]	adaptive immune response [GO:0002250]; antibacterial humoral response [GO:0019731]; antigen processing and presentation of endogenous peptide antigen via MHC class Ib [GO:0002476]; antigen processing and presentation of exogenous peptide antigen via MHC class Ib [GO:0002477]; antigen processing and presentation of peptide antigen via MHC class I [GO:0002474]; CD8-positive, alpha-beta T cell activation [GO:0036037]; defense response to Gram-positive bacterium [GO:0050830]; innate immune response [GO:0045087]; natural killer cell tolerance induction [GO:0002519]; negative regulation of natural killer cell mediated cytotoxicity [GO:0045953]; positive regulation of antibody-dependent cellular cytotoxicity [GO:0001815]; positive regulation of CD8-positive, alpha-beta T cell activation [GO:2001187]; positive regulation of CD8-positive, alpha-beta T cell proliferation [GO:2000566]; positive regulation of immunoglobulin production [GO:0002639]; positive regulation of interleukin-13 production [GO:0032736]; positive regulation of interleukin-4 production [GO:0032753]; positive regulation of natural killer cell cytokine production [GO:0002729]; positive regulation of natural killer cell mediated cytotoxicity [GO:0045954]; positive regulation of natural killer cell mediated immunity [GO:0002717]; positive regulation of natural killer cell proliferation [GO:0032819]; positive regulation of T cell mediated cytotoxicity [GO:0001916]; positive regulation of TRAIL production [GO:0032759]; positive regulation of tumor necrosis factor production [GO:0032760]; protection from natural killer cell mediated cytotoxicity [GO:0042270]; regulation of natural killer cell mediated immunity [GO:0002715]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=HLA-E&keywords=HLA-E	49.60455423023646	86	1622.59	142	0.08773495982265815	647	1.4803149606299195	1.2045908183632708	3.2654867256637057	1.7189448441246598	2.0202020202020305	1.3993231810490645	2.4351767905711816	1.77977161500815	1.0088790233074303	0.6768260114836635	2.932470542786394	24	38	16	1.8110896848354063	0.5594886576931649	0.3771511184775835	1.6157746470637662	321	350	30
HLA-G	major histocompatibility complex, class I, G	No		ENSG00000276051, ENSG00000233095, ENSG00000235680, ENSG00000230413, ENSG00000235346, ENSG00000237216, ENSG00000206506, ENSG00000204632	P17693	MHC class I family	6	adhesion, cell_surface_ligand, ligand	adhesion, cell_adhesion, cell_surface, cell_surface_ligand, extracellular, intracellular, ligand, plasma_membrane, plasma_membrane_transmembrane, secreted, transmembrane, transmembrane_predicted	A6NJW9, P01730, P01732, P10966, P26715, P43629, Q13241, Q8N423, Q8NHL6, Q99706	CD4, CD8A, CD8B, CD8B2, KIR2DL4, KIR3DL1, KLRC1, KLRD1, LILRB1, LILRB2	KLRC1 [CellTalkDB:9295021;Cellinker:9295021;LRdb:9295021;SIGNOR:9560253;connectomeDB2020:9295021], LILRB1 [CellChatDB:28484462;Cellinker:12853576;Cellinker:12874224;Cellinker:15718280;Cellinker:9933109;HPRD:12853576;HPRD:12874224;HPRD:9933109;ICELLNET:17056715;ICELLNET:19841038;IntAct:16455647;IntAct:19583775;LRdb:12853576;LRdb:12874224;LRdb:15718280;LRdb:9933109;SIGNOR:15718280;connectomeDB2020:12853576;connectomeDB2020:12874224;connectomeDB2020:15718280;connectomeDB2020:9933109], KIR2DL4 [CellTalkDB:10190900;Cellinker:10190900;Cellinker:26973020;HPRD:10190900;ICELLNET:11955593;ICELLNET:15580655;ICELLNET:17056715;InnateDB:16487070;LRdb:10190900;SIGNOR:10190900;connectomeDB2020:10190900], LILRB2 [CellChatDB:28484462;Cellinker:10190906;Cellinker:12853576;Cellinker:15670976;Cellinker:9531263;DIP:17056715;HPRD:10190906;HPRD:12853576;HPRD:15670976;HPRD:9531263;ICELLNET:17056715;IntAct:16455647;IntAct:17056715;IntAct:24899623;LRdb:10190906;LRdb:12853576;LRdb:15670976;LRdb:9531263;connectomeDB2020:10190906;connectomeDB2020:12853576;connectomeDB2020:15670976;connectomeDB2020:9531263], CD4 [CellTalkDB:32196115], KLRD1 [Cellinker:9295021;Cellinker:9405670;HPRD:9405670;LRdb:93;LRdb:9405670;connectomeDB2020:9295021;connectomeDB2020:9405670], KIR3DL1 [CellTalkDB:21746965;InnateDB:21115737], CD8A [BioGRID:1908512;HPRD:10809759;HPRD:10843658;HPRD:1908512], CD8B [NA], CD8B2 [NA]	cis-Golgi network membrane [GO:0033106]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; ER to Golgi transport vesicle membrane [GO:0012507]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; filopodium membrane [GO:0031527]; Golgi membrane [GO:0000139]; integral component of lumenal side of endoplasmic reticulum membrane [GO:0071556]; membrane [GO:0016020]; MHC class I protein complex [GO:0042612]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; recycling endosome membrane [GO:0055038]	CD8 receptor binding [GO:0042610]; identical protein binding [GO:0042802]; peptide antigen binding [GO:0042605]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]	antigen processing and presentation of endogenous peptide antigen via MHC class Ib [GO:0002476]; antigen processing and presentation of peptide antigen via MHC class I [GO:0002474]; cellular defense response [GO:0006968]; immune response-inhibiting cell surface receptor signaling pathway [GO:0002767]; negative regulation of angiogenesis [GO:0016525]; negative regulation of dendritic cell differentiation [GO:2001199]; negative regulation of G0 to G1 transition [GO:0070317]; negative regulation of immune response [GO:0050777]; negative regulation of natural killer cell mediated cytotoxicity [GO:0045953]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of T cell mediated cytotoxicity [GO:0001915]; negative regulation of T cell proliferation [GO:0042130]; peripheral B cell tolerance induction [GO:0002451]; positive regulation of cellular senescence [GO:2000774]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of macrophage cytokine production [GO:0060907]; positive regulation of natural killer cell cytokine production [GO:0002729]; positive regulation of regulatory T cell differentiation [GO:0045591]; positive regulation of T cell tolerance induction [GO:0002666]; positive regulation of tolerance induction [GO:0002645]; protection from natural killer cell mediated cytotoxicity [GO:0042270]; protein homotrimerization [GO:0070207]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=HLA-G&keywords=HLA-G	0.2170996894887218	608	NA	NA	0.06960590272070533	674	0.03937007874015748	0.032934131736526914	0.03207964601769914	0.03189448441247002	0.02188552188552188	0.03214890016920473	0.03626473254759746	0.035889070146818934	0.027376988531261522	0.012718654025904629	0.04635889511299902	214	229	156	0.03172010030237834	0.8958988176049704	0.5445493625673165	1.3508811029820598	186	302	46
HMGB2	high mobility group box 2	No		ENSG00000164104	P26583	HMGB family	1	ligand	extracellular, intracellular, ligand, secreted	P09086, P14859, P15918, Q03052	POU2F1, POU2F2, POU3F1, RAG1	POU2F2 [HPRD:7720710;Lit-BM-17:7720710;SIGNOR:7720710], POU2F1 [HPRD:7720710;SIGNOR:7720710], POU3F1 [HPRD:7720710;SIGNOR:7720710], RAG1 [HPRD:10490593]	chromatin [GO:0000785]; condensed chromosome [GO:0000793]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991]	chemoattractant activity [GO:0042056]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; DNA binding, bending [GO:0008301]; DNA-binding transcription factor binding [GO:0140297]; double-stranded DNA binding [GO:0003690]; four-way junction DNA binding [GO:0000400]; non-sequence-specific DNA binding, bending [GO:0044378]; protein domain specific binding [GO:0019904]; RAGE receptor binding [GO:0050786]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; supercoiled DNA binding [GO:0097100]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator activity [GO:0003713]; transcription factor binding [GO:0008134]	cell chemotaxis [GO:0060326]; cellular response to lipopolysaccharide [GO:0071222]; chromatin organization [GO:0006325]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; DNA geometric change [GO:0032392]; DNA topological change [GO:0006265]; double-strand break repair via nonhomologous end joining [GO:0006303]; inflammatory response to antigenic stimulus [GO:0002437]; innate immune response [GO:0045087]; male gonad development [GO:0008584]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nucleosome assembly [GO:0006334]; positive regulation of DNA binding [GO:0043388]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of innate immune response [GO:0045089]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of megakaryocyte differentiation [GO:0045654]; positive regulation of nuclease activity [GO:0032075]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of neurogenesis [GO:0050767]; regulation of stem cell proliferation [GO:0072091]; regulation of transcription by RNA polymerase II [GO:0006357]; response to lipopolysaccharide [GO:0032496]; response to steroid hormone [GO:0048545]; spermatid nucleus differentiation [GO:0007289]; V(D)J recombination [GO:0033151]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=HMGB2&keywords=HMGB2	26.461738330786517	145	26248.1	40	0.38748465649608743	424	0.8897637795275584	0.3338323353293455	0.1747787610619471	0.42901678657075143	0.3030303030303025	0.6006768189509311	0.5249320036264726	0.43719412724306755	0.47206807251202965	0.43099879823748277	0.30535058914427665	40	50	53	0.445603852294015	1.0580860326021486	0.9679435237805953	0.692159619714478	120	145	240
HP	haptoglobin	No		ENSG00000257017	P00738	Peptidase S1 family	8	ligand	extracellular, intracellular, ligand, secreted	O00206, P02647, P05107, P07306, P07307, P11215, P20273, P68871, P69905, Q86VB7	APOA1, ASGR1, ASGR2, CD163, CD22, HBA1, HBB, ITGAM, ITGB2, TLR4	APOA1 [BioGRID:15533931;Lit-BM-17:19758344;SIGNOR:17824618], HBB [BioGRID:7378053;HPRD:7378053;SIGNOR:9315856], HBA1 [SIGNOR:9315856], ITGAM [CellTalkDB:11967116;Cellinker:11967116;HPRD:11967116;LRdb:11967116;connectomeDB2020:8786317], ITGB2 [CellTalkDB:11967116;Cellinker:11967116;HPRD:11967116;LRdb:11967116;connectomeDB2020:8786317], TLR4 [CellTalkDB:31076532], CD163 [CellTalkDB:25389409;HPRD:11854028;connectomeDB2020:27294203], CD22 [CellTalkDB:9127741;HPRD:11967116], ASGR1 [CellTalkDB:32196115], ASGR2 [CellTalkDB:32196115]	blood microparticle [GO:0072562]; endocytic vesicle lumen [GO:0071682]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; haptoglobin-hemoglobin complex [GO:0031838]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724]	antioxidant activity [GO:0016209]; hemoglobin binding [GO:0030492]; serine-type endopeptidase activity [GO:0004252]	acute inflammatory response [GO:0002526]; acute-phase response [GO:0006953]; defense response [GO:0006952]; defense response to bacterium [GO:0042742]; immune system process [GO:0002376]; negative regulation of hydrogen peroxide catabolic process [GO:2000296]; negative regulation of oxidoreductase activity [GO:0051354]; positive regulation of cell death [GO:0010942]; response to hydrogen peroxide [GO:0042542]; zymogen activation [GO:0031638]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=HP&keywords=HP	0.4955123878880292	524	9326.39	71	0.002168553422589948	889	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
HPX	hemopexin	No		ENSG00000110169	P02790	Hemopexin family	1	ligand	extracellular, intracellular, ligand, secreted	Q07954	LRP1	LRP1 [CellTalkDB:31078524]	blood microparticle [GO:0072562]; collagen-containing extracellular matrix [GO:0062023]; endocytic vesicle lumen [GO:0071682]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	heme transmembrane transporter activity [GO:0015232]; metal ion binding [GO:0046872]	cellular iron ion homeostasis [GO:0006879]; heme metabolic process [GO:0042168]; heme transport [GO:0015886]; hemoglobin metabolic process [GO:0020027]; positive regulation of humoral immune response mediated by circulating immunoglobulin [GO:0002925]; positive regulation of immunoglobulin production [GO:0002639]; positive regulation of interferon-gamma-mediated signaling pathway [GO:0060335]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=HPX&keywords=HPX	2.5941395173531325	356	1312.45	149	0.06725385342703555	680	0	9.98003992015968e-4	0	9.592326139088729e-4	0.028619528619528618	0.015228426395939085	0.003626473254759746	0	0.020347761746207907	0.0026372012284684174	0.001043075140042496	234	332	365	0.006678154817351919	1.8196114665295082	0.7577097926516847	0.6621281107519942	39	238	254
HRNR	hornerin			ENSG00000197915	Q86YZ3	S100-fused protein family; S-100 family	1	ligand	intracellular, ligand, secreted	NA	NA	NA	azurophil granule lumen [GO:0035578]; collagen-containing extracellular matrix [GO:0062023]; cornified envelope [GO:0001533]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; keratohyalin granule [GO:0036457]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]	calcium ion binding [GO:0005509]; transition metal ion binding [GO:0046914]	cell envelope organization [GO:0043163]; establishment of skin barrier [GO:0061436]; keratinization [GO:0031424]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=HRNR&keywords=HRNR	0.3678307860674157	554	10986.6	64	2.3509187726439507	136	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
IAPP	islet amyloid polypeptide	Yes		ENSG00000121351	P10997	Calcitonin family	14	ligand	extracellular, intracellular, ligand, secreted	O60894, O60895, O60896, P07550, P13945, P16473, P30988, P32241, P41586, Q03431, Q16602, Q99678, Q9NQS5	ADCYAP1R1, ADRB2, ADRB3, CALCR, CALCRL, GPR20, GPR84, PTH1R, RAMP1, RAMP2, RAMP3, TSHR, VIPR1	CALCR [Baccin2019:10342886;Baccin2019:12529937;Baccin2019:9487987;CellTalkDB:10342886;Cellinker:10342886;Cellinker:12529937;Cellinker:9487987;Guide2Pharma:10342886;Guide2Pharma:24169554;Guide2Pharma:9487987;LRdb:10342886;LRdb:12529937;LRdb:9487987;connectomeDB2020:10342886;connectomeDB2020:12529937;connectomeDB2020:9487987;scConnect:10342886;scConnect:24169554;scConnect:9487987], RAMP1 [Baccin2019:10385705;CellTalkDB:10385705;Cellinker:10385705;Guide2Pharma:24169554;HPRD:10385705;LRdb:10385705;connectomeDB2020:10385705], RAMP2 [Baccin2019:16531504;CellTalkDB:16531504;Cellinker:16531504;Guide2Pharma:24169554;HPRD:16531504;LRdb:16531504;connectomeDB2020:16531504], RAMP3 [CellTalkDB:25409149;Guide2Pharma:24169554], PTH1R [CellTalkDB:32196115], ADCYAP1R1 [CellTalkDB:32196115], VIPR1 [CellTalkDB:32196115], GPR20 [CellTalkDB:32196115], ADRB2 [CellTalkDB:32196115], ADRB3 [CellTalkDB:32196115], TSHR [CellTalkDB:32196115], GPR84 [CellTalkDB:32196115], CALCRL [NA]	extracellular region [GO:0005576]; extracellular space [GO:0005615]; inclusion body [GO:0016234]	amyloid-beta binding [GO:0001540]; hormone activity [GO:0005179]; identical protein binding [GO:0042802]; signaling receptor binding [GO:0005102]	adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; amylin receptor signaling pathway [GO:0097647]; amyloid fibril formation [GO:1990000]; apoptotic process [GO:0006915]; cell-cell signaling [GO:0007267]; eating behavior [GO:0042755]; negative regulation of amyloid fibril formation [GO:1905907]; negative regulation of bone resorption [GO:0045779]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of mitochondrion organization [GO:0010823]; negative regulation of protein-containing complex assembly [GO:0031333]; positive regulation of apoptotic process [GO:0043065]; positive regulation of calcium ion import across plasma membrane [GO:1905665]; positive regulation of cell death [GO:0010942]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein kinase A signaling [GO:0010739]; positive regulation of protein kinase B signaling [GO:0051897]; protein destabilization [GO:0031648]; protein homooligomerization [GO:0051260]; sensory perception of pain [GO:0019233]; signal transduction [GO:0007165]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IAPP&keywords=IAPP	4619.406245803303	7	4685.77	94	13660.331928946169	1	1.6535433070866141	3.6956087824351087	0.3971238938053089	0.4335731414868154	3.7929292929292964	37.343485617597324	49.503173164098044	2.2185970636215315	0.5135035146133958	47.548838296165115	0.4304423411241836	37	2	43	13.41189258317843	0.03900370319380289	3.5433779551901865	0.03281521874762931	513	3	517
ICAM4	intercellular adhesion molecule 4 (Landsteiner-Wiener blood group)	No		ENSG00000105371	Q14773	Immunoglobulin superfamily, ICAM family	6	adhesion, cell_surface_ligand, ligand	adhesion, cell_adhesion, cell_surface, cell_surface_ligand, intracellular, ligand, plasma_membrane, plasma_membrane_transmembrane, secreted, transmembrane, transmembrane_predicted	P05106, P05107, P05556, P06756, P08514, P11215, P13612, P20701, Q02094	ITGA2B, ITGA2B_ITGB3, ITGA4, ITGA4_ITGB1, ITGAL, ITGAM, ITGAV, ITGAV_ITGB3, ITGB1, ITGB2, ITGB3, RHAG	ITGAM [CellTalkDB:10846180;Cellinker:10846180;Cellinker:15355350;HPRD:10846180;LRdb:11;LRdb:15355350;connectomeDB2020:10846180;connectomeDB2020:15355350], ITGAL [CellTalkDB:10846180;Cellinker:15355350;LRdb:15355350;connectomeDB2020:15355350], ITGA4 [CellTalkDB:11435317;Cellinker:11435317;HPRD:11435317;LRdb:11435317;connectomeDB2020:11435317], ITGB3 [CellTalkDB:15355350;Cellinker:15355350;LRdb:15355350;connectomeDB2020:15355350], ITGB2 [Cellinker:10846180;Cellinker:15355350;HPRD:10846180;InnateDB:16985175;LRdb:11;LRdb:15355350;connectomeDB2020:10846180;connectomeDB2020:15355350], ITGB1 [CellTalkDB:11435317;Cellinker:11435317;HPRD:11435317;LRdb:11435317;connectomeDB2020:11435317], RHAG [Baccin2019:8563755;CellTalkDB:8563755;Cellinker:8563755;HPRD:8563755;LRdb:8563755], ITGAV [CellTalkDB:15355350;Cellinker:11435317;Cellinker:15355350;HPRD:11435317;LRdb:11;LRdb:15355350;connectomeDB2020:11435317;connectomeDB2020:15355350], ITGA2B [Cellinker:15355350;LRdb:15355350;connectomeDB2020:15355350]	extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	integrin binding [GO:0005178]	cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=ICAM4&keywords=ICAM4	0.2752479617977528	584	NA	NA	NA	NA	0.023622047244094488	0.00249500998003992	0.0022123893805309734	0.0021582733812949635	0.006734006734006734	0.00338409475465313	0.001813236627379873	0.0016313213703099511	3.699593044765076e-4	1.3352917612498332e-4	0.0020088854548966596	302	405	335	0.004232977582528017	0.7285867798461486	0.7119753486132518	0.8437366942556288	250	247	168
ICOS	inducible T cell costimulator	No		ENSG00000163600	Q9Y6W8	NA	1	adhesion, cell_surface_ligand, ligand, receptor	adhesion, cell_adhesion, cell_surface, cell_surface_ligand, extracellular, ligand, plasma_membrane, plasma_membrane_transmembrane, receptor, secreted, transmembrane, transmembrane_predicted	O00459, O75144, P27986	ICOSLG, PIK3R1, PIK3R2	ICOSLG [BioGRID:11956294;CellPhoneDB:23954143;HPRD:10657606;HPRD:11023515;HPRD:11956294;IntAct:11956294;IntAct:16951355;NetPath:10657606;connectomeDB2020:23954143], PIK3R1 [InnateDB:18641334;IntAct:27135603;NetPath:16217039], PIK3R2 [NetPath:16217039]	extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	NA	cell-cell adhesion [GO:0098609]; immune response [GO:0006955]; T cell costimulation [GO:0031295]; T cell tolerance induction [GO:0002517]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=ICOS&keywords=ICOS	0.03566433370786517	762	NA	NA	0.1388916768121989	586	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
IDE	insulin degrading enzyme	No		ENSG00000119912	P14735	Peptidase M16 family	1	cell_surface_enzyme, ligand, receptor, secreted_enzyme	cell_surface_enzyme, cell_surface_peptidase, extracellular, intracellular, ligand, plasma_membrane, receptor, secreted, secreted_enzyme, secreted_peptidase, transmembrane	P01308	INS	INS [DIP:17051221;HPRD:11145591;HPRD:17051221;IntAct:17051221;SIGNOR:29596046]	basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; peroxisomal matrix [GO:0005782]; peroxisome [GO:0005777]	ATP binding [GO:0005524]; endopeptidase activity [GO:0004175]; identical protein binding [GO:0042802]; insulin binding [GO:0043559]; metalloendopeptidase activity [GO:0004222]; peptide binding [GO:0042277]; protein homodimerization activity [GO:0042803]; ubiquitin-dependent protein binding [GO:0140036]; virus receptor activity [GO:0001618]; zinc ion binding [GO:0008270]	amyloid-beta clearance [GO:0097242]; amyloid-beta clearance by cellular catabolic process [GO:0150094]; amyloid-beta metabolic process [GO:0050435]; antigen processing and presentation of endogenous peptide antigen via MHC class I [GO:0019885]; bradykinin catabolic process [GO:0010815]; cellular protein catabolic process [GO:0044257]; determination of adult lifespan [GO:0008340]; hormone catabolic process [GO:0042447]; insulin catabolic process [GO:1901143]; insulin metabolic process [GO:1901142]; insulin receptor signaling pathway [GO:0008286]; peptide catabolic process [GO:0043171]; positive regulation of protein binding [GO:0032092]; positive regulation of protein catabolic process [GO:0045732]; protein catabolic process [GO:0030163]; proteolysis [GO:0006508]; proteolysis involved in cellular protein catabolic process [GO:0051603]; regulation of aerobic respiration [GO:1903715]; ubiquitin recycling [GO:0010992]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IDE&keywords=IDE	19.0413573448675	172	8825.17	73	1.7896649915599223	179	0.10236220472440945	0.15668662674650755	0.04424778761061951	0.08105515587530017	0.11784511784511803	0.10321489001692041	0.07615593834995454	0.05220228384991847	0.03847576766555677	0.052844171451464035	0.04330693451806011	188	142	159	0.07894517078671173	0.5450073032272931	0.7065495618886692	0.5993235388337023	330	249	286
IFNA1	interferon alpha 1	Yes		ENSG00000197919	P01562	Alpha/beta interferon family	15	ligand	extracellular, ligand, secreted	P17181, P20023, P48551, P60568, Q00978	CR2, IFNA2_IFNAR1_IFNAR2, IFNAR1, IFNAR1_IFNAR2, IFNAR2, IL2, IRF9	IFNAR1 [CellTalkDB:11698684;CellTalkDB:21856167;HPMR:11698684;HPRD:7932753;LRdb:11698684;LRdb:79;Ramilowski2015:21856167;SIGNOR:8181059;SignaLink3:23331499;SignaLink3:8181059;connectomeDB2020:11698684;connectomeDB2020:21856167;connectomeDB2020:7932753;talklr:21856167], IFNAR2 [CellTalkDB:11698684;CellTalkDB:21856167;DIP:10395669;HPMR:11698684;LRdb:11698684;Ramilowski2015:21856167;SIGNOR:11278538;SignaLink3:23331499;SignaLink3:8181059;connectomeDB2020:11698684;connectomeDB2020:21856167;talklr:21856167], CR2 [CellTalkDB:16785534;Cellinker:16785534;HPRD:1849076;InnateDB:19164292], IRF9 [HPRD:8454630], IL2 [HPRD:3262520]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	cytokine activity [GO:0005125]; type I interferon receptor binding [GO:0005132]	adaptive immune response [GO:0002250]; B cell differentiation [GO:0030183]; B cell proliferation [GO:0042100]; cytokine-mediated signaling pathway [GO:0019221]; defense response to virus [GO:0051607]; humoral immune response [GO:0006959]; natural killer cell activation involved in immune response [GO:0002323]; positive regulation of peptidyl-serine phosphorylation of STAT protein [GO:0033141]; response to exogenous dsRNA [GO:0043330]; T cell activation involved in immune response [GO:0002286]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IFNA1&keywords=IFNA1	0.010795493258426967	824	NA	NA	0.9919328243467841	269	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
IFNA10	interferon alpha 10	Yes		ENSG00000186803	P01566	Alpha/beta interferon family	15	ligand	extracellular, ligand, secreted	P17181, P48551	IFNA2_IFNAR1_IFNAR2, IFNAR1, IFNAR1_IFNAR2, IFNAR2	IFNAR1 [CellTalkDB:21856167;LRdb:21856167;Ramilowski2015:21856167;connectomeDB2020:21856167;talklr:21856167], IFNAR2 [CellTalkDB:21856167;LRdb:21856167;Ramilowski2015:21856167;connectomeDB2020:21856167;talklr:21856167]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	cytokine activity [GO:0005125]; type I interferon receptor binding [GO:0005132]	adaptive immune response [GO:0002250]; B cell differentiation [GO:0030183]; B cell proliferation [GO:0042100]; cytokine-mediated signaling pathway [GO:0019221]; defense response to virus [GO:0051607]; humoral immune response [GO:0006959]; natural killer cell activation involved in immune response [GO:0002323]; positive regulation of peptidyl-serine phosphorylation of STAT protein [GO:0033141]; response to exogenous dsRNA [GO:0043330]; T cell activation involved in immune response [GO:0002286]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IFNA10&keywords=IFNA10	0.0022577629213483144	877	NA	NA	1.2257762921348316	236	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
IFNA13	interferon alpha 13	Yes		ENSG00000233816	P01562	Alpha/beta interferon family	15	ligand	extracellular, ligand, secreted	P17181, P20023, P48551, P60568, Q00978	CR2, IFNA2_IFNAR1_IFNAR2, IFNAR1, IFNAR1_IFNAR2, IFNAR2, IL2, IRF9	IFNAR1 [CellTalkDB:11698684;CellTalkDB:21856167;HPMR:11698684;HPRD:7932753;LRdb:11698684;LRdb:79;Ramilowski2015:21856167;SIGNOR:8181059;SignaLink3:23331499;SignaLink3:8181059;connectomeDB2020:11698684;connectomeDB2020:21856167;connectomeDB2020:7932753;talklr:21856167], IFNAR2 [CellTalkDB:11698684;CellTalkDB:21856167;DIP:10395669;HPMR:11698684;LRdb:11698684;Ramilowski2015:21856167;SIGNOR:11278538;SignaLink3:23331499;SignaLink3:8181059;connectomeDB2020:11698684;connectomeDB2020:21856167;talklr:21856167], CR2 [CellTalkDB:16785534;Cellinker:16785534;HPRD:1849076;InnateDB:19164292], IRF9 [HPRD:8454630], IL2 [HPRD:3262520]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	cytokine activity [GO:0005125]; type I interferon receptor binding [GO:0005132]	adaptive immune response [GO:0002250]; B cell differentiation [GO:0030183]; B cell proliferation [GO:0042100]; cytokine-mediated signaling pathway [GO:0019221]; defense response to virus [GO:0051607]; humoral immune response [GO:0006959]; natural killer cell activation involved in immune response [GO:0002323]; positive regulation of peptidyl-serine phosphorylation of STAT protein [GO:0033141]; response to exogenous dsRNA [GO:0043330]; T cell activation involved in immune response [GO:0002286]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IFNA13&keywords=IFNA13	0.02391363370786517	782	NA	NA	0.9304345247151247	278	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
IFNA14	interferon alpha 14	Yes		ENSG00000228083	P01570	Alpha/beta interferon family	15	ligand	extracellular, ligand, secreted	P17181, P48551	IFNA2_IFNAR1_IFNAR2, IFNAR1, IFNAR1_IFNAR2, IFNAR2	IFNAR1 [CellTalkDB:21856167;LRdb:21856167;Ramilowski2015:21856167;connectomeDB2020:21856167;talklr:21856167], IFNAR2 [CellTalkDB:21856167;LRdb:21856167;Ramilowski2015:21856167;connectomeDB2020:21856167;talklr:21856167]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	cytokine activity [GO:0005125]; cytokine receptor binding [GO:0005126]; type I interferon receptor binding [GO:0005132]	adaptive immune response [GO:0002250]; B cell differentiation [GO:0030183]; B cell proliferation [GO:0042100]; cytokine-mediated signaling pathway [GO:0019221]; defense response to virus [GO:0051607]; humoral immune response [GO:0006959]; natural killer cell activation involved in immune response [GO:0002323]; positive regulation of peptidyl-serine phosphorylation of STAT protein [GO:0033141]; response to exogenous dsRNA [GO:0043330]; T cell activation involved in immune response [GO:0002286]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IFNA14&keywords=IFNA14	0.005460460674157303	853	NA	NA	1.3942429595275012	213	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
IFNA16	interferon alpha 16	Yes		ENSG00000147885	P05015	Alpha/beta interferon family	15	ligand	extracellular, ligand, secreted	P17181, P48551	IFNA2_IFNAR1_IFNAR2, IFNAR1, IFNAR1_IFNAR2, IFNAR2	IFNAR1 [CellTalkDB:21856167;LRdb:21856167;Ramilowski2015:21856167;connectomeDB2020:21856167;talklr:21856167], IFNAR2 [CellTalkDB:21856167;LRdb:21856167;Ramilowski2015:21856167;connectomeDB2020:21856167;talklr:21856167]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	cytokine activity [GO:0005125]; type I interferon receptor binding [GO:0005132]	adaptive immune response [GO:0002250]; B cell differentiation [GO:0030183]; B cell proliferation [GO:0042100]; cytokine-mediated signaling pathway [GO:0019221]; defense response to virus [GO:0051607]; humoral immune response [GO:0006959]; natural killer cell activation involved in immune response [GO:0002323]; positive regulation of peptidyl-serine phosphorylation of STAT protein [GO:0033141]; response to exogenous dsRNA [GO:0043330]; T cell activation involved in immune response [GO:0002286]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IFNA16&keywords=IFNA16	0.003840503370786517	862	NA	NA	1.3840503370786517	214	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
IFNA17	interferon alpha 17	Yes		ENSG00000234829	P01571	Alpha/beta interferon family	15	ligand	extracellular, ligand, secreted	P17181, P48551	IFNA2_IFNAR1_IFNAR2, IFNAR1, IFNAR1_IFNAR2, IFNAR2	IFNAR1 [CellTalkDB:21856167;LRdb:21856167;Macrophage:7623815;Ramilowski2015:21856167;connectomeDB2020:21856167;talklr:21856167], IFNAR2 [CellTalkDB:21856167;LRdb:21856167;Macrophage:7623815;Ramilowski2015:21856167;connectomeDB2020:21856167;talklr:21856167]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	cytokine activity [GO:0005125]; type I interferon receptor binding [GO:0005132]	adaptive immune response [GO:0002250]; B cell differentiation [GO:0030183]; B cell proliferation [GO:0042100]; cytokine-mediated signaling pathway [GO:0019221]; defense response to virus [GO:0051607]; humoral immune response [GO:0006959]; natural killer cell activation involved in immune response [GO:0002323]; positive regulation of peptidyl-serine phosphorylation of STAT protein [GO:0033141]; response to exogenous dsRNA [GO:0043330]; response to virus [GO:0009615]; T cell activation involved in immune response [GO:0002286]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IFNA17&keywords=IFNA17	0.0011298539325842697	892	NA	NA	1.0610789814545327	252	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
IFNA2	interferon alpha 2	Yes	manually added ensembl_gene_ID, hgnc_symbol, and description by searching the uniprot ID on genenames.org	ENSG00000188379	P01563	Alpha/beta interferon family	15	ligand	extracellular, ligand, secreted	P17181, P20023, P48551	CR2, IFNA2_IFNAR1_IFNAR2, IFNAR1, IFNAR1_IFNAR2, IFNAR2, IRF9_STAT1_STAT2	IFNAR1 [CellTalkDB:1834641;DIP:7592797;DIP:9334213;HPRD:1834641;LRdb:1834641;connectomeDB2020:1834641], IFNAR2 [CellTalkDB:10339405;DIP:10395669;DIP:10984492;HPRD:10339405;HPRD:11888273;InnateDB:10339405;InnateDB:17001036;InnateDB:18027911;InnateDB:21854986;LRdb:10339405;LRdb:12;Lit-BM-17:10339405;Lit-BM-17:10395669;Lit-BM-17:10984492;Lit-BM-17:21854986;connectomeDB2020:10339405;connectomeDB2020:11888273], CR2 [Cellinker:16785534]	collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	cytokine activity [GO:0005125]; type I interferon receptor binding [GO:0005132]	adaptive immune response [GO:0002250]; apoptotic process [GO:0006915]; B cell differentiation [GO:0030183]; B cell proliferation [GO:0042100]; cell-cell signaling [GO:0007267]; cell surface receptor signaling pathway [GO:0007166]; cytokine-mediated signaling pathway [GO:0019221]; defense response to virus [GO:0051607]; humoral immune response [GO:0006959]; inflammatory response [GO:0006954]; natural killer cell activation involved in immune response [GO:0002323]; negative regulation of gene expression [GO:0010629]; negative regulation of interleukin-13 production [GO:0032696]; negative regulation of interleukin-5 production [GO:0032714]; negative regulation of T cell differentiation [GO:0045581]; negative regulation of T-helper 2 cell cytokine production [GO:2000552]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of viral entry into host cell [GO:0046597]; positive regulation of peptidyl-serine phosphorylation of STAT protein [GO:0033141]; positive regulation of phosphorylation [GO:0042327]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; response to exogenous dsRNA [GO:0043330]; T cell activation involved in immune response [GO:0002286]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IFNA2&keywords=IFNA2	0	899	NA	NA	0.08678857117950202	650	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
IFNA21	interferon alpha 21	Yes		ENSG00000137080	P01568	Alpha/beta interferon family	15	ligand	extracellular, ligand, secreted	P17181, P48551	IFNA2_IFNAR1_IFNAR2, IFNAR1, IFNAR1_IFNAR2, IFNAR2	IFNAR1 [CellTalkDB:21856167;LRdb:21856167;Ramilowski2015:21856167;connectomeDB2020:21856167;talklr:21856167], IFNAR2 [CellTalkDB:21856167;LRdb:21856167;Ramilowski2015:21856167;connectomeDB2020:21856167;talklr:21856167]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	cytokine activity [GO:0005125]; cytokine receptor binding [GO:0005126]; type I interferon receptor binding [GO:0005132]	adaptive immune response [GO:0002250]; B cell differentiation [GO:0030183]; B cell proliferation [GO:0042100]; cytokine-mediated signaling pathway [GO:0019221]; defense response to virus [GO:0051607]; humoral immune response [GO:0006959]; natural killer cell activation involved in immune response [GO:0002323]; positive regulation of peptidyl-serine phosphorylation of STAT protein [GO:0033141]; response to exogenous dsRNA [GO:0043330]; T cell activation involved in immune response [GO:0002286]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IFNA21&keywords=IFNA21	0.05989663370786517	716	NA	NA	1.0437899403417967	257	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
IFNA4	interferon alpha 4	Yes		ENSG00000236637	P05014	Alpha/beta interferon family	15	ligand	extracellular, ligand, secreted	P17181, P48551	IFNA2_IFNAR1_IFNAR2, IFNAR1, IFNAR1_IFNAR2, IFNAR2	IFNAR1 [CellTalkDB:21856167;LRdb:21856167;Ramilowski2015:21856167;connectomeDB2020:21856167;talklr:21856167], IFNAR2 [CellTalkDB:21856167;LRdb:21856167;Ramilowski2015:21856167;connectomeDB2020:21856167;talklr:21856167]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	cytokine activity [GO:0005125]; type I interferon receptor binding [GO:0005132]	adaptive immune response [GO:0002250]; B cell differentiation [GO:0030183]; B cell proliferation [GO:0042100]; cytokine-mediated signaling pathway [GO:0019221]; defense response to virus [GO:0051607]; humoral immune response [GO:0006959]; natural killer cell activation involved in immune response [GO:0002323]; positive regulation of peptidyl-serine phosphorylation of STAT protein [GO:0033141]; response to exogenous dsRNA [GO:0043330]; response to virus [GO:0009615]; T cell activation involved in immune response [GO:0002286]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IFNA4&keywords=IFNA4	0.008917930337078652	833	NA	NA	1.8917930337078652	170	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
IFNA5	interferon alpha 5	Yes		ENSG00000147873	P01569	Alpha/beta interferon family	15	ligand	extracellular, ligand, secreted	P17181, P48551	IFNA2_IFNAR1_IFNAR2, IFNAR1, IFNAR1_IFNAR2, IFNAR2	IFNAR1 [CellTalkDB:21856167;LRdb:21856167;Ramilowski2015:21856167;connectomeDB2020:21856167;talklr:21856167], IFNAR2 [CellTalkDB:10395669;DIP:10395669;HPRD:10395669;LRdb:10395669;connectomeDB2020:10395669]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	cytokine activity [GO:0005125]; cytokine receptor binding [GO:0005126]; type I interferon receptor binding [GO:0005132]	adaptive immune response [GO:0002250]; B cell differentiation [GO:0030183]; B cell proliferation [GO:0042100]; cytokine-mediated signaling pathway [GO:0019221]; defense response to virus [GO:0051607]; humoral immune response [GO:0006959]; natural killer cell activation involved in immune response [GO:0002323]; positive regulation of peptidyl-serine phosphorylation of STAT protein [GO:0033141]; response to exogenous dsRNA [GO:0043330]; T cell activation involved in immune response [GO:0002286]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IFNA5&keywords=IFNA5	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
IFNA6	interferon alpha 6	Yes		ENSG00000120235	P05013	Alpha/beta interferon family	15	ligand	extracellular, ligand, secreted	P17181, P48551	IFNA2_IFNAR1_IFNAR2, IFNAR1, IFNAR1_IFNAR2, IFNAR2	IFNAR1 [CellTalkDB:21856167;LRdb:21856167;Ramilowski2015:21856167;connectomeDB2020:21856167;talklr:21856167], IFNAR2 [CellTalkDB:21856167;LRdb:21856167;Ramilowski2015:21856167;connectomeDB2020:21856167;talklr:21856167]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	cytokine activity [GO:0005125]; type I interferon receptor binding [GO:0005132]	adaptive immune response [GO:0002250]; B cell differentiation [GO:0030183]; B cell proliferation [GO:0042100]; cytokine-mediated signaling pathway [GO:0019221]; defense response to virus [GO:0051607]; humoral immune response [GO:0006959]; natural killer cell activation involved in immune response [GO:0002323]; positive regulation of peptidyl-serine phosphorylation of STAT protein [GO:0033141]; response to exogenous dsRNA [GO:0043330]; T cell activation involved in immune response [GO:0002286]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IFNA6&keywords=IFNA6	4.178415730337079e-4	898	NA	NA	0.18094529472867543	546	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
IFNA7	interferon alpha 7	Yes		ENSG00000214042	P01567	Alpha/beta interferon family	15	ligand	extracellular, ligand, secreted	P17181, P48551	IFNA2_IFNAR1_IFNAR2, IFNAR1, IFNAR1_IFNAR2, IFNAR2	IFNAR1 [CellTalkDB:21856167;LRdb:21856167;Ramilowski2015:21856167;connectomeDB2020:21856167;talklr:21856167], IFNAR2 [CellTalkDB:21856167;LRdb:21856167;Ramilowski2015:21856167;connectomeDB2020:21856167;talklr:21856167]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	cytokine activity [GO:0005125]; type I interferon receptor binding [GO:0005132]	adaptive immune response [GO:0002250]; B cell differentiation [GO:0030183]; B cell proliferation [GO:0042100]; cell-cell signaling [GO:0007267]; cytokine-mediated signaling pathway [GO:0019221]; defense response to virus [GO:0051607]; humoral immune response [GO:0006959]; natural killer cell activation involved in immune response [GO:0002323]; positive regulation of peptidyl-serine phosphorylation of STAT protein [GO:0033141]; response to exogenous dsRNA [GO:0043330]; response to virus [GO:0009615]; T cell activation involved in immune response [GO:0002286]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IFNA7&keywords=IFNA7	0	899	NA	NA	0.9389250143186064	276	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
IFNA8	interferon alpha 8	Yes		ENSG00000120242	P32881	Alpha/beta interferon family	15	ligand	extracellular, intracellular, ligand, secreted	P17181, P48551, Q8TDT2	GPR152, IFNA2_IFNAR1_IFNAR2, IFNAR1, IFNAR1_IFNAR2, IFNAR2	IFNAR1 [CellTalkDB:21856167;DIP:7592797;LRdb:21856167;Ramilowski2015:21856167;connectomeDB2020:21856167;talklr:21856167], IFNAR2 [CellTalkDB:8969169;DIP:10395669;HPRD:8969169;LRdb:8969169;connectomeDB2020:8969169], GPR152 [NA]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	cytokine activity [GO:0005125]; cytokine receptor binding [GO:0005126]; type I interferon receptor binding [GO:0005132]	adaptive immune response [GO:0002250]; B cell differentiation [GO:0030183]; B cell proliferation [GO:0042100]; cytokine-mediated signaling pathway [GO:0019221]; defense response to virus [GO:0051607]; humoral immune response [GO:0006959]; natural killer cell activation involved in immune response [GO:0002323]; positive regulation of peptidyl-serine phosphorylation of STAT protein [GO:0033141]; response to exogenous dsRNA [GO:0043330]; T cell activation involved in immune response [GO:0002286]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IFNA8&keywords=IFNA8	0.002769541573033708	869	NA	NA	0.5899899559530738	344	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
IFNAR2	interferon alpha and beta receptor subunit 2	No		ENSG00000159110	P48551	Type II cytokine receptor family	1	adhesion, ligand, receptor	adhesion, cell_adhesion, cell_surface, extracellular, intracellular, ligand, plasma_membrane, plasma_membrane_transmembrane, receptor, secreted, transmembrane, transmembrane_predicted	P21860, P23458, P29597, P42224, P52630, Q00978	ERBB3, IRF9, JAK1, STAT1, STAT2, TYK2	JAK1 [HPRD:12133952;InnateDB:12133952;Macrophage:9334213;SignaLink3:12133952;SignaLink3:18988627;SignaLink3:23180781;SignaLink3:23331499;SignaLink3:7988557], TYK2 [HPRD:12960323;SignaLink3:12040185;SignaLink3:12960323;SignaLink3:18988627;SignaLink3:23331499], IRF9 [InnateDB:17923090;InnateDB:18456457;IntAct:17923090;Lit-BM-17:17923090], ERBB3 [Cellinker:14647452], STAT2 [HPRD:11786546;HPRD:9121453;InnateDB:11786546;InnateDB:12220192;InnateDB:18456457;InnateDB:9121453;IntAct:17923090;IntAct:9121453], STAT1 [HPRD:11301323;InnateDB:9121453]	extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	cytokine receptor activity [GO:0004896]; protein kinase binding [GO:0019901]; type I interferon binding [GO:0019962]; type I interferon receptor activity [GO:0004905]	cell surface receptor signaling pathway [GO:0007166]; cytokine-mediated signaling pathway [GO:0019221]; defense response to virus [GO:0051607]; receptor signaling pathway via JAK-STAT [GO:0007259]; response to interferon-alpha [GO:0035455]; response to interferon-beta [GO:0035456]; response to virus [GO:0009615]; type I interferon signaling pathway [GO:0060337]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IFNAR2&keywords=IFNAR2	34.34540924341212	124	NA	NA	2.5955660502099986	125	0.1417322834645669	0.22405189620758661	0.12721238938053112	0.07002398081534789	0.12457912457912478	0.09813874788494073	0.1051677243880324	0.06688417618270806	0.03477617462079168	0.0756776605688359	0.062584508402548	197	121	140	0.10280260604500129	0.39694273200504565	0.7595361807036248	0.6434648183003082	379	236	263
IFNB1	interferon beta 1	Yes		ENSG00000171855	P01574	Alpha/beta interferon family	16	ligand	extracellular, intracellular, ligand, secreted	P17181, P23458, P29597, P48551	IFNA2_IFNAR1_IFNAR2, IFNAR1, IFNAR1_IFNAR2, IFNAR2, JAK1, TYK2	IFNAR1 [Baccin2019:112785381834641;CellTalkDB:11278538;DIP:10049744;DIP:7592797;Guide2Pharma:29311663;HPRD:1834641;LRdb:11278538;LRdb:18;Macrophage:7623815;SIGNOR:11278538;SignaLink3:1834641;SignaLink3:18988627;SignaLink3:23331499;SignaLink3:8181059;connectomeDB2020:11278538;connectomeDB2020:1834641;scConnect:29311663], IFNAR2 [Baccin2019:1127853810395660;CellTalkDB:11278538;DIP:10395669;HPRD:10395669;LRdb:1;LRdb:11278538;Macrophage:7623815;SIGNOR:11278538;SignaLink3:23331499;SignaLink3:8181059;connectomeDB2020:10395669;connectomeDB2020:11278538], TYK2 [SignaLink3:10542297;SignaLink3:23331499], JAK1 [SignaLink3:10918594;SignaLink3:23331499]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	chloramphenicol O-acetyltransferase activity [GO:0008811]; cytokine activity [GO:0005125]; type I interferon receptor binding [GO:0005132]	adaptive immune response [GO:0002250]; B cell activation involved in immune response [GO:0002312]; B cell differentiation [GO:0030183]; B cell proliferation [GO:0042100]; cell surface receptor signaling pathway [GO:0007166]; cellular response to exogenous dsRNA [GO:0071360]; cellular response to interferon-beta [GO:0035458]; cellular response to virus [GO:0098586]; cytokine-mediated signaling pathway [GO:0019221]; defense response to virus [GO:0051607]; humoral immune response [GO:0006959]; natural killer cell activation [GO:0030101]; natural killer cell activation involved in immune response [GO:0002323]; negative regulation of T cell differentiation [GO:0045581]; negative regulation of T-helper 2 cell cytokine production [GO:2000552]; negative regulation of viral genome replication [GO:0045071]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of innate immune response [GO:0045089]; positive regulation of peptidyl-serine phosphorylation of STAT protein [GO:0033141]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of MHC class I biosynthetic process [GO:0045343]; response to exogenous dsRNA [GO:0043330]; response to virus [GO:0009615]; T cell activation involved in immune response [GO:0002286]; type I interferon signaling pathway [GO:0060337]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IFNB1&keywords=IFNB1	0.012596197752808989	818	NA	NA	1.80358098361026	177	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
IFNE	interferon epsilon	Yes		ENSG00000184995	Q86WN2	Alpha/beta interferon family	9	ligand	extracellular, ligand, secreted	P17181, P48551, Q8WXG9	ADGRV1, IFNA2_IFNAR1_IFNAR2, IFNAR1, IFNAR1_IFNAR2, IFNAR2	IFNAR1 [CellTalkDB:32196115;connectomeDB2020:22410872], IFNAR2 [CellTalkDB:32196115;connectomeDB2020:22410872], ADGRV1 [CellTalkDB:32103204]	extracellular space [GO:0005615]	cytokine activity [GO:0005125]; type I interferon receptor binding [GO:0005132]	adaptive immune response [GO:0002250]; B cell differentiation [GO:0030183]; B cell proliferation [GO:0042100]; cytokine-mediated signaling pathway [GO:0019221]; defense response to bacterium [GO:0042742]; defense response to virus [GO:0051607]; humoral immune response [GO:0006959]; natural killer cell activation involved in immune response [GO:0002323]; positive regulation of peptidyl-serine phosphorylation of STAT protein [GO:0033141]; response to exogenous dsRNA [GO:0043330]; T cell activation involved in immune response [GO:0002286]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IFNE&keywords=IFNE	0.06560487191011236	704	NA	NA	0.22393003731757127	517	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
IFNG	interferon gamma	Yes		ENSG00000111537	P01579	Type II (or gamma) interferon family	17	ligand	extracellular, intracellular, ligand, secreted, transmembrane	P01375, P15260, P28062, P28065, P38484, P40238, P40306, Q06323, Q9UL46	IFNG_IFNGR1, IFNGR1, IFNGR1_IFNGR2, IFNGR2, MPL, PSMB10, PSMB8, PSMB9, PSME1, PSME2, TNF	IFNGR1 [Baccin2019:10811850;Baccin2019:10986460;Baccin2019:11250200;Baccin2019:12165521;BioGRID:10986460;CellTalkDB:10811850;DIP:10860730;DIP:7617032;HPMR:10811850;HPMR:12438563;HPRD:10986460;HPRD:11250200;HPRD:12165521;InnateDB:10986460;InnateDB:7673114;IntAct:11250200;IntAct:7617032;LRdb:10811850;LRdb:10986460;LRdb:11250200;LRdb:12165521;Lit-BM-17:10860730;Lit-BM-17:10986460;Lit-BM-17:11250200;Lit-BM-17:7617032;Lit-BM-17:7673114;Macrophage:7617032;SIGNOR:10986460;SIGNOR:12438563;SIGNOR:23898330;SPIKE:16110316;SignaLink3:10986460;SignaLink3:11250200;SignaLink3:12165521;SignaLink3:12438563;SignaLink3:12915721;SignaLink3:1396683;SignaLink3:15143187;SignaLink3:15530433;SignaLink3:16237089;SignaLink3:16467876;SignaLink3:18591661;SignaLink3:18988627;SignaLink3:20304997;SignaLink3:23331499;SignaLink3:29145629;SignaLink3:7510216;SignaLink3:7514165;SignaLink3:7615558;SignaLink3:7617032;SignaLink3:7673114;SignaLink3:8550631;SignaLink3:8631301;SignaLink3:9111318;connectomeDB2020:10811850;connectomeDB2020:10986460;connectomeDB2020:11250200;connectomeDB2020:12165521], IFNGR2 [CellTalkDB:10811850;HPMR:10811850;HPMR:12438563;HPRD:7673114;InnateDB:7673114;LRdb:10811850;LRdb:77;SIGNOR:7673114;SignaLink3:10986460;SignaLink3:12438563;SignaLink3:12915721;SignaLink3:1396683;SignaLink3:15143187;SignaLink3:15530433;SignaLink3:16237089;SignaLink3:16467876;SignaLink3:18591661;SignaLink3:18988627;SignaLink3:20304997;SignaLink3:23331499;SignaLink3:29145629;SignaLink3:7510216;SignaLink3:7514165;SignaLink3:7615558;SignaLink3:7617032;SignaLink3:7673114;SignaLink3:8550631;SignaLink3:8631301;SignaLink3:9111318;connectomeDB2020:10811850;connectomeDB2020:7673114], PSME1 [Macrophage:8051173], PSME2 [Macrophage:8051173], PSMB8 [Macrophage:8811196], PSMB9 [Macrophage:8811196], PSMB10 [Macrophage:8811196], MPL [Cellinker:30803992], TNF [HPRD:3139842]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	cytokine activity [GO:0005125]; interferon-gamma receptor binding [GO:0005133]	adaptive immune response [GO:0002250]; apoptotic process [GO:0006915]; astrocyte activation [GO:0048143]; cell surface receptor signaling pathway [GO:0007166]; defense response to virus [GO:0051607]; extrinsic apoptotic signaling pathway [GO:0097191]; humoral immune response [GO:0006959]; interferon-gamma-mediated signaling pathway [GO:0060333]; macrophage activation involved in immune response [GO:0002281]; macrophage differentiation [GO:0030225]; microglial cell activation [GO:0001774]; negative regulation of amyloid-beta clearance [GO:1900222]; negative regulation of epithelial cell differentiation [GO:0030857]; negative regulation of gene expression [GO:0010629]; negative regulation of interleukin-17 production [GO:0032700]; negative regulation of smooth muscle cell proliferation [GO:0048662]; negative regulation of tau-protein kinase activity [GO:1902948]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuroinflammatory response [GO:0150076]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of autophagy [GO:0010508]; positive regulation of calcidiol 1-monooxygenase activity [GO:0060559]; positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation involved in immune response [GO:0032834]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cellular respiration [GO:1901857]; positive regulation of chemokine production [GO:0032722]; positive regulation of core promoter binding [GO:1904798]; positive regulation of cytokine production [GO:0001819]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of fructose 1,6-bisphosphate 1-phosphatase activity [GO:0060550]; positive regulation of fructose 1,6-bisphosphate metabolic process [GO:0060552]; positive regulation of gene expression [GO:0010628]; positive regulation of glycolytic process [GO:0045821]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-23 production [GO:0032747]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of iron ion import across plasma membrane [GO:1904440]; positive regulation of killing of cells of other organism [GO:0051712]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; positive regulation of MHC class II biosynthetic process [GO:0045348]; positive regulation of neurogenesis [GO:0050769]; positive regulation of neuron death [GO:1901216]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of nitrogen compound metabolic process [GO:0051173]; positive regulation of NMDA glutamate receptor activity [GO:1904783]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of peptidyl-serine phosphorylation of STAT protein [GO:0033141]; positive regulation of phagocytosis [GO:0050766]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of protein deacetylation [GO:0090312]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of signaling receptor activity [GO:2000273]; positive regulation of smooth muscle cell apoptotic process [GO:0034393]; positive regulation of tumor necrosis factor (ligand) superfamily member 11 production [GO:2000309]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; positive regulation of vitamin D biosynthetic process [GO:0060557]; receptor signaling pathway via JAK-STAT [GO:0007259]; regulation of growth [GO:0040008]; regulation of insulin secretion [GO:0050796]; regulation of protein ADP-ribosylation [GO:0010835]; response to virus [GO:0009615]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IFNG&keywords=IFNG	0.01045254382022472	827	NA	NA	0.14960732403750263	576	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
IFNK	interferon kappa	Yes		ENSG00000147896	Q9P0W0	Alpha/beta interferon family	11	ligand	ligand, secreted, transmembrane, transmembrane_predicted	P17181, P48551	IFNA2_IFNAR1_IFNAR2, IFNAR1, IFNAR1_IFNAR2, IFNAR2	IFNAR1 [SignaLink3:17208301;SignaLink3:23331499;connectomeDB2020:22410872], IFNAR2 [SignaLink3:17208301;SignaLink3:23331499;connectomeDB2020:22410872]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	cytokine activity [GO:0005125]; type I interferon receptor binding [GO:0005132]	adaptive immune response [GO:0002250]; B cell differentiation [GO:0030183]; B cell proliferation [GO:0042100]; cytokine-mediated signaling pathway [GO:0019221]; defense response to virus [GO:0051607]; humoral immune response [GO:0006959]; natural killer cell activation [GO:0030101]; natural killer cell activation involved in immune response [GO:0002323]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of innate immune response [GO:0045089]; positive regulation of peptidyl-serine phosphorylation of STAT protein [GO:0033141]; regulation of transcription, DNA-templated [GO:0006355]; response to exogenous dsRNA [GO:0043330]; response to virus [GO:0009615]; T cell activation involved in immune response [GO:0002286]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IFNK&keywords=IFNK	NA	NA	NA	NA	NA	NA	0	0.001497005988023952	0	0	0	0	0	0	0.004439511653718092	0	0	289	409	401	5.396834219765494e-4	1.3700137922178872	0.9487951012977066	0.9487951012977066	66	151	118
IFNL1	interferon lambda 1	Yes		ENSG00000182393	Q8IU54	Lambda interferon family	14	ligand	extracellular, ligand, secreted, transmembrane	Q08334, Q8IU57	IFNLR1, IFNLR1_IL10RB, IL10RB	IL10RB [CellTalkDB:12974481;Cellinker:12974481;LRdb:12974481;SIGNOR:12469119;SignaLink3:17208301;SignaLink3:23331499;connectomeDB2020:12974481], IFNLR1 [CellTalkDB:12974481;HPRD:12469119;LRdb:12;LRdb:12974481;SIGNOR:12469119;SignaLink3:17208301;SignaLink3:23331499;connectomeDB2020:12469119;connectomeDB2020:12974481]	extracellular region [GO:0005576]; extracellular space [GO:0005615]; interleukin-28 receptor complex [GO:0032002]	cytokine activity [GO:0005125]; interleukin-28 receptor binding [GO:0032003]; signaling receptor binding [GO:0005102]	defense response to virus [GO:0051607]; innate immune response [GO:0045087]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of interleukin-13 production [GO:0032696]; negative regulation of interleukin-5 production [GO:0032714]; negative regulation of memory T cell differentiation [GO:0043381]; negative regulation of T cell differentiation [GO:0045581]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of type 2 immune response [GO:0002829]; positive regulation of immune response [GO:0050778]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of MHC class I biosynthetic process [GO:0045345]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; receptor signaling pathway via JAK-STAT [GO:0007259]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IFNL1&keywords=IFNL1	0.004813251685393258	857	NA	NA	0.7281096370393103	315	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
IFNL2	interferon lambda 2	Yes		ENSG00000183709	Q8IZJ0	Lambda interferon family	14	ligand	extracellular, ligand, secreted	Q08334, Q8IU57	IFNLR1, IFNLR1_IL10RB, IL10RB	IL10RB [CellTalkDB:12974481;Cellinker:12469119;Cellinker:12974481;HPRD:12469119;LRdb:12;LRdb:12974481;SIGNOR:12469119;SignaLink3:12469119;SignaLink3:17208301;SignaLink3:23331499;connectomeDB2020:12469119;connectomeDB2020:12974481], IFNLR1 [CellTalkDB:12974481;Cellinker:12469119;Cellinker:12974481;HPRD:12469119;LRdb:12;LRdb:12974481;SIGNOR:12469119;SignaLink3:17208301;SignaLink3:23331499;connectomeDB2020:12469119;connectomeDB2020:12974481]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	cytokine activity [GO:0005125]; signaling receptor binding [GO:0005102]	defense response to virus [GO:0051607]; innate immune response [GO:0045087]; mucosal immune response [GO:0002385]; positive regulation of immune response [GO:0050778]; receptor signaling pathway via JAK-STAT [GO:0007259]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IFNL2&keywords=IFNL2	0.00667653595505618	845	NA	NA	0.6696846674540722	323	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
IFNL3	interferon lambda 3	Yes		ENSG00000197110	Q8IZI9	Lambda interferon family	15	ligand	extracellular, ligand, secreted	Q08334, Q8IU57	IFNL3_IFNLR1_IL10RB, IFNLR1, IFNLR1_IL10RB, IL10RB	IL10RB [CellTalkDB:12974481;Cellinker:12469119;Cellinker:12974481;HPRD:12469119;LRdb:12;LRdb:12974481;SIGNOR:12469119;SignaLink3:12469119;SignaLink3:17208301;SignaLink3:23331499;connectomeDB2020:12469119;connectomeDB2020:12974481], IFNLR1 [CellTalkDB:12974481;LRdb:12974481;SIGNOR:12469119;SignaLink3:17208301;SignaLink3:23331499;connectomeDB2020:12974481]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	cytokine activity [GO:0005125]; signaling receptor binding [GO:0005102]	defense response to virus [GO:0051607]; innate immune response [GO:0045087]; negative regulation of viral genome replication [GO:0045071]; positive regulation of immune response [GO:0050778]; receptor signaling pathway via JAK-STAT [GO:0007259]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IFNL3&keywords=IFNL3	0.0012282808988764045	890	NA	NA	0.29628779633832736	468	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
IFNL4	interferon lambda 4 (gene/pseudogene)		manually added ensembl_gene_ID, hgnc_symbol, and description by searching the uniprot ID on genenames.org	ENSG00000272395	K9M1U5	Lambda interferon family	2	ligand	intracellular, ligand, secreted	Q08334, Q8IU57	IFNLR1, IL10RB	IFNLR1 [connectomeDB2020:26134097], IL10RB [connectomeDB2020:26134097]	cytoplasm [GO:0005737]; extracellular space [GO:0005615]	cytokine activity [GO:0005125]; signaling receptor binding [GO:0005102]	defense response to virus [GO:0051607]; innate immune response [GO:0045087]; positive regulation of immune response [GO:0050778]; tyrosine phosphorylation of STAT protein [GO:0007260]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IFNL4&keywords=IFNL4	0.0018565550561797752	886	NA	NA	0.37512622928583417	431	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
IFNW1	interferon omega 1	Yes		ENSG00000177047	P05000	Alpha/beta interferon family	15	ligand	ligand, secreted	P17181, P48551	IFNA2_IFNAR1_IFNAR2, IFNAR1, IFNAR1_IFNAR2, IFNAR2	IFNAR1 [CellTalkDB:11278538;HPRD:1834641;LRdb:11278538;LRdb:18;SIGNOR:11278538;connectomeDB2020:11278538;connectomeDB2020:1834641], IFNAR2 [CellTalkDB:11278538;InnateDB:21854986;LRdb:11278538;SIGNOR:11278538;connectomeDB2020:11278538]	extracellular space [GO:0005615]	cytokine activity [GO:0005125]; cytokine receptor binding [GO:0005126]; type I interferon receptor binding [GO:0005132]	adaptive immune response [GO:0002250]; B cell differentiation [GO:0030183]; B cell proliferation [GO:0042100]; cytokine-mediated signaling pathway [GO:0019221]; defense response to virus [GO:0051607]; humoral immune response [GO:0006959]; natural killer cell activation involved in immune response [GO:0002323]; positive regulation of peptidyl-serine phosphorylation of STAT protein [GO:0033141]; regulation of cell cycle [GO:0051726]; response to exogenous dsRNA [GO:0043330]; response to virus [GO:0009615]; T cell activation involved in immune response [GO:0002286]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IFNW1&keywords=IFNW1	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
IGF1	insulin like growth factor 1	Yes		ENSG00000017427	P05019	Insulin family	19	ligand	extracellular, intracellular, ligand, secreted, transmembrane	P06213, P08069, P11717	APC_AXIN1_GSK3B, IGF1R, IGF2R, INSR, ITGA6_ITGB4, ITGAV_ITGB3	IGF1R [Baccin2019:1852007;Baccin2019:2877871;CA1:8408032;CellChatDB:14604834;CellTalkDB:2877871;Cellinker:14604834;Cellinker:1852007;Cellinker:2877871;DIP:11287679;DIP:21645859;HPMR:2877871;HPRD:1852007;IntAct:21645859;IntAct:8452530;LRdb:185;LRdb:2877871;ProtMapper:19258508;ProtMapper:23675206;SIGNOR:19029956;SIGNOR:21798082;SPIKE:1852007;SignaLink3:12067807;SignaLink3:1852007;SignaLink3:21071413;SignaLink3:23331499;connectomeDB2020:1852007;connectomeDB2020:2877871], INSR [Baccin2019:23518924;CellTalkDB:32196115], IGF2R [CellTalkDB:32196115]	alphav-beta3 integrin-IGF-1-IGF1R complex [GO:0035867]; exocytic vesicle [GO:0070382]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; insulin-like growth factor binding protein complex [GO:0016942]; insulin-like growth factor ternary complex [GO:0042567]; platelet alpha granule lumen [GO:0031093]	growth factor activity [GO:0008083]; hormone activity [GO:0005179]; insulin-like growth factor receptor binding [GO:0005159]; insulin receptor binding [GO:0005158]; integrin binding [GO:0005178]	activation of protein kinase B activity [GO:0032148]; bone mineralization involved in bone maturation [GO:0035630]; cell activation [GO:0001775]; cell population proliferation [GO:0008283]; cellular response to amyloid-beta [GO:1904646]; ERK1 and ERK2 cascade [GO:0070371]; glycolate metabolic process [GO:0009441]; insulin-like growth factor receptor signaling pathway [GO:0048009]; muscle hypertrophy [GO:0014896]; muscle organ development [GO:0007517]; myoblast differentiation [GO:0045445]; myoblast proliferation [GO:0051450]; myotube cell development [GO:0014904]; negative regulation of amyloid-beta formation [GO:1902430]; negative regulation of apoptotic process [GO:0043066]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of gene expression [GO:0010629]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of neuroinflammatory response [GO:0150079]; negative regulation of oocyte development [GO:0060283]; negative regulation of release of cytochrome c from mitochondria [GO:0090201]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; negative regulation of tumor necrosis factor production [GO:0032720]; negative regulation of vascular associated smooth muscle cell apoptotic process [GO:1905460]; phosphatidylinositol 3-kinase signaling [GO:0014065]; phosphatidylinositol-mediated signaling [GO:0048015]; positive regulation of activated T cell proliferation [GO:0042104]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of cell growth involved in cardiac muscle cell development [GO:0061051]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA binding [GO:0043388]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of gene expression [GO:0010628]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of glycolytic process [GO:0045821]; positive regulation of glycoprotein biosynthetic process [GO:0010560]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein secretion [GO:0050714]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of smooth muscle cell migration [GO:0014911]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription regulatory region DNA binding [GO:2000679]; positive regulation of trophectodermal cell proliferation [GO:1904075]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; protein kinase B signaling [GO:0043491]; protein stabilization [GO:0050821]; proteoglycan biosynthetic process [GO:0030166]; Ras protein signal transduction [GO:0007265]; regulation of gene expression [GO:0010468]; regulation of multicellular organism growth [GO:0040014]; response to heat [GO:0009408]; signal transduction [GO:0007165]; skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration [GO:0014834]; skeletal system development [GO:0001501]; wound healing [GO:0042060]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IGF1&keywords=IGF1	0.19206893404494382	616	NA	NA	0.024810474888122484	786	0.06299212598425197	0	0	0.013908872901678653	0.00505050505050505	0	0	0	0	1.0014688209373749e-4	1.5452965037666603e-4	303	406	397	0.007473289133536916	0.572302096278299	0.5780335233340971	0.5811458605630708	309	292	292
IGF2	insulin like growth factor 2	Yes		ENSG00000167244	P01344	Insulin family	18	ligand	extracellular, intracellular, ligand, secreted	P06213, P08069, P08833, P11717, Q8TDT2	GPR152, IGF1R, IGF2R, IGFBP1, INSR, ITGA6_ITGB4, ITGAV_ITGB3	IGF2R [Baccin2019:2964083;Baccin2019:7797478;Baccin2019:9722981;CellChatDB:14604834;CellTalkDB:2964083;Cellinker:14604834;Cellinker:2964083;Cellinker:7797478;Cellinker:9722981;DIP:11502794;DIP:17850746;DOMINO:18046459;HPMR:2852162;HPMR:2964083;HPRD:7797478;HPRD:9722981;LRdb:2964083;LRdb:7797478;LRdb:9722981;Lit-BM-17:11502794;Lit-BM-17:17850746;Lit-BM-17:18046459;SIGNOR:11867533;SPIKE:18046459;SPIKE:20980691;connectomeDB2020:2964083;connectomeDB2020:7797478;connectomeDB2020:9722981], IGF1R [Baccin2019:9972281;CellChatDB:14604834;CellPhoneDB:27102148;CellTalkDB:9972281;Cellinker:14604834;Cellinker:9972281;HPRD:9972281;LRdb:9972281;SIGNOR:22810696;SPIKE:20980691;SignaLink3:11867533;SignaLink3:23331499;connectomeDB2020:9972281], INSR [Baccin2019:9281335;Baccin2019:9722981;CellTalkDB:9281335;Cellinker:9281335;Cellinker:9722981;HPRD:9722981;LRdb:9281335;LRdb:972;SIGNOR:9281335;connectomeDB2020:9281335;connectomeDB2020:9722981], GPR152 [NA], IGFBP1 [BioGRID:10810289;DIP:22578544;HPRD:10810289]	extracellular region [GO:0005576]; extracellular space [GO:0005615]; platelet alpha granule lumen [GO:0031093]	growth factor activity [GO:0008083]; hormone activity [GO:0005179]; insulin-like growth factor receptor binding [GO:0005159]; insulin receptor binding [GO:0005158]; integrin binding [GO:0005178]; protein serine/threonine kinase activator activity [GO:0043539]; receptor ligand activity [GO:0048018]	animal organ morphogenesis [GO:0009887]; embryonic placenta development [GO:0001892]; embryonic placenta morphogenesis [GO:0060669]; exocrine pancreas development [GO:0031017]; glucose metabolic process [GO:0006006]; insulin receptor signaling pathway [GO:0008286]; insulin receptor signaling pathway via phosphatidylinositol 3-kinase [GO:0038028]; in utero embryonic development [GO:0001701]; negative regulation of muscle cell differentiation [GO:0051148]; negative regulation of transcription by RNA polymerase II [GO:0000122]; osteoblast differentiation [GO:0001649]; positive regulation of activated T cell proliferation [GO:0042104]; positive regulation of catalytic activity [GO:0043085]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of glycogen (starch) synthase activity [GO:2000467]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of multicellular organism growth [GO:0040018]; positive regulation of organ growth [GO:0046622]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of skeletal muscle tissue growth [GO:0048633]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; regulation of gene expression by genetic imprinting [GO:0006349]; regulation of histone modification [GO:0031056]; regulation of muscle cell differentiation [GO:0051147]; regulation of transcription, DNA-templated [GO:0006355]; spongiotrophoblast cell proliferation [GO:0060720]; striated muscle cell differentiation [GO:0051146]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IGF2&keywords=IGF2	45.076473858426965	97	NA	NA	1.878951081501793	171	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
IGFBP7	insulin like growth factor binding protein 7	Yes		ENSG00000163453	Q16270	NA	1	ecm, ligand	ecm, extracellular, intracellular, ligand, ligand_regulator, secreted	O95866, P01308	INS, MPIG6B	MPIG6B [Cellinker:32822567], INS [HPRD:9388210]	collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	insulin-like growth factor binding [GO:0005520]	cell adhesion [GO:0007155]; cellular response to hormone stimulus [GO:0032870]; embryo implantation [GO:0007566]; negative regulation of cell population proliferation [GO:0008285]; regulation of cell growth [GO:0001558]; regulation of signal transduction [GO:0009966]; regulation of steroid biosynthetic process [GO:0050810]; response to cortisol [GO:0051414]; response to heat [GO:0009408]; response to retinoic acid [GO:0032526]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IGFBP7&keywords=IGFBP7	225.34962650561798	33	63828.8	18	0.3535065541104154	444	0.03937007874015748	0.8078842315369251	1.0884955752212373	5.487529976019175	0.07744107744107745	0.6159052453468695	1.2384406165004602	0.5269168026101146	0.1520532741398439	0.3515823207371044	0.4899362565191928	90	59	36	0.988686859528378	0.16226635265469727	0.36205775342619284	0.5005936062433862	452	357	325
IGFBPL1	insulin like growth factor binding protein like 1	Yes		ENSG00000137142	Q8WX77	NA	1	ecm, ligand	ecm, extracellular, ligand, ligand_regulator, secreted	P43146	DCC	DCC [Cellinker:32822567]	extracellular space [GO:0005615]	insulin-like growth factor binding [GO:0005520]	cellular response to tumor cell [GO:0071228]; regulation of cell growth [GO:0001558]; regulation of signal transduction [GO:0009966]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IGFBPL1&keywords=IGFBPL1	5.613982617977528	285	NA	NA	6.771198036576294	58	0	0.00249500998003992	0	2.3980815347721823e-4	0	0.013536379018612519	0.015412511332728921	0	0.007029226785053647	0.0019361730538122557	0.0060266563646899805	279	347	277	0.004243251335310405	1.1955996832574693	0.8380230589782068	1.1252105286493357	87	195	72
IGFL1	IGF like family member 1	Yes		ENSG00000188293	Q6UW32	IGFL family	8	ligand	ligand, secreted	Q9H665	IGFLR1	IGFLR1 [CellTalkDB:21454693;IntAct:21454693;LRdb:21454693;Ramilowski2015:21454693;connectomeDB2020:21454693;talklr:21454693]	extracellular space [GO:0005615]	signaling receptor binding [GO:0005102]	NA	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IGFL1&keywords=IGFL1	0.059303426966292136	718	NA	NA	0.04462821371710454	722	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
IGFL2	IGF like family member 2	Yes		ENSG00000204866	Q6UWQ7	IGFL family	8	ligand	intracellular, ligand, secreted	Q9H665	IGFLR1	IGFLR1 [CellTalkDB:21454693;LRdb:21454693;Ramilowski2015:21454693;connectomeDB2020:21454693;talklr:21454693]	extracellular space [GO:0005615]	signaling receptor binding [GO:0005102]	NA	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IGFL2&keywords=IGFL2	0.30043621471910115	576	NA	NA	0.14954821725579862	577	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
IGFL3	IGF like family member 3	Yes		ENSG00000188624	Q6UXB1	IGFL family	11	ligand	ligand, secreted	Q9H665	IGFLR1	IGFLR1 [CellChatDB:21454693;CellTalkDB:21454693;Cellinker:21454693;LRdb:21454693;Ramilowski2015:21454693;connectomeDB2020:21454693;talklr:21454693]	extracellular space [GO:0005615]	signaling receptor binding [GO:0005102]	NA	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IGFL3&keywords=IGFL3	0.07162624943820224	698	NA	NA	0.060845266183862774	692	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
IGFL4	IGF like family member 4	Yes		ENSG00000204869	Q6B9Z1	IGFL family	1	ligand	ligand, secreted	NA	NA	NA	extracellular space [GO:0005615]	signaling receptor binding [GO:0005102]	NA	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IGFL4&keywords=IGFL4	0.7662808271910112	484	NA	NA	1.085265614558906	248	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
IGHG1	immunoglobulin heavy constant gamma 1 (G1m marker)			ENSG00000277633, ENSG00000211896	P01857	NA	1	ligand, receptor	cell_surface, extracellular, ligand, plasma_membrane, receptor, secreted	NA	NA	NA	blood microparticle [GO:0072562]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; immunoglobulin complex, circulating [GO:0042571]	antigen binding [GO:0003823]; immunoglobulin receptor binding [GO:0034987]	B cell receptor signaling pathway [GO:0050853]; complement activation, classical pathway [GO:0006958]; defense response to bacterium [GO:0042742]; innate immune response [GO:0045087]; phagocytosis, engulfment [GO:0006911]; phagocytosis, recognition [GO:0006910]; positive regulation of B cell activation [GO:0050871]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IGHG1&keywords=IGHG1	1.0803276164044944	443	15254.4	55	0.010868028487007199	826	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
IGLC1	immunoglobulin lambda constant 1		manually added ensembl_gene_ID, hgnc_symbol, and description by searching the uniprot ID on genenames.org	ENSG00000211675	P0CG04	NA	1	ligand, receptor	cell_surface, extracellular, ligand, plasma_membrane, receptor, secreted	NA	NA	NA	blood microparticle [GO:0072562]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; immunoglobulin complex, circulating [GO:0042571]; plasma membrane [GO:0005886]	antigen binding [GO:0003823]; immunoglobulin receptor binding [GO:0034987]	B cell receptor signaling pathway [GO:0050853]; complement activation, classical pathway [GO:0006958]; defense response to bacterium [GO:0042742]; immune response [GO:0006955]; innate immune response [GO:0045087]; phagocytosis, engulfment [GO:0006911]; phagocytosis, recognition [GO:0006910]; positive regulation of B cell activation [GO:0050871]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IGLC1&keywords=IGLC1	1.0602952696629213	445	NA	NA	0.007270623713565442	852	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
IGSF1	immunoglobulin superfamily member 1	Yes		ENSG00000147255	Q8N6C5	NA	1	ligand, receptor	cell_surface, extracellular, intracellular, ligand, plasma_membrane_transmembrane, receptor, secreted, transmembrane	P36896	ACVR1B	ACVR1B [Cellinker:11266516;HPRD:11266516]	extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; membrane [GO:0016020]	activin receptor antagonist activity [GO:0038102]; coreceptor activity [GO:0015026]; inhibin binding [GO:0034711]	negative regulation of activin receptor signaling pathway [GO:0032926]; regulation of transcription, DNA-templated [GO:0006355]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IGSF1&keywords=IGSF1	9.495433442967183	243	2126.67	129	1.8200376853945412	176	0	0.001497005988023952	0	7.194244604316547e-4	0.003367003367003367	0.04906937394247041	0.035358114233907514	0.0016313213703099511	0.04402515723270439	0.037354787020964564	0.0022793123430558254	176	162	329	0.015936499996261056	2.0829779361321896	1.8257971209604658	0.47343752413879986	28	24	336
IGSF10	immunoglobulin superfamily member 10	TBD		ENSG00000152580	Q6WRI0	NA	1	ecm, ligand	ecm, intracellular, ligand, secreted	P20916, Q5DX21, Q6Q8B3, Q7Z6M3, Q96A28	CD200R1L, IGSF11, MAG, MILR1, SLAMF9	CD200R1L [Cellinker:32822567], IGSF11 [Cellinker:32822567], MAG [Cellinker:32822567], SLAMF9 [Cellinker:32822567], MILR1 [Cellinker:32822567]	extracellular region [GO:0005576]	NA	cell differentiation [GO:0030154]; ossification [GO:0001503]; regulation of neuron migration [GO:2001222]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IGSF10&keywords=IGSF10	0.3370996404480879	566	NA	NA	0.10662208759044314	625	0	0.001996007984031936	0	0.006714628297362108	0.003367003367003367	0.08629441624365479	0.013599274705349048	0.0831973898858076	0.10173880873103922	0.01615703031112294	0.012285107204944865	124	217	239	0.029577242430028714	2.823309605983535	0.6609108847683798	0.5630788260284737	15	269	301
IHH	Indian hedgehog signaling molecule	Yes		ENSG00000163501	Q14623	Hedgehog family	15	cell_surface_ligand, ligand	cell_surface_ligand, extracellular, ligand, plasma_membrane, secreted	Q13635, Q4KMG0, Q96QV1, Q9BWV1, Q9Y6C5	BOC, CDON, HHIP, PTCH1, PTCH1_SMO, PTCH2, PTCH2_SMO	PTCH2 [Baccin2019:9811851;CancerCellMap:9811851;CellTalkDB:9811851;Cellinker:9811851;HPRD:9811851;ICELLNET:29274272;LRdb:9811851;NetPath:9811851;SIGNOR:9811851;SignaLink3:23331499;SignaLink3:9811851;connectomeDB2020:9811851], PTCH1 [Baccin2019:115627869811851;CancerCellMap:9811851;CellTalkDB:11562786;Cellinker:11562786;Cellinker:9811851;HPRD:9811851;ICELLNET:29274272;LRdb:11562786;LRdb:98;NetPath:9811851;SIGNOR:9811851;SignaLink3:19399989;SignaLink3:23331499;connectomeDB2020:11562786;connectomeDB2020:9811851], HHIP [Baccin2019:10050855;Baccin2019:11435703;CancerCellMap:10050855;CancerCellMap:11435703;CellTalkDB:10050855;Cellinker:10050855;Cellinker:11435703;HPMR:10050855;HPRD:10050855;HPRD:11435703;LRdb:10050855;LRdb:11;NetPath:10050855;connectomeDB2020:10050855;connectomeDB2020:11435703], BOC [CellTalkDB:20519495;Cellinker:20519495;LRdb:20519495;Ramilowski2015:20519495;connectomeDB2020:20519495;talklr:20519495], CDON [CellTalkDB:20519495;Cellinker:20519495;LRdb:20519495;Ramilowski2015:20519495;connectomeDB2020:20519495;talklr:20519495]	extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]	calcium ion binding [GO:0005509]; patched binding [GO:0005113]; peptidase activity [GO:0008233]	bone resorption [GO:0045453]; branching involved in blood vessel morphogenesis [GO:0001569]; camera-type eye photoreceptor cell fate commitment [GO:0060220]; cartilage development [GO:0051216]; cell-cell signaling [GO:0007267]; cell fate specification [GO:0001708]; cell maturation [GO:0048469]; chondrocyte differentiation involved in endochondral bone morphogenesis [GO:0003413]; chondrocyte proliferation [GO:0035988]; embryonic camera-type eye morphogenesis [GO:0048596]; embryonic digestive tract morphogenesis [GO:0048557]; embryonic digit morphogenesis [GO:0042733]; embryonic pattern specification [GO:0009880]; embryonic skeletal joint development [GO:0072498]; epithelial cell-cell adhesion [GO:0090136]; epithelial cell morphogenesis [GO:0003382]; head morphogenesis [GO:0060323]; heart looping [GO:0001947]; intein-mediated protein splicing [GO:0016539]; in utero embryonic development [GO:0001701]; liver regeneration [GO:0097421]; maternal process involved in female pregnancy [GO:0060135]; multicellular organism growth [GO:0035264]; negative regulation of alpha-beta T cell differentiation [GO:0046639]; negative regulation of apoptotic process [GO:0043066]; negative regulation of eye pigmentation [GO:0048074]; negative regulation of immature T cell proliferation in thymus [GO:0033088]; negative regulation of T cell differentiation in thymus [GO:0033085]; neuron development [GO:0048666]; osteoblast differentiation [GO:0001649]; pancreas development [GO:0031016]; positive regulation of alpha-beta T cell differentiation [GO:0046638]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of smoothened signaling pathway [GO:0045880]; positive regulation of T cell differentiation in thymus [GO:0033089]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein autoprocessing [GO:0016540]; proteoglycan metabolic process [GO:0006029]; regulation of gene expression [GO:0010468]; regulation of growth [GO:0040008]; response to estradiol [GO:0032355]; response to mechanical stimulus [GO:0009612]; retinal pigment epithelium development [GO:0003406]; skeletal system development [GO:0001501]; smoothened signaling pathway [GO:0007224]; smooth muscle tissue development [GO:0048745]; somite development [GO:0061053]; vitelline membrane formation [GO:0030704]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IHH&keywords=IHH	0.057213643820224716	721	NA	NA	0.04772488339539416	712	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
IL10	interleukin 10	Yes		ENSG00000136634	P22301	IL-10 family	21	ligand	extracellular, ligand, secreted	P19838, P26842, P32970, Q08334, Q13651, Q8IU57, Q9P1W8	CD27, CD70, IFNLR1, IL10RA, IL10RA_IL10RB, IL10RB, NFKB1, SIRPG	IL10RA [Baccin2019:10231374;Baccin2019:11485736;Baccin2019:11717514;Baccin2019:12974481;Baccin2019:7759550;Baccin2019:8248239;Baccin2019:8897595;BioGRID:10231374;BioGRID:11485736;BioGRID:11717514;BioGRID:7759550;BioGRID:8248239;CellTalkDB:12974481;DIP:15837194;DIP:20462497;DIP:8120391;HPRD:10231374;HPRD:11485736;HPRD:11717514;HPRD:7759550;HPRD:8248239;HPRD:8897595;InnateDB:10788470;InnateDB:11717514;InnateDB:9568901;IntAct:11485736;IntAct:12513909;IntAct:15837194;IntAct:20462497;LRdb:10231374;LRdb:11485736;LRdb:11717514;LRdb:12974481;LRdb:7759550;LRdb:8248239;LRdb:8897595;Lit-BM-17:10231374;Lit-BM-17:11485736;Lit-BM-17:11717514;Lit-BM-17:12513909;Lit-BM-17:15837194;Lit-BM-17:8120391;SIGNOR:10347215;SIGNOR:26260587;SPIKE:11591769;SignaLink3:17208301;SignaLink3:21071413;SignaLink3:23331499;SignaLink3:8248239;connectomeDB2020:10231374;connectomeDB2020:11485736;connectomeDB2020:11717514;connectomeDB2020:12974481;connectomeDB2020:7759550;connectomeDB2020:8248239;connectomeDB2020:8897595;scConnect:19161426], NFKB1 [SPIKE:12773629], IL10RB [CellTalkDB:12974481;DIP:20462497;DIP:9312047;HPRD:11485736;HPRD:9312047;LRdb:11485736;LRdb:12974481;LRdb:9312047;Lit-BM-17:12513909;Lit-BM-17:9312047;SIGNOR:10347215;SIGNOR:11035029;SignaLink3:11485736;SignaLink3:17208301;SignaLink3:23331499;SignaLink3:9312047;connectomeDB2020:11485736;connectomeDB2020:12974481;connectomeDB2020:9312047], SIRPG [NA], CD27 [Cellinker:9767422], CD70 [Cellinker:9767422], IFNLR1 [Cellinker:27133025]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; interleukin-10 receptor binding [GO:0005141]; protein dimerization activity [GO:0046983]	aging [GO:0007568]; B cell differentiation [GO:0030183]; B cell proliferation [GO:0042100]; branching involved in labyrinthine layer morphogenesis [GO:0060670]; cellular response to estradiol stimulus [GO:0071392]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to lipopolysaccharide [GO:0071222]; cytoplasmic sequestering of NF-kappaB [GO:0007253]; defense response to bacterium [GO:0042742]; defense response to protozoan [GO:0042832]; endothelial cell apoptotic process [GO:0072577]; hemopoiesis [GO:0030097]; leukocyte chemotaxis [GO:0030595]; liver regeneration [GO:0097421]; negative regulation of apoptotic process [GO:0043066]; negative regulation of autophagy [GO:0010507]; negative regulation of B cell proliferation [GO:0030889]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of chemokine (C-C motif) ligand 5 production [GO:0071650]; negative regulation of chronic inflammatory response to antigenic stimulus [GO:0002875]; negative regulation of cytokine activity [GO:0060302]; negative regulation of cytokine production [GO:0001818]; negative regulation of cytokine production involved in immune response [GO:0002719]; negative regulation of heterotypic cell-cell adhesion [GO:0034115]; negative regulation of hydrogen peroxide-induced neuron death [GO:1903208]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interferon-alpha production [GO:0032687]; negative regulation of interferon-gamma production [GO:0032689]; negative regulation of interleukin-12 production [GO:0032695]; negative regulation of interleukin-18 production [GO:0032701]; negative regulation of interleukin-1 production [GO:0032692]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of interleukin-8 production [GO:0032717]; negative regulation of membrane protein ectodomain proteolysis [GO:0051045]; negative regulation of MHC class II biosynthetic process [GO:0045347]; negative regulation of mitotic cell cycle [GO:0045930]; negative regulation of myeloid dendritic cell activation [GO:0030886]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of nitric oxide biosynthetic process [GO:0045019]; negative regulation of sensory perception of pain [GO:1904057]; negative regulation of T cell proliferation [GO:0042130]; negative regulation of tumor necrosis factor production [GO:0032720]; negative regulation of vascular associated smooth muscle cell proliferation [GO:1904706]; positive regulation of B cell apoptotic process [GO:0002904]; positive regulation of cell cycle [GO:0045787]; positive regulation of cytokine production [GO:0001819]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of heterotypic cell-cell adhesion [GO:0034116]; positive regulation of immunoglobulin production [GO:0002639]; positive regulation of macrophage activation [GO:0043032]; positive regulation of MHC class II biosynthetic process [GO:0045348]; positive regulation of plasma cell differentiation [GO:1900100]; positive regulation of pri-miRNA transcription by RNA polymerase II [GO:1902895]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of signaling receptor activity [GO:2000273]; positive regulation of sprouting angiogenesis [GO:1903672]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; regulation of gene expression [GO:0010468]; regulation of isotype switching [GO:0045191]; regulation of response to wounding [GO:1903034]; regulation of synapse organization [GO:0050807]; response to activity [GO:0014823]; response to carbon monoxide [GO:0034465]; response to glucocorticoid [GO:0051384]; response to inactivity [GO:0014854]; response to insulin [GO:0032868]; response to molecule of bacterial origin [GO:0002237]; response to xenobiotic stimulus [GO:0009410]; type 2 immune response [GO:0042092]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IL10&keywords=IL10	0.3419050397752809	561	NA	NA	0.49307441532269736	385	0.14960629921259838	4.99001996007984e-4	0.0011061946902654867	0.007434052757793763	0	0.001692047377326565	0.001813236627379873	0	3.699593044765076e-4	5.007344104686875e-4	3.86324125941665e-4	302	388	390	0.014855259136568991	0.4172138881151079	0.42247535432125877	0.41787229289677763	369	339	348
IL11	interleukin 11	Yes		ENSG00000095752	P20809	IL-6 superfamily	21	ligand	extracellular, intracellular, ligand, secreted	P08887, P40189, Q14626	IL11RA, IL11RA_IL6ST, IL6R, IL6ST	IL11RA [Baccin2019:10504396;Baccin2019:10948192;Baccin2019:7670098;CellTalkDB:10948192;DIP:8940087;HPMR:10948192;HPRD:10504396;HPRD:7670098;InnateDB:8940087;LRdb:10504396;LRdb:10948192;LRdb:7670098;Lit-BM-17:26551460;Lit-BM-17:8940087;SIGNOR:10948192;SignaLink3:12740032;SignaLink3:23331499;connectomeDB2020:10504396;connectomeDB2020:10948192;connectomeDB2020:7670098], IL6ST [Baccin2019:10948192;CellTalkDB:10948192;DIP:8360477;HPMR:10948192;InnateDB:9560294;LRdb:10948192;SIGNOR:9143707;connectomeDB2020:10948192], IL6R [Cellinker:26551279]	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; interleukin-11 receptor binding [GO:0005142]	B cell differentiation [GO:0030183]; fat cell differentiation [GO:0045444]; megakaryocyte differentiation [GO:0030219]; negative regulation of hormone secretion [GO:0046888]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of transcription by RNA polymerase II [GO:0045944]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IL11&keywords=IL11	91.42429219101123	53	NA	NA	98.34741266363903	10	0.047244094488188976	0.13323353293413165	0.00995575221238938	6.425659472422007	0.04545454545454545	0.12859560067681894	0.03807796917497733	0.23980424143556275	0.3799482056973736	0.0794498597943654	0.05126521151245868	51	119	150	0.688971680527529	0.5578884188885468	0.12797351063902282	0.08765049174269908	323	454	481
IL11RA	interleukin 11 receptor subunit alpha			ENSG00000137070	Q14626	Type I cytokine receptor family, Type 3 subfamily	1	ligand, receptor	cell_surface, extracellular, intracellular, ligand, plasma_membrane_transmembrane, receptor, secreted, transmembrane, transmembrane_predicted	P25942	CD40	CD40 [Cellinker:32589946]	external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]; interleukin-11 binding [GO:0019970]; interleukin-11 receptor activity [GO:0004921]; transmembrane signaling receptor activity [GO:0004888]	cytokine-mediated signaling pathway [GO:0019221]; developmental process [GO:0032502]; head development [GO:0060322]; positive regulation of cell population proliferation [GO:0008284]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IL11RA&keywords=IL11RA	1.2696875080323329	425	NA	NA	0.0419395015966004	732	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
IL12A	interleukin 12A	Yes	manually added ensembl_gene_ID, hgnc_symbol, and description by searching the uniprot ID on genenames.org	ENSG00000168811	P29459	IL-6 superfamily	17	ligand	extracellular, intracellular, ligand, secreted, transmembrane	P10747, P29460, P42701, Q99665	CD28, IL12B, IL12RB1, IL12RB2	IL12RB1 [Baccin2019:11086056;CellTalkDB:11086056;Cellinker:11086056;DIP:8943050;HPMR:11086056;InnateDB:7911493;InnateDB:8943050;LRdb:11086056;Lit-BM-17:11114383;Lit-BM-17:8943050;SIGNOR:12023369;SignaLink3:23331499;SignaLink3:7527811;connectomeDB2020:11086056], IL12RB2 [CellTalkDB:943050;DIP:8943050;HPMR:11086056;LRdb:943050;Ramilowski2015:943050;SIGNOR:11086056;connectomeDB2020:943050;talklr:943050], IL12B [DIP:10779781;DIP:7527811;HPRD:10899108;InnateDB:10899108;InnateDB:7527811;InnateDB:8943050;IntAct:10899108;IntAct:7527811;Lit-BM-17:10779781;Lit-BM-17:10899108;Lit-BM-17:7527811;SIGNOR:7527811], CD28 [CellTalkDB:7516408;Cellinker:7516408;HPRD:7516408;LRdb:7516408]	endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; interleukin-12 complex [GO:0043514]; late endosome lumen [GO:0031906]	cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; interleukin-12 beta subunit binding [GO:0042163]; interleukin-12 receptor binding [GO:0005143]; interleukin-27 binding [GO:0045513]; protein heterodimerization activity [GO:0046982]	cell migration [GO:0016477]; cellular response to virus [GO:0098586]; defense response to Gram-positive bacterium [GO:0050830]; extrinsic apoptotic signaling pathway [GO:0097191]; immune response [GO:0006955]; negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:1903588]; negative regulation of interleukin-17 production [GO:0032700]; negative regulation of protein secretion [GO:0050709]; negative regulation of smooth muscle cell proliferation [GO:0048662]; negative regulation of vascular endothelial growth factor signaling pathway [GO:1900747]; positive regulation of cell adhesion [GO:0045785]; positive regulation of dendritic cell chemotaxis [GO:2000510]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of lymphocyte proliferation [GO:0050671]; positive regulation of mononuclear cell proliferation [GO:0032946]; positive regulation of natural killer cell activation [GO:0032816]; positive regulation of natural killer cell mediated cytotoxicity [GO:0045954]; positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target [GO:0002860]; positive regulation of natural killer cell proliferation [GO:0032819]; positive regulation of NK T cell activation [GO:0051135]; positive regulation of NK T cell proliferation [GO:0051142]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of smooth muscle cell apoptotic process [GO:0034393]; positive regulation of T cell mediated cytotoxicity [GO:0001916]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; response to lipopolysaccharide [GO:0032496]; response to UV-B [GO:0010224]; response to virus [GO:0009615]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IL12A&keywords=IL12A	0.2343275292696629	602	NA	NA	0.2096082720513005	528	0	0.005988023952095809	0.0055309734513274336	0.0079136690647482	0	0	0.003626473254759746	0.0032626427406199023	3.699593044765076e-4	6.676458806249166e-5	0.003670079196445821	302	407	305	0.0027662350502305373	0.8122958149896545	0.7885460786561894	1.0707995852073053	218	213	84
IL12B	interleukin 12B	Yes		ENSG00000113302	P29460	IL-12B family	16	ligand	extracellular, intracellular, ligand, secreted, transmembrane	P42701, Q5VWK5, Q99665, Q9BWV1	BOC, IL12RB1, IL12RB1_IL12RB2, IL12RB2, IL23R	IL12RB1 [Baccin2019:7527811;Baccin2019:7843232;CellTalkDB:7843232;HPMR:11086056;HPRD:7527811;HPRD:7843232;InnateDB:7911493;InnateDB:8943050;LRdb:753;LRdb:7843232;SIGNOR:7527811;connectomeDB2020:7527811;connectomeDB2020:7843232], IL12RB2 [Baccin2019:1108605611940480;CellTalkDB:11086056;HPMR:11086056;HPRD:11940489;InnateDB:8943050;LRdb:11086056;LRdb:12;connectomeDB2020:11086056;connectomeDB2020:11940489], IL23R [CellTalkDB:17587057;InnateDB:12023369;LRdb:17587057;Ramilowski2015:17587057;connectomeDB2020:17587057;talklr:17587057], BOC [Cellinker:32822567]	cytosol [GO:0005829]; endoplasmic reticulum lumen [GO:0005788]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; interleukin-12 complex [GO:0043514]; interleukin-23 complex [GO:0070743]; late endosome lumen [GO:0031906]; receptor complex [GO:0043235]	cytokine activity [GO:0005125]; cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]; identical protein binding [GO:0042802]; interleukin-12 alpha subunit binding [GO:0042164]; interleukin-12 receptor binding [GO:0005143]; protein-containing complex binding [GO:0044877]; protein heterodimerization activity [GO:0046982]	cell migration [GO:0016477]; cell population proliferation [GO:0008283]; cellular response to interferon-gamma [GO:0071346]; cellular response to lipopolysaccharide [GO:0071222]; cytokine-mediated signaling pathway [GO:0019221]; defense response to Gram-negative bacterium [GO:0050829]; defense response to protozoan [GO:0042832]; defense response to virus [GO:0051607]; natural killer cell activation [GO:0030101]; natural killer cell activation involved in immune response [GO:0002323]; negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:1903588]; negative regulation of inflammatory response to antigenic stimulus [GO:0002862]; negative regulation of interleukin-10 production [GO:0032693]; negative regulation of interleukin-17 production [GO:0032700]; negative regulation of protein secretion [GO:0050709]; negative regulation of smooth muscle cell proliferation [GO:0048662]; negative regulation of vascular endothelial growth factor signaling pathway [GO:1900747]; positive regulation of activated T cell proliferation [GO:0042104]; positive regulation of activation of Janus kinase activity [GO:0010536]; positive regulation of cell adhesion [GO:0045785]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of granulocyte macrophage colony-stimulating factor production [GO:0032725]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of lymphocyte proliferation [GO:0050671]; positive regulation of memory T cell differentiation [GO:0043382]; positive regulation of mononuclear cell proliferation [GO:0032946]; positive regulation of natural killer cell activation [GO:0032816]; positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target [GO:0002860]; positive regulation of natural killer cell proliferation [GO:0032819]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of NK T cell activation [GO:0051135]; positive regulation of NK T cell proliferation [GO:0051142]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of smooth muscle cell apoptotic process [GO:0034393]; positive regulation of T cell mediated cytotoxicity [GO:0001916]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of T-helper 17 cell lineage commitment [GO:2000330]; positive regulation of T-helper 17 type immune response [GO:2000318]; positive regulation of T-helper 1 type immune response [GO:0002827]; positive regulation of tissue remodeling [GO:0034105]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; regulation of cytokine production [GO:0001817]; regulation of tyrosine phosphorylation of STAT protein [GO:0042509]; response to UV-B [GO:0010224]; sensory perception of pain [GO:0019233]; sexual reproduction [GO:0019953]; T-helper 1 type immune response [GO:0042088]; T-helper cell differentiation [GO:0042093]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IL12B&keywords=IL12B	0.08356042921348315	687	NA	NA	1.4562718909407895	205	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
IL13	interleukin 13	Yes	manually added ensembl_gene_ID, hgnc_symbol, and description by searching the uniprot ID on genenames.org	ENSG00000169194	P35225	IL-4/IL-13 family	20	ligand	extracellular, intracellular, ligand, secreted, transmembrane	P24394, P31785, P78552, Q14627, Q86XT9	IL13_IL13RA1_IL4R, IL13RA1, IL13RA1_IL4R, IL13RA2, IL13RA2_IL4R, IL2RG, IL4R, TMEM219	IL13RA1 [Baccin2019:1270434311278620;CellTalkDB:12704343;DIP:20223216;DIP:8910586;HPMR:12704343;HPRD:11278629;InnateDB:9013879;IntAct:18243101;IntAct:20223216;LRdb:11;LRdb:12704343;Lit-BM-17:18243101;Lit-BM-17:8910586;SIGNOR:12704343;SignaLink3:10485906;SignaLink3:11867689;SignaLink3:12223527;SignaLink3:12401408;SignaLink3:14610620;SignaLink3:14657224;SignaLink3:15099563;SignaLink3:16243976;SignaLink3:16413922;SignaLink3:17404308;SignaLink3:17485448;SignaLink3:18250477;SignaLink3:18451175;SignaLink3:19833085;SignaLink3:20184663;SignaLink3:20406969;SignaLink3:20510870;SignaLink3:20856220;SignaLink3:21097505;SignaLink3:21115385;SignaLink3:21469115;SignaLink3:21840487;SignaLink3:23124025;SignaLink3:23180781;SignaLink3:23331499;SignaLink3:23390297;SignaLink3:24030977;SignaLink3:24091328;SignaLink3:26192618;SignaLink3:26755705;SignaLink3:27216177;SignaLink3:7512720;SignaLink3:7521688;SignaLink3:7543512;SignaLink3:8910586;SignaLink3:9013879;SignaLink3:9535722;connectomeDB2020:11278629;connectomeDB2020:12704343], IL13RA2 [Baccin2019:1270434311003390;CellPhoneDB:26471366;CellTalkDB:26471366;DIP:20223216;DIP:8663118;HPMR:12704343;HPRD:11003391;ICELLNET:8663118;InnateDB:8663118;IntAct:20223216;IntAct:23972995;IntAct:27629921;LRdb:11;LRdb:12704343;SignaLink3:12223527;SignaLink3:12401408;SignaLink3:14610620;SignaLink3:14657224;SignaLink3:14985454;SignaLink3:15099563;SignaLink3:18250477;SignaLink3:18451175;SignaLink3:20184663;SignaLink3:21097505;SignaLink3:23180781;SignaLink3:23331499;SignaLink3:26192618;SignaLink3:26755705;SignaLink3:8663118;SignaLink3:9535722;connectomeDB2020:11003391;connectomeDB2020:12704343], IL4R [Baccin2019:1270434311709750;CellTalkDB:8920992;DIP:7721786;HPMR:12704343;HPRD:11709756;InnateDB:18243101;InnateDB:8910586;LRdb:12;LRdb:12704343;NetPath:7721786;SIGNOR:12704343;SIGNOR:19880493;connectomeDB2020:11709756;connectomeDB2020:12704343], TMEM219 [CellTalkDB:32103204], IL2RG [CellTalkDB:8920992;Ramilowski2015:8920992;connectomeDB2020:8920992;talklr:8920992]	cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	cytokine activity [GO:0005125]; interleukin-13 receptor binding [GO:0005144]	cellular response to cytokine stimulus [GO:0071345]; cellular response to mechanical stimulus [GO:0071260]; immune response [GO:0006955]; inflammatory response [GO:0006954]; macrophage activation [GO:0042116]; microglial cell activation [GO:0001774]; negative regulation of complement-dependent cytotoxicity [GO:1903660]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of inflammatory response [GO:0050728]; negative regulation of lung ciliated cell differentiation [GO:1901247]; negative regulation of NAD(P)H oxidase activity [GO:0033861]; negative regulation of neuron death [GO:1901215]; negative regulation of transforming growth factor beta production [GO:0071635]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of connective tissue growth factor production [GO:0032723]; positive regulation of gene expression [GO:0010628]; positive regulation of immunoglobulin production [GO:0002639]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of lung goblet cell differentiation [GO:1901251]; positive regulation of macrophage activation [GO:0043032]; positive regulation of mast cell degranulation [GO:0043306]; positive regulation of pancreatic stellate cell proliferation [GO:2000231]; positive regulation of protein secretion [GO:0050714]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; regulation of proton transport [GO:0010155]; response to ethanol [GO:0045471]; response to lipopolysaccharide [GO:0032496]; response to nicotine [GO:0035094]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IL13&keywords=IL13	0.0237966797752809	783	NA	NA	0.026288920208275175	783	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
IL15	interleukin 15	Yes		ENSG00000164136	P40933	IL-15/IL-21 family	20	ligand, receptor	extracellular, intracellular, ligand, receptor, secreted	P01589, P14784, P31785, P80370, Q13261	DLK1, IL15_IL15RA_IL2RB_IL2RG, IL15RA, IL15RA_IL2RB, IL15RA_IL2RB_IL2RG, IL2RA, IL2RB, IL2RG	IL15RA [Baccin2019:15265897;Baccin2019:16284400;Baccin2019:7641685;CellTalkDB:15265897;Guide2Pharma:19710453;HPMR:15265897;HPRD:16284400;HPRD:7641685;InnateDB:16284400;IntAct:16284400;LRdb:15265897;LRdb:16284400;LRdb:7641685;Lit-BM-17:10903799;Lit-BM-17:16284400;SIGNOR:17709786;SignaLink3:23331499;SignaLink3:8530383;connectomeDB2020:15265897;connectomeDB2020:16284400;connectomeDB2020:7641685], IL2RG [Baccin2019:1526589;Baccin2019:78568232;CellTalkDB:15265897;Cellinker:15265897;Cellinker:8568232;DIP:10903799;DIP:8178155;DIP:9371812;Guide2Pharma:19710453;HPMR:15265897;HPRD:8568232;LRdb:15265897;LRdb:86;Lit-BM-17:10903799;Lit-BM-17:8178155;Lit-BM-17:9371812;NetPath:8026467;SIGNOR:11418623;connectomeDB2020:15265897;connectomeDB2020:8568232;scConnect:19710453], IL2RB [Baccin2019:15265897;Baccin2019:8026467;Baccin2019:9176231;CellTalkDB:15265897;DIP:10903799;Guide2Pharma:19710453;HPMR:15265897;HPRD:8026467;HPRD:9176231;InnateDB:8026467;InnateDB:8178155;IntAct:23104097;IntAct:25416956;LRdb:15265897;LRdb:8026467;LRdb:9176231;Lit-BM-17:10903799;NetPath:8026467;connectomeDB2020:15265897;connectomeDB2020:8026467;connectomeDB2020:9176231], IL2RA [CellTalkDB:8734356;LRdb:8734356;Ramilowski2015:8734356;connectomeDB2020:8734356;talklr:8734356], DLK1 [Cellinker:10733486]	cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]	cytokine activity [GO:0005125]; cytokine receptor binding [GO:0005126]	aging [GO:0007568]; cell-cell signaling [GO:0007267]; cell maturation [GO:0048469]; cellular response to vitamin D [GO:0071305]; extrathymic T cell selection [GO:0045062]; hyaluronan metabolic process [GO:0030212]; immune response [GO:0006955]; inflammatory response [GO:0006954]; interleukin-15-mediated signaling pathway [GO:0035723]; lymph node development [GO:0048535]; macrophage differentiation [GO:0030225]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of smooth muscle cell proliferation [GO:0048662]; neutrophil activation [GO:0042119]; NK T cell proliferation [GO:0001866]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytokine production [GO:0001819]; positive regulation of immune response [GO:0050778]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of natural killer cell differentiation [GO:0032825]; positive regulation of natural killer cell proliferation [GO:0032819]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phagocytosis [GO:0050766]; positive regulation of protein O-linked glycosylation [GO:1904100]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of tissue remodeling [GO:0034105]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; regulation of defense response to virus by host [GO:0050691]; regulation of T cell differentiation [GO:0045580]; signal transduction [GO:0007165]; skeletal muscle atrophy [GO:0014732]; tyrosine phosphorylation of STAT protein [GO:0007260]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IL15&keywords=IL15	2.413933202273938	371	NA	NA	1.0252313197875251	260	0.11811023622047244	0.07135728542914165	0.040929203539823045	0.04964028776978416	0.08754208754208759	0.035532994923857864	0.024478694469628286	0.024469820554649267	0.02848686644469104	0.01942849512618502	0.024879273710643277	210	201	196	0.04771411324826942	0.666853639059335	0.5099011917516977	0.6043456573715813	271	315	284
IL15RA	interleukin 15 receptor subunit alpha	No		ENSG00000134470	Q13261	NA	1	ligand, receptor	cell_surface, extracellular, intracellular, ligand, plasma_membrane_transmembrane, receptor, secreted, transmembrane, transmembrane_predicted	P14784, P23458, P29597, P30530, P52333	AXL, IL2RB, JAK1, JAK3, TYK2	IL2RB [HPRD:7641685;SIGNOR:17709786], JAK1 [SIGNOR:30029643], TYK2 [SIGNOR:30029643], JAK3 [SIGNOR:30029643], AXL [HPRD:16308569]	cell surface [GO:0009986]; cytoplasmic vesicle membrane [GO:0030659]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; extracellular space [GO:0005615]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886]	cytokine receptor activity [GO:0004896]; interleukin-15 receptor activity [GO:0042010]; protein kinase binding [GO:0019901]	interleukin-15-mediated signaling pathway [GO:0035723]; positive regulation of natural killer cell differentiation [GO:0032825]; positive regulation of phagocytosis [GO:0050766]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IL15RA&keywords=IL15RA	11.551687636538947	226	NA	NA	1.1586869465777585	242	0.05511811023622047	0.10578842315369248	0.11836283185840722	0.1402877697841737	0.12289562289562307	0.01015228426395939	0.009972801450589302	0.02773246329526917	0.009618941916389201	0.004973961810655618	0.025497392312149977	266	292	193	0.0573091457251936	0.29147512875127596	0.22246548592059923	0.5273784406219765	410	405	313
IL16	interleukin 16	Yes		ENSG00000172349	Q14005	NA	16	ligand, transporter	extracellular, intracellular, ion_channel, ligand, secreted, transporter	O15399, P01730, P21926, P22001, P42574, P48050, P51681, P78508, Q12879, Q13224, Q14957, Q99712, Q9NSA2, Q9NZV8	CASP3, CCR5, CD4, CD9, GRIN2A, GRIN2B, GRIN2C, GRIN2D, KCNA3, KCND1, KCND2, KCNJ10, KCNJ15, KCNJ4	CD9 [ICELLNET:16144798;ICELLNET:29884309;InnateDB:16144798], CD4 [Baccin2019:1851800;Baccin2019:7910967;CellTalkDB:1851800;Cellinker:1851800;Cellinker:7910967;DIP:7910967;HPRD:1851800;HPRD:7910967;ICELLNET:10438516;ICELLNET:7615501;InnateDB:7910967;LRdb:1851800;LRdb:791;connectomeDB2020:1851800;connectomeDB2020:7910967], GRIN2B [CellTalkDB:32103204;HPRD:10479680], KCNJ4 [Baccin2019:10479680;CellTalkDB:10479680;Cellinker:10479680;HPRD:10479680;LRdb:10479680], KCNJ15 [Baccin2019:10479680;Cellinker:10479680;HPRD:10479680;LRdb:10479680;connectomeDB2020:10479680], KCNA3 [Baccin2019:10479680;Cellinker:10479680;HPRD:10479680;LRdb:10479680], KCNJ10 [Baccin2019:10479680;CellTalkDB:32196115;Cellinker:10479680;HPRD:10479680;LRdb:10479680;connectomeDB2020:10479680], KCND2 [Baccin2019:10479680;Cellinker:10479680;HPRD:10479680;LRdb:10479680], GRIN2A [CellTalkDB:32103204;HPRD:10479680], KCND1 [Baccin2019:10479680;Cellinker:10479680;HPRD:10479680;LRdb:10479680], GRIN2D [Baccin2019:10479680;Cellinker:10479680;HPRD:10479680;LRdb:10479680;connectomeDB2020:10479680], CCR5 [CellTalkDB:32196115], GRIN2C [Baccin2019:10479680;Cellinker:10479680;HPRD:10479680;LRdb:10479680], CASP3 [HPRD:10479680;HPRD:9422780]	cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Flemming body [GO:0090543]; focal adhesion [GO:0005925]; nuclear speck [GO:0016607]; plasma membrane [GO:0005886]	CD4 receptor binding [GO:0042609]; cytokine activity [GO:0005125]	cytokine-mediated signaling pathway [GO:0019221]; immune response [GO:0006955]; induction of positive chemotaxis [GO:0050930]; leukocyte chemotaxis [GO:0030595]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-1 alpha production [GO:0032730]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of neutrophil activation [GO:1902565]; regulation of calcium ion transport [GO:0051924]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IL16&keywords=IL16	1.9707122067701346	387	58.5869	168	0.18322785259985244	544	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
IL17A	interleukin 17A	Yes		ENSG00000112115	Q16552	IL-17 family	17	ligand, receptor	extracellular, ligand, receptor, secreted	Q8NAC3, Q96F46	IL17RA, IL17RA_IL17RC, IL17RC	IL17RC [CellTalkDB:18684971;InnateDB:17911633;InnateDB:18684971;InnateDB:19838198;LRdb:18684971;Ramilowski2015:18684971;connectomeDB2020:18684971;talklr:18684971], IL17RA [Baccin2019:93675399367539;CellTalkDB:9367539;HPMR:9367539;HPRD:9367539;InnateDB:11058597;InnateDB:17911633;InnateDB:18684971;InnateDB:19838198;InnateDB:9367539;LRdb:9367539;SIGNOR:9367539;connectomeDB2020:9367539]	external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	cytokine activity [GO:0005125]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]	adaptive immune response [GO:0002250]; apoptotic process [GO:0006915]; cell-cell signaling [GO:0007267]; cell death [GO:0008219]; cellular response to interleukin-1 [GO:0071347]; defense response to fungus [GO:0050832]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; fibroblast activation [GO:0072537]; granulocyte migration [GO:0097530]; immune response [GO:0006955]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; interleukin-17-mediated signaling pathway [GO:0097400]; intestinal epithelial structure maintenance [GO:0060729]; Notch signaling pathway [GO:0007219]; positive regulation of antimicrobial peptide production [GO:0002225]; positive regulation of bicellular tight junction assembly [GO:1903348]; positive regulation of chemokine (C-X-C motif) ligand 1 production [GO:2000340]; positive regulation of cytokine production involved in inflammatory response [GO:1900017]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-16 production [GO:0032739]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-23 production [GO:0032747]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IL17A&keywords=IL17A	0.004977842696629213	855	NA	NA	1.4172781466714917	211	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
IL17B	interleukin 17B	Yes		ENSG00000127743	Q9UHF5	IL-17 family	16	ligand	ligand, secreted	Q96F46, Q9NRM6	IL17RA, IL17RB	IL17RA [NA], IL17RB [Baccin2019:1074988710749880;CellTalkDB:10749887;Cellinker:10749887;HPRD:10749887;ICELLNET:24011563;InnateDB:10749887;InnateDB:11058597;LRdb:10749887;SIGNOR:10749887;connectomeDB2020:10749887]	extracellular space [GO:0005615]	cytokine activity [GO:0005125]	cell-cell signaling [GO:0007267]; immune response [GO:0006955]; inflammatory response [GO:0006954]; positive regulation of cytokine production involved in inflammatory response [GO:1900017]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IL17B&keywords=IL17B	0.24200601460674157	596	NA	NA	0.10702959634695348	623	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
IL17C	interleukin 17C	Yes		ENSG00000124391	Q9P0M4	IL-17 family	12	ligand	ligand, secreted	Q8NFR9, Q96F46	IL17RA, IL17RA_IL17RE, IL17RE	IL17RE [CellTalkDB:21993849;connectomeDB2020:21993848], IL17RA [connectomeDB2020:21993848]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	cytokine activity [GO:0005125]	cell-cell signaling [GO:0007267]; cell surface receptor signaling pathway [GO:0007166]; inflammatory response [GO:0006954]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IL17C&keywords=IL17C	0.055001012359550565	728	NA	NA	0.4553379949725151	400	0	0.001497005988023952	0	0	0.04882154882154882	0	0	0.0032626427406199023	3.699593044765076e-4	0	0	302	409	401	0.004904650623151744	0.6957532629693853	0.6709315268663034	0.6709315268663034	264	263	247
IL17D	interleukin 17D	Yes		ENSG00000172458	Q8TAD2	IL-17 family	3	ligand	extracellular, ligand, secreted	NA	NA	NA	extracellular space [GO:0005615]	cytokine activity [GO:0005125]; protein homodimerization activity [GO:0042803]; receptor ligand activity [GO:0048018]	inflammatory response [GO:0006954]; negative regulation of hemopoiesis [GO:1903707]; positive regulation of cytokine production involved in inflammatory response [GO:1900017]; positive regulation of granulocyte macrophage colony-stimulating factor production [GO:0032725]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IL17D&keywords=IL17D	3.550971426966292	319	NA	NA	0.20085835128534416	533	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
IL17F	interleukin 17F	Yes		ENSG00000112116	Q96PD4	IL-17 family	17	ligand	extracellular, ligand, secreted	Q8NAC3, Q96F46	IL17RA, IL17RA_IL17RC, IL17RC	IL17RC [CellTalkDB:28827714;InnateDB:17911633;InnateDB:18684971;InnateDB:19838198], IL17RA [CellTalkDB:18684971;InnateDB:18684971;InnateDB:19838198;LRdb:18684971;Ramilowski2015:18684971;connectomeDB2020:18684971;talklr:18684971]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	cytokine activity [GO:0005125]; cytokine binding [GO:0019955]; cytokine receptor binding [GO:0005126]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]	adaptive immune response [GO:0002250]; cartilage development [GO:0051216]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; interleukin-17-mediated signaling pathway [GO:0097400]; negative regulation of angiogenesis [GO:0016525]; positive regulation of antimicrobial peptide production [GO:0002225]; positive regulation of chemokine (C-X-C motif) ligand 1 production [GO:2000340]; positive regulation of cytokine production [GO:0001819]; positive regulation of cytokine production involved in inflammatory response [GO:1900017]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of lymphotoxin A production [GO:0032761]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of granulocyte macrophage colony-stimulating factor production [GO:0032645]; regulation of interleukin-2 production [GO:0032663]; regulation of interleukin-6 production [GO:0032675]; regulation of interleukin-8 production [GO:0032677]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IL17F&keywords=IL17F	8.374483146067416e-4	895	NA	NA	0.31693288252556456	457	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
IL17RA	interleukin 17 receptor A	No	isoform 2 is secreted	ENSG00000177663	Q96F46	NA	1	adhesion, ligand, receptor	adhesion, cell_adhesion, cell_surface, extracellular, intracellular, ligand, plasma_membrane, plasma_membrane_transmembrane, receptor, secreted, transmembrane, transmembrane_predicted	Q16552	IL17A	IL17A [HPMR:9367539;HPRD:9367539;InnateDB:11058597;InnateDB:17911633;InnateDB:18684971;InnateDB:19838198;InnateDB:9367539]	extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	interleukin-17 receptor activity [GO:0030368]; signaling receptor binding [GO:0005102]	cell surface receptor signaling pathway [GO:0007166]; defense response to fungus [GO:0050832]; fibroblast activation [GO:0072537]; granulocyte chemotaxis [GO:0071621]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; interleukin-17-mediated signaling pathway [GO:0097400]; positive regulation of chemokine (C-X-C motif) ligand 1 production [GO:2000340]; positive regulation of cytokine production involved in inflammatory response [GO:1900017]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-13 production [GO:0032736]; positive regulation of interleukin-23 production [GO:0032747]; positive regulation of interleukin-5 production [GO:0032754]; positive regulation of interleukin-6 production [GO:0032755]; protein catabolic process [GO:0030163]; response to virus [GO:0009615]; T-helper 17 type immune response [GO:0072538]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IL17RA&keywords=IL17RA	6.151030431910113	275	NA	NA	0.5856575487549062	347	0.09448818897637795	0.06437125748502986	0.03650442477876109	0.05347721822541965	0.07070707070707072	0.07275803722504233	0.08794197642792367	0.03752039151712889	0.04365519792822788	0.05391240486046403	0.034807803747344	177	140	176	0.059103997443526374	0.7764413046014645	0.924872760258116	0.6484111687455147	228	161	260
IL17RB	interleukin 17 receptor B	No		ENSG00000056736	Q9NRM6	NA	1	ligand, receptor	cell_surface, extracellular, intracellular, ligand, plasma_membrane, plasma_membrane_transmembrane, receptor, secreted, transmembrane, transmembrane_predicted	NA	NA	NA	centriolar satellite [GO:0034451]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	cytokine receptor activity [GO:0004896]; interleukin-17 receptor activity [GO:0030368]	defense response [GO:0006952]; regulation of cell growth [GO:0001558]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IL17RB&keywords=IL17RB	12.800353191011236	210	NA	NA	0.9877120541452645	270	0	0.020958083832335314	0.0011061946902654867	0.0021582733812949635	0.030303030303030293	0.08798646362098138	0.09791477787851294	0.15660685154975526	0.04402515723270441	0.09817732674589352	0.02549739231214994	175	105	194	0.05133941377699305	0.8807576386223626	1.7635859243648047	0.5787044597655442	196	29	295
IL17RE	interleukin 17 receptor E	No		ENSG00000163701	Q8NFR9	NA	1	ligand, receptor	cell_surface, extracellular, intracellular, ligand, plasma_membrane, plasma_membrane_transmembrane, receptor, secreted, transmembrane	NA	NA	NA	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	interleukin-17 receptor activity [GO:0030368]	inflammatory response [GO:0006954]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IL17RE&keywords=IL17RE	4.445362350043219	303	NA	NA	0.43764050572927427	405	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
IL18	interleukin 18	Yes		ENSG00000150782	Q14116	IL-1 family	18	ligand	extracellular, intracellular, ligand, secreted	O95256, O95998, P09326, P24158, Q13478, Q9HB29, Q9NZN1	CD48, IL18_IL18R1_IL18RAP, IL18BP, IL18R1, IL18R1_IL18RAP, IL18RAP, IL1RAPL1, IL1RL2, PRTN3	IL18R1 [Baccin2019:9325300;CellTalkDB:9325300;HPMR:11046021;HPMR:9325300;HPRD:9325300;InnateDB:12096920;InnateDB:9325300;LRdb:9325300;Lit-BM-17:25261253;Lit-BM-17:9325300;SIGNOR:9792649;connectomeDB2020:9325300], IL18RAP [Baccin2019:9792649;CellTalkDB:9792649;HPRD:9792649;LRdb:9792649;connectomeDB2020:9792649], CD48 [CellTalkDB:15760905], IL1RAPL1 [Baccin2019:9325300;CellTalkDB:9325300;Cellinker:9325300;HPMR:11046021;HPMR:9325300;LRdb:9325300;connectomeDB2020:9325300], IL18BP [CellTalkDB:24115947;HPRD:11907126;InnateDB:10023777;InnateDB:10094485;InnateDB:10655506;InnateDB:11278524;InnateDB:11907126;InnateDB:12381835;InnateDB:18203261], IL1RL2 [Baccin2019:9325300;CellTalkDB:9325300;Cellinker:9325300;HPRD:9325300;LRdb:9325300], PRTN3 [InnateDB:22270365]	cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	cytokine activity [GO:0005125]; interleukin-18 receptor binding [GO:0045515]	activation of protein kinase B activity [GO:0032148]; angiogenesis [GO:0001525]; cell-cell signaling [GO:0007267]; cell population proliferation [GO:0008283]; cellular response to organic cyclic compound [GO:0071407]; cholesterol homeostasis [GO:0042632]; inflammatory response [GO:0006954]; interleukin-18-mediated signaling pathway [GO:0035655]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; MAPK cascade [GO:0000165]; natural killer cell activation [GO:0030101]; natural killer cell mediated cytotoxicity [GO:0042267]; negative regulation of myoblast differentiation [GO:0045662]; neutrophil activation [GO:0042119]; positive regulation of activated T cell proliferation [GO:0042104]; positive regulation of chemokine production [GO:0032722]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of granulocyte macrophage colony-stimulating factor production [GO:0032725]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-13 production [GO:0032736]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of macrophage derived foam cell differentiation [GO:0010744]; positive regulation of natural killer cell proliferation [GO:0032819]; positive regulation of neuroinflammatory response [GO:0150078]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of NK T cell proliferation [GO:0051142]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of T-helper 1 cell cytokine production [GO:2000556]; positive regulation of T-helper 2 cell differentiation [GO:0045630]; positive regulation of tissue remodeling [GO:0034105]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; regulation of cell adhesion [GO:0030155]; sleep [GO:0030431]; T-helper 1 type immune response [GO:0042088]; triglyceride homeostasis [GO:0070328]; type 2 immune response [GO:0042092]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IL18&keywords=IL18	12.118081091011236	220	NA	NA	0.5981649351644578	342	0.05511811023622047	0.03493013972055885	0	9.592326139088729e-4	0.12794612794612803	0.001692047377326565	0.0027198549410698096	0	0.0014798372179060304	0.0030711710508746107	9.271779022599965e-4	299	318	369	0.02080397263693211	0.37267391947175005	0.42433393916221906	0.35473274928049275	385	338	370
IL18BP	interleukin 18 binding protein	No		ENSG00000137496	O95998	NA	1	ligand	extracellular, intracellular, ligand, secreted	P08887, P20916, Q14116, Q8N6C8, Q8N743	IL18, IL6R, KIR3DL3, LILRA3, MAG	IL18 [HPRD:11907126;InnateDB:10023777;InnateDB:10094485;InnateDB:10655506;InnateDB:11278524;InnateDB:11907126;InnateDB:12381835;InnateDB:18203261], LILRA3 [Cellinker:32822567], KIR3DL3 [Cellinker:32822567], IL6R [Cellinker:32822567], MAG [Cellinker:32822567]	extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	interleukin-18 binding [GO:0042007]; receptor antagonist activity [GO:0048019]	cellular response to hydrogen peroxide [GO:0070301]; cellular response to tumor necrosis factor [GO:0071356]; response to lipopolysaccharide [GO:0032496]; T-helper 1 type immune response [GO:0042088]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IL18BP&keywords=IL18BP	4.923180668986608	292	NA	NA	0.4712842788326444	397	0.05511811023622047	0.022954091816367247	0.018805309734513276	0.013429256594724217	0.02861952861952861	0.12521150592216576	0.15412511332728887	0.12724306688417633	0.09064002959674412	0.068567231940181	0.12965037666601795	133	127	96	0.07585123830344799	1.1722606637428337	0.9151554886427952	1.626655356704497	93	166	28
IL19	interleukin 19	Yes		ENSG00000142224	Q9UHD0	IL-10 family	19	ligand	extracellular, intracellular, ligand, secreted	Q6UXL0, Q9UHF4	IL20RA, IL20RA_IL20RB, IL20RB	IL20RA [Baccin2019:1297448111564760;CellTalkDB:12974481;HPRD:11564763;LRdb:12;LRdb:12974481;SIGNOR:11564763;SignaLink3:11564763;SignaLink3:17208301;SignaLink3:18988627;SignaLink3:23331499;connectomeDB2020:11564763;connectomeDB2020:12974481], IL20RB [CellTalkDB:12974481;InnateDB:14580208;IntAct:22802649;LRdb:12974481;Lit-BM-17:22802649;SIGNOR:17208301;SignaLink3:17208301;SignaLink3:23331499;connectomeDB2020:12974481]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	cytokine activity [GO:0005125]	apoptotic process [GO:0006915]; immune response [GO:0006955]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of low-density lipoprotein particle clearance [GO:0010989]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; reactive oxygen species metabolic process [GO:0072593]; signal transduction [GO:0007165]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IL19&keywords=IL19	0.12270765393258427	656	NA	NA	1.5795702256127273	196	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
IL1A	interleukin 1 alpha	Yes		ENSG00000115008	P01583	IL-1 family	20	ligand, receptor	extracellular, intracellular, ligand, receptor, secreted	P14778, P27930, Q9NPH3	IL1B_IL1R1_IL1RAP, IL1B_IL1R2_IL1RAP, IL1R1, IL1R1_IL1RAP, IL1R2, IL1R2_IL1RAP, IL1RAP	IL1R1 [Baccin2019:29469592946959;CellTalkDB:2946959;HPRD:2946959;InnateDB:8142597;LRdb:2946959;NetPath:17507369;NetPath:2946959;NetPath:7775431;SIGNOR:7964161;SIGNOR:9565970;SPIKE:19479203;SignaLink3:23331499;SignaLink3:2946959;SignaLink3:9565970;connectomeDB2020:2946959], IL1RAP [Baccin2019:9820540;CellTalkDB:9820540;HPRD:9820540;LRdb:9820540;NetPath:17507369;NetPath:7775431;NetPath:9862719;connectomeDB2020:9820540], IL1R2 [Baccin2019:78780467878046;CellTalkDB:7878046;Cellinker:7878046;HPRD:7878046;InnateDB:1833184;InnateDB:23395675;IntAct:16971486;IntAct:25241761;LRdb:7878046;NetPath:7878046;NetPath:9862719;connectomeDB2020:7878046]	cell surface [GO:0009986]; cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]	copper ion binding [GO:0005507]; cytokine activity [GO:0005125]; interleukin-1 receptor binding [GO:0005149]	apoptotic process [GO:0006915]; cellular response to heat [GO:0034605]; cellular response to lipopolysaccharide [GO:0071222]; cellular sodium ion homeostasis [GO:0006883]; connective tissue replacement involved in inflammatory response wound healing [GO:0002248]; cytokine-mediated signaling pathway [GO:0019221]; ectopic germ cell programmed cell death [GO:0035234]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; fever generation [GO:0001660]; heart development [GO:0007507]; immune response [GO:0006955]; inflammatory response [GO:0006954]; keratinization [GO:0031424]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of establishment of Sertoli cell barrier [GO:1904445]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell division [GO:0051781]; positive regulation of cytokine production [GO:0001819]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of immature T cell proliferation in thymus [GO:0033092]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of JNK cascade [GO:0046330]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of neutrophil migration [GO:1902624]; positive regulation of prostaglandin secretion [GO:0032308]; positive regulation of protein secretion [GO:0050714]; positive regulation of steroid biosynthetic process [GO:0010893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of vascular endothelial growth factor production [GO:0010575]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of nitric-oxide synthase activity [GO:0050999]; regulation of sensory perception of pain [GO:0051930]; response to copper ion [GO:0046688]; response to gamma radiation [GO:0010332]; response to hypoxia [GO:0001666]; response to L-ascorbic acid [GO:0033591]; response to organonitrogen compound [GO:0010243]; response to ozone [GO:0010193]; spermatogenesis [GO:0007283]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IL1A&keywords=IL1A	3.1612575539325842	332	NA	NA	3.9643369509995394	92	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
IL1B	interleukin 1 beta	Yes		ENSG00000125538	P01584	IL-1 family	20	ligand	extracellular, intracellular, ligand, secreted	P05187, P07550, P14778, P27930, Q6IA17, Q9NPH3	ADRB2, ALPP, IL1B_IL1R1_IL1RAP, IL1B_IL1R2_IL1RAP, IL1R1, IL1R1_IL1RAP, IL1R2, IL1R2_IL1RAP, IL1RAP, SIGIRR	IL1R2 [Baccin2019:7878046;Baccin2019:8332913;CellTalkDB:8332913;Cellinker:7878046;Cellinker:8332913;HPMR:8332913;HPRD:7878046;InnateDB:1833184;InnateDB:20802483;InnateDB:7878046;LRdb:788;LRdb:8332913;NetPath:7878046;SIGNOR:8332913;SPIKE:7878046;connectomeDB2020:7878046;connectomeDB2020:8332913], IL1R1 [Baccin2019:62193;Baccin2019:9062193;Baccin2019:9820540;CellTalkDB:9062193;HPRD:9062193;InnateDB:8142597;LRdb:62193;LRdb:9062193;LRdb:9820540;Lit-BM-17:7878046;Lit-BM-17:9062193;Macrophage:9062193;NetPath:2946959;NetPath:7775431;SIGNOR:24166242;SIGNOR:9625767;SPIKE:17145710;SPIKE:9062193;SignaLink3:23331499;SignaLink3:9062193;connectomeDB2020:62193;connectomeDB2020:9062193;connectomeDB2020:9820540], IL1RAP [Baccin2019:9820540;CellTalkDB:9820540;HPRD:9820540;InnateDB:20802483;LRdb:9820540;NetPath:7775431;SIGNOR:9820540;connectomeDB2020:9820540], SIGIRR [CellTalkDB:14715412], ADRB2 [CellTalkDB:11238007;HPRD:11238007;LRdb:11238007], ALPP [InnateDB:9099704]	cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosome [GO:0005764]; secretory granule [GO:0030141]	cytokine activity [GO:0005125]; integrin binding [GO:0005178]; interleukin-1 receptor binding [GO:0005149]; protein domain specific binding [GO:0019904]	apoptotic process [GO:0006915]; astrocyte activation [GO:0048143]; cell-cell signaling [GO:0007267]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to mechanical stimulus [GO:0071260]; cellular response to organic cyclic compound [GO:0071407]; cellular response to organic substance [GO:0071310]; cellular response to xenobiotic stimulus [GO:0071466]; cytokine-mediated signaling pathway [GO:0019221]; ectopic germ cell programmed cell death [GO:0035234]; embryo implantation [GO:0007566]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; fever generation [GO:0001660]; hyaluronan biosynthetic process [GO:0030213]; immune response [GO:0006955]; inflammatory response [GO:0006954]; interleukin-1-mediated signaling pathway [GO:0070498]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; MAPK cascade [GO:0000165]; monocyte aggregation [GO:0070487]; negative regulation of adiponectin secretion [GO:0070164]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of gap junction assembly [GO:1903597]; negative regulation of glucose transmembrane transport [GO:0010829]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of lipid catabolic process [GO:0050995]; negative regulation of lipid metabolic process [GO:0045833]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of neurogenesis [GO:0050768]; negative regulation of synaptic transmission [GO:0050805]; neutrophil chemotaxis [GO:0030593]; positive regulation of angiogenesis [GO:0045766]; positive regulation of calcidiol 1-monooxygenase activity [GO:0060559]; positive regulation of cell adhesion molecule production [GO:0060355]; positive regulation of cell division [GO:0051781]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of complement activation [GO:0045917]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of fever generation [GO:0031622]; positive regulation of gene expression [GO:0010628]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of granulocyte macrophage colony-stimulating factor production [GO:0032725]; positive regulation of heterotypic cell-cell adhesion [GO:0034116]; positive regulation of histone acetylation [GO:0035066]; positive regulation of histone phosphorylation [GO:0033129]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of immature T cell proliferation in thymus [GO:0033092]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of JNK cascade [GO:0046330]; positive regulation of lipid catabolic process [GO:0050996]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of monocyte chemotactic protein-1 production [GO:0071639]; positive regulation of myosin light chain kinase activity [GO:0035505]; positive regulation of neuroinflammatory response [GO:0150078]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of phagocytosis [GO:0050766]; positive regulation of prostaglandin biosynthetic process [GO:0031394]; positive regulation of prostaglandin secretion [GO:0032308]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of RNA biosynthetic process [GO:1902680]; positive regulation of T cell mediated immunity [GO:0002711]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of T-helper 1 cell cytokine production [GO:2000556]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of vascular endothelial growth factor production [GO:0010575]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; protein kinase B signaling [GO:0043491]; regulation of defense response to virus by host [GO:0050691]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of establishment of endothelial barrier [GO:1903140]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of insulin secretion [GO:0050796]; regulation of neurogenesis [GO:0050767]; regulation of nitric-oxide synthase activity [GO:0050999]; response to ATP [GO:0033198]; response to carbohydrate [GO:0009743]; response to interleukin-1 [GO:0070555]; response to lipopolysaccharide [GO:0032496]; sequestering of triglyceride [GO:0030730]; signal transduction [GO:0007165]; smooth muscle adaptation [GO:0014805]; vascular endothelial growth factor production [GO:0010573]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IL1B&keywords=IL1B	3.9834124603112357	314	NA	NA	2.353474351588146	135	12.771653543307082	0.003992015968063873	0	0.005035971223021582	0	0.001692047377326565	0	0	0.0014798372179060304	8.679396448123918e-4	8.885454896658299e-4	299	376	371	1.1623281727479888	0.0097923409884425	0.009270390234960799	0.00928796709213479	527	524	526
IL1F10	interleukin 1 family member 10	Yes		ENSG00000136697	Q8WWZ1	IL-1 family	14	ligand	intracellular, ligand, secreted	P14778, Q6IA17, Q9HB29, Q9NP60, Q9NZN1	IL1R1, IL1RAP_IL1RL2, IL1RAPL1, IL1RAPL2, IL1RL2, SIGIRR	IL1RAPL1 [ICELLNET:22315422;ICELLNET:31387327], IL1RL2 [CellTalkDB:22315422;ICELLNET:22315422;ICELLNET:31387327], IL1RAPL2 [ICELLNET:22315422;ICELLNET:31387327], SIGIRR [ICELLNET:22315422;ICELLNET:31387327], IL1R1 [Baccin2019:11278614;CellTalkDB:11278614;Cellinker:11278614;HPRD:11278614;LRdb:11278614;connectomeDB2020:11278614]	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	cytokine activity [GO:0005125]; interleukin-1 receptor binding [GO:0005149]	cellular response to lipopolysaccharide [GO:0071222]; cytokine-mediated signaling pathway [GO:0019221]; inflammatory response [GO:0006954]; inflammatory response to antigenic stimulus [GO:0002437]; positive regulation of gene expression [GO:0010628]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IL1F10&keywords=IL1F10	0	899	NA	NA	0.023737929460685318	788	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
IL1R2	interleukin 1 receptor type 2	No		ENSG00000115590	P27930	Interleukin-1 receptor family	1	adhesion, ligand, receptor	adhesion, cell_adhesion, cell_surface, extracellular, intracellular, ligand, plasma_membrane, plasma_membrane_transmembrane, receptor, secreted, transmembrane, transmembrane_predicted	Q9Y275	TNFSF13B	TNFSF13B [Cellinker:32822567]	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	interleukin-1, type II, blocking receptor activity [GO:0004910]; interleukin-1 binding [GO:0019966]; interleukin-1 receptor activity [GO:0004908]	immune response [GO:0006955]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of interleukin-1 alpha production [GO:0032690]; negative regulation of interleukin-1-mediated signaling pathway [GO:2000660]; negative regulation of protein processing [GO:0010955]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IL1R2&keywords=IL1R2	2.867764688814607	344	NA	NA	0.21502600474061265	525	0.015748031496062992	0.16367265469061934	0	0.012470023980815344	0.026936026936026928	0.035532994923857864	0.06980961015412504	0.013050570962479609	0.02219755826859044	0.0061757243957804644	0.1016418775352487	227	275	112	0.0424759157585097	0.6135682970595736	0.30825044521795403	2.1274879327312055	298	375	15
IL1RAP	interleukin 1 receptor accessory protein	No		ENSG00000196083	Q9NPH3	Interleukin-1 receptor family	1	adhesion, ligand, receptor	adhesion, cell_adhesion, cell_surface, extracellular, intracellular, ligand, plasma_membrane, plasma_membrane_transmembrane, receptor, secreted, transmembrane, transmembrane_predicted	P01584, P14778, Q9H0E2	IL1B, IL1R1, TOLLIP	IL1R1 [Cellinker:11756486;HPRD:9371760;InnateDB:15044087;InnateDB:15866876;InnateDB:9371760;InnateDB:9430229;NetPath:10854325;NetPath:17507369;NetPath:7775431;NetPath:9430229;SIGNOR:12530978;SignaLink3:12530978;SignaLink3:23331499;SignaLink3:9371760], IL1B [HPRD:9820540;InnateDB:20802483;NetPath:7775431], TOLLIP [HPRD:10854325;InnateDB:13679373;NetPath:10854325;SIGNOR:10854325]	extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; plasma membrane [GO:0005886]	interleukin-1 receptor activity [GO:0004908]; interleukin-1 receptor binding [GO:0005149]; interleukin-33 receptor activity [GO:0002114]; NAD(P)+ nucleosidase activity [GO:0050135]; NAD+ nucleotidase, cyclic ADP-ribose generating [GO:0061809]	immune response [GO:0006955]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; positive regulation of interleukin-13 production [GO:0032736]; positive regulation of interleukin-4 production [GO:0032753]; positive regulation of interleukin-5 production [GO:0032754]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of synapse assembly [GO:0051965]; protein-containing complex assembly [GO:0065003]; regulation of postsynaptic density assembly [GO:0099151]; regulation of presynapse assembly [GO:1905606]; synaptic membrane adhesion [GO:0099560]; trans-synaptic signaling by trans-synaptic complex [GO:0099545]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IL1RAP&keywords=IL1RAP	7.375137359414087	265	NA	NA	2.8670426418801567	117	0.015748031496062992	0.03493013972055885	0.01327433628318584	0.04004796163069543	0.026936026936026928	0.04230118443316414	0.007252946509519492	0.07993474714518767	0.036995930447650725	0.0038723461076245083	0.002820166119374157	193	305	319	0.027646710620822794	1.248340948588926	0.3684876016751266	0.34053881223511695	81	353	376
IL1RL1	interleukin 1 receptor like 1	No		ENSG00000115602	Q01638	Interleukin-1 receptor family	1	adhesion, ligand, receptor	adhesion, cell_adhesion, cell_surface, extracellular, intracellular, ligand, plasma_membrane, plasma_membrane_transmembrane, receptor, secreted, transmembrane, transmembrane_predicted	O95760	IL33	IL33 [DIP:19439663;HPRD:16286016;InnateDB:18450470;InnateDB:19439663;InnateDB:19559631;InnateDB:19836339;InnateDB:23980170]	cytosol [GO:0005829]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	cytokine receptor activity [GO:0004896]; interleukin-1 receptor activity [GO:0004908]; interleukin-33 binding [GO:0002113]; interleukin-33 receptor activity [GO:0002114]; NAD(P)+ nucleosidase activity [GO:0050135]; NAD+ nucleotidase, cyclic ADP-ribose generating [GO:0061809]	immune response [GO:0006955]; negative regulation of interferon-gamma production [GO:0032689]; negative regulation of T-helper 1 type immune response [GO:0002826]; positive regulation of chemokine production [GO:0032722]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-5 production [GO:0032754]; positive regulation of macrophage activation [GO:0043032]; signal transduction [GO:0007165]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IL1RL1&keywords=IL1RL1	12.881361246264046	209	NA	NA	1.9497434983622288	163	0.007874015748031496	0.8582834331337316	0.5597345132743348	1.0510791366906538	0.22390572390572386	0.00338409475465313	0.007252946509519492	0.0032626427406199023	0.008879023307436182	0.00270396581653091	0.006915201854355808	270	327	266	0.24847951797596282	0.07303875933872575	0.04914882972550386	0.06544116913715704	493	500	492
IL1RN	interleukin 1 receptor antagonist	Yes		ENSG00000136689	P18510	NA	16	ligand, receptor	extracellular, intracellular, ligand, ligand_regulator, receptor, secreted	P01589, P14778, P14784, P27930, P31785, Q9HB29, Q9NPH3	IL1B_IL1R1_IL1RAP, IL1B_IL1R2_IL1RAP, IL1R1, IL1R2, IL1RAP, IL1RL2, IL2RA, IL2RB, IL2RG	IL1RAP [NA], IL1R1 [Baccin2019:11641511;Baccin2019:9062194;BioGRID:9062194;CellTalkDB:11641511;Cellinker:11641511;Cellinker:9062194;HPRD:11641511;HPRD:9062194;ICELLNET:20959797;ICELLNET:24332029;InnateDB:8142597;LRdb:11641511;LRdb:91;NetPath:7589429;SIGNOR:2876877;connectomeDB2020:9062194], IL2RG [NA], IL2RA [NA], IL2RB [NA], IL1R2 [Baccin2019:1834644;CellTalkDB:1834644;Cellinker:1834644;HPRD:1834644;ICELLNET:20959797;ICELLNET:24332029;InnateDB:1833184;LRdb:1834644;NetPath:7878046;connectomeDB2020:1834644], IL1RL2 [CellTalkDB:22047735]	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]	cytokine activity [GO:0005125]; interleukin-1, type II receptor binding [GO:0005151]; interleukin-1, type I receptor binding [GO:0005150]; interleukin-1 receptor antagonist activity [GO:0005152]; interleukin-1 receptor binding [GO:0005149]; interleukin-1 type II receptor antagonist activity [GO:0045353]; interleukin-1 type I receptor antagonist activity [GO:0045352]	acute-phase response [GO:0006953]; immune response [GO:0006955]; inflammatory response [GO:0006954]; inflammatory response to antigenic stimulus [GO:0002437]; insulin secretion [GO:0030073]; lipid metabolic process [GO:0006629]; negative regulation of heterotypic cell-cell adhesion [GO:0034115]; negative regulation of interleukin-1-mediated signaling pathway [GO:2000660]; response to glucocorticoid [GO:0051384]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IL1RN&keywords=IL1RN	12.313337945278562	215	NA	NA	0.27347502483820074	480	1.2755905511811017	0.1701596806387234	0	0.021822541966426853	0.023569023569023566	0	0.003626473254759746	0	7.399186089530152e-4	1.6691147015622916e-4	4.635889511299981e-4	301	404	385	0.13601260814911587	0.07355473438283383	0.06963036685005473	0.07166222892508038	491	486	490
IL2	interleukin 2	Yes		ENSG00000109471	P60568	IL-2 family	21	ligand	extracellular, ligand, secreted	P01562, P01589, P08138, P14784, P15421, P19397, P29353, P31785, P80370	CD53, DLK1, GYPE, IFNA1, IL2_IL2RA_IL2RB_IL2RG, IL20RA_IL20RB_IL2RG, IL2RA, IL2RA_IL2RB_IL2RG, IL2RB, IL2RB_IL2RG, IL2RG, NGFR, SHC1	IL2RG [Baccin2019:10662798;Baccin2019:15265897;Baccin2019:8049354;CellTalkDB:15265897;DIP:8006584;HPMR:15265897;HPMR:15933202;HPRD:10662798;HPRD:8049354;InnateDB:11418623;InnateDB:7681595;InnateDB:8568232;LRdb:10662798;LRdb:15265897;LRdb:8049354;NetPath:8049354;NetPath:8260650;SIGNOR:16477002;SignaLink3:10807786;SignaLink3:10820393;SignaLink3:10849428;SignaLink3:11418623;SignaLink3:12095053;SignaLink3:15289500;SignaLink3:15563472;SignaLink3:16212621;SignaLink3:16799562;SignaLink3:17371980;SignaLink3:1825141;SignaLink3:18758473;SignaLink3:19528259;SignaLink3:19833085;SignaLink3:20856220;SignaLink3:21840487;SignaLink3:22224781;SignaLink3:23124025;SignaLink3:23180781;SignaLink3:23331499;SignaLink3:23650441;SignaLink3:24829413;SignaLink3:26192618;SignaLink3:26755705;SignaLink3:2965306;SignaLink3:6164929;SignaLink3:7512720;SignaLink3:7521688;SignaLink3:7681595;SignaLink3:7829965;SignaLink3:8683106;SignaLink3:9625766;connectomeDB2020:10662798;connectomeDB2020:15265897;connectomeDB2020:8049354], IL2RA [Baccin2019:15265897;Baccin2019:1993646;CellTalkDB:15265897;DIP:17032757;HPMR:15265897;HPMR:15933202;HPRD:1993646;InnateDB:12649439;InnateDB:15178252;InnateDB:1940342;InnateDB:3095922;InnateDB:6815536;InnateDB:8580082;InnateDB:8894436;InnateDB:8960125;IntAct:17032757;LRdb:15265897;LRdb:2;NetPath:3116143;NetPath:8260650;SIGNOR:16477002;connectomeDB2020:15265897;connectomeDB2020:1993646], IL2RB [Baccin2019:11035066;Baccin2019:15265897;Baccin2019:8049354;CellTalkDB:15265897;DIP:22446627;DIP:8006584;HPMR:15265897;HPMR:15933202;HPRD:11035066;HPRD:8049354;InnateDB:15178252;InnateDB:1940342;InnateDB:3095922;InnateDB:3098894;InnateDB:8568232;IntAct:22446627;LRdb:11035066;LRdb:15265897;LRdb:8049354;NetPath:3116143;NetPath:8260650;SIGNOR:16477002;connectomeDB2020:11035066;connectomeDB2020:15265897;connectomeDB2020:8049354], CD53 [CellTalkDB:7963560;Cellinker:7963560;HPRD:7963560;LRdb:7963560;connectomeDB2020:7963560], NGFR [Baccin2019:1316918;CellTalkDB:1316918;Cellinker:1316918;HPRD:1316918;LRdb:1316918], GYPE [NA], DLK1 [Cellinker:10733486], IFNA1 [HPRD:3262520], SHC1 [HPRD:10662798]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	carbohydrate binding [GO:0030246]; cytokine activity [GO:0005125]; glycosphingolipid binding [GO:0043208]; growth factor activity [GO:0008083]; interleukin-2 receptor binding [GO:0005134]; kappa-type opioid receptor binding [GO:0031851]; kinase activator activity [GO:0019209]	adaptive immune response [GO:0002250]; cell adhesion [GO:0007155]; cell-cell signaling [GO:0007267]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; gene expression [GO:0010467]; immune response [GO:0006955]; leukocyte activation involved in immune response [GO:0002366]; natural killer cell activation [GO:0030101]; negative regulation of apoptotic process [GO:0043066]; negative regulation of B cell apoptotic process [GO:0002903]; negative regulation of heart contraction [GO:0045822]; negative regulation of inflammatory response [GO:0050728]; negative regulation of lymphocyte proliferation [GO:0050672]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of T-helper 17 cell differentiation [GO:2000320]; positive regulation of activated T cell proliferation [GO:0042104]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of immunoglobulin production [GO:0002639]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of isotype switching to IgG isotypes [GO:0048304]; positive regulation of plasma cell differentiation [GO:1900100]; positive regulation of regulatory T cell differentiation [GO:0045591]; positive regulation of tissue remodeling [GO:0034105]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein kinase C-activating G protein-coupled receptor signaling pathway [GO:0007205]; regulation of T cell homeostatic proliferation [GO:0046013]; response to ethanol [GO:0045471]; T cell differentiation [GO:0030217]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IL2&keywords=IL2	0.007752326966292135	840	NA	NA	0.3250463943940035	453	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
IL20	interleukin 20	Yes		ENSG00000162891	Q9NYY1	IL-10 family	18	ligand	ligand, secreted	Q6UXL0, Q8N6P7, Q9UHF4	IL20RA, IL20RA_IL20RB, IL20RB, IL20RB_IL22RA1, IL22RA1	IL22RA1 [Baccin2019:12974481;CellTalkDB:12974481;LRdb:12974481;SIGNOR:11163236;SignaLink3:17208301;SignaLink3:23331499;connectomeDB2020:12974481], IL20RA [Baccin2019:11163236;Baccin2019:12351624;Baccin2019:12974481;Baccin2019:14580208;CellTalkDB:12974481;HPRD:11163236;HPRD:12351624;HPRD:14580208;IntAct:22802649;LRdb:11163236;LRdb:12351624;LRdb:12974481;LRdb:14580208;Lit-BM-17:22802649;SignaLink3:17208301;SignaLink3:23331499;connectomeDB2020:11163236;connectomeDB2020:12351624;connectomeDB2020:12974481;connectomeDB2020:14580208], IL20RB [CellTalkDB:12974481;InnateDB:11163236;InnateDB:14580208;InnateDB:22232181;IntAct:22802649;LRdb:11163236;LRdb:12351624;LRdb:12974481;LRdb:14580208;Lit-BM-17:22802649;SIGNOR:11163236;SignaLink3:17208301;SignaLink3:23331499;connectomeDB2020:11163236;connectomeDB2020:12351624;connectomeDB2020:12974481;connectomeDB2020:14580208]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	cytokine activity [GO:0005125]; interleukin-20 receptor binding [GO:0045517]; interleukin-22 receptor binding [GO:0045518]	positive regulation of epidermal cell differentiation [GO:0045606]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; regulation of inflammatory response [GO:0050727]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IL20&keywords=IL20	0.04553844797752809	744	NA	NA	0.7884996995512599	303	0	0	0	0.011990407673860908	0.0016835016835016834	0	0	0	3.699593044765076e-4	5.007344104686875e-4	1.5452965037666603e-4	302	388	397	0.001336284792971314	0.9147581852306724	0.9262941609388041	0.8957546352992688	178	158	146
IL21	interleukin 21	Yes		ENSG00000138684	Q9HBE4	IL-15/IL-21 family	17	ligand	extracellular, ligand, secreted	P24394, P31785, Q9HBE5	IL21R, IL21R_IL2RG, IL2RG, IL4R	IL21R [Baccin2019:1141862311418620;CellTalkDB:11418623;HPMR:11418623;HPRD:11418623;LRdb:11418623;SIGNOR:16424177;SignaLink3:11418623;SignaLink3:16424177;SignaLink3:18988627;SignaLink3:21071413;SignaLink3:23331499;connectomeDB2020:11418623], IL2RG [Baccin2019:11418623;CellTalkDB:11418623;HPMR:11418623;InnateDB:11418623;LRdb:11418623;SIGNOR:11418623;connectomeDB2020:11418623], IL4R [Cellinker:21058223]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	cytokine activity [GO:0005125]; cytokine receptor binding [GO:0005126]; interleukin-2 receptor binding [GO:0005134]	cell maturation [GO:0048469]; cellular response to virus [GO:0098586]; defense response to virus [GO:0051607]; germinal center B cell differentiation [GO:0002314]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytokine production [GO:0001819]; positive regulation of immunoglobulin production [GO:0002639]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of natural killer cell mediated cytotoxicity [GO:0045954]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of tissue remodeling [GO:0034105]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; signal transduction [GO:0007165]; T follicular helper cell differentiation [GO:0061470]; tyrosine phosphorylation of STAT protein [GO:0007260]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IL21&keywords=IL21	0.0018090293913921348	888	NA	NA	0.3240825886125088	454	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
IL22	interleukin 22	Yes		ENSG00000127318	Q9GZX6	IL-10 family	18	ligand	extracellular, ligand, secreted	Q08334, Q13651, Q8N6P7, Q969J5, Q9HBE5, Q9UHF4	IL10RA, IL10RB, IL10RB_IL22RA1, IL20RA, IL20RB_IL22RA1, IL21R, IL22_IL22RA1, IL22RA1, IL22RA2	IL10RB [CellTalkDB:10875937;HPRD:10875937;LRdb:10875937;Lit-BM-17:10875937;Lit-BM-17:12513909;Lit-BM-17:15120653;SIGNOR:17208301;SPIKE:18509351;SignaLink3:10875937;SignaLink3:17208301;SignaLink3:23331499;connectomeDB2020:10875937], IL20RA [SignaLink3:17208301;SignaLink3:23331499], IL22RA2 [Baccin2019:1139045311390450;CellTalkDB:11390453;Cellinker:11390453;HPMR:11390453;HPRD:11390453;ICELLNET:15032600;InnateDB:19193995;InnateDB:19285080;LRdb:11390453;Lit-BM-17:11390453;Lit-BM-17:15120653;Lit-BM-17:18599299;Lit-BM-17:19285080;SIGNOR:11390453;connectomeDB2020:11390453], IL22RA1 [Baccin2019:5898511035029;BioGRID:10875937;BioGRID:11035029;CellTalkDB:18675809;DIP:18599299;DIP:20462497;DOMINO:18675809;HPRD:11035029;InnateDB:18599299;IntAct:12513909;IntAct:18599299;IntAct:18675809;IntAct:20462497;LRdb:11035;LRdb:58985;Lit-BM-17:10875937;Lit-BM-17:11035029;Lit-BM-17:12513909;Lit-BM-17:15120653;Lit-BM-17:18599299;Lit-BM-17:18675809;SIGNOR:12941475;connectomeDB2020:11035029;connectomeDB2020:58985], IL10RA [Baccin2019:58985;CellTalkDB:10875937;LRdb:58985;connectomeDB2020:58985], IL21R [CellTalkDB:15546387]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	cytokine activity [GO:0005125]; interleukin-22 receptor binding [GO:0045518]	acute-phase response [GO:0006953]; inflammatory response [GO:0006954]; response to glucocorticoid [GO:0051384]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IL22&keywords=IL22	0.009047535955056179	832	NA	NA	0.78177853383693785	305	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
IL23A	interleukin 23 subunit alpha	Yes		ENSG00000110944	Q9NPF7	IL-6 superfamily	17	ligand	extracellular, intracellular, ligand, secreted	O43699, O75019, P42701, Q5VWK5, Q8N423, Q99665, Q9HCN6	GP6, IL12RB1, IL12RB1_IL23R, IL12RB2, IL23R, LILRA1, LILRB2, SIGLEC6	IL12RB1 [Baccin2019:11114383;Baccin2019:12023369;Baccin2019:12671732;CellTalkDB:12023369;HPMR:12023369;HPRD:11114383;HPRD:12023369;HPRD:12671732;LRdb:11114383;LRdb:12023369;LRdb:12671732;SIGNOR:12023369;SIGNOR:12671732;SignaLink3:11114383;SignaLink3:12023369;SignaLink3:12671732;SignaLink3:18988627;SignaLink3:23331499;connectomeDB2020:11114383;connectomeDB2020:12023369;connectomeDB2020:12671732], IL23R [Baccin2019:1202336912023360;CellTalkDB:12023369;HPMR:12023369;HPRD:12023369;InnateDB:12023369;LRdb:12023369;Lit-BM-17:12023369;SIGNOR:12023369;SignaLink3:12023369;SignaLink3:23331499;connectomeDB2020:12023369], IL12RB2 [CellTalkDB:32196115], LILRB2 [Cellinker:32822567], LILRA1 [Cellinker:32822567], SIGLEC6 [Cellinker:32822567], GP6 [Cellinker:32822567]	endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; interleukin-23 complex [GO:0070743]	cytokine activity [GO:0005125]; interleukin-23 receptor binding [GO:0045519]	defense response to Gram-negative bacterium [GO:0050829]; defense response to virus [GO:0051607]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; negative regulation of interleukin-10 production [GO:0032693]; positive regulation of activated T cell proliferation [GO:0042104]; positive regulation of activation of Janus kinase activity [GO:0010536]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of granulocyte macrophage colony-stimulating factor production [GO:0032725]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of memory T cell differentiation [GO:0043382]; positive regulation of natural killer cell activation [GO:0032816]; positive regulation of natural killer cell proliferation [GO:0032819]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of NK T cell activation [GO:0051135]; positive regulation of NK T cell proliferation [GO:0051142]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of T cell mediated cytotoxicity [GO:0001916]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of T-helper 17 cell lineage commitment [GO:2000330]; positive regulation of T-helper 17 type immune response [GO:2000318]; positive regulation of T-helper 1 type immune response [GO:0002827]; positive regulation of tissue remodeling [GO:0034105]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; regulation of tyrosine phosphorylation of STAT protein [GO:0042509]; T cell proliferation [GO:0042098]; tissue remodeling [GO:0048771]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IL23A&keywords=IL23A	2.3185499457644188	374	NA	NA	1.4757682288251461	204	0.031496062992125984	0.17614770459081927	0.008849557522123894	0.028297362110311745	0.0101010101010101	0.027072758037225038	0.005439709882139619	0.011419249592169658	0.0073991860895301536	0.010448658031779919	0.006528877728414146	277	242	269	0.029381830607059047	0.44180744829092367	0.5192409219320184	0.41970821248343404	361	310	347
IL24	interleukin 24	Yes		ENSG00000162892	Q13007	IL-10 family	18	ligand	extracellular, intracellular, ligand, secreted, transmembrane	P01574, Q04721, Q08334, Q6UXL0, Q8N6P7, Q9UHF4	IFNB1, IL10RB, IL20RA, IL20RA_IL20RB, IL20RB, IL20RB_IL22RA1, IL22RA1, NOTCH2	IFNB1 [SPIKE:18511292], IL22RA1 [Baccin2019:12974481;CellTalkDB:12974481;LRdb:12974481;SignaLink3:17208301;SignaLink3:23331499;connectomeDB2020:12974481], IL20RA [Baccin2019:1297448111706020;CellTalkDB:12974481;HPRD:11706020;LRdb:12;LRdb:12974481;SignaLink3:17208301;SignaLink3:23331499;connectomeDB2020:11706020;connectomeDB2020:12974481], IL20RB [CellTalkDB:12974481;InnateDB:11706020;LRdb:12974481;SignaLink3:17208301;SignaLink3:23331499;connectomeDB2020:12974481], IL10RB [CellTalkDB:20061404], NOTCH2 [NA]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	cytokine activity [GO:0005125]	apoptotic process [GO:0006915]; cellular response to interleukin-4 [GO:0071353]; cellular response to lipopolysaccharide [GO:0071222]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; serine phosphorylation of STAT protein [GO:0042501]; wound healing [GO:0042060]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IL24&keywords=IL24	21.133672847185608	164	NA	NA	9.30527389064708	48	0.1653543307086614	0.006487025948103793	0.007743362831858407	4.967146282973566	0.03872053872053872	0.008460236886632826	0	0.09951060358890702	0.012208657047724752	0.009280277740686326	0.00625845084025498	256	247	272	0.483742706116994	0.04498022304447438	0.039049240630438395	0.032928994471874765	508	506	516
IL25	interleukin 25	Yes		ENSG00000166090	Q9H293	IL-17 family	15	ligand	extracellular, ligand, secreted, transmembrane	Q96F46, Q9NRM6	IL17RA, IL17RA_IL17RB, IL17RB	IL17RA [InnateDB:19838198], IL17RB [CellTalkDB:11058597;HPMR:11058597;HPRD:11058597;ICELLNET:24011563;InnateDB:11058597;InnateDB:19838198;LRdb:11058597;connectomeDB2020:11058597]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	cytokine activity [GO:0005125]; interleukin-17E receptor binding [GO:0030380]	eosinophil differentiation [GO:0030222]; inflammatory response to antigenic stimulus [GO:0002437]; positive regulation of transcription by RNA polymerase II [GO:0045944]; response to fungus [GO:0009620]; response to nematode [GO:0009624]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IL25&keywords=IL25	0.0021741584269662924	879	NA	NA	0.1281948538636918	593	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
IL26	interleukin 26	Yes		ENSG00000111536	Q9NPH9	IL-10 family	11	ligand	intracellular, ligand, secreted	Q08334, Q6UXL0, Q9UHF4	IL10RB, IL10RB_IL20RA, IL20RA, IL20RB	IL20RA [CellTalkDB:14764663;InnateDB:15178681;SIGNOR:17208301;SignaLink3:17208301;SignaLink3:23106140;SignaLink3:23331499;connectomeDB2020:14764663], IL10RB [CellTalkDB:14764663;SIGNOR:17208301;SignaLink3:17208301;SignaLink3:23106140;SignaLink3:23331499], IL20RB [connectomeDB2020:14764663]	cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	cytokine activity [GO:0005125]	cell-cell signaling [GO:0007267]; negative regulation of epithelial cell proliferation [GO:0050680]; positive regulation of cytokine production [GO:0001819]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of stress-activated MAPK cascade [GO:0032874]; positive regulation of transcription by RNA polymerase II [GO:0045944]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IL26&keywords=IL26	0.002744596629213483	870	NA	NA	0.3831404717367843	426	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
IL27	interleukin 27	Yes		ENSG00000197272	Q8NEV9	IL-6 superfamily	15	ligand	extracellular, intracellular, ligand, secreted	P40189, Q6UWB1	IL27RA, IL6ST	IL27RA [Baccin2019:12121660;CellTalkDB:12121660;Cellinker:12121660;HPRD:12121660;LRdb:12121660;SIGNOR:14764690;SignaLink3:12121660;SignaLink3:17318299;SignaLink3:18988627;SignaLink3:23331499;connectomeDB2020:12121660], IL6ST [NA]	cytosol [GO:0005829]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	cytokine activity [GO:0005125]; interleukin-27 receptor binding [GO:0045523]; signaling receptor binding [GO:0005102]	inflammatory response [GO:0006954]; innate immune response [GO:0045087]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of interferon-gamma production [GO:0032729]; regulation of T cell proliferation [GO:0042129]; regulation of T-helper 1 cell differentiation [GO:0045625]; response to bacterium [GO:0009617]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IL27&keywords=IL27	0.00877765393258427	835	NA	NA	0.05120779312401715	706	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
IL3	interleukin 3	Yes		ENSG00000164399	P08700	IL-3 family	19	ligand	extracellular, ligand, secreted	P15509, P26951, P32927, P42336	CSF2RA, CSF2RB, CSF2RB_IL3RA, IL3RA, PIK3CA	IL3RA [BioGRID:8649415;CellTalkDB:11700046;DIP:8649415;HPMR:11700046;HPRD:8649415;HPRD:9278420;InnateDB:7957082;LRdb:11700046;LRdb:8649415;LRdb:9278420;NetPath:9278420;SIGNOR:11700046;SIGNOR:1465408;SignaLink3:1465408;SignaLink3:23331499;connectomeDB2020:11700046;connectomeDB2020:8649415;connectomeDB2020:9278420], CSF2RB [CellTalkDB:11700046;DIP:7957082;HPMR:11700046;HPRD:9278420;LRdb:11700046;LRdb:93;Lit-BM-17:18692472;Lit-BM-17:7957082;Lit-BM-17:8649415;NetPath:9278420;connectomeDB2020:11700046;connectomeDB2020:9278420], CSF2RA [Cellinker:23046136], PIK3CA [HPRD:9113989]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; interleukin-3 receptor binding [GO:0005135]	cell-cell signaling [GO:0007267]; embryonic hemopoiesis [GO:0035162]; immune response [GO:0006955]; nervous system development [GO:0007399]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IL3&keywords=IL3	0.0033700988764044943	864	NA	NA	1.0136618834414586	264	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
IL31	interleukin 31	Yes		ENSG00000204671	Q6EBC2	NA	14	ligand	extracellular, ligand, secreted	Q8NI17, Q99650	IL31RA, IL31RA_OSMR, OSMR	OSMR [CellTalkDB:15184896;HPMR:15184896;HPMR:15194700;LRdb:15184896;SIGNOR:15184896;SignaLink3:16286453;SignaLink3:23331499;connectomeDB2020:15184896], IL31RA [CellTalkDB:15184896;HPMR:15184896;HPMR:15194700;LRdb:15184896;SIGNOR:15184896;SignaLink3:15184896;SignaLink3:23331499;connectomeDB2020:15184896]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	cytokine activity [GO:0005125]; cytokine receptor binding [GO:0005126]	immune system process [GO:0002376]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IL31&keywords=IL31	0.024735962921348314	781	NA	NA	1.929265613672937	165	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
IL32	interleukin 32	Yes		ENSG00000008517	P24001	NA	3	ligand	extracellular, intracellular, ligand, secreted	P05106	ITGB3	ITGB3 [connectomeDB2020:30391782]	cytosol [GO:0005829]; extracellular space [GO:0005615]; membrane [GO:0016020]	cytokine activity [GO:0005125]	cell adhesion [GO:0007155]; defense response [GO:0006952]; immune response [GO:0006955]; negative regulation of viral life cycle [GO:1903901]; positive regulation of gene expression [GO:0010628]; positive regulation of RNA polymerase II regulatory region sequence-specific DNA binding [GO:1905636]; positive regulation of type III interferon production [GO:0034346]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IL32&keywords=IL32	353.62719034538657	27	NA	NA	14.018761643055994	37	0.05511811023622047	3.6671656686626277	2.3384955752212266	1.7906474820143616	13.873737373737429	0.05752961082910323	0.12058023572076144	0.3833605220228385	0.14724380318164967	0.0474696221124323	0.2543558045199845	92	147	61	2.0668821643871484	0.07571147072181131	0.0276711038776678	0.12728493173708355	490	514	459
IL33	interleukin 33	Yes		ENSG00000137033	O95760	IL-1 family	11	ligand	extracellular, intracellular, ligand, secreted	Q01638, Q9NPH3	IL1RAP, IL1RAP_IL1RL1, IL1RL1	IL1RAP [InnateDB:18450470;InnateDB:19836339], IL1RL1 [Baccin2019:29247993;CellTalkDB:23980170;DIP:19439663;HPRD:16286016;InnateDB:18450470;InnateDB:19439663;InnateDB:19559631;InnateDB:19836339;InnateDB:23980170;connectomeDB2020:16286016;connectomeDB2020:19996325;connectomeDB2020:20926795;connectomeDB2020:29763370]	chromosome [GO:0005694]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transport vesicle [GO:0030133]	cytokine activity [GO:0005125]	interleukin-33-mediated signaling pathway [GO:0038172]; negative regulation of macrophage proliferation [GO:0120042]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of CD80 production [GO:0150145]; positive regulation of CD86 production [GO:0150142]; positive regulation of cellular defense response [GO:0010186]; positive regulation of chemokine production [GO:0032722]; positive regulation of cytokine production [GO:0001819]; positive regulation of gene expression [GO:0010628]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of macrophage activation [GO:0043032]; positive regulation of neuroinflammatory response [GO:0150078]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IL33&keywords=IL33	23.43758854174534	158	NA	NA	1.1216219972975412	244	0	0.012475049900199596	0.00663716814159292	1.8810551558752866	0.05218855218855217	0	9.066183136899365e-4	0.0016313213703099511	0.0014798372179060304	0.001635732407531044	0.001970253042302493	299	354	336	0.1781799716779428	0.06100456448974808	0.06183300116255096	0.06361066449084585	497	489	494
IL34	interleukin 34	Yes		ENSG00000157368	Q6ZMJ4	IL-34 family	17	ligand	extracellular, ligand, secreted	P07333, P23471	CSF1R, PTPRZ1	CSF1R [Baccin2019:30205037;CellTalkDB:22729249;Cellinker:31616414;DIP:22483114;DIP:23478061;ICELLNET:26095744;IntAct:22483114;IntAct:23478061;LRdb:22729249;ProtMapper:29796177;Ramilowski2015:22729249;SIGNOR:24890514;connectomeDB2020:22729249;scConnect:18467591;talklr:22729249], PTPRZ1 [connectomeDB2020:23744080]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; identical protein binding [GO:0042802]; macrophage colony-stimulating factor receptor binding [GO:0005157]	inflammatory response [GO:0006954]; innate immune response [GO:0045087]; interleukin-34-mediated signaling pathway [GO:0061514]; microglial cell proliferation [GO:0061518]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of macrophage chemotaxis [GO:0010759]; positive regulation of macrophage differentiation [GO:0045651]; positive regulation of macrophage proliferation [GO:0120041]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of monocyte differentiation [GO:0045657]; positive regulation of oligodendrocyte differentiation [GO:0048714]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein tyrosine kinase activity [GO:0061098]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IL34&keywords=IL34	0.1605334831460674	639	NA	NA	0.008817102078715338	841	0	0.01696606786427145	0.004424778761061947	0.0033573141486810546	0.00505050505050505	0.00338409475465313	0.001813236627379873	0	3.699593044765076e-4	8.011750567499001e-4	3.476917133474985e-4	302	379	391	0.0033195293891933103	0.7785529804746772	0.8109276792852264	0.7768811803323181	227	207	200
IL36A	interleukin 36 alpha	Yes		ENSG00000136694	Q9UHA7	IL-1 family	10	ligand	intracellular, ligand, secreted	Q9HB29, Q9NPH3, Q9UBH0	IL1RAP, IL1RAP_IL1RL2, IL1RL2, IL36RN	IL1RAP [NA], IL1RL2 [CellTalkDB:11466363;connectomeDB2020:30452921], IL36RN [CellTalkDB:29180446]	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	cytokine activity [GO:0005125]; interleukin-1 receptor binding [GO:0005149]	cellular response to lipopolysaccharide [GO:0071222]; cytokine-mediated signaling pathway [GO:0019221]; immune response [GO:0006955]; inflammatory response [GO:0006954]; inflammatory response to antigenic stimulus [GO:0002437]; innate immune response [GO:0045087]; positive regulation of gene expression [GO:0010628]; positive regulation of interleukin-6 production [GO:0032755]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IL36A&keywords=IL36A	0.0019724303370786517	883	NA	NA	0.003616793144063253	873	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
IL36B	interleukin 36 beta	Yes		ENSG00000136696	Q9NZH7	IL-1 family	9	ligand	extracellular, intracellular, ligand, secreted	Q9HB29, Q9NPH3, Q9UBH0	IL1RAP, IL1RAP_IL1RL2, IL1RL2, IL36RN	IL1RAP [NA], IL1RL2 [CellTalkDB:21965679], IL36RN [CellTalkDB:25673295]	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	cytokine activity [GO:0005125]; interleukin-1 receptor binding [GO:0005149]	cellular response to lipopolysaccharide [GO:0071222]; cytokine-mediated signaling pathway [GO:0019221]; immune response [GO:0006955]; inflammatory response [GO:0006954]; inflammatory response to antigenic stimulus [GO:0002437]; innate immune response [GO:0045087]; positive regulation of gene expression [GO:0010628]; positive regulation of T cell differentiation [GO:0045582]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IL36B&keywords=IL36B	0.3505715146067416	557	NA	NA	1.433868981971501	209	0	0	0	0.0033573141486810546	0	0	0	0	0	3.004406462812125e-4	0	303	400	401	3.325231631783879e-4	0.9678178158493379	0.9968949968569626	0.9678178158493379	145	133	109
IL36G	interleukin 36 gamma	Yes		ENSG00000136688	Q9NZH8	IL-1 family	10	ligand	intracellular, ligand, secreted	P17181, P48551, Q9HB29, Q9NPH3, Q9UBH0	IFNAR1, IFNAR2, IL1RAP, IL1RAP_IL1RL2, IL1RL2, IL36RN	IFNAR1 [SignaLink3:17208301;SignaLink3:23331499], IFNAR2 [SignaLink3:17208301;SignaLink3:23331499], IL1RAP [NA], IL1RL2 [CellTalkDB:25673295], IL36RN [CellTalkDB:25673295]	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	cytokine activity [GO:0005125]; interleukin-1 receptor binding [GO:0005149]	cell-cell signaling [GO:0007267]; cellular response to lipopolysaccharide [GO:0071222]; cytokine-mediated signaling pathway [GO:0019221]; inflammatory response [GO:0006954]; inflammatory response to antigenic stimulus [GO:0002437]; innate immune response [GO:0045087]; positive regulation of gene expression [GO:0010628]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IL36G&keywords=IL36G	0.12338699662921349	655	NA	NA	0.1328777716057881	588	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
IL36RN	interleukin 36 receptor antagonist	Yes		ENSG00000136695	Q9UBH0	IL-1 family	9	ligand	extracellular, intracellular, ligand, ligand_regulator, secreted	Q9HB29, Q9NPH3	IL1RAP, IL1RAP_IL1RL2, IL1RL2	IL1RAP [NA], IL1RL2 [ICELLNET:20959797;ICELLNET:24332029;connectomeDB2020:20081871]	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	cytokine activity [GO:0005125]; interleukin-1 receptor antagonist activity [GO:0005152]; interleukin-1 receptor binding [GO:0005149]	antifungal humoral response [GO:0019732]; cellular response to lipopolysaccharide [GO:0071222]; inflammatory response [GO:0006954]; inflammatory response to antigenic stimulus [GO:0002437]; innate immune response [GO:0045087]; negative regulation of cytokine-mediated signaling pathway [GO:0001960]; negative regulation of interferon-gamma production [GO:0032689]; negative regulation of interleukin-17 production [GO:0032700]; negative regulation of interleukin-6 production [GO:0032715]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IL36RN&keywords=IL36RN	0.042301242696629215	750	NA	NA	0.01795989347173074	803	0	0	0.0011061946902654867	0.011990407673860908	0	0	0	0	0	0	0	303	409	401	0.0011906002149205813	0.8936071173972298	0.8936071173972298	0.8936071173972298	188	174	148
IL37	interleukin 37	Yes		ENSG00000125571	Q9NZH6	IL-1 family	10	ligand	extracellular, intracellular, ligand, secreted	O95256, Q13478, Q6IA17, Q9NZN1	IL18R1, IL18R1_IL18RAP, IL18R1_SIGIRR, IL18RAP, IL1RAPL1, SIGIRR	IL18R1 [HPRD:12096920;InnateDB:12096920;InnateDB:25654981], IL18RAP [NA], IL1RAPL1 [CellTalkDB:25654981;InnateDB:25654981], SIGIRR [Cellinker:25729923;scConnect:25729923]	cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]	cytokine activity [GO:0005125]; interleukin-1 receptor binding [GO:0005149]	cellular response to lipopolysaccharide [GO:0071222]; cytokine-mediated signaling pathway [GO:0019221]; immune response [GO:0006955]; inflammatory response [GO:0006954]; inflammatory response to antigenic stimulus [GO:0002437]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of tumor necrosis factor production [GO:0032720]; positive regulation of gene expression [GO:0010628]; regulation of inflammatory response [GO:0050727]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IL37&keywords=IL37	0.01222723595505618	820	NA	NA	0.007232265614815177	853	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
IL4	interleukin 4	Yes		ENSG00000113520	P05112	IL-4/IL-13 family	21	ligand	extracellular, ligand, secreted	P19397, P24394, P31785, P78552, P80370, Q14627, Q9HBE5	CD53, DLK1, IL13_IL13RA1_IL4R, IL13RA1, IL13RA1_IL4R, IL13RA2, IL13RA2_IL4R, IL21R, IL2RG, IL2RG_IL4R, IL4R	IL4R [Baccin2019:791837811786020;CellTalkDB:7918378;DIP:10219247;DIP:7721786;DIP:9874253;HPMR:11815609;HPMR:7918378;HPRD:11786020;InnateDB:21889455;InnateDB:2278997;InnateDB:2307934;InnateDB:8266078;InnateDB:8639787;IntAct:10219247;IntAct:18243101;IntAct:23597562;IntAct:8266078;LRdb:118;LRdb:7918378;Lit-BM-17:10219247;Lit-BM-17:11786020;Lit-BM-17:18243101;Lit-BM-17:23597562;Lit-BM-17:7721786;Lit-BM-17:8266078;Lit-BM-17:9874253;NetPath:10850446;NetPath:8266078;SIGNOR:10219247;SIGNOR:12704343;SIGNOR:18852293;SPIKE:11786020;SPIKE:17312100;SignaLink3:10219247;SignaLink3:23331499;connectomeDB2020:11786020;connectomeDB2020:7918378], IL2RG [Baccin2019:79183788266078;CellTalkDB:7918378;HPMR:11815609;HPMR:7918378;HPRD:8266078;InnateDB:8266078;LRdb:7918378;LRdb:827;Lit-BM-17:18243101;Lit-BM-17:8266078;NetPath:8266078;SIGNOR:11418623;connectomeDB2020:7918378;connectomeDB2020:8266078], IL13RA1 [CellTalkDB:18480254;IntAct:18243101;LRdb:10641437;LRdb:18480254;Lit-BM-17:18243101;Ramilowski2015:10641437;SIGNOR:12704343;connectomeDB2020:10641437;talklr:10641437], IL13RA2 [Baccin2019:9130652;CellTalkDB:9130652;HPRD:9130652;LRdb:9130652;connectomeDB2020:9130652], CD53 [Baccin2019:7963560;CellTalkDB:7963560;Cellinker:7963560;HPRD:7963560;LRdb:7963560;connectomeDB2020:7963560], DLK1 [Cellinker:10733486], IL21R [Cellinker:21058223]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; interleukin-4 receptor binding [GO:0005136]	activation of Janus kinase activity [GO:0042976]; B cell costimulation [GO:0031296]; B cell differentiation [GO:0030183]; cholesterol metabolic process [GO:0008203]; dendritic cell differentiation [GO:0097028]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; immune response [GO:0006955]; innate immune response in mucosa [GO:0002227]; macrophage activation [GO:0042116]; microglial cell activation [GO:0001774]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of acute inflammatory response [GO:0002674]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cellular response to transforming growth factor beta stimulus [GO:1903845]; negative regulation of chronic inflammatory response [GO:0002677]; negative regulation of complement-dependent cytotoxicity [GO:1903660]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of inflammatory response [GO:0050728]; negative regulation of macrophage activation [GO:0043031]; negative regulation of neuroinflammatory response [GO:0150079]; negative regulation of osteoclast differentiation [GO:0045671]; negative regulation of T-helper 17 cell differentiation [GO:2000320]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of tumor necrosis factor production [GO:0032720]; neuroinflammatory response [GO:0150076]; positive regulation of amyloid-beta clearance [GO:1900223]; positive regulation of ATP biosynthetic process [GO:2001171]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cellular respiration [GO:1901857]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of eosinophil chemotaxis [GO:2000424]; positive regulation of gene expression [GO:0010628]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of interleukin-13 production [GO:0032736]; positive regulation of isotype switching to IgE isotypes [GO:0048295]; positive regulation of isotype switching to IgG isotypes [GO:0048304]; positive regulation of macroautophagy [GO:0016239]; positive regulation of mast cell degranulation [GO:0043306]; positive regulation of MHC class II biosynthetic process [GO:0045348]; positive regulation of mononuclear cell migration [GO:0071677]; positive regulation of myoblast fusion [GO:1901741]; positive regulation of receptor-mediated endocytosis [GO:0048260]; positive regulation of T cell differentiation [GO:0045582]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of T-helper 2 cell cytokine production [GO:2000553]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; regulation of immune response [GO:0050776]; regulation of isotype switching [GO:0045191]; regulation of phosphorylation [GO:0042325]; T cell activation [GO:0042110]; T-helper 2 cell differentiation [GO:0045064]; type 2 immune response [GO:0042092]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IL4&keywords=IL4	0.4722452814606742	529	NA	NA	3.9990010344811053	91	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
IL4R	interleukin 4 receptor	No		ENSG00000077238	P24394	Type I cytokine receptor family, Type 4 subfamily	1	adhesion, ligand, receptor	adhesion, cell_adhesion, cell_surface, extracellular, intracellular, ligand, plasma_membrane, plasma_membrane_transmembrane, receptor, secreted, transmembrane, transmembrane_predicted	O60674, P23458, P29353, P31785, P35568, P42226, P42229, P52333, P78552, Q9NYZ4, Q9Y4H2, Q9Y5F9	IL13RA1, IL2RG, IRS1, IRS2, JAK1, JAK2, JAK3, PCDHGB6, SHC1, SIGLEC8, STAT5A, STAT6	JAK1 [HPRD:12133952;InnateDB:12133952;InnateDB:12223527;NetPath:11127821;SIGNOR:12704343;SIGNOR:23124025;SPIKE:17312100;SignaLink3:23331499;SignaLink3:7929391], JAK3 [HPRD:7538655;InnateDB:12207328;NetPath:12207328;SPIKE:17312100;SignaLink3:23331499;SignaLink3:7538655], IL2RG [HPRD:8266076;InnateDB:8266078;Lit-BM-17:18243101;Lit-BM-17:8266078;NetPath:8266078;SIGNOR:12704343;SIGNOR:8266078;SignaLink3:23331499;SignaLink3:8266078], IL13RA1 [HPRD:8910586;InnateDB:18243101;InnateDB:8910586;Lit-BM-17:18243101;NetPath:16682236], JAK2 [HPRD:8609418;InnateDB:12223527;InnateDB:8609418;NetPath:8609418;SIGNOR:18852293], IRS1 [ELM:8599766;ELM:9697832;HPRD:8599766;LMPID:7537849;LMPID:8599766;NetPath:8124718;SIGNOR:12704343], STAT5A [SIGNOR:20824124], IRS2 [HPRD:8954948;NetPath:8266078;SIGNOR:12704343], SIGLEC8 [Cellinker:32589946], PCDHGB6 [Cellinker:32589946], STAT6 [BioGRID:9651359;HPRD:15661890;InnateDB:21268015;IntAct:8816495;IntAct:9392697;IntAct:9651359;LMPID:9712048;Lit-BM-17:8816495;Lit-BM-17:9392697;Lit-BM-17:9651359;NetPath:10358772], SHC1 [BioGRID:10652211;HPRD:10652211;HPRD:11714803;NetPath:10652211]	centriolar satellite [GO:0034451]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	interleukin-4 receptor activity [GO:0004913]	defense response to protozoan [GO:0042832]; immune response [GO:0006955]; immunoglobulin mediated immune response [GO:0016064]; negative regulation of T-helper 1 cell differentiation [GO:0045626]; ovulation [GO:0030728]; positive regulation of chemokine production [GO:0032722]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of immunoglobulin production [GO:0002639]; positive regulation of macrophage activation [GO:0043032]; positive regulation of mast cell degranulation [GO:0043306]; positive regulation of myoblast fusion [GO:1901741]; positive regulation of T-helper 2 cell differentiation [GO:0045630]; production of molecular mediator involved in inflammatory response [GO:0002532]; regulation of cell population proliferation [GO:0042127]; response to estrogen [GO:0043627]; response to odorant [GO:1990834]; signal transduction [GO:0007165]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IL4R&keywords=IL4R	34.43175314262646	122	NA	NA	0.8364367236979375	294	0.13385826771653542	0.3103792415169697	0.3207964601769905	0.20863309352518036	0.14646464646464658	0.005076142131979695	0.0027198549410698096	0.0016313213703099511	0.0011098779134295228	8.679396448123918e-4	0.0027042688815916574	300	376	321	0.10311282857122869	0.09821943323107231	0.09608052227222577	0.11231501362015368	477	471	469
IL5	interleukin 5	Yes		ENSG00000113525	P05113	IL-5 family	20	ligand	extracellular, ligand, secreted	P15509, P32927, Q01344	CSF2RA, CSF2RB, CSF2RB_IL5RA, IL5RA	IL5RA [Baccin2019:10880230;Baccin2019:11748263;Baccin2019:1732409;Baccin2019:7721873;BioGRID:10823900;BioGRID:1732409;CellTalkDB:11748263;DIP:1495999;DIP:22153509;HPRD:10880230;HPRD:1732409;HPRD:7721873;InnateDB:1732409;InnateDB:7721873;IntAct:22153509;LRdb:10880230;LRdb:11748263;LRdb:1732409;LRdb:7721873;Lit-BM-17:1495999;Lit-BM-17:1732409;Lit-BM-17:7721873;Lit-BM-17:7957082;NetPath:1732409;NetPath:1833065;SIGNOR:8567620;SignaLink3:22528658;SignaLink3:23331499;SignaLink3:8567620;connectomeDB2020:10880230;connectomeDB2020:11748263;connectomeDB2020:1732409;connectomeDB2020:7721873], CSF2RB [Baccin2019:11748263;CellTalkDB:11748263;DIP:7957082;InnateDB:1495999;LMPID:7957082;LRdb:11748263;Lit-BM-17:1495999;Lit-BM-17:7957082;NetPath:1833065;connectomeDB2020:11748263], CSF2RA [Cellinker:23046136]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; interleukin-5 receptor binding [GO:0005137]	cytokine-mediated signaling pathway [GO:0019221]; immune response [GO:0006955]; inflammatory response [GO:0006954]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of eosinophil differentiation [GO:0045645]; positive regulation of immunoglobulin production [GO:0002639]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of podosome assembly [GO:0071803]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of transcription, DNA-templated [GO:0045893]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IL5&keywords=IL5	0.15338018876404494	642	NA	NA	0.8192076809446387	296	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
IL6	interleukin 6	Yes		ENSG00000136244	P05231	IL-6 superfamily	21	ligand	extracellular, intracellular, ligand, secreted	O15146, O75015, P01023, P02741, P08887, P12272, P13726, P35367, P40189	A2M, CRP, F3, FCGR3B, HRH1, IL6_IL6R_IL6ST, IL6R, IL6R_IL6ST, IL6ST, MUSK, PTHLH	IL6ST [Baccin2019:14557255;Baccin2019:3136546;Baccin2019:8293462;CellTalkDB:14557255;DIP:11251120;DIP:7744001;Guide2Pharma:1995637;HPMR:15895091;HPMR:3136546;HPRD:14557255;InnateDB:15895091;LRdb:14557255;LRdb:3136546;LRdb:8293462;Lit-BM-17:11251120;Lit-BM-17:12829785;Lit-BM-17:18775332;Lit-BM-17:7744001;NetPath:2788034;SIGNOR:15895091;SPIKE:15895091;SPIKE:19715447;connectomeDB2020:14557255;connectomeDB2020:3136546;connectomeDB2020:8293462;scConnect:1995637], IL6R [AlzPathway:18067990;Baccin2019:12829785;Baccin2019:14557255;Baccin2019:3136546;BioGRID:14557255;BioGRID:2788034;CellTalkDB:12829785;DIP:7744001;DIP:8702737;DIP:9028955;DIP:9694899;Guide2Pharma:1995637;HPMR:15895091;HPMR:3136546;HPRD:12829785;HPRD:14557255;InnateDB:14557255;InnateDB:14656210;InnateDB:15895091;InnateDB:7744875;InnateDB:8706672;InnateDB:9694899;IntAct:11238858;IntAct:28265003;LRdb:12829785;LRdb:14557255;LRdb:3136546;Lit-BM-17:12643274;Lit-BM-17:12829785;Lit-BM-17:14557255;Lit-BM-17:18775332;Lit-BM-17:2788034;Lit-BM-17:7744001;Lit-BM-17:8702737;Lit-BM-17:9028955;Lit-BM-17:9694899;NetPath:2788034;NetPath:7893704;SIGNOR:15895091;SIGNOR:18923185;SIGNOR:23663276;SIGNOR:8676083;SignaLink3:11238858;SignaLink3:12643274;SignaLink3:21071413;SignaLink3:23331499;SignaLink3:2788034;connectomeDB2020:12829785;connectomeDB2020:14557255;connectomeDB2020:3136546;scConnect:1995637], F3 [CellTalkDB:32196115], HRH1 [CellTalkDB:32103204], MUSK [Cellinker:32822567], FCGR3B [Cellinker:32822567], CRP [InnateDB:14656210], A2M [InnateDB:9780213], PTHLH [HPRD:12000745]	endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; interleukin-6 receptor complex [GO:0005896]	cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; interleukin-6 receptor binding [GO:0005138]	acute-phase response [GO:0006953]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to virus [GO:0098586]; cytokine-mediated signaling pathway [GO:0019221]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; defense response to virus [GO:0051607]; endocrine pancreas development [GO:0031018]; germinal center B cell differentiation [GO:0002314]; glucagon secretion [GO:0070091]; glucose homeostasis [GO:0042593]; hepatic immune response [GO:0002384]; hepatocyte proliferation [GO:0072574]; humoral immune response [GO:0006959]; inflammatory response [GO:0006954]; interleukin-6-mediated signaling pathway [GO:0070102]; liver regeneration [GO:0097421]; maintenance of blood-brain barrier [GO:0035633]; monocyte chemotaxis [GO:0002548]; negative regulation of apoptotic process [GO:0043066]; negative regulation of bone resorption [GO:0045779]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of chemokine production [GO:0032682]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of interleukin-1-mediated signaling pathway [GO:2000660]; negative regulation of lipid storage [GO:0010888]; negative regulation of neurogenesis [GO:0050768]; negative regulation of primary miRNA processing [GO:2000635]; neuron cellular homeostasis [GO:0070050]; neuron projection development [GO:0031175]; neutrophil apoptotic process [GO:0001781]; neutrophil mediated immunity [GO:0002446]; platelet activation [GO:0030168]; positive regulation of acute inflammatory response [GO:0002675]; positive regulation of apoptotic DNA fragmentation [GO:1902512]; positive regulation of apoptotic process [GO:0043065]; positive regulation of B cell activation [GO:0050871]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of chemokine production [GO:0032722]; positive regulation of cytokine production involved in inflammatory response [GO:1900017]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of extracellular matrix disassembly [GO:0090091]; positive regulation of gene expression [GO:0010628]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of immunoglobulin production [GO:0002639]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-21 production [GO:0032745]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of leukocyte adhesion to vascular endothelial cell [GO:1904996]; positive regulation of leukocyte chemotaxis [GO:0002690]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of neuroinflammatory response [GO:0150078]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of platelet aggregation [GO:1901731]; positive regulation of production of miRNAs involved in gene silencing by miRNA [GO:1903800]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of receptor signaling pathway via STAT [GO:1904894]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of T-helper 2 cell cytokine production [GO:2000553]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of translation [GO:0045727]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of type B pancreatic cell apoptotic process [GO:2000676]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; positive regulation of vascular endothelial growth factor production [GO:0010575]; regulation of angiogenesis [GO:0045765]; regulation of astrocyte activation [GO:0061888]; regulation of glucagon secretion [GO:0070092]; regulation of insulin secretion [GO:0050796]; regulation of microglial cell activation [GO:1903978]; regulation of neuroinflammatory response [GO:0150077]; regulation of vascular endothelial growth factor production [GO:0010574]; response to activity [GO:0014823]; response to glucocorticoid [GO:0051384]; response to peptidoglycan [GO:0032494]; T follicular helper cell differentiation [GO:0061470]; T-helper 17 cell lineage commitment [GO:0072540]; vascular endothelial growth factor production [GO:0010573]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IL6&keywords=IL6	43.547410696629214	99	NA	NA	9.44274074804068	47	0	0.005988023952095809	0.0022123893805309734	1.307913669064736	0.03703703703703703	0.00338409475465313	0	0.0016313213703099511	0.0011098779134295228	0.001769261583656028	0.001970253042302493	300	352	336	0.12391053891806826	0.08296492571228456	0.08788898677240725	0.08938992508742248	486	476	479
IL6R	interleukin 6 receptor	No		ENSG00000160712	P08887	Type I cytokine receptor family, Type 3 subfamily	1	adhesion, ligand, receptor	adhesion, cell_adhesion, cell_surface, extracellular, intracellular, ligand, plasma_membrane, plasma_membrane_transmembrane, receptor, secreted, transmembrane, transmembrane_predicted	O60674, P12931, P20916, P23458, P40189, P40763, Q6UXG8, Q6UXK2, Q86SU0, Q8N6C8, Q8N967, Q8NHL6, Q9HCN6	BTNL9, GP6, IL6ST, ILDR1, ISLR2, JAK1, JAK2, LILRA3, LILRB1, LRTM2, MAG, SRC, STAT3	IL6ST [HPRD:2788034;InnateDB:14656210;InnateDB:2788034;InnateDB:7744875;InnateDB:8706672;InnateDB:9694899;NetPath:2788034;SIGNOR:11238858;SIGNOR:23663276;SignaLink3:11238858;SignaLink3:23331499], JAK2 [SIGNOR:23869758], LRTM2 [Cellinker:32589946], ILDR1 [Cellinker:32822567], ISLR2 [Cellinker:32822567], BTNL9 [Cellinker:32822567], GP6 [Cellinker:32822567], LILRB1 [Cellinker:32589946], MAG [Cellinker:32822567], LILRA3 [Cellinker:32822567], JAK1 [DOMINO:11557047], STAT3 [HPRD:10982829;ProtMapper:24058749;ProtMapper:28128332], SRC [HPRD:10462375]	apical plasma membrane [GO:0016324]; ciliary neurotrophic factor receptor complex [GO:0070110]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; interleukin-6 receptor complex [GO:0005896]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	ciliary neurotrophic factor binding [GO:0070119]; cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]; enzyme binding [GO:0019899]; interleukin-11 binding [GO:0019970]; interleukin-11 receptor activity [GO:0004921]; interleukin-6 binding [GO:0019981]; interleukin-6 receptor activity [GO:0004915]; protein homodimerization activity [GO:0042803]	acute-phase response [GO:0006953]; ciliary neurotrophic factor-mediated signaling pathway [GO:0070120]; cytokine-mediated signaling pathway [GO:0019221]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; endocrine pancreas development [GO:0031018]; extrinsic apoptotic signaling pathway [GO:0097191]; hepatic immune response [GO:0002384]; interleukin-6-mediated signaling pathway [GO:0070102]; monocyte chemotaxis [GO:0002548]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of interleukin-8 production [GO:0032717]; neutrophil mediated immunity [GO:0002446]; positive regulation of activation of Janus kinase activity [GO:0010536]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of chemokine production [GO:0032722]; positive regulation of glomerular mesangial cell proliferation [GO:0072126]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of leukocyte chemotaxis [GO:0002690]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of platelet aggregation [GO:1901731]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; response to cytokine [GO:0034097]; T-helper 17 cell lineage commitment [GO:0072540]; vascular endothelial growth factor production [GO:0010573]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IL6R&keywords=IL6R	14.309196413793932	195	NA	NA	1.0811585667201706	249	0.1653543307086614	0.08832335329341306	0.027654867256637183	0.11103117505995315	0.10606060606060619	0.3214890016920475	0.46509519492293594	0.20228384991843382	0.1305956344802066	0.14324342368807189	0.3310025111068002	102	91	49	0.190193995289797	0.7022969608887772	0.7654746260807656	1.7033603361238256	262	231	25
IL6ST	interleukin 6 cytokine family signal transducer	No		ENSG00000134352	P40189	Type I cytokine receptor family, Type 2 subfamily	1	adhesion, ligand, receptor	adhesion, cell_adhesion, cell_surface, extracellular, intracellular, ligand, ligand_regulator, plasma_membrane, plasma_membrane_transmembrane, receptor, secreted, transmembrane, transmembrane_predicted	O60674, P04626, P15498, P19235, P21860, P23458, P29353, P29597, P40763, P42224, P62993, Q06124, Q8N0Z9, Q9UQC2	EPOR, ERBB2, ERBB3, GAB2, GRB2, JAK1, JAK2, PTPN11, SHC1, STAT1, STAT3, TYK2, VAV1, VSIG10	JAK2 [NetPath:7896787;ProtMapper:9716487;SIGNOR:9716487;SignaLink3:23331499;SignaLink3:8174677;iPTMnet:9716487], TYK2 [DIP:9388212;HPRD:9388212;SignaLink3:10929036;SignaLink3:23331499;SignaLink3:9388212], JAK1 [BioGRID:11742534;DIP:21220115;DIP:9388212;HPRD:11468294;HPRD:11742534;NetPath:7896787;SIGNOR:23663276;SIGNOR:24710148;SignaLink3:11468294;SignaLink3:11742534;SignaLink3:12487370;SignaLink3:23331499], GAB2 [SignaLink3:10068651;SignaLink3:23331499], SHC1 [NetPath:7963520;SIGNOR:9126968], ERBB3 [Cellinker:11821958;HPRD:11821958], VSIG10 [Cellinker:32589946], ERBB2 [Cellinker:11821958;HPRD:11821958;NetPath:9590694], EPOR [Cellinker:19002875], PTPN11 [BioGRID:10946280;HPRD:10946280;HPRD:12403768;HPRD:9195977;NetPath:12040451;NetPath:8978300], GRB2 [InnateDB:9013873;NetPath:7963520], STAT3 [HPRD:12361954;NetPath:12040451;NetPath:12361954;NetPath:8272872;ProtMapper:18060032], VAV1 [HPRD:9013873;InnateDB:9013873;NetPath:9013873], STAT1 [NetPath:8662591]	ciliary neurotrophic factor receptor complex [GO:0070110]; dendrite [GO:0030425]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; interleukin-6 receptor complex [GO:0005896]; membrane [GO:0016020]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; oncostatin-M receptor complex [GO:0005900]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	ciliary neurotrophic factor receptor activity [GO:0004897]; ciliary neurotrophic factor receptor binding [GO:0005127]; cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]; growth factor binding [GO:0019838]; identical protein binding [GO:0042802]; interleukin-11 binding [GO:0019970]; interleukin-11 receptor activity [GO:0004921]; interleukin-27 receptor activity [GO:0045509]; scaffold protein binding [GO:0097110]	ciliary neurotrophic factor-mediated signaling pathway [GO:0070120]; cytokine-mediated signaling pathway [GO:0019221]; glycogen metabolic process [GO:0005977]; interleukin-27-mediated signaling pathway [GO:0070106]; interleukin-6-mediated signaling pathway [GO:0070102]; intestinal epithelial cell development [GO:0060576]; leukemia inhibitory factor signaling pathway [GO:0048861]; negative regulation of apoptotic process [GO:0043066]; negative regulation of interleukin-6-mediated signaling pathway [GO:0070104]; negative regulation of neuron apoptotic process [GO:0043524]; oncostatin-M-mediated signaling pathway [GO:0038165]; positive regulation of acute inflammatory response [GO:0002675]; positive regulation of adaptive immune response [GO:0002821]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of platelet aggregation [GO:1901731]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; positive regulation of vascular endothelial growth factor production [GO:0010575]; response to cytokine [GO:0034097]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IL6ST&keywords=IL6ST	106.97732950996212	46	NA	NA	1.801572361313642	178	0.12598425196850394	1.2719560878243508	1.1371681415929216	0.8383693045563745	0.41245791245791197	0.7969543147208126	0.854941069809616	0.6345840130505718	0.38623751387347566	0.5284083322206737	0.4273131157040512	50	43	44	0.6740340052526603	0.5792658125631023	0.7871075532594362	0.6393148766668724	307	215	265
IL7	interleukin 7	Yes		ENSG00000104432	P13232	IL-7/IL-9 family	21	ligand	extracellular, ligand, secreted	P16871, P31785, P80370	DLK1, IL2RG, IL2RG_IL7R, IL7R	IL7R [Baccin2019:10390077;Baccin2019:11858939;Baccin2019:7522165;CellTalkDB:11858939;DIP:1558969;DIP:19141282;DIP:8409434;HPMR:7522165;HPMR:8128231;HPRD:10390077;HPRD:11858939;InnateDB:8266077;IntAct:19141282;IntAct:8266077;LRdb:10390077;LRdb:11858939;LRdb:7522165;Lit-BM-17:1558969;Lit-BM-17:19141282;Lit-BM-17:8409434;NetPath:2317865;SIGNOR:20089933;SIGNOR:8204885;SignaLink3:23331499;SignaLink3:8204885;connectomeDB2020:10390077;connectomeDB2020:11858939;connectomeDB2020:7522165], IL2RG [Baccin2019:11858939;Baccin2019:7522165;Baccin2019:9010926;CellTalkDB:11858939;DIP:8128231;DIP:9371812;HPMR:7522165;HPMR:8128231;HPRD:11858939;HPRD:9010926;InnateDB:8266077;LRdb:11858939;LRdb:7522165;LRdb:9010926;Lit-BM-17:8128231;Lit-BM-17:9371812;SIGNOR:11418623;SIGNOR:20089933;connectomeDB2020:11858939;connectomeDB2020:7522165;connectomeDB2020:9010926], DLK1 [Cellinker:10733486]	collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; interleukin-7 receptor binding [GO:0005139]	animal organ morphogenesis [GO:0009887]; bone resorption [GO:0045453]; cell-cell signaling [GO:0007267]; cytokine-mediated signaling pathway [GO:0019221]; homeostasis of number of cells within a tissue [GO:0048873]; humoral immune response [GO:0006959]; negative regulation of apoptotic process [GO:0043066]; negative regulation of catalytic activity [GO:0043086]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of chemokine production [GO:0032722]; positive regulation of cytokine-mediated signaling pathway [GO:0001961]; positive regulation of organ growth [GO:0046622]; positive regulation of T cell differentiation [GO:0045582]; regulation of peptidyl-tyrosine phosphorylation [GO:0050730]; T cell lineage commitment [GO:0002360]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IL7&keywords=IL7	2.476462785028186	365	NA	NA	1.676851224627096	189	0.031496062992125984	0.005489021956087825	0.00663716814159292	0.013189448441246998	0.03703703703703703	0.02538071065989847	0.02629193109700816	0.0407830342577488	0.03329633740288565	0.006743223394311642	0.030519605949391706	198	266	181	0.0233512346663032	1.2981929405639245	0.5020270932046886	1.2149357094216109	73	320	59
IL7R	interleukin 7 receptor	No		ENSG00000168685	P16871	Type I cytokine receptor family, Type 4 subfamily	1	adhesion, ligand, receptor	adhesion, cell_adhesion, cell_surface, extracellular, intracellular, ligand, plasma_membrane, plasma_membrane_transmembrane, receptor, secreted, transmembrane, transmembrane_predicted	O00300, P06241, P23458, P27986, P42229, P51692, P52333, Q14289, Q9HC73	CRLF2, FYN, JAK1, JAK3, PIK3R1, PTK2B, STAT5A, STAT5B, TNFRSF11B	JAK3 [HPRD:15996891;HPRD:7481769;InnateDB:20167604;NetPath:7481769;SPIKE:7535338], CRLF2 [HPRD:11418668;NetPath:10881176;SignaLink3:10974032;SignaLink3:23331499], JAK1 [HPRD:15996891;HPRD:8647212;InnateDB:20167604;NetPath:20974963;NetPath:8647212;SIGNOR:18445337], TNFRSF11B [Cellinker:32589946], STAT5A [HPRD:7719938;InnateDB:20167604;NetPath:20974963;NetPath:7719938], STAT5B [HPRD:7719938;NetPath:20974963;NetPath:7719938], FYN [HPRD:7515933;InnateDB:7515933;NetPath:7515933], PIK3R1 [HPRD:7522165;NetPath:7522165], PTK2B [HPRD:10702271;NetPath:10702271]	clathrin-coated endocytic vesicle membrane [GO:0030669]; cytosol [GO:0005829]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]	antigen binding [GO:0003823]; cytokine receptor activity [GO:0004896]; interleukin-7 receptor activity [GO:0004917]	B cell proliferation [GO:0042100]; cell morphogenesis [GO:0000902]; cell surface receptor signaling pathway [GO:0007166]; defense response to Gram-positive bacterium [GO:0050830]; homeostasis of number of cells [GO:0048872]; immune response [GO:0006955]; lymph node development [GO:0048535]; negative regulation of T cell apoptotic process [GO:0070233]; negative regulation of T cell mediated cytotoxicity [GO:0001915]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of receptor signaling pathway via STAT [GO:1904894]; positive regulation of T cell differentiation in thymus [GO:0033089]; regulation of cell size [GO:0008361]; regulation of DNA recombination [GO:0000018]; signal transduction [GO:0007165]; T cell differentiation [GO:0030217]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IL7R&keywords=IL7R	2.3957392710280785	372	NA	NA	0.3539207147428821	442	2.6141732283464547	0.007485029940119762	0.0055309734513274336	0.05443645083932852	0.0016835016835016834	0.00676818950930626	0.007252946509519492	0.0032626427406199023	0.0029596744358120607	0.0032380825210308393	0.014332625072435677	295	316	229	0.24737484954995057	0.050353305532663886	0.05143502771999341	0.09454158055841146	501	495	475
IL9	interleukin 9	Yes		ENSG00000145839	P15248	IL-7/IL-9 family	20	ligand	extracellular, ligand, secreted	P31785, P80370, Q01113	DLK1, IL2RG, IL2RG_IL9R, IL9R	IL9R [Baccin2019:953591811588013;CellTalkDB:9535918;DIP:9261146;HPMR:9535918;HPRD:11588013;LRdb:116;LRdb:9535918;NetPath:1376929;SIGNOR:10642536;SignaLink3:10642536;SignaLink3:23331499;connectomeDB2020:11588013;connectomeDB2020:9535918], IL2RG [Baccin2019:9535918;CellTalkDB:9535918;HPMR:9535918;LRdb:9535918;NetPath:7718508;SIGNOR:11418623;connectomeDB2020:9535918], DLK1 [Cellinker:10733486]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; interleukin-9 receptor binding [GO:0005140]	B cell differentiation [GO:0030183]; B cell proliferation [GO:0042100]; immunoglobulin mediated immune response [GO:0016064]; inflammatory response [GO:0006954]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:2001268]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of interleukin-5 production [GO:0032754]; regulation of peptidyl-tyrosine phosphorylation [GO:0050730]; regulation of receptor signaling pathway via JAK-STAT [GO:0046425]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IL9&keywords=IL9	0	899	NA	NA	0.14963686043577856	575	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
IL9R	interleukin 9 receptor	No		ENSG00000124334	Q01113	Type I cytokine receptor family, Type 4 subfamily	1	adhesion, ligand, receptor	adhesion, cell_adhesion, cell_surface, extracellular, ligand, plasma_membrane, plasma_membrane_transmembrane, receptor, secreted, transmembrane, transmembrane_predicted	P23458, P52333	JAK1, JAK3	JAK1 [HPRD:8756628;InnateDB:8756628;NetPath:8756628;SignaLink3:23180781;SignaLink3:23331499;SignaLink3:8756628;SignaLink3:9535918], JAK3 [SignaLink3:23331499;SignaLink3:9535918]	extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	interleukin-9 receptor activity [GO:0004919]	regulation of cell population proliferation [GO:0042127]; signal transduction [GO:0007165]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IL9R&keywords=IL9R	0.2353366404494382	600	NA	NA	1.7759721002766262	180	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
IMPG2	interphotoreceptor matrix proteoglycan 2			ENSG00000081148	Q9BZV3	NA	1	ecm, ligand, receptor	cell_surface, ecm, extracellular, ligand, plasma_membrane_transmembrane, receptor, secreted, transmembrane	P16471, Q8N126	CADM3, PRLR	CADM3 [Cellinker:32589946], PRLR [Cellinker:32589946]	cell projection [GO:0042995]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; interphotoreceptor matrix [GO:0033165]; receptor complex [GO:0043235]	extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; hyaluronic acid binding [GO:0005540]	extracellular matrix organization [GO:0030198]; protein localization [GO:0008104]; retina morphogenesis in camera-type eye [GO:0060042]; visual perception [GO:0007601]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IMPG2&keywords=IMPG2	0.07476013471910112	693	NA	NA	0.3722355240715412	432	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
INHA	inhibin subunit alpha	Yes		ENSG00000123999	P05111	TGF-beta family	16	ligand	extracellular, intracellular, ligand, secreted	P27037, P36896, Q03167, Q04771, Q13705, Q8NER5	ACVR1, ACVR1B, ACVR1C, ACVR2A, ACVR2B, TGFBR3	ACVR2A [Baccin2019:12493742;CellTalkDB:12493742;LRdb:12493742;connectomeDB2020:12493742], ACVR1B [NA], ACVR2B [CellTalkDB:32196115;LRdb:29747587], ACVR1C [NA], TGFBR3 [Baccin2019:1249374210746730;CellTalkDB:12493742;Cellinker:10746731;Cellinker:12493742;HPRD:10746731;LRdb:11;LRdb:12493742;SIGNOR:10746731;connectomeDB2020:10746731;connectomeDB2020:12493742], ACVR1 [CellTalkDB:32196115;LRdb:29747587]	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; inhibin A complex [GO:0043512]; inhibin B complex [GO:0043513]; inhibin-betaglycan-ActRII complex [GO:0034673]; neuronal cell body [GO:0043025]; photoreceptor inner segment [GO:0001917]; photoreceptor outer segment [GO:0001750]	cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; hormone activity [GO:0005179]; inhibin binding [GO:0034711]; protein-containing complex binding [GO:0044877]; signaling receptor binding [GO:0005102]	cell-cell signaling [GO:0007267]; cell differentiation [GO:0030154]; cell surface receptor signaling pathway [GO:0007166]; erythrocyte differentiation [GO:0030218]; hemoglobin biosynthetic process [GO:0042541]; male gonad development [GO:0008584]; negative regulation of B cell differentiation [GO:0045578]; negative regulation of cell cycle [GO:0045786]; negative regulation of follicle-stimulating hormone secretion [GO:0046882]; negative regulation of interferon-gamma production [GO:0032689]; negative regulation of macrophage differentiation [GO:0045650]; negative regulation of phosphorylation [GO:0042326]; ovarian follicle development [GO:0001541]; positive regulation of follicle-stimulating hormone secretion [GO:0046881]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; regulation of cell cycle [GO:0051726]; regulation of cell population proliferation [GO:0042127]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; SMAD protein signal transduction [GO:0060395]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=INHA&keywords=INHA	0.2943434891011236	577	NA	NA	0.029311377819044068	768	0	0	0	0	0.006734006734006734	0.00338409475465313	9.066183136899365e-4	0	0.019607843137254898	8.011750567499001e-4	0.0011976047904191623	238	379	357	0.002966485707888524	2.283413085416208	0.8330071308510912	0.8635805446966086	23	196	158
INHBA	inhibin subunit beta A	Yes		ENSG00000122641	P08476	TGF-beta family	21	ligand	extracellular, intracellular, ligand, ligand_regulator, secreted	P17813, P27037, P36896, P61160, P84022, Q03167, Q04771, Q13145, Q13705, Q8NER5	ACTR2, ACVR1, ACVR1_ACVR2A, ACVR1_ACVR2B, ACVR1B, ACVR1B_ACVR2A, ACVR1B_ACVR2B, ACVR1C, ACVR1C_ACVR2A, ACVR1C_ACVR2B, ACVR2A, ACVR2B, BAMBI, ENG, SMAD3, TGFBR3	ACVR2B [Baccin2019:9202237;CellTalkDB:9202237;HPRD:9202237;LRdb:9202237;SIGNOR:8622651;SignaLink3:16446785;SignaLink3:23331499;connectomeDB2020:9202237], ACTR2 [SignaLink3:16446785;SignaLink3:23331499], ACVR2A [Baccin2019:11266510;Baccin2019:12466190;BioGRID:10746731;CellTalkDB:12466190;DIP:9605406;HPMR:12466190;HPRD:11266516;LRdb:11;LRdb:12466190;SIGNOR:1646080;connectomeDB2020:11266516;connectomeDB2020:12466190], ACVR1B [Baccin2019:81675688397373;CellTalkDB:8167568;DIP:7890768;DIP:9605406;HPMR:8167568;HPRD:8397373;LRdb:8167568;LRdb:84;connectomeDB2020:8167568;connectomeDB2020:8397373], ACVR1C [connectomeDB2020:15196700], ACVR1 [CellTalkDB:11266516;HPRD:11266516;LRdb:11266516;connectomeDB2020:11266516], ENG [Baccin2019:9872992;CellTalkDB:9872992;HPRD:9872992;LRdb:9872992;connectomeDB2020:9872992], SMAD3 [CellTalkDB:32196115], BAMBI [CellTalkDB:10918299;HPMR:10918299;LRdb:10918299;connectomeDB2020:10918299], TGFBR3 [Baccin2019:10746731;CellTalkDB:10746731;Cellinker:10746731;HPRD:10746731;LRdb:10746731;connectomeDB2020:10746731]	activin A complex [GO:0043509]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; inhibin A complex [GO:0043512]; perinuclear region of cytoplasm [GO:0048471]	cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; hormone activity [GO:0005179]; identical protein binding [GO:0042802]; inhibin binding [GO:0034711]; peptide hormone binding [GO:0017046]; protein-containing complex binding [GO:0044877]; type II activin receptor binding [GO:0070699]	activin receptor signaling pathway [GO:0032924]; cell-cell signaling [GO:0007267]; cell differentiation [GO:0030154]; cell surface receptor signaling pathway [GO:0007166]; cellular response to cholesterol [GO:0071397]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; defense response [GO:0006952]; endodermal cell differentiation [GO:0035987]; erythrocyte differentiation [GO:0030218]; extrinsic apoptotic signaling pathway [GO:0097191]; eyelid development in camera-type eye [GO:0061029]; GABAergic neuron differentiation [GO:0097154]; hair follicle development [GO:0001942]; hematopoietic progenitor cell differentiation [GO:0002244]; hemoglobin biosynthetic process [GO:0042541]; male gonad development [GO:0008584]; mesodermal cell differentiation [GO:0048333]; negative regulation of B cell differentiation [GO:0045578]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of follicle-stimulating hormone secretion [GO:0046882]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of interferon-gamma production [GO:0032689]; negative regulation of macrophage differentiation [GO:0045650]; negative regulation of phosphorylation [GO:0042326]; nervous system development [GO:0007399]; odontogenesis [GO:0042476]; ovarian follicle development [GO:0001541]; positive regulation of cellular protein metabolic process [GO:0032270]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; positive regulation of follicle-stimulating hormone secretion [GO:0046881]; positive regulation of gene expression [GO:0010628]; positive regulation of ovulation [GO:0060279]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progesterone secretion [GO:0042701]; regulation of follicle-stimulating hormone secretion [GO:0046880]; regulation of transcription by RNA polymerase II [GO:0006357]; response to xenobiotic stimulus [GO:0009410]; roof of mouth development [GO:0060021]; SMAD protein signal transduction [GO:0060395]; striatal medium spiny neuron differentiation [GO:0021773]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=INHBA&keywords=INHBA	64.60275091011236	67	NA	NA	23.51163550222701	26	1.7716535433070857	0.09680638722554881	0.021017699115044253	17.2194244604314	0.06734006734006732	0.5786802030456855	0.7325475974614714	0.33768352365416016	0.42101368849426773	0.42899586059557965	0.7041143519412435	44	51	34	2.034479762055596	0.21081827098200795	0.2147225268467304	0.34928902951000423	431	408	375
INHBB	inhibin subunit beta B	Yes		ENSG00000163083	P09529	TGF-beta family	19	ligand	extracellular, intracellular, ligand, ligand_regulator, secreted	P0CG36, P0CG37, P27037, P36896, P84022, Q04771, Q13145, Q13705, Q8NER5	ACVR1, ACVR1_ACVR2A, ACVR1_ACVR2B, ACVR1B, ACVR1B_ACVR2A, ACVR1B_ACVR2B, ACVR1C, ACVR1C_ACVR2A, ACVR1C_ACVR2B, ACVR2A, ACVR2B, BAMBI, CFC1, CFC1B, SMAD3	ACVR2A [Baccin2019:1246619011266510;CellTalkDB:12466190;HPRD:11266516;LRdb:11;LRdb:12466190;connectomeDB2020:11266516;connectomeDB2020:12466190], ACVR1B [Baccin2019:11266516;Baccin2019:12032389;Baccin2019:15196700;CellTalkDB:11266516;HPRD:11266516;HPRD:12032389;HPRD:15196700;LRdb:11266516;LRdb:12032389;LRdb:15196700;connectomeDB2020:11266516;connectomeDB2020:15196700], ACVR2B [Baccin2019:9202237;CellTalkDB:9202237;HPRD:9202237;LRdb:9202237;connectomeDB2020:9202237], ACVR1C [Baccin2019:15196700;CellTalkDB:15196700;HPRD:15196700;LRdb:15196700;connectomeDB2020:15196700], SMAD3 [CellTalkDB:32196115], ACVR1 [Baccin2019:11266516;CellTalkDB:11266516;HPRD:11266516;LRdb:11266516;connectomeDB2020:11266516], CFC1 [connectomeDB2020:28126904], CFC1B [connectomeDB2020:28126904], BAMBI [HPMR:10918299]	cell periphery [GO:0071944]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; inhibin B complex [GO:0043513]; perinuclear region of cytoplasm [GO:0048471]	cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; hormone activity [GO:0005179]; host cell surface receptor binding [GO:0046789]; inhibin binding [GO:0034711]; protein-containing complex binding [GO:0044877]; protein homodimerization activity [GO:0042803]	activin receptor signaling pathway [GO:0032924]; cell differentiation [GO:0030154]; cellular response to calcium ion [GO:0071277]; cellular response to cAMP [GO:0071320]; cellular response to cholesterol [GO:0071397]; cellular response to insulin stimulus [GO:0032869]; cellular response to interleukin-1 [GO:0071347]; cellular response to leptin stimulus [GO:0044320]; cellular response to starvation [GO:0009267]; cellular response to Thyroglobulin triiodothyronine [GO:1904017]; cellular response to thyroid hormone stimulus [GO:0097067]; defense response [GO:0006952]; fat cell differentiation [GO:0045444]; negative regulation of follicle-stimulating hormone secretion [GO:0046882]; negative regulation of hepatocyte growth factor production [GO:0032686]; negative regulation of insulin secretion [GO:0046676]; oocyte development [GO:0048599]; ovarian follicle development [GO:0001541]; pituitary gland development [GO:0021983]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of follicle-stimulating hormone secretion [GO:0046881]; positive regulation of ovulation [GO:0060279]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; reproductive senescence [GO:1990636]; response to gonadotropin [GO:0034698]; response to insecticide [GO:0017085]; response to wounding [GO:0009611]; seminiferous tubule development [GO:0072520]; SMAD protein signal transduction [GO:0060395]; spermatogenesis [GO:0007283]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=INHBB&keywords=INHBB	0.8893368696629214	465	NA	NA	0.07348313977945949	669	0	0.00249500998003992	0.028761061946902658	0.0021582733812949635	0	0	0.009066183136899365	0	0	6.676458806249168e-4	7.726482518833301e-5	303	384	399	0.003929585377359105	0.7178964577261444	0.7658265189977523	0.7234432721570978	253	229	225
INHBC	inhibin subunit beta C	Yes		ENSG00000175189	P55103	TGF-beta family	16	ligand	ligand, ligand_regulator, secreted	P27037, P36896, Q04771, Q13705	ACVR1, ACVR1B, ACVR1B_ACVR2A, ACVR1B_ACVR2B, ACVR1C_ACVR2A, ACVR1C_ACVR2B, ACVR2A, ACVR2B	ACVR2B [Baccin2019:12651901;CellPhoneDB:22710174;CellTalkDB:22710174;Cellinker:22710174;HPRD:12651901;LRdb:12651901;connectomeDB2020:12651901], ACVR1B [Baccin2019:12651901;HPRD:12651901;LRdb:12651901], ACVR2A [Baccin2019:12651901;CellPhoneDB:22710174;CellTalkDB:22710174;Cellinker:22710174;HPRD:12651901;LRdb:12651901;connectomeDB2020:12651901], ACVR1 [Baccin2019:12651901;HPRD:12651901;LRdb:12651901]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; hormone activity [GO:0005179]; transforming growth factor beta receptor binding [GO:0005160]	positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; SMAD protein signal transduction [GO:0060395]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=INHBC&keywords=INHBC	0.09175710561797752	678	NA	NA	0.11937493827719695	603	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
INHBE	inhibin subunit beta E	Yes		ENSG00000139269	P58166	TGF-beta family	12	ligand	extracellular, intracellular, ligand, ligand_regulator, secreted	P17813, P27037, P36896, Q04771, Q13705	ACVR1, ACVR1B, ACVR1B_ACVR2A, ACVR1B_ACVR2B, ACVR1C_ACVR2A, ACVR1C_ACVR2B, ACVR2A, ACVR2B, ENG	ACVR2B [CellPhoneDB:22710174;CellTalkDB:22710174;Cellinker:22710174;LRdb:22710174], ACVR2A [CellPhoneDB:22710174;CellTalkDB:22710174;Cellinker:22710174], ACVR1 [NA], ACVR1B [NA], ENG [NA]	collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615]	cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; hormone activity [GO:0005179]	positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; SMAD protein signal transduction [GO:0060395]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=INHBE&keywords=INHBE	0.5477069924573034	514	NA	NA	0.3343545979319673	450	0	0	0	4.7961630695443646e-4	0.003367003367003367	0	0	0	0	5.674989985311792e-4	4.6358895112999797e-4	303	386	387	4.4342796578354367e-4	0.9575399986253198	1.0118802976526613	1.001930494988093	151	126	100
INS	insulin	Yes		ENSG00000254647	P01308	Insulin family	17	ligand	extracellular, intracellular, ligand, secreted	P06213, P08069, P98164, Q8N423, Q8NHL6	IGF1R, INSR, LILRB1, LILRB2, LRP2	INSR [Baccin2019:2550426;CellChatDB:24633815;CellTalkDB:2550426;Cellinker:2550426;DIP:11278498;DIP:23302862;HPRD:2550426;IntAct:23302862;IntAct:29512653;LRdb:2550426;ProtMapper:17227660;ProtMapper:19752148;ProtMapper:19902173;ProtMapper:20332342;ProtMapper:21317886;ProtMapper:21743783;ProtMapper:22521887;ProtMapper:22832498;ProtMapper:23223021;ProtMapper:23304064;ProtMapper:23363978;ProtMapper:24296476;ProtMapper:26245346;ProtMapper:26374090;ProtMapper:29069585;ProtMapper:30197476;ProtMapper:8393875;SIGNOR:16956584;SIGNOR:2550426;SPIKE:15870194;SignaLink3:16956584;SignaLink3:18988627;SignaLink3:23331499;SignaLink3:2550426;connectomeDB2020:2550426], IGF1R [Baccin2019:1851182;CellTalkDB:1851182;Cellinker:1851182;HPRD:1851182;LRdb:1851182;SIGNOR:1851182;SignaLink3:1851182;SignaLink3:18988627;SignaLink3:23331499;connectomeDB2020:1851182], LRP2 [Baccin2019:9773776;CellTalkDB:9773776;Cellinker:9773776;HPRD:9773776;LRdb:9773776;connectomeDB2020:9773776], LILRB1 [CellTalkDB:32103204], LILRB2 [CellTalkDB:32103204]	endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; endoplasmic reticulum lumen [GO:0005788]; endosome lumen [GO:0031904]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; Golgi membrane [GO:0000139]; secretory granule lumen [GO:0034774]; transport vesicle [GO:0030133]	hormone activity [GO:0005179]; identical protein binding [GO:0042802]; insulin-like growth factor receptor binding [GO:0005159]; insulin receptor binding [GO:0005158]; protease binding [GO:0002020]	activation of protein kinase B activity [GO:0032148]; acute-phase response [GO:0006953]; alpha-beta T cell activation [GO:0046631]; cell-cell signaling [GO:0007267]; cognition [GO:0050890]; fatty acid homeostasis [GO:0055089]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; G protein-coupled receptor signaling pathway [GO:0007186]; insulin receptor signaling pathway [GO:0008286]; negative regulation of acute inflammatory response [GO:0002674]; negative regulation of fatty acid metabolic process [GO:0045922]; negative regulation of feeding behavior [GO:2000252]; negative regulation of gene expression [GO:0010629]; negative regulation of gluconeogenesis [GO:0045721]; negative regulation of glycogen catabolic process [GO:0045818]; negative regulation of lipid catabolic process [GO:0050995]; negative regulation of NAD(P)H oxidase activity [GO:0033861]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of protein secretion [GO:0050709]; negative regulation of proteolysis [GO:0045861]; negative regulation of reactive oxygen species biosynthetic process [GO:1903427]; negative regulation of respiratory burst involved in inflammatory response [GO:0060266]; neuron projection maintenance [GO:1990535]; nitric oxide-cGMP-mediated signaling pathway [GO:0038060]; positive regulation of brown fat cell differentiation [GO:0090336]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cellular protein metabolic process [GO:0032270]; positive regulation of cytokine production [GO:0001819]; positive regulation of dendritic spine maintenance [GO:1902952]; positive regulation of gene expression [GO:0010628]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of glycolytic process [GO:0045821]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of nitric oxide mediated signal transduction [GO:0010750]; positive regulation of nitric-oxide synthase activity [GO:0051000]; positive regulation of peptide hormone secretion [GO:0090277]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein autophosphorylation [GO:0031954]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein secretion [GO:0050714]; positive regulation of respiratory burst [GO:0060267]; regulation of cellular amino acid metabolic process [GO:0006521]; regulation of protein localization [GO:0032880]; regulation of protein localization to plasma membrane [GO:1903076]; regulation of protein secretion [GO:0050708]; regulation of synaptic plasticity [GO:0048167]; regulation of transcription, DNA-templated [GO:0006355]; regulation of transmembrane transporter activity [GO:0022898]; vasodilation [GO:0042311]; wound healing [GO:0042060]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=INS&keywords=INS	17572.127807202247	4	NA	NA	406.7937562647474	4	43.58267716535436	135.83383233532953	22.340707964601762	27.083932853717304	199.8350168350168	1541.8815566835872	2026.973708068901	119.91517128874393	38.609692933777225	2085.649819735611	28.527757388450013	2	1	4	570.0212612048264	0.06775013154918921	3.65885164846456	0.05006349533906648	495	1	503
INS-IGF2	INS-IGF2 readthrough	Yes		ENSG00000129965	F8WCM5	NA	3	ligand	ligand, secreted	NA	NA	NA	extracellular space [GO:0005615]	hormone activity [GO:0005179]	NA	https://www.genecards.org/cgi-bin/carddisp.pl?gene=INS-IGF2&keywords=INS-IGF2	9.266813846067416	248	NA	NA	47.389043408450824	16	0	4.99001996007984e-4	0	0	0.003367003367003367	0.02538071065989847	0.02629193109700816	0	0	0.028174656162371404	2.31794475564999e-4	303	175	395	0.007631372523441308	0.5671708193281478	2.1651551013182515	0.5803175255903418	315	16	294
INSL3	insulin like 3	Yes		ENSG00000248099	P51460	Insulin family	16	ligand	extracellular, intracellular, ligand, secreted	O60895, O60896, P07550, P13945, P16473, P32241, P41586, Q03431, Q8TDU9, Q8WXD0, Q99678, Q9HBX9, Q9NQS5, Q9NSD7	ADCYAP1R1, ADRB2, ADRB3, GPR20, GPR84, PTH1R, RAMP2, RAMP3, RXFP1, RXFP2, RXFP3, RXFP4, TSHR, VIPR1	RXFP2 [Baccin2019:12114498;Baccin2019:15649866;Baccin2019:20560146;CellTalkDB:12114498;Cellinker:12114498;Cellinker:15649866;Cellinker:20560146;Cellinker:22973049;Cellinker:25761609;Guide2Pharma:15649866;Guide2Pharma:18434306;HPMR:12114498;HPRD:12114498;HPRD:15649866;LRdb:12114498;LRdb:15649866;LRdb:20560146;connectomeDB2020:12114498;connectomeDB2020:15649866;connectomeDB2020:20560146;scConnect:15649866;scConnect:18434306], ADCYAP1R1 [CellTalkDB:32196115], TSHR [CellTalkDB:32196115], GPR84 [CellTalkDB:32196115], RXFP1 [CellTalkDB:32103204;Cellinker:25761609;scConnect:23303914], RAMP3 [CellTalkDB:32196115], RAMP2 [CellTalkDB:32196115], ADRB2 [CellTalkDB:32196115], PTH1R [CellTalkDB:32196115], VIPR1 [CellTalkDB:32196115], ADRB3 [CellTalkDB:32196115], GPR20 [CellTalkDB:32196115], RXFP4 [NA], RXFP3 [NA]	extracellular region [GO:0005576]; extracellular space [GO:0005615]; perinuclear region of cytoplasm [GO:0048471]	G protein-coupled receptor binding [GO:0001664]; hormone activity [GO:0005179]; insulin receptor binding [GO:0005158]; protease binding [GO:0002020]; signaling receptor binding [GO:0005102]	adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway [GO:0007193]; cell-cell signaling [GO:0007267]; male gonad development [GO:0008584]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; oocyte maturation [GO:0001556]; positive regulation of cAMP-mediated signaling [GO:0043950]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of wound healing [GO:0090303]; spermatogenesis [GO:0007283]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=INSL3&keywords=INSL3	0.28975602927390226	581	NA	NA	0.06353027141370557	689	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
INSL4	insulin like 4	Yes		ENSG00000120211	Q14641	Insulin family	2	ligand	extracellular, ligand, secreted	NA	NA	NA	extracellular space [GO:0005615]	hormone activity [GO:0005179]; insulin-like growth factor receptor binding [GO:0005159]; signaling receptor binding [GO:0005102]	cell-cell signaling [GO:0007267]; positive regulation of chorionic trophoblast cell proliferation [GO:1901384]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=INSL4&keywords=INSL4	0.04723753595505618	739	NA	NA	4.744791369732993	76	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
INSL5	insulin like 5	Yes		ENSG00000172410	Q9Y5Q6	Insulin family	16	ligand	extracellular, ligand, secreted	P08913, P48039, Q14831, Q8TDU9, Q8WXD0, Q9HBX9, Q9NSD7	ADRA2A, GRM7, MTNR1A, RXFP1, RXFP2, RXFP3, RXFP4	RXFP3 [Baccin2019:15525639;CellTalkDB:15525639;Cellinker:15525639;Cellinker:25761609;Guide2Pharma:18582868;LRdb:15525639;connectomeDB2020:15525639;scConnect:18582868], RXFP4 [Baccin2019:1546592515525630;CellTalkDB:15465925;Cellinker:15465925;Cellinker:15525639;Cellinker:25761609;Cellinker:27888281;Guide2Pharma:15525639;Guide2Pharma:18582868;Guide2Pharma:18682868;Guide2Pharma:22257012;Guide2Pharma:24188028;Guide2Pharma:26824523;LRdb:15465925;LRdb:16;connectomeDB2020:15465925;connectomeDB2020:15525639;scConnect:15525639;scConnect:18582868;scConnect:18682868;scConnect:22257012;scConnect:24188028;scConnect:26824523;scConnect:27243554], MTNR1A [CellTalkDB:32196115], GRM7 [CellTalkDB:32196115], ADRA2A [CellTalkDB:32196115], RXFP2 [NA], RXFP1 [NA]	extracellular region [GO:0005576]	G protein-coupled receptor binding [GO:0001664]; hormone activity [GO:0005179]	positive regulation of feeding behavior [GO:2000253]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=INSL5&keywords=INSL5	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
INSL6	insulin like 6	Yes		ENSG00000120210	Q9Y581	Insulin family	3	ligand	extracellular, ligand, secreted	NA	NA	NA	extracellular region [GO:0005576]	hormone activity [GO:0005179]	NA	https://www.genecards.org/cgi-bin/carddisp.pl?gene=INSL6&keywords=INSL6	0.8218195975956475	473	NA	NA	1.7706343464343672	182	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
ISM1	isthmin 1	Yes		ENSG00000101230	B1AKI9	Isthmin family	1	ligand	ligand, secreted	NA	NA	NA	extracellular region [GO:0005576]	NA	negative regulation of angiogenesis [GO:0016525]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=ISM1&keywords=ISM1	0.2243532426966292	605	NA	NA	0.027823798787425417	776	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
ISM2	isthmin 2	Yes		ENSG00000100593	Q6H9L7	Isthmin family	1	ligand	intracellular, ligand, secreted	NA	NA	NA	extracellular region [GO:0005576]	NA	NA	https://www.genecards.org/cgi-bin/carddisp.pl?gene=ISM2&keywords=ISM2	0.07560967831460674	692	NA	NA	0.19566187338077679	535	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
IZUMO4	IZUMO family member 4	No		ENSG00000099840	Q1ZYL8	Izumo family	0	ligand	intracellular, ligand, secreted	NA	NA	NA	extracellular region [GO:0005576]; nucleus [GO:0005634]	NA	NA	https://www.genecards.org/cgi-bin/carddisp.pl?gene=IZUMO4&keywords=IZUMO4	0.8373400803525164	471	NA	NA	0.032412513643264376	761	0	0.005489021956087825	0	9.592326139088729e-4	0.008417508417508417	0.013536379018612519	0.012692656391659111	0.017944535073409464	0.014058453570107295	0.014020563493123212	0.008305968707745798	252	227	255	0.008674938112923865	1.288274875377381	1.2862459488687643	0.9802425366581148	75	79	105
JAM3	junctional adhesion molecule 3	No		ENSG00000166086	Q9BX67	Immunoglobulin superfamily	3	adhesion, cell_surface_ligand, ligand	adhesion, cell_adhesion, cell_surface, cell_surface_ligand, extracellular, intracellular, ligand, plasma_membrane, plasma_membrane_transmembrane, secreted, tight_junction, transmembrane	P05107, P05556, P11215, P57087, Q9Y624	F11R, ITGAM, ITGAM_ITGB2, ITGB1, ITGB2, JAM2	ITGB1 [CellTalkDB:32196115], ITGB2 [InnateDB:12208882], JAM2 [Baccin2019:24357068;HPRD:11823489;Lit-BM-17:21982860;connectomeDB2020:24357068], F11R [Cellinker:15065765], ITGAM [Cellinker:16118203;HPRD:12208882]	bicellular tight junction [GO:0005923]; cell-cell contact zone [GO:0044291]; cell-cell junction [GO:0005911]; desmosome [GO:0030057]; extracellular space [GO:0005615]; filamentous actin [GO:0031941]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; microvillus [GO:0005902]; paranodal junction [GO:0033010]; plasma membrane [GO:0005886]; protein complex involved in cell adhesion [GO:0098636]; Schmidt-Lanterman incisure [GO:0043220]; tight junction [GO:0070160]	cell-cell adhesion mediator activity [GO:0098632]; integrin binding [GO:0005178]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]	adaptive immune response [GO:0002250]; adherens junction assembly [GO:0034333]; angiogenesis [GO:0001525]; apical protein localization [GO:0045176]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; establishment of cell polarity [GO:0030010]; granulocyte migration [GO:0097530]; hematopoietic stem cell migration to bone marrow [GO:0097241]; heterotypic cell-cell adhesion [GO:0034113]; leukocyte migration involved in inflammatory response [GO:0002523]; maintenance of blood-brain barrier [GO:0035633]; myelination [GO:0042552]; myeloid progenitor cell differentiation [GO:0002318]; negative regulation of cell adhesion mediated by integrin [GO:0033629]; negative regulation of integrin activation [GO:0033624]; neutrophil homeostasis [GO:0001780]; positive regulation of cellular extravasation [GO:0002693]; positive regulation of membrane permeability [GO:1905710]; protein localization to cell junction [GO:1902414]; protein localization to cell surface [GO:0034394]; regulation of actin cytoskeleton organization by cell-cell adhesion [GO:0090138]; regulation of neutrophil chemotaxis [GO:0090022]; spermatid development [GO:0007286]; transmission of nerve impulse [GO:0019226]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=JAM3&keywords=JAM3	24.44650750961438	154	3836.34	101	0.5760468639105516	355	0.007874015748031496	0.013473053892215566	0.1769911504424781	0.2707434052757798	0.01683501683501683	0.15905245346869695	0.12330009066183106	0.08482871125611756	0.1046984831668513	0.09300307117105104	0.06374348078037297	121	110	139	0.10132208479076751	1.0303299959071897	0.9252707705272296	0.6624335226830829	126	159	253
KCP	kielin cysteine rich BMP regulator			ENSG00000135253	Q6ZWJ8	NA	1	ecm, ligand	ecm, ligand, ligand_regulator, secreted	NA	NA	NA	extracellular region [GO:0005576]	NA	NA	https://www.genecards.org/cgi-bin/carddisp.pl?gene=KCP&keywords=KCP	0.18389121561797753	619	NA	NA	0.11412801649176905	611	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
KDR	kinase insert domain receptor	No		ENSG00000128052	P35968	Protein kinase superfamily, Tyr protein kinase family, CSF-1/PDGF receptor subfamily	1	adhesion, cell_surface_ligand, ligand, receptor	adhesion, cell_adhesion, cell_surface, cell_surface_ligand, extracellular, intracellular, ligand, matrix_adhesion, plasma_membrane, plasma_membrane_transmembrane, receptor, secreted, transmembrane, transmembrane_predicted	O14786, O43915, P05106, P07550, P07737, P07900, P08758, P12931, P15692, P16070, P16333, P16885, P17813, P17948, P19174, P19235, P20936, P22681, P24666, P27986, P29350, P29353, P29992, P32927, P33151, P35222, P35625, P35916, P39060, P41231, P42224, P46108, P46940, P49767, P50148, P50570, P51813, P52799, P62993, P98077, Q03135, Q05397, Q06124, Q12913, Q13322, Q15464, Q8NFY4, Q8WU20, Q96PV0, Q9NP31	ACP1, ADRB2, ANXA5, BMX, CAV1, CBL, CD44, CDH5, COL18A1, CRK, CSF2RB, CTNNB1, DNM2, EFNB2, ENG, EPOR, FLT1, FLT4, FRS2, GNA11, GNAQ, GRB10, GRB2, HSP90AA1, IQGAP1, ITGB3, NCK1, NRP1, P2RY2, PFN1, PIK3CA_PIK3R1, PIK3R1, PLCG1, PLCG2, PTK2, PTPN11, PTPN6, PTPRJ, RASA1, SEMA6D, SH2D2A, SHB, SHC1, SHC2, SRC, STAT1, SYNGAP1, TIMP3, VEGFA, VEGFC, VEGFD	SHC2 [HPRD:10749680;HPRD:9790910;Lit-BM-17:10749680;Lit-BM-17:12214271;Lit-BM-17:9790910;SignaLink3:10749680;SignaLink3:23331499;SignaLink3:9790910], ANXA5 [HPRD:10329451;Lit-BM-17:10329451;SignaLink3:10329451;SignaLink3:23331499], SHC1 [DOMINO:11950700;HPRD:10749680;SIGNOR:9405464;SignaLink3:11950700;SignaLink3:23331499], VEGFA [BioGRID:16901919;DIP:11333271;DIP:20145116;DIP:8621427;DIP:8631822;DIP:9556609;HPMR:8356051;HPRD:17318185;HPRD:8621427;IntAct:1417831;IntAct:16763549;IntAct:20145116;IntAct:20660291;IntAct:21596751;IntAct:22897854;IntAct:23374253;IntAct:23583373;IntAct:31932617;Lit-BM-17:11333271;Lit-BM-17:12716911;Lit-BM-17:16423422;Lit-BM-17:16763549;Lit-BM-17:18325345;Lit-BM-17:19818105;Lit-BM-17:20145116;Lit-BM-17:22897854;Lit-BM-17:23374253;Lit-BM-17:23583373;Lit-BM-17:8621427;Lit-BM-17:8631822;Lit-BM-17:9556609], VEGFC [DIP:20145116;HPRD:11332691;IntAct:20145116;Lit-BM-17:20145116], PTPN6 [HPRD:16453023;HPRD:9405464;SIGNOR:18840653], PLCG1 [HPRD:12598525;MPPI:10672011;ProtMapper:15212693;SIGNOR:16835467], VEGFD [HPRD:9435229], PIK3R1 [SIGNOR:11278468], GRB2 [HPRD:10319320;HPRD:16966330;SIGNOR:9405464], PTK2 [ProtMapper:24043698;ProtMapper:29435030;SIGNOR:22264731], PTPRJ [IntAct:18936167], TIMP3 [HPRD:12652295], SEMA6D [NA], COL18A1 [HPRD:12029087], ADRB2 [Cellinker:30956148], ENG [Cellinker:29401587], CD44 [Cellinker:26181364], EPOR [Cellinker:24630601], EFNB2 [Cellinker:20445540], SRC [BioGRID:18194650;HPRD:10455194;HPRD:16966330;IntAct:12509223;IntAct:18377662;IntAct:18662404], PFN1 [PhosphoSite:24747440;ProtMapper:23000962;ProtMapper:27669692], ACP1 [HPRD:10608891], PTPN11 [HPRD:9405464], FLT4 [HPRD:15474514;IntAct:16530705;IntAct:20224550;IntAct:21130043;iPTMnet:12881528], FLT1 [BioGRID:12796773;BioGRID:25387128;HPRD:10865839], CBL [BioGRID:20011623;HPRD:12649282;ProtMapper:21242968], NRP1 [BioGRID:11948691;BioGRID:19857463;BioGRID:26037503;HPRD:11333271;HPRD:16763549;HPRD:17222790], CDH5 [BioGRID:25657827;HPRD:10428027;HPRD:11950700], STAT1 [HPRD:10961983;InnateDB:15703780], IQGAP1 [HPRD:15217908;InnateDB:15217908], PLCG2 [HPRD:9398617], SHB [HPRD:15026417], GRB10 [HPRD:11494124], P2RY2 [HPRD:15175347], HSP90AA1 [HPRD:15247219], RASA1 [HPRD:10319320], ITGB3 [HPRD:10022831], NCK1 [HPRD:16966330;HPRD:9405464], GNA11 [HPRD:12670961], SH2D2A [HPRD:10692392;HPRD:15962004], GNAQ [HPRD:12670961], CAV1 [HPRD:12529448], BMX [HPRD:14532277], DNM2 [HPRD:16049137], FRS2 [HPRD:12154000], CSF2RB [HPRD:16007196], CTNNB1 [HPRD:12920240], CRK [HPRD:15051508], SYNGAP1 [HPRD:9405464]	cell junction [GO:0030054]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; endosome [GO:0005768]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; sorting endosome [GO:0097443]	ATP binding [GO:0005524]; cadherin binding [GO:0045296]; growth factor binding [GO:0019838]; Hsp90 protein binding [GO:0051879]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; vascular endothelial growth factor-activated receptor activity [GO:0005021]; vascular endothelial growth factor binding [GO:0038085]	angiogenesis [GO:0001525]; branching involved in blood vessel morphogenesis [GO:0001569]; calcium ion homeostasis [GO:0055074]; calcium-mediated signaling using intracellular calcium source [GO:0035584]; cell fate commitment [GO:0045165]; cell maturation [GO:0048469]; cell migration [GO:0016477]; cell migration involved in sprouting angiogenesis [GO:0002042]; cellular response to hydrogen sulfide [GO:1904881]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; embryonic hemopoiesis [GO:0035162]; endocardium development [GO:0003157]; endothelial cell differentiation [GO:0045446]; endothelium development [GO:0003158]; ERK1 and ERK2 cascade [GO:0070371]; hematopoietic progenitor cell differentiation [GO:0002244]; lung alveolus development [GO:0048286]; lymph vessel development [GO:0001945]; negative regulation of apoptotic process [GO:0043066]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of gene expression [GO:0010629]; ovarian follicle development [GO:0001541]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cell migration [GO:0030335]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of kinase activity [GO:0033674]; positive regulation of macroautophagy [GO:0016239]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of mitochondrial depolarization [GO:0051901]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of nitric-oxide synthase biosynthetic process [GO:0051770]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of positive chemotaxis [GO:0050927]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of vasculogenesis [GO:2001214]; post-embryonic camera-type eye morphogenesis [GO:0048597]; protein autophosphorylation [GO:0046777]; protein kinase B signaling [GO:0043491]; regulation of bone development [GO:1903010]; regulation of cell shape [GO:0008360]; regulation of hematopoietic progenitor cell differentiation [GO:1901532]; surfactant homeostasis [GO:0043129]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; vascular endothelial growth factor receptor-2 signaling pathway [GO:0036324]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; vascular endothelial growth factor signaling pathway [GO:0038084]; vascular wound healing [GO:0061042]; vasculogenesis [GO:0001570]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=KDR&keywords=KDR	27.60083414710581	142	NA	NA	1.667070869563208	191	0	0.0029940119760479044	1.1803097345132736	0.10383693045563586	0	0.001692047377326565	0.0027198549410698096	0.0016313213703099511	0.0011098779134295228	7.010281746561626e-4	0.003206490245315821	300	383	312	0.11801829972427866	0.08678351405508111	0.08358983206075743	0.10316095647075064	483	477	472
KISS1	KiSS-1 metastasis suppressor	Yes		ENSG00000170498	Q15726	KISS1 family	12	ligand	extracellular, intracellular, ligand, secreted	Q969F8, Q9Y5R2	KISS1R, MMP24	KISS1R [Baccin2019:11385580;Baccin2019:11457843;Baccin2019:12944565;Baccin2019:15665093;CellTalkDB:12944565;Cellinker:11385580;Cellinker:11457843;Cellinker:12944565;Cellinker:15665093;Guide2Pharma:11385580;Guide2Pharma:11457843;HPMR:12944565;HPRD:11457843;LRdb:11385580;LRdb:11457843;LRdb:12944565;LRdb:15665093;SIGNOR:11385580;connectomeDB2020:11385580;connectomeDB2020:11457843;connectomeDB2020:12944565;connectomeDB2020:15665093;scConnect:11385580;scConnect:11457843], MMP24 [Baccin2019:12879005;CellTalkDB:12879005;HPRD:12879005;LRdb:12879005;connectomeDB2020:12879005]	apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]	kisspeptin receptor binding [GO:0031773]	cytoskeleton organization [GO:0007010]; generation of ovulation cycle rhythm [GO:0060112]; G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway [GO:0051482]; positive regulation of growth hormone secretion [GO:0060124]; positive regulation of luteinizing hormone secretion [GO:0033686]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of synaptic transmission [GO:0050806]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=KISS1&keywords=KISS1	0.13304191123595505	649	NA	NA	0.2680318970387004	483	0.007874015748031496	0.014970059880239512	0.0011061946902654867	4.7961630695443646e-4	0.00505050505050505	0.01353637901861252	0.021758839528558477	0.008156606851549756	0.012578616352201264	0.0060421952196554815	0.014641684373188971	254	276	225	0.009654064819978405	1.1488013578366776	0.8162278575243405	1.2537703828136681	101	204	56
KITLG	KIT ligand	Yes		ENSG00000049130	P21583	SCF family	19	cell_surface_ligand, ligand	cell_surface, cell_surface_ligand, extracellular, intracellular, ligand, plasma_membrane, plasma_membrane_transmembrane, secreted, transmembrane	P10721, P19235, Q9H3W5	EPOR, KIT, LRRN3	KIT [Baccin2019:1375232;Baccin2019:1698556;Baccin2019:7680037;BioGRID:1375232;BioGRID:7680037;CancerCellMap:7680037;CellTalkDB:1698556;Cellinker:12036870;Cellinker:1375232;Cellinker:1698556;Cellinker:7680037;Guide2Pharma:7536489;HPRD:1375232;HPRD:7680037;ICELLNET:17662946;LRdb:1375232;LRdb:1698556;LRdb:7680037;Lit-BM-17:1375232;Lit-BM-17:17662946;Lit-BM-17:7680037;NetPath:7680037;ProtMapper:25717186;ProtMapper:26358753;SIGNOR:1698556;SIGNOR:17259966;SPIKE:1375232;SPIKE:7680037;connectomeDB2020:1375232;connectomeDB2020:1698556;connectomeDB2020:7680037;scConnect:7536489], EPOR [CellTalkDB:11124255;Cellinker:11124255;HPRD:11124255;LRdb:11124255], LRRN3 [Cellinker:32589946]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; filopodium [GO:0030175]; integral component of membrane [GO:0016021]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]	cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; stem cell factor receptor binding [GO:0005173]	cell adhesion [GO:0007155]; ectopic germ cell programmed cell death [GO:0035234]; embryonic hemopoiesis [GO:0035162]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; male gonad development [GO:0008584]; negative regulation of mast cell apoptotic process [GO:0033026]; neural crest cell migration [GO:0001755]; ovarian follicle development [GO:0001541]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of hematopoietic progenitor cell differentiation [GO:1901534]; positive regulation of hematopoietic stem cell proliferation [GO:1902035]; positive regulation of leukocyte migration [GO:0002687]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of mast cell proliferation [GO:0070668]; positive regulation of melanocyte differentiation [GO:0045636]; positive regulation of myeloid leukocyte differentiation [GO:0002763]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of Ras protein signal transduction [GO:0046579]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=KITLG&keywords=KITLG	13.935125481347963	199	NA	NA	1.291121324198364	225	0.007874015748031496	0.20858283433133884	0.08517699115044257	0.26091127098321404	0.040404040404040394	0.00676818950930626	0.001813236627379873	0	0.01331853496115428	7.344104686874084e-4	0.0012362372030133289	253	382	355	0.056983614671509863	0.3481229711998859	0.16025427294912878	0.16774605637686552	391	439	441
KL	klotho	Yes		ENSG00000133116	Q9UEF7	Glycosyl hydrolase 1 family, Klotho subfamily	3	adhesion, cell_surface_enzyme, cell_surface_ligand, ligand	adhesion, cell_adhesion, cell_surface, cell_surface_enzyme, cell_surface_ligand, extracellular, intracellular, ligand, ligand_regulator, plasma_membrane, plasma_membrane_transmembrane, receptor_regulator, secreted, transmembrane, transmembrane_predicted	P06213, P08069, P11362, Q9H1D0, Q9NQA5	FGFR1, IGF1R, INSR, TRPV5, TRPV6	TRPV5 [TRIP:16239475;TRIP:18495742;TRIP:18606998], TRPV6 [TRIP:16239475;TRIP:18495742], INSR [SPIKE:17684529], IGF1R [HPRD:18762812;SPIKE:17684529], FGFR1 [NA]	apical plasma membrane [GO:0016324]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	beta-glucosidase activity [GO:0008422]; beta-glucuronidase activity [GO:0004566]; fibroblast growth factor binding [GO:0017134]; fibroblast growth factor receptor binding [GO:0005104]; hormone activity [GO:0005179]; vitamin D binding [GO:0005499]	acute inflammatory response [GO:0002526]; aging [GO:0007568]; calcium ion homeostasis [GO:0055074]; carbohydrate metabolic process [GO:0005975]; energy reserve metabolic process [GO:0006112]; fibroblast growth factor receptor signaling pathway [GO:0008543]; insulin receptor signaling pathway [GO:0008286]; negative regulation of systemic arterial blood pressure [GO:0003085]; norepinephrine biosynthetic process [GO:0042421]; positive regulation of bone mineralization [GO:0030501]; positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway [GO:0090080]; response to activity [GO:0014823]; response to angiotensin [GO:1990776]; response to vitamin D [GO:0033280]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=KL&keywords=KL	6.5822478269662925	271	NA	NA	3.0313729760763692	111	0	0.006487025948103794	0.00663716814159292	0.009352517985611509	0	0.03722504230118443	0.053490480507706176	0.07830342577487773	0.018497965223825377	0.021064227533716062	0.040293606335715285	240	194	164	0.02466831452293939	0.8220176151040972	0.8960408938588991	1.450708147419077	212	170	36
KMT2E	lysine methyltransferase 2E (inactive)			ENSG00000005483	Q8IZD2	Class V-like SAM-binding methyltransferase superfamily, Histone-lysine methyltransferase family, TRX/MLL subfamily	1	ligand, receptor	extracellular, intracellular, ligand, receptor, secreted	O95944, P10276, P68431	H3C8, NCR2, RARA	H3C8 [SPIKE:18022353], NCR2 [IntAct:23958951;Lit-BM-17:23958951;SIGNOR:23958951;connectomeDB2020:23958951], RARA [SIGNOR:21205756]	chromatin [GO:0000785]; cytoplasm [GO:0005737]; microtubule organizing center [GO:0005815]; nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; transcriptionally active chromatin [GO:0035327]	enzyme binding [GO:0019899]; metal ion binding [GO:0046872]; methylated histone binding [GO:0035064]	cell cycle [GO:0007049]; chromatin organization [GO:0006325]; DNA methylation [GO:0006306]; erythrocyte differentiation [GO:0030218]; neutrophil activation [GO:0042119]; neutrophil mediated immunity [GO:0002446]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of histone H3-K4 trimethylation [GO:1905437]; positive regulation of transcription, DNA-templated [GO:0045893]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=KMT2E&keywords=KMT2E	13.60501666242988	204	NA	NA	0.4789296517238424	393	0.46456692913385783	0.6556886227544915	0.40818584070796254	0.5175059952038484	0.47138047138047023	0.685279187817259	0.7506799637352738	0.6035889070146836	0.4705882352941233	0.545433302176646	0.4455862468610914	41	42	40	0.5471348820072461	0.8626066161261695	0.9969458386370107	0.8177306099013308	201	132	177
KNG1	kininogen 1	Yes	secreted & binds GPCR	ENSG00000113889	P01042	NA	13	ligand	ecm_regulator, extracellular, intracellular, ligand, secreted	P05107, P07359, P08311, P08913, P11215, P30411, P34741, P46663, P48039, Q03405, Q14831, Q8IZ08, Q8TDU9, Q9NPY3	ADRA2A, BDKRB1, BDKRB2, CD93, CTSG, GP1BA, GP1BA_GP1BB_GP5_GP9, GPR135, GRM7, ITGAM, ITGB2, MTNR1A, PLAUR, RXFP4, SDC2	BDKRB1 [CellTalkDB:8856107;Cellinker:10422787;Cellinker:8063797;Cellinker:9111052;Cellinker:9313952;Guide2Pharma:10422787;Guide2Pharma:8735629;Guide2Pharma:9111052;Guide2Pharma:9313952;HPMR:8063797;LRdb:10422787;LRdb:8063797;LRdb:9111052;LRdb:9313952;connectomeDB2020:10422787;connectomeDB2020:8063797;connectomeDB2020:9111052;connectomeDB2020:9313952;scConnect:10422787;scConnect:8735629;scConnect:9111052;scConnect:9313952], BDKRB2 [CellTalkDB:8063797;Cellinker:8063797;Cellinker:8302267;Cellinker:9203620;Guide2Pharma:8302267;Guide2Pharma:9203620;HPMR:8063797;LRdb:8063797;LRdb:8302267;LRdb:9203620;SIGNOR:28966616;connectomeDB2020:8063797;connectomeDB2020:8302267;connectomeDB2020:9203620;scConnect:8302267;scConnect:9203620], ITGAM [CellTalkDB:32196115], ADRA2A [CellTalkDB:32196115], RXFP4 [CellTalkDB:14530218;Cellinker:14530218;HPRD:14530218;LRdb:14530218;connectomeDB2020:14530218], PLAUR [CellTalkDB:14764580;Cellinker:14764580;HPRD:14764580;LRdb:14764580;connectomeDB2020:14764580], MTNR1A [CellTalkDB:32196115], ITGB2 [CellTalkDB:10845911;Cellinker:10845911;HPRD:10845911;LRdb:10845911;connectomeDB2020:10845911], SDC2 [Baccin2019:10843988;CellTalkDB:32196115], GRM7 [CellTalkDB:32196115], GP1BA [CellTalkDB:9269768;HPRD:9269768;LRdb:9269768;connectomeDB2020:9269768], CD93 [CellTalkDB:12213329;Cellinker:12213329;Cellinker:8710908;HPRD:12213329;HPRD:8710908;LRdb:12213329;LRdb:87], GPR135 [Cellinker:1374385;Cellinker:14530218;HPMR:1374385;LRdb:14;LRdb:14530218;connectomeDB2020:1374385;connectomeDB2020:14530218], CTSG [HPRD:11920276]	blood microparticle [GO:0072562]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; platelet alpha granule lumen [GO:0031093]	cysteine-type endopeptidase inhibitor activity [GO:0004869]; endopeptidase inhibitor activity [GO:0004866]; heparin binding [GO:0008201]; signaling receptor binding [GO:0005102]; zinc ion binding [GO:0008270]	antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; blood coagulation [GO:0007596]; inflammatory response [GO:0006954]; killing of cells of other organism [GO:0031640]; negative regulation of blood coagulation [GO:0030195]; negative regulation of cell adhesion [GO:0007162]; negative regulation of endopeptidase activity [GO:0010951]; negative regulation of proteolysis [GO:0045861]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; vasodilation [GO:0042311]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=KNG1&keywords=KNG1	0.03075539629213483	770	NA	NA	0.003342351788253256	876	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
L1CAM	L1 cell adhesion molecule			ENSG00000198910	P32004	Immunoglobulin superfamily, L1/neurofascin/NgCAM family	7	adhesion, cell_surface_ligand, ligand	adhesion, cell_adhesion, cell_surface, cell_surface_ligand, extracellular, intracellular, ligand, plasma_membrane, plasma_membrane_transmembrane, secreted, transmembrane, transmembrane_predicted	O00533, O14786, P00533, P04626, P06756, P08648, P11362, P13591, P15311, P21802, P21860, P21926, P23471, P29323, Q12860, Q13740, Q6Q4G3, Q9UIW2	ALCAM, CD9, CHL1, CNTN1, EGFR, EPHB2, ERBB2, ERBB3, EZR, FGFR1, FGFR2, ITGA4_ITGB7, ITGA5, ITGA5_ITGB1, ITGAV, ITGAV_ITGB3, LVRN, NCAM1, NRP1, PLXNA1, PTPRZ1	EZR [BioGRID:12070130;BioGRID:22846990;CA1:12070130;HPRD:12070130], FGFR2 [CellTalkDB:32196115], EPHB2 [CellTalkDB:32196115;connectomeDB2020:22579729], CNTN1 [Baccin2019:7595520;CellTalkDB:7595520;Cellinker:7595520;HPRD:7595520;LRdb:7595520;connectomeDB2020:7595520], ITGAV [CellTalkDB:10871287;HPRD:10871287;LRdb:10871287;connectomeDB2020:10871287], ERBB3 [CellTalkDB:22815787;LRdb:22815787;Ramilowski2015:22815787;connectomeDB2020:22815787;talklr:22815787], ERBB2 [CellTalkDB:22815787;LRdb:22815787;Ramilowski2015:22815787;connectomeDB2020:22815787;talklr:22815787], EGFR [CellTalkDB:14718570;Cellinker:14718570;LRdb:14718570;Ramilowski2015:14718570;connectomeDB2020:14718570;talklr:14718570], ITGA5 [CellTalkDB:10871287;Cellinker:10871287;HPRD:10871287;LRdb:10871287;connectomeDB2020:10871287], NCAM1 [HPRD:10611478;HPRD:8509458], ALCAM [Baccin2019:22983139;connectomeDB2020:22983139], CD9 [Baccin2019:8838570;connectomeDB2020:8838570], PTPRZ1 [Baccin2019:9117260;connectomeDB2020:9117260], CHL1 [Cellinker:32822567], FGFR1 [BioGRID:18222703;BioGRID:23212305;Cellinker:23212305], LVRN [Cellinker:32589946], PLXNA1 [HPMR:10520994;HPMR:15121181], NRP1 [BioGRID:16377081;HPMR:10520994;HPMR:15121181]	axon [GO:0030424]; axonal growth cone [GO:0044295]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; dendrite [GO:0030425]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]	axon guidance receptor activity [GO:0008046]; protein domain specific binding [GO:0019904]	axon development [GO:0061564]; axon guidance [GO:0007411]; cell adhesion [GO:0007155]; cell-matrix adhesion [GO:0007160]; cell migration [GO:0016477]; chemotaxis [GO:0006935]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; nervous system development [GO:0007399]; neuron projection development [GO:0031175]; positive regulation of axon extension [GO:0045773]; synapse organization [GO:0050808]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=L1CAM&keywords=L1CAM	3.1165239691504976	335	723.654	158	0.1288422579040126	592	0	0.00249500998003992	0	4.7961630695443646e-4	0	0.02538071065989847	0.03445149592021758	0.03099510603588907	0.017758046614872364	0.010815863266123622	0.03028781147382671	242	239	182	0.013878514568892926	1.1624695721664944	0.8717402921386455	1.6871992333354997	96	181	26
LACRT	lacritin	No		ENSG00000135413	Q9GZZ8	NA	9	ligand	intracellular, ligand, secreted	P18827	SDC1	SDC1 [BioGRID:23504321;CellTalkDB:16982797;Cellinker:16982797;HPRD:16982797;LRdb:16982797;connectomeDB2020:16982797]	extracellular region [GO:0005576]; extracellular space [GO:0005615]; secretory granule [GO:0030141]	collagen binding [GO:0005518]; fibronectin binding [GO:0001968]; growth factor activity [GO:0008083]; laminin-1 binding [GO:0043237]; protein N-terminus binding [GO:0047485]	calcineurin-NFAT signaling cascade [GO:0033173]; calcium-mediated signaling [GO:0019722]; defense response to bacterium [GO:0042742]; epithelial structure maintenance [GO:0010669]; negative regulation of apoptotic process [GO:0043066]; negative regulation of lipopolysaccharide-mediated signaling pathway [GO:0031665]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of calcium-mediated signaling [GO:0050850]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial cell proliferation involved in wound healing [GO:0060054]; positive regulation of macroautophagy [GO:0016239]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; positive regulation of secretion [GO:0051047]; protein acetylation [GO:0006473]; protein localization to Golgi apparatus [GO:0034067]; tear secretion [GO:0070075]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=LACRT&keywords=LACRT	0.006444808988764044	846	NA	NA	0.7139351630945978	316	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
LAIR2	leukocyte associated immunoglobulin like receptor 2	No		ENSG00000274084, ENSG00000275819, ENSG00000277335, ENSG00000167618	Q6ISS4	NA	1	ligand	ligand, secreted	P22455	FGFR4	FGFR4 [Cellinker:32822567]	extracellular region [GO:0005576]; plasma membrane [GO:0005886]	NA	NA	https://www.genecards.org/cgi-bin/carddisp.pl?gene=LAIR2&keywords=LAIR2	0.01539585859775281	807	NA	NA	0.22779651481913823	514	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
LAMA1	laminin subunit alpha 1	No		ENSG00000101680	P25391	NA	8	adhesion, ecm, ligand	adhesion, ecm, extracellular, ligand, matrix_adhesion, secreted	P05556, P08865, P16070, P16144, P17301, P21589, P23229, P26006, P26012, P31431, P34741, P35052, P56199, Q13683, Q14118, Q496J9, Q7L0J3, Q7L1I2, Q8IU80	CD44, DAG1, GPC1, ITGA1, ITGA1_ITGB1, ITGA2, ITGA2_ITGB1, ITGA3, ITGA3_ITGB1, ITGA6, ITGA6_ITGB1, ITGA6_ITGB4, ITGA7, ITGA7_ITGB1, ITGA9_ITGB1, ITGAV_ITGB8, ITGB1, ITGB4, ITGB8, NT5E, RPSA, SDC2, SDC4, SV2A, SV2B, SV2C, TMPRSS6	ITGA6 [CellTalkDB:32196115;HPMR:10842354;NetPath:7721947], ITGA7 [CellTalkDB:11278916;HPMR:11278916;LRdb:11278916;connectomeDB2020:11278916], ITGB1 [HPMR:10842354;HPMR:11278916;HPRD:9688542;LRdb:11278916;LRdb:97;connectomeDB2020:11278916;connectomeDB2020:9688542], ITGA3 [CellTalkDB:32196115], ITGB4 [CellTalkDB:32196115;HPMR:10842354;NetPath:7721947], ITGB8 [CellTalkDB:7542940;HPMR:7542940;LRdb:7542940;connectomeDB2020:7542940], NT5E [Baccin2019:10470109;CellTalkDB:10470109;Cellinker:10470109;HPRD:10470109;LRdb:10470109], GPC1 [CellTalkDB:32196115], ITGA1 [CellTalkDB:9688542;HPRD:9688542;LRdb:9688542;connectomeDB2020:9688542], ITGA2 [CellTalkDB:9688542;HPRD:9688542;LRdb:9688542;connectomeDB2020:9688542], SDC2 [CellTalkDB:32196115], RPSA [Baccin2019:2970671;CellTalkDB:2970671;Cellinker:2970671;LRdb:2970671;connectomeDB2020:2970671], SDC4 [CellTalkDB:32196115], TMPRSS6 [Baccin2019:12149247;Cellinker:12149247;HPRD:12149247], CD44 [NA], SV2A [NA], SV2B [NA], SV2C [NA], DAG1 [HPRD:11798066;HPRD:16709410;HPRD:7925941]	basement membrane [GO:0005604]; cell-cell junction [GO:0005911]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; laminin-1 complex [GO:0005606]; laminin-3 complex [GO:0005608]; membrane [GO:0016020]	extracellular matrix structural constituent [GO:0005201]; glycosphingolipid binding [GO:0043208]; protein C-terminus binding [GO:0008022]; signaling receptor binding [GO:0005102]	animal organ morphogenesis [GO:0009887]; axon guidance [GO:0007411]; blood vessel morphogenesis [GO:0048514]; branching involved in salivary gland morphogenesis [GO:0060445]; camera-type eye development [GO:0043010]; cell adhesion [GO:0007155]; cell surface receptor signaling pathway [GO:0007166]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; establishment of epithelial cell apical/basal polarity [GO:0045198]; morphogenesis of an epithelial sheet [GO:0002011]; protein phosphorylation [GO:0006468]; regulation of cell adhesion [GO:0030155]; regulation of cell migration [GO:0030334]; regulation of embryonic development [GO:0045995]; retinal blood vessel morphogenesis [GO:0061304]; tissue development [GO:0009888]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=LAMA1&keywords=LAMA1	0.9897269811127988	453	NA	NA	0.5265693035873062	374	0	0.001497005988023952	0	0.02853717026378896	0.006734006734006734	0.011844331641285955	0	0.009787928221859707	0.022937476877543456	0.0022032314060622215	8.499130770716634e-4	225	340	373	0.007671914928149332	1.8638317925058498	0.6905438066943088	0.6139636321918344	37	257	278
LAMA2	laminin subunit alpha 2	No		ENSG00000196569	P24043	NA	8	adhesion, ecm, ligand	adhesion, ecm, extracellular, ligand, matrix_adhesion, secreted	P05556, P08865, P16070, P16144, P17301, P23229, P26006, P56199, Q13683, Q14118, Q496J9, Q7L0J3, Q7L1I2	CD44, DAG1, ITGA1, ITGA2, ITGA2_ITGB1, ITGA3, ITGA3_ITGB1, ITGA6, ITGA6_ITGB1, ITGA6_ITGB4, ITGA7, ITGA7_ITGB1, ITGA9_ITGB1, ITGAV_ITGB8, ITGB1, ITGB4, RPSA, SV2A, SV2B, SV2C	ITGA7 [CellTalkDB:11278916;LRdb:11278916;connectomeDB2020:11278916], ITGA3 [CellTalkDB:32196115], ITGB4 [CellTalkDB:32196115;NetPath:7721947], ITGA1 [CellTalkDB:32196115], ITGA2 [CellTalkDB:32196115], RPSA [Baccin2019:11054877;Baccin2019:2970671;CellTalkDB:2970671;Cellinker:11054877;Cellinker:2970671;HPRD:11054877;LRdb:111;LRdb:2970671;connectomeDB2020:11054877;connectomeDB2020:2970671], ITGB1 [CellTalkDB:11278916;LRdb:11278916;connectomeDB2020:11278916], ITGA6 [CellTalkDB:32196115;NetPath:7721947], CD44 [NA], SV2A [NA], SV2B [NA], SV2C [NA], DAG1 [HPRD:16709410;HPRD:7925941;connectomeDB2020:30530204]	basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; neuromuscular junction [GO:0031594]; sarcolemma [GO:0042383]; synaptic cleft [GO:0043083]	extracellular matrix structural constituent [GO:0005201]; signaling receptor binding [GO:0005102]; structural molecule activity [GO:0005198]	animal organ morphogenesis [GO:0009887]; axon guidance [GO:0007411]; cell adhesion [GO:0007155]; maintenance of blood-brain barrier [GO:0035633]; muscle organ development [GO:0007517]; positive regulation of synaptic transmission, cholinergic [GO:0032224]; regulation of cell adhesion [GO:0030155]; regulation of cell migration [GO:0030334]; regulation of embryonic development [GO:0045995]; tissue development [GO:0009888]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=LAMA2&keywords=LAMA2	NA	NA	10935.4	65	NA	NA	0	0.012974051896207579	0.0011061946902654867	0.07074340527577955	0.00505050505050505	0.001692047377326565	0.001813236627379873	0	0.001849796522382538	0.0012351448791560952	3.09059300753332e-4	298	365	392	0.008797585601796006	0.6303892836774928	0.5976908480247931	0.5484246498001508	294	290	304
LAMA3	laminin subunit alpha 3	No	manually added ensembl_gene_ID, hgnc_symbol, and description by searching the uniprot ID on genenames.org	ENSG00000053747	Q16787	NA	9	adhesion, ecm, ligand	adhesion, ecm, extracellular, intracellular, ligand, matrix_adhesion, secreted	P05556, P16070, P16144, P23229, P26006, P34741, Q14118, Q496J9, Q7L0J3, Q7L1I2	CD44, DAG1, ITGA2_ITGB1, ITGA3, ITGA3_ITGB1, ITGA6, ITGA6_ITGB1, ITGA6_ITGB4, ITGA7_ITGB1, ITGA9_ITGB1, ITGAV_ITGB8, ITGB1, ITGB4, SDC2, SV2A, SV2B, SV2C	ITGB1 [CellTalkDB:32196115], ITGA3 [CellTalkDB:32196115], ITGB4 [CellTalkDB:32196115;NetPath:12867433;NetPath:8143784], SDC2 [Baccin2019:11373281;CellTalkDB:11373281;Cellinker:11373281;HPRD:11373281;LRdb:11373281;MatrixDB:11373281;connectomeDB2020:11373281], CD44 [NA], SV2A [NA], SV2B [NA], SV2C [NA], DAG1 [NA], ITGA6 [NetPath:8143784]	basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; laminin-5 complex [GO:0005610]	extracellular matrix structural constituent [GO:0005201]; integrin binding [GO:0005178]; structural molecule activity [GO:0005198]	animal organ morphogenesis [GO:0009887]; axon guidance [GO:0007411]; cell-cell adhesion [GO:0098609]; cell migration [GO:0016477]; endodermal cell differentiation [GO:0035987]; epidermis development [GO:0008544]; integrin-mediated signaling pathway [GO:0007229]; morphogenesis of a polarized epithelium [GO:0001738]; regulation of cell adhesion [GO:0030155]; regulation of cell migration [GO:0030334]; regulation of embryonic development [GO:0045995]; tissue development [GO:0009888]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=LAMA3&keywords=LAMA3	7.782850464405158	263	NA	NA	0.985557345077908	271	0	0.4840319361277496	0	0.0052757793764987996	0.028619528619528614	0.001692047377326565	0.009066183136899365	0.0065252854812398045	0.0014798372179060304	0.0018026438776872727	0.009039984547034946	299	351	251	0.04977574779653372	0.19204840827723985	0.19744870307371856	0.31852356932185527	441	416	386
LAMA4	laminin subunit alpha 4	No	manually added ensembl_gene_ID, hgnc_symbol, and description by searching the uniprot ID on genenames.org	ENSG00000112769	Q16363	NA	3	adhesion, ecm, ligand	adhesion, cell_surface, ecm, extracellular, intracellular, ligand, matrix_adhesion, secreted	P05556, P06756, P16070, P23229, P26006, Q14118, Q496J9, Q7L0J3, Q7L1I2	CD44, DAG1, ITGA2_ITGB1, ITGA3, ITGA3_ITGB1, ITGA6, ITGA6_ITGB1, ITGA6_ITGB4, ITGA7_ITGB1, ITGA9_ITGB1, ITGAV, ITGAV_ITGB8, ITGB1, SV2A, SV2B, SV2C	ITGA6 [CellTalkDB:32196115], ITGAV [CellTalkDB:32196115], ITGB1 [CellTalkDB:32196115], ITGA3 [CellTalkDB:32196115], CD44 [NA], SV2A [NA], SV2B [NA], SV2C [NA], DAG1 [NA]	basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]	extracellular matrix structural constituent [GO:0005201]; signaling receptor binding [GO:0005102]	cell adhesion [GO:0007155]; negative regulation of cold-induced thermogenesis [GO:0120163]; regulation of cell adhesion [GO:0030155]; regulation of cell migration [GO:0030334]; regulation of embryonic development [GO:0045995]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=LAMA4&keywords=LAMA4	23.75047683565247	156	1104.29	154	0.6415016813509106	328	0.007874015748031496	0.006487025948103793	2.059734513274341	0.9232613908873083	0.006734006734006734	0.001692047377326565	0.013599274705349048	0	0.002589715131335553	0.002804112698624645	0.0059493915395016465	296	322	280	0.27552049945853896	0.044093909737516875	0.04484481052290943	0.05586075805326787	509	501	497
LAMA5	laminin subunit alpha 5	No		ENSG00000130702	O15230	NA	8	adhesion, ecm, ligand, receptor	adhesion, ecm, extracellular, intracellular, ligand, matrix_adhesion, receptor, secreted	P05556, P16070, P16144, P17301, P18827, P23229, P26006, P48509, P50895, Q14118, Q496J9, Q7L0J3, Q7L1I2	BCAM, CD151, CD44, DAG1, ITGA2, ITGA2_ITGB1, ITGA3, ITGA3_ITGB1, ITGA6, ITGA6_ITGB1, ITGA6_ITGB4, ITGA7_ITGB1, ITGA9_ITGB1, ITGAV_ITGB8, ITGB1, ITGB4, SDC1, SV2A, SV2B, SV2C	SDC1 [CellTalkDB:32196115], ITGA6 [CellTalkDB:32196115;NetPath:10671376;NetPath:11733063], BCAM [Baccin2019:11133776;Baccin2019:12244066;BioGRID:11133776;BioGRID:12244066;CellTalkDB:12244066;Cellinker:11133776;Cellinker:12244066;HPRD:11133776;HPRD:12244066;LRdb:11;LRdb:12244066;connectomeDB2020:11133776;connectomeDB2020:12244066], ITGB1 [CellTalkDB:32196115;HPMR:10842354;HPMR:15677332], ITGA2 [CellTalkDB:32196115], ITGA3 [CellTalkDB:32196115;HPMR:10842354;HPMR:15677332], ITGB4 [CellTalkDB:32196115;NetPath:10671376;NetPath:11733063], CD44 [NA], SV2A [HPRD:10617638], SV2B [NA], SV2C [NA], DAG1 [HPRD:10207021], CD151 [HPMR:10842354;HPMR:15677332]	basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; laminin-10 complex [GO:0043259]; laminin-11 complex [GO:0043260]; laminin-5 complex [GO:0005610]; neuromuscular junction [GO:0031594]; nucleus [GO:0005634]; synaptic cleft [GO:0043083]	extracellular matrix structural constituent [GO:0005201]; integrin binding [GO:0005178]	animal organ morphogenesis [GO:0009887]; axon guidance [GO:0007411]; branching involved in salivary gland morphogenesis [GO:0060445]; branching involved in ureteric bud morphogenesis [GO:0001658]; cell-cell adhesion [GO:0098609]; cell migration [GO:0016477]; cilium assembly [GO:0060271]; hair follicle development [GO:0001942]; integrin-mediated signaling pathway [GO:0007229]; lung development [GO:0030324]; morphogenesis of a polarized epithelium [GO:0001738]; morphogenesis of embryonic epithelium [GO:0016331]; muscle organ development [GO:0007517]; neural crest cell migration [GO:0001755]; odontogenesis of dentin-containing tooth [GO:0042475]; protein localization to plasma membrane [GO:0072659]; regulation of cell adhesion [GO:0030155]; regulation of cell migration [GO:0030334]; regulation of cell population proliferation [GO:0042127]; regulation of embryonic development [GO:0045995]; substrate adhesion-dependent cell spreading [GO:0034446]; tissue development [GO:0009888]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=LAMA5&keywords=LAMA5	5.44002898139663	288	9090.8	72	0.0992445739115854	633	0.007874015748031496	0.1087824351297404	0.04867256637168145	0.0184652278177458	0.023569023569023566	0.09644670050761417	0.08431550317316391	0.04893964110929857	0.03773584905660376	0.06676458806249404	0.03422831755843152	191	128	177	0.052344897100348065	0.7656737163230839	1.2312890329891244	0.7094135946241636	236	87	233
LAMB1	laminin subunit beta 1	No		ENSG00000091136	P07942	NA	7	adhesion, ecm, ligand	adhesion, ecm, extracellular, intracellular, ligand, matrix_adhesion, secreted	P05556, P06756, P16070, P16144, P17301, P23229, P26006, P26012, P48509, P56199, Q13683, Q14118, Q496J9, Q7L0J3, Q7L1I2	CD151, CD44, DAG1, ITGA1, ITGA2, ITGA2_ITGB1, ITGA3, ITGA3_ITGB1, ITGA6, ITGA6_ITGB1, ITGA6_ITGB4, ITGA7, ITGA7_ITGB1, ITGA9_ITGB1, ITGAV, ITGAV_ITGB8, ITGB1, ITGB4, ITGB8, SV2A, SV2B, SV2C	ITGA7 [CellTalkDB:32196115], ITGAV [CellTalkDB:32196115], ITGB1 [CellTalkDB:10842354;HPMR:10842354;HPMR:15677332;LRdb:10842354;connectomeDB2020:10842354], ITGA6 [CellTalkDB:10842354;HPMR:10842354;LRdb:10842354;NetPath:11733063;NetPath:7721947;connectomeDB2020:10842354], ITGA1 [CellTalkDB:32196115], ITGA2 [CellTalkDB:32196115], ITGA3 [CellTalkDB:32196115;HPMR:10842354;HPMR:15677332], ITGB4 [CellTalkDB:32196115;HPMR:10842354;NetPath:11733063;NetPath:7721947], CD44 [NA], SV2A [NA], SV2B [NA], SV2C [NA], DAG1 [NA], ITGB8 [HPMR:7542940], CD151 [HPMR:10842354;HPMR:15677332]	basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; laminin-10 complex [GO:0043259]; laminin-1 complex [GO:0005606]; laminin-2 complex [GO:0005607]; laminin-8 complex [GO:0043257]; laminin complex [GO:0043256]; perinuclear region of cytoplasm [GO:0048471]	extracellular matrix structural constituent [GO:0005201]; integrin binding [GO:0005178]; structural molecule activity [GO:0005198]	animal organ morphogenesis [GO:0009887]; basement membrane assembly [GO:0070831]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; endodermal cell differentiation [GO:0035987]; neuronal-glial interaction involved in cerebral cortex radial glia guided migration [GO:0021812]; neuron projection development [GO:0031175]; odontogenesis [GO:0042476]; positive regulation of cell migration [GO:0030335]; positive regulation of epithelial cell proliferation [GO:0050679]; substrate adhesion-dependent cell spreading [GO:0034446]; tissue development [GO:0009888]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=LAMB1&keywords=LAMB1	47.37730012247191	90	11287.2	63	0.6631615529680049	324	0.007874015748031496	0.16367265469061928	0.31415929203539766	0.1937649880095927	0.08080808080808083	0.0439932318104907	0.06708975521305519	0.04567699836867866	0.032556418793932625	0.020263052476966165	0.07197218466292991	201	198	128	0.09471187932888865	0.40641443040352215	0.2890125998208207	0.7828355788120674	376	383	197
LAMB2	laminin subunit beta 2	No		ENSG00000172037	P55268	NA	8	adhesion, ecm, ligand	adhesion, ecm, extracellular, intracellular, ligand, matrix_adhesion, secreted	P05556, P08865, P16070, P16144, P23229, P26006, Q14118, Q496J9, Q7L0J3, Q7L1I2	CD44, DAG1, ITGA2_ITGB1, ITGA3, ITGA3_ITGB1, ITGA6, ITGA6_ITGB1, ITGA6_ITGB4, ITGA7_ITGB1, ITGA9_ITGB1, ITGAV_ITGB8, ITGB1, ITGB4, RPSA, SV2A, SV2B, SV2C	ITGA3 [CellTalkDB:32196115], ITGB4 [CellTalkDB:32196115;NetPath:10671376;NetPath:7721947], RPSA [Baccin2019:2970671;CellTalkDB:2970671;LRdb:2970671;connectomeDB2020:2970671], ITGB1 [CellTalkDB:32196115], CD44 [NA], SV2A [NA], SV2B [NA], SV2C [NA], DAG1 [NA], ITGA6 [NetPath:10671376;NetPath:7721947]	basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; laminin-11 complex [GO:0043260]; laminin-3 complex [GO:0005608]; laminin complex [GO:0043256]; neuromuscular junction [GO:0031594]; synaptic cleft [GO:0043083]	extracellular matrix structural constituent [GO:0005201]; integrin binding [GO:0005178]; structural molecule activity [GO:0005198]	animal organ morphogenesis [GO:0009887]; astrocyte development [GO:0014002]; axon extension involved in regeneration [GO:0048677]; axon guidance [GO:0007411]; basement membrane assembly [GO:0070831]; cell migration [GO:0016477]; metanephric glomerular basement membrane development [GO:0072274]; metanephric glomerular visceral epithelial cell development [GO:0072249]; neuromuscular junction development [GO:0007528]; retina development in camera-type eye [GO:0060041]; Schwann cell development [GO:0014044]; substrate adhesion-dependent cell spreading [GO:0034446]; tissue development [GO:0009888]; visual perception [GO:0007601]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=LAMB2&keywords=LAMB2	30.198019460423318	136	6942.43	81	0.25231759535630677	495	0	0.09431137724550887	0.08185840707964612	0.10407673860911373	0.0101010101010101	0	9.066183136899365e-4	0.011419249592169658	0.005549389567147615	0.002770730404593399	0.004288197797952486	285	323	299	0.028661974428257447	0.4021881912937898	0.33031759483187356	0.369567204190934	378	368	365
LAMB3	laminin subunit beta 3	No		ENSG00000196878	Q13751	NA	3	adhesion, ecm, ligand	adhesion, ecm, extracellular, intracellular, ligand, matrix_adhesion, secreted	P05556, P16070, P16144, P17301, P23229, P26006, P48509, Q14118, Q496J9, Q7L0J3, Q7L1I2, Q9UMD9	CD151, CD44, COL17A1, DAG1, ITGA2, ITGA2_ITGB1, ITGA3, ITGA3_ITGB1, ITGA6, ITGA6_ITGB1, ITGA6_ITGB4, ITGA7_ITGB1, ITGA9_ITGB1, ITGAV_ITGB8, ITGB1, ITGB4, SV2A, SV2B, SV2C	CD151 [CellTalkDB:32196115], ITGB1 [CellTalkDB:32196115], ITGA6 [CellTalkDB:32196115;NetPath:8143784], ITGA3 [CellTalkDB:32196115], ITGB4 [CellTalkDB:32196115;NetPath:12867433;NetPath:8143784], ITGA2 [CellTalkDB:32196115], COL17A1 [CellTalkDB:32196115], CD44 [NA], SV2A [NA], SV2B [NA], SV2C [NA], DAG1 [NA]	collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; laminin-5 complex [GO:0005610]; laminin complex [GO:0043256]	extracellular matrix structural constituent [GO:0005201]; protein-containing complex binding [GO:0044877]; structural molecule activity [GO:0005198]	animal organ morphogenesis [GO:0009887]; basement membrane assembly [GO:0070831]; brown fat cell differentiation [GO:0050873]; cell migration [GO:0016477]; endodermal cell differentiation [GO:0035987]; epidermis development [GO:0008544]; substrate adhesion-dependent cell spreading [GO:0034446]; tissue development [GO:0009888]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=LAMB3&keywords=LAMB3	37.93159330812916	111	NA	NA	3.8829335756032113	94	0.007874015748031496	1.5998003992015981	0.018805309734513276	0.16330935251798617	1.0976430976431013	0.059221658206429814	0.01813236627379873	0.06851549755301799	0.058083610802811755	0.00998130591534248	0.027699439830017453	158	244	189	0.2844605503115135	0.23121471019050002	0.06785732721820972	0.12802883031405987	421	487	458
LAMC1	laminin subunit gamma 1	No		ENSG00000135862	P11047	NA	4	adhesion, ecm, ligand, receptor	adhesion, ecm, extracellular, intracellular, ligand, matrix_adhesion, receptor, secreted	P05556, P06756, P16070, P16144, P17301, P23229, P26006, P56199, Q13683, Q14118, Q496J9, Q7L0J3, Q7L1I2	CD44, DAG1, ITGA1, ITGA2, ITGA2_ITGB1, ITGA3, ITGA3_ITGB1, ITGA6, ITGA6_ITGB1, ITGA6_ITGB4, ITGA7, ITGA7_ITGB1, ITGA9_ITGB1, ITGAV, ITGAV_ITGB8, ITGB1, ITGB4, SV2A, SV2B, SV2C	ITGA6 [CellTalkDB:32196115;NetPath:10671376;NetPath:11733063;NetPath:7721947], ITGA1 [CellTalkDB:32196115], ITGA7 [CellTalkDB:32196115], ITGAV [CellTalkDB:32196115], ITGB1 [CellTalkDB:32196115], ITGA2 [CellTalkDB:32196115], ITGA3 [CellTalkDB:32196115], ITGB4 [CellTalkDB:32196115;NetPath:10671376;NetPath:11733063;NetPath:7721947], CD44 [NA], SV2A [NA], SV2B [NA], SV2C [NA], DAG1 [NA]	basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; laminin-10 complex [GO:0043259]; laminin-11 complex [GO:0043260]; laminin-1 complex [GO:0005606]	extracellular matrix structural constituent [GO:0005201]	animal organ morphogenesis [GO:0009887]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; endoderm development [GO:0007492]; extracellular matrix disassembly [GO:0022617]; hemidesmosome assembly [GO:0031581]; maintenance of blood-brain barrier [GO:0035633]; positive regulation of epithelial cell proliferation [GO:0050679]; protein-containing complex assembly [GO:0065003]; substrate adhesion-dependent cell spreading [GO:0034446]; tissue development [GO:0009888]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=LAMC1&keywords=LAMC1	93.00075737124955	52	20923.7	47	1.267144236924105	230	0.05511811023622047	0.6182634730538948	0.32079646017699015	0.5342925659472528	0.2188552188552189	0.1573604060913704	0.12692656391659085	0.09624796084828724	0.04328523862375138	0.0632928294832448	0.09124975854741786	179	130	118	0.2114262350709309	0.24064555226114998	0.3310033675989949	0.45726179878813306	419	367	341
LAMC2	laminin subunit gamma 2	No		ENSG00000058085	Q13753	NA	7	adhesion, ecm, ligand, receptor	adhesion, ecm, extracellular, intracellular, ligand, matrix_adhesion, receptor, secreted	P05556, P16070, P16144, P17301, P23229, P26006, P48509, Q14118, Q496J9, Q7L0J3, Q7L1I2, Q9UMD9	CD151, CD44, COL17A1, DAG1, ITGA2, ITGA2_ITGB1, ITGA3, ITGA3_ITGB1, ITGA6, ITGA6_ITGB1, ITGA6_ITGB4, ITGA7_ITGB1, ITGA9_ITGB1, ITGAV_ITGB8, ITGB1, ITGB4, SV2A, SV2B, SV2C	ITGA6 [CellTalkDB:10842354;LRdb:10842354;NetPath:8143784;connectomeDB2020:10842354], CD151 [CellTalkDB:32196115], ITGB1 [CellTalkDB:10842354;LRdb:10842354;connectomeDB2020:10842354], ITGA2 [CellTalkDB:32196115], COL17A1 [CellTalkDB:32196115], ITGA3 [CellTalkDB:10842354;LRdb:10842354;connectomeDB2020:10842354], ITGB4 [CellTalkDB:10842354;LRdb:10842354;NetPath:12867433;NetPath:8143784;connectomeDB2020:10842354], CD44 [NA], SV2A [NA], SV2B [NA], SV2C [NA], DAG1 [NA]	basement membrane [GO:0005604]; cell cortex [GO:0005938]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; laminin-2 complex [GO:0005607]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]	heparin binding [GO:0008201]; signaling receptor binding [GO:0005102]	animal organ morphogenesis [GO:0009887]; cell adhesion [GO:0007155]; dendrite development [GO:0016358]; epidermis development [GO:0008544]; motor neuron axon guidance [GO:0008045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; tissue development [GO:0009888]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=LAMC2&keywords=LAMC2	145.58360208988765	40	NA	NA	30.036886668048	22	0	2.9610778443113626	0.00663716814159292	0.04724220623501198	0.5942760942760942	0.13536379018612513	0.1405258386219398	0.1305057096247962	0.1239363669996296	0.04045934036587074	0.14058334943016593	107	160	88	0.392782518926599	0.3325277555653737	0.12527688763738576	0.3738577082030898	399	455	362
LAMC3	laminin subunit gamma 3	No		ENSG00000050555	Q9Y6N6	NA	3	adhesion, ecm, ligand	adhesion, ecm, extracellular, ligand, matrix_adhesion, secreted	P05556, P16070, P16144, P17301, P23229, P26006, Q14118, Q496J9, Q7L0J3, Q7L1I2	CD44, DAG1, ITGA2, ITGA2_ITGB1, ITGA3, ITGA3_ITGB1, ITGA6, ITGA6_ITGB1, ITGA6_ITGB4, ITGA7_ITGB1, ITGA9_ITGB1, ITGAV_ITGB8, ITGB1, ITGB4, SV2A, SV2B, SV2C	ITGA6 [CellTalkDB:32196115], ITGB1 [CellTalkDB:32196115], ITGA3 [CellTalkDB:32196115], ITGB4 [CellTalkDB:32196115], ITGA2 [CellTalkDB:32196115], CD44 [NA], SV2A [NA], SV2B [NA], SV2C [NA], DAG1 [NA]	basement membrane [GO:0005604]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; membrane [GO:0016020]	structural molecule activity [GO:0005198]	animal organ morphogenesis [GO:0009887]; astrocyte development [GO:0014002]; cell migration [GO:0016477]; retina development in camera-type eye [GO:0060041]; substrate adhesion-dependent cell spreading [GO:0034446]; tissue development [GO:0009888]; visual perception [GO:0007601]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=LAMC3&keywords=LAMC3	4.325718684719652	306	6866.77	83	0.5797068333544787	353	0	4.99001996007984e-4	0	0.30839328537170496	0.0016835016835016834	0	0.001813236627379873	0	0	0.0013019094672185867	3.476917133474985e-4	303	363	391	0.028548966078105507	0.2594103297021929	0.29318320611555093	0.2684298119016124	414	380	402
LEAP2	liver enriched antimicrobial peptide 2	No		ENSG00000164406	Q969E1	LEAP2 family	4	ligand	extracellular, ligand, ligand_regulator, secreted	Q92847	GHSR	GHSR [Cellinker:29233536;connectomeDB2020:29233536;scConnect:29233536]	extracellular region [GO:0005576]	NA	antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; defense response to bacterium [GO:0042742]; defense response to fungus [GO:0050832]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=LEAP2&keywords=LEAP2	1.9405349764044943	389	NA	NA	0.4068227986328211	411	0.015748031496062992	0.07085828343313366	0.04867256637168146	0.08489208633093584	0.020202020202020197	0.07614213197969542	0.08431550317316391	0.058727569331158296	0.08805031446540855	0.05498063826946408	0.05806451612903085	136	138	145	0.060059423743795935	1.39953070159375	0.9275074614814884	0.9715254921013856	62	157	108
LEFTY1	left-right determination factor 1	Yes		ENSG00000243709	O75610	TGF-beta family	5	ligand	extracellular, ligand, ligand_regulator, secreted	P27037, P36896, Q13705	ACVR1B, ACVR2A, ACVR2B	ACVR2B [CellTalkDB:32196115], ACVR1B [CellTalkDB:32196115], ACVR2A [CellTalkDB:32196115]	extracellular space [GO:0005615]	cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; transforming growth factor beta receptor binding [GO:0005160]	BMP signaling pathway [GO:0030509]; determination of left/right symmetry [GO:0007368]; heart morphogenesis [GO:0003007]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; SMAD protein signal transduction [GO:0060395]; transforming growth factor beta receptor signaling pathway [GO:0007179]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=LEFTY1&keywords=LEFTY1	0.5839802651685393	511	NA	NA	0.21950985403755696	520	0	0.005988023952095807	0	2.3980815347721823e-4	0	0	0.001813236627379873	0	0	2.00293764187475e-4	3.09059300753332e-4	303	403	392	7.773110725357914e-4	0.9278752309083255	0.9464599931778206	0.9565520779134119	165	153	115
LEFTY2	left-right determination factor 2	Yes		ENSG00000143768	O00292	TGF-beta family	12	ligand	extracellular, intracellular, ligand, ligand_regulator, secreted	P27037, P36896, Q13705	ACVR1B, ACVR2A, ACVR2B	ACVR1B [CellTalkDB:32196115], ACVR2A [CellTalkDB:32196115;Cellinker:11952836], ACVR2B [Baccin2019:11952836;CellTalkDB:11952836;Cellinker:11952836;LRdb:11952836;connectomeDB2020:11952836]	collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; platelet alpha granule lumen [GO:0031093]	cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; transforming growth factor beta receptor binding [GO:0005160]	BMP signaling pathway [GO:0030509]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; SMAD protein signal transduction [GO:0060395]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=LEFTY2&keywords=LEFTY2	0.021800859550561796	788	NA	NA	0.007630822128830193	850	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
LEP	leptin	Yes		ENSG00000174697	P41159	Leptin family	18	ligand	extracellular, intracellular, ligand, secreted	P02741, P48357, P54646, P98164, Q6UXK2	CRP, ISLR2, LEPR, LRP2, PRKAA2	LEPR [Baccin2019:8608603;Baccin2019:9463481;CellTalkDB:9463481;Cellinker:8608603;Cellinker:9463481;DIP:22405007;DIP:9786864;HPMR:9463481;HPRD:8608603;ICELLNET:9463481;LRdb:861;LRdb:9463481;NetPath:12226096;NetPath:9218470;SIGNOR:9463481;SignaLink3:23331499;SignaLink3:9207021;connectomeDB2020:8608603;connectomeDB2020:9463481], LRP2 [CellTalkDB:32196115], ISLR2 [Cellinker:32822567], CRP [HPRD:16582918;NetPath:16582918], PRKAA2 [HPRD:11797013]	cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	DNA binding [GO:0003677]; hormone activity [GO:0005179]; leptin receptor binding [GO:1990460]; peptide hormone receptor binding [GO:0051428]	activation of protein kinase C activity [GO:1990051]; adipose tissue development [GO:0060612]; adult feeding behavior [GO:0008343]; angiogenesis [GO:0001525]; aorta development [GO:0035904]; bile acid metabolic process [GO:0008206]; bone growth [GO:0098868]; bone mineralization involved in bone maturation [GO:0035630]; cardiac muscle hypertrophy [GO:0003300]; cellular response to insulin stimulus [GO:0032869]; cellular response to L-ascorbic acid [GO:0071298]; cellular response to leptin stimulus [GO:0044320]; cellular response to retinoic acid [GO:0071300]; central nervous system neuron development [GO:0021954]; cholesterol metabolic process [GO:0008203]; circadian rhythm [GO:0007623]; determination of adult lifespan [GO:0008340]; eating behavior [GO:0042755]; elastin metabolic process [GO:0051541]; energy reserve metabolic process [GO:0006112]; fatty acid beta-oxidation [GO:0006635]; female pregnancy [GO:0007565]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; glycerol biosynthetic process [GO:0006114]; hormone metabolic process [GO:0042445]; insulin secretion [GO:0030073]; intestinal absorption [GO:0050892]; intracellular signal transduction [GO:0035556]; leptin-mediated signaling pathway [GO:0033210]; leukocyte tethering or rolling [GO:0050901]; lipid metabolic process [GO:0006629]; negative regulation of apoptotic process [GO:0043066]; negative regulation of appetite [GO:0032099]; negative regulation of appetite by leptin-mediated signaling pathway [GO:0038108]; negative regulation of autophagy [GO:0010507]; negative regulation of cartilage development [GO:0061037]; negative regulation of glucagon secretion [GO:0070093]; negative regulation of glucose import [GO:0046325]; negative regulation of glutamine transport [GO:2000486]; negative regulation of lipid storage [GO:0010888]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of vasoconstriction [GO:0045906]; ovulation from ovarian follicle [GO:0001542]; phagocytosis [GO:0006909]; placenta development [GO:0001890]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of developmental growth [GO:0048639]; positive regulation of fat cell apoptotic process [GO:1904651]; positive regulation of follicle-stimulating hormone secretion [GO:0046881]; positive regulation of hepatic stellate cell activation [GO:2000491]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of ion transport [GO:0043270]; positive regulation of luteinizing hormone secretion [GO:0033686]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of peroxisome proliferator activated receptor signaling pathway [GO:0035360]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of TOR signaling [GO:0032008]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; prostaglandin secretion [GO:0032310]; regulation of angiogenesis [GO:0045765]; regulation of blood pressure [GO:0008217]; regulation of bone remodeling [GO:0046850]; regulation of brown fat cell differentiation [GO:0090335]; regulation of cell cycle [GO:0051726]; regulation of cytokine production involved in inflammatory response [GO:1900015]; regulation of endothelial cell proliferation [GO:0001936]; regulation of gluconeogenesis [GO:0006111]; regulation of insulin secretion [GO:0050796]; regulation of intestinal cholesterol absorption [GO:0030300]; regulation of lipoprotein lipid oxidation [GO:0060587]; regulation of natural killer cell activation [GO:0032814]; regulation of natural killer cell mediated cytotoxicity [GO:0042269]; regulation of natural killer cell proliferation [GO:0032817]; regulation of nitric-oxide synthase activity [GO:0050999]; regulation of steroid biosynthetic process [GO:0050810]; response to activity [GO:0014823]; response to dietary excess [GO:0002021]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to hypoxia [GO:0001666]; response to insulin [GO:0032868]; response to vitamin E [GO:0033197]; sexual reproduction [GO:0019953]; T cell differentiation [GO:0030217]; tyrosine phosphorylation of STAT protein [GO:0007260]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=LEP&keywords=LEP	0.036914865168539326	760	NA	NA	0.008079041107329253	845	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
LEPR	leptin receptor	No		ENSG00000116678	P48357	Type I cytokine receptor family, Type 2 subfamily	1	adhesion, ligand, receptor	adhesion, cell_adhesion, cell_surface, extracellular, intracellular, ligand, plasma_membrane, plasma_membrane_transmembrane, receptor, secreted, transmembrane, transmembrane_predicted	O14543, O60674, P23458, P29597, P40763, P52333, Q06124, Q8N109, Q9NRF2	JAK1, JAK2, JAK3, KIR2DL5A, PTPN11, SH2B1, SOCS3, STAT3, TYK2	JAK2 [Cellinker:30044226;HPRD:8608603;NetPath:9092791;SIGNOR:18718905;SPIKE:17312100;SignaLink3:12657512;SignaLink3:21166956;SignaLink3:23331499;SignaLink3:8608603], STAT3 [HPRD:8608603;NetPath:11445068;SIGNOR:11018044;SIGNOR:18718905;SignaLink3:21166956], JAK1 [SignaLink3:16173077;SignaLink3:23331499], TYK2 [SignaLink3:17228025;SignaLink3:23331499], SOCS3 [BioGRID:11018044;BioGRID:21239736;HPRD:11018044], PTPN11 [HPRD:11018044;Lit-BM-17:11342028;Lit-BM-17:9600917;NetPath:10449753;SIGNOR:11085989], SH2B1 [SIGNOR:27154742], KIR2DL5A [Cellinker:32589946], JAK3 [NetPath:11585385]	basolateral plasma membrane [GO:0016323]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; receptor complex [GO:0043235]	cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]; identical protein binding [GO:0042802]; leptin receptor activity [GO:0038021]; peptide hormone binding [GO:0017046]; transmembrane signaling receptor activity [GO:0004888]	angiogenesis [GO:0001525]; bone growth [GO:0098868]; cell surface receptor signaling pathway [GO:0007166]; cholesterol metabolic process [GO:0008203]; cytokine-mediated signaling pathway [GO:0019221]; energy homeostasis [GO:0097009]; energy reserve metabolic process [GO:0006112]; glial cell proliferation [GO:0014009]; glucose homeostasis [GO:0042593]; glycogen metabolic process [GO:0005977]; leptin-mediated signaling pathway [GO:0033210]; multicellular organism development [GO:0007275]; negative regulation of autophagy [GO:0010507]; negative regulation of gluconeogenesis [GO:0045721]; negative regulation of hydrolase activity [GO:0051346]; phagocytosis [GO:0006909]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of protein phosphorylation [GO:0001934]; regulation of bone remodeling [GO:0046850]; regulation of feeding behavior [GO:0060259]; regulation of transport [GO:0051049]; response to leptin [GO:0044321]; sexual reproduction [GO:0019953]; T cell differentiation [GO:0030217]; transport across blood-brain barrier [GO:0150104]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=LEPR&keywords=LEPR	11.960006490334894	224	NA	NA	2.35812699849936	134	0.023622047244094488	0.02644710578842313	0.02323008849557523	0.018944844124700235	0.015151515151515148	0.5042301184433171	0.024478694469628286	0.0065252854812398045	0.3984461709212001	0.010916010148217359	0.011164767239714057	49	237	245	0.096650604318875	3.8297595548543315	0.1961171273411683	0.19844957630463536	8	418	420
LGALS1	galectin 1	No		ENSG00000100097	P09382	NA	4	ecm, ligand, receptor	ecm, extracellular, intracellular, ligand, receptor, secreted, secreted_receptor	P05556, P08575, Q07108	CD69, ITGB1, PTPRC	CD69 [ICELLNET:21427408;connectomeDB2020:24752896], ITGB1 [CellTalkDB:14550305;Cellinker:14550305;HPRD:14550305;InnateDB:14550305;LRdb:14550305;connectomeDB2020:14550305], PTPRC [CellTalkDB:10369126;Cellinker:10369126;HPRD:10490978;LRdb:10369126;connectomeDB2020:10369126]	collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; galectin complex [GO:1990724]	carbohydrate binding [GO:0030246]; laminin binding [GO:0043236]; RNA binding [GO:0003723]	apoptotic process [GO:0006915]; cell-cell adhesion [GO:0098609]; myoblast differentiation [GO:0045445]; plasma cell differentiation [GO:0002317]; positive regulation of apoptotic process [GO:0043065]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of inflammatory response [GO:0050729]; positive regulation of viral entry into host cell [GO:0046598]; regulation of apoptotic process [GO:0042981]; T cell costimulation [GO:0031295]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=LGALS1&keywords=LGALS1	174.858427957287	36	18133.1	52	0.222097704763093	519	6.968503937007866	1.9960079840319418	5.570796460176989	9.639088729016539	0.5202020202020198	0.05583756345177667	0.05077062556663639	0.08809135399673741	0.04920458749537553	0.0219655494725597	0.11242032064902209	170	191	106	2.2793535573697694	0.025860831895006858	0.01396269674889571	0.053473750375922884	522	521	500
LGALS3	galectin 3	No		ENSG00000131981	P17931	NA	5	ligand, receptor	extracellular, intracellular, ligand, receptor, secreted, secreted_receptor	P07355, P17813, P18627, P43121, Q15262	ANXA2, ENG, LAG3, MCAM, PTPRK	LAG3 [ICELLNET:25691328;connectomeDB2020:25691328], ENG [Cellinker:31540324;IntAct:31540324], ANXA2 [Cellinker:26438086], MCAM [Cellinker:28364041], PTPRK [Baccin2019:21094132]	cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule membrane [GO:0101003]; immunological synapse [GO:0001772]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; spliceosomal complex [GO:0005681]	carbohydrate binding [GO:0030246]; chemoattractant activity [GO:0042056]; IgE binding [GO:0019863]; laminin binding [GO:0043236]; oligosaccharide binding [GO:0070492]; protein phosphatase binding [GO:0019903]; protein phosphatase inhibitor activity [GO:0004864]; RNA binding [GO:0003723]	antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; eosinophil chemotaxis [GO:0048245]; epithelial cell differentiation [GO:0030855]; innate immune response [GO:0045087]; killing of cells of other organism [GO:0031640]; macrophage chemotaxis [GO:0048246]; monocyte chemotaxis [GO:0002548]; mononuclear cell migration [GO:0071674]; mRNA processing [GO:0006397]; negative regulation of endocytosis [GO:0045806]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of immunological synapse formation [GO:2000521]; negative regulation of protein tyrosine phosphatase activity [GO:1903614]; negative regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell [GO:2001189]; negative regulation of T cell receptor signaling pathway [GO:0050860]; neutrophil chemotaxis [GO:0030593]; positive chemotaxis [GO:0050918]; positive regulation of calcium ion import [GO:0090280]; positive regulation of mononuclear cell migration [GO:0071677]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of protein localization to plasma membrane [GO:1903078]; regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902041]; regulation of T cell apoptotic process [GO:0070232]; regulation of T cell proliferation [GO:0042129]; RNA splicing [GO:0008380]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=LGALS3&keywords=LGALS3	97.66648765505619	50	33663.4	27	0.4711930543161969	398	4.039370078740153	2.290419161676639	0.3174778761061937	2.5187050359711667	2.272727272727282	0.045685279187817264	0.04079782411604713	0.019575856443719414	0.017758046614872364	0.03611964214180828	0.007958276994398305	242	164	258	1.0551449409745544	0.02606034685709077	0.04329893554168423	0.016859937369619743	521	502	523
LGALS3BP	galectin 3 binding protein	No		ENSG00000108679	Q08380	NA	7	adhesion, ecm, ligand	adhesion, cell_adhesion, ecm, extracellular, intracellular, ligand, matrix_adhesion_regulator, plasma_membrane, secreted	P05556, P20138, Q8TAA9	CD33, ITGB1, VANGL1	ITGB1 [CellTalkDB:9501082;Cellinker:9501082;HPRD:9501082;LRdb:9501082;connectomeDB2020:9501082], CD33 [CellTalkDB:25320078], VANGL1 [NA]	blood microparticle [GO:0072562]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; platelet dense granule lumen [GO:0031089]	scavenger receptor activity [GO:0005044]	cell adhesion [GO:0007155]; cellular defense response [GO:0006968]; signal transduction [GO:0007165]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=LGALS3BP&keywords=LGALS3BP	89.79141583296057	55	123739	12	0.621968272163529	334	0.031496062992125984	0.4890219560878313	0.00663716814159292	0.249640287769784	0.11784511784511795	0.47715736040609263	0.4569356300997266	0.5611745513866245	0.4058453570107337	0.3589931900120584	0.32613482711993663	48	58	50	0.31644377353378406	1.2738651820776645	1.1303422516461963	1.0296867466064554	76	104	90
LGALS9	galectin 9	No		ENSG00000168961	O00182	NA	8	cell_surface_ligand, ligand	cell_surface_ligand, extracellular, intracellular, ligand, secreted, secreted_receptor	P08575, P08581, P16070, Q07954, Q08722, Q15262, Q15758, Q5KU26, Q8TDQ0, Q9UBG0	CD44, CD47, COLEC12, HAVCR2, LRP1, MET, MRC2, PTPRC, PTPRK, SLC1A5	HAVCR2 [CellChatDB:27192565;CellPhoneDB:27192565;CellTalkDB:27192565;Cellinker:27192565;ICELLNET:16286920;ICELLNET:27192565;InnateDB:23967307;LRdb:22437870;connectomeDB2020:27192565], CD44 [CellChatDB:25065622;CellTalkDB:32103204;Cellinker:25065622;InnateDB:20206131;connectomeDB2020:25065622], SLC1A5 [CellTalkDB:32103204], MRC2 [CellTalkDB:32103204], CD47 [CellTalkDB:32103204], PTPRC [CellChatDB:30120235;Cellinker:30120235], LRP1 [NA], COLEC12 [NA], PTPRK [NA], MET [NA]	collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular space [GO:0005615]; nucleus [GO:0005634]	carbohydrate binding [GO:0030246]; disaccharide binding [GO:0048030]; enzyme binding [GO:0019899]; galactose binding [GO:0005534]; galactoside binding [GO:0016936]	cellular response to interferon-gamma [GO:0071346]; cellular response to virus [GO:0098586]; chemotaxis [GO:0006935]; ERK1 and ERK2 cascade [GO:0070371]; female pregnancy [GO:0007565]; inflammatory response [GO:0006954]; maternal process involved in female pregnancy [GO:0060135]; natural killer cell tolerance induction [GO:0002519]; negative regulation of activated T cell proliferation [GO:0046007]; negative regulation of CD4-positive, alpha-beta T cell proliferation [GO:2000562]; negative regulation of chemokine production [GO:0032682]; negative regulation of gene expression [GO:0010629]; negative regulation of interferon-gamma production [GO:0032689]; negative regulation of mast cell degranulation [GO:0043305]; negative regulation of natural killer cell mediated cytotoxicity [GO:0045953]; negative regulation of tumor necrosis factor production [GO:0032720]; p38MAPK cascade [GO:0038066]; positive regulation of activated T cell autonomous cell death [GO:0070241]; positive regulation of CD4-positive, alpha-beta T cell proliferation [GO:2000563]; positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation involved in immune response [GO:0032834]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:2001269]; positive regulation of dendritic cell apoptotic process [GO:2000670]; positive regulation of dendritic cell chemotaxis [GO:2000510]; positive regulation of dendritic cell differentiation [GO:2001200]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-13 production [GO:0032736]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-4 production [GO:0032753]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of monocyte chemotactic protein-1 production [GO:0071639]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell [GO:2001190]; positive regulation of transforming growth factor beta production [GO:0071636]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of viral entry into host cell [GO:0046598]; response to interleukin-1 [GO:0070555]; response to lipopolysaccharide [GO:0032496]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=LGALS9&keywords=LGALS9	36.50079548410544	119	2001.07	132	1.992226708125294	156	0.22047244094488178	0.1147704590818362	0.053097345132743404	0.023980815347721816	0.06228956228956227	0.00338409475465313	0	0.0016313213703099511	3.699593044765076e-4	0.0015689678194685526	0.001970253042302493	302	357	336	0.04395774718981419	0.19218666168542492	0.21440791030008885	0.22184493730238913	440	409	412
LGI1	leucine rich glioma inactivated 1	TBD		ENSG00000108231	O95970	NA	2	ecm, ligand	ecm, intracellular, ligand, secreted	O75077, O75078, Q9BZR6, Q9P0K1	ADAM11, ADAM22, ADAM23, RTN4R	ADAM11 [connectomeDB2020:18974846], ADAM22 [HPRD:16990550;LMPID:16990550;connectomeDB2020:18974846], ADAM23 [connectomeDB2020:18974846], RTN4R [connectomeDB2020:20463223]	extracellular region [GO:0005576]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; synaptic cleft [GO:0043083]	signaling receptor binding [GO:0005102]	axon guidance [GO:0007411]; nervous system development [GO:0007399]; neuron projection development [GO:0031175]; neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0099645]; positive regulation of cell growth [GO:0030307]; positive regulation of synaptic transmission [GO:0050806]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=LGI1&keywords=LGI1	0.5372419904633268	516	NA	NA	0.18361178413531537	543	0	0	0	0	0	0	0.0027198549410698096	0.0016313213703099511	0.0036995930447650763	0.0019027907597810101	3.476917133474985e-4	292	348	391	9.364774390248496e-4	1.252651333223671	1.0883569070702825	0.946163128945306	80	115	120
LGI2	leucine rich repeat LGI family member 2	TBD		ENSG00000153012	Q8N0V4	NA	2	ecm, ligand	ecm, ligand, secreted	O75077, O75078, Q9P0K1	ADAM11, ADAM22, ADAM23	ADAM11 [connectomeDB2020:20220021], ADAM22 [connectomeDB2020:21829378], ADAM23 [connectomeDB2020:21829378]	extracellular region [GO:0005576]	NA	inhibitory synapse assembly [GO:1904862]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=LGI2&keywords=LGI2	1.8188834808880898	393	NA	NA	0.5180766398502388	378	0	0.011976047904191614	0	0.0035971223021582723	0.003367003367003367	0.05076142131979698	0.0888485947416136	0.01468189233278956	0.001849796522382538	0.0569501936173072	0.013869036121305679	298	136	231	0.022354646202595346	0.36624713644471873	2.069260569195677	0.7377313283490954	388	20	220
LGI3	leucine rich repeat LGI family member 3	TBD		ENSG00000168481	Q8N145	NA	2	ecm, ligand	ecm, intracellular, ligand, secreted	O75077, O75955, Q16623, Q9P0K1	ADAM22, ADAM23, FLOT1, STX1A	ADAM22 [connectomeDB2020:20220021], ADAM23 [connectomeDB2020:20220021;connectomeDB2020:22405860], FLOT1 [connectomeDB2020:20461023], STX1A [connectomeDB2020:18760330]	extracellular region [GO:0005576]; neuron projection [GO:0043005]; synaptic vesicle [GO:0008021]	catalytic activity [GO:0003824]	exocytosis [GO:0006887]; regulation of exocytosis [GO:0017157]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=LGI3&keywords=LGI3	4.564329670535664	298	4016.78	100	0.24549617897899617	499	0	0.0029940119760479044	0	2.3980815347721823e-4	0.0016835016835016834	0.011844331641285955	0.019038984587488667	0.0065252854812398045	0.008879023307436186	0.010715716384029886	0.00737879080548581	269	240	264	0.006299950365453919	1.158225815671706	1.2709067156385172	1.0661867316061515	98	82	85
LGI4	leucine rich repeat LGI family member 4	TBD		ENSG00000153902	Q8N135	NA	2	ecm, ligand	ecm, ligand, secreted	O75077, O75078, Q9P0K1	ADAM11, ADAM22, ADAM23	ADAM11 [connectomeDB2020:18974846;connectomeDB2020:20220021], ADAM22 [connectomeDB2020:18974846;connectomeDB2020:20220021], ADAM23 [connectomeDB2020:18974846;connectomeDB2020:20220021]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	NA	adult locomotory behavior [GO:0008344]; glial cell proliferation [GO:0014009]; myelination in peripheral nervous system [GO:0022011]; neuron maturation [GO:0042551]; regulation of myelination [GO:0031641]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=LGI4&keywords=LGI4	0.17491771937562153	625	NA	NA	0.0037966239780190566	870	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
LHB	luteinizing hormone subunit beta	Yes		ENSG00000104826	P01229	Glycoprotein hormones subunit beta family	12	ligand	extracellular, intracellular, ligand, secreted	O60895, O60896, P07550, P13945, P16473, P22888, P32241, P41586, Q03431, Q99678, Q9NQS5	ADCYAP1R1, ADRB2, ADRB3, GPR20, GPR84, LHCGR, PTH1R, RAMP2, RAMP3, TSHR, VIPR1	LHCGR [CellTalkDB:1922095;Cellinker:12727981;Cellinker:1922095;Cellinker:3470775;Guide2Pharma:12727981;Guide2Pharma:1922095;HPRD:3470775;LRdb:12727981;LRdb:1922095;LRdb:3470775;SIGNOR:10446903;connectomeDB2020:12727981;connectomeDB2020:1922095;connectomeDB2020:3470775;scConnect:12727981;scConnect:1922095], PTH1R [CellTalkDB:32196115], ADCYAP1R1 [CellTalkDB:32196115], RAMP2 [CellTalkDB:32196115], VIPR1 [CellTalkDB:32196115], RAMP3 [CellTalkDB:32196115], GPR20 [CellTalkDB:32196115], ADRB2 [CellTalkDB:32196115], ADRB3 [CellTalkDB:32196115], TSHR [CellTalkDB:32196115], GPR84 [CellTalkDB:32196115]	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]	hormone activity [GO:0005179]; signaling receptor binding [GO:0005102]	cell-cell signaling [GO:0007267]; G protein-coupled receptor signaling pathway [GO:0007186]; male gonad development [GO:0008584]; progesterone biosynthetic process [GO:0006701]; signal transduction [GO:0007165]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=LHB&keywords=LHB	0.02056796629213483	792	NA	NA	5.268132795207398e-4	901	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
LIF	LIF interleukin 6 family cytokine	Yes		ENSG00000128342	P15018	LIF/OSM family	21	ligand	extracellular, intracellular, ligand, secreted	P40189, P42702	IL6ST, IL6ST_LIFR, LIFR	LIFR [Baccin2019:12601009;Baccin2019:16051226;Baccin2019:9716487;CellTalkDB:12601009;DIP:8662595;DIP:8999038;DIP:9852103;DOMINO:16051226;HPMR:9716487;HPRD:12601009;HPRD:16051226;LRdb:12601009;LRdb:16051226;LRdb:9716487;SIGNOR:16051226;SIGNOR:24710148;SIGNOR:9143707;SignaLink3:10428964;SignaLink3:11306493;SignaLink3:12601009;SignaLink3:16051226;SignaLink3:19833085;SignaLink3:21840487;SignaLink3:22595692;SignaLink3:23331499;SignaLink3:24857661;SignaLink3:26192618;SignaLink3:7512720;SignaLink3:7521688;connectomeDB2020:12601009;connectomeDB2020:16051226;connectomeDB2020:9716487], IL6ST [Baccin2019:971648712707269;CellTalkDB:9716487;DOMINO:16051226;HPMR:9716487;HPRD:12707269;IntAct:14527405;IntAct:16051226;LRdb:127;LRdb:9716487;Lit-BM-17:14527405;Lit-BM-17:16051226;ProtMapper:10811661;SIGNOR:9143707;connectomeDB2020:12707269;connectomeDB2020:9716487]	cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; leukemia inhibitory factor receptor binding [GO:0005146]; signaling receptor binding [GO:0005102]	blood vessel remodeling [GO:0001974]; decidualization [GO:0046697]; embryo implantation [GO:0007566]; immune response [GO:0006955]; leukemia inhibitory factor signaling pathway [GO:0048861]; lung alveolus development [GO:0048286]; lung lobe morphogenesis [GO:0060463]; lung vasculature development [GO:0060426]; multicellular organism development [GO:0007275]; muscle organ morphogenesis [GO:0048644]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of hormone secretion [GO:0046888]; negative regulation of meiotic nuclear division [GO:0045835]; neuron development [GO:0048666]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of histone H3-K27 acetylation [GO:1901676]; positive regulation of macrophage differentiation [GO:0045651]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis [GO:0072108]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-serine phosphorylation of STAT protein [GO:0033141]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; regulation of cell differentiation [GO:0045595]; regulation of metanephric nephron tubule epithelial cell differentiation [GO:0072307]; regulation of RNA polymerase II regulatory region sequence-specific DNA binding [GO:1903025]; spongiotrophoblast differentiation [GO:0060708]; stem cell differentiation [GO:0048863]; stem cell population maintenance [GO:0019827]; trophoblast giant cell differentiation [GO:0060707]; tyrosine phosphorylation of STAT protein [GO:0007260]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=LIF&keywords=LIF	51.51628593258427	83	NA	NA	14.780806936917575	35	0.007874015748031496	0.14770459081836343	0.0011061946902654867	0.6515587529976107	0.016835016835016835	0.005076142131979695	0.009066183136899365	0.0065252854812398045	0.017388087310395865	0.0034717585792495634	0.0028587985319683228	243	310	318	0.07904225693282005	0.30758527752794307	0.15129623892410587	0.14441231584763103	405	444	451
LIFR	LIF receptor subunit alpha	No		ENSG00000113594	P42702	Type I cytokine receptor family, Type 2 subfamily	1	adhesion, ligand, receptor	adhesion, cell_adhesion, cell_surface, extracellular, intracellular, ligand, ligand_regulator, plasma_membrane, plasma_membrane_transmembrane, receptor, secreted, transmembrane, transmembrane_predicted	O60674, P23458, P29597, P40189, Q7Z3B1	IL6ST, JAK1, JAK2, NEGR1, TYK2	IL6ST [BioGRID:12047380;BioGRID:8999038;HPRD:12047380;SIGNOR:24710148;SignaLink3:16254248;SignaLink3:21071413;SignaLink3:23331499;SignaLink3:8999038], JAK2 [SignaLink3:11294841;SignaLink3:23331499], TYK2 [SignaLink3:11294841;SignaLink3:23331499], JAK1 [SignaLink3:11294841;SignaLink3:23331499], NEGR1 [Cellinker:30651602]	external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	ciliary neurotrophic factor receptor binding [GO:0005127]; cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]; growth factor binding [GO:0019838]; leukemia inhibitory factor receptor activity [GO:0004923]	cell surface receptor signaling pathway [GO:0007166]; ciliary neurotrophic factor-mediated signaling pathway [GO:0070120]; cytokine-mediated signaling pathway [GO:0019221]; leukemia inhibitory factor signaling pathway [GO:0048861]; oncostatin-M-mediated signaling pathway [GO:0038165]; positive regulation of cell population proliferation [GO:0008284]; response to cytokine [GO:0034097]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=LIFR&keywords=LIFR	5.709988171017033	284	NA	NA	0.2805028535315342	476	0	0.04640718562874247	0.06858407079646024	0.03645083932853716	0.10942760942760957	0.016920473773265648	0.012692656391659111	0.0065252854812398045	0.008879023307436186	0.007477633862999048	0.007494688043268309	269	257	263	0.029169042367383415	0.48198838078198714	0.44621039491006054	0.4466457943796035	350	333	342
LILRB1	leukocyte immunoglobulin like receptor B1			ENSG00000277807, ENSG00000276452, ENSG00000274669, ENSG00000277134, ENSG00000104972	Q8NHL6	NA	1	adhesion, ligand, receptor	adhesion, cell_adhesion, cell_surface, extracellular, intracellular, ligand, plasma_membrane, plasma_membrane_transmembrane, receptor, secreted, transmembrane	A6NI73, P17693, P30511, Q3KPI0, Q86SU0, Q9UNE0	CEACAM21, EDAR, HLA-F, HLA-G, ILDR1, LILRA5	HLA-G [HPRD:12853576;HPRD:12874224;HPRD:9933109;IntAct:16455647;IntAct:19583775], HLA-F [Cellinker:11169396;HPRD:11169396], EDAR [Cellinker:32822567], LILRA5 [Cellinker:32589946], ILDR1 [Cellinker:32822567], CEACAM21 [Cellinker:32822567]	cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	HLA-A specific inhibitory MHC class I receptor activity [GO:0030107]; HLA-B specific inhibitory MHC class I receptor activity [GO:0030109]; inhibitory MHC class I receptor activity [GO:0032396]; MHC class Ib protein binding [GO:0023029]; MHC class Ib protein complex binding [GO:0023025]; MHC class Ib receptor activity [GO:0032394]; MHC class I protein binding [GO:0042288]; MHC class I receptor activity [GO:0032393]; protein homodimerization activity [GO:0042803]; protein phosphatase 1 binding [GO:0008157]; SH2 domain binding [GO:0042169]	adaptive immune response [GO:0002250]; cellular response to lipopolysaccharide [GO:0071222]; cytokine-mediated signaling pathway [GO:0019221]; defense response to virus [GO:0051607]; dendritic cell differentiation [GO:0097028]; Fc receptor mediated inhibitory signaling pathway [GO:0002774]; immune response-inhibiting cell surface receptor signaling pathway [GO:0002767]; negative regulation of alpha-beta T cell activation [GO:0046636]; negative regulation of calcium ion transport [GO:0051926]; negative regulation of CD8-positive, alpha-beta T cell activation [GO:2001186]; negative regulation of cell cycle [GO:0045786]; negative regulation of cytokine production involved in immune response [GO:0002719]; negative regulation of dendritic cell apoptotic process [GO:2000669]; negative regulation of dendritic cell differentiation [GO:2001199]; negative regulation of endocytosis [GO:0045806]; negative regulation of interferon-beta production [GO:0032688]; negative regulation of interferon-gamma production [GO:0032689]; negative regulation of interleukin-10 production [GO:0032693]; negative regulation of interleukin-12 production [GO:0032695]; negative regulation of mononuclear cell proliferation [GO:0032945]; negative regulation of natural killer cell mediated cytotoxicity [GO:0045953]; negative regulation of osteoclast development [GO:2001205]; negative regulation of serotonin secretion [GO:0014063]; negative regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell [GO:2001189]; negative regulation of T cell mediated cytotoxicity [GO:0001915]; negative regulation of T cell proliferation [GO:0042130]; negative regulation of transforming growth factor beta production [GO:0071635]; negative regulation of tumor necrosis factor production [GO:0032720]; positive regulation of apoptotic process [GO:0043065]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of gamma-delta T cell activation involved in immune response [GO:2001193]; positive regulation of gene expression [GO:0010628]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of macrophage cytokine production [GO:0060907]; positive regulation of transcription by RNA polymerase II [GO:0045944]; receptor internalization [GO:0031623]; response to virus [GO:0009615]; signal transduction [GO:0007165]; T cell proliferation involved in immune response [GO:0002309]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=LILRB1&keywords=LILRB1	0.7608498427415731	485	NA	NA	0.16624268882827403	562	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
LIN7C	lin-7 homolog C, crumbs cell polarity complex component			ENSG00000148943	Q9NUP9	Lin-7 family	1	cell_surface_ligand, receptor	cell_surface, cell_surface_ligand, intracellular, intracellular_intercellular_related, plasma_membrane, receptor, secreted, tight_junction	O95477, P28335, P48050	ABCA1, HTR2C, KCNJ4	ABCA1 [CellTalkDB:16192275;Cellinker:16192275;HPRD:16192275;LRdb:16192275], KCNJ4 [CellTalkDB:32196115], HTR2C [Baccin2019:12006486;BioGRID:12006486;Cellinker:12006486;HPRD:12006486;LRdb:12006486;connectomeDB2020:12006486]	basolateral plasma membrane [GO:0016323]; bicellular tight junction [GO:0005923]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; MPP7-DLG1-LIN7 complex [GO:0097025]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; presynapse [GO:0098793]; synapse [GO:0045202]	cytoskeletal protein binding [GO:0008092]; L27 domain binding [GO:0097016]; protein domain specific binding [GO:0019904]	exocytosis [GO:0006887]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; morphogenesis of an epithelial sheet [GO:0002011]; neurotransmitter secretion [GO:0007269]; protein localization to basolateral plasma membrane [GO:1903361]; protein transport [GO:0015031]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=LIN7C&keywords=LIN7C	17.66381846823579	179	38801	25	1.3691584581743481	215	0.10236220472440945	0.2574850299401222	0.08185840707964612	0.1889688249400481	0.1734006734006734	0.26226734348561737	0.29374433363553853	0.14845024469820559	0.1409544950055487	0.19748965148884112	0.13451806065288158	93	78	91	0.18013629718650292	0.793927815147672	1.09126797228683	0.7600761285002051	224	114	207
LINGO4	leucine rich repeat and Ig domain containing 4			ENSG00000213171	Q6UY18	NA	1	ecm, ligand, receptor	cell_surface, ecm, extracellular, ligand, plasma_membrane_transmembrane, receptor, secreted, transmembrane, transmembrane_predicted	O94856	NFASC	NFASC [Cellinker:32589946]	extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]	NA	NA	https://www.genecards.org/cgi-bin/carddisp.pl?gene=LINGO4&keywords=LINGO4	0.46294138764044945	531	NA	NA	0.5495494079864139	367	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
LPA	lipoprotein(a)	No	manually added ensembl_gene_ID, hgnc_symbol, and description by searching the uniprot ID on genenames.org	ENSG00000198670	P08519	Peptidase S1 family, Plasminogen subfamily	7	ligand	ecm_regulator, extracellular, intracellular, ligand, secreted	P05107, P11215, P98164, Q92633, Q99677, Q9HBW0, Q9NZC2, Q9UBY5	ITGAM, ITGB2, LPAR1, LPAR2, LPAR3, LPAR4, LRP2, TREM2	ITGAM [CellTalkDB:16403785], LPAR3 [CellTalkDB:25849892], ITGB2 [CellTalkDB:16403785], LPAR1 [CellTalkDB:25849892], LPAR4 [CellTalkDB:25849892], LPAR2 [CellTalkDB:25849892], LRP2 [CellTalkDB:32196115;Cellinker:10073957;HPRD:10073957;LRdb:10073957;connectomeDB2020:10073957], TREM2 [Cellinker:28432014]	extracellular region [GO:0005576]; extracellular space [GO:0005615]; extrinsic component of plasma membrane [GO:0019897]; plasma lipoprotein particle [GO:0034358]	apolipoprotein binding [GO:0034185]; endopeptidase activity [GO:0004175]; endopeptidase inhibitor activity [GO:0004866]; fibronectin binding [GO:0001968]; heparin binding [GO:0008201]; serine-type endopeptidase activity [GO:0004252]; signaling receptor binding [GO:0005102]	blood circulation [GO:0008015]; lipid metabolic process [GO:0006629]; lipid transport [GO:0006869]; proteolysis [GO:0006508]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=LPA&keywords=LPA	0.020456071460674158	793	NA	NA	0.08970763353687956	645	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
LRFN5	leucine rich repeat and fibronectin type III domain containing 5	No		ENSG00000165379	Q96NI6	LRFN family	1	adhesion, ligand, receptor	adhesion, cell_adhesion, cell_surface, extracellular, ligand, plasma_membrane, plasma_membrane_transmembrane, receptor, secreted, transmembrane	P10586, P23468, Q13332	PTPRD, PTPRF, PTPRS	PTPRF [SIGNOR:27225731], PTPRD [SIGNOR:27225731], PTPRS [SIGNOR:27225731]	cell surface [GO:0009986]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; integral component of postsynaptic density membrane [GO:0099061]	NA	negative regulation of inflammatory response [GO:0050728]; negative regulation of macrophage activation [GO:0043031]; regulation of presynapse assembly [GO:1905606]; synaptic membrane adhesion [GO:0099560]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=LRFN5&keywords=LRFN5	0.41734535920268245	539	NA	NA	0.1913757467459882	538	0	0.00249500998003992	0.004424778761061947	0.06834532374100732	0.0016835016835016834	0.2098138747884938	0.0027198549410698096	0	0.16204217536070936	0.0016023501134997985	0.0011589723778249958	88	355	358	0.041298712886109874	3.353732787461284	0.22617234352952667	0.21752928582437212	10	402	415
LRP1B	LDL receptor related protein 1B			ENSG00000168702	Q9NZR2	LDLR family	1	cell_surface_ligand, receptor	cell_surface, cell_surface_ligand, intracellular, plasma_membrane_transmembrane, receptor, secreted, transmembrane	O14641, Q03405	DVL2, PLAUR	DVL2 [SIGNOR:28408316], PLAUR [Baccin2019:11384978;Baccin2019:12194987;Cellinker:11384978;Cellinker:12194987;HPRD:11384978;HPRD:12194987;LRdb:11384978;LRdb:12]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	calcium ion binding [GO:0005509]; low-density lipoprotein particle receptor activity [GO:0005041]	protein transport [GO:0015031]; receptor-mediated endocytosis [GO:0006898]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=LRP1B&keywords=LRP1B	0.10285273156179775	673	NA	NA	0.10692015958695592	624	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
LRRC4B	leucine rich repeat containing 4B			ENSG00000131409	Q9NT99	NA	1	adhesion, cell_surface_ligand, ligand, receptor	adhesion, cell_adhesion, cell_surface, cell_surface_ligand, extracellular, intracellular, ligand, plasma_membrane, plasma_membrane_transmembrane, receptor, secreted, transmembrane, transmembrane_predicted	P10586, P23468, P78352, Q13332, Q6UXZ4	DLG4, PTPRD, PTPRF, PTPRS, UNC5D	DLG4 [SIGNOR:19467332], PTPRF [Cellinker:32589946;connectomeDB2020:19252495;connectomeDB2020:23345436], PTPRD [connectomeDB2020:23345436], PTPRS [connectomeDB2020:23345436], UNC5D [Cellinker:32589946]	cerebellar mossy fiber [GO:0044300]; glutamatergic synapse [GO:0098978]; integral component of postsynaptic density membrane [GO:0099061]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]	signaling receptor binding [GO:0005102]	positive regulation of synapse assembly [GO:0051965]; regulation of postsynaptic density assembly [GO:0099151]; regulation of presynapse assembly [GO:1905606]; synaptic membrane adhesion [GO:0099560]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=LRRC4B&keywords=LRRC4B	0.1486874606741573	643	NA	NA	0.005188141265085419	861	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
LTA	lymphotoxin alpha	Yes	cytokine	ENSG00000230279, ENSG00000238130, ENSG00000231408, ENSG00000223919, ENSG00000173503, ENSG00000226275, ENSG00000226979	P01374	Tumor necrosis factor family	19	cell_surface_ligand, ligand	cell_surface_ligand, extracellular, intracellular, ligand, secreted, transmembrane	P19438, P20333, P25101, P36941, Q13546, Q5VU97, Q92956	CACHD1, EDNRA, LTB_LTBR, LTBR, RIPK1, TNFRSF14, TNFRSF1A, TNFRSF1B	TNFRSF1A [Baccin2019:8387891;BioGRID:8387891;CellTalkDB:8387891;Cellinker:8387891;DIP:2170974;DIP:8387891;HPRD:8387891;ICELLNET:7995952;InnateDB:8171323;LRdb:8387891;Lit-BM-17:1310388;Lit-BM-17:2170974;Lit-BM-17:8182064;Lit-BM-17:8288897;Lit-BM-17:8387891;SPIKE:12387745;connectomeDB2020:8387891], TNFRSF14 [Baccin2019:9153189;Baccin2019:9462508;CellTalkDB:9153189;Cellinker:9153189;Cellinker:9462508;HPRD:9153189;HPRD:9462508;ICELLNET:7995952;InnateDB:11164894;LRdb:9153189;LRdb:946;connectomeDB2020:9153189;connectomeDB2020:9462508], TNFRSF1B [Baccin2019:2160731;Baccin2019:8123048;Baccin2019:9552007;CellTalkDB:9552007;Cellinker:2160731;Cellinker:8123048;Cellinker:9552007;DIP:1328224;HPRD:2160731;HPRD:8123048;HPRD:9552007;ICELLNET:7995952;LRdb:2160731;LRdb:8123048;LRdb:9552007;Lit-BM-17:1310388;Lit-BM-17:1328224;Lit-BM-17:8182064;connectomeDB2020:2160731;connectomeDB2020:8123048;connectomeDB2020:9552007], LTBR [Baccin2019:8171323;CellTalkDB:8171323;DIP:8171323;HPRD:8171323;LRdb:8171323;SIGNOR:7995952;connectomeDB2020:8171323], RIPK1 [CellTalkDB:32103204], CACHD1 [NA], EDNRA [NA]	extracellular space [GO:0005615]; plasma membrane [GO:0005886]	cytokine activity [GO:0005125]; signaling receptor binding [GO:0005102]; tumor necrosis factor receptor binding [GO:0005164]	apoptotic process [GO:0006915]; cell-cell signaling [GO:0007267]; defense response to Gram-positive bacterium [GO:0050830]; humoral immune response [GO:0006959]; lymph node development [GO:0048535]; negative regulation of fibroblast proliferation [GO:0048147]; positive regulation of apoptotic process [GO:0043065]; positive regulation of chronic inflammatory response to antigenic stimulus [GO:0002876]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of humoral immune response mediated by circulating immunoglobulin [GO:0002925]; positive regulation of interferon-gamma production [GO:0032729]; response to hypoxia [GO:0001666]; response to lipopolysaccharide [GO:0032496]; response to nutrient [GO:0007584]; response to xenobiotic stimulus [GO:0009410]; signal transduction [GO:0007165]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=LTA&keywords=LTA	0.01826853224719101	801	NA	NA	0.0044472926435940975	865	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
LTB	lymphotoxin beta			ENSG00000223448, ENSG00000231314, ENSG00000204487, ENSG00000236925, ENSG00000238114, ENSG00000236237, ENSG00000206437, ENSG00000227507	Q06643	Tumor necrosis factor family	9	adhesion, cell_surface_ligand, ligand	adhesion, cell_adhesion, cell_surface, cell_surface_ligand, extracellular, intracellular, ligand, plasma_membrane, secreted, transmembrane, transmembrane_predicted	P19438, P25942, P36941	CD40, LTBR, TNFRSF1A	LTBR [Baccin2019:7916655;Baccin2019:7995952;CellTalkDB:7995952;Cellinker:7916655;Cellinker:7995952;HPRD:7916655;InnateDB:8171323;LRdb:792;LRdb:7995952;SIGNOR:7995952;SPIKE:12387745;connectomeDB2020:7916655;connectomeDB2020:7995952], TNFRSF1A [Baccin2019:7995952;CellTalkDB:7995952;Cellinker:7995952;HPRD:7995952;LRdb:7995952;connectomeDB2020:7995952], CD40 [CellTalkDB:7916655;LRdb:7916655;connectomeDB2020:7916655]	extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	cytokine activity [GO:0005125]; signaling receptor binding [GO:0005102]; tumor necrosis factor receptor binding [GO:0005164]	cell-cell signaling [GO:0007267]; gene expression [GO:0010467]; immune response [GO:0006955]; lymph node development [GO:0048535]; positive regulation of interleukin-12 production [GO:0032735]; signal transduction [GO:0007165]; skin development [GO:0043588]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=LTB&keywords=LTB	0.9073070993258427	463	NA	NA	0.06870833867556615	677	0	0.12375249500998001	0.007743362831858407	7.194244604316547e-4	0.3148148148148147	0	0	0	0	4.0058752837495007e-4	4.6358895112999797e-4	303	393	387	0.04071766123605361	0.19716997504000264	0.20506835833710518	0.20631055723231492	436	414	418
LTBP3	latent transforming growth factor beta binding protein 3	No		ENSG00000168056	Q9NS15	LTBP family	8	ecm, ligand	ecm, extracellular, intracellular, ligand, ligand_regulator, secreted	P18084	ITGB5	ITGB5 [CellTalkDB:12358597;Cellinker:12358597;HPRD:12358597;LRdb:12358597;connectomeDB2020:12358597]	collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]	calcium ion binding [GO:0005509]; transforming growth factor beta binding [GO:0050431]	bone morphogenesis [GO:0060349]; bone remodeling [GO:0046849]; elastic fiber assembly [GO:0048251]; lung saccule development [GO:0060430]; negative regulation of bone mineralization [GO:0030502]; negative regulation of chondrocyte differentiation [GO:0032331]; positive regulation of bone resorption [GO:0045780]; positive regulation of mesenchymal stem cell differentiation [GO:2000741]; positive regulation of mesenchymal stem cell proliferation [GO:1902462]; transforming growth factor beta activation [GO:0036363]; transforming growth factor beta receptor signaling pathway [GO:0007179]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=LTBP3&keywords=LTBP3	8.561408276634104	251	2612.46	122	0.10812554298461699	619	0.007874015748031496	0.10079840319361265	0.028761061946902658	0.05563549160671461	0.06565656565656565	0.16920473773265635	0.22756119673617345	0.0864600326264275	0.07584165741768396	0.10922686607023571	0.05226965423990626	143	99	149	0.08902633481590094	0.8668568575952195	1.2039915068238103	0.6288191353913206	200	92	271
LUM	lumican	No		ENSG00000139329	P51884	Small leucine-rich proteoglycan (SLRP) family, SLRP class II subfamily	1	ecm, ligand	ecm, extracellular, intracellular, ligand, secreted	P05556	ITGB1	ITGB1 [CellTalkDB:32196115]	collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; fibrillar collagen trimer [GO:0005583]; Golgi lumen [GO:0005796]; lysosomal lumen [GO:0043202]	collagen binding [GO:0005518]; extracellular matrix structural constituent [GO:0005201]; extracellular matrix structural constituent conferring compression resistance [GO:0030021]	collagen fibril organization [GO:0030199]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta1 production [GO:0032914]; visual perception [GO:0007601]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=LUM&keywords=LUM	54.472031559499776	79	NA	NA	0.5320428357411842	372	0	0.00249500998003992	0.015486725663716814	2.541726618705004	0.0202020202020202	0.001692047377326565	0.004533091568449683	0.0032626427406199023	0.001849796522382538	0.0023701428762184502	0.001970253042302493	298	337	336	0.23596257715255275	0.04817723354326771	0.050292784452921666	0.04866696869450271	502	496	505
LY6G5C	lymphocyte antigen 6 family member G5C	No		ENSG00000231325, ENSG00000237495, ENSG00000228883, ENSG00000226404, ENSG00000111971, ENSG00000206404, ENSG00000204428	Q5SRR4	NA	2	ligand	extracellular, ligand, secreted, transmembrane, transmembrane_predicted	Q9HCN3	PGAP6	PGAP6 [NA]	external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; protein-containing complex [GO:0032991]	identical protein binding [GO:0042802]	NA	https://www.genecards.org/cgi-bin/carddisp.pl?gene=LY6G5C&keywords=LY6G5C	0.916258273371726	460	NA	NA	0.2576810338158481	490	0	0.015469061876247496	0.017699115044247787	0.008153477218225418	0.035353535353535345	0.030456852791878163	0.025385312783318223	0.024469820554649267	0.030706622271550073	0.026772599813059083	0.02723585087888749	207	180	190	0.02197293168959985	1.27315889161303	1.1501166102018872	1.164605461907003	77	102	67
LY96	lymphocyte antigen 96	No		ENSG00000154589	Q9Y6Y9	NA	1	ligand	cell_surface, extracellular, intracellular, ligand, plasma_membrane_transmembrane, secreted	P09429	HMGB1	HMGB1 [SIGNOR:25559892]	endosome membrane [GO:0010008]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intrinsic component of plasma membrane [GO:0031226]; lipopolysaccharide receptor complex [GO:0046696]; plasma membrane [GO:0005886]	coreceptor activity [GO:0015026]; lipopolysaccharide binding [GO:0001530]; lipopolysaccharide immune receptor activity [GO:0001875]; Toll-like receptor 4 binding [GO:0035662]	cell surface receptor signaling pathway [GO:0007166]; cellular defense response [GO:0006968]; cellular response to lipopolysaccharide [GO:0071222]; detection of lipopolysaccharide [GO:0032497]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; positive regulation of lipopolysaccharide-mediated signaling pathway [GO:0031666]; positive regulation of tumor necrosis factor production [GO:0032760]; response to lipopolysaccharide [GO:0032496]; toll-like receptor 4 signaling pathway [GO:0034142]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=LY96&keywords=LY96	6.4884382247191015	273	NA	NA	0.545818863598662	370	0.661417322834645	0.008982035928143712	0.11393805309734528	0.14412470023980894	0.040404040404040394	0.1725888324873095	0.13055303717135053	0.11419249592169672	0.16315205327413893	0.06312591801308853	0.14537376859184284	87	131	87	0.1598047507239464	1.0197126554817908	0.43064706789016877	0.9150142615528809	130	337	136
MANF	mesencephalic astrocyte derived neurotrophic factor			ENSG00000145050	P55145	ARMET family	2	ligand	intracellular, ligand, secreted	NA	NA	NA	cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; sarcoplasmic reticulum lumen [GO:0033018]	growth factor activity [GO:0008083]; RNA binding [GO:0003723]; sulfatide binding [GO:0120146]	dopaminergic neuron differentiation [GO:0071542]; neuron projection development [GO:0031175]; regulation of response to endoplasmic reticulum stress [GO:1905897]; response to unfolded protein [GO:0006986]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=MANF&keywords=MANF	251.43261168651685	31	15968.2	54	6.572742739358151	61	0.8031496062992118	0.9860279441117706	0.8860619469026527	2.4544364508392675	1.7020202020202126	1.8646362098138702	2.220308250226667	0.7748776508972293	1.0418054014058455	2.3998865002007785	1.1557272551672026	22	16	22	1.4808124925349735	0.7055249447349066	1.6164920218122225	0.7819408953201105	260	41	199
MAPT	microtubule associated protein tau			ENSG00000276155, ENSG00000277956, ENSG00000186868	P10636	NA	1	ligand	extracellular, intracellular, ligand, plasma_membrane, secreted	P68363, Q13509	TUBA1B, TUBB3	TUBA1B [BioGRID:16687396;CA1:1421571], TUBB3 [Lit-BM-17:24251416;Lit-BM-17:24905733]	axolemma [GO:0030673]; axon [GO:0030424]; axon cytoplasm [GO:1904115]; cell body [GO:0044297]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; extracellular region [GO:0005576]; glial cell projection [GO:0097386]; growth cone [GO:0030426]; main axon [GO:0044304]; membrane raft [GO:0045121]; microtubule [GO:0005874]; microtubule cytoskeleton [GO:0015630]; mitochondrion [GO:0005739]; neurofibrillary tangle [GO:0097418]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; nuclear periphery [GO:0034399]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; somatodendritic compartment [GO:0036477]; tubulin complex [GO:0045298]	actin binding [GO:0003779]; apolipoprotein binding [GO:0034185]; chaperone binding [GO:0051087]; DNA binding [GO:0003677]; double-stranded DNA binding [GO:0003690]; dynactin binding [GO:0034452]; enzyme binding [GO:0019899]; histone-dependent DNA binding [GO:0099077]; Hsp90 protein binding [GO:0051879]; identical protein binding [GO:0042802]; lipoprotein particle binding [GO:0071813]; microtubule binding [GO:0008017]; microtubule lateral binding [GO:0099609]; minor groove of adenine-thymine-rich DNA binding [GO:0003680]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol bisphosphate binding [GO:1902936]; protein kinase binding [GO:0019901]; protein-macromolecule adaptor activity [GO:0030674]; protein phosphatase 2A binding [GO:0051721]; RNA binding [GO:0003723]; sequence-specific DNA binding [GO:0043565]; SH3 domain binding [GO:0017124]; single-stranded DNA binding [GO:0003697]	activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; amyloid fibril formation [GO:1990000]; astrocyte activation [GO:0048143]; axonal transport [GO:0098930]; axonal transport of mitochondrion [GO:0019896]; axon development [GO:0061564]; cell-cell signaling [GO:0007267]; cellular response to brain-derived neurotrophic factor stimulus [GO:1990416]; cellular response to heat [GO:0034605]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to reactive oxygen species [GO:0034614]; central nervous system neuron development [GO:0021954]; cytoplasmic microtubule organization [GO:0031122]; generation of neurons [GO:0048699]; internal protein amino acid acetylation [GO:0006475]; intracellular distribution of mitochondria [GO:0048312]; learning or memory [GO:0007611]; memory [GO:0007613]; microglial cell activation [GO:0001774]; microtubule cytoskeleton organization [GO:0000226]; microtubule polymerization [GO:0046785]; negative regulation of establishment of protein localization to mitochondrion [GO:1903748]; negative regulation of gene expression [GO:0010629]; negative regulation of kinase activity [GO:0033673]; negative regulation of mitochondrial fission [GO:0090258]; negative regulation of mitochondrial membrane potential [GO:0010917]; negative regulation of tubulin deacetylation [GO:1904428]; neurofibrillary tangle assembly [GO:1902988]; neuron projection development [GO:0031175]; plus-end-directed organelle transport along microtubule [GO:0072386]; positive regulation of axon extension [GO:0045773]; positive regulation of diacylglycerol kinase activity [GO:1905689]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of neuron death [GO:1901216]; positive regulation of protein localization [GO:1903829]; positive regulation of protein localization to synapse [GO:1902474]; positive regulation of superoxide anion generation [GO:0032930]; protein homooligomerization [GO:0051260]; protein polymerization [GO:0051258]; regulation of autophagy [GO:0010506]; regulation of calcium-mediated signaling [GO:0050848]; regulation of cellular response to heat [GO:1900034]; regulation of chromosome organization [GO:0033044]; regulation of long-term synaptic depression [GO:1900452]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of microtubule polymerization [GO:0031113]; regulation of microtubule polymerization or depolymerization [GO:0031110]; regulation of mitochondrial fission [GO:0090140]; regulation of response to DNA damage stimulus [GO:2001020]; regulation of synaptic plasticity [GO:0048167]; response to lead ion [GO:0010288]; rRNA metabolic process [GO:0016072]; stress granule assembly [GO:0034063]; supramolecular fiber organization [GO:0097435]; synapse assembly [GO:0007416]; synapse organization [GO:0050808]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=MAPT&keywords=MAPT	2.634299364973964	355	13139.5	60	0.08585701412993635	652	0	0.021457085828343297	0.004424778761061947	0.009832134292565945	0.0101010101010101	0.10659898477157355	0.10607434270172234	0.03915171288743884	0.053644099149093634	0.1650420616904738	0.012169209967162368	164	86	240	0.04804503819549508	1.096460630015282	3.015624885988256	0.38193118062041237	111	5	358
MDK	midkine	Yes		ENSG00000110492	P21741	Pleiotrophin family	15	ligand	extracellular, intracellular, ligand, secreted	O60635, O75056, P05107, P05556, P13612, P18827, P19338, P23229, P23467, P23471, P31431, P34741, P98164, Q04721, Q07954, Q8N158, Q92673, Q9UM73	ALK, GPC2, ITGA4, ITGA4_ITGB1, ITGA6, ITGA6_ITGB1, ITGB1, ITGB2, LRP1, LRP2, NCL, NOTCH2, PTPRB, PTPRZ1, SDC1, SDC2, SDC3, SDC4, SORL1, TSPAN1	NOTCH2 [SIGNOR:18469519;SignaLink3:18469519;SignaLink3:23331499;connectomeDB2020:18469519], ALK [Baccin2019:1212200912122000;CellChatDB:19459784;CellTalkDB:12122009;Cellinker:19459784;HPMR:12122009;HPRD:12122009;LRdb:12122009;SignaLink3:12122009;SignaLink3:23331499;connectomeDB2020:12122009], ITGA6 [CellTalkDB:32196115;connectomeDB2020:15466886], LRP1 [Baccin2019:10772929;CellChatDB:28356350;Cellinker:10772929;Cellinker:28356350;HPRD:10772929;LRdb:10772929;connectomeDB2020:10772929], SORL1 [CellTalkDB:32103204], LRP2 [Baccin2019:10772929;CellTalkDB:10772929;Cellinker:10772929;HPRD:10772929;LRdb:10772929], GPC2 [CellTalkDB:32196115], SDC3 [Baccin2019:9089390;CellTalkDB:9089390;HPRD:9089390;LRdb:9089390;connectomeDB2020:9089390], TSPAN1 [Baccin2019:18851943;CellTalkDB:18851943;Cellinker:18851943;HPRD:18851943;LRdb:18851943;connectomeDB2020:18851943], SDC4 [Baccin2019:8621465;CellChatDB:28356350;CellTalkDB:8621465;Cellinker:28356350;Cellinker:8621465;HPRD:8621465;LRdb:8621465;connectomeDB2020:8621465], SDC1 [Baccin2019:9089390;CellChatDB:28356350;CellTalkDB:9089390;Cellinker:28356350;Cellinker:9089390;HPRD:9089390;LRdb:9089390;connectomeDB2020:9089390], PTPRZ1 [Baccin2019:10212223;CellChatDB:28356350;CellPhoneDB:10212223;CellTalkDB:10212223;Cellinker:10212223;Cellinker:28356350;HPRD:10212223;LRdb:10212223;connectomeDB2020:10212223], ITGB1 [CellTalkDB:32196115;connectomeDB2020:15466886], ITGA4 [CellTalkDB:32196115;connectomeDB2020:15466886], SDC2 [CellChatDB:28356350;Cellinker:28356350], NCL [CellChatDB:28356350;Cellinker:28356350;HPRD:12147681], PTPRB [NA], ITGB2 [Baccin2019:24458438]	cell projection [GO:0042995]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]	chondroitin sulfate binding [GO:0035374]; growth factor activity [GO:0008083]; heparan sulfate binding [GO:1904399]; heparin binding [GO:0008201]	adrenal gland development [GO:0030325]; behavioral fear response [GO:0001662]; cell differentiation [GO:0030154]; cerebellar granular layer development [GO:0021681]; cerebral cortex development [GO:0021987]; cytoskeleton organization [GO:0007010]; defecation [GO:0030421]; dentate gyrus development [GO:0021542]; estrous cycle [GO:0044849]; glial cell projection elongation [GO:0106091]; leukocyte chemotaxis involved in inflammatory response [GO:0002232]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cell adhesion [GO:0007162]; negative regulation of epithelial cell apoptotic process [GO:1904036]; negative regulation of inflammatory response to wounding [GO:0106015]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of ossification [GO:0030279]; negative regulation of regulatory T cell differentiation [GO:0045590]; nervous system development [GO:0007399]; oogenesis [GO:0048477]; positive regulation of artery morphogenesis [GO:1905653]; positive regulation of blood vessel branching [GO:1905555]; positive regulation of cartilage development [GO:0061036]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell division [GO:0051781]; positive regulation of cell migration [GO:0030335]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of hepatocyte proliferation [GO:2000347]; positive regulation of inflammatory response [GO:0050729]; positive regulation of inflammatory response to wounding [GO:0106016]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of keratinocyte proliferation [GO:0010838]; positive regulation of leukocyte adhesion to vascular endothelial cell [GO:1904996]; positive regulation of leukocyte cell-cell adhesion [GO:1903039]; positive regulation of leukocyte chemotaxis [GO:0002690]; positive regulation of macrophage chemotaxis [GO:0010759]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neuron migration [GO:2001224]; positive regulation of neuron projection development [GO:0010976]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of neutrophil extravasation [GO:2000391]; positive regulation of oligodendrocyte differentiation [GO:0048714]; positive regulation of smooth muscle cell chemotaxis [GO:0071673]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive regulation of T cell differentiation [GO:0045582]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; regulation of actin cytoskeleton reorganization [GO:2000249]; regulation of behavior [GO:0050795]; regulation of bone remodeling [GO:0046850]; regulation of chondrocyte differentiation [GO:0032330]; response to auditory stimulus [GO:0010996]; response to glucocorticoid [GO:0051384]; response to wounding [GO:0009611]; response to xenobiotic stimulus [GO:0009410]; short-term memory [GO:0007614]; signal transduction [GO:0007165]; T cell activation involved in immune response [GO:0002286]; tissue regeneration [GO:0042246]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=MDK&keywords=MDK	10.758128771881655	232	NA	NA	0.2235190161338557	518	0.023622047244094488	0.3547904191616802	0.09402654867256645	0.18393285371702658	0.2727272727272726	1.120135363790182	0.7751586582049049	1.0375203915171323	1.9815020347762073	0.40195620243029617	1.0498358122465172	18	54	25	0.66320069131708	2.9582590458722544	0.6119366895246744	1.5743237134427281	14	285	32
MEGF10	multiple EGF like domains 10	TBD		ENSG00000145794	Q96KG7	MEGF family	2	adhesion, ligand, receptor	adhesion, cell_adhesion, cell_surface, ligand, plasma_membrane, plasma_membrane_transmembrane, receptor, secreted, transmembrane, transmembrane_predicted	O95477	ABCA1	ABCA1 [CellTalkDB:17205124;SIGNOR:17205124]	cell projection [GO:0042995]; integral component of membrane [GO:0016021]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886]	complement component C1q complex binding [GO:0001849]; Notch binding [GO:0005112]; scavenger receptor activity [GO:0005044]	apoptotic cell clearance [GO:0043277]; apoptotic process involved in development [GO:1902742]; engulfment of apoptotic cell [GO:0043652]; homotypic cell-cell adhesion [GO:0034109]; muscle cell development [GO:0055001]; muscle cell proliferation [GO:0033002]; myoblast development [GO:0048627]; myoblast migration [GO:0051451]; positive regulation of cell-cell adhesion [GO:0022409]; positive regulation of myoblast proliferation [GO:2000288]; recognition of apoptotic cell [GO:0043654]; regulation of muscle cell differentiation [GO:0051147]; regulation of skeletal muscle tissue development [GO:0048641]; skeletal muscle satellite cell activation [GO:0014719]; skeletal muscle satellite cell differentiation [GO:0014816]; skeletal muscle satellite cell proliferation [GO:0014841]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=MEGF10&keywords=MEGF10	0.22083240668539325	607	NA	NA	0.10980991825972554	615	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
MEGF11	multiple EGF like domains 11			ENSG00000277848, ENSG00000157890	A6BM72	MEGF family	1	adhesion, ligand, receptor	adhesion, cell_adhesion, cell_surface, extracellular, ligand, plasma_membrane, plasma_membrane_transmembrane, receptor, secreted, transmembrane, transmembrane_predicted	NA	NA	NA	basolateral plasma membrane [GO:0016323]; integral component of membrane [GO:0016021]	NA	homotypic cell-cell adhesion [GO:0034109]; retina layer formation [GO:0010842]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=MEGF11&keywords=MEGF11	0.5479652102808988	513	NA	NA	0.23490688219286462	507	0	0.001996007984031936	0	9.592326139088729e-4	0	0.02030456852791878	0.014505893019038985	0	0.011098779134295233	0.01231806649752968	0.0011976047904191623	261	232	357	0.005670922960649332	1.3463648048858123	1.4241705197308252	0.7145466044684827	67	59	231
MEGF6	multiple EGF like domains 6	TBD		ENSG00000162591	O75095	NA	1	ligand	intracellular, ligand, secreted	NA	NA	NA	extracellular region [GO:0005576]	calcium ion binding [GO:0005509]	NA	https://www.genecards.org/cgi-bin/carddisp.pl?gene=MEGF6&keywords=MEGF6	0.29390324054767225	578	NA	NA	0.014232620794713107	815	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
MEGF8	multiple EGF like domains 8			ENSG00000105429	Q7Z7M0	NA	1	ligand, receptor	cell_surface, intracellular, ligand, plasma_membrane_transmembrane, receptor, secreted, transmembrane, transmembrane_predicted	NA	NA	NA	extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]	calcium ion binding [GO:0005509]	animal organ morphogenesis [GO:0009887]; BMP signaling pathway [GO:0030509]; cell migration involved in gastrulation [GO:0042074]; coronary vasculature development [GO:0060976]; craniofacial suture morphogenesis [GO:0097094]; determination of digestive tract left/right asymmetry [GO:0071907]; determination of heart left/right asymmetry [GO:0061371]; embryonic heart tube left/right pattern formation [GO:0060971]; embryonic heart tube morphogenesis [GO:0003143]; embryonic limb morphogenesis [GO:0030326]; embryonic skeletal system morphogenesis [GO:0048704]; epiboly involved in gastrulation with mouth forming second [GO:0055113]; fasciculation of sensory neuron axon [GO:0097155]; left/right pattern formation [GO:0060972]; limb morphogenesis [GO:0035108]; negative regulation of smoothened signaling pathway [GO:0045879]; positive regulation of axon extension involved in axon guidance [GO:0048842]; regulation of gene expression [GO:0010468]; tissue development [GO:0009888]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=MEGF8&keywords=MEGF8	8.619581158472315	250	NA	NA	0.49226260519162174	386	0.031496062992125984	0.06536926147704583	0.026548672566371695	0.04556354916067145	0.02188552188552188	0.06768189509306263	0.06527651858567533	0.0652528548123981	0.03995560488346281	0.046935505407933	0.029244736333784164	183	148	185	0.04592819847255026	0.8932096196157862	1.0180107166490824	0.7016985600393619	190	124	236
MEGF9	multiple EGF like domains 9			ENSG00000106780	Q9H1U4	NA	1	ecm, ligand	cell_surface, ecm, ligand, plasma_membrane_transmembrane, secreted, transmembrane, transmembrane_predicted	NA	NA	NA	basement membrane [GO:0005604]; integral component of membrane [GO:0016021]	NA	animal organ morphogenesis [GO:0009887]; cell migration [GO:0016477]; substrate adhesion-dependent cell spreading [GO:0034446]; tissue development [GO:0009888]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=MEGF9&keywords=MEGF9	21.45425168539326	163	NA	NA	1.288945964736796	226	0.023622047244094488	0.0693612774451097	0.02212389380530974	0.039808153477218215	0.09259259259259267	0.2927241962774958	0.25838621940163115	0.12071778140293656	0.13725490196078377	0.15990118840966216	0.06953834266949771	98	89	132	0.116911872244212	1.1602925664623907	1.3387336062833222	0.6267210566119843	97	71	273
MEPE	matrix extracellular phosphoglycoprotein	No		ENSG00000152595	Q9NQ76	PF07175/osteoregulin family	6	ecm, ligand	ecm, extracellular, intracellular, ligand, secreted	P78562	PHEX	PHEX [CellTalkDB:15664000;Cellinker:15664000;LRdb:15664000;Ramilowski2015:15664000;connectomeDB2020:15664000;talklr:15664000]	endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]	extracellular matrix protein binding [GO:1990430]; extracellular matrix structural constituent [GO:0005201]	biomineral tissue development [GO:0031214]; skeletal system development [GO:0001501]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=MEPE&keywords=MEPE	0.03869926330804494	754	NA	NA	0.19959010008067338	534	0	0	0.0011061946902654867	0	0	0	0	0.0016313213703099511	7.399186089530152e-4	3.0044064628121254e-4	0.0010044427274483294	301	399	367	4.347561857507268e-4	1.0292448062772186	0.9871280615398633	1.054595098491668	127	136	87
METRN	meteorin, glial cell differentiation regulator	Yes		ENSG00000103260	Q9UJH8	Meteorin family	2	ligand	extracellular, intracellular, ligand, secreted	NA	NA	NA	extracellular space [GO:0005615]	hormone activity [GO:0005179]	glial cell differentiation [GO:0010001]; positive regulation of axonogenesis [GO:0050772]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=METRN&keywords=METRN	3.4938058525779776	321	3082.55	113	0.12927966224555462	591	0.015748031496062992	0.450598802395215	0.045353982300885	0.14964028776978486	0.17508417508417512	1.5752961082910295	1.4632819582955658	0.3507340946166396	0.49722530521642955	1.156529576712707	0.10620050222135999	38	27	108	0.5441538931272595	0.9153148818534909	2.105064299250204	0.20968995014291986	177	19	417
METRNL	meteorin like, glial cell differentiation regulator	Yes		ENSG00000275031, ENSG00000176845	Q641Q3	Meteorin family	2	ligand	extracellular, ligand, secreted	NA	NA	NA	extracellular exosome [GO:0070062]; extracellular space [GO:0005615]	hormone activity [GO:0005179]	brown fat cell differentiation [GO:0050873]; energy homeostasis [GO:0097009]; fat cell differentiation [GO:0045444]; negative regulation of inflammatory response [GO:0050728]; positive regulation of brown fat cell differentiation [GO:0090336]; response to cold [GO:0009409]; response to muscle activity [GO:0014850]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=METRNL&keywords=METRNL	2.1369831273556192	381	NA	NA	0.05444004631718204	702	0.1732283464566929	0.07884231536926138	0.028761061946902672	0.055155875299760175	0.06902356902356903	0.00676818950930626	0.013599274705349048	0.0032626427406199023	0.0011098779134295228	0.008445720389905174	0.0056016998261541485	300	253	284	0.04034532483463184	0.22067347762521924	0.36638397806536	0.30989371659435516	426	355	391
MFAP2	microfibril associated protein 2	No		ENSG00000117122	P55001	MFAP family	8	ecm, ligand	ecm, extracellular, ligand, secreted	P46531	NOTCH1	NOTCH1 [Baccin2019:18417156;CellTalkDB:16492672;Cellinker:16492672;LRdb:16492672;Ramilowski2015:16492672;SignaLink3:16492672;SignaLink3:23331499;talklr:16492672]	collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; microfibril [GO:0001527]	NA	embryonic eye morphogenesis [GO:0048048]; positive regulation of cold-induced thermogenesis [GO:0120162]; post-embryonic eye morphogenesis [GO:0048050]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=MFAP2&keywords=MFAP2	2.696636016137274	353	NA	NA	0.2800354623471231	478	0	9.98003992015968e-4	0.02433628318584071	0.0661870503597123	0.006734006734006734	0	0	0.0016313213703099511	7.399186089530152e-4	2.00293764187475e-4	4.6358895112999797e-4	301	403	387	0.00920822426965056	0.5591312584746491	0.5310378315555266	0.5447452510049412	322	306	306
MFGE8	milk fat globule EGF and factor V/VIII domain containing	No		ENSG00000140545	Q08431	NA	9	ecm, ligand	ecm, extracellular, intracellular, ligand, secreted	P05106, P06756, P09619, P18084	ITGAV, ITGAV_ITGB3, ITGAV_ITGB5, ITGB3, ITGB5, PDGFRB	ITGB3 [CellTalkDB:24441829;Cellinker:24441829;LRdb:24441829;Ramilowski2015:24441829;connectomeDB2020:24441829;talklr:24441829], ITGAV [Cellinker:24441829;LRdb:24441829;Ramilowski2015:24441829;connectomeDB2020:24441829;talklr:24441829], PDGFRB [CellTalkDB:21868707;Cellinker:21868707;LRdb:21868707;Ramilowski2015:21868707;connectomeDB2020:21868707;talklr:21868707], ITGB5 [Cellinker:24441829]	acrosomal membrane [GO:0002080]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular vesicle [GO:1903561]; extrinsic component of plasma membrane [GO:0019897]; membrane [GO:0016020]	integrin binding [GO:0005178]; phosphatidylethanolamine binding [GO:0008429]; phosphatidylserine binding [GO:0001786]	angiogenesis [GO:0001525]; apoptotic cell clearance [GO:0043277]; cell adhesion [GO:0007155]; phagocytosis, engulfment [GO:0006911]; phagocytosis, recognition [GO:0006910]; positive regulation of phagocytosis [GO:0050766]; single fertilization [GO:0007338]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=MFGE8&keywords=MFGE8	26.224058517580254	147	1607.94	143	0.15978533456829122	568	0.015748031496062992	0.010479041916167662	0.09292035398230099	1.196163069544356	0.013468013468013466	0.00338409475465313	0.005439709882139619	0	0.004069552349241584	0.004339698224061949	0.003592814371257488	290	298	307	0.12269130727165953	0.10603220842821998	0.10806810573283612	0.10243937339036728	475	465	473
MIA	MIA SH3 domain containing	TBD		ENSG00000261857	Q16674	MIA/OTOR family	11	ligand	extracellular, ligand, secreted	P05556, P08648, P13612, Q9H159, Q9ULB5	CDH19, CDH7, ITGA4, ITGA5, ITGB1	CDH7 [CellTalkDB:19200257;Cellinker:19200257;LRdb:19200257;Ramilowski2015:19200257;connectomeDB2020:19200257;talklr:19200257], CDH19 [NA], ITGB1 [Cellinker:19200257], ITGA5 [Cellinker:19200257], ITGA4 [Cellinker:19200257]	extracellular space [GO:0005615]	growth factor activity [GO:0008083]	extracellular matrix organization [GO:0030198]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=MIA&keywords=MIA	0.7251464654738572	492	NA	NA	0.13142506719025365	590	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
MICA	MHC class I polypeptide-related sequence A			ENSG00000233051, ENSG00000231225, ENSG00000235233, ENSG00000183214, ENSG00000204520	Q29983	MHC class I family, MIC subfamily	4	adhesion, cell_surface_ligand, ligand	adhesion, cell_adhesion, cell_surface, cell_surface_ligand, extracellular, intracellular, ligand, plasma_membrane, plasma_membrane_transmembrane, secreted, transmembrane	P26718, Q9UBK5	HCST, HCST_KLRK1, KLRK1	KLRK1 [CellTalkDB:11491531;Cellinker:23679194;HPRD:10426993;HPRD:12902493;ICELLNET:11955595;IntAct:11323699;IntAct:21712812;LRdb:11491531;Lit-BM-17:11323699;Lit-BM-17:21712812;connectomeDB2020:10426993;connectomeDB2020:26041808], HCST [Cellinker:11513139]	cell surface [GO:0009986]; cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	natural killer cell lectin-like receptor binding [GO:0046703]	cellular response to DNA damage stimulus [GO:0006974]; cytolysis [GO:0019835]; defense response to bacterium [GO:0042742]; defense response to virus [GO:0051607]; gamma-delta T cell activation [GO:0046629]; immune response to tumor cell [GO:0002418]; natural killer cell mediated cytotoxicity [GO:0042267]; negative regulation of natural killer cell activation [GO:0032815]; negative regulation of natural killer cell mediated cytotoxicity [GO:0045953]; response to heat [GO:0009408]; T cell mediated cytotoxicity [GO:0001913]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=MICA&keywords=MICA	7.926657358643006	261	NA	NA	0.30039648651539863	466	0.12598425196850394	0.12325349301397191	0.18805309734513298	0.2580335731414867	0.2508417508417507	0.00338409475465313	0.001813236627379873	0.004893964110929854	0.0022197558268590455	0.0020029376418747476	0.0017770909793316605	297	344	338	0.08747793147744314	0.1253592032745048	0.12313492356628727	0.12081802312410515	466	459	462
MICB	MHC class I polypeptide-related sequence B	No		ENSG00000231179, ENSG00000238289, ENSG00000234218, ENSG00000224378, ENSG00000227772, ENSG00000231372, ENSG00000206449, ENSG00000204516	Q29980	MHC class I family, MIC subfamily	4	adhesion, cell_surface_ligand, ligand, receptor	adhesion, cell_adhesion, cell_surface, cell_surface_ligand, extracellular, intracellular, ligand, plasma_membrane, plasma_membrane_transmembrane, receptor, secreted, transmembrane	P26718, Q9UBK5	HCST, HCST_KLRK1, KLRK1	KLRK1 [CellTalkDB:11491531;HPRD:12902493;ICELLNET:11955595;LRdb:11491531;connectomeDB2020:19329438;connectomeDB2020:26041808], HCST [Cellinker:11513139]	cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	natural killer cell lectin-like receptor binding [GO:0046703]	adaptive immune response [GO:0002250]; cytolysis [GO:0019835]; gamma-delta T cell activation [GO:0046629]; immune response-activating cell surface receptor signaling pathway [GO:0002429]; negative regulation of defense response to virus by host [GO:0050689]; response to heat [GO:0009408]; response to oxidative stress [GO:0006979]; response to retinoic acid [GO:0032526]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=MICB&keywords=MICB	0.36439440184949345	555	NA	NA	0.1028362315538167	628	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
MIF	macrophage migration inhibitory factor	Yes		ENSG00000276701, ENSG00000240972	P14174	MIF family	8	ligand, receptor	extracellular, intracellular, ligand, receptor, secreted	P00441, P00533, P04233, P16070, P25025, P25106, P61073, Q92956, Q9UBN6	ACKR3, CD44, CD44_CD74, CD74, CD74_CXCR2, CD74_CXCR4, CXCR2, CXCR4, EGFR, SOD1, TNFRSF10D, TNFRSF14	CD74 [HPRD:12782713;ICELLNET:12782713;SIGNOR:12782713;connectomeDB2020:12782713;connectomeDB2020:26039541], CXCR2 [CellTalkDB:18852457;ICELLNET:17435771;SIGNOR:17435771;connectomeDB2020:17435771], SOD1 [SIGNOR:29371591], CXCR4 [CellTalkDB:19665027;ICELLNET:17435771;SIGNOR:17435771;connectomeDB2020:17435771], CD44 [CellTalkDB:30682543], EGFR [CellTalkDB:26280537;Cellinker:26280537], ACKR3 [CellChatDB:26175090;Cellinker:26175090;Cellinker:29637711], TNFRSF14 [NA], TNFRSF10D [NA]	cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; secretory granule lumen [GO:0034774]; vesicle [GO:0031982]	chemoattractant activity [GO:0042056]; cytokine activity [GO:0005125]; cytokine receptor binding [GO:0005126]; dopachrome isomerase activity [GO:0004167]; identical protein binding [GO:0042802]; phenylpyruvate tautomerase activity [GO:0050178]; protease binding [GO:0002020]	carboxylic acid metabolic process [GO:0019752]; cell aging [GO:0007569]; cell surface receptor signaling pathway [GO:0007166]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell aging [GO:0090344]; negative regulation of cell migration [GO:0030336]; negative regulation of cellular protein metabolic process [GO:0032269]; negative regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043518]; negative regulation of gene expression [GO:0010629]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; negative regulation of macrophage chemotaxis [GO:0010760]; negative regulation of mature B cell apoptotic process [GO:0002906]; negative regulation of myeloid cell apoptotic process [GO:0033033]; positive regulation of arachidonic acid secretion [GO:0090238]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of chemokine (C-X-C motif) ligand 2 production [GO:2000343]; positive regulation of cytokine production [GO:0001819]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of lipopolysaccharide-mediated signaling pathway [GO:0031666]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of myeloid leukocyte cytokine production involved in immune response [GO:0061081]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphorylation [GO:0042327]; positive regulation of prostaglandin secretion involved in immune response [GO:0061078]; positive regulation of protein kinase A signaling [GO:0010739]; positive regulation of tumor necrosis factor production [GO:0032760]; prostaglandin biosynthetic process [GO:0001516]; protein homotrimerization [GO:0070207]; regulation of macrophage activation [GO:0043030]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=MIF&keywords=MIF	41.96523325957304	102	704583	1	8.87715344682561	50	0.2598425196850392	0.874750499001986	0.2997787610619463	1.0371702637889892	1.6026936026936125	1.038917089678508	0.9818676337262147	0.877650897226757	0.7624861265260772	0.8551208439046295	0.7841607108363479	29	33	29	0.8522217225572825	0.8959251504763108	1.0033623849544737	0.9210632138574856	185	129	132
MLN	motilin	Yes		ENSG00000096395	P12872	Motilin family	12	ligand	extracellular, ligand, secreted	O43193	MLNR	MLNR [CellTalkDB:10381885;Cellinker:10381885;Cellinker:11259768;Cellinker:11461914;Cellinker:11781320;Cellinker:12054506;Cellinker:15677347;Cellinker:16531413;Guide2Pharma:11461914;Guide2Pharma:11781320;Guide2Pharma:15677347;Guide2Pharma:16531413;HPMR:10381885;HPRD:10381885;HPRD:11259768;HPRD:11461914;HPRD:12054506;LRdb:10381885;LRdb:11259768;LRdb:11461914;LRdb:11781320;LRdb:12054506;LRdb:15677347;LRdb:16531413;SIGNOR:10381885;connectomeDB2020:10381885;connectomeDB2020:11259768;connectomeDB2020:11461914;connectomeDB2020:11781320;connectomeDB2020:12054506;connectomeDB2020:15677347;connectomeDB2020:16531413;scConnect:11461914;scConnect:11781320;scConnect:15677347;scConnect:16531413]	extracellular region [GO:0005576]	hormone activity [GO:0005179]; motilin receptor binding [GO:0031788]	NA	https://www.genecards.org/cgi-bin/carddisp.pl?gene=MLN&keywords=MLN	0.0372011011235955	758	NA	NA	1.3272177595350583	221	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
MMRN2	multimerin 2	No		ENSG00000173269	Q9H8L6	NA	1	ecm, ligand	ecm, extracellular, intracellular, ligand, secreted	Q86T13, Q9HCU0, Q9NPY3	CD248, CD93, CLEC14A	CD248 [connectomeDB2020:28671670], CD93 [connectomeDB2020:28671670], CLEC14A [connectomeDB2020:28671670]	basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]	NA	cell migration involved in sprouting angiogenesis [GO:0002042]; negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:1903588]; negative regulation of cell migration [GO:0030336]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030948]; positive regulation of defense response to bacterium [GO:1900426]; positive regulation of epithelial tube formation [GO:1905278]; positive regulation of morphogenesis of an epithelium [GO:1905332]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=MMRN2&keywords=MMRN2	5.429547799778872	289	NA	NA	0.24584529795984733	498	0	9.98003992015968e-4	0.13606194690265502	0.016306954436450836	0	0	0.0027198549410698096	0	0	7.344104686874084e-4	0.0012748696156074954	303	382	353	0.01437236730513514	0.41030072601495093	0.4404336408644933	0.4626087189007666	373	334	340
MSMB	microseminoprotein beta	TBD		ENSG00000263639	P08118	Beta-microseminoprotein family	1	ligand	extracellular, intracellular, ligand, secreted	Q9Y2T6	GPR55	GPR55 [scConnect:31675498]	extracellular space [GO:0005615]; nucleus [GO:0005634]	NA	NA	https://www.genecards.org/cgi-bin/carddisp.pl?gene=MSMB&keywords=MSMB	3.481098388764045	322	NA	NA	0.04226379958569275	730	0	0.001497005988023952	0	0.001199040767386091	0.008417508417508417	0.016920473773265648	0.08250226654578421	0.0016313213703099511	0.06733259341472436	0.010415275737748676	0.19254394436932531	153	243	73	0.03476903912582515	1.7273677283396245	0.45601326578331824	4.524196818253516	43	332	3
MSMP	microseminoprotein, prostate associated	TBD		ENSG00000215183	Q1L6U9	Beta-microseminoprotein family	2	ligand	intracellular, ligand, secreted	P41597	CCR2	CCR2 [connectomeDB2020:28698550]	cytoplasm [GO:0005737]; extracellular space [GO:0005615]	CCR2 chemokine receptor binding [GO:0031727]; cytokine activity [GO:0005125]	inflammatory response [GO:0006954]; lymphocyte chemotaxis [GO:0048247]; monocyte chemotaxis [GO:0002548]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=MSMP&keywords=MSMP	0.3060709878	575	NA	NA	NA	NA	0	0.00598802395209581	0.00663716814159292	0.0035971223021582727	0.00505050505050505	0.013536379018612519	0.008159564823209429	0.008156606851549756	0.04661487236403999	0.008479102683936424	0.004481359860923319	172	252	296	0.010063700458965772	2.8217562597601864	0.9210216590767909	0.7217691417662737	16	163	227
MST1	macrophage stimulating 1	Yes	manually added ensembl_gene_ID, hgnc_symbol, and description by searching the uniprot ID on genenames.org	ENSG00000173531	P26927	Peptidase S1 family, Plasminogen subfamily	15	ligand	extracellular, ligand, secreted	P06899, P33778, Q04912, Q13043, Q15208	H2BC11, H2BC3, MST1R, STK38, STK4	H2BC11 [SPIKE:18675384], MST1R [Baccin2019:8062829;Baccin2019:9045873;CellPhoneDB:23792360;CellTalkDB:8062829;Cellinker:8062829;Cellinker:9045873;DIP:9374547;HPMR:8062829;HPRD:9045873;IntAct:22087277;IntAct:25193665;LRdb:8062829;LRdb:905;Lit-BM-17:22087277;Lit-BM-17:25193665;Lit-BM-17:9374547;SIGNOR:8062829;SignaLink3:12764615;SignaLink3:23331499;connectomeDB2020:8062829;connectomeDB2020:9045873], H2BC3 [KEA:12757711;ProtMapper:21212262;SIGNOR:21212262;iPTMnet:12757711;iPTMnet:21212262], STK4 [KEA:11805089;KEA:12223493;ProtMapper:11805089;SIGNOR:11805089;iPTMnet:11805089], STK38 [ProtMapper:19062280;ProtMapper:28137909;iPTMnet:19062280;iPTMnet:19836237;iPTMnet:21730291]	collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	receptor tyrosine kinase binding [GO:0030971]; signaling receptor binding [GO:0005102]	histone H2A-S139 phosphorylation [GO:0035978]; negative regulation of gluconeogenesis [GO:0045721]; proteolysis [GO:0006508]; regulation of cAMP-dependent protein kinase activity [GO:2000479]; regulation of receptor signaling pathway via JAK-STAT [GO:0046425]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=MST1&keywords=MST1	2.5180176460931483	359	NA	NA	0.11618750073804404	608	0	0.003992015968063873	0	0.0026378896882493998	0.006734006734006734	0.01015228426395939	0.007252946509519492	0.0032626427406199023	0.0033296337402885685	0.005441313927093058	0.005678964651342482	294	285	283	0.004407427111194809	0.9251918220659414	1.0717606834252107	1.0882556982821499	167	117	80
MST1L	macrophage stimulating 1 like (pseudogene)		manually added ensembl_gene_ID, hgnc_symbol, and description by searching the uniprot ID on genenames.org	ENSG00000186715	Q2TV78	Peptidase S1 family, Plasminogen subfamily	1	ligand	ligand, secreted	NA	NA	NA	extracellular space [GO:0005615]	peptidase activity [GO:0008233]; receptor tyrosine kinase binding [GO:0030971]; signaling receptor binding [GO:0005102]	regulation of receptor signaling pathway via JAK-STAT [GO:0046425]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=MST1L&keywords=MST1L	4.250656508229352	311	NA	NA	1.4776893320777877	203	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
MSTN	myostatin	Yes		ENSG00000138379	O14793	TGF-beta family	15	ligand	extracellular, intracellular, ligand, secreted	Q13705	ACVR1B_ACVR2A, ACVR1B_ACVR2B, ACVR2A_TGFBR1, ACVR2B, ACVR2B_TGFBR1	ACVR2B [Baccin2019:11459935;CellTalkDB:11459935;HPRD:11459935;LRdb:11459935;Lit-BM-17:11459935;Lit-BM-17:23829672;SIGNOR:11459935;connectomeDB2020:11459935]	cytoplasm [GO:0005737]; extracellular space [GO:0005615]	cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]	cellular response to dexamethasone stimulus [GO:0071549]; muscle cell cellular homeostasis [GO:0046716]; muscle organ development [GO:0007517]; myoblast migration involved in skeletal muscle regeneration [GO:0014839]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of kinase activity [GO:0033673]; negative regulation of muscle hypertrophy [GO:0014741]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myoblast proliferation [GO:2000818]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of satellite cell differentiation [GO:1902725]; negative regulation of skeletal muscle satellite cell proliferation [GO:1902723]; negative regulation of skeletal muscle tissue growth [GO:0048632]; ovulation cycle process [GO:0022602]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of macrophage chemotaxis [GO:0010759]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of transcription, DNA-templated [GO:0045893]; response to electrical stimulus [GO:0051602]; response to estrogen [GO:0043627]; response to ethanol [GO:0045471]; response to gravity [GO:0009629]; response to heat [GO:0009408]; response to muscle activity [GO:0014850]; response to testosterone [GO:0033574]; skeletal muscle atrophy [GO:0014732]; SMAD protein signal transduction [GO:0060395]; transforming growth factor beta receptor signaling pathway [GO:0007179]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=MSTN&keywords=MSTN	0.06401279775280899	708	NA	NA	0.09239081170463623	642	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
MT-RNR2	mitochondrially encoded 16S rRNA		humanin protein; manually added ensembl_gene_ID, hgnc_symbol, and description by searching the uniprot ID on genenames.org	ENSG00000210082	Q8IVG9	Humanin family	3	ligand	intracellular, ligand, secreted	P08913, P25089, P25090, P48039, Q14831	ADRA2A, CNTFR_IL27RA_IL6ST, FPR2, FPR3, GRM7, MTNR1A	FPR2 [Guide2Pharma:15465011;scConnect:15465011], FPR3 [Guide2Pharma:15465011;scConnect:15465011], ADRA2A [NA], GRM7 [NA], MTNR1A [NA]	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; sperm flagellum [GO:0036126]; sperm midpiece [GO:0097225]	G protein-coupled receptor binding [GO:0001664]; identical protein binding [GO:0042802]; protein self-association [GO:0043621]; receptor antagonist activity [GO:0048019]; signaling receptor binding [GO:0005102]	apoptotic process [GO:0006915]; cellular iron ion homeostasis [GO:0006879]; cellular response to amyloid-beta [GO:1904646]; leukocyte chemotaxis [GO:0030595]; mitochondrion organization [GO:0007005]; negative regulation of amyloid fibril formation [GO:1905907]; negative regulation of apoptotic process [GO:0043066]; negative regulation of execution phase of apoptosis [GO:1900118]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interleukin-18 production [GO:0032701]; negative regulation of interleukin-1 production [GO:0032692]; negative regulation of neuroinflammatory response [GO:0150079]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron death [GO:1901215]; negative regulation of NLRP3 inflammasome complex assembly [GO:1900226]; negative regulation of response to oxidative stress [GO:1902883]; supramolecular fiber organization [GO:0097435]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=MT-RNR2&keywords=MT-RNR2	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
MUC1	mucin 1, cell surface associated	No	manually added ensembl_gene_ID, hgnc_symbol, and description by searching the uniprot ID on genenames.org	ENSG00000185499	P15941	NA	1	adhesion, ecm, ligand, receptor	adhesion, cell_adhesion, cell_surface, ecm, extracellular, intracellular, ligand, plasma_membrane, plasma_membrane_transmembrane, receptor, secreted, transmembrane, transmembrane_predicted	P00519, P12931, P17931, P45983, P62993, Q9Y336	ABL1, GRB2, LGALS3, MAPK8, SIGLEC9, SRC	ABL1 [DOMINO:16888623;HPRD:16888623;IntAct:16888623;ProtMapper:19556858], MAPK8 [SignaLink3:24055030], SRC [BioGRID:21798038;HPRD:11152665;HPRD:11483589;IntAct:11152665;IntAct:11483589;IntAct:21798038], SIGLEC9 [connectomeDB2020:27595232], LGALS3 [InnateDB:17090543;InnateDB:19556244], GRB2 [HPRD:7664271;Lit-BM-17:20936779;Lit-BM-17:7664271]	apical plasma membrane [GO:0016324]; chromatin [GO:0000785]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; integral component of plasma membrane [GO:0005887]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; vesicle [GO:0031982]	p53 binding [GO:0002039]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription coregulator activity [GO:0003712]	DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:0006978]; negative regulation of cell adhesion mediated by integrin [GO:0033629]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; negative regulation of transcription by competitive promoter binding [GO:0010944]; positive regulation of histone H4 acetylation [GO:0090240]; positive regulation of transcription from RNA polymerase II promoter in response to stress [GO:0036003]; regulation of transcription from RNA polymerase II promoter in response to stress [GO:0043618]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=MUC1&keywords=MUC1	52.43565746809569	82	5950.8	88	1.8929849919373885	169	0	0.2949101796407204	0.00331858407079646	0.0052757793764987996	1.139730639730644	0.02538071065989847	0.022665457842248413	0.0407830342577488	0.04402515723270441	0.005341167044999322	0.023952095808383266	175	286	198	0.1459438914240584	0.34643971456242384	0.09837619739321542	0.21771994720881557	392	470	414
MXRA5	matrix remodeling associated 5	No		ENSG00000101825	Q9NR99	NA	1	ecm, ligand	ecm, ligand, secreted	O60939, O75121, O95866, P20916, P30530, P41217, Q07108, Q15109, Q86SU0, Q9BZZ2, Q9NYZ4, Q9UKJ0, Q9UKJ1, Q9Y286	AGER, AXL, CD200, CD69, ILDR1, MAG, MFAP3L, MPIG6B, PILRA, PILRB, SCN2B, SIGLEC1, SIGLEC7, SIGLEC8	ILDR1 [Cellinker:32822567], CD200 [Cellinker:32822567], SCN2B [Cellinker:32822567], MAG [Cellinker:32822567], PILRB [Cellinker:32822567], PILRA [Cellinker:32822567], SIGLEC1 [Cellinker:32822567], CD69 [Cellinker:32589946], MPIG6B [Cellinker:32822567], AGER [Cellinker:32822567], MFAP3L [Cellinker:32822567], AXL [Cellinker:32822567], SIGLEC7 [Cellinker:32822567], SIGLEC8 [Cellinker:32822567]	collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]	extracellular matrix structural constituent [GO:0005201]	response to transforming growth factor beta [GO:0071559]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=MXRA5&keywords=MXRA5	7.958116426966292	260	NA	NA	1.8508171073954196	173	0	0.0074850299401197605	0.004424778761061947	0.01294964028776978	0.10101010101010106	0	0	0	0	0	3.8632412594166507e-5	303	409	400	0.011446198401058793	0.46628310589098637	0.46628310589098637	0.46808447002423337	355	328	339
MYL9	myosin light chain 9			ENSG00000101335	P24844	NA	1	ligand	intracellular, ligand, secreted	Q07108	CD69	CD69 [connectomeDB2020:28783682]	cell cortex [GO:0005938]; cytosol [GO:0005829]; muscle myosin complex [GO:0005859]; stress fiber [GO:0001725]; Z disc [GO:0030018]	calcium ion binding [GO:0005509]; myosin heavy chain binding [GO:0032036]; structural constituent of muscle [GO:0008307]	platelet aggregation [GO:0070527]; regulation of muscle contraction [GO:0006937]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=MYL9&keywords=MYL9	13.920276741573034	200	2534.76	123	0.013508775896051437	819	0.03937007874015748	0.6087824351297405	0.017699115044247787	0.9242206235012156	0.06060606060606059	0.040609137055837574	0.07434270172257469	0.06688417618270803	0.0399556048834628	0.016591000133529137	0.1296890090786131	184	212	95	0.1835227220071043	0.2581381884532862	0.13740505434061107	0.7218222626771706	415	450	226
MYOC	myocilin	No		ENSG00000034971	Q99972	NA	7	ecm, ligand	ecm, extracellular, intracellular, ligand, secreted	O75084, Q9NPG1, Q9ULV1, Q9ULW2, Q9UP38	FZD1, FZD10, FZD3, FZD4, FZD7	FZD1 [Baccin2019:19188438;Cellinker:19188438;LRdb:19188438;Ramilowski2015:19188438;connectomeDB2020:19188438;talklr:19188438], FZD10 [Baccin2019:19188438;Cellinker:19188438;LRdb:19188438;Ramilowski2015:19188438;connectomeDB2020:19188438;talklr:19188438], FZD3 [Baccin2019:19188438;Cellinker:19188438;LRdb:19188438;Ramilowski2015:19188438;connectomeDB2020:19188438;talklr:19188438], FZD4 [Baccin2019:19188438;Cellinker:19188438;LRdb:19188438;Ramilowski2015:19188438;connectomeDB2020:19188438;talklr:19188438], FZD7 [Baccin2019:19188438;Cellinker:19188438;LRdb:19188438;Ramilowski2015:19188438;connectomeDB2020:19188438;talklr:19188438]	cilium [GO:0005929]; collagen-containing extracellular matrix [GO:0062023]; cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrial outer membrane [GO:0005741]; node of Ranvier [GO:0033268]; rough endoplasmic reticulum [GO:0005791]	fibronectin binding [GO:0001968]; frizzled binding [GO:0005109]; metal ion binding [GO:0046872]; myosin light chain binding [GO:0032027]; receptor tyrosine kinase binding [GO:0030971]	bone development [GO:0060348]; clustering of voltage-gated sodium channels [GO:0045162]; ERBB2-ERBB3 signaling pathway [GO:0038133]; myelination in peripheral nervous system [GO:0022011]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of stress fiber assembly [GO:0051497]; neuron projection development [GO:0031175]; non-canonical Wnt signaling pathway via JNK cascade [GO:0038031]; osteoblast differentiation [GO:0001649]; positive regulation of cell migration [GO:0030335]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of mitochondrial depolarization [GO:0051901]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; regulation of MAPK cascade [GO:0043408]; skeletal muscle hypertrophy [GO:0014734]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=MYOC&keywords=MYOC	0.02197439438202247	787	NA	NA	0.0012883368180034408	895	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NBL1	NBL1, DAN family BMP antagonist	Yes		ENSG00000158747	P41271	DAN family	2	ligand	extracellular, intracellular, ligand, ligand_regulator, secreted	NA	NA	NA	extracellular space [GO:0005615]	BMP binding [GO:0036122]; identical protein binding [GO:0042802]; morphogen activity [GO:0016015]; receptor ligand activity [GO:0048018]	animal organ morphogenesis [GO:0009887]; determination of dorsal identity [GO:0048263]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of monocyte chemotaxis [GO:0090027]; nervous system development [GO:0007399]; neuron projection morphogenesis [GO:0048812]; positive regulation of neuron differentiation [GO:0045666]; sequestering of BMP from receptor via BMP binding [GO:0038098]; sequestering of BMP in extracellular matrix [GO:0035582]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=NBL1&keywords=NBL1	62.41268783876325	70	NA	NA	0.4054529399502256	412	0.007874015748031496	0.3517964071856327	0.04646017699115049	0.832613908872917	0.03872053872053871	0.10152284263959384	0.15412511332728882	0.3947797716150084	0.07103218645948944	0.05397916944852624	0.10917519799111002	148	139	107	0.19655266627266246	0.39230762750126824	0.30974748766529947	0.5769724503763668	381	374	297
NCAM1	neural cell adhesion molecule 1	No		ENSG00000149294	P13591	NA	3	adhesion, cell_surface_ligand	adhesion, cell_adhesion, cell_surface, cell_surface_ligand, extracellular, intracellular, peripheral, plasma_membrane, plasma_membrane_peripheral, plasma_membrane_transmembrane, secreted, transmembrane, transmembrane_predicted	O15394, P0C7M8, P11362, P18433, P21802, P23471, P32004, P56159, Q12860, Q13332, Q13936, Q6UXK2, Q86T13, Q96MS0, Q9Y6N7	CACNA1C, CLEC14A, CLEC2L, CNTN1, FGFR1, FGFR2, GFRA1, ISLR2, L1CAM, NCAM2, PTPRA, PTPRS, PTPRZ1, ROBO1, ROBO3	CACNA1C [CellTalkDB:32196115], GFRA1 [CellTalkDB:12837245;Cellinker:12837245;HPRD:12837245;LRdb:12837245;connectomeDB2020:12837245], PTPRA [CellTalkDB:32196115], FGFR1 [Baccin2019:12121226;BioGRID:12121226;BioGRID:12791257;CellChatDB:12791257;CellTalkDB:12121226;Cellinker:12121226;Cellinker:12791257;HPRD:12121226;LRdb:12121226;connectomeDB2020:12121226], FGFR2 [Baccin2019:21710437;CellTalkDB:12121226], ROBO1 [Baccin2019:16226035;CellTalkDB:16226035;Cellinker:16226035;HPMR:16226035;LRdb:16226035;connectomeDB2020:16226035], NCAM2 [NA], L1CAM [HPRD:10611478;HPRD:8509458], PTPRZ1 [Baccin2019:9117260;connectomeDB2020:9117260], ROBO3 [Baccin2019:16226035;Cellinker:16226035;HPMR:16226035;LRdb:16226035;connectomeDB2020:16226035], PTPRS [Cellinker:32589946], CNTN1 [Cellinker:7595520], ISLR2 [Cellinker:32589946], CLEC2L [Cellinker:32589946], CLEC14A [Cellinker:32589946]	anchored component of membrane [GO:0031225]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; cytosol [GO:0005829]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]	virus receptor activity [GO:0001618]	cell adhesion [GO:0007155]; commissural neuron axon guidance [GO:0071679]; regulation of semaphorin-plexin signaling pathway [GO:2001260]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=NCAM1&keywords=NCAM1	14.232144734372586	196	8576.01	76	0.5199753527124397	377	0.015748031496062992	0.11626746506986015	0.00331858407079646	0.010791366906474817	0.02861952861952861	0.5245346869712366	0.3907524932003615	0.23164763458401266	0.3607103218645972	0.1978568567231848	0.2703109909213689	54	77	59	0.19550526912977134	1.8038969192099066	1.0114429552262647	1.36400877752852	40	127	44
NDP	norrin cystine knot growth factor NDP	Yes		ENSG00000124479	Q00604	NA	11	ligand, receptor	extracellular, intracellular, ligand, receptor, secreted	O75197, Q9BXB1, Q9ULV1	FZD4, LGR4, LRP5	FZD4 [Baccin2019:15035989;BioGRID:17955262;CellTalkDB:15035989;Cellinker:15035989;InnateDB:21856951;LRdb:15035989;SignaLink3:21856951;SignaLink3:23180781;SignaLink3:24186977;connectomeDB2020:15035989], LRP5 [SignaLink3:24186977], LGR4 [Baccin2019:23444378;CellTalkDB:23444378;Cellinker:23444378;LRdb:23444378;connectomeDB2020:23444378]	cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]	cytokine activity [GO:0005125]; frizzled binding [GO:0005109]; protein homodimerization activity [GO:0042803]	decidualization [GO:0046697]; extracellular matrix-cell signaling [GO:0035426]; nervous system development [GO:0007399]; Norrin signaling pathway [GO:0110135]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of transcription, DNA-templated [GO:0045893]; retina vasculature morphogenesis in camera-type eye [GO:0061299]; vacuole organization [GO:0007033]; visual perception [GO:0007601]; Wnt signaling pathway [GO:0016055]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=NDP&keywords=NDP	0.26632593370786517	589	NA	NA	0.033160603675218336	760	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NECTIN1	nectin cell adhesion molecule 1	No		ENSG00000110400	Q15223	Nectin family	2	adhesion, cell_surface_ligand, receptor	adhesion, cell_adhesion, cell_surface, cell_surface_ligand, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, secreted, tight_junction, transmembrane, transmembrane_predicted	P11362, P40200, Q8N126, Q8TEW0, Q96NY8, Q9NQS3	CADM3, CD96, FGFR1, NECTIN3, NECTIN4, PARD3	CD96 [CellChatDB:23027581;CellPhoneDB:17971293;Cellinker:17971293;Cellinker:23027581;Cellinker:30759143;ICELLNET:26927206;connectomeDB2020:17971293;connectomeDB2020:30759143], CADM3 [CellChatDB:23027581;Cellinker:23027581;connectomeDB2020:15741237], NECTIN4 [CellChatDB:23027581;Cellinker:11544254;Cellinker:23027581;DIP:22902367;HPMR:12011057;HPRD:12011057;IntAct:12011057;IntAct:21982860;IntAct:22902367;Lit-BM-17:12011057;Lit-BM-17:21982860;connectomeDB2020:11544254], NECTIN3 [DIP:22902367;HPRD:12011057;LRdb:12740392;Lit-BM-17:12011057;Lit-BM-17:21982860;Lit-BM-17:26186194;connectomeDB2020:11544254;connectomeDB2020:12740392], FGFR1 [Cellinker:22955284], PARD3 [HPRD:12515806]	adherens junction [GO:0005912]; apical junction complex [GO:0043296]; cell-cell contact zone [GO:0044291]; dendrite [GO:0030425]; extracellular region [GO:0005576]; growth cone membrane [GO:0032584]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; integral component of membrane [GO:0016021]; integral component of presynaptic active zone membrane [GO:0099059]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; plasma membrane [GO:0005886]	carbohydrate binding [GO:0030246]; cell adhesion molecule binding [GO:0050839]; coreceptor activity [GO:0015026]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; protein homodimerization activity [GO:0042803]; virion binding [GO:0046790]; virus receptor activity [GO:0001618]	axon guidance [GO:0007411]; cell adhesion [GO:0007155]; cell-cell adhesion [GO:0098609]; desmosome organization [GO:0002934]; enamel mineralization [GO:0070166]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; immune response [GO:0006955]; iron ion transport [GO:0006826]; lens morphogenesis in camera-type eye [GO:0002089]; protein localization to cell junction [GO:1902414]; regulation of synapse assembly [GO:0051963]; retina development in camera-type eye [GO:0060041]; viral entry into host cell [GO:0046718]; virion attachment to host cell [GO:0019062]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=NECTIN1&keywords=NECTIN1	20.34677104494382	168	3792.55	102	1.166476573670329	241	0	0.09481037924151685	0.014380530973451327	0.03453237410071942	0.07070707070707072	0.16751269035532979	0.15593834995466868	0.08809135399673747	0.10543840177580428	0.10462010949392385	0.057562294765306644	119	102	146	0.08123577776041173	1.2652755816796946	1.256306597121583	0.7405241279657586	78	85	219
NECTIN4	nectin cell adhesion molecule 4	No		ENSG00000143217	Q96NY8	Nectin family	3	adhesion, cell_surface_ligand, ligand, receptor	adherens_junction, adhesion, cell_adhesion, cell_surface, cell_surface_ligand, extracellular, intracellular, ligand, plasma_membrane, plasma_membrane_transmembrane, receptor, secreted, transmembrane, transmembrane_predicted	Q495A1	TIGIT	TIGIT [Cellinker:32589946;Lit-BM-17:21982860;connectomeDB2020:32503945]	adherens junction [GO:0005912]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	identical protein binding [GO:0042802]; virus receptor activity [GO:0001618]	heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=NECTIN4&keywords=NECTIN4	13.147108370786517	207	NA	NA	0.88056395065738	289	0.007874015748031496	0.12824351297405184	0	7.194244604316547e-4	0.10774410774410786	0	0	0	0	4.0058752837495007e-4	4.2495653853583153e-4	303	393	388	0.022309691363048514	0.3095046587611993	0.32190302938856746	0.3226572616059866	404	369	384
NELL2	neural EGFL like 2	TBD		ENSG00000184613	Q99435	NA	1	ecm, ligand	ecm, extracellular, intracellular, ligand, secreted	Q96MS0	ROBO3	ROBO3 [DIP:26586761;connectomeDB2020:26586761]	cytoplasm [GO:0005737]; extracellular region [GO:0005576]	calcium ion binding [GO:0005509]; heparin binding [GO:0008201]; protein kinase C binding [GO:0005080]	fertilization [GO:0009566]; neuron cellular homeostasis [GO:0070050]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=NELL2&keywords=NELL2	1.808105469725787	394	NA	NA	0.2057415212994251	530	0	9.98003992015968e-4	0.0011061946902654867	0.0016786570743405273	0.0016835016835016834	0.018612521150592216	0.02901178603807797	0.004893964110929854	0.008509064002959678	0.02006275871277869	0.004906316399459151	271	199	290	0.00831479707772011	1.0106071022471712	1.641446453662866	0.8138947068975521	132	37	179
NENF	neudesin neurotrophic factor	TBD		ENSG00000117691	Q9UMX5	Cytochrome b5 family, MAPR subfamily	2	ligand	intracellular, ligand, secreted	NA	NA	NA	endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; membrane [GO:0016020]; mitochondrion [GO:0005739]	growth factor activity [GO:0008083]; metal ion binding [GO:0046872]	negative regulation of appetite [GO:0032099]; negative regulation of neuron death [GO:1901215]; positive regulation of MAPK cascade [GO:0043410]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=NENF&keywords=NENF	86.69023797912497	58	26302.1	39	1.0421862448516899	258	0.2125984251968504	0.4760479041916228	0.03318584070796462	0.24124700239808175	0.244107744107744	1.0473773265651443	1.5158658204895825	0.512234910277325	0.407695153533114	0.6895112832155067	0.4423411242031816	47	37	42	0.5292920486260106	0.7745249621189539	1.2970917798578654	0.838768391552667	231	76	171
NGF	nerve growth factor	Yes		ENSG00000134259	P01138	NGF-beta family	20	ligand	extracellular, intracellular, ligand, secreted	P04626, P04629, P08138, Q00994, Q8NER1, Q96PQ0, Q99523, Q9ULH0, Q9UPU3, Q9Y5V3	BEX3, ERBB2, KIDINS220, MAGED1, NGFR, NTRK1, SORCS2, SORCS3, SORT1, TRPV1	NTRK1 [AlzPathway:17404842;AlzPathway:9775403;Baccin2019:10490030;Baccin2019:14985763;BioGRID:10490030;CA1:1706478;CA1:9290260;CA1:9547236;CellChatDB:27908981;CellTalkDB:10490030;Cellinker:10490030;Cellinker:14985763;Cellinker:24224055;Cellinker:27908981;DIP:10490030;DIP:10713102;DIP:1849459;DIP:9083066;DIP:9857023;HPMR:10490030;HPRD:10490030;HPRD:14985763;IntAct:10490030;IntAct:14985763;LRdb:10490030;LRdb:15;Lit-BM-17:10490030;Lit-BM-17:10713102;Lit-BM-17:11729324;Lit-BM-17:11738045;Lit-BM-17:14985763;Lit-BM-17:1849459;Lit-BM-17:9083066;Lit-BM-17:9857023;ProtMapper:12067229;ProtMapper:17409494;ProtMapper:22666365;ProtMapper:23772401;ProtMapper:25611061;ProtMapper:27229480;ProtMapper:28090201;SIGNOR:11114882;SPIKE:14985763;SPIKE:17145710;SPIKE:8155326;connectomeDB2020:10490030;connectomeDB2020:14985763], NGFR [AlzPathway:16893414;AlzPathway:9775403;Baccin2019:11114882;Baccin2019:14985763;CellTalkDB:11114882;Cellinker:11114882;Cellinker:14985763;Cellinker:24224055;DIP:1372492;DIP:1714587;DIP:2172988;DIP:3037029;Guide2Pharma:22227462;HPMR:11114882;HPRD:14985763;LRdb:11114882;LRdb:15;Lit-BM-17:11729324;Lit-BM-17:1372492;Lit-BM-17:14985763;Lit-BM-17:1714587;Lit-BM-17:2172988;Lit-BM-17:3037029;SIGNOR:10764727;SIGNOR:14699954;connectomeDB2020:11114882;connectomeDB2020:14985763;scConnect:22227462], SORCS2 [CellTalkDB:30061605], TRPV1 [CellTalkDB:17074976], MAGED1 [CellTalkDB:32196115], BEX3 [CellTalkDB:32196115], SORCS3 [Baccin2019:15710408;CellTalkDB:15710408;Cellinker:15710408;HPRD:15710408;LRdb:15710408;connectomeDB2020:15710408], SORT1 [CellTalkDB:14985763;Cellinker:14985763;DIP:19122660;HPMR:14985763;HPRD:14985763;IntAct:14985763;IntAct:19122660;LRdb:14985763;Lit-BM-17:14985763;Lit-BM-17:19122660;connectomeDB2020:14985763], KIDINS220 [CellTalkDB:32196115], ERBB2 [Cellinker:12181354]	axon [GO:0030424]; cytosol [GO:0005829]; dendrite [GO:0030425]; endosome lumen [GO:0031904]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; synaptic vesicle [GO:0008021]	cysteine-type endopeptidase activator activity involved in apoptotic process [GO:0008656]; death receptor agonist activity [GO:0038177]; growth factor activity [GO:0008083]; lipid binding [GO:0008289]; metalloendopeptidase inhibitor activity [GO:0008191]; nerve growth factor receptor binding [GO:0005163]	activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; memory [GO:0007613]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of neuron apoptotic process [GO:0043524]; nerve development [GO:0021675]; nerve growth factor signaling pathway [GO:0038180]; neuron apoptotic process [GO:0051402]; neuron projection morphogenesis [GO:0048812]; peripheral nervous system development [GO:0007422]; positive regulation of collateral sprouting [GO:0048672]; positive regulation of DNA binding [GO:0043388]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of Ras protein signal transduction [GO:0046579]; regulation of neuron differentiation [GO:0045664]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=NGF&keywords=NGF	1.5920866741573034	405	NA	NA	0.240891656339297	503	0	0.027445109780439098	0	0.051318944844124685	0.0016835016835016834	0.005076142131979695	0.0027198549410698096	0	7.399186089530152e-4	2.3367605821872085e-4	0.011898783079003212	301	401	241	0.009192357375208175	0.5595935089676038	0.5332162098772776	1.1410158038892644	320	305	69
NID1	nidogen 1	No		ENSG00000116962	P14543	NA	8	ecm, ligand	ecm, extracellular, ligand, secreted	P05106, P05556, P06756, P10586, P26006, Q5TAT6	COL13A1, ITGA3, ITGAV, ITGB1, ITGB3, PTPRF	ITGB1 [CellTalkDB:32196115], ITGB3 [CellTalkDB:8831898;Cellinker:8831898;Cellinker:9686320;HPRD:8831898;HPRD:9686320;LRdb:8831898;LRdb:969;connectomeDB2020:8831898;connectomeDB2020:9686320], COL13A1 [Baccin2019:11956183;CellTalkDB:11956183;HPRD:11956183;LRdb:11956183;connectomeDB2020:11956183], PTPRF [Baccin2019:9647658;CellTalkDB:9647658;Cellinker:9647658;LRdb:9647658;connectomeDB2020:9647658], ITGA3 [CellTalkDB:32196115], ITGAV [CellTalkDB:9686320;Cellinker:9686320;HPRD:9686320;LRdb:9686320;connectomeDB2020:9686320]	basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]	calcium ion binding [GO:0005509]; collagen binding [GO:0005518]; extracellular matrix structural constituent [GO:0005201]; laminin-1 binding [GO:0043237]; laminin binding [GO:0043236]; proteoglycan binding [GO:0043394]	basement membrane organization [GO:0071711]; cell-matrix adhesion [GO:0007160]; glomerular basement membrane development [GO:0032836]; positive regulation of cell-substrate adhesion [GO:0010811]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=NID1&keywords=NID1	25.536081635292962	150	10635.6	68	0.35404132924413384	441	0	0.005489021956087825	0.08738938053097355	0.4388489208633153	0.0101010101010101	0	0.003626473254759746	0	3.699593044765076e-4	6.676458806249168e-4	0.0013907668533899946	302	384	349	0.04980756170405799	0.17338876571811315	0.17836617271593447	0.19045696779538032	449	427	424
NID2	nidogen 2	No		ENSG00000087303	Q14112	NA	8	adhesion, ecm, ligand	adhesion, ecm, extracellular, ligand, matrix_adhesion, secreted	Q5TAT6	COL13A1	COL13A1 [Baccin2019:11956183;CellTalkDB:11956183;Cellinker:11956183;HPRD:11956183;LRdb:11956183;connectomeDB2020:11956183]	basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]	calcium ion binding [GO:0005509]; collagen binding [GO:0005518]; extracellular matrix structural constituent [GO:0005201]	basement membrane organization [GO:0071711]; cell adhesion [GO:0007155]; cell-matrix adhesion [GO:0007160]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=NID2&keywords=NID2	20.811060923033708	166	4730.45	93	2.1729301511092753	143	0.007874015748031496	9.98003992015968e-4	0.053097345132743404	0.19256594724220674	0.03198653198653198	0.001692047377326565	0.001813236627379873	0.0032626427406199023	3.699593044765076e-4	4.339698224061959e-4	5.794861889124976e-4	302	391	381	0.026788471469331922	0.2818806786555741	0.2836206399905551	0.28757612823712736	412	387	400
NLGN1	neuroligin 1		manually added ensembl_gene_ID, hgnc_symbol, and description by searching the uniprot ID on genenames.org	ENSG00000169760	Q8N2Q7	Type-B carboxylesterase/lipase family	6	adhesion, cell_surface_ligand, ligand, receptor	adhesion, cell_adhesion, cell_surface, cell_surface_ligand, extracellular, intracellular, ligand, plasma_membrane, plasma_membrane_transmembrane, receptor, secreted, transmembrane	P58400, P58401, P78352, Q9HDB5, Q9P2S2, Q9ULB1, Q9Y4C0	DLG4, NRXN1, NRXN2, NRXN3	DLG4 [BioGRID:30864948;CA1:9278515;DOMINO:11937501;HPRD:9278515;Lit-BM-17:11937501;Lit-BM-17:9278515;SIGNOR:18923512], NRXN2 [CellTalkDB:7736595;LRdb:7736595;Ramilowski2015:7736595;SIGNOR:18923512;connectomeDB2020:7736595;talklr:7736595], NRXN1 [Baccin2019:14522992;Baccin2019:8576240;BioGRID:12796785;BioGRID:14522992;BioGRID:8576240;CellTalkDB:8576240;Cellinker:14522992;Cellinker:8576240;HPRD:14522992;HPRD:8576240;LRdb:145;LRdb:8576240;SIGNOR:18923512;connectomeDB2020:14522992;connectomeDB2020:8576240], NRXN3 [Baccin2019:8576240;CellTalkDB:8576240;Cellinker:8576240;LRdb:8576240;SIGNOR:18923512;connectomeDB2020:8576240], NRXN1 [Baccin2019:14522992;Baccin2019:8576240;BioGRID:12796785;BioGRID:14522992;BioGRID:8576240;CellTalkDB:8576240;Cellinker:14522992;Cellinker:8576240;HPRD:14522992;HPRD:8576240;LRdb:145;LRdb:8576240;SIGNOR:18923512;connectomeDB2020:14522992;connectomeDB2020:8576240], NRXN2 [CellTalkDB:7736595;LRdb:7736595;Ramilowski2015:7736595;SIGNOR:18923512;connectomeDB2020:7736595;talklr:7736595], NRXN3 [Baccin2019:8576240;CellTalkDB:8576240;Cellinker:8576240;LRdb:8576240;SIGNOR:18923512;connectomeDB2020:8576240]	asymmetric, glutamatergic, excitatory synapse [GO:0098985]; cell surface [GO:0009986]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; excitatory synapse [GO:0060076]; external side of plasma membrane [GO:0009897]; filopodium tip [GO:0032433]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic membrane [GO:0099055]; integral component of postsynaptic specialization membrane [GO:0099060]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; receptor complex [GO:0043235]; spanning component of membrane [GO:0089717]; synapse [GO:0045202]; synaptic cleft [GO:0043083]	amyloid-beta binding [GO:0001540]; cell adhesion molecule binding [GO:0050839]; identical protein binding [GO:0042802]; neurexin family protein binding [GO:0042043]; PDZ domain binding [GO:0030165]; scaffold protein binding [GO:0097110]; signaling receptor activity [GO:0038023]	AMPA glutamate receptor clustering [GO:0097113]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cellular response to calcium ion [GO:0071277]; chemical synaptic transmission [GO:0007268]; cytoskeletal matrix organization at active zone [GO:0048789]; establishment of protein localization [GO:0045184]; excitatory synapse assembly [GO:1904861]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of dendritic spine morphogenesis [GO:0061002]; nervous system development [GO:0007399]; neurexin clustering involved in presynaptic membrane assembly [GO:0097115]; neuronal signal transduction [GO:0023041]; neuron cell-cell adhesion [GO:0007158]; neuron projection arborization [GO:0140058]; neuron projection development [GO:0031175]; NMDA glutamate receptor clustering [GO:0097114]; positive regulation of circadian sleep/wake cycle, wakefulness [GO:0010841]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of ruffle assembly [GO:1900029]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; positive regulation of synaptic vesicle clustering [GO:2000809]; positive regulation of synaptic vesicle endocytosis [GO:1900244]; positive regulation of synaptic vesicle exocytosis [GO:2000302]; postsynaptic density protein 95 clustering [GO:0097119]; postsynaptic membrane assembly [GO:0097104]; postsynaptic specialization assembly [GO:0098698]; presynapse assembly [GO:0099054]; presynaptic membrane assembly [GO:0097105]; protein localization to synapse [GO:0035418]; protein targeting [GO:0006605]; receptor localization to synapse [GO:0097120]; regulation of AMPA receptor activity [GO:2000311]; regulation of neuron differentiation [GO:0045664]; regulation of NMDA receptor activity [GO:2000310]; regulation of respiratory gaseous exchange by nervous system process [GO:0002087]; rhythmic process [GO:0048511]; synapse assembly [GO:0007416]; synaptic membrane adhesion [GO:0099560]; synaptic vesicle clustering [GO:0097091]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle targeting [GO:0016080]; terminal button organization [GO:0072553]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=NLGN1&keywords=NLGN1	5.791970321878652	282	NA	NA	4.181183170054627	87	0	0.0214570858283433	0	0.006954436450839326	0.011784511784511783	0.159052453468697	0.1622846781504982	0.10766721044045692	0.0732519422863484	0.09614100680998809	0.08897044620436219	147	109	121	0.06614216103854957	1.0933750914187905	1.3939846907713924	1.2998113640911113	112	65	49
NMB	neuromedin B	Yes		ENSG00000197696	P08949	Bombesin/neuromedin-B/ranatensin family	14	ligand	extracellular, intracellular, ligand, secreted	P28336, P30550, P32247	BRS3, GRPR, NMBR	NMBR [Baccin2019:10454496;Baccin2019:10544247;Baccin2019:15169928;Baccin2019:7838118;Baccin2019:8253343;Baccin2019:8392057;CellTalkDB:10544247;Cellinker:10454496;Cellinker:10544247;Cellinker:15169928;Cellinker:7838118;Cellinker:8253343;Cellinker:8392057;Guide2Pharma:18055507;Guide2Pharma:21729729;Guide2Pharma:25976083;HPMR:15169928;HPRD:10544247;HPRD:8253343;HPRD:8392057;LRdb:10454496;LRdb:10544247;LRdb:15169928;LRdb:7838118;LRdb:8253343;LRdb:8392057;SIGNOR:11313903;connectomeDB2020:10454496;connectomeDB2020:10544247;connectomeDB2020:15169928;connectomeDB2020:7838118;connectomeDB2020:8253343;connectomeDB2020:8392057;scConnect:18055507;scConnect:21729729;scConnect:25976083], GRPR [Baccin2019:10454496;Baccin2019:1720612;Baccin2019:19463875;Baccin2019:21729729;Baccin2019:7838118;CellTalkDB:10454496;Cellinker:10454496;Cellinker:1720612;Cellinker:19463875;Cellinker:21729729;Cellinker:7838118;Guide2Pharma:10454496;Guide2Pharma:7838118;LRdb:10454496;LRdb:1720612;LRdb:19463875;LRdb:21729729;LRdb:7838118;connectomeDB2020:10454496;connectomeDB2020:1720612;connectomeDB2020:19463875;connectomeDB2020:21729729;connectomeDB2020:7838118;scConnect:10454496;scConnect:19463875;scConnect:21729729;scConnect:7838118], BRS3 [LRdb:9920658;Ramilowski2015:9920658;connectomeDB2020:9920658;talklr:9920658]	extracellular region [GO:0005576]; neuron projection [GO:0043005]	hormone activity [GO:0005179]; neuromedin B receptor binding [GO:0031710]; neuropeptide hormone activity [GO:0005184]	arachidonic acid secretion [GO:0050482]; cell-cell signaling [GO:0007267]; glucose homeostasis [GO:0042593]; negative regulation of hormone secretion [GO:0046888]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of hormone secretion [GO:0046887]; signal transduction [GO:0007165]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=NMB&keywords=NMB	14.17494295505618	197	NA	NA	1.2174079073567814	237	0.5984251968503936	0.18263473053892315	0.033185840707964626	0.6249400479616375	0.08585858585858593	0.18443316412859542	0.23300090661831308	0.13050570962479618	0.10950795412504571	0.13252770730404367	0.12312149893760364	117	93	99	0.22164921296871842	0.5159005402758864	0.6152738680933503	0.5746684706223464	335	284	299
NMS	neuromedin S	Yes		ENSG00000204640	Q5H8A3	NmU family	12	ligand	ligand, secreted	P08913, P48039, Q14831, Q9GZQ4, Q9HB89	ADRA2A, GRM7, MTNR1A, NMUR1, NMUR2	NMUR1 [CellChatDB:29288685;CellTalkDB:15635449;Cellinker:15635449;Cellinker:29288685;Guide2Pharma:15635449;HPRD:15635449;LRdb:15635449;SIGNOR:15635449;connectomeDB2020:15635449;scConnect:15635449], NMUR2 [Baccin2019:1563544915635440;CellChatDB:29288685;CellTalkDB:15635449;Cellinker:15635449;Cellinker:29288685;Guide2Pharma:15635449;LRdb:15635449;SIGNOR:15635449;connectomeDB2020:15635449;scConnect:15635449], ADRA2A [CellTalkDB:32196115], MTNR1A [CellTalkDB:32196115], GRM7 [CellTalkDB:32196115]	extracellular region [GO:0005576]	G protein-coupled receptor binding [GO:0001664]	locomotor rhythm [GO:0045475]; neuropeptide signaling pathway [GO:0007218]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=NMS&keywords=NMS	0	899	NA	NA	0.7640275457397825	310	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NMU	neuromedin U	Yes		ENSG00000109255	P48645	NmU family	12	ligand	extracellular, ligand, secreted	P08913, P48039, Q14831, Q9GZQ4, Q9HB89	ADRA2A, GRM7, MTNR1A, NMUR1, NMUR2	NMUR1 [Baccin2019:10811630;Baccin2019:10894543;Baccin2019:10899166;Baccin2019:15292653;Baccin2019:15331768;CellTalkDB:10894543;Cellinker:10811630;Cellinker:10894543;Cellinker:10899166;Cellinker:15292653;Cellinker:15331768;Guide2Pharma:10894543;Guide2Pharma:10899166;Guide2Pharma:15292653;Guide2Pharma:15331768;HPMR:10894543;HPRD:10811630;LRdb:10811630;LRdb:10894543;LRdb:10899166;LRdb:15292653;LRdb:15331768;connectomeDB2020:10811630;connectomeDB2020:10894543;connectomeDB2020:10899166;connectomeDB2020:15292653;connectomeDB2020:15331768;scConnect:10894543;scConnect:10899166;scConnect:15292653;scConnect:15331768], NMUR2 [Baccin2019:10887190;Baccin2019:10894543;Baccin2019:10899166;Baccin2019:15292653;Baccin2019:15331768;BioGRID:10887190;CellTalkDB:10894543;Cellinker:10887190;Cellinker:10894543;Cellinker:10899166;Cellinker:15292653;Cellinker:15331768;Guide2Pharma:10894543;Guide2Pharma:10899166;Guide2Pharma:15292653;Guide2Pharma:15331768;HPMR:10894543;HPRD:10887190;HPRD:10894543;HPRD:10899166;LRdb:10887190;LRdb:10894543;LRdb:10899166;LRdb:15292653;LRdb:15331768;connectomeDB2020:10887190;connectomeDB2020:10894543;connectomeDB2020:10899166;connectomeDB2020:15292653;connectomeDB2020:15331768;scConnect:10894543;scConnect:10899166;scConnect:15292653;scConnect:15331768], ADRA2A [CellTalkDB:32196115], GRM7 [CellTalkDB:32196115], MTNR1A [CellTalkDB:32196115]	extracellular region [GO:0005576]; terminal bouton [GO:0043195]	neuromedin U receptor binding [GO:0042922]; signaling receptor binding [GO:0005102]; type 1 neuromedin U receptor binding [GO:0031839]; type 2 neuromedin U receptor binding [GO:0031840]	energy homeostasis [GO:0097009]; G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218]; positive regulation of smooth muscle contraction [GO:0045987]; positive regulation of synaptic transmission [GO:0050806]; regulation of feeding behavior [GO:0060259]; regulation of grooming behavior [GO:2000821]; temperature homeostasis [GO:0001659]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=NMU&keywords=NMU	0.0647240584269663	707	NA	NA	0.01777110117715925	804	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NODAL	nodal growth differentiation factor	Yes		ENSG00000156574	Q96S42	TGF-beta family	17	ligand	extracellular, intracellular, ligand, secreted	P0CG37, P13385, P27037, P36896, P84022, Q13705, Q8NER5	ACVR1B, ACVR1B_ACVR2A, ACVR1B_ACVR2A_CFC1, ACVR1B_ACVR2B, ACVR1B_ACVR2B_CFC1, ACVR1B_ACVR2B_TDGF1, ACVR1C, ACVR1C_ACVR2A, ACVR1C_ACVR2A_CFC1, ACVR1C_ACVR2B, ACVR1C_ACVR2B_CFC1, ACVR2A, ACVR2B, CFC1, SMAD3, TDGF1	ACVR2B [Baccin2019:11952836;CellTalkDB:11952836;HPMR:11952836;LRdb:11952836;SignaLink3:16446785;SignaLink3:23331499;connectomeDB2020:11952836], ACVR1B [Baccin2019:11952836;CellTalkDB:11952836;LRdb:11952836;SIGNOR:19874624;connectomeDB2020:11952836], ACVR1C [Baccin2019:12606401;CellTalkDB:12606401;HPMR:12606401;LRdb:12606401;SIGNOR:15531507;connectomeDB2020:12606401], TDGF1 [connectomeDB2020:28126904], SMAD3 [CellTalkDB:32196115;ProtMapper:19688838;ProtMapper:21557273], ACVR2A [Baccin2019:11952836;CellTalkDB:11952836;LRdb:11952836;connectomeDB2020:11952836], CFC1 [connectomeDB2020:28126904]	extracellular space [GO:0005615]	cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; morphogen activity [GO:0016015]; type I activin receptor binding [GO:0070698]	axial mesodermal cell fate specification [GO:0048327]; BMP signaling pathway [GO:0030509]; brain development [GO:0007420]; cell migration involved in gastrulation [GO:0042074]; digestive tract morphogenesis [GO:0048546]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic pattern specification [GO:0009880]; embryonic placenta development [GO:0001892]; embryonic process involved in female pregnancy [GO:0060136]; endodermal cell differentiation [GO:0035987]; epiblast cell-extraembryonic ectoderm cell signaling involved in anterior/posterior axis specification [GO:0060802]; floor plate morphogenesis [GO:0033505]; formation of anatomical boundary [GO:0048859]; heart looping [GO:0001947]; inhibition of neuroepithelial cell differentiation [GO:0002085]; left lung morphogenesis [GO:0060460]; liver development [GO:0001889]; maternal placenta development [GO:0001893]; maternal process involved in parturition [GO:0060137]; mesendoderm development [GO:0048382]; negative regulation of androgen receptor signaling pathway [GO:0060766]; negative regulation of cell development [GO:0010721]; negative regulation of chorionic trophoblast cell proliferation [GO:1901383]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of trophoblast cell migration [GO:1901164]; neural fold formation [GO:0001842]; nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry [GO:1900164]; placenta development [GO:0001890]; polarity specification of proximal/distal axis [GO:0010085]; positive regulation of activin receptor signaling pathway [GO:0032927]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell-cell adhesion [GO:0022409]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry [GO:1900224]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of vascular endothelial growth factor production [GO:0010575]; regulation of gastrulation [GO:0010470]; regulation of stem cell population maintenance [GO:2000036]; SMAD protein signal transduction [GO:0060395]; stem cell population maintenance [GO:0019827]; transforming growth factor beta receptor signaling pathway involved in primitive streak formation [GO:0090010]; trophectodermal cellular morphogenesis [GO:0001831]; vasculature development [GO:0001944]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=NODAL&keywords=NODAL	0.10919103651685394	668	NA	NA	0.14165916766268968	585	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NOG	noggin	Yes		ENSG00000183691	Q13253	Noggin family	1	ligand	extracellular, ligand, ligand_regulator, secreted	O00238, P12643, P12644, P18075, P22003, P36894, P43026, Q13873	BMP2, BMP4, BMP5, BMP7, BMPR1A, BMPR1A_BMPR1B_BMPR2, BMPR1B, BMPR2, GDF5	GDF5 [SIGNOR:19956691;SIGNOR:21976273], BMPR2 [SIGNOR:12478285;SIGNOR:22298955], BMPR1B [SIGNOR:22298955], BMP2 [HPRD:10657699;HPRD:15064755;SIGNOR:12700180], BMP4 [HPRD:10657699;HPRD:11706034;SIGNOR:12700180], BMP7 [HPRD:12478285;Lit-BM-17:12478285;SIGNOR:12478285], BMPR1A [SIGNOR:12478285;SIGNOR:22298955], BMP5 [HPRD:11580864]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	cytokine binding [GO:0019955]; protein homodimerization activity [GO:0042803]	atrial cardiac muscle tissue morphogenesis [GO:0055009]; axial mesoderm development [GO:0048318]; BMP signaling pathway involved in heart development [GO:0061312]; cartilage development [GO:0051216]; cell differentiation in hindbrain [GO:0021533]; dorsal/ventral pattern formation [GO:0009953]; embryonic digit morphogenesis [GO:0042733]; embryonic skeletal joint morphogenesis [GO:0060272]; embryonic skeletal system development [GO:0048706]; endocardial cushion morphogenesis [GO:0003203]; endoderm formation [GO:0001706]; epithelial to mesenchymal transition [GO:0001837]; face morphogenesis [GO:0060325]; fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation [GO:0060825]; heart trabecula morphogenesis [GO:0061384]; in utero embryonic development [GO:0001701]; limb development [GO:0060173]; lung morphogenesis [GO:0060425]; membranous septum morphogenesis [GO:0003149]; mesoderm formation [GO:0001707]; middle ear morphogenesis [GO:0042474]; motor neuron axon guidance [GO:0008045]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of astrocyte differentiation [GO:0048712]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle cell proliferation [GO:0060044]; negative regulation of cartilage development [GO:0061037]; negative regulation of cell migration [GO:0030336]; negative regulation of cytokine activity [GO:0060302]; negative regulation of epithelial to mesenchymal transition involved in endocardial cushion formation [GO:1905006]; negative regulation of gene expression [GO:0010629]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of pathway-restricted SMAD protein phosphorylation [GO:0060394]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; neural plate morphogenesis [GO:0001839]; neural tube closure [GO:0001843]; notochord morphogenesis [GO:0048570]; osteoblast differentiation [GO:0001649]; outflow tract morphogenesis [GO:0003151]; pharyngeal arch artery morphogenesis [GO:0061626]; pituitary gland development [GO:0021983]; positive regulation of branching involved in ureteric bud morphogenesis [GO:0090190]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of gene expression [GO:0010628]; positive regulation of glomerulus development [GO:0090193]; positive regulation of transcription by RNA polymerase II [GO:0045944]; prostatic bud formation [GO:0060513]; regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation [GO:2000313]; skeletal system development [GO:0001501]; somatic stem cell population maintenance [GO:0035019]; somite development [GO:0061053]; spinal cord development [GO:0021510]; ureteric bud formation [GO:0060676]; ventricular compact myocardium morphogenesis [GO:0003223]; ventricular septum morphogenesis [GO:0060412]; wound healing [GO:0042060]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=NOG&keywords=NOG	0.06202374157303371	712	NA	NA	0.04230532569167778	729	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NPB	neuropeptide B	Yes		ENSG00000183979	Q8NG41	Neuropeptide B/W family	11	ligand	extracellular, ligand, secreted	P08913, P48039, P48145, P48146, Q14831	ADRA2A, GRM7, MTNR1A, NPBWR1, NPBWR2	NPBWR1 [Baccin2019:12118011;Baccin2019:12401809;CellTalkDB:12401809;Guide2Pharma:12118011;Guide2Pharma:12401809;HPMR:12401809;HPRD:12118011;HPRD:12401809;LRdb:12;LRdb:12401809;connectomeDB2020:12118011;connectomeDB2020:12401809;scConnect:12118011;scConnect:12401809], NPBWR2 [CellTalkDB:12401809;Guide2Pharma:12401809;HPRD:12401809;LRdb:12401809;connectomeDB2020:12401809;scConnect:12401809], GRM7 [CellTalkDB:32196115], ADRA2A [CellTalkDB:32196115], MTNR1A [CellTalkDB:32196115]	extracellular region [GO:0005576]	G protein-coupled receptor binding [GO:0001664]	feeding behavior [GO:0007631]; G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=NPB&keywords=NPB	0.14133222213483146	647	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NPFF	neuropeptide FF-amide peptide precursor	Yes		ENSG00000139574	O15130	FARP (FMRFamide related peptide) family	13	ligand	extracellular, intracellular, ligand, secreted	Q9GZQ6, Q9Y5X5	NPFFR1, NPFFR2	NPFFR1 [CellTalkDB:11024015;Cellinker:11024015;Cellinker:12242085;Cellinker:12421602;Cellinker:17011599;Guide2Pharma:12242085;Guide2Pharma:12421602;Guide2Pharma:17011599;HPRD:11024015;LRdb:11024015;LRdb:12242085;LRdb:12421602;LRdb:17011599;SIGNOR:11024015;connectomeDB2020:11024015;connectomeDB2020:12242085;connectomeDB2020:12421602;connectomeDB2020:17011599;scConnect:12242085;scConnect:12421602;scConnect:17011599], NPFFR2 [Baccin2019:10851242;Baccin2019:11024015;Baccin2019:11325787;Baccin2019:12421602;Baccin2019:12609745;CellTalkDB:11024015;Cellinker:10851242;Cellinker:11024015;Cellinker:11325787;Cellinker:12421602;Cellinker:12609745;Guide2Pharma:11325787;Guide2Pharma:12421602;HPMR:11024015;HPRD:10851242;HPRD:12609745;LRdb:10851242;LRdb:11024015;LRdb:11325787;LRdb:12421602;LRdb:12609745;SIGNOR:11024015;connectomeDB2020:10851242;connectomeDB2020:11024015;connectomeDB2020:11325787;connectomeDB2020:12421602;connectomeDB2020:12609745;scConnect:11325787;scConnect:12421602]	axon terminus [GO:0043679]; dendrite [GO:0030425]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; perikaryon [GO:0043204]; postsynapse [GO:0098794]	G protein-coupled receptor binding [GO:0001664]; neuropeptide hormone activity [GO:0005184]; signaling receptor binding [GO:0005102]	chemical synaptic transmission [GO:0007268]; excitatory postsynaptic potential [GO:0060079]; neuropeptide signaling pathway [GO:0007218]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=NPFF&keywords=NPFF	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NPNT	nephronectin	No		ENSG00000168743	Q6UXI9	Nephronectin family	9	ecm, ligand	ecm, extracellular, intracellular, ligand, secreted	P05556, P53708	ITGA8, ITGA8_ITGB1, ITGB1	ITGA8 [CellTalkDB:11470831;Cellinker:11470831;HPRD:11470831;LRdb:11470831;connectomeDB2020:11470831], ITGB1 [CellTalkDB:11470831;Cellinker:11470831;LRdb:11470831;connectomeDB2020:11470831]	basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; membrane [GO:0016020]; smooth muscle contractile fiber [GO:0030485]	calcium ion binding [GO:0005509]; integrin binding [GO:0005178]	branching involved in ureteric bud morphogenesis [GO:0001658]; cell-cell adhesion mediated by integrin [GO:0033631]; cell-matrix adhesion [GO:0007160]; cellular response to tumor necrosis factor [GO:0071356]; establishment of protein localization [GO:0045184]; extracellular matrix organization [GO:0030198]; pilomotor reflex [GO:0097195]; positive regulation of alkaline phosphatase activity [GO:0010694]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of smooth muscle contraction [GO:0045987]; positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation [GO:2000721]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; ureteric bud development [GO:0001657]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=NPNT&keywords=NPNT	9.77691700228765	240	NA	NA	0.34841383451417557	445	0	0.198103792415171	0.00331858407079646	0.016546762589928054	0.03198653198653198	0.09306260575296102	0.25475974614687147	0.2349102773246327	0.011468738438771739	0.015889971958872973	0.21162835619083362	260	219	67	0.09742503335230646	0.19984856200475917	0.24100501671677727	2.0630978578707158	435	399	18
NPPA	natriuretic peptide A	Yes		ENSG00000175206	P01160	Natriuretic peptide family	16	ligand	extracellular, intracellular, ligand, secreted	P08473, P16066, P17342, P20594	MME, NPR1, NPR2, NPR3	NPR1 [CellChatDB:29934640;Cellinker:12488235;Cellinker:12547834;Cellinker:15911069;Cellinker:8700153;Guide2Pharma:8700153;HPMR:15911069;HPRD:12547834;LRdb:12547834;LRdb:15911069;LRdb:8700153;SIGNOR:15911069;connectomeDB2020:12547834;connectomeDB2020:15911069;connectomeDB2020:8700153;scConnect:8700153], NPR3 [Baccin2019:21697332169733;CellTalkDB:2169733;Cellinker:12488235;Cellinker:2169733;HPMR:2169733;HPRD:2169733;LRdb:2169733;Lit-BM-17:1309330;Lit-BM-17:1660465;Lit-BM-17:1672777;Lit-BM-17:16870210;connectomeDB2020:2169733], NPR2 [CellTalkDB:32103204;connectomeDB2020:1309330;connectomeDB2020:1660465;connectomeDB2020:1672777], MME [HPRD:2531377;HPRD:2972276;HPRD:9232196]	cell projection [GO:0042995]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nucleus [GO:0005634]; perikaryon [GO:0043204]; protein-containing complex [GO:0032991]	hormone activity [GO:0005179]; hormone receptor binding [GO:0051427]; neuropeptide hormone activity [GO:0005184]; neuropeptide receptor binding [GO:0071855]; signaling receptor binding [GO:0005102]	aortic valve morphogenesis [GO:0003180]; cardiac conduction system development [GO:0003161]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; female pregnancy [GO:0007565]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of JUN kinase activity [GO:0043508]; negative regulation of systemic arterial blood pressure [GO:0003085]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cardiac muscle contraction [GO:0060452]; positive regulation of delayed rectifier potassium channel activity [GO:1902261]; positive regulation of heart rate [GO:0010460]; positive regulation of potassium ion export across plasma membrane [GO:1903766]; protein folding [GO:0006457]; receptor guanylyl cyclase signaling pathway [GO:0007168]; regulation of atrial cardiac muscle cell membrane repolarization [GO:0060372]; regulation of blood pressure [GO:0008217]; regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1902514]; regulation of high voltage-gated calcium channel activity [GO:1901841]; response to muscle stretch [GO:0035994]; vasodilation [GO:0042311]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=NPPA&keywords=NPPA	0.04314893005920472	749	NA	NA	9.916612192642143e-5	907	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NPPB	natriuretic peptide B	Yes		ENSG00000120937	P16860	Natriuretic peptide family	14	ligand	extracellular, intracellular, ligand, secreted	P16066, P17342, P20594, P27487, Q12884	DPP4, FAP, NPR1, NPR2, NPR3	NPR1 [BioGRID:15709752;CellChatDB:29934641;Cellinker:1309330;Cellinker:7901875;Cellinker:8700153;Guide2Pharma:8700153;HPRD:1309330;HPRD:7901875;LRdb:1309330;LRdb:7901875;LRdb:8700153;connectomeDB2020:1309330;connectomeDB2020:7901875;connectomeDB2020:8700153;scConnect:8700153], NPR3 [CellTalkDB:1309330;Cellinker:1309330;Cellinker:7901875;HPRD:1309330;HPRD:7901875;LRdb:1309330;LRdb:79;Lit-BM-17:1309330;Lit-BM-17:1660465;Lit-BM-17:1672777;Lit-BM-17:16870210;connectomeDB2020:1309330;connectomeDB2020:7901875], NPR2 [Cellinker:2570358;HPMR:2570358;LRdb:2570358;connectomeDB2020:2570358], DPP4 [CellTalkDB:16254193;Cellinker:21314817], FAP [Cellinker:21314817]	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	diuretic hormone activity [GO:0008613]; hormone activity [GO:0005179]; hormone receptor binding [GO:0051427]; signaling receptor binding [GO:0005102]	antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; blood vessel diameter maintenance [GO:0097746]; body fluid secretion [GO:0007589]; cardiac conduction system development [GO:0003161]; cell surface receptor signaling pathway [GO:0007166]; cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; killing of cells of other organism [GO:0031640]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell growth [GO:0030308]; negative regulation of systemic arterial blood pressure [GO:0003085]; neuropeptide signaling pathway [GO:0007218]; positive regulation of renal sodium excretion [GO:0035815]; positive regulation of urine volume [GO:0035810]; protein folding [GO:0006457]; receptor guanylyl cyclase signaling pathway [GO:0007168]; regulation of blood pressure [GO:0008217]; regulation of vascular permeability [GO:0043114]; vasodilation [GO:0042311]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=NPPB&keywords=NPPB	1.1617401483146068	437	NA	NA	0.03735854522586942	743	0	0.06886227544910178	0.0011061946902654867	0	0.0016835016835016834	0.042301184433164135	9.066183136899365e-4	0	0.0022197558268590455	0.002737348110562157	0.0012362372030133286	297	324	356	0.011004828700923414	0.5817593659462618	0.60640095151084	0.5349359122609442	305	287	309
NPPC	natriuretic peptide C	Yes		ENSG00000163273	P23582	Natriuretic peptide family	16	ligand	intracellular, ligand, secreted	P16066, P17342, P20594	NPR1, NPR2, NPR3	NPR2 [CellChatDB:29934642;CellTalkDB:11952095;Cellinker:11952095;Cellinker:12709393;Cellinker:1309330;Guide2Pharma:1309330;HPRD:12709393;LRdb:11952095;LRdb:12709393;LRdb:1309330;connectomeDB2020:11952095;connectomeDB2020:12709393;connectomeDB2020:1309330;scConnect:1309330], NPR3 [Baccin2019:11533490;Baccin2019:1309330;CellTalkDB:11533490;Cellinker:11533490;Cellinker:1309330;HPRD:11533490;HPRD:1309330;LRdb:11533490;LRdb:13;connectomeDB2020:11533490;connectomeDB2020:1309330], NPR1 [CellTalkDB:32103204]	extracellular region [GO:0005576]; extracellular space [GO:0005615]; protein-containing complex [GO:0032991]; secretory granule [GO:0030141]	hormone activity [GO:0005179]; hormone receptor binding [GO:0051427]; signaling receptor binding [GO:0005102]	cGMP biosynthetic process [GO:0006182]; cGMP-mediated signaling [GO:0019934]; growth plate cartilage chondrocyte differentiation [GO:0003418]; growth plate cartilage chondrocyte proliferation [GO:0003419]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of DNA biosynthetic process [GO:2000279]; negative regulation of meiotic cell cycle [GO:0051447]; negative regulation of oocyte maturation [GO:1900194]; ossification [GO:0001503]; positive regulation of cGMP-mediated signaling [GO:0010753]; positive regulation of osteoblast differentiation [GO:0045669]; post-embryonic development [GO:0009791]; protein folding [GO:0006457]; receptor guanylyl cyclase signaling pathway [GO:0007168]; regulation of multicellular organism growth [GO:0040014]; regulation of smooth muscle cell proliferation [GO:0048660]; reproductive process [GO:0022414]; response to ethanol [GO:0045471]; response to hypoxia [GO:0001666]; response to xenobiotic stimulus [GO:0009410]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=NPPC&keywords=NPPC	0.09614521123595506	676	NA	NA	0.09321690029646776	641	0	4.99001996007984e-4	0	7.194244604316547e-4	0	0.015228426395939083	0.012692656391659111	0	0.007399186089530152	0.009480571504873794	0.0010044427274483296	278	245	366	0.004274882687808191	1.2188671858151483	1.36467471788834	0.7708954930219455	85	68	203
NPS	neuropeptide S	Yes		ENSG00000214285	P0C0P6	NA	12	ligand	extracellular, ligand, secreted	O60895, O60896, P07550, P13945, P16473, P32241, P41586, Q03431, Q6W5P4, Q99678, Q9NQS5	ADCYAP1R1, ADRB2, ADRB3, GPR20, GPR84, NPSR1, PTH1R, RAMP2, RAMP3, TSHR, VIPR1	NPSR1 [Baccin2019:1531264815312640;CellChatDB:19732772;CellTalkDB:15312648;Cellinker:15312648;Cellinker:19732772;Guide2Pharma:15312648;HPMR:15312648;LRdb:15312648;connectomeDB2020:15312648;scConnect:15312648], ADCYAP1R1 [CellTalkDB:32196115], GPR84 [CellTalkDB:32196115], TSHR [CellTalkDB:32196115], RAMP3 [CellTalkDB:32196115], RAMP2 [CellTalkDB:32196115], ADRB2 [CellTalkDB:32196115], PTH1R [CellTalkDB:32196115], VIPR1 [CellTalkDB:32196115], ADRB3 [CellTalkDB:32196115], GPR20 [CellTalkDB:32196115]	extracellular region [GO:0005576]	NA	neuropeptide signaling pathway [GO:0007218]; positive regulation of action potential [GO:0045760]; positive regulation of circadian sleep/wake cycle, wakefulness [GO:0010841]; positive regulation of synaptic transmission, GABAergic [GO:0032230]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; visual learning [GO:0008542]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=NPS&keywords=NPS	0.03805274606741573	756	NA	NA	4.805274606741573	75	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NPTX1	neuronal pentraxin 1	TBD	either keep or get rid of entire pentraxin family	ENSG00000171246	Q15818	NA	1	ligand, receptor	extracellular, intracellular, ligand, receptor, secreted	O95502, P42261, Q07812, Q92934	BAD, BAX, GRIA1, NPTXR	GRIA1 [SIGNOR:15115814], BAX [SIGNOR:23069675], BAD [SIGNOR:23069675], NPTXR [CellTalkDB:31969807;HPRD:10748068]	glutamatergic synapse [GO:0098978]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; synaptic cleft [GO:0043083]; transport vesicle [GO:0030133]	metal ion binding [GO:0046872]	axonogenesis involved in innervation [GO:0060385]; cellular response to glucose stimulus [GO:0071333]; cellular response to potassium ion [GO:0035865]; central nervous system development [GO:0007417]; chemical synaptic transmission [GO:0007268]; mitochondrial fragmentation involved in apoptotic process [GO:0043653]; mitochondrial transport [GO:0006839]; neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0099645]; regulation of postsynaptic density assembly [GO:0099151]; regulation of postsynaptic neurotransmitter receptor activity [GO:0098962]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=NPTX1&keywords=NPTX1	0.32196105572234046	569	NA	NA	0.013863983650232488	816	0	4.99001996007984e-4	0.004424778761061947	0.015587529976019183	0	0	9.066183136899365e-4	0	0	1.3352917612498332e-4	7.726482518833301e-5	303	405	399	0.0019662475498265788	0.8356838648340452	0.8468426826312684	0.8421407616069565	206	191	170
NPTX2	neuronal pentraxin 2	TBD		ENSG00000106236	P47972	NA	1	ligand	extracellular, intracellular, ligand, secreted, secreted_receptor	O95502	NPTXR	NPTXR [CellTalkDB:31969807;HPRD:10748068]	extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]	carbohydrate binding [GO:0030246]; metal ion binding [GO:0046872]	associative learning [GO:0008306]; chemical synaptic transmission [GO:0007268]; regulation of postsynaptic neurotransmitter receptor activity [GO:0098962]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=NPTX2&keywords=NPTX2	211.75317274157302	34	30060.1	35	12.298959225359706	40	0	0.07984031936127736	0.0055309734513274336	0.005755395683453236	0.11111111111111116	0.5786802030456861	0.7398005439709917	0.053833605220228405	0.10765815760266334	0.6262518360262717	0.01892988217114152	118	39	206	0.21158109342219564	0.5309936682119359	2.871417530258196	0.1305611490779097	332	7	457
NPVF	neuropeptide VF precursor	Yes	manually added ensembl_gene_ID, hgnc_symbol, and description by searching the uniprot ID on genenames.org	ENSG00000105954	Q9HCQ7	FARP (FMRFamide related peptide) family	13	ligand	extracellular, ligand, secreted	Q9GZQ6, Q9Y5X5	NPFFR1, NPFFR2	NPFFR1 [CellChatDB:29106375;CellTalkDB:11024015;Cellinker:11024015;Cellinker:12242085;Cellinker:12421602;Cellinker:17337079;Cellinker:29106375;Guide2Pharma:12242085;Guide2Pharma:12421602;Guide2Pharma:17337079;HPMR:11024015;LRdb:11024015;LRdb:12242085;LRdb:12421602;LRdb:17337079;connectomeDB2020:11024015;connectomeDB2020:12242085;connectomeDB2020:12421602;connectomeDB2020:17337079;scConnect:12242085;scConnect:12421602;scConnect:17337079], NPFFR2 [Baccin2019:12242085;Baccin2019:12421602;CellChatDB:29106375;CellTalkDB:12242085;Cellinker:12242085;Cellinker:12421602;Cellinker:29106375;LRdb:12;LRdb:12242085;connectomeDB2020:12242085;connectomeDB2020:12421602;scConnect:12242085;scConnect:12421602]	extracellular region [GO:0005576]	signaling receptor binding [GO:0005102]	negative regulation of gonadotropin secretion [GO:0032277]; neuropeptide signaling pathway [GO:0007218]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=NPVF&keywords=NPVF	0.002272085393258427	876	NA	NA	0.5620552191153109	362	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NPW	neuropeptide W	Yes		ENSG00000183971	Q8N729	Neuropeptide B/W family	10	ligand	extracellular, ligand, secreted	P08913, P48039, P48145, P48146, Q14831	ADRA2A, GRM7, MTNR1A, NPBWR1, NPBWR2	NPBWR1 [CellTalkDB:12130646;Guide2Pharma:12130646;HPRD:12130646;HPRD:12401809;LRdb:12130646;LRdb:12401809;connectomeDB2020:12130646;connectomeDB2020:12401809;scConnect:12130646], NPBWR2 [CellTalkDB:12130646;Guide2Pharma:12401809;HPMR:12130646;HPRD:12130646;HPRD:12719537;LRdb:12130646;LRdb:12401809;LRdb:12719537;connectomeDB2020:12130646;connectomeDB2020:12401809;connectomeDB2020:12719537;scConnect:12401809], GRM7 [CellTalkDB:32196115], ADRA2A [CellTalkDB:32196115], MTNR1A [CellTalkDB:32196115]	extracellular region [GO:0005576]	G protein-coupled receptor binding [GO:0001664]	feeding behavior [GO:0007631]; G protein-coupled receptor signaling pathway [GO:0007186]; neuropeptide signaling pathway [GO:0007218]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=NPW&keywords=NPW	0.12437730337078652	654	NA	NA	0.16920573949980397	558	0	0.005988023952095809	0.0022123893805309734	0.0023980815347721817	0	0.0930626057529611	0.021758839528558477	0.17128874388254486	0.024787273399925994	0.017225263720122806	0.002742901294185824	220	207	320	0.031042192949608912	0.84759782311431	0.6633481732701185	0.31048295372109863	203	267	389
NPY	neuropeptide Y	Yes		ENSG00000122585	P01303	NPY family	15	ligand	extracellular, intracellular, ligand, secreted, transmembrane	P07550, P08588, P08913, P25929, P27487, P32245, P48039, P49146, P49683, P50391, Q12884, Q14831, Q15761, Q99463, Q9NYM4, Q9Y5X5	ADRA2A, ADRB1, ADRB2, DPP4, FAP, GPR83, GRM7, MC4R, MTNR1A, NPFFR2, NPY1R, NPY2R, NPY4R, NPY5R, NPY6R, PRLHR	PRLHR [Baccin2019:15885496;CellTalkDB:15885496;Cellinker:15885496;Guide2Pharma:15885496;LRdb:15885496;connectomeDB2020:15885496;scConnect:15885496], NPY1R [Baccin2019:12007534;Baccin2019:7559383;Baccin2019:9001438;Baccin2019:9549761;CellTalkDB:9001438;Cellinker:12007534;Cellinker:7559383;Cellinker:9001438;Cellinker:9549761;HPMR:9549761;HPRD:12007534;HPRD:7559383;HPRD:9001438;LRdb:12007534;LRdb:7559383;LRdb:9001438;LRdb:9549761;Lit-BM-17:23597562;Lit-BM-17:7559383;SIGNOR:9549761;connectomeDB2020:12007534;connectomeDB2020:7559383;connectomeDB2020:9001438;connectomeDB2020:9549761], NPY2R [Baccin2019:12007534;Baccin2019:7559383;Baccin2019:7592910;Baccin2019:8632753;Baccin2019:9001438;Baccin2019:9549761;CellTalkDB:9001438;Cellinker:12007534;Cellinker:7559383;Cellinker:7592910;Cellinker:8632753;Cellinker:9001438;Cellinker:9549761;Guide2Pharma:7592910;Guide2Pharma:8632753;HPMR:9549761;HPRD:12007534;HPRD:7559383;HPRD:9001438;LRdb:12007534;LRdb:7559383;LRdb:7592910;LRdb:8632753;LRdb:9001438;LRdb:9549761;SIGNOR:9549761;connectomeDB2020:12007534;connectomeDB2020:7559383;connectomeDB2020:7592910;connectomeDB2020:8632753;connectomeDB2020:9001438;connectomeDB2020:9549761;scConnect:7592910;scConnect:8632753], NPY4R [CellTalkDB:7592911;Cellinker:7493937;Cellinker:7592911;Guide2Pharma:7493937;HPMR:7592911;HPRD:7493937;LRdb:749;LRdb:7592911;SIGNOR:7592911;connectomeDB2020:7493937;connectomeDB2020:7592911;scConnect:7493937], NPY5R [CellTalkDB:8824284;Cellinker:12007534;Cellinker:12417094;Cellinker:8824284;Guide2Pharma:8824284;HPMR:12417094;HPRD:12007534;LRdb:12007534;LRdb:12417094;LRdb:8824284;SIGNOR:11825645;connectomeDB2020:12007534;connectomeDB2020:12417094;connectomeDB2020:8824284;scConnect:8824284], FAP [Baccin2019:26621486;CellTalkDB:21314817;Cellinker:21314817;LRdb:21314817;Ramilowski2015:21314817;connectomeDB2020:21314817;talklr:21314817], ADRA2A [CellTalkDB:32196115], MC4R [Baccin2019:12015205;Cellinker:12015205;HPRD:12015205;LRdb:12015205], MTNR1A [CellTalkDB:32196115], NPFFR2 [Baccin2019:12609745;CellTalkDB:11325787;Cellinker:12609745;HPRD:12609745;LRdb:12609745;connectomeDB2020:12609745], GRM7 [CellTalkDB:32196115], DPP4 [CellTalkDB:30759373;Cellinker:21314817], NPY6R [NA], GPR83 [Cellinker:17240481], ADRB1 [Cellinker:8190350], ADRB2 [Cellinker:8190350]	extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; neuronal dense core vesicle [GO:0098992]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; terminal bouton [GO:0043195]	calcium channel regulator activity [GO:0005246]; G protein-coupled receptor activity [GO:0004930]; G protein-coupled receptor binding [GO:0001664]; hormone activity [GO:0005179]; neuropeptide hormone activity [GO:0005184]; neuropeptide Y receptor binding [GO:0031841]; signaling receptor binding [GO:0005102]	adult feeding behavior [GO:0008343]; aging [GO:0007568]; antibacterial humoral response [GO:0019731]; antifungal humoral response [GO:0019732]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; central nervous system neuron development [GO:0021954]; cerebral cortex development [GO:0021987]; chemical synaptic transmission [GO:0007268]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; feeding behavior [GO:0007631]; G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger [GO:0007187]; innate immune response [GO:0045087]; intestinal epithelial cell differentiation [GO:0060575]; monocyte activation [GO:0042117]; negative regulation of acute inflammatory response to antigenic stimulus [GO:0002865]; negative regulation of blood pressure [GO:0045776]; negative regulation of neuron death [GO:1901215]; neuron projection development [GO:0031175]; neuropeptide signaling pathway [GO:0007218]; positive regulation of appetite [GO:0032100]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of dopamine metabolic process [GO:0045964]; positive regulation of eating behavior [GO:1904000]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of nitric oxide metabolic process [GO:1904407]; regulation of nerve growth factor production [GO:0032903]; response to yeast [GO:0001878]; sensory perception of taste [GO:0050909]; short-day photoperiodism [GO:0048572]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=NPY&keywords=NPY	26.29089711235955	146	NA	NA	2.305494628484825	138	0.05511811023622047	0.07335329341317362	0.02323008849557523	0.08177458033573161	0.19865319865319858	1.7884940778341758	1.3608340888485948	1.5269168026101132	3.163152053274136	2.257644545333323	1.0694224454317247	14	18	23	1.0544175713150878	2.98111581280428	2.130408785465321	1.0140967929513776	13	18	95
NR0B2	nuclear receptor subfamily 0 group B member 2			ENSG00000131910	Q15466	Nuclear hormone receptor family, NR0 subfamily	1	ligand, receptor	intracellular, ligand, receptor, secreted	O00482, O75469, O95718, P03372, P10275, P10276, P10826, P10827, P10828, P11474, P19793, P28702, P41235, P49715, P55055, P62508, Q07869, Q13133, Q14994, Q8N441, Q92731, Q96EB6, Q9UBC0	AR, CEBPA, ESR1, ESR2, ESRRA, ESRRB, ESRRG, FGFRL1, HNF4A, NR1H2, NR1H3, NR1I2, NR1I3, NR5A2, ONECUT1, PPARA, RARA, RARB, RXRA, RXRB, SIRT1, THRA, THRB	HNF4A [BioGRID:11535594;HPRD:15604093;HPRD:16488887;Lit-BM-17:15604093;Lit-BM-17:16455805;Lit-BM-17:20516075;SignaLink3:10594021;SignaLink3:15604093;SignaLink3:20516075;SignaLink3:21071413;SignaLink3:23331499], ESR1 [BioGRID:11861507;HPRD:11861507;HPRD:9773978;Lit-BM-17:11861507;Lit-BM-17:9773978;SIGNOR:11861507;SignaLink3:11861507;SignaLink3:18988627;SignaLink3:21071413;SignaLink3:23331499;SignaLink3:9773978], SIRT1 [IntAct:20375098;SignaLink3:20375098], ONECUT1 [SignaLink3:18459945], RXRA [HPRD:10594021;Lit-BM-17:12198243;Lit-BM-17:21988832;SignaLink3:10594021;SignaLink3:23331499], NR5A2 [BioGRID:11668176;DIP:22504882;HPRD:11668176;HPRD:14963109;Lit-BM-17:11668176;Lit-BM-17:12198243;Lit-BM-17:14963109;Lit-BM-17:20375098;Lit-BM-17:20516075;Lit-BM-17:21262773;Lit-BM-17:21566081;SIGNOR:12198243;SIGNOR:15723037;SignaLink3:11030331;SignaLink3:12198243;SignaLink3:20375098;SignaLink3:20516075;SignaLink3:21566081;SignaLink3:23331499], RXRB [HPRD:10594021;SignaLink3:10594021;SignaLink3:10845098;SignaLink3:23331499], ESR2 [HPRD:10648597;HPRD:9773978;SignaLink3:10648597;SignaLink3:23331499;SignaLink3:9773978], NR1I2 [Lit-BM-17:16455805;SIGNOR:12805410;SignaLink3:12805410;SignaLink3:23331499], THRA [SignaLink3:11368516;SignaLink3:23331499], THRB [SignaLink3:11368516;SignaLink3:23331499], RARA [BioGRID:8650544;HPRD:9773978;Lit-BM-17:8650544;Lit-BM-17:9773978;SignaLink3:11368516;SignaLink3:23331499], RARB [SignaLink3:11368516;SignaLink3:23331499], PPARA [SIGNOR:11369442;SignaLink3:11369442;SignaLink3:23331499], NR1H2 [HPRD:12198243;SignaLink3:12198243;SignaLink3:23331499], NR1H3 [HPRD:12198243;Lit-BM-17:12198243;SignaLink3:12198243;SignaLink3:23331499], NR1I3 [HPRD:14963109;HPRD:8650544;HPRD:9773978;SIGNOR:15000748;SignaLink3:14963109;SignaLink3:15000748;SignaLink3:23331499;SignaLink3:8650544;SignaLink3:9773978], ESRRB [SignaLink3:11705994;SignaLink3:23331499], ESRRG [BioGRID:21459093;HPRD:14963109;Lit-BM-17:14963109;Lit-BM-17:20516075;Lit-BM-17:21459093;SignaLink3:11705994;SignaLink3:14963109;SignaLink3:20516075;SignaLink3:21459093;SignaLink3:23331499], ESRRA [HPRD:15604093;SignaLink3:11705994;SignaLink3:15604093;SignaLink3:23331499], AR [CancerCellMap:11735420;HPRD:11735420;Lit-BM-17:11735420;NetPath:11735420;SIGNOR:11735420;SignaLink3:11735420;SignaLink3:23331499], CEBPA [SIGNOR:17094771], FGFRL1 [Cellinker:23640895]	chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]	peroxisome proliferator activated receptor binding [GO:0042975]; protein-containing complex binding [GO:0044877]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; retinoid X receptor binding [GO:0046965]; thyroid hormone receptor binding [GO:0046966]; transcription corepressor activity [GO:0003714]; transcription regulator inhibitor activity [GO:0140416]	animal organ regeneration [GO:0031100]; bile acid and bile salt transport [GO:0015721]; cholesterol metabolic process [GO:0008203]; circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; positive regulation of gene expression [GO:0010628]; positive regulation of insulin secretion [GO:0032024]; positive regulation of transcription, DNA-templated [GO:0045893]; response to ethanol [GO:0045471]; response to glucose [GO:0009749]; response to organic cyclic compound [GO:0014070]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=NR0B2&keywords=NR0B2	3.469386157303371	323	NA	NA	0.9355747001417892	277	0	0.055888223552894155	0.0011061946902654867	0.0052757793764987996	0.24242424242424238	0.10152284263959387	0.12511332728921096	0.03425774877650898	0.04254532001479838	0.09774335692348762	0.1283368746378162	182	108	97	0.07583762821139244	0.6121478553134642	1.2551996038164979	1.6116111025008033	302	86	31
NRG1	neuregulin 1	Yes		ENSG00000157168	Q02297	Neuregulin family	15	cell_surface_ligand, ligand, receptor	cell_adhesion, cell_surface, cell_surface_ligand, extracellular, intracellular, ligand, plasma_membrane_transmembrane, receptor, secreted, transmembrane, transmembrane_predicted	O94910, P00533, P04440, P04626, P21860, P35052, Q15303, Q86X29, Q8NC67, Q8WWV6, Q96JQ5, Q9BXB1, Q9Y286	ADGRL1, EGFR, ERBB2, ERBB2_ERBB3, ERBB2_ERBB4, ERBB3, ERBB4, FCAMR, GPC1, HLA-DPB1, ITGAV_ITGB3, LGR4, LSR, MS4A4A, NETO2, SIGLEC7	ERBB2 [CellTalkDB:1350381;HPMR:1350381;LRdb:1350381;LRdb:751;ProtMapper:19293191;SIGNOR:7514177;SPIKE:14737100;SignaLink3:23331499;SignaLink3:9275162;connectomeDB2020:1350381;connectomeDB2020:7514177], ERBB4 [CellTalkDB:10537356;HPRD:10537356;HPRD:7721889;HPRD:8062828;HPRD:9565587;LRdb:10537356;LRdb:7721889;LRdb:8062828;LRdb:9565587;Lit-BM-17:10970856;Lit-BM-17:9168115;ProtMapper:25052836;SIGNOR:14967450;SignaLink3:23331499;SignaLink3:9275162;connectomeDB2020:10537356;connectomeDB2020:7721889;connectomeDB2020:8062828;connectomeDB2020:9565587], ERBB3 [BioGRID:7592681;CellTalkDB:7514177;DIP:17697999;HPRD:11555649;HPRD:7592681;HPRD:8702572;HPRD:9565587;IntAct:7592681;LRdb:11555649;LRdb:7514177;LRdb:7592681;LRdb:8702572;LRdb:9565587;Lit-BM-17:10970856;Lit-BM-17:11555649;Lit-BM-17:17697999;Lit-BM-17:7592681;Lit-BM-17:9168115;ProtMapper:16843264;ProtMapper:26148232;SIGNOR:7477375;SIGNOR:7514177;SignaLink3:11555649;SignaLink3:23331499;SignaLink3:9275162;connectomeDB2020:11555649;connectomeDB2020:7514177;connectomeDB2020:7592681;connectomeDB2020:8702572;connectomeDB2020:9565587], GPC1 [CellTalkDB:32196115], EGFR [BioGRID:7730382;CellTalkDB:32251632;Cellinker:30813222;Lit-BM-17:24658140;Lit-BM-17:25402006;Lit-BM-17:7730382], MS4A4A [CellTalkDB:32103204], ADGRL1 [CellTalkDB:32103204], LGR4 [CellTalkDB:32103204], FCAMR [Cellinker:32822567], SIGLEC7 [Cellinker:32822567], LSR [NA], HLA-DPB1 [NA], NETO2 [NA]	apical plasma membrane [GO:0016324]; axon [GO:0030424]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]; integral component of postsynaptic density membrane [GO:0099061]; integral component of presynaptic active zone membrane [GO:0099059]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; nucleoplasm [GO:0005654]	chemorepellent activity [GO:0045499]; cytokine activity [GO:0005125]; ErbB-2 class receptor binding [GO:0005176]; ErbB-3 class receptor binding [GO:0043125]; growth factor activity [GO:0008083]; integrin binding [GO:0005178]; protein tyrosine kinase activator activity [GO:0030296]; receptor tyrosine kinase binding [GO:0030971]; signaling receptor binding [GO:0005102]; transcription coregulator activity [GO:0003712]; transmembrane receptor protein tyrosine kinase activator activity [GO:0030297]	activation of protein kinase B activity [GO:0032148]; activation of transmembrane receptor protein tyrosine kinase activity [GO:0007171]; animal organ development [GO:0048513]; cardiac conduction system development [GO:0003161]; cardiac muscle cell differentiation [GO:0055007]; cardiac muscle cell myoblast differentiation [GO:0060379]; cell communication [GO:0007154]; cell differentiation [GO:0030154]; cell morphogenesis [GO:0000902]; cell population proliferation [GO:0008283]; cellular protein complex disassembly [GO:0043624]; chemorepulsion involved in interneuron migration from the subpallium to the cortex [GO:0021842]; endocardial cell differentiation [GO:0060956]; ERBB3 signaling pathway [GO:0038129]; ERBB4 signaling pathway [GO:0038130]; ERBB signaling pathway [GO:0038127]; glial cell fate commitment [GO:0021781]; intracellular signal transduction [GO:0035556]; locomotory behavior [GO:0007626]; mammary gland development [GO:0030879]; MAPK cascade [GO:0000165]; myelination in peripheral nervous system [GO:0022011]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of neuron migration [GO:2001223]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of secretion [GO:0051048]; negative regulation of transcription, DNA-templated [GO:0045892]; nervous system development [GO:0007399]; neural crest cell development [GO:0014032]; neuron fate commitment [GO:0048663]; neurotransmitter receptor metabolic process [GO:0045213]; oligodendrocyte differentiation [GO:0048709]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of peptidyl-tyrosine autophosphorylation [GO:1900086]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of striated muscle cell differentiation [GO:0051155]; postsynapse to nucleus signaling pathway [GO:0099527]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; synapse assembly [GO:0007416]; synaptic membrane adhesion [GO:0099560]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]; ventricular cardiac muscle cell differentiation [GO:0055012]; ventricular trabecula myocardium morphogenesis [GO:0003222]; wound healing [GO:0042060]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=NRG1&keywords=NRG1	2.766376527379705	351	NA	NA	2.606992630775235	124	0	0.014471057884231529	0	0.0052757793764987996	0.0016835016835016834	0.016920473773265648	0.030825022665457842	0.021207177814029365	0.02145763965963743	0.02593804246227794	0.004442727448329152	230	182	297	0.012929220251566308	1.3719454614898445	1.567346907918641	0.6298830614330446	65	45	270
NRG2	neuregulin 2	Yes		ENSG00000158458	O14511	Neuregulin family	18	cell_surface_ligand, ligand	cell_surface, cell_surface_ligand, extracellular, intracellular, ligand, plasma_membrane_transmembrane, secreted, transmembrane, transmembrane_predicted	O43300, O60462, O95866, P04626, P21860, Q15303, Q16653	ERBB2, ERBB2_ERBB3, ERBB2_ERBB4, ERBB3, ERBB4, LRRTM2, MOG, MPIG6B, NRP2	ERBB3 [Baccin2019:9168114;Baccin2019:9168115;CellTalkDB:9168115;HPMR:9168115;HPRD:9168114;HPRD:9168115;LRdb:9168115;LRdb:917;SIGNOR:7514177;SignaLink3:23331499;SignaLink3:9168114;SignaLink3:9168115;connectomeDB2020:9168114;connectomeDB2020:9168115], ERBB4 [Baccin2019:9168114;Baccin2019:9168115;CellTalkDB:9168115;HPRD:9168114;HPRD:9168115;LRdb:9168115;LRdb:917;SIGNOR:14967450;SIGNOR:7477375;SignaLink3:23331499;SignaLink3:9168114;SignaLink3:9168115;connectomeDB2020:9168114;connectomeDB2020:9168115], ERBB2 [CellTalkDB:32196115], MOG [Cellinker:32589946], NRP2 [Cellinker:32589946], LRRTM2 [Cellinker:32822567], MPIG6B [Cellinker:32822567]	extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	growth factor activity [GO:0008083]; signaling receptor binding [GO:0005102]	animal organ development [GO:0048513]; intracellular signal transduction [GO:0035556]; nervous system development [GO:0007399]; signal transduction [GO:0007165]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=NRG2&keywords=NRG2	1.300256105643344	420	NA	NA	0.4000864928571603	418	0	0.00499001996007984	0	0.0014388489208633092	0.0016835016835016834	0.020304568527918777	0.03717135086128738	0.016313213703099513	0.007769145394006662	0.016323941781279168	0.007881012169209974	275	215	259	0.010352327545567846	0.8730768190627058	1.293411857800597	0.8785733292261183	198	77	152
NRG3	neuregulin 3	Yes		ENSG00000185737	P56975	Neuregulin family	17	cell_surface_ligand, ligand	cell_surface, cell_surface_ligand, extracellular, intracellular, ligand, plasma_membrane_transmembrane, secreted, transmembrane	P00533, P04626, P21860, Q15303	EGFR, ERBB2, ERBB2_ERBB4, ERBB3, ERBB4	ERBB4 [Baccin2019:9275162;CellTalkDB:9275162;HPMR:9275162;HPRD:9275162;LRdb:9275162;SIGNOR:14967450;SIGNOR:7477375;SIGNOR:9275162;SignaLink3:18988627;SignaLink3:23331499;SignaLink3:9275162;connectomeDB2020:9275162], EGFR [SignaLink3:23331499;SignaLink3:9772300], ERBB3 [CellTalkDB:9772300], ERBB2 [CellTalkDB:9772300]	extracellular region [GO:0005576]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]	chemorepellent activity [GO:0045499]; growth factor activity [GO:0008083]; receptor tyrosine kinase binding [GO:0030971]; signaling receptor binding [GO:0005102]; transmembrane receptor protein tyrosine kinase activator activity [GO:0030297]	animal organ development [GO:0048513]; chemorepulsion involved in interneuron migration from the subpallium to the cortex [GO:0021842]; intracellular signal transduction [GO:0035556]; mammary placode formation [GO:0060596]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of neuron migration [GO:2001223]; pattern specification process [GO:0007389]; regulation of cell growth [GO:0001558]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=NRG3&keywords=NRG3	0.8060887663036287	478	NA	NA	0.5151153798098539	380	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NRG4	neuregulin 4	Yes		ENSG00000169752	Q8WWG1	Neuregulin family	18	cell_surface_ligand, ligand	cell_surface, cell_surface_ligand, ligand, plasma_membrane_transmembrane, secreted, transmembrane, transmembrane_predicted	P00533, P04626, Q15303	EGFR, ERBB2, ERBB2_ERBB4, ERBB4	ERBB4 [Baccin2019:10348342;CellTalkDB:10348342;HPRD:10348342;LRdb:10348342;SIGNOR:14967450;SIGNOR:7477375;SignaLink3:10348342;SignaLink3:18988627;SignaLink3:23331499;connectomeDB2020:10348342], ERBB2 [CellTalkDB:32196115], EGFR [CellTalkDB:32196115]	extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	growth factor activity [GO:0008083]	nervous system development [GO:0007399]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=NRG4&keywords=NRG4	5.823670975813145	281	NA	NA	3.491471621460031	100	0	0.001996007984031936	0	4.7961630695443646e-4	0.11784511784511799	0.001692047377326565	0	0	3.699593044765076e-4	0.0010348511149686208	6.567510141008307e-4	302	370	378	0.011279486449725172	0.4873218782312501	0.5185675481896387	0.5007992575045656	347	312	324
NRP1	neuropilin 1	No	is more of a receptor	ENSG00000099250	O14786	Neuropilin family	2	adhesion, ligand, receptor	adhesion, cell_adhesion, cell_surface, extracellular, intracellular, ligand, ligand_regulator, plasma_membrane, plasma_membrane_transmembrane, receptor, receptor_regulator, secreted, transmembrane	P09619, P16234, P35968, Q9UIW2	KDR, PDGFRA, PDGFRB, PLXNA1	PDGFRA [Cellinker:25744030], PDGFRB [Cellinker:25744030], KDR [BioGRID:11948691;BioGRID:19857463;BioGRID:26037503;HPRD:11333271;HPRD:16763549;HPRD:17222790], PLXNA1 [HPRD:10520994]	axon [GO:0030424]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; early endosome [GO:0005769]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; integral component of postsynaptic membrane [GO:0099055]; mitochondrial membrane [GO:0031966]; neurofilament [GO:0005883]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; semaphorin receptor complex [GO:0002116]; sorting endosome [GO:0097443]	coreceptor activity [GO:0015026]; cytokine binding [GO:0019955]; growth factor binding [GO:0019838]; GTPase activator activity [GO:0005096]; heparin binding [GO:0008201]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; semaphorin receptor activity [GO:0017154]; vascular endothelial growth factor-activated receptor activity [GO:0005021]; vascular endothelial growth factor binding [GO:0038085]	actin cytoskeleton reorganization [GO:0031532]; angiogenesis [GO:0001525]; angiogenesis involved in coronary vascular morphogenesis [GO:0060978]; animal organ morphogenesis [GO:0009887]; artery morphogenesis [GO:0048844]; axonal fasciculation [GO:0007413]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; axonogenesis involved in innervation [GO:0060385]; basal dendrite arborization [GO:0150020]; basal dendrite development [GO:0150018]; branching involved in blood vessel morphogenesis [GO:0001569]; branchiomotor neuron axon guidance [GO:0021785]; cell-cell signaling [GO:0007267]; cell migration involved in sprouting angiogenesis [GO:0002042]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; commissural neuron axon guidance [GO:0071679]; coronary artery morphogenesis [GO:0060982]; dichotomous subdivision of terminal units involved in salivary gland branching [GO:0060666]; dorsal root ganglion morphogenesis [GO:1904835]; endothelial cell chemotaxis [GO:0035767]; endothelial cell migration [GO:0043542]; endothelial tip cell fate specification [GO:0097102]; facial nerve structural organization [GO:0021612]; facioacoustic ganglion development [GO:1903375]; gonadotrophin-releasing hormone neuronal migration to the hypothalamus [GO:0021828]; hepatocyte growth factor receptor signaling pathway [GO:0048012]; integrin-mediated signaling pathway [GO:0007229]; motor neuron migration [GO:0097475]; negative regulation of axon extension involved in axon guidance [GO:0048843]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of neuron apoptotic process [GO:0043524]; nerve development [GO:0021675]; neural crest cell migration involved in autonomic nervous system development [GO:1901166]; neuron migration [GO:0001764]; neuropilin signaling pathway [GO:0038189]; otic placode development [GO:1905040]; outflow tract septum morphogenesis [GO:0003148]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive chemotaxis [GO:0050918]; positive regulation of actin cytoskeleton reorganization [GO:2000251]; positive regulation of angiogenesis [GO:0045766]; positive regulation of axon extension involved in axon guidance [GO:0048842]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; positive regulation of cytokine activity [GO:0060301]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphorylation [GO:0042327]; positive regulation of retinal ganglion cell axon guidance [GO:1902336]; positive regulation of smooth muscle cell migration [GO:0014911]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; postsynapse organization [GO:0099173]; protein localization to early endosome [GO:1902946]; regulation of Cdc42 protein signal transduction [GO:0032489]; regulation of retinal ganglion cell axon guidance [GO:0090259]; regulation of vesicle-mediated transport [GO:0060627]; renal artery morphogenesis [GO:0061441]; retinal ganglion cell axon guidance [GO:0031290]; retina vasculature morphogenesis in camera-type eye [GO:0061299]; semaphorin-plexin signaling pathway [GO:0071526]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]; semaphorin-plexin signaling pathway involved in neuron projection guidance [GO:1902285]; sensory neuron axon guidance [GO:0097374]; signal transduction [GO:0007165]; sprouting angiogenesis [GO:0002040]; substrate adhesion-dependent cell spreading [GO:0034446]; substrate-dependent cell migration, cell extension [GO:0006930]; sympathetic ganglion development [GO:0061549]; sympathetic neuron projection extension [GO:0097490]; sympathetic neuron projection guidance [GO:0097491]; toxin transport [GO:1901998]; trigeminal ganglion development [GO:0061551]; trigeminal nerve structural organization [GO:0021637]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; VEGF-activated neuropilin signaling pathway [GO:0038190]; VEGF-activated neuropilin signaling pathway involved in axon guidance [GO:1902378]; ventral trunk neural crest cell migration [GO:0036486]; vestibulocochlear nerve structural organization [GO:0021649]; viral entry into host cell [GO:0046718]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=NRP1&keywords=NRP1	69.38980403365409	63	1131.65	153	3.881435020526741	95	0.47244094488188937	0.4161676646706637	0.6061946902654849	0.6131894484412582	0.05218855218855217	0.21658206429780003	0.27470534904805	0.17944535073409457	0.12393636699962961	0.13753505140873076	0.1337840448135926	106	92	93	0.29328813888634053	0.4416142599293118	0.48645176811223934	0.47408396959261484	362	324	335
NRP2	neuropilin 2	Yes		ENSG00000118257	O60462	Neuropilin family	1	adhesion, cell_surface_ligand, receptor	adhesion, cell_adhesion, cell_surface, cell_surface_ligand, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, receptor_regulator, secreted, transmembrane, transmembrane_predicted	O94856, O95754, P49767, Q6DN72, Q9UHF4, Q9Y286	FCRL6, IL20RA, NFASC, SEMA4F, SIGLEC7, VEGFC	VEGFC [ELM:25752543;SIGNOR:16816121], SEMA4F [HPRD:9856463], NFASC [Cellinker:32589946], IL20RA [Cellinker:32589946], FCRL6 [Cellinker:32589946], SIGLEC7 [Cellinker:32589946]	axon [GO:0030424]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; integral component of membrane [GO:0016021]; integral component of postsynaptic membrane [GO:0099055]; membrane [GO:0016020]; plasma membrane [GO:0005886]; semaphorin receptor complex [GO:0002116]	cytokine binding [GO:0019955]; growth factor binding [GO:0019838]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; semaphorin receptor activity [GO:0017154]; signaling receptor activity [GO:0038023]; vascular endothelial growth factor-activated receptor activity [GO:0005021]	angiogenesis [GO:0001525]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; cell adhesion [GO:0007155]; cellular response to leukemia inhibitory factor [GO:1990830]; dorsal root ganglion morphogenesis [GO:1904835]; facial nerve structural organization [GO:0021612]; facioacoustic ganglion development [GO:1903375]; gonadotrophin-releasing hormone neuronal migration to the hypothalamus [GO:0021828]; negative chemotaxis [GO:0050919]; nerve development [GO:0021675]; neural crest cell migration involved in autonomic nervous system development [GO:1901166]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; regulation of postsynapse organization [GO:0099175]; semaphorin-plexin signaling pathway involved in neuron projection guidance [GO:1902285]; sensory neuron axon guidance [GO:0097374]; sympathetic ganglion development [GO:0061549]; sympathetic neuron projection extension [GO:0097490]; sympathetic neuron projection guidance [GO:0097491]; trigeminal ganglion development [GO:0061551]; ventral trunk neural crest cell migration [GO:0036486]; vestibulocochlear nerve structural organization [GO:0021649]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=NRP2&keywords=NRP2	18.077953882022474	176	NA	NA	1.2944469876768465	224	0.8110236220472435	0.04341317365269458	3.013274336283172	1.6573141486810314	0.011784511784511783	0.13536379018612515	0.10970081595648212	0.16802610114192504	0.10987791342952237	0.0655628254773688	0.1028781147382619	116	129	110	0.5662017593980307	0.20804850293196114	0.13113952577359492	0.19590032987089084	432	452	422
NRTN	neurturin	Yes		ENSG00000171119	Q99748	TGF-beta family, GDNF subfamily	16	ligand	extracellular, intracellular, ligand, secreted	O00451, O60609, P07949, P56159	GFRA1, GFRA1_RET, GFRA2, GFRA2_RET, GFRA3, RET	RET [Baccin2019:91828039192898;CellTalkDB:9182803;Cellinker:9182803;Cellinker:9192898;HPMR:9182803;HPMR:9192898;HPRD:9192898;LRdb:9182803;LRdb:919;SIGNOR:9182803;connectomeDB2020:9182803;connectomeDB2020:9192898], GFRA1 [Baccin2019:91828039407096;CellTalkDB:9182803;Cellinker:9182803;Cellinker:9407096;HPRD:9407096;LRdb:9182803;LRdb:941;SIGNOR:9182803;connectomeDB2020:9182803;connectomeDB2020:9407096], GFRA2 [Baccin2019:918280310829012;CellTalkDB:9182803;Cellinker:10829012;Cellinker:11544105;Cellinker:9182803;HPMR:9182803;HPMR:9192898;HPRD:10829012;LRdb:108;LRdb:9182803;connectomeDB2020:10829012;connectomeDB2020:9182803], GFRA3 [CellTalkDB:32196115]	axon [GO:0030424]; extracellular region [GO:0005576]	glial cell-derived neurotrophic factor receptor binding [GO:0030116]; growth factor activity [GO:0008083]; receptor tyrosine kinase binding [GO:0030971]; signaling receptor binding [GO:0005102]	MAPK cascade [GO:0000165]; nerve development [GO:0021675]; nervous system development [GO:0007399]; neural crest cell migration [GO:0001755]; neuron projection development [GO:0031175]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=NRTN&keywords=NRTN	NA	NA	NA	NA	NA	NA	0	0.00598802395209581	0.0011061946902654867	0	0.006734006734006734	0.005076142131979695	0.006346328195829556	0.0016313213703099511	0.001849796522382538	0.006709841100280396	8.112806644774968e-4	298	267	375	0.003295721396511606	0.8912488588615857	1.2567833366803665	0.813139832135325	192	84	180
NTF3	neurotrophin 3	Yes		ENSG00000185652	P20783	NGF-beta family	20	ligand	extracellular, intracellular, ligand, secreted	P04629, P08138, P23560, Q16288, Q16620	BDNF, NGFR, NTRK1, NTRK2, NTRK3	NTRK3 [AlzPathway:9775403;Baccin2019:7679912;Baccin2019:9488719;Baccin2019:9973222;CellChatDB:27908981;CellTalkDB:7679912;Cellinker:27908981;Cellinker:7679912;Cellinker:9488719;Cellinker:9973222;DIP:10713102;HPMR:1653651;HPMR:7679912;HPRD:9488719;HPRD:9973222;LRdb:7679912;LRdb:9488719;LRdb:9973222;SIGNOR:1653651;SignaLink3:1653651;SignaLink3:23331499;connectomeDB2020:7679912;connectomeDB2020:9488719;connectomeDB2020:9973222], NGFR [AlzPathway:9775403;CellTalkDB:20036257;connectomeDB2020:27434667], NTRK1 [CellChatDB:27908981;CellTalkDB:17439940;Cellinker:27908981;LRdb:17439940;Ramilowski2015:17439940;connectomeDB2020:17439940;talklr:17439940], NTRK2 [Baccin2019:8621424;CellChatDB:27908981;CellTalkDB:8621424;Cellinker:27908981;HPRD:8621424;LRdb:8621424;connectomeDB2020:8621424], BDNF [BioGRID:7703225;DIP:7703225;HPRD:7703225]	axon [GO:0030424]; dendrite [GO:0030425]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; synaptic vesicle [GO:0008021]	chemoattractant activity [GO:0042056]; growth factor activity [GO:0008083]; nerve growth factor receptor binding [GO:0005163]; signaling receptor binding [GO:0005102]	activation of GTPase activity [GO:0090630]; activation of protein kinase B activity [GO:0032148]; cell-cell signaling [GO:0007267]; induction of positive chemotaxis [GO:0050930]; memory [GO:0007613]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of peptidyl-tyrosine phosphorylation [GO:0050732]; nerve development [GO:0021675]; nerve growth factor signaling pathway [GO:0038180]; nervous system development [GO:0007399]; neuron projection morphogenesis [GO:0048812]; peripheral nervous system development [GO:0007422]; positive regulation of actin cytoskeleton reorganization [GO:2000251]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of receptor internalization [GO:0002092]; regulation of apoptotic process [GO:0042981]; regulation of neuron differentiation [GO:0045664]; signal transduction [GO:0007165]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=NTF3&keywords=NTF3	0.06837450224719101	701	NA	NA	0.02917002315537874	770	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NTF4	neurotrophin 4	Yes		ENSG00000225950	P34130	NGF-beta family	19	ligand	extracellular, intracellular, ligand, secreted	P04629, P08138, P23560, Q00994, Q16288, Q16620	BDNF, BEX3, NGFR, NTRK1, NTRK2, NTRK3	NGFR [AlzPathway:9775403;Baccin2019:7541633;CellTalkDB:7541633;Cellinker:7541633;HPRD:7541633;LRdb:7541633;connectomeDB2020:7541633], NTRK1 [Baccin2019:11114882;CellTalkDB:11114882;Cellinker:11114882;LRdb:11114882;SIGNOR:11114882;connectomeDB2020:11114882], NTRK2 [AlzPathway:9775403;Baccin2019:767991211855816;CellChatDB:27908981;CellTalkDB:7679912;Cellinker:11855816;Cellinker:27908981;Cellinker:7679912;HPRD:11855816;LRdb:119;LRdb:7679912;Lit-BM-17:11738045;Lit-BM-17:11855816;Lit-BM-17:25241761;SIGNOR:7679912;connectomeDB2020:11855816;connectomeDB2020:7679912], BEX3 [CellTalkDB:7679912;LRdb:7679912;connectomeDB2020:7679912], NTRK3 [NA], BDNF [IntAct:10631974;IntAct:25241761;IntAct:29997244]	axon [GO:0030424]; dendrite [GO:0030425]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; synaptic vesicle [GO:0008021]	growth factor activity [GO:0008083]; nerve growth factor receptor binding [GO:0005163]	adult locomotory behavior [GO:0008344]; epidermis development [GO:0008544]; ganglion mother cell fate determination [GO:0007402]; innervation [GO:0060384]; long-term memory [GO:0007616]; mechanoreceptor differentiation [GO:0042490]; memory [GO:0007613]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of neuron apoptotic process [GO:0043524]; nerve development [GO:0021675]; nerve growth factor signaling pathway [GO:0038180]; neuron projection morphogenesis [GO:0048812]; peripheral nervous system development [GO:0007422]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; regulation of neuron differentiation [GO:0045664]; sensory organ boundary specification [GO:0008052]; taste bud development [GO:0061193]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=NTF4&keywords=NTF4	0.05191060224719101	733	NA	NA	0.028024514544565678	774	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NTN1	netrin 1	Yes	act as growth factors	ENSG00000065320	O95631	NA	10	ecm, ligand	ecm, extracellular, intracellular, ligand, secreted	O60469, O95185, P29275, P43121, P43146, Q6UXZ4, Q6ZN44, Q8IZJ1, Q92859	ADORA2B, DCC, DSCAM, MCAM, NEO1, UNC5A, UNC5B, UNC5C, UNC5D	UNC5C [Baccin2019:10399920;Baccin2019:12810718;CellTalkDB:12810718;Cellinker:10399920;Cellinker:12810718;HPMR:12810718;HPRD:12810718;LRdb:1;LRdb:12810718;SIGNOR:10399920;connectomeDB2020:10399920;connectomeDB2020:12810718], UNC5D [CellTalkDB:9126742;LRdb:9126742;Ramilowski2015:9126742;connectomeDB2020:9126742;talklr:9126742], UNC5B [Baccin2019:23599441;CellTalkDB:9126742;Cellinker:26840727;LRdb:9126742;Ramilowski2015:9126742;connectomeDB2020:9126742;talklr:9126742], DCC [Baccin2019:10399920;Baccin2019:12810718;Baccin2019:8861902;Baccin2019:9950216;BioGRID:12810718;BioGRID:9950216;CellTalkDB:8861902;Cellinker:10399920;Cellinker:12810718;Cellinker:8861902;Cellinker:9950216;DIP:19721007;HPMR:11239160;HPMR:12810718;HPMR:8861902;HPRD:12810718;HPRD:9950216;IntAct:19721007;IntAct:26190107;LRdb:10399920;LRdb:12810718;LRdb:8861902;LRdb:9950216;connectomeDB2020:10399920;connectomeDB2020:12810718;connectomeDB2020:8861902;connectomeDB2020:9950216], UNC5A [CellTalkDB:9126742;Cellinker:28710382;LRdb:9126742;Ramilowski2015:9126742;connectomeDB2020:9126742;talklr:9126742], ADORA2B [Baccin2019:11048721;CellTalkDB:11048721;HPRD:11048721;LRdb:11048721;connectomeDB2020:11048721], NEO1 [Baccin2019:12636918;Baccin2019:8861902;CellTalkDB:8861902;Cellinker:12636918;Cellinker:8861902;HPRD:12636918;HPRD:8861902;LRdb:126;LRdb:8861902;connectomeDB2020:12636918;connectomeDB2020:8861902], MCAM [connectomeDB2020:25656845], DSCAM [Cellinker:25754961]	basement membrane [GO:0005604]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]	NA	animal organ morphogenesis [GO:0009887]; anterior/posterior axon guidance [GO:0033564]; apoptotic process [GO:0006915]; Cdc42 protein signal transduction [GO:0032488]; cell-cell adhesion [GO:0098609]; chemorepulsion of axon [GO:0061643]; dendrite development [GO:0016358]; inner ear morphogenesis [GO:0042472]; mammary gland duct morphogenesis [GO:0060603]; motor neuron axon guidance [GO:0008045]; negative regulation of axon extension [GO:0030517]; neuron migration [GO:0001764]; nuclear migration [GO:0007097]; positive regulation of axon extension [GO:0045773]; positive regulation of cell motility [GO:2000147]; positive regulation of cell population proliferation [GO:0008284]; Ras protein signal transduction [GO:0007265]; regulation of cell migration [GO:0030334]; regulation of synapse assembly [GO:0051963]; substrate-dependent cell migration, cell extension [GO:0006930]; tissue development [GO:0009888]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=NTN1&keywords=NTN1	2.3315238314606743	373	NA	NA	0.1788119385149939	548	0	0.009481037924151696	0	4.7961630695443646e-4	0.0016835016835016834	0.027072758037225034	0.009972801450589302	0	3.699593044765076e-4	0.018093203364935192	0.0012748696156074954	302	205	353	0.006220704335221941	0.6393038853410935	1.7319348645011103	0.695091247741014	284	34	239
NTN3	netrin 3	Yes		ENSG00000162068	O00634	NA	8	ecm, ligand	ecm, extracellular, intracellular, ligand, secreted	Q4KMG0, Q92859	CDON, NEO1	NEO1 [CellTalkDB:15520228;Cellinker:10366627;Cellinker:15520228;HPMR:15520228;HPRD:10366627;LRdb:1;LRdb:15520228;connectomeDB2020:10366627;connectomeDB2020:15520228], CDON [CellTalkDB:15520228;Cellinker:15520228;HPMR:15520228;LRdb:15520228;connectomeDB2020:15520228]	basement membrane [GO:0005604]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]	signaling receptor binding [GO:0005102]	animal organ morphogenesis [GO:0009887]; axon guidance [GO:0007411]; dendrite development [GO:0016358]; motor neuron axon guidance [GO:0008045]; tissue development [GO:0009888]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=NTN3&keywords=NTN3	0.0015523022471910113	889	NA	NA	0.06644115414545747	684	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NTN4	netrin 4	Yes	act as growth factors	ENSG00000074527	Q9HB63	NA	10	ecm, ligand	ecm, extracellular, ligand, secreted	P43146, Q6ZN44	DCC, UNC5A	UNC5A [Baccin2019:17174565;CellTalkDB:17174565;Cellinker:17174565;LRdb:17174565;SIGNOR:12598531;connectomeDB2020:17174565], DCC [Baccin2019:17174565;CellTalkDB:17174565;Cellinker:17174565;DIP:19721007;LRdb:17174565;connectomeDB2020:17174565]	extracellular region [GO:0005576]; laminin complex [GO:0043256]; plasma membrane [GO:0005886]	laminin-1 binding [GO:0043237]	animal organ morphogenesis [GO:0009887]; basement membrane assembly [GO:0070831]; cell migration [GO:0016477]; neuron remodeling [GO:0016322]; regulation of branching involved in salivary gland morphogenesis by extracellular matrix-epithelial cell signaling [GO:0060668]; substrate adhesion-dependent cell spreading [GO:0034446]; tissue development [GO:0009888]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=NTN4&keywords=NTN4	30.303959706491447	135	NA	NA	1.2867561649238097	227	0	0.3652694610778483	0.015486725663716814	0.02853717026378896	0.11111111111111124	0.001692047377326565	0	0.0016313213703099511	0.0033296337402885685	6.008812925624251e-4	0.0039018736720108204	294	385	302	0.048323656869905786	0.22854591868306665	0.18175954426534485	0.2383573736300475	422	424	407
NTN5	netrin 5	Yes		ENSG00000142233	Q8WTR8	NA	1	ecm, ligand	ecm, ligand, secreted	NA	NA	NA	basement membrane [GO:0005604]; extracellular region [GO:0005576]	signaling receptor binding [GO:0005102]	animal organ morphogenesis [GO:0009887]; dendrite development [GO:0016358]; motor neuron axon guidance [GO:0008045]; neurogenesis [GO:0022008]; tissue development [GO:0009888]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=NTN5&keywords=NTN5	0.04719944382022472	740	NA	NA	0.033686432220191014	756	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NTNG1	netrin G1	No		ENSG00000162631	Q9Y2I2	NA	1	adhesion, cell_surface_ligand, ecm	adhesion, cell_adhesion, cell_surface, cell_surface_ligand, ecm, extracellular, plasma_membrane, plasma_membrane_peripheral, secreted	Q9HCJ2, Q9NYZ4	LRRC4C, SIGLEC8	LRRC4C [Baccin2019:1459544314595440;BioGRID:21946559;CellTalkDB:14595443;HPMR:14595443;HPRD:14595443;IntAct:21946559;LRdb:14595443;Lit-BM-17:14595443;Lit-BM-17:21946559;SIGNOR:19467332;connectomeDB2020:14595443], SIGLEC8 [Cellinker:32589946]	anchored component of plasma membrane [GO:0046658]; anchored component of presynaptic active zone membrane [GO:0099029]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; laminin complex [GO:0043256]; plasma membrane [GO:0005886]; Schaffer collateral - CA1 synapse [GO:0098685]	cell adhesion molecule binding [GO:0050839]; cell-cell adhesion mediator activity [GO:0098632]	animal organ morphogenesis [GO:0009887]; axonogenesis [GO:0007409]; basement membrane assembly [GO:0070831]; cell migration [GO:0016477]; modulation of chemical synaptic transmission [GO:0050804]; regulation of neuron migration [GO:2001222]; regulation of neuron projection arborization [GO:0150011]; regulation of neuron projection development [GO:0010975]; substrate adhesion-dependent cell spreading [GO:0034446]; synaptic membrane adhesion [GO:0099560]; tissue development [GO:0009888]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=NTNG1&keywords=NTNG1	0.6023648426640369	506	NA	NA	0.3979675716617066	420	0	0.03143712574850297	0.0011061946902654867	0.003117505995203836	0.0016835016835016834	0.05752961082910323	0.003626473254759746	0.0016313213703099511	0.07806141324454305	0.00527440245693683	0.0010044427274483296	141	288	366	0.016770181090961372	3.28953371459545	0.5705752383607912	0.4110709109533759	11	295	349
NTNG2	netrin G2	No		ENSG00000196358	Q96CW9	NA	8	adhesion, cell_surface_ligand, ecm, ligand, receptor	adhesion, cell_adhesion, cell_surface, cell_surface_ligand, ecm, extracellular, intracellular, ligand, peripheral, plasma_membrane, receptor, secreted	Q9HBW1, Q9HCJ2	LRRC4, LRRC4C	LRRC4 [CellTalkDB:17973922;Cellinker:25411505;IntAct:21946559;LRdb:17973922;Lit-BM-17:21946559;Ramilowski2015:17973922;SIGNOR:19467332;connectomeDB2020:17973922;talklr:17973922], LRRC4C [CellTalkDB:32196115]	anchored component of plasma membrane [GO:0046658]; anchored component of presynaptic active zone membrane [GO:0099029]; axon [GO:0030424]; extracellular region [GO:0005576]; Flemming body [GO:0090543]; glutamatergic synapse [GO:0098978]; intercellular bridge [GO:0045171]; laminin complex [GO:0043256]; plasma membrane [GO:0005886]; Schaffer collateral - CA1 synapse [GO:0098685]	NA	animal organ morphogenesis [GO:0009887]; axonogenesis [GO:0007409]; basement membrane assembly [GO:0070831]; cell migration [GO:0016477]; modulation of chemical synaptic transmission [GO:0050804]; postsynaptic specialization assembly [GO:0098698]; regulation of neuron migration [GO:2001222]; regulation of neuron projection arborization [GO:0150011]; regulation of neuron projection development [GO:0010975]; regulation of presynapse assembly [GO:1905606]; substrate adhesion-dependent cell spreading [GO:0034446]; synaptic membrane adhesion [GO:0099560]; tissue development [GO:0009888]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=NTNG2&keywords=NTNG2	0.23238122674157302	603	NA	NA	0.08236674004839184	656	0	0.001996007984031936	0	0.0021582733812949635	0.00505050505050505	0.030456852791878167	0.021758839528558477	0.004893964110929854	0.007029226785053647	0.018360261717185158	0.0014680316785783281	279	204	345	0.008470178457092326	0.9219849621168458	1.5354622470523644	0.6208944707935262	169	51	276
NTS	neurotensin	Yes		ENSG00000133636	P30990	Neurotensin family	14	ligand	extracellular, intracellular, ligand, secreted	O95665, P08138, P30989, Q99523	NGFR, NTSR1, NTSR2, SORT1	NTSR1 [Baccin2019:10930533;Baccin2019:11559354;Baccin2019:11723247;Baccin2019:11811984;Baccin2019:1331689;Baccin2019:16087676;Baccin2019:1694443;CellTalkDB:11811984;Cellinker:10930533;Cellinker:11559354;Cellinker:11723247;Cellinker:11811984;Cellinker:1331689;Cellinker:16087676;Cellinker:1694443;DIP:17620610;Guide2Pharma:10930533;Guide2Pharma:11723247;Guide2Pharma:11811984;HPMR:1694443;HPRD:11559354;HPRD:16087676;LRdb:10930533;LRdb:11559354;LRdb:11723247;LRdb:11811984;LRdb:1331689;LRdb:16087676;LRdb:1694443;Lit-BM-17:11559354;Lit-BM-17:23597562;SIGNOR:1331689;connectomeDB2020:10930533;connectomeDB2020:11559354;connectomeDB2020:11723247;connectomeDB2020:11811984;connectomeDB2020:1331689;connectomeDB2020:16087676;connectomeDB2020:1694443;scConnect:10930533;scConnect:11723247;scConnect:11811984], NTSR2 [Baccin2019:11723247;Baccin2019:11801734;Baccin2019:16087676;Baccin2019:9851594;CellTalkDB:11723247;Cellinker:11723247;Cellinker:11801734;Cellinker:16087676;Cellinker:9851594;Guide2Pharma:11723247;HPMR:9851594;HPRD:11801734;HPRD:16087676;LRdb:11723247;LRdb:11801734;LRdb:16087676;LRdb:9851594;SIGNOR:9851594;connectomeDB2020:11723247;connectomeDB2020:11801734;connectomeDB2020:16087676;connectomeDB2020:9851594;scConnect:11723247], SORT1 [Baccin2019:16087676;Baccin2019:9756851;CellTalkDB:9756851;Cellinker:16087676;Cellinker:9756851;HPRD:16087676;HPRD:9756851;LRdb:161;LRdb:9756851;connectomeDB2020:16087676;connectomeDB2020:9756851], NGFR [CellTalkDB:32196115]	axon terminus [GO:0043679]; extracellular region [GO:0005576]; intracellular membrane-bounded organelle [GO:0043231]; transport vesicle [GO:0030133]	neuropeptide hormone activity [GO:0005184]; neuropeptide receptor binding [GO:0071855]; receptor ligand activity [GO:0048018]	antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; killing of cells of other organism [GO:0031640]; negative regulation of gene expression [GO:0010629]; neuropeptide signaling pathway [GO:0007218]; positive regulation of gene expression [GO:0010628]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein kinase B signaling [GO:0051897]; signal transduction [GO:0007165]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=NTS&keywords=NTS	1.423632577688754	415	NA	NA	0.8825512489881148	288	0	0	0	0	0	0	9.066183136899365e-4	0	0.015908250092489827	3.672052343437042e-4	0.005601699826154144	248	395	285	0.0020712521333343284	2.1462769401481663	0.8588342882603736	1.2924673972363323	27	187	50
NXPH1	neurexophilin 1	Yes		ENSG00000122584	P58417	Neurexophilin family	9	ligand	extracellular, ligand, secreted	P58400, P58401, Q9HDB5, Q9P2S2, Q9ULB1, Q9Y4C0	NRXN1, NRXN2, NRXN3	NRXN1 [Baccin2019:8699246;Baccin2019:9856994;Cellinker:8699246;Cellinker:9856994;HPMR:9856994;HPRD:8699246;HPRD:9856994;LRdb:8699246;LRdb:9856994;SIGNOR:9856994;connectomeDB2020:8699246;connectomeDB2020:9856994], NRXN1 [Baccin2019:8699246;Baccin2019:9856994;Cellinker:8699246;Cellinker:9856994;HPRD:8699246;HPRD:9856994;LRdb:8699246;LRdb:9856994;SIGNOR:9856994;connectomeDB2020:8699246;connectomeDB2020:9856994], NRXN3 [Baccin2019:9856994;Cellinker:9856994;HPMR:9856994;LRdb:9856994;SIGNOR:9856994;connectomeDB2020:9856994], NRXN3 [Baccin2019:9856994;Cellinker:9856994;LRdb:9856994;connectomeDB2020:9856994], NRXN2 [Cellinker:9856994;HPMR:9856994;LRdb:9856994;connectomeDB2020:9856994], NRXN2 [Baccin2019:9856994;Cellinker:9856994;LRdb:9856994;connectomeDB2020:9856994]	extracellular region [GO:0005576]	signaling receptor binding [GO:0005102]	NA	https://www.genecards.org/cgi-bin/carddisp.pl?gene=NXPH1&keywords=NXPH1	0.04214749550561798	751	NA	NA	0.02516466761118196	785	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NXPH2	neurexophilin 2	Yes		ENSG00000144227	O95156	Neurexophilin family	9	ligand	intracellular, ligand, secreted	P58400, Q9ULB1	NRXN1	NRXN1 [Baccin2019:8699246;CellTalkDB:8699246;Cellinker:8699246;HPRD:8699246;LRdb:8699246;connectomeDB2020:8699246], NRXN1 [Baccin2019:8699246;CellTalkDB:8699246;Cellinker:8699246;HPRD:8699246;LRdb:8699246;connectomeDB2020:8699246]	extracellular region [GO:0005576]	signaling receptor binding [GO:0005102]	neuropeptide signaling pathway [GO:0007218]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=NXPH2&keywords=NXPH2	0.03601546966292135	761	NA	NA	0.16957641970512147	556	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
NXPH3	neurexophilin 3	Yes		ENSG00000182575	O95157	Neurexophilin family	9	ligand	ligand, secreted	P58400, P58401, Q9HDB5, Q9P2S2, Q9ULB1, Q9Y4C0	NRXN1, NRXN2, NRXN3	NRXN1 [Baccin2019:98569949856994;Cellinker:9856994;HPRD:9856994;LRdb:9856994;connectomeDB2020:9856994], NRXN1 [Baccin2019:98569949856994;Cellinker:9856994;HPRD:9856994;LRdb:9856994;connectomeDB2020:9856994], NRXN3 [Baccin2019:9856994;Cellinker:9856994;LRdb:9856994;connectomeDB2020:9856994], NRXN3 [Baccin2019:9856994;Cellinker:9856994;LRdb:9856994;connectomeDB2020:9856994], NRXN2 [Cellinker:9856994;LRdb:9856994;connectomeDB2020:9856994], NRXN2 [Baccin2019:9856994;Cellinker:9856994;LRdb:9856994;connectomeDB2020:9856994]	extracellular region [GO:0005576]	signaling receptor binding [GO:0005102]	neuropeptide signaling pathway [GO:0007218]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=NXPH3&keywords=NXPH3	0.46120110625456645	532	NA	NA	0.035868690360490486	749	0	4.99001996007984e-4	0	4.7961630695443646e-4	0.0016835016835016834	0.00676818950930626	0.007252946509519492	0.004893964110929854	7.399186089530152e-4	0.009046601682467598	2.704268881591655e-4	301	248	394	0.0028758333905272264	0.8341144439515964	1.4792519524584884	0.7976514278070059	207	55	190
OBP2A	odorant binding protein 2A	TBD		ENSG00000122136	Q9NY56	Calycin superfamily, Lipocalin family	6	ligand	extracellular, ligand, secreted	P47890	OR1G1	OR1G1 [CellTalkDB:12379593;Cellinker:12379593;HPRD:12379593;LRdb:12379593]	extracellular space [GO:0005615]	odorant binding [GO:0005549]; small molecule binding [GO:0036094]	response to stimulus [GO:0050896]; sensory perception of chemical stimulus [GO:0007606]; sensory perception of smell [GO:0007608]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=OBP2A&keywords=OBP2A	0.008057842696629213	838	NA	NA	0.07927340079325287	661	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
OGN	osteoglycin	No		ENSG00000106809	P20774	Small leucine-rich proteoglycan (SLRP) family, SLRP class III subfamily	3	ecm, ligand	ecm, extracellular, intracellular, ligand, secreted	P01911	HLA-DRB1	HLA-DRB1 [NA]	collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular vesicle [GO:1903561]; Golgi lumen [GO:0005796]; lysosomal lumen [GO:0043202]	growth factor activity [GO:0008083]	negative regulation of smooth muscle cell proliferation [GO:0048662]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=OGN&keywords=OGN	0.6337005175194382	502	NA	NA	0.01489214513406456	813	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
OLFM2	olfactomedin 2	Yes		ENSG00000105088	O95897	NA	8	ligand	intracellular, ligand, secreted	Q9HCK4	ROBO2	ROBO2 [Baccin2019:16169070;Cellinker:16169070;HPRD:16169070;LRdb:16169070]	AMPA glutamate receptor complex [GO:0032281]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; synapse [GO:0045202]	NA	positive regulation of smooth muscle cell differentiation [GO:0051152]; protein secretion [GO:0009306]; regulation of vascular associated smooth muscle cell dedifferentiation [GO:1905174]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=OLFM2&keywords=OLFM2	18.913140830062066	173	3501.32	106	0.5844285670984297	348	0	0.02245508982035927	0.004424778761061947	0.3446043165467652	0.02861952861952861	0.4230118443316421	0.3281958295557561	0.137030995106036	0.19422863485016537	0.2822139137401533	0.014448522310218157	82	65	227	0.16174849578560782	1.1891145475014944	1.701405956445298	0.14235072160828144	89	36	452
OMD	osteomodulin	No	ECM	ENSG00000127083	Q99983	Small leucine-rich proteoglycan (SLRP) family, SLRP class II subfamily	1	ecm, ligand	ecm, extracellular, intracellular, ligand, secreted	NA	NA	NA	collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; lysosomal lumen [GO:0043202]	NA	cell adhesion [GO:0007155]; regulation of bone mineralization [GO:0030500]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=OMD&keywords=OMD	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
OOSP1	oocyte secreted protein 1		manually added ensembl_gene_ID, hgnc_symbol, and description by searching the uniprot ID on genenames.org	ENSG00000284873	A8MZH6	PLAC1 family	1	ligand	ligand, secreted	NA	NA	NA	extracellular region [GO:0005576]	NA	NA	https://www.genecards.org/cgi-bin/carddisp.pl?gene=OOSP1&keywords=OOSP1	0.057563523595505615	720	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
OOSP2	oocyte secreted protein 2	TBD		ENSG00000285422, ENSG00000149507	Q86WS3	PLAC1 family	1	ligand	ligand, secreted	NA	NA	NA	extracellular region [GO:0005576]	NA	NA	https://www.genecards.org/cgi-bin/carddisp.pl?gene=OOSP2&keywords=OOSP2	0.00274188202247191	871	NA	NA	0.0254619799065793	784	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
OOSP3	oocyte secreted protein family member 3			ENSG00000285231	A0A2R8YFM6	PLAC1 family	1	ligand	ligand, secreted	NA	NA	NA	extracellular region [GO:0005576]	NA	NA	https://www.genecards.org/cgi-bin/carddisp.pl?gene=OOSP3&keywords=OOSP3	0.04625928876404495	741	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
OOSP4A	oocyte secreted protein family member 4A			ENSG00000285375, ENSG00000285010	A0A2R8YFL7	PLAC1 family	1	ligand	ligand, secreted	NA	NA	NA	extracellular region [GO:0005576]	NA	NA	https://www.genecards.org/cgi-bin/carddisp.pl?gene=OOSP4A&keywords=OOSP4A	0.062377716853932584	711	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
OOSP4B	oocyte secreted protein family member 4B			ENSG00000285463, ENSG00000255393	A0A2R8Y4Y8	PLAC1 family	1	ligand	ligand, secreted	NA	NA	NA	extracellular region [GO:0005576]	NA	NA	https://www.genecards.org/cgi-bin/carddisp.pl?gene=OOSP4B&keywords=OOSP4B	0.030603611235955057	772	NA	NA	1.7046824893284682	187	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
ORM1	orosomucoid 1	TBD	manually added ensembl_gene_ID, hgnc_symbol, and description by searching the uniprot ID on genenames.org	ENSG00000229314	P02763	Calycin superfamily, Lipocalin family	7	ligand	extracellular, intracellular, ligand, secreted	P51681	CCR5	CCR5 [CellTalkDB:11336643;Cellinker:11336643;HPRD:11336643;LRdb:11336643;connectomeDB2020:11336643]	blood microparticle [GO:0072562]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; platelet alpha granule lumen [GO:0031093]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724]	NA	acute-phase response [GO:0006953]; inflammatory response [GO:0006954]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of tumor necrosis factor production [GO:0032720]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-1 production [GO:0032732]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of immune system process [GO:0002682]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=ORM1&keywords=ORM1	0.019669113483146067	797	NA	NA	1.7981960881782616e-4	904	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
OSM	oncostatin M	Yes		ENSG00000099985	P13725	LIF/OSM family	21	ligand	extracellular, intracellular, ligand, secreted	P05231, P40189, P42702, Q99650	IL6, IL6ST, IL6ST_LIFR, IL6ST_OSMR, LIFR, OSMR	OSMR [Baccin2019:10997905;Baccin2019:8999038;CellTalkDB:8999038;HPMR:10854424;HPMR:8999038;HPRD:10997905;HPRD:8999038;LRdb:10997905;LRdb:8999038;SIGNOR:16286453;SignaLink3:16286453;SignaLink3:23331499;connectomeDB2020:10997905;connectomeDB2020:8999038], IL6ST [Baccin2019:10854424;Baccin2019:16051226;Baccin2019:8999038;CellTalkDB:16051226;DIP:8999038;DOMINO:16051226;HPMR:10854424;HPMR:8999038;HPRD:16051226;HPRD:8999038;LRdb:10854424;LRdb:16051226;LRdb:8999038;SIGNOR:9143707;connectomeDB2020:10854424;connectomeDB2020:16051226;connectomeDB2020:8999038], LIFR [Baccin2019:10854424;Baccin2019:1536831;Baccin2019:1542794;Baccin2019:16051226;CellTalkDB:10854424;DIP:8999038;DOMINO:16051226;HPRD:1536831;HPRD:1542794;HPRD:16051226;LRdb:10854424;LRdb:1536831;LRdb:1542794;LRdb:16051226;SIGNOR:1536831;connectomeDB2020:10854424;connectomeDB2020:1536831;connectomeDB2020:1542794;connectomeDB2020:16051226], IL6 [DIP:10681548]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; oncostatin-M receptor binding [GO:0005147]	immune response [GO:0006955]; multicellular organism development [GO:0007275]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of hormone secretion [GO:0046888]; oncostatin-M-mediated signaling pathway [GO:0038165]; positive regulation of acute inflammatory response [GO:0002675]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; regulation of growth [GO:0040008]; regulation of hematopoietic stem cell differentiation [GO:1902036]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=OSM&keywords=OSM	0.06505438629213484	706	NA	NA	0.0404036041778177	736	0.7086614173228345	0	0	4.7961630695443646e-4	0	0	9.066183136899365e-4	0	0	6.676458806249166e-5	3.8632412594166507e-5	303	407	400	0.0645593680858305	0.1341213083845923	0.13501676377506225	0.13463945135691058	464	451	456
OSTN	osteocrin	Yes		ENSG00000188729	P61366	Osteocrin family	16	ligand	extracellular, ligand, secreted	P17342	NPR3	NPR3 [Baccin2019:17951249;CellChatDB:29326144;CellTalkDB:17951249;Cellinker:17951249;Cellinker:29326144;Guide2Pharma:17951249;ICELLNET:17951249;ICELLNET:19244276;LRdb:17951249;connectomeDB2020:17951249;scConnect:17951249]	extracellular space [GO:0005615]	hormone activity [GO:0005179]; signaling receptor binding [GO:0005102]	cell differentiation [GO:0030154]; cell surface receptor signaling pathway [GO:0007166]; endochondral bone growth [GO:0003416]; hormone-mediated signaling pathway [GO:0009755]; negative regulation of dendrite extension [GO:1903860]; negative regulation of glucose import [GO:0046325]; negative regulation of osteoblast differentiation [GO:0045668]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=OSTN&keywords=OSTN	0.001917491011235955	884	NA	NA	0.06825486478821854	678	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
OTOL1	otolin 1	No		ENSG00000182447	A6NHN0	OTOL1 family	1	ecm, ligand	ecm, ligand, secreted	NA	NA	NA	collagen type IV trimer [GO:0005587]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	calcium ion binding [GO:0005509]; extracellular matrix structural constituent [GO:0005201]	collagen-activated tyrosine kinase receptor signaling pathway [GO:0038063]; extracellular matrix organization [GO:0030198]; otolith mineralization [GO:0045299]; protein homooligomerization [GO:0051260]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=OTOL1&keywords=OTOL1	0.0032461786516853933	867	NA	NA	0.8893882926104907	286	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
OTOR	otoraplin	No		ENSG00000125879	Q9NRC9	MIA/OTOR family	1	ligand	extracellular, ligand, secreted	NA	NA	NA	extracellular region [GO:0005576]	NA	cartilage condensation [GO:0001502]; sensory perception of sound [GO:0007605]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=OTOR&keywords=OTOR	0.01286542584269663	817	NA	NA	1.9022623414281206	167	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
OXT	oxytocin/neurophysin I prepropeptide	Yes		ENSG00000101405	P01178	Vasopressin/oxytocin family	15	ligand	extracellular, intracellular, ligand, secreted	P30518, P30559, P37288, P47901	AVPR1A, AVPR1B, AVPR2, OXTR	OXTR [Baccin2019:10519430;Baccin2019:10698266;Baccin2019:12660315;Baccin2019:1313946;Baccin2019:16158071;Baccin2019:7475979;Baccin2019:7774575;Baccin2019:8955347;CellTalkDB:10519430;Cellinker:10519430;Cellinker:10698266;Cellinker:12660315;Cellinker:1313946;Cellinker:16158071;Cellinker:7475979;Cellinker:7774575;Cellinker:8955347;Guide2Pharma:10519430;Guide2Pharma:12660315;Guide2Pharma:16158071;Guide2Pharma:7475979;Guide2Pharma:7774575;Guide2Pharma:8955347;HPMR:1313946;HPRD:10698266;LRdb:10519430;LRdb:10698266;LRdb:12660315;LRdb:1313946;LRdb:16158071;LRdb:7475979;LRdb:7774575;LRdb:8955347;SIGNOR:1313946;connectomeDB2020:10519430;connectomeDB2020:10698266;connectomeDB2020:12660315;connectomeDB2020:1313946;connectomeDB2020:16158071;connectomeDB2020:7475979;connectomeDB2020:7774575;connectomeDB2020:8955347;scConnect:10519430;scConnect:12660315;scConnect:16158071;scConnect:7475979;scConnect:7774575;scConnect:8955347], AVPR1A [Baccin2019:10519430;Baccin2019:12660315;Baccin2019:8106369;Baccin2019:9264324;Baccin2019:9322919;Baccin2019:9334232;Baccin2019:9459574;Baccin2019:9884074;CellTalkDB:8106369;Cellinker:10519430;Cellinker:12660315;Cellinker:8106369;Cellinker:9264324;Cellinker:9322919;Cellinker:9334232;Cellinker:9459574;Cellinker:9884074;Guide2Pharma:10519430;Guide2Pharma:12660315;Guide2Pharma:8106369;Guide2Pharma:9264324;Guide2Pharma:9322919;Guide2Pharma:9334232;Guide2Pharma:9459574;Guide2Pharma:9884074;LRdb:10519430;LRdb:12660315;LRdb:8106369;LRdb:9264324;LRdb:9322919;LRdb:9334232;LRdb:9459574;LRdb:9884074;connectomeDB2020:10519430;connectomeDB2020:12660315;connectomeDB2020:8106369;connectomeDB2020:9264324;connectomeDB2020:9322919;connectomeDB2020:9334232;connectomeDB2020:9459574;connectomeDB2020:9884074;scConnect:10519430;scConnect:12660315;scConnect:8106369;scConnect:9264324;scConnect:9322919;scConnect:9334232;scConnect:9459574;scConnect:9884074], AVPR1B [Baccin2019:16158071;Baccin2019:9264324;Baccin2019:9322919;Baccin2019:9459574;Baccin2019:9884074;CellTalkDB:16158071;Guide2Pharma:16158071;Guide2Pharma:9264324;Guide2Pharma:9322919;Guide2Pharma:9459574;Guide2Pharma:9884074;LRdb:16158071;LRdb:9264324;LRdb:9322919;LRdb:9459574;LRdb:9884074;connectomeDB2020:16158071;connectomeDB2020:9264324;connectomeDB2020:9322919;connectomeDB2020:9459574;connectomeDB2020:9884074;scConnect:16158071;scConnect:9264324;scConnect:9322919;scConnect:9459574;scConnect:9884074], AVPR2 [Baccin2019:12660315;Baccin2019:7774575;Baccin2019:9264324;Baccin2019:9322919;Baccin2019:9459574;Baccin2019:9884074;CellTalkDB:9884074;Guide2Pharma:12660315;Guide2Pharma:7774575;Guide2Pharma:9264324;Guide2Pharma:9322919;Guide2Pharma:9459574;Guide2Pharma:9884074;LRdb:12660315;LRdb:7774575;LRdb:9264324;LRdb:9322919;LRdb:9459574;LRdb:9884074;connectomeDB2020:12660315;connectomeDB2020:7774575;connectomeDB2020:9264324;connectomeDB2020:9322919;connectomeDB2020:9459574;connectomeDB2020:9884074;scConnect:12660315;scConnect:7774575;scConnect:9264324;scConnect:9322919;scConnect:9459574;scConnect:9884074]	extracellular region [GO:0005576]; extracellular space [GO:0005615]; secretory granule [GO:0030141]; terminal bouton [GO:0043195]	neurohypophyseal hormone activity [GO:0005185]; neuropeptide hormone activity [GO:0005184]; oxytocin receptor binding [GO:0031855]	drinking behavior [GO:0042756]; eating behavior [GO:0042755]; female pregnancy [GO:0007565]; grooming behavior [GO:0007625]; heart development [GO:0007507]; hyperosmotic salinity response [GO:0042538]; male mating behavior [GO:0060179]; maternal aggressive behavior [GO:0002125]; maternal behavior [GO:0042711]; memory [GO:0007613]; negative regulation of blood pressure [GO:0045776]; negative regulation of gastric acid secretion [GO:0060455]; negative regulation of urine volume [GO:0035811]; positive regulation of blood pressure [GO:0045777]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of female receptivity [GO:0045925]; positive regulation of hindgut contraction [GO:0060450]; positive regulation of norepinephrine secretion [GO:0010701]; positive regulation of ossification [GO:0045778]; positive regulation of penile erection [GO:0060406]; positive regulation of prostaglandin secretion [GO:0032308]; positive regulation of renal sodium excretion [GO:0035815]; positive regulation of synapse assembly [GO:0051965]; positive regulation of synaptic transmission [GO:0050806]; positive regulation of uterine smooth muscle contraction [GO:0070474]; regulation of heart rate [GO:0002027]; regulation of sensory perception of pain [GO:0051930]; response to activity [GO:0014823]; response to amphetamine [GO:0001975]; response to cAMP [GO:0051591]; response to cocaine [GO:0042220]; response to electrical stimulus [GO:0051602]; response to estradiol [GO:0032355]; response to ether [GO:0045472]; response to food [GO:0032094]; response to glucocorticoid [GO:0051384]; response to peptide hormone [GO:0043434]; response to progesterone [GO:0032570]; response to prostaglandin E [GO:0034695]; response to retinoic acid [GO:0032526]; response to sucrose [GO:0009744]; signal transduction [GO:0007165]; sleep [GO:0030431]; social behavior [GO:0035176]; sperm ejaculation [GO:0042713]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=OXT&keywords=OXT	0.0018518988764044944	887	NA	NA	0.001886240123334347	890	0	9.98003992015968e-4	0	0.004796163069544363	0	0.01015228426395939	0.004533091568449683	0.0032626427406199023	0.004439511653718092	0.006910134864467871	0.0014293992659841616	289	264	346	0.0033201119471599483	1.0840383107138087	1.2695189748816917	0.8580557964770772	117	83	160
PAM	peptidylglycine alpha-amidating monooxygenase	No		ENSG00000145730	P19021	Peptidyl-alpha-hydroxyglycine alpha-amidating lyase family; Copper type II ascorbate-dependent monooxygenase family	1	ligand	cell_surface, extracellular, intracellular, ligand, plasma_membrane_transmembrane, secreted, transmembrane, transmembrane_predicted	O00168, P01189, P27487, Q12884	DPP4, FAP, FXYD1, POMC	DPP4 [Cellinker:21314817], FAP [Cellinker:21314817], POMC [HPRD-phos:18052119;HPRD:18052119], FXYD1 [HPRD-phos:18052119;HPRD:18052119]	cell surface [GO:0009986]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; neuron projection [GO:0043005]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; trans-Golgi network [GO:0005802]; transport vesicle membrane [GO:0030658]	calcium ion binding [GO:0005509]; copper ion binding [GO:0005507]; identical protein binding [GO:0042802]; L-ascorbic acid binding [GO:0031418]; peptidylamidoglycolate lyase activity [GO:0004598]; peptidylglycine monooxygenase activity [GO:0004504]; protein kinase binding [GO:0019901]; zinc ion binding [GO:0008270]	central nervous system development [GO:0007417]; fatty acid primary amide biosynthetic process [GO:0062112]; heart development [GO:0007507]; lactation [GO:0007595]; limb development [GO:0060173]; long-chain fatty acid metabolic process [GO:0001676]; maternal process involved in female pregnancy [GO:0060135]; odontogenesis [GO:0042476]; ovulation cycle process [GO:0022602]; peptide amidation [GO:0001519]; protein amidation [GO:0018032]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of protein secretion [GO:0050708]; regulation of transcription by RNA polymerase II [GO:0006357]; response to copper ion [GO:0046688]; response to estradiol [GO:0032355]; response to glucocorticoid [GO:0051384]; response to hypoxia [GO:0001666]; response to pH [GO:0009268]; response to xenobiotic stimulus [GO:0009410]; response to zinc ion [GO:0010043]; toxin metabolic process [GO:0009404]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=PAM&keywords=PAM	413.87955080561795	24	37354.4	26	6.580028374421683	60	0.10236220472440945	0.17514970059880283	0.2676991150442479	0.3285371702637923	0.3097643097643096	1.6598984771573537	2.0698096101541394	1.8548123980424127	0.7199408065112836	1.4407798103890064	1.1623720301333857	31	23	21	0.9173750575257403	0.7871042040517929	1.5643938216968256	1.2641832671899798	225	46	55
PATE1	prostate and testis expressed 1	No		ENSG00000171053	Q8WXA2	PATE family	1	ligand	ligand, secreted, transmembrane	NA	NA	NA	extracellular region [GO:0005576]	acetylcholine receptor regulator activity [GO:0030548]	regulation of neurotransmitter receptor activity [GO:0099601]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=PATE1&keywords=PATE1	0.005308193258426967	854	NA	NA	1.2651000534036672	231	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
PATE2	prostate and testis expressed 2	No		ENSG00000196844	Q6UY27	PATE family	1	ligand	ligand, secreted	NA	NA	NA	extracellular space [GO:0005615]	NA	NA	https://www.genecards.org/cgi-bin/carddisp.pl?gene=PATE2&keywords=PATE2	0.05290187865168539	731	NA	NA	0.7070613067481166	317	0	4.99001996007984e-4	0	0	0	0.005076142131979695	0.008159564823209429	0.004893964110929854	0.0029596744358120607	0.001001468820937375	0.003438284720880822	295	371	309	0.0023661910036142926	1.0479924199799526	0.8896408617432767	1.0866955489328272	122	175	81
PATE3	prostate and testis expressed 3	No		ENSG00000236027	B3GLJ2	PATE family	1	ligand	ligand, secreted	NA	NA	NA	extracellular region [GO:0005576]	NA	NA	https://www.genecards.org/cgi-bin/carddisp.pl?gene=PATE3&keywords=PATE3	4.5787415730337073e-4	897	NA	NA	0.7016013046125488	320	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
PATE4	prostate and testis expressed 4	No		ENSG00000237353	P0C8F1	PATE family	1	ligand	intracellular, ligand, receptor_regulator, secreted, transmembrane	NA	NA	NA	acrosomal vesicle [GO:0001669]; extracellular space [GO:0005615]	acetylcholine receptor regulator activity [GO:0030548]	regulation of neurotransmitter receptor activity [GO:0099601]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=PATE4&keywords=PATE4	0.17568261528089887	624	NA	NA	4.2084765276070595	85	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
PCNA	proliferating cell nuclear antigen			ENSG00000132646	P12004	PCNA family	1	ligand	extracellular, intracellular, ligand, secreted	O60673, O95944, P24941, P26358, P30281, P39748, Q00534, Q13112, Q9H211, Q9HCU8, Q9UGP5, Q9UNA4, Q9UQ84, Q9Y253	_POLD1_POLD2_POLD3_POLD4, CCND3, CDK2, CDK6, CDT1, CHAF1B, DNMT1, EXO1, FEN1, NCR2, POLD4, POLE_POLE2_POLE3_POLE4, POLH, POLI, POLL, REV3L	POLI [BioGRID:11724965;BioGRID:18931444;ELM:19208623;HPRD:16763556;Lit-BM-17:15342632;Lit-BM-17:16763556;Lit-BM-17:18931444;Lit-BM-17:23248005;Lit-BM-17:26903512;SPIKE:16357261], POLH [BioGRID:15149598;BioGRID:21855803;BioGRID:24474685;BioGRID:26988343;BioGRID:30963698;ELM:19208623;HPRD:11585903;HPRD:16763556;Lit-BM-17:11585903;Lit-BM-17:15149598;Lit-BM-17:15342632;Lit-BM-17:16763556;Lit-BM-17:20129057;Lit-BM-17:20159558;Lit-BM-17:21791603;Lit-BM-17:21855803;Lit-BM-17:23042605;Lit-BM-17:23345618;Lit-BM-17:23388460;Lit-BM-17:23761444;Lit-BM-17:24474685;Lit-BM-17:25766642;Lit-BM-17:26988343;Lit-BM-17:27770570;SPIKE:16357261], DNMT1 [BioGRID:12354094;BioGRID:9302295;ELM:28073635;ELM:31235252;ELM:9302295;HPRD:12354094;HPRD:9302295;LMPID:9302295;SPIKE:17991895;SPIKE:18384127], CHAF1B [SPIKE:10648606;SPIKE:20112283], CDT1 [BioGRID:16362051;BioGRID:16407242;BioGRID:16407252;BioGRID:16482215;BioGRID:24423875;ELM:16861906;HPRD:16407252;HPRD:16482215;LMPID:16861906;SPIKE:16407252;SPIKE:16482215;SPIKE:19231300], REV3L [SPIKE:19806028], POLD4 [HPRD:16510448;Lit-BM-17:16510448;Lit-BM-17:24022480;SPIKE:9038370], FEN1 [BioGRID:15616578;BioGRID:22592530;BioGRID:24728180;BioGRID:9305916;DIP:15576034;DIP:26751069;DIP:8668533;DIP:9305916;ELM:15576034;ELM:15616578;ELM:28073635;ELM:3113402;ELM:9178907;HPRD:11430825;HPRD:14657243;HPRD:1477073;HPRD:7673186;HPRD:8876181;HPRD:9305916;HPRD:9545252;IntAct:14657243;IntAct:15576034;IntAct:18692475;IntAct:26030842;IntAct:26751069;IntAct:28514442;IntAct:29997244;IntAct:31467278;IntAct:31515488;LMPID:15576034;LMPID:9178907;LMPID:9305916;Lit-BM-17:11313979;Lit-BM-17:11430825;Lit-BM-17:11601988;Lit-BM-17:12853968;Lit-BM-17:14657243;Lit-BM-17:15576034;Lit-BM-17:15616578;Lit-BM-17:16216273;Lit-BM-17:17115032;Lit-BM-17:18692475;Lit-BM-17:22556262;Lit-BM-17:22592530;Lit-BM-17:22606318;Lit-BM-17:24958773;Lit-BM-17:26186194;Lit-BM-17:26496610;Lit-BM-17:8668533;Lit-BM-17:8876181;Lit-BM-17:9305916;Lit-BM-17:9545252;SPIKE:16189514;SPIKE:16326861;SPIKE:19153658], EXO1 [ELM:20970388;SPIKE:15225546;SPIKE:16189514], NCR2 [IntAct:22021614;Lit-BM-17:22021614;SIGNOR:22021614;connectomeDB2020:22021614], POLL [BioGRID:11784855;BioGRID:12081642;BioGRID:12368291;HPRD:11784855;HPRD:12081642;HPRD:12368291;HPRD:16174846], CDK2 [BioGRID:10930425;DIP:10930425;HPRD:10930425], CDK6 [HPRD:9667749], CCND3 [HPRD:7908906]	centrosome [GO:0005813]; chromatin [GO:0000785]; chromosome, telomeric region [GO:0000781]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; extracellular exosome [GO:0070062]; nuclear body [GO:0016604]; nuclear lamina [GO:0005652]; nuclear replication fork [GO:0043596]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PCNA complex [GO:0043626]; PCNA-p21 complex [GO:0070557]; replication fork [GO:0005657]; replisome [GO:0030894]	chromatin binding [GO:0003682]; damaged DNA binding [GO:0003684]; dinucleotide insertion or deletion binding [GO:0032139]; DNA polymerase binding [GO:0070182]; DNA polymerase processivity factor activity [GO:0030337]; enzyme binding [GO:0019899]; estrogen receptor binding [GO:0030331]; histone acetyltransferase binding [GO:0035035]; identical protein binding [GO:0042802]; MutLalpha complex binding [GO:0032405]; protein-containing complex binding [GO:0044877]; protein C-terminus binding [GO:0008022]; purine-specific mismatch base pair DNA N-glycosylase activity [GO:0000701]; receptor tyrosine kinase binding [GO:0030971]	base-excision repair, gap-filling [GO:0006287]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to UV [GO:0034644]; cellular response to xenobiotic stimulus [GO:0071466]; epithelial cell differentiation [GO:0030855]; estrous cycle [GO:0044849]; heart development [GO:0007507]; leading strand elongation [GO:0006272]; liver regeneration [GO:0097421]; mismatch repair [GO:0006298]; mitotic telomere maintenance via semi-conservative replication [GO:1902990]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of deoxyribonuclease activity [GO:0032077]; positive regulation of DNA-directed DNA polymerase activity [GO:1900264]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA replication [GO:0045740]; replication fork processing [GO:0031297]; response to cadmium ion [GO:0046686]; response to dexamethasone [GO:0071548]; response to estradiol [GO:0032355]; response to L-glutamate [GO:1902065]; translesion synthesis [GO:0019985]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=PCNA&keywords=PCNA	57.01098417977528	73	12517	62	1.0446346203907542	256	0.1574803149606299	0.28942115768463345	0.19358407079646042	0.3462829736211085	0.1717171717171718	0.20473773265651415	0.2148685403445143	0.14845024469820559	0.16833148353680982	0.1715516090265655	0.1886420706973056	86	85	74	0.20500612452181083	0.8294251335092521	0.8444020347343565	0.9238902898189525	210	192	130
PCSK1N	proprotein convertase subtilisin/kexin type 1 inhibitor	No		ENSG00000102109	Q9UHG2	NA	2	ligand	extracellular, intracellular, ligand, secreted	O14626	GPR171	GPR171 [CellTalkDB:31308196]	extracellular space [GO:0005615]; secretory granule [GO:0030141]; trans-Golgi network [GO:0005802]	endopeptidase inhibitor activity [GO:0004866]; serine-type endopeptidase inhibitor activity [GO:0004867]; signaling receptor binding [GO:0005102]	neuropeptide signaling pathway [GO:0007218]; peptide hormone processing [GO:0016486]; response to cold [GO:0009409]; response to dietary excess [GO:0002021]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=PCSK1N&keywords=PCSK1N	11.414353146067416	228	130726	11	0.09482181976368519	638	0.18110236220472442	0.9725548902195584	0.09402654867256643	0.19976019184652313	0.6296296296296297	11.463620981387484	14.363553943789697	4.799347471451877	3.954864964853887	6.779376418748994	3.361522117056372	11	5	15	4.254487229078301	0.9297401426878765	1.5920733382560524	0.7906043413770689	164	42	194
PCSK9	proprotein convertase subtilisin/kexin type 9	No		ENSG00000169174	Q8NBP7	Peptidase S8 family	9	ligand, receptor	extracellular, intracellular, ligand, receptor, secreted	P01130, P16671, P60033, P98155, Q06481, Q07954, Q14114, Q99523	APLP2, CD36, CD81, LDLR, LRP1, LRP8, SORT1, VLDLR	VLDLR [CellTalkDB:17452316;Cellinker:29209441;LRdb:17452316;Ramilowski2015:17452316;connectomeDB2020:17452316;talklr:17452316], LDLR [CellTalkDB:18250299;Cellinker:29209441;DIP:18250299;DIP:18753623;HPRD:17435765;IntAct:18250299;IntAct:18753623;IntAct:22081141;Lit-BM-17:18250299;Lit-BM-17:18753623;Lit-BM-17:22081141;Lit-BM-17:23085658;Lit-BM-17:25613181], LRP1 [CellTalkDB:28495363], SORT1 [CellTalkDB:24506872], APLP2 [CellTalkDB:28495363], CD81 [Cellinker:29209441], LRP8 [Cellinker:29209441], CD36 [Cellinker:29209441]	cell surface [GO:0009986]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; cytoplasm [GO:0005737]; early endosome [GO:0005769]; endolysosome membrane [GO:0036020]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extrinsic component of external side of plasma membrane [GO:0031232]; Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; PCSK9-AnxA2 complex [GO:1990667]; PCSK9-LDLR complex [GO:1990666]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; rough endoplasmic reticulum [GO:0005791]	apolipoprotein binding [GO:0034185]; apolipoprotein receptor binding [GO:0034190]; low-density lipoprotein particle binding [GO:0030169]; low-density lipoprotein particle receptor binding [GO:0050750]; protein self-association [GO:0043621]; RNA binding [GO:0003723]; serine-type endopeptidase activity [GO:0004252]; signaling receptor inhibitor activity [GO:0030547]; sodium channel inhibitor activity [GO:0019871]; very-low-density lipoprotein particle binding [GO:0034189]; very-low-density lipoprotein particle receptor binding [GO:0070326]	apoptotic process [GO:0006915]; cellular response to insulin stimulus [GO:0032869]; cellular response to starvation [GO:0009267]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; kidney development [GO:0001822]; lipoprotein metabolic process [GO:0042157]; liver development [GO:0001889]; low-density lipoprotein particle receptor catabolic process [GO:0032802]; lysosomal transport [GO:0007041]; negative regulation of low-density lipoprotein particle clearance [GO:0010989]; negative regulation of low-density lipoprotein particle receptor binding [GO:1905596]; negative regulation of low-density lipoprotein receptor activity [GO:1905598]; negative regulation of receptor internalization [GO:0002091]; negative regulation of receptor-mediated endocytosis involved in cholesterol transport [GO:1905601]; negative regulation of receptor recycling [GO:0001920]; negative regulation of sodium ion transmembrane transporter activity [GO:2000650]; neurogenesis [GO:0022008]; neuron differentiation [GO:0030182]; phospholipid metabolic process [GO:0006644]; positive regulation of low-density lipoprotein particle receptor catabolic process [GO:0032805]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of receptor internalization [GO:0002092]; protein autoprocessing [GO:0016540]; regulation of neuron apoptotic process [GO:0043523]; regulation of signaling receptor activity [GO:0010469]; triglyceride metabolic process [GO:0006641]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=PCSK9&keywords=PCSK9	1.4565286598098308	413	NA	NA	0.7723326677754174	308	0	0.011976047904191612	0	2.3980815347721823e-4	0.015151515151515148	0.020304568527918777	0.025385312783318223	0.008156606851549756	0	0.028241420750433895	6.953834266949972e-4	303	174	377	0.010013696686281784	0.49965781718149116	1.9107624818080782	0.534403193690152	342	22	311
PDCD1LG2	programmed cell death 1 ligand 2	TBD		ENSG00000197646	Q9BQ51	Immunoglobulin superfamily, BTN/MOG family	6	adhesion, cell_surface_ligand, ligand, receptor	adhesion, cell_adhesion, cell_surface, cell_surface_ligand, extracellular, intracellular, ligand, plasma_membrane, plasma_membrane_transmembrane, receptor, secreted, transmembrane	Q15116, Q16342, Q6NW40	PDCD1, PDCD2, RGMB	PDCD1 [CellChatDB:23954143;CellPhoneDB:23954143;CellTalkDB:23954143;Cellinker:23223433;Cellinker:23954143;Cellinker:31727844;ICELLNET:23954143;InnateDB:12893276;IntAct:20587542;IntAct:23417675;connectomeDB2020:12810690], PDCD2 [CellTalkDB:15207811;LRdb:15207811;LRdb:25], RGMB [connectomeDB2020:24752301]	endomembrane system [GO:0012505]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	NA	adaptive immune response [GO:0002250]; cell surface receptor signaling pathway [GO:0007166]; cellular response to lipopolysaccharide [GO:0071222]; immune response [GO:0006955]; negative regulation of activated T cell proliferation [GO:0046007]; negative regulation of interferon-gamma production [GO:0032689]; negative regulation of interleukin-10 production [GO:0032693]; negative regulation of T cell proliferation [GO:0042130]; positive regulation of T cell proliferation [GO:0042102]; T cell costimulation [GO:0031295]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=PDCD1LG2&keywords=PDCD1LG2	0.25186253258426966	592	NA	NA	0.11424004288812001	610	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
PDGFA	platelet derived growth factor subunit A	Yes		ENSG00000197461	P04085	PDGF/VEGF growth factor family	18	ligand	extracellular, intracellular, ligand, ligand_regulator, secreted	P09619, P09958, P16234	FURIN, PDGFRA, PDGFRB	PDGFRA [Baccin2019:152078112544881;CellChatDB:15207812;CellTalkDB:15207811;Cellinker:15207812;Cellinker:28267575;HPRD:2544881;ICELLNET:15207811;ICELLNET:9739761;IntAct:25241761;IntAct:7679113;LRdb:15207811;LRdb:25;Lit-BM-17:11297552;Lit-BM-17:15767546;Lit-BM-17:25241761;Lit-BM-17:2544881;Lit-BM-17:7679113;SIGNOR:11803579;SignaLink3:11803579;SignaLink3:21071413;SignaLink3:23331499;SignaLink3:2544881;connectomeDB2020:15207811;connectomeDB2020:2544881], PDGFRB [CellChatDB:15207812;CellTalkDB:25737405;Cellinker:15207812;Lit-BM-17:7679113], FURIN [HPRD-phos:12670890;HPRD:12670890]	cell surface [GO:0009986]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; Golgi membrane [GO:0000139]; microvillus [GO:0005902]; platelet alpha granule lumen [GO:0031093]; platelet-derived growth factor complex [GO:1990265]	collagen binding [GO:0005518]; growth factor activity [GO:0008083]; growth factor receptor binding [GO:0070851]; identical protein binding [GO:0042802]; platelet-derived growth factor binding [GO:0048407]; platelet-derived growth factor receptor binding [GO:0005161]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]	actin cytoskeleton organization [GO:0030036]; angiogenesis [GO:0001525]; animal organ morphogenesis [GO:0009887]; cell activation [GO:0001775]; cell-cell signaling [GO:0007267]; cell projection assembly [GO:0030031]; cellular response to transforming growth factor beta stimulus [GO:0071560]; embryonic lung development [GO:1990401]; hair follicle development [GO:0001942]; inner ear development [GO:0048839]; lung alveolus development [GO:0048286]; male gonad development [GO:0008584]; negative chemotaxis [GO:0050919]; negative regulation of phosphatidylinositol biosynthetic process [GO:0010512]; negative regulation of platelet activation [GO:0010544]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of cell division [GO:0051781]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway [GO:0035793]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein autophosphorylation [GO:0031954]; positive regulation of protein kinase B signaling [GO:0051897]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of branching involved in salivary gland morphogenesis by epithelial-mesenchymal signaling [GO:0060683]; regulation of peptidyl-tyrosine phosphorylation [GO:0050730]; regulation of smooth muscle cell migration [GO:0014910]; response to estradiol [GO:0032355]; response to hypoxia [GO:0001666]; response to inorganic substance [GO:0010035]; response to retinoic acid [GO:0032526]; response to wounding [GO:0009611]; response to xenobiotic stimulus [GO:0009410]; skin development [GO:0043588]; wound healing [GO:0042060]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=PDGFA&keywords=PDGFA	17.63608515955056	180	NA	NA	0.6423142068815644	327	0	0.18612774451097916	0.15265486725663735	0.22973621103117486	0.34175084175084125	0.201353637901861	0.17497733454215733	0.11908646003262659	0.09100998890122064	0.1229803712111081	0.08526173459532231	132	96	123	0.15499447197581168	0.6122022616371582	0.8059686462138145	0.5773631895333302	301	208	296
PDGFB	platelet derived growth factor subunit B	Yes		ENSG00000100311	P01127	PDGF/VEGF growth factor family	18	ligand, receptor	extracellular, intracellular, ligand, ligand_regulator, receptor, secreted	P01112, P06756, P09619, P16234, P21453, P52961, Q07954, Q8WXG9	ADGRV1, ART1, HRAS, ITGAV, LRP1, PDGFRA, PDGFRA_PDGFRB, PDGFRB, S1PR1	PDGFRA [Baccin2019:152078112544881;CellChatDB:15207812;CellTalkDB:15207811;Cellinker:15207812;Cellinker:28267575;HPRD:2544881;ICELLNET:15207811;ICELLNET:9739761;IntAct:10806482;IntAct:7679113;LRdb:15207811;LRdb:25;Lit-BM-17:10806482;Lit-BM-17:11297552;Lit-BM-17:15767546;Lit-BM-17:2544881;Lit-BM-17:7679113;Lit-BM-17:9677323;SIGNOR:11331882;SignaLink3:11803579;SignaLink3:18988627;SignaLink3:21071413;SignaLink3:23331499;SignaLink3:2544881;connectomeDB2020:15207811;connectomeDB2020:2544881], PDGFRB [Baccin2019:285049611903042;CellChatDB:15207812;CellTalkDB:2850496;Cellinker:15207812;Cellinker:28267575;DIP:11297552;DIP:20534510;HPMR:2850496;HPRD:11903042;ICELLNET:15207811;ICELLNET:9739761;IntAct:10806482;IntAct:11297552;IntAct:17981115;IntAct:20534510;IntAct:7679113;LRdb:119;LRdb:2850496;Lit-BM-17:10806482;Lit-BM-17:11297552;Lit-BM-17:17981115;Lit-BM-17:20577048;Lit-BM-17:7679113;ProtMapper:30150707;SIGNOR:11331882;connectomeDB2020:11903042;connectomeDB2020:2850496], LRP1 [CellTalkDB:11854294;Cellinker:11854294;HPRD:11854294;LRdb:11854294;connectomeDB2020:11854294], ART1 [Baccin2019:11498506;CellTalkDB:11498506;Cellinker:11498506;HPRD:11498506;LRdb:11498506;connectomeDB2020:11498506], ITGAV [CellTalkDB:32196115], S1PR1 [CellTalkDB:32196115], ADGRV1 [NA], HRAS [HPRD:10485711]	basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; Golgi membrane [GO:0000139]; platelet alpha granule lumen [GO:0031093]; platelet-derived growth factor complex [GO:1990265]	chemoattractant activity [GO:0042056]; collagen binding [GO:0005518]; growth factor activity [GO:0008083]; growth factor receptor binding [GO:0070851]; identical protein binding [GO:0042802]; platelet-derived growth factor binding [GO:0048407]; platelet-derived growth factor receptor binding [GO:0005161]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; superoxide-generating NADPH oxidase activator activity [GO:0016176]	activation of protein kinase activity [GO:0032147]; activation of protein kinase B activity [GO:0032148]; cell chemotaxis [GO:0060326]; cellular response to growth factor stimulus [GO:0071363]; cellular response to mycophenolic acid [GO:0071506]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; embryonic placenta development [GO:0001892]; heart development [GO:0007507]; interleukin-18-mediated signaling pathway [GO:0035655]; metanephric glomerular mesangial cell development [GO:0072255]; monocyte chemotaxis [GO:0002548]; negative regulation of gene expression [GO:0010629]; negative regulation of phosphatidylinositol biosynthetic process [GO:0010512]; negative regulation of platelet activation [GO:0010544]; negative regulation of pri-miRNA transcription by RNA polymerase II [GO:1902894]; negative regulation of protein binding [GO:0032091]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of vascular associated smooth muscle cell differentiation [GO:1905064]; paracrine signaling [GO:0038001]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-tyrosine phosphorylation [GO:0018108]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of calcium ion import [GO:0090280]; positive regulation of cell division [GO:0051781]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of chemotaxis [GO:0050921]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of gene expression [GO:0010628]; positive regulation of glomerular filtration [GO:0003104]; positive regulation of glomerular mesangial cell proliferation [GO:0072126]; positive regulation of hyaluronan biosynthetic process [GO:1900127]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of metanephric mesenchymal cell migration [GO:2000591]; positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway [GO:0035793]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of pri-miRNA transcription by RNA polymerase II [GO:1902895]; positive regulation of protein autophosphorylation [GO:0031954]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; positive regulation of smooth muscle cell migration [GO:0014911]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of vascular associated smooth muscle cell dedifferentiation [GO:1905176]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; protein kinase C signaling [GO:0070528]; protein phosphorylation [GO:0006468]; reactive oxygen species metabolic process [GO:0072593]; response to wounding [GO:0009611]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=PDGFB&keywords=PDGFB	6.48672172247191	274	NA	NA	0.48482164432314506	389	0.023622047244094488	0.11576846307385216	0.5022123893805286	0.07242206235012003	0.018518518518518514	0.015228426395939085	0.005439709882139619	0	0.0258971513133555	0.00410602216584323	0.00726289356770331	217	300	265	0.07186160762655405	0.43851021686643843	0.17231547943932093	0.2108789952727928	363	429	416
PDGFC	platelet derived growth factor C	Yes		ENSG00000145431	Q9NRA1	PDGF/VEGF growth factor family	19	cell_surface_ligand, ligand, receptor	cell_surface_ligand, extracellular, intracellular, ligand, plasma_membrane, receptor, secreted, transmembrane	P09619, P16234, P17948, P35916, P35968	FLT1, FLT4, KDR, PDGFRA, PDGFRB	PDGFRA [Baccin2019:10806482;Baccin2019:11297552;Baccin2019:11342471;CellChatDB:15207812;CellTalkDB:10806482;Cellinker:15207812;Cellinker:28267575;DIP:11297552;DIP:20534510;HPMR:10806482;HPMR:15207811;HPRD:10806482;HPRD:11297552;HPRD:11342471;ICELLNET:15207811;ICELLNET:9739761;IntAct:11297552;IntAct:20534510;LRdb:10806482;LRdb:11297552;LRdb:11342471;SignaLink3:10806482;SignaLink3:11297552;SignaLink3:11342471;SignaLink3:18988627;SignaLink3:21071413;SignaLink3:23331499;connectomeDB2020:10806482;connectomeDB2020:11297552;connectomeDB2020:11342471], PDGFRB [Baccin2019:19795151;CellTalkDB:32196115;SignaLink3:11297552;SignaLink3:23331499;connectomeDB2020:19795151], FLT4 [NA], KDR [NA], FLT1 [CellTalkDB:32196115]	cell surface [GO:0009986]; cytosol [GO:0005829]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi membrane [GO:0000139]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	growth factor activity [GO:0008083]; growth factor receptor binding [GO:0070851]; platelet-derived growth factor receptor binding [GO:0005161]; protein homodimerization activity [GO:0042803]	activation of transmembrane receptor protein tyrosine kinase activity [GO:0007171]; animal organ morphogenesis [GO:0009887]; bone development [GO:0060348]; cellular response to amino acid stimulus [GO:0071230]; central nervous system development [GO:0007417]; digestive tract development [GO:0048565]; embryonic organ development [GO:0048568]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of cell division [GO:0051781]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein autophosphorylation [GO:0031954]; regulation of peptidyl-tyrosine phosphorylation [GO:0050730]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=PDGFC&keywords=PDGFC	14.46805422039335	194	NA	NA	1.6070885010195235	194	0.015748031496062992	0.19910179640718692	0	0.024460431654676252	0.025252525252525245	0.00338409475465313	0	0	0.001849796522382538	3.338229403124584e-4	5.022213637241645e-4	298	397	384	0.02460297458104761	0.34245022764235966	0.2986397286773258	0.3035063167510557	394	376	393
PDGFD	platelet derived growth factor D	Yes		ENSG00000170962	Q9GZP0	PDGF/VEGF growth factor family	16	ligand	extracellular, intracellular, ligand, secreted	P09619, P16234	PDGFRA, PDGFRA_PDGFRB, PDGFRB	PDGFRB [Baccin2019:1520781114514730;CellChatDB:15207812;CellTalkDB:15207811;Cellinker:15207812;Cellinker:28267575;HPRD:14514732;LRdb:15;LRdb:15207811;SignaLink3:14514732;SignaLink3:21098708;SignaLink3:23331499;connectomeDB2020:14514732;connectomeDB2020:15207811], PDGFRA [CellTalkDB:32196115]	endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi membrane [GO:0000139]	growth factor activity [GO:0008083]; growth factor receptor binding [GO:0070851]; platelet-derived growth factor receptor binding [GO:0005161]	cellular response to amino acid stimulus [GO:0071230]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to transforming growth factor beta stimulus [GO:0071560]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of cell division [GO:0051781]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of glomerular mesangial cell proliferation [GO:0072126]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of monocyte extravasation [GO:2000439]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein autophosphorylation [GO:0031954]; positive regulation of smooth muscle cell chemotaxis [GO:0071673]; positive regulation of smooth muscle cell proliferation [GO:0048661]; regulation of peptidyl-tyrosine phosphorylation [GO:0050730]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=PDGFD&keywords=PDGFD	12.577751258426966	213	1556.87	145	0.8008930658166742	299	0	0.07984031936127736	0.09402654867256648	0.014388489208633089	0.006734006734006734	0.01015228426395939	0.005439709882139619	0.02936378466557912	0.011098779134295233	3.338229403124584e-4	0.00289743094456249	261	397	317	0.023115925073393814	0.6371188208553634	0.3120499553435371	0.38946310320422295	286	373	355
PDYN	prodynorphin	Yes		ENSG00000101327	P01213	Opioid neuropeptide precursor family	13	ligand	extracellular, intracellular, ligand, secreted	P08913, P35372, P41143, P41145, P41146, P48039, Q14831	ADRA2A, GRM7, MTNR1A, OPRD1, OPRK1, OPRL1, OPRM1	OPRD1 [Baccin2019:9686407;Cellinker:9686407;Guide2Pharma:9686407;LRdb:9686407;SIGNOR:9686407;connectomeDB2020:9686407;scConnect:9686407], OPRK1 [Baccin2019:1967312;Baccin2019:7624359;Baccin2019:7869844;Baccin2019:8170987;Baccin2019:9262330;Baccin2019:9686407;CellTalkDB:7869844;Cellinker:17503481;Cellinker:1967312;Cellinker:7624359;Cellinker:7869844;Cellinker:8170987;Cellinker:9262330;Cellinker:9686407;Guide2Pharma:1967312;Guide2Pharma:7624359;Guide2Pharma:7869844;Guide2Pharma:9262330;Guide2Pharma:9686407;LRdb:1967312;LRdb:7624359;LRdb:7869844;LRdb:8170987;LRdb:9262330;LRdb:9686407;SIGNOR:9262330;SIGNOR:9686407;connectomeDB2020:1967312;connectomeDB2020:7624359;connectomeDB2020:7869844;connectomeDB2020:8170987;connectomeDB2020:9262330;connectomeDB2020:9686407;scConnect:1967312;scConnect:7624359;scConnect:7869844;scConnect:9262330;scConnect:9686407], OPRM1 [Baccin2019:9686407;Cellinker:9686407;Guide2Pharma:9686407;LRdb:9686407;SIGNOR:9686407;connectomeDB2020:9686407;scConnect:9686407], ADRA2A [CellTalkDB:32196115], MTNR1A [CellTalkDB:32196115], GRM7 [CellTalkDB:32196115], OPRL1 [NA]	axon terminus [GO:0043679]; dendrite [GO:0030425]; extracellular region [GO:0005576]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]	opioid peptide activity [GO:0001515]; opioid receptor binding [GO:0031628]	chemical synaptic transmission [GO:0007268]; neuropeptide signaling pathway [GO:0007218]; sensory perception [GO:0007600]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=PDYN&keywords=PDYN	0.0023041820224719103	875	NA	NA	0.003676222739869068	871	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
PENK	proenkephalin	Yes		ENSG00000181195	P01210	Opioid neuropeptide precursor family	14	ligand	extracellular, intracellular, ligand, secreted	P08913, P35372, P41143, P41145, P41146, P48039, Q14831, Q96LA9, Q96LB2, Q9NZT2	ADRA2A, GRM7, MRGPRX1, MRGPRX4, MTNR1A, OGFR, OPRD1, OPRK1, OPRL1, OPRM1	OPRD1 [Baccin2019:9686407;CA1:15082510;Cellinker:9686407;Guide2Pharma:9686407;LRdb:9686407;connectomeDB2020:9686407;scConnect:9686407], MRGPRX1 [CellTalkDB:15163697;Cellinker:11850634;Cellinker:15163697;Cellinker:23396314;Guide2Pharma:11850634;Guide2Pharma:15163697;Guide2Pharma:23396314;LRdb:11850634;LRdb:15163697;LRdb:23396314;connectomeDB2020:11850634;connectomeDB2020:15163697;connectomeDB2020:23396314;scConnect:11850634;scConnect:15163697;scConnect:23396314], OPRM1 [Baccin2019:9686407;CA1:15082510;Cellinker:9686407;Guide2Pharma:9686407;LRdb:9686407;connectomeDB2020:9686407;scConnect:9686407], OPRK1 [CA1:15082510;CellTalkDB:32196115], OPRL1 [CA1:15082510], GRM7 [CellTalkDB:32196115], ADRA2A [CellTalkDB:32196115], OGFR [Baccin2019:16820893;CellTalkDB:16820893;Cellinker:16820893;HPMR:16820893;LRdb:16820893;connectomeDB2020:16820893], MTNR1A [CellTalkDB:32196115], MRGPRX4 [Baccin2019:11850634;Baccin2019:15163697;Baccin2019:23396314]	axon terminus [GO:0043679]; cell body fiber [GO:0070852]; chromaffin granule lumen [GO:0034466]; dendrite [GO:0030425]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; neuronal cell body [GO:0043025]; neuronal dense core vesicle lumen [GO:0099013]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; symmetric synapse [GO:0032280]; synaptic vesicle lumen [GO:0034592]	neuropeptide hormone activity [GO:0005184]; opioid peptide activity [GO:0001515]; opioid receptor binding [GO:0031628]	aggressive behavior [GO:0002118]; aging [GO:0007568]; behavioral fear response [GO:0001662]; cellular response to cAMP [GO:0071320]; cellular response to oxidative stress [GO:0034599]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular response to virus [GO:0098586]; cellular response to vitamin D [GO:0071305]; chemical synaptic transmission [GO:0007268]; general adaptation syndrome, behavioral process [GO:0051867]; glial cell proliferation [GO:0014009]; locomotory exploration behavior [GO:0035641]; neuropeptide signaling pathway [GO:0007218]; osteoblast differentiation [GO:0001649]; positive regulation of behavioral fear response [GO:2000987]; response to calcium ion [GO:0051592]; response to epinephrine [GO:0071871]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to hypoxia [GO:0001666]; response to lipopolysaccharide [GO:0032496]; response to morphine [GO:0043278]; response to nicotine [GO:0035094]; response to radiation [GO:0009314]; response to toxic substance [GO:0009636]; sensory perception [GO:0007600]; sensory perception of pain [GO:0019233]; signal transduction [GO:0007165]; startle response [GO:0001964]; synaptic signaling via neuropeptide [GO:0099538]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=PENK&keywords=PENK	0.6779822284188765	495	NA	NA	0.04978500928987698	708	0	0	0	0.04172661870503596	0	0.001692047377326565	0.001813236627379873	0.03425774877650898	0.0014798372179060304	1.6691147015622916e-4	0.006219818427660811	299	404	274	0.007941474418361313	0.6398491534317581	0.5666709007901495	0.9040404400131932	283	297	143
PF4	platelet factor 4	Yes		ENSG00000163737	P02776	Intercrine alpha (chemokine CxC) family	15	ligand	extracellular, intracellular, ligand, secreted	P01130, P04070, P07204, P08913, P09038, P10145, P13501, P21802, P34741, P48039, P49682, Q07954, Q14831, Q16570, Q9UNN8	ACKR1, ADRA2A, CCL5, CXCL8, CXCR3, FGF2, FGFR2, GRM7, LDLR, LRP1, MTNR1A, PROC, PROCR, SDC2, THBD	CXCR3 [Baccin2019:12782716;CellPhoneDB:24218476;Cellinker:12782716;HPRD:12782716;ICELLNET:12782716;ICELLNET:21655676;LRdb:10699158;connectomeDB2020:12782716], FGFR2 [Baccin2019:9558385;CellTalkDB:9558385;Cellinker:9558385;LRdb:9558385;connectomeDB2020:9558385], SDC2 [Baccin2019:7524669;CellTalkDB:7524669;Cellinker:7524669;HPRD:7524669;LRdb:7524669;connectomeDB2020:7524669], ACKR1 [CellTalkDB:32103204;InnateDB:8132497], GRM7 [CellTalkDB:32196115], LDLR [Baccin2019:1198621511986210;CellTalkDB:11986215;Cellinker:11986215;HPRD:11986215;LRdb:11986215;connectomeDB2020:11986215], THBD [Baccin2019:93955249395524;CellTalkDB:9395524;Cellinker:9395524;HPMR:9395524;HPRD:9395524;LRdb:9395524;connectomeDB2020:9395524], MTNR1A [CellTalkDB:32196115], PROCR [Baccin2019:9395524;CellTalkDB:9395524;Cellinker:9395524;HPMR:9395524;LRdb:9395524;connectomeDB2020:9395524], LRP1 [CellTalkDB:20806113], ADRA2A [CellTalkDB:32196115], CXCL8 [HPRD:12586630;HPRD:15531763;InnateDB:12586630], PROC [HPRD:9395524], CCL5 [HPRD:15459010], FGF2 [HPRD:9558385]	collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; platelet alpha granule lumen [GO:0031093]	chemokine activity [GO:0008009]; CXCR3 chemokine receptor binding [GO:0048248]; CXCR chemokine receptor binding [GO:0045236]; heparin binding [GO:0008201]	adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cellular response to lipopolysaccharide [GO:0071222]; chemokine-mediated signaling pathway [GO:0070098]; cytokine-mediated signaling pathway [GO:0019221]; defense response to protozoan [GO:0042832]; inflammatory response [GO:0006954]; killing by host of symbiont cells [GO:0051873]; killing of cells of other organism [GO:0031640]; leukocyte chemotaxis [GO:0030595]; negative regulation of angiogenesis [GO:0016525]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of megakaryocyte differentiation [GO:0045653]; negative regulation of MHC class II biosynthetic process [GO:0045347]; neutrophil chemotaxis [GO:0030593]; platelet activation [GO:0030168]; positive regulation of gene expression [GO:0010628]; positive regulation of macrophage derived foam cell differentiation [GO:0010744]; positive regulation of macrophage differentiation [GO:0045651]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of cell population proliferation [GO:0042127]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=PF4&keywords=PF4	0.07950805617977529	689	NA	NA	0.029536918572237073	767	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
PF4V1	platelet factor 4 variant 1	Yes		ENSG00000109272	P10720	Intercrine alpha (chemokine CxC) family	6	ligand	extracellular, intracellular, ligand, secreted	P49682	CXCR3	CXCR3 [ICELLNET:22633458;connectomeDB2020:28859966]	extracellular space [GO:0005615]	chemokine activity [GO:0008009]; CXCR chemokine receptor binding [GO:0045236]; heparin binding [GO:0008201]	antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cellular response to lipopolysaccharide [GO:0071222]; chemokine-mediated signaling pathway [GO:0070098]; inflammatory response [GO:0006954]; neutrophil chemotaxis [GO:0030593]; platelet activation [GO:0030168]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=PF4V1&keywords=PF4V1	0.12990912134831462	651	NA	NA	0.5179355989016136	379	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
PGF	placental growth factor	Yes		ENSG00000119630	P49763	PDGF/VEGF growth factor family	16	adhesion, ligand	adhesion, cell_adhesion, extracellular, intracellular, ligand, plasma_membrane, secreted	O14786, O60462, P15692, P17948	FLT1, FLT1_KDR, NRP1, NRP2, VEGFA	NRP1 [Baccin2019:1198631111986310;CellTalkDB:11986311;Cellinker:11986311;HPRD:11986311;ICELLNET:9712843;LRdb:11986311;connectomeDB2020:11986311], NRP2 [CellTalkDB:10748121;Cellinker:10748121;HPRD:10748121;ICELLNET:12613545;LRdb:10748121;connectomeDB2020:10748121], FLT1 [Baccin2019:14684734;Baccin2019:9452434;CellChatDB:16633338;CellTalkDB:9452434;Cellinker:14684734;Cellinker:9452434;DIP:8700872;HPRD:14684734;HPRD:9452434;ICELLNET:19029957;IntAct:14684734;LRdb:147;LRdb:9452434;Lit-BM-17:14684734;Lit-BM-17:8700872;Lit-BM-17:9452434;ProtMapper:27009237;ProtMapper:29193887;connectomeDB2020:14684734;connectomeDB2020:9452434], VEGFA [DIP:8621715;HPRD:12086892;HPRD:12796773;Lit-BM-17:12086892;Lit-BM-17:25241761;Lit-BM-17:8621715]	extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]	chemoattractant activity [GO:0042056]; growth factor activity [GO:0008083]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; vascular endothelial growth factor receptor binding [GO:0005172]	animal organ regeneration [GO:0031100]; cell-cell signaling [GO:0007267]; cell differentiation [GO:0030154]; cellular response to hormone stimulus [GO:0032870]; female pregnancy [GO:0007565]; induction of positive chemotaxis [GO:0050930]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of mast cell chemotaxis [GO:0060754]; positive regulation of protein phosphorylation [GO:0001934]; response to hypoxia [GO:0001666]; response to xenobiotic stimulus [GO:0009410]; signal transduction [GO:0007165]; sprouting angiogenesis [GO:0002040]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; vascular endothelial growth factor signaling pathway [GO:0038084]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=PGF&keywords=PGF	8.29144049406847	255	NA	NA	0.5801811765089935	351	0	0.00598802395209581	1.9568584070796484	0.6856115107913751	0.00505050505050505	0.005076142131979695	0.001813236627379873	0.013050570962479609	0.004439511653718092	0.003371611697155823	0.0062198184276608115	289	314	273	0.2443163034885453	0.0567777663313216	0.05257866488987442	0.06377813063955365	498	493	493
PGLYRP1	peptidoglycan recognition protein 1	No		ENSG00000008438	O75594	N-acetylmuramoyl-L-alanine amidase 2 family	1	ligand, receptor	intracellular, ligand, receptor, secreted, secreted_receptor	Q9NP99	TREM1	TREM1 [InnateDB:25595774;connectomeDB2020:25595774]	extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; phagocytic vesicle lumen [GO:0097013]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724]	N-acetylmuramoyl-L-alanine amidase activity [GO:0008745]; peptidoglycan binding [GO:0042834]; peptidoglycan immune receptor activity [GO:0016019]; zinc ion binding [GO:0008270]	antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; biological process involved in interaction with host [GO:0051701]; defense response to Gram-positive bacterium [GO:0050830]; detection of bacterium [GO:0016045]; innate immune response [GO:0045087]; killing of cells of other organism [GO:0031640]; negative regulation of inflammatory response [GO:0050728]; negative regulation of interferon-gamma production [GO:0032689]; negative regulation of natural killer cell differentiation involved in immune response [GO:0032827]; peptidoglycan catabolic process [GO:0009253]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=PGLYRP1&keywords=PGLYRP1	0.020882533707865168	791	NA	NA	0.004105380833790206	868	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
PI16	peptidase inhibitor 16	TBD	enzyme inhibitor	ENSG00000164530	Q6UXB8	CRISP family	1	ligand	cell_surface, ligand, plasma_membrane_transmembrane, secreted, transmembrane, transmembrane_predicted	O75121, O75509	MFAP3L, TNFRSF21	MFAP3L [Cellinker:32589946], TNFRSF21 [Cellinker:32589946]	extracellular space [GO:0005615]	peptidase inhibitor activity [GO:0030414]	negative regulation of cell growth involved in cardiac muscle cell development [GO:0061052]; negative regulation of peptidase activity [GO:0010466]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=PI16&keywords=PI16	0.06369520337078652	709	NA	NA	0.003032627689699091	881	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
PI3	peptidase inhibitor 3	TBD	enzyme inhibitor	ENSG00000124102	P19957	NA	2	ecm, ligand	ecm, ecm_regulator, extracellular, intracellular, ligand, secreted, secreted_peptidase_inhibitor	O14939	PLD2	PLD2 [CellTalkDB:32196115]	cornified envelope [GO:0001533]; cytosol [GO:0005829]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	endopeptidase inhibitor activity [GO:0004866]; serine-type endopeptidase inhibitor activity [GO:0004867]; structural constituent of skin epidermis [GO:0030280]	antibacterial humoral response [GO:0019731]; copulation [GO:0007620]; innate immune response [GO:0045087]; peptide cross-linking [GO:0018149]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=PI3&keywords=PI3	66.42502393258427	65	NA	NA	1.6864226370879487	188	0	0.7010978043912143	0.00995575221238938	0.1294964028776982	0.021885521885521883	0	0	0.0016313213703099511	0	7.677927627186542e-4	5.408537763183311e-4	303	381	382	0.0786704953887428	0.11277708505133215	0.12143602802162404	0.11887667628455081	469	460	464
PIK3IP1	phosphoinositide-3-kinase interacting protein 1			ENSG00000100100	Q96FE7	NA	1	ligand	cell_surface, intracellular, ligand, plasma_membrane, plasma_membrane_transmembrane, secreted, transmembrane, transmembrane_predicted	NA	PIK3CA_PIK3R1	NA	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	phosphatidylinositol 3-kinase catalytic subunit binding [GO:0036313]	negative regulation of phosphatidylinositol 3-kinase activity [GO:0043553]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=PIK3IP1&keywords=PIK3IP1	9.912108224874023	238	NA	NA	0.20746656432223615	529	0.03937007874015748	0.08383233532934123	0.17367256637168163	0.17410071942446098	0.042087542087542076	0.07445008460236888	0.07162284678150485	0.05709624796084834	0.05697373288938223	0.07197222593136791	0.019663898010430697	160	123	205	0.0786220252844624	0.7557233393663411	0.9249644844862245	0.3347237655110496	240	160	381
PILRA	paired immunoglobin like type 2 receptor alpha	No		ENSG00000085514	Q9UKJ1	NA	1	adhesion, ligand, receptor	adhesion, cell_adhesion, cell_surface, extracellular, intracellular, ligand, plasma_membrane, plasma_membrane_transmembrane, receptor, secreted, transmembrane, transmembrane_predicted	O43699, O75019, O75023, P78410, Q8N423, Q8N6C8, Q9HCN6	BTN3A2, GP6, LILRA1, LILRA3, LILRB2, LILRB5, SIGLEC6	SIGLEC6 [Cellinker:32822567], LILRA1 [Cellinker:32822567], LILRB5 [Cellinker:32822567], LILRA3 [Cellinker:32822567], GP6 [Cellinker:32822567], BTN3A2 [Cellinker:32822567], LILRB2 [Cellinker:32822567]	extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	MHC class I protein binding [GO:0042288]	signal transduction [GO:0007165]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=PILRA&keywords=PILRA	0.7415357612359551	491	NA	NA	0.060529314799389014	693	0.9999999999999989	0.007485029940119762	0	0.003836930455635491	0	0	0.005439709882139619	0.0016313213703099511	3.699593044765076e-4	0.001402056349312324	0.0015839289163608278	302	361	341	0.09288626692894121	0.10079050989029041	0.11082194630685939	0.1125896512929302	476	464	468
PIP	prolactin induced protein	TBD		ENSG00000159763	P12273	PIP family	8	ligand	extracellular, intracellular, ligand, secreted	P01730, P55064, Q9Y639	AQP5, CD4, NPTN	AQP5 [CellTalkDB:18696337], CD4 [Baccin2019:10820003;CellTalkDB:10820003;Cellinker:10820003;HPRD:10820003;InnateDB:10820003;LRdb:10820003;connectomeDB2020:10820003], NPTN [CellTalkDB:32196115]	extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nucleus [GO:0005634]	actin binding [GO:0003779]; aspartic-type endopeptidase activity [GO:0004190]; identical protein binding [GO:0042802]; IgG binding [GO:0019864]	detection of chemical stimulus involved in sensory perception of bitter taste [GO:0001580]; negative regulation of T cell apoptotic process [GO:0070233]; positive regulation of gene expression [GO:0010628]; proteolysis [GO:0006508]; regulation of immune system process [GO:0002682]; retina homeostasis [GO:0001895]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=PIP&keywords=PIP	0.48750762696629213	525	NA	NA	0.0025885095453623834	884	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
PLA2G2A	phospholipase A2 group IIA	No		ENSG00000188257	P14555	Phospholipase A2 family	3	cell_surface_ligand, ligand, receptor, secreted_enzyme	cell_surface_ligand, extracellular, intracellular, ligand, plasma_membrane, receptor, secreted, secreted_enzyme	P00533, P05106, P05556, P06756, P08648, P13612, P21860	EGFR, ERBB3, ITGA4, ITGA5, ITGAV, ITGB1, ITGB3	ITGA4 [connectomeDB2020:25398877], ITGA5 [connectomeDB2020:25398877], ITGAV [connectomeDB2020:25398877], ITGB1 [connectomeDB2020:25398877], ITGB3 [connectomeDB2020:25398877], ERBB3 [Cellinker:28440478], EGFR [Cellinker:28440478]	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; mitochondrial outer membrane [GO:0005741]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; secretory granule [GO:0030141]	calcium-dependent phospholipase A2 activity [GO:0047498]; calcium ion binding [GO:0005509]; phospholipase A2 activity [GO:0004623]; phospholipid binding [GO:0005543]	arachidonic acid secretion [GO:0050482]; cytolysis [GO:0019835]; defense response to Gram-positive bacterium [GO:0050830]; inflammatory response [GO:0006954]; intestinal stem cell homeostasis [GO:0036335]; lipid catabolic process [GO:0016042]; low-density lipoprotein particle remodeling [GO:0034374]; phosphatidic acid metabolic process [GO:0046473]; phosphatidylcholine metabolic process [GO:0046470]; phosphatidylethanolamine metabolic process [GO:0046337]; phospholipid metabolic process [GO:0006644]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of inflammatory response [GO:0050729]; positive regulation of macrophage derived foam cell differentiation [GO:0010744]; regulation of neutrophil activation [GO:1902563]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=PLA2G2A&keywords=PLA2G2A	1.7690578628536422	395	NA	NA	0.017061050428110056	808	0	0	0	0.002158273381294964	0	0	0	0	0	0	1.1589723778249952e-4	303	409	398	2.0674278355249667e-4	0.979744489702861	0.979744489702861	0.9910994577117795	139	139	102
PLAC1	placenta enriched 1	TBD		ENSG00000170965	Q9HBJ0	PLAC1 family	1	ligand	ligand, secreted	NA	NA	NA	extracellular region [GO:0005576]	NA	placenta development [GO:0001890]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=PLAC1&keywords=PLAC1	0.0717164617977528	697	NA	NA	1.2104552458455256	238	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
PLAUR	plasminogen activator, urokinase receptor	No		ENSG00000011422	Q03405	NA	1	adhesion, cell_surface_ligand, ligand, receptor	adhesion, cell_adhesion, cell_surface, cell_surface_ligand, extracellular, intracellular, ligand, matrix_adhesion, plasma_membrane, plasma_membrane_peripheral, plasma_membrane_transmembrane, receptor, secreted, transmembrane	P00749, P04264, P05106, Q9NZR2	ITGB3, KRT1, LRP1B, PLAU	KRT1 [SIGNOR:14691569], ITGB3 [SIGNOR:27383564], PLAU [BioGRID:11501527;BioGRID:16879932;BioGRID:19017363;DIP:18376415;HPMR:16456079;HPRD:11501527;HPRD:3023326;HPRD:3031025], LRP1B [Baccin2019:21711236;HPRD:11384978;HPRD:12194987]	anchored component of membrane [GO:0031225]; cell projection [GO:0042995]; cell surface [GO:0009986]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; extrinsic component of membrane [GO:0019898]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; protein complex involved in cell-matrix adhesion [GO:0098637]; serine-type endopeptidase complex [GO:1905370]; specific granule membrane [GO:0035579]	enzyme binding [GO:0019899]; protein domain specific binding [GO:0019904]; signaling receptor activity [GO:0038023]; signaling receptor binding [GO:0005102]; urokinase plasminogen activator receptor activity [GO:0030377]	blood coagulation [GO:0007596]; chemotaxis [GO:0006935]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:2001268]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; positive regulation of DNA binding [GO:0043388]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of homotypic cell-cell adhesion [GO:0034112]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; regulation of cell adhesion [GO:0030155]; regulation of proteolysis [GO:0030162]; signal transduction [GO:0007165]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=PLAUR&keywords=PLAUR	39.600878161981214	105	NA	NA	4.182386572050004	86	3.055118110236218	1.3043912175648695	0.11393805309734525	1.9990407673860522	0.5690235690235689	0.09644670050761417	0.06436990027198537	0.058727569331158296	0.08620051794302613	0.017191881426091557	0.15518640139076084	138	208	82	0.68360315347079	0.138696771290094	0.03920380305369633	0.23815693536594829	461	505	408
PLG	plasminogen	No		ENSG00000122194	P00747	Peptidase S1 family, Plasminogen subfamily	11	ligand	cell_surface, ecm_regulator, extracellular, intracellular, ligand, secreted	O00254, P00450, P00749, P00750, P01138, P02749, P02751, P05107, P05556, P08254, P11215, P11717, P13726, P14780, P17936, P17948, P25116, P55085, P98164, Q03405, Q13797, Q8TEW0, Q96RI0, Q9HBL7	APOH, CP, F2R, F2RL1, F2RL2, F2RL3, F3, FLT1, FN1, IGF2R, IGFBP3, ITGA9, ITGAD_ITGB2, ITGAM, ITGB1, ITGB2, LRP2, MMP3, MMP9, NGF, PARD3, PLAT, PLAU, PLAUR, PLGRKT	PLAT [HPRD:11928826;SIGNOR:1447176], APOH [HPRD:8460120;HPRD:9596664;SIGNOR:9596664], F2R [Baccin2019:10978167;CellTalkDB:10978167;HPRD:10978167;LRdb:10978167;SIGNOR:10978167;connectomeDB2020:10978167], ITGAM [CellTalkDB:32196115], ITGB1 [CellTalkDB:15247268;Cellinker:15247268;HPMR:15247268;LRdb:15247268;connectomeDB2020:15247268], PLAUR [CellTalkDB:10092105], ITGB2 [CellTalkDB:32196115], IGF2R [NA], F3 [Baccin2019:9490681;Cellinker:9490681;HPRD:9490681;LRdb:9490681;connectomeDB2020:9490681], PLGRKT [CellTalkDB:19897580;Cellinker:19897580;LRdb:19897580;Ramilowski2015:19897580;connectomeDB2020:19897580;talklr:19897580], ITGA9 [CellTalkDB:15247268;Cellinker:15247268;HPMR:15247268;LRdb:15247268;connectomeDB2020:15247268], FLT1 [CellTalkDB:32196115], F2RL1 [Baccin2019:10978167;Baccin2019:12604689;Baccin2019:9020112;CellTalkDB:12604689;Cellinker:10978167;Cellinker:12604689;Cellinker:9020112;HPRD-phos:10978167;HPRD-phos:12604689;HPRD-phos:9020112;HPRD:10978167;HPRD:12604689;HPRD:9020112;LRdb:10978167;LRdb:12604689;LRdb:9020112;connectomeDB2020:10978167;connectomeDB2020:12604689;connectomeDB2020:9020112], F2RL2 [NA], F2RL3 [NA], PARD3 [NA], FN1 [Cellinker:2413022], LRP2 [Baccin2019:10073957], CP [HPRD-phos:146197;HPRD-phos:6582496;HPRD:146197;HPRD:6582496], IGFBP3 [HPRD-phos:7538844;HPRD-phos:8843739;HPRD:7538844;HPRD:8843739;HPRD:9337997;HPRD:9688635], PLAU [HPRD:2829380;HPRD:3920216;HPRD:4226004], NGF [HPRD:11729324], MMP9 [HPRD:9360944], MMP3 [HPRD:9548733]	blood microparticle [GO:0072562]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extrinsic component of external side of plasma membrane [GO:0031232]; extrinsic component of plasma membrane [GO:0019897]; glutamatergic synapse [GO:0098978]; plasma membrane [GO:0005886]; platelet alpha granule lumen [GO:0031093]; Schaffer collateral - CA1 synapse [GO:0098685]	apolipoprotein binding [GO:0034185]; chaperone binding [GO:0051087]; endopeptidase activity [GO:0004175]; enzyme binding [GO:0019899]; kinase binding [GO:0019900]; protein antigen binding [GO:1990405]; protein domain specific binding [GO:0019904]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; signaling receptor binding [GO:0005102]	biological process involved in interaction with symbiont [GO:0051702]; blood coagulation [GO:0007596]; extracellular matrix disassembly [GO:0022617]; fibrinolysis [GO:0042730]; labyrinthine layer blood vessel development [GO:0060716]; mononuclear cell migration [GO:0071674]; muscle cell cellular homeostasis [GO:0046716]; myoblast differentiation [GO:0045445]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of fibrinolysis [GO:0051918]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of fibrinolysis [GO:0051919]; proteolysis [GO:0006508]; tissue regeneration [GO:0042246]; tissue remodeling [GO:0048771]; trans-synaptic signaling by BDNF, modulating synaptic transmission [GO:0099183]; trophoblast giant cell differentiation [GO:0060707]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=PLG&keywords=PLG	0.6472518831730899	501	NA	NA	0.10198481785650974	629	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
PLXNB1	plexin B1	No		ENSG00000164050	O43157	Plexin family	1	adhesion, cell_surface_ligand, receptor	adhesion, cell_adhesion, cell_surface, cell_surface_ligand, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, secreted, transmembrane, transmembrane_predicted	O15031, P04626, Q92854, Q9NPR2, Q9NTN9	ERBB2, PLXNB2, SEMA4B, SEMA4D, SEMA4G	SEMA4D [Baccin2019:29981480;CellPhoneDB:22325954;DIP:20877282;HPMR:10520995;HPRD:11937491;IntAct:20877282], SEMA4G [Cellinker:32589946], SEMA4B [Cellinker:32589946;HPRD:12123608], PLXNB2 [Cellinker:24043639], ERBB2 [Cellinker:15210733]	extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]; semaphorin receptor complex [GO:0002116]	GTPase activating protein binding [GO:0032794]; GTPase activator activity [GO:0005096]; semaphorin receptor activity [GO:0017154]; semaphorin receptor binding [GO:0030215]; transmembrane signaling receptor activity [GO:0004888]	cell migration [GO:0016477]; inhibitory synapse assembly [GO:1904862]; intracellular signal transduction [GO:0035556]; negative regulation of cell adhesion [GO:0007162]; negative regulation of osteoblast proliferation [GO:0033689]; neuron projection morphogenesis [GO:0048812]; ossification involved in bone maturation [GO:0043931]; positive regulation of axonogenesis [GO:0050772]; positive regulation of GTPase activity [GO:0043547]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; regulation of cell migration [GO:0030334]; regulation of cell shape [GO:0008360]; regulation of cytoskeleton organization [GO:0051493]; regulation of GTPase activity [GO:0043087]; semaphorin-plexin signaling pathway [GO:0071526]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]; semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis [GO:1900220]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=PLXNB1&keywords=PLXNB1	23.336914722561414	160	NA	NA	0.3829577349729964	427	0.007874015748031496	0.10928143712574837	0.0165929203539823	0.01702637889688249	0.03703703703703703	0.1133671742808798	0.069809610154125	0.09461663947797727	0.08694043655197908	0.04336359994658943	0.038709677419354556	137	153	167	0.057692629726598804	1.4320678180698274	0.7883221579973722	0.7195713568240181	59	214	228
PMCH	pro-melanin concentrating hormone	Yes		ENSG00000183395	P20382	Melanin-concentrating hormone family	14	ligand	extracellular, intracellular, ligand, secreted	P08913, P48039, Q12866, Q14831, Q969V1, Q99705	ADRA2A, GRM7, MCHR1, MCHR2, MERTK, MTNR1A	MCHR1 [Baccin2019:10421367;Baccin2019:10421368;Baccin2019:11375253;Baccin2019:11478907;Baccin2019:11839762;CellTalkDB:10421368;Cellinker:10421367;Cellinker:10421368;Cellinker:11375253;Cellinker:11478907;Cellinker:11839762;Guide2Pharma:10421367;Guide2Pharma:11375253;HPMR:10421367;HPMR:10421368;HPRD:11478907;HPRD:11839762;LRdb:10421367;LRdb:10421368;LRdb:11375253;LRdb:11478907;LRdb:11839762;SIGNOR:10421367;connectomeDB2020:10421367;connectomeDB2020:10421368;connectomeDB2020:11375253;connectomeDB2020:11478907;connectomeDB2020:11839762;scConnect:10421367;scConnect:11375253], MCHR2 [CellTalkDB:11416225;Cellinker:10471841;Cellinker:11274220;Cellinker:11404457;Cellinker:11416225;Cellinker:11478907;Cellinker:11839762;Guide2Pharma:11404457;HPMR:10471841;HPRD:11274220;HPRD:11404457;HPRD:11416225;HPRD:11478907;HPRD:11839762;LRdb:10471841;LRdb:11274220;LRdb:11404457;LRdb:11416225;LRdb:11478907;LRdb:11839762;SIGNOR:10471841;connectomeDB2020:10471841;connectomeDB2020:11274220;connectomeDB2020:11404457;connectomeDB2020:11416225;connectomeDB2020:11478907;connectomeDB2020:11839762;scConnect:11404457], GRM7 [CellTalkDB:32196115], ADRA2A [CellTalkDB:32196115], MTNR1A [CellTalkDB:32196115], MERTK [CellChatDB:30501104;Cellinker:30501104]	extracellular region [GO:0005576]; nucleus [GO:0005634]; synapse [GO:0045202]	melanin-concentrating hormone activity [GO:0030354]; type 1 melanin-concentrating hormone receptor binding [GO:0031777]	cell differentiation [GO:0030154]; chemical synaptic transmission [GO:0007268]; feeding behavior [GO:0007631]; neuropeptide signaling pathway [GO:0007218]; spermatogenesis [GO:0007283]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=PMCH&keywords=PMCH	0.07171957865168539	696	NA	NA	0.09545967890441821	637	0.031496062992125984	0	0	2.3980815347721823e-4	0	0.00338409475465313	0.0027198549410698096	0	0	1.0014688209373749e-4	0.005524435000965814	303	406	286	0.003951309338580518	0.7167786017292521	0.7239569159407214	1.1127582812628936	254	244	75
PNOC	prepronociceptin	Yes		ENSG00000168081	Q13519	Opioid neuropeptide precursor family	12	ligand	extracellular, intracellular, ligand, secreted	P08913, P41146, P48039, Q14831	ADRA2A, GRM7, MTNR1A, OPRL1	OPRL1 [Baccin2019:10369464;Baccin2019:10692489;Baccin2019:11097863;Baccin2019:12070757;Baccin2019:12967935;Baccin2019:22827708;Baccin2019:7481766;Baccin2019:8849681;BioGRID:10692489;BioGRID:11097863;CellTalkDB:12967935;Cellinker:10369464;Cellinker:10692489;Cellinker:11097863;Cellinker:12070757;Cellinker:12967935;Cellinker:22827708;Cellinker:7481766;Cellinker:8849681;Guide2Pharma:10369464;Guide2Pharma:12070757;Guide2Pharma:9413015;HPMR:7481766;HPRD:10692489;HPRD:11097863;LRdb:10369464;LRdb:10692489;LRdb:11097863;LRdb:12070757;LRdb:12967935;LRdb:22827708;LRdb:7481766;LRdb:8849681;Lit-BM-17:10692489;Lit-BM-17:11097863;Lit-BM-17:23597562;connectomeDB2020:10369464;connectomeDB2020:10692489;connectomeDB2020:11097863;connectomeDB2020:12070757;connectomeDB2020:12967935;connectomeDB2020:22827708;connectomeDB2020:7481766;connectomeDB2020:8849681;scConnect:10369464;scConnect:12070757;scConnect:9353393;scConnect:9413015], GRM7 [CellTalkDB:32196115], MTNR1A [CellTalkDB:32196115], ADRA2A [CellTalkDB:32196115]	axon terminus [GO:0043679]; dendrite [GO:0030425]; extracellular region [GO:0005576]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]	neuropeptide hormone activity [GO:0005184]; opioid peptide activity [GO:0001515]; opioid receptor binding [GO:0031628]	chemical synaptic transmission [GO:0007268]; female pregnancy [GO:0007565]; neuropeptide signaling pathway [GO:0007218]; sensory perception [GO:0007600]; signal transduction [GO:0007165]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=PNOC&keywords=PNOC	0.25397628651685394	591	NA	NA	0.15203607218480414	574	0	0	0	2.3980815347721823e-4	0	0	0	0.0016313213703099511	0	2.3367605821872085e-4	0.0012748696156074952	303	401	354	3.07243199783035e-4	0.9701915251413199	0.9928625782725431	1.0938782948135763	140	135	77
PODXL	podocalyxin like			ENSG00000128567	O00592	Podocalyxin family	1	adhesion, cell_surface_ligand, receptor	adhesion, cell_adhesion, cell_surface, cell_surface_ligand, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, secreted, transmembrane, transmembrane_predicted	P14151	SELL	SELL [CellTalkDB:9625756;HPRD:9625756;LRdb:9625756;connectomeDB2020:9625756]	apical plasma membrane [GO:0016324]; centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; filopodium [GO:0030175]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; lamellipodium [GO:0030027]; membrane raft [GO:0045121]; microvillus membrane [GO:0031528]; nucleolus [GO:0005730]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; slit diaphragm [GO:0036057]	NA	cell adhesion [GO:0007155]; cell migration [GO:0016477]; epithelial tube formation [GO:0072175]; glomerular visceral epithelial cell development [GO:0072015]; negative regulation of cell adhesion [GO:0007162]; negative regulation of cell-cell adhesion [GO:0022408]; positive regulation of cell-cell adhesion mediated by integrin [GO:0033634]; positive regulation of cell migration [GO:0030335]; regulation of microvillus assembly [GO:0032534]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=PODXL&keywords=PODXL	26.514129545098047	144	10156.3	70	0.8326286952442847	295	0	0.04191616766467062	2.3838495575221237	0.2870503597122311	0.13804713804713817	0.00676818950930626	0.005439709882139619	0.0016313213703099511	0.0029596744358120607	0.0034717585792495595	0.006876569441761642	295	312	267	0.2616373132877039	0.047709478049821	0.0495946540488014	0.06212905450101721	503	497	496
POMC	proopiomelanocortin	Yes		ENSG00000115138	P01189	POMC family	16	ligand	extracellular, intracellular, ligand, secreted	O60895, O60896, P07550, P08913, P13945, P16473, P32241, P32245, P33032, P35372, P41143, P41145, P41146, P41586, P41968, P48039, Q01718, Q01726, Q03431, Q14831, Q8TCY5, Q99678, Q9NQS5	ADCYAP1R1, ADRA2A, ADRB2, ADRB3, GPR20, GPR84, GRM7, MC1R, MC2R, MC3R, MC4R, MC5R, MRAP, MTNR1A, OPRD1, OPRK1, OPRL1, OPRM1, PTH1R, RAMP2, RAMP3, TSHR, VIPR1	OPRD1 [Baccin2019:154641439686407;CellTalkDB:15464143;Cellinker:15464143;Cellinker:9686407;Guide2Pharma:9686407;LRdb:15464143;LRdb:97;SIGNOR:9686407;connectomeDB2020:15464143;connectomeDB2020:9686407;scConnect:9686407], OPRK1 [Baccin2019:7624359;Baccin2019:8624732;Baccin2019:9686407;CellTalkDB:8624732;Cellinker:7624359;Cellinker:8624732;Cellinker:9686407;Guide2Pharma:7624359;Guide2Pharma:9686407;HPMR:8624732;LRdb:7624359;LRdb:8624732;LRdb:9686407;SIGNOR:9686407;connectomeDB2020:7624359;connectomeDB2020:8624732;connectomeDB2020:9686407;scConnect:7624359;scConnect:9686407], MC1R [Baccin2019:10942578;Baccin2019:11041375;Baccin2019:12007532;Baccin2019:1516719;Baccin2019:7774675;CellTalkDB:10942578;Cellinker:10942578;Cellinker:11041375;Cellinker:12007532;Cellinker:1516719;Cellinker:7774675;Guide2Pharma:12007532;HPRD:10942578;HPRD:11041375;LRdb:10942578;LRdb:11041375;LRdb:12007532;LRdb:1516719;LRdb:7774675;SIGNOR:19656324;connectomeDB2020:10942578;connectomeDB2020:11041375;connectomeDB2020:12007532;connectomeDB2020:1516719;connectomeDB2020:7774675;scConnect:12007532;scConnect:7774675], MC3R [Baccin2019:10358030;Baccin2019:10493100;Baccin2019:7774675;CellChatDB:11024027;CellTalkDB:10358030;Cellinker:10358030;Cellinker:10493100;Cellinker:7774675;Guide2Pharma:10358030;Guide2Pharma:10493100;LRdb:10358030;LRdb:10493100;LRdb:7774675;SIGNOR:17702843;connectomeDB2020:10358030;connectomeDB2020:10493100;connectomeDB2020:7774675;scConnect:10358030;scConnect:10493100;scConnect:7774675], MC4R [Baccin2019:10493100;Baccin2019:11101306;Baccin2019:12165561;Baccin2019:8884876;BioGRID:11101306;BioGRID:9058374;CellChatDB:11024027;Cellinker:10493100;Cellinker:11101306;Cellinker:12165561;Cellinker:8884876;Guide2Pharma:10493100;Guide2Pharma:11101306;HPRD:11101306;HPRD:12165561;LRdb:10493100;LRdb:11101306;LRdb:12165561;LRdb:8884876;SIGNOR:20694162;connectomeDB2020:10493100;connectomeDB2020:11101306;connectomeDB2020:12165561;connectomeDB2020:8884876;scConnect:10493100;scConnect:11101306;scConnect:8884876], MC5R [Baccin2019:11606131;Baccin2019:11785979;Baccin2019:12007532;Baccin2019:7774675;Baccin2019:8185570;Cellinker:11606131;Cellinker:11785979;Cellinker:12007532;Cellinker:7774675;Cellinker:8185570;Guide2Pharma:12007532;HPMR:11785979;HPRD:11606131;HPRD:8185570;LRdb:11606131;LRdb:11785979;LRdb:12007532;LRdb:7774675;LRdb:8185570;SIGNOR:11785979;connectomeDB2020:11606131;connectomeDB2020:11785979;connectomeDB2020:12007532;connectomeDB2020:7774675;connectomeDB2020:8185570;scConnect:12007532;scConnect:7774675], ADCYAP1R1 [CellTalkDB:32196115], OPRM1 [Baccin2019:15464143;CellTalkDB:15464143;Cellinker:15464143;HPMR:15464143;LRdb:15464143;connectomeDB2020:15464143], GPR84 [CellTalkDB:32196115], TSHR [CellTalkDB:32196115], RAMP3 [CellTalkDB:32196115], RAMP2 [CellTalkDB:32196115], ADRA2A [CellTalkDB:32196115], MTNR1A [CellTalkDB:32196115], ADRB2 [CellTalkDB:32196115], PTH1R [CellTalkDB:32196115], VIPR1 [CellTalkDB:32196115], MC2R [Baccin2019:905837412213892;CellTalkDB:9058374;Cellinker:12213892;Cellinker:9058374;HPMR:9058374;HPRD:12213892;LRdb:122;LRdb:9058374;connectomeDB2020:12213892;connectomeDB2020:9058374], ADRB3 [CellTalkDB:32196115], GRM7 [CellTalkDB:32196115], GPR20 [CellTalkDB:32196115], OPRL1 [NA], MRAP [Cellinker:19028547]	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; peroxisomal matrix [GO:0005782]; secretory granule [GO:0030141]; secretory granule lumen [GO:0034774]	G protein-coupled receptor binding [GO:0001664]; hormone activity [GO:0005179]; signaling receptor binding [GO:0005102]; type 1 melanocortin receptor binding [GO:0070996]; type 3 melanocortin receptor binding [GO:0031781]; type 4 melanocortin receptor binding [GO:0031782]	antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; calcium-mediated signaling [GO:0019722]; cell-cell signaling [GO:0007267]; cellular pigmentation [GO:0033059]; generation of precursor metabolites and energy [GO:0006091]; glucose homeostasis [GO:0042593]; killing of cells of other organism [GO:0031640]; modulation of process of other organism [GO:0035821]; negative regulation of tumor necrosis factor production [GO:0032720]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cAMP-mediated signaling [GO:0043950]; positive regulation of neutrophil mediated killing of fungus [GO:0070965]; positive regulation of oxytocin production [GO:0140668]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of appetite [GO:0032098]; regulation of blood pressure [GO:0008217]; regulation of corticosterone secretion [GO:2000852]; regulation of glycogen metabolic process [GO:0070873]; response to melanocyte-stimulating hormone [GO:1990680]; signal transduction [GO:0007165]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=POMC&keywords=POMC	0.4870858711516174	527	NA	NA	9.113318637261506e-4	897	0.07874015748031496	0.02944111776447103	0.045353982300885	0.05539568345323739	0.040404040404040394	0.11844331641285952	0.14233907524931969	0.15823817292006523	0.12393636699962947	0.10261717185204919	0.09515163221942867	108	103	115	0.09000551973239096	1.339289744786443	1.1261095602863351	1.0514582845107792	71	105	88
POSTN	periostin	TBD		ENSG00000133110	Q15063	NA	3	adhesion, ecm, ligand	adhesion, cell_adhesion, ecm, intracellular, ligand, secreted	Q13308	ITGAV_ITGB3, ITGAV_ITGB5, PTK7	PTK7 [connectomeDB2020:30348980]	collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; trans-Golgi network [GO:0005802]	cell adhesion molecule binding [GO:0050839]; heparin binding [GO:0008201]; metal ion binding [GO:0046872]	cell adhesion [GO:0007155]; cellular response to vitamin K [GO:0071307]; extracellular matrix organization [GO:0030198]; regulation of Notch signaling pathway [GO:0008593]; tissue development [GO:0009888]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=POSTN&keywords=POSTN	6.102292515230538	276	NA	NA	0.2896441114137135	472	0	0	0.0011061946902654867	0.3685851318944872	0	0.001692047377326565	0	0	0	4.0058752837495e-4	3.09059300753332e-4	303	394	392	0.03382663825374614	0.2281717329561602	0.23731200801115396	0.2352235925800709	424	400	409
PPBP	pro-platelet basic protein	Yes		ENSG00000163736	P02775	Intercrine alpha (chemokine CxC) family	17	ligand	extracellular, intracellular, ligand, secreted	P08913, P25024, P25025, P35372, P41143, P48039, Q14831, Q16570	ACKR1, ADRA2A, CXCR1, CXCR2, GRM7, MTNR1A, OPRD1, OPRM1	CXCR2 [CellPhoneDB:24218476;CellTalkDB:1427896;Cellinker:8195702;Cellinker:8702798;DIP:8550564;DIP:8702798;Guide2Pharma:8702798;HPRD:8195702;HPRD:8702798;ICELLNET:22633458;ICELLNET:24335961;InnateDB:8702798;InnateDB:9126332;LRdb:10699158;connectomeDB2020:8195702;connectomeDB2020:8702798;scConnect:8702798], OPRM1 [SIGNOR:9686407], OPRD1 [SIGNOR:9686407], CXCR1 [CellPhoneDB:24218476;CellTalkDB:1427896;Cellinker:1427896;Cellinker:8137938;Cellinker:8195702;DIP:8702798;HPRD:1427896;HPRD:8195702;ICELLNET:22633458;ICELLNET:24335961;LRdb:1427896;LRdb:8137938;LRdb:8195702;connectomeDB2020:1427896;connectomeDB2020:8137938;connectomeDB2020:8195702], ACKR1 [CellTalkDB:10699158;ICELLNET:22633458;LRdb:10699158], MTNR1A [CellTalkDB:32196115], GRM7 [CellTalkDB:32196115], ADRA2A [CellTalkDB:32196115]	extracellular region [GO:0005576]; extracellular space [GO:0005615]; platelet alpha granule [GO:0031091]; platelet alpha granule lumen [GO:0031093]; tertiary granule lumen [GO:1904724]	chemokine activity [GO:0008009]; CXCR chemokine receptor binding [GO:0045236]; glucose transmembrane transporter activity [GO:0005355]; growth factor activity [GO:0008083]	antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cellular response to lipopolysaccharide [GO:0071222]; chemokine-mediated signaling pathway [GO:0070098]; defense response to bacterium [GO:0042742]; glucose transmembrane transport [GO:1904659]; inflammatory response [GO:0006954]; killing of cells of other organism [GO:0031640]; neutrophil chemotaxis [GO:0030593]; positive regulation of cell division [GO:0051781]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=PPBP&keywords=PPBP	0.21462472808988764	610	NA	NA	0.06446182813382333	687	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
PPY	pancreatic polypeptide	Yes		ENSG00000108849	P01298	NPY family	15	ligand	extracellular, intracellular, ligand, secreted	P08913, P25929, P48039, P49146, P50391, Q14831, Q15761, Q99463, Q9NYM4	ADRA2A, GPR83, GRM7, MTNR1A, NPY1R, NPY2R, NPY4R, NPY5R, NPY6R	NPY4R [CellTalkDB:18767100;Cellinker:16807358;Cellinker:7493937;Cellinker:7592911;Cellinker:8643460;Guide2Pharma:16807358;Guide2Pharma:7493937;Guide2Pharma:7592911;Guide2Pharma:8643460;HPRD:7493937;LRdb:16807358;LRdb:7493937;LRdb:7592911;LRdb:8643460;SIGNOR:7592911;connectomeDB2020:16807358;connectomeDB2020:7493937;connectomeDB2020:7592911;connectomeDB2020:8643460;scConnect:16807358;scConnect:7493937;scConnect:7592911;scConnect:8643460], NPY5R [Baccin2019:8824284;CellTalkDB:8824284;Cellinker:8824284;Guide2Pharma:8824284;LRdb:8824284;connectomeDB2020:8824284;scConnect:8824284], ADRA2A [CellTalkDB:32196115], MTNR1A [CellTalkDB:32196115], NPY2R [CellTalkDB:15966750], GRM7 [CellTalkDB:32196115], NPY1R [CellTalkDB:15966750], NPY6R [NA], GPR83 [NA]	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	G protein-coupled receptor binding [GO:0001664]; hormone activity [GO:0005179]; neuropeptide hormone activity [GO:0005184]; neuropeptide Y receptor binding [GO:0031841]	feeding behavior [GO:0007631]; neuropeptide signaling pathway [GO:0007218]; protein secretion [GO:0009306]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=PPY&keywords=PPY	2402.0795301685393	10	30903.5	34	10877.230485112379	2	0.11023622047244094	0.23852295409181826	0.15818584070796474	0.3482014388489233	0.3333333333333329	0.22673434856175936	1.0308250226654605	649.2756933115822	0.7295597484276725	0.31576311924156925	0.9506277767046394	30	62	27	59.42888028314889	0.0124423566679694	0.005480640242375564	0.016161606210085024	526	528	524
PRG4	proteoglycan 4	No		ENSG00000116690	Q92954	NA	2	ecm, ligand	ecm, extracellular, ligand, secreted	O00206, O60603, P16070	CD44, TLR2, TLR4	CD44 [CellTalkDB:30157934], TLR2 [connectomeDB2020:26643105], TLR4 [connectomeDB2020:26643105]	collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615]	polysaccharide binding [GO:0030247]; scavenger receptor activity [GO:0005044]	immune response [GO:0006955]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=PRG4&keywords=PRG4	40.614521834566	103	1768.2	136	7.751747953400279	55	0.007874015748031496	0.08532934131736523	0.012168141592920354	0.03764988009592325	0.06734006734006732	2.9407783417935747	0.44061650045330836	0.5252854812398049	5.798372179060343	0.49939911870745946	0.09584701564612569	8	46	114	0.9555145529995386	6.015830793037377	0.5275934134031669	0.10962757145119517	3	307	470
PRL	prolactin	Yes		ENSG00000172179	P01236	Somatotropin/prolactin family	17	ligand	extracellular, intracellular, ligand, secreted	P04626, P05538, P16471	ERBB2, HLA-DQB2, PRLR	PRLR [CellChatDB:23192981;CellTalkDB:2558309;Cellinker:10966654;Cellinker:11356126;Cellinker:18253483;Cellinker:2558309;Cellinker:7984244;Cellinker:9175708;Cellinker:9626554;DIP:22325776;HPMR:11356126;HPMR:2558309;HPRD:10966654;HPRD:7984244;HPRD:9626554;ICELLNET:18467331;InnateDB:21889455;IntAct:23048206;LRdb:10966654;LRdb:11356126;LRdb:2558309;LRdb:7984244;LRdb:9626554;Lit-BM-17:23048206;SIGNOR:10585417;SignaLink3:10585417;SignaLink3:10966654;SignaLink3:15082796;SignaLink3:16546209;SignaLink3:18988627;SignaLink3:20053995;SignaLink3:23331499;SignaLink3:24243840;SignaLink3:29145629;SignaLink3:7984244;SignaLink3:9626554;connectomeDB2020:10966654;connectomeDB2020:11356126;connectomeDB2020:2558309;connectomeDB2020:7984244;connectomeDB2020:9626554], ERBB2 [Cellinker:22270933], HLA-DQB2 [NA]	endosome lumen [GO:0031904]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	hormone activity [GO:0005179]; prolactin receptor binding [GO:0005148]	cell surface receptor signaling pathway [GO:0007166]; female pregnancy [GO:0007565]; lactation [GO:0007595]; mammary gland development [GO:0030879]; negative regulation of angiogenesis [GO:0016525]; negative regulation of endothelial cell proliferation [GO:0001937]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of lactation [GO:1903489]; positive regulation of pri-miRNA transcription by RNA polymerase II [GO:1902895]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; regulation of multicellular organism growth [GO:0040014]; response to nutrient levels [GO:0031667]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=PRL&keywords=PRL	0.14579228089887641	644	NA	NA	1.5193724108792243e-4	905	0	0	0	0.004796163069544363	0	0.001692047377326565	0	0.0016313213703099511	0.0011098779134295228	0	0	300	409	401	8.390372482373093e-4	1.0249875204770846	0.9225911647850682	0.9225911647850682	128	162	131
PRLH	prolactin releasing hormone	Yes		ENSG00000071677	P81277	NA	13	ligand	extracellular, intracellular, ligand, secreted	P49683	PRLHR	PRLHR [CellTalkDB:11030716;Cellinker:10475064;Cellinker:11030716;Cellinker:12606605;Cellinker:9607765;Guide2Pharma:11030716;Guide2Pharma:12606605;HPMR:11030716;HPRD:10475064;HPRD:11030716;HPRD:9607765;LRdb:10475064;LRdb:11030716;LRdb:12606605;LRdb:9607765;connectomeDB2020:10475064;connectomeDB2020:11030716;connectomeDB2020:12606605;connectomeDB2020:9607765;scConnect:11030716;scConnect:12606605]	cytoplasm [GO:0005737]; extracellular region [GO:0005576]	hormone activity [GO:0005179]; neuropeptide hormone activity [GO:0005184]; prolactin-releasing peptide receptor binding [GO:0031861]	autonomic nervous system development [GO:0048483]; energy reserve metabolic process [GO:0006112]; fat cell differentiation [GO:0045444]; feeding behavior [GO:0007631]; G protein-coupled receptor signaling pathway [GO:0007186]; lipid metabolic process [GO:0006629]; reduction of food intake in response to dietary excess [GO:0002023]; regulation of multicellular organism growth [GO:0040014]; response to glucose [GO:0009749]; response to insulin [GO:0032868]; response to peptide hormone [GO:0043434]; tissue homeostasis [GO:0001894]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=PRLH&keywords=PRLH	0	899	NA	NA	0.5805421618745061	350	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
PRLR	prolactin receptor	No		ENSG00000113494	P16471	Type I cytokine receptor family, Type 1 subfamily	1	adhesion, ligand, receptor	adhesion, cell_adhesion, cell_surface, extracellular, intracellular, ligand, plasma_membrane, plasma_membrane_transmembrane, receptor, secreted, transmembrane, transmembrane_predicted	O60674, O95944, Q8N126, Q8N766	CADM3, EMC1, JAK2, NCR2	JAK2 [BioGRID:9202403;HPRD:10772872;SPIKE:17312100;SignaLink3:10772872;SignaLink3:11713228;SignaLink3:18988627;SignaLink3:20962278;SignaLink3:21071413;SignaLink3:23331499], CADM3 [Cellinker:32589946], EMC1 [Cellinker:32589946], NCR2 [Cellinker:32589946]	cell surface [GO:0009986]; endosome lumen [GO:0031904]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	ciliary neurotrophic factor receptor binding [GO:0005127]; cytokine binding [GO:0019955]; cytokine receptor activity [GO:0004896]; leukemia inhibitory factor receptor activity [GO:0004923]; metal ion binding [GO:0046872]; peptide hormone binding [GO:0017046]; prolactin receptor activity [GO:0004925]; protein kinase binding [GO:0019901]	activation of Janus kinase activity [GO:0042976]; activation of transmembrane receptor protein tyrosine kinase activity [GO:0007171]; cytokine-mediated signaling pathway [GO:0019221]; embryo implantation [GO:0007566]; lactation [GO:0007595]; mammary gland alveolus development [GO:0060749]; mammary gland epithelial cell differentiation [GO:0060644]; negative regulation of apoptotic process [GO:0043066]; oncostatin-M-mediated signaling pathway [GO:0038165]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cold-induced thermogenesis [GO:0120162]; prostate gland growth [GO:0060736]; receptor signaling pathway via JAK-STAT [GO:0007259]; regulation of cell adhesion [GO:0030155]; regulation of epithelial cell differentiation [GO:0030856]; response to bacterium [GO:0009617]; steroid biosynthetic process [GO:0006694]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=PRLR&keywords=PRLR	3.138280481718296	333	NA	NA	0.9711552858876125	272	0.007874015748031496	0.05988023952095802	0.004424778761061947	0.010311750599520381	0.05723905723905722	0.13367174280879854	0.12964641885766062	0.07830342577487774	0.11912689604143506	0.012651889437842137	0.11365655785203313	111	231	104	0.06607152478557057	1.6974406179633745	0.29777093993702625	1.6255301599461116	46	377	29
PRND	prion like protein doppel			ENSG00000171864	Q9UKY0	Prion family	6	adhesion, cell_surface_ligand, ligand	adhesion, cell_adhesion, cell_surface, cell_surface_ligand, intracellular, ligand, plasma_membrane, secreted, transmembrane, transmembrane_predicted	P08865	RPSA	RPSA [Baccin2019:1524687315246870;Cellinker:15246873;HPRD:15246873;LRdb:15246873;connectomeDB2020:15246873]	anchored component of external side of plasma membrane [GO:0031362]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]	copper ion binding [GO:0005507]	acrosome reaction [GO:0007340]; cellular copper ion homeostasis [GO:0006878]; protein homooligomerization [GO:0051260]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=PRND&keywords=PRND	0.03832907528089888	755	NA	NA	0.01739552942877191	806	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
PROK1	prokineticin 1	Yes		ENSG00000143125	P58294	AVIT (prokineticin) family	15	ligand	extracellular, intracellular, ligand, secreted	Q8NFJ6, Q8TCW9	PROKR1, PROKR2	PROKR1 [Baccin2019:11886876;Baccin2019:12054613;Baccin2019:15772293;CellChatDB:24496457;CellTalkDB:11886876;Cellinker:11886876;Cellinker:12054613;Cellinker:15772293;Cellinker:24496457;Guide2Pharma:12054613;Guide2Pharma:15772293;HPMR:11886876;HPMR:12054613;LRdb:11886876;LRdb:12054613;LRdb:15772293;SIGNOR:12054613;connectomeDB2020:11886876;connectomeDB2020:12054613;connectomeDB2020:15772293;scConnect:12054613;scConnect:15772293], PROKR2 [Baccin2019:11886876;Baccin2019:12054613;Baccin2019:15772293;CellChatDB:24496457;CellTalkDB:12054613;Cellinker:11886876;Cellinker:12054613;Cellinker:15772293;Cellinker:24496457;Guide2Pharma:12054613;Guide2Pharma:15772293;HPMR:11886876;HPMR:12054613;LRdb:11886876;LRdb:12054613;LRdb:15772293;connectomeDB2020:11886876;connectomeDB2020:12054613;connectomeDB2020:15772293;scConnect:12054613;scConnect:15772293]	extracellular region [GO:0005576]	growth factor activity [GO:0008083]	angiogenesis [GO:0001525]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of MAPK cascade [GO:0043410]; regulation of angiogenesis [GO:0045765]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=PROK1&keywords=PROK1	0.03476992359550562	763	NA	NA	0.0048272904854843755	862	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
PROK2	prokineticin 2	Yes		ENSG00000163421	Q9HC23	AVIT (prokineticin) family	13	ligand	ligand, secreted	Q8NFJ6, Q8TCW9	PROKR1, PROKR2	PROKR1 [Baccin2019:12054613;Baccin2019:15772293;CellChatDB:24496457;CellTalkDB:12054613;Cellinker:12054613;Cellinker:15772293;Cellinker:24496457;Guide2Pharma:12054613;Guide2Pharma:15772293;LRdb:12054613;LRdb:16;connectomeDB2020:12054613;connectomeDB2020:15772293;scConnect:12054613;scConnect:15772293], PROKR2 [Baccin2019:12024206;Baccin2019:12054613;Baccin2019:15772293;CellChatDB:24496457;CellTalkDB:15772293;Cellinker:12024206;Cellinker:12054613;Cellinker:15772293;Cellinker:24496457;Guide2Pharma:12054613;Guide2Pharma:15772293;LRdb:12024206;LRdb:12054613;LRdb:15772293;SIGNOR:12024206;connectomeDB2020:12024206;connectomeDB2020:12054613;connectomeDB2020:15772293;scConnect:12054613;scConnect:15772293]	extracellular region [GO:0005576]	G protein-coupled receptor binding [GO:0001664]	angiogenesis [GO:0001525]; chemotaxis [GO:0006935]; circadian rhythm [GO:0007623]; endothelial cell proliferation [GO:0001935]; G protein-coupled receptor signaling pathway [GO:0007186]; inflammatory response [GO:0006954]; negative regulation of apoptotic process [GO:0043066]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of smooth muscle contraction [GO:0045987]; sensory perception of pain [GO:0019233]; spermatogenesis [GO:0007283]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=PROK2&keywords=PROK2	0.014435325357303372	809	NA	NA	0.004545215493523552	864	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
PRSS1	serine protease 1	No	extracellular enzyme	ENSG00000274247, ENSG00000204983	P07477	Peptidase S1 family	1	ligand, receptor, secreted_enzyme	ecm_regulator, extracellular, ligand, receptor, secreted, secreted_enzyme, secreted_peptidase	O00254, P25116, P55085, Q8TEW0, Q96RI0	F2R, F2RL1, F2RL2, F2RL3, PARD3	F2RL1 [CA1:9349532;SIGNOR:10978167], F2R [NA], F2RL2 [NA], F2RL3 [NA], PARD3 [NA]	blood microparticle [GO:0072562]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	metal ion binding [GO:0046872]; serine-type endopeptidase activity [GO:0004252]	digestion [GO:0007586]; extracellular matrix disassembly [GO:0022617]; proteolysis [GO:0006508]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=PRSS1&keywords=PRSS1	2881.320558783146	9	369745	4	1.971958731497195	159	0	1.7969061876247578	0.03761061946902657	0.05107913669064747	556.1531986531984	0.07106598984771575	0.07071622846781492	0.04893964110929857	0.06733259341472439	0.0693684069969309	0.05126521151245799	152	126	151	50.76522569712107	0.0015230379058484246	0.0015631325298359245	0.0012065965374119785	530	530	530
PRSS2	serine protease 2	No	extracellular enzyme	ENSG00000282049, ENSG00000275896	P07478	Peptidase S1 family	1	ecm, ligand, receptor, secreted_enzyme	ecm, ecm_regulator, intracellular, ligand, receptor, secreted, secreted_enzyme, secreted_peptidase	O00254, P25116, P55085, Q8TEW0, Q96RI0	F2R, F2RL1, F2RL2, F2RL3, PARD3	F2RL1 [SIGNOR:10978167], F2R [NA], F2RL2 [NA], F2RL3 [NA], PARD3 [NA]	azurophil granule lumen [GO:0035578]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	calcium ion binding [GO:0005509]; metalloendopeptidase activity [GO:0004222]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]	antimicrobial humoral response [GO:0019730]; collagen catabolic process [GO:0030574]; digestion [GO:0007586]; extracellular matrix disassembly [GO:0022617]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell growth [GO:0030307]; proteolysis [GO:0006508]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=PRSS2&keywords=PRSS2	8693.830996460674	5	364557	5	4.733608406074619	77	0.047244094488188976	4.927145708582866	0.08738938053097353	0.09784172661870531	1164.2003367003374	0.09644670050761418	0.10607434270172242	0.07993474714518768	0.11653718091009951	0.1046534917879542	0.08935677033030442	112	101	119	106.35936007672191	0.001189601787759473	0.0010778808080189363	9.340732167481363e-4	531	531	531
PRSS3	serine protease 3	No	manually added ensembl_gene_ID, hgnc_symbol, and description by searching the uniprot ID on genenames.org	ENSG00000010438	P35030	Peptidase S1 family	1	ligand, receptor, secreted_enzyme	ecm_regulator, extracellular, intracellular, ligand, receptor, secreted, secreted_enzyme, secreted_peptidase	O00254, P25116, P55085, Q8TEW0, Q96RI0	F2R, F2RL1, F2RL2, F2RL3, PARD3	F2RL1 [SIGNOR:10978167], F2R [NA], F2RL2 [NA], F2RL3 [NA], PARD3 [NA]	extracellular region [GO:0005576]; extracellular space [GO:0005615]; tertiary granule lumen [GO:1904724]	calcium ion binding [GO:0005509]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]	antimicrobial humoral response [GO:0019730]; digestion [GO:0007586]; endothelial cell migration [GO:0043542]; proteolysis [GO:0006508]; zymogen activation [GO:0031638]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=PRSS3&keywords=PRSS3	4.282718280898877	310	53117.1	21	0.10016828242326396	632	0.015748031496062992	0.301896207584832	0.3329646017699108	0.09664268585131947	54.73400673400685	0.15905245346869704	0.3318223028105161	0.33768352365416004	0.3144654088050322	0.027740686339965216	0.7293026849526434	58	178	33	5.216484120067271	0.06208100921214623	0.007221046782684848	0.1414531581783755	496	527	453
PSEN1	presenilin 1			ENSG00000080815	P49768	Peptidase A22A family	1	cell_surface_ligand, receptor	cell_surface, cell_surface_ligand, extracellular, intracellular, plasma_membrane, receptor, secreted, transmembrane	O00548, O60716, O75460, P12830, P16070, P35222, P46531, P49841, Q04721, Q92542, Q99466, Q9UM47, Q9Y4K3	_APH1A_NCSTN_PSEN1_PSENEN, CD44, CDH1, CTNNB1, CTNND1, DLL1, ERN1, GSK3B, NCSTN, NOTCH1, NOTCH2, NOTCH3, NOTCH4, TRAF6	CDH1 [BioGRID:10635315;HPRD:10635315;HPRD:11226248;HPRD:11953314;InnateDB:16126725;SPIKE:11226248;SPIKE:11953314], CTNNB1 [BioGRID:10341227;BioGRID:9738936;BioGRID:9852041;CA1:9223106;HPRD:10092585;HPRD:10341227;HPRD:11168528;HPRD:11226248;HPRD:12070348;HPRD:16306047;HPRD:9738936;InnateDB:16126725;MPPI:10037471;ProtMapper:12297048;ProtMapper:18070361;SIGNOR:2195779;SPIKE:11161700;SPIKE:17145710;SPIKE:9632714], NCSTN [CellTalkDB:10993067;Cellinker:10993067;Cellinker:12603837;HPMR:10993067;HPRD:10993067;HPRD:12603837;IntAct:18201567;LRdb:10993067;LRdb:13;connectomeDB2020:10993067;connectomeDB2020:12603837], NOTCH1 [BioGRID:10077672;CellTalkDB:10077672;Cellinker:10077672;Cellinker:10206645;Cellinker:12374741;HPRD:10077672;HPRD:10206645;HPRD:12374741;LRdb:10077672;LRdb:10206645;LRdb:12374741;NetPath:10077672;SIGNOR:10593990;connectomeDB2020:10077672;connectomeDB2020:10206645;connectomeDB2020:12374741], GSK3B [BioGRID:10997338;HPRD:11104755;HPRD:16814287], NOTCH4 [Cellinker:11518718;HPRD:11518718;LRdb:11518718;NetPath:11518718;connectomeDB2020:11518718], CD44 [CellTalkDB:32196115], NOTCH2 [Cellinker:11518718;HPRD:11518718;LRdb:11518718;NetPath:11518718;connectomeDB2020:11518718], NOTCH3 [HPRD:11518718;LRdb:11518718;NetPath:11518718;connectomeDB2020:11518718], TRAF6 [BioGRID:19012753;InnateDB:18996842], DLL1 [HPRD:12794186;NetPath:12794186], CTNND1 [HPRD:11226248;Lit-BM-17:10208590], ERN1 [HPRD:10587643]	aggresome [GO:0016235]; apical plasma membrane [GO:0016324]; azurophil granule membrane [GO:0035577]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cell surface [GO:0009986]; centrosome [GO:0005813]; ciliary rootlet [GO:0035253]; dendritic shaft [GO:0043198]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; gamma-secretase complex [GO:0070765]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; growth cone [GO:0030426]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; integral component of presynaptic membrane [GO:0099056]; kinetochore [GO:0000776]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; membrane raft [GO:0045121]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; neuromuscular junction [GO:0031594]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; nuclear membrane [GO:0031965]; nuclear outer membrane [GO:0005640]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; rough endoplasmic reticulum [GO:0005791]; sarcolemma [GO:0042383]; smooth endoplasmic reticulum [GO:0005790]; synaptic vesicle [GO:0008021]; Z disc [GO:0030018]	aspartic endopeptidase activity, intramembrane cleaving [GO:0042500]; aspartic-type endopeptidase activity [GO:0004190]; ATPase binding [GO:0051117]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; calcium channel activity [GO:0005262]; endopeptidase activity [GO:0004175]; growth factor receptor binding [GO:0070851]; PDZ domain binding [GO:0030165]	amyloid-beta formation [GO:0034205]; amyloid-beta metabolic process [GO:0050435]; amyloid precursor protein catabolic process [GO:0042987]; amyloid precursor protein metabolic process [GO:0042982]; astrocyte activation [GO:0048143]; astrocyte activation involved in immune response [GO:0002265]; autophagosome assembly [GO:0000045]; blood vessel development [GO:0001568]; brain morphogenesis [GO:0048854]; Cajal-Retzius cell differentiation [GO:0021870]; calcium ion transport [GO:0006816]; cell-cell adhesion [GO:0098609]; cell fate specification [GO:0001708]; cellular response to amyloid-beta [GO:1904646]; cellular response to DNA damage stimulus [GO:0006974]; cerebellum development [GO:0021549]; cerebral cortex cell migration [GO:0021795]; choline transport [GO:0015871]; dorsal/ventral neural tube patterning [GO:0021904]; embryonic limb morphogenesis [GO:0030326]; endoplasmic reticulum calcium ion homeostasis [GO:0032469]; epithelial cell proliferation [GO:0050673]; heart looping [GO:0001947]; hematopoietic progenitor cell differentiation [GO:0002244]; intracellular signal transduction [GO:0035556]; learning or memory [GO:0007611]; L-glutamate import across plasma membrane [GO:0098712]; membrane protein ectodomain proteolysis [GO:0006509]; membrane protein intracellular domain proteolysis [GO:0031293]; memory [GO:0007613]; mitochondrial transport [GO:0006839]; modulation of age-related behavioral decline [GO:0090647]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of apoptotic process [GO:0043066]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of axonogenesis [GO:0050771]; negative regulation of core promoter binding [GO:1904797]; negative regulation of epidermal growth factor-activated receptor activity [GO:0007175]; negative regulation of gene expression [GO:0010629]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; negative regulation of ubiquitin-protein transferase activity [GO:0051444]; neural retina development [GO:0003407]; neuron apoptotic process [GO:0051402]; neuron development [GO:0048666]; neuron migration [GO:0001764]; neuron projection maintenance [GO:1990535]; Notch receptor processing [GO:0007220]; Notch signaling pathway [GO:0007219]; positive regulation of amyloid fibril formation [GO:1905908]; positive regulation of apoptotic process [GO:0043065]; positive regulation of catalytic activity [GO:0043085]; positive regulation of coagulation [GO:0050820]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of gene expression [GO:0010628]; positive regulation of glycolytic process [GO:0045821]; positive regulation of L-glutamate import across plasma membrane [GO:0002038]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of phosphorylation [GO:0042327]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein binding [GO:0032092]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of receptor recycling [GO:0001921]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of tumor necrosis factor production [GO:0032760]; post-embryonic development [GO:0009791]; protein glycosylation [GO:0006486]; protein processing [GO:0016485]; protein transport [GO:0015031]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of gene expression [GO:0010468]; regulation of neuron projection development [GO:0010975]; regulation of phosphorylation [GO:0042325]; regulation of resting membrane potential [GO:0060075]; regulation of synaptic plasticity [GO:0048167]; regulation of synaptic transmission, glutamatergic [GO:0051966]; response to oxidative stress [GO:0006979]; sequestering of calcium ion [GO:0051208]; skeletal system morphogenesis [GO:0048705]; skin morphogenesis [GO:0043589]; smooth endoplasmic reticulum calcium ion homeostasis [GO:0051563]; somitogenesis [GO:0001756]; synapse organization [GO:0050808]; synaptic vesicle targeting [GO:0016080]; T cell activation involved in immune response [GO:0002286]; T cell receptor signaling pathway [GO:0050852]; thymus development [GO:0048538]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=PSEN1&keywords=PSEN1	47.33167992013742	91	3222.05	109	3.4514908360948096	101	0.12598425196850394	0.1906187624750511	0.07853982300884964	0.09736211031175138	0.1026936026936028	0.104906937394247	0.11514052583862167	0.0799347471451877	0.062153163152053346	0.07230604887168035	0.06045972570986895	155	122	142	0.09909997259721981	0.6613490492654077	0.7544094367057408	0.6458271623036546	276	240	261
PSG1	pregnancy specific beta-1-glycoprotein 1	TBD		ENSG00000231924	P11464	Immunoglobulin superfamily, CEA family	1	ligand	extracellular, ligand, secreted	NA	NA	NA	extracellular region [GO:0005576]	NA	female pregnancy [GO:0007565]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=PSG1&keywords=PSG1	0.13209747968540358	650	NA	NA	5.643784837027099	70	0	0	0.0022123893805309734	0.0019184652278177458	0	0	0	0	3.699593044765076e-4	3.338229403124583e-5	3.8632412594166507e-5	302	408	400	4.1571169267733084e-4	0.9956073680271902	0.9632930125250223	0.963797070117804	136	148	111
PSG11	pregnancy specific beta-1-glycoprotein 11	TBD		ENSG00000243130	Q9UQ72	Immunoglobulin superfamily, CEA family	1	ligand	extracellular, intracellular, ligand, secreted	NA	NA	NA	extracellular region [GO:0005576]	NA	female pregnancy [GO:0007565]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=PSG11&keywords=PSG11	0.0601516	714	NA	NA	6.6845301415037275	59	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
PSG2	pregnancy specific beta-1-glycoprotein 2	TBD		ENSG00000242221	P11465	Immunoglobulin superfamily, CEA family	1	ligand	ligand, secreted	NA	NA	NA	extracellular region [GO:0005576]	NA	cell migration [GO:0016477]; female pregnancy [GO:0007565]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=PSG2&keywords=PSG2	1.0217320561797754	450	NA	NA	84.44374677864775	12	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
PSG3	pregnancy specific beta-1-glycoprotein 3	TBD		ENSG00000221826	Q16557	Immunoglobulin superfamily, CEA family	1	ligand	extracellular, ligand, secreted	NA	NA	NA	extracellular region [GO:0005576]	NA	defense response [GO:0006952]; female pregnancy [GO:0007565]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=PSG3&keywords=PSG3	0.33871025328844945	563	NA	NA	9.659790258536518	45	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
PSG4	pregnancy specific beta-1-glycoprotein 4	TBD		ENSG00000243137	Q00888	Immunoglobulin superfamily, CEA family	2	ligand	extracellular, ligand, secreted	O60469, P32971	DSCAM, TNFSF8	TNFSF8 [Cellinker:32822567], DSCAM [Cellinker:32822567]	extracellular region [GO:0005576]	NA	female pregnancy [GO:0007565]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=PSG4&keywords=PSG4	3.3421360008618852	328	NA	NA	24.818454858893777	24	0	0.012475049900199597	0	7.194244604316547e-4	0	0.03553299492385787	0	0	0.03884572697003329	0.001268527173187341	5.40853776318331e-4	187	364	383	0.008125688836729825	2.69483424381933	0.6216882169108432	0.581542244891592	18	283	291
PSG5	pregnancy specific beta-1-glycoprotein 5	TBD		ENSG00000204941	Q15238	Immunoglobulin superfamily, CEA family	2	ligand	extracellular, ligand, secreted	P16234, Q9NP84	PDGFRA, TNFRSF12A	PDGFRA [Cellinker:32822567], TNFRSF12A [Cellinker:32822567]	extracellular region [GO:0005576]	NA	female pregnancy [GO:0007565]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=PSG5&keywords=PSG5	1.0776675955957022	444	NA	NA	2.8646767233109345	118	0	0.001497005988023952	0	0	0	0.015228426395939085	0	0	0.01849796522382538	2.3367605821872085e-4	0	239	401	401	0.003223370333273376	2.1551211609129046	0.7739083002514252	0.756236855504035	26	222	210
PSG6	pregnancy specific beta-1-glycoprotein 6	TBD		ENSG00000170848	Q00889	Immunoglobulin superfamily, CEA family	2	ligand	extracellular, ligand, secreted	O60469	DSCAM	DSCAM [Cellinker:32822567]	extracellular region [GO:0005576]	NA	female pregnancy [GO:0007565]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=PSG6&keywords=PSG6	0.032335017977528094	765	NA	NA	3.7275989686840614	97	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
PSG7	pregnancy specific beta-1-glycoprotein 7			ENSG00000221878	Q13046	Immunoglobulin superfamily, CEA family	2	ligand	ligand, secreted	O60469, P22455, P43146, Q9UMR7	CLEC4A, DCC, DSCAM, FGFR4	FGFR4 [Cellinker:32822567], DSCAM [Cellinker:32822567], DCC [Cellinker:32822567], CLEC4A [Cellinker:32822567]	extracellular region [GO:0005576]	NA	female pregnancy [GO:0007565]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=PSG7&keywords=PSG7	0.10751055842696629	670	NA	NA	7.893035230691856	54	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
PSG8	pregnancy specific beta-1-glycoprotein 8	TBD		ENSG00000124467	Q9UQ74	Immunoglobulin superfamily, CEA family	1	ligand	extracellular, ligand, secreted	NA	NA	NA	extracellular region [GO:0005576]	NA	NA	https://www.genecards.org/cgi-bin/carddisp.pl?gene=PSG8&keywords=PSG8	0.4009538374680618	544	NA	NA	21.533915285251958	28	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
PSG9	pregnancy specific beta-1-glycoprotein 9	TBD		ENSG00000183668	Q00887	Immunoglobulin superfamily, CEA family	2	ligand	extracellular, ligand, secreted	O60469, P22455, P30530, P43146	AXL, DCC, DSCAM, FGFR4	DCC [Cellinker:32822567], FGFR4 [Cellinker:32822567], DSCAM [Cellinker:32822567], AXL [Cellinker:32822567]	extracellular region [GO:0005576]; transforming growth factor beta ligand-receptor complex [GO:0070021]	protein-containing complex binding [GO:0044877]	Fc receptor mediated inhibitory signaling pathway [GO:0002774]; female pregnancy [GO:0007565]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; positive regulation of gene expression [GO:0010628]; regulation of regulatory T cell differentiation [GO:0045589]; tolerance induction dependent upon immune response [GO:0002461]; transforming growth factor beta1 activation [GO:0036364]; transforming growth factor beta receptor signaling pathway [GO:0007179]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=PSG9&keywords=PSG9	0.6684706756916899	496	NA	NA	37.269288577836264	19	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
PSPN	persephin	Yes		ENSG00000125650	O60542	TGF-beta family, GDNF subfamily	15	ligand	extracellular, ligand, secreted	O00451, O60609, O75056, P07949, P56159, Q9GZZ7	GFRA1, GFRA2, GFRA3, GFRA4, GFRA4_RET, RET, SDC3	GFRA4 [Baccin2019:1111614411116140;CellTalkDB:11116144;Cellinker:11116144;Cellinker:11544105;HPMR:11116144;HPRD:11116144;LRdb:11116144;SIGNOR:11116144;connectomeDB2020:11116144], GFRA3 [CellTalkDB:32196115], RET [Baccin2019:11116144;CellTalkDB:11116144;Cellinker:11116144;HPMR:11116144;LRdb:11116144;connectomeDB2020:11116144], SDC3 [CellTalkDB:32196115], GFRA2 [CellTalkDB:32196115], GFRA1 [CellTalkDB:20350599;Cellinker:20350599;LRdb:20350599;Ramilowski2015:20350599;connectomeDB2020:20350599;talklr:20350599]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	glial cell-derived neurotrophic factor receptor binding [GO:0030116]; growth factor activity [GO:0008083]; receptor tyrosine kinase binding [GO:0030971]; signaling receptor binding [GO:0005102]	central nervous system development [GO:0007417]; nervous system development [GO:0007399]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=PSPN&keywords=PSPN	0.7937877865168539	480	NA	NA	0.41366791238440975	410	0	0.009481037924151696	0.00331858407079646	0.0014388489208633092	0	0.016920473773265648	0.012692656391659111	0	0.004439511653718092	0.006409400453999185	0.004597257098705818	289	272	294	0.0053907063897417565	0.938196810988633	1.0661889089727816	0.9484462070197902	163	118	119
PTH	parathyroid hormone	Yes		ENSG00000152266	P01270	Parathyroid hormone family	12	ligand	extracellular, intracellular, ligand, secreted	O60895, O60896, O75581, P07550, P13945, P16473, P32241, P41586, P49190, Q03431, Q99678, Q9NQS5	ADCYAP1R1, ADRB2, ADRB3, GPR20, GPR84, LRP6, PTH1R, PTH2R, RAMP2, RAMP3, TSHR, VIPR1	PTH2R [CellTalkDB:7797535;Cellinker:7797535;Cellinker:9482662;HPMR:7797535;HPRD:9482662;LRdb:7797535;LRdb:948;SIGNOR:11861531;connectomeDB2020:7797535;connectomeDB2020:9482662], PTH1R [CellTalkDB:12947048;Cellinker:12947048;Cellinker:9108031;HPRD:9108031;IntAct:19674967;LRdb:12947048;LRdb:91;ProtMapper:29444827;SIGNOR:18981475;connectomeDB2020:12947048;connectomeDB2020:9108031], ADCYAP1R1 [CellTalkDB:32196115], ADRB2 [CellTalkDB:32196115], GPR84 [CellTalkDB:32196115], VIPR1 [CellTalkDB:32196115], GPR20 [CellTalkDB:32196115], ADRB3 [CellTalkDB:32196115], TSHR [CellTalkDB:32196115], RAMP3 [CellTalkDB:32196115], RAMP2 [CellTalkDB:32196115], LRP6 [CellTalkDB:22589223;ProtMapper:19884009]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	hormone activity [GO:0005179]; parathyroid hormone receptor binding [GO:0031856]; peptide hormone receptor binding [GO:0051428]; protein N-terminus binding [GO:0047485]; receptor ligand activity [GO:0048018]; type 1 parathyroid hormone receptor binding [GO:0031857]	activation of phospholipase C activity [GO:0007202]; adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; bone mineralization [GO:0030282]; bone resorption [GO:0045453]; cAMP metabolic process [GO:0046058]; cell-cell signaling [GO:0007267]; cellular calcium ion homeostasis [GO:0006874]; cellular macromolecule biosynthetic process [GO:0034645]; G protein-coupled receptor signaling pathway [GO:0007186]; homeostasis of number of cells within a tissue [GO:0048873]; hormone-mediated apoptotic signaling pathway [GO:0008628]; magnesium ion homeostasis [GO:0010960]; negative regulation of apoptotic process in bone marrow cell [GO:0071866]; negative regulation of bone mineralization involved in bone maturation [GO:1900158]; negative regulation of chondrocyte differentiation [GO:0032331]; negative regulation of gene expression [GO:0010629]; phosphate ion homeostasis [GO:0055062]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cell proliferation in bone marrow [GO:0071864]; positive regulation of glucose import [GO:0046326]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of inositol phosphate biosynthetic process [GO:0060732]; positive regulation of osteoclast proliferation [GO:0090290]; positive regulation of signal transduction [GO:0009967]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of gene expression [GO:0010468]; response to cadmium ion [GO:0046686]; response to ethanol [GO:0045471]; response to fibroblast growth factor [GO:0071774]; response to lead ion [GO:0010288]; response to parathyroid hormone [GO:0071107]; response to vitamin D [GO:0033280]; response to xenobiotic stimulus [GO:0009410]; Rho protein signal transduction [GO:0007266]; skeletal system development [GO:0001501]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=PTH&keywords=PTH	0.007364973033707865	843	NA	NA	1.233591350468601	235	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
PTH2	parathyroid hormone 2	Yes		ENSG00000142538	Q96A98	Parathyroid hormone family	12	ligand	extracellular, ligand, secreted	O60895, O60896, P07550, P13945, P16473, P32241, P41586, P49190, Q03431, Q99678, Q9NQS5	ADCYAP1R1, ADRB2, ADRB3, GPR20, GPR84, PTH1R, PTH2R, RAMP2, RAMP3, TSHR, VIPR1	PTH1R [Baccin2019:10854439;Baccin2019:11159842;CellTalkDB:11159842;Cellinker:10854439;Cellinker:11159842;Guide2Pharma:10854439;Guide2Pharma:11159842;LRdb:11;LRdb:11159842;connectomeDB2020:10854439;connectomeDB2020:11159842;scConnect:10854439;scConnect:11159842], PTH2R [Baccin2019:10854439;Baccin2019:11602681;Baccin2019:11861531;CellTalkDB:11861531;Cellinker:10854439;Cellinker:11602681;Cellinker:11861531;HPRD:10854439;LRdb:10854439;LRdb:11602681;LRdb:11861531;SIGNOR:11861531;connectomeDB2020:10854439;connectomeDB2020:11602681;connectomeDB2020:11861531;scConnect:10854439;scConnect:11602681], ADCYAP1R1 [CellTalkDB:32196115], TSHR [CellTalkDB:32196115], GPR20 [CellTalkDB:32196115], GPR84 [CellTalkDB:32196115], ADRB2 [CellTalkDB:32196115], ADRB3 [CellTalkDB:32196115], VIPR1 [CellTalkDB:32196115], RAMP3 [CellTalkDB:12446722], RAMP2 [CellTalkDB:32196115]	extracellular region [GO:0005576]	NA	neuropeptide signaling pathway [GO:0007218]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=PTH2&keywords=PTH2	0	899	NA	NA	0.08719300433087653	648	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
PTHLH	parathyroid hormone like hormone	Yes		ENSG00000087494	P12272	Parathyroid hormone family	16	ligand	extracellular, intracellular, ligand, secreted	O60895, O60896, P05231, P07550, P13945, P16473, P32241, P41586, P49190, P49683, Q03431, Q99678, Q9NQS5	ADCYAP1R1, ADRB2, ADRB3, GPR20, GPR84, IL6, PRLHR, PTH1R, PTH2R, RAMP2, RAMP3, TSHR, VIPR1	PRLHR [NA], PTH1R [CellChatDB:29577935;CellTalkDB:9108031;Cellinker:2558877;Cellinker:29577935;Cellinker:8702701;Cellinker:9108031;Guide2Pharma:8702701;HPMR:2558877;HPRD:9108031;IntAct:19674967;LRdb:2558877;LRdb:8702701;LRdb:9108031;connectomeDB2020:2558877;connectomeDB2020:8702701;connectomeDB2020:9108031;scConnect:8702701], PTH2R [Baccin2019:8702701;CellTalkDB:8702701;Cellinker:8702701;Guide2Pharma:8702701;LRdb:8702701;connectomeDB2020:8702701;scConnect:8702701], ADCYAP1R1 [CellTalkDB:32196115], GPR84 [CellTalkDB:32196115], RAMP3 [CellTalkDB:32196115], RAMP2 [CellTalkDB:32196115], ADRB2 [CellTalkDB:32196115], VIPR1 [CellTalkDB:32196115], ADRB3 [CellTalkDB:32196115], GPR20 [CellTalkDB:32196115], TSHR [CellTalkDB:32196115], IL6 [HPRD:12000745]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]	hormone activity [GO:0005179]; peptide hormone receptor binding [GO:0051428]	adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; bone mineralization [GO:0030282]; cAMP metabolic process [GO:0046058]; cell-cell signaling [GO:0007267]; epidermis development [GO:0008544]; female pregnancy [GO:0007565]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of chondrocyte development [GO:0061182]; negative regulation of chondrocyte differentiation [GO:0032331]; osteoblast development [GO:0002076]; positive regulation of cell population proliferation [GO:0008284]; regulation of chondrocyte differentiation [GO:0032330]; regulation of gene expression [GO:0010468]; skeletal system development [GO:0001501]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=PTHLH&keywords=PTHLH	2.2495796720090224	377	NA	NA	1.4390593950823516	207	0	0.01696606786427145	0	0.05995203836930454	0.030303030303030297	0.001692047377326565	0.007252946509519492	0.016313213703099513	0.0036995930447650763	0.002169849112030977	0.10349623333977144	292	341	109	0.021985910874829033	0.42830085716101407	0.3804753023809589	3.5483195643206167	366	349	6
PTN	pleiotrophin	Yes		ENSG00000105894	P21246	Pleiotrophin family	15	ecm, ligand	ecm, extracellular, intracellular, ligand, secreted	O15031, O75056, P18827, P19338, P23467, P23471, P31431, P34741, Q13332, Q9UM73, Q9Y6N8	ALK, CDH10, ITGAV_ITGB3, NCL, PLXNB2, PTPRB, PTPRS, PTPRZ1, SDC1, SDC2, SDC3, SDC4	ALK [Baccin2019:11278720;CellChatDB:25620911;CellChatDB:28356350;CellTalkDB:11278720;Cellinker:11278720;Cellinker:25620911;Cellinker:28356350;DIP:1848244;HPRD:11278720;LRdb:11278720;SIGNOR:11278720;SignaLink3:11278720;SignaLink3:23331499;connectomeDB2020:11278720], SDC1 [Baccin2019:7592855;CellChatDB:25620911;CellChatDB:28356350;CellTalkDB:15226297;Cellinker:25620911;Cellinker:28356350;Cellinker:7592855;HPRD:7592855;LRdb:7592855], SDC3 [Baccin2019:8175719;CellChatDB:25620911;CellChatDB:28356350;Cellinker:11461706;Cellinker:25620911;Cellinker:28356350;Cellinker:8175719;HPRD:8175719;LRdb:8175719;connectomeDB2020:8175719], PTPRZ1 [Baccin2019:10706604;Baccin2019:16814777;BioGRID:10706604;CellChatDB:25620911;CellChatDB:28356350;CellPhoneDB:25644401;CellTalkDB:25644401;Cellinker:10706604;Cellinker:16814777;Cellinker:25620911;Cellinker:28356350;HPMR:10706604;HPRD:10706604;HPRD:16814777;LRdb:10706604;LRdb:17;connectomeDB2020:10706604;connectomeDB2020:16814777], PTPRS [CellTalkDB:16169070;Cellinker:16169070;HPRD:16169070;LRdb:16169070;connectomeDB2020:16169070], PTPRB [CellTalkDB:26198319;Ramilowski2015:22839765;connectomeDB2020:22839765;talklr:22839765], SDC2 [CellChatDB:25620911;CellChatDB:28356350;Cellinker:25620911;Cellinker:28356350], SDC4 [CellChatDB:25620911;CellChatDB:28356350;Cellinker:25620911;Cellinker:28356350], NCL [CellChatDB:25620911;CellChatDB:28356350;Cellinker:25620911;Cellinker:28356350], PLXNB2 [Cellinker:16169070;HPRD:16169070;LRdb:16169070;connectomeDB2020:16169070], CDH10 [Baccin2019:16169070;Cellinker:16169070;HPRD:16169070;LRdb:16169070]	endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]	chondroitin sulfate binding [GO:0035374]; growth factor activity [GO:0008083]; heparin binding [GO:0008201]; integrin binding [GO:0005178]; protein kinase binding [GO:0019901]; protein phosphatase inhibitor activity [GO:0004864]	bone mineralization [GO:0030282]; decidualization [GO:0046697]; dendrite arborization [GO:0140059]; dendrite regeneration [GO:0031104]; estrous cycle [GO:0044849]; integrin-mediated signaling pathway [GO:0007229]; learning [GO:0007612]; leukocyte chemotaxis involved in inflammatory response [GO:0002232]; memory [GO:0007613]; negative regulation of long-term synaptic potentiation [GO:1900272]; negative regulation of neuroblast proliferation [GO:0007406]; nervous system development [GO:0007399]; oogenesis [GO:0048477]; ossification involved in bone remodeling [GO:0043932]; positive regulation of axon regeneration [GO:0048680]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of dendrite development [GO:1900006]; positive regulation of hepatocyte proliferation [GO:2000347]; positive regulation of leukocyte chemotaxis [GO:0002690]; positive regulation of neuron projection development [GO:0010976]; positive regulation of oligodendrocyte differentiation [GO:0048714]; positive regulation of ossification [GO:0045778]; positive regulation of stem cell differentiation [GO:2000738]; receptor clustering [GO:0043113]; regulation of endothelial cell migration [GO:0010594]; regulation of hemopoiesis [GO:1903706]; regulation of myelination [GO:0031641]; regulation of stem cell population maintenance [GO:2000036]; regulation of synaptic plasticity [GO:0048167]; response to auditory stimulus [GO:0010996]; tissue regeneration [GO:0042246]; transmembrane receptor protein tyrosine phosphatase signaling pathway [GO:0007185]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=PTN&keywords=PTN	0.8143709505617978	475	NA	NA	0.012021926951142757	823	0.007874015748031496	0.0029940119760479044	0	0.06498800959232616	0.0016835016835016834	0.00338409475465313	0	0.004893964110929854	7.399186089530152e-4	2.00293764187475e-4	1.9316206297083252e-4	301	403	396	0.007904633845600141	0.5998401699564623	0.5697013327471134	0.5693030167983962	303	296	300
PTPN6	protein tyrosine phosphatase non-receptor type 6			ENSG00000111679	P29350	Protein-tyrosine phosphatase family, Non-receptor class 2 subfamily	2	ligand	extracellular, intracellular, ligand, secreted, transmembrane	O00459, O15524, O43561, O60674, O60716, O94916, P00519, P00533, P03372, P04629, P06213, P06239, P07384, P07948, P08922, P10721, P10912, P11274, P11912, P12814, P12931, P14784, P15498, P16284, P17181, P17252, P19235, P20138, P20273, P20963, P21854, P22681, P23458, P24394, P27986, P29353, P29475, P29597, P31260, P32927, P35222, P35968, P40189, P40259, P40763, P42226, P42702, P43403, P43405, P51692, P52333, P52735, P62993, P63261, P78314, P78324, Q12809, Q13094, Q14289, Q14790, Q5QGZ9, Q8TDQ1, Q8WV28, Q96PJ5, Q9UKW4, Q9UQC2	ABL1, ACTG1, ACTN1, BCR, BLNK, CAPN1, CASP8, CBL, CD22, CD247, CD300LF, CD33, CD72, CD79A, CD79B, CLEC12A, CSF2RB, CTNNB1, CTNND1, EGFR, EPOR, ESR1, FCRL4, GAB2, GHR, GRB2, HOXA10, IFNAR1, IL2RB, IL4R, IL6ST, INSR, JAK1, JAK2, JAK3, KCNH2, KDR, KIT, LAT, LCK, LCP2, LIFR, LYN, NFAT5, NOS1, NTRK1, PECAM1, PIK3R1, PIK3R2, PRKCA, PTK2B, ROS1, SH3BP2, SHC1, SIRPA, SOCS1, SRC, STAT3, STAT5B, STAT6, SYK, TYK2, VAV1, VAV2, VAV3, ZAP70	ABL1 [Adhesome:8692915;HPRD:10488096;HPRD:10574931;HPRD:12468540;HPRD:7512963;HPRD:8114715;HPRD:8692915;SIGNOR:12468540;SIGNOR:8692915], JAK1 [HPRD:7629131;HPRD:9520455;InnateDB:8524272;SIGNOR:14624462;SignaLink3:23180781;SignaLink3:23331499;SignaLink3:8524272;SignaLink3:9852037], ZAP70 [HPRD:10458769;HPRD:8638162;InnateDB:12763134;SIGNOR:10458769;SignaLink3:10458769;SignaLink3:12763134;SignaLink3:23109003;SignaLink3:23180781;SignaLink3:8638162], JAK3 [HPRD:9520455;SIGNOR:11021818;SignaLink3:11021818;SignaLink3:18988627;SignaLink3:23331499;SignaLink3:9520455], SOCS1 [SIGNOR:14551136;SignaLink3:14551136;SignaLink3:23331499], JAK2 [BioGRID:10772872;BioGRID:8943354;DEPOD:8943354;HPRD:8943354;InnateDB:10772872;SIGNOR:8943354;SignaLink3:10772872;SignaLink3:15983048;SignaLink3:18988627;SignaLink3:21071413;SignaLink3:23331499;SignaLink3:8943354], STAT6 [HPRD:12791978;SignaLink3:12459556;SignaLink3:12791978;SignaLink3:23331499], ROS1 [DEPOD:11266449;DOMINO:17416557;HPRD:11266449;IntAct:11266449;IntAct:17416557;Lit-BM-17:11266449;Lit-BM-17:17416557;ProtMapper:11266449;SIGNOR:11266449;SignaLink3:11266449;SignaLink3:23331499], LCK [BioGRID:11294838;BioGRID:8114715;DEPOD:10617656;DEPOD:11294838;HPRD-phos:11294838;HPRD:10488096;HPRD:10574931;HPRD:11294838;HPRD:12468540;HPRD:7512963;HPRD:8114715;HPRD:8692915;IntAct:19167335;IntAct:8114715;ProtMapper:11294838;ProtMapper:8790380;SIGNOR:11294838;SignaLink3:10488096;SignaLink3:10574931;SignaLink3:11294838;SignaLink3:12468540;SignaLink3:15489916;SignaLink3:23109003;SignaLink3:23331499;SignaLink3:7512963;SignaLink3:8114715;SignaLink3:8692915], PIK3R1 [HPRD:11160222;HPRD:11337495;Lit-BM-17:10488096;Lit-BM-17:11160222;NetPath:9065461;SignaLink3:10488096;SignaLink3:11526404;SignaLink3:15032589;SignaLink3:21780115;SignaLink3:22880054;SignaLink3:23109003], PIK3R2 [NetPath:9065461;SignaLink3:10488096;SignaLink3:11526404;SignaLink3:15032589;SignaLink3:21780115;SignaLink3:22880054;SignaLink3:23109003], CD247 [HPRD:14672952;SignaLink3:11238643;SignaLink3:23109003], LYN [Adhesome:10574931;Adhesome:19171907;Adhesome:22624718;BioGRID:10574931;DEPOD:15537644;HPRD-phos:11042209;HPRD:10488096;HPRD:10574931;HPRD:11042209;HPRD:12468540;HPRD:8114715;HPRD:8692915;NetPath:19171907;ProtMapper:15537644;SIGNOR:15537644], SRC [Adhesome:9261115;BioGRID:14699166;DEPOD:9261115;HPRD-phos:12468645;HPRD-phos:8647855;HPRD-phos:9261115;HPRD:12468645;HPRD:8647855;HPRD:9261115;InnateDB:9261115;ProtMapper:17974954;ProtMapper:9261115;SIGNOR:17974954;SIGNOR:9261115], INSR [Adhesome:12468540;Adhesome:7512963;Adhesome:8114715;Adhesome:8692915;HPRD:12468540;HPRD:7512963;HPRD:8114715;HPRD:8692915;ProtMapper:10734133;SIGNOR:10734133], KIT [DEPOD:7684496;HPRD:7684496;HPRD:9528781;LMPID:23416972;NetPath:9528781;ProtMapper:15526160;SIGNOR:9528781], CSF2RB [HPRD:8246974;HPRD:9162089;HPRD:9254654;NetPath:9162089;ProtMapper:11812650;ProtMapper:9162089;SIGNOR:11812650;SIGNOR:9162089], KDR [DEPOD:18377662;HPRD:16453023;HPRD:9405464;ProtMapper:16337972;ProtMapper:18377662;ProtMapper:18840653;SIGNOR:18377662;SIGNOR:18840653], NTRK1 [DEPOD:14662744;ProtMapper:14662744;SIGNOR:14662744], SH3BP2 [Lit-BM-17:16649996;ProtMapper:16649996;SIGNOR:16649996], PTK2B [Adhesome:10521452;Adhesome:10747947;HPRD:10521452;HPRD:10747947;ProtMapper:10521452;SIGNOR:10521452], PRKCA [Adhesome:11781100;Adhesome:15269224;HPRD:15269224], NFAT5 [DEPOD:20351292;InnateDB:20351292;IntAct:20351292;ProtMapper:20351292;SIGNOR:20351292], EGFR [CancerCellMap:7518460;CancerCellMap:7673163;Cellinker:9733788;DEPOD:9038217;HPRD-phos:9733788;HPRD:9733788;NetPath:7673163;ProtMapper:9733788;SIGNOR:9733788], IL2RB [HPRD:9520455;InnateDB:9520455;NetPath:9520455;SIGNOR:9520455], CD72 [HPRD:15588985;HPRD:9590210;HPRD:9740800;NetPath:11356834;SIGNOR:9740800], STAT3 [Adhesome:10545526;Adhesome:15870198;SIGNOR:18508557], SYK [Adhesome:10072516;Adhesome:10458769;Adhesome:10592173;Adhesome:10747947;Adhesome:11356834;Adhesome:12763134;HPRD:10072516;HPRD:11356834;InnateDB:12763134;SIGNOR:10458769], ACTG1 [ProtMapper:12646642;SIGNOR:12646642], KCNH2 [SIGNOR:12361947], CASP8 [Adhesome:18086677;DEPOD:18086677;ProtMapper:18086677;SIGNOR:18086677], GRB2 [Adhesome:10747947;Adhesome:11171044;Adhesome:11328818;Adhesome:11964172;Adhesome:14551136;Adhesome:25535246;Adhesome:8632004;BioGRID:8632004;HPRD:11964172;HPRD:8632004;InnateDB:11171044;InnateDB:11328818;IntAct:10660620;IntAct:25535246;Lit-BM-17:10747947;Lit-BM-17:11964172;Lit-BM-17:25535246;Lit-BM-17:8632004], CBL [Adhesome:11157475;Adhesome:12176909;HPRD:12176909], VAV1 [Adhesome:10592173;Adhesome:8632004;HPRD:8632004], SIRPA [Adhesome:10660565;Adhesome:10660620;Adhesome:16920950;Adhesome:17954568;Adhesome:18233962;BioGRID:10660565;HPRD:10660565;HPRD:14662855;HPRD:8943344;HPRD:9632768;Lit-BM-17:10660565;Lit-BM-17:10660620], CAPN1 [Adhesome:9813145], ACTN1 [Adhesome:15070900;DEPOD:15070900;HPRD:15070900], VAV2 [Adhesome:10592173], VAV3 [Adhesome:10592173], SHC1 [Adhesome:8541543;HPRD:8541543], CD300LF [CellTalkDB:15549731;Cellinker:15549731;HPRD:14662855;HPRD:15184070;HPRD:15549731], FCRL4 [CellTalkDB:21908428], CLEC12A [CellTalkDB:28606940], NOS1 [DEPOD:11511520;HPRD:11511520], CTNND1 [CancerCellMap:10835420;DEPOD:10835420;HPRD:10835420;NetPath:10835420], CD33 [DEPOD:10206955;HPRD-phos:10206955;HPRD:10206955;InnateDB:10206955;InnateDB:10887109;InnateDB:17947393;IntAct:10206955;IntAct:10556798;IntAct:17947393;IntAct:24216507], HOXA10 [DEPOD:12145285;HPRD-phos:12145285;HPRD:12145285], ESR1 [DEPOD:7539106;HPRD:7539106], GAB2 [DEPOD:11812650;HPRD:11812650;HPRD:11895767;NetPath:11812650;NetPath:19171907], CD22 [BioGRID:11356834;BioGRID:8627166;DEPOD:10228003;DEPOD:8627166;DEPOD:9890995;HPRD-phos:9890995;HPRD:15588985;HPRD:7618087;HPRD:9890995;InnateDB:11551923;InnateDB:8627166;NetPath:7618087], EPOR [DOMINO:7228577;DOMINO:7528577;HPRD:7528577;HPRD:7889566;IntAct:7228577;IntAct:7528537;IntAct:7528577], PECAM1 [HPRD-phos:9774457;HPRD:9774457;Lit-BM-17:10350061;Lit-BM-17:9774457], LCP2 [BioGRID:9765283;HPRD:15588985;HPRD:8760799;HPRD:9765283], IL4R [HPRD:11714803;InnateDB:9065461;NetPath:11714803], BLNK [HPRD:10903736;HPRD:11356834;HPRD:15588985;NetPath:10903736], CD79A [HPRD:7539038;NetPath:7539038], CD79B [HPRD:7539038;NetPath:7539038], TYK2 [HPRD:7629131;HPRD:8780698;InnateDB:8524272], IFNAR1 [HPRD:8524272;HPRD:9029147;InnateDB:8524272], LAT [Lit-BM-17:27221712], IL6ST [HPRD:10800945], GHR [HPRD:9632636], STAT5B [HPRD:9211920], CTNNB1 [HPRD:12571228;HPRD:15588985;ProtMapper:12571228;ProtMapper:20840866], BCR [HPRD:9211920], LIFR [HPRD:10800945]	alpha-beta T cell receptor complex [GO:0042105]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724]	cell adhesion molecule binding [GO:0050839]; phosphorylation-dependent protein binding [GO:0140031]; phosphotyrosine residue binding [GO:0001784]; protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725]; SH2 domain binding [GO:0042169]; SH3 domain binding [GO:0017124]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]	abortive mitotic cell cycle [GO:0033277]; B cell receptor signaling pathway [GO:0050853]; cell differentiation [GO:0030154]; cytokine-mediated signaling pathway [GO:0019221]; epididymis development [GO:1905867]; G protein-coupled receptor signaling pathway [GO:0007186]; hematopoietic progenitor cell differentiation [GO:0002244]; intracellular signal transduction [GO:0035556]; megakaryocyte development [GO:0035855]; natural killer cell mediated cytotoxicity [GO:0042267]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of humoral immune response mediated by circulating immunoglobulin [GO:0002924]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of mast cell activation involved in immune response [GO:0033007]; negative regulation of peptidyl-tyrosine phosphorylation [GO:0050732]; negative regulation of T cell proliferation [GO:0042130]; negative regulation of T cell receptor signaling pathway [GO:0050860]; negative regulation of tumor necrosis factor production [GO:0032720]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine phosphorylation [GO:0018108]; platelet aggregation [GO:0070527]; platelet formation [GO:0030220]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; protein dephosphorylation [GO:0006470]; regulation of apoptotic process [GO:0042981]; regulation of B cell differentiation [GO:0045577]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; regulation of type I interferon-mediated signaling pathway [GO:0060338]; T cell costimulation [GO:0031295]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=PTPN6&keywords=PTPN6	16.212228714230555	187	8623.8	75	0.5273384934081261	373	0.44094488188976355	0.052894211576846255	0.026548672566371688	0.006954436450839326	0.07239057239057241	0.08460236886632823	0.05983680870353572	0.03915171288743884	0.05771365149833526	0.05518093203365155	0.03816882364303626	159	137	169	0.08494427931879264	0.7131935908531614	0.6865177396817638	0.5073378194941129	257	259	321
PTPRZ1	protein tyrosine phosphatase receptor type Z1	No		ENSG00000106278	P23471	Protein-tyrosine phosphatase family, Receptor class 5 subfamily	3	adhesion, cell_surface_ligand, receptor	adhesion, cell_adhesion, cell_surface, cell_surface_ligand, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, secreted, transmembrane	P04629, P13591, P21246, P32004, P35612, Q12860, Q9NRY4, Q9UM73	ADD2, ALK, ARHGAP35, CNTN1, L1CAM, NCAM1, NTRK1, PTN	ALK [HPRD:17681947;SIGNOR:17681947;SignaLink3:17681947;SignaLink3:23331499], ARHGAP35 [DEPOD:15588986;DEPOD:16513268;HPRD:16513268;ProtMapper:16513268;SIGNOR:16513268], PTN [BioGRID:10706604;CellPhoneDB:25644401;HPMR:10706604;HPRD:10706604;HPRD:16814777], CNTN1 [Cellinker:20133774;DIP:21969550;HPMR:9118959;IntAct:21969550], L1CAM [Baccin2019:9117260;connectomeDB2020:9117260], NCAM1 [Baccin2019:9117260;connectomeDB2020:9117260], NTRK1 [DEPOD:18477627], ADD2 [DEPOD:16105548;HPRD-phos:16105548;HPRD:16105548]	extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; intrinsic component of plasma membrane [GO:0031226]; perineuronal net [GO:0072534]; plasma membrane [GO:0005886]; synapse [GO:0045202]	integrin binding [GO:0005178]; protein tyrosine phosphatase activity [GO:0004725]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001]	axonogenesis [GO:0007409]; central nervous system development [GO:0007417]; hematopoietic progenitor cell differentiation [GO:0002244]; learning or memory [GO:0007611]; negative regulation of neuron apoptotic process [GO:0043524]; oligodendrocyte differentiation [GO:0048709]; peptidyl-tyrosine dephosphorylation [GO:0035335]; positive regulation of oligodendrocyte differentiation [GO:0048714]; protein dephosphorylation [GO:0006470]; regulation of myelination [GO:0031641]; regulation of oligodendrocyte progenitor proliferation [GO:0070445]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=PTPRZ1&keywords=PTPRZ1	1.4120416826994533	416	NA	NA	0.1102123943788864	614	0	0	0	7.194244604316547e-4	0	0.013536379018612519	0.004533091568449683	0	0.016278209396966337	1.6691147015622916e-4	0.0025497392312149912	247	404	323	0.0034348868314392194	1.9559680499483054	0.7567545300318017	0.9341157382767916	33	239	125
PVR	PVR cell adhesion molecule	No	manually added ensembl_gene_ID, hgnc_symbol, and description by searching the uniprot ID on genenames.org	ENSG00000073008	P15151	Nectin family	2	adhesion, cell_surface_ligand, receptor	adhesion, cell_adhesion, cell_surface, cell_surface_ligand, extracellular, intracellular, matrix_adhesion, plasma_membrane, plasma_membrane_transmembrane, receptor, secreted, transmembrane, transmembrane_predicted	P40200, Q15762, Q495A1, Q6DKI7, Q8N109, Q96NY8, Q9NQS3	CD226, CD96, KIR2DL5A, NECTIN3, NECTIN4, PVRIG, TIGIT	TIGIT [CellPhoneDB:19815499;ICELLNET:27192565;IntAct:21982860;IntAct:28515320;Lit-BM-17:21982860;SIGNOR:30591568;connectomeDB2020:19815499], CD226 [CellPhoneDB:15607800;CellPhoneDB:24440149;HPRD:12913096;ICELLNET:15034010;Lit-BM-17:12913096;Lit-BM-17:21982860;SIGNOR:30591568;connectomeDB2020:15607800], CD96 [HPRD:19056733;ICELLNET:9626554;LRdb:24658051;connectomeDB2020:17971293], PVRIG [connectomeDB2020:30659055], NECTIN3 [DIP:22902367;HPMR:12759359;HPRD:12759359;LRdb:19011627;connectomeDB2020:11544254;connectomeDB2020:12011057], KIR2DL5A [Cellinker:32822567], NECTIN4 [Cellinker:32589946]	adherens junction [GO:0005912]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	cell adhesion molecule binding [GO:0050839]; signaling receptor activity [GO:0038023]; virus receptor activity [GO:0001618]	heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; positive regulation of natural killer cell mediated cytotoxicity [GO:0045954]; positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target [GO:0002860]; susceptibility to natural killer cell mediated cytotoxicity [GO:0042271]; susceptibility to T cell mediated cytotoxicity [GO:0060370]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=PVR&keywords=PVR	39.45297520224719	107	6736.11	86	1.9714443624920581	160	0.015748031496062992	0.3592814371257525	0.23783185840707996	0.0882494004796169	0.23232323232323235	0.13874788494077822	0.20761559383499484	0.14681892332789567	0.08805031446540856	0.09059954600080153	0.17566158006566637	135	113	76	0.16190252749702636	0.5703832043255133	0.5852127217998102	1.0800398503092286	314	291	83
PYY	peptide YY	Yes		ENSG00000131096	P10082	NPY family	15	ligand	ligand, secreted	P08913, P25929, P27487, P48039, P49146, P50391, Q12884, Q14831, Q15761, Q99463, Q9NYM4	ADRA2A, DPP4, FAP, GPR83, GRM7, MTNR1A, NPY1R, NPY2R, NPY4R, NPY5R, NPY6R	NPY1R [Baccin2019:954976112665544;CellTalkDB:9549761;Cellinker:12665544;Cellinker:9549761;HPRD:12665544;LRdb:127;LRdb:9549761;connectomeDB2020:12665544;connectomeDB2020:9549761], NPY2R [Baccin2019:11408607;Baccin2019:7592910;Baccin2019:8632753;CellTalkDB:8632753;Cellinker:11408607;Cellinker:7592910;Cellinker:8632753;Guide2Pharma:7592910;Guide2Pharma:8632753;HPRD:11408607;LRdb:11408607;LRdb:7592910;LRdb:8632753;connectomeDB2020:11408607;connectomeDB2020:7592910;connectomeDB2020:8632753;scConnect:7592910;scConnect:8632753], NPY4R [CellTalkDB:7592911;Cellinker:7493937;Cellinker:7592911;Guide2Pharma:7493937;HPRD:7493937;LRdb:749;LRdb:7592911;SIGNOR:7592911;connectomeDB2020:7493937;connectomeDB2020:7592911;scConnect:7493937], NPY5R [Baccin2019:1182564512665540;CellTalkDB:11825645;Cellinker:11825645;Cellinker:12665544;HPRD:12665544;LRdb:11825645;LRdb:13;SIGNOR:11825645;connectomeDB2020:11825645;connectomeDB2020:12665544], DPP4 [CellTalkDB:30759373;Cellinker:21314817], FAP [CellTalkDB:21314817;Cellinker:21314817;LRdb:21314817;Ramilowski2015:21314817;connectomeDB2020:21314817;talklr:21314817], ADRA2A [CellTalkDB:32196115], MTNR1A [CellTalkDB:32196115], GRM7 [CellTalkDB:32196115], NPY6R [NA], GPR83 [NA]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	G protein-coupled receptor binding [GO:0001664]; hormone activity [GO:0005179]; neuropeptide hormone activity [GO:0005184]; neuropeptide Y receptor binding [GO:0031841]	feeding behavior [GO:0007631]; intestinal epithelial cell differentiation [GO:0060575]; neuropeptide signaling pathway [GO:0007218]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=PYY&keywords=PYY	0.33964115393258426	562	NA	NA	0.2614286809823241	487	0	0	0	0.0028776978417266188	0	0.001692047377326565	0.04442429737080687	0.10114192495921705	7.399186089530152e-4	0.0014354386433435699	0.03805292640525383	301	359	170	0.01730584101878432	0.39331945870353446	0.41879093324673167	1.7598039325064962	380	342	23
PYY2	peptide YY 2 (pseudogene)		manually added ensembl_gene_ID, hgnc_symbol, and description by searching the uniprot ID on genenames.org	ENSG00000237575	Q9NRI6	NPY family	1	ligand	ligand, secreted	NA	NA	NA	extracellular region [GO:0005576]	NA	NA	https://www.genecards.org/cgi-bin/carddisp.pl?gene=PYY2&keywords=PYY2	0.41528788876404493	541	NA	NA	0.2662072176485872	485	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
PYY3	peptide YY 3 (pseudogene)		manually added ensembl_gene_ID, hgnc_symbol, and description by searching the uniprot ID on genenames.org	ENSG00000181977	Q5JQD4	NPY family	2	ligand	ligand, secreted	NA	NA	NA	extracellular space [GO:0005615]	G protein-coupled receptor binding [GO:0001664]; hormone activity [GO:0005179]; neuropeptide hormone activity [GO:0005184]; neuropeptide Y receptor binding [GO:0031841]	feeding behavior [GO:0007631]; neuropeptide signaling pathway [GO:0007218]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=PYY3&keywords=PYY3	0	899	NA	NA	1	266	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
QRFP	pyroglutamylated RFamide peptide	Yes		ENSG00000188710	P83859	RFamide neuropeptide family	14	ligand	ligand, secreted, transmembrane, transmembrane_predicted	Q15391, Q96P65	P2RY14, QRFPR	QRFPR [Baccin2019:12714592;Baccin2019:16500002;Baccin2019:23396314;CellChatDB:25386115;CellTalkDB:12714592;Cellinker:12714592;Cellinker:16500002;Cellinker:23396314;Cellinker:25386115;Guide2Pharma:12714592;Guide2Pharma:14657341;Guide2Pharma:16500002;Guide2Pharma:23396314;LRdb:12714592;LRdb:16500002;LRdb:23396314;connectomeDB2020:12714592;connectomeDB2020:16500002;connectomeDB2020:23396314;scConnect:12714592;scConnect:14657341;scConnect:16500002;scConnect:23396314], P2RY14 [Baccin2019:12714592;Cellinker:12714592;LRdb:12714592;connectomeDB2020:12714592]	extracellular region [GO:0005576]	neuropeptide hormone activity [GO:0005184]; orexigenic neuropeptide QRFP receptor binding [GO:0031854]	grooming behavior [GO:0007625]; locomotory behavior [GO:0007626]; neuropeptide signaling pathway [GO:0007218]; positive regulation of blood pressure [GO:0045777]; regulation of feeding behavior [GO:0060259]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=QRFP&keywords=QRFP	0.17468007415730338	626	NA	NA	0.2569761645600407	491	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
RAET1E	retinoic acid early transcript 1E	No		ENSG00000164520	Q8TD07	MHC class I family	7	adhesion, cell_surface_ligand, ligand	adhesion, cell_adhesion, cell_surface, cell_surface_ligand, extracellular, intracellular, ligand, plasma_membrane, plasma_membrane_transmembrane, secreted, transmembrane, transmembrane_predicted	P26718	HCST_KLRK1, KLRK1	KLRK1 [CellChatDB:24223577;CellTalkDB:12732206;HPRD:12732206;HPRD:14508119;IntAct:19436053;IntAct:19658097;IntAct:28559451;LRdb:12732206;LRdb:15;connectomeDB2020:12732206;connectomeDB2020:14508119;connectomeDB2020:29651291]	external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	natural killer cell lectin-like receptor binding [GO:0046703]	natural killer cell mediated cytotoxicity [GO:0042267]; positive regulation of natural killer cell mediated cytotoxicity [GO:0045954]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=RAET1E&keywords=RAET1E	0.11820415730337079	661	NA	NA	0.060056144518431956	694	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
RAET1G	retinoic acid early transcript 1G	No		ENSG00000203722	Q6H3X3	MHC class I family	2	adhesion, cell_surface_ligand, ligand, receptor	adhesion, cell_adhesion, cell_surface, cell_surface_ligand, extracellular, intracellular, ligand, plasma_membrane, plasma_membrane_transmembrane, receptor, secreted, transmembrane, transmembrane_predicted	P26718	HCST_KLRK1, KLRK1	KLRK1 [CellChatDB:24223577;CellTalkDB:19424970;HPRD:15240696;IntAct:15240696;IntAct:19424970;IntAct:19658097;connectomeDB2020:26041808;connectomeDB2020:29651291]	anchored component of membrane [GO:0031225]; endoplasmic reticulum [GO:0005783]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	natural killer cell lectin-like receptor binding [GO:0046703]	natural killer cell mediated cytotoxicity [GO:0042267]; positive regulation of natural killer cell cytokine production [GO:0002729]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=RAET1G&keywords=RAET1G	0.710250102247191	493	NA	NA	0.5148445319361739	381	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
RARRES1	retinoic acid receptor responder 1	No		ENSG00000118849	P49788	Protease inhibitor I47 (latexin) family	1	ligand	ligand, secreted, transmembrane	O60462	NRP2	NRP2 [Cellinker:32589946]	extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]	metalloendopeptidase inhibitor activity [GO:0008191]	negative regulation of cell population proliferation [GO:0008285]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=RARRES1&keywords=RARRES1	9.498810640449438	242	NA	NA	0.321437684394616	455	0	0.0054890219560878245	0.0022123893805309734	0.11990407673860978	0.011784511784511783	0.043993231810490696	0.03626473254759746	0.009787928221859707	0.010728819829818725	0.032948324208839676	0.009658103148541599	262	167	248	0.025706467238808022	0.5805340441882009	1.202816395181228	0.5505474125195994	306	93	303
RARRES2	retinoic acid receptor responder 2	Yes	Chemerin	ENSG00000106538	Q99969	NA	13	ecm, ligand	ecm, extracellular, intracellular, ligand, secreted	O00421, P46091, Q99788	CCRL2, CMKLR1, CMKLR2	CMKLR1 [Baccin2019:14530373;Baccin2019:14675762;Baccin2019:14701797;Baccin2019:18165312;Baccin2019:23396314;CellChatDB:24671882;CellTalkDB:14675762;Cellinker:14530373;Cellinker:14675762;Cellinker:14701797;Cellinker:18165312;Cellinker:23396314;Cellinker:24671882;Guide2Pharma:14530373;Guide2Pharma:14701797;Guide2Pharma:18165312;Guide2Pharma:23396314;HPMR:14675762;HPMR:14701797;LRdb:14530373;LRdb:14675762;LRdb:14701797;LRdb:18165312;LRdb:23396314;connectomeDB2020:14530373;connectomeDB2020:14675762;connectomeDB2020:14701797;connectomeDB2020:18165312;connectomeDB2020:23396314;scConnect:14530373;scConnect:14701797;scConnect:18165312;scConnect:23396314;scConnect:25437209], CMKLR2 [Baccin2019:18165312;Baccin2019:23396314;CellChatDB:24671882;CellTalkDB:18165312;Cellinker:18165312;Cellinker:23396314;Cellinker:24671882;Guide2Pharma:18165312;Guide2Pharma:23396314;LRdb:18165312;LRdb:23;connectomeDB2020:18165312;connectomeDB2020:23396314;scConnect:18165312;scConnect:23396314], CCRL2 [Baccin2019:24671882;CellTalkDB:18794339;Cellinker:18794339;LRdb:18794339;Ramilowski2015:18794339;connectomeDB2020:18794339;talklr:18794339]	collagen-containing extracellular matrix [GO:0062023]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; platelet dense granule lumen [GO:0031089]	signaling receptor binding [GO:0005102]	antifungal humoral response [GO:0019732]; antifungal innate immune response [GO:0061760]; cell differentiation [GO:0030154]; chemotaxis [GO:0006935]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; embryonic digestive tract development [GO:0048566]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; insulin receptor signaling pathway [GO:0008286]; positive regulation of chemotaxis [GO:0050921]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of macrophage chemotaxis [GO:0010759]; positive regulation of protein phosphorylation [GO:0001934]; regulation of lipid catabolic process [GO:0050994]; retinoid metabolic process [GO:0001523]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=RARRES2&keywords=RARRES2	18.05047636966292	177	1264.05	151	0.11428471400583086	609	0	0.0214570858283433	0.0022123893805309734	0.4609112709832208	1.1111111111111163	0.023688663282571906	0.006346328195829556	0	0.027376988531261547	0.008946454800373864	0.002240679930461659	212	249	331	0.1512991792767009	0.23172460454459687	0.11746156976950356	0.07588804844111059	420	461	487
RBP3	retinol binding protein 3	No		ENSG00000265203	P10745	Peptidase S41A family	7	ecm, ligand, receptor	ecm, extracellular, ligand, receptor, secreted	P46531	NOTCH1	NOTCH1 [Baccin2019:11511084;HPRD:11511084;LRdb:11511084;connectomeDB2020:11511084]	cone matrix sheath [GO:0090658]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular vesicle [GO:1903561]	retinal binding [GO:0016918]; retinoid binding [GO:0005501]; retinol binding [GO:0019841]; serine-type peptidase activity [GO:0008236]	lipid metabolic process [GO:0006629]; retinoid metabolic process [GO:0001523]; visual perception [GO:0007601]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=RBP3&keywords=RBP3	4.6560112359550563e-4	896	NA	NA	0.09456909946194164	639	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
REG1A	regenerating family member 1 alpha	TBD		ENSG00000115386	P05451	NA	2	ligand	extracellular, ligand, secreted	NA	NA	NA	extracellular exosome [GO:0070062]; extracellular space [GO:0005615]	growth factor activity [GO:0008083]; oligosaccharide binding [GO:0070492]; peptidoglycan binding [GO:0042834]; signaling receptor activity [GO:0038023]	antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cell wall disruption in other organism [GO:0044278]; positive regulation of cell population proliferation [GO:0008284]; response to peptide hormone [GO:0043434]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=REG1A&keywords=REG1A	25612.03282926966	2	49960.5	22	23.601266274557396	25	0.05511811023622047	1.2195608782435197	0.06858407079646023	0.07937649880095951	615.1010101010099	0.07783417935702198	0.05893019038984583	0.07340946166394785	0.10136884942656278	0.09166777940980089	0.07278346532740756	125	112	127	56.0908766895147	0.001985153459239572	0.0018122315623064528	0.0014756180333074876	529	529	529
RELN	reelin	TBD		ENSG00000189056	P78509	Reelin family	8	adhesion, ecm, ligand	adhesion, ecm, extracellular, intracellular, ligand, matrix_adhesion, secreted, transmembrane	O75553, P05556, P26006, P98155, Q14114	DAB1, ITGA3, ITGA3_ITGB1, ITGB1, LRP8, VLDLR	ITGB1 [CA1:10725376;CA1:10939329;CellTalkDB:10939329;HPMR:10939329;LRdb:10939329;connectomeDB2020:10939329], VLDLR [AlzPathway:16504486;Baccin2019:10571240;Baccin2019:10571241;BioGRID:14724251;CellTalkDB:10571240;Cellinker:10571240;Cellinker:10571241;HPMR:10571240;HPRD:10571240;HPRD:10571241;LRdb:10571240;LRdb:11;SIGNOR:11278667;connectomeDB2020:10571240;connectomeDB2020:10571241], ITGA3 [HPMR:10939329;LRdb:10939329;connectomeDB2020:10939329], LRP8 [AlzPathway:16504486;Baccin2019:10571240;Baccin2019:12167620;Baccin2019:12670700;Baccin2019:12899622;BioGRID:23951306;BioGRID:28446613;CellTalkDB:12899622;Cellinker:10571240;Cellinker:12167620;Cellinker:12670700;Cellinker:12899622;HPRD:10571240;HPRD:12167620;HPRD:12670700;HPRD:12899622;LRdb:10571240;LRdb:12167620;LRdb:12670700;LRdb:12899622;connectomeDB2020:10571240;connectomeDB2020:12167620;connectomeDB2020:12670700;connectomeDB2020:12899622], DAB1 [HPRD:11137154;ProtMapper:15110774]	cytoplasm [GO:0005737]; dendrite [GO:0030425]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; reelin complex [GO:0110157]	lipoprotein particle receptor binding [GO:0070325]; metal ion binding [GO:0046872]; serine-type peptidase activity [GO:0008236]; very-low-density lipoprotein particle receptor binding [GO:0070326]	associative learning [GO:0008306]; axon guidance [GO:0007411]; brain development [GO:0007420]; cell adhesion [GO:0007155]; cell morphogenesis involved in differentiation [GO:0000904]; central nervous system development [GO:0007417]; cerebral cortex tangential migration [GO:0021800]; dendrite development [GO:0016358]; glial cell differentiation [GO:0010001]; hippocampus development [GO:0021766]; lateral motor column neuron migration [GO:0097477]; layer formation in cerebral cortex [GO:0021819]; locomotory behavior [GO:0007626]; long-term memory [GO:0007616]; long-term synaptic potentiation [GO:0060291]; modulation of chemical synaptic transmission [GO:0050804]; neuron migration [GO:0001764]; NMDA glutamate receptor clustering [GO:0097114]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of AMPA receptor activity [GO:2000969]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of dendritic spine morphogenesis [GO:0061003]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of lateral motor column neuron migration [GO:1902078]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of neuron projection development [GO:0010976]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of small GTPase mediated signal transduction [GO:0051057]; positive regulation of synapse maturation [GO:0090129]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; positive regulation of TOR signaling [GO:0032008]; postsynaptic density protein 95 clustering [GO:0097119]; protein localization to synapse [GO:0035418]; receptor localization to synapse [GO:0097120]; reelin-mediated signaling pathway [GO:0038026]; regulation of behavior [GO:0050795]; regulation of NMDA receptor activity [GO:2000310]; response to pain [GO:0048265]; spinal cord patterning [GO:0021511]; ventral spinal cord development [GO:0021517]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=RELN&keywords=RELN	0.7542735332578281	488	NA	NA	0.10861747328441274	617	0	0.008982035928143712	0	2.3980815347721823e-4	0.003367003367003367	0	0.008159564823209429	0.0032626427406199023	0.0022197558268590455	3.672052343437042e-4	0.010778443113772409	297	395	247	0.00339785992612989	0.9120677402386344	0.7737956129937223	1.5508777691613378	179	223	33
RETN	resistin	Yes		ENSG00000104918	Q9HD89	Resistin/FIZZ family	6	ligand	extracellular, intracellular, ligand, secreted	O00155, O00206, Q01518	CAP1, GPR25, TLR4	GPR25 [CellTalkDB:32103204], TLR4 [CellChatDB:30809105;Cellinker:30809105], CAP1 [CellChatDB:30809105;Cellinker:30809105]	azurophil granule lumen [GO:0035578]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nucleus [GO:0005634]; specific granule lumen [GO:0035580]	hormone activity [GO:0005179]	aging [GO:0007568]; fat cell differentiation [GO:0045444]; negative regulation of feeding behavior [GO:2000252]; positive regulation of progesterone secretion [GO:2000872]; positive regulation of synaptic transmission [GO:0050806]; response to insulin [GO:0032868]; response to mechanical stimulus [GO:0009612]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=RETN&keywords=RETN	0.027339887640449437	779	NA	NA	0.009599660934477757	835	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
RETNLB	resistin like beta	Yes		ENSG00000163515	Q9BQ08	Resistin/FIZZ family	2	ligand	extracellular, ligand, secreted	NA	NA	NA	extracellular space [GO:0005615]	hormone activity [GO:0005179]	epithelial cell proliferation [GO:0050673]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=RETNLB&keywords=RETNLB	0	899	NA	NA	0.014541252994835009	814	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
RGMA	repulsive guidance molecule BMP co-receptor a	No	manually added ensembl_gene_ID, hgnc_symbol, and description by searching the uniprot ID on genenames.org	ENSG00000182175	Q96B86	Repulsive guidance molecule (RGM) family	8	cell_surface_ligand, ligand	cell_surface, cell_surface_ligand, extracellular, intracellular, ligand, plasma_membrane, secreted, transmembrane	O00238, Q13873, Q30201, Q6ZVN8, Q92859, Q9UP52	BMPR1B, BMPR2, HFE, HJV, NEO1, TFR2	HJV [CellTalkDB:32196115], NEO1 [Baccin2019:15258590;Cellinker:15258590;HPMR:15258590;LRdb:15258590;connectomeDB2020:15258590], BMPR2 [CellTalkDB:32196115], BMPR1B [CellTalkDB:32196115], HFE [CellTalkDB:22728873], TFR2 [CellTalkDB:22728873]	anchored component of membrane [GO:0031225]; cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; plasma membrane [GO:0005886]	coreceptor activity [GO:0015026]; transferrin receptor binding [GO:1990459]	BMP signaling pathway [GO:0030509]; negative regulation of axon regeneration [GO:0048681]; negative regulation of receptor binding [GO:1900121]; neural tube closure [GO:0001843]; neuron projection development [GO:0031175]; positive regulation of GTPase activity [GO:0043547]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of BMP signaling pathway [GO:0030510]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=RGMA&keywords=RGMA	0.9335769712821833	457	NA	NA	0.07501432300081755	665	0	0.06686626746506978	0.0011061946902654867	0.008393285371702636	0.0016835016835016834	0.005076142131979695	0.013599274705349048	0.0016313213703099511	0.002589715131335553	0.0034717585792495608	0.00289743094456249	296	311	317	0.009755899279393262	0.6372635815402985	0.6819106732995707	0.6528394765615849	285	261	258
RGMB	repulsive guidance molecule BMP co-receptor b			ENSG00000174136	Q6NW40	Repulsive guidance molecule (RGM) family	1	adhesion, cell_surface_ligand, receptor	adhesion, cell_adhesion, cell_surface, cell_surface_ligand, extracellular, intracellular, plasma_membrane, receptor, secreted, transmembrane	O00238, Q13873, Q6ZVN8, Q92859	BMPR1B, BMPR2, HJV, NEO1	HJV [CellTalkDB:32196115], BMPR2 [CellTalkDB:32196115], NEO1 [Baccin2019:15258590;CellTalkDB:19944164;Cellinker:19944164;LRdb:19944164;Ramilowski2015:19944164;connectomeDB2020:19944164;talklr:19944164], BMPR1B [CellTalkDB:32196115]	anchored component of plasma membrane [GO:0046658]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]	coreceptor activity [GO:0015026]; identical protein binding [GO:0042802]	BMP signaling pathway [GO:0030509]; cell adhesion [GO:0007155]; positive regulation of transcription, DNA-templated [GO:0045893]; signal transduction [GO:0007165]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=RGMB&keywords=RGMB	8.047137533978733	258	NA	NA	0.5942536620303611	343	0	0.050898203592814314	0.03207964601769914	0.06762589928057565	0.03367003367003366	0.050761421319796975	0.05802357207615584	0.024469820554649267	0.032556418793932625	0.04269595406596441	0.01421672783465315	201	156	230	0.03699979065511591	0.9054597520702015	1.1211955060108012	0.5152518234039659	180	107	318
RLF	RLF zinc finger			ENSG00000117000	Q13129	Krueppel C2H2-type zinc-finger protein family	2	ligand	intracellular, ligand, secreted	Q13671, Q8WXD0, Q92963	RIN1, RIT1, RXFP2	RIN1 [SIGNOR:10545207], RIT1 [HPRD:10545207;InnateDB:10545207;Lit-BM-17:10545207;SIGNOR:10545207], RXFP2 [Baccin2019:12114498;Baccin2019:15649866;Baccin2019:20560146]	nucleus [GO:0005634]	DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]	histone H3-K4 monomethylation [GO:0097692]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA methylation [GO:0044030]; regulation of transcription by RNA polymerase II [GO:0006357]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=RLF&keywords=RLF	8.035591011235955	259	NA	NA	0.6604313059944033	325	0.09448818897637795	0.21157684630738682	0.0829646017699116	0.16306954436450916	0.058922558922558904	0.1269035532994923	0.15140525838621902	0.06851549755301801	0.07658157602663697	0.07998397649886631	0.06961560749468594	142	118	131	0.107638837236333	0.7359948301146254	0.7649172553286218	0.6767799594511505	249	232	245
RLN1	relaxin 1	Yes		ENSG00000107018	P04808	Insulin family	14	ligand	ligand, secreted	Q8TDU9, Q8WXD0, Q9HBX9, Q9NSD7	RXFP1, RXFP2, RXFP3, RXFP4	RXFP1 [CellTalkDB:11809971;Cellinker:11809971;Cellinker:16411781;Cellinker:25761609;Guide2Pharma:16411781;HPRD:11809971;LRdb:11809971;LRdb:16;connectomeDB2020:11809971;connectomeDB2020:16411781;scConnect:16411781], RXFP2 [CellTalkDB:11809971;Cellinker:11809971;Cellinker:16411781;Guide2Pharma:16411781;LRdb:11809971;LRdb:16;connectomeDB2020:11809971;connectomeDB2020:16411781;scConnect:16411781], RXFP3 [NA], RXFP4 [NA]	extracellular region [GO:0005576]	hormone activity [GO:0005179]	female pregnancy [GO:0007565]; signal transduction [GO:0007165]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=RLN1&keywords=RLN1	1.0381187662921347	446	NA	NA	5.402685863047111	72	0	4.99001996007984e-4	0	4.7961630695443646e-4	0	0.011844331641285955	0.005439709882139619	0	0.005179430262671108	0.005007344104686864	0.0022793123430558254	287	291	329	0.0027935224124365264	1.1864934279487602	1.1730423898033187	0.9598069981977098	90	98	114
RLN2	relaxin 2	Yes		ENSG00000107014	P04090	Insulin family	12	ligand	extracellular, intracellular, ligand, secreted	O60895, O60896, P07550, P13945, P16473, P32241, P41586, Q03431, Q8WXD0, Q99678, Q9HBX9, Q9NQS5, Q9NSD7	ADCYAP1R1, ADRB2, ADRB3, GPR20, GPR84, PTH1R, RAMP2, RAMP3, RXFP1, RXFP2, RXFP3, TSHR, VIPR1	RXFP1 [CellTalkDB:11809971;Cellinker:11809971;Cellinker:12506116;Cellinker:15649866;Cellinker:22973049;Guide2Pharma:12506116;Guide2Pharma:15649866;Guide2Pharma:18434306;HPMR:11809971;HPRD:12506116;HPRD:15649866;LRdb:11809971;LRdb:12506116;LRdb:15649866;SIGNOR:11809971;connectomeDB2020:11809971;connectomeDB2020:12506116;connectomeDB2020:15649866;scConnect:12506116;scConnect:15649866;scConnect:18434306], RXFP2 [CellTalkDB:11809971;Cellinker:11809971;Cellinker:12506116;Cellinker:15649866;Cellinker:22973049;Guide2Pharma:15649866;Guide2Pharma:18434306;HPRD:12506116;HPRD:15649866;LRdb:11809971;LRdb:12506116;LRdb:15649866;SIGNOR:11809971;connectomeDB2020:11809971;connectomeDB2020:12506116;connectomeDB2020:15649866;scConnect:15649866;scConnect:18434306], ADCYAP1R1 [CellTalkDB:32196115], TSHR [CellTalkDB:32196115], GPR84 [CellTalkDB:32196115], RAMP3 [CellTalkDB:32196115], RAMP2 [CellTalkDB:32196115], ADRB2 [CellTalkDB:32196115], PTH1R [CellTalkDB:32196115], VIPR1 [CellTalkDB:32196115], RXFP3 [CellTalkDB:32103204;connectomeDB2020:24641548;scConnect:20159943;scConnect:24641548], ADRB3 [CellTalkDB:32196115], GPR20 [CellTalkDB:32196115]	extracellular region [GO:0005576]	hormone activity [GO:0005179]	female pregnancy [GO:0007565]; positive regulation of angiogenesis [GO:0045766]; positive regulation of gene expression [GO:0010628]; regulation of catalytic activity [GO:0050790]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=RLN2&keywords=RLN2	3.035610988764045	338	NA	NA	9.519193422921887	46	0	0.008483033932135729	0	0.0019184652278177454	0.00505050505050505	0.06260575296108295	0.05439709882139611	0.03752039151712889	0.03847576766555677	0.044231539591401865	0.025613289549932458	188	151	192	0.025299622210632505	1.3732659056888012	1.5363206798022593	1.0088858554187436	64	50	97
RLN3	relaxin 3	Yes		ENSG00000288474, ENSG00000171136	Q8WXF3	Insulin family	15	ligand, receptor	extracellular, ligand, receptor, secreted	O60895, O60896, P07550, P08913, P13945, P16473, P32241, P41586, P48039, Q03431, Q14831, Q8TDU9, Q8WXD0, Q99678, Q9HBX9, Q9NQS5, Q9NSD7	ADCYAP1R1, ADRA2A, ADRB2, ADRB3, GPR20, GPR84, GRM7, MTNR1A, PTH1R, RAMP2, RAMP3, RXFP1, RXFP2, RXFP3, RXFP4, TSHR, VIPR1	RXFP1 [Baccin2019:12506116;Baccin2019:14522968;Baccin2019:15649866;CellTalkDB:12506116;Cellinker:12506116;Cellinker:14522968;Cellinker:15649866;Cellinker:16365033;Cellinker:25761609;Guide2Pharma:12506116;Guide2Pharma:15649866;HPRD:12506116;HPRD:14522968;HPRD:15649866;LRdb:12506116;LRdb:14522968;LRdb:15649866;connectomeDB2020:12506116;connectomeDB2020:14522968;connectomeDB2020:15649866;scConnect:12506116;scConnect:15649866], RXFP2 [Baccin2019:16411781;CellTalkDB:16411781;Cellinker:16411781;Guide2Pharma:16411781;LRdb:16411781;connectomeDB2020:16411781;scConnect:16411781], RXFP3 [Baccin2019:14522968;Baccin2019:15367576;CellTalkDB:27245781;Cellinker:14522968;Cellinker:15367576;Cellinker:25761609;Guide2Pharma:14522968;Guide2Pharma:15367576;Guide2Pharma:17351017;Guide2Pharma:18434306;Guide2Pharma:22257012;HPMR:14522968;LMPID:24615237;connectomeDB2020:14522968;connectomeDB2020:15367576;scConnect:14522968;scConnect:15367576;scConnect:17351017;scConnect:18434306;scConnect:20159943;scConnect:22257012;scConnect:24641548], RXFP4 [CellTalkDB:14522967;Cellinker:14522967;Cellinker:25761609;Cellinker:27888281;Guide2Pharma:14522967;Guide2Pharma:17606621;Guide2Pharma:18582868;HPMR:14522967;HPMR:15367576;HPRD:14522967;LMPID:24802387;LRdb:14522967;connectomeDB2020:14522967;scConnect:14522967;scConnect:15525639;scConnect:17606621;scConnect:18582868], ADCYAP1R1 [CellTalkDB:32196115], TSHR [CellTalkDB:32196115], GPR84 [CellTalkDB:32196115], RAMP3 [CellTalkDB:32196115], RAMP2 [CellTalkDB:32196115], ADRA2A [CellTalkDB:32196115], MTNR1A [CellTalkDB:32196115], ADRB2 [CellTalkDB:32196115], PTH1R [CellTalkDB:32196115], VIPR1 [CellTalkDB:32196115], ADRB3 [CellTalkDB:32196115], GRM7 [CellTalkDB:32196115], GPR20 [CellTalkDB:32196115]	extracellular region [GO:0005576]	G protein-coupled receptor binding [GO:0001664]; hormone activity [GO:0005179]	NA	https://www.genecards.org/cgi-bin/carddisp.pl?gene=RLN3&keywords=RLN3	0.017602611235955055	802	NA	NA	0.37125815309955484	433	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
RPH3A	rabphilin 3A			ENSG00000089169	Q9Y2J0	NA	7	adhesion, cell_surface_ligand, ligand	adhesion, cell_adhesion, cell_surface, cell_surface_ligand, intracellular, ligand, plasma_membrane, secreted	P20336, P58400, Q9ULB1	NRXN1, RAB3A	RAB3A [BioGRID:10025402;BioGRID:8636125;CA1:8262955;CA1:8266731;HPRD:10025402;HPRD:12937130;Lit-BM-17:10025402;Lit-BM-17:8636125], NRXN1 [Baccin2019:8901523;CellTalkDB:8901523;Cellinker:8901523;HPRD:8901523;LRdb:8901523;connectomeDB2020:8901523], NRXN1 [Baccin2019:8901523;CellTalkDB:8901523;Cellinker:8901523;HPRD:8901523;LRdb:8901523;connectomeDB2020:8901523]	cytosol [GO:0005829]; dendritic spine [GO:0043197]; extrinsic component of membrane [GO:0019898]; neuron projection [GO:0043005]; postsynaptic membrane [GO:0045211]; protein-containing complex [GO:0032991]; secretory granule [GO:0030141]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; synaptic vesicle membrane [GO:0030672]	calcium-dependent phospholipid binding [GO:0005544]; calcium ion binding [GO:0005509]; inositol 1,4,5 trisphosphate binding [GO:0070679]; phosphate ion binding [GO:0042301]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylinositol phosphate binding [GO:1901981]; protein-containing complex binding [GO:0044877]; selenium binding [GO:0008430]; small GTPase binding [GO:0031267]; zinc ion binding [GO:0008270]	intracellular protein transport [GO:0006886]; spontaneous neurotransmitter secretion [GO:0061669]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=RPH3A&keywords=RPH3A	2.4422370700226583	368	444.015	162	0.2606272594582335	488	0	0.00249500998003992	0	0	0	0.011844331641285955	0.009066183136899365	0	0.0014798372179060304	0.014053945787154461	3.09059300753332e-4	299	226	392	0.003568033369458097	0.8460944121605246	1.7728395215551542	0.7598049783662254	204	28	208
RPTN	repetin	No		ENSG00000215853	Q6XPR3	S100-fused protein family	1	ecm, ligand	ecm, intracellular, ligand, secreted	NA	NA	NA	cornified envelope [GO:0001533]; cytosol [GO:0005829]; extracellular region [GO:0005576]	calcium ion binding [GO:0005509]; transition metal ion binding [GO:0046914]	NA	https://www.genecards.org/cgi-bin/carddisp.pl?gene=RPTN&keywords=RPTN	0.33819443033707863	564	NA	NA	0.9106201187994133	282	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
RSPO1	R-spondin 1	Yes	probably regulates wnt pathway	ENSG00000169218	Q2MKA7	R-spondin family	13	ecm, ligand	ecm, extracellular, intracellular, ligand, ligand_regulator, secreted	O75473, O75581, Q68DV7, Q9BXB1, Q9H461, Q9HBX8, Q9ULT6	FZD8, LGR4, LGR5, LGR6, LRP6, RNF43, ZNRF3	LGR4 [Baccin2019:2169364621693640;BioGRID:24225776;CellTalkDB:21693646;Cellinker:21693646;Cellinker:24349440;Guide2Pharma:21693646;LRdb:21693646;Lit-BM-17:24050775;Lit-BM-17:24165923;Lit-BM-17:24225776;Lit-BM-17:25504990;connectomeDB2020:21693646;scConnect:21693646], LGR5 [Baccin2019:2169364621693640;CellTalkDB:21693646;Cellinker:21693646;Cellinker:24349440;Guide2Pharma:21693646;LRdb:21693646;connectomeDB2020:21693646;scConnect:21693646], LGR6 [Baccin2019:21693646;Baccin2019:21727895;CellTalkDB:21727895;Cellinker:21693646;Cellinker:21727895;Cellinker:24349440;Guide2Pharma:21693646;Guide2Pharma:21727895;LRdb:21727895;LRdb:22;connectomeDB2020:21693646;connectomeDB2020:21727895;scConnect:21693646;scConnect:21727895], ZNRF3 [CellTalkDB:24349440;Cellinker:24349440;Cellinker:29405118;IntAct:22575959;IntAct:24165923;LRdb:24349440;Lit-BM-17:22575959;Lit-BM-17:24050775;Lit-BM-17:24165923;Lit-BM-17:25504990;Ramilowski2015:24349440;SIGNOR:22575959;SIGNOR:23151663;connectomeDB2020:24349440;talklr:24349440], FZD8 [CellTalkDB:32196115;NetPath:17976036], LRP6 [ACSN:17804805;Baccin2019:18400942;CellTalkDB:18400942;Cellinker:18400942;LRdb:18400942;NetPath:17976036;connectomeDB2020:18400942], RNF43 [BioGRID:23756651;Cellinker:29405118]	extracellular region [GO:0005576]; nucleus [GO:0005634]	G protein-coupled receptor binding [GO:0001664]; heparin binding [GO:0008201]; signaling receptor binding [GO:0005102]	positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of Wnt signaling pathway [GO:0030177]; regulation of receptor internalization [GO:0002090]; Wnt signaling pathway [GO:0016055]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=RSPO1&keywords=RSPO1	0.04614495475067416	742	NA	NA	0.008831886091344318	840	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
RSPO2	R-spondin 2	Yes		ENSG00000147655	Q6UXX9	R-spondin family	13	ecm, ligand, receptor	ecm, ligand, ligand_regulator, receptor, secreted	O75473, P31431, Q68DV7, Q9BXB1, Q9HBX8, Q9ULT6, Q9ULV1	FZD4, LGR4, LGR5, LGR6, RNF43, SDC4, ZNRF3	LGR4 [Baccin2019:2169364621693640;CellTalkDB:21693646;Cellinker:21693646;Cellinker:29769720;Guide2Pharma:21693646;LRdb:21693646;Lit-BM-17:24050775;Lit-BM-17:25504990;SIGNOR:21693646;connectomeDB2020:21693646;scConnect:21693646], LGR5 [Baccin2019:2169364621693640;CellTalkDB:21693646;Cellinker:21693646;Cellinker:29769720;Guide2Pharma:21693646;LRdb:21693646;SIGNOR:21693646;connectomeDB2020:21693646;scConnect:21693646], LGR6 [Baccin2019:21693646;Baccin2019:21727895;CellTalkDB:21727895;Cellinker:21693646;Cellinker:21727895;Cellinker:29769720;Guide2Pharma:21693646;Guide2Pharma:21727895;LRdb:21727895;LRdb:22;connectomeDB2020:21693646;connectomeDB2020:21727895;scConnect:21693646;scConnect:21727895], FZD4 [SIGNOR:22575959], SDC4 [SIGNOR:21397842], ZNRF3 [BioGRID:28600110;CellTalkDB:26123262;Cellinker:29405118;Cellinker:29769720;Lit-BM-17:24050775;Lit-BM-17:25504990;connectomeDB2020:29769720], RNF43 [Cellinker:29405118;Cellinker:29769720;connectomeDB2020:29769720]	cell surface [GO:0009986]; extracellular region [GO:0005576]	heparin binding [GO:0008201]; signaling receptor binding [GO:0005102]	bone mineralization [GO:0030282]; dopaminergic neuron differentiation [GO:0071542]; embryonic forelimb morphogenesis [GO:0035115]; embryonic hindlimb morphogenesis [GO:0035116]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; limb development [GO:0060173]; lung growth [GO:0060437]; negative regulation of odontogenesis of dentin-containing tooth [GO:0042489]; osteoblast differentiation [GO:0001649]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of Wnt signaling pathway [GO:0030177]; trachea cartilage morphogenesis [GO:0060535]; Wnt signaling pathway [GO:0016055]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=RSPO2&keywords=RSPO2	0.07573170561797753	691	NA	NA	0.05173522169619634	705	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
RSPO3	R-spondin 3	Yes		ENSG00000146374	Q9BXY4	R-spondin family	13	ecm, ligand	ecm, extracellular, ligand, ligand_regulator, secreted, transmembrane, transmembrane_predicted	O75473, O75581, P31431, Q68DV7, Q9BXB1, Q9H461, Q9HBX8, Q9ULT6	FZD8, LGR4, LGR5, LGR6, LRP6, RNF43, SDC4, ZNRF3	LGR4 [Baccin2019:21693646;Baccin2019:21909076;CellTalkDB:21693646;Cellinker:29405118;Cellinker:29769720;Guide2Pharma:21693646;LRdb:21693646;LRdb:21909076;Lit-BM-17:24050775;Lit-BM-17:25504990;connectomeDB2020:21693646;connectomeDB2020:21909076;scConnect:21693646;scConnect:21909076], LGR5 [Baccin2019:21693640;Baccin2019:21693646;CellTalkDB:21693646;Cellinker:21693646;Cellinker:29405118;Cellinker:29769720;Guide2Pharma:21693646;LRdb:21693646;SIGNOR:21693646;connectomeDB2020:21693646;scConnect:21693646], LGR6 [Baccin2019:21693646;Baccin2019:21727895;CellTalkDB:21727895;Cellinker:21693646;Cellinker:21727895;Cellinker:29405118;Cellinker:29769720;Guide2Pharma:21693646;Guide2Pharma:21727895;LRdb:21727895;LRdb:22;connectomeDB2020:21693646;connectomeDB2020:21727895;scConnect:21693646;scConnect:21727895], SDC4 [Baccin2019:24275095;CellTalkDB:21397842;Cellinker:21397842;LRdb:21397842;Ramilowski2015:21397842;SIGNOR:21397842;connectomeDB2020:21397842;talklr:21397842], FZD8 [Cellinker:16543246;LRdb:16543246;NetPath:17976036;Ramilowski2015:16543246;connectomeDB2020:16543246;talklr:16543246], LRP6 [Cellinker:16543246;LRdb:16543246;NetPath:17976036;Ramilowski2015:16543246;connectomeDB2020:16543246;talklr:16543246], ZNRF3 [Cellinker:29405118;Cellinker:29769720;Lit-BM-17:24050775;Lit-BM-17:25504990], RNF43 [Cellinker:29405118;Cellinker:29769720]	extracellular region [GO:0005576]	frizzled binding [GO:0005109]; heparin binding [GO:0008201]; signaling receptor binding [GO:0005102]	blood vessel remodeling [GO:0001974]; branching involved in labyrinthine layer morphogenesis [GO:0060670]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of non-canonical Wnt signaling pathway [GO:2000052]; positive regulation of Wnt signaling pathway [GO:0030177]; positive regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000096]; sprouting angiogenesis [GO:0002040]; Wnt signaling pathway [GO:0016055]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=RSPO3&keywords=RSPO3	0.7550213387414831	487	NA	NA	0.08679222403861565	649	0.015748031496062992	0.0034930139720558886	0.004424778761061947	0.038609112709832125	0	0	0	0	0	1.3352917612498332e-4	4.6358895112999797e-4	303	405	387	0.005715641369660721	0.6363087426584542	0.6448053208752849	0.6658073129188423	287	274	250
RSPO4	R-spondin 4	Yes		ENSG00000101282	Q2I0M5	R-spondin family	13	ecm, ligand	ecm, intracellular, ligand, ligand_regulator, secreted	O75473, Q68DV7, Q9BXB1, Q9HBX8, Q9ULT6	LGR4, LGR4_LRP5, LGR4_LRP6, LGR5, LGR5_LRP5, LGR5_LRP6, LGR6, RNF43, ZNRF3	LGR4 [Baccin2019:2169364621693640;CellTalkDB:21693646;Cellinker:21693646;Guide2Pharma:21693646;LRdb:21693646;Lit-BM-17:24050775;Lit-BM-17:25504990;connectomeDB2020:21693646;scConnect:21693646], LGR5 [Baccin2019:2169364621693640;CellTalkDB:21693646;Cellinker:21693646;Guide2Pharma:21693646;LRdb:21693646;connectomeDB2020:21693646;scConnect:21693646], LGR6 [Baccin2019:21693646;Baccin2019:21727895;CellTalkDB:21727895;Cellinker:21693646;Cellinker:21727895;Guide2Pharma:21693646;Guide2Pharma:21727895;LRdb:21727895;LRdb:22;connectomeDB2020:21693646;connectomeDB2020:21727895;scConnect:21693646;scConnect:21727895], ZNRF3 [Cellinker:29405118], RNF43 [Cellinker:29405118]	extracellular region [GO:0005576]	heparin binding [GO:0008201]	nail development [GO:0035878]; positive regulation of Wnt signaling pathway [GO:0030177]; Wnt signaling pathway [GO:0016055]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=RSPO4&keywords=RSPO4	0.022042414606741573	786	NA	NA	0.015078952977642213	812	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
S100A1	S100 calcium binding protein A1			ENSG00000160678	P23297	S-100 family	2	ligand	extracellular, intracellular, ligand, secreted	O00206, P14136, P21817, P36871, Q15109, Q92736, Q9HCF6	AGER, GFAP, PGM1, RYR1, RYR2, TLR4, TRPM3	TRPM3 [CellTalkDB:22451665], RYR2 [CellTalkDB:22728873], RYR1 [CellTalkDB:18650434;HPRD:9298970], TLR4 [CellTalkDB:24833748], AGER [CellTalkDB:20192808;HPRD:11007787], PGM1 [HPRD:8894274;Lit-BM-17:8894274], GFAP [HPRD:10510252]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; Golgi apparatus [GO:0005794]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; sarcoplasmic reticulum [GO:0016529]	ATPase binding [GO:0051117]; calcium-dependent protein binding [GO:0048306]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; S100 protein binding [GO:0044548]	intracellular signal transduction [GO:0035556]; positive regulation of nitric-oxide synthase activity [GO:0051000]; positive regulation of sprouting angiogenesis [GO:1903672]; regulation of heart contraction [GO:0008016]; substantia nigra development [GO:0021762]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=S100A1&keywords=S100A1	1.758204997752809	396	NA	NA	0.31299754599080026	458	0.023622047244094488	4.99001996007984e-4	0	0.0019184652278177458	0	0	0	0	0	1.3352917612498332e-4	1.1589723778249952e-4	303	405	398	0.002389903716529791	0.8071087741108642	0.8178860310758911	0.816462941861811	220	203	178
S100A10	S100 calcium binding protein A10			ENSG00000197747	P60903	S-100 family	3	ligand	extracellular, intracellular, ligand, secreted, transmembrane, transmembrane_predicted	P13569, P28222, P47712, Q9H1D0, Q9NQA5	CFTR, HTR1B, PLA2G4A, TRPV5, TRPV6	TRPV5 [Lit-BM-17:12660155;TRIP:12660155], TRPV6 [CellTalkDB:18187190;HPRD:12660155;TRIP:12660155;TRIP:16189514;TRIP:18187190], CFTR [CellTalkDB:19847291], HTR1B [Cellinker:19211900], PLA2G4A [BioGRID:12163506;InnateDB:12163506]	AnxA2-p11 complex [GO:1990665]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extrinsic component of plasma membrane [GO:0019897]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]; RNA polymerase II transcription regulator complex [GO:0090575]	calcium-dependent protein binding [GO:0048306]; calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]; transmembrane transporter binding [GO:0044325]	membrane raft assembly [GO:0001765]; mRNA transcription by RNA polymerase II [GO:0042789]; positive regulation of binding [GO:0051099]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of GTPase activity [GO:0043547]; positive regulation of plasminogen activation [GO:0010756]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to plasma membrane [GO:0072659]; regulation of neurogenesis [GO:0050767]; vesicle budding from membrane [GO:0006900]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=S100A10&keywords=S100A10	339.25126845472124	28	25314.5	41	1.7723021600252513	181	3.1023622047244066	19.50499001996016	1.2511061946902684	0.6587529976019277	10.50841750841755	1.8460236886632773	2.1722574796010936	4.928221859706359	2.5612282648908735	0.39721591667781786	3.713617925440357	15	55	13	4.60401764185219	0.5572645066564405	0.08825625480581183	0.807022905951785	324	475	184
S100A11	S100 calcium binding protein A11			ENSG00000163191	P31949	S-100 family	1	ligand, receptor	extracellular, intracellular, ligand, receptor, secreted	NA	NA	NA	adherens junction [GO:0005912]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nucleus [GO:0005634]; ruffle [GO:0001726]; secretory granule lumen [GO:0034774]	cadherin binding involved in cell-cell adhesion [GO:0098641]; calcium-dependent protein binding [GO:0048306]; calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]; S100 protein binding [GO:0044548]	negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA replication [GO:0008156]; positive regulation of smooth muscle cell migration [GO:0014911]; signal transduction [GO:0007165]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=S100A11&keywords=S100A11	702.3622111685394	20	28091.3	36	1.272803580807143	228	12.283464566929121	23.83383233532942	4.030973451327405	9.767146282973451	12.146464646464706	2.6683587140439955	2.8458748866727315	2.7145187601957574	3.2197558268590507	1.5012351448795762	3.5096387869432384	13	21	14	7.138296672965314	0.451821738047598	0.2114119228703855	0.49237447016635827	357	412	330
S100A12	S100 calcium binding protein A12	TBD	binds calcium, plays role in exporting proteins without sigl peptide	ENSG00000163221	P80511	S-100 family	2	ligand	extracellular, intracellular, ligand, plasma_membrane, secreted	O00206, P16671	CD36, TLR4	TLR4 [CellTalkDB:23611140], CD36 [CellTalkDB:27734162]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; secretory granule lumen [GO:0034774]	calcium-dependent protein binding [GO:0048306]; calcium ion binding [GO:0005509]; copper ion binding [GO:0005507]; RAGE receptor binding [GO:0050786]; zinc ion binding [GO:0008270]	antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; defense response to bacterium [GO:0042742]; defense response to fungus [GO:0050832]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; killing of cells of other organism [GO:0031640]; mast cell activation [GO:0045576]; monocyte chemotaxis [GO:0002548]; neutrophil chemotaxis [GO:0030593]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of inflammatory response [GO:0050729]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; xenobiotic metabolic process [GO:0006805]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=S100A12&keywords=S100A12	0.09850331460674157	675	NA	NA	0.0021829628046431304	888	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
S100A13	S100 calcium binding protein A13	TBD		ENSG00000189171	Q99584	S-100 family	1	ligand	extracellular, intracellular, ligand, ligand_regulator, secreted	NA	NA	NA	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]	calcium-dependent protein binding [GO:0048306]; calcium ion binding [GO:0005509]; copper ion binding [GO:0005507]; fibroblast growth factor binding [GO:0017134]; lipid binding [GO:0008289]; protein homodimerization activity [GO:0042803]; RAGE receptor binding [GO:0050786]; zinc ion binding [GO:0008270]	mast cell degranulation [GO:0043303]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cytokine production [GO:0001819]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of interleukin-1 alpha production [GO:0032730]; protein transport [GO:0015031]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=S100A13&keywords=S100A13	20.967288064044943	165	4265.71	97	0.3055301125979533	462	0.12598425196850394	1.1017964071856257	0.48008849557521827	0.9031175059952233	0.79629629629629906	0.3164128595600678	0.1813236627379868	0.15008156606851553	0.29596744358120625	0.16217118440378672	0.10225999613675499	59	87	111	0.41959087904628983	0.7122298412398026	0.40077942247287496	0.2613183882906848	258	345	403
S100A14	S100 calcium binding protein A14			ENSG00000189334	Q9HCY8	S-100 family	1	ligand	extracellular, intracellular, ligand, secreted	NA	NA	NA	extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; perinuclear region of cytoplasm [GO:0048471]	calcium-dependent protein binding [GO:0048306]; calcium ion binding [GO:0005509]; chemokine receptor binding [GO:0042379]	apoptotic process [GO:0006915]; calcium ion homeostasis [GO:0055074]; defense response to bacterium [GO:0042742]; positive regulation of granulocyte chemotaxis [GO:0071624]; positive regulation of monocyte chemotaxis [GO:0090026]; response to lipopolysaccharide [GO:0032496]; toll-like receptor 4 signaling pathway [GO:0034142]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=S100A14&keywords=S100A14	68.0208350185107	64	683.178	159	0.48927512004033746	387	0	2.1422155688622735	0	0.0035971223021582736	0.15151515151515163	0.001692047377326565	0.001813236627379873	0	0	8.011750567499001e-4	0.001120339965230829	303	379	361	0.2093413310642064	0.04559104274366222	0.04924368336940629	0.050698789467889395	507	499	502
S100A16	S100 calcium binding protein A16			ENSG00000188643	Q96FQ6	S-100 family	1	ligand	extracellular, intracellular, ligand, secreted	NA	NA	NA	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]	calcium-dependent protein binding [GO:0048306]; calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]	response to calcium ion [GO:0051592]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=S100A16&keywords=S100A16	80.58236235128336	60	2344.26	127	0.5637602535499737	361	0	4.582834331337291	1.07853982300885	2.625179856115059	0.8888888888888902	0.06091370558375638	0.07252946509519478	0.07504078303425782	0.08472068072512005	0.010482040325811164	0.13996523082865978	140	241	90	0.8744631640857173	0.10709398036156115	0.023157595655194697	0.1695550893673238	473	517	440
S100A2	S100 calcium binding protein A2			ENSG00000196754	P29034	S-100 family	1	ligand	extracellular, intracellular, ligand, secreted	NA	NA	NA	NA	calcium-dependent protein binding [GO:0048306]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; transition metal ion binding [GO:0046914]	endothelial cell migration [GO:0043542]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=S100A2&keywords=S100A2	49.51871130890814	87	NA	NA	1.2363659092173311	234	0.015748031496062992	1.1172654690618748	0.012168141592920354	0.02733812949640287	0.45622895622895576	0.03553299492385787	0.03445149592021758	0.060358890701468215	0.09914909359970377	0.02049672853518489	0.11334749855128172	127	196	105	0.18109867546435734	0.5711661440587098	0.15958628944486308	0.6454649580985076	311	441	262
S100A3	S100 calcium binding protein A3			ENSG00000188015	P33764	S-100 family	1	ligand	extracellular, intracellular, ligand, secreted	NA	NA	NA	cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; plasma membrane [GO:0005886]	calcium-dependent protein binding [GO:0048306]; calcium ion binding [GO:0005509]; zinc ion binding [GO:0008270]	NA	https://www.genecards.org/cgi-bin/carddisp.pl?gene=S100A3&keywords=S100A3	0.9270330685710112	458	NA	NA	0.23321162986706653	508	0.007874015748031496	0.12425149700598788	0.1426991150442479	0.06378896882494005	0.03198653198653198	0.005076142131979695	0.005439709882139619	0.009787928221859707	0.00924898261191269	0.0011349979970623585	0.008267336295151632	268	367	256	0.03723229324998591	0.4075385988572222	0.2357496795281199	0.3867552269475521	375	401	357
S100A4	S100 calcium binding protein A4			ENSG00000196154	P26447	S-100 family	3	ligand	extracellular, intracellular, ligand, secreted	O75594, P00533, P04626, P04637, P21860, P51681, Q00987	CCR5, EGFR, ERBB2, ERBB3, MDM2, PGLYRP1, TP53	PGLYRP1 [NA], ERBB2 [CellTalkDB:30083275], EGFR [CellTalkDB:30083275;Cellinker:30083275;IntAct:24658140;IntAct:30083275;IntAct:31980649;Lit-BM-17:24658140;Lit-BM-17:25402006], CCR5 [CellTalkDB:30713770], ERBB3 [Cellinker:30083275], TP53 [BioGRID:11527429;HPRD:11278647;HPRD:11527429;HPRD:12942774;HPRD:15116098;IntAct:19740107;IntAct:20591429;IntAct:23752197;IntAct:31837246;Lit-BM-17:11527429;Lit-BM-17:19740107;Lit-BM-17:20070253;Lit-BM-17:20591429;Lit-BM-17:23752197], MDM2 [IntAct:20591429;Lit-BM-17:20591429]	collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; neuron projection [GO:0043005]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]	actin binding [GO:0003779]; calcium-dependent protein binding [GO:0048306]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; RAGE receptor binding [GO:0050786]; RNA binding [GO:0003723]; transition metal ion binding [GO:0046914]	epithelial to mesenchymal transition [GO:0001837]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=S100A4&keywords=S100A4	29.103499424044944	139	3341.06	107	0.13285398080896332	589	1.700787401574802	0.10978043912175638	0.018805309734513276	0.20503597122302175	0.030303030303030297	0.01353637901861252	0.001813236627379873	0.008156606851549756	0.019977802441731397	0.0011349979970623585	0.004635889511299982	237	367	293	0.19217882403679631	0.14827370069318174	0.0550749963558785	0.0723908133358035	458	491	488
S100A5	S100 calcium binding protein A5			ENSG00000196420	P33763	S-100 family	1	ligand	extracellular, intracellular, ligand, secreted	NA	NA	NA	neuronal cell body [GO:0043025]; nucleus [GO:0005634]	calcium-dependent protein binding [GO:0048306]; calcium ion binding [GO:0005509]; copper ion binding [GO:0005507]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270]	NA	https://www.genecards.org/cgi-bin/carddisp.pl?gene=S100A5&keywords=S100A5	0.060865340449438206	713	NA	NA	0.1551629564397377	572	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
S100A6	S100 calcium binding protein A6			ENSG00000197956	P06703	S-100 family	1	ligand	extracellular, intracellular, ligand, plasma_membrane, secreted	NA	NA	NA	collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ruffle [GO:0001726]	calcium-dependent protein binding [GO:0048306]; calcium ion binding [GO:0005509]; ion transmembrane transporter activity [GO:0015075]; protein homodimerization activity [GO:0042803]; S100 protein binding [GO:0044548]; tropomyosin binding [GO:0005523]; zinc ion binding [GO:0008270]	axonogenesis [GO:0007409]; positive regulation of fibroblast proliferation [GO:0048146]; signal transduction [GO:0007165]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=S100A6&keywords=S100A6	1271.2895354269663	15	31001	33	1.3058007449739977	223	9.409448818897628	44.51497005988024	2.5752212389380356	11.565707434052579	20.617845117845203	19.082910321489045	12.523118766999163	15.02936378466557	34.36773954864952	5.075243690747811	21.659146223681418	3	9	5	17.85642863689511	1.9241528481891272	0.28462564030544507	1.2128415064963514	36	386	61
S100A7	S100 calcium binding protein A7	TBD		ENSG00000143556	P31151	S-100 family	1	ligand	extracellular, intracellular, ligand, secreted	NA	NA	NA	azurophil granule lumen [GO:0035578]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; nucleus [GO:0005634]	calcium-dependent protein binding [GO:0048306]; calcium ion binding [GO:0005509]; RAGE receptor binding [GO:0050786]; zinc ion binding [GO:0008270]	angiogenesis [GO:0001525]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; defense response to Gram-negative bacterium [GO:0050829]; epidermis development [GO:0008544]; innate immune response [GO:0045087]; keratinocyte differentiation [GO:0030216]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of granulocyte chemotaxis [GO:0071624]; positive regulation of monocyte chemotaxis [GO:0090026]; positive regulation of T cell chemotaxis [GO:0010820]; response to lipopolysaccharide [GO:0032496]; response to reactive oxygen species [GO:0000302]; sequestering of metal ion [GO:0051238]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=S100A7&keywords=S100A7	0.7600957415730337	486	6045.04	87	0.1698286456307913	555	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
S100A7A	S100 calcium binding protein A7A			ENSG00000184330	Q86SG5	S-100 family	1	ligand	intracellular, ligand, secreted	NA	NA	NA	cytosol [GO:0005829]; extracellular space [GO:0005615]	calcium-dependent protein binding [GO:0048306]; calcium ion binding [GO:0005509]; protein self-association [GO:0043621]; transition metal ion binding [GO:0046914]	NA	https://www.genecards.org/cgi-bin/carddisp.pl?gene=S100A7A&keywords=S100A7A	0.004296055056179775	861	NA	NA	0.4256096052367955	408	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
S100A7L2	S100 calcium binding protein A7 like 2			ENSG00000197364	Q5SY68	S-100 family	1	ligand	intracellular, ligand, secreted	NA	NA	NA	extracellular space [GO:0005615]	calcium-dependent protein binding [GO:0048306]; calcium ion binding [GO:0005509]; transition metal ion binding [GO:0046914]	NA	https://www.genecards.org/cgi-bin/carddisp.pl?gene=S100A7L2&keywords=S100A7L2	0	899	NA	NA	1	266	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
S100A8	S100 calcium binding protein A8	TBD		ENSG00000143546	P05109	S-100 family	9	ligand	extracellular, intracellular, ligand, plasma_membrane, secreted	O00206, P05107, P16671, P34810, Q07108, Q15109	AGER, CD36, CD68, CD69, ITGB2, TLR4	AGER [CellTalkDB:28504650;Cellinker:28504650;SIGNOR:28137827], TLR4 [CellTalkDB:17767165;LRdb:17767165;Ramilowski2015:17767165;SIGNOR:28137827;connectomeDB2020:17767165;talklr:17767165], ITGB2 [CellTalkDB:9570563], CD36 [CellTalkDB:31794767], CD69 [CellTalkDB:26296369], CD68 [CellTalkDB:27312849]	collagen-containing extracellular matrix [GO:0062023]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intermediate filament cytoskeleton [GO:0045111]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; secretory granule lumen [GO:0034774]	arachidonic acid binding [GO:0050544]; calcium-dependent protein binding [GO:0048306]; calcium ion binding [GO:0005509]; microtubule binding [GO:0008017]; RAGE receptor binding [GO:0050786]; Toll-like receptor 4 binding [GO:0035662]; zinc ion binding [GO:0008270]	activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; acute inflammatory response [GO:0002526]; apoptotic process [GO:0006915]; astrocyte development [GO:0014002]; autocrine signaling [GO:0035425]; autophagy [GO:0006914]; chronic inflammatory response [GO:0002544]; defense response to bacterium [GO:0042742]; defense response to fungus [GO:0050832]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; leukocyte migration involved in inflammatory response [GO:0002523]; neutrophil aggregation [GO:0070488]; neutrophil chemotaxis [GO:0030593]; peptidyl-cysteine S-nitrosylation [GO:0018119]; positive regulation of cell growth [GO:0030307]; positive regulation of inflammatory response [GO:0050729]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of peptide secretion [GO:0002793]; regulation of cytoskeleton organization [GO:0051493]; response to ethanol [GO:0045471]; response to lipopolysaccharide [GO:0032496]; response to zinc ion [GO:0010043]; sequestering of zinc ion [GO:0032119]; wound healing [GO:0042060]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=S100A8&keywords=S100A8	37.32172275168539	114	4039.57	99	0.07490519483434847	666	3.275590551181101	0	0.0011061946902654867	0	0.0016835016835016834	0	0	0	3.699593044765076e-4	2.3367605821872085e-4	3.09059300753332e-4	302	401	392	0.29811754020166514	0.03365585515738343	0.03321354588096707	0.033458203301266067	516	512	515
S100A9	S100 calcium binding protein A9	TBD		ENSG00000163220	P06702	S-100 family	8	ligand	extracellular, intracellular, ligand, plasma_membrane, secreted	O00206, P05107, P16671, P34810, Q13740, Q15109	AGER, ALCAM, CD36, CD68, ITGB2, TLR4	TLR4 [CellTalkDB:17767165;LRdb:17767165;Ramilowski2015:17767165;SIGNOR:28137827;connectomeDB2020:17767165;talklr:17767165], AGER [CellTalkDB:28504650;Cellinker:28504650;InnateDB:23667563;SIGNOR:28137827], ITGB2 [CellTalkDB:9570563], CD36 [CellTalkDB:24691441], CD68 [CellTalkDB:27312849], ALCAM [CellTalkDB:27151304]	cell junction [GO:0030054]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; secretory granule lumen [GO:0034774]	antioxidant activity [GO:0016209]; arachidonic acid binding [GO:0050544]; calcium-dependent protein binding [GO:0048306]; calcium ion binding [GO:0005509]; microtubule binding [GO:0008017]; RAGE receptor binding [GO:0050786]; Toll-like receptor 4 binding [GO:0035662]; zinc ion binding [GO:0008270]	activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; apoptotic process [GO:0006915]; astrocyte development [GO:0014002]; autocrine signaling [GO:0035425]; autophagy [GO:0006914]; cell-cell signaling [GO:0007267]; chronic inflammatory response [GO:0002544]; defense response to bacterium [GO:0042742]; defense response to fungus [GO:0050832]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; leukocyte migration involved in inflammatory response [GO:0002523]; modulation of process of other organism [GO:0035821]; neutrophil aggregation [GO:0070488]; neutrophil chemotaxis [GO:0030593]; peptidyl-cysteine S-nitrosylation [GO:0018119]; peptidyl-cysteine S-trans-nitrosylation [GO:0035606]; positive regulation of cell growth [GO:0030307]; positive regulation of inflammatory response [GO:0050729]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of neuron projection development [GO:0010976]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; regulation of cytoskeleton organization [GO:0051493]; regulation of integrin biosynthetic process [GO:0045113]; response to lipopolysaccharide [GO:0032496]; sequestering of zinc ion [GO:0032119]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=S100A9&keywords=S100A9	48.73068393258427	88	7919.69	78	0.02872932344003774	772	9.204724409448811	0.24251497005988085	0	0.0023980815347721817	0.06565656565656565	0.01015228426395939	0	0.004893964110929854	0.12393636699963001	0.001134997997062358	0.001313502028201662	105	368	351	0.8778841038272558	0.1508489299699055	0.012541048937653638	0.012742093229774485	455	522	525
S100B	S100 calcium binding protein B			ENSG00000160307	P04271	S-100 family	2	ligand	extracellular, intracellular, ligand, secreted	P36871, P46940, Q13740, Q15109	AGER, ALCAM, IQGAP1, PGM1	ALCAM [CellTalkDB:23729438], AGER [CellTalkDB:20192808;HPRD:10399917;IntAct:17660747;IntAct:17726019;Lit-BM-17:17660747], IQGAP1 [HPRD:12377780;InnateDB:12377780], PGM1 [HPRD:8894274;Lit-BM-17:8894274]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ruffle [GO:0001726]	calcium-dependent protein binding [GO:0048306]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803]; RAGE receptor binding [GO:0050786]; S100 protein binding [GO:0044548]; tau protein binding [GO:0048156]; zinc ion binding [GO:0008270]	axonogenesis [GO:0007409]; central nervous system development [GO:0007417]; learning or memory [GO:0007611]; memory [GO:0007613]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; regulation of neuronal synaptic plasticity [GO:0048168]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=S100B&keywords=S100B	4.303927292134832	308	4463	95	0.01992004540651118	796	0.023622047244094488	0.006986027944111778	0.0022123893805309734	0.002877697841726618	0	0.15566835871404386	0.05711695376246595	0.1778140293637846	0.28782833888272286	0.04389771665108915	0.05103341703689305	61	152	153	0.07355063425649666	3.564644859168913	0.6450904547968553	0.7304961545776328	9	273	222
S100G	S100 calcium binding protein G			ENSG00000169906	P29377	S-100 family	1	ligand	intracellular, ligand, secreted	NA	NA	NA	apical plasma membrane [GO:0016324]; basolateral plasma membrane [GO:0016323]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]	calcium-dependent protein binding [GO:0048306]; calcium ion binding [GO:0005509]; transition metal ion binding [GO:0046914]; vitamin D binding [GO:0005499]	NA	https://www.genecards.org/cgi-bin/carddisp.pl?gene=S100G&keywords=S100G	0	899	NA	NA	1	266	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
S100P	S100 calcium binding protein P			ENSG00000163993	P25815	S-100 family	1	ligand	extracellular, intracellular, ligand, secreted	Q9HB71	CACYBP	CACYBP [HPRD:12042313]	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; microvillus membrane [GO:0031528]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; secretory granule lumen [GO:0034774]	cadherin binding [GO:0045296]; calcium-dependent protein binding [GO:0048306]; calcium ion binding [GO:0005509]; magnesium ion binding [GO:0000287]; protein homodimerization activity [GO:0042803]; transition metal ion binding [GO:0046914]	endothelial cell migration [GO:0043542]; response to organic substance [GO:0010033]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=S100P&keywords=S100P	34.43143624809134	123	NA	NA	2.0291757563281103	152	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
S100Z	S100 calcium binding protein Z			ENSG00000171643	Q8WXG8	S-100 family	1	ligand	extracellular, intracellular, ligand, secreted	NA	NA	NA	NA	calcium-dependent protein binding [GO:0048306]; calcium ion binding [GO:0005509]; protein homodimerization activity [GO:0042803]	NA	https://www.genecards.org/cgi-bin/carddisp.pl?gene=S100Z&keywords=S100Z	3.2680448325842697	329	NA	NA	15.074473966460575	34	0	0.0029940119760479044	0	0.0026378896882493998	0.0016835016835016834	0.032148900169204735	0.05258386219401624	0.058727569331158296	0.020717721050684413	0.01599011884096671	0.07004056403322181	232	218	130	0.023411285360641017	0.919381601728808	0.7778844351670305	2.3956146304838293	171	219	11
SAA1	serum amyloid A1	Yes	manually added ensembl_gene_ID, hgnc_symbol, and description by searching the uniprot ID on genenames.org	ENSG00000173432	P0DJI8	SAA family	13	ligand	extracellular, intracellular, ligand, secreted	O60603, P08913, P16671, P21462, P25090, P48039, Q14831, Q8WTV0	ADRA2A, CD36, FPR1, FPR2, GRM7, MTNR1A, SCARB1, TLR2	FPR2 [Baccin2019:9892621;CellChatDB:22610094;CellTalkDB:9892621;Cellinker:22610094;Cellinker:9892621;Guide2Pharma:9892621;ICELLNET:26130702;LRdb:9892621;connectomeDB2020:9892621;scConnect:9892621], FPR1 [Baccin2019:10753626;CellTalkDB:10753626;Cellinker:10753626;HPRD:10753626;LRdb:10753626], TLR2 [CellTalkDB:26290589], SCARB1 [CellTalkDB:15576377], ADRA2A [CellTalkDB:32196115], MTNR1A [CellTalkDB:32196115], GRM7 [CellTalkDB:32196115], CD36 [connectomeDB2020:20075072]	cytoplasmic microtubule [GO:0005881]; endocytic vesicle lumen [GO:0071682]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; high-density lipoprotein particle [GO:0034364]	G protein-coupled receptor binding [GO:0001664]; heparin binding [GO:0008201]	acute-phase response [GO:0006953]; lymphocyte chemotaxis [GO:0048247]; macrophage chemotaxis [GO:0048246]; negative regulation of inflammatory response [GO:0050728]; neutrophil chemotaxis [GO:0030593]; platelet activation [GO:0030168]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cytokine production [GO:0001819]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of interleukin-1 production [GO:0032732]; regulation of protein secretion [GO:0050708]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=SAA1&keywords=SAA1	8.291953161011236	254	NA	NA	0.03356179473786966	757	0	0.03692614770459081	0	0.0035971223021582727	0	0	9.066183136899365e-4	0	3.699593044765076e-4	0	1.1589723778249952e-4	302	409	398	0.003810522260245275	0.7508737981855537	0.724085578485748	0.7324775303322121	241	243	221
SCEL	sciellin			ENSG00000136155	O95171	NA	1	ligand	intracellular, ligand, secreted	P17813	ENG	ENG [Cellinker:31540324]	cornified envelope [GO:0001533]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; perinuclear region of cytoplasm [GO:0048471]	metal ion binding [GO:0046872]	embryo development ending in birth or egg hatching [GO:0009792]; epidermis development [GO:0008544]; keratinocyte differentiation [GO:0030216]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; response to mechanical stimulus [GO:0009612]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=SCEL&keywords=SCEL	0.9730801863024896	455	NA	NA	0.047404099182790246	713	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
SCG2	secretogranin II	Yes	include all chromogranins	ENSG00000171951	P13521	Chromogranin/secretogranin protein family	1	ligand	extracellular, intracellular, ligand, secreted	NA	NA	NA	endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; neuronal dense core vesicle [GO:0098992]; secretory granule [GO:0030141]	chemoattractant activity [GO:0042056]; cytokine activity [GO:0005125]	angiogenesis [GO:0001525]; endothelial cell migration [GO:0043542]; eosinophil chemotaxis [GO:0048245]; induction of positive chemotaxis [GO:0050930]; inflammatory response [GO:0006954]; intracellular signal transduction [GO:0035556]; MAPK cascade [GO:0000165]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; positive chemotaxis [GO:0050918]; positive regulation of endothelial cell proliferation [GO:0001938]; protein secretion [GO:0009306]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=SCG2&keywords=SCG2	791.3750657977528	16	109980	14	23.008084617232715	27	0.13385826771653542	0.4665668662674665	0.06526548672566376	0.4326139088729047	0.4663299663299665	6.7884940778341845	7.173164097914787	11.450244698205529	5.001849796522418	5.5242689277623835	4.590148734789764	9	8	10	3.826618620812873	1.30631952035424	1.4424860729549984	1.199011209984463	72	58	63
SCGB1A1	secretoglobin family 1A member 1	Yes		ENSG00000149021	P11684	Secretoglobin family	8	ligand	extracellular, intracellular, ligand, ligand_regulator, secreted	P98164, Q6UX01	LMBR1L, LRP2	LRP2 [Baccin2019:11278724;CellTalkDB:11278724;Cellinker:11278724;HPRD:11278724;LRdb:11278724;connectomeDB2020:11278724], LMBR1L [Baccin2019:16423471;CellTalkDB:16423471;Cellinker:16423471;HPRD:16423471;LRdb:16423471]	cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; nuclear envelope [GO:0005635]; rough endoplasmic reticulum [GO:0005791]; secretory granule [GO:0030141]	phospholipase A2 inhibitor activity [GO:0019834]; polychlorinated biphenyl binding [GO:0097160]	embryo implantation [GO:0007566]; female pregnancy [GO:0007565]; negative regulation of interferon-gamma production [GO:0032689]; negative regulation of interleukin-13 production [GO:0032696]; negative regulation of interleukin-4 production [GO:0032713]; negative regulation of interleukin-5 production [GO:0032714]; negative regulation of T cell proliferation [GO:0042130]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of inflammatory response [GO:0050727]; regulation of mRNA stability [GO:0043488]; response to cytokine [GO:0034097]; response to fibroblast growth factor [GO:0071774]; response to glucocorticoid [GO:0051384]; response to lipopolysaccharide [GO:0032496]; response to ozone [GO:0010193]; response to silicon dioxide [GO:0034021]; response to xenobiotic stimulus [GO:0009410]; signal transduction [GO:0007165]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=SCGB1A1&keywords=SCGB1A1	17.48636208988764	183	NA	NA	4.556825861690698	80	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
SCGB3A1	secretoglobin family 3A member 1	Yes		ENSG00000161055	Q96QR1	Secretoglobin family, UGRP subfamily	10	ligand	ligand, ligand_regulator, secreted	Q9UEW3, Q9UM47	MARCO, NOTCH3	MARCO [Baccin2019:12847263;CellTalkDB:12847263;Cellinker:12847263;HPRD:12847263;LRdb:12847263;connectomeDB2020:12847263], NOTCH3 [CellTalkDB:32103204]	extracellular exosome [GO:0070062]; extracellular space [GO:0005615]	cytokine activity [GO:0005125]	negative regulation of cell growth [GO:0030308]; positive regulation of myoblast fusion [GO:1901741]; regulation of cell population proliferation [GO:0042127]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=SCGB3A1&keywords=SCGB3A1	2.1149478213483146	382	NA	NA	0.13350035937877222	587	0	0.23752495009980049	0.0011061946902654867	0	0	0	0	0	0	1.0014688209373749e-4	0	303	406	401	0.021702844697469064	0.3154291072434371	0.3185880314046412	0.3154291072434371	402	371	387
SCGB3A2	secretoglobin family 3A member 2	Yes		ENSG00000164265	Q96PL1	Secretoglobin family, UGRP subfamily	9	ligand	intracellular, ligand, ligand_regulator, secreted	Q9UEW3	MARCO	MARCO [Baccin2019:12847263;CellChatDB:12847263;CellTalkDB:12847263;Cellinker:12847263;HPRD:12847263;InnateDB:12847263;LRdb:12847263;connectomeDB2020:12847263]	endocytic vesicle lumen [GO:0071682]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	NA	NA	https://www.genecards.org/cgi-bin/carddisp.pl?gene=SCGB3A2&keywords=SCGB3A2	3.0774210561797752	336	NA	NA	1.3449571204921056	217	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
SCT	secretin	Yes		ENSG00000274473, ENSG00000070031	P09683	Glucagon family	14	ligand	extracellular, intracellular, ligand, secreted	O60895, O60896, P07550, P13945, P16473, P32241, P41586, P41587, P47872, Q03431, Q99678, Q9NQS5	ADCYAP1R1, ADRB2, ADRB3, GPR20, GPR84, PTH1R, RAMP2, RAMP3, SCTR, TSHR, VIPR1, VIPR2	SCTR [Baccin2019:7612008;Baccin2019:7782300;Baccin2019:8579602;Baccin2019:9440501;CellTalkDB:7782300;Cellinker:7612008;Cellinker:7782300;Cellinker:8579602;Cellinker:9440501;Guide2Pharma:7612008;HPMR:7782300;HPRD:7782300;HPRD:8579602;HPRD:9440501;LRdb:7612008;LRdb:7782300;LRdb:8579602;LRdb:9440501;connectomeDB2020:7612008;connectomeDB2020:7782300;connectomeDB2020:8579602;connectomeDB2020:9440501;scConnect:7612008], PTH1R [CellTalkDB:32196115], ADCYAP1R1 [CellTalkDB:32196115], RAMP2 [CellTalkDB:32196115], VIPR1 [Baccin2019:12133828;CellTalkDB:12133828;HPRD:12133828;LRdb:12133828;connectomeDB2020:12133828], RAMP3 [CellTalkDB:32196115], GPR20 [CellTalkDB:32196115], ADRB2 [CellTalkDB:32196115], VIPR2 [CellTalkDB:9437714;LRdb:9437714;Ramilowski2015:9437714;connectomeDB2020:9437714;talklr:9437714], ADRB3 [CellTalkDB:32196115], TSHR [CellTalkDB:32196115], GPR84 [CellTalkDB:32196115]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	digestive hormone activity [GO:0046659]; G protein-coupled receptor binding [GO:0001664]; hormone activity [GO:0005179]; protein N-terminus binding [GO:0047485]; signaling receptor binding [GO:0005102]	brain development [GO:0007420]; cellular water homeostasis [GO:0009992]; diet induced thermogenesis [GO:0002024]; embryonic digestive tract development [GO:0048566]; hippocampus development [GO:0021766]; negative regulation of gastrin-induced gastric acid secretion [GO:1903640]; pancreatic juice secretion [GO:0030157]; positive regulation of cAMP-mediated signaling [GO:0043950]; positive regulation of lipid catabolic process [GO:0050996]; positive regulation of pancreatic juice secretion [GO:0090187]; positive regulation of somatostatin secretion [GO:0090274]; regulation of appetite [GO:0032098]; regulation of synaptic plasticity [GO:0048167]; response to nutrient levels [GO:0031667]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=SCT&keywords=SCT	0.018409449438202247	799	NA	NA	0.038323446011976924	741	0	0	0	2.3980815347721823e-4	0	0.01015228426395939	0.009972801450589302	0.0016313213703099511	0.0014798372179060304	0.0028374949926558914	0.0011589723778249958	299	321	358	0.0024975018024293435	0.9185705590916183	1.0272048922737869	0.8928962407235537	173	121	149
SCUBE1	signal peptide, CUB domain and EGF like domain containing 1	TBD		ENSG00000159307	Q8IWY4	NA	1	ligand, receptor	extracellular, ligand, plasma_membrane, receptor, secreted	NA	NA	NA	cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; extrinsic component of plasma membrane [GO:0019897]; plasma membrane [GO:0005886]	calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]	adult heart development [GO:0007512]; blood coagulation [GO:0007596]; endothelial cell differentiation [GO:0045446]; inflammatory response [GO:0006954]; positive regulation of smoothened signaling pathway [GO:0045880]; post-embryonic development [GO:0009791]; signal transduction [GO:0007165]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=SCUBE1&keywords=SCUBE1	0.23681720337078652	598	NA	NA	0.053955677138949894	703	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
SCUBE2	signal peptide, CUB domain and EGF like domain containing 2	TBD		ENSG00000175356	Q9NQ36	NA	2	ligand, receptor	extracellular, ligand, receptor, secreted	P35968	KDR	KDR [Cellinker:27834687]	cell surface [GO:0009986]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	calcium ion binding [GO:0005509]; lipid binding [GO:0008289]	signal transduction [GO:0007165]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=SCUBE2&keywords=SCUBE2	1.0827026694644073	442	NA	NA	0.19525698200917949	536	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
SCUBE3	signal peptide, CUB domain and EGF like domain containing 3	TBD		ENSG00000146197	Q8IX30	NA	1	ligand	extracellular, ligand, secreted	NA	NA	NA	cell surface [GO:0009986]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]	BMP binding [GO:0036122]; BMP receptor binding [GO:0070700]; calcium ion binding [GO:0005509]; identical protein binding [GO:0042802]	positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of osteoblast differentiation [GO:0045669]; signal transduction [GO:0007165]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=SCUBE3&keywords=SCUBE3	0.06591819662921349	703	NA	NA	0.013718074005769807	818	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
SDC4	syndecan 4	No		ENSG00000124145	P31431	Syndecan proteoglycan family	1	adhesion, cell_surface_ligand	adhesion, cell_adhesion, cell_surface, cell_surface_ligand, extracellular, intracellular, ligand_regulator, matrix_adhesion, plasma_membrane, plasma_membrane_transmembrane, receptor_regulator, secreted, transmembrane, transmembrane_predicted	O14640, O14641, O43184, P06241, P17252, P49023, P63000, Q92997, Q9BRJ7	ADAM12, DVL1, DVL2, DVL3, FYN, NUDT16L1, PRKCA, PXN, RAC1	DVL2 [SIGNOR:23151663], DVL1 [SIGNOR:23151663], ADAM12 [Adhesome:12509413;Baccin2019:12509413;Cellinker:12509413], PRKCA [ACSN:18851840;Adhesome:11916978;Adhesome:12571249;Adhesome:14670076;Adhesome:9556568;HPRD:11916978;HPRD:14670076;HPRD:9556568], RAC1 [SIGNOR:23290138], DVL3 [SIGNOR:23151663], NUDT16L1 [Adhesome:10633082], FYN [Adhesome:9952400], PXN [Adhesome:11805099;HPRD:11805099]	cell surface [GO:0009986]; costamere [GO:0043034]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; Golgi lumen [GO:0005796]; integral component of plasma membrane [GO:0005887]; lysosomal lumen [GO:0043202]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]	fibronectin binding [GO:0001968]; identical protein binding [GO:0042802]; protein kinase C binding [GO:0005080]; thrombospondin receptor activity [GO:0070053]	cell migration [GO:0016477]; inner ear receptor cell stereocilium organization [GO:0060122]; negative regulation of T cell proliferation [GO:0042130]; neural tube closure [GO:0001843]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of extracellular exosome assembly [GO:1903553]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of stress fiber assembly [GO:0051496]; regulation of fibroblast migration [GO:0010762]; ureteric bud development [GO:0001657]; wound healing [GO:0042060]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=SDC4&keywords=SDC4	202.89358876404495	35	2042.96	131	1.9777942992650732	157	0.11023622047244094	0.7100798403193591	0.015486725663716814	0.11342925659472528	0.885521885521888	0.05076142131979697	0.02085222121486854	0.004893964110929854	0.06844247132815387	0.021364668179997274	0.00602665636468998	151	193	278	0.18246321191732423	0.40757124723581006	0.16296448483604484	0.08327127145511058	374	436	482
SECTM1	secreted and transmembrane 1	No		ENSG00000141574	Q8WVN6	SECTM family	2	cell_surface_ligand, ligand	cell_surface, cell_surface_ligand, extracellular, intracellular, ligand, plasma_membrane, plasma_membrane_transmembrane, secreted, transmembrane, transmembrane_predicted	P09564	CD7	CD7 [BioGRID:10652336;HPRD:10652336;connectomeDB2020:10652336;connectomeDB2020:24157461;connectomeDB2020:24211252]	extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	cytokine activity [GO:0005125]	immune response [GO:0006955]; mesoderm development [GO:0007498]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=SECTM1&keywords=SECTM1	3.802289386106963	317	NA	NA	0.30105892848416016	465	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
SEMA3A	semaphorin 3A	Yes		ENSG00000075213	Q14563	Semaphorin family	13	ligand	extracellular, intracellular, ligand, secreted, transmembrane	O14786, O60462, O75051, P51805, Q9HCM2, Q9UIW2	NRP1, NRP1_PLXNA1, NRP1_PLXNA2, NRP1_PLXNA3, NRP1_PLXNA4, NRP2, PLXNA1, PLXNA2, PLXNA3, PLXNA4	NRP1 [Baccin2019:10520994;Baccin2019:15721238;Baccin2019:9331348;CellTalkDB:10520994;DIP:10498602;HPMR:10520994;HPMR:15121181;HPMR:15721238;HPMR:15814794;HPRD:10520994;HPRD:9331348;ICELLNET:29067024;LRdb:10520994;LRdb:15721238;LRdb:9331348;SIGNOR:10196546;SIGNOR:25335892;connectomeDB2020:10520994;connectomeDB2020:15721238;connectomeDB2020:9331348], PLXNA2 [CellTalkDB:10934324;LRdb:10934324;SIGNOR:10679438], PLXNA4 [Baccin2019:15721238;CellTalkDB:15721238;HPMR:15721238;HPMR:15814794;LRdb:15721238;SIGNOR:25335892;connectomeDB2020:15721238], PLXNA1 [Baccin2019:10520994;CellTalkDB:10520994;HPMR:10520994;HPMR:15121181;LRdb:10520994;SIGNOR:25335892;connectomeDB2020:10520994], PLXNA3 [CellTalkDB:32196115], NRP2 [CellTalkDB:21059704;Cellinker:26633812;LRdb:21059704;Ramilowski2015:21059704;connectomeDB2020:21059704;talklr:21059704]	axon [GO:0030424]; dendrite [GO:0030425]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]	chemorepellent activity [GO:0045499]; neuropilin binding [GO:0038191]; semaphorin receptor binding [GO:0030215]	apoptotic process [GO:0006915]; axonal fasciculation [GO:0007413]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; axonogenesis involved in innervation [GO:0060385]; basal dendrite arborization [GO:0150020]; branchiomotor neuron axon guidance [GO:0021785]; dichotomous subdivision of terminal units involved in salivary gland branching [GO:0060666]; facial nerve structural organization [GO:0021612]; facioacoustic ganglion development [GO:1903375]; gonadotrophin-releasing hormone neuronal migration to the hypothalamus [GO:0021828]; motor neuron axon guidance [GO:0008045]; negative chemotaxis [GO:0050919]; negative regulation of axon extension involved in axon guidance [GO:0048843]; negative regulation of epithelial cell migration [GO:0010633]; negative regulation of neuron projection development [GO:0010977]; nerve development [GO:0021675]; neural crest cell migration [GO:0001755]; neural crest cell migration involved in autonomic nervous system development [GO:1901166]; neural crest cell migration involved in sympathetic nervous system development [GO:1903045]; neuron migration [GO:0001764]; olfactory bulb development [GO:0021772]; positive regulation of cell migration [GO:0030335]; positive regulation of JNK cascade [GO:0046330]; positive regulation of male gonad development [GO:2000020]; positive regulation of neuron migration [GO:2001224]; regulation of axon extension involved in axon guidance [GO:0048841]; regulation of heart rate [GO:0002027]; semaphorin-plexin signaling pathway [GO:0071526]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]; semaphorin-plexin signaling pathway involved in neuron projection guidance [GO:1902285]; sensory system development [GO:0048880]; sympathetic ganglion development [GO:0061549]; sympathetic nervous system development [GO:0048485]; sympathetic neuron projection extension [GO:0097490]; sympathetic neuron projection guidance [GO:0097491]; trigeminal ganglion development [GO:0061551]; trigeminal nerve structural organization [GO:0021637]; ventral trunk neural crest cell migration [GO:0036486]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=SEMA3A&keywords=SEMA3A	1.2271503956357304	430	NA	NA	0.6022074334119097	336	0.007874015748031496	0	0.0022123893805309734	0.02206235011990407	0	0.02538071065989847	0.016319129646418858	0	0.02774694783573803	0.017826145012685226	0.003940506084604987	211	206	301	0.011214744953437465	1.7792788892152964	1.3116417413340857	0.6571140079789732	41	74	257
SEMA3B	semaphorin 3B	Yes		ENSG00000012171	Q13214	Semaphorin family	11	ligand, receptor	extracellular, intracellular, ligand, receptor, secreted, transmembrane	O14786, O60462, O75051, Q9HCM2	NRP1, NRP1_PLXNA1, NRP1_PLXNA2, NRP1_PLXNA3, NRP1_PLXNA4, NRP2, NRP2_PLXNA1, NRP2_PLXNA2, NRP2_PLXNA3, NRP2_PLXNA4, PLXNA2, PLXNA4	NRP1 [Baccin2019:10196540;Baccin2019:10196546;CellTalkDB:10196546;HPRD:10196546;LRdb:10196546;SIGNOR:25335892;connectomeDB2020:10196546], NRP2 [Baccin2019:10196546;CellTalkDB:10196546;HPRD:10196546;LRdb:10196546;SIGNOR:25335892;connectomeDB2020:10196546], PLXNA2 [SIGNOR:25335892], PLXNA4 [SIGNOR:25335892]	collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]	chemorepellent activity [GO:0045499]; semaphorin receptor binding [GO:0030215]	axon guidance [GO:0007411]; cell-cell signaling [GO:0007267]; chemorepulsion of axon [GO:0061643]; negative chemotaxis [GO:0050919]; negative regulation of axon extension involved in axon guidance [GO:0048843]; neural crest cell migration [GO:0001755]; positive regulation of cell migration [GO:0030335]; semaphorin-plexin signaling pathway [GO:0071526]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=SEMA3B&keywords=SEMA3B	7.536921336840303	264	NA	NA	0.12430380530291206	598	0	0.18113772455089905	0.00331858407079646	0.0014388489208633092	0.13804713804713814	0	0.001813236627379873	0	0.0029596744358120607	0.0019695553478435014	0.0016225613289549943	295	346	339	0.030209756666335217	0.32230173744528723	0.2976778856725777	0.2890482880908788	400	378	399
SEMA3C	semaphorin 3C	Yes		ENSG00000075223	Q99985	Semaphorin family	13	ligand, receptor	extracellular, intracellular, ligand, receptor, secreted, transmembrane	O14786, O60462, O75051, Q9Y4D7	NRP1, NRP1_NRP2, NRP1_NRP2_PLXND1, NRP1_PLXNA1, NRP1_PLXNA2, NRP1_PLXNA3, NRP1_PLXNA4, NRP2, NRP2_PLXNA1, NRP2_PLXNA2, NRP2_PLXNA3, NRP2_PLXNA4, PLXNA2, PLXND1	NRP2 [Baccin2019:10196546;Baccin2019:9331348;CellTalkDB:10196546;HPMR:10196546;HPRD:9331348;ICELLNET:29067024;LRdb:10196546;LRdb:93;SIGNOR:16816121;connectomeDB2020:10196546;connectomeDB2020:9331348], PLXNA2 [SIGNOR:19666519], PLXND1 [Baccin2019:27439112;CellChatDB:27533782;CellTalkDB:15239958;Cellinker:27533782;LRdb:15239958;Ramilowski2015:15239958;connectomeDB2020:15239958;talklr:15239958], NRP1 [Baccin2019:9331348;CellTalkDB:9331348;HPRD:9331348;LRdb:9331348;connectomeDB2020:9331348]	extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]	chemorepellent activity [GO:0045499]; semaphorin receptor binding [GO:0030215]	axon guidance [GO:0007411]; blood vessel remodeling [GO:0001974]; cardiac endothelial to mesenchymal transition [GO:0140074]; cardiac right ventricle morphogenesis [GO:0003215]; dichotomous subdivision of terminal units involved in salivary gland branching [GO:0060666]; immune response [GO:0006955]; limb bud formation [GO:0060174]; negative chemotaxis [GO:0050919]; negative regulation of axon extension involved in axon guidance [GO:0048843]; neural crest cell migration [GO:0001755]; neural tube development [GO:0021915]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of cardiac neural crest cell migration involved in outflow tract morphogenesis [GO:1905312]; positive regulation of cell migration [GO:0030335]; post-embryonic development [GO:0009791]; pulmonary myocardium development [GO:0003350]; response to xenobiotic stimulus [GO:0009410]; semaphorin-plexin signaling pathway [GO:0071526]; somitogenesis [GO:0001756]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=SEMA3C&keywords=SEMA3C	4.4063563784025845	304	NA	NA	0.3019197626776389	464	0.047244094488188976	0.041916167664670614	0.0055309734513274336	0.09400479616307021	0.020202020202020197	0	0.001813236627379873	0	7.399186089530152e-4	5.341167044999334e-4	0.0011203399652308292	301	387	360	0.01937324217048555	0.36563613055097355	0.3586296889992175	0.37858741982540245	389	360	359
SEMA3D	semaphorin 3D	Yes		ENSG00000153993	O95025	Semaphorin family	11	ligand, receptor	ligand, receptor, secreted, transmembrane, transmembrane_predicted	O14786, Q9Y4D7	NRP1, NRP1_PLXNA1, NRP1_PLXNA2, NRP1_PLXNA3, NRP1_PLXNA4, NRP2_PLXNA1, NRP2_PLXNA2, NRP2_PLXNA3, NRP2_PLXNA4, PLXND1	PLXND1 [CellTalkDB:31163177], NRP1 [Baccin2019:27439112;CellTalkDB:15456815;LRdb:15456815;Ramilowski2015:15456815;connectomeDB2020:15456815;talklr:15456815]	extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]	chemorepellent activity [GO:0045499]; semaphorin receptor binding [GO:0030215]	axon guidance [GO:0007411]; negative chemotaxis [GO:0050919]; negative regulation of axon extension involved in axon guidance [GO:0048843]; neural crest cell migration [GO:0001755]; positive regulation of cell migration [GO:0030335]; semaphorin-plexin signaling pathway [GO:0071526]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=SEMA3D&keywords=SEMA3D	0.21565345893258428	609	NA	NA	0.10456494052702454	627	0	0.001996007984031936	0.0011061946902654867	4.7961630695443646e-4	0.003367003367003367	0.04737732656514384	0	0	0.0525342212356641	6.008812925624251e-4	3.86324125941665e-4	166	385	390	0.009804325051597023	3.1576042643584734	0.5352811199040368	0.524447265881657	12	304	314
SEMA3E	semaphorin 3E	Yes		ENSG00000170381	O15041	Semaphorin family	12	ligand, receptor	extracellular, intracellular, ligand, receptor, secreted, transmembrane	O14786, O60462, Q9Y4D7	NRP1, NRP2, PLXND1	PLXND1 [Baccin2019:15550623;CellChatDB:22325954;CellPhoneDB:22325954;CellTalkDB:22325954;Cellinker:15550623;Cellinker:19887479;Cellinker:22325954;Cellinker:26633812;HPMR:15550623;LRdb:15550623;Lit-BM-17:17318185;connectomeDB2020:15550623], NRP1 [Baccin2019:27439112;CellTalkDB:20664165;Cellinker:20664165], NRP2 [Cellinker:20664165]	extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]	chemorepellent activity [GO:0045499]; semaphorin receptor binding [GO:0030215]	axon guidance [GO:0007411]; branching involved in blood vessel morphogenesis [GO:0001569]; negative chemotaxis [GO:0050919]; negative regulation of angiogenesis [GO:0016525]; negative regulation of axon extension involved in axon guidance [GO:0048843]; negative regulation of cell-matrix adhesion [GO:0001953]; neural crest cell migration [GO:0001755]; positive regulation of cell migration [GO:0030335]; regulation of actin cytoskeleton reorganization [GO:2000249]; regulation of cell shape [GO:0008360]; semaphorin-plexin signaling pathway [GO:0071526]; sprouting angiogenesis [GO:0002040]; synapse organization [GO:0050808]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=SEMA3E&keywords=SEMA3E	5.741462039073931	283	NA	NA	5.739410467488451	67	0	0.024950099800399188	0.0011061946902654867	0.009352517985611509	0.008417508417508417	0.17428087986463603	0.21396192203082437	0.4241435562805877	0.20976692563817834	0.006542929630124168	0.2788101216920855	76	269	57	0.12284842327547461	1.654268227049029	0.12452484735796025	2.173982306837083	48	458	12
SEMA3F	semaphorin 3F	Yes		ENSG00000001617	Q13275	Semaphorin family	13	ligand	extracellular, ligand, secreted, transmembrane	O14786, O60462, P51805, Q9UIW2	NRP1, NRP2, NRP2_PLXNA1, NRP2_PLXNA2, NRP2_PLXNA3, NRP2_PLXNA4, PLXNA1, PLXNA3	NRP2 [Baccin2019:15721238;Baccin2019:9883722;CellTalkDB:15721238;ELM:20387901;HPMR:15721238;HPRD:9883722;ICELLNET:25068647;ICELLNET:29067024;LRdb:15721238;LRdb:99;SIGNOR:16816121;connectomeDB2020:15721238;connectomeDB2020:9883722], PLXNA3 [Baccin2019:15721238;CellTalkDB:15721238;HPMR:15721238;LRdb:15721238;connectomeDB2020:15721238], PLXNA1 [CellTalkDB:26156437], NRP1 [Baccin2019:9883722;CellTalkDB:9883722;Cellinker:26633812;Cellinker:9883722;ELM:20387901;HPRD:9883722;LRdb:9883722;connectomeDB2020:9883722]	extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; integral component of plasma membrane [GO:0005887]	chemorepellent activity [GO:0045499]; semaphorin receptor binding [GO:0030215]	axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; branchiomotor neuron axon guidance [GO:0021785]; facial nerve structural organization [GO:0021612]; negative chemotaxis [GO:0050919]; negative regulation of axon extension involved in axon guidance [GO:0048843]; nerve development [GO:0021675]; neural crest cell migration [GO:0001755]; neural crest cell migration involved in autonomic nervous system development [GO:1901166]; positive regulation of cell migration [GO:0030335]; regulation of postsynapse organization [GO:0099175]; semaphorin-plexin signaling pathway [GO:0071526]; semaphorin-plexin signaling pathway involved in axon guidance [GO:1902287]; semaphorin-plexin signaling pathway involved in neuron projection guidance [GO:1902285]; sympathetic ganglion development [GO:0061549]; sympathetic neuron projection extension [GO:0097490]; sympathetic neuron projection guidance [GO:0097491]; trigeminal nerve structural organization [GO:0021637]; ventral trunk neural crest cell migration [GO:0036486]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=SEMA3F&keywords=SEMA3F	8.283249316434798	256	NA	NA	0.3618958693267333	436	0	9.98003992015968e-4	0.05420353982300888	0.0074340527577937635	0	0	0	0	0	1.0014688209373749e-4	3.86324125941665e-4	303	406	390	0.005738369780077637	0.6353898237070569	0.6417530546828919	0.6599364655346426	289	275	255
SEMA3G	semaphorin 3G	Yes		ENSG00000010319	Q9NS98	Semaphorin family	11	ligand, receptor	ligand, receptor, secreted, transmembrane	O60462, P12318, Q8N6C8, Q9HCN6	FCGR2A, GP6, LILRA3, NRP2, NRP2_PLXNA1, NRP2_PLXNA2, NRP2_PLXNA3, NRP2_PLXNA4	NRP2 [Baccin2019:27439112;CellTalkDB:19887479;LRdb:19887479;Ramilowski2015:19887479;connectomeDB2020:19887479;talklr:19887479], FCGR2A [Cellinker:32822567], LILRA3 [Cellinker:32822567], GP6 [Cellinker:32822567]	extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]	chemorepellent activity [GO:0045499]; semaphorin receptor binding [GO:0030215]; signaling receptor binding [GO:0005102]	axon guidance [GO:0007411]; negative chemotaxis [GO:0050919]; negative regulation of axon extension [GO:0030517]; negative regulation of axon extension involved in axon guidance [GO:0048843]; neural crest cell migration [GO:0001755]; positive regulation of cell migration [GO:0030335]; semaphorin-plexin signaling pathway [GO:0071526]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=SEMA3G&keywords=SEMA3G	0.9939326302247191	452	NA	NA	0.06364564109788853	688	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
SERPINF1	serpin family F member 1	TBD		ENSG00000282307, ENSG00000132386	P36955	Serpin family	2	ecm, ligand	ecm, ecm_regulator, extracellular, intracellular, ligand, ligand_regulator, secreted	Q6UX71, Q8IUK5	PLXDC1, PLXDC2	PLXDC1 [connectomeDB2020:25535841], PLXDC2 [connectomeDB2020:25535841]	axon hillock [GO:0043203]; basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; melanosome [GO:0042470]; perinuclear region of cytoplasm [GO:0048471]	serine-type endopeptidase inhibitor activity [GO:0004867]	aging [GO:0007568]; cellular response to cobalt ion [GO:0071279]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to glucose stimulus [GO:0071333]; cellular response to retinoic acid [GO:0071300]; kidney development [GO:0001822]; negative regulation of angiogenesis [GO:0016525]; negative regulation of endopeptidase activity [GO:0010951]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of epithelial cell proliferation involved in prostate gland development [GO:0060770]; negative regulation of gene expression [GO:0010629]; negative regulation of inflammatory response [GO:0050728]; negative regulation of neuron death [GO:1901215]; ovulation cycle [GO:0042698]; positive regulation of neurogenesis [GO:0050769]; positive regulation of neuron projection development [GO:0010976]; response to acidic pH [GO:0010447]; response to arsenic-containing substance [GO:0046685]; response to peptide [GO:1901652]; retina development in camera-type eye [GO:0060041]; short-term memory [GO:0007614]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=SERPINF1&keywords=SERPINF1	15.644715606039165	189	1869.46	135	0.08363050468642651	653	0.023622047244094488	0.0034930139720558886	0.0055309734513274336	1.7275779376498581	0.15993265993265998	0.00338409475465313	0.003626473254759746	0	3.699593044765076e-4	0.0030377887568433654	0.0030905930075333225	302	319	313	0.17578777648438745	0.055816154866076134	0.07017570802317549	0.07045992613315645	499	485	491
SFRP2	secreted frizzled related protein 2	Yes	soluble modulators of Wnt sigling	ENSG00000145423	Q96HF1	Secreted frizzled-related protein (sFRP) family	5	ecm, ligand	ecm, extracellular, intracellular, ligand, ligand_regulator, secreted	P04628, P41221, P56704, P56705, Q13467, Q99972	FZD5, MYOC, WNT1, WNT3A, WNT4, WNT5A	WNT1 [HPRD:10654605;SPIKE:10654605], FZD5 [CellTalkDB:28840375;connectomeDB2020:28840375], MYOC [Cellinker:19188438], WNT4 [HPRD:9853965;NetPath:9853965], WNT3A [NetPath:17462603], WNT5A [NetPath:17462603]	collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615]	endopeptidase activator activity [GO:0061133]; fibronectin binding [GO:0001968]; integrin binding [GO:0005178]; receptor ligand activity [GO:0048018]; Wnt-protein binding [GO:0017147]	apoptotic process [GO:0006915]; bone morphogenesis [GO:0060349]; branching involved in blood vessel morphogenesis [GO:0001569]; canonical Wnt signaling pathway [GO:0060070]; cardiac left ventricle morphogenesis [GO:0003214]; cell-cell signaling [GO:0007267]; cellular response to extracellular stimulus [GO:0031668]; cellular response to X-ray [GO:0071481]; chondrocyte development [GO:0002063]; collagen fibril organization [GO:0030199]; convergent extension involved in axis elongation [GO:0060028]; digestive tract morphogenesis [GO:0048546]; embryonic digit morphogenesis [GO:0042733]; hematopoietic stem cell proliferation [GO:0071425]; male gonad development [GO:0008584]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cell growth [GO:0030308]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of dermatome development [GO:0061185]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of gene expression [GO:0010629]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902230]; negative regulation of JUN kinase activity [GO:0043508]; negative regulation of mesodermal cell fate specification [GO:0042662]; negative regulation of peptidyl-tyrosine phosphorylation [GO:0050732]; negative regulation of planar cell polarity pathway involved in axis elongation [GO:2000041]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of Wnt signaling pathway [GO:0030178]; outflow tract morphogenesis [GO:0003151]; planar cell polarity pathway involved in neural tube closure [GO:0090179]; positive regulation of angiogenesis [GO:0045766]; positive regulation of apoptotic process [GO:0043065]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-anal tail morphogenesis [GO:0036342]; regulation of midbrain dopaminergic neuron differentiation [GO:1904956]; regulation of neuron projection development [GO:0010975]; regulation of stem cell division [GO:2000035]; response to nutrient [GO:0007584]; response to xenobiotic stimulus [GO:0009410]; sclerotome development [GO:0061056]; Wnt signaling pathway involved in somitogenesis [GO:0090244]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=SFRP2&keywords=SFRP2	35.96451966292135	120	NA	NA	0.783054481455583	304	0.007874015748031496	0.01047904191616766	0.00331858407079646	4.813429256594701	0.013468013468013466	0.00338409475465313	0.006346328195829556	0.0065252854812398045	0.0048094709581946	0.005341167044999322	0.004017770909793319	288	286	300	0.4435448208311291	0.0326527176102595	0.03382502972228049	0.0309071347879257	518	511	519
SFRP4	secreted frizzled related protein 4	Yes	soluble modulators of Wnt sigling	ENSG00000106483	Q6FHJ7	Secreted frizzled-related protein (sFRP) family	1	ligand, receptor	extracellular, intracellular, ligand, ligand_regulator, receptor, secreted	O00755	WNT7A	WNT7A [NetPath:18567805]	cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; nucleus [GO:0005634]	Wnt-protein binding [GO:0017147]	bone morphogenesis [GO:0060349]; canonical Wnt signaling pathway [GO:0060070]; cell differentiation [GO:0030154]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of non-canonical Wnt signaling pathway [GO:2000051]; negative regulation of sodium-dependent phosphate transport [GO:2000119]; negative regulation of Wnt signaling pathway [GO:0030178]; phosphate ion homeostasis [GO:0055062]; positive regulation of apoptotic process [GO:0043065]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of epidermal cell differentiation [GO:0045606]; positive regulation of gene expression [GO:0010628]; positive regulation of keratinocyte apoptotic process [GO:1902174]; positive regulation of receptor internalization [GO:0002092]; regulation of BMP signaling pathway [GO:0030510]; response to hormone [GO:0009725]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=SFRP4&keywords=SFRP4	2.31098287752809	375	NA	NA	0.06946918161587627	675	0.007874015748031496	4.99001996007984e-4	0	0.5390887290167903	0	0	0	0	0.0014798372179060304	4.3396982240619586e-4	2.704268881591655e-4	299	392	394	0.049967816426300105	0.19143330376243803	0.1739928255555119	0.1712656471456056	443	428	437
SFRP5	secreted frizzled related protein 5	Yes	soluble modulators of Wnt sigling	ENSG00000120057	Q5T4F7	Secreted frizzled-related protein (sFRP) family	1	ligand	intracellular, ligand, ligand_regulator, secreted	Q99972	MYOC	MYOC [Cellinker:19188438]	extracellular space [GO:0005615]	Wnt-protein binding [GO:0017147]	anatomical structure morphogenesis [GO:0009653]; apoptotic process [GO:0006915]; canonical Wnt signaling pathway [GO:0060070]; cell differentiation [GO:0030154]; establishment or maintenance of cell polarity [GO:0007163]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of protein kinase B signaling [GO:0051898]; negative regulation of Wnt signaling pathway [GO:0030178]; negative regulation of Wnt signaling pathway involved in digestive tract morphogenesis [GO:2000057]; regulation of BMP signaling pathway [GO:0030510]; signal transduction [GO:0007165]; visual perception [GO:0007601]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=SFRP5&keywords=SFRP5	6.659025494382022	270	NA	NA	0.4015195591106533	415	0	0.10229540918163661	0	4.7961630695443646e-4	0.020202020202020197	0	0	0	7.399186089530152e-4	4.6735211643744175e-4	7.726482518833301e-5	301	389	399	0.01129650738556273	0.5043042229653953	0.4915055753946509	0.4731886145809939	340	323	337
SFTPA1	surfactant protein A1	No		ENSG00000122852	Q8IWL2	SFTPA family	6	adhesion, ecm, ligand, receptor	adhesion, cell_adhesion, ecm, intracellular, ligand, plasma_membrane, receptor, secreted	O60603, Q8IWL1	SFTPA2, TLR2	TLR2 [CellTalkDB:11724772;Cellinker:11724772;HPRD:11724772;InnateDB:11724772;LRdb:11724772;connectomeDB2020:11724772], SFTPA2 [HPRD:10781424;HPRD:11087951;HPRD:1986781]	clathrin-coated endocytic vesicle [GO:0045334]; collagen trimer [GO:0005581]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lamellar body [GO:0042599]; multivesicular body [GO:0005771]; rough endoplasmic reticulum [GO:0005791]	carbohydrate binding [GO:0030246]; lipid transporter activity [GO:0005319]	opsonization [GO:0008228]; respiratory gaseous exchange by respiratory system [GO:0007585]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=SFTPA1&keywords=SFTPA1	3.411966361764574	326	NA	NA	0.10060233655947266	631	0	0.0029940119760479044	0.0011061946902654867	4.7961630695443646e-4	0	0.05922165820642981	0.05349048050770619	0	0.017758046614872364	0.07190546134330535	0.0014680316785783281	242	124	345	0.01894759102946908	0.9589069635056767	2.8294396331606437	0.3961653205236906	150	8	353
SFTPD	surfactant protein D	No		ENSG00000133661	P35247	SFTPD family	5	ecm, ligand, receptor	ecm, extracellular, intracellular, ligand, receptor, secreted	O00206, P78324, Q6GTX8, Q9Y6Y9	LAIR1, LY96, SIRPA, TLR4	SIRPA [CellTalkDB:22511785;Cellinker:22511785;LRdb:22511785;connectomeDB2020:22511785], TLR4 [CellTalkDB:16834340;InnateDB:16834340;InnateDB:18990700], LY96 [CellTalkDB:18991397;InnateDB:18990700;InnateDB:18991397], LAIR1 [connectomeDB2020:24585933]	clathrin-coated endocytic vesicle [GO:0045334]; collagen trimer [GO:0005581]; endocytic vesicle [GO:0030139]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; lysosome [GO:0005764]; multivesicular body [GO:0005771]; rough endoplasmic reticulum [GO:0005791]	carbohydrate binding [GO:0030246]; identical protein binding [GO:0042802]	defense response to bacterium [GO:0042742]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; lung alveolus development [GO:0048286]; macrophage chemotaxis [GO:0048246]; negative regulation by host of symbiont catalytic activity [GO:0052403]; negative regulation of interleukin-2 production [GO:0032703]; negative regulation of T cell proliferation [GO:0042130]; positive regulation of phagocytosis [GO:0050766]; reactive oxygen species metabolic process [GO:0072593]; receptor-mediated endocytosis [GO:0006898]; regulation of adhesion of symbiont to host epithelial cell [GO:1905226]; regulation of cytokine production [GO:0001817]; respiratory gaseous exchange by respiratory system [GO:0007585]; surfactant homeostasis [GO:0043129]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=SFTPD&keywords=SFTPD	1.2168515910112359	432	NA	NA	0.1877503342573948	541	0	0.004990019960079841	0	4.7961630695443646e-4	0.013468013468013466	0.030456852791878163	0.03445149592021758	0.022838499184339316	0.01738808731039586	0.014154092669248195	0.021440988989762395	244	225	202	0.01451524241826266	1.1171860691042186	0.9852683590538176	1.2825077742792537	106	137	52
SHH	sonic hedgehog signaling molecule	Yes		ENSG00000164690	Q15465	Hedgehog family	16	adhesion, cell_surface_ligand, ligand, receptor	adhesion, cell_adhesion, cell_surface_ligand, extracellular, intracellular, ligand, plasma_membrane, receptor, secreted	P00450, P35052, P54826, P78333, P98164, Q13635, Q4KMG0, Q96QV1, Q99835, Q9BWV1, Q9NQ36, Q9Y6C5	BOC, CDON, CP, GAS1, GPC1, GPC5, HHIP, LRP2, PTCH1, PTCH1_SMO, PTCH2, PTCH2_SMO, SCUBE2, SMO	PTCH1 [Baccin2019:16867986;Baccin2019:9811851;BioGRID:16282375;CellTalkDB:9811851;Cellinker:16867986;Cellinker:21339334;Cellinker:30613383;Cellinker:9811851;HPMR:16867986;HPRD:9811851;ICELLNET:27647915;IntAct:29954986;IntAct:30139912;LRdb:169;LRdb:9811851;NetPath:8906787;NetPath:9811851;SIGNOR:14556242;SIGNOR:15618519;SIGNOR:9811851;SPIKE:20083481;SPIKE:9811851;SignaLink3:14556242;SignaLink3:23331499;connectomeDB2020:16867986;connectomeDB2020:9811851], PTCH2 [Baccin2019:9811851;CellTalkDB:9811851;Cellinker:9811851;HPRD:9811851;LRdb:9811851;NetPath:9811851;SIGNOR:9811851;SignaLink3:23331499;SignaLink3:9811851;connectomeDB2020:9811851], HHIP [Baccin2019:1005085510050850;CellTalkDB:10050855;Cellinker:10050855;HPRD:10050855;IntAct:19561609;LRdb:10050855;Lit-BM-17:19561609;NetPath:10050855;connectomeDB2020:10050855], GAS1 [CellTalkDB:17848687;Cellinker:17848687;Cellinker:30613383;HPRD:11572986;LRdb:17848687;NetPath:11572986;connectomeDB2020:17848687;connectomeDB2020:25535338], LRP2 [CellTalkDB:16828734;Cellinker:30613383;LRdb:22340494;Ramilowski2015:22340494;connectomeDB2020:22340494;talklr:22340494], BOC [Baccin2019:17086203;CellTalkDB:17086203;Cellinker:17086203;Cellinker:30613383;HPMR:17086203;LRdb:17086203;NetPath:16647304;connectomeDB2020:17086203], CP [SIGNOR:14556242;SIGNOR:15618519;SIGNOR:17419683;SIGNOR:9811851], SCUBE2 [CellTalkDB:19480626], GPC5 [CellTalkDB:21339334;Cellinker:21339334;LRdb:21339334;Ramilowski2015:21339334;connectomeDB2020:21339334;talklr:21339334], CDON [Baccin2019:17086203;CellTalkDB:17086203;Cellinker:17086203;LRdb:17086203;NetPath:16647304;connectomeDB2020:17086203], SMO [Baccin2019:16867986;CellTalkDB:16867986;Cellinker:16867986;HPMR:16867986;LRdb:16867986;NetPath:8906787;connectomeDB2020:16867986], GPC1 [CellTalkDB:23931997]	cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]	calcium ion binding [GO:0005509]; endopeptidase activity [GO:0004175]; glycosaminoglycan binding [GO:0005539]; laminin-1 binding [GO:0043237]; morphogen activity [GO:0016015]; patched binding [GO:0005113]; zinc ion binding [GO:0008270]	androgen metabolic process [GO:0008209]; animal organ formation [GO:0048645]; apoptotic signaling pathway [GO:0097190]; artery development [GO:0060840]; axon guidance [GO:0007411]; Bergmann glial cell differentiation [GO:0060020]; blood coagulation [GO:0007596]; branching involved in blood vessel morphogenesis [GO:0001569]; branching involved in salivary gland morphogenesis [GO:0060445]; branching involved in ureteric bud morphogenesis [GO:0001658]; branching morphogenesis of an epithelial tube [GO:0048754]; bud outgrowth involved in lung branching [GO:0060447]; camera-type eye development [GO:0043010]; canonical Wnt signaling pathway [GO:0060070]; CD4-positive or CD8-positive, alpha-beta T cell lineage commitment [GO:0043369]; cell-cell signaling [GO:0007267]; cell development [GO:0048468]; cell fate specification [GO:0001708]; cellular response to lithium ion [GO:0071285]; central nervous system development [GO:0007417]; cerebellar granule cell precursor proliferation [GO:0021930]; determination of left/right asymmetry in lateral mesoderm [GO:0003140]; dopaminergic neuron differentiation [GO:0071542]; dorsal/ventral neural tube patterning [GO:0021904]; dorsal/ventral pattern formation [GO:0009953]; ectoderm development [GO:0007398]; embryonic digestive tract morphogenesis [GO:0048557]; embryonic digit morphogenesis [GO:0042733]; embryonic foregut morphogenesis [GO:0048617]; embryonic forelimb morphogenesis [GO:0035115]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic limb morphogenesis [GO:0030326]; embryonic pattern specification [GO:0009880]; embryonic skeletal system development [GO:0048706]; endocytosis [GO:0006897]; epithelial cell proliferation involved in salivary gland morphogenesis [GO:0060664]; epithelial-mesenchymal signaling involved in prostate gland development [GO:0060738]; establishment of cell polarity [GO:0030010]; forebrain development [GO:0030900]; formation of anatomical boundary [GO:0048859]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; hindbrain development [GO:0030902]; hindgut morphogenesis [GO:0007442]; inner ear development [GO:0048839]; intein-mediated protein splicing [GO:0016539]; intermediate filament organization [GO:0045109]; left lung development [GO:0060459]; limb bud formation [GO:0060174]; lung-associated mesenchyme development [GO:0060484]; lung development [GO:0030324]; lung epithelium development [GO:0060428]; lung lobe morphogenesis [GO:0060463]; lymphoid progenitor cell differentiation [GO:0002320]; male genitalia development [GO:0030539]; mesenchymal cell proliferation involved in lung development [GO:0060916]; mesenchymal smoothened signaling pathway involved in prostate gland development [GO:0060783]; metanephric collecting duct development [GO:0072205]; metanephric mesenchymal cell proliferation involved in metanephros development [GO:0072136]; metanephros development [GO:0001656]; midbrain development [GO:0030901]; myoblast differentiation [GO:0045445]; myotube differentiation [GO:0014902]; negative regulation of alpha-beta T cell differentiation [GO:0046639]; negative regulation of apoptotic process [GO:0043066]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell migration [GO:0030336]; negative regulation of cholesterol efflux [GO:0090370]; negative regulation of dopaminergic neuron differentiation [GO:1904339]; negative regulation of gene expression [GO:0010629]; negative regulation of kidney smooth muscle cell differentiation [GO:2000357]; negative regulation of mesenchymal cell apoptotic process [GO:2001054]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of T cell proliferation [GO:0042130]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription elongation from RNA polymerase II promoter [GO:0034244]; negative regulation of ureter smooth muscle cell differentiation [GO:2000062]; negative thymic T cell selection [GO:0045060]; neural crest cell migration [GO:0001755]; neuroblast proliferation [GO:0007405]; neuron fate commitment [GO:0048663]; odontogenesis of dentin-containing tooth [GO:0042475]; oligodendrocyte development [GO:0014003]; oligodendrocyte differentiation [GO:0048709]; osteoblast development [GO:0002076]; pancreas development [GO:0031016]; pattern specification process [GO:0007389]; polarity specification of anterior/posterior axis [GO:0009949]; positive regulation of alpha-beta T cell differentiation [GO:0046638]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial cell proliferation involved in prostate gland development [GO:0060769]; positive regulation of gene expression [GO:0010628]; positive regulation of hh target transcription factor activity [GO:0007228]; positive regulation of immature T cell proliferation in thymus [GO:0033092]; positive regulation of kidney smooth muscle cell differentiation [GO:2000358]; positive regulation of mesenchymal cell proliferation involved in ureter development [GO:2000729]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of oligodendrocyte differentiation [GO:0048714]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of sclerotome development [GO:0061189]; positive regulation of skeletal muscle cell proliferation [GO:0014858]; positive regulation of skeletal muscle tissue development [GO:0048643]; positive regulation of smoothened signaling pathway [GO:0045880]; positive regulation of striated muscle cell differentiation [GO:0051155]; positive regulation of T cell differentiation in thymus [GO:0033089]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of ureter smooth muscle cell differentiation [GO:2000063]; positive regulation of Wnt signaling pathway [GO:0030177]; positive thymic T cell selection [GO:0045059]; primary prostatic bud elongation [GO:0060516]; prostate epithelial cord elongation [GO:0060523]; prostate gland development [GO:0030850]; protein autoprocessing [GO:0016540]; protein localization to nucleus [GO:0034504]; regulation of cell population proliferation [GO:0042127]; regulation of gene expression [GO:0010468]; regulation of mesenchymal cell proliferation involved in prostate gland development [GO:0060782]; regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry [GO:1900175]; regulation of odontogenesis [GO:0042481]; regulation of prostatic bud formation [GO:0060685]; regulation of protein localization to nucleus [GO:1900180]; regulation of proteolysis [GO:0030162]; right lung development [GO:0060458]; roof of mouth development [GO:0060021]; salivary gland cavitation [GO:0060662]; smoothened signaling pathway [GO:0007224]; smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation [GO:0021938]; smooth muscle tissue development [GO:0048745]; somite development [GO:0061053]; spinal cord dorsal/ventral patterning [GO:0021513]; spinal cord motor neuron differentiation [GO:0021522]; stem cell development [GO:0048864]; striated muscle tissue development [GO:0014706]; T cell differentiation in thymus [GO:0033077]; telencephalon regionalization [GO:0021978]; thalamus development [GO:0021794]; thymus development [GO:0048538]; thyroid gland development [GO:0030878]; trachea morphogenesis [GO:0060439]; tracheoesophageal septum formation [GO:1905327]; vasculogenesis [GO:0001570]; ventral midline development [GO:0007418]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=SHH&keywords=SHH	0.5129600968325843	521	NA	NA	0.43556569392128663	406	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
SI	sucrase-isomaltase			ENSG00000090402	P14410	Glycosyl hydrolase 31 family	2	ligand	extracellular, intracellular, ligand, plasma_membrane, secreted, transmembrane, transmembrane_predicted	P09619, P16234, P52961	ART1, PDGFRA, PDGFRB	PDGFRA [Baccin2019:152078112544881], PDGFRB [Baccin2019:285049611903042], ART1 [Baccin2019:11498506]	apical plasma membrane [GO:0016324]; brush border [GO:0005903]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	alpha-1,4-glucosidase activity [GO:0004558]; carbohydrate binding [GO:0030246]; hydrolase activity, hydrolyzing O-glycosyl compounds [GO:0004553]; oligo-1,6-glucosidase activity [GO:0004574]; sucrose alpha-glucosidase activity [GO:0004575]	polysaccharide digestion [GO:0044245]; sucrose catabolic process [GO:0005987]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=SI&keywords=SI	0.0571288608988764	723	NA	NA	0.040858328715281375	735	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
SIGLEC1	sialic acid binding Ig like lectin 1	No		ENSG00000088827	Q9BZZ2	Immunoglobulin superfamily, SIGLEC (sialic acid binding Ig-like lectin) family	4	adhesion, cell_surface_ligand, receptor	adhesion, cell_adhesion, cell_surface, cell_surface_ligand, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, secreted, transmembrane, transmembrane_predicted	P08575, P16150	PTPRC, SPN	SPN [CellChatDB:11238599;HPRD:11238599;connectomeDB2020:11238599], PTPRC [Cellinker:10575006]	early endosome [GO:0005769]; extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; late endosome [GO:0005770]; plasma membrane [GO:0005886]	carbohydrate binding [GO:0030246]; virion binding [GO:0046790]	cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; clathrin-dependent endocytosis of virus by host cell [GO:0075512]; inflammatory response [GO:0006954]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=SIGLEC1&keywords=SIGLEC1	0.006810140449438202	844	NA	NA	0.003214599002695133	879	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
SIGLEC10	sialic acid binding Ig like lectin 10	No		ENSG00000142512	Q96LC7	Immunoglobulin superfamily, SIGLEC (sialic acid binding Ig-like lectin) family	1	adhesion, cell_surface_ligand, ligand, receptor	adhesion, cell_adhesion, cell_surface, cell_surface_ligand, extracellular, intracellular, ligand, plasma_membrane, plasma_membrane_transmembrane, receptor, secreted, transmembrane, transmembrane_predicted	NA	NA	NA	extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	carbohydrate binding [GO:0030246]; phosphatase binding [GO:0019902]; SH2 domain binding [GO:0042169]; sialic acid binding [GO:0033691]	adaptive immune response [GO:0002250]; cell adhesion [GO:0007155]; innate immune response [GO:0045087]; negative regulation of inflammatory response to wounding [GO:0106015]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=SIGLEC10&keywords=SIGLEC10	0.3723280175020112	551	NA	NA	0.066610411108450035	683	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
SIRPB2	signal regulatory protein beta 2			ENSG00000196209	Q5JXA9	NA	1	ligand	cell_surface, ligand, plasma_membrane_transmembrane, secreted, transmembrane, transmembrane_predicted	Q08722	CD47	CD47 [connectomeDB2020:15383453]	integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	NA	NA	https://www.genecards.org/cgi-bin/carddisp.pl?gene=SIRPB2&keywords=SIRPB2	0.15663694078651685	641	NA	NA	0.057945037174263345	699	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
SLAMF1	signaling lymphocytic activation molecule family member 1	TBD		ENSG00000117090	Q13291	NA	2	adhesion, cell_surface_ligand, ligand, receptor	adhesion, cell_adhesion, cell_surface, cell_surface_ligand, intracellular, ligand, plasma_membrane, plasma_membrane_transmembrane, receptor, secreted, transmembrane, transmembrane_predicted	O14796, O60880, Q92835	INPP5D, SH2D1A, SH2D1B	SH2D1A [DOMINO:10607564;HPRD:11477068;HPRD:11806999;HPRD:12458214;InnateDB:19150402;IntAct:10549287;IntAct:10607564;IntAct:11389028;IntAct:11477068;IntAct:11806999;IntAct:11823424;IntAct:12225753;IntAct:12545174;IntAct:14674764;IntAct:9774102;Lit-BM-17:10549287;Lit-BM-17:10607564;Lit-BM-17:11389028;Lit-BM-17:11477068;Lit-BM-17:11806999;Lit-BM-17:11823424;Lit-BM-17:12225753;Lit-BM-17:12545174;Lit-BM-17:14674764;Lit-BM-17:9774102], INPP5D [BioGRID:10229804], SH2D1B [HPRD:11689425;Lit-BM-17:10549287;Lit-BM-17:11689425]	external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; integral component of membrane [GO:0016021]; phagocytic vesicle [GO:0045335]	antigen binding [GO:0003823]; identical protein binding [GO:0042802]; SH2 domain binding [GO:0042169]; signaling receptor activity [GO:0038023]; transmembrane signaling receptor activity [GO:0004888]; virus receptor activity [GO:0001618]	adaptive immune response [GO:0002250]; cell adhesion [GO:0007155]; innate immune response [GO:0045087]; leukocyte chemotaxis involved in inflammatory response [GO:0002232]; myeloid dendritic cell activation involved in immune response [GO:0002277]; natural killer cell differentiation [GO:0001779]; natural killer cell proliferation [GO:0001787]; negative regulation of CD40 signaling pathway [GO:2000349]; negative regulation of interferon-gamma production [GO:0032689]; negative regulation of interleukin-12 production [GO:0032695]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of T cell cytokine production [GO:0002725]; negative regulation of tumor necrosis factor production [GO:0032720]; phagocytosis [GO:0006909]; positive regulation of activated T cell proliferation [GO:0042104]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of dendritic cell chemotaxis [GO:2000510]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of JNK cascade [GO:0046330]; positive regulation of macrophage chemotaxis [GO:0010759]; positive regulation of T-helper 1 cell cytokine production [GO:2000556]; regulation of catalytic activity [GO:0050790]; regulation of vesicle fusion [GO:0031338]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=SLAMF1&keywords=SLAMF1	0.0432164011235955	748	NA	NA	0.013397284838813953	820	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
SLAMF7	SLAM family member 7			ENSG00000026751	Q9NQ25	NA	1	adhesion, cell_surface_ligand, ligand, receptor	adhesion, cell_adhesion, cell_surface, cell_surface_ligand, intracellular, ligand, plasma_membrane, plasma_membrane_transmembrane, receptor, secreted, transmembrane, transmembrane_predicted	NA	NA	NA	external side of plasma membrane [GO:0009897]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	identical protein binding [GO:0042802]	adaptive immune response [GO:0002250]; cell adhesion [GO:0007155]; natural killer cell activation [GO:0030101]; natural killer cell mediated cytotoxicity [GO:0042267]; T cell activation [GO:0042110]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=SLAMF7&keywords=SLAMF7	2.156805984585887	380	NA	NA	0.2585402066929191	489	0.4724409448818895	0.02045908183632733	0.011061946902654867	0.02709832134292565	0.008417508417508417	0.00676818950930626	0.006346328195829556	0.013050570962479609	0.008879023307436186	0.005674989985311778	0.00614255360247248	269	280	275	0.05330358717674015	0.2982299131758045	0.2476161412709214	0.2550021937525176	408	396	405
SLC6A8	solute carrier family 6 member 8			ENSG00000130821	P48029	Sodium:neurotransmitter symporter (SNF) (TC 2.A.22) family, SLC6A8 subfamily	1	ligand, receptor, transporter	cell_surface, ligand, receptor, secreted, transmembrane, transporter	P42702	LIFR	LIFR [Cellinker:26187859]	integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	creatine:sodium symporter activity [GO:0005309]; creatine transmembrane transporter activity [GO:0005308]	creatine metabolic process [GO:0006600]; creatine transmembrane transport [GO:0015881]; muscle contraction [GO:0006936]; neurotransmitter transport [GO:0006836]; nitrogen compound transport [GO:0071705]; sodium ion transmembrane transport [GO:0035725]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=SLC6A8&keywords=SLC6A8	17.676938037294942	178	NA	NA	0.4594785026018011	399	0.023622047244094488	0.02894211576846305	0.015486725663716814	0.055155875299760175	0.06060606060606059	0.033840947546531296	0.02901178603807797	0.03752039151712889	0.023677395486496465	0.019795700360528724	0.01769364496812816	222	200	214	0.03139569913627151	0.8135481750322184	0.7197776817935491	0.6689981216880231	217	246	249
SLIT1	slit guidance ligand 1	Yes		ENSG00000187122	O75093	NA	10	ecm, ligand	ecm, extracellular, intracellular, ligand, secreted	P18827, P35052, Q9HCK4, Q9NZU0, Q9Y6N7	FLRT3, GPC1, ROBO1, ROBO2, SDC1	GPC1 [Baccin2019:1036423410364230;CellTalkDB:10364234;Cellinker:10364234;HPRD:10364234;LRdb:10364234;SIGNOR:10364234;connectomeDB2020:10364234], ROBO2 [Cellinker:21600986;ICELLNET:21600986;connectomeDB2020:30547091], ROBO1 [Baccin2019:1043382210433820;Cellinker:10433822;HPMR:10433822;HPMR:14761655;HPRD:10433822;ICELLNET:21600986;LRdb:10433822;connectomeDB2020:10433822], FLRT3 [CellTalkDB:24560577], SDC1 [Baccin2019:10433822;Cellinker:10433822;HPMR:10433822;HPMR:14761655;LRdb:10433822;connectomeDB2020:10433822]	extracellular space [GO:0005615]	calcium ion binding [GO:0005509]; heparan sulfate proteoglycan binding [GO:0043395]; heparin binding [GO:0008201]; Roundabout binding [GO:0048495]	axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; dorsal/ventral axon guidance [GO:0033563]; forebrain morphogenesis [GO:0048853]; motor neuron axon guidance [GO:0008045]; negative chemotaxis [GO:0050919]; negative regulation of axon extension involved in axon guidance [GO:0048843]; negative regulation of synapse assembly [GO:0051964]; nuclear migration [GO:0007097]; retinal ganglion cell axon guidance [GO:0031290]; spinal cord development [GO:0021510]; tangential migration from the subventricular zone to the olfactory bulb [GO:0022028]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=SLIT1&keywords=SLIT1	2.4444306484171126	367	2814.12	119	0.6120680019284143	335	0	0.004491017964071857	0.0022123893805309734	0.001199040767386091	0.0016835016835016834	0.033840947546531296	0.032638259292837715	0.0016313213703099511	0.02404735479097297	0.02914274268927753	0.004713154336488318	221	173	291	0.012327248165628035	1.524923919795347	1.7531377982144851	0.6589775070955082	56	30	256
SLIT2	slit guidance ligand 2	Yes		ENSG00000145147	O94813	NA	9	ecm, ligand	ecm, extracellular, intracellular, ligand, secreted	O60565, P05067, P18827, P35052, P43146, Q8WZ75, Q9HCK4, Q9UIW2, Q9Y6N7	APP, DCC, GPC1, GREM1, PLXNA1, ROBO1, ROBO2, ROBO4, SDC1	GPC1 [Baccin2019:10364234;Baccin2019:11375980;CellTalkDB:11375980;Cellinker:10364234;Cellinker:11375980;Cellinker:29317497;HPRD:10364234;HPRD:11375980;LRdb:10364234;LRdb:11375980;SIGNOR:10364234;connectomeDB2020:10364234;connectomeDB2020:11375980], ROBO4 [Baccin2019:15894287;CellTalkDB:15894287;Cellinker:15894287;Cellinker:31217826;HPMR:15894287;LRdb:15894287;SIGNOR:12941633;connectomeDB2020:15894287], SDC1 [Baccin2019:10102268;Baccin2019:15130495;CellTalkDB:10102268;Cellinker:10102268;Cellinker:15130495;HPMR:14761655;HPMR:15130495;LRdb:10102268;LRdb:15;connectomeDB2020:10102268;connectomeDB2020:15130495], DCC [CellTalkDB:32196115], ROBO2 [Baccin2019:1513049510102260;CellTalkDB:15130495;Cellinker:10102268;Cellinker:15130495;Cellinker:29317497;Cellinker:31217826;HPMR:14761655;HPMR:15130495;HPRD:10102268;LRdb:1;LRdb:15130495;connectomeDB2020:10102268;connectomeDB2020:15130495], ROBO1 [Baccin2019:1010226810102260;CellTalkDB:10102268;Cellinker:10102268;Cellinker:31217826;DIP:17848514;HPRD:10102268;LRdb:10102268;Lit-BM-17:17848514;connectomeDB2020:10102268], APP [connectomeDB2020:28785723], GREM1 [Cellinker:29317497], PLXNA1 [Cellinker:29317497]	cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]	calcium ion binding [GO:0005509]; GTPase inhibitor activity [GO:0005095]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; laminin-1 binding [GO:0043237]; protein homodimerization activity [GO:0042803]; proteoglycan binding [GO:0043394]; Roundabout binding [GO:0048495]	aortic valve morphogenesis [GO:0003180]; apoptotic process involved in luteolysis [GO:0061364]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; branching morphogenesis of an epithelial tube [GO:0048754]; cell migration involved in sprouting angiogenesis [GO:0002042]; cellular response to heparin [GO:0071504]; cellular response to hormone stimulus [GO:0032870]; chemorepulsion involved in postnatal olfactory bulb interneuron migration [GO:0021836]; corticospinal neuron axon guidance through spinal cord [GO:0021972]; induction of negative chemotaxis [GO:0050929]; motor neuron axon guidance [GO:0008045]; negative chemotaxis [GO:0050919]; negative regulation of actin filament polymerization [GO:0030837]; negative regulation of cell growth [GO:0030308]; negative regulation of cell migration [GO:0030336]; negative regulation of cellular response to growth factor stimulus [GO:0090288]; negative regulation of chemokine-mediated signaling pathway [GO:0070100]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of lamellipodium assembly [GO:0010593]; negative regulation of leukocyte chemotaxis [GO:0002689]; negative regulation of monocyte chemotaxis [GO:0090027]; negative regulation of mononuclear cell migration [GO:0071676]; negative regulation of neutrophil chemotaxis [GO:0090024]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of retinal ganglion cell axon guidance [GO:0090260]; negative regulation of small GTPase mediated signal transduction [GO:0051058]; negative regulation of smooth muscle cell chemotaxis [GO:0071672]; negative regulation of smooth muscle cell migration [GO:0014912]; negative regulation of vascular permeability [GO:0043116]; positive regulation of apoptotic process [GO:0043065]; positive regulation of axonogenesis [GO:0050772]; pulmonary valve morphogenesis [GO:0003184]; response to cortisol [GO:0051414]; retinal ganglion cell axon guidance [GO:0031290]; Roundabout signaling pathway [GO:0035385]; ureteric bud development [GO:0001657]; ventricular septum morphogenesis [GO:0060412]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=SLIT2&keywords=SLIT2	2.5246278116532883	358	NA	NA	0.21111479661111648	527	0	0.05189620758483029	0	0.04820143884892085	0.0016835016835016834	0	0.001813236627379873	0.0065252854812398045	0.0011098779134295228	4.6735211643744175e-4	1.9316206297083252e-4	300	389	396	0.010171823847155481	0.5507621917388583	0.5189095540269398	0.5053168290683946	326	311	322
SLIT3	slit guidance ligand 3	Yes		ENSG00000184347	O75094	NA	9	ecm, ligand	ecm, extracellular, intracellular, ligand, secreted	Q8WZ75, Q9HCK4, Q9Y6N7	ROBO1, ROBO2, ROBO4	ROBO2 [Baccin2019:11754167;CellTalkDB:11754167;Cellinker:11754167;HPRD:11754167;LRdb:11754167;connectomeDB2020:31180321], ROBO1 [CellTalkDB:30288875;connectomeDB2020:19741192], ROBO4 [Cellinker:30288875;connectomeDB2020:19741192]	extracellular space [GO:0005615]; mitochondrion [GO:0005739]	calcium ion binding [GO:0005509]; heparin binding [GO:0008201]; Roundabout binding [GO:0048495]	aortic valve morphogenesis [GO:0003180]; apoptotic process involved in luteolysis [GO:0061364]; atrioventricular valve morphogenesis [GO:0003181]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; cellular response to hormone stimulus [GO:0032870]; negative chemotaxis [GO:0050919]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of chemokine-mediated signaling pathway [GO:0070100]; negative regulation of gene expression [GO:0010629]; response to cortisol [GO:0051414]; Roundabout signaling pathway [GO:0035385]; ventricular septum morphogenesis [GO:0060412]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=SLIT3&keywords=SLIT3	1.0256653640734454	448	NA	NA	0.04529078418930253	719	0	0.0029940119760479044	0	0.03525179856115107	0	0.001692047377326565	9.066183136899365e-4	0.017944535073409464	0.0014798372179060304	4.673521164374417e-4	4.249565385358315e-4	299	390	389	0.005560105197682204	0.7377737535872211	0.6727044569079541	0.6699798237924964	248	262	248
SLITRK1	SLIT and NTRK like family member 1	Yes		ENSG00000178235	Q96PX8	SLITRK family	1	cell_surface_ligand, ligand, receptor	cell_surface, cell_surface_ligand, extracellular, intracellular, ligand, plasma_membrane_transmembrane, receptor, secreted, transmembrane, transmembrane_predicted	O00300, P23468, Q07075, Q13332	ENPEP, PTPRD, PTPRS, TNFRSF11B	PTPRD [Cellinker:32589946;connectomeDB2020:23345436], PTPRS [Cellinker:32589946;connectomeDB2020:23345436], TNFRSF11B [Cellinker:32589946], ENPEP [Cellinker:32589946]	extracellular region [GO:0005576]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; integral component of postsynaptic density membrane [GO:0099061]; plasma membrane [GO:0005886]; synapse [GO:0045202]	NA	adult behavior [GO:0030534]; axonogenesis [GO:0007409]; homeostatic process [GO:0042592]; multicellular organism growth [GO:0035264]; positive regulation of axonogenesis [GO:0050772]; positive regulation of synapse assembly [GO:0051965]; regulation of presynapse assembly [GO:1905606]; synapse assembly [GO:0007416]; synaptic membrane adhesion [GO:0099560]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=SLITRK1&keywords=SLITRK1	0.7796255363280805	482	NA	NA	0.5661709562637633	360	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
SLURP1	secreted LY6/PLAUR domain containing 1	TBD		ENSG00000126233	P55000	NA	6	ligand	ligand, secreted, secreted_receptor, transmembrane	P02708, P07510, P11230, P17787, P30532, P30926, P32297, P36544, P43681, Q04844, Q05901, Q07001, Q15822, Q15825, Q9GZZ6, Q9UGM1	CHRNA1, CHRNA10, CHRNA2, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNA9, CHRNB1, CHRNB2, CHRNB3, CHRNB4, CHRND, CHRNE, CHRNG	CHRNA7 [CellChatDB:29545933;CellTalkDB:29545933;Cellinker:25558396;connectomeDB2020:29545933], CHRNB1 [NA], CHRNB2 [Cellinker:29192197], CHRNB3 [NA], CHRNB4 [Cellinker:29192197], CHRNA1 [NA], CHRNA2 [NA], CHRNA3 [Cellinker:29192197], CHRNA4 [Cellinker:29192197], CHRNA5 [NA], CHRNA6 [NA], CHRNA9 [Cellinker:29192197], CHRNA10 [Cellinker:29192197], CHRND [NA], CHRNE [NA], CHRNG [NA]	extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	acetylcholine receptor activator activity [GO:0030549]; cytokine activity [GO:0005125]	cell activation [GO:0001775]; cell adhesion [GO:0007155]; locomotory behavior [GO:0007626]; negative regulation of cell migration [GO:0030336]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of keratinocyte proliferation [GO:0010839]; neuromuscular process controlling posture [GO:0050884]; urokinase plasminogen activator signaling pathway [GO:0038195]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=SLURP1&keywords=SLURP1	0	899	NA	NA	2.1283125500666682e-4	903	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
SLURP2	secreted LY6/PLAUR domain containing 2	TBD		ENSG00000283992	P0DP57	NA	2	ligand	cell_surface, ligand, receptor_regulator, secreted, transmembrane, transmembrane_predicted	P02708, P07510, P11230, P17787, P30532, P30926, P32297, P36544, P43681, Q04844, Q05901, Q07001, Q15822, Q15825, Q9GZZ6, Q9UGM1	CHRNA1, CHRNA10, CHRNA2, CHRNA3, CHRNA4, CHRNA5, CHRNA6, CHRNA7, CHRNA9, CHRNB1, CHRNB2, CHRNB3, CHRNB4, CHRND, CHRNE, CHRNG	CHRNB1 [NA], CHRNB2 [Cellinker:27485575], CHRNB3 [NA], CHRNB4 [Cellinker:27485575], CHRNA1 [NA], CHRNA2 [NA], CHRNA3 [Cellinker:27485575], CHRNA4 [Cellinker:27485575], CHRNA5 [NA], CHRNA6 [NA], CHRNA7 [Cellinker:27485575], CHRNA9 [NA], CHRNA10 [NA], CHRND [NA], CHRNE [NA], CHRNG [NA]	anchored component of membrane [GO:0031225]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; synapse [GO:0045202]	acetylcholine receptor binding [GO:0033130]; acetylcholine receptor inhibitor activity [GO:0030550]; acetylcholine receptor regulator activity [GO:0030548]	acetylcholine receptor signaling pathway [GO:0095500]; regulation of neurotransmitter receptor activity [GO:0099601]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=SLURP2&keywords=SLURP2	0.01748252808988764	804	NA	NA	7.440086421420051e-4	899	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
SNCA	synuclein alpha	No		ENSG00000145335	P37840	Synuclein family	1	ligand	extracellular, intracellular, ligand, secreted	P07101, P17980, P18627, P27361, P28482, P63027, Q02156	LAG3, MAPK1, MAPK3, PRKCE, PSMC3, TH, VAMP2	VAMP2 [BioGRID:29608598;IntAct:20798282;SIGNOR:31110017], LAG3 [connectomeDB2020:27708076], MAPK1 [BioGRID:12121974;HPRD:11279280;InnateDB:12121974;NetPath:11279280], PSMC3 [BioGRID:12551928;BioGRID:15591046], MAPK3 [InnateDB:12121974], PRKCE [HPRD:10407019], TH [HPRD:11943812]	actin cytoskeleton [GO:0015629]; axon [GO:0030424]; axon terminus [GO:0043679]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; growth cone [GO:0030426]; inclusion body [GO:0016234]; lysosome [GO:0005764]; membrane [GO:0016020]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; protein-containing complex [GO:0032991]; supramolecular fiber [GO:0099512]; synaptic vesicle membrane [GO:0030672]	actin binding [GO:0003779]; alpha-tubulin binding [GO:0043014]; calcium ion binding [GO:0005509]; copper ion binding [GO:0005507]; cuprous ion binding [GO:1903136]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; dynein complex binding [GO:0070840]; ferrous iron binding [GO:0008198]; histone binding [GO:0042393]; Hsp70 protein binding [GO:0030544]; identical protein binding [GO:0042802]; kinesin binding [GO:0019894]; magnesium ion binding [GO:0000287]; oxidoreductase activity [GO:0016491]; phospholipid binding [GO:0005543]; phosphoprotein binding [GO:0051219]; protein kinase inhibitor activity [GO:0004860]; SNARE binding [GO:0000149]; tau protein binding [GO:0048156]; transcription cis-regulatory region binding [GO:0000976]; zinc ion binding [GO:0008270]	activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; adult locomotory behavior [GO:0008344]; cellular response to copper ion [GO:0071280]; cellular response to epinephrine stimulus [GO:0071872]; cellular response to oxidative stress [GO:0034599]; chemical synaptic transmission [GO:0007268]; dopamine biosynthetic process [GO:0042416]; dopamine uptake involved in synaptic transmission [GO:0051583]; excitatory postsynaptic potential [GO:0060079]; fatty acid metabolic process [GO:0006631]; long-term synaptic potentiation [GO:0060291]; microglial cell activation [GO:0001774]; mitochondrial ATP synthesis coupled electron transport [GO:0042775]; mitochondrial membrane organization [GO:0007006]; negative regulation of apoptotic process [GO:0043066]; negative regulation of chaperone-mediated autophagy [GO:1904715]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of dopamine uptake involved in synaptic transmission [GO:0051585]; negative regulation of exocytosis [GO:0045920]; negative regulation of histone acetylation [GO:0035067]; negative regulation of microtubule polymerization [GO:0031115]; negative regulation of mitochondrial electron transport, NADH to ubiquinone [GO:1902957]; negative regulation of monooxygenase activity [GO:0032769]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of neuron death [GO:1901215]; negative regulation of norepinephrine uptake [GO:0051622]; negative regulation of platelet-derived growth factor receptor signaling pathway [GO:0010642]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of serotonin uptake [GO:0051612]; negative regulation of thrombin-activated receptor signaling pathway [GO:0070495]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transporter activity [GO:0032410]; neutral lipid metabolic process [GO:0006638]; phospholipid metabolic process [GO:0006644]; positive regulation of apoptotic process [GO:0043065]; positive regulation of endocytosis [GO:0045807]; positive regulation of exocytosis [GO:0045921]; positive regulation of glutathione peroxidase activity [GO:1903284]; positive regulation of hydrogen peroxide catabolic process [GO:1903285]; positive regulation of inflammatory response [GO:0050729]; positive regulation of inositol phosphate biosynthetic process [GO:0060732]; positive regulation of neuron death [GO:1901216]; positive regulation of neurotransmitter secretion [GO:0001956]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of receptor recycling [GO:0001921]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; positive regulation of SNARE complex assembly [GO:0035543]; protein destabilization [GO:0031648]; protein tetramerization [GO:0051262]; receptor internalization [GO:0031623]; regulation of acyl-CoA biosynthetic process [GO:0050812]; regulation of dopamine secretion [GO:0014059]; regulation of glutamate secretion [GO:0014048]; regulation of locomotion [GO:0040012]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; regulation of macrophage activation [GO:0043030]; regulation of neuron death [GO:1901214]; regulation of norepinephrine uptake [GO:0051621]; regulation of phospholipase activity [GO:0010517]; regulation of presynapse assembly [GO:1905606]; regulation of reactive oxygen species biosynthetic process [GO:1903426]; regulation of synaptic vesicle recycling [GO:1903421]; regulation of transmembrane transporter activity [GO:0022898]; response to interferon-gamma [GO:0034341]; response to interleukin-1 [GO:0070555]; response to iron(II) ion [GO:0010040]; response to lipopolysaccharide [GO:0032496]; response to magnesium ion [GO:0032026]; response to xenobiotic stimulus [GO:0009410]; SNARE complex assembly [GO:0035493]; supramolecular fiber organization [GO:0097435]; synapse organization [GO:0050808]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle exocytosis [GO:0016079]; synaptic vesicle priming [GO:0016082]; synaptic vesicle transport [GO:0048489]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=SNCA&keywords=SNCA	15.492407855257056	190	10896.7	66	0.861399300763067	292	0.06299212598425197	0.017465069860279434	0.014380530973451327	0.015107913669064743	0.008417508417508417	0.22504230118443283	0.29827742520398826	0.25122349102773206	0.15427302996670267	0.1887101081586241	0.23106045972569797	89	80	64	0.1333590876519758	1.1458850126439029	1.386100535468115	1.681515024083481	102	66	27
SNX14	sorting nexin 14			ENSG00000135317	Q9Y5W7	Sorting nexin family	1	ligand	extracellular, intracellular, ligand, secreted, transmembrane, transmembrane_predicted	P50406	HTR6	HTR6 [Cellinker:25795301]	cytosol [GO:0005829]; dendrite [GO:0030425]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]	phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol binding [GO:0035091]	autophagosome maturation [GO:0097352]; protein transport [GO:0015031]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=SNX14&keywords=SNX14	43.585787340291276	98	2508.59	124	2.2337153083374637	140	0.10236220472440945	0.24401197604790617	0.08628318584070806	0.12182254196642828	0.24410774410774397	0.34179357021996654	0.3354487760652755	0.19412724306688403	0.1960784313725476	0.24132060355186274	0.16156074946879645	80	68	79	0.206265184221139	0.9528969358369997	1.1620946037013444	0.7932888046065213	153	100	193
SOCS2	suppressor of cytokine signaling 2			ENSG00000120833	O14508	NA	1	ligand	intracellular, ligand, secreted	P06213, P08069, P10912, P16471, P19235, P48357	EPOR, GHR, IGF1R, INSR, LEPR, PRLR	IGF1R [HPRD:9727029;Lit-BM-17:9727029;SignaLink3:16574995;SignaLink3:23331499;SignaLink3:9727029], LEPR [NetPath:16684815;SignaLink3:18708154;SignaLink3:23331499], EPOR [Cellinker:31182716;HPRD:11781573;HPRD:15644415;Lit-BM-17:11781573;Lit-BM-17:15644415;Lit-BM-17:16961462], GHR [BioGRID:12135564;BioGRID:28967904;HPRD:10585430;InnateDB:12135564;Lit-BM-17:10585430;Lit-BM-17:12135564;Lit-BM-17:16675548;Lit-BM-17:21980433], PRLR [HPRD:10455112;HPRD:9202403], INSR [HPRD:10453981]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; phosphatidylinositol 3-kinase complex [GO:0005942]	1-phosphatidylinositol-3-kinase regulator activity [GO:0046935]; growth hormone receptor binding [GO:0005131]; insulin-like growth factor receptor binding [GO:0005159]; JAK pathway signal transduction adaptor activity [GO:0008269]	cellular response to hormone stimulus [GO:0032870]; growth hormone receptor signaling pathway [GO:0060396]; intracellular signal transduction [GO:0035556]; lactation [GO:0007595]; mammary gland alveolus development [GO:0060749]; negative regulation of apoptotic process [GO:0043066]; negative regulation of multicellular organism growth [GO:0040015]; negative regulation of receptor signaling pathway via JAK-STAT [GO:0046426]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; positive regulation of neuron differentiation [GO:0045666]; protein ubiquitination [GO:0016567]; receptor signaling pathway via JAK-STAT [GO:0007259]; regulation of cell growth [GO:0001558]; regulation of signal transduction [GO:0009966]; response to estradiol [GO:0032355]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=SOCS2&keywords=SOCS2	20.40083236715024	167	NA	NA	1.6101758717155175	193	0.3622047244094485	0.1332335329341317	0.22013274336283212	0.9441247002398337	0.06565656565656564	0.30626057529610856	0.39800543970988095	0.05872756933115828	0.04994450610432857	0.4230871945520703	0.02808576395595915	169	52	188	0.27176939232293795	0.21274314293025035	1.5370271092316012	0.13516643394790295	429	49	455
SORL1	sortilin related receptor 1	No		ENSG00000137642	Q92673	VPS10-related sortilin family, SORL1 subfamily	1	adhesion, ligand	adhesion, cell_adhesion, cell_surface, extracellular, intracellular, ligand, plasma_membrane, plasma_membrane_transmembrane, secreted, transmembrane, transmembrane_predicted	P26992	CNTFR	CNTFR [Cellinker:26858303;IntAct:26858303]	cell surface [GO:0009986]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; Golgi cisterna [GO:0031985]; Golgi membrane [GO:0000139]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; multivesicular body [GO:0005771]; multivesicular body membrane [GO:0032585]; neuronal cell body [GO:0043025]; nuclear envelope lumen [GO:0005641]; perinucleolar compartment [GO:0097356]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]; trans-Golgi network [GO:0005802]; transport vesicle membrane [GO:0030658]	amyloid-beta binding [GO:0001540]; low-density lipoprotein particle binding [GO:0030169]; low-density lipoprotein particle receptor activity [GO:0005041]; neuropeptide binding [GO:0042923]; small GTPase binding [GO:0031267]; transmembrane signaling receptor activity [GO:0004888]	adaptive thermogenesis [GO:1990845]; cell migration [GO:0016477]; cell population proliferation [GO:0008283]; diet induced thermogenesis [GO:0002024]; insulin receptor recycling [GO:0038020]; negative regulation of amyloid-beta formation [GO:1902430]; negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902960]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902963]; negative regulation of neurofibrillary tangle assembly [GO:1902997]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron death [GO:1901215]; negative regulation of protein binding [GO:0032091]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of tau-protein kinase activity [GO:1902948]; negative regulation of triglyceride catabolic process [GO:0010897]; neuropeptide signaling pathway [GO:0007218]; positive regulation of adipose tissue development [GO:1904179]; positive regulation of choline O-acetyltransferase activity [GO:1902771]; positive regulation of early endosome to recycling endosome transport [GO:1902955]; positive regulation of endocytic recycling [GO:2001137]; positive regulation of ER to Golgi vesicle-mediated transport [GO:1902953]; positive regulation of glial cell-derived neurotrophic factor production [GO:1900168]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein exit from endoplasmic reticulum [GO:0070863]; positive regulation of protein localization to early endosome [GO:1902966]; post-Golgi vesicle-mediated transport [GO:0006892]; protein localization to Golgi apparatus [GO:0034067]; protein maturation [GO:0051604]; protein retention in Golgi apparatus [GO:0045053]; protein targeting [GO:0006605]; protein targeting to lysosome [GO:0006622]; receptor-mediated endocytosis [GO:0006898]; regulation of smooth muscle cell migration [GO:0014910]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=SORL1&keywords=SORL1	42.467986819558725	101	18738.5	50	2.458971743805809	131	0.11811023622047244	0.17664670658682707	0.011061946902654867	0.015107913669064743	0.1094276094276095	1.3147208121827363	1.11695376246601	0.3181076672104404	0.6958934517203115	1.011717185205216	0.05984160710836259	33	29	143	0.4497808089727005	1.5352825475632756	2.2221831909166974	0.15190196229462335	55	15	446
SOST	sclerostin	No		ENSG00000167941	Q9BQB4	Sclerostin family	11	ecm, ligand	ecm, extracellular, intracellular, ligand, ligand_regulator, secreted	O75096, O75197, O75581	LRP4, LRP5, LRP6	LRP6 [Baccin2019:15778503;CellTalkDB:15778503;Cellinker:15778503;DIP:21944579;ELM:21944579;ELM:22696217;IntAct:15908424;IntAct:21944579;LMPID:21944579;LRdb:15778503;connectomeDB2020:15778503], LRP5 [Baccin2019:15778503;CellTalkDB:15778503;Cellinker:15778503;ELM:21944579;ELM:22696217;IntAct:15908424;LRdb:15778503;connectomeDB2020:15778503], LRP4 [IntAct:21471202;connectomeDB2020:19936252]	extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; protein-containing complex [GO:0032991]	BMP binding [GO:0036122]; DNA-binding transcription factor binding [GO:0140297]; heparin binding [GO:0008201]	cellular response to parathyroid hormone stimulus [GO:0071374]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of ossification [GO:0030279]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of Wnt signaling pathway [GO:0030178]; ossification [GO:0001503]; positive regulation of transcription, DNA-templated [GO:0045893]; response to mechanical stimulus [GO:0009612]; Wnt signaling pathway [GO:0016055]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=SOST&keywords=SOST	0.010525967415730336	826	NA	NA	0.009458544641758061	837	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
SOSTDC1	sclerostin domain containing 1	No		ENSG00000171243	Q6X4U4	Sclerostin family	3	ligand	extracellular, ligand, ligand_regulator, secreted, transmembrane	O75096, O75197, O75581, P18075	BMP7, LRP4, LRP5, LRP6	LRP6 [LMPID:12900447;LMPID:21944579;connectomeDB2020:20724449], LRP4 [connectomeDB2020:20724449], LRP5 [connectomeDB2020:20724449], BMP7 [HPRD:14623234;HPRD:15020244]	extracellular space [GO:0005615]	BMP binding [GO:0036122]; BMP receptor activity [GO:0098821]	hair follicle morphogenesis [GO:0031069]; mammary gland bud morphogenesis [GO:0060648]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell fate commitment [GO:0010454]; negative regulation of determination of dorsal identity [GO:2000016]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of Wnt signaling pathway [GO:0030178]; odontogenesis of dentin-containing tooth [GO:0042475]; pattern specification process [GO:0007389]; Wnt signaling pathway [GO:0016055]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=SOSTDC1&keywords=SOSTDC1	0.12011957640449439	659	NA	NA	0.05945548098341411	696	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
SPAG11B	sperm associated antigen 11B	No		ENSG00000274405, ENSG00000164871	Q08648	SPAG11 family	1	ligand	extracellular, ligand, secreted	Q9Y2T6	GPR55	GPR55 [scConnect:31675498]	extracellular region [GO:0005576]	NA	antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cytolysis by host of symbiont cells [GO:0051838]; defense response to bacterium [GO:0042742]; spermatogenesis [GO:0007283]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=SPAG11B&keywords=SPAG11B	0.028222467415730337	776	NA	NA	3.6820834615384195	98	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
SPARC	secreted protein acidic and cysteine rich	TBD		ENSG00000113140	P09486	SPARC family	1	ecm, ligand	ecm, extracellular, intracellular, ligand, ligand_regulator, secreted	P11362, P17813	ENG, FGFR1	FGFR1 [Cellinker:14505356], ENG [Cellinker:21708981]	basement membrane [GO:0005604]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; endocytic vesicle lumen [GO:0071682]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; nuclear matrix [GO:0016363]; plasma membrane [GO:0005886]; platelet alpha granule [GO:0031091]; platelet alpha granule lumen [GO:0031093]; platelet alpha granule membrane [GO:0031092]	calcium ion binding [GO:0005509]; collagen binding [GO:0005518]; extracellular matrix binding [GO:0050840]	anatomical structure development [GO:0048856]; negative regulation of angiogenesis [GO:0016525]; negative regulation of endothelial cell proliferation [GO:0001937]; positive regulation of endothelial cell migration [GO:0010595]; regulation of cell morphogenesis [GO:0022604]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=SPARC&keywords=SPARC	533.1868579084681	22	2310.76	128	0.9428808749622877	275	0.007874015748031496	0.01297405189620758	1.661504424778768	2.873141486810493	0.013468013468013466	0.00338409475465313	0.009066183136899365	0.0065252854812398045	0.005919348871624123	0.003605287755374543	0.005331272937994983	284	308	288	0.4184357696035727	0.03715690892558793	0.031755723309385156	0.035784297263930266	514	513	513
SPON1	spondin 1	TBD		ENSG00000262655	Q9HCB6	NA	1	ecm, ligand	ecm, extracellular, intracellular, ligand, secreted	P05067, Q14114	APP, LRP8	APP [HPRD:14983046;connectomeDB2020:14983046], LRP8 [connectomeDB2020:21488757]	endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]	extracellular matrix structural constituent [GO:0005201]; LBD domain binding [GO:0050693]; metal ion binding [GO:0046872]	cell adhesion [GO:0007155]; negative regulation of amyloid-beta formation [GO:1902430]; positive regulation of amyloid precursor protein catabolic process [GO:1902993]; positive regulation of protein binding [GO:0032092]; positive regulation of protein processing [GO:0010954]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=SPON1&keywords=SPON1	17.62974810223135	181	NA	NA	0.7665299610672548	309	0.007874015748031496	0.058882235528942055	0.019911504424778764	0.2151079136690655	0.01683501683501683	0.042301184433164135	0.047144152311876644	0.04893964110929857	0.021457639659637432	0.0223327547069034	0.0649024531581979	229	189	138	0.05142622832590116	0.5121206448284065	0.5263672471531169	1.2193887725093209	336	308	58
SPON2	spondin 2	TBD	manually added ensembl_gene_ID, hgnc_symbol, and description by searching the uniprot ID on genenames.org	ENSG00000159674	Q9BUD6	NA	4	ecm, ligand	ecm, extracellular, intracellular, ligand, secreted	P05107, P05556, P08648, P11215, P13612	ITGA4, ITGA5, ITGAM, ITGB1, ITGB2	ITGB2 [CellTalkDB:32196115;connectomeDB2020:30869196], ITGAM [CellTalkDB:30869196;connectomeDB2020:30869196], ITGA4 [connectomeDB2020:29440144], ITGA5 [connectomeDB2020:29440144], ITGB1 [connectomeDB2020:29440144]	extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]	antigen binding [GO:0003823]; lipopolysaccharide binding [GO:0001530]; metal ion binding [GO:0046872]	cell adhesion [GO:0007155]; cellular response to lipopolysaccharide [GO:0071222]; defense response to fungus [GO:0050832]; defense response to virus [GO:0051607]; induction of bacterial agglutination [GO:0043152]; innate immune response [GO:0045087]; mast cell mediated immunity [GO:0002448]; opsonization [GO:0008228]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of macrophage cytokine production [GO:0060907]; positive regulation of tumor necrosis factor production [GO:0032760]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=SPON2&keywords=SPON2	17.044375471418203	184	1208.81	152	0.6000862426322493	337	0	0.007984031936127746	0.00331858407079646	1.445323741007181	0.030303030303030297	0.11167512690355322	0.046237533998186725	0.03915171288743884	0.10432852386237476	0.04292963012418305	0.02113192968900906	122	154	204	0.1683985313438074	0.6408602301890158	0.2966931943076243	0.17450776895137102	282	379	435
SPP1	secreted phosphoprotein 1	Yes	has non-integrin signalling role too	ENSG00000118785	P10451	Osteopontin family	13	ecm, ligand	ecm, intracellular, ligand, secreted	P05106, P05556, P06756, P08648, P13612, P16070, P18084, P21453, P35408, P51685, Q13797	CCR8, CD44, ITGA4, ITGA4_ITGB1, ITGA4_ITGB7, ITGA5, ITGA5_ITGB1, ITGA8_ITGB1, ITGA9, ITGA9_ITGB1, ITGAV, ITGAV_ITGB1, ITGAV_ITGB3, ITGAV_ITGB5, ITGAV_ITGB6, ITGB1, ITGB3, ITGB5, PTGER4, S1PR1	CD44 [Baccin2019:10657301;Baccin2019:12377945;CellChatDB:21907263;CellTalkDB:10657301;Cellinker:10657301;Cellinker:12377945;Cellinker:21907263;HPRD:10657301;HPRD:12377945;ICELLNET:8560266;LRdb:10657301;LRdb:12;Lit-BM-17:20146103;Lit-BM-17:20549562;connectomeDB2020:10657301;connectomeDB2020:12377945], ITGA4 [CellTalkDB:19417209;LRdb:19417209;Ramilowski2015:19417209;connectomeDB2020:19417209;talklr:19417209], ITGB1 [CellTalkDB:10593924;HPRD:10593924;LMPID:8910476;LRdb:10593924;connectomeDB2020:10593924;connectomeDB2020:7592829], ITGB3 [CellTalkDB:32196115;connectomeDB2020:7592829], ITGAV [CellTalkDB:10835423;HPRD:10835423;LRdb:10835423;connectomeDB2020:10835423;connectomeDB2020:7592829], ITGA9 [CellTalkDB:10593924;HPRD:10593924;LRdb:10593924;connectomeDB2020:10593924], ITGA5 [CellTalkDB:7592829;HPRD:7592829;LRdb:7592829], ITGB5 [CellTalkDB:32196115;connectomeDB2020:7592829], PTGER4 [CellTalkDB:32103204], S1PR1 [Cellinker:9488656;LRdb:9488656;Ramilowski2015:9488656;talklr:9488656], CCR8 [NA]	cell projection [GO:0042995]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; perinuclear region of cytoplasm [GO:0048471]	cytokine activity [GO:0005125]; extracellular matrix binding [GO:0050840]; integrin binding [GO:0005178]	androgen catabolic process [GO:0006710]; biomineral tissue development [GO:0031214]; cell adhesion [GO:0007155]; cellular response to testosterone stimulus [GO:0071394]; decidualization [GO:0046697]; embryo implantation [GO:0007566]; inflammatory response [GO:0006954]; negative regulation of collateral sprouting of intact axon in response to injury [GO:0048685]; osteoblast differentiation [GO:0001649]; positive regulation of bone resorption [GO:0045780]; positive regulation of estradiol secretion [GO:2000866]; positive regulation of transcription, DNA-templated [GO:0045893]; response to steroid hormone [GO:0048545]; response to vitamin D [GO:0033280]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=SPP1&keywords=SPP1	2334.400302911864	12	1671.51	140	12.968012079534954	39	0.7322834645669289	2.8323353293413014	0.033185840707964626	0.06187050359712228	0.48989898989898983	0.8697123519458544	3.3934723481414393	0.05709624796084831	0.18682944876063598	2.5020363199360016	0.03816882364303643	84	15	168	1.0178990607727385	0.1914871374750226	2.443855059121798	0.046861433657527415	442	14	506
SPX	spexin hormone	Yes		ENSG00000134548	Q9BT56	Spexin family	4	ligand	intracellular, ligand, secreted	O43603, O60755	GALR2, GALR3	GALR2 [CellTalkDB:31730796;Guide2Pharma:24517231;connectomeDB2020:24517231;connectomeDB2020:30305242], GALR3 [Guide2Pharma:24517231;connectomeDB2020:24517231;connectomeDB2020:30305242]	cytoplasm [GO:0005737]; dense core granule [GO:0031045]; extracellular space [GO:0005615]; transport vesicle [GO:0030133]	neuropeptide hormone activity [GO:0005184]; type 2 galanin receptor binding [GO:0031765]; type 3 galanin receptor binding [GO:0031766]	long-chain fatty acid import into cell [GO:0044539]; negative regulation of appetite [GO:0032099]; negative regulation of heart rate [GO:0010459]; negative regulation of renal sodium excretion [GO:0035814]; positive regulation of gastro-intestinal system smooth muscle contraction [GO:1904306]; positive regulation of systemic arterial blood pressure [GO:0003084]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of sensory perception of pain [GO:0051930]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=SPX&keywords=SPX	1.7083043597888992	398	NA	NA	0.26683412706738907	484	0	0	0	4.7961630695443646e-4	0.11111111111111122	0	0.001813236627379873	0.0016313213703099511	0	0.002971024168780874	4.6358895112999797e-4	303	320	387	0.010769990775969669	0.4814638633142647	0.6245079407443939	0.5037839960543504	351	281	323
SST	somatostatin	Yes		ENSG00000157005	P61278	Somatostatin family	16	ligand	extracellular, ligand, secreted	P08913, P30872, P30874, P31391, P32745, P35346, P48039, Q14831, Q96LB1	ADRA2A, GRM7, MRGPRX2, MTNR1A, SSTR1, SSTR2, SSTR3, SSTR4, SSTR5	SSTR1 [Baccin2019:10598788;Baccin2019:11520208;Baccin2019:1346068;Baccin2019:15333679;Baccin2019:7988476;Baccin2019:8769372;Baccin2019:9600011;Baccin2019:9650799;Baccin2019:9724791;Baccin2019:9784130;CellTalkDB:9784130;Cellinker:10598788;Cellinker:11520208;Cellinker:1346068;Cellinker:15333679;Cellinker:7988476;Cellinker:8769372;Cellinker:9600011;Cellinker:9650799;Cellinker:9724791;Cellinker:9784130;Guide2Pharma:10598788;Guide2Pharma:11520208;Guide2Pharma:15333679;Guide2Pharma:7988476;Guide2Pharma:8769372;Guide2Pharma:9600011;Guide2Pharma:9650799;Guide2Pharma:9724791;Guide2Pharma:9784130;HPRD:1346068;LRdb:10598788;LRdb:11520208;LRdb:1346068;LRdb:15333679;LRdb:7988476;LRdb:8769372;LRdb:9600011;LRdb:9650799;LRdb:9724791;LRdb:9784130;connectomeDB2020:10598788;connectomeDB2020:11520208;connectomeDB2020:1346068;connectomeDB2020:15333679;connectomeDB2020:7988476;connectomeDB2020:8769372;connectomeDB2020:9600011;connectomeDB2020:9650799;connectomeDB2020:9724791;connectomeDB2020:9784130;scConnect:10598788;scConnect:11520208;scConnect:15333679;scConnect:7988476;scConnect:8769372;scConnect:9600011;scConnect:9650799;scConnect:9724791;scConnect:9784130], SSTR2 [Baccin2019:10598788;Baccin2019:11520208;Baccin2019:1346068;Baccin2019:15333679;Baccin2019:7988476;Baccin2019:8702767;Baccin2019:8769372;Baccin2019:9650799;Baccin2019:9652348;Baccin2019:9724791;Baccin2019:9784130;CellTalkDB:10598788;Cellinker:10598788;Cellinker:11520208;Cellinker:1346068;Cellinker:15333679;Cellinker:7988476;Cellinker:8702767;Cellinker:8769372;Cellinker:9650799;Cellinker:9652348;Cellinker:9724791;Cellinker:9784130;Guide2Pharma:10598788;Guide2Pharma:11520208;Guide2Pharma:15333679;Guide2Pharma:7988476;Guide2Pharma:8769372;Guide2Pharma:9650799;Guide2Pharma:9652348;Guide2Pharma:9724791;Guide2Pharma:9784130;HPMR:8702767;HPRD:1346068;LRdb:10598788;LRdb:11520208;LRdb:1346068;LRdb:15333679;LRdb:7988476;LRdb:8702767;LRdb:8769372;LRdb:9650799;LRdb:9652348;LRdb:9724791;LRdb:9784130;connectomeDB2020:10598788;connectomeDB2020:11520208;connectomeDB2020:1346068;connectomeDB2020:15333679;connectomeDB2020:7988476;connectomeDB2020:8702767;connectomeDB2020:8769372;connectomeDB2020:9650799;connectomeDB2020:9652348;connectomeDB2020:9724791;connectomeDB2020:9784130;scConnect:10598788;scConnect:11520208;scConnect:15333679;scConnect:7988476;scConnect:8769372;scConnect:9650799;scConnect:9652348;scConnect:9724791;scConnect:9784130], SSTR3 [Baccin2019:10598788;Baccin2019:11520208;Baccin2019:1337145;Baccin2019:15333679;Baccin2019:7988476;Baccin2019:8097479;Baccin2019:8769372;Baccin2019:9600011;Baccin2019:9650799;Baccin2019:9724791;Baccin2019:9784130;CellTalkDB:9784130;Cellinker:10598788;Cellinker:11520208;Cellinker:1337145;Cellinker:15333679;Cellinker:7988476;Cellinker:8097479;Cellinker:8769372;Cellinker:9600011;Cellinker:9650799;Cellinker:9724791;Cellinker:9784130;Guide2Pharma:10598788;Guide2Pharma:11520208;Guide2Pharma:15333679;Guide2Pharma:7988476;Guide2Pharma:8097479;Guide2Pharma:8769372;Guide2Pharma:9600011;Guide2Pharma:9650799;Guide2Pharma:9724791;Guide2Pharma:9784130;HPRD:1337145;LRdb:10598788;LRdb:11520208;LRdb:1337145;LRdb:15333679;LRdb:7988476;LRdb:8097479;LRdb:8769372;LRdb:9600011;LRdb:9650799;LRdb:9724791;LRdb:9784130;connectomeDB2020:10598788;connectomeDB2020:11520208;connectomeDB2020:1337145;connectomeDB2020:15333679;connectomeDB2020:7988476;connectomeDB2020:8097479;connectomeDB2020:8769372;connectomeDB2020:9600011;connectomeDB2020:9650799;connectomeDB2020:9724791;connectomeDB2020:9784130;scConnect:10598788;scConnect:11520208;scConnect:15333679;scConnect:7988476;scConnect:8097479;scConnect:8769372;scConnect:9600011;scConnect:9650799;scConnect:9724791;scConnect:9784130], SSTR4 [Baccin2019:10598788;Baccin2019:11520208;Baccin2019:15333679;Baccin2019:7988476;Baccin2019:8100352;Baccin2019:8769372;Baccin2019:9600011;Baccin2019:9650799;Baccin2019:9724791;Baccin2019:9784130;CellTalkDB:9784130;Cellinker:10598788;Cellinker:11520208;Cellinker:15333679;Cellinker:7988476;Cellinker:8100352;Cellinker:8769372;Cellinker:9600011;Cellinker:9650799;Cellinker:9724791;Cellinker:9784130;Guide2Pharma:10598788;Guide2Pharma:11520208;Guide2Pharma:15333679;Guide2Pharma:7988476;Guide2Pharma:8769372;Guide2Pharma:9600011;Guide2Pharma:9650799;Guide2Pharma:9724791;Guide2Pharma:9784130;HPMR:8769372;HPRD:8100352;LRdb:10598788;LRdb:11520208;LRdb:15333679;LRdb:7988476;LRdb:8100352;LRdb:8769372;LRdb:9600011;LRdb:9650799;LRdb:9724791;LRdb:9784130;SIGNOR:10433861;connectomeDB2020:10598788;connectomeDB2020:11520208;connectomeDB2020:15333679;connectomeDB2020:7988476;connectomeDB2020:8100352;connectomeDB2020:8769372;connectomeDB2020:9600011;connectomeDB2020:9650799;connectomeDB2020:9724791;connectomeDB2020:9784130;scConnect:10598788;scConnect:11520208;scConnect:15333679;scConnect:7988476;scConnect:8769372;scConnect:9600011;scConnect:9650799;scConnect:9724791;scConnect:9784130], SSTR5 [Baccin2019:10598788;Baccin2019:11520208;Baccin2019:15333679;Baccin2019:7908405;Baccin2019:7988476;Baccin2019:8769372;Baccin2019:9600011;Baccin2019:9650799;Baccin2019:9652348;Baccin2019:9724791;Baccin2019:9784130;CellTalkDB:7908405;Cellinker:10598788;Cellinker:11520208;Cellinker:15333679;Cellinker:7908405;Cellinker:7988476;Cellinker:8769372;Cellinker:9600011;Cellinker:9650799;Cellinker:9652348;Cellinker:9724791;Cellinker:9784130;Guide2Pharma:10598788;Guide2Pharma:11520208;Guide2Pharma:15333679;Guide2Pharma:7988476;Guide2Pharma:8769372;Guide2Pharma:9600011;Guide2Pharma:9650799;Guide2Pharma:9652348;Guide2Pharma:9724791;Guide2Pharma:9784130;HPMR:8769372;HPRD:7908405;LRdb:10598788;LRdb:11520208;LRdb:15333679;LRdb:7908405;LRdb:7988476;LRdb:8769372;LRdb:9600011;LRdb:9650799;LRdb:9652348;LRdb:9724791;LRdb:9784130;connectomeDB2020:10598788;connectomeDB2020:11520208;connectomeDB2020:15333679;connectomeDB2020:7908405;connectomeDB2020:7988476;connectomeDB2020:8769372;connectomeDB2020:9600011;connectomeDB2020:9650799;connectomeDB2020:9652348;connectomeDB2020:9724791;connectomeDB2020:9784130;scConnect:10598788;scConnect:11520208;scConnect:15333679;scConnect:7988476;scConnect:8769372;scConnect:9600011;scConnect:9650799;scConnect:9652348;scConnect:9724791;scConnect:9784130], MTNR1A [CellTalkDB:32196115], GRM7 [CellTalkDB:32196115], ADRA2A [CellTalkDB:32196115], MRGPRX2 [scConnect:23396314]	extracellular region [GO:0005576]; extracellular space [GO:0005615]; neuronal cell body [GO:0043025]; synapse [GO:0045202]	hormone activity [GO:0005179]; identical protein binding [GO:0042802]	cell-cell signaling [GO:0007267]; cell surface receptor signaling pathway [GO:0007166]; chemical synaptic transmission [GO:0007268]; digestion [GO:0007586]; G protein-coupled receptor signaling pathway [GO:0007186]; hormone-mediated apoptotic signaling pathway [GO:0008628]; hyperosmotic response [GO:0006972]; negative regulation of cell population proliferation [GO:0008285]; regulation of cell migration [GO:0030334]; response to acidic pH [GO:0010447]; response to amino acid [GO:0043200]; response to heat [GO:0009408]; response to nutrient [GO:0007584]; response to steroid hormone [GO:0048545]; response to xenobiotic stimulus [GO:0009410]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=SST&keywords=SST	7794.808887640449	6	205386	9	259.83383715451475	6	1.078740157480314	3.8183632734530715	2.247787610619464	2.5050359712229184	14.265993265993302	780.1878172588838	3.695376246600209	10.898858075040716	1621.4073251942307	2.3324876485518584	1.6181958663323952	1	17	18	222.1869073244008	7.297209239852336	0.010542395376961286	0.007327716150231012	1	523	528
ST6GAL1	ST6 beta-galactoside alpha-2,6-sialyltransferase 1	No		ENSG00000073849	P15907	Glycosyltransferase 29 family	1	adhesion, cell_surface_ligand	adhesion, cell_adhesion, cell_surface, cell_surface_ligand, extracellular, intracellular, plasma_membrane, secreted, transmembrane	P00533, P20273	CD22, EGFR	CD22 [CellTalkDB:1717156;Cellinker:1717156;HPRD:8702538;LRdb:1717156;SIGNOR:8702538;connectomeDB2020:1717156], EGFR [CellTalkDB:29402301]	endoplasmic reticulum [GO:0005783]; extracellular region [GO:0005576]; Golgi cisterna membrane [GO:0032580]; Golgi medial cisterna [GO:0005797]; Golgi membrane [GO:0000139]; Golgi trans cisterna [GO:0000138]; integral component of membrane [GO:0016021]	beta-galactoside alpha-2,6-sialyltransferase activity [GO:0003835]; protein homodimerization activity [GO:0042803]; sialyltransferase activity [GO:0008373]	humoral immune response [GO:0006959]; N-acetylneuraminate metabolic process [GO:0006054]; negative regulation of chemotaxis [GO:0050922]; negative regulation of macrophage apoptotic process [GO:2000110]; O-glycan processing [GO:0016266]; positive regulation of mononuclear cell proliferation [GO:0032946]; protein N-linked glycosylation via asparagine [GO:0018279]; protein sialylation [GO:1990743]; regulation of substrate adhesion-dependent cell spreading [GO:1900024]; response to ethanol [GO:0045471]; sialylation [GO:0097503]; viral protein processing [GO:0019082]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=ST6GAL1&keywords=ST6GAL1	19.435630670321913	171	2837.97	118	0.8784862775950392	290	0.007874015748031496	0.0818363273453093	0.02986725663716816	0.005755395683453236	0.013468013468013466	0.0287648054145516	0.01813236627379873	0.0016313213703099511	0.038105808361080275	0.023300841233809527	0.0010817075526366625	189	186	363	0.02271071446256022	1.4706437676908848	1.0180407790213433	0.3387791350543712	58	123	377
STC1	stanniocalcin 1	Yes		ENSG00000159167	P52823	Stanniocalcin family	2	ligand	extracellular, intracellular, ligand, secreted	NA	NA	NA	apical plasma membrane [GO:0016324]; cytoplasm [GO:0005737]; extracellular space [GO:0005615]; nucleus [GO:0005634]	hormone activity [GO:0005179]; identical protein binding [GO:0042802]	bone development [GO:0060348]; cellular calcium ion homeostasis [GO:0006874]; cellular response to cAMP [GO:0071320]; cellular response to glucocorticoid stimulus [GO:0071385]; cellular response to hypoxia [GO:0071456]; chondrocyte proliferation [GO:0035988]; decidualization [GO:0046697]; embryo implantation [GO:0007566]; endothelial cell morphogenesis [GO:0001886]; growth plate cartilage axis specification [GO:0003421]; negative regulation of calcium ion transport [GO:0051926]; negative regulation of cell migration [GO:0030336]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of renal phosphate excretion [GO:1903403]; ossification [GO:0001503]; positive regulation of calcium ion import [GO:0090280]; regulation of anion transport [GO:0044070]; regulation of cardiac muscle cell contraction [GO:0086004]; response to vitamin D [GO:0033280]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=STC1&keywords=STC1	62.60774784222061	69	NA	NA	7.039903579157789	57	0.06299212598425197	0.1576846307385233	2.3274336283185835	1.2836930455635491	0.011784511784511783	0.005076142131979695	0.0027198549410698096	0	0.0033296337402885685	0.0026705835224996623	0.006606142553602476	294	330	268	0.35127184538898726	0.036896408924244666	0.035072158775221025	0.0459657810746984	515	509	508
STC2	stanniocalcin 2	Yes		ENSG00000113739	O76061	Stanniocalcin family	2	ligand	extracellular, intracellular, ligand, secreted	NA	NA	NA	endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; perinuclear region of cytoplasm [GO:0048471]	enzyme binding [GO:0019899]; heme binding [GO:0020037]; hormone activity [GO:0005179]; protein homodimerization activity [GO:0042803]	cellular calcium ion homeostasis [GO:0006874]; cellular response to hypoxia [GO:0071456]; decidualization [GO:0046697]; embryo implantation [GO:0007566]; endoplasmic reticulum unfolded protein response [GO:0030968]; negative regulation of gene expression [GO:0010629]; negative regulation of multicellular organism growth [GO:0040015]; regulation of hormone biosynthetic process [GO:0046885]; regulation of store-operated calcium entry [GO:2001256]; response to oxidative stress [GO:0006979]; response to peptide hormone [GO:0043434]; response to vitamin D [GO:0033280]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=STC2&keywords=STC2	2.564293346191578	357	NA	NA	0.33902115757141027	448	0	0.17914171656686706	0.12168141592920369	0.139088729016787	0.22222222222222227	0.11675126903553293	0.2003626473254754	0.12234910277324648	0.052534221235664105	0.005708372279343025	0.28514583735752813	165	278	56	0.13136232124926092	0.4423683813553043	0.11112135214336792	2.0878677907184637	360	463	17
TAC1	tachykinin precursor 1	Yes		ENSG00000006128	P20366	Tachykinin family	13	ligand	extracellular, ligand, secreted	P21452, P25103, P27487, P29371, Q12884, Q96LB1	DPP4, FAP, MRGPRX2, TACR1, TACR2, TACR3	TACR1 [Baccin2019:11786503;Baccin2019:12548712;Baccin2019:1311270;Baccin2019:15265501;Baccin2019:7557266;Baccin2019:8702757;Baccin2019:8985159;Baccin2019:9190866;BioGRID:8702757;CellTalkDB:7557266;Cellinker:11786503;Cellinker:12548712;Cellinker:1311270;Cellinker:15265501;Cellinker:7557266;Cellinker:8702757;Cellinker:8985159;Cellinker:9190866;Guide2Pharma:11786503;Guide2Pharma:1311270;Guide2Pharma:15265501;Guide2Pharma:8702757;Guide2Pharma:8985159;Guide2Pharma:9190866;HPRD:12548712;LRdb:11786503;LRdb:12548712;LRdb:1311270;LRdb:15265501;LRdb:7557266;LRdb:8702757;LRdb:8985159;LRdb:9190866;Lit-BM-17:11786503;Lit-BM-17:23597562;Lit-BM-17:8702757;connectomeDB2020:11786503;connectomeDB2020:12548712;connectomeDB2020:1311270;connectomeDB2020:15265501;connectomeDB2020:7557266;connectomeDB2020:8702757;connectomeDB2020:8985159;connectomeDB2020:9190866;scConnect:11786503;scConnect:1311270;scConnect:15265501;scConnect:8702757;scConnect:8985159;scConnect:9190866], TACR2 [Baccin2019:10189055;Baccin2019:11137709;Baccin2019:11786503;Baccin2019:12954451;Baccin2019:7682062;Baccin2019:7961636;Baccin2019:8925404;Baccin2019:9190866;BioGRID:7961636;CellTalkDB:12954451;Cellinker:10189055;Cellinker:11137709;Cellinker:11786503;Cellinker:12954451;Cellinker:7682062;Cellinker:7961636;Cellinker:9190866;Guide2Pharma:11137709;Guide2Pharma:11786503;Guide2Pharma:7682062;Guide2Pharma:9190866;HPMR:12954451;HPMR:7534932;HPRD:10189055;HPRD:7961636;LRdb:10189055;LRdb:11137709;LRdb:11786503;LRdb:12954451;LRdb:7682062;LRdb:7961636;LRdb:9190866;Lit-BM-17:11786503;Lit-BM-17:23597562;Lit-BM-17:7961636;SIGNOR:8925404;connectomeDB2020:10189055;connectomeDB2020:11137709;connectomeDB2020:11786503;connectomeDB2020:12954451;connectomeDB2020:7682062;connectomeDB2020:7961636;connectomeDB2020:9190866;scConnect:11137709;scConnect:11786503;scConnect:7682062;scConnect:9190866], TACR3 [Baccin2019:10189055;Baccin2019:10866201;Baccin2019:11226387;Baccin2019:1312036;Baccin2019:2176308;Baccin2019:7557266;Baccin2019:8990205;Baccin2019:9190866;Baccin2019:9272936;CellTalkDB:9272936;Cellinker:11226387;Cellinker:1312036;Cellinker:9190866;Cellinker:9272936;Guide2Pharma:11226387;Guide2Pharma:1312036;Guide2Pharma:9190866;HPRD:9272936;LRdb:11226387;LRdb:1312036;LRdb:9190866;LRdb:9272936;connectomeDB2020:11226387;connectomeDB2020:1312036;connectomeDB2020:9190866;connectomeDB2020:9272936;scConnect:11226387;scConnect:1312036;scConnect:9190866], DPP4 [Cellinker:21314817], FAP [Cellinker:21314817], MRGPRX2 [scConnect:25517090;scConnect:28288109]	axon [GO:0030424]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; neuronal cell body [GO:0043025]; synapse [GO:0045202]	neuromedin K receptor binding [GO:0031836]; receptor ligand activity [GO:0048018]; substance K receptor binding [GO:0031837]; substance P receptor binding [GO:0031835]	antibacterial humoral response [GO:0019731]; antifungal humoral response [GO:0019732]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cell-cell signaling [GO:0007267]; cellular response to nerve growth factor stimulus [GO:1990090]; chemical synaptic transmission [GO:0007268]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; detection of abiotic stimulus [GO:0009582]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; insemination [GO:0007320]; killing of cells of other organism [GO:0031640]; negative regulation of neuron death [GO:1901215]; negative regulation of systemic arterial blood pressure [GO:0003085]; neuropeptide signaling pathway [GO:0007218]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of flagellated sperm motility [GO:1902093]; positive regulation of neuron death [GO:1901216]; positive regulation of sensory perception of pain [GO:1904058]; regulation of sensory perception of pain [GO:0051930]; response to pain [GO:0048265]; response to yeast [GO:0001878]; sensory perception of pain [GO:0019233]; tachykinin receptor signaling pathway [GO:0007217]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=TAC1&keywords=TAC1	5.910681494382023	279	NA	NA	0.39876995452263947	419	0	0.013972055888223549	0	0.029256594724220618	0.18518518518518515	0.02707275803722504	0.07343608340888486	0.008156606851549756	0.014428412874583796	0.0025370543463746806	0.1532161483484633	251	333	83	0.04611462724224643	0.4353305737758271	0.2234186514730341	2.9086203788516745	365	404	8
TAC3	tachykinin precursor 3	Yes		ENSG00000166863	Q9UHF0	Tachykinin family	12	ligand	extracellular, intracellular, ligand, secreted	P21452, P25103, P29371	TACR1, TACR2, TACR3	TACR1 [CellTalkDB:8925404;Cellinker:12727971;Cellinker:8925404;Cellinker:9190866;Guide2Pharma:9190866;HPRD:12727971;LRdb:12727971;LRdb:8925404;LRdb:9190866;connectomeDB2020:12727971;connectomeDB2020:8925404;connectomeDB2020:9190866], TACR2 [Baccin2019:10189055;Baccin2019:7682062;Baccin2019:7961636;Baccin2019:8925404;Baccin2019:9190866;Cellinker:10189055;Cellinker:7682062;Cellinker:7961636;Cellinker:8925404;Cellinker:9190866;Guide2Pharma:7682062;Guide2Pharma:9190866;HPRD:10189055;HPRD:7961636;LRdb:10189055;LRdb:7682062;LRdb:7961636;LRdb:8925404;LRdb:9190866;connectomeDB2020:10189055;connectomeDB2020:7682062;connectomeDB2020:7961636;connectomeDB2020:8925404;connectomeDB2020:9190866], TACR3 [Baccin2019:10189055;Baccin2019:10866201;Baccin2019:11226387;Baccin2019:1312036;Baccin2019:2176308;Baccin2019:7557266;Baccin2019:8990205;Baccin2019:9190866;CellTalkDB:11226387;Cellinker:10189055;Cellinker:10866201;Cellinker:11226387;Cellinker:1312036;Cellinker:2176308;Cellinker:7557266;Cellinker:8990205;Cellinker:9190866;Guide2Pharma:11226387;Guide2Pharma:1312036;Guide2Pharma:2176308;Guide2Pharma:9190866;HPRD:10189055;HPRD:10866201;HPRD:8990205;LRdb:10189055;LRdb:10866201;LRdb:11226387;LRdb:1312036;LRdb:2176308;LRdb:7557266;LRdb:8990205;LRdb:9190866;connectomeDB2020:10189055;connectomeDB2020:10866201;connectomeDB2020:11226387;connectomeDB2020:1312036;connectomeDB2020:2176308;connectomeDB2020:7557266;connectomeDB2020:8990205;connectomeDB2020:9190866]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	neuromedin K receptor binding [GO:0031836]; signaling receptor binding [GO:0005102]; substance K receptor binding [GO:0031837]	female pregnancy [GO:0007565]; neuropeptide signaling pathway [GO:0007218]; positive regulation of blood pressure [GO:0045777]; positive regulation of flagellated sperm motility [GO:1902093]; tachykinin receptor signaling pathway [GO:0007217]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=TAC3&keywords=TAC3	0.390987397752809	546	NA	NA	0.16659781726881645	561	0	0	0	0.009832134292565945	0	0	0	0	0	2.00293764187475e-4	3.8632412594166507e-5	303	403	400	9.155509517588715e-4	0.9161241648905185	0.9344735606354213	0.9196633735630722	176	155	135
TAC4	tachykinin precursor 4	Yes		ENSG00000176358	Q86UU9	Tachykinin family	9	ligand	ligand, secreted	P21452, P25103, P29371	TACR1, TACR2, TACR3	TACR2 [CellTalkDB:11786503;Cellinker:11786503;HPRD:11786503;LRdb:11786503;connectomeDB2020:11786503], TACR3 [CellTalkDB:11786503;Cellinker:11786503;HPRD:11786503;LRdb:11786503;connectomeDB2020:11786503], TACR1 [CellTalkDB:11786503;Cellinker:11062498;Cellinker:11786503;Cellinker:15224188;HPRD:11786503;LRdb:11062498;LRdb:11786503;LRdb:15224188;connectomeDB2020:11062498;connectomeDB2020:11786503;connectomeDB2020:15224188]	extracellular space [GO:0005615]	receptor ligand activity [GO:0048018]; substance K receptor binding [GO:0031837]; substance P receptor binding [GO:0031835]	detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; inflammatory response [GO:0006954]; negative regulation of sensory perception of pain [GO:1904057]; negative regulation of systemic arterial blood pressure [GO:0003085]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of flagellated sperm motility [GO:1902093]; positive regulation of sensory perception of pain [GO:1904058]; regulation of blood pressure [GO:0008217]; regulation of sensory perception of pain [GO:0051930]; tachykinin receptor signaling pathway [GO:0007217]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=TAC4&keywords=TAC4	0.8686209269662921	467	NA	NA	2.0482428548229312	149	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TAFA1	TAFA chemokine like family member 1	TBD		ENSG00000183662	Q7Z5A9	TAFA family	2	ligand	extracellular, intracellular, ligand, secreted	NA	NA	NA	endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]	receptor ligand activity [GO:0048018]	neuroblast differentiation [GO:0014016]; regulation of neuroblast proliferation [GO:1902692]; regulation of signaling receptor activity [GO:0010469]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=TAFA1&keywords=TAFA1	0.16602038651685394	632	NA	NA	0.1871161706480286	542	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TAFA3	TAFA chemokine like family member 3	TBD		ENSG00000184599	Q7Z5A8	TAFA family	2	ligand	ligand, secreted	NA	NA	NA	extracellular space [GO:0005615]	receptor ligand activity [GO:0048018]	negative regulation of microglial cell activation [GO:1903979]; neuroblast differentiation [GO:0014016]; positive regulation of microglial cell activation [GO:1903980]; regulation of neuroblast proliferation [GO:1902692]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=TAFA3&keywords=TAFA3	0.0033516898876404496	865	NA	NA	0.01828642358845027	801	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TAFA4	TAFA chemokine like family member 4	TBD		ENSG00000163377	Q96LR4	TAFA family	3	ligand	ligand, secreted	P21462	FPR1	FPR1 [connectomeDB2020:25109685]	extracellular space [GO:0005615]	receptor ligand activity [GO:0048018]	macrophage chemotaxis [GO:0048246]; phagocytosis [GO:0006909]; regulation of membrane potential [GO:0042391]; regulation of sensory perception of pain [GO:0051930]; regulation of signaling receptor activity [GO:0010469]; superoxide anion generation [GO:0042554]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=TAFA4&keywords=TAFA4	0.8390981202247191	470	NA	NA	1.937742164566509	164	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TAFA5	TAFA chemokine like family member 5	TBD		ENSG00000219438	Q7Z5A7	TAFA family	2	ligand, receptor	intracellular, ligand, plasma_membrane_transmembrane, receptor, secreted	NA	NA	NA	cytoplasm [GO:0005737]; extracellular space [GO:0005615]	cytokine activity [GO:0005125]; G protein-coupled receptor binding [GO:0001664]; receptor ligand activity [GO:0048018]	G protein-coupled receptor signaling pathway [GO:0007186]; negative regulation of vascular associated smooth muscle cell migration [GO:1904753]; negative regulation of vascular associated smooth muscle cell proliferation [GO:1904706]; negative regulation of vascular wound healing [GO:0061044]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=TAFA5&keywords=TAFA5	0.6002164330370037	508	NA	NA	0.029155677860689254	771	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TCHH	trichohyalin			ENSG00000159450	Q07283	S100-fused protein family	1	ligand	intracellular, ligand, secreted	NA	NA	NA	cornified envelope [GO:0001533]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]	calcium ion binding [GO:0005509]; transition metal ion binding [GO:0046914]	intermediate filament organization [GO:0045109]; keratinization [GO:0031424]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=TCHH&keywords=TCHH	NA	NA	NA	NA	NA	NA	0.11811023622047244	0.001497005988023952	0.011061946902654867	0.008872901678657072	0.003367003367003367	0.018612521150592212	0.025385312783318223	0.0016313213703099511	0.0022197558268590455	0.0191948190679663	5.794861889124976e-4	297	203	381	0.01913930095861545	0.419356519369285	1.0019052656558132	0.3630658883662932	368	130	367
TCHHL1	trichohyalin like 1			ENSG00000182898	Q5QJ38	S-100 family	1	ligand	intracellular, ligand, secreted	NA	NA	NA	NA	transition metal ion binding [GO:0046914]	NA	https://www.genecards.org/cgi-bin/carddisp.pl?gene=TCHHL1&keywords=TCHHL1	0.0024778955056179775	874	NA	NA	1.0238547196732903	261	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TCN1	transcobalamin 1	No		ENSG00000134827	P20061	Eukaryotic cobalamin transport proteins family	1	ligand	extracellular, intracellular, ligand, secreted	Q9NPF0	CD320	CD320 [connectomeDB2020:27411955]	extracellular region [GO:0005576]; extracellular space [GO:0005615]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724]	cobalamin binding [GO:0031419]	cobalamin transport [GO:0015889]; cobalt ion transport [GO:0006824]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=TCN1&keywords=TCN1	37.17586569662922	115	NA	NA	1.7561647593437903	184	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TDGF1	teratocarcinoma-derived growth factor 1	Yes		ENSG00000241186	P13385	EGF-CFC (Cripto-1/FRL1/Cryptic) family	1	cell_surface_ligand, receptor	cell_surface, cell_surface_ligand, extracellular, intracellular, plasma_membrane, receptor, secreted, transmembrane, transmembrane_predicted	O75197, O75581, P01137, P27037, P35052, P36896, P84022, Q13705, Q8NER5, Q96S42	ACVR1B, ACVR1C, ACVR2A, ACVR2B, GPC1, LRP5, LRP6, NODAL, SMAD3, TGFB1	LRP5 [SignaLink3:23022962], LRP6 [SignaLink3:23022962], TGFB1 [SIGNOR:17030617], ACVR2A [CellTalkDB:12682303;Cellinker:12682303;LRdb:12682303;SIGNOR:12682303;connectomeDB2020:12682303], ACVR1B [BioGRID:11909953;CellTalkDB:11909953;Cellinker:11909953;HPRD:11909953;LRdb:11909953;SIGNOR:19874624;connectomeDB2020:11909953], NODAL [SIGNOR:19874624], ACVR2B [CellTalkDB:19035567], SMAD3 [CellTalkDB:32196115], ACVR1C [CellTalkDB:11485994;Cellinker:11485994;HPRD:11485994;LRdb:11485994], GPC1 [CellTalkDB:12649175]	anchored component of membrane [GO:0031225]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extrinsic component of plasma membrane [GO:0019897]; membrane raft [GO:0045121]; plasma membrane [GO:0005886]	activin receptor binding [GO:0070697]; growth factor activity [GO:0008083]; nodal binding [GO:0038100]; signaling receptor binding [GO:0005102]	anatomical structure development [GO:0048856]; anterior/posterior axis specification, embryo [GO:0008595]; anterior/posterior pattern specification [GO:0009952]; blood vessel development [GO:0001568]; cell differentiation [GO:0030154]; cell migration involved in sprouting angiogenesis [GO:0002042]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-6 [GO:0071354]; cellular response to tumor necrosis factor [GO:0071356]; determination of left/right symmetry [GO:0007368]; embryo development ending in birth or egg hatching [GO:0009792]; heart development [GO:0007507]; mammary gland development [GO:0030879]; morphogenesis of a branching structure [GO:0001763]; negative regulation of apoptotic process [GO:0043066]; nodal signaling pathway [GO:0038092]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; regulation of signal transduction [GO:0009966]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=TDGF1&keywords=TDGF1	0.10988776191011236	667	NA	NA	0.10195826617973268	630	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TEK	TEK receptor tyrosine kinase	No		ENSG00000120156	Q02763	Protein kinase superfamily, Tyr protein kinase family, Tie subfamily	1	adhesion, ligand, receptor	adhesion, cell_adhesion, cell_surface, extracellular, intracellular, ligand, matrix_adhesion, plasma_membrane, plasma_membrane_transmembrane, receptor, secreted, transmembrane	O15123, O15524, O60496, O95841, P08648, P23467, P27986, P29353, P35590, P42229, P51692, P62993, Q06124, Q13588, Q14449, Q14451, Q15389, Q8NFZ5, Q8TEW6, Q9Y264	ANGPT1, ANGPT2, ANGPT4, ANGPTL1, DOK2, DOK4, GRAP, GRB14, GRB2, GRB7, ITGA5, PIK3CA_PIK3R1, PIK3R1, PTPN11, PTPRB, SHC1, SOCS1, STAT5A, STAT5B, TIE1, TNIP2	ANGPT2 [DIP:15893672;DIP:16732286;HPRD:9723709;IntAct:15893672;IntAct:16732286;IntAct:20708158;Lit-BM-17:12427764;Lit-BM-17:15893672;Lit-BM-17:16732286;Lit-BM-17:20708158;Lit-BM-17:25237190;Lit-BM-17:9204896;Lit-BM-17:9723709], ANGPT1 [BioGRID:8980223;HPMR:8980223;HPRD:12427764;HPRD:8980223;HPRD:8980224;HPRD:9723709;IntAct:20708158;IntAct:29106382;Lit-BM-17:12427764;Lit-BM-17:20708158;Lit-BM-17:8980223;Lit-BM-17:9204896;Lit-BM-17:9723709], ANGPT4 [HPRD:10051567], TNIP2 [HPRD:12609966;InnateDB:12609966;Lit-BM-17:12609966;SignaLink3:12609966;SignaLink3:23331499], ANGPTL1 [HPRD:10051567], DOK2 [BioGRID:11689432;BioGRID:9764820;HPRD:9764820;SignaLink3:11689432;SignaLink3:23331499;SignaLink3:9764820], GRAP [SignaLink3:23331499;SignaLink3:7478529], GRB7 [HPRD:10521483;SignaLink3:10521483;SignaLink3:23331499], GRB14 [HPRD:10521483;SignaLink3:20973951;SignaLink3:23331499], PIK3R1 [HPRD:10521483;SIGNOR:14665640], SHC1 [HPRD:14665640;InnateDB:14665640;SIGNOR:14665640], TIE1 [HPRD:10995770], ITGA5 [Cellinker:30185785], PTPRB [HPRD:10557082;InnateDB:12237455], PTPN11 [HPRD:10521483], GRB2 [HPRD:10521483;HPRD:7478529], SOCS1 [HPRD:10022833], STAT5A [HPRD:14726409], STAT5B [HPRD:14726409], DOK4 [HPRD:11470823]	apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell-cell junction [GO:0005911]; cell surface [GO:0009986]; centriolar satellite [GO:0034451]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; integral component of plasma membrane [GO:0005887]; membrane raft [GO:0045121]; microvillus [GO:0005902]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	ATP binding [GO:0005524]; identical protein binding [GO:0042802]; protein kinase activity [GO:0004672]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; signaling receptor activity [GO:0038023]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]	angiogenesis [GO:0001525]; cell-cell signaling [GO:0007267]; definitive hemopoiesis [GO:0060216]; endothelial cell proliferation [GO:0001935]; glomerulus vasculature development [GO:0072012]; heart development [GO:0007507]; heart trabecula formation [GO:0060347]; negative regulation of angiogenesis [GO:0016525]; negative regulation of apoptotic process [GO:0043066]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of inflammatory response [GO:0050728]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of actin cytoskeleton reorganization [GO:2000251]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of kinase activity [GO:0033674]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; protein autophosphorylation [GO:0046777]; regulation of endothelial cell apoptotic process [GO:2000351]; regulation of establishment or maintenance of cell polarity [GO:0032878]; regulation of vascular permeability [GO:0043114]; signal transduction [GO:0007165]; sprouting angiogenesis [GO:0002040]; substrate adhesion-dependent cell spreading [GO:0034446]; Tie signaling pathway [GO:0048014]; transmembrane receptor protein tyrosine kinase signaling pathway [GO:0007169]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=TEK&keywords=TEK	0.7845818712076722	481	NA	NA	0.0834148344443421	654	0	4.99001996007984e-4	0.19026548672566396	0.02470023980815347	0	0	0	0	0	6.676458806249166e-5	3.86324125941665e-4	303	407	390	0.01962889247671178	0.3375083968413592	0.3397617577496337	0.35054716048213025	396	365	374
TF	transferrin	TBD		ENSG00000091513	P02787	Transferrin family	7	adhesion, ligand, receptor	adhesion, cell_adhesion, extracellular, intracellular, ligand, plasma_membrane, receptor, secreted	P01130, P02786, P07550, P17936, P98164, Q16538, Q30201, Q9UP52	ADRB2, GPR162, HFE, IGFBP3, LDLR, LRP2, TFR2, TFRC	LDLR [CellTalkDB:32196115], TFR2 [Baccin2019:11027676;CellTalkDB:11027676;Cellinker:11027676;HPRD:11027676;LRdb:11027676;connectomeDB2020:11027676], HFE [CellTalkDB:15056661;InnateDB:19254567], LRP2 [CellTalkDB:32196115], ADRB2 [CellTalkDB:32196115], TFRC [Baccin2019:12210842;Baccin2019:16354665;Baccin2019:6268632;Baccin2019:6270680;CellTalkDB:16354665;Cellinker:12210842;Cellinker:16354665;Cellinker:6268632;Cellinker:6270680;DIP:14691533;DIP:16271884;DIP:20404192;DIP:21788477;DIP:9546397;HPMR:6270680;HPRD:12210842;HPRD:16354665;HPRD:6268632;IntAct:14691533;IntAct:16271884;IntAct:16354665;IntAct:20404192;IntAct:21788477;IntAct:29302006;LRdb:12210842;LRdb:16354665;LRdb:6268632;LRdb:6270680;Lit-BM-17:11027676;Lit-BM-17:14691533;Lit-BM-17:16271884;Lit-BM-17:16354665;Lit-BM-17:9546397;connectomeDB2020:12210842;connectomeDB2020:16354665;connectomeDB2020:6268632;connectomeDB2020:6270680], GPR162 [NA], IGFBP3 [HPRD:11297622;HPRD:11749962]	apical plasma membrane [GO:0016324]; basal part of cell [GO:0045178]; basal plasma membrane [GO:0009925]; blood microparticle [GO:0072562]; cell surface [GO:0009986]; clathrin-coated endocytic vesicle membrane [GO:0030669]; clathrin-coated pit [GO:0005905]; cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; endoplasmic reticulum lumen [GO:0005788]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extrinsic component of external side of plasma membrane [GO:0031232]; HFE-transferrin receptor complex [GO:1990712]; late endosome [GO:0005770]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; secretory granule lumen [GO:0034774]; vesicle [GO:0031982]	ferric iron binding [GO:0008199]; ferrous iron binding [GO:0008198]; iron chaperone activity [GO:0034986]; transferrin receptor binding [GO:1990459]	actin filament organization [GO:0007015]; antibacterial humoral response [GO:0019731]; cellular iron ion homeostasis [GO:0006879]; cellular response to iron ion [GO:0071281]; ERK1 and ERK2 cascade [GO:0070371]; iron ion homeostasis [GO:0055072]; iron ion transport [GO:0006826]; osteoclast differentiation [GO:0030316]; positive regulation of bone resorption [GO:0045780]; positive regulation of cell motility [GO:2000147]; positive regulation of phosphorylation [GO:0042327]; positive regulation of receptor-mediated endocytosis [GO:0048260]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of iron ion transport [GO:0034756]; regulation of protein stability [GO:0031647]; retina homeostasis [GO:0001895]; SMAD protein signal transduction [GO:0060395]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=TF&keywords=TF	1.9559863549438201	388	12972	61	0.019214748050353603	797	0.007874015748031496	0.004990019960079841	0.00331858407079646	0.004316546762589927	0.0016835016835016834	0.001692047377326565	0.008159564823209429	0.0016313213703099511	0.006289308176100631	0.007978368273467736	0.0051767432876183165	281	255	289	0.004828183775730185	1.0985369767780946	1.2124457415272645	1.0235065546232731	110	91	92
TFF1	trefoil factor 1	Yes		ENSG00000160182	P04155	NA	4	ligand	extracellular, intracellular, ligand, secreted	P98088, Q96PJ5	FCRL4, MUC5AC	MUC5AC [CellTalkDB:15289936], FCRL4 [CellTalkDB:32103204;Lit-BM-17:21982860]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	growth factor activity [GO:0008083]	carbohydrate metabolic process [GO:0005975]; cell differentiation [GO:0030154]; maintenance of gastrointestinal epithelium [GO:0030277]; negative regulation of cell population proliferation [GO:0008285]; response to immobilization stress [GO:0035902]; response to iron ion [GO:0010039]; response to peptide hormone [GO:0043434]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=TFF1&keywords=TFF1	59.341091044943816	72	NA	NA	3.063139218502782	109	0	1.161676646706587	0	0.003117505995203837	0.023569023569023566	0.001692047377326565	9.066183136899365e-4	0	0	5.341167044999334e-4	6.181186015066642e-4	303	387	379	0.10837400702434888	0.08447800536094935	0.08899011674356115	0.0896997480141276	484	473	478
TFF2	trefoil factor 2	Yes		ENSG00000160181	Q03403	NA	2	ligand	extracellular, ligand, secreted	P61073, Q6W4X9	CXCR4, MUC6	MUC6 [CellTalkDB:26201258], CXCR4 [connectomeDB2020:19064997;connectomeDB2020:23183167]	extracellular space [GO:0005615]	CXCR4 chemokine receptor binding [GO:0031723]	chemokine-mediated signaling pathway [GO:0070098]; maintenance of gastrointestinal epithelium [GO:0030277]; negative regulation of gastric acid secretion [GO:0060455]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=TFF2&keywords=TFF2	33.550004393258426	126	NA	NA	1.735982783717688	186	0	0.049401197604790406	0	0	0	0	0	0	0	3.338229403124583e-5	0	303	408	401	0.004494052718074695	0.6899381556360409	0.6922413274735226	0.6899381556360409	267	256	241
TFF3	trefoil factor 3		manually added ensembl_gene_ID, hgnc_symbol, and description by searching the uniprot ID on genenames.org	ENSG00000160180	Q07654	NA	1	ecm, ligand	ecm, extracellular, intracellular, ligand, secreted, transmembrane	P25106, P61073	ACKR3, CXCR4	ACKR3 [connectomeDB2020:26780310], CXCR4 [connectomeDB2020:26780310]	extracellular region [GO:0005576]; extracellular space [GO:0005615]; secretory granule [GO:0030141]	identical protein binding [GO:0042802]	maintenance of gastrointestinal epithelium [GO:0030277]; regulation of glucose metabolic process [GO:0010906]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=TFF3&keywords=TFF3	7.82759520425909	262	NA	NA	0.16240398875313933	567	0.023622047244094488	0.16317365269461084	0.02433628318584071	0.03093525179856114	0.1430976430976431	1.1844331641285948	1.8658204895738923	0.5758564437194139	0.10284868664446878	1.616337294699138	0.3345953254780582	123	20	48	0.5513687529331197	0.20102416825810276	2.897092661822765	0.613848426150489	434	6	279
TFRC	transferrin receptor	No		ENSG00000072274	P02786	Peptidase M28 family, M28B subfamily	1	adhesion, ligand, receptor	adhesion, cell_adhesion, cell_surface, extracellular, intracellular, ligand, plasma_membrane, plasma_membrane_transmembrane, receptor, secreted, transmembrane, transmembrane_predicted	P02787	TF	TF [DIP:14691533;DIP:16271884;DIP:20404192;DIP:21788477;DIP:9546397;HPMR:6270680;HPRD:12210842;HPRD:16354665;HPRD:6268632;IntAct:14691533;IntAct:16271884;IntAct:16354665;IntAct:20404192;IntAct:21788477;IntAct:29302006;Lit-BM-17:11027676;Lit-BM-17:14691533;Lit-BM-17:16271884;Lit-BM-17:16354665;Lit-BM-17:9546397]	basolateral plasma membrane [GO:0016323]; blood microparticle [GO:0072562]; cell surface [GO:0009986]; clathrin-coated endocytic vesicle membrane [GO:0030669]; clathrin-coated pit [GO:0005905]; cytoplasmic vesicle [GO:0031410]; early endosome [GO:0005769]; endosome [GO:0005768]; endosome membrane [GO:0010008]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular vesicle [GO:1903561]; HFE-transferrin receptor complex [GO:1990712]; integral component of plasma membrane [GO:0005887]; intracellular membrane-bounded organelle [GO:0043231]; melanosome [GO:0042470]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038]	chaperone binding [GO:0051087]; double-stranded RNA binding [GO:0003725]; Hsp70 protein binding [GO:0030544]; identical protein binding [GO:0042802]; metalloexopeptidase activity [GO:0008235]; protein-containing complex binding [GO:0044877]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723]; transferrin receptor activity [GO:0004998]; virus receptor activity [GO:0001618]	acute-phase response [GO:0006953]; aging [GO:0007568]; cellular iron ion homeostasis [GO:0006879]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to xenobiotic stimulus [GO:0071466]; intracellular signal transduction [GO:0035556]; iron ion transport [GO:0006826]; negative regulation of apoptotic process [GO:0043066]; negative regulation of mitochondrial fusion [GO:0010637]; osteoclast differentiation [GO:0030316]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of bone resorption [GO:0045780]; positive regulation of gene expression [GO:0010628]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of isotype switching [GO:0045830]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of T cell proliferation [GO:0042102]; receptor internalization [GO:0031623]; response to copper ion [GO:0046688]; response to hypoxia [GO:0001666]; response to iron ion [GO:0010039]; response to manganese ion [GO:0010042]; response to nutrient [GO:0007584]; response to retinoic acid [GO:0032526]; transferrin transport [GO:0033572]; transport across blood-brain barrier [GO:0150104]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=TFRC&keywords=TFRC	102.99117061797753	48	6865.34	84	3.166358249138092	104	1.1496062992125977	0.4446107784431194	0.04756637168141596	0.2724220623501208	0.19696969696969696	0.19289340101522826	0.19945602901178547	0.1256117455138664	0.09359970403255624	0.10552143143276767	0.09233146610005437	131	100	117	0.2655080896148372	0.3760314413177107	0.4193032284252258	0.37142817201162653	384	341	363
TG	thyroglobulin	Yes		ENSG00000042832	P01266	Type-B carboxylesterase/lipase family	11	ligand	extracellular, intracellular, ligand, secreted	P07202, P07306, P98164	ASGR1, LRP2, TPO	TPO [CellTalkDB:28153798], ASGR1 [Baccin2019:12477859;CellTalkDB:12477859;HPRD:12477859;LRdb:12477859;connectomeDB2020:12477859], LRP2 [Baccin2019:9492085;CellTalkDB:11029276;HPRD:9492085;LRdb:9492085;connectomeDB2020:9492085]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	hormone activity [GO:0005179]; identical protein binding [GO:0042802]	hormone biosynthetic process [GO:0042446]; iodide transport [GO:0015705]; regulation of myelination [GO:0031641]; signal transduction [GO:0007165]; thyroid gland development [GO:0030878]; thyroid hormone generation [GO:0006590]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=TG&keywords=TG	0.592284066398815	509	NA	NA	0.0044280761063922045	866	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TGFA	transforming growth factor alpha	Yes		ENSG00000163235	P01135	NA	20	cell_surface_ligand, ligand, receptor	cell_surface, cell_surface_ligand, extracellular, intracellular, ligand, plasma_membrane, plasma_membrane_transmembrane, receptor, secreted, transmembrane, transmembrane_predicted	O95406, P00533, P04626, P21860, P23468, P78536, Q15303, Q969F2	ADAM17, CNIH1, EGFR, EGFR_ERBB2, ERBB2, ERBB3, ERBB4, NKD2, PTPRD	EGFR [Baccin2019:12297049;Baccin2019:3018723;CellTalkDB:3018723;HPRD:12297049;ICELLNET:27635238;IntAct:12297049;IntAct:24658140;IntAct:28988771;IntAct:31980649;LRdb:123;LRdb:3018723;Lit-BM-17:10775655;Lit-BM-17:12297049;Lit-BM-17:24658140;Lit-BM-17:25402006;Lit-BM-17:8663070;ProtMapper:21722395;ProtMapper:23155381;SIGNOR:16585207;SPIKE:12648464;SPIKE:17145710;SignaLink3:10209155;SignaLink3:12297049;SignaLink3:23331499;connectomeDB2020:12297049;connectomeDB2020:3018723], ADAM17 [Cellinker:23801765;HPRD:11823465], ERBB4 [Baccin2019:10918572;CellTalkDB:10918572;HPRD:10918572;LRdb:10918572;connectomeDB2020:10918572], ERBB3 [CellTalkDB:32196115], ERBB2 [Baccin2019:10918572;CellTalkDB:10918572;HPRD:10918572;LRdb:10918572;connectomeDB2020:10918572], PTPRD [Cellinker:32589946], NKD2 [Cellinker:27635238;HPRD:15064403], CNIH1 [Cellinker:27635238]	basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; clathrin-coated endocytic vesicle membrane [GO:0030669]; cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; endoplasmic reticulum membrane [GO:0005789]; ER to Golgi transport vesicle membrane [GO:0012507]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]	epidermal growth factor receptor binding [GO:0005154]; growth factor activity [GO:0008083]	angiogenesis [GO:0001525]; epidermal growth factor receptor signaling pathway [GO:0007173]; hepatocyte proliferation [GO:0072574]; intracellular signal transduction [GO:0035556]; mammary gland alveolus development [GO:0060749]; negative regulation of apoptotic process [GO:0043066]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epidermal growth factor-activated receptor activity [GO:0045741]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of mitotic nuclear division [GO:0045840]; response to xenobiotic stimulus [GO:0009410]; wound healing [GO:0042060]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=TGFA&keywords=TGFA	25.055055022094894	152	NA	NA	5.676865749910626	68	0.06299212598425197	0.7450099800399207	0.0022123893805309734	0.002158273381294964	0.10101010101010104	0.005076142131979695	0.001813236627379873	0.0032626427406199023	0	0.001769261583656027	0.0010044427274483296	303	353	366	0.08420987232792577	0.10614598823775066	0.12492599016257634	0.11680774483107313	474	456	465
TGFB1	transforming growth factor beta 1	Yes	manually added ensembl_gene_ID, hgnc_symbol, and description by searching the uniprot ID on genenames.org	ENSG00000105329	P01137	TGF-beta family	21	ecm, ligand, receptor	ecm, extracellular, intracellular, ligand, receptor, secreted	O15105, P00533, P02458, P04004, P05067, P05106, P05556, P06756, P07585, P07996, P08253, P09486, P12643, P14780, P17813, P18084, P18564, P21810, P26012, P27986, P29279, P34741, P35228, P36897, P37023, P37173, P61073, P61812, P63151, P84022, Q03135, Q03167, Q06710, Q6EMK4, Q6YHK3, Q93052	ACVR1_TGFBR1, ACVR1_TGFBR1_TGFBR2, ACVR1_TGFBR2, ACVR1B_TGFBR2, ACVR1C_TGFBR2, ACVRL1, APP, BGN, BMP2, CAV1, CCN2, CD109, COL2A1, CXCR4, DCN, EGFR, ENG, ITGAV, ITGAV_ITGB1, ITGAV_ITGB3, ITGAV_ITGB5, ITGAV_ITGB6, ITGAV_ITGB8, ITGB1, ITGB3, ITGB5, ITGB6, ITGB8, LPP, MMP2, MMP9, NOS2, PAX8, PIK3CA_PIK3R1, PIK3R1, PPP2R2A, SDC2, SMAD3, SMAD7, SPARC, TGFB2, TGFBR1, TGFBR1_TGFBR2, TGFBR2, TGFBR3, THBS1, VASN, VTN	NOS2 [SPIKE:10362813], APP [HPRD:12867422;HPRD:2119582;IntAct:2119582;IntAct:25241761;Lit-BM-17:2119582;Lit-BM-17:25241761;SPIKE:12867422;SPIKE:16189514], TGFBR2 [Baccin2019:10716993;Baccin2019:12809600;Baccin2019:7935686;CancerCellMap:11382746;CancerCellMap:12729750;CancerCellMap:8106553;CellTalkDB:10716993;DIP:10026191;DIP:7706250;DIP:7878020;DIP:9261125;HPMR:10716993;HPMR:12809600;HPRD:7935686;InnateDB:15034927;InnateDB:18382895;IntAct:20856203;IntAct:20860622;IntAct:21054789;IntAct:21441952;LRdb:10716993;LRdb:12809600;LRdb:7935686;Lit-BM-17:10026191;Lit-BM-17:11157754;Lit-BM-17:20860622;Lit-BM-17:21054789;Lit-BM-17:7706250;Lit-BM-17:7878020;Lit-BM-17:8242742;Lit-BM-17:9261125;NetPath:11323414;NetPath:1333888;NetPath:8047140;SIGNOR:1310899;SIGNOR:26194464;SPIKE:11382746;SPIKE:7852346;SignaLink3:10678166;SignaLink3:11013220;SignaLink3:11133108;SignaLink3:11157754;SignaLink3:11274345;SignaLink3:11278410;SignaLink3:11279127;SignaLink3:11792802;SignaLink3:12154066;SignaLink3:12717440;SignaLink3:12724770;SignaLink3:12738796;SignaLink3:12767520;SignaLink3:12809600;SignaLink3:14557817;SignaLink3:15003992;SignaLink3:15099563;SignaLink3:15265520;SignaLink3:15282297;SignaLink3:15548370;SignaLink3:15653932;SignaLink3:15761148;SignaLink3:15761153;SignaLink3:16127449;SignaLink3:16200688;SignaLink3:16424049;SignaLink3:16446785;SignaLink3:16474430;SignaLink3:16572188;SignaLink3:17070508;SignaLink3:17404308;SignaLink3:17673906;SignaLink3:17768418;SignaLink3:17934056;SignaLink3:17979848;SignaLink3:18423981;SignaLink3:18490733;SignaLink3:18758450;SignaLink3:18855897;SignaLink3:18922473;SignaLink3:19010789;SignaLink3:19038247;SignaLink3:19050695;SignaLink3:19109155;SignaLink3:19732719;SignaLink3:19747910;SignaLink3:19920116;SignaLink3:20060931;SignaLink3:20519943;SignaLink3:20538542;SignaLink3:20616810;SignaLink3:20644162;SignaLink3:21041659;SignaLink3:21071413;SignaLink3:21098712;SignaLink3:21278795;SignaLink3:21372296;SignaLink3:21614932;SignaLink3:21900405;SignaLink3:22315516;SignaLink3:22703233;SignaLink3:22710166;SignaLink3:22874531;SignaLink3:22943793;SignaLink3:22949611;SignaLink3:23034983;SignaLink3:23070005;SignaLink3:23331499;SignaLink3:23784029;SignaLink3:24132110;SignaLink3:24336330;SignaLink3:24403530;SignaLink3:26192618;SignaLink3:26201938;SignaLink3:26966341;SignaLink3:2871107;SignaLink3:7594497;SignaLink3:8515656;SignaLink3:9311995;SignaLink3:9865696;connectomeDB2020:10716993;connectomeDB2020:12809600;connectomeDB2020:7935686], TGFBR3 [Baccin2019:7935686;CellTalkDB:7935686;Cellinker:7935686;DIP:10519421;DIP:11323414;DIP:9312157;HPRD:7935686;LRdb:7935686;Lit-BM-17:10519421;Lit-BM-17:11323414;Lit-BM-17:8106553;Lit-BM-17:9312157;NetPath:11278442;NetPath:11323414;SPIKE:11278442;SPIKE:8106553;connectomeDB2020:7935686], TGFBR1 [Baccin2019:12809600;Baccin2019:8235612;BioGRID:8235612;CellTalkDB:12809600;DIP:10187774;DIP:7706250;HPMR:12809600;HPRD:8235612;LRdb:12809600;LRdb:82;NetPath:11323414;NetPath:8047140;SIGNOR:22326956;SIGNOR:22703233;SIGNOR:26194464;SPIKE:7852346;connectomeDB2020:12809600;connectomeDB2020:8235612], ITGB8 [CellTalkDB:11970960;Cellinker:11970960;ELM:12415008;ELM:22278742;ELM:25383667;ELM:25617764;ELM:27033701;ELM:28117447;ELM:31792290;ELM:31955848;HPRD:11970960;LRdb:11970960;connectomeDB2020:11970960], ITGB6 [CellTalkDB:10025398;Cellinker:10025398;ELM:12415008;ELM:22278742;ELM:25383667;ELM:25617764;ELM:27033701;ELM:28117447;ELM:31792290;ELM:31955848;HPRD:10025398;LRdb:10025398;connectomeDB2020:10025398], MMP2 [HPRD:10652271;Lit-BM-17:10652271;Lit-BM-17:25241761], MMP9 [Lit-BM-17:10652271;Lit-BM-17:25241761], PIK3R1 [SIGNOR:19114990], PPP2R2A [SIGNOR:19114990], PAX8 [SIGNOR:14623893], ENG [Baccin2019:12015308;CellTalkDB:12015308;Cellinker:12015308;Cellinker:9872992;HPRD:12015308;InnateDB:8655583;LRdb:12015308;connectomeDB2020:12015308], EGFR [CellTalkDB:32103204;ProtMapper:19132220;ProtMapper:20953304;ProtMapper:28943431], SMAD3 [CellTalkDB:32196115;ProtMapper:21557273;ProtMapper:24075003;ProtMapper:24485922;ProtMapper:24899689;ProtMapper:28756206], ITGB3 [CellTalkDB:32196115;ELM:12415008;ELM:22278742;ELM:25383667;ELM:25617764;ELM:27033701;ELM:28117447;ELM:31792290;ELM:31955848], ACVRL1 [Baccin2019:1071699310716990;CellTalkDB:10716993;Cellinker:10716993;DIP:10187774;HPMR:10716993;HPRD:10716993;InnateDB:18333754;LRdb:10716993;NetPath:10716993;connectomeDB2020:10716993], ITGAV [CellTalkDB:11970960;Cellinker:11970960;ELM:12415008;ELM:22278742;ELM:25383667;ELM:25617764;ELM:27033701;ELM:28117447;ELM:31792290;ELM:31955848;HPRD:11970960;LRdb:11970960;connectomeDB2020:11970960], ITGB1 [CellTalkDB:12415008;ELM:12415008;ELM:22278742;ELM:25383667;ELM:25617764;ELM:27033701;ELM:28117447;ELM:31792290;ELM:31955848;ProtMapper:19115199], CAV1 [CellTalkDB:32196115], SDC2 [Baccin2019:14976204;CancerCellMap:14976204;CellTalkDB:14976204;Cellinker:14976204;HPRD:14976204;LRdb:14976204;NetPath:14976204;connectomeDB2020:14976204], CXCR4 [Baccin2019:27314628;CellTalkDB:32196115], ITGB5 [CellTalkDB:32196115], VASN [HPRD:15247411;connectomeDB2020:15247411;connectomeDB2020:21170088], CD109 [NA], DCN [BioGRID:7798269;BioGRID:8093006;BioGRID:9675033;Cellinker:23350913;HPRD:7638106;HPRD:7798269], LPP [Cellinker:23447672], SMAD7 [ACSN:11133108;ACSN:14557817;ACSN:15548370;ACSN:16474430;ACSN:17934056;ACSN:19010789;ACSN:19920116;ACSN:20519943;ACSN:21900405;ACSN:9335507;NetPath:14718519], SPARC [HPRD:15034927], THBS1 [HPRD:1550960], TGFB2 [HPRD:11157754], VTN [HPRD:11796824], BGN [HPRD:10383378;HPRD:8093006], BMP2 [HPRD:11456401], COL2A1 [HPRD:10085302], CCN2 [HPRD:10457363]	blood microparticle [GO:0072562]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; platelet alpha granule lumen [GO:0031093]; transforming growth factor beta complex [GO:0099126]; transforming growth factor beta ligand-receptor complex [GO:0070021]	antigen binding [GO:0003823]; cytokine activity [GO:0005125]; enzyme binding [GO:0019899]; growth factor activity [GO:0008083]; identical protein binding [GO:0042802]; type III transforming growth factor beta receptor binding [GO:0034714]; type II transforming growth factor beta receptor binding [GO:0005114]; type I transforming growth factor beta receptor binding [GO:0034713]	aortic valve morphogenesis [GO:0003180]; ATP biosynthetic process [GO:0006754]; BMP signaling pathway [GO:0030509]; cell-cell junction organization [GO:0045216]; cell migration [GO:0016477]; cellular response to organic cyclic compound [GO:0071407]; cellular response to transforming growth factor beta stimulus [GO:0071560]; chondrocyte differentiation [GO:0002062]; common-partner SMAD protein phosphorylation [GO:0007182]; connective tissue replacement involved in inflammatory response wound healing [GO:0002248]; embryonic liver development [GO:1990402]; epidermal growth factor receptor signaling pathway [GO:0007173]; epithelial to mesenchymal transition [GO:0001837]; extracellular matrix assembly [GO:0085029]; extrinsic apoptotic signaling pathway [GO:0097191]; heart development [GO:0007507]; heart valve morphogenesis [GO:0003179]; hematopoietic progenitor cell differentiation [GO:0002244]; hyaluronan catabolic process [GO:0030214]; inflammatory response [GO:0006954]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; lymph node development [GO:0048535]; macrophage derived foam cell differentiation [GO:0010742]; MAPK cascade [GO:0000165]; membrane protein intracellular domain proteolysis [GO:0031293]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of cell-cell adhesion [GO:0022408]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cytolysis [GO:0045918]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of extracellular matrix disassembly [GO:0010716]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of gene expression [GO:0010629]; negative regulation of gene silencing by miRNA [GO:0060965]; negative regulation of hyaluronan biosynthetic process [GO:1900126]; negative regulation of macrophage cytokine production [GO:0010936]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of pri-miRNA transcription by RNA polymerase II [GO:1902894]; negative regulation of production of miRNAs involved in gene silencing by miRNA [GO:1903799]; negative regulation of protein localization to plasma membrane [GO:1903077]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of skeletal muscle tissue development [GO:0048642]; negative regulation of transcription, DNA-templated [GO:0045892]; neural tube closure [GO:0001843]; neural tube development [GO:0021915]; ossification involved in bone remodeling [GO:0043932]; pathway-restricted SMAD protein phosphorylation [GO:0060389]; phosphate-containing compound metabolic process [GO:0006796]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of bone mineralization [GO:0030501]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cardiac muscle cell differentiation [GO:2000727]; positive regulation of cell division [GO:0051781]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cellular protein metabolic process [GO:0032270]; positive regulation of chemotaxis [GO:0050921]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of extracellular matrix assembly [GO:1901203]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of gene expression [GO:0010628]; positive regulation of interleukin-17 production [GO:0032740]; positive regulation of isotype switching to IgA isotypes [GO:0048298]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of microglia differentiation [GO:0014008]; positive regulation of NAD+ ADP-ribosyltransferase activity [GO:1901666]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphatidylinositol 3-kinase activity [GO:0043552]; positive regulation of pri-miRNA transcription by RNA polymerase II [GO:1902895]; positive regulation of production of miRNAs involved in gene silencing by miRNA [GO:1903800]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein secretion [GO:0050714]; positive regulation of receptor signaling pathway via STAT [GO:1904894]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of superoxide anion generation [GO:0032930]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription regulatory region DNA binding [GO:2000679]; positive regulation of vascular endothelial growth factor production [GO:0010575]; positive regulation of vascular permeability [GO:0043117]; protein export from nucleus [GO:0006611]; protein kinase B signaling [GO:0043491]; protein phosphorylation [GO:0006468]; receptor catabolic process [GO:0032801]; regulation of binding [GO:0051098]; regulation of blood vessel remodeling [GO:0060312]; regulation of cell migration [GO:0030334]; regulation of cell population proliferation [GO:0042127]; regulation of DNA binding [GO:0051101]; regulation of protein import into nucleus [GO:0042306]; regulation of SMAD protein signal transduction [GO:0060390]; regulation of striated muscle tissue development [GO:0016202]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]; response to cholesterol [GO:0070723]; response to estradiol [GO:0032355]; response to progesterone [GO:0032570]; response to wounding [GO:0009611]; salivary gland morphogenesis [GO:0007435]; SMAD protein complex assembly [GO:0007183]; SMAD protein signal transduction [GO:0060395]; transforming growth factor beta receptor signaling pathway [GO:0007179]; transforming growth factor beta receptor signaling pathway involved in heart development [GO:1905313]; vasculogenesis [GO:0001570]; ventricular cardiac muscle tissue morphogenesis [GO:0055010]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=TGFB1&keywords=TGFB1	25.681031056179776	149	NA	NA	0.44994563254606634	401	0.047244094488188976	0.025948103792415148	0.23783185840707996	0.7630695443645197	0.07239057239057241	0.20642978003384074	0.14143245693562975	0.044045676998368706	0.11912689604143516	0.12354787020963942	0.02167278346532739	110	95	201	0.1638854215570016	0.7425975960791279	0.7680222356413067	0.1821474346826982	244	227	431
TGFB2	transforming growth factor beta 2	Yes		ENSG00000092969	P61812	TGF-beta family	21	ecm, ligand	ecm, extracellular, intracellular, ligand, secreted	P01137, P10600, P17813, P29279, P36897, P37173, Q03167, Q04771	ACVR1, ACVR1_TGFBR1, ACVR1_TGFBR1_TGFBR2, ACVR1_TGFBR2, ACVR1B_TGFBR2, ACVR1C_TGFBR2, CCN2, ENG, TGFB1, TGFB3, TGFBR1, TGFBR1_TGFBR2, TGFBR2, TGFBR3	TGFBR2 [Baccin2019:11157754;Baccin2019:12809600;Baccin2019:8106553;CellTalkDB:11157754;HPMR:12809600;HPRD:11157754;HPRD:8106553;LRdb:11157754;LRdb:12809600;LRdb:8106553;NetPath:12729750;SIGNOR:11157754;SIGNOR:1310899;SignaLink3:11157754;SignaLink3:16446785;SignaLink3:21071413;SignaLink3:23331499;connectomeDB2020:11157754;connectomeDB2020:12809600;connectomeDB2020:8106553], TGFBR1 [Baccin2019:11157750;Baccin2019:12809600;CellTalkDB:12809600;DIP:10187774;HPMR:12809600;HPRD:11157754;LRdb:11;LRdb:12809600;NetPath:7608141;SIGNOR:22326956;connectomeDB2020:11157754;connectomeDB2020:12809600], TGFBR3 [Baccin2019:11157750;Baccin2019:12809600;CellTalkDB:12809600;Cellinker:11157754;Cellinker:12809600;DIP:10519421;DIP:8041735;DIP:9312157;HPMR:12809600;HPRD:11157754;LRdb:11;LRdb:12809600;NetPath:11278442;SIGNOR:10746731;connectomeDB2020:11157754;connectomeDB2020:12809600], ENG [Baccin2019:12015308;CellTalkDB:12015308;Cellinker:12015308;HPRD:12015308;LRdb:12015308;connectomeDB2020:12015308], ACVR1 [Baccin2019:21102460;CellTalkDB:32196115;connectomeDB2020:21102460], TGFB1 [HPRD:11157754], TGFB3 [HPRD:11157754], CCN2 [HPRD:10457363]	axon [GO:0030424]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; neuronal cell body [GO:0043025]; platelet alpha granule lumen [GO:0031093]; transforming growth factor beta complex [GO:0099126]	amyloid-beta binding [GO:0001540]; cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; protein homodimerization activity [GO:0042803]; signaling receptor binding [GO:0005102]; transforming growth factor beta receptor binding [GO:0005160]; type III transforming growth factor beta receptor binding [GO:0034714]; type II transforming growth factor beta receptor binding [GO:0005114]	activation of protein kinase activity [GO:0032147]; ascending aorta morphogenesis [GO:0035910]; atrial septum morphogenesis [GO:0060413]; atrial septum primum morphogenesis [GO:0003289]; atrioventricular valve morphogenesis [GO:0003181]; BMP signaling pathway [GO:0030509]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac muscle cell proliferation [GO:0060038]; cardiac right ventricle morphogenesis [GO:0003215]; cardioblast differentiation [GO:0010002]; cell-cell junction organization [GO:0045216]; cell death [GO:0008219]; cell migration [GO:0016477]; cell morphogenesis [GO:0000902]; collagen fibril organization [GO:0030199]; cranial skeletal system development [GO:1904888]; dopamine biosynthetic process [GO:0042416]; embryo development ending in birth or egg hatching [GO:0009792]; embryonic digestive tract development [GO:0048566]; embryonic limb morphogenesis [GO:0030326]; endocardial cushion fusion [GO:0003274]; endocardial cushion morphogenesis [GO:0003203]; epithelial to mesenchymal transition [GO:0001837]; extrinsic apoptotic signaling pathway [GO:0097191]; eye development [GO:0001654]; generation of neurons [GO:0048699]; glial cell migration [GO:0008347]; hair follicle development [GO:0001942]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart morphogenesis [GO:0003007]; heart valve morphogenesis [GO:0003179]; hemopoiesis [GO:0030097]; inner ear development [GO:0048839]; kidney development [GO:0001822]; male gonad development [GO:0008584]; membranous septum morphogenesis [GO:0003149]; negative regulation of alkaline phosphatase activity [GO:0010693]; negative regulation of angiogenesis [GO:0016525]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of epithelial to mesenchymal transition involved in endocardial cushion formation [GO:1905006]; negative regulation of gene expression [GO:0010629]; negative regulation of macrophage cytokine production [GO:0010936]; negative regulation of Ras protein signal transduction [GO:0046580]; neural retina development [GO:0003407]; neural tube closure [GO:0001843]; neuron development [GO:0048666]; neutrophil chemotaxis [GO:0030593]; odontogenesis [GO:0042476]; outflow tract septum morphogenesis [GO:0003148]; pathway-restricted SMAD protein phosphorylation [GO:0060389]; pharyngeal arch artery morphogenesis [GO:0061626]; positive regulation of cardioblast differentiation [GO:0051891]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cell cycle [GO:0045787]; positive regulation of cell division [GO:0051781]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation [GO:1905007]; positive regulation of heart contraction [GO:0045823]; positive regulation of immune response [GO:0050778]; positive regulation of integrin biosynthetic process [GO:0045726]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of ossification [GO:0045778]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of pri-miRNA transcription by RNA polymerase II [GO:1902895]; positive regulation of protein secretion [GO:0050714]; positive regulation of stress-activated MAPK cascade [GO:0032874]; positive regulation of timing of catagen [GO:0051795]; protein phosphorylation [GO:0006468]; pulmonary valve morphogenesis [GO:0003184]; regulation of apoptotic process involved in outflow tract morphogenesis [GO:1902256]; regulation of cell population proliferation [GO:0042127]; regulation of timing of catagen [GO:0051794]; regulation of transforming growth factor beta2 production [GO:0032909]; response to hypoxia [GO:0001666]; response to progesterone [GO:0032570]; response to wounding [GO:0009611]; response to xenobiotic stimulus [GO:0009410]; salivary gland morphogenesis [GO:0007435]; secondary palate development [GO:0062009]; skeletal system development [GO:0001501]; SMAD protein signal transduction [GO:0060395]; somatic stem cell division [GO:0048103]; substantia propria of cornea development [GO:1903701]; transforming growth factor beta receptor signaling pathway [GO:0007179]; uterine wall breakdown [GO:0042704]; uterus development [GO:0060065]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222]; wound healing [GO:0042060]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=TGFB2&keywords=TGFB2	12.385756767592135	214	NA	NA	3.051516639829271	110	0.047244094488188976	0.22405189620758667	0.008849557522123894	0.12589928057554073	0.0101010101010101	0.00338409475465313	0	0	0.005549389567147615	0.001001468820937375	6.567510141008307e-4	285	371	378	0.03879432209557176	0.31867210977317323	0.22546616795677943	0.21840145648970835	401	403	413
TGFB3	transforming growth factor beta 3	Yes		ENSG00000119699	P10600	TGF-beta family	21	cell_surface_ligand, ecm, ligand	cell_surface_ligand, ecm, extracellular, intracellular, ligand, ligand_regulator, secreted, transmembrane	P05106, P05556, P17813, P18084, P18564, P36897, P37023, P37173, P61812, Q03167	ACVR1_TGFBR1, ACVR1_TGFBR1_TGFBR2, ACVR1_TGFBR2, ACVR1B_TGFBR2, ACVR1C_TGFBR2, ACVRL1, ENG, ITGB1, ITGB3, ITGB5, ITGB6, TGFB2, TGFBR1, TGFBR1_TGFBR2, TGFBR2, TGFBR3	TGFBR2 [Baccin2019:11382746;Baccin2019:11850637;Baccin2019:12729750;Baccin2019:8106553;BioGRID:11850637;BioGRID:12729750;CancerCellMap:11382746;CancerCellMap:11850637;CancerCellMap:12729750;CellTalkDB:11850637;DIP:7878020;Guide2Pharma:29170498;HPRD:11382746;HPRD:11850637;HPRD:12729750;HPRD:8106553;InnateDB:15017149;InnateDB:18243111;IntAct:11850637;IntAct:21423151;LRdb:11382746;LRdb:11850637;LRdb:12729750;LRdb:8106553;Lit-BM-17:11157754;Lit-BM-17:11850637;Lit-BM-17:12729750;Lit-BM-17:21423151;Lit-BM-17:7878020;Lit-BM-17:9872992;NetPath:11382746;SIGNOR:11157754;SignaLink3:11157754;SignaLink3:11382746;SignaLink3:11850637;SignaLink3:12729750;SignaLink3:15017149;SignaLink3:16446785;SignaLink3:18243111;SignaLink3:18988627;SignaLink3:21071413;SignaLink3:23180781;SignaLink3:23331499;SignaLink3:8106553;SignaLink3:9872992;connectomeDB2020:11382746;connectomeDB2020:11850637;connectomeDB2020:12729750;connectomeDB2020:8106553;scConnect:29170498], TGFBR1 [Baccin2019:11850637;Baccin2019:12060054;Baccin2019:12607775;CellTalkDB:11850637;DIP:10187774;HPRD:11850637;HPRD:12060054;HPRD:12607775;InnateDB:18243111;LRdb:11850637;LRdb:12060054;LRdb:12607775;Lit-BM-17:10187774;Lit-BM-17:21423151;connectomeDB2020:11850637], TGFBR3 [Baccin2019:11382746;CancerCellMap:11382746;CellTalkDB:11382746;Cellinker:11382746;HPRD:11382746;LRdb:11382746;NetPath:11382746;connectomeDB2020:11382746], ENG [Baccin2019:9872992;CellTalkDB:9872992;Cellinker:9872992;HPRD:9872992;LRdb:9872992;connectomeDB2020:9872992], ITGB1 [CellTalkDB:32196115], ITGB3 [CellTalkDB:32196115;ELM:25383667;ELM:31955848], ACVRL1 [Baccin2019:1185063710187770;CellTalkDB:11850637;Cellinker:10187774;Cellinker:11850637;DIP:10187774;HPRD:10187774;LRdb:1;LRdb:11850637;connectomeDB2020:10187774;connectomeDB2020:11850637], ITGB6 [CellTalkDB:11821050;ELM:25383667;ELM:31955848], ITGB5 [CellTalkDB:32196115], TGFB2 [HPRD:11157754]	cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; platelet alpha granule lumen [GO:0031093]; transforming growth factor beta complex [GO:0099126]; transforming growth factor beta ligand-receptor complex [GO:0070021]; T-tubule [GO:0030315]	cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; transforming growth factor beta binding [GO:0050431]; type III transforming growth factor beta receptor binding [GO:0034714]; type II transforming growth factor beta receptor binding [GO:0005114]; type I transforming growth factor beta receptor binding [GO:0034713]	aging [GO:0007568]; BMP signaling pathway [GO:0030509]; cell-cell junction organization [GO:0045216]; detection of hypoxia [GO:0070483]; digestive tract development [GO:0048565]; embryonic neurocranium morphogenesis [GO:0048702]; face morphogenesis [GO:0060325]; female pregnancy [GO:0007565]; frontal suture morphogenesis [GO:0060364]; inner ear development [GO:0048839]; in utero embryonic development [GO:0001701]; lung alveolus development [GO:0048286]; mammary gland development [GO:0030879]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of macrophage cytokine production [GO:0010936]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of vascular associated smooth muscle cell proliferation [GO:1904706]; odontogenesis [GO:0042476]; ossification involved in bone remodeling [GO:0043932]; positive regulation of apoptotic process [GO:0043065]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of pathway-restricted SMAD protein phosphorylation [GO:0010862]; positive regulation of protein secretion [GO:0050714]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of tight junction disassembly [GO:1905075]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell population proliferation [GO:0042127]; response to estrogen [GO:0043627]; response to hypoxia [GO:0001666]; response to laminar fluid shear stress [GO:0034616]; response to progesterone [GO:0032570]; salivary gland morphogenesis [GO:0007435]; secondary palate development [GO:0062009]; SMAD protein signal transduction [GO:0060395]; transforming growth factor beta receptor signaling pathway [GO:0007179]; uterine wall breakdown [GO:0042704]; wound healing [GO:0042060]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=TGFB3&keywords=TGFB3	3.436146797752809	325	NA	NA	0.18227758416508213	545	0	0.008483033932135729	0.004424778761061947	0.7594724220623631	0.006734006734006734	0.01015228426395939	0.007252946509519492	0.0032626427406199023	0.007769145394006662	0.004072639871811983	0.00289743094456249	275	301	317	0.07404739374673158	0.2114181606576904	0.16743695722699597	0.1534542639528789	430	433	444
TGFBR3	transforming growth factor beta receptor 3	No		ENSG00000069702	Q03167	NA	1	ligand, receptor	cell_surface, extracellular, intracellular, ligand, ligand_regulator, plasma_membrane, plasma_membrane_transmembrane, receptor, secreted, transmembrane, transmembrane_predicted	P01137	TGFB1	TGFB1 [DIP:10519421;DIP:11323414;DIP:9312157;HPRD:7935686;Lit-BM-17:10519421;Lit-BM-17:11323414;Lit-BM-17:8106553;Lit-BM-17:9312157;NetPath:11278442;NetPath:11323414;SPIKE:11278442;SPIKE:8106553]	cell surface [GO:0009986]; cytoplasm [GO:0005737]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; inhibin-betaglycan-ActRII complex [GO:0034673]; integral component of plasma membrane [GO:0005887]; receptor complex [GO:0043235]	activin binding [GO:0048185]; coreceptor activity [GO:0015026]; fibroblast growth factor binding [GO:0017134]; glycosaminoglycan binding [GO:0005539]; heparin binding [GO:0008201]; PDZ domain binding [GO:0030165]; SMAD binding [GO:0046332]; transforming growth factor beta-activated receptor activity [GO:0005024]; transforming growth factor beta binding [GO:0050431]; transforming growth factor beta receptor activity, type III [GO:0070123]; transforming growth factor beta receptor binding [GO:0005160]; type II transforming growth factor beta receptor binding [GO:0005114]	animal organ regeneration [GO:0031100]; BMP signaling pathway [GO:0030509]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac muscle cell proliferation [GO:0060038]; cell migration [GO:0016477]; definitive erythrocyte differentiation [GO:0060318]; definitive hemopoiesis [GO:0060216]; epicardium-derived cardiac fibroblast cell development [GO:0060939]; epithelial to mesenchymal transition [GO:0001837]; heart morphogenesis [GO:0003007]; heart trabecula formation [GO:0060347]; heart trabecula morphogenesis [GO:0061384]; immune response [GO:0006955]; intracellular signal transduction [GO:0035556]; liver development [GO:0001889]; muscular septum morphogenesis [GO:0003150]; negative regulation of cellular component movement [GO:0051271]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; outflow tract morphogenesis [GO:0003151]; pathway-restricted SMAD protein phosphorylation [GO:0060389]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; regulation of protein binding [GO:0043393]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]; response to follicle-stimulating hormone [GO:0032354]; response to hypoxia [GO:0001666]; response to luteinizing hormone [GO:0034699]; response to prostaglandin E [GO:0034695]; secondary palate development [GO:0062009]; transforming growth factor beta receptor complex assembly [GO:0007181]; transforming growth factor beta receptor signaling pathway [GO:0007179]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; ventricular cardiac muscle tissue morphogenesis [GO:0055010]; ventricular compact myocardium morphogenesis [GO:0003223]; ventricular septum morphogenesis [GO:0060412]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=TGFBR3&keywords=TGFBR3	32.28265367771906	128	4454.92	96	1.1416502512014224	243	0.007874015748031496	0.0573852295409181	0.004424778761061947	0.10071942446043244	0.1144781144781146	0.243654822335025	0.24297370806890234	0.013050570962479609	0.07399186089530146	0.22376151689142937	0.0036314467838516546	145	70	306	0.09872231717504983	0.772535603339554	2.150078502420607	0.1253785527943096	233	17	460
THBS1	thrombospondin 1	TBD	look at all spondins	ENSG00000137801	P07996	Thrombospondin family	8	adhesion, cell_surface_ligand, ecm, ligand, receptor	adhesion, cell_surface_ligand, ecm, extracellular, intracellular, ligand, ligand_regulator, matrix_adhesion, receptor, secreted	O00300, O75096, O75197, P00747, P01137, P01138, P02751, P05106, P05556, P07359, P08246, P08253, P08514, P13224, P13612, P14770, P14780, P16671, P18827, P23229, P26006, P31431, P40197, P98164, Q07954, Q08722, Q12913, Q8WTV0	CALR_LRP1, CD36, CD47, ELANE, FN1, GP1BA, GP1BB, GP5, GP9, ITGA2B, ITGA2B_ITGB3, ITGA3, ITGA3_ITGB1, ITGA4, ITGA6, ITGA6_ITGB1, ITGAV_ITGB3, ITGB1, ITGB3, LRP1, LRP2, LRP4, LRP5, MMP2, MMP9, NGF, PLG, PTPRJ, SCARB1, SDC1, SDC4, TGFB1, TNFRSF11B	NGF [SIGNOR:10708953], ITGA4 [CellTalkDB:14699013;Cellinker:14699013;LRdb:14699013;Ramilowski2015:14699013;connectomeDB2020:14699013;talklr:14699013], CD47 [Baccin2019:10397731;Baccin2019:11980922;Baccin2019:8550562;Baccin2019:9169439;CellTalkDB:11980922;Cellinker:10397731;Cellinker:11980922;Cellinker:15842360;Cellinker:8550562;Cellinker:9169439;HPMR:11980922;HPRD:10397731;HPRD:8550562;HPRD:9169439;LRdb:10397731;LRdb:11980922;LRdb:8550562;LRdb:9169439;connectomeDB2020:10397731;connectomeDB2020:11980922;connectomeDB2020:8550562;connectomeDB2020:9169439], SDC1 [Baccin2019:11257118;CellTalkDB:11257118;Cellinker:11257118;Cellinker:1969657;LRdb:11257118;connectomeDB2020:11257118], ITGB1 [CellTalkDB:15292271;LRdb:15292271;Ramilowski2015:15292271;connectomeDB2020:15292271;talklr:15292271], LRP5 [CellTalkDB:7775583;Cellinker:7775583;HPRD:7775583;LRdb:7775583], ITGA2B [CellTalkDB:2478219;LRdb:2478219;Ramilowski2015:2478219;connectomeDB2020:2478219;talklr:2478219], ITGB3 [BioGRID:14963009;BioGRID:2478219;CellTalkDB:2478219;HPRD:2478219;LRdb:2478219;connectomeDB2020:2478219], SDC4 [Baccin2019:17879962;CellTalkDB:32196115;connectomeDB2020:17879962], SCARB1 [CellTalkDB:32196115], ITGA6 [CellTalkDB:12909644;Cellinker:12909644;LRdb:12909644;Ramilowski2015:12909644;connectomeDB2020:12909644;talklr:12909644], TNFRSF11B [Baccin2019:15799029;CellTalkDB:15799029;Cellinker:15799029;HPRD:15799029;LRdb:15799029;connectomeDB2020:15799029], CD36 [Baccin2019:10487979;Baccin2019:10772961;Baccin2019:1379600;CellTalkDB:10487979;Cellinker:10487979;Cellinker:10772961;Cellinker:1379600;HPRD:10487979;HPRD:10772961;LRdb:10487979;LRdb:10772961;LRdb:1379600;Lit-BM-17:23640500;connectomeDB2020:10487979;connectomeDB2020:10772961;connectomeDB2020:1379600], ITGA3 [CellTalkDB:10196234;LRdb:10196234;Ramilowski2015:10196234;connectomeDB2020:10196234;talklr:10196234], LRP1 [Baccin2019:14991768;Baccin2019:9045712;BioGRID:14991768;BioGRID:7775583;BioGRID:9045712;CellTalkDB:9045712;Cellinker:14991768;Cellinker:9045712;HPRD:14991768;HPRD:9045712;LRdb:15;LRdb:9045712;connectomeDB2020:14991768;connectomeDB2020:7775583;connectomeDB2020:9045712], PTPRJ [Baccin2019:22308318;connectomeDB2020:22308318], GP1BA [Cellinker:19286885], GP9 [Cellinker:19286885], LRP4 [Cellinker:12871303], GP1BB [Cellinker:19286885], LRP2 [Cellinker:12871303], GP5 [Cellinker:19286885], PLG [BioGRID:2522013;BioGRID:6438154;HPRD:2522013], FN1 [HPRD:11773026;IntAct:19542224;Lit-BM-17:18042364;Lit-BM-17:18226512;Lit-BM-17:19542224;MatrixDB:18226512;MatrixDB:19542224], MMP2 [HPRD:10900205;Lit-BM-17:10900205], TGFB1 [ACSN:21900405;ACSN:22943793;ACSN:8349738;HPRD:1550960], MMP9 [HPRD:10900205;HPRD:11606713], ELANE [HPRD:8463250]	cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; fibrinogen complex [GO:0005577]; platelet alpha granule [GO:0031091]; platelet alpha granule lumen [GO:0031093]; sarcoplasmic reticulum [GO:0016529]; secretory granule [GO:0030141]	calcium ion binding [GO:0005509]; collagen V binding [GO:0070052]; extracellular matrix structural constituent [GO:0005201]; fibrinogen binding [GO:0070051]; fibroblast growth factor binding [GO:0017134]; fibronectin binding [GO:0001968]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; laminin binding [GO:0043236]; low-density lipoprotein particle binding [GO:0030169]; phosphatidylserine binding [GO:0001786]; proteoglycan binding [GO:0043394]; transforming growth factor beta binding [GO:0050431]	behavioral response to pain [GO:0048266]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cellular response to growth factor stimulus [GO:0071363]; cellular response to heat [GO:0034605]; cellular response to tumor necrosis factor [GO:0071356]; chronic inflammatory response [GO:0002544]; engulfment of apoptotic cell [GO:0043652]; immune response [GO:0006955]; inflammatory response [GO:0006954]; negative regulation of angiogenesis [GO:0016525]; negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II [GO:0002581]; negative regulation of apoptotic process [GO:0043066]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:1903588]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cGMP-mediated signaling [GO:0010754]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of dendritic cell antigen processing and presentation [GO:0002605]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of fibrinolysis [GO:0051918]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of interleukin-12 production [GO:0032695]; negative regulation of long-chain fatty acid import across plasma membrane [GO:0010748]; negative regulation of nitric oxide mediated signal transduction [GO:0010751]; negative regulation of plasminogen activation [GO:0010757]; negative regulation of sprouting angiogenesis [GO:1903671]; peptide cross-linking [GO:0018149]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood coagulation [GO:0030194]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of chemotaxis [GO:0050921]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902043]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of macrophage activation [GO:0043032]; positive regulation of macrophage chemotaxis [GO:0010759]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of phosphorylation [GO:0042327]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transforming growth factor beta1 production [GO:0032914]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; positive regulation of translation [GO:0045727]; positive regulation of tumor necrosis factor production [GO:0032760]; response to calcium ion [GO:0051592]; response to endoplasmic reticulum stress [GO:0034976]; response to glucose [GO:0009749]; response to hypoxia [GO:0001666]; response to magnesium ion [GO:0032026]; response to mechanical stimulus [GO:0009612]; response to progesterone [GO:0032570]; response to testosterone [GO:0033574]; response to unfolded protein [GO:0006986]; response to xenobiotic stimulus [GO:0009410]; sprouting angiogenesis [GO:0002040]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=THBS1&keywords=THBS1	66.00863087140449	66	1735.85	138	0.6320227225230644	331	0.716535433070866	0.39071856287425516	1.273230088495575	0.9836930455635606	0.3619528619528618	0.005076142131979695	0.006346328195829556	0.004893964110929854	0.004069552349241583	0.003338229403124577	0.005447170175777481	291	315	287	0.34139103439309104	0.04003958829951927	0.03795836574533511	0.0439600577813752	512	507	509
THBS2	thrombospondin 2	TBD		ENSG00000186340	P35442	Thrombospondin family	8	adhesion, ecm, ligand	adhesion, ecm, extracellular, intracellular, ligand, matrix_adhesion, secreted	O75096, P05106, P05556, P13612, P16671, P18827, P23229, P31431, P98164, Q08722, Q99466, Q9UM47	CD36, CD47, ITGA3_ITGB1, ITGA4, ITGA6, ITGAV_ITGB3, ITGB1, ITGB3, LRP2, LRP4, NOTCH3, NOTCH4, SDC1, SDC4	CD47 [Baccin2019:8550562;CellTalkDB:8550562;Cellinker:8550562;LRdb:8550562;SIGNOR:8550562;connectomeDB2020:8550562], ITGA4 [CellTalkDB:14699013;Cellinker:14699013;LRdb:14699013;Ramilowski2015:14699013;connectomeDB2020:14699013;talklr:14699013], ITGB1 [CellTalkDB:15292271;LRdb:15292271;Ramilowski2015:15292271;connectomeDB2020:15292271;talklr:15292271], ITGB3 [CellTalkDB:32196115], NOTCH4 [CellTalkDB:32196115], ITGA6 [CellTalkDB:12909644;Cellinker:12909644;LRdb:12909644;Ramilowski2015:12909644;connectomeDB2020:12909644;talklr:12909644], CD36 [CellTalkDB:20714802], NOTCH3 [Baccin2019:19147503;CellTalkDB:19147503;Cellinker:19147503;LRdb:19147503;Ramilowski2015:19147503;connectomeDB2020:19147503;talklr:19147503], SDC1 [Cellinker:1969657], SDC4 [NA], LRP2 [Cellinker:12871303], LRP4 [Cellinker:12871303]	basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; platelet alpha granule [GO:0031091]	calcium ion binding [GO:0005509]; heparin binding [GO:0008201]	cell adhesion [GO:0007155]; negative regulation of angiogenesis [GO:0016525]; positive regulation of synapse assembly [GO:0051965]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=THBS2&keywords=THBS2	26.141305830393257	148	NA	NA	0.5665317507338825	359	0	0.0034930139720558886	0.0022123893805309734	0.5621103117506097	0.003367003367003367	0	0.0027198549410698096	0	7.399186089530152e-4	7.344104686874084e-4	8.112806644774968e-4	301	382	375	0.05238074392303524	0.1721672095190757	0.1720789107922698	0.17331118522434344	451	431	436
THBS4	thrombospondin 4	TBD		ENSG00000113296	P35443	Thrombospondin family	2	adhesion, ecm, ligand	adhesion, ecm, extracellular, intracellular, ligand, matrix_adhesion, secreted	P16671, P18827, P31431, Q08722	CD36, CD47, ITGA3_ITGB1, ITGAV_ITGB3, SDC1, SDC4	SDC1 [Cellinker:1969657], SDC4 [NA], CD36 [NA], CD47 [NA]	basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; sarcoplasmic reticulum [GO:0016529]	calcium ion binding [GO:0005509]; growth factor activity [GO:0008083]; heparin binding [GO:0008201]; integrin binding [GO:0005178]	behavioral response to pain [GO:0048266]; endothelial cell-cell adhesion [GO:0071603]; myoblast migration [GO:0051451]; negative regulation of angiogenesis [GO:0016525]; positive regulation of cell division [GO:0051781]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; regulation of tissue remodeling [GO:0034103]; response to endoplasmic reticulum stress [GO:0034976]; response to unfolded protein [GO:0006986]; tissue remodeling [GO:0048771]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=THBS4&keywords=THBS4	11.979181023440043	222	NA	NA	0.9035985442734024	284	0	0	0.0011061946902654867	0.1844124700239811	0	0.001692047377326565	0.001813236627379873	0.004893964110929854	0.0036995930447650763	0.001134997997062358	3.86324125941665e-4	292	368	390	0.01810352981796836	0.4874687675711846	0.3962135030434167	0.36957365118245866	346	346	364
THNSL2	threonine synthase like 2	No		ENSG00000144115	Q86YJ6	Threonine synthase family	1	ligand	intracellular, ligand, secreted	NA	NA	NA	extracellular space [GO:0005615]	cytokine activity [GO:0005125]; lyase activity [GO:0016829]; pyridoxal phosphate binding [GO:0030170]; serine binding [GO:0070905]	2-oxobutyrate biosynthetic process [GO:0046360]; dephosphorylation [GO:0016311]; serine family amino acid catabolic process [GO:0009071]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=THNSL2&keywords=THNSL2	12.606238928997378	212	1906.92	134	0.8705889951671515	291	0.015748031496062992	0.025449101796407164	0.0011061946902654867	0.014388489208633089	0.05555555555555554	0.05414551607445011	0.053490480507706176	0.02773246329526917	0.02663706992230851	0.04676859393777681	0.028085763955959173	216	149	187	0.031737023676399474	0.8778074403763779	1.3601495491849616	0.9125174869020444	197	69	139
THPO	thrombopoietin	Yes		ENSG00000090534	P40225	EPO/TPO family	20	ligand	extracellular, intracellular, ligand, secreted	O00241, P40238, Q5TFQ8	MPL, SIRPB1	MPL [Baccin2019:10495959;Baccin2019:9766811;CellTalkDB:10495959;Cellinker:10495959;Cellinker:8521814;Cellinker:9766811;DIP:9252374;HPRD:9766811;ICELLNET:11784712;LRdb:10495959;LRdb:98;SIGNOR:11784712;SignaLink3:23331499;SignaLink3:7543416;SignaLink3:9766811;connectomeDB2020:10495959;connectomeDB2020:9766811], SIRPB1 [NA], SIRPB1 [NA]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; hormone activity [GO:0005179]; signaling receptor binding [GO:0005102]	cell population proliferation [GO:0008283]; cellular response to lipopolysaccharide [GO:0071222]; megakaryocyte development [GO:0035855]; multicellular organism development [GO:0007275]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of hematopoietic stem cell proliferation [GO:1902035]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of megakaryocyte differentiation [GO:0045654]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; receptor signaling pathway via STAT [GO:0097696]; thrombopoietin-mediated signaling pathway [GO:0038163]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=THPO&keywords=THPO	0.16771460618426967	630	NA	NA	0.0669090308580953	681	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TNC	tenascin C	No		ENSG00000041982	P24821	Tenascin family	9	adhesion, ecm, ligand	adhesion, ecm, extracellular, intracellular, ligand, matrix_adhesion, secreted	P00533, P02751, P05106, P05556, P06756, P08648, P17301, P18564, P18827, P21589, P23467, P23471, P31431, P53708, Q12860, Q13683, Q13797	CNTN1, EGFR, FN1, ITGA2, ITGA2B_ITGB3, ITGA5, ITGA7, ITGA8, ITGA8_ITGB1, ITGA9, ITGA9_ITGB1, ITGAV, ITGAV_ITGB3, ITGAV_ITGB6, ITGB1, ITGB3, ITGB6, NT5E, PTPRB, PTPRZ1, SDC1, SDC4	ITGA5 [CellTalkDB:9314546;Cellinker:9314546;HPRD:9314546;LRdb:9314546], SDC1 [CellTalkDB:32196115], EGFR [Baccin2019:11470832;CellTalkDB:11470832;Cellinker:11470832;HPRD:11470832;LRdb:11470832;connectomeDB2020:11470832], ITGB3 [connectomeDB2020:9314546], ITGB6 [NA], PTPRB [CellTalkDB:11313993;Cellinker:11313993;HPRD:11313993;LRdb:11313993;connectomeDB2020:11313993], ITGA8 [NA], ITGA7 [CellTalkDB:14715956;Cellinker:14715956;LRdb:14715956;Ramilowski2015:14715956;connectomeDB2020:14715956;talklr:14715956], ITGB1 [CellTalkDB:14715956;LRdb:14715956;Ramilowski2015:14715956;connectomeDB2020:14715956;talklr:14715956], SDC4 [CellTalkDB:19723805], CNTN1 [Baccin2019:10103110;Cellinker:10103110;HPRD:10103110;LRdb:10103110;connectomeDB2020:10103110], ITGA2 [NA], ITGAV [CellTalkDB:32196115;connectomeDB2020:9314546], ITGA9 [CellTalkDB:32196115], PTPRZ1 [Baccin2019:20689858;connectomeDB2020:20689858], NT5E [NA], FN1 [HPRD:7499434;Lit-BM-17:20708078;Lit-BM-17:21349332;Lit-BM-17:7499434;MatrixDB:20708078;MatrixDB:21349332]	basement membrane [GO:0005604]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; interstitial matrix [GO:0005614]; membrane [GO:0016020]; perisynaptic extracellular matrix [GO:0098966]; tenascin complex [GO:0090733]	extracellular matrix structural constituent [GO:0005201]; syndecan binding [GO:0045545]	cell adhesion [GO:0007155]; mesenchymal-epithelial cell signaling involved in prostate gland development [GO:0060739]; neuromuscular junction development [GO:0007528]; osteoblast differentiation [GO:0001649]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; prostate gland epithelium morphogenesis [GO:0060740]; regulation of cell adhesion [GO:0030155]; regulation of cell growth [GO:0001558]; regulation of inflammatory response [GO:0050727]; response to wounding [GO:0009611]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=TNC&keywords=TNC	12.227771995114272	218	NA	NA	0.401068720378662	416	0	0.19211576846307432	0.0011061946902654867	0.11630695443645173	0.021885521885521883	0.00338409475465313	0.004533091568449683	0.004893964110929854	0.011838697743248245	8.34557350781146e-4	0.015452965037666492	259	378	222	0.033850164549185636	0.49803000667767894	0.24708133851192945	0.5804531248478335	344	397	293
TNF	tumor necrosis factor	Yes		ENSG00000228978, ENSG00000204490, ENSG00000223952, ENSG00000228849, ENSG00000228321, ENSG00000230108, ENSG00000206439, ENSG00000232810	P01375	Tumor necrosis factor family	19	cell_surface_ligand, ligand, receptor	cell_surface, cell_surface_ligand, extracellular, intracellular, ligand, plasma_membrane, receptor, secreted, transmembrane, transmembrane_predicted	O15111, O15552, O75475, O75509, O94759, P01579, P09601, P10415, P19438, P20333, P25445, P35916, P36941, P46531, P48736, P78536, Q12933, Q13332, Q13546, Q15628, Q16236, Q8WWX8, Q9C0C4, Q9H7M9, Q9HCU4, Q9UHD2, Q9Y6K9, Q9Y6W8	ADAM17, BCL2, CELSR2, CHUK, FAS, FFAR2, FLT4, HMOX1, ICOS, IFNG, IKBKG, LTBR, NFE2L2, NOTCH1, PIK3CG, PSIP1, PTPRS, RIPK1, SEMA4C, SLC5A11, TBK1, TNFRSF1A, TNFRSF1B, TNFRSF21, TRADD, TRAF2, TRPM2, VSIR	PSIP1 [SPIKE:16403949], TNFRSF1B [Baccin2019:19084540;Baccin2019:2158863;Baccin2019:7664431;BioGRID:7930591;BioGRID:7966397;CancerCellMap:2158863;CancerCellMap:7664431;CellTalkDB:19084540;Cellinker:19084540;Cellinker:2158863;Cellinker:7664431;DIP:1328224;DIP:14743216;DIP:2172983;HPMR:2158863;HPRD:19084540;HPRD:2158863;HPRD:7664431;ICELLNET:11239407;InnateDB:11448951;InnateDB:14743216;InnateDB:19287455;IntAct:14743216;IntAct:24070898;LRdb:19084540;LRdb:2158863;LRdb:7664431;Lit-BM-17:1310388;Lit-BM-17:1328224;Lit-BM-17:14743216;Lit-BM-17:15485837;Lit-BM-17:2172983;Lit-BM-17:24070898;Lit-BM-17:7930591;Lit-BM-17:7966397;Lit-BM-17:8182064;Lit-BM-17:8805640;Lit-BM-17:9488135;Lit-BM-17:9568681;Macrophage:7852363;Macrophage:8590321;NetPath:15485837;NetPath:1655744;NetPath:7664431;SIGNOR:12040173;SIGNOR:14732063;SIGNOR:17151142;SPIKE:15450251;connectomeDB2020:19084540;connectomeDB2020:2158863;connectomeDB2020:7664431], TNFRSF1A [AlzPathway:18067990;Baccin2019:10634209;Baccin2019:14743216;Baccin2019:19084540;Baccin2019:7852363;BioGRID:2170559;CancerCellMap:10634209;CancerCellMap:14743216;CellTalkDB:19084540;Cellinker:10634209;Cellinker:14743216;Cellinker:19084540;Cellinker:7852363;DIP:14743216;DIP:20080539;DIP:2158863;DIP:2170974;DIP:22801493;DIP:23955153;HPMR:7852363;HPRD:10634209;HPRD:14743216;HPRD:19084540;ICELLNET:11239407;InnateDB:11448951;InnateDB:12887920;InnateDB:14743216;InnateDB:19287455;InnateDB:2158863;InnateDB:2848815;InnateDB:7852363;IntAct:14743216;IntAct:20103630;IntAct:24070898;IntAct:25241761;IntAct:2848815;LRdb:10634209;LRdb:14743216;LRdb:19084540;LRdb:7852363;Lit-BM-17:12753742;Lit-BM-17:12887920;Lit-BM-17:1310388;Lit-BM-17:14743216;Lit-BM-17:15485837;Lit-BM-17:20103630;Lit-BM-17:2158863;Lit-BM-17:2170559;Lit-BM-17:2170974;Lit-BM-17:22028622;Lit-BM-17:22099304;Lit-BM-17:22675546;Lit-BM-17:23032187;Lit-BM-17:23746843;Lit-BM-17:24070898;Lit-BM-17:24726327;Lit-BM-17:24980434;Lit-BM-17:25241761;Lit-BM-17:25911380;Lit-BM-17:26186194;Lit-BM-17:26670046;Lit-BM-17:27560715;Lit-BM-17:2848815;Lit-BM-17:8182064;Lit-BM-17:8288897;Lit-BM-17:8805640;Lit-BM-17:9488135;Lit-BM-17:9568681;Macrophage:1331108;Macrophage:2158863;NetPath:10634209;NetPath:15485837;NetPath:3034874;ProtMapper:21724995;SIGNOR:10634209;SIGNOR:11502070;SIGNOR:14732063;SIGNOR:17151142;SIGNOR:21133840;SIGNOR:23070005;SPIKE:10634209;SPIKE:19442713;SPIKE:2158863;connectomeDB2020:10634209;connectomeDB2020:14743216;connectomeDB2020:19084540;connectomeDB2020:7852363], HMOX1 [NRF2ome:18202225], NFE2L2 [NRF2ome:18202225], TNFRSF21 [Baccin2019:9714541;CellTalkDB:9714541;Cellinker:9714541;HPMR:9714541;LRdb:9714541;SIGNOR:9714541;connectomeDB2020:9714541], PIK3CG [SIGNOR:10485710], ADAM17 [HPRD:10799478;HPRD:12135369], FFAR2 [CellTalkDB:32103204], TRAF2 [Baccin2019:12887920;CellTalkDB:12887920;Cellinker:12887920;HPRD:12887920;InnateDB:12887920;InnateDB:19287455;LRdb:12887920;NetPath:15485837;ProtMapper:18981220;ProtMapper:19336568;ProtMapper:21119000;ProtMapper:23612498;ProtMapper:25134449;ProtMapper:27098354], RIPK1 [InnateDB:12887920;ProtMapper:28506461;ProtMapper:28842570], FLT4 [CellTalkDB:32103204], CELSR2 [CellTalkDB:32103204], NOTCH1 [CellTalkDB:32103204], ICOS [CellTalkDB:32103204], TRADD [CellTalkDB:32196115;InnateDB:12887920;InnateDB:19287455;NetPath:15485837], FAS [CellTalkDB:32103204], PTPRS [CellTalkDB:32103204], VSIR [CellTalkDB:32103204], TRPM2 [CellTalkDB:16306129], LTBR [Baccin2019:24636534;DIP:8171323], SLC5A11 [NA], SEMA4C [NA], BCL2 [HPRD-phos:10669763;HPRD-phos:15225643], TBK1 [NetPath:15485837;ProtMapper:23396211], CHUK [InnateDB:19287455;ProtMapper:21887257], IKBKG [IntAct:23104095], IFNG [HPRD:3139842]	cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; phagocytic cup [GO:0001891]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; recycling endosome [GO:0055037]	cytokine activity [GO:0005125]; identical protein binding [GO:0042802]; protease binding [GO:0002020]; transcription cis-regulatory region binding [GO:0000976]; tumor necrosis factor receptor binding [GO:0005164]	activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; acute inflammatory response [GO:0002526]; astrocyte activation [GO:0048143]; calcium-mediated signaling [GO:0019722]; cellular response to amino acid stimulus [GO:0071230]; cellular response to amyloid-beta [GO:1904646]; cellular response to interferon-gamma [GO:0071346]; cellular response to nicotine [GO:0071316]; cellular response to organic cyclic compound [GO:0071407]; cellular response to retinoic acid [GO:0071300]; cellular response to toxic substance [GO:0097237]; chronic inflammatory response to antigenic stimulus [GO:0002439]; circadian rhythm [GO:0007623]; cognition [GO:0050890]; cortical actin cytoskeleton organization [GO:0030866]; defense response to Gram-positive bacterium [GO:0050830]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; embryonic digestive tract development [GO:0048566]; endothelial cell apoptotic process [GO:0072577]; epithelial cell proliferation involved in salivary gland morphogenesis [GO:0060664]; extracellular matrix organization [GO:0030198]; extrinsic apoptotic signaling pathway [GO:0097191]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; glucose metabolic process [GO:0006006]; humoral immune response [GO:0006959]; inflammatory response [GO:0006954]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; JNK cascade [GO:0007254]; leukocyte migration involved in inflammatory response [GO:0002523]; leukocyte tethering or rolling [GO:0050901]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; liver regeneration [GO:0097421]; MAPK cascade [GO:0000165]; microglial cell activation [GO:0001774]; necroptotic signaling pathway [GO:0097527]; negative regulation of alkaline phosphatase activity [GO:0010693]; negative regulation of amyloid-beta clearance [GO:1900222]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of bicellular tight junction assembly [GO:1903347]; negative regulation of bile acid secretion [GO:0120190]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of branching involved in lung morphogenesis [GO:0061048]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of cytokine production involved in immune response [GO:0002719]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of gene expression [GO:0010629]; negative regulation of glucose import [GO:0046325]; negative regulation of heart rate [GO:0010459]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of L-glutamate import across plasma membrane [GO:0002037]; negative regulation of lipid catabolic process [GO:0050995]; negative regulation of lipid storage [GO:0010888]; negative regulation of mitotic cell cycle [GO:0045930]; negative regulation of myelination [GO:0031642]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myosin-light-chain-phosphatase activity [GO:0035509]; negative regulation of neurogenesis [GO:0050768]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of oxidative phosphorylation [GO:0090324]; negative regulation of production of miRNAs involved in gene silencing by miRNA [GO:1903799]; negative regulation of protein-containing complex disassembly [GO:0043242]; negative regulation of signaling receptor activity [GO:2000272]; negative regulation of systemic arterial blood pressure [GO:0003085]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of vascular wound healing [GO:0061044]; negative regulation of viral genome replication [GO:0045071]; osteoclast differentiation [GO:0030316]; positive regulation of action potential [GO:0045760]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of apoptotic process [GO:0043065]; positive regulation of blood microparticle formation [GO:2000334]; positive regulation of calcidiol 1-monooxygenase activity [GO:0060559]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of cell adhesion [GO:0045785]; positive regulation of chemokine (C-X-C motif) ligand 2 production [GO:2000343]; positive regulation of chemokine production [GO:0032722]; positive regulation of chronic inflammatory response to antigenic stimulus [GO:0002876]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:2001272]; positive regulation of cytokine production [GO:0001819]; positive regulation of cytokine production involved in inflammatory response [GO:1900017]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of fever generation [GO:0031622]; positive regulation of fractalkine production [GO:0032724]; positive regulation of gene expression [GO:0010628]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of hair follicle development [GO:0051798]; positive regulation of hepatocyte proliferation [GO:2000347]; positive regulation of heterotypic cell-cell adhesion [GO:0034116]; positive regulation of humoral immune response mediated by circulating immunoglobulin [GO:0002925]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of I-kappaB phosphorylation [GO:1903721]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-18 production [GO:0032741]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-33 production [GO:0150129]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of JNK cascade [GO:0046330]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of leukocyte adhesion to arterial endothelial cell [GO:1904999]; positive regulation of leukocyte adhesion to vascular endothelial cell [GO:1904996]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of mononuclear cell migration [GO:0071677]; positive regulation of neuroinflammatory response [GO:0150078]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of neutrophil activation [GO:1902565]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of nitric-oxide synthase activity [GO:0051000]; positive regulation of nitrogen compound metabolic process [GO:0051173]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of oxidative stress-induced neuron death [GO:1903223]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of phagocytosis [GO:0050766]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of podosome assembly [GO:0071803]; positive regulation of pri-miRNA transcription by RNA polymerase II [GO:1902895]; positive regulation of programmed cell death [GO:0043068]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of protein-containing complex disassembly [GO:0043243]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein localization to cell surface [GO:2000010]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein transport [GO:0051222]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of superoxide dismutase activity [GO:1901671]; positive regulation of synaptic transmission [GO:0050806]; positive regulation of synoviocyte proliferation [GO:1901647]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of translational initiation by iron [GO:0045994]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; positive regulation of vitamin D biosynthetic process [GO:0060557]; protein kinase B signaling [GO:0043491]; protein localization to plasma membrane [GO:0072659]; regulation of branching involved in salivary gland morphogenesis [GO:0060693]; regulation of endothelial cell apoptotic process [GO:2000351]; regulation of establishment of endothelial barrier [GO:1903140]; regulation of fat cell differentiation [GO:0045598]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of immunoglobulin production [GO:0002637]; regulation of insulin secretion [GO:0050796]; regulation of reactive oxygen species metabolic process [GO:2000377]; regulation of synapse organization [GO:0050807]; regulation of synaptic transmission, glutamatergic [GO:0051966]; regulation of transcription by RNA polymerase II [GO:0006357]; response to 3,3',5-triiodo-L-thyronine [GO:1905242]; response to activity [GO:0014823]; response to ethanol [GO:0045471]; response to glucocorticoid [GO:0051384]; response to gold nanoparticle [GO:1990268]; response to Gram-negative bacterium [GO:0140460]; response to hypoxia [GO:0001666]; response to nutrient levels [GO:0031667]; response to paracetamol [GO:1901554]; response to radiation [GO:0009314]; response to salt stress [GO:0009651]; response to virus [GO:0009615]; response to xenobiotic stimulus [GO:0009410]; sequestering of triglyceride [GO:0030730]; skeletal muscle contraction [GO:0003009]; toll-like receptor 3 signaling pathway [GO:0034138]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; vascular endothelial growth factor production [GO:0010573]; vasodilation [GO:0042311]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=TNF&keywords=TNF	0.25895994473033707	590	NA	NA	0.08595218221586927	651	0.07086614173228346	0.02894211576846306	0	0	0.006734006734006734	0	0	0	0	0	0	303	409	401	0.00968566038497757	0.5079839743466851	0.5079839743466851	0.5079839743466851	339	317	320
TNFRSF11B	TNF receptor superfamily member 11b	No		ENSG00000164761	O00300	NA	1	adhesion, cell_surface_ligand, receptor	adhesion, cell_adhesion, cell_surface, cell_surface_ligand, extracellular, matrix_adhesion, plasma_membrane, plasma_membrane_transmembrane, receptor, secreted	O14786, O14788, P50591, P58401, Q86TY3, Q9BYF1, Q9H158, Q9HDB5, Q9P2S2, Q9Y4C0, Q9Y625	ACE2, ARMH4, GPC6, NRP1, NRXN2, NRXN3, PCDHAC1, TNFSF10, TNFSF11	TNFSF11 [HPMR:9568710;HPRD:12221720;HPRD:9520411;IntAct:22664871;NetPath:14741739;NetPath:9568710], TNFSF10 [HPRD:12221720;HPRD:9520411], GPC6 [Cellinker:32589946], NRXN3 [Cellinker:32589946], ACE2 [Cellinker:32589946], NRP1 [Cellinker:32589946], ARMH4 [Cellinker:32589946], PCDHAC1 [Cellinker:32589946], NRXN3 [Cellinker:32589946], NRXN2 [Cellinker:32589946], NRXN2 [Cellinker:32589946]	extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]	cytokine activity [GO:0005125]; signaling receptor activity [GO:0038023]	apoptotic process [GO:0006915]; extracellular matrix organization [GO:0030198]; negative regulation of bone resorption [GO:0045779]; negative regulation of odontogenesis of dentin-containing tooth [GO:0042489]; negative regulation of osteoclast differentiation [GO:0045671]; response to arsenic-containing substance [GO:0046685]; response to estrogen [GO:0043627]; response to magnesium ion [GO:0032026]; response to nutrient [GO:0007584]; response to xenobiotic stimulus [GO:0009410]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=TNFRSF11B&keywords=TNFRSF11B	24.882358294382023	153	NA	NA	2.0030810801843586	155	0	0.42714570858283724	0.014380530973451327	0.022541966426858507	0.0101010101010101	0.11336717428087983	0.04895738893925651	0.24469820554649246	0.22641509433962145	0.04997329416477648	0.028472088081900725	73	144	186	0.10782295103973497	2.0065283737452146	0.5090119848088928	0.3265245670932676	29	316	383
TNFRSF18	TNF receptor superfamily member 18	No		ENSG00000186891	Q9Y5U5	NA	1	adhesion, cell_surface_ligand, receptor	adhesion, cell_adhesion, cell_surface, cell_surface_ligand, extracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, secreted, transmembrane, transmembrane_predicted	Q9UNG2	TNFSF18	TNFSF18 [DIP:18040044;DIP:18378892;HPMR:10037686;HPRD:10037686;HPRD:10074428;IntAct:18040044;IntAct:18378892;Lit-BM-17:10037686;Lit-BM-17:18040044;Lit-BM-17:18378892]	external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	tumor necrosis factor-activated receptor activity [GO:0005031]	apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066]; positive regulation of cell adhesion [GO:0045785]; positive regulation of leukocyte migration [GO:0002687]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; signal transduction [GO:0007165]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=TNFRSF18&keywords=TNFRSF18	0.10720424157303371	671	NA	NA	0.03352393925328965	758	0	0.001996007984031936	0	0.004076738609112709	0	0.016920473773265648	0.010879419764279238	0.03425774877650898	0.02737698853126153	0.005574843103218042	0.03770523469190626	213	282	172	0.012617041384871304	1.6526029154398263	0.6886330903402849	2.109260618137995	49	258	16
TNFRSF1A	TNF receptor superfamily member 1A	No		ENSG00000067182	P19438	NA	1	adhesion, ligand, receptor	adhesion, cell_adhesion, cell_surface, extracellular, intracellular, ligand, plasma_membrane, plasma_membrane_transmembrane, receptor, secreted, transmembrane	O14920, O15111, P01375, P20333, P21580, Q12933, Q13158, Q13546, Q14790, Q15628, Q5VWQ8, Q92636, Q9NY59, Q9UER7, Q9Y572, Q9Y6K9	CASP8, CHUK, DAB2IP, DAXX, FADD, IKBKB, IKBKG, NSMAF, RIPK1, RIPK3, SMPD3, TNF, TNFAIP3, TNFRSF1B, TRADD, TRAF2	RIPK3 [HPRD:10339433;SPIKE:10339433], RIPK1 [BioGRID:11002422;BioGRID:18621737;BioGRID:18724939;BioGRID:25388546;BioGRID:28817177;CancerCellMap:12887920;DIP:7538908;HPRD:8612133;InnateDB:10356400;InnateDB:10795740;InnateDB:12721308;InnateDB:15115707;InnateDB:15357952;InnateDB:23815148;IntAct:16611992;IntAct:19524513;IntAct:22817896;Lit-BM-17:11002422;Lit-BM-17:15258597;Lit-BM-17:16115877;Lit-BM-17:16611992;Lit-BM-17:16968706;Lit-BM-17:18022363;Lit-BM-17:18450452;Lit-BM-17:18621737;Lit-BM-17:18724939;Lit-BM-17:18939944;Lit-BM-17:18949366;Lit-BM-17:19524513;Lit-BM-17:19773432;Lit-BM-17:19815541;Lit-BM-17:20448643;Lit-BM-17:20825417;Lit-BM-17:21113135;Lit-BM-17:21331078;Lit-BM-17:21737329;Lit-BM-17:22179575;Lit-BM-17:22733818;Lit-BM-17:22817896;Lit-BM-17:22848449;Lit-BM-17:24098568;Lit-BM-17:24130170;Lit-BM-17:24758719;Lit-BM-17:25388546;Lit-BM-17:25681446;Lit-BM-17:26802121;Lit-BM-17:27321185;Lit-BM-17:27552911;Lit-BM-17:7538908;Lit-BM-17:8612133;Lit-BM-17:8985253;NetPath:10744744;NetPath:10755617;NetPath:12887920;NetPath:20448643;NetPath:20547836;NetPath:21119000;NetPath:21741934;SPIKE:18329793;SPIKE:8612133], TRADD [CancerCellMap:10634209;CancerCellMap:12887920;CancerCellMap:7758105;CancerCellMap:8791485;CancerCellMap:8943045;DIP:19641494;DIP:23955153;DIP:9129204;DOMINO:8565075;DOMINO:8621670;HPRD:11934887;HPRD:7758105;HPRD:8565075;HPRD:8612133;HPRD:8621670;InnateDB:10795740;InnateDB:12721308;InnateDB:15115707;InnateDB:15173123;InnateDB:15310755;InnateDB:15357952;InnateDB:15465831;IntAct:11684708;IntAct:23955153;IntAct:7758105;IntAct:8565075;IntAct:8621670;Lit-BM-17:10187805;Lit-BM-17:11035039;Lit-BM-17:11684708;Lit-BM-17:11821416;Lit-BM-17:15310755;Lit-BM-17:16611992;Lit-BM-17:18776134;Lit-BM-17:18939944;Lit-BM-17:19524513;Lit-BM-17:21724995;Lit-BM-17:22297296;Lit-BM-17:24130170;Lit-BM-17:24758719;Lit-BM-17:27552911;Lit-BM-17:7758105;Lit-BM-17:8565075;Lit-BM-17:8612133;Lit-BM-17:8621670;Lit-BM-17:8943045;Lit-BM-17:9082980;Lit-BM-17:9129204;Lit-BM-17:9915703;MPPI:9916731;Macrophage:15725726;Macrophage:7758105;Macrophage:9430227;NetPath:12887920;NetPath:15485837;NetPath:21119000;NetPath:21741934;NetPath:21760970;NetPath:7758105;SIGNOR:11502070;SIGNOR:21232017;SIGNOR:7758105;SPIKE:7758105;SPIKE:8565075], TNF [AlzPathway:18067990;BioGRID:2170559;CancerCellMap:10634209;CancerCellMap:14743216;DIP:14743216;DIP:20080539;DIP:2158863;DIP:2170974;DIP:22801493;DIP:23955153;HPMR:7852363;HPRD:10634209;HPRD:14743216;HPRD:19084540;InnateDB:11448951;InnateDB:12887920;InnateDB:14743216;InnateDB:19287455;InnateDB:2158863;InnateDB:2848815;InnateDB:7852363;IntAct:14743216;IntAct:20103630;IntAct:24070898;IntAct:25241761;IntAct:2848815;Lit-BM-17:12753742;Lit-BM-17:12887920;Lit-BM-17:1310388;Lit-BM-17:14743216;Lit-BM-17:15485837;Lit-BM-17:20103630;Lit-BM-17:2158863;Lit-BM-17:2170559;Lit-BM-17:2170974;Lit-BM-17:22028622;Lit-BM-17:22099304;Lit-BM-17:22675546;Lit-BM-17:23032187;Lit-BM-17:23746843;Lit-BM-17:24070898;Lit-BM-17:24726327;Lit-BM-17:24980434;Lit-BM-17:25241761;Lit-BM-17:25911380;Lit-BM-17:26186194;Lit-BM-17:26670046;Lit-BM-17:27560715;Lit-BM-17:2848815;Lit-BM-17:8182064;Lit-BM-17:8288897;Lit-BM-17:8805640;Lit-BM-17:9488135;Lit-BM-17:9568681;Macrophage:1331108;Macrophage:2158863;NetPath:10634209;NetPath:15485837;NetPath:3034874], CASP8 [InnateDB:15357952;Macrophage:12887920;Macrophage:15725726;Macrophage:8875942;NetPath:21741934], TRAF2 [CancerCellMap:12887920;HPRD:8565075;InnateDB:10795740;InnateDB:12721308;InnateDB:15115707;InnateDB:15743837;IntAct:25241761;Lit-BM-17:11821416;Lit-BM-17:15743837;Lit-BM-17:16611992;Lit-BM-17:18022363;Lit-BM-17:18776134;Lit-BM-17:19815541;Lit-BM-17:20333651;Lit-BM-17:20448643;Lit-BM-17:22179575;Lit-BM-17:24735611;Lit-BM-17:25241761;Lit-BM-17:26212014;Lit-BM-17:27321185;Lit-BM-17:8565075;Lit-BM-17:8612133;Lit-BM-17:8943045;NetPath:12887920;NetPath:15485837;NetPath:20448643;NetPath:21119000;NetPath:21741934;ProtMapper:19150425;SIGNOR:10795740], IKBKB [HPRD:10755617;InnateDB:10755617;InnateDB:23815148;Lit-BM-17:10755617;Lit-BM-17:11002417;Lit-BM-17:11821416;Lit-BM-17:18949366;Lit-BM-17:21331078;Lit-BM-17:21724995;Lit-BM-17:25241761;NetPath:10755617;NetPath:21119000;NetPath:21724995], NSMAF [CancerCellMap:12391233;HPRD:8808629;Lit-BM-17:10187805;Lit-BM-17:17599063;Lit-BM-17:8808629;NetPath:8808629], FADD [AlzPathway:15033800;DIP:9129204;InnateDB:15357952;NetPath:21741934;NetPath:21760970], CHUK [HPRD:10755617;InnateDB:10755617;InnateDB:10795740;InnateDB:23815148;InnateDB:24323043;NetPath:10755617;NetPath:21724995], TNFRSF1B [NetPath:15485837], IKBKG [HPRD:10755617;InnateDB:10755617;NetPath:10755617], SMPD3 [NetPath:20080539], TNFAIP3 [NetPath:20448643], DAB2IP [ACSN:15310755;InnateDB:15310755], DAXX [Lit-BM-17:9215629]	cell surface [GO:0009986]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi membrane [GO:0000139]; integral component of plasma membrane [GO:0005887]; membrane [GO:0016020]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; tumor necrosis factor receptor superfamily complex [GO:0002947]	tumor necrosis factor-activated receptor activity [GO:0005031]; tumor necrosis factor binding [GO:0043120]	aortic valve development [GO:0003176]; cellular response to mechanical stimulus [GO:0071260]; cytokine-mediated signaling pathway [GO:0019221]; defense response to bacterium [GO:0042742]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; inflammatory response [GO:0006954]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of extracellular matrix constituent secretion [GO:0003332]; negative regulation of inflammatory response [GO:0050728]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of inflammatory response [GO:0050729]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; prostaglandin metabolic process [GO:0006693]; protein localization to plasma membrane [GO:0072659]; pulmonary valve development [GO:0003177]; regulation of establishment of endothelial barrier [GO:1903140]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]; tumor necrosis factor-mediated signaling pathway [GO:0033209]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=TNFRSF1A&keywords=TNFRSF1A	107.2761816019337	45	NA	NA	1.3373278299908227	220	0.25196850393700776	0.46606786427146374	0.21238938053097373	0.5395683453237528	0.38215488215488147	0.3976311336717437	0.4904805077062541	0.36541598694942945	0.2815390307066221	0.29613433035119263	0.3417809542205729	62	63	47	0.3659209927112631	0.7755327219263518	0.8143581664414467	0.9357842765933755	229	206	124
TNFRSF1B	TNF receptor superfamily member 1B	No		ENSG00000028137	P20333	NA	1	adhesion, ligand, receptor	adhesion, cell_adhesion, cell_surface, extracellular, intracellular, ligand, plasma_membrane, plasma_membrane_transmembrane, receptor, secreted, transmembrane, transmembrane_predicted	P01375, P19438, Q12933, Q13077, Q13490	BIRC2, TNF, TNFRSF1A, TRAF1, TRAF2	TNF [BioGRID:7930591;BioGRID:7966397;CancerCellMap:2158863;CancerCellMap:7664431;DIP:1328224;DIP:14743216;DIP:2172983;HPMR:2158863;HPRD:19084540;HPRD:2158863;HPRD:7664431;InnateDB:11448951;InnateDB:14743216;InnateDB:19287455;IntAct:14743216;IntAct:24070898;Lit-BM-17:1310388;Lit-BM-17:1328224;Lit-BM-17:14743216;Lit-BM-17:15485837;Lit-BM-17:2172983;Lit-BM-17:24070898;Lit-BM-17:7930591;Lit-BM-17:7966397;Lit-BM-17:8182064;Lit-BM-17:8805640;Lit-BM-17:9488135;Lit-BM-17:9568681;Macrophage:7852363;Macrophage:8590321;NetPath:15485837;NetPath:1655744;NetPath:7664431], TRAF2 [BioGRID:11907088;BioGRID:18671942;CancerCellMap:11112773;CancerCellMap:14743216;CancerCellMap:7544915;CancerCellMap:8548810;HPRD:7639698;HPRD:8069916;HPRD:8702708;HPRD:9461607;InnateDB:15572357;InnateDB:8855313;InnateDB:9168896;LMPID:10206649;Lit-BM-17:10206649;Lit-BM-17:11907088;Lit-BM-17:14743216;Lit-BM-17:18671942;Lit-BM-17:7639698;Lit-BM-17:8069916;Lit-BM-17:8548810;Lit-BM-17:8702708;Lit-BM-17:8710854;Lit-BM-17:9162022;Lit-BM-17:9168896;Macrophage:8069916;Macrophage:8702708;NetPath:11112773;NetPath:15485837;NetPath:7544915;SIGNOR:8069916;SPIKE:18161752], TRAF1 [CancerCellMap:8548810;HPRD:8069916;InnateDB:18429822;InnateDB:9168896;Lit-BM-17:18429822;Lit-BM-17:7859281;Lit-BM-17:8069916;Lit-BM-17:9162022;Lit-BM-17:9168896;SIGNOR:8069916], BIRC2 [CancerCellMap:8548810;InnateDB:8548810;InnateDB:9718306], TNFRSF1A [NetPath:15485837]	extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; membrane [GO:0016020]; membrane raft [GO:0045121]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; specific granule membrane [GO:0035579]; tumor necrosis factor receptor superfamily complex [GO:0002947]; varicosity [GO:0043196]	tumor necrosis factor-activated receptor activity [GO:0005031]; tumor necrosis factor binding [GO:0043120]; ubiquitin protein ligase binding [GO:0031625]	aging [GO:0007568]; aortic valve development [GO:0003176]; cellular response to growth factor stimulus [GO:0071363]; cellular response to lipopolysaccharide [GO:0071222]; extrinsic apoptotic signaling pathway [GO:0097191]; glial cell-neuron signaling [GO:0150098]; immune response [GO:0006955]; inflammatory response [GO:0006954]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of cell death [GO:0060548]; negative regulation of extracellular matrix constituent secretion [GO:0003332]; negative regulation of neuroinflammatory response [GO:0150079]; negative regulation of neuron death [GO:1901215]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; positive regulation of myelination [GO:0031643]; positive regulation of oligodendrocyte differentiation [GO:0048714]; pulmonary valve development [GO:0003177]; regulation of cytokine production involved in immune response [GO:0002718]; regulation of myelination [GO:0031641]; regulation of neuroinflammatory response [GO:0150077]; regulation of RNA biosynthetic process [GO:2001141]; regulation of T cell cytokine production [GO:0002724]; regulation of T cell proliferation [GO:0042129]; RNA destabilization [GO:0050779]; tumor necrosis factor-mediated signaling pathway [GO:0033209]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=TNFRSF1B&keywords=TNFRSF1B	2.0098962972339103	386	NA	NA	0.05182996568674942	704	0.22834645669291329	0.003992015968063873	0.024336283185840718	0.01558752997601918	0.0016835016835016834	0.005076142131979695	0.008159564823209429	0	0.0014798372179060304	0.002670583522499662	0.00301332818234499	299	331	315	0.026758658489479867	0.3123029427526986	0.34469657063589293	0.35402075911092723	403	364	371
TNFRSF25	TNF receptor superfamily member 25	No		ENSG00000215788	Q93038	NA	1	adhesion, ligand, receptor	adhesion, cell_adhesion, cell_surface, extracellular, intracellular, ligand, plasma_membrane, plasma_membrane_transmembrane, receptor, secreted, transmembrane, transmembrane_predicted	Q15628	TRADD	TRADD [BioGRID:21421854;HPRD:8934525;SIGNOR:14585074]	cytosol [GO:0005829]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	signaling receptor activity [GO:0038023]; tumor necrosis factor-activated receptor activity [GO:0005031]	apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; cell surface receptor signaling pathway [GO:0007166]; regulation of apoptotic process [GO:0042981]; signal transduction [GO:0007165]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=TNFRSF25&keywords=TNFRSF25	0.33772752005741574	565	NA	NA	0.009696170013053087	834	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TNFRSF6B	TNF receptor superfamily member 6b	No		ENSG00000243509	O95407	NA	1	adhesion, ligand, receptor	adhesion, cell_adhesion, cell_surface, extracellular, intracellular, ligand, plasma_membrane, plasma_membrane_transmembrane, receptor, secreted	O95150, P48023, Q96LC7	FASLG, SIGLEC10, TNFSF15	TNFSF15 [HPMR:14697332;HPRD:11911831;SIGNOR:11911831], FASLG [BioGRID:9872321;HPMR:14697332;HPRD:10318773;HPRD:11994433;HPRD:9872321;SIGNOR:10318773], SIGLEC10 [Cellinker:32822567]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	signaling receptor activity [GO:0038023]	apoptotic process [GO:0006915]; negative regulation of apoptotic process [GO:0043066]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=TNFRSF6B&keywords=TNFRSF6B	0.0074267798876404495	842	NA	NA	5.624673807663503e-4	900	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TNFSF10	TNF superfamily member 10	Yes		ENSG00000121858	P50591	Tumor necrosis factor family	18	cell_surface_ligand, ligand	cell_surface, cell_surface_ligand, extracellular, intracellular, ligand, plasma_membrane, secreted, transmembrane, transmembrane_predicted	O00220, O00300, O14763, O14798, P51684, Q13546, Q14790, Q9UBN6	CASP8, CCR6, RIPK1, TNFRSF10A, TNFRSF10B, TNFRSF10C, TNFRSF10D, TNFRSF11B	TNFRSF10C [CellTalkDB:9314565;Cellinker:9314565;Cellinker:9325248;Cellinker:9613612;HPMR:9325248;HPRD:9314565;HPRD:9325248;HPRD:9613612;ICELLNET:11239407;LRdb:9314565;LRdb:9325248;LRdb:9613612;Lit-BM-17:20103630;Lit-BM-17:9325248;SPIKE:9082980;SPIKE:9314565;connectomeDB2020:9314565;connectomeDB2020:9325248;connectomeDB2020:9613612], TNFRSF10D [CellTalkDB:9242610;Cellinker:9242610;Cellinker:9430226;DIP:9382840;HPMR:9242610;HPRD:9430226;ICELLNET:11239407;LRdb:9242610;LRdb:943;Lit-BM-17:20103630;Lit-BM-17:9382840;Lit-BM-17:9430226;SPIKE:9430226;connectomeDB2020:9242610;connectomeDB2020:9430226], TNFRSF10B [BioGRID:11094155;BioGRID:9311998;CellTalkDB:10549288;Cellinker:10549288;Cellinker:15766588;Cellinker:9311998;Cellinker:9325248;HPMR:15766588;HPRD:10549288;HPRD:9311998;HPRD:9325248;ICELLNET:11239407;InnateDB:10894161;InnateDB:16227629;IntAct:10542098;IntAct:10549288;IntAct:20103630;LRdb:10549288;LRdb:15766588;LRdb:9311998;LRdb:9325248;Lit-BM-17:10542098;Lit-BM-17:10549288;Lit-BM-17:10894160;Lit-BM-17:11094155;Lit-BM-17:19427028;Lit-BM-17:20097879;Lit-BM-17:20103630;Lit-BM-17:21459798;Lit-BM-17:21525171;Lit-BM-17:21822306;Lit-BM-17:22266862;Lit-BM-17:22585859;Lit-BM-17:23678861;Lit-BM-17:9311998;Lit-BM-17:9325248;Macrophage:10549288;Macrophage:12628743;Macrophage:9242610;Macrophage:9311998;SIGNOR:14585074;SIGNOR:15766588;SPIKE:15538968;connectomeDB2020:10549288;connectomeDB2020:15766588;connectomeDB2020:9311998;connectomeDB2020:9325248], TNFRSF10A [Baccin2019:10549288;Baccin2019:15766588;Baccin2019:9082980;Baccin2019:9242610;Baccin2019:9311998;Baccin2019:9314565;Baccin2019:9325248;Baccin2019:9430226;Baccin2019:9613612;CellTalkDB:15766588;Cellinker:10549288;Cellinker:15766588;Cellinker:9082980;Cellinker:9325248;HPMR:15766588;HPRD:10549288;HPRD:9082980;HPRD:9325248;ICELLNET:11239407;InnateDB:10894161;IntAct:20103630;LRdb:10549288;LRdb:15766588;LRdb:9082980;LRdb:9325248;Lit-BM-17:10894160;Lit-BM-17:19427028;Lit-BM-17:20103630;Lit-BM-17:9082980;Macrophage:10549288;Macrophage:12628743;Macrophage:9082980;SIGNOR:14585074;SPIKE:15538968;connectomeDB2020:10549288;connectomeDB2020:15766588;connectomeDB2020:9082980;connectomeDB2020:9325248], TNFRSF11B [Baccin2019:12221720;Baccin2019:9520411;CellTalkDB:9520411;Cellinker:12221720;Cellinker:9520411;HPRD:12221720;HPRD:9520411;ICELLNET:11239407;LRdb:122;LRdb:9520411;connectomeDB2020:12221720;connectomeDB2020:9520411], RIPK1 [CellTalkDB:32103204], CCR6 [Cellinker:16230375], CASP8 [InnateDB:10894161;IntAct:23678861;ProtMapper:27821809]	extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; integral component of plasma membrane [GO:0005887]	cytokine activity [GO:0005125]; identical protein binding [GO:0042802]; signaling receptor binding [GO:0005102]; TRAIL binding [GO:0045569]; tumor necrosis factor receptor binding [GO:0005164]; zinc ion binding [GO:0008270]	apoptotic process [GO:0006915]; cell-cell signaling [GO:0007267]; immune response [GO:0006955]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; signal transduction [GO:0007165]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=TNFSF10&keywords=TNFSF10	103.04027530449439	47	NA	NA	2.592821337797323	126	0	0.883732534930137	0.421460176991149	0.04148681055155874	0.6616161616161621	0.09644670050761418	0.1532184950135989	0.09624796084828724	0.09766925638179773	0.044565362531714336	0.16136758740582652	129	150	80	0.24161918607071325	0.4279055904407032	0.21685692328874984	0.6810593026783999	367	406	243
TNFSF11	TNF superfamily member 11	Yes		ENSG00000120659	O14788	Tumor necrosis factor family	17	adhesion, cell_surface_ligand, ligand	adhesion, cell_adhesion, cell_surface, cell_surface_ligand, extracellular, intracellular, ligand, plasma_membrane, secreted, transmembrane, transmembrane_predicted	O00300, P19838, Q9BXB1, Q9Y4K3, Q9Y6Q6	LGR4, NFKB1, TNFRSF11A, TNFRSF11B, TRAF6	TNFRSF11A [Baccin2019:11581298;Baccin2019:9367155;CellTalkDB:11581298;Cellinker:11581298;Cellinker:9367155;HPMR:11581298;HPMR:15110169;HPRD:9367155;ICELLNET:11239407;IntAct:23333834;LRdb:11581298;LRdb:94;NetPath:14741739;NetPath:20483727;NetPath:9520411;SIGNOR:12897775;connectomeDB2020:11581298;connectomeDB2020:9367155], TNFRSF11B [Baccin2019:11733492;Baccin2019:12221720;Baccin2019:9520411;Baccin2019:9568710;CellTalkDB:11733492;Cellinker:11733492;Cellinker:12221720;Cellinker:9520411;Cellinker:9568710;HPMR:9568710;HPRD:12221720;HPRD:9520411;ICELLNET:11239407;IntAct:22664871;LRdb:11733492;LRdb:12221720;LRdb:9520411;LRdb:9568710;NetPath:14741739;NetPath:9568710;SIGNOR:11733492;connectomeDB2020:11733492;connectomeDB2020:12221720;connectomeDB2020:9520411;connectomeDB2020:9568710], LGR4 [CellTalkDB:27064449], TRAF6 [HPRD:10635328], NFKB1 [HPRD:10635328]	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	cytokine activity [GO:0005125]; identical protein binding [GO:0042802]; tumor necrosis factor receptor binding [GO:0005164]; tumor necrosis factor receptor superfamily binding [GO:0032813]	bone resorption [GO:0045453]; calcium ion homeostasis [GO:0055074]; calcium-mediated signaling [GO:0019722]; cellular response to leukemia inhibitory factor [GO:1990830]; cytokine-mediated signaling pathway [GO:0019221]; ERK1 and ERK2 cascade [GO:0070371]; immune response [GO:0006955]; mammary gland alveolus development [GO:0060749]; mammary gland epithelial cell proliferation [GO:0033598]; monocyte chemotaxis [GO:0002548]; ossification [GO:0001503]; osteoclast development [GO:0036035]; osteoclast differentiation [GO:0030316]; osteoclast proliferation [GO:0002158]; paracrine signaling [GO:0038001]; positive regulation of bone resorption [GO:0045780]; positive regulation of corticotropin-releasing hormone secretion [GO:0051466]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of ERK1 and ERK2 cascade via TNFSF11-mediated signaling [GO:0071848]; positive regulation of fever generation by positive regulation of prostaglandin secretion [GO:0071812]; positive regulation of gene expression [GO:0010628]; positive regulation of homotypic cell-cell adhesion [GO:0034112]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of JNK cascade [GO:0046330]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of osteoclast development [GO:2001206]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of T cell activation [GO:0050870]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of actin binding [GO:1904616]; TNFSF11-mediated signaling pathway [GO:0071847]; tooth eruption [GO:0044691]; tumor necrosis factor-mediated signaling pathway [GO:0033209]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=TNFSF11&keywords=TNFSF11	1.561052617111743	407	NA	NA	4.318329615856643	83	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TNFSF12	TNF superfamily member 12	Yes		ENSG00000239697	O43508	Tumor necrosis factor family	16	adhesion, cell_surface_ligand, ligand	adhesion, cell_adhesion, cell_surface, cell_surface_ligand, extracellular, intracellular, ligand, plasma_membrane, secreted, transmembrane	P28908, Q86VB7, Q93038, Q9NP84	CD163, TNFRSF12A, TNFRSF25, TNFRSF8	TNFRSF12A [Baccin2019:11728344;Baccin2019:12529173;Baccin2019:12787562;CellTalkDB:11728344;Cellinker:11728344;Cellinker:12529173;Cellinker:12787562;HPMR:12787562;HPRD:11728344;HPRD:12529173;ICELLNET:11239407;InnateDB:23750247;LRdb:11728344;LRdb:12529173;LRdb:12787562;Lit-BM-17:23438059;NetPath:16526941;connectomeDB2020:11728344;connectomeDB2020:12529173;connectomeDB2020:12787562], TNFRSF25 [CellTalkDB:11094155;Cellinker:11094155;HPRD:11094155;LRdb:11094155;NetPath:11094155], TNFRSF8 [CellTalkDB:32196115], CD163 [NetPath:17548657;connectomeDB2020:19473660]	extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]	cytokine activity [GO:0005125]; receptor ligand activity [GO:0048018]; signaling receptor binding [GO:0005102]; tumor necrosis factor receptor binding [GO:0005164]	angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; cell differentiation [GO:0030154]; endothelial cell migration [GO:0043542]; extrinsic apoptotic signaling pathway [GO:0097191]; immune response [GO:0006955]; positive regulation of angiogenesis [GO:0045766]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of protein catabolic process [GO:0045732]; signal transduction [GO:0007165]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=TNFSF12&keywords=TNFSF12	13.630934504494382	202	NA	NA	0.22396776249158093	516	0.23622047244094474	0.055389221556886165	0.029867256637168153	0.04916067146282972	0.03198653198653198	0.10490693739424699	0.11151405258386193	0.032626427406199025	0.031446540880503096	0.05912004272933884	0.0299401197604792	203	134	184	0.0701980249853627	0.5168025133794466	0.8618671437601392	0.4980187450721991	334	183	329
TNFSF13	TNF superfamily member 13	Yes		ENSG00000161955	O75888	Tumor necrosis factor family	17	adhesion, cell_surface_ligand, ligand	adhesion, cell_adhesion, cell_surface, cell_surface_ligand, extracellular, intracellular, ligand, plasma_membrane, secreted, transmembrane, transmembrane_predicted	O00300, O14836, P19438, P25445, P34741, Q02223, Q92956	FAS, SDC2, TNFRSF11B, TNFRSF13B, TNFRSF14, TNFRSF17, TNFRSF1A	TNFRSF17 [Baccin2019:10973284;Baccin2019:14764606;CellTalkDB:14764606;Cellinker:10973284;Cellinker:14764606;HPMR:14764606;HPRD:10973284;ICELLNET:11239407;LRdb:11;LRdb:14764606;SIGNOR:10973284;connectomeDB2020:10973284;connectomeDB2020:14764606], TNFRSF13B [Baccin2019:1095664610956640;CellTalkDB:10956646;Cellinker:10956646;HPMR:10956646;HPRD:10956646;ICELLNET:11239407;LRdb:10956646;SIGNOR:10956646;connectomeDB2020:10956646], TNFRSF14 [Baccin2019:10706119;CellTalkDB:10706119;Cellinker:10706119;HPRD:10706119;LRdb:10706119;connectomeDB2020:10706119], FAS [Baccin2019:10706119;CellTalkDB:10706119;Cellinker:10706119;HPRD:10706119;LRdb:10706119;connectomeDB2020:10706119], TNFRSF1A [Baccin2019:10706119;CellTalkDB:10706119;Cellinker:10706119;HPRD:10706119;LRdb:10706119;connectomeDB2020:10706119], TNFRSF11B [Baccin2019:10706119;CellTalkDB:10706119;Cellinker:10706119;HPRD:10706119;LRdb:10706119;connectomeDB2020:10706119], SDC2 [Baccin2019:15846369;CellTalkDB:15846369;Cellinker:15846369;HPRD:15846369;LRdb:15846369;connectomeDB2020:15846369]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; nucleoplasm [GO:0005654]	cytokine activity [GO:0005125]; receptor ligand activity [GO:0048018]; signaling receptor binding [GO:0005102]; tumor necrosis factor receptor binding [GO:0005164]	immune response [GO:0006955]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of isotype switching to IgA isotypes [GO:0048298]; signal transduction [GO:0007165]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=TNFSF13&keywords=TNFSF13	10.133140334734534	236	NA	NA	0.3171114735056352	456	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TNFSF13B	TNF superfamily member 13b	Yes		ENSG00000102524	Q9Y275	Tumor necrosis factor family	18	adhesion, cell_surface_ligand, ligand	adhesion, cell_adhesion, cell_surface, cell_surface_ligand, extracellular, intracellular, ligand, plasma_membrane, secreted, transmembrane, transmembrane_predicted	O14836, P02786, P04440, P25942, Q02223, Q96RJ3, Q99558	CD40, HLA-DPB1, MAP3K14, TFRC, TNFRSF13B, TNFRSF13C, TNFRSF17	MAP3K14 [SPIKE:17183360], TNFRSF13C [Baccin2019:11509692;Baccin2019:12721620;Baccin2019:15851487;CellTalkDB:15851487;Cellinker:11509692;Cellinker:12721620;Cellinker:15851487;HPMR:15851487;HPRD:11509692;HPRD:12721620;ICELLNET:11239407;InnateDB:12571250;LRdb:11509692;LRdb:12721620;LRdb:15851487;SIGNOR:15644327;SIGNOR:15851487;connectomeDB2020:11509692;connectomeDB2020:12721620;connectomeDB2020:15851487], TNFRSF17 [Baccin2019:10801128;Baccin2019:10908663;Baccin2019:10973284;BioGRID:10908663;CellTalkDB:10973284;Cellinker:10801128;Cellinker:10908663;Cellinker:10973284;HPRD:10801128;HPRD:10908663;HPRD:10973284;ICELLNET:11239407;InnateDB:12571250;LRdb:10801128;LRdb:10908663;LRdb:10973284;Lit-BM-17:10801128;Lit-BM-17:10908663;Lit-BM-17:12721620;connectomeDB2020:10801128;connectomeDB2020:10908663;connectomeDB2020:10973284], TNFRSF13B [Baccin2019:10801128;Baccin2019:10956646;CellTalkDB:10956646;Cellinker:10801128;Cellinker:10956646;DIP:10956646;HPRD:10801128;ICELLNET:11239407;IntAct:10801128;IntAct:10880535;IntAct:10956646;LRdb:10956646;LRdb:11;Lit-BM-17:10801128;Lit-BM-17:10880535;Lit-BM-17:10956646;SIGNOR:10956646;connectomeDB2020:10801128;connectomeDB2020:10956646], TFRC [CellTalkDB:32103204], CD40 [CellTalkDB:32103204], HLA-DPB1 [NA]	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; integral component of membrane [GO:0016021]; intracellular membrane-bounded organelle [GO:0043231]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]	cytokine activity [GO:0005125]; receptor ligand activity [GO:0048018]; signaling receptor binding [GO:0005102]; tumor necrosis factor receptor binding [GO:0005164]	B cell costimulation [GO:0031296]; B cell differentiation [GO:0030183]; B cell homeostasis [GO:0001782]; immune response [GO:0006955]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of germinal center formation [GO:0002636]; positive regulation of T cell proliferation [GO:0042102]; signal transduction [GO:0007165]; T cell costimulation [GO:0031295]; tumor necrosis factor-mediated signaling pathway [GO:0033209]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=TNFSF13B&keywords=TNFSF13B	0.523716597840482	518	NA	NA	0.15935499325666563	569	0.29921259842519665	0.009980039920159679	0.011061946902654867	0.014148681055155871	0.0101010101010101	0.05245346869712354	0.030825022665457842	0.013050570962479609	0.01627820939696634	0.01121645079449857	0.018427660807417326	246	235	211	0.04425051452073822	0.4843863625831793	0.3910829414601811	0.5240072109647983	348	348	315
TNFSF14	TNF superfamily member 14	Yes		ENSG00000125735	O43557	Tumor necrosis factor family	18	adhesion, cell_surface_ligand, ligand	adhesion, cell_adhesion, cell_surface, cell_surface_ligand, extracellular, intracellular, ligand, plasma_membrane, secreted, transmembrane, transmembrane_predicted	O95407, P36941, Q92956	LTBR, TNFRSF14, TNFRSF6B	LTBR [Baccin2019:10318773;Baccin2019:10799510;Baccin2019:9462508;CellTalkDB:10318773;Cellinker:10318773;Cellinker:10799510;Cellinker:9462508;HPMR:10799510;HPRD:10318773;HPRD:10799510;HPRD:9462508;ICELLNET:11239407;InnateDB:12571250;LRdb:10318773;LRdb:10799510;LRdb:9462508;Lit-BM-17:12571250;Lit-BM-17:26977880;SPIKE:9739048;connectomeDB2020:10318773;connectomeDB2020:10799510;connectomeDB2020:9462508], TNFRSF14 [Baccin2019:10894944;Baccin2019:11390428;Baccin2019:9462508;CellTalkDB:10894944;Cellinker:10894944;Cellinker:11390428;Cellinker:9462508;HPMR:10894944;HPRD:11390428;HPRD:9462508;ICELLNET:11239407;InnateDB:11164894;IntAct:10318773;IntAct:26977880;IntAct:9462508;LRdb:10894944;LRdb:11390428;LRdb:9462508;Lit-BM-17:10318773;Lit-BM-17:11390428;Lit-BM-17:26977880;Lit-BM-17:9462508;SIGNOR:10894944;connectomeDB2020:10894944;connectomeDB2020:11390428;connectomeDB2020:9462508], TNFRSF6B [CellTalkDB:11994433;Cellinker:11994433;HPMR:14697332;HPRD:11994433;ICELLNET:11239407;IntAct:21300286;IntAct:25087510;LRdb:11994433;connectomeDB2020:11994433]	cytoplasm [GO:0005737]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; cytokine activity [GO:0005125]; identical protein binding [GO:0042802]; signaling receptor binding [GO:0005102]; tumor necrosis factor receptor binding [GO:0005164]	apoptotic process [GO:0006915]; cellular response to mechanical stimulus [GO:0071260]; immune response [GO:0006955]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of myoblast fusion [GO:1901741]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of T cell chemotaxis [GO:0010820]; signal transduction [GO:0007165]; T cell activation [GO:0042110]; T cell costimulation [GO:0031295]; T cell homeostasis [GO:0043029]; T cell proliferation [GO:0042098]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=TNFSF14&keywords=TNFSF14	0.8045850875403033	479	NA	NA	0.26921126563695164	481	0.007874015748031496	0.006986027944111778	0	0.0028776978417266183	0	0	0.001813236627379873	0.0016313213703099511	0.0011098779134295228	5.341167044999334e-4	2.31794475564999e-4	300	387	395	0.002096189875004925	0.9184609392075206	0.8708623800844268	0.845869201897001	174	182	166
TNFSF15	TNF superfamily member 15	Yes		ENSG00000181634	O95150	Tumor necrosis factor family	15	adhesion, cell_surface_ligand, ligand, receptor	adhesion, cell_adhesion, cell_surface, cell_surface_ligand, extracellular, intracellular, ligand, plasma_membrane, receptor, secreted, transmembrane, transmembrane_predicted	O95407, Q93038	TNFRSF25, TNFRSF6B	TNFRSF25 [CellTalkDB:11911831;Cellinker:11911831;DIP:21300286;HPMR:11911831;HPRD:11911831;ICELLNET:11239407;InnateDB:20403353;LRdb:11911831;SIGNOR:14585074;connectomeDB2020:11911831], TNFRSF6B [CellTalkDB:11911831;Cellinker:11911831;HPMR:14697332;HPRD:11911831;ICELLNET:11239407;LRdb:11911831;connectomeDB2020:11911831]	extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	cytokine activity [GO:0005125]; signaling receptor binding [GO:0005102]; tumor necrosis factor receptor binding [GO:0005164]	activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; activation of NF-kappaB-inducing kinase activity [GO:0007250]; apoptotic process [GO:0006915]; immune response [GO:0006955]; signal transduction [GO:0007165]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=TNFSF15&keywords=TNFSF15	1.8593834921348316	392	NA	NA	2.8270754365665858	120	0.023622047244094488	0.036926147704590795	0.0022123893805309734	0.06258992805755394	0	0.00676818950930626	0.0027198549410698096	0	0.0029596744358120607	0.0023701428762184502	0.001390766853389995	295	337	348	0.012869012818415161	0.5666914675641943	0.5409128489471768	0.49808738767322897	317	303	328
TNFSF18	TNF superfamily member 18	Yes	manually added ensembl_gene_ID, hgnc_symbol, and description by searching the uniprot ID on genenames.org	ENSG00000120337	Q9UNG2	Tumor necrosis factor family	14	adhesion, cell_surface_ligand, ligand	adhesion, cell_adhesion, cell_surface, cell_surface_ligand, extracellular, ligand, plasma_membrane, plasma_membrane_transmembrane, secreted, transmembrane	Q9Y5U5	TNFRSF18	TNFRSF18 [Baccin2019:10037686;Baccin2019:10074428;CellTalkDB:10037686;Cellinker:10037686;Cellinker:10074428;DIP:18040044;DIP:18378892;HPMR:10037686;HPRD:10037686;HPRD:10074428;ICELLNET:11239407;IntAct:18040044;IntAct:18378892;LRdb:1;LRdb:10037686;Lit-BM-17:10037686;Lit-BM-17:18040044;Lit-BM-17:18378892;connectomeDB2020:10037686;connectomeDB2020:10074428]	cell surface [GO:0009986]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	cytokine activity [GO:0005125]; identical protein binding [GO:0042802]; signaling receptor binding [GO:0005102]; tumor necrosis factor receptor superfamily binding [GO:0032813]	adaptive immune response [GO:0002250]; cell-cell signaling [GO:0007267]; negative regulation of apoptotic process [GO:0043066]; positive regulation of cell adhesion [GO:0045785]; positive regulation of leukocyte migration [GO:0002687]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; regulation of T cell proliferation [GO:0042129]; signal transduction [GO:0007165]; T cell proliferation involved in immune response [GO:0002309]; tumor necrosis factor-mediated signaling pathway [GO:0033209]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=TNFSF18&keywords=TNFSF18	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TNFSF4	TNF superfamily member 4	Yes		ENSG00000117586	P23510	Tumor necrosis factor family	13	adhesion, cell_surface_ligand, ligand	adhesion, cell_adhesion, cell_surface, cell_surface_ligand, extracellular, intracellular, ligand, plasma_membrane, secreted, transmembrane, transmembrane_predicted	P43489, Q12933	TNFRSF4, TRAF2	TNFRSF4 [Baccin2019:12134113;CellTalkDB:12134113;Cellinker:12134113;DIP:16905106;DIP:8076595;HPMR:12134113;HPRD:12134113;ICELLNET:11239407;InnateDB:16905106;LRdb:12134113;Lit-BM-17:16905106;Lit-BM-17:8076595;SIGNOR:9488716;connectomeDB2020:12134113], TRAF2 [Baccin2019:9418902;CellTalkDB:9418902;Cellinker:9418902;HPRD:9418902;LRdb:9418902]	cell surface [GO:0009986]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	cytokine activity [GO:0005125]; signaling receptor binding [GO:0005102]; tumor necrosis factor receptor binding [GO:0005164]; tumor necrosis factor receptor superfamily binding [GO:0032813]	acute inflammatory response [GO:0002526]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to prostaglandin E stimulus [GO:0071380]; defense response to nematode [GO:0002215]; immune response [GO:0006955]; inflammatory response [GO:0006954]; memory T cell activation [GO:0035709]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of interferon-gamma production [GO:0032689]; negative regulation of interleukin-17 production [GO:0032700]; negative regulation of regulatory T cell differentiation [GO:0045590]; negative regulation of T-helper 1 cell differentiation [GO:0045626]; negative regulation of transcription, DNA-templated [GO:0045892]; positive regulation of alpha-beta T cell proliferation [GO:0046641]; positive regulation of B cell activation [GO:0050871]; positive regulation of CD4-positive, alpha-beta T cell costimulation [GO:1900281]; positive regulation of CD4-positive, alpha-beta T cell differentiation [GO:0043372]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of chemokine production [GO:0032722]; positive regulation of cytokine production [GO:0001819]; positive regulation of immunoglobulin mediated immune response [GO:0002891]; positive regulation of immunoglobulin production [GO:0002639]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-13 production [GO:0032736]; positive regulation of interleukin-4-dependent isotype switching to IgE isotypes [GO:2000572]; positive regulation of interleukin-4 production [GO:0032753]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of memory T cell differentiation [GO:0043382]; positive regulation of T cell cytokine production [GO:0002726]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of T-helper 2 cell differentiation [GO:0045630]; positive regulation of type 2 immune response [GO:0002830]; regulation of adaptive immune response [GO:0002819]; regulation of inflammatory response [GO:0050727]; response to nitrogen dioxide [GO:0035713]; response to virus [GO:0009615]; signal transduction [GO:0007165]; T-helper 2 cell activation [GO:0035712]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=TNFSF4&keywords=TNFSF4	1.1634669616298212	436	NA	NA	0.7034669257771968	319	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TNFSF8	TNF superfamily member 8	Yes		ENSG00000106952	P32971	Tumor necrosis factor family	13	adhesion, cell_surface_ligand, ligand	adhesion, cell_adhesion, cell_surface, cell_surface_ligand, extracellular, ligand, plasma_membrane, secreted, transmembrane, transmembrane_predicted	P28908	TNFRSF8	TNFRSF8 [Baccin2019:11754357;Baccin2019:8391931;CellTalkDB:8391931;Cellinker:11754357;Cellinker:8391931;DIP:10768840;HPMR:8391931;HPRD:11754357;ICELLNET:11239407;LRdb:118;LRdb:8391931;connectomeDB2020:11754357;connectomeDB2020:8391931]	extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	cytokine activity [GO:0005125]; signaling receptor binding [GO:0005102]; tumor necrosis factor receptor binding [GO:0005164]	CD8-positive, alpha-beta T cell differentiation [GO:0043374]; cell-cell signaling [GO:0007267]; defense response to Gram-positive bacterium [GO:0050830]; immune response [GO:0006955]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of T cell proliferation [GO:0042129]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=TNFSF8&keywords=TNFSF8	0.012935562921348315	816	NA	NA	0.027218951743826422	777	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TNFSF9	TNF superfamily member 9	Yes		ENSG00000125657	P41273	Tumor necrosis factor family	13	cell_surface_ligand, ligand	cell_surface, cell_surface_ligand, extracellular, intracellular, ligand, secreted, transmembrane, transmembrane_predicted	A4D1S0, P15151, P20036, Q07011, Q12933, Q14627, Q8IZF4, Q96LA6	ADGRG5, FCRL1, HLA-DPA1, IL13RA2, KLRG2, PVR, TNFRSF9, TRAF2	TNFRSF9 [CellTalkDB:13130507;Cellinker:13130507;Cellinker:8088337;Cellinker:9045669;DIP:8088337;HPMR:8088337;HPRD:13130507;HPRD:8088337;HPRD:9045669;ICELLNET:11239407;LRdb:13130507;LRdb:8088337;LRdb:9045669;SPIKE:16596186;connectomeDB2020:13130507;connectomeDB2020:8088337;connectomeDB2020:9045669], PVR [CellTalkDB:32103204], TRAF2 [CellTalkDB:9607925;Cellinker:9607925;HPRD:9607925;LRdb:9607925], FCRL1 [Cellinker:32589946], IL13RA2 [NA], HLA-DPA1 [NA], ADGRG5 [NA], KLRG2 [NA]	extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	cytokine activity [GO:0005125]; signaling receptor binding [GO:0005102]; tumor necrosis factor receptor binding [GO:0005164]; tumor necrosis factor receptor superfamily binding [GO:0032813]	cell-cell signaling [GO:0007267]; immune response [GO:0006955]; positive regulation of activated T cell proliferation [GO:0042104]; positive regulation of cytotoxic T cell differentiation [GO:0045585]; regulation of apoptotic process [GO:0042981]; regulation of T cell proliferation [GO:0042129]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=TNFSF9&keywords=TNFSF9	0.3482908191011236	558	NA	NA	0.0799250205899538	660	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TOR2A	torsin family 2 member A			ENSG00000160404	Q5JU69, Q8N2E6	ClpA/ClpB family, Torsin subfamily	1	ligand	extracellular, intracellular, ligand, secreted, extracellular, ligand, secreted	P06576	ATP5F1B	ATP5F1B [connectomeDB2020:30552345]	endoplasmic reticulum lumen [GO:0005788]; nuclear envelope [GO:0005635], extracellular region [GO:0005576]	ATP binding [GO:0005524]; identical protein binding [GO:0042802], ATP binding [GO:0005524]; hormone activity [GO:0005179]	chaperone cofactor-dependent protein refolding [GO:0051085], antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; killing of cells of other organism [GO:0031640]; membrane disruption in other organism [GO:0051673]; positive regulation of calcium ion transmembrane transport [GO:1904427]; positive regulation of cAMP-mediated signaling [GO:0043950]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; vasopressin secretion [GO:0030103]; water homeostasis [GO:0030104]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=TOR2A&keywords=TOR2A	2.9317034048807655	341	NA	NA	0.2531983587971214	493	0.047244094488188976	0.05189620758483029	0.011061946902654867	0.027577937649880088	0.05218855218855217	0.06768189509306262	0.08068902991840418	0.05872756933115829	0.04291527931927488	0.03885699025237077	0.061695962912882256	181	161	141	0.04913958778556903	0.8947522514214585	0.8261300438805668	1.2123175963424144	187	200	62
TPO	thyroid peroxidase	No		ENSG00000277603, ENSG00000115705	P07202	Peroxidase family, XPO subfamily	1	adhesion, cell_surface_enzyme, ligand, receptor	adhesion, cell_adhesion, cell_surface, cell_surface_enzyme, ligand, plasma_membrane, plasma_membrane_transmembrane, receptor, secreted, transmembrane, transmembrane_predicted	P01266, P40238	MPL, TG	TG [SIGNOR:23349248], MPL [Cellinker:30803992]	cell surface [GO:0009986]; extracellular space [GO:0005615]; integral component of plasma membrane [GO:0005887]; plasma membrane [GO:0005886]	calcium ion binding [GO:0005509]; heme binding [GO:0020037]; iodide peroxidase activity [GO:0004447]; peroxidase activity [GO:0004601]	embryonic hemopoiesis [GO:0035162]; hormone biosynthetic process [GO:0042446]; hydrogen peroxide catabolic process [GO:0042744]; response to oxidative stress [GO:0006979]; thyroid hormone generation [GO:0006590]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=TPO&keywords=TPO	0.04586362842696629	743	NA	NA	0.0023673837723305114	886	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TPSAB1	tryptase alpha/beta 1	No		ENSG00000172236	Q15661	Peptidase S1 family, Tryptase subfamily	1	ligand, receptor	extracellular, intracellular, ligand, receptor, secreted	P55085	F2RL1	F2RL1 [Cellinker:9020112;SIGNOR:21999702]	extracellular region [GO:0005576]; extracellular space [GO:0005615]; peptidase complex [GO:1905368]	identical protein binding [GO:0042802]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]	defense response [GO:0006952]; extracellular matrix disassembly [GO:0022617]; proteolysis [GO:0006508]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=TPSAB1&keywords=TPSAB1	0.5299916429213483	517	NA	NA	0.02700466819027177	778	0	0	0.01327433628318584	0.0052757793764988	0.018518518518518517	0	0	0	0.005549389567147614	8.679396448123917e-4	0.0035928143712574863	286	377	308	0.004279888887401878	1.0889012995658338	0.7610661210676782	0.9518851637038612	115	235	117
TPSB2	tryptase beta 2	No		ENSG00000197253	P20231	Peptidase S1 family, Tryptase subfamily	1	ligand	extracellular, intracellular, ligand, secreted	P55085	F2RL1	F2RL1 [Cellinker:9020112]	collagen-containing extracellular matrix [GO:0062023]; extracellular space [GO:0005615]; peptidase complex [GO:1905368]	serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]	proteolysis [GO:0006508]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=TPSB2&keywords=TPSB2	1.099236808988764	441	42746.7	23	0.07139294307450862	672	0.007874015748031496	0	0.004424778761061947	0.0026378896882494006	0.013468013468013466	0.001692047377326565	9.066183136899365e-4	0	0.0029596744358120607	0.0010014688209373749	0.002086150280084992	295	372	334	0.0033682415357461125	0.9694374836928581	0.822955569101584	0.9040942481303271	142	201	142
TREM2	triggering receptor expressed on myeloid cells 2	No		ENSG00000095970	Q9NZC2	NA	1	adhesion, cell_surface_ligand, receptor	adhesion, cell_adhesion, cell_surface, cell_surface_ligand, extracellular, intracellular, plasma_membrane, plasma_membrane_transmembrane, receptor, secreted, transmembrane	Q8N7C0, Q8NFY4, Q9NP84	LRRC52, SEMA6D, TNFRSF12A	SEMA6D [NA], TNFRSF12A [Cellinker:32822567], LRRC52 [Cellinker:32589946]	extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; integral component of plasma membrane [GO:0005887]; intrinsic component of plasma membrane [GO:0031226]; plasma membrane [GO:0005886]; plasma membrane raft [GO:0044853]	amyloid-beta binding [GO:0001540]; apolipoprotein A-I binding [GO:0034186]; apolipoprotein binding [GO:0034185]; high-density lipoprotein particle binding [GO:0008035]; kinase activator activity [GO:0019209]; lipid binding [GO:0008289]; lipopolysaccharide binding [GO:0001530]; lipoprotein particle binding [GO:0071813]; lipoteichoic acid binding [GO:0070891]; low-density lipoprotein particle binding [GO:0030169]; peptidoglycan binding [GO:0042834]; phosphatidylethanolamine binding [GO:0008429]; phosphatidylserine binding [GO:0001786]; phospholipid binding [GO:0005543]; protein-containing complex binding [GO:0044877]; protein tyrosine kinase binding [GO:1990782]; scaffold protein binding [GO:0097110]; signaling receptor activity [GO:0038023]; sulfatide binding [GO:0120146]; transmembrane signaling receptor activity [GO:0004888]; very-low-density lipoprotein particle binding [GO:0034189]	amyloid-beta clearance by cellular catabolic process [GO:0150094]; apoptotic cell clearance [GO:0043277]; astrocyte activation [GO:0048143]; cellular response to amyloid-beta [GO:1904646]; cellular response to glucose stimulus [GO:0071333]; cellular response to hypoxia [GO:0071456]; cellular response to lipid [GO:0071396]; cellular response to lipoteichoic acid [GO:0071223]; cellular response to oxidised low-density lipoprotein particle stimulus [GO:0140052]; cellular response to peptidoglycan [GO:0071224]; complement-mediated synapse pruning [GO:0150062]; CXCL12-activated CXCR4 signaling pathway [GO:0038160]; defense response to Gram-negative bacterium [GO:0050829]; dendritic cell differentiation [GO:0097028]; dendritic spine maintenance [GO:0097062]; detection of lipopolysaccharide [GO:0032497]; detection of lipoteichoic acid [GO:0070392]; detection of peptidoglycan [GO:0032499]; excitatory synapse pruning [GO:1905805]; humoral immune response [GO:0006959]; import into cell [GO:0098657]; lipid homeostasis [GO:0055088]; memory [GO:0007613]; microglial cell activation [GO:0001774]; microglial cell activation involved in immune response [GO:0002282]; microglial cell proliferation [GO:0061518]; negative regulation of amyloid fibril formation [GO:1905907]; negative regulation of astrocyte activation [GO:0061889]; negative regulation of autophagic cell death [GO:1904093]; negative regulation of autophagy [GO:0010507]; negative regulation of cell activation [GO:0050866]; negative regulation of cholesterol storage [GO:0010887]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of fat cell proliferation [GO:0070345]; negative regulation of glial cell apoptotic process [GO:0034351]; negative regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043124]; negative regulation of inflammatory response to antigenic stimulus [GO:0002862]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of macrophage colony-stimulating factor signaling pathway [GO:1902227]; negative regulation of neuroinflammatory response [GO:0150079]; negative regulation of NLRP3 inflammasome complex assembly [GO:1900226]; negative regulation of p38MAPK cascade [GO:1903753]; negative regulation of phosphatidylinositol 3-kinase signaling [GO:0014067]; negative regulation of sequestering of triglyceride [GO:0010891]; negative regulation of toll-like receptor 2 signaling pathway [GO:0034136]; negative regulation of toll-like receptor 4 signaling pathway [GO:0034144]; negative regulation of tumor necrosis factor production [GO:0032720]; neuroinflammatory response [GO:0150076]; osteoclast differentiation [GO:0030316]; phagocytosis, engulfment [GO:0006911]; phagocytosis, recognition [GO:0006910]; positive regulation of amyloid-beta clearance [GO:1900223]; positive regulation of antigen processing and presentation of peptide antigen via MHC class II [GO:0002588]; positive regulation of ATP biosynthetic process [GO:2001171]; positive regulation of calcium-mediated signaling [GO:0050850]; positive regulation of CAMKK-AMPK signaling cascade [GO:1905291]; positive regulation of C-C chemokine receptor CCR7 signaling pathway [GO:1903082]; positive regulation of CD40 signaling pathway [GO:2000350]; positive regulation of chemotaxis [GO:0050921]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of complement activation, classical pathway [GO:0045960]; positive regulation of engulfment of apoptotic cell [GO:1901076]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of establishment of protein localization [GO:1904951]; positive regulation of gene expression [GO:0010628]; positive regulation of high-density lipoprotein particle clearance [GO:0010983]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of inward rectifier potassium channel activity [GO:1901980]; positive regulation of kinase activity [GO:0033674]; positive regulation of low-density lipoprotein particle clearance [GO:1905581]; positive regulation of macrophage fusion [GO:0034241]; positive regulation of microglial cell activation [GO:1903980]; positive regulation of microglial cell migration [GO:1904141]; positive regulation of mitochondrion organization [GO:0010822]; positive regulation of NIK/NF-kappaB signaling [GO:1901224]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phagocytosis [GO:0050766]; positive regulation of phagocytosis, engulfment [GO:0060100]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of proteasomal protein catabolic process [GO:1901800]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein secretion [GO:0050714]; positive regulation of synapse pruning [GO:1905808]; positive regulation of TOR signaling [GO:0032008]; pyroptosis [GO:0070269]; regulation of cytokine production involved in inflammatory response [GO:1900015]; regulation of gene expression [GO:0010468]; regulation of hippocampal neuron apoptotic process [GO:0110089]; regulation of innate immune response [GO:0045088]; regulation of interleukin-6 production [GO:0032675]; regulation of intracellular signal transduction [GO:1902531]; regulation of lipid metabolic process [GO:0019216]; regulation of macrophage inflammatory protein 1 alpha production [GO:0071640]; regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903376]; regulation of peptidyl-tyrosine phosphorylation [GO:0050730]; regulation of plasma membrane bounded cell projection organization [GO:0120035]; regulation of resting membrane potential [GO:0060075]; regulation of toll-like receptor 6 signaling pathway [GO:0034151]; regulation of TOR signaling [GO:0032006]; respiratory burst after phagocytosis [GO:0045728]; response to axon injury [GO:0048678]; response to ischemia [GO:0002931]; social behavior [GO:0035176]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=TREM2&keywords=TREM2	1.0373004606741574	447	NA	NA	0.22878880811805333	512	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TREML4	triggering receptor expressed on myeloid cells like 4	No		ENSG00000188056	Q6UXN2	NA	1	ligand, receptor	ligand, plasma_membrane_transmembrane, receptor, secreted, transmembrane, transmembrane_predicted	Q9NYZ4	SIGLEC8	SIGLEC8 [Cellinker:32589946]	cell surface [GO:0009986]; extracellular region [GO:0005576]; plasma membrane [GO:0005886]	signaling receptor activity [GO:0038023]	innate immune response [GO:0045087]; positive regulation of toll-like receptor 7 signaling pathway [GO:0034157]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=TREML4&keywords=TREML4	0.10891064953595506	669	NA	NA	1.739534573744587	185	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TRH	thyrotropin releasing hormone	Yes		ENSG00000170893	P20396	TRH family	13	ligand	extracellular, intracellular, ligand, secreted	P34981	TRHR	TRHR [Baccin2019:15117874;Baccin2019:2175902;Baccin2019:9794253;CellTalkDB:9794253;Cellinker:15117874;Cellinker:2175902;Cellinker:9794253;HPMR:2175902;HPRD:15117874;HPRD:9794253;LRdb:15117874;LRdb:2175902;LRdb:9794253;SIGNOR:27515033;connectomeDB2020:15117874;connectomeDB2020:2175902;connectomeDB2020:9794253]	extracellular region [GO:0005576]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; secretory granule [GO:0030141]	thyrotropin-releasing hormone activity [GO:0008437]	adult walking behavior [GO:0007628]; cell-cell signaling [GO:0007267]; eating behavior [GO:0042755]; histamine metabolic process [GO:0001692]; hormone-mediated signaling pathway [GO:0009755]; negative regulation of glutamate secretion [GO:0014050]; positive regulation of gamma-aminobutyric acid secretion [GO:0014054]; positive regulation of insulin secretion [GO:0032024]; signal transduction [GO:0007165]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=TRH&keywords=TRH	0.0896533607114762	681	NA	NA	0.12264890637518082	600	0	0	0	0	0	0	0	0.014681892332789562	0.0033296337402885685	0	3.8632412594166507e-5	294	409	400	0.0016409234986974816	1.1450666900937918	0.8590383745000054	0.8623570469917959	103	186	159
TSHB	thyroid stimulating hormone subunit beta	Yes		ENSG00000134200	P01222	Glycoprotein hormones subunit beta family	15	ligand	extracellular, intracellular, ligand, secreted	O60895, O60896, P07550, P10321, P13945, P16473, P32241, P41586, Q03431, Q99678, Q9NQS5	ADCYAP1R1, ADRB2, ADRB3, GPR20, GPR84, HLA-C, PTH1R, RAMP2, RAMP3, TSHR, VIPR1	TSHR [Baccin2019:15571461;Baccin2019:2558651;CellTalkDB:15571461;Cellinker:15571461;Cellinker:2558651;HPMR:15571461;HPRD:2558651;LRdb:15571461;LRdb:26;NetPath:20181794;SIGNOR:12045258;connectomeDB2020:15571461;connectomeDB2020:2558651], PTH1R [CellTalkDB:32196115], ADCYAP1R1 [CellTalkDB:32196115], VIPR1 [CellTalkDB:32196115], GPR20 [CellTalkDB:32196115], ADRB2 [CellTalkDB:32196115], ADRB3 [CellTalkDB:32196115], GPR84 [CellTalkDB:32196115], RAMP3 [CellTalkDB:32196115], RAMP2 [CellTalkDB:32196115], HLA-C [NA]	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	hormone activity [GO:0005179]	anatomical structure morphogenesis [GO:0009653]; cell-cell signaling [GO:0007267]; G protein-coupled receptor signaling pathway [GO:0007186]; response to calcium ion [GO:0051592]; response to estrogen [GO:0043627]; response to vitamin A [GO:0033189]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=TSHB&keywords=TSHB	1.2410457752808988	429	NA	NA	0.10487724694585604	626	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
TSLP	thymic stromal lymphopoietin	Yes		ENSG00000145777	Q969D9	NA	18	ligand	extracellular, intracellular, ligand, secreted, transmembrane	P16871, P42229, Q9HC73	CRLF2, CRLF2_IL7R, CRLF2_IL7R_TSLP, IL7R, STAT5A	CRLF2 [HPRD:11418668;InnateDB:11418668;NetPath:10881176;NetPath:10974032;SIGNOR:11418668;SignaLink3:10570284;SignaLink3:11418668;SignaLink3:18988627;SignaLink3:23331499;SignaLink3:29145629;connectomeDB2020:22915648;connectomeDB2020:26198769], IL7R [Baccin2019:11418668;CellTalkDB:11418668;HPRD:11418668;InnateDB:11418668;LRdb:11418668;NetPath:10881176;NetPath:10974032;connectomeDB2020:11418668], STAT5A [HPRD:10570284;HPRD:11418668]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	cytokine activity [GO:0005125]; interleukin-7 receptor binding [GO:0005139]	antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; defense response to fungus [GO:0050832]; defense response to Gram-negative bacterium [GO:0050829]; negative regulation of apoptotic process [GO:0043066]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of chemokine (C-C motif) ligand 1 production [GO:0071654]; positive regulation of chemokine production [GO:0032722]; positive regulation of cytokine-mediated signaling pathway [GO:0001961]; positive regulation of granulocyte colony-stimulating factor production [GO:0071657]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of interleukin-13 production [GO:0032736]; positive regulation of interleukin-5 production [GO:0032754]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of mast cell activation [GO:0033005]; positive regulation of receptor signaling pathway via STAT [GO:1904894]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=TSLP&keywords=TSLP	0.8098923016123596	476	NA	NA	0.8398546369518545	293	0.007874015748031496	0.008982035928143712	0.0022123893805309734	0.7163069544364621	0.006734006734006734	0.001692047377326565	0.003626473254759746	0.0016313213703099511	0.008139104698483168	0.007344104686874068	0.005988023952095813	274	258	279	0.07004822523336585	0.22660220942565504	0.21667069614985876	0.1997298991387464	425	407	419
TTR	TTR	TBD		ENSG00000118271	P02766	Transthyretin family	3	ligand, receptor	extracellular, intracellular, ligand, receptor, secreted	P02647, P08138	APOA1, NGFR	NGFR [NA], APOA1 [HPRD:10627502]	azurophil granule lumen [GO:0035578]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; protein-containing complex [GO:0032991]	hormone activity [GO:0005179]; identical protein binding [GO:0042802]; protein-containing complex binding [GO:0044877]; thyroid hormone binding [GO:0070324]	purine nucleobase metabolic process [GO:0006144]; retinol metabolic process [GO:0042572]; thyroid hormone transport [GO:0070327]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=TTR&keywords=TTR	17576.7298953382	3	263406	6	307.5818397392051	5	8.133858267716532	12.341317365269663	3.0530973451327243	13.56858513189404	7.452861952861985	80.74450084602366	255.20580235720732	170.5040783034256	21.76544580096156	24.480471357999534	361.1688622754453	4	3	1	87.12898918217617	0.24989325679962807	0.28105067074853024	4.144859444264962	418	388	5
TXLNA	taxilin alpha			ENSG00000084652	P40222	Taxilin family	2	ligand	intracellular, ligand, secreted	Q12846, Q13277, Q16623	STX1A, STX3, STX4	STX3 [Cellinker:12558796;ICELLNET:12558796], STX4 [Cellinker:12558796;HPRD:12558796;ICELLNET:12558796], STX1A [Cellinker:12558796;HPRD:12558796;ICELLNET:12558796;IntAct:24722188;IntAct:32296183;Lit-BM-17:12558796;Lit-BM-17:24722188]	cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; membrane [GO:0016020]	syntaxin binding [GO:0019905]	B cell activation [GO:0042113]; exocytosis [GO:0006887]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=TXLNA&keywords=TXLNA	31.844388988764045	129	15215	56	0.732625205276629	314	0.07086614173228346	0.253493013972058	0.13495575221238953	0.24940047961630663	0.13299663299663317	0.4043993231810502	0.45965548504079634	0.20717781402936367	0.1945985941546415	0.3347910268393898	0.20289743094455195	81	61	70	0.2404756086108604	0.8168403913233183	1.3765453201275903	0.8499727064255187	215	67	164
TYK2	tyrosine kinase 2			ENSG00000105397	P29597	Protein kinase superfamily, Tyr protein kinase family, JAK subfamily	1	ligand, receptor	extracellular, intracellular, intracellular_intercellular_related, ligand, receptor, secreted	O14744, O15304, O75886, P06241, P08575, P10912, P13010, P15498, P17181, P18031, P19525, P22681, P23458, P25105, P27986, P29350, P35568, P40189, P40763, P42224, P42229, P46109, P48551, P51452, P51692, P52630, P61978, P63244, P78552, Q03405, Q06124, Q13651, Q14765, Q5VWK5, Q96N16, Q9BZL6, Q9Y4H2	CBL, CRKL, DUSP3, EIF2AK2, FYN, GHR, HNRNPK, IFNAR1, IFNAR2, IL10RA, IL13RA1, IL23R, IL6ST, IRF9_STAT1_STAT2, IRS1, IRS2, JAK1, JAKMIP1, PIK3R1, PLAUR, PRKD2, PRMT5, PTAFR, PTPN1, PTPN11, PTPN6, PTPRC, RACK1, SIVA1, STAM2, STAT1, STAT2, STAT3, STAT4, STAT5A, STAT5B, VAV1, XRCC5	STAT1 [HPRD-phos:10918587;HPRD-phos:11294897;HPRD-phos:11839738;HPRD-phos:12637327;HPRD-phos:12817007;HPRD-phos:15322115;HPRD-phos:7543024;HPRD-phos:7657660;HPRD-phos:7690989;HPRD:10918587;HPRD:11294897;HPRD:11839738;HPRD:12637327;HPRD:12817007;HPRD:15322115;HPRD:7543024;HPRD:7657660;HPRD:7690989;KEA:10748192;KEA:10918587;KEA:10982844;KEA:11152457;KEA:11294897;KEA:11438544;KEA:11839738;KEA:12637327;KEA:12817007;KEA:15322115;KEA:7543024;KEA:7592750;KEA:7657660;KEA:7690989;KEA:9355737;ProtMapper:23257612;ProtMapper:7657660;SIGNOR:7657660;SPIKE:10435617;SignaLink3:10918587;SignaLink3:10982844;SignaLink3:11294897;SignaLink3:11839738;SignaLink3:12637327;SignaLink3:12817007;SignaLink3:14565860;SignaLink3:14764663;SignaLink3:15261459;SignaLink3:15322115;SignaLink3:18389480;SignaLink3:18988627;SignaLink3:23124025;SignaLink3:23331499;SignaLink3:24243840;SignaLink3:29145629;SignaLink3:7543024;SignaLink3:7657660;SignaLink3:7690989;SignaLink3:8232552;SignaLink3:8780896;iPTMnet:10918587;iPTMnet:11294897;iPTMnet:11839738;iPTMnet:12637327;iPTMnet:12817007;iPTMnet:15322115;iPTMnet:7543024;iPTMnet:7657660;iPTMnet:7690989], STAT2 [HPRD:8605877;KEA:8197134;Macrophage:1638633;ProtMapper:18989459;ProtMapper:21994561;ProtMapper:23223197;SignaLink3:10022928;SignaLink3:10542297;SignaLink3:10982844;SignaLink3:11694501;SignaLink3:12040185;SignaLink3:15312780;SignaLink3:15449939;SignaLink3:16171819;SignaLink3:16987978;SignaLink3:17351669;SignaLink3:17969444;SignaLink3:18508557;SignaLink3:18988627;SignaLink3:23331499;SignaLink3:24243840;SignaLink3:29145629;SignaLink3:7526154;SignaLink3:8197134;SignaLink3:8232552;SignaLink3:8605876;SignaLink3:8605877;SignaLink3:8621447;SignaLink3:8702790;SignaLink3:8943354;SignaLink3:9334213], IFNAR1 [BioGRID:9733772;Cellinker:16551269;DIP:24704786;DIP:7526154;HPRD:95059042;HPRD:9677371;HPRD:9733772;InnateDB:14647450;InnateDB:15337770;InnateDB:7559568;InnateDB:8524272;InnateDB:8605876;InnateDB:8702790;InnateDB:9461596;InnateDB:9733772;KEA:7526154;KEA:8605876;KEA:8700538;KEA:95059042;KEA:9677371;LMPID:24704786;MPPI:8628273;Macrophage:7526154;Macrophage:8628273;PhosphoSite:12220192;PhosphoSite:8605876;PhosphoSite:9121453;ProtMapper:18166147;ProtMapper:20937132;ProtMapper:21949722;ProtMapper:21994561;ProtMapper:23223197;ProtMapper:7526154;ProtMapper:8605876;SIGNOR:7526154;SIGNOR:8605876;iPTMnet:7526154;iPTMnet:8605876;iPTMnet:8700538;iPTMnet:95059042;iPTMnet:9677371;phosphoELM:7526154;phosphoELM:8605876;phosphoELM:8700538], STAT3 [PhosphoSite:30910759;SIGNOR:10542297;SIGNOR:30029643;SignaLink3:10542297;SignaLink3:12023369;SignaLink3:12626585;SignaLink3:14565860;SignaLink3:14764663;SignaLink3:15261459;SignaLink3:18389480;SignaLink3:21098725;SignaLink3:23124025;SignaLink3:23331499;SignaLink3:23673666;SignaLink3:25516297;SignaLink3:29145629;SignaLink3:8662928], PTPN1 [HPRD:11694501], IFNAR2 [Cellinker:16551269;HPRD:12960323], IL10RA [KEA:10433356;iPTMnet:10433356;phosphoELM:10433356], IL13RA1 [HPRD:10409622;InnateDB:12223527;KEA:10409622], STAT5A [InnateDB:9872990;SignaLink3:23331499;SignaLink3:9872990], GHR [HPRD:10502458], IL6ST [DIP:9388212;HPRD:9388212], IL23R [Cellinker:12023369], STAT4 [ProtMapper:16324152;SignaLink3:16324152;SignaLink3:23331499], JAK1 [Cellinker:14647450;HPRD:7589562;HPRD:8702790;Macrophage:7504784], PTPRC [HPRD:11201744], DUSP3 [ProtMapper:17785772;SIGNOR:17785772;iPTMnet:17785772], SIVA1 [Lit-BM-17:20727854;PhosphoSite:20727854;ProtMapper:20727854], RACK1 [HPRD:12960323;InnateDB:15240704;KEA:15240704;PhosphoSite:15240704;iPTMnet:15240704;phosphoELM:15240704], FYN [HPRD:9196040;ProtMapper:27521342], STAT5B [InnateDB:9872990;KEA:10830280;KEA:11751923;KEA:12411494], PRKD2 [iPTMnet:21865166], PLAUR [DIP:9417082;HPRD:9974409;MPPI:9974409], PTPN11 [InnateDB:9794795;NetPath:9794795], PTPN6 [HPRD:7629131;HPRD:8780698;InnateDB:8524272], PTAFR [HPRD:14500680;InnateDB:11309383;InnateDB:14500680], VAV1 [HPRD:10673353;InnateDB:9038355], EIF2AK2 [HPRD:17290288;InnateDB:23236554], HNRNPK [IntAct:25416956;IntAct:29892012], CBL [HPRD:8780698], PIK3R1 [HPRD:10995743], IRS2 [HPRD:8550573], CRKL [HPRD:9374471], PRMT5 [HPRD:10531356], STAM2 [HPRD:10899310], XRCC5 [HPRD:10673353], JAKMIP1 [HPRD:15277531], IRS1 [HPRD:8550573]	cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleus [GO:0005634]	ATP binding [GO:0005524]; growth hormone receptor binding [GO:0005131]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713]; type 1 angiotensin receptor binding [GO:0031702]	cytokine-mediated signaling pathway [GO:0019221]; intracellular signal transduction [GO:0035556]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of natural killer cell proliferation [GO:0032819]; positive regulation of NK T cell proliferation [GO:0051142]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of T cell proliferation [GO:0042102]; protein phosphorylation [GO:0006468]; type I interferon signaling pathway [GO:0060337]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=TYK2&keywords=TYK2	17.62556777863547	182	NA	NA	0.4753587563203126	395	0.06299212598425197	0.090319361277445	0.03097345132743365	0.0515587529976019	0.05218855218855217	0.07445008460236889	0.06436990027198539	0.04730831973898861	0.03810580836108025	0.052844171451464125	0.035232760285879766	190	141	174	0.05457666258973198	0.7449410736306666	0.9731715596813246	0.7004505725737522	243	140	237
UCN	urocortin	Yes		ENSG00000163794	P55089	Sauvagine/corticotropin-releasing factor/urotensin I family	13	ligand	extracellular, intracellular, ligand, secreted	P34998, Q13324	CRHR1, CRHR2	CRHR1 [Baccin2019:11123370;Baccin2019:11416224;Baccin2019:15450949;Baccin2019:8612563;Baccin2019:9423932;BioGRID:8612563;CellTalkDB:11416224;Cellinker:11123370;Cellinker:11416224;Cellinker:15450949;Cellinker:8612563;Cellinker:9423932;Guide2Pharma:11123370;Guide2Pharma:15450949;Guide2Pharma:8612563;HPRD:8612563;HPRD:9423932;LRdb:11123370;LRdb:11416224;LRdb:15450949;LRdb:8612563;LRdb:9423932;connectomeDB2020:11123370;connectomeDB2020:11416224;connectomeDB2020:15450949;connectomeDB2020:8612563;connectomeDB2020:9423932;scConnect:11123370;scConnect:15450949;scConnect:8612563], CRHR2 [Baccin2019:10816663;Baccin2019:11123370;Baccin2019:11416224;Baccin2019:15450949;Baccin2019:8612563;Baccin2019:9423932;CellTalkDB:15450949;Cellinker:10816663;Cellinker:11123370;Cellinker:11416224;Cellinker:15450949;Cellinker:8612563;Cellinker:9423932;Guide2Pharma:11123370;Guide2Pharma:15450949;HPRD:11416224;HPRD:8612563;HPRD:9423932;LRdb:10816663;LRdb:11123370;LRdb:11416224;LRdb:15450949;LRdb:8612563;LRdb:9423932;connectomeDB2020:10816663;connectomeDB2020:11123370;connectomeDB2020:11416224;connectomeDB2020:15450949;connectomeDB2020:8612563;connectomeDB2020:9423932;scConnect:11123370;scConnect:15450949]	axon terminus [GO:0043679]; dendrite [GO:0030425]; extracellular region [GO:0005576]; perikaryon [GO:0043204]; varicosity [GO:0043196]	corticotropin-releasing hormone receptor 1 binding [GO:0051430]; corticotropin-releasing hormone receptor 2 binding [GO:0051431]; histone deacetylase inhibitor activity [GO:0046811]; neuropeptide hormone activity [GO:0005184]	activation of protein kinase A activity [GO:0034199]; aerobic respiration [GO:0009060]; associative learning [GO:0008306]; drinking behavior [GO:0042756]; female pregnancy [GO:0007565]; gastric emptying [GO:0035483]; G protein-coupled receptor signaling pathway [GO:0007186]; inflammatory response [GO:0006954]; negative regulation of apoptotic process [GO:0043066]; negative regulation of appetite [GO:0032099]; negative regulation of blood pressure [GO:0045776]; negative regulation of cell size [GO:0045792]; negative regulation of feeding behavior [GO:2000252]; negative regulation of gastric acid secretion [GO:0060455]; negative regulation of gene expression [GO:0010629]; negative regulation of hormone secretion [GO:0046888]; negative regulation of necrotic cell death [GO:0060547]; negative regulation of neuron death [GO:1901215]; neuron projection development [GO:0031175]; neuropeptide signaling pathway [GO:0007218]; pancreatic juice secretion [GO:0030157]; positive regulation of behavioral fear response [GO:2000987]; positive regulation of calcium ion import [GO:0090280]; positive regulation of cAMP-mediated signaling [GO:0043950]; positive regulation of cardiac muscle contraction [GO:0060452]; positive regulation of cell growth [GO:0030307]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of corticotropin secretion [GO:0051461]; positive regulation of DNA replication [GO:0045740]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of translation [GO:0045727]; positive regulation of vascular permeability [GO:0043117]; regulation of synaptic transmission, glutamatergic [GO:0051966]; response to auditory stimulus [GO:0010996]; response to estradiol [GO:0032355]; response to glucocorticoid [GO:0051384]; response to oxidative stress [GO:0006979]; response to pain [GO:0048265]; sensory perception of sound [GO:0007605]; social behavior [GO:0035176]; startle response [GO:0001964]; vasodilation [GO:0042311]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=UCN&keywords=UCN	0.16447527078651686	634	NA	NA	0.036094165154313455	748	0	0.001996007984031936	0	9.592326139088729e-4	0.0016835016835016834	0.005076142131979695	0.013599274705349048	0.0032626427406199023	0.0036995930447650763	0.0050407263987181095	0.0024338419934324916	292	290	326	0.0034319057542097106	1.0199292114949117	1.1197760521811415	0.9256945530261471	129	108	129
UCN2	urocortin 2	Yes		ENSG00000145040	Q96RP3	Sauvagine/corticotropin-releasing factor/urotensin I family	15	ligand	intracellular, ligand, secreted	P34998, Q08334, Q13324	CRHR1, CRHR2, IL10RB	CRHR1 [Baccin2019:15450949;CellTalkDB:15450949;Cellinker:15450949;Guide2Pharma:15450949;LRdb:15450949;connectomeDB2020:15450949;scConnect:15450949], CRHR2 [Baccin2019:11226328;Baccin2019:11329063;Baccin2019:11416224;Baccin2019:15450949;CellTalkDB:11329063;Cellinker:11226328;Cellinker:11329063;Cellinker:11416224;Cellinker:15450949;Guide2Pharma:15450949;HPRD:11226328;HPRD:11416224;LRdb:11226328;LRdb:11329063;LRdb:11416224;LRdb:15450949;connectomeDB2020:11226328;connectomeDB2020:11329063;connectomeDB2020:11416224;connectomeDB2020:15450949;scConnect:15450949], IL10RB [CellTalkDB:11416224;Cellinker:11416224;HPRD:11416224;LRdb:11416224;connectomeDB2020:11416224]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	corticotropin-releasing hormone receptor 2 binding [GO:0051431]; corticotropin-releasing hormone receptor binding [GO:0051429]; hormone activity [GO:0005179]; hormone binding [GO:0042562]	adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular response to nutrient levels [GO:0031669]; digestion [GO:0007586]; hormone-mediated signaling pathway [GO:0009755]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=UCN2&keywords=UCN2	0.48733908988764046	526	NA	NA	0.34531799712372296	447	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
UCN3	urocortin 3	Yes		ENSG00000178473	Q969E3	Sauvagine/corticotropin-releasing factor/urotensin I family	14	ligand	intracellular, ligand, secreted	P34998, Q08334, Q13324	CRHR1, CRHR2, IL10RB	CRHR2 [Baccin2019:11329063;Baccin2019:11416224;Baccin2019:15450949;CellTalkDB:11329063;Cellinker:11329063;Cellinker:11416224;Cellinker:15450949;Guide2Pharma:15450949;HPRD:11329063;HPRD:11416224;LRdb:11329063;LRdb:11416224;LRdb:15450949;connectomeDB2020:11329063;connectomeDB2020:11416224;connectomeDB2020:15450949;scConnect:15450949], CRHR1 [Baccin2019:11416224;CellTalkDB:11416224;Cellinker:11416224;HPRD:11416224;LRdb:11416224;connectomeDB2020:11416224], IL10RB [CellTalkDB:11416224;Cellinker:11416224;HPRD:11416224;LRdb:11416224;connectomeDB2020:11416224]	axon terminus [GO:0043679]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; varicosity [GO:0043196]	corticotropin-releasing hormone receptor 2 binding [GO:0051431]; corticotropin-releasing hormone receptor binding [GO:0051429]; hormone activity [GO:0005179]	adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; cellular response to hypoxia [GO:0071456]; cellular response to nutrient levels [GO:0031669]; digestion [GO:0007586]; hormone-mediated signaling pathway [GO:0009755]; positive regulation of insulin secretion [GO:0032024]; positive regulation of membrane potential [GO:0045838]; response to corticosterone [GO:0051412]; response to glucose [GO:0009749]; response to immobilization stress [GO:0035902]; response to starvation [GO:0042594]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=UCN3&keywords=UCN3	36.57503033707865	118	21620	45	164.0798092521992	8	0.007874015748031496	0.020958083832335314	0.0055309734513274336	0.007673860911270982	0.040404040404040394	0.2538071065989845	0.3445149592021749	0.2724306688417617	0.011098779134295233	0.3600614234210633	0.12203979138496726	261	57	100	0.13149033663002296	0.14911816338005843	2.615453692704973	0.9332071329382194	457	9	126
ULBP1	UL16 binding protein 1			ENSG00000111981	Q9BZM6	MHC class I family	2	adhesion, cell_surface_ligand, ligand, receptor	adhesion, cell_adhesion, cell_surface, cell_surface_ligand, extracellular, intracellular, ligand, peripheral, plasma_membrane, receptor, secreted, transmembrane, transmembrane_predicted	P26718	HCST_KLRK1, KLRK1	KLRK1 [CellChatDB:24223577;CellTalkDB:21764762;connectomeDB2020:26041808;connectomeDB2020:29651291]	anchored component of plasma membrane [GO:0046658]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; external side of plasma membrane [GO:0009897]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]	natural killer cell lectin-like receptor binding [GO:0046703]	natural killer cell activation [GO:0030101]; natural killer cell mediated cytotoxicity [GO:0042267]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=ULBP1&keywords=ULBP1	0.7507551550561797	490	NA	NA	1.062389719785505	251	0	4.99001996007984e-4	0.004424778761061947	0.0014388489208633092	0	0	0	0	7.399186089530152e-4	4.339698224061959e-4	8.885454896658298e-4	301	391	372	7.659148726325709e-4	0.9975853177377764	0.9691670374368095	1.0113906359546823	135	142	96
ULBP2	UL16 binding protein 2	No		ENSG00000131015	Q9BZM5	MHC class I family	7	adhesion, cell_surface_ligand, ligand	adhesion, cell_adhesion, cell_surface, cell_surface_ligand, extracellular, intracellular, ligand, plasma_membrane, plasma_membrane_peripheral, plasma_membrane_transmembrane, secreted, transmembrane, transmembrane_predicted	P26718, Q9UBK5	HCST, HCST_KLRK1, KLRK1	KLRK1 [CellTalkDB:10894171;HPMR:10894171;IntAct:19424970;IntAct:28559451;LRdb:10894171;SIGNOR:10894171;connectomeDB2020:10894171;connectomeDB2020:26041808], HCST [Cellinker:11513139]	anchored component of plasma membrane [GO:0046658]; cell surface [GO:0009986]; endoplasmic reticulum [GO:0005783]; external side of plasma membrane [GO:0009897]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886]	natural killer cell lectin-like receptor binding [GO:0046703]	natural killer cell activation [GO:0030101]; natural killer cell mediated cytotoxicity [GO:0042267]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=ULBP2&keywords=ULBP2	1.8984465393258427	390	NA	NA	1.484049881560915	201	0	0.008982035928143712	0.0542035398230089	0.021582733812949634	0.04377104377104376	0	0.003626473254759746	0.0032626427406199023	0.0014798372179060304	0.0038389638135932626	0.0024338419934324916	299	306	326	0.01301646475958704	0.4987663108916124	0.6012636587827384	0.5402151078937276	343	289	307
UTS2	urotensin 2	Yes		ENSG00000049247	O95399	Urotensin-2 family	14	ligand	extracellular, intracellular, ligand, secreted	Q9UKP6	UTS2R	UTS2R [Baccin2019:10499587;Baccin2019:10581185;Baccin2019:11976263;Baccin2019:12238917;Baccin2019:15109617;Baccin2019:15852036;Cellinker:10499587;Cellinker:10581185;Cellinker:11976263;Cellinker:12238917;Cellinker:15109617;Cellinker:15852036;Guide2Pharma:10499587;Guide2Pharma:10548501;Guide2Pharma:10559967;Guide2Pharma:10581185;HPMR:15109617;HPRD:10581185;LRdb:10499587;LRdb:10581185;LRdb:11976263;LRdb:12238917;LRdb:15109617;LRdb:15852036;connectomeDB2020:10499587;connectomeDB2020:10581185;connectomeDB2020:11976263;connectomeDB2020:12238917;connectomeDB2020:15109617;connectomeDB2020:15852036;scConnect:11976263;scConnect:12238917;scConnect:15852036]	extracellular region [GO:0005576]; extracellular space [GO:0005615]; synapse [GO:0045202]	hormone activity [GO:0005179]; signaling receptor binding [GO:0005102]	blood vessel diameter maintenance [GO:0097746]; chemical synaptic transmission [GO:0007268]; muscle contraction [GO:0006936]; regulation of blood pressure [GO:0008217]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=UTS2&keywords=UTS2	0.04394346741573034	747	500163	3	0.48330278755438744	390	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
UTS2B	urotensin 2B	Yes		ENSG00000188958	Q765I0	Urotensin-2 family	14	ligand	extracellular, ligand, secreted	P35346, Q9UKP6	SSTR5, UTS2R	UTS2R [Baccin2019:11015293;Baccin2019:14550283;CellChatDB:31556942;CellTalkDB:14550283;Cellinker:11015293;Cellinker:14550283;Cellinker:31556942;Guide2Pharma:14550283;Guide2Pharma:17628210;Guide2Pharma:18710417;HPRD:14550283;LRdb:11;LRdb:14550283;connectomeDB2020:11015293;connectomeDB2020:14550283;scConnect:11015293;scConnect:14550283;scConnect:18710417], SSTR5 [CellChatDB:31556942;Cellinker:31556942]	extracellular region [GO:0005576]	G protein-coupled receptor binding [GO:0001664]; hormone activity [GO:0005179]	blood vessel diameter maintenance [GO:0097746]; regulation of blood pressure [GO:0008217]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=UTS2B&keywords=UTS2B	0.6930728615955056	494	NA	NA	2.699066947465848	122	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
VCAM1	vascular cell adhesion molecule 1			ENSG00000162692	P19320	NA	9	adhesion, cell_surface_ligand, ligand, receptor	adhesion, cell_adhesion, cell_surface, cell_surface_ligand, extracellular, intracellular, ligand, matrix_adhesion, plasma_membrane, plasma_membrane_transmembrane, receptor, secreted, transmembrane, transmembrane_predicted	P05107, P05556, P13612, P15311, P26010, P26038, Q13349, Q13797	EZR, ITGA4, ITGA4_ITGB1, ITGA4_ITGB7, ITGA9, ITGA9_ITGB1, ITGAD, ITGAD_ITGB2, ITGB1, ITGB2, ITGB7, ITGB7_VCAM1, MSN	ITGA4 [BioGRID:22623428;CellTalkDB:11751331;LRdb:11751331;Lit-BM-17:19738201;Lit-BM-17:22623428;connectomeDB2020:11751331], ITGB1 [CellTalkDB:11751331;Cellinker:11751331;Cellinker:12097820;Cellinker:19057841;HPRD:12097820;HPRD:19057841;IntAct:19738201;LRdb:11751331;LRdb:12097820;LRdb:19057841;Lit-BM-17:19738201;Lit-BM-17:22623428;connectomeDB2020:11751331;connectomeDB2020:12097820;connectomeDB2020:19057841], ITGB2 [CellTalkDB:10438935;Cellinker:10438935;HPMR:10438935;LRdb:10438935;connectomeDB2020:10438935], EZR [CellTalkDB:12082081;Cellinker:12082081;HPRD:12082081;InnateDB:12082081;LRdb:12082081], MSN [CellTalkDB:12082081;Cellinker:12082081;HPRD:12082081;HPRD:7884872;InnateDB:12082081;LRdb:12082081;Lit-BM-17:12082081;Lit-BM-17:19738201;Lit-BM-17:22623428;Lit-BM-17:23463506], ITGAD [CellTalkDB:10438935;Cellinker:10438935;HPMR:10438935;HPRD:10438935;LRdb:10438935;connectomeDB2020:10438935], ITGA9 [CellTalkDB:10926928;connectomeDB2020:10209034], ITGB7 [CellTalkDB:12682249;Cellinker:12682249;HPRD:12682249;LRdb:12682249;connectomeDB2020:12682249]	alpha9-beta1 integrin-vascular cell adhesion molecule-1 complex [GO:0071065]; apical part of cell [GO:0045177]; cell surface [GO:0009986]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; filopodium [GO:0030175]; Golgi apparatus [GO:0005794]; integral component of plasma membrane [GO:0005887]; microvillus [GO:0005902]; plasma membrane [GO:0005886]; podosome [GO:0002102]; sarcolemma [GO:0042383]	cell adhesion molecule binding [GO:0050839]; integrin binding [GO:0005178]; primary amine oxidase activity [GO:0008131]	acute inflammatory response [GO:0002526]; aging [GO:0007568]; amine metabolic process [GO:0009308]; B cell differentiation [GO:0030183]; calcium-mediated signaling using intracellular calcium source [GO:0035584]; cardiac neuron differentiation [GO:0060945]; cell adhesion [GO:0007155]; cell-cell adhesion in response to extracellular stimulus [GO:0140039]; cell chemotaxis [GO:0060326]; cell-matrix adhesion [GO:0007160]; cellular response to amyloid-beta [GO:1904646]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; chronic inflammatory response [GO:0002544]; heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0007157]; heterotypic cell-cell adhesion [GO:0034113]; innervation [GO:0060384]; leukocyte cell-cell adhesion [GO:0007159]; leukocyte tethering or rolling [GO:0050901]; membrane to membrane docking [GO:0022614]; positive regulation of T cell proliferation [GO:0042102]; response to ethanol [GO:0045471]; response to hypoxia [GO:0001666]; response to ionizing radiation [GO:0010212]; response to lipopolysaccharide [GO:0032496]; response to nicotine [GO:0035094]; response to nutrient [GO:0007584]; response to zinc ion [GO:0010043]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=VCAM1&keywords=VCAM1	29.27876905904832	138	NA	NA	1.825833816108168	174	0	0.6631736526946105	0	0.01175059952038369	0.02861952861952861	0	9.066183136899365e-4	0	0	3.6720523434370417e-4	2.31794475564999e-4	303	396	395	0.06409539989619285	0.1349611448755244	0.13991698875865557	0.13808946965533184	463	449	454
VCAN	versican	No		ENSG00000038427	P13611	Aggrecan/versican proteoglycan family	9	adhesion, ecm, ligand	adhesion, ecm, extracellular, intracellular, ligand, matrix_adhesion, secreted	O15455, O60603, P00533, P01130, P02452, P02751, P05556, P08123, P13612, P14151, P16070, P16109, P24821, Q14242, Q15399, Q92752, Q9Y2C9	CD44, COL1A1, COL1A2, EGFR, FN1, ITGA4, ITGB1, LDLR, SELL, SELP, SELPLG, TLR1, TLR2, TLR3, TLR6, TNC, TNR	CD44 [Baccin2019:16045811;BioGRID:10950950;CellTalkDB:10950950;Cellinker:10950950;HPRD:10950950;ICELLNET:10950950;InnateDB:10950950;LRdb:10950950;MatrixDB:12556525;connectomeDB2020:10950950], ITGA4 [CellTalkDB:11083865;Cellinker:11083865;HPRD:11083865;LRdb:11083865], EGFR [Baccin2019:23449934;CellTalkDB:16045811;Cellinker:16045811;LRdb:16045811;Ramilowski2015:16045811;connectomeDB2020:16045811;talklr:16045811], ITGB1 [CellTalkDB:11805102;Cellinker:11805102;HPRD:11805102;LRdb:11805102;connectomeDB2020:11805102], TLR1 [CellTalkDB:32196115], SELL [Baccin2019:16148216;CellTalkDB:32196115;InnateDB:10221651;InnateDB:10950950;MatrixDB:12556525], TLR2 [Baccin2019:19608024;CellTalkDB:19122641;Cellinker:19122641;LRdb:19122641;Ramilowski2015:19122641;connectomeDB2020:19122641;talklr:19122641], SELP [Baccin2019:10950950;CellTalkDB:10950950;Cellinker:10950950;HPRD:10950950;InnateDB:10950950;LRdb:10950950;MatrixDB:12556525;connectomeDB2020:10950950], TLR6 [Cellinker:23350913], TNC [Cellinker:16045811], COL1A2 [Cellinker:16045811], TLR3 [Cellinker:23350913], SELPLG [Cellinker:16045811;HPRD:15522894;InnateDB:15522894], FN1 [Cellinker:16045811], TNR [Cellinker:16045811;HPRD:9294172], COL1A1 [Cellinker:16045811], LDLR [Cellinker:16045811]	collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; interphotoreceptor matrix [GO:0033165]; lysosomal lumen [GO:0043202]; membrane [GO:0016020]; photoreceptor outer segment [GO:0001750]	calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; extracellular matrix structural constituent conferring compression resistance [GO:0030021]; glycosaminoglycan binding [GO:0005539]; hyaluronic acid binding [GO:0005540]	cell adhesion [GO:0007155]; cell recognition [GO:0008037]; central nervous system development [GO:0007417]; glial cell migration [GO:0008347]; multicellular organism development [GO:0007275]; osteoblast differentiation [GO:0001649]; skeletal system development [GO:0001501]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=VCAN&keywords=VCAN	15.393266117553022	191	NA	NA	0.9101098819172224	283	0.007874015748031496	0.06936127744510971	0.015486725663716814	2.4390887290167664	0.01683501683501683	0.01015228426395939	0.02085222121486854	0.0016313213703099511	0.0014798372179060304	0.030144211510214906	0.0022020475178674923	299	172	332	0.23773706252761523	0.04633879606377577	0.16204362440012396	0.049254025188529595	506	437	504
VEGFA	vascular endothelial growth factor A	Yes		ENSG00000112715	P15692	PDGF/VEGF growth factor family	20	ligand, receptor	extracellular, intracellular, ligand, receptor, secreted, transmembrane	O14786, O60462, P00533, P05106, P05556, P06756, P07949, P13611, P16070, P17948, P29323, P35052, P35968, P78324, Q06418, Q13224, Q13797, Q16236, Q16665	CD44, EGFR, EPHB2, FLT1, FLT1_KDR, GPC1, GRIN2B, HIF1A, ITGA9, ITGAV, ITGB1, ITGB3, KDR, NFE2L2, NRP1, NRP2, RET, SIRPA, TYRO3, VCAN	FLT1 [Baccin2019:15637071;Baccin2019:17051153;Baccin2019:8621427;Baccin2019:9393862;CellChatDB:16633338;CellTalkDB:17051153;Cellinker:15637071;Cellinker:17051153;Cellinker:8621427;Cellinker:9393862;DIP:8621427;DIP:8631822;HPMR:8356051;HPRD:17051153;HPRD:8621427;HPRD:9393862;ICELLNET:26285753;IntAct:10543948;IntAct:20660291;IntAct:9393862;LRdb:15637071;LRdb:17051153;LRdb:8621427;LRdb:9393862;Lit-BM-17:10543948;Lit-BM-17:21939755;Lit-BM-17:8621427;Lit-BM-17:8631822;Lit-BM-17:9393862;ProtMapper:21441409;ProtMapper:22348123;SIGNOR:14704231;connectomeDB2020:15637071;connectomeDB2020:17051153;connectomeDB2020:8621427;connectomeDB2020:9393862], KDR [Baccin2019:15637071;Baccin2019:17318185;Baccin2019:8621427;BioGRID:16901919;CellChatDB:16633338;CellTalkDB:8621427;Cellinker:15637071;Cellinker:17318185;Cellinker:8621427;DIP:11333271;DIP:20145116;DIP:8621427;DIP:8631822;DIP:9556609;HPMR:8356051;HPRD:17318185;HPRD:8621427;ICELLNET:11181169;ICELLNET:1417831;IntAct:1417831;IntAct:16763549;IntAct:20145116;IntAct:20660291;IntAct:21596751;IntAct:22897854;IntAct:23374253;IntAct:23583373;IntAct:31932617;LRdb:15637071;LRdb:17318185;LRdb:8621427;Lit-BM-17:11333271;Lit-BM-17:12716911;Lit-BM-17:16423422;Lit-BM-17:16763549;Lit-BM-17:18325345;Lit-BM-17:19818105;Lit-BM-17:20145116;Lit-BM-17:22897854;Lit-BM-17:23374253;Lit-BM-17:23583373;Lit-BM-17:8621427;Lit-BM-17:8631822;Lit-BM-17:9556609;ProtMapper:12189247;ProtMapper:22174934;ProtMapper:24023956;ProtMapper:24966171;ProtMapper:27005951;SIGNOR:17658244;connectomeDB2020:15637071;connectomeDB2020:17318185;connectomeDB2020:8621427;scConnect:31023826], NFE2L2 [NRF2ome:22033923], NRP1 [Baccin2019:10409677;Baccin2019:11986311;Baccin2019:15637071;Baccin2019:16763549;Baccin2019:17222790;Baccin2019:9529250;BioGRID:11986311;BioGRID:20363638;CellTalkDB:11986311;Cellinker:10409677;Cellinker:11986311;Cellinker:15637071;Cellinker:16763549;Cellinker:17222790;Cellinker:9529250;DIP:10498602;DIP:11333271;DIP:9712843;HPRD:10409677;HPRD:11986311;HPRD:16763549;HPRD:17222790;HPRD:9529250;ICELLNET:11181169;ICELLNET:21653826;IntAct:16763549;IntAct:17222790;LRdb:10409677;LRdb:11986311;LRdb:15637071;LRdb:16763549;LRdb:17222790;LRdb:9529250;Lit-BM-17:10498602;Lit-BM-17:11333271;Lit-BM-17:11986311;Lit-BM-17:16423422;Lit-BM-17:16763549;Lit-BM-17:17222790;Lit-BM-17:18325345;Lit-BM-17:20363638;Lit-BM-17:21939755;Lit-BM-17:22318724;Lit-BM-17:22897854;Lit-BM-17:9529250;Lit-BM-17:9712843;connectomeDB2020:10409677;connectomeDB2020:11986311;connectomeDB2020:15637071;connectomeDB2020:16763549;connectomeDB2020:17222790;connectomeDB2020:9529250], NRP2 [Baccin2019:10748121;CellTalkDB:10748121;Cellinker:10748121;DIP:10748121;ELM:26991001;HPRD:10748121;ICELLNET:11181169;LRdb:10748121;connectomeDB2020:10748121], ITGAV [CellTalkDB:32196115], TYRO3 [CellTalkDB:32196115], GPC1 [CellTalkDB:10196157;Cellinker:10196157;HPRD:10196157;LRdb:10196157;connectomeDB2020:10196157], ITGA9 [CellTalkDB:17363377], EGFR [CellTalkDB:32196115], RET [CellTalkDB:32196115], EPHB2 [Baccin2019:17318185;HPRD:17318185;LRdb:17318185], ITGB1 [CellTalkDB:32196115], SIRPA [CellTalkDB:32196115], ITGB3 [CellTalkDB:32196115], GRIN2B [CellTalkDB:32103204], CD44 [Cellinker:26181364], VCAN [Cellinker:16045811], HIF1A [BioGRID:11901189;BioGRID:22952674]	adherens junction [GO:0005912]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; platelet alpha granule lumen [GO:0031093]; secretory granule [GO:0030141]	chemoattractant activity [GO:0042056]; cytokine activity [GO:0005125]; extracellular matrix binding [GO:0050840]; fibronectin binding [GO:0001968]; growth factor activity [GO:0008083]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; neuropilin binding [GO:0038191]; platelet-derived growth factor receptor binding [GO:0005161]; protein homodimerization activity [GO:0042803]; receptor ligand activity [GO:0048018]; vascular endothelial growth factor receptor 1 binding [GO:0043183]; vascular endothelial growth factor receptor 2 binding [GO:0043184]; vascular endothelial growth factor receptor binding [GO:0005172]	activation of protein kinase activity [GO:0032147]; angiogenesis [GO:0001525]; artery morphogenesis [GO:0048844]; basophil chemotaxis [GO:0002575]; branching involved in blood vessel morphogenesis [GO:0001569]; camera-type eye morphogenesis [GO:0048593]; cardiac muscle cell development [GO:0055013]; cardiac vascular smooth muscle cell development [GO:0060948]; cell maturation [GO:0048469]; cell migration involved in sprouting angiogenesis [GO:0002042]; cellular response to hypoxia [GO:0071456]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; cellular stress response to acid chemical [GO:0097533]; commissural neuron axon guidance [GO:0071679]; coronary artery morphogenesis [GO:0060982]; coronary vein morphogenesis [GO:0003169]; dopaminergic neuron differentiation [GO:0071542]; endothelial cell chemotaxis [GO:0035767]; epithelial cell differentiation [GO:0030855]; eye photoreceptor cell development [GO:0042462]; heart morphogenesis [GO:0003007]; induction of positive chemotaxis [GO:0050930]; in utero embryonic development [GO:0001701]; kidney development [GO:0001822]; lactation [GO:0007595]; lung development [GO:0030324]; lymph vessel morphogenesis [GO:0036303]; macrophage differentiation [GO:0030225]; mammary gland alveolus development [GO:0060749]; mesoderm development [GO:0007498]; monocyte differentiation [GO:0030224]; motor neuron migration [GO:0097475]; negative regulation of adherens junction organization [GO:1903392]; negative regulation of apoptotic process [GO:0043066]; negative regulation of blood-brain barrier permeability [GO:1905604]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of establishment of endothelial barrier [GO:1903141]; negative regulation of gene expression [GO:0010629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; outflow tract morphogenesis [GO:0003151]; ovarian follicle development [GO:0001541]; positive chemotaxis [GO:0050918]; positive regulation of angiogenesis [GO:0045766]; positive regulation of axon extension involved in axon guidance [GO:0048842]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:1903589]; positive regulation of branching involved in ureteric bud morphogenesis [GO:0090190]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell division [GO:0051781]; positive regulation of cell migration [GO:0030335]; positive regulation of cell migration by vascular endothelial growth factor signaling pathway [GO:0038089]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway [GO:0038091]; positive regulation of cellular component movement [GO:0051272]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of CREB transcription factor activity [GO:0032793]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial tube formation [GO:1905278]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of gene expression [GO:0010628]; positive regulation of histone deacetylase activity [GO:1901727]; positive regulation of leukocyte migration [GO:0002687]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of mast cell chemotaxis [GO:0060754]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-tyrosine autophosphorylation [GO:1900086]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; positive regulation of phosphorylation [GO:0042327]; positive regulation of positive chemotaxis [GO:0050927]; positive regulation of protein autophosphorylation [GO:0031954]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein kinase C signaling [GO:0090037]; positive regulation of protein kinase D signaling [GO:1903572]; positive regulation of protein localization to early endosome [GO:1902966]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of receptor internalization [GO:0002092]; positive regulation of retinal ganglion cell axon guidance [GO:1902336]; positive regulation of sprouting angiogenesis [GO:1903672]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription from RNA polymerase II promoter in response to hypoxia [GO:0061419]; positive regulation of trophoblast cell migration [GO:1901165]; positive regulation of vascular permeability [GO:0043117]; post-embryonic camera-type eye development [GO:0031077]; primitive erythrocyte differentiation [GO:0060319]; regulation of cell shape [GO:0008360]; regulation of nitric oxide mediated signal transduction [GO:0010749]; regulation of retinal ganglion cell axon guidance [GO:0090259]; regulation of transcription by RNA polymerase II [GO:0006357]; response to hypoxia [GO:0001666]; sprouting angiogenesis [GO:0002040]; surfactant homeostasis [GO:0043129]; tube formation [GO:0035148]; vascular endothelial growth factor receptor-2 signaling pathway [GO:0036324]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; vascular endothelial growth factor signaling pathway [GO:0038084]; vascular wound healing [GO:0061042]; vasculogenesis [GO:0001570]; VEGF-activated neuropilin signaling pathway [GO:0038190]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=VEGFA&keywords=VEGFA	167.30984321793864	39	2852.25	117	2.036717771839175	150	0.23622047244094485	0.4046906187624794	0.038716814159292054	0.4386091127098381	0.2441077441077442	0.9204737732656516	1.021758839528566	0.2202283849918433	0.20125786163521878	0.8252436907465851	0.1704848367780485	79	35	77	0.42925383173874654	0.4809471116028144	1.9015057590740838	0.41088961264974194	352	23	350
VEGFB	vascular endothelial growth factor B	Yes		ENSG00000173511	P49765	PDGF/VEGF growth factor family	21	ligand	extracellular, intracellular, ligand, secreted	O14786, P07550, P07949, P17948, P35968, Q06418	ADRB2, FLT1, FLT1_KDR, KDR, NRP1, RET, TYRO3	FLT1 [Baccin2019:9751730;Baccin2019:97517301;BioGRID:10409677;CellChatDB:16633338;CellTalkDB:9751730;Cellinker:9751730;HPRD:9751730;ICELLNET:11181169;ICELLNET:26285753;LRdb:97517301;LRdb:98;ProtMapper:29397867;SignaLink3:10409677;SignaLink3:18988627;SignaLink3:21071413;SignaLink3:23331499;SignaLink3:9751730;connectomeDB2020:9751730;connectomeDB2020:97517301], NRP1 [Baccin2019:40967710409677;CellTalkDB:10409677;Cellinker:10409677;Cellinker:409677;HPRD:10409677;ICELLNET:11181169;LRdb:1041;LRdb:409677;connectomeDB2020:10409677;connectomeDB2020:409677], RET [CellTalkDB:32196115], TYRO3 [NA], KDR [Cellinker:27834687], ADRB2 [NA]	extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; platelet alpha granule lumen [GO:0031093]	chemoattractant activity [GO:0042056]; growth factor activity [GO:0008083]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; vascular endothelial growth factor receptor 1 binding [GO:0043183]; vascular endothelial growth factor receptor binding [GO:0005172]	cardiac muscle contraction [GO:0060048]; coronary vasculature development [GO:0060976]; induction of positive chemotaxis [GO:0050930]; negative regulation of apoptotic process [GO:0043066]; negative regulation of gene expression [GO:0010629]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell division [GO:0051781]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of mast cell chemotaxis [GO:0060754]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein kinase B signaling [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; positive regulation of vascular wound healing [GO:0035470]; protein O-linked glycosylation [GO:0006493]; response to hypoxia [GO:0001666]; sprouting angiogenesis [GO:0002040]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; vascular endothelial growth factor signaling pathway [GO:0038084]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=VEGFB&keywords=VEGFB	37.44092180898876	113	NA	NA	0.26920925812722496	482	0.06299212598425197	0.08083832335329333	0.04424778761061951	0.15251798561151175	0.07575757575757577	0.4162436548223359	0.3880326382592915	0.18433931484502442	0.25379208287088234	0.2945319802376891	0.09267915781340186	69	64	116	0.18599751156053432	1.3458950614758673	1.553754319700297	0.5238799053920087	68	47	316
VEGFC	vascular endothelial growth factor C	Yes		ENSG00000150630	P49767	PDGF/VEGF growth factor family	20	ligand	extracellular, intracellular, ligand, secreted	O60462, P05556, P17948, P35916, P35968, P41587, Q13797, Q6UXH8, Q9Y5Y7	CCBE1, FLT1, FLT4, FLT4_KDR, ITGA9, ITGB1, KDR, LYVE1, NRP2, VIPR2	FLT4 [Baccin2019:12881528;Baccin2019:16530705;Baccin2019:8700872;CellChatDB:16633338;CellTalkDB:12881528;Cellinker:12881528;Cellinker:16530705;Cellinker:8700872;DIP:8700872;HPMR:12881528;HPRD:16530705;HPRD:8700872;ICELLNET:11532940;ICELLNET:16336962;LRdb:12881528;LRdb:16530705;LRdb:8700872;ProtMapper:24798152;SIGNOR:9435229;connectomeDB2020:12881528;connectomeDB2020:16530705;connectomeDB2020:8700872], KDR [Baccin2019:11332691;Baccin2019:8612600;CellChatDB:16633338;CellTalkDB:8612600;Cellinker:11332691;Cellinker:8612600;DIP:20145116;HPRD:11332691;ICELLNET:11181169;IntAct:20145116;LRdb:11332691;LRdb:8612600;Lit-BM-17:20145116;SIGNOR:9435229;connectomeDB2020:11332691;connectomeDB2020:8612600], NRP2 [Baccin2019:8612600;CellTalkDB:8612600;Cellinker:8612600;ELM:25752543;ICELLNET:16621967;LRdb:8612600;SIGNOR:16816121;connectomeDB2020:8612600], LYVE1 [CellTalkDB:32196115], ITGA9 [CellTalkDB:15590642], FLT1 [CellTalkDB:32196115], ITGB1 [CellTalkDB:15590642], CCBE1 [CellTalkDB:27159393], VIPR2 [Cellinker:12881528;HPMR:12881528;LRdb:12881528;connectomeDB2020:12881528]	extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; platelet alpha granule lumen [GO:0031093]	chemoattractant activity [GO:0042056]; growth factor activity [GO:0008083]; vascular endothelial growth factor receptor 3 binding [GO:0043185]; vascular endothelial growth factor receptor binding [GO:0005172]	animal organ morphogenesis [GO:0009887]; cellular response to leukemia inhibitory factor [GO:1990830]; induction of positive chemotaxis [GO:0050930]; morphogenesis of embryonic epithelium [GO:0016331]; negative regulation of blood pressure [GO:0045776]; negative regulation of osteoblast differentiation [GO:0045668]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of lymphangiogenesis [GO:1901492]; positive regulation of mast cell chemotaxis [GO:0060754]; positive regulation of mesenchymal stem cell proliferation [GO:1902462]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of protein autophosphorylation [GO:0031954]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein secretion [GO:0050714]; regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030947]; response to hypoxia [GO:0001666]; response to xenobiotic stimulus [GO:0009410]; signal transduction [GO:0007165]; sprouting angiogenesis [GO:0002040]; substrate-dependent cell migration [GO:0006929]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; vascular endothelial growth factor signaling pathway [GO:0038084]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=VEGFC&keywords=VEGFC	2.4318397146067414	369	NA	NA	0.2632165325731809	486	0	0.008483033932135729	0.0165929203539823	0.0621103117505995	0	0.01015228426395939	0.022665457842248413	0.0407830342577488	0.032186459489456115	9.347042328748835e-4	0.031408151439057536	202	374	180	0.02048330523291479	1.3839201217558483	0.3587112404421283	1.358387849436566	63	359	45
VEGFD	vascular endothelial growth factor D	Yes		ENSG00000165197	O43915	PDGF/VEGF growth factor family	16	ligand	extracellular, intracellular, ligand, secreted	O60462, P05556, P08648, P13612, P17301, P17948, P35916, P35968, P56199, Q13797	FLT1, FLT4, FLT4_KDR, ITGA1, ITGA2, ITGA4, ITGA5, ITGA9, ITGB1, KDR, NRP2	FLT4 [BioGRID:11279005;CellChatDB:16633338;CellTalkDB:9435229;Cellinker:9435229;HPRD:9435229;ICELLNET:11532940;ICELLNET:16336962;SIGNOR:9435229;connectomeDB2020:21148085;connectomeDB2020:9435229], KDR [CellChatDB:16633338;CellTalkDB:9435229;Cellinker:9435229;HPRD:9435229;ICELLNET:16835467;SIGNOR:9435229;connectomeDB2020:9435229], ITGA4 [CellTalkDB:32196115], ITGB1 [CellTalkDB:15590642], NRP2 [CellTalkDB:16816121;Cellinker:16816121;Cellinker:9435229;connectomeDB2020:16816121;connectomeDB2020:9435229], ITGA9 [CellTalkDB:15590642;Cellinker:15590642;HPRD:15590642;connectomeDB2020:15590642], FLT1 [CellTalkDB:32196115], ITGA1 [CellTalkDB:32196115], ITGA5 [CellTalkDB:32196115], ITGA2 [CellTalkDB:32196115]	extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; platelet alpha granule lumen [GO:0031093]	chemoattractant activity [GO:0042056]; growth factor activity [GO:0008083]; identical protein binding [GO:0042802]; platelet-derived growth factor receptor binding [GO:0005161]; vascular endothelial growth factor receptor 3 binding [GO:0043185]; vascular endothelial growth factor receptor binding [GO:0005172]	cell population proliferation [GO:0008283]; dopaminergic neuron differentiation [GO:0071542]; induction of positive chemotaxis [GO:0050930]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell division [GO:0051781]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of mast cell chemotaxis [GO:0060754]; positive regulation of protein phosphorylation [GO:0001934]; response to bacterium [GO:0009617]; response to hypoxia [GO:0001666]; sprouting angiogenesis [GO:0002040]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; vascular endothelial growth factor signaling pathway [GO:0038084]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=VEGFD&keywords=VEGFD	0.4435286685393258	536	NA	NA	0.07561259809637005	663	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
VGF	VGF nerve growth factor inducible	Yes		ENSG00000128564	O15240	NA	3	ligand	intracellular, ligand, secreted	P04629	NTRK1	NTRK1 [NA]	cytoplasmic vesicle [GO:0031410]; endoplasmic reticulum lumen [GO:0005788]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; neuronal cell body [GO:0043025]; neuron projection [GO:0043005]; secretory granule membrane [GO:0030667]; synapse [GO:0045202]; transport vesicle [GO:0030133]	growth factor activity [GO:0008083]; hormone activity [GO:0005179]; neuropeptide hormone activity [GO:0005184]	carbohydrate homeostasis [GO:0033500]; defense response to bacterium [GO:0042742]; generation of precursor metabolites and energy [GO:0006091]; glucose homeostasis [GO:0042593]; insulin secretion [GO:0030073]; ovarian follicle development [GO:0001541]; penile erection [GO:0043084]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of synaptic plasticity [GO:0048167]; response to cAMP [GO:0051591]; response to cold [GO:0009409]; response to dietary excess [GO:0002021]; response to insulin [GO:0032868]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=VGF&keywords=VGF	60.00724411235955	71	102079	15	5.961451196207737	63	0.10236220472440945	0.6896207584830341	0.04203539823008852	0.21175059952038366	0.3417508417508417	5.142131979695436	10.630099728014546	3.8172920065252853	1.217906030336667	3.368073173989013	4.813444079583	20	13	8	2.7614969818957005	0.44304794064642306	1.218862295739689	1.7403750071139428	359	89	24
VIP	vasoactive intestinal peptide	Yes		ENSG00000146469	P01282	Glucagon family	16	ligand	extracellular, intracellular, ligand, secreted	O60894, O60895, O60896, P07550, P08588, P13945, P16473, P17342, P27487, P32241, P37288, P41586, P41587, P47872, Q03431, Q99678, Q9NQS5	ADCYAP1R1, ADRB1, ADRB2, ADRB3, AVPR1A, DPP4, GPR20, GPR84, NPR3, PTH1R, RAMP1, RAMP2, RAMP3, SCTR, TSHR, VIPR1, VIPR2	ADCYAP1R1 [Baccin2019:10583729;Baccin2019:11931347;Baccin2019:16930633;CellTalkDB:10583729;Cellinker:10583729;Cellinker:11931347;Cellinker:12488235;Cellinker:16930633;Guide2Pharma:10583729;Guide2Pharma:11931347;Guide2Pharma:16930633;LRdb:10583729;LRdb:11931347;LRdb:16930633;connectomeDB2020:10583729;connectomeDB2020:11931347;connectomeDB2020:16930633;scConnect:10583729;scConnect:11931347;scConnect:16930633], SCTR [Baccin2019:1646711;CellTalkDB:8390245;Cellinker:1646711;Guide2Pharma:1646711;LRdb:1646711;connectomeDB2020:1646711;scConnect:1646711], VIPR1 [Baccin2019:10570056;Baccin2019:10801840;Baccin2019:11027527;Baccin2019:11931347;Baccin2019:15247290;Baccin2019:16930633;Baccin2019:8074647;Baccin2019:807467;Baccin2019:8390245;Baccin2019:8791009;Baccin2019:9152366;Baccin2019:9437714;Baccin2019:9454823;Baccin2019:9726637;Baccin2019:9928018;CellChatDB:10655512;CellTalkDB:11027527;Cellinker:10570056;Cellinker:10655511;Cellinker:10801840;Cellinker:11027527;Cellinker:11931347;Cellinker:12488235;Cellinker:15247290;Cellinker:16930633;Cellinker:8074647;Cellinker:8390245;Cellinker:8791009;Cellinker:9152366;Cellinker:9437714;Cellinker:9454823;Cellinker:9726637;Cellinker:9928018;Guide2Pharma:10570056;Guide2Pharma:10801840;Guide2Pharma:11931347;Guide2Pharma:16930633;Guide2Pharma:8074647;Guide2Pharma:8390245;Guide2Pharma:8791009;Guide2Pharma:9152366;Guide2Pharma:9437714;Guide2Pharma:9454823;Guide2Pharma:9726637;Guide2Pharma:9928018;HPMR:11027527;HPRD:11027527;HPRD:15247290;HPRD:807467;LRdb:10570056;LRdb:10801840;LRdb:11027527;LRdb:11931347;LRdb:15247290;LRdb:16930633;LRdb:8074647;LRdb:807467;LRdb:8390245;LRdb:8791009;LRdb:9152366;LRdb:9437714;LRdb:9454823;LRdb:9726637;LRdb:9928018;SIGNOR:11897681;connectomeDB2020:10570056;connectomeDB2020:10801840;connectomeDB2020:11027527;connectomeDB2020:11931347;connectomeDB2020:15247290;connectomeDB2020:16930633;connectomeDB2020:8074647;connectomeDB2020:807467;connectomeDB2020:8390245;connectomeDB2020:8791009;connectomeDB2020:9152366;connectomeDB2020:9437714;connectomeDB2020:9454823;connectomeDB2020:9726637;connectomeDB2020:9928018;scConnect:10570056;scConnect:10801840;scConnect:11931347;scConnect:16930633;scConnect:8074647;scConnect:8390245;scConnect:8791009;scConnect:9152366;scConnect:9437714;scConnect:9454823;scConnect:9726637;scConnect:9928018], VIPR2 [Baccin2019:10570056;Baccin2019:10801840;Baccin2019:11931347;Baccin2019:12220741;Baccin2019:16930633;Baccin2019:8146174;Baccin2019:9152366;Baccin2019:9437714;Baccin2019:9454823;Baccin2019:9726637;Baccin2019:9928018;CellTalkDB:16930633;Cellinker:10570056;Cellinker:10801840;Cellinker:11931347;Cellinker:12220741;Cellinker:12488235;Cellinker:16930633;Cellinker:8146174;Cellinker:9152366;Cellinker:9437714;Cellinker:9454823;Cellinker:9726637;Cellinker:9928018;Guide2Pharma:10570056;Guide2Pharma:10801840;Guide2Pharma:11931347;Guide2Pharma:16930633;Guide2Pharma:9152366;Guide2Pharma:9437714;Guide2Pharma:9454823;Guide2Pharma:9726637;Guide2Pharma:9928018;HPMR:12220741;HPRD:10801840;HPRD:8146174;HPRD:9454823;LRdb:10570056;LRdb:10801840;LRdb:11931347;LRdb:12220741;LRdb:16930633;LRdb:8146174;LRdb:9152366;LRdb:9437714;LRdb:9454823;LRdb:9726637;LRdb:9928018;connectomeDB2020:10570056;connectomeDB2020:10801840;connectomeDB2020:11931347;connectomeDB2020:12220741;connectomeDB2020:16930633;connectomeDB2020:8146174;connectomeDB2020:9152366;connectomeDB2020:9437714;connectomeDB2020:9454823;connectomeDB2020:9726637;connectomeDB2020:9928018;scConnect:10570056;scConnect:10801840;scConnect:11931347;scConnect:16930633;scConnect:9152366;scConnect:9437714;scConnect:9454823;scConnect:9726637;scConnect:9928018], GPR84 [CellTalkDB:32196115], GPR20 [CellTalkDB:32196115], TSHR [CellTalkDB:32196115], RAMP3 [CellTalkDB:23745705], RAMP2 [CellTalkDB:23745705], RAMP1 [CellTalkDB:15361343], NPR3 [CellTalkDB:16723209], AVPR1A [CellTalkDB:32103204], ADRB2 [CellTalkDB:32196115], PTH1R [CellTalkDB:32196115], ADRB3 [CellTalkDB:32196115], DPP4 [CellTalkDB:26919392;Cellinker:21314817], ADRB1 [Cellinker:8190350]	extracellular region [GO:0005576]; neuron projection [GO:0043005]; perikaryon [GO:0043204]	hormone activity [GO:0005179]; neuropeptide hormone activity [GO:0005184]; peptide hormone receptor binding [GO:0051428]	adenylate cyclase-activating G protein-coupled receptor signaling pathway [GO:0007189]; antibacterial humoral response [GO:0019731]; antifungal humoral response [GO:0019732]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; body fluid secretion [GO:0007589]; defense response to Gram-negative bacterium [GO:0050829]; defense response to Gram-positive bacterium [GO:0050830]; epinephrine secretion [GO:0048242]; G protein-coupled receptor signaling pathway [GO:0007186]; innate immune response [GO:0045087]; learning or memory [GO:0007611]; mRNA stabilization [GO:0048255]; negative regulation of apoptotic process [GO:0043066]; negative regulation of potassium ion transport [GO:0043267]; negative regulation of smooth muscle cell proliferation [GO:0048662]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of epinephrine secretion [GO:0032812]; positive regulation of penile erection [GO:0060406]; positive regulation of protein catabolic process [GO:0045732]; prolactin secretion [GO:0070459]; regulation of protein localization [GO:0032880]; regulation of sensory perception of pain [GO:0051930]; response to yeast [GO:0001878]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=VIP&keywords=VIP	14.042874288764045	198	NA	NA	2.1159941094799732	145	0	0	0	4.7961630695443646e-4	0	0	0	0	0	0	0.003051960594939154	303	409	314	3.2105244562669006e-4	0.9688934391799618	0.9688934391799618	1.2645958988871937	143	143	54
VSTM1	V-set and transmembrane domain containing 1	No		ENSG00000276159, ENSG00000274953, ENSG00000275577, ENSG00000276363, ENSG00000276066, ENSG00000277607, ENSG00000274887, ENSG00000275962, ENSG00000275330, ENSG00000189068	Q6UX27	NA	2	ligand, receptor	cell_surface, intracellular, ligand, plasma_membrane_transmembrane, receptor, secreted, transmembrane, transmembrane_predicted	P11279, Q86Y34	ADGRG3, LAMP1	ADGRG3 [NA], LAMP1 [NA]	extracellular space [GO:0005615]; integral component of membrane [GO:0016021]	cytokine activity [GO:0005125]	immune system process [GO:0002376]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=VSTM1&keywords=VSTM1	0.023431182022471908	784	NA	NA	0.03716188889172288	745	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
VTN	vitronectin	No	nectin	ENSG00000109072	P04004	NA	10	ecm, ligand	ecm, extracellular, intracellular, ligand, secreted	O00300, P05106, P05121, P05556, P06756, P08514, P08648, P09038, P15151, P15692, P18084, P18564, P19320, P26006, P26012, P35968, P53708, Q03405, Q08722	CD47, FGF2, ITGA2B, ITGA2B_ITGB3, ITGA3, ITGA5, ITGA8, ITGA8_ITGB1, ITGAD_ITGB2, ITGAV, ITGAV_ITGB1, ITGAV_ITGB3, ITGAV_ITGB5, ITGAV_ITGB8, ITGB1, ITGB3, ITGB5, ITGB6, ITGB8, KDR, PLAUR, PVR, SERPINE1, TNFRSF11B, VCAM1, VEGFA	ITGB1 [CA1:7716514;CellTalkDB:32196115], ITGAV [CellTalkDB:23154389;ICELLNET:7685013;LRdb:23154389;Ramilowski2015:23154389;connectomeDB2020:23154389;talklr:23154389], ITGA5 [CellTalkDB:11331280;Cellinker:11331280;Cellinker:23154389;LRdb:11331280;connectomeDB2020:11331280], ITGA8 [CellTalkDB:7559467;HPRD:7559467;LRdb:7559467;connectomeDB2020:7559467], CD47 [CellTalkDB:32196115], KDR [CellTalkDB:32196115;Cellinker:31677479], PLAUR [Baccin2019:8830783;CellTalkDB:8830783;Cellinker:8830783;HPRD:8830783;LRdb:8830783;connectomeDB2020:8830783], ITGA2B [CellTalkDB:1692034], ITGB3 [CellTalkDB:11331280;HPRD:16195248;LRdb:11331280;LRdb:16;connectomeDB2020:11331280;connectomeDB2020:16195248], ITGB6 [CellTalkDB:8120056;Cellinker:8120056;HPRD:8120056;LRdb:8120056;connectomeDB2020:8120056], TNFRSF11B [CellTalkDB:15799029;Cellinker:15799029;HPRD:15799029;LRdb:15799029;connectomeDB2020:15799029], PVR [CellTalkDB:11437656;Cellinker:11437656;HPRD:11437656;LRdb:11437656;connectomeDB2020:11437656], ITGB5 [CellTalkDB:32196115], ITGA3 [CellTalkDB:32196115], ITGB8 [CellTalkDB:11156415;HPRD:11156415;LRdb:11156415;connectomeDB2020:11156415], VCAM1 [Cellinker:16601240], SERPINE1 [HPRD:11796824;HPRD:12808446;HPRD:8830783;HPRD:9065424;Lit-BM-17:11113116;Lit-BM-17:12808446], VEGFA [HPRD:11796824], FGF2 [HPRD:11796824]	alphav-beta3 integrin-vitronectin complex [GO:0071062]; blood microparticle [GO:0072562]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; peptidase inhibitor complex [GO:1904090]; protein complex involved in cell-matrix adhesion [GO:0098637]	extracellular matrix binding [GO:0050840]; extracellular matrix structural constituent [GO:0005201]; heparin binding [GO:0008201]; integrin binding [GO:0005178]; polysaccharide binding [GO:0030247]; scavenger receptor activity [GO:0005044]	cell adhesion [GO:0007155]; cell adhesion mediated by integrin [GO:0033627]; cell-matrix adhesion [GO:0007160]; cell migration [GO:0016477]; endodermal cell differentiation [GO:0035987]; immune response [GO:0006955]; negative regulation of blood coagulation [GO:0030195]; negative regulation of endopeptidase activity [GO:0010951]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein binding [GO:0032092]; positive regulation of receptor-mediated endocytosis [GO:0048260]; positive regulation of smooth muscle cell migration [GO:0014911]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; positive regulation of wound healing [GO:0090303]; regulation of cell adhesion [GO:0030155]; smooth muscle cell-matrix adhesion [GO:0061302]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=VTN&keywords=VTN	13.020830818589495	208	3063.9	114	0.243679725886158	502	0.007874015748031496	0.02594810379241515	0	9.592326139088729e-4	0.003367003367003367	0.008460236886632826	0.003626473254759746	0.011419249592169658	7.399186089530152e-4	0.0027373481105621533	0.0029746957697508233	301	326	316	0.0061914797949261	0.6633067974626117	0.7866697962068692	0.8013285959086139	274	216	188
VWC2	von Willebrand factor C domain containing 2	TBD		ENSG00000188730	Q2TAL6	NA	2	ecm, ligand	ecm, ligand, secreted	NA	NA	NA	AMPA glutamate receptor complex [GO:0032281]; basement membrane [GO:0005604]; extracellular space [GO:0005615]; interstitial matrix [GO:0005614]; synapse [GO:0045202]	NA	negative regulation of BMP signaling pathway [GO:0030514]; positive regulation of cell-substrate adhesion [GO:0010811]; positive regulation of neuron differentiation [GO:0045666]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=VWC2&keywords=VWC2	0.005770297640449438	849	NA	NA	0.010686076741157574	828	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
VWC2L	von Willebrand factor C domain containing 2 like	TBD		ENSG00000174453	B2RUY7	NA	2	ligand	ligand, secreted	NA	NA	NA	AMPA glutamate receptor complex [GO:0032281]; extracellular space [GO:0005615]; synapse [GO:0045202]	NA	negative regulation of BMP signaling pathway [GO:0030514]; positive regulation of neuron differentiation [GO:0045666]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=VWC2L&keywords=VWC2L	0.2875416374104651	582	NA	NA	1.0893761726179143	247	0	4.99001996007984e-4	0	7.194244604316547e-4	0	0.00338409475465313	0.015412511332728921	0.0016313213703099511	0.001849796522382538	0.006309253571905447	0.0010817075526366627	298	274	362	0.002807919232823299	0.9251929456280964	1.2733726123216922	0.8652230976158239	166	81	157
VWCE	von Willebrand factor C and EGF domains	TBD		ENSG00000167992	Q96DN2	NA	1	ecm, ligand	ecm, intracellular, ligand, secreted	NA	NA	NA	cytoplasm [GO:0005737]; extracellular region [GO:0005576]	calcium ion binding [GO:0005509]	cellular response to virus [GO:0098586]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=VWCE&keywords=VWCE	0.1425076538202247	646	NA	NA	0.04912714603294752	710	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
VWF	von Willebrand factor	TBD		ENSG00000110799	P04275	NA	10	ecm, ligand	ecm, extracellular, intracellular, ligand, secreted	O00300, P00451, P02452, P02461, P02462, P05106, P05556, P07359, P08123, P08514, P08572, P13224, P13612, P14770, P16109, P29400, P40197, P78324, Q01955, Q07954, Q13797, Q14031, Q6ZMJ2, Q76LX8, Q8WWQ8	ADAMTS13, COL1A1, COL1A2, COL3A1, COL4A1, COL4A2, COL4A3, COL4A5, COL4A6, F8, GP1BA, GP1BA_GP1BB, GP1BA_GP1BB_GP5_GP9, GP1BB, GP5, GP9, ITGA2B, ITGA2B_ITGB3, ITGA4, ITGA9, ITGAV_ITGB3, ITGB1, ITGB3, LRP1, SCARA5, SELP, SIRPA, STAB2, TNFRSF11B	ADAMTS13 [DIP:18492805;HPRD:12775718;HPRD:15824096;InnateDB:18577516;IntAct:16221672;IntAct:18492805;IntAct:25512528;Lit-BM-17:16221672;Lit-BM-17:18492805;Lit-BM-17:25512528], F8 [DIP:18492805;HPRD:3134349;HPRD:9218428;IntAct:18492805;IntAct:27749002;Lit-BM-17:18492805;Lit-BM-17:9218428;SIGNOR:23020315], SCARA5 [CellTalkDB:31126000], ITGA2B [CellTalkDB:31035301;HPRD:1737795;LRdb:1737795;connectomeDB2020:1737795], ITGB3 [CellTalkDB:2545728], STAB2 [CellTalkDB:30124466], SELP [CellTalkDB:16418330], SIRPA [CellTalkDB:32196115], TNFRSF11B [Baccin2019:15799029;CellTalkDB:15799029;Cellinker:15799029;HPRD:15799029;LRdb:15799029;connectomeDB2020:15799029], GP1BA [Baccin2019:12087105;Baccin2019:12183630;Baccin2019:6336654;BioGRID:12183630;BioGRID:2690940;BioGRID:7690774;CellTalkDB:12183630;Cellinker:12087105;Cellinker:12183630;Cellinker:19286885;Cellinker:6336654;HPRD:12087105;HPRD:12183630;HPRD:6336654;IntAct:12183630;IntAct:15039442;LRdb:12087105;LRdb:12183630;LRdb:6336654;Lit-BM-17:12183630;Lit-BM-17:15039442;connectomeDB2020:12087105;connectomeDB2020:12183630;connectomeDB2020:6336654], LRP1 [CellTalkDB:22234691], COL4A6 [Cellinker:19286885], GP1BB [Cellinker:19286885], COL4A1 [Cellinker:19286885], COL1A2 [Cellinker:19286885;HPRD:3490481], ITGA4 [Cellinker:10816592], COL4A2 [Cellinker:19286885], COL4A5 [Cellinker:19286885], ITGB1 [Cellinker:10816592], GP5 [Cellinker:9268316], COL3A1 [Cellinker:19286885], ITGA9 [Cellinker:10816592], COL4A3 [Cellinker:19286885], GP9 [Cellinker:9268316], COL1A1 [Cellinker:19286885;HPRD:3490481]	collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; platelet alpha granule [GO:0031091]; platelet alpha granule lumen [GO:0031093]; Weibel-Palade body [GO:0033093]	chaperone binding [GO:0051087]; collagen binding [GO:0005518]; identical protein binding [GO:0042802]; immunoglobulin binding [GO:0019865]; integrin binding [GO:0005178]; protease binding [GO:0002020]; protein N-terminus binding [GO:0047485]	blood coagulation [GO:0007596]; cell adhesion [GO:0007155]; cell-substrate adhesion [GO:0031589]; hemostasis [GO:0007599]; platelet activation [GO:0030168]; positive regulation of intracellular signal transduction [GO:1902533]; response to wounding [GO:0009611]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=VWF&keywords=VWF	1.8888221868351929	391	1485.1	146	0.03542957761888921	753	0	4.99001996007984e-4	0.17256637168141614	0.023980815347721816	0	0	0	0.0016313213703099511	3.699593044765076e-4	2.3367605821872085e-4	5.794861889124977e-4	302	401	380	0.018169148358823967	0.3681318005209811	0.36329376834046273	0.37556996946265436	387	356	361
WFIKKN1	WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 1	TBD		ENSG00000127578	Q96NZ8	WFIKKN family	1	ligand	extracellular, ligand, secreted, secreted_peptidase_inhibitor	NA	NA	NA	extracellular region [GO:0005576]	metalloendopeptidase inhibitor activity [GO:0008191]; receptor antagonist activity [GO:0048019]; serine-type endopeptidase inhibitor activity [GO:0004867]; transforming growth factor beta binding [GO:0050431]	muscle cell development [GO:0055001]; negative regulation of DNA binding [GO:0043392]; negative regulation of protein binding [GO:0032091]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; roof of mouth development [GO:0060021]; skeletal system development [GO:0001501]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=WFIKKN1&keywords=WFIKKN1	0.05109403438202247	736	NA	NA	0.023558468930670512	790	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
WFIKKN2	WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 2	TBD		ENSG00000173714	Q8TEU8	WFIKKN family	2	ligand	extracellular, ligand, ligand_regulator, secreted, secreted_peptidase_inhibitor	Q2VWP7, Q8IVU1, Q8TDY8	IGDCC3, IGDCC4, PRTG	IGDCC4 [Cellinker:32822567], PRTG [Cellinker:32822567], IGDCC3 [Cellinker:32822567]	extracellular space [GO:0005615]	metalloendopeptidase inhibitor activity [GO:0008191]; receptor antagonist activity [GO:0048019]; serine-type endopeptidase inhibitor activity [GO:0004867]; transforming growth factor beta binding [GO:0050431]	muscle cell development [GO:0055001]; negative regulation of DNA binding [GO:0043392]; negative regulation of protein binding [GO:0032091]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; roof of mouth development [GO:0060021]; skeletal system development [GO:0001501]; transforming growth factor beta receptor signaling pathway [GO:0007179]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=WFIKKN2&keywords=WFIKKN2	0.027596436629213482	778	NA	NA	0.008083621457310737	844	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
WIF1	WNT inhibitory factor 1	Yes		ENSG00000156076	Q9Y5W5	NA	2	ligand, receptor	ligand, ligand_regulator, receptor, secreted	O00755, O14904, O96014, P34925, P41221, P56704, P56705, Q9H1J5, Q9H1J7	RYK, WNT11, WNT3A, WNT4, WNT5A, WNT5B, WNT7A, WNT8A, WNT9A	WNT8A [SIGNOR:10201374;SignaLink3:10201374;SignaLink3:23331499], RYK [CellTalkDB:28529460], WNT3A [NetPath:19755491], WNT4 [NetPath:15555925;NetPath:19755491], WNT5A [NetPath:19755491], WNT5B [NetPath:19755491], WNT7A [IntAct:22986341;IntAct:26342861;Lit-BM-17:22986341;Lit-BM-17:26342861;NetPath:19755491], WNT9A [NetPath:19755491], WNT11 [NetPath:19755491]	cell surface [GO:0009986]; extracellular region [GO:0005576]	signaling receptor binding [GO:0005102]; Wnt-protein binding [GO:0017147]	anatomical structure development [GO:0048856]; negative regulation of Wnt signaling pathway [GO:0030178]; positive regulation of fat cell differentiation [GO:0045600]; signal transduction [GO:0007165]; Wnt signaling pathway [GO:0016055]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=WIF1&keywords=WIF1	0.019755680898876405	796	NA	NA	0.0033415255332317267	877	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
WNT1	Wnt family member 1	Yes		ENSG00000125084	P04628	Wnt family	17	adhesion, ecm, ligand	adhesion, ecm, extracellular, intracellular, ligand, matrix_adhesion, secreted	O00144, O60353, O75084, O75197, O75581, P16671, P34925, P46531, P48436, P52951, P56178, P78504, Q01974, Q02962, Q06710, Q13467, Q14332, Q14469, Q6ZQN5, Q9H461, Q9NPG1, Q9ULV1, Q9ULW2, Q9UP38	CD36, DLX5, FOXI2, FZD1, FZD1_LRP5, FZD1_LRP6, FZD10, FZD10_LRP5, FZD10_LRP6, FZD2, FZD2_LRP5, FZD2_LRP6, FZD3, FZD3_LRP5, FZD3_LRP6, FZD4, FZD4_LRP5, FZD4_LRP6, FZD5, FZD5_LRP5, FZD5_LRP6, FZD6, FZD6_LRP5, FZD6_LRP6, FZD7, FZD7_LRP5, FZD7_LRP6, FZD8, FZD8_LRP5, FZD8_LRP6, FZD9, FZD9_LRP5, FZD9_LRP6, GBX2, HES1, JAG1, LRP5, LRP6, NOTCH1, PAX2, PAX8, ROR2, RYK, SOX9	FOXI2 [SPIKE:18495817], JAG1 [SPIKE:18495817], NOTCH1 [SPIKE:18495817], DLX5 [SPIKE:18495817], GBX2 [SPIKE:18495817], PAX2 [SPIKE:18495817], PAX8 [SPIKE:18495817], HES1 [SPIKE:18495817], SOX9 [SPIKE:18495817], LRP6 [Baccin2019:11029007;Baccin2019:11448771;CancerCellMap:11029007;CancerCellMap:11448771;CellTalkDB:11029007;HPRD:11029007;HPRD:11448771;LRdb:11;LRdb:11029007;NetPath:11029007;ProtMapper:29444668;SIGNOR:21078818;SignaLink3:11029007;SignaLink3:11448771;SignaLink3:18988627;SignaLink3:21071413;SignaLink3:23331499;connectomeDB2020:11029007;connectomeDB2020:11448771], RYK [Baccin2019:1545408415454080;CellTalkDB:15454084;Cellinker:15454084;HPMR:15454084;HPRD:15454084;LRdb:15454084;NetPath:15454084;SIGNOR:15454084;SignaLink3:15454084;SignaLink3:23331499;connectomeDB2020:15454084], FZD8 [Baccin2019:1545408415454080;CellTalkDB:15454084;HPMR:15454084;HPRD:15454084;LRdb:15454084;NetPath:15454084;SIGNOR:11448771;connectomeDB2020:15454084], FZD3 [Baccin2019:14642436;CellTalkDB:14642436;HPMR:14642436;LRdb:14642436;SIGNOR:15578921;connectomeDB2020:14642436], FZD6 [SIGNOR:22944199], LRP5 [Baccin2019:11336703;CellTalkDB:11336703;HPRD:11336703;LRdb:11336703;NetPath:11336703;SIGNOR:15578921;SIGNOR:21078818], FZD1 [CancerCellMap:10557084;CellPhoneDB:24032637;CellTalkDB:24032637;NetPath:10557084;SIGNOR:15578921;SIGNOR:16936075;SIGNOR:22944199;connectomeDB2020:24032637], ROR2 [CellTalkDB:15388793;NetPath:18762249;connectomeDB2020:15388793], FZD9 [Baccin2019:91476519147651;CellTalkDB:9147651;HPMR:9147651;HPRD:9147651;LRdb:9147651;connectomeDB2020:9147651], FZD5 [CellTalkDB:32196115], FZD7 [CellTalkDB:32196115], FZD10 [connectomeDB2020:24599775], FZD2 [connectomeDB2020:28733458], FZD4 [connectomeDB2020:28733458], CD36 [InnateDB:25721714]	cell surface [GO:0009986]; cytoplasm [GO:0005737]; endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; plasma membrane [GO:0005886]	cytokine activity [GO:0005125]; frizzled binding [GO:0005109]; morphogen activity [GO:0016015]; protein domain specific binding [GO:0019904]; receptor ligand activity [GO:0048018]	animal organ regeneration [GO:0031100]; astrocyte-dopaminergic neuron signaling [GO:0036520]; bone development [GO:0060348]; branching involved in ureteric bud morphogenesis [GO:0001658]; canonical Wnt signaling pathway [GO:0060070]; canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation [GO:1904954]; cell-cell signaling [GO:0007267]; cell fate commitment [GO:0045165]; cell proliferation in midbrain [GO:0033278]; cellular response to peptide hormone stimulus [GO:0071375]; central nervous system morphogenesis [GO:0021551]; cerebellum formation [GO:0021588]; diencephalon development [GO:0021536]; embryonic axis specification [GO:0000578]; embryonic brain development [GO:1990403]; forebrain anterior/posterior pattern specification [GO:0021797]; hematopoietic stem cell proliferation [GO:0071425]; hepatocyte differentiation [GO:0070365]; inner ear morphogenesis [GO:0042472]; midbrain development [GO:0030901]; midbrain-hindbrain boundary maturation during brain development [GO:0022004]; myoblast fusion [GO:0007520]; negative regulation of apoptotic process [GO:0043066]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of cell aging [GO:0090344]; negative regulation of cell-cell adhesion [GO:0022408]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of oxidative stress-induced neuron death [GO:1903204]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; neuron differentiation [GO:0030182]; neuron fate determination [GO:0048664]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of dermatome development [GO:0061184]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; response to wounding [GO:0009611]; signal transduction in response to DNA damage [GO:0042770]; Spemann organizer formation [GO:0060061]; spinal cord association neuron differentiation [GO:0021527]; T cell differentiation in thymus [GO:0033077]; ubiquitin-dependent SMAD protein catabolic process [GO:0030579]; Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation [GO:1904953]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=WNT1&keywords=WNT1	0.004458308988764045	859	NA	NA	0.037187744847394504	744	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
WNT10A	Wnt family member 10A	Yes		ENSG00000135925	Q9GZT5	Wnt family	8	ecm, ligand	ecm, ligand, secreted	O75197, O75581, Q13467, Q9H461, Q9NPG1, Q9UP38	FZD1, FZD1_LRP5, FZD1_LRP6, FZD10_LRP5, FZD10_LRP6, FZD2_LRP5, FZD2_LRP6, FZD3, FZD3_LRP5, FZD3_LRP6, FZD4_LRP5, FZD4_LRP6, FZD5, FZD5_LRP5, FZD5_LRP6, FZD6_LRP5, FZD6_LRP6, FZD7_LRP5, FZD7_LRP6, FZD8, FZD8_LRP5, FZD8_LRP6, FZD9_LRP5, FZD9_LRP6, LRP5, LRP6	LRP5 [SIGNOR:15578921], LRP6 [SIGNOR:15578921], FZD3 [SIGNOR:15578921], FZD1 [connectomeDB2020:28733458], FZD5 [connectomeDB2020:28733458], FZD8 [connectomeDB2020:28733458]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	cytokine activity [GO:0005125]; frizzled binding [GO:0005109]; receptor ligand activity [GO:0048018]	canonical Wnt signaling pathway [GO:0060070]; cell fate commitment [GO:0045165]; cellular response to transforming growth factor beta stimulus [GO:0071560]; epidermis morphogenesis [GO:0048730]; hair follicle development [GO:0001942]; hair follicle morphogenesis [GO:0031069]; neural crest cell differentiation [GO:0014033]; neuron differentiation [GO:0030182]; odontogenesis [GO:0042476]; positive regulation of gene expression [GO:0010628]; regulation of odontogenesis of dentin-containing tooth [GO:0042487]; sebaceous gland development [GO:0048733]; skin development [GO:0043588]; tongue development [GO:0043586]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=WNT10A&keywords=WNT10A	0.23737775786516854	597	NA	NA	0.1109832813591342	613	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
WNT10B	Wnt family member 10B	Yes		ENSG00000169884	O00744	Wnt family	8	ecm, ligand	ecm, ligand, secreted	O75084, O75197, O75581, Q13467, Q14332, Q9NPG1, Q9UP38	FZD1, FZD1_LRP5, FZD1_LRP6, FZD10_LRP5, FZD10_LRP6, FZD2, FZD2_LRP5, FZD2_LRP6, FZD3, FZD3_LRP5, FZD3_LRP6, FZD4_LRP5, FZD4_LRP6, FZD5, FZD5_LRP5, FZD5_LRP6, FZD6_LRP5, FZD6_LRP6, FZD7, FZD7_LRP5, FZD7_LRP6, FZD8_LRP5, FZD8_LRP6, FZD9_LRP5, FZD9_LRP6, LRP5, LRP6	FZD5 [SIGNOR:12055200;SignaLink3:11092808;SignaLink3:23331499], LRP6 [Cellinker:23209147;SIGNOR:15578921], FZD1 [SIGNOR:12055200;SIGNOR:19008118], LRP5 [Cellinker:23209147;SIGNOR:15578921], FZD2 [SIGNOR:12055200], FZD3 [SIGNOR:15578921], FZD7 [connectomeDB2020:29979633]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	cytokine activity [GO:0005125]; frizzled binding [GO:0005109]; receptor ligand activity [GO:0048018]	bone trabecula formation [GO:0060346]; canonical Wnt signaling pathway [GO:0060070]; cell fate commitment [GO:0045165]; cellular response to cAMP [GO:0071320]; cellular response to parathyroid hormone stimulus [GO:0071374]; cellular response to retinoic acid [GO:0071300]; chondrocyte differentiation [GO:0002062]; fungiform papilla development [GO:0061196]; G2/M transition of mitotic cell cycle [GO:0000086]; hematopoietic stem cell proliferation [GO:0071425]; lipid metabolic process [GO:0006629]; myoblast differentiation involved in skeletal muscle regeneration [GO:0014835]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron differentiation [GO:0030182]; positive regulation of apoptotic process [GO:0043065]; positive regulation of bone mineralization [GO:0030501]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of epithelial cell differentiation [GO:0030858]; positive regulation of G2/M transition of mitotic cell cycle [GO:0010971]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of RNA polymerase II transcription preinitiation complex assembly [GO:0045899]; positive regulation of timing of anagen [GO:0051885]; protein stabilization [GO:0050821]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434]; regulation of skeletal muscle tissue development [GO:0048641]; sensory perception of taste [GO:0050909]; skeletal muscle fiber development [GO:0048741]; smoothened signaling pathway [GO:0007224]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=WNT10B&keywords=WNT10B	0.03070598035105674	771	NA	NA	0.009195574427421093	839	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
WNT11	Wnt family member 11	Yes		ENSG00000085741	O96014	Wnt family	16	ecm, ligand	ecm, intracellular, ligand, secreted	A4D1S0, O00144, O15146, O60353, O75084, O75581, Q13467, Q14332, Q96CG8, Q9H461, Q9NPG1, Q9ULV1, Q9ULW2, Q9UP38	CTHRC1, FZD1, FZD10, FZD2, FZD3, FZD4, FZD5, FZD6, FZD7, FZD8, FZD9, KLRG2, LRP6, MUSK	MUSK [CellTalkDB:22309736;SIGNOR:22309736;SIGNOR:23151663], FZD6 [SIGNOR:16273260], FZD7 [Baccin2019:10862746;CellTalkDB:10862746;Cellinker:10862746;LRdb:10862746;SIGNOR:10862746;connectomeDB2020:10862746], LRP6 [SIGNOR:15578921], FZD3 [SIGNOR:15578921;SIGNOR:16273260], KLRG2 [CellTalkDB:32103204], FZD1 [NA], FZD10 [NA], FZD2 [NA], FZD4 [NA], FZD5 [NA], FZD8 [connectomeDB2020:29717114], FZD9 [NA], CTHRC1 [Cellinker:18606138]	cytoplasm [GO:0005737]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	cytokine activity [GO:0005125]; frizzled binding [GO:0005109]; GTPase activator activity [GO:0005096]; protein kinase activator activity [GO:0030295]	adrenal gland development [GO:0030325]; artery morphogenesis [GO:0048844]; atrial septum development [GO:0003283]; bicellular tight junction assembly [GO:0070830]; bone mineralization [GO:0030282]; canonical Wnt signaling pathway [GO:0060070]; cell fate commitment [GO:0045165]; cellular response to mechanical stimulus [GO:0071260]; cellular response to retinoic acid [GO:0071300]; cloacal septation [GO:0060197]; convergent extension involved in axis elongation [GO:0060028]; embryonic skeletal system development [GO:0048706]; epithelial to mesenchymal transition [GO:0001837]; lung-associated mesenchyme development [GO:0060484]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; mesonephric duct development [GO:0072177]; negative regulation of apoptotic process [GO:0043066]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cartilage development [GO:0061037]; negative regulation of cell death [GO:0060548]; negative regulation of cell growth [GO:0030308]; negative regulation of cell migration [GO:0030336]; negative regulation of fibroblast growth factor production [GO:0090272]; negative regulation of mesenchymal cell proliferation [GO:0072201]; negative regulation of transcription, DNA-templated [GO:0045892]; neuroendocrine cell differentiation [GO:0061101]; neuron differentiation [GO:0030182]; notochord morphogenesis [GO:0048570]; osteoblast differentiation [GO:0001649]; outflow tract morphogenesis [GO:0003151]; paraxial mesoderm formation [GO:0048341]; planar cell polarity pathway involved in axis elongation [GO:0003402]; planar cell polarity pathway involved in gastrula mediolateral intercalation [GO:0060775]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell migration [GO:0030335]; positive regulation of gene expression [GO:0010628]; positive regulation of GTPase activity [GO:0043547]; positive regulation of heart induction by negative regulation of canonical Wnt signaling pathway [GO:0090082]; positive regulation of protein kinase C signaling [GO:0090037]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transforming growth factor beta2 production [GO:0032915]; primary heart field specification [GO:0003138]; protein localization to cell surface [GO:0034394]; protein phosphorylation [GO:0006468]; response to nutrient levels [GO:0031667]; secondary heart field specification [GO:0003139]; secondary palate development [GO:0062009]; somite development [GO:0061053]; ureteric bud morphogenesis [GO:0060675]; ventricular septum morphogenesis [GO:0060412]; Wnt signaling pathway, calcium modulating pathway [GO:0007223]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=WNT11&keywords=WNT11	0.18000413595505618	622	NA	NA	0.03164327965626202	762	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
WNT16	Wnt family member 16	Yes		ENSG00000002745	Q9UBV4	Wnt family	12	ecm, ligand	ecm, extracellular, intracellular, ligand, secreted, transmembrane	O60353, O75197, O75581, Q14332, Q9NPG1	FZD1_LRP5, FZD1_LRP6, FZD10_LRP5, FZD10_LRP6, FZD2, FZD2_LRP5, FZD2_LRP6, FZD3, FZD3_LRP5, FZD3_LRP6, FZD4_LRP5, FZD4_LRP6, FZD5_LRP5, FZD5_LRP6, FZD6, FZD6_LRP5, FZD6_LRP6, FZD7_LRP5, FZD7_LRP6, FZD8_LRP5, FZD8_LRP6, FZD9_LRP5, FZD9_LRP6, LRP5, LRP6	LRP6 [SIGNOR:15578921], FZD3 [SIGNOR:15578921], FZD6 [CellTalkDB:32196115], FZD2 [connectomeDB2020:26861315], LRP5 [connectomeDB2020:26861315]	cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	cytokine activity [GO:0005125]; frizzled binding [GO:0005109]	bone remodeling [GO:0046849]; canonical Wnt signaling pathway [GO:0060070]; cardiac epithelial to mesenchymal transition [GO:0060317]; cell fate commitment [GO:0045165]; keratinocyte differentiation [GO:0030216]; keratinocyte proliferation [GO:0043616]; negative regulation of cell death [GO:0060548]; neuron differentiation [GO:0030182]; optic cup formation involved in camera-type eye development [GO:0003408]; oxidative stress-induced premature senescence [GO:0090403]; positive regulation of gene expression [GO:0010628]; positive regulation of JNK cascade [GO:0046330]; positive regulation of phosphatidylinositol 3-kinase signaling [GO:0014068]; replicative senescence [GO:0090399]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=WNT16&keywords=WNT16	0.3694927313483146	553	NA	NA	0.5579127354573438	364	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
WNT2	Wnt family member 2	Yes		ENSG00000105989	P09544	Wnt family	16	ecm, ligand, receptor	ecm, intracellular, ligand, receptor, secreted	O00144, O75084, O75197, O75581, Q13467, Q14332, Q9H461, Q9NPG1, Q9ULV1, Q9UP38	FZD1, FZD1_LRP5, FZD1_LRP6, FZD10_LRP5, FZD10_LRP6, FZD2, FZD2_LRP5, FZD2_LRP6, FZD3, FZD3_LRP5, FZD3_LRP6, FZD4, FZD4_LRP5, FZD4_LRP6, FZD5, FZD5_LRP5, FZD5_LRP6, FZD6_LRP5, FZD6_LRP6, FZD7, FZD7_LRP5, FZD7_LRP6, FZD8, FZD8_LRP5, FZD8_LRP6, FZD9, FZD9_LRP5, FZD9_LRP6, LRP5, LRP6	FZD9 [Baccin2019:12138115;CellPhoneDB:24032637;CellTalkDB:12138115;HPRD:12138115;LRdb:12138115;NetPath:19038973;SignaLink3:12138115;SignaLink3:23331499;connectomeDB2020:12138115], LRP5 [Cellinker:23209147;SIGNOR:15578921], LRP6 [CellTalkDB:32196115;Cellinker:23209147;SIGNOR:15578921], FZD1 [Baccin2019:10557084;CancerCellMap:10557084;CellTalkDB:10557084;HPRD:10557084;LRdb:10557084;NetPath:10557084;connectomeDB2020:10557084], FZD4 [CellPhoneDB:24032637;CellTalkDB:24032637;LRdb:24032637;connectomeDB2020:24032637], FZD7 [LRdb:23815780;Ramilowski2015:23815780;connectomeDB2020:23815780;talklr:23815780], FZD3 [CellPhoneDB:24032637;CellTalkDB:24032637;LRdb:24032637;NetPath:19038973;connectomeDB2020:24032637], FZD8 [CellTalkDB:23815780;LRdb:23815780;Ramilowski2015:23815780;connectomeDB2020:23815780;talklr:23815780], FZD5 [Baccin2019:24032637;LRdb:18302287;Ramilowski2015:18302287;connectomeDB2020:18302287;talklr:18302287], FZD2 [CellPhoneDB:24032637;CellTalkDB:24032637;connectomeDB2020:24032637]	collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extrinsic component of external side of plasma membrane [GO:0031232]; Wnt signalosome [GO:1990909]	cytokine activity [GO:0005125]; frizzled binding [GO:0005109]; receptor ligand activity [GO:0048018]	atrial cardiac muscle tissue morphogenesis [GO:0055009]; canonical Wnt signaling pathway [GO:0060070]; canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation [GO:1904954]; cardiac epithelial to mesenchymal transition [GO:0060317]; cell-cell signaling [GO:0007267]; cell fate commitment [GO:0045165]; cell proliferation in midbrain [GO:0033278]; cellular response to retinoic acid [GO:0071300]; cellular response to transforming growth factor beta stimulus [GO:0071560]; iris morphogenesis [GO:0061072]; labyrinthine layer blood vessel development [GO:0060716]; lens development in camera-type eye [GO:0002088]; lung development [GO:0030324]; lung induction [GO:0060492]; mammary gland epithelium development [GO:0061180]; midbrain dopaminergic neuron differentiation [GO:1904948]; neurogenesis [GO:0022008]; neuron differentiation [GO:0030182]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of epithelial cell proliferation involved in lung morphogenesis [GO:0060501]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of neurogenesis [GO:0050769]; positive regulation of transcription by RNA polymerase II [GO:0045944]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=WNT2&keywords=WNT2	0.059366186853932586	717	NA	NA	0.06288819447660372	691	0	9.98003992015968e-4	0.00331858407079646	0.014628297362110307	0.003367003367003367	0	0.005439709882139619	0.0065252854812398045	0.001849796522382538	4.0058752837495e-4	0.011551091365655738	298	394	243	0.004370759961065341	0.8245768876863268	0.7237326040204716	1.499648691095255	211	245	34
WNT2B	Wnt family member 2B	Yes		ENSG00000134245	Q93097	Wnt family	10	ecm, ligand	ecm, extracellular, intracellular, ligand, secreted, transmembrane, transmembrane_predicted	O75084, O75197, O75581, Q9NPG1, Q9ULV1	FZD1_LRP5, FZD1_LRP6, FZD10_LRP5, FZD10_LRP6, FZD2_LRP5, FZD2_LRP6, FZD3, FZD3_LRP5, FZD3_LRP6, FZD4, FZD4_LRP5, FZD4_LRP6, FZD5_LRP5, FZD5_LRP6, FZD6_LRP5, FZD6_LRP6, FZD7, FZD7_LRP5, FZD7_LRP6, FZD8_LRP5, FZD8_LRP6, FZD9_LRP5, FZD9_LRP6, LRP5, LRP6	LRP5 [Cellinker:23209147;SIGNOR:15578921], FZD3 [SIGNOR:15578921], FZD4 [CellPhoneDB:24032637;CellTalkDB:24032637;InnateDB:21856951;LRdb:24032637;connectomeDB2020:24032637], FZD7 [connectomeDB2020:18567805], LRP6 [Cellinker:23209147]	collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]	cytokine activity [GO:0005125]; frizzled binding [GO:0005109]	canonical Wnt signaling pathway [GO:0060070]; cell fate commitment [GO:0045165]; cellular response to starvation [GO:0009267]; chondrocyte differentiation [GO:0002062]; cornea development in camera-type eye [GO:0061303]; forebrain regionalization [GO:0021871]; hematopoietic stem cell proliferation [GO:0071425]; iris morphogenesis [GO:0061072]; lens development in camera-type eye [GO:0002088]; lung induction [GO:0060492]; male gonad development [GO:0008584]; mesenchymal-epithelial cell signaling [GO:0060638]; neuron differentiation [GO:0030182]; positive regulation of branching involved in ureteric bud morphogenesis [GO:0090190]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=WNT2B&keywords=WNT2B	0.896590611148764	464	NA	NA	0.25370174699206455	492	0.023622047244094488	0.05588822355289415	0.03982300884955755	0.03285371702637889	0.008417508417508417	0.05583756345177667	0.038077969174977314	0.017944535073409464	0.02330743618201996	0.016991587661904083	0.03728027815337051	224	210	173	0.031822170435262864	0.796406208366852	0.6453894520774514	1.1305075193683773	223	272	71
WNT3	Wnt family member 3	Yes		ENSG00000277641, ENSG00000277626, ENSG00000108379	P56703	Wnt family	16	ecm, ligand	ecm, extracellular, intracellular, ligand, secreted	O75084, O75581, P34925, Q01974, Q13467, Q9H461, Q9NPG1, Q9UP38	FZD1, FZD1_LRP5, FZD1_LRP6, FZD10_LRP5, FZD10_LRP6, FZD2_LRP5, FZD2_LRP6, FZD3, FZD3_LRP5, FZD3_LRP6, FZD4_LRP5, FZD4_LRP6, FZD5, FZD5_LRP5, FZD5_LRP6, FZD6_LRP5, FZD6_LRP6, FZD7, FZD7_LRP5, FZD7_LRP6, FZD8, FZD8_LRP5, FZD8_LRP6, FZD9_LRP5, FZD9_LRP6, LRP6, ROR2, RYK	LRP6 [Baccin2019:18528331;CellTalkDB:18528331;LRdb:18528331;SIGNOR:15578921;connectomeDB2020:18528331], FZD3 [SIGNOR:15578921], RYK [Baccin2019:15454084;CellTalkDB:15454084;Cellinker:15454084;LRdb:15454084;connectomeDB2020:15454084], ROR2 [CellTalkDB:15388793;NetPath:15388793], FZD1 [Baccin2019:10557084;CancerCellMap:10557084;CellTalkDB:10557084;HPRD:10557084;LRdb:10557084;NetPath:10557084;connectomeDB2020:10557084], FZD7 [Baccin2019:24032637;CellPhoneDB:24032637;CellTalkDB:18313787;LRdb:18313787;NetPath:18313787;Ramilowski2015:18313787;connectomeDB2020:18313787;connectomeDB2020:25892522;talklr:18313787], FZD8 [Baccin2019:15454084;Baccin2019:18528331;CellTalkDB:18528331;LRdb:15;LRdb:18528331;connectomeDB2020:15454084;connectomeDB2020:18528331], FZD5 [CellTalkDB:32196115]	endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; plasma membrane [GO:0005886]; Wnt signalosome [GO:1990909]	cytokine activity [GO:0005125]; frizzled binding [GO:0005109]; protein domain specific binding [GO:0019904]; receptor ligand activity [GO:0048018]	anterior/posterior axis specification [GO:0009948]; axon guidance [GO:0007411]; canonical Wnt signaling pathway [GO:0060070]; canonical Wnt signaling pathway involved in mesenchymal stem cell differentiation [GO:0044338]; canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation [GO:1904954]; canonical Wnt signaling pathway involved in osteoblast differentiation [GO:0044339]; canonical Wnt signaling pathway involved in stem cell proliferation [GO:1905474]; cell fate commitment [GO:0045165]; cell morphogenesis [GO:0000902]; cellular response to retinoic acid [GO:0071300]; dorsal/ventral axis specification [GO:0009950]; embryonic forelimb morphogenesis [GO:0035115]; embryonic hindlimb morphogenesis [GO:0035116]; gamete generation [GO:0007276]; head morphogenesis [GO:0060323]; limb bud formation [GO:0060174]; mammary gland epithelium development [GO:0061180]; mesoderm formation [GO:0001707]; negative regulation of axon extension involved in axon guidance [GO:0048843]; neuron differentiation [GO:0030182]; positive regulation of collateral sprouting in absence of injury [GO:0048697]; positive regulation of gene expression [GO:0010628]; positive regulation of Wnt signaling pathway [GO:0030177]; regulation of neurogenesis [GO:0050767]; Spemann organizer formation at the anterior end of the primitive streak [GO:0060064]; stem cell proliferation [GO:0072089]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=WNT3&keywords=WNT3	0.4445826207102295	534	NA	NA	0.14488632443071464	581	0	0.011477045908183629	0	0.007434052757793763	0.0016835016835016834	0.001692047377326565	0.003626473254759746	0.0016313213703099511	0.009248982611912693	0.0032380825210308393	7.340158392891637e-4	267	316	376	0.0037059566658280032	1.4044245929877104	0.9658634449090534	0.783164291337025	61	147	196
WNT3A	Wnt family member 3A	Yes		ENSG00000154342	P56704	Wnt family	18	adhesion, ecm, ligand, receptor	adhesion, ecm, extracellular, intracellular, ligand, matrix_adhesion, receptor, secreted	O60353, O75084, O75197, O75473, O75581, O75787, P34925, Q01973, Q07954, Q13467, Q14332, Q8J025, Q96CG8, Q9H461, Q9NPG1, Q9ULV1, Q9ULW2, Q9UP38	APCDD1, ATP6AP2, CTHRC1, FZD1, FZD1_LRP5, FZD1_LRP6, FZD10, FZD10_LRP5, FZD10_LRP6, FZD2, FZD2_LRP5, FZD2_LRP6, FZD3, FZD3_LRP5, FZD3_LRP6, FZD4, FZD4_LRP5, FZD4_LRP6, FZD5, FZD5_LRP5, FZD5_LRP6, FZD6, FZD6_LRP5, FZD6_LRP6, FZD7, FZD7_LRP5, FZD7_LRP6, FZD8, FZD8_LRP5, FZD8_LRP6, FZD9_LRP5, FZD9_LRP6, LGR5, LRP1, LRP5, LRP6, ROR1, RYK	RYK [Baccin2019:15454084;CellTalkDB:15454084;Cellinker:15454084;HPRD:15454084;LRdb:15454084;NetPath:15454084;SIGNOR:15454084;SignaLink3:15454084;SignaLink3:18988627;SignaLink3:23331499;connectomeDB2020:15454084], FZD6 [Baccin2019:21128903;Baccin2019:21665003;CellTalkDB:21665003;Guide2Pharma:21128903;Guide2Pharma:21665003;LRdb:21;LRdb:21665003;connectomeDB2020:21128903;connectomeDB2020:21665003;scConnect:21128903;scConnect:21665003], LRP5 [CellTalkDB:25425204;SIGNOR:15578921;SIGNOR:21078818], FZD8 [CellTalkDB:22303445;LRdb:22303445;NetPath:20093360;Ramilowski2015:22303445;SIGNOR:22653731;connectomeDB2020:22303445;talklr:22303445], LRP6 [Baccin2019:12897152;Baccin2019:14739301;BioGRID:19910923;CellTalkDB:14739301;DIP:21944579;HPRD:12897152;HPRD:14739301;IntAct:21944579;IntAct:22726442;LRdb:13;LRdb:14739301;NetPath:12897152;NetPath:19339249;NetPath:20093360;ProtMapper:16890161;ProtMapper:18772438;ProtMapper:22491013;ProtMapper:23400998;ProtMapper:24265322;SIGNOR:15578921;SIGNOR:16890161;SIGNOR:21078818;connectomeDB2020:12897152;connectomeDB2020:14739301], FZD2 [CellTalkDB:18215320;LRdb:18215320;NetPath:19910923;Ramilowski2015:18215320;SIGNOR:19910923;connectomeDB2020:18215320;connectomeDB2020:19910923;talklr:18215320], FZD3 [CellTalkDB:18212053;SIGNOR:10601008;SIGNOR:21078818], FZD1 [Baccin2019:10557084;CancerCellMap:10557084;CellTalkDB:10557084;HPRD:10557084;LRdb:10557084;MPPI:10557084;NetPath:10557084;SIGNOR:10601008;SIGNOR:21078818;connectomeDB2020:10557084], FZD5 [Baccin2019:24032637;CellTalkDB:22753465;LRdb:22753465;NetPath:17117926;Ramilowski2015:22753465;connectomeDB2020:22753465;talklr:22753465], ROR1 [CellTalkDB:27709494], ATP6AP2 [CellTalkDB:32196115], APCDD1 [CellTalkDB:20393562;Cellinker:20393562;LRdb:20393562;Ramilowski2015:20393562;connectomeDB2020:20393562;talklr:20393562], FZD7 [CellTalkDB:18215320;LRdb:18215320;Ramilowski2015:18215320;connectomeDB2020:18215320;talklr:18215320], LRP1 [Baccin2019:14739301;CellTalkDB:14739301;Cellinker:14739301;HPRD:14739301;LRdb:14739301;connectomeDB2020:14739301], LGR5 [CellTalkDB:22473993], FZD10 [connectomeDB2020:24599775], CTHRC1 [Cellinker:18606138], FZD4 [NetPath:19020754]	cell surface [GO:0009986]; early endosome membrane [GO:0031901]; endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; Golgi lumen [GO:0005796]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; Wnt-Frizzled-LRP5/6 complex [GO:1990851]	co-receptor binding [GO:0039706]; cytokine activity [GO:0005125]; frizzled binding [GO:0005109]; protein domain specific binding [GO:0019904]; receptor ligand activity [GO:0048018]; signaling receptor binding [GO:0005102]; transcription coactivator activity [GO:0003713]	axis elongation involved in somitogenesis [GO:0090245]; axon guidance [GO:0007411]; calcium ion transmembrane transport via low voltage-gated calcium channel [GO:0090676]; canonical Wnt signaling pathway [GO:0060070]; canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment [GO:0061317]; cell fate commitment [GO:0045165]; cell population proliferation [GO:0008283]; cell proliferation in forebrain [GO:0021846]; cell proliferation in midbrain [GO:0033278]; cellular protein localization [GO:0034613]; cellular response to retinoic acid [GO:0071300]; COP9 signalosome assembly [GO:0010387]; dorsal/ventral neural tube patterning [GO:0021904]; extracellular matrix organization [GO:0030198]; heart looping [GO:0001947]; hemopoiesis [GO:0030097]; hippocampus development [GO:0021766]; inner ear morphogenesis [GO:0042472]; in utero embryonic development [GO:0001701]; mammary gland development [GO:0030879]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of axon extension involved in axon guidance [GO:0048843]; negative regulation of dopaminergic neuron differentiation [GO:1904339]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of heart induction by canonical Wnt signaling pathway [GO:0003136]; negative regulation of neurogenesis [GO:0050768]; negative regulation of neuron death [GO:1901215]; negative regulation of neuron projection development [GO:0010977]; neuron differentiation [GO:0030182]; osteoblast differentiation [GO:0001649]; paraxial mesodermal cell fate commitment [GO:0048343]; platelet aggregation [GO:0070527]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of canonical Wnt signaling pathway involved in controlling type B pancreatic cell proliferation [GO:2000081]; positive regulation of cardiac muscle cell differentiation [GO:2000727]; positive regulation of cell-cell adhesion mediated by cadherin [GO:2000049]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of collateral sprouting in absence of injury [GO:0048697]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of cytokine production [GO:0001819]; positive regulation of dermatome development [GO:0061184]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of gene expression [GO:0010628]; positive regulation of hepatocyte proliferation [GO:2000347]; positive regulation of mesodermal cell fate specification [GO:0048337]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein binding [GO:0032092]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein tyrosine kinase activity [GO:0061098]; positive regulation of receptor internalization [GO:0002092]; positive regulation of skeletal muscle tissue development [GO:0048643]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-anal tail morphogenesis [GO:0036342]; postsynapse to nucleus signaling pathway [GO:0099527]; presynapse assembly [GO:0099054]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of presynapse assembly [GO:1905606]; regulation of synapse organization [GO:0050807]; secondary palate development [GO:0062009]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell division [GO:0048103]; spinal cord association neuron differentiation [GO:0021527]; synaptic vesicle recycling [GO:0036465]; Wnt signaling pathway involved in forebrain neuroblast division [GO:0021874]; Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation [GO:1904953]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=WNT3A&keywords=WNT3A	0.0018939269662921348	885	NA	NA	0.029194169509321674	769	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
WNT4	Wnt family member 4	Yes		ENSG00000162552	P56705	Wnt family	19	ecm, ligand	ecm, extracellular, intracellular, ligand, secreted	O60353, O75197, O75581, P46531, Q14332, Q99835, Q9H461, Q9NPG1, Q9UP38	FZD1, FZD1_LRP5, FZD1_LRP6, FZD10_LRP5, FZD10_LRP6, FZD2, FZD2_LRP5, FZD2_LRP6, FZD3, FZD3_LRP5, FZD3_LRP6, FZD4_LRP5, FZD4_LRP6, FZD5_LRP5, FZD5_LRP6, FZD6, FZD6_LRP5, FZD6_LRP6, FZD7_LRP5, FZD7_LRP6, FZD8, FZD8_LRP5, FZD8_LRP6, FZD9_LRP5, FZD9_LRP6, LRP5, LRP6, NOTCH1, SMO	FZD3 [SignaLink3:14671310;SignaLink3:23331499], FZD6 [Baccin2019:15265686;Baccin2019:21541287;CellPhoneDB:24032637;Guide2Pharma:15265686;Guide2Pharma:21541287;HPMR:15265686;HPRD:15265686;LRdb:15265686;LRdb:21541287;NetPath:15265686;connectomeDB2020:15265686;connectomeDB2020:21541287;scConnect:15265686;scConnect:21541287], LRP5 [SIGNOR:15578921], LRP6 [SIGNOR:15578921], FZD8 [CellTalkDB:32103204], FZD2 [Baccin2019:12325120;CellTalkDB:12325120;HPMR:12325120;LRdb:12325120;connectomeDB2020:12325120], SMO [CellTalkDB:32103204], NOTCH1 [CellTalkDB:32103204], FZD1 [CellTalkDB:32103204]	cell surface [GO:0009986]; cytoplasm [GO:0005737]; endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; plasma membrane [GO:0005886]	cytokine activity [GO:0005125]; frizzled binding [GO:0005109]; receptor ligand activity [GO:0048018]; transcription corepressor activity [GO:0003714]	adrenal gland development [GO:0030325]; branching involved in ureteric bud morphogenesis [GO:0001658]; canonical Wnt signaling pathway [GO:0060070]; cell fate commitment [GO:0045165]; cellular response to starvation [GO:0009267]; cellular response to transforming growth factor beta stimulus [GO:0071560]; embryonic epithelial tube formation [GO:0001838]; epithelial to mesenchymal transition [GO:0001837]; female gonad development [GO:0008585]; female sex determination [GO:0030237]; hormone metabolic process [GO:0042445]; immature T cell proliferation in thymus [GO:0033080]; kidney development [GO:0001822]; liver development [GO:0001889]; male gonad development [GO:0008584]; mammary gland epithelium development [GO:0061180]; mesenchymal to epithelial transition [GO:0060231]; metanephric mesenchymal cell differentiation [GO:0072162]; metanephric nephron morphogenesis [GO:0072273]; metanephric tubule formation [GO:0072174]; negative regulation of androgen biosynthetic process [GO:2000180]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell migration [GO:0030336]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of gene expression [GO:0010629]; negative regulation of male gonad development [GO:2000019]; negative regulation of steroid biosynthetic process [GO:0010894]; negative regulation of testicular blood vessel morphogenesis [GO:0061369]; negative regulation of testosterone biosynthetic process [GO:2000225]; negative regulation of transcription, DNA-templated [GO:0045892]; negative regulation of wound healing [GO:0061045]; neuron differentiation [GO:0030182]; non-canonical Wnt signaling pathway via MAPK cascade [GO:0038030]; oocyte development [GO:0048599]; paramesonephric duct development [GO:0061205]; positive regulation of aldosterone biosynthetic process [GO:0032349]; positive regulation of bone mineralization [GO:0030501]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of cortisol biosynthetic process [GO:2000066]; positive regulation of dermatome development [GO:0061184]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of GTPase activity [GO:0043547]; positive regulation of meiotic nuclear division [GO:0045836]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of transcription, DNA-templated [GO:0045893]; regulation of cell-cell adhesion [GO:0022407]; renal vesicle formation [GO:0072033]; renal vesicle induction [GO:0072034]; smooth muscle cell differentiation [GO:0051145]; somatotropin secreting cell differentiation [GO:0060126]; tertiary branching involved in mammary gland duct morphogenesis [GO:0060748]; thyroid-stimulating hormone-secreting cell differentiation [GO:0060129]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=WNT4&keywords=WNT4	36.94479630337079	116	NA	NA	11.309084641456597	43	0.023622047244094488	0.1836327345309387	0.008849557522123894	0.025659472422062343	0.12794612794612797	1.4196277495769862	1.9537624660018194	0.5285481239804244	0.2404735479097283	1.44418480438002	0.21854355804518966	70	22	66	0.5613500172326832	0.438388974105382	2.545173292237429	0.4000062153706297	364	11	352
WNT5A	Wnt family member 5A	Yes		ENSG00000114251	P41221	Wnt family	20	ecm, ligand, receptor	ecm, extracellular, intracellular, ligand, receptor, secreted	O00144, O60353, O75084, O75197, O75581, P01130, P07550, P34925, P43121, P98164, Q01973, Q01974, Q13308, Q13467, Q14332, Q15262, Q15375, Q96CG8, Q9H461, Q9H6X2, Q9NPG1, Q9UBE8, Q9ULK5, Q9ULV1, Q9ULW2, Q9UP38	ADRB2, ANTXR1, CTHRC1, EPHA7, FZD1, FZD10, FZD2, FZD3, FZD4, FZD5, FZD6, FZD7, FZD8, FZD9, LDLR, LRP2, LRP5, LRP6, MCAM, NLK, PTK7, PTPRK, ROR1, ROR2, RYK, VANGL2	FZD2 [Baccin2019:9389482;CellPhoneDB:24032637;CellTalkDB:24032637;Cellinker:9389482;LRdb:9389482;NetPath:19910923;SIGNOR:19008118;SIGNOR:19910923;SIGNOR:2808370;SPIKE:19910923;connectomeDB2020:19910923;connectomeDB2020:9389482], FZD5 [Baccin2019:9054360;CellPhoneDB:24032637;CellTalkDB:9054360;Cellinker:9054360;HPRD:9054360;ICELLNET:11029007;LRdb:9054360;SIGNOR:9054360;SPIKE:9054360;SignaLink3:23331499;SignaLink3:9054360;connectomeDB2020:9054360], ROR2 [Baccin2019:12839624;CellTalkDB:12839624;Cellinker:18606138;HPRD:12839624;LRdb:12839624;NetPath:12839624;SIGNOR:26690702;SPIKE:12839624;SPIKE:20215527;SPIKE:21069266;SignaLink3:17203201;SignaLink3:23331499;connectomeDB2020:12839624], FZD4 [Baccin2019:10990458;Cellinker:10990458;HPMR:10990458;LRdb:10990458;SIGNOR:16602827;SignaLink3:10990458;SignaLink3:23331499;connectomeDB2020:10990458], ROR1 [CellTalkDB:18287027;Cellinker:18287027;LRdb:18287027;NetPath:18287027;Ramilowski2015:18287027;SIGNOR:22343533;SIGNOR:23151663;SIGNOR:26690702;SignaLink3:21481194;SignaLink3:23331499;connectomeDB2020:18287027;talklr:18287027], NLK [SignaLink3:20706670;SignaLink3:23331499], FZD6 [Baccin2019:21665003;CellPhoneDB:24032637;Cellinker:21665003;Guide2Pharma:21665003;LRdb:21665003;SIGNOR:16273260;connectomeDB2020:21665003;scConnect:21665003], LRP6 [Baccin2019:28143772;CellTalkDB:23462101;Cellinker:18606138;NetPath:19056682;SIGNOR:15578921], RYK [Baccin2019:15598975;CellTalkDB:15598975;Cellinker:15598975;HPMR:15598975;LRdb:15598975;SIGNOR:22773843;connectomeDB2020:15598975], FZD3 [CellPhoneDB:24032637;CellTalkDB:24032637;Cellinker:24032637;LRdb:24032637;NetPath:17804197;SIGNOR:15578921;SIGNOR:16273260;SIGNOR:21903638;connectomeDB2020:24032637], PTK7 [CellTalkDB:26499793], LDLR [CellTalkDB:32196115], LRP5 [Baccin2019:19056682;CellTalkDB:16602827;LRdb:16602827;Ramilowski2015:16602827;connectomeDB2020:16602827;talklr:16602827], EPHA7 [CellTalkDB:32103204], VANGL2 [CellTalkDB:21316585], PTPRK [CellTalkDB:32103204], ADRB2 [CellTalkDB:32196115], FZD1 [Baccin2019:10557084;CellPhoneDB:24032637;CellTalkDB:10557084;Cellinker:10557084;HPRD:10557084;LRdb:10557084;MPPI:10557084;connectomeDB2020:10557084], FZD9 [CellTalkDB:27402827], FZD7 [Baccin2019:10990458;Cellinker:10990458;HPMR:10990458;LRdb:10990458;connectomeDB2020:10990458], FZD8 [CellTalkDB:21518267;LRdb:21518267;NetPath:20093360;Ramilowski2015:21518267;connectomeDB2020:21518267;talklr:21518267], ANTXR1 [CellTalkDB:32103204], LRP2 [CellTalkDB:32196115], MCAM [CellChatDB:24335906;CellTalkDB:24335906;Cellinker:24335906;LRdb:24335906;Ramilowski2015:24335906;connectomeDB2020:24335906;talklr:24335906], FZD10 [NA], CTHRC1 [Cellinker:18606138]	cell surface [GO:0009986]; clathrin-coated endocytic vesicle membrane [GO:0030669]; endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; Golgi lumen [GO:0005796]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]	chemoattractant activity involved in axon guidance [GO:1902379]; cytokine activity [GO:0005125]; frizzled binding [GO:0005109]; phospholipid binding [GO:0005543]; protein domain specific binding [GO:0019904]; receptor ligand activity [GO:0048018]; receptor tyrosine kinase-like orphan receptor binding [GO:0005115]	activation of GTPase activity [GO:0090630]; activation of protein kinase B activity [GO:0032148]; anterior/posterior axis specification, embryo [GO:0008595]; atrial septum development [GO:0003283]; axon guidance [GO:0007411]; canonical Wnt signaling pathway [GO:0060070]; cartilage development [GO:0051216]; cell fate commitment [GO:0045165]; cellular protein localization [GO:0034613]; cellular response to calcium ion [GO:0071277]; cellular response to interferon-gamma [GO:0071346]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to retinoic acid [GO:0071300]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cervix development [GO:0060067]; chemoattraction of serotonergic neuron axon [GO:0036517]; chemorepulsion of dopaminergic neuron axon [GO:0036518]; cochlea morphogenesis [GO:0090103]; convergent extension involved in axis elongation [GO:0060028]; convergent extension involved in organogenesis [GO:0060029]; embryonic digit morphogenesis [GO:0042733]; embryonic skeletal system development [GO:0048706]; epithelial cell proliferation involved in mammary gland duct elongation [GO:0060750]; epithelial to mesenchymal transition [GO:0001837]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment of planar polarity [GO:0001736]; excitatory synapse assembly [GO:1904861]; face development [GO:0060324]; genitalia development [GO:0048806]; heart looping [GO:0001947]; hematopoietic stem cell proliferation [GO:0071425]; hindgut morphogenesis [GO:0007442]; hypophysis morphogenesis [GO:0048850]; inhibitory synapse assembly [GO:1904862]; JNK cascade [GO:0007254]; keratinocyte differentiation [GO:0030216]; kidney development [GO:0001822]; lateral sprouting involved in mammary gland duct morphogenesis [GO:0060599]; lens development in camera-type eye [GO:0002088]; lung development [GO:0030324]; male gonad development [GO:0008584]; mammary gland branching involved in thelarche [GO:0060744]; melanocyte proliferation [GO:0097325]; mesenchymal-epithelial cell signaling [GO:0060638]; mesodermal to mesenchymal transition involved in gastrulation [GO:0060809]; midgut development [GO:0007494]; negative regulation of apoptotic process [GO:0043066]; negative regulation of axon extension involved in axon guidance [GO:0048843]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell proliferation in midbrain [GO:1904934]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of melanin biosynthetic process [GO:0048022]; negative regulation of mesenchymal cell proliferation [GO:0072201]; negative regulation of prostatic bud formation [GO:0060686]; negative regulation of synapse assembly [GO:0051964]; negative regulation of transcription, DNA-templated [GO:0045892]; neuron differentiation [GO:0030182]; non-canonical Wnt signaling pathway [GO:0035567]; non-canonical Wnt signaling pathway via JNK cascade [GO:0038031]; notochord morphogenesis [GO:0048570]; olfactory bulb interneuron development [GO:0021891]; optic cup formation involved in camera-type eye development [GO:0003408]; paraxial mesoderm formation [GO:0048341]; planar cell polarity pathway involved in axis elongation [GO:0003402]; planar cell polarity pathway involved in axon guidance [GO:1904938]; planar cell polarity pathway involved in cardiac muscle tissue morphogenesis [GO:0061350]; planar cell polarity pathway involved in cardiac right atrium morphogenesis [GO:0061349]; planar cell polarity pathway involved in gastrula mediolateral intercalation [GO:0060775]; planar cell polarity pathway involved in midbrain dopaminergic neuron differentiation [GO:1904955]; planar cell polarity pathway involved in neural tube closure [GO:0090179]; planar cell polarity pathway involved in outflow tract morphogenesis [GO:0061347]; planar cell polarity pathway involved in pericardium morphogenesis [GO:0061354]; planar cell polarity pathway involved in ventricular septum morphogenesis [GO:0061348]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cartilage development [GO:0061036]; positive regulation of cell-cell adhesion mediated by cadherin [GO:2000049]; positive regulation of chemokine production [GO:0032722]; positive regulation of cytokine production involved in immune response [GO:0002720]; positive regulation of endocytosis [GO:0045807]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of gene expression [GO:0010628]; positive regulation of heart induction by negative regulation of canonical Wnt signaling pathway [GO:0090082]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of JNK cascade [GO:0046330]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of macrophage activation [GO:0043032]; positive regulation of macrophage cytokine production [GO:0060907]; positive regulation of meiotic nuclear division [GO:0045836]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of neuron death [GO:1901216]; positive regulation of neuron projection arborization [GO:0150012]; positive regulation of neuron projection development [GO:0010976]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of non-canonical Wnt signaling pathway [GO:2000052]; positive regulation of ossification [GO:0045778]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of protein binding [GO:0032092]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein kinase C activity [GO:1900020]; positive regulation of protein kinase C signaling [GO:0090037]; positive regulation of protein localization to synapse [GO:1902474]; positive regulation of response to cytokine stimulus [GO:0060760]; positive regulation of T cell chemotaxis [GO:0010820]; positive regulation of thymocyte apoptotic process [GO:0070245]; positive regulation of timing of anagen [GO:0051885]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; post-anal tail morphogenesis [GO:0036342]; postsynapse assembly [GO:0099068]; presynapse assembly [GO:0099054]; primary heart field specification [GO:0003138]; primitive streak formation [GO:0090009]; protein phosphorylation [GO:0006468]; regulation of branching involved in mammary gland duct morphogenesis [GO:0060762]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of inflammatory response [GO:0050727]; regulation of postsynapse organization [GO:0099175]; regulation of postsynaptic cytosolic calcium ion concentration [GO:0099566]; regulation of synapse organization [GO:0050807]; response to organic substance [GO:0010033]; secondary heart field specification [GO:0003139]; secondary palate development [GO:0062009]; somitogenesis [GO:0001756]; type B pancreatic cell development [GO:0003323]; urinary bladder development [GO:0060157]; uterus development [GO:0060065]; vagina development [GO:0060068]; Wnt signaling pathway [GO:0016055]; Wnt signaling pathway, calcium modulating pathway [GO:0007223]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]; Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation [GO:1904953]; wound healing [GO:0042060]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=WNT5A&keywords=WNT5A	8.454385851270272	253	NA	NA	1.4005262293077367	212	0.16535433070866137	0.00249500998003992	0	0.5105515587530052	0.018518518518518514	0.001692047377326565	0.005439709882139619	0.0016313213703099511	0.0029596744358120607	9.013219388436377e-4	0.0023565771682441585	295	375	328	0.06471818819390009	0.1734473860926686	0.14589917398095598	0.16537576013189434	448	445	442
WNT5B	Wnt family member 5B	Yes		ENSG00000111186	Q9H1J7	Wnt family	11	ecm, ligand	ecm, extracellular, intracellular, ligand, secreted	A4D1S0, O00144, O60353, O75084, O75197, O75581, Q13467, Q14332, Q9H461, Q9NPG1, Q9ULV1, Q9ULW2, Q9UP38	FZD1, FZD1_LRP5, FZD1_LRP6, FZD10, FZD10_LRP5, FZD10_LRP6, FZD2, FZD2_LRP5, FZD2_LRP6, FZD3, FZD3_LRP5, FZD3_LRP6, FZD4, FZD5, FZD5_LRP5, FZD5_LRP6, FZD6, FZD6_LRP5, FZD6_LRP6, FZD7, FZD7_LRP5, FZD7_LRP6, FZD8, FZD8_LRP5, FZD8_LRP6, FZD9, FZD9_LRP5, FZD9_LRP6, KLRG2, LRP5, LRP6	FZD6 [SIGNOR:16273260], LRP5 [SIGNOR:15578921], LRP6 [SIGNOR:15578921], FZD3 [SIGNOR:15578921;SIGNOR:16273260], KLRG2 [CellTalkDB:32103204], FZD1 [NA], FZD10 [NA], FZD2 [connectomeDB2020:27036869], FZD4 [NA], FZD5 [NA], FZD7 [NA], FZD8 [NetPath:20093360;connectomeDB2020:26849959], FZD9 [NA]	endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; plasma membrane [GO:0005886]	cytokine activity [GO:0005125]; frizzled binding [GO:0005109]; signaling receptor binding [GO:0005102]	canonical Wnt signaling pathway [GO:0060070]; cell fate commitment [GO:0045165]; cellular response to retinoic acid [GO:0071300]; chondrocyte differentiation [GO:0002062]; fat cell differentiation [GO:0045444]; lens fiber cell development [GO:0070307]; muscle cell differentiation [GO:0042692]; neuron differentiation [GO:0030182]; positive regulation of cell migration [GO:0030335]; positive regulation of convergent extension involved in gastrulation [GO:1904105]; positive regulation of non-canonical Wnt signaling pathway [GO:2000052]; wound healing [GO:0042060]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=WNT5B&keywords=WNT5B	2.0626113921348312	384	NA	NA	0.34666893367037627	446	0	0.007485029940119762	0	0.02589928057553956	0.00505050505050505	0.001692047377326565	0.019038984587488667	0.0032626427406199023	0.001849796522382538	0.008579249566030159	0.0025111068186208247	298	251	324	0.006851694834421184	0.7031812905950685	1.102515192007885	0.7424242452495462	261	112	218
WNT6	Wnt family member 6	Yes		ENSG00000115596	Q9Y6F9	Wnt family	9	ecm, ligand, receptor	ecm, intracellular, ligand, receptor, secreted	O75084, O75197, O75581, Q9BQ69, Q9NPG1, Q9ULV1, Q9UP38	FZD1, FZD1_LRP5, FZD1_LRP6, FZD10_LRP5, FZD10_LRP6, FZD2_LRP5, FZD2_LRP6, FZD3, FZD3_LRP5, FZD3_LRP6, FZD4, FZD4_LRP5, FZD4_LRP6, FZD5_LRP5, FZD5_LRP6, FZD6_LRP5, FZD6_LRP6, FZD7, FZD7_LRP5, FZD7_LRP6, FZD8_LRP5, FZD8_LRP6, FZD9_LRP5, FZD9_LRP6, LRP5, LRP6, MACROD1	FZD1 [CA1:12857724;CA1:8717036], MACROD1 [CA1:12857724], LRP5 [Cellinker:23209147;SIGNOR:15578921], FZD3 [SIGNOR:15578921], FZD4 [CellTalkDB:31618077], FZD7 [connectomeDB2020:27122540], LRP6 [Cellinker:23209147]	cell surface [GO:0009986]; endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; plasma membrane [GO:0005886]	cytokine activity [GO:0005125]; frizzled binding [GO:0005109]	axis specification [GO:0009798]; branching involved in ureteric bud morphogenesis [GO:0001658]; canonical Wnt signaling pathway [GO:0060070]; cell fate commitment [GO:0045165]; cellular response to retinoic acid [GO:0071300]; cornea development in camera-type eye [GO:0061303]; epithelial-mesenchymal cell signaling [GO:0060684]; nephron tubule formation [GO:0072079]; neuron differentiation [GO:0030182]; odontogenesis of dentin-containing tooth [GO:0042475]; positive regulation of gene expression [GO:0010628]; positive regulation of tooth mineralization [GO:0070172]; positive regulation of transcription, DNA-templated [GO:0045893]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=WNT6&keywords=WNT6	0.008872521348314608	834	NA	NA	0.0042181875568589565	867	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
WNT7A	Wnt family member 7A	Yes		ENSG00000154764	O00755	Wnt family	17	ecm, ligand	ecm, extracellular, intracellular, ligand, secreted, transmembrane	O00144, O75084, O75197, O75581, O95980, P01130, Q13467, Q96PE1, Q9NPG1, Q9ULW2, Q9UP38	ADGRA2, FZD1, FZD1_LRP5, FZD1_LRP6, FZD10, FZD10_LRP5, FZD10_LRP6, FZD2_LRP5, FZD2_LRP6, FZD3, FZD3_LRP5, FZD3_LRP6, FZD4_LRP5, FZD4_LRP6, FZD5, FZD5_LRP5, FZD5_LRP6, FZD6_LRP5, FZD6_LRP6, FZD7, FZD7_LRP5, FZD7_LRP6, FZD8_LRP5, FZD8_LRP6, FZD9, FZD9_LRP5, FZD9_LRP6, LDLR, LRP5, LRP6, RECK	FZD5 [Baccin2019:1285772412857720;CancerCellMap:12857724;CellPhoneDB:24032637;CellTalkDB:12857724;HPMR:12857724;HPRD:12857724;LRdb:12857724;NetPath:18567805;SignaLink3:12857724;SignaLink3:23331499;connectomeDB2020:12857724], FZD7 [NetPath:19497282;SIGNOR:22944199;SIGNOR:23290138], LRP5 [SIGNOR:15578921], LRP6 [CellTalkDB:12857724;SIGNOR:15578921], FZD3 [SIGNOR:15578921], LDLR [CellTalkDB:32103204], RECK [CellTalkDB:30304675], FZD9 [Baccin2019:15705594;CellTalkDB:15705594;HPRD:15705594;LRdb:15705594;NetPath:15705594;connectomeDB2020:15705594], FZD10 [LRdb:18567805;NetPath:18567805;Ramilowski2015:18567805;connectomeDB2020:12857724;connectomeDB2020:18567805;talklr:18567805], FZD1 [connectomeDB2020:28733458], ADGRA2 [Cellinker:28289266]	cell surface [GO:0009986]; endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; Golgi lumen [GO:0005796]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; Schaffer collateral - CA1 synapse [GO:0098685]	cytokine activity [GO:0005125]; frizzled binding [GO:0005109]; receptor ligand activity [GO:0048018]; signaling receptor binding [GO:0005102]	angiogenesis [GO:0001525]; asymmetric protein localization involved in cell fate determination [GO:0045167]; axonogenesis [GO:0007409]; canonical Wnt signaling pathway [GO:0060070]; cartilage condensation [GO:0001502]; cell fate commitment [GO:0045165]; cell proliferation in forebrain [GO:0021846]; cellular response to transforming growth factor beta stimulus [GO:0071560]; central nervous system vasculogenesis [GO:0022009]; cerebellar granule cell differentiation [GO:0021707]; chondrocyte differentiation [GO:0002062]; dendritic spine morphogenesis [GO:0060997]; dorsal/ventral pattern formation [GO:0009953]; embryonic axis specification [GO:0000578]; embryonic digit morphogenesis [GO:0042733]; embryonic forelimb morphogenesis [GO:0035115]; embryonic hindlimb morphogenesis [GO:0035116]; establishment of cell polarity [GO:0030010]; excitatory synapse assembly [GO:1904861]; lens fiber cell development [GO:0070307]; negative regulation of apoptotic process [GO:0043066]; negative regulation of neurogenesis [GO:0050768]; neuron differentiation [GO:0030182]; neurotransmitter secretion [GO:0007269]; oviduct development [GO:0060066]; positive regulation of cellular protein metabolic process [GO:0032270]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of epithelial cell proliferation involved in wound healing [GO:0060054]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of excitatory synapse assembly [GO:1904891]; positive regulation of gene expression [GO:0010628]; positive regulation of JNK cascade [GO:0046330]; positive regulation of protein localization to presynapse [GO:1905386]; positive regulation of synapse assembly [GO:0051965]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; postsynapse assembly [GO:0099068]; presynapse assembly [GO:0099054]; regulation of axon diameter [GO:0031133]; regulation of postsynapse organization [GO:0099175]; regulation of presynapse assembly [GO:1905606]; regulation of synaptic vesicle exocytosis [GO:2000300]; response to estradiol [GO:0032355]; response to estrogen [GO:0043627]; secondary palate development [GO:0062009]; sex differentiation [GO:0007548]; skeletal muscle satellite cell activation [GO:0014719]; skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration [GO:0014834]; somatic stem cell division [GO:0048103]; somatic stem cell population maintenance [GO:0035019]; stem cell development [GO:0048864]; synaptic vesicle recycling [GO:0036465]; uterus morphogenesis [GO:0061038]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]; wound healing, spreading of epidermal cells [GO:0035313]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=WNT7A&keywords=WNT7A	0.9088918808988764	461	NA	NA	1.2543263023924949	232	0	0.029940119760479014	0	0	0.003367003367003367	0	0	0	0	3.338229403124583e-5	0	303	408	401	0.0030309550383194207	0.7674034612653903	0.769965230063846	0.7674034612653903	234	226	204
WNT7B	Wnt family member 7B	Yes		ENSG00000188064	P56706	Wnt family	15	ecm, ligand	ecm, extracellular, intracellular, ligand, secreted, transmembrane	O75197, Q13467, Q96PE1, Q9H461, Q9NPG1, Q9ULV1, Q9ULW2, Q9UP38, Q9Y3A6	ADGRA2, FZD1, FZD1_LRP5, FZD1_LRP6, FZD10, FZD10_LRP5, FZD10_LRP6, FZD2_LRP5, FZD2_LRP6, FZD3, FZD3_LRP5, FZD3_LRP6, FZD4, FZD4_LRP5, FZD4_LRP6, FZD5, FZD5_LRP5, FZD5_LRP6, FZD6_LRP5, FZD6_LRP6, FZD7_LRP5, FZD7_LRP6, FZD8, FZD8_LRP5, FZD8_LRP6, FZD9_LRP5, FZD9_LRP6, LRP5, TMED5	LRP5 [Baccin2019:15923619;CellTalkDB:15923619;HPMR:15923619;LRdb:15923619;SIGNOR:15578921;SIGNOR:15923619;connectomeDB2020:15923619], FZD3 [SIGNOR:15578921], FZD10 [Baccin2019:15923619;CellPhoneDB:24032637;HPMR:15923619;LRdb:15923619;NetPath:15923619;SIGNOR:15923619;connectomeDB2020:15923619], FZD1 [Baccin2019:15923619;CellPhoneDB:24032637;CellTalkDB:15923619;LRdb:15923619;NetPath:15923619;SIGNOR:15923619;connectomeDB2020:15923619], FZD4 [CellPhoneDB:24032637;CellTalkDB:24032637;LRdb:24032637;NetPath:15923619;connectomeDB2020:24032637], TMED5 [CellTalkDB:30394198], FZD5 [connectomeDB2020:28733458], FZD8 [connectomeDB2020:28733458], ADGRA2 [Cellinker:28289266]	endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; plasma membrane [GO:0005886]	cytokine activity [GO:0005125]; frizzled binding [GO:0005109]; receptor ligand activity [GO:0048018]	canonical Wnt signaling pathway [GO:0060070]; cell fate commitment [GO:0045165]; cellular response to retinoic acid [GO:0071300]; central nervous system vasculogenesis [GO:0022009]; chorio-allantoic fusion [GO:0060710]; developmental growth involved in morphogenesis [GO:0060560]; embryonic organ development [GO:0048568]; embryonic placenta morphogenesis [GO:0060669]; establishment or maintenance of polarity of embryonic epithelium [GO:0016332]; fibroblast proliferation [GO:0048144]; forebrain regionalization [GO:0021871]; homeostatic process [GO:0042592]; inner medullary collecting duct development [GO:0072061]; in utero embryonic development [GO:0001701]; lens fiber cell development [GO:0070307]; lobar bronchus development [GO:0060482]; lung development [GO:0030324]; lung epithelium development [GO:0060428]; lung morphogenesis [GO:0060425]; mammary gland epithelium development [GO:0061180]; metanephric collecting duct development [GO:0072205]; metanephric epithelium development [GO:0072207]; metanephric loop of Henle development [GO:0072236]; metanephros morphogenesis [GO:0003338]; neuron differentiation [GO:0030182]; neuron projection morphogenesis [GO:0048812]; outer medullary collecting duct development [GO:0072060]; oxygen homeostasis [GO:0032364]; positive regulation of JNK cascade [GO:0046330]; positive regulation of osteoblast differentiation [GO:0045669]; regulation of cell projection size [GO:0032536]; renal inner medulla development [GO:0072053]; renal outer medulla development [GO:0072054]; response to glucocorticoid [GO:0051384]; stem cell proliferation [GO:0072089]; synapse organization [GO:0050808]; trachea cartilage morphogenesis [GO:0060535]; Wnt signaling pathway [GO:0016055]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=WNT7B&keywords=WNT7B	0.9502863887640449	456	NA	NA	0.4009525732226977	417	0	0.042415169660678605	0	0.001199040767386091	0.00505050505050505	0.015228426395939085	0.001813236627379873	0.0065252854812398045	0.028856825749167564	7.010281746561626e-4	0.0013521344407958285	208	383	350	0.009376513849795279	2.0053569001308302	0.5522679805877063	0.5858708397597417	30	301	288
WNT8A	Wnt family member 8A	Yes		ENSG00000061492	Q9H1J5	Wnt family	10	ecm, ligand	ecm, ligand, secreted	O75084, O75197, O75581, Q13467, Q9H461, Q9NPG1, Q9ULV1	FZD1_LRP5, FZD1_LRP6, FZD10_LRP5, FZD10_LRP6, FZD2_LRP5, FZD2_LRP6, FZD3, FZD3_LRP5, FZD3_LRP6, FZD4, FZD4_LRP5, FZD4_LRP6, FZD5, FZD5_LRP5, FZD5_LRP6, FZD6_LRP5, FZD6_LRP6, FZD7, FZD7_LRP5, FZD7_LRP6, FZD8, FZD8_LRP5, FZD8_LRP6, FZD9_LRP5, FZD9_LRP6, LRP5, LRP6	FZD7 [SignaLink3:10097073;SignaLink3:23331499], FZD8 [SignaLink3:10097073;SignaLink3:23331499;connectomeDB2020:28733458], LRP5 [CellTalkDB:32196115;Cellinker:23209147;SIGNOR:15578921], FZD3 [SIGNOR:15578921], FZD4 [connectomeDB2020:28733458], FZD5 [connectomeDB2020:28733458], LRP6 [Cellinker:23209147;ProtMapper:24316074]	collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]	cytokine activity [GO:0005125]; frizzled binding [GO:0005109]; receptor ligand activity [GO:0048018]	anterior/posterior axis specification [GO:0009948]; canonical Wnt signaling pathway [GO:0060070]; canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment [GO:0061317]; canonical Wnt signaling pathway involved in neural crest cell differentiation [GO:0044335]; cell fate commitment [GO:0045165]; neural crest cell fate commitment [GO:0014034]; neuron differentiation [GO:0030182]; positive regulation of transcription by RNA polymerase II [GO:0045944]; response to retinoic acid [GO:0032526]; secondary palate development [GO:0062009]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=WNT8A&keywords=WNT8A	0.012145749438202248	821	NA	NA	0.20150891418201333	532	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
WNT8B	Wnt family member 8B	Yes		ENSG00000075290	Q93098	Wnt family	8	ecm, ligand	ecm, ligand, secreted	O75197, O75581, Q9NPG1	FZD1_LRP5, FZD1_LRP6, FZD10_LRP5, FZD10_LRP6, FZD2_LRP5, FZD2_LRP6, FZD3, FZD3_LRP5, FZD3_LRP6, FZD4_LRP5, FZD4_LRP6, FZD5_LRP5, FZD5_LRP6, FZD6_LRP5, FZD6_LRP6, FZD7_LRP5, FZD7_LRP6, FZD8_LRP5, FZD8_LRP6, FZD9_LRP5, FZD9_LRP6, LRP5, LRP6	LRP6 [SIGNOR:15578921], FZD3 [SIGNOR:15578921], LRP5 [CellTalkDB:32196115]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	cytokine activity [GO:0005125]; frizzled binding [GO:0005109]; receptor ligand activity [GO:0048018]	canonical Wnt signaling pathway [GO:0060070]; cell fate commitment [GO:0045165]; cellular response to retinoic acid [GO:0071300]; determination of dorsal identity [GO:0048263]; gastrulation [GO:0007369]; nervous system development [GO:0007399]; neuron differentiation [GO:0030182]; response to estradiol [GO:0032355]; response to retinoic acid [GO:0032526]; signal transduction [GO:0007165]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=WNT8B&keywords=WNT8B	0.023056739325842696	785	NA	NA	0.19322806785124677	537	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
WNT9A	Wnt family member 9A	Yes		ENSG00000143816	O14904	Wnt family	8	ecm, ligand	ecm, extracellular, ligand, secreted	O15146, O75197, O75581, P02708, Q9NPG1, Q9ULV1, Q9ULW2	CHRNA1, FZD1_LRP5, FZD1_LRP6, FZD10, FZD10_LRP5, FZD10_LRP6, FZD2_LRP5, FZD2_LRP6, FZD3, FZD3_LRP5, FZD3_LRP6, FZD4, FZD4_LRP5, FZD4_LRP6, FZD5_LRP5, FZD5_LRP6, FZD6_LRP5, FZD6_LRP6, FZD7_LRP5, FZD7_LRP6, FZD8_LRP5, FZD8_LRP6, FZD9_LRP5, FZD9_LRP6, LRP5, LRP6, MUSK	MUSK [SIGNOR:22309736], LRP5 [Cellinker:23209147;SIGNOR:15578921], LRP6 [Cellinker:23209147;SIGNOR:15578921], CHRNA1 [SIGNOR:22309736], FZD3 [SIGNOR:15578921], FZD10 [connectomeDB2020:28733458], FZD4 [connectomeDB2020:28733458]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	cytokine activity [GO:0005125]; frizzled binding [GO:0005109]; receptor ligand activity [GO:0048018]	canonical Wnt signaling pathway [GO:0060070]; cell fate commitment [GO:0045165]; cellular response to retinoic acid [GO:0071300]; cornea development in camera-type eye [GO:0061303]; embryonic skeletal joint development [GO:0072498]; iris morphogenesis [GO:0061072]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of chondrocyte differentiation [GO:0032331]; neuron differentiation [GO:0030182]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=WNT9A&keywords=WNT9A	2.495355011235955	363	NA	NA	0.47978423440080226	392	0	9.98003992015968e-4	0	0.009592326139088727	0.011784511784511783	0.01015228426395939	0.004533091568449683	0	0.0029596744358120607	0.0070436640405928536	0.0011589723778249958	295	262	358	0.004383866236568678	0.9009868572654105	1.1849153600484734	0.7757978414353642	184	97	201
WNT9B	Wnt family member 9B	Yes		ENSG00000276799, ENSG00000158955	O14905	Wnt family	9	ecm, ligand	ecm, ligand, secreted	O75197, O75581, P02708, Q13467, Q9H461, Q9NPG1, Q9ULV1, Q9ULW2	CHRNA1, FZD1_LRP5, FZD1_LRP6, FZD10, FZD10_LRP5, FZD10_LRP6, FZD2_LRP5, FZD2_LRP6, FZD3, FZD3_LRP5, FZD3_LRP6, FZD4, FZD4_LRP5, FZD4_LRP6, FZD5, FZD5_LRP5, FZD5_LRP6, FZD6_LRP5, FZD6_LRP6, FZD7_LRP5, FZD7_LRP6, FZD8, FZD8_LRP5, FZD8_LRP6, FZD9_LRP5, FZD9_LRP6, LRP5, LRP6	LRP6 [CellTalkDB:20093360;NetPath:20093360;SIGNOR:20093360], LRP5 [Cellinker:23209147;SIGNOR:15578921], CHRNA1 [SIGNOR:22309736], FZD3 [SIGNOR:15578921], FZD10 [connectomeDB2020:28733458], FZD4 [connectomeDB2020:28733458], FZD5 [connectomeDB2020:25892522;connectomeDB2020:28733458;connectomeDB2020:30978219], FZD8 [connectomeDB2020:28733458]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	co-receptor binding [GO:0039706]; cytokine activity [GO:0005125]; frizzled binding [GO:0005109]; receptor ligand activity [GO:0048018]	branching involved in ureteric bud morphogenesis [GO:0001658]; canonical Wnt signaling pathway [GO:0060070]; cell fate commitment [GO:0045165]; cellular response to retinoic acid [GO:0071300]; cellular response to starvation [GO:0009267]; collecting duct development [GO:0072044]; cornea development in camera-type eye [GO:0061303]; embryonic cranial skeleton morphogenesis [GO:0048701]; establishment of planar polarity involved in nephron morphogenesis [GO:0072046]; in utero embryonic development [GO:0001701]; kidney rudiment formation [GO:0072003]; male genitalia development [GO:0030539]; mesenchymal stem cell maintenance involved in nephron morphogenesis [GO:0072038]; mesonephric duct formation [GO:0072181]; metanephric tubule formation [GO:0072174]; midbrain dopaminergic neuron differentiation [GO:1904948]; negative regulation of stem cell population maintenance [GO:1902455]; neuron differentiation [GO:0030182]; non-canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation [GO:1905438]; positive regulation of catalytic activity [GO:0043085]; regulation of asymmetric cell division [GO:0009786]; regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis [GO:0003339]; regulation of protein phosphorylation [GO:0001932]; regulation of tube size [GO:0035150]; response to retinoic acid [GO:0032526]; roof of mouth development [GO:0060021]; uterus morphogenesis [GO:0061038]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=WNT9B&keywords=WNT9B	0.05183160573033708	735	NA	NA	0.28005713840576485	477	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
XCL1	X-C motif chemokine ligand 1	Yes		ENSG00000143184	P47992	Intercrine gamma family	18	ligand	extracellular, intracellular, ligand, secreted	P46094, Q8WXG9	ADGRV1, XCR1	XCR1 [Baccin2019:11446740;Baccin2019:9632725;CellPhoneDB:24218476;Cellinker:11446740;Cellinker:19556286;Cellinker:9632725;Guide2Pharma:25497737;HPMR:9632725;HPRD:11446740;HPRD:9632725;ICELLNET:22633458;InnateDB:9632725;LRdb:10699158;SIGNOR:10518929;connectomeDB2020:11446740;connectomeDB2020:9632725;scConnect:25497737], ADGRV1 [CellTalkDB:32103204]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	CCR chemokine receptor binding [GO:0048020]; chemokine activity [GO:0008009]; chemokine receptor binding [GO:0042379]; protein homodimerization activity [GO:0042803]	antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cell-cell signaling [GO:0007267]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-1 [GO:0071347]; cellular response to interleukin-4 [GO:0071353]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular response to tumor necrosis factor [GO:0071356]; chemokine-mediated signaling pathway [GO:0070098]; G protein-coupled receptor signaling pathway [GO:0007186]; inflammatory response [GO:0006954]; killing of cells of other organism [GO:0031640]; lymphocyte chemotaxis [GO:0048247]; mature natural killer cell chemotaxis [GO:0035782]; monocyte chemotaxis [GO:0002548]; negative regulation of CD4-positive, alpha-beta T cell proliferation [GO:2000562]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of interferon-gamma production [GO:0032689]; negative regulation of interleukin-2 production [GO:0032703]; negative regulation of T cell cytokine production [GO:0002725]; negative regulation of T-helper 1 cell activation [GO:2000518]; negative regulation of T-helper 1 type immune response [GO:0002826]; negative regulation of transcription, DNA-templated [GO:0045892]; neutrophil chemotaxis [GO:0030593]; positive regulation of B cell chemotaxis [GO:2000538]; positive regulation of CD4-positive, alpha-beta T cell proliferation [GO:2000563]; positive regulation of CD8-positive, alpha-beta T cell proliferation [GO:2000566]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of granzyme A production [GO:2000513]; positive regulation of granzyme B production [GO:0071663]; positive regulation of GTPase activity [GO:0043547]; positive regulation of immunoglobulin production in mucosal tissue [GO:2000558]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of leukocyte chemotaxis [GO:0002690]; positive regulation of natural killer cell chemotaxis [GO:2000503]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; positive regulation of T cell chemotaxis [GO:0010820]; positive regulation of T cell cytokine production [GO:0002726]; positive regulation of T cell mediated cytotoxicity [GO:0001916]; positive regulation of T-helper 1 cell cytokine production [GO:2000556]; positive regulation of T-helper 2 cell cytokine production [GO:2000553]; positive regulation of thymocyte migration [GO:2000412]; positive regulation of transforming growth factor beta production [GO:0071636]; regulation of inflammatory response [GO:0050727]; release of sequestered calcium ion into cytosol [GO:0051209]; response to virus [GO:0009615]; signal transduction [GO:0007165]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=XCL1&keywords=XCL1	0.03187166629213483	767	NA	NA	0.09098191141531978	644	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
XCL2	X-C motif chemokine ligand 2	Yes		ENSG00000143185	Q9UBD3	Intercrine gamma family	17	ligand	intracellular, ligand, secreted	P46094	XCR1	XCR1 [CellTalkDB:10699158;Cellinker:19556286;Cellinker:9632725;Guide2Pharma:25497737;HPRD:9632725;ICELLNET:22633458;LRdb:10699158;connectomeDB2020:9632725;scConnect:25497737]	extracellular region [GO:0005576]; extracellular space [GO:0005615]	CCR chemokine receptor binding [GO:0048020]; chemokine activity [GO:0008009]	blood circulation [GO:0008015]; cellular response to interferon-gamma [GO:0071346]; cellular response to interleukin-1 [GO:0071347]; cellular response to tumor necrosis factor [GO:0071356]; chemokine-mediated signaling pathway [GO:0070098]; G protein-coupled receptor signaling pathway [GO:0007186]; inflammatory response [GO:0006954]; lymphocyte chemotaxis [GO:0048247]; monocyte chemotaxis [GO:0002548]; neutrophil chemotaxis [GO:0030593]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of GTPase activity [GO:0043547]; positive regulation of T cell chemotaxis [GO:0010820]; signal transduction [GO:0007165]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=XCL2&keywords=XCL2	0.02169466853932584	789	NA	NA	0.04577327771206486	717	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
YBX1	Y-box binding protein 1	No		ENSG00000065978	P67809	YBX1 family	1	ligand	extracellular, intracellular, ligand, secreted	P46531, Q969S2	NEIL2, NOTCH1	NEIL2 [SPIKE:17611195], NOTCH1 [connectomeDB2020:30321499]	CRD-mediated mRNA stability complex [GO:0070937]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; histone pre-mRNA 3'end processing complex [GO:0071204]; intracellular membrane-bounded organelle [GO:0043231]; messenger ribonucleoprotein complex [GO:1990124]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; U12-type spliceosomal complex [GO:0005689]	C5-methylcytidine-containing RNA binding [GO:0062153]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; double-stranded DNA binding [GO:0003690]; GTPase binding [GO:0051020]; miRNA binding [GO:0035198]; mRNA binding [GO:0003729]; nucleic acid binding [GO:0003676]; RNA binding [GO:0003723]; sequence-specific double-stranded DNA binding [GO:1990837]; single-stranded DNA binding [GO:0003697]	cellular response to interleukin-7 [GO:0098761]; CRD-mediated mRNA stabilization [GO:0070934]; embryonic morphogenesis [GO:0048598]; epidermis development [GO:0008544]; in utero embryonic development [GO:0001701]; miRNA transport [GO:1990428]; mRNA processing [GO:0006397]; mRNA stabilization [GO:0048255]; negative regulation of cellular senescence [GO:2000773]; negative regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900152]; negative regulation of striated muscle cell differentiation [GO:0051154]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translation [GO:0017148]; positive regulation of cell division [GO:0051781]; positive regulation of cytoplasmic translation [GO:2000767]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to cytoplasmic stress granule [GO:1903608]; regulation of gene expression [GO:0010468]; regulation of transcription, DNA-templated [GO:0006355]; RNA splicing [GO:0008380]; RNA transport [GO:0050658]; tRNA transport [GO:0051031]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=YBX1&keywords=YBX1	445.7436823595506	23	41406.4	24	1.0207550474825275	262	1.464566929133857	6.470059880239483	0.6449115044247768	3.841007194244599	2.8787878787878882	3.4416243654822356	4.139619220308264	1.1990212071778148	1.4750277469478448	2.0297436239822195	1.4418389028396084	19	19	20	2.6387462230516903	0.560653087118669	0.7700789174253837	0.5481230667568094	318	225	305
ZFP91	ZFP91 zinc finger protein, atypical E3 ubiquitin ligase			ENSG00000186660	Q96JP5	Krueppel C2H2-type zinc-finger protein family	1	ligand	intracellular, ligand, secreted	Q99558	MAP3K14	MAP3K14 [SIGNOR:20682767]	nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]	metal ion binding [GO:0046872]; ubiquitin-protein transferase activity [GO:0004842]	activation of NF-kappaB-inducing kinase activity [GO:0007250]; protein K63-linked ubiquitination [GO:0070534]; regulation of transcription by RNA polymerase II [GO:0006357]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=ZFP91&keywords=ZFP91	36.78453820224719	117	31687.7	30	0.8877377070026007	287	0.03937007874015748	0.2889221556886256	0.09070796460177001	0.19472422062350164	0.15993265993265998	0.1759729272419626	0.16772438803263778	0.07830342577487774	0.10506844247132778	0.11660435305114007	0.08920224067992717	120	97	120	0.13695753243987163	0.7830047263375803	0.8615029862653745	0.6750401904068185	226	184	246
ZP3	zona pellucida glycoprotein 3	TBD		ENSG00000188372	P21754	ZP domain family, ZPC subfamily	9	ecm, ligand, receptor	cell_surface, ecm, extracellular, ligand, plasma_membrane, plasma_membrane_transmembrane, receptor, secreted, transmembrane, transmembrane_predicted	P00533, P36544, Q12866	CHRNA7, EGFR, MERTK	EGFR [CellTalkDB:22577141;connectomeDB2020:22577141], CHRNA7 [connectomeDB2020:22577141], MERTK [Baccin2019:7541556;Cellinker:7541556;LRdb:7541556;connectomeDB2020:7541556]	collagen-containing extracellular matrix [GO:0062023]; egg coat [GO:0035805]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]	acrosin binding [GO:0032190]; carbohydrate binding [GO:0030246]; extracellular matrix structural constituent [GO:0005201]; identical protein binding [GO:0042802]; receptor ligand activity [GO:0048018]; structural constituent of egg coat [GO:0035804]	binding of sperm to zona pellucida [GO:0007339]; blastocyst formation [GO:0001825]; egg coat formation [GO:0035803]; humoral immune response mediated by circulating immunoglobulin [GO:0002455]; negative regulation of binding of sperm to zona pellucida [GO:2000360]; negative regulation of transcription, DNA-templated [GO:0045892]; oocyte development [GO:0048599]; positive regulation of acrosomal vesicle exocytosis [GO:2000368]; positive regulation of acrosome reaction [GO:2000344]; positive regulation of antral ovarian follicle growth [GO:2000388]; positive regulation of humoral immune response [GO:0002922]; positive regulation of inflammatory response [GO:0050729]; positive regulation of interferon-gamma production [GO:0032729]; positive regulation of interleukin-4 production [GO:0032753]; positive regulation of leukocyte migration [GO:0002687]; positive regulation of ovarian follicle development [GO:2000386]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of transcription, DNA-templated [GO:0045893]; positive regulation of type IV hypersensitivity [GO:0001809]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=ZP3&keywords=ZP3	4.482663708205221	300	NA	NA	2.5065057853244626	128	0.047244094488188976	0.001497005988023952	0.008849557522123894	0.013429256594724217	0.011784511784511783	0.013536379018612519	0.004533091568449683	0.013050570962479609	0.005919348871624123	0.0049071972225931265	0.009658103148541597	284	293	249	0.01221901065180668	0.7164742445600152	0.6709208369446903	0.8847425052628592	255	264	151
ZPBP2	zona pellucida binding protein 2	No		ENSG00000186075	Q6X784	Zona pellucida-binding protein Sp38 family	1	ligand	intracellular, ligand, secreted	P33681	CD80	CD80 [Cellinker:32822567]	acrosomal vesicle [GO:0001669]; cell body [GO:0044297]; extracellular region [GO:0005576]; nucleus [GO:0005634]; zona pellucida receptor complex [GO:0002199]	NA	acrosome assembly [GO:0001675]; binding of sperm to zona pellucida [GO:0007339]; circadian regulation of gene expression [GO:0032922]; membrane lipid catabolic process [GO:0046466]; negative regulation of immunoglobulin production [GO:0002638]; sphingolipid metabolic process [GO:0006665]	https://www.genecards.org/cgi-bin/carddisp.pl?gene=ZPBP2&keywords=ZPBP2	0.11967430337078652	660	NA	NA	0.044885450809859805	720	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
